data_2jwn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jwn _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.525 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 7.8 mm-40 . . . . . 0 C--O 1.221 -0.401 0 CA-C-O 120.341 0.115 . . . . 71.439999999999998 111.163 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.4 pt -70.89 -35.91 61.89 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 C-N-CA 120.763 -0.375 . . . . 63.210000000000001 111.863 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.316 2.1 p30 -76.53 -27.84 56.11 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 118.929 -1.108 . . . . 71.329999999999998 112.208 178.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -65.6 -19.3 65.86 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-O 121.364 0.602 . . . . 74.430000000000007 111.318 174.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 12.6 ptp180 -125.06 25.87 7.13 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-O 122.07 0.938 . . . . 71.340000000000003 109.624 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.553 ' OG ' ' HG2' ' A' ' 84' ' ' GLU . 39.6 t -104.2 157.23 17.27 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.332 -1.304 . . . . 62.109999999999999 110.331 177.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.464 HG23 HG21 ' A' ' 91' ' ' VAL . 17.0 t -131.07 157.04 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 N-CA-C 107.963 -1.125 . . . . 73.219999999999999 107.963 -177.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.679 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 25.6 t80 -107.19 125.63 51.36 Favored 'General case' 0 C--N 1.279 -2.5 0 N-CA-C 106.398 -1.705 . . . . 74.409999999999997 106.398 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.445 ' HA ' HG11 ' A' ' 109' ' ' VAL . 62.6 t -116.7 107.8 23.38 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.137 0 N-CA-C 106.656 -1.609 . . . . 75.299999999999997 106.656 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.483 ' HA3' ' CZ ' ' A' ' 40' ' ' TYR . . . -117.04 172.56 14.3 Favored Glycine 0 C--N 1.275 -2.812 0 C-N-CA 117.734 -2.174 . . . . 75.450000000000003 113.652 -176.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.1 t30 57.73 11.67 1.4 Allowed 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 125.003 1.321 . . . . 74.099999999999994 112.92 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.7 p -55.45 142.79 9.38 Favored 'Isoleucine or valine' 0 C--O 1.246 0.906 0 CA-C-O 121.376 0.608 . . . . 74.349999999999994 109.858 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -77.6 150.05 34.71 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 107.737 -1.209 . . . . 60.43 107.737 -177.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -62.12 -20.85 64.5 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 123.886 0.741 . . . . 74.25 110.075 -176.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.16 -23.61 71.51 Favored Glycine 0 N--CA 1.424 -2.163 0 CA-C-N 115.52 -0.763 . . . . 37.920000000000002 112.82 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 72.9 m -100.97 75.6 1.69 Allowed 'General case' 0 N--CA 1.427 -1.594 0 C-N-CA 118.667 -1.213 . . . . 61.32 113.264 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.9 p -71.71 -178.0 2.1 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 116.199 -0.455 . . . . 53.420000000000002 111.93 170.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.02 -51.09 32.95 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.469 1.285 . . . . 71.239999999999995 114.469 -165.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.523 ' HG2' ' CE2' ' B' ' 46' ' ' TYR . 50.5 mt-30 -56.77 -51.88 67.19 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.441 0.534 . . . . 73.450000000000003 112.441 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -68.48 -39.19 81.44 Favored 'General case' 0 C--O 1.256 1.407 0 CA-C-O 121.591 0.71 . . . . 73.299999999999997 110.657 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.21 -46.69 73.09 Favored 'General case' 0 C--O 1.259 1.583 0 CA-C-N 114.673 -1.148 . . . . 74.239999999999995 109.061 -175.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -58.9 -40.94 86.0 Favored 'General case' 0 C--O 1.187 -2.191 0 N-CA-C 112.331 0.493 . . . . 64.109999999999999 112.331 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.56 -44.04 72.56 Favored 'General case' 0 C--O 1.266 1.926 0 CA-C-O 121.285 0.564 . . . . 64.299999999999997 111.717 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -64.82 -40.65 95.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.197 -0.911 . . . . 73.439999999999998 110.386 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -82.34 -22.76 35.42 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.028 1.122 . . . . 70.010000000000005 114.028 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.0 t -68.64 -24.69 64.58 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.01 -0.737 . . . . 72.150000000000006 109.01 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.0 m -66.31 -22.68 66.29 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 120.605 -0.438 . . . . 73.129999999999995 111.099 173.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 67.6 m -97.19 7.74 45.96 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.42 0.526 . . . . 71.329999999999998 112.42 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.21 -163.41 27.78 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 119.055 -1.545 . . . . 52.329999999999998 114.286 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.7 p -106.12 127.44 53.2 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.219 0.533 . . . . 73.109999999999999 111.236 -177.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.3 mt -86.87 133.93 28.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.683 -0.69 . . . . 53.350000000000001 112.14 -177.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.518 ' OD1' ' HG3' ' A' ' 65' ' ' ARG . 24.0 t-20 -96.99 -47.99 5.58 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.389 -0.823 . . . . 71.409999999999997 109.695 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.518 ' HG3' ' OD1' ' A' ' 64' ' ' ASN . 54.1 mtp180 -151.58 159.44 44.09 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.359 -0.978 . . . . 74.450000000000003 108.359 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 30.5 pt -146.36 141.87 21.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 107.921 -1.14 . . . . 72.439999999999998 107.921 174.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.0 m -127.37 125.4 40.63 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 107.38 -1.341 . . . . 74.340000000000003 107.38 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.469 HD13 ' O ' ' B' ' 68' ' ' ILE . 2.9 mp -122.37 125.45 72.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.272 -1.381 . . . . 61.039999999999999 107.272 -176.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.415 HD13 ' NH2' ' B' ' 65' ' ' ARG . 1.6 pt? -119.68 130.35 55.0 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 120.309 -0.556 . . . . 74.040000000000006 110.925 176.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.675 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 62.7 m -116.69 127.61 54.58 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.934 -0.576 . . . . 73.329999999999998 109.459 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -109.86 128.86 55.6 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.986 -0.686 . . . . 64.140000000000001 111.057 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' B' ' 64' ' ' ASN . 52.0 mttm -99.84 8.9 43.82 Favored 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 123.438 0.695 . . . . 75.450000000000003 110.213 173.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.599 ' CE2' ' HD2' ' B' ' 65' ' ' ARG . 7.6 m-85 -57.7 -25.87 60.93 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 121.58 0.705 . . . . 74.140000000000001 109.361 170.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.456 ' C ' ' H ' ' A' ' 76' ' ' HIS . 19.4 m -89.49 6.48 40.71 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 114.913 -1.04 . . . . 62.0 111.229 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.84 -52.94 4.67 Favored Glycine 0 N--CA 1.475 1.3 0 N-CA-C 110.488 -1.045 . . . . 65.019999999999996 110.488 -177.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.456 ' H ' ' C ' ' A' ' 74' ' ' SER . 53.9 m80 -96.7 130.88 29.26 Favored Pre-proline 0 C--N 1.289 -2.043 0 N-CA-C 106.867 -1.531 . . . . 75.299999999999997 106.867 174.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.69 120.32 7.25 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 122.007 1.805 . . . . 75.200000000000003 111.252 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.675 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 15.1 mtmm -102.97 152.93 20.74 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.324 -1.361 . . . . 62.409999999999997 107.324 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.439 ' C ' ' HD1' ' A' ' 80' ' ' TYR . . . -120.48 137.28 12.02 Favored Glycine 0 N--CA 1.417 -2.632 0 C-N-CA 119.027 -1.558 . . . . 62.299999999999997 112.979 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.439 ' HD1' ' C ' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -129.06 142.23 50.97 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 102.743 -3.058 . . . . 72.219999999999999 102.743 172.373 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -140.47 141.89 35.37 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-N 119.042 0.837 . . . . 63.210000000000001 110.63 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.432 ' CD1' ' HD3' ' A' ' 112' ' ' LYS . 44.0 m-85 -110.07 117.2 33.1 Favored 'General case' 0 C--N 1.275 -2.632 0 N-CA-C 107.241 -1.392 . . . . 75.109999999999999 107.241 175.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 25.1 mm -102.98 121.17 53.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 107.347 -1.353 . . . . 74.310000000000002 107.347 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.553 ' HG2' ' OG ' ' A' ' 38' ' ' SER . 28.7 mt-10 -108.16 119.53 39.76 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.512 -0.922 . . . . 73.329999999999998 108.512 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -93.38 165.47 12.76 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.529 0.681 . . . . 75.409999999999997 112.819 -175.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.76 -37.81 64.9 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.065 -0.97 . . . . 74.299999999999997 111.011 174.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -118.63 158.61 25.15 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.126 1.158 . . . . 71.519999999999996 114.126 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -71.93 -26.47 62.31 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 114.701 -1.136 . . . . 54.450000000000003 110.778 175.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -60.21 -41.98 94.2 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.859 -0.61 . . . . 73.230000000000004 110.034 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.0 m -69.73 -39.7 76.65 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 115.603 -0.726 . . . . 40.100000000000001 111.765 -173.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.464 HG21 HG23 ' A' ' 39' ' ' VAL . 8.3 p -64.86 -39.22 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 120.33 -0.548 . . . . 75.340000000000003 109.807 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.68 -34.66 74.27 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.715 0.769 . . . . 73.019999999999996 109.928 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.75 -31.8 63.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.261 -0.881 . . . . 63.329999999999998 110.581 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.33 -45.05 33.96 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.088 -0.506 . . . . 51.229999999999997 110.57 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.1 m -59.44 -21.72 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 113.277 0.843 . . . . 73.019999999999996 113.277 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.97 -17.43 64.67 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.446 0.641 . . . . 75.120000000000005 110.61 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 71.8 mtm -94.98 9.96 37.4 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.562 -0.745 . . . . 70.299999999999997 110.129 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 2.2 p-10 -37.45 -47.53 0.89 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 116.418 2.007 . . . . 74.239999999999995 116.418 -174.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -115.47 30.68 7.2 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 118.95 0.795 . . . . 72.239999999999995 110.622 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.7 t -69.36 164.94 21.79 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-O 121.38 0.61 . . . . 72.230000000000004 110.056 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -109.13 132.13 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.936 0 N-CA-C 107.968 -1.123 . . . . 74.340000000000003 107.968 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -138.04 126.27 23.04 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 116.153 -0.476 . . . . 75.400000000000006 110.23 -174.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 55.54 32.44 19.09 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.845 1.258 . . . . 64.120000000000005 111.256 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.25 -10.58 72.59 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 114.237 -1.347 . . . . 61.020000000000003 113.202 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -113.16 150.65 31.93 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.828 -0.434 . . . . 74.209999999999994 109.828 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.4 m -86.6 123.16 31.48 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.252 -1.018 . . . . 72.450000000000003 108.252 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 44.4 pt -101.6 171.61 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.782 -0.767 . . . . 72.310000000000002 109.541 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 55.6 tptt -132.36 124.76 29.37 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.674 -0.491 . . . . 75.340000000000003 109.674 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 30.2 m -127.78 123.88 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 121.337 0.589 . . . . 75.209999999999994 111.317 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.57 163.69 26.45 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 106.65 -1.611 . . . . 71.519999999999996 106.65 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.83 149.2 86.84 Favored 'Trans proline' 0 N--CA 1.478 0.6 0 C-N-CA 121.839 1.692 . . . . 54.420000000000002 112.046 -174.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.475 ' HE3' ' OG ' ' A' ' 38' ' ' SER . 25.5 ttpp . . . . . 0 N--CA 1.437 -1.108 0 CA-C-O 122.518 1.151 . . . . 74.040000000000006 112.109 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.375 0 N-CA-C 109.655 -1.378 . . . . 73.010000000000005 109.655 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.477 ' N ' ' HD2' ' B' ' 23' ' ' PRO . 33.1 Cg_exo -58.36 -43.09 49.35 Favored 'Trans proline' 0 CA--C 1.574 2.505 0 C-N-CA 123.055 2.503 . . . . 71.109999999999999 114.169 174.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' B' ' 22' ' ' PRO . 7.1 Cg_endo -53.43 154.98 13.73 Favored 'Trans proline' 0 C--N 1.397 3.099 0 C-N-CA 122.525 2.15 . . . . 73.230000000000004 112.008 175.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -84.26 133.02 45.86 Favored Pre-proline 0 N--CA 1.41 -2.467 0 N-CA-C 107.697 -1.223 . . . . 71.209999999999994 107.697 177.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -61.39 138.6 77.58 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.351 2.034 . . . . 72.25 112.128 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.557 HD11 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -68.79 176.19 3.18 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.71 -0.677 . . . . 71.349999999999994 110.555 175.393 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 15.7 m -53.68 143.02 21.48 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.097 0.777 . . . . 52.140000000000001 113.097 -170.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.56 -43.21 75.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.758 -1.11 . . . . 72.140000000000001 112.13 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . 0.319 49.2 mt-10 -76.8 -29.66 56.09 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.966 1.099 . . . . 74.420000000000002 113.966 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.457 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.4 OUTLIER -57.02 -35.62 69.47 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.847 -0.797 . . . . 74.010000000000005 108.847 169.174 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -72.33 -39.64 68.04 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.097 -0.956 . . . . 61.130000000000003 110.715 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.655 ' HE2' ' N ' ' B' ' 32' ' ' LYS . 0.0 OUTLIER -65.38 -45.92 82.18 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 112.109 0.411 . . . . 75.150000000000006 112.109 178.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -64.5 -35.48 81.07 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 123.279 0.362 . . . . 74.239999999999995 111.773 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.457 HG12 ' O ' ' B' ' 30' ' ' GLU 0.301 20.0 pt -70.78 -34.04 54.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 112.401 0.519 . . . . 55.229999999999997 112.401 179.484 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -67.51 -43.34 81.1 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 121.941 0.877 . . . . 73.230000000000004 109.055 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -60.88 -19.8 60.85 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.957 -1.019 . . . . 75.340000000000003 111.141 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -112.21 11.64 20.28 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.353 -0.61 . . . . 72.450000000000003 109.353 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' SER . . . . . 0.508 ' OG ' ' HE3' ' B' ' 112' ' ' LYS . 31.4 t -99.08 151.17 21.25 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.679 0.752 . . . . 75.310000000000002 111.876 -177.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.427 HG23 HG21 ' B' ' 91' ' ' VAL . 10.5 t -129.09 158.9 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.079 0 N-CA-C 106.718 -1.586 . . . . 61.32 106.718 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . 0.671 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 36.7 t80 -110.0 125.44 52.9 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 106.353 -1.721 . . . . 73.319999999999993 106.353 174.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.443 ' HA ' HG11 ' B' ' 109' ' ' VAL . 59.9 t -117.22 106.91 21.01 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.098 0 N-CA-C 106.97 -1.493 . . . . 61.530000000000001 106.97 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.27 173.72 15.07 Favored Glycine 0 C--N 1.275 -2.842 0 C-N-CA 118.164 -1.97 . . . . 74.120000000000005 112.415 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.0 t30 62.25 6.0 1.72 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 124.842 1.257 . . . . 44.310000000000002 112.948 -177.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.9 p -61.57 131.24 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 107.274 -1.38 . . . . 55.43 107.274 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.511 ' OD1' ' HD2' ' B' ' 103' ' ' ARG . 3.6 p-10 -87.53 167.38 14.0 Favored 'General case' 0 N--CA 1.419 -1.977 0 C-N-CA 118.596 -1.242 . . . . 62.020000000000003 111.194 -172.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' TYR . . . . . 0.523 ' CE2' ' HG2' ' A' ' 51' ' ' GLN . 49.2 t80 -63.81 -12.19 33.58 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 113.981 -1.463 . . . . 72.420000000000002 111.189 -174.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.37 -23.6 67.69 Favored Glycine 0 N--CA 1.42 -2.431 0 CA-C-N 115.937 -0.574 . . . . 72.549999999999997 112.555 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.7 t -90.04 152.04 21.36 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 119.381 -0.927 . . . . 71.120000000000005 108.537 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' THR . . . . . 0.518 ' O ' ' HB2' ' B' ' 53' ' ' LEU . 32.8 p -133.21 178.33 6.98 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.883 -0.784 . . . . 74.120000000000005 108.883 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.495 ' HB3' HD13 ' B' ' 66' ' ' ILE . . . -57.15 -46.61 82.57 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.576 0.954 . . . . 61.310000000000002 113.576 -172.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -57.59 -52.2 66.39 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.088 0.47 . . . . 71.510000000000005 111.442 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -64.82 -40.04 94.56 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-N 115.518 -0.765 . . . . 54.020000000000003 110.767 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . 0.518 ' HB2' ' O ' ' B' ' 49' ' ' THR . 1.0 OUTLIER -67.3 -47.05 71.74 Favored 'General case' 0 C--O 1.255 1.386 0 CA-C-N 114.875 -1.057 . . . . 60.439999999999998 109.135 -177.3 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -58.93 -42.63 90.21 Favored 'General case' 0 C--O 1.188 -2.17 0 C-N-CA 120.671 -0.412 . . . . 73.239999999999995 111.932 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.1 -43.5 70.45 Favored 'General case' 0 C--O 1.266 1.955 0 O-C-N 123.196 0.31 . . . . 37.920000000000002 110.842 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -65.13 -41.51 94.76 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.073 -0.651 . . . . 71.319999999999993 110.534 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -82.32 -23.65 35.03 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 113.891 1.071 . . . . 72.200000000000003 113.891 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 34.5 t -71.26 -24.08 62.1 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 123.658 0.783 . . . . 74.030000000000001 108.947 -177.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 38.7 m -67.26 -24.71 65.82 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 115.56 -0.746 . . . . 73.5 109.899 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 61.5 m -106.59 14.37 27.11 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.554 0.576 . . . . 54.420000000000002 112.554 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . 0.435 ' HA3' ' OG ' ' B' ' 90' ' ' SER . . . 151.17 -174.96 30.29 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 118.953 -1.594 . . . . 75.340000000000003 115.158 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 46.7 m -105.35 120.0 40.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.422 0.629 . . . . 71.040000000000006 110.947 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 67.7 mt -83.23 131.28 34.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.609 -0.723 . . . . 71.510000000000005 112.553 -176.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 72' ' ' LYS . 43.3 t-20 -99.47 -42.32 7.0 Favored 'General case' 0 C--O 1.208 -1.1 0 CA-C-N 115.615 -0.72 . . . . 70.519999999999996 110.478 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.599 ' HD2' ' CE2' ' A' ' 73' ' ' PHE . 55.6 mtp180 -151.57 160.34 43.71 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.318 -0.993 . . . . 71.420000000000002 108.318 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.495 HD13 ' HB3' ' B' ' 50' ' ' ALA . 18.0 pt -148.23 141.47 18.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 107.869 -1.16 . . . . 50.119999999999997 107.869 176.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 47.9 m -127.73 126.44 41.83 Favored 'General case' 0 C--N 1.268 -2.942 0 N-CA-C 107.96 -1.126 . . . . 74.430000000000007 107.96 177.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.469 ' O ' HD13 ' A' ' 68' ' ' ILE . 2.3 mp -121.83 127.42 75.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 106.567 -1.642 . . . . 64.140000000000001 106.567 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -120.99 132.0 54.64 Favored 'General case' 0 C--N 1.286 -2.19 0 C-N-CA 119.801 -0.76 . . . . 74.439999999999998 110.52 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' CYS . . . . . 0.581 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 63.1 m -116.6 127.5 54.53 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 109.35 -0.611 . . . . 73.310000000000002 109.35 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -107.29 131.5 54.14 Favored 'General case' 0 CA--C 1.474 -1.956 0 C-N-CA 119.09 -1.044 . . . . 63.140000000000001 108.857 177.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' B' ' 77' ' ' PRO . 40.1 ttmt -125.16 7.42 7.87 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 109.158 -0.682 . . . . 74.340000000000003 109.158 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -69.64 -18.32 63.58 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.418 0.627 . . . . 72.099999999999994 110.247 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 22.5 p -84.26 1.98 42.2 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 114.85 -1.068 . . . . 71.549999999999997 109.955 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.46 -44.05 2.46 Favored Glycine 0 N--CA 1.439 -1.135 0 N-CA-C 110.733 -0.947 . . . . 60.420000000000002 110.733 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -95.85 128.1 38.74 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 108.096 -1.076 . . . . 70.209999999999994 108.096 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.474 ' HB3' ' HE2' ' B' ' 72' ' ' LYS . 94.2 Cg_endo -78.32 119.0 4.43 Favored 'Trans proline' 0 N--CA 1.434 -1.99 0 C-N-CA 121.298 1.332 . . . . 52.240000000000002 110.535 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' LYS . . . . . 0.581 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 1.2 mtpt -116.57 163.52 15.96 Favored 'General case' 0 CA--C 1.471 -2.095 0 CA-C-N 114.798 -1.092 . . . . 71.010000000000005 110.324 -174.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . 0.42 ' C ' ' HD1' ' B' ' 80' ' ' TYR . . . -134.2 137.84 9.61 Favored Glycine 0 N--CA 1.428 -1.838 0 C-N-CA 119.585 -1.293 . . . . 61.100000000000001 113.853 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . 0.42 ' HD1' ' C ' ' B' ' 79' ' ' GLY . 0.1 OUTLIER -130.77 142.6 50.41 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 102.794 -3.039 . . . . 74.430000000000007 102.794 172.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.81 141.79 36.7 Favored 'General case' 0 C--N 1.279 -2.467 0 CA-C-N 118.939 0.79 . . . . 63.420000000000002 110.486 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' TYR . . . . . 0.508 ' CD1' ' HG3' ' B' ' 112' ' ' LYS . 27.9 m-85 -109.51 117.18 33.31 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 106.793 -1.558 . . . . 71.340000000000003 106.793 175.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 33.0 mm -102.7 121.43 53.81 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 107.674 -1.232 . . . . 74.420000000000002 107.674 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' B' ' 38' ' ' SER . 31.1 mt-10 -108.07 119.3 39.09 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.704 -0.85 . . . . 72.420000000000002 108.704 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -95.31 164.58 12.77 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.408 0.623 . . . . 72.409999999999997 112.3 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.91 -30.33 31.93 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.194 -0.912 . . . . 62.350000000000001 111.864 176.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.02 147.62 42.18 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 114.79 1.404 . . . . 75.0 114.79 177.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.599 ' O ' HG12 ' B' ' 91' ' ' VAL . 20.4 mmm180 -64.25 -27.44 69.05 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.428 1.091 . . . . 73.230000000000004 110.279 175.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -58.44 -42.16 86.7 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.765 -0.652 . . . . 73.530000000000001 109.771 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' SER . . . . . 0.435 ' OG ' ' HA3' ' B' ' 61' ' ' GLY . 50.1 m -71.58 -37.32 71.04 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 113.082 0.771 . . . . 62.409999999999997 113.082 -173.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . 0.599 HG12 ' O ' ' B' ' 88' ' ' ARG . 12.3 p -65.48 -38.58 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 109.15 -0.685 . . . . 64.040000000000006 109.15 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -69.37 -35.81 76.2 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.612 0.72 . . . . 71.0 109.847 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.25 -31.85 64.36 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.374 -0.83 . . . . 63.310000000000002 110.554 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.31 -45.45 32.28 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.297 -0.41 . . . . 71.019999999999996 111.103 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 33.7 m -58.77 -22.23 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 112.874 0.694 . . . . 61.420000000000002 112.874 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.63 -13.0 61.7 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.371 0.605 . . . . 73.540000000000006 110.796 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 69.6 mtm -99.83 12.81 35.76 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.428 -0.805 . . . . 74.129999999999995 110.75 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . 0.446 ' HA ' HG22 ' B' ' 109' ' ' VAL . 3.9 p-10 -47.72 -40.47 20.46 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.054 0.761 . . . . 74.310000000000002 113.054 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -104.48 108.22 19.53 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 108.2 -1.037 . . . . 72.219999999999999 108.2 170.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 11.5 t -163.38 169.34 19.12 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.49 -0.93 . . . . 74.120000000000005 108.49 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.77 125.21 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 CA-C-O 121.606 0.717 . . . . 73.319999999999993 109.572 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' PHE . . . . . 0.407 ' O ' ' HG2' ' B' ' 105' ' ' ARG . 83.5 t80 -129.64 129.03 43.81 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.628 -0.879 . . . . 74.430000000000007 108.628 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' ARG . . . . . 0.511 ' HD2' ' OD1' ' B' ' 45' ' ' ASP . 24.2 ttm-85 55.57 31.91 18.09 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.541 1.136 . . . . 75.230000000000004 110.514 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.29 5.62 87.04 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 114.497 -1.229 . . . . 61.43 114.083 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' B' ' 102' ' ' PHE . 12.8 ptm180 -129.11 148.31 51.04 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 117.558 0.679 . . . . 73.450000000000003 110.262 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 37.2 m -80.76 120.98 25.34 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.725 -0.472 . . . . 74.310000000000002 109.725 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 34.7 pt -102.43 171.1 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 C-N-CA 120.352 -0.539 . . . . 73.439999999999998 110.393 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -128.61 125.16 37.6 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 109.267 -0.642 . . . . 75.150000000000006 109.267 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . 0.671 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 33.2 m -127.66 124.4 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-O 121.203 0.525 . . . . 73.299999999999997 111.727 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.02 164.05 24.11 Favored Pre-proline 0 C--O 1.197 -1.71 0 N-CA-C 106.916 -1.513 . . . . 71.349999999999994 106.916 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -66.45 143.82 70.96 Favored 'Trans proline' 0 CA--C 1.568 2.195 0 C-N-CA 122.182 1.921 . . . . 73.439999999999998 114.328 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.508 ' HE3' ' OG ' ' B' ' 38' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.83 0 C-N-CA 123.125 0.57 . . . . 73.129999999999995 109.83 -177.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 120.964 0.411 . . . . 71.400000000000006 111.06 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.8 pt -70.77 -33.42 52.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.705 -0.68 . . . . 65.129999999999995 110.566 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -56.13 -44.57 79.28 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.46 1.104 . . . . 74.0 109.654 175.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -55.56 -29.67 59.41 Favored 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 115.19 -0.914 . . . . 74.540000000000006 112.888 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' A' ' 86' ' ' ALA . 17.4 ptp180 -119.53 18.03 12.83 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 121.45 0.643 . . . . 63.219999999999999 111.566 -172.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.433 ' OG ' ' HG2' ' A' ' 84' ' ' GLU . 47.2 t -107.57 169.15 8.76 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.788 -0.642 . . . . 72.019999999999996 111.249 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.509 ' CG1' HG23 ' A' ' 91' ' ' VAL . 11.2 m -140.33 163.72 23.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 124.496 1.118 . . . . 71.219999999999999 111.488 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.417 ' CE2' ' HG2' ' B' ' 22' ' ' PRO . 21.4 t80 -116.26 129.7 56.41 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 125.227 1.411 . . . . 72.439999999999998 109.608 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 63.0 t -109.12 117.49 54.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.744 -1.206 . . . . 62.340000000000003 107.744 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.04 163.75 12.13 Favored Glycine 0 N--CA 1.426 -2.01 0 C-N-CA 119.522 -1.323 . . . . 60.210000000000001 113.055 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.9 t30 63.38 13.06 6.76 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.895 1.678 . . . . 63.450000000000003 112.883 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.9 p -64.49 137.62 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.452 0.644 . . . . 71.420000000000002 109.533 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -91.09 159.02 16.32 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.394 -0.821 . . . . 65.25 111.435 -174.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 77' ' ' PRO . 4.5 m-85 -61.09 -19.16 61.12 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 114.951 -1.022 . . . . 72.120000000000005 112.013 178.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.86 -24.11 77.34 Favored Glycine 0 N--CA 1.428 -1.856 0 CA-C-N 115.88 -0.6 . . . . 73.5 111.727 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.5 m -86.32 140.01 30.46 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 120.581 -0.447 . . . . 74.519999999999996 109.844 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 76.0 p -109.15 173.25 6.4 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.119 -0.492 . . . . 72.230000000000004 110.778 -176.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.19 -45.27 77.42 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 110.062 -0.348 . . . . 72.510000000000005 110.062 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -58.49 -42.28 87.22 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.472 -0.331 . . . . 73.099999999999994 111.229 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.474 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 1.4 t70 -64.35 -37.9 89.13 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.689 0.757 . . . . 72.340000000000003 109.02 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 33.7 mt -68.51 -47.93 65.71 Favored 'General case' 0 C--O 1.249 1.038 0 CA-C-N 114.965 -1.016 . . . . 75.400000000000006 111.096 177.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -60.81 -49.8 76.03 Favored 'General case' 0 C--O 1.198 -1.654 0 CA-C-N 116.355 -0.384 . . . . 64.439999999999998 111.144 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.49 -40.08 77.84 Favored 'General case' 0 C--O 1.258 1.53 0 CA-C-O 121.367 0.603 . . . . 75.25 111.184 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -69.02 -41.09 78.2 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.154 -0.93 . . . . 61.140000000000001 110.715 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -82.66 -22.85 34.46 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 113.055 0.761 . . . . 75.319999999999993 113.055 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.7 m -72.11 -21.23 61.51 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-N 115.19 -0.914 . . . . 75.349999999999994 110.979 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.1 m -57.68 -17.78 16.92 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.388 -0.369 . . . . 53.200000000000003 111.161 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.86 ' SG ' ' HA ' ' A' ' 90' ' ' SER . 44.1 t -94.4 -76.56 0.48 Allowed 'General case' 0 N--CA 1.417 -2.08 0 CA-C-O 120.789 0.328 . . . . 54.210000000000001 110.638 175.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -130.06 -143.33 5.38 Favored Glycine 0 CA--C 1.508 -0.351 0 C-N-CA 120.257 -0.973 . . . . 54.450000000000003 115.217 -176.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.0 m -105.13 121.51 43.96 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 122.437 0.295 . . . . 74.040000000000006 110.991 -173.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 61.2 mt -85.22 129.27 38.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 116.028 -0.533 . . . . 64.310000000000002 112.014 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -93.4 -44.75 8.12 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.51 0.724 . . . . 75.439999999999998 111.504 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -149.12 159.55 44.14 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.216 -0.902 . . . . 75.140000000000001 110.27 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.435 HG21 HD13 ' A' ' 66' ' ' ILE . 39.4 pt -145.34 135.0 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.994 0 N-CA-C 106.753 -1.573 . . . . 73.319999999999993 106.753 170.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.0 m -124.78 123.8 40.75 Favored 'General case' 0 C--N 1.272 -2.799 0 N-CA-C 106.112 -1.81 . . . . 75.510000000000005 106.112 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.6 mp -121.24 117.39 52.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 106.562 -1.644 . . . . 72.329999999999998 106.562 -175.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.35 0.9 OUTLIER -121.32 129.83 53.31 Favored 'General case' 0 C--N 1.274 -2.676 0 C-N-CA 120.127 -0.629 . . . . 74.329999999999998 112.558 177.763 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.504 ' HB2' HG12 ' B' ' 66' ' ' ILE . 81.0 m -116.55 121.21 41.1 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 115.647 -0.706 . . . . 74.349999999999994 109.256 -177.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.555 ' HA ' ' HA ' ' B' ' 65' ' ' ARG . 1.1 t70 -117.48 125.45 50.92 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 123.757 0.823 . . . . 70.140000000000001 110.586 -173.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.458 ' HE2' ' HB3' ' A' ' 77' ' ' PRO . 39.6 ttmt -115.9 16.73 16.17 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.224 -0.658 . . . . 73.5 109.224 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.426 ' HD1' ' N ' ' A' ' 74' ' ' SER . 0.0 OUTLIER -63.61 -23.15 67.26 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 119.934 -0.706 . . . . 74.5 112.817 -175.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.426 ' N ' ' HD1' ' A' ' 73' ' ' PHE . 14.9 m -81.79 -0.9 45.32 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.154 -0.475 . . . . 62.32 111.134 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.9 -40.57 2.38 Favored Glycine 0 CA--C 1.5 -0.881 0 N-CA-C 110.095 -1.202 . . . . 75.329999999999998 110.095 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -95.14 130.28 33.0 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 107.923 -1.14 . . . . 65.430000000000007 107.923 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.458 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 36.8 Cg_endo -70.74 118.07 5.49 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.387 1.392 . . . . 72.319999999999993 110.505 177.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -108.61 151.45 26.11 Favored 'General case' 0 CA--C 1.476 -1.898 0 CA-C-N 116.242 -0.436 . . . . 72.200000000000003 109.943 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.42 140.07 11.5 Favored Glycine 0 N--CA 1.409 -3.159 0 C-N-CA 120.517 -0.849 . . . . 72.209999999999994 111.025 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -151.41 144.13 24.37 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.788 -0.449 . . . . 73.510000000000005 109.788 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.42 154.81 49.89 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.968 -0.382 . . . . 74.420000000000002 109.968 -173.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -122.39 120.57 34.37 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 108.544 -0.91 . . . . 75.230000000000004 108.544 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.5 mm -101.73 119.22 49.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 107.17 -1.418 . . . . 74.140000000000001 107.17 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.433 ' HG2' ' OG ' ' A' ' 38' ' ' SER . 32.9 mt-10 -104.97 120.47 41.53 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.157 -0.682 . . . . 55.109999999999999 109.157 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -100.38 165.44 11.45 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 121.378 0.609 . . . . 65.140000000000001 112.055 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.456 ' O ' ' HD3' ' A' ' 37' ' ' ARG . . . -81.16 -32.37 33.67 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.728 -1.124 . . . . 51.240000000000002 110.965 175.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -123.5 160.67 26.46 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 113.246 0.832 . . . . 74.030000000000001 113.246 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -69.54 -32.48 71.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.359 -1.291 . . . . 75.239999999999995 112.279 174.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -60.74 -36.56 79.19 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.948 -0.301 . . . . 73.510000000000005 110.702 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.86 ' HA ' ' SG ' ' A' ' 60' ' ' CYS . 14.8 m -63.33 -45.2 92.34 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 116.574 -0.284 . . . . 61.350000000000001 111.403 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.509 HG23 ' CG1' ' A' ' 39' ' ' VAL . 0.6 OUTLIER -65.7 -43.2 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 119.317 -0.373 . . . . 73.340000000000003 111.71 177.54 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.2 -35.28 75.04 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.687 0.625 . . . . 73.239999999999995 112.687 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.557 ' HB2' ' SG ' ' A' ' 60' ' ' CYS . . . -75.34 -37.89 60.46 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.122 0.486 . . . . 64.209999999999994 110.954 177.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.51 -40.64 76.83 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 116.086 -0.507 . . . . 73.219999999999999 111.861 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 91' ' ' VAL . 24.5 m -56.64 -22.16 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 112.282 0.475 . . . . 62.310000000000002 112.282 177.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.89 -19.38 62.62 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-O 120.894 0.378 . . . . 64.510000000000005 110.043 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 32.4 mtm -88.46 7.68 31.67 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.202 0.601 . . . . 75.400000000000006 111.935 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 7.3 t70 -33.39 -54.11 0.41 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 116.938 2.199 . . . . 55.329999999999998 116.938 -178.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -124.42 45.37 2.53 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 120.495 1.498 . . . . 74.329999999999998 110.125 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 42.9 m -84.95 162.37 19.44 Favored 'General case' 0 CA--C 1.571 1.759 0 CA-C-N 114.3 -1.318 . . . . 63.200000000000003 109.752 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.0 p -99.71 137.86 25.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 O-C-N 121.465 -0.772 . . . . 72.200000000000003 110.646 -174.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -151.2 117.87 5.77 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.467 -0.938 . . . . 65.219999999999999 108.467 -177.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.381 83.2 mtt85 59.99 55.09 3.92 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 116.078 1.881 . . . . 71.230000000000004 116.078 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.99 -13.05 1.45 Allowed Glycine 0 N--CA 1.469 0.856 0 CA-C-N 114.806 -1.088 . . . . 44.200000000000003 114.893 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -119.39 161.08 21.09 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-O 121.012 0.434 . . . . 71.450000000000003 110.383 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.9 m -94.59 127.81 40.78 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 108.366 -0.975 . . . . 72.219999999999999 108.366 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 48.2 pt -101.37 171.27 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.334 0 C-N-CA 119.782 -0.767 . . . . 75.25 109.949 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 55.1 tptt -125.88 129.35 49.17 Favored 'General case' 0 N--CA 1.409 -2.522 0 CA-C-N 114.791 -1.095 . . . . 64.109999999999999 108.809 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.456 ' HB ' ' HA ' ' A' ' 98' ' ' ASP . 47.3 t -119.95 112.25 36.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 107.658 -1.238 . . . . 72.409999999999997 107.658 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 72.8 mt -112.4 152.59 44.67 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 109.017 -0.734 . . . . 75.200000000000003 109.017 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.42 ' HA ' HG13 ' A' ' 39' ' ' VAL . 3.3 Cg_exo -75.44 129.9 12.36 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 N-CA-C 107.892 -1.618 . . . . 52.409999999999997 107.892 171.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 87.1 tttt . . . . . 0 CA--C 1.487 -1.446 0 N-CA-C 107.584 -1.265 . . . . 71.239999999999995 107.584 -178.516 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.411 0 N-CA-C 112.141 -0.384 . . . . 51.229999999999997 112.141 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.438 ' N ' ' HD2' ' B' ' 23' ' ' PRO . 72.1 Cg_exo -49.74 -44.9 34.19 Favored 'Trans proline' 0 CA--C 1.567 2.125 0 C-N-CA 123.871 3.048 . . . . 73.019999999999996 116.031 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' B' ' 22' ' ' PRO . 10.3 Cg_endo -53.84 142.2 63.82 Favored 'Trans proline' 0 C--N 1.395 2.975 0 C-N-CA 121.96 1.774 . . . . 75.049999999999997 111.36 176.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -54.16 129.16 58.84 Favored Pre-proline 0 C--O 1.241 0.63 0 N-CA-C 113.454 0.909 . . . . 71.420000000000002 113.454 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -59.99 135.51 63.38 Favored 'Trans proline' 0 CA--C 1.501 -1.155 0 C-N-CA 123.641 2.894 . . . . 55.020000000000003 114.139 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.452 HD22 ' O ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -113.92 125.89 54.54 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 107.037 -1.468 . . . . 73.109999999999999 107.037 173.346 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 32.8 t -71.84 173.94 7.58 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 113.479 0.918 . . . . 72.019999999999996 113.479 -168.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.512 ' O ' ' HG3' ' B' ' 32' ' ' LYS . . . -49.0 -46.17 43.54 Favored 'General case' 0 C--O 1.21 -0.982 0 CA-C-N 114.491 -1.231 . . . . 72.299999999999997 112.288 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -68.0 -33.01 73.8 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 112.054 0.39 . . . . 72.329999999999998 112.054 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.444 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.9 OUTLIER -65.71 -39.42 91.2 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.446 -0.576 . . . . 60.020000000000003 109.446 172.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -67.06 -36.87 82.98 Favored 'General case' 0 C--O 1.207 -1.149 0 CA-C-N 115.573 -0.739 . . . . 74.010000000000005 110.087 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' B' ' 28' ' ' ALA . 59.9 mtpt -66.35 -40.24 89.69 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 113.497 0.925 . . . . 75.530000000000001 113.497 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -70.08 -39.77 75.39 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 120.299 -0.56 . . . . 73.5 111.281 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.444 HG12 ' O ' ' B' ' 30' ' ' GLU . 11.1 pt -70.57 -32.99 51.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.785 -0.643 . . . . 63.210000000000001 110.328 178.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.433 ' HB3' ' O ' ' B' ' 32' ' ' LYS . 10.4 t70 -56.35 -42.96 78.6 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.827 1.251 . . . . 72.400000000000006 109.699 176.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 97.7 mttt -57.64 -33.28 68.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.05 -0.977 . . . . 64.219999999999999 112.015 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -102.89 2.55 35.42 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 123.713 0.805 . . . . 73.420000000000002 111.23 -172.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 71.1 p -104.33 162.94 12.79 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 114.51 1.3 . . . . 62.229999999999997 114.51 -175.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 13.9 m -133.4 163.61 37.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.674 -1.148 . . . . 43.509999999999998 111.08 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . 0.437 ' CD2' HD12 ' B' ' 110' ' ' LEU . 23.1 t80 -116.17 130.53 56.84 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 125.281 1.432 . . . . 74.109999999999999 109.346 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 71.7 t -109.89 120.49 61.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 124.766 1.226 . . . . 41.109999999999999 109.06 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -118.59 169.38 13.44 Favored Glycine 0 N--CA 1.427 -1.95 0 C-N-CA 120.139 -1.029 . . . . 41.119999999999997 112.453 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 60.6 t30 65.97 12.54 8.5 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 126.451 1.901 . . . . 75.230000000000004 112.834 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -72.09 117.43 15.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 108.218 -1.03 . . . . 63.200000000000003 108.218 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -77.04 162.0 27.86 Favored 'General case' 0 C--O 1.253 1.288 0 C-N-CA 119.941 -0.703 . . . . 73.129999999999995 111.611 -173.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -69.01 98.52 0.97 Allowed 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 107.21 -1.404 . . . . 74.349999999999994 107.21 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 159.15 -26.08 0.36 Allowed Glycine 0 N--CA 1.417 -2.574 0 C-N-CA 120.539 -0.838 . . . . 61.210000000000001 112.051 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.7 t -77.18 149.46 35.57 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.7 -1.222 . . . . 74.25 107.7 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 25.2 p -99.55 167.54 10.53 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.444 -0.502 . . . . 74.120000000000005 110.883 -173.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.403 ' HB3' HD12 ' B' ' 66' ' ' ILE . . . -71.04 -41.78 70.34 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 109.102 -0.703 . . . . 74.150000000000006 109.102 177.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -57.39 -44.16 84.25 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.136 -0.484 . . . . 75.340000000000003 111.094 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.88 -45.95 78.45 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.133 0.492 . . . . 64.219999999999999 110.381 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 74.6 mt -64.26 -47.68 78.69 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.094 -0.957 . . . . 73.430000000000007 111.862 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -62.92 -50.85 69.22 Favored 'General case' 0 C--O 1.199 -1.59 0 C-N-CA 120.498 -0.481 . . . . 73.430000000000007 111.372 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.97 -40.08 72.73 Favored 'General case' 0 C--O 1.257 1.467 0 CA-C-O 121.594 0.711 . . . . 73.239999999999995 111.454 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -69.35 -41.56 76.45 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.78 -1.1 . . . . 73.450000000000003 110.542 -176.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -83.06 -23.19 33.27 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.903 0.705 . . . . 73.340000000000003 112.903 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 67.1 m -71.32 -22.72 61.89 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 115.472 -0.785 . . . . 71.540000000000006 109.534 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 58.3 m -65.84 -18.12 65.12 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.739 -0.664 . . . . 62.299999999999997 109.96 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . 0.574 ' O ' ' HA ' ' B' ' 90' ' ' SER . 70.3 m -115.29 19.18 15.74 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 116.245 -0.434 . . . . 54.25 111.669 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . 0.418 ' HA3' ' OG ' ' B' ' 90' ' ' SER . . . 149.03 -162.64 28.99 Favored Glycine 0 N--CA 1.46 0.284 0 C-N-CA 118.282 -1.913 . . . . 72.040000000000006 116.034 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 15.1 m -111.1 115.1 28.86 Favored 'General case' 0 C--O 1.25 1.092 0 C-N-CA 123.018 0.527 . . . . 71.140000000000001 110.399 -175.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 65.5 mt -80.73 130.85 35.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.668 0.747 . . . . 71.450000000000003 112.995 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -100.31 -43.81 6.14 Favored 'General case' 0 C--O 1.21 -1.001 0 N-CA-C 107.09 -1.448 . . . . 61.25 107.09 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.555 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 86.4 mtt180 -153.64 161.88 41.76 Favored 'General case' 0 C--O 1.21 -1.014 0 C-N-CA 123.732 0.813 . . . . 75.409999999999997 110.384 176.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' B' ' 82' ' ' TYR . 31.9 pt -144.79 137.81 22.15 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.495 0 N-CA-C 106.656 -1.609 . . . . 73.319999999999993 106.656 169.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' B' ' 81' ' ' ALA . 53.3 m -125.75 120.82 31.64 Favored 'General case' 0 C--N 1.273 -2.745 0 N-CA-C 106.912 -1.514 . . . . 63.329999999999998 106.912 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mp -117.08 116.72 52.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 106.278 -1.749 . . . . 72.310000000000002 106.278 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.306 1.5 pt? -122.12 132.69 54.61 Favored 'General case' 0 C--N 1.275 -2.669 0 C-N-CA 119.666 -0.814 . . . . 73.040000000000006 111.531 176.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 73.5 m -116.68 120.5 38.82 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 115.108 -0.951 . . . . 54.43 108.592 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . 0.407 ' HB2' ' CE2' ' B' ' 73' ' ' PHE . 2.4 p-10 -106.14 121.66 44.62 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 116.513 -2.075 . . . . 71.430000000000007 111.061 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . 0.407 ' HG2' ' HB3' ' B' ' 77' ' ' PRO . 43.8 mtpt -118.05 -6.79 10.91 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.446 -1.252 . . . . 74.099999999999994 111.157 -176.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.407 ' CE2' ' HB2' ' B' ' 71' ' ' ASP . 52.6 p90 -69.93 -17.2 63.31 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.556 0.693 . . . . 71.239999999999995 109.837 -177.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 20.1 m -81.21 -1.78 46.12 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.283 -0.871 . . . . 71.310000000000002 109.692 176.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.26 -59.66 0.37 Allowed Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 110.979 -0.849 . . . . 65.239999999999995 110.979 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . 0.428 ' HA ' ' HD3' ' B' ' 77' ' ' PRO . 72.5 m80 -96.5 131.15 28.9 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 110.167 -0.308 . . . . 74.450000000000003 110.167 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' B' ' 76' ' ' HIS . 13.6 Cg_exo -72.87 119.28 5.98 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.589 2.193 . . . . 51.450000000000003 112.616 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 37.1 mtmm -112.31 154.83 25.08 Favored 'General case' 0 CA--C 1.48 -1.732 0 N-CA-C 108.069 -1.086 . . . . 72.299999999999997 108.069 174.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.56 141.13 12.29 Favored Glycine 0 N--CA 1.411 -3.027 0 C-N-CA 119.612 -1.28 . . . . 74.310000000000002 112.325 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -154.61 145.33 22.4 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.001 -0.599 . . . . 74.519999999999996 109.634 175.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' B' ' 67' ' ' THR . . . -137.69 154.98 49.59 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 116.216 -0.447 . . . . 72.150000000000006 110.381 -172.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' B' ' 66' ' ' ILE . 49.1 m-85 -123.61 119.08 28.82 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.624 -0.88 . . . . 70.450000000000003 108.624 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.481 HG23 HG23 ' B' ' 66' ' ' ILE . 19.5 mm -101.66 119.94 50.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 107.07 -1.456 . . . . 75.420000000000002 107.07 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -107.19 125.55 51.25 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 108.579 -0.897 . . . . 64.530000000000001 108.579 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -106.7 164.52 12.02 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 120.994 0.426 . . . . 73.25 110.471 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.95 -18.72 23.31 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.743 -0.662 . . . . 72.319999999999993 111.097 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -127.24 142.06 51.57 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.297 -0.411 . . . . 74.409999999999997 111.118 -176.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -61.29 -34.4 75.15 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.116 0.784 . . . . 63.329999999999998 113.116 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -56.84 -37.16 70.89 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.537 -0.301 . . . . 74.109999999999999 111.103 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' B' ' 60' ' ' CYS . 15.0 m -62.92 -43.91 97.5 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 111.766 0.284 . . . . 74.329999999999998 111.766 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . 0.492 ' O ' HG13 ' B' ' 95' ' ' VAL 0.3 0.7 OUTLIER -67.31 -42.9 88.18 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 C-N-CA 120.426 -0.51 . . . . 65.510000000000005 111.924 177.515 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -59.55 -36.29 75.88 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.491 -0.484 . . . . 75.25 112.291 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.19 -35.68 63.97 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.802 0.334 . . . . 74.230000000000004 111.402 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.57 -38.42 62.68 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.254 -0.43 . . . . 75.040000000000006 111.958 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . 0.492 HG13 ' O ' ' B' ' 91' ' ' VAL . 28.0 m -58.94 -23.3 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 112.175 0.435 . . . . 72.430000000000007 112.175 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.24 -9.89 58.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.419 0.628 . . . . 54.130000000000003 111.142 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 8.0 ttp -103.23 7.05 38.52 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.383 -0.969 . . . . 61.229999999999997 108.383 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . 0.439 ' HA ' ' HB ' ' B' ' 109' ' ' VAL . 4.1 p-10 -41.24 -56.79 2.3 Favored 'General case' 0 C--O 1.209 -1.062 0 N-CA-C 113.463 0.912 . . . . 61.039999999999999 113.463 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -101.7 97.12 7.57 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 118.474 0.579 . . . . 71.450000000000003 109.735 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 26.0 p -145.83 165.04 30.05 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.212 -0.904 . . . . 74.209999999999994 110.537 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 p -107.63 119.46 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-O 121.359 0.599 . . . . 73.299999999999997 109.968 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -131.91 127.77 37.13 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.688 -0.687 . . . . 72.129999999999995 109.255 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 48.6 ttt-85 62.17 33.2 17.02 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 122.547 1.165 . . . . 74.430000000000007 110.229 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.41 5.98 86.45 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 114.073 -1.421 . . . . 70.140000000000001 114.899 175.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -136.92 155.72 49.39 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 117.76 0.78 . . . . 71.109999999999999 111.077 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 46.8 m -78.49 123.92 27.57 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.921 -0.77 . . . . 63.140000000000001 108.921 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 41.4 pt -101.38 171.35 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 C-N-CA 119.969 -0.692 . . . . 74.510000000000005 109.643 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -124.43 137.48 54.44 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 106.858 -1.534 . . . . 55.0 106.858 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' B' ' 98' ' ' ASP . 24.9 t -127.33 122.72 60.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.636 -1.246 . . . . 72.519999999999996 107.636 174.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . 0.437 HD12 ' CD2' ' B' ' 40' ' ' TYR . 73.9 mt -121.08 150.1 52.75 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 109.308 -0.627 . . . . 74.0 109.308 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -81.63 135.28 9.05 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 C-N-CA 121.778 1.652 . . . . 75.010000000000005 108.16 170.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt . . . . . 0 C--N 1.304 -1.374 0 C-N-CA 119.484 -0.887 . . . . 74.239999999999995 109.477 -179.107 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 . . . . . 0 C--O 1.22 -0.482 0 N-CA-C 112.259 0.466 . . . . 72.540000000000006 112.259 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.9 pt -70.12 -35.87 65.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 120.513 -0.475 . . . . 72.450000000000003 111.059 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.665 ' OD1' ' HE3' ' A' ' 112' ' ' LYS . 30.0 t70 -68.44 -39.27 81.57 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.397 0.679 . . . . 64.239999999999995 110.563 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -66.61 -14.5 62.48 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.709 -0.678 . . . . 72.409999999999997 112.295 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -112.73 12.69 19.7 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 110.003 -0.369 . . . . 71.010000000000005 110.003 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.49 ' OG ' ' HB3' ' A' ' 112' ' ' LYS . 97.5 p -97.02 157.32 15.96 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.639 0.733 . . . . 75.140000000000001 112.392 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.466 HG23 HG21 ' A' ' 91' ' ' VAL . 49.0 t -127.82 151.53 34.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 114.912 -1.04 . . . . 75.109999999999999 108.401 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.653 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 24.4 t80 -104.4 127.66 52.12 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 125.055 1.342 . . . . 72.430000000000007 107.847 174.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.6 t -115.44 116.43 52.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 107.927 -1.138 . . . . 75.430000000000007 107.927 177.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.26 164.34 12.09 Favored Glycine 0 C--N 1.29 -1.987 0 C-N-CA 119.669 -1.253 . . . . 75.209999999999994 112.946 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 t30 68.75 25.02 6.46 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 125.677 1.591 . . . . 74.299999999999997 113.163 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.7 p -78.56 119.82 28.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 118.457 -1.297 . . . . 72.420000000000002 108.489 174.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -110.87 149.66 30.29 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.995 -1.113 . . . . 70.140000000000001 107.995 -173.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -51.45 115.58 1.67 Allowed 'General case' 0 CA--C 1.496 -1.102 0 CA-C-O 122.287 1.041 . . . . 74.329999999999998 112.128 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.19 -33.47 0.93 Allowed Glycine 0 N--CA 1.406 -3.318 0 N-CA-C 107.116 -2.393 . . . . 63.100000000000001 107.116 -174.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.5 m -102.61 141.85 34.75 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 108.327 -0.99 . . . . 74.329999999999998 108.327 173.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.6 p -115.88 178.73 4.2 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 120.4 0.143 . . . . 75.200000000000003 111.148 -176.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.422 ' HB3' HD13 ' A' ' 66' ' ' ILE . . . -64.64 -40.39 95.37 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 122.88 0.472 . . . . 75.319999999999993 110.542 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.54 -43.19 84.19 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 116.039 -0.528 . . . . 75.319999999999993 109.792 176.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -60.57 -38.8 85.78 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.382 0.61 . . . . 45.539999999999999 109.924 176.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.25 -46.94 75.38 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.187 -0.915 . . . . 53.509999999999998 111.066 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -58.75 -50.71 72.92 Favored 'General case' 0 C--O 1.19 -2.047 0 C-N-CA 120.434 -0.507 . . . . 70.129999999999995 111.762 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.8 -48.27 78.32 Favored 'General case' 0 C--O 1.271 2.187 0 CA-C-O 121.595 0.712 . . . . 71.340000000000003 111.795 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -67.31 -40.47 86.0 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.848 -1.069 . . . . 73.109999999999999 110.609 -175.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -81.57 -22.9 37.5 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 114.365 1.246 . . . . 54.219999999999999 114.365 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.1 m -69.85 -24.41 63.43 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.391 -0.368 . . . . 72.349999999999994 110.144 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.4 m -59.18 -31.22 68.8 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 119.908 -0.717 . . . . 74.340000000000003 109.674 172.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 60.9 m -85.92 3.05 43.64 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 112.909 0.707 . . . . 55.210000000000001 112.909 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.94 -158.09 26.15 Favored Glycine 0 N--CA 1.463 0.479 0 C-N-CA 119.528 -1.32 . . . . 65.519999999999996 114.138 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.1 m -105.46 126.03 51.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.925 0.393 . . . . 72.150000000000006 110.981 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 63.3 mt -91.74 127.28 44.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 115.633 -0.712 . . . . 65.510000000000005 111.885 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.555 ' ND2' ' HA ' ' A' ' 86' ' ' ALA . 90.3 m-20 -89.23 -42.1 11.82 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 121.325 0.583 . . . . 72.239999999999995 111.276 175.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -153.32 161.23 42.57 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.716 -0.675 . . . . 73.140000000000001 110.03 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.445 HD11 HG21 ' A' ' 66' ' ' ILE . 35.0 pt -146.0 139.69 21.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 107.562 -1.273 . . . . 74.510000000000005 107.562 172.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.4 m -124.74 125.98 44.93 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 106.295 -1.743 . . . . 72.109999999999999 106.295 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mp -123.27 117.69 52.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 105.883 -1.895 . . . . 51.229999999999997 105.883 -177.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.288 1.0 OUTLIER -120.38 128.46 53.25 Favored 'General case' 0 C--N 1.284 -2.28 0 C-N-CA 120.443 -0.503 . . . . 74.129999999999995 112.175 179.031 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 78.3 m -115.31 129.31 56.57 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 115.759 -0.655 . . . . 64.230000000000004 110.1 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -114.69 125.33 53.61 Favored 'General case' 0 CA--C 1.492 -1.285 0 N-CA-C 112.174 0.435 . . . . 64.019999999999996 112.174 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -122.12 9.56 9.91 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 109.078 -0.712 . . . . 73.150000000000006 109.078 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.437 ' HB3' ' HB3' ' B' ' 64' ' ' ASN . 0.1 OUTLIER -64.79 -16.76 63.48 Favored 'General case' 0 C--N 1.361 1.095 0 N-CA-C 113.438 0.903 . . . . 71.329999999999998 113.438 -175.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.3 t -100.14 16.57 23.72 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-O 121.542 0.687 . . . . 70.129999999999995 109.847 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.64 -53.1 1.01 Allowed Glycine 0 CA--C 1.497 -1.066 0 C-N-CA 120.324 -0.941 . . . . 53.130000000000003 111.909 176.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -88.19 132.33 39.92 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 109.061 -0.718 . . . . 72.109999999999999 109.061 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -80.17 117.74 3.55 Favored 'Trans proline' 0 N--CA 1.431 -2.164 0 C-N-CA 121.329 1.353 . . . . 70.439999999999998 110.001 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 34.2 mtmm -115.19 162.7 16.69 Favored 'General case' 0 CA--C 1.466 -2.268 0 C-N-CA 123.9 0.88 . . . . 74.049999999999997 108.692 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -144.13 149.99 22.03 Favored Glycine 0 N--CA 1.411 -3.027 0 C-N-CA 118.914 -1.612 . . . . 37.68 113.481 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -146.99 144.32 29.09 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 114.199 -1.0 . . . . 64.140000000000001 108.451 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.17 152.49 50.85 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 110.302 -0.258 . . . . 70.400000000000006 110.302 -172.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.451 ' CZ ' ' HD1' ' A' ' 40' ' ' TYR . 69.1 m-85 -121.5 123.51 42.19 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 109.679 -0.489 . . . . 75.409999999999997 109.679 176.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.41 HG23 HG23 ' A' ' 66' ' ' ILE . 22.9 mm -102.35 121.05 52.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 107.433 -1.321 . . . . 72.420000000000002 107.433 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -103.0 119.3 38.6 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.516 -0.55 . . . . 75.319999999999993 109.516 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -96.38 158.94 15.2 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.458 0.647 . . . . 74.319999999999993 112.637 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.555 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . . . -67.0 -46.98 72.9 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.671 -1.149 . . . . 71.409999999999997 112.054 177.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -119.74 156.93 29.61 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 113.316 0.858 . . . . 73.040000000000006 113.316 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -61.98 -28.36 69.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.606 -1.179 . . . . 72.129999999999995 112.22 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.351 2.0 p-10 -71.26 -24.48 62.18 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 113.605 0.965 . . . . 50.399999999999999 113.605 177.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -72.35 -41.58 66.3 Favored 'General case' 0 N--CA 1.433 -1.294 0 O-C-N 122.204 -0.31 . . . . 74.430000000000007 111.344 177.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.466 HG21 HG23 ' A' ' 39' ' ' VAL . 7.6 p -63.42 -39.88 86.96 Favored 'Isoleucine or valine' 0 C--N 1.354 0.79 0 N-CA-C 109.646 -0.501 . . . . 72.409999999999997 109.646 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -62.98 -34.84 78.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.583 -0.735 . . . . 72.430000000000007 110.155 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.15 -38.68 63.65 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.878 -0.601 . . . . 64.329999999999998 112.252 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.88 -40.18 65.81 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 116.049 -0.523 . . . . 74.329999999999998 110.923 -176.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 91' ' ' VAL . 30.0 m -59.43 -22.13 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 113.071 0.767 . . . . 70.409999999999997 113.071 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.15 -9.87 58.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 122.192 0.996 . . . . 71.409999999999997 110.709 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.404 ' HG2' ' OG1' ' A' ' 100' ' ' THR . 8.5 ttp -104.51 7.77 35.37 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.416 -1.266 . . . . 60.229999999999997 108.406 -176.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.567 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 2.8 p-10 -36.53 -50.92 0.82 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 116.645 2.091 . . . . 72.310000000000002 116.645 -175.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -123.69 55.58 1.25 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 119.999 1.272 . . . . 73.510000000000005 112.942 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.404 ' OG1' ' HG2' ' A' ' 97' ' ' MET . 41.5 p -92.97 -175.71 3.97 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.119 -1.401 . . . . 71.200000000000003 110.837 174.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.95 126.07 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 121.322 0.582 . . . . 61.5 110.58 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -111.12 118.76 36.87 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.079 -0.712 . . . . 72.019999999999996 109.079 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 43.42 31.67 0.43 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.562 1.545 . . . . 75.420000000000002 113.7 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.59 -8.84 37.65 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.837 -0.697 . . . . 37.68 114.395 175.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -123.41 146.08 48.27 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 118.112 0.956 . . . . 75.549999999999997 110.033 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.7 m -78.41 118.87 20.99 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 120.551 -0.46 . . . . 75.049999999999997 110.014 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 pp -104.51 169.98 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 116.305 -0.407 . . . . 73.409999999999997 110.938 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 57.8 tptt -130.49 131.16 44.99 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.708 -0.849 . . . . 74.209999999999994 108.708 -176.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 36.0 m -126.47 135.33 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 120.975 0.417 . . . . 63.439999999999998 110.511 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.8 mt -131.03 148.53 70.64 Favored Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 108.981 -0.748 . . . . 60.229999999999997 108.981 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.415 ' HB3' HG11 ' A' ' 95' ' ' VAL . 55.5 Cg_endo -79.5 135.29 11.66 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 121.126 1.217 . . . . 61.100000000000001 109.341 175.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.665 ' HE3' ' OD1' ' A' ' 35' ' ' ASP . 37.3 ttpt . . . . . 0 C--N 1.294 -1.811 0 C-N-CA 118.03 -1.468 . . . . 73.439999999999998 109.731 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.411 -2.98 0 N-CA-C 107.606 -2.197 . . . . 60.130000000000003 107.606 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.517 ' HG2' ' CE2' ' A' ' 40' ' ' TYR . 57.9 Cg_exo -55.75 -36.31 94.9 Favored 'Trans proline' 0 CA--C 1.58 2.817 0 C-N-CA 123.08 2.52 . . . . 73.340000000000003 115.258 174.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -53.73 158.74 7.83 Favored 'Trans proline' 0 C--N 1.405 3.518 0 C-N-CA 121.952 1.768 . . . . 74.299999999999997 114.033 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -89.6 167.24 18.0 Favored Pre-proline 0 C--N 1.309 -1.178 0 CA-C-N 115.021 -0.99 . . . . 72.420000000000002 109.712 -177.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -77.35 159.75 32.7 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 121.208 1.272 . . . . 70.329999999999998 112.596 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.73 162.23 38.97 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.322 -0.854 . . . . 73.239999999999995 109.131 176.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.539 ' HB2' ' HG2' ' B' ' 30' ' ' GLU . 71.2 m -65.44 143.74 57.51 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 115.088 1.514 . . . . 55.240000000000002 115.088 -171.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' B' ' 31' ' ' LYS . . . -55.72 -34.65 65.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.043 -1.435 . . . . 71.430000000000007 112.699 174.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . 0.274 6.0 mt-10 -72.89 -29.22 63.0 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 113.327 0.862 . . . . 71.5 113.327 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.539 ' HG2' ' HB2' ' B' ' 27' ' ' SER . 2.3 mm-40 -67.87 -35.39 78.46 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.085 -1.08 . . . . 72.340000000000003 108.085 172.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' B' ' 28' ' ' ALA . 74.7 mmtt -60.81 -48.41 81.93 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.151 -0.932 . . . . 64.230000000000004 108.955 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -54.24 -49.39 69.59 Favored 'General case' 0 C--N 1.363 1.156 0 N-CA-C 112.752 0.649 . . . . 62.25 112.752 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -70.63 -42.51 70.78 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 112.825 0.676 . . . . 65.409999999999997 112.825 -170.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.494 HG12 ' O ' ' B' ' 30' ' ' GLU . 24.2 pt -68.9 -35.6 70.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.018 0.437 . . . . 74.329999999999998 110.31 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -67.53 -43.22 81.32 Favored 'General case' 0 C--O 1.201 -1.476 0 CA-C-N 115.533 -0.758 . . . . 73.0 110.418 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -63.24 -14.32 48.0 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.226 1.011 . . . . 72.409999999999997 113.388 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -118.57 20.86 12.83 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 121.598 0.713 . . . . 72.150000000000006 110.644 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' SER . . . . . 0.459 ' HB2' ' HB3' ' B' ' 112' ' ' LYS . 40.1 m -97.91 160.42 14.31 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.288 -0.869 . . . . 73.310000000000002 111.719 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.436 HG23 HG21 ' B' ' 91' ' ' VAL . 46.2 t -129.9 154.64 40.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.772 -0.825 . . . . 74.519999999999996 108.772 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . 0.648 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 30.0 t80 -108.49 125.58 51.95 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 125.214 1.405 . . . . 71.510000000000005 107.953 175.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 59.6 t -113.33 117.45 55.45 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.442 0 N-CA-C 108.431 -0.952 . . . . 64.340000000000003 108.431 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.93 173.8 15.33 Favored Glycine 0 N--CA 1.433 -1.555 0 C-N-CA 119.963 -1.113 . . . . 74.129999999999995 112.671 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 t30 67.97 22.53 8.53 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.697 1.599 . . . . 72.120000000000005 112.139 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 13.2 p -95.09 128.44 46.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 O-C-N 121.628 -0.67 . . . . 75.430000000000007 110.106 175.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -116.08 167.17 11.22 Favored 'General case' 0 CA--C 1.483 -1.596 0 N-CA-C 108.456 -0.942 . . . . 74.109999999999999 108.456 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -51.33 128.14 21.59 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.817 0.818 . . . . 73.129999999999995 110.694 173.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.96 -41.78 1.1 Allowed Glycine 0 N--CA 1.415 -2.748 0 N-CA-C 107.41 -2.276 . . . . 61.409999999999997 107.41 -172.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.2 m -95.76 140.23 30.85 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.046 -1.094 . . . . 72.310000000000002 108.046 174.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 74.0 p -111.3 177.62 4.6 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.693 -0.403 . . . . 72.040000000000006 110.499 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.421 ' HB3' HD13 ' B' ' 66' ' ' ILE . . . -66.88 -39.05 87.38 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.996 -0.372 . . . . 70.030000000000001 109.996 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.73 -44.05 85.73 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.848 -0.615 . . . . 73.150000000000006 109.997 175.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -56.99 -44.67 82.96 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.577 0.703 . . . . 73.019999999999996 109.525 175.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 78.3 mt -60.9 -47.76 84.92 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 114.597 -1.183 . . . . 75.129999999999995 112.16 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -58.89 -50.84 72.52 Favored 'General case' 0 C--O 1.198 -1.614 0 C-N-CA 120.412 -0.515 . . . . 63.130000000000003 112.126 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.67 -48.38 77.72 Favored 'General case' 0 C--O 1.265 1.9 0 CA-C-O 121.629 0.728 . . . . 65.140000000000001 111.783 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -66.73 -41.05 88.51 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.707 -1.133 . . . . 74.519999999999996 110.662 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -81.59 -23.09 37.31 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 114.229 1.196 . . . . 65.340000000000003 114.229 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 66.7 m -70.61 -24.16 62.69 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.307 -0.406 . . . . 54.229999999999997 109.964 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.3 m -58.79 -29.01 66.5 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-O 121.096 0.475 . . . . 65.129999999999995 109.94 172.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 60.0 m -92.27 6.37 47.03 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 113.07 0.767 . . . . 52.229999999999997 113.07 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 142.84 -158.38 27.1 Favored Glycine 0 C--O 1.226 -0.397 0 C-N-CA 119.143 -1.503 . . . . 61.130000000000003 114.371 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 49.9 m -106.21 125.79 51.43 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 122.444 -0.445 . . . . 72.450000000000003 111.241 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.465 HD12 HG23 ' B' ' 63' ' ' ILE . 71.3 mt -91.42 127.15 43.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 116.029 -0.532 . . . . 75.299999999999997 112.401 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . 0.637 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 87.3 m-20 -89.06 -43.54 11.02 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-N 116.029 -0.532 . . . . 73.430000000000007 110.792 175.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 40.0 mtt180 -150.96 161.25 43.08 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.869 -0.605 . . . . 75.129999999999995 110.524 -176.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.447 HG23 HG23 ' B' ' 83' ' ' ILE . 38.2 pt -146.17 140.15 20.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 107.65 -1.241 . . . . 73.219999999999999 107.65 172.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 85.3 m -124.91 126.41 45.48 Favored 'General case' 0 C--N 1.273 -2.73 0 N-CA-C 106.786 -1.561 . . . . 53.130000000000003 106.786 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.439 HD11 HG13 ' B' ' 66' ' ' ILE . 2.6 mp -124.28 116.71 48.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 105.817 -1.92 . . . . 74.450000000000003 105.817 -177.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.469 ' N ' HD22 ' B' ' 69' ' ' LEU . 1.3 pt? -120.56 129.37 53.75 Favored 'General case' 0 C--N 1.283 -2.287 0 C-N-CA 120.216 -0.594 . . . . 65.319999999999993 110.996 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 79.4 m -116.22 129.57 56.36 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.383 -0.599 . . . . 73.329999999999998 109.383 -177.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -109.43 124.71 51.47 Favored 'General case' 0 CA--C 1.482 -1.665 0 N-CA-C 112.595 0.591 . . . . 64.319999999999993 112.595 -178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -119.76 3.01 11.14 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 114.973 -1.012 . . . . 70.540000000000006 111.358 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -69.42 -22.44 63.67 Favored 'General case' 0 C--N 1.364 1.216 0 C-N-CA 119.084 -1.046 . . . . 73.019999999999996 110.67 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 35.2 t -88.97 15.01 9.23 Favored 'General case' 0 CA--C 1.56 1.345 0 CA-C-N 115.242 -0.89 . . . . 62.119999999999997 109.599 177.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.75 -61.2 2.74 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.91 -0.586 . . . . 63.229999999999997 112.046 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . 0.434 ' HA ' ' HD3' ' B' ' 77' ' ' PRO . 37.0 m80 -85.87 129.32 54.87 Favored Pre-proline 0 C--O 1.252 1.216 0 C-N-CA 120.836 -0.346 . . . . 74.129999999999995 110.19 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' B' ' 76' ' ' HIS . 9.2 Cg_exo -72.01 117.47 5.16 Favored 'Trans proline' 0 CA--C 1.504 -1.019 0 C-N-CA 121.975 1.783 . . . . 75.049999999999997 110.699 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 35.0 mtmm -118.34 159.36 23.54 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 107.666 -1.235 . . . . 65.120000000000005 107.666 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -138.94 152.13 22.06 Favored Glycine 0 N--CA 1.411 -3.023 0 C-N-CA 119.055 -1.545 . . . . 73.510000000000005 113.312 177.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -149.64 144.99 26.51 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.273 -1.01 . . . . 72.239999999999995 108.273 173.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.22 152.83 51.17 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 116.56 -0.291 . . . . 70.219999999999999 110.604 -171.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' TYR . . . . . 0.421 ' CZ ' ' HD1' ' B' ' 40' ' ' TYR . 78.2 m-85 -122.45 124.17 42.99 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 109.517 -0.549 . . . . 74.0 109.517 175.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.447 HG23 HG23 ' B' ' 66' ' ' ILE . 23.2 mm -102.97 120.07 52.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.488 -1.301 . . . . 63.149999999999999 107.488 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -102.31 119.15 38.34 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.549 -0.908 . . . . 73.319999999999993 108.549 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -93.84 160.04 14.92 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 112.734 0.642 . . . . 75.329999999999998 112.734 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.637 ' HA ' ' ND2' ' B' ' 64' ' ' ASN . . . -66.61 -43.56 84.47 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.067 -0.969 . . . . 72.150000000000006 112.224 176.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -127.0 160.04 32.3 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.381 0.882 . . . . 73.310000000000002 113.381 -176.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -63.89 -24.98 67.95 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.517 1.127 . . . . 73.109999999999999 112.787 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -63.48 -39.3 94.09 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.457 -0.942 . . . . 72.510000000000005 108.457 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 18.6 m -68.97 -38.68 79.5 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.314 -0.857 . . . . 73.400000000000006 112.074 -172.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . 0.436 HG21 HG23 ' B' ' 39' ' ' VAL . 7.5 p -65.01 -40.6 89.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 109.201 -0.666 . . . . 75.049999999999997 109.201 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.0 -34.33 77.76 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.549 0.69 . . . . 60.299999999999997 110.271 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.86 -37.68 64.68 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.73 -0.668 . . . . 74.519999999999996 111.111 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.1 -38.78 61.05 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 120.635 -0.426 . . . . 61.240000000000002 111.176 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . 0.439 HG11 ' HB3' ' B' ' 111' ' ' PRO . 30.1 m -59.66 -22.47 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 112.787 0.662 . . . . 71.049999999999997 112.787 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.87 -9.17 50.07 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.145 0.497 . . . . 60.049999999999997 110.177 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 22.7 mtm -97.51 4.0 50.54 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 112.843 0.683 . . . . 75.329999999999998 112.843 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . 0.454 ' HA ' HG22 ' B' ' 109' ' ' VAL . 2.3 p30 -43.86 -38.18 3.2 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 116.77 2.137 . . . . 71.430000000000007 116.77 -174.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -117.09 28.03 8.76 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 119.629 1.104 . . . . 74.340000000000003 111.405 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 73.6 p -84.41 177.46 8.13 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 121.245 -0.909 . . . . 61.520000000000003 111.55 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 13.0 p -101.27 145.73 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 N-CA-C 109.387 -0.598 . . . . 65.010000000000005 109.387 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -143.85 121.75 12.01 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.381 -0.97 . . . . 74.530000000000001 108.381 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 56.9 ttt-85 52.01 33.59 12.19 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 124.529 1.132 . . . . 72.340000000000003 111.868 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.65 1.57 70.95 Favored Glycine 0 C--N 1.313 -0.725 0 CA-C-N 115.188 -0.914 . . . . 71.109999999999999 114.33 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -126.94 157.9 38.24 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 117.544 0.672 . . . . 72.319999999999993 109.806 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 41.8 m -88.43 120.21 29.59 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.086 -1.079 . . . . 62.049999999999997 108.086 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 43.4 pt -101.83 172.0 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 C-N-CA 119.737 -0.785 . . . . 70.150000000000006 110.484 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -128.65 127.16 41.65 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.957 -0.757 . . . . 61.299999999999997 108.957 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . 0.648 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 27.0 m -126.6 134.52 66.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 O-C-N 123.441 0.463 . . . . 71.530000000000001 111.018 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 96.4 mt -128.31 148.28 67.19 Favored Pre-proline 0 C--N 1.298 -1.642 0 N-CA-C 109.206 -0.665 . . . . 70.329999999999998 109.206 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . 0.439 ' HB3' HG11 ' B' ' 95' ' ' VAL . 53.2 Cg_endo -79.28 133.82 11.05 Favored 'Trans proline' 0 N--CA 1.439 -1.711 0 C-N-CA 121.493 1.462 . . . . 74.150000000000006 111.22 175.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.459 ' HB3' ' HB2' ' B' ' 38' ' ' SER . 27.9 ttpp . . . . . 0 N--CA 1.41 -2.446 0 N-CA-C 105.75 -1.945 . . . . 71.439999999999998 105.75 173.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 . . . . . 0 C--O 1.224 -0.26 0 CA-C-O 121.138 0.494 . . . . 55.420000000000002 111.62 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.539 HD13 ' NH2' ' A' ' 65' ' ' ARG . 12.7 pt -70.82 -33.77 53.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.656 -0.702 . . . . 70.040000000000006 110.679 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -66.0 -38.83 89.48 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.837 0.855 . . . . 74.439999999999998 108.887 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -57.4 -30.72 65.15 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.278 -0.874 . . . . 75.340000000000003 110.859 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.407 ' HD2' ' O ' ' A' ' 85' ' ' PHE . 54.2 mtm180 -104.09 18.82 21.27 Favored 'General case' 0 N--CA 1.419 -2.013 0 CA-C-N 114.842 -1.072 . . . . 71.140000000000001 111.856 -175.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.0 m -95.87 146.44 24.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.605 0.717 . . . . 72.5 111.152 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.7 m -127.95 160.69 37.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.932 -0.766 . . . . 74.030000000000001 108.932 176.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 28.1 t80 -109.14 126.06 52.83 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.497 -0.927 . . . . 74.109999999999999 108.497 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.423 ' HA ' HG13 ' A' ' 109' ' ' VAL . 61.3 t -114.49 111.82 37.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.841 -1.17 . . . . 65.420000000000002 107.841 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.2 171.62 13.87 Favored Glycine 0 C--N 1.304 -1.243 0 C-N-CA 120.267 -0.968 . . . . 52.420000000000002 113.215 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.466 ' ND2' ' HB3' ' A' ' 105' ' ' ARG . 4.8 t30 58.65 24.89 12.61 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 125.391 1.477 . . . . 44.340000000000003 110.037 -178.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 p -92.63 9.17 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.418 0 CA-C-N 114.524 -1.216 . . . . 61.439999999999998 110.069 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.556 ' OD2' ' HA ' ' A' ' 78' ' ' LYS . 6.0 m-20 -37.07 106.84 0.05 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 128.235 2.614 . . . . 72.030000000000001 113.617 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.432 ' C ' ' H ' ' A' ' 48' ' ' SER 0.4 41.3 m-85 50.11 162.81 0.0 OUTLIER 'General case' 0 C--N 1.351 0.643 0 N-CA-C 118.116 2.636 . . . . 75.540000000000006 118.116 179.436 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.423 ' HA3' ' NH1' ' A' ' 103' ' ' ARG . . . 80.94 -36.97 2.33 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.284 -0.871 . . . . 70.140000000000001 111.462 -177.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.432 ' H ' ' C ' ' A' ' 46' ' ' TYR . 19.4 m -76.84 118.27 19.28 Favored 'General case' 0 N--CA 1.415 -2.218 0 C-N-CA 124.733 1.213 . . . . 70.329999999999998 109.866 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.7 p -100.59 162.99 12.56 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.6 -0.519 . . . . 71.349999999999994 109.6 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.439 ' HB1' HD13 ' A' ' 66' ' ' ILE . . . -65.81 -50.25 65.31 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.171 0.434 . . . . 63.240000000000002 112.171 -175.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -57.79 -38.74 76.04 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 116.824 -0.171 . . . . 60.32 111.091 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.72 -37.67 76.61 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.018 0.437 . . . . 73.200000000000003 110.347 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 44.1 mt -68.22 -47.58 67.45 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.362 -0.835 . . . . 51.32 110.803 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -61.9 -48.24 81.34 Favored 'General case' 0 C--O 1.2 -1.538 0 CA-C-N 115.738 -0.665 . . . . 72.230000000000004 110.069 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.48 -41.18 84.71 Favored 'General case' 0 C--O 1.248 1.0 0 CA-C-O 121.036 0.446 . . . . 62.149999999999999 110.663 177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -65.82 -39.68 91.1 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.852 -0.613 . . . . 73.349999999999994 110.307 -175.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -82.33 -21.53 35.97 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 112.967 0.729 . . . . 72.549999999999997 112.967 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.9 t -70.11 -24.11 63.15 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.651 -0.704 . . . . 72.239999999999995 109.324 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.4 m -62.25 -30.24 70.97 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 109.197 -0.668 . . . . 71.530000000000001 109.197 173.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 57.5 m -96.1 11.83 32.83 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.772 -0.649 . . . . 72.319999999999993 112.378 -178.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.96 -167.58 30.58 Favored Glycine 0 N--CA 1.464 0.526 0 C-N-CA 118.609 -1.758 . . . . 61.32 115.386 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.4 m -104.32 115.06 29.72 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.212 -0.662 . . . . 70.329999999999998 109.212 -176.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.3 mt -91.11 131.8 37.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 112.537 0.569 . . . . 75.140000000000001 112.537 -176.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.418 HD22 ' HB1' ' A' ' 86' ' ' ALA . 1.0 OUTLIER -95.64 -40.47 9.39 Favored 'General case' 0 C--O 1.204 -1.296 0 CA-C-N 115.26 -0.882 . . . . 54.229999999999997 111.915 176.515 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.539 ' NH2' HD13 ' A' ' 34' ' ' ILE . 73.2 mtm180 -155.86 161.16 40.64 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.763 -0.458 . . . . 75.109999999999999 109.763 -177.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.47 HG21 HD11 ' A' ' 66' ' ' ILE . 23.0 pt -146.51 141.42 20.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.1 -1.074 . . . . 71.409999999999997 108.1 174.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.9 m -126.23 129.24 48.56 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 106.478 -1.675 . . . . 73.0 106.478 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.6 mp -125.06 121.4 60.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 106.878 -1.527 . . . . 73.340000000000003 106.878 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -120.62 134.61 55.26 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 120.528 -0.469 . . . . 72.099999999999994 112.123 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 83.6 m -117.5 122.66 44.31 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.892 -0.781 . . . . 60.219999999999999 108.892 176.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.454 ' HA ' ' HG2' ' B' ' 65' ' ' ARG . 2.5 p30 -113.55 128.87 56.6 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 119.734 -0.786 . . . . 72.010000000000005 112.287 -178.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' B' ' 64' ' ' ASN . 38.4 mttm -95.8 4.05 53.22 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.73 -0.668 . . . . 73.120000000000005 111.516 175.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -64.34 -6.25 6.68 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.38 0.881 . . . . 74.450000000000003 113.38 172.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.461 ' C ' ' H ' ' A' ' 76' ' ' HIS . 25.7 t -95.91 0.56 52.12 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.947 -0.76 . . . . 72.420000000000002 108.947 176.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.37 -48.78 3.63 Favored Glycine 0 CA--C 1.506 -0.521 0 N-CA-C 109.187 -1.565 . . . . 64.120000000000005 109.187 -175.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.461 ' H ' ' C ' ' A' ' 74' ' ' SER . 40.8 m80 -96.96 147.94 33.66 Favored Pre-proline 0 C--N 1.291 -1.961 0 N-CA-C 105.916 -1.883 . . . . 73.239999999999995 105.916 173.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.83 118.32 5.02 Favored 'Trans proline' 0 N--CA 1.443 -1.474 0 C-N-CA 120.679 0.919 . . . . 64.239999999999995 110.448 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.572 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 30.1 mtmm -96.59 149.22 22.02 Favored 'General case' 0 CA--C 1.483 -1.597 0 C-N-CA 119.873 -0.731 . . . . 72.439999999999998 109.262 175.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.9 135.13 8.32 Favored Glycine 0 N--CA 1.409 -3.105 0 C-N-CA 120.327 -0.94 . . . . 52.109999999999999 112.636 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . 0.349 1.3 p90 -150.8 144.77 25.28 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 124.382 1.073 . . . . 74.25 111.092 175.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.49 154.36 49.9 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.893 -0.594 . . . . 60.329999999999998 110.659 -171.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -120.36 124.49 45.66 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.325 -0.991 . . . . 74.239999999999995 108.325 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 27.2 mm -108.48 127.59 64.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.823 -1.177 . . . . 74.439999999999998 107.823 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -108.94 120.84 43.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.582 0.23 . . . . 63.439999999999998 111.039 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.407 ' O ' ' HD2' ' A' ' 37' ' ' ARG . 94.0 m-85 -98.89 162.88 12.85 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.98 0.419 . . . . 74.0 111.875 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.418 ' HB1' HD22 ' A' ' 64' ' ' ASN . . . -76.79 -37.88 55.01 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.264 0.626 . . . . 72.200000000000003 111.747 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.435 ' HG2' ' OG ' ' A' ' 90' ' ' SER . 0.2 OUTLIER -113.47 138.5 50.02 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 112.509 0.559 . . . . 73.430000000000007 112.509 179.422 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.411 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -57.79 -34.31 69.49 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 123.623 0.769 . . . . 73.040000000000006 111.26 179.051 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -66.65 -21.14 66.11 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 116.019 -0.537 . . . . 70.030000000000001 112.239 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.435 ' OG ' ' HG2' ' A' ' 87' ' ' GLU . 71.4 m -69.15 -36.13 77.09 Favored 'General case' 0 N--CA 1.414 -2.241 0 C-N-CA 120.635 -0.426 . . . . 64.040000000000006 111.263 176.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 88' ' ' ARG . 3.0 m -64.69 -41.22 91.62 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.85 0 C-N-CA 119.239 -0.984 . . . . 72.129999999999995 108.56 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.484 ' HA ' HG22 ' A' ' 95' ' ' VAL . 9.7 m-20 -61.99 -31.13 71.46 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 116.299 -0.41 . . . . 74.349999999999994 111.292 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.31 -39.81 62.64 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.172 -0.467 . . . . 71.319999999999993 111.225 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.83 -41.85 59.13 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-N 116.222 -0.445 . . . . 70.310000000000002 111.338 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.484 HG22 ' HA ' ' A' ' 92' ' ' ASP . 22.6 m -56.21 -22.18 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 111.98 0.363 . . . . 62.549999999999997 111.98 177.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.78 -13.86 62.47 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.367 0.603 . . . . 55.299999999999997 111.067 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 47.4 mtm -99.36 9.76 42.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.568 -0.742 . . . . 51.25 109.79 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 2.9 p-10 -37.67 -45.59 0.8 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 114.456 1.28 . . . . 70.120000000000005 114.456 -177.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -114.67 97.4 6.25 Favored 'General case' 0 N--CA 1.424 -1.741 0 C-N-CA 120.033 -0.667 . . . . 62.340000000000003 110.033 174.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.8 p -142.64 165.71 26.65 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.02 -0.991 . . . . 63.509999999999998 110.775 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.3 p -104.53 119.68 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-O 121.636 0.731 . . . . 60.119999999999997 110.171 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -113.47 116.64 29.91 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.858 -1.164 . . . . 75.219999999999999 107.858 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.423 ' NH1' ' HA3' ' A' ' 47' ' ' GLY . 7.1 ptm180 43.09 32.08 0.41 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 126.548 1.939 . . . . 72.450000000000003 114.147 -177.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.19 -12.02 33.91 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.007 -0.997 . . . . 70.219999999999999 113.87 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.466 ' HB3' ' ND2' ' A' ' 43' ' ' ASN . 65.1 mtt180 -112.42 138.74 48.72 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 117.37 0.585 . . . . 62.43 109.933 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 39.2 m -79.18 120.19 23.33 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.766 -1.198 . . . . 74.140000000000001 107.766 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.2 pt -101.57 171.44 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 C-N-CA 120.464 -0.495 . . . . 74.530000000000001 110.723 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 54.7 tptt -133.91 125.75 28.94 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 115.123 -0.944 . . . . 73.510000000000005 108.772 -177.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 27.7 m -128.82 132.49 67.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 O-C-N 123.238 0.336 . . . . 61.109999999999999 110.948 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.444 ' HB2' ' HD2' ' A' ' 111' ' ' PRO 0.25 0.0 OUTLIER -148.24 158.79 40.81 Favored Pre-proline 0 C--N 1.292 -1.929 0 N-CA-C 108.561 -0.903 . . . . 64.120000000000005 108.561 176.26 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 110' ' ' LEU . 91.8 Cg_endo -76.09 130.28 12.07 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 CA-C-N 120.45 1.196 . . . . 53.350000000000001 110.641 -176.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.423 -1.783 0 N-CA-C 104.874 -2.269 . . . . 74.239999999999995 104.874 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.19 0 N-CA-C 114.363 0.505 . . . . 74.439999999999998 114.363 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -53.36 -52.66 8.15 Favored 'Trans proline' 0 CA--C 1.559 1.73 0 C-N-CA 123.609 2.873 . . . . 74.120000000000005 114.181 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.12 141.65 48.43 Favored 'Trans proline' 0 C--N 1.376 1.979 0 CA-C-N 120.813 1.326 . . . . 75.340000000000003 108.83 172.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -84.21 146.35 47.91 Favored Pre-proline 0 C--N 1.284 -2.276 0 C-N-CA 119.818 -0.753 . . . . 74.150000000000006 109.102 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.69 131.08 35.93 Favored 'Trans proline' 0 N--CA 1.438 -1.777 0 C-N-CA 122.275 1.983 . . . . 72.209999999999994 111.71 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.533 ' H ' HD13 ' B' ' 26' ' ' LEU 0.25 0.0 OUTLIER -70.09 178.7 2.64 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.598 -0.728 . . . . 73.209999999999994 110.764 176.815 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 13.8 m -57.47 144.6 36.06 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 113.441 0.904 . . . . 74.209999999999994 113.441 -171.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.495 ' O ' ' HE2' ' B' ' 32' ' ' LYS . . . -56.5 -44.68 80.91 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.919 -1.037 . . . . 72.200000000000003 110.733 174.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -60.51 -45.91 92.05 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.638 -0.256 . . . . 72.010000000000005 111.082 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.478 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.5 OUTLIER -55.83 -35.32 66.26 Favored 'General case' 0 C--O 1.22 -0.485 0 O-C-N 123.276 0.36 . . . . 63.439999999999998 110.583 174.101 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.474 ' HE2' ' O ' ' B' ' 26' ' ' LEU . 43.2 mttm -70.83 -35.47 72.48 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.757 -0.656 . . . . 74.209999999999994 112.399 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.568 ' O ' ' HB2' ' B' ' 36' ' ' LYS . 0.4 OUTLIER -69.76 -38.99 76.94 Favored 'General case' 0 C--O 1.211 -0.953 0 C-N-CA 119.651 -0.82 . . . . 74.129999999999995 111.35 174.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.536 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 5.9 mm-40 -64.8 -46.26 82.77 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.869 0.366 . . . . 72.120000000000005 111.06 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.478 HG12 ' O ' ' B' ' 30' ' ' GLU . 16.2 pt -70.72 -34.67 57.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.87 -0.605 . . . . 74.120000000000005 111.401 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -70.95 -35.12 72.05 Favored 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 108.69 -0.855 . . . . 75.099999999999994 108.69 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.568 ' HB2' ' O ' ' B' ' 32' ' ' LYS . 31.8 ttmt -62.71 -31.34 72.24 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 124.987 1.315 . . . . 74.209999999999994 110.234 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.536 ' HG2' ' O ' ' B' ' 33' ' ' GLU . 10.5 ptt180 -115.35 31.78 6.48 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.567 0.699 . . . . 74.349999999999994 112.004 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' SER . . . . . 0.465 ' OG ' ' HE3' ' B' ' 112' ' ' LYS . 25.4 t -100.9 163.07 12.47 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.307 -0.861 . . . . 74.219999999999999 109.945 174.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.458 ' HA ' ' H ' ' B' ' 112' ' ' LYS . 35.0 m -134.69 164.05 35.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 122.984 0.514 . . . . 53.109999999999999 110.732 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . 0.536 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 34.7 t80 -109.63 125.2 52.34 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.309 -0.997 . . . . 74.409999999999997 108.309 177.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.414 ' HA ' HG13 ' B' ' 109' ' ' VAL . 61.8 t -116.03 112.88 41.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 108.836 -0.801 . . . . 72.219999999999999 108.836 175.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.21 173.54 18.15 Favored Glycine 0 N--CA 1.426 -2.024 0 N-CA-C 110.822 -0.911 . . . . 63.539999999999999 110.822 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.409 ' HB3' ' HA ' ' B' ' 107' ' ' ILE . 25.7 t-20 80.96 -19.28 0.44 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.102 1.361 . . . . 63.509999999999998 113.022 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.5 p -55.39 117.8 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.833 0.825 . . . . 74.019999999999996 111.074 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -69.98 153.57 43.06 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.874 -1.057 . . . . 75.219999999999999 113.104 -174.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -49.46 -32.33 11.71 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 127.859 2.464 . . . . 74.120000000000005 110.817 176.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.31 0.26 71.39 Favored Glycine 0 N--CA 1.429 -1.796 0 CA-C-O 119.292 -0.727 . . . . 51.109999999999999 114.067 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 29.1 t -75.61 147.0 39.92 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 118.703 1.252 . . . . 73.099999999999994 109.877 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 36.8 p -98.52 157.56 16.15 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 116.002 -0.545 . . . . 74.319999999999993 112.228 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.465 ' HB1' HD13 ' B' ' 66' ' ' ILE . . . -72.6 -47.64 46.24 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.865 0.866 . . . . 71.129999999999995 112.274 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -34.49 72.31 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 119.523 -0.871 . . . . 73.010000000000005 112.533 -178.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -68.8 -39.12 80.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.109 -0.496 . . . . 75.209999999999994 110.343 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 55.7 mt -65.46 -47.7 75.24 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.657 -0.701 . . . . 73.319999999999993 111.29 176.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -49.11 78.29 Favored 'General case' 0 C--O 1.207 -1.168 0 CA-C-N 116.213 -0.448 . . . . 73.109999999999999 110.001 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.75 -40.71 80.32 Favored 'General case' 0 C--O 1.263 1.783 0 CA-C-O 122.015 0.912 . . . . 63.43 112.059 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -66.09 -40.61 90.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.608 -1.178 . . . . 73.549999999999997 109.854 -175.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -82.41 -21.84 35.61 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 112.833 0.679 . . . . 73.120000000000005 112.833 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 47.1 t -68.58 -24.59 64.62 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.4 -0.818 . . . . 71.140000000000001 110.226 -176.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 32.7 m -63.63 -20.44 65.68 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 120.06 -0.656 . . . . 71.25 110.963 174.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 58.6 m -106.02 17.23 23.91 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 111.852 0.316 . . . . 65.049999999999997 111.852 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.54 177.06 20.0 Favored Glycine 0 C--O 1.226 -0.353 0 C-N-CA 119.904 -1.141 . . . . 71.510000000000005 113.603 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 23.9 t -93.34 121.09 34.37 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.265 -1.013 . . . . 73.5 108.265 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 76.8 mt -87.53 133.84 29.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-O 121.413 0.625 . . . . 74.219999999999999 112.139 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . 0.493 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 68.6 m-20 -97.4 -38.71 9.51 Favored 'General case' 0 C--O 1.206 -1.202 0 CA-C-N 115.173 -0.922 . . . . 55.039999999999999 112.676 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.526 ' HB2' ' OE1' ' B' ' 84' ' ' GLU . 71.7 mtm180 -157.39 161.74 39.01 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.12 -0.696 . . . . 72.5 109.12 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.465 HD13 ' HB1' ' B' ' 50' ' ' ALA . 24.1 pt -146.68 140.91 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 N-CA-C 107.875 -1.157 . . . . 72.530000000000001 107.875 175.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 68.8 m -126.32 127.97 46.39 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.922 -1.14 . . . . 75.430000000000007 107.922 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.43 HD12 ' N ' ' B' ' 68' ' ' ILE . 1.9 mp -124.5 121.43 61.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 106.599 -1.63 . . . . 72.049999999999997 106.599 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.435 HD23 ' N ' ' B' ' 69' ' ' LEU . 1.4 pt? -121.36 135.33 55.1 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 120.458 -0.497 . . . . 74.230000000000004 111.289 178.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 73.1 m -116.9 121.76 42.38 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.192 -1.04 . . . . 74.400000000000006 108.192 176.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . 0.632 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 3.4 p30 -111.7 128.38 56.06 Favored 'General case' 0 C--O 1.212 -0.88 0 C-N-CA 119.261 -0.976 . . . . 71.329999999999998 111.873 -177.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -121.97 5.11 9.88 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.81 -0.632 . . . . 73.5 109.646 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.436 ' CD1' ' HD3' ' A' ' 65' ' ' ARG . 28.3 p90 -59.28 -16.92 24.52 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 114.191 1.182 . . . . 72.310000000000002 114.191 -175.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 38.4 p -96.96 4.19 51.67 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 120.855 0.36 . . . . 71.239999999999995 111.407 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.25 -60.1 0.35 Allowed Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 111.581 -0.608 . . . . 75.329999999999998 111.581 -177.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -96.73 129.17 33.53 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 112.009 0.374 . . . . 72.099999999999994 112.009 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.632 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 91.9 Cg_endo -78.41 126.42 7.57 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.546 2.164 . . . . 73.409999999999997 113.933 -177.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 32.9 mtmm -109.86 165.23 11.87 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 123.683 0.793 . . . . 73.430000000000007 109.753 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -134.11 135.68 8.15 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 119.925 -1.131 . . . . 71.019999999999996 113.808 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . 0.436 0.4 OUTLIER -150.02 143.96 25.5 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 124.755 1.222 . . . . 72.439999999999998 112.083 173.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.94 154.89 50.32 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.086 -0.506 . . . . 73.109999999999999 110.504 -172.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -122.43 126.83 48.77 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.978 -1.119 . . . . 73.200000000000003 107.978 177.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.404 HG22 HG23 ' B' ' 66' ' ' ILE . 28.5 mm -109.66 127.41 66.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 107.594 -1.261 . . . . 73.120000000000005 107.594 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' GLU . . . . . 0.526 ' OE1' ' HB2' ' B' ' 65' ' ' ARG . 45.2 mt-10 -107.82 121.33 44.53 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 110.331 -0.248 . . . . 73.109999999999999 110.331 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -98.47 162.14 13.31 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.201 0.524 . . . . 74.420000000000002 112.018 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.493 ' HA ' ' ND2' ' B' ' 64' ' ' ASN . . . -69.18 -36.7 77.6 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.253 -0.885 . . . . 70.200000000000003 112.075 176.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.94 157.75 30.54 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.485 0.659 . . . . 75.409999999999997 111.341 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.69 -35.3 78.57 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 114.76 -1.109 . . . . 75.200000000000003 111.5 175.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -60.38 -32.15 71.03 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 123.525 0.516 . . . . 75.109999999999999 110.15 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 14.7 m -63.48 -37.06 85.87 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 116.4 -0.364 . . . . 74.209999999999994 111.212 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . 0.589 ' O ' HG11 ' B' ' 95' ' ' VAL . 3.0 m -67.47 -40.21 84.04 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 C-N-CA 119.582 -0.847 . . . . 64.120000000000005 108.984 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -63.0 -30.89 71.95 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.961 0.41 . . . . 75.140000000000001 110.933 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.73 -40.25 63.69 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.22 -0.445 . . . . 74.010000000000005 110.546 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.97 -40.41 63.02 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-N 116.409 -0.359 . . . . 54.130000000000003 111.401 -177.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . 0.589 HG11 ' O ' ' B' ' 91' ' ' VAL . 16.6 m -58.24 -21.66 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 112.873 0.694 . . . . 63.100000000000001 112.873 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.91 -15.94 63.84 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.44 0.638 . . . . 45.130000000000003 109.759 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 34.0 mtp -94.68 6.26 49.43 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 123.954 0.902 . . . . 72.140000000000001 110.021 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 2.0 p-10 -38.87 -46.65 1.32 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.455 1.28 . . . . 73.430000000000007 114.455 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -113.19 99.05 7.52 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 118.998 0.817 . . . . 71.439999999999998 109.931 171.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' B' ' 106' ' ' THR . 19.0 p -139.65 167.44 22.1 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.064 -0.971 . . . . 73.400000000000006 111.462 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' B' ' 105' ' ' ARG . 7.4 p -102.64 125.27 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 CA-C-O 121.671 0.748 . . . . 73.099999999999994 109.907 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -135.44 120.4 18.65 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.941 -1.133 . . . . 73.340000000000003 107.941 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 56.41 32.61 20.94 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.554 1.142 . . . . 74.109999999999999 112.31 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.71 4.5 82.62 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 114.661 -1.154 . . . . 63.119999999999997 113.488 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' B' ' 101' ' ' VAL . 99.2 mtt180 -120.89 162.85 19.14 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 117.224 0.512 . . . . 71.010000000000005 109.929 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' B' ' 100' ' ' THR . 62.9 m -94.12 120.52 34.48 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.067 -1.086 . . . . 71.430000000000007 108.067 175.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . 0.409 ' HA ' ' HB3' ' B' ' 43' ' ' ASN . 40.8 pt -100.68 170.45 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.116 -1.034 . . . . 73.140000000000001 110.164 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 55.5 tptt -133.1 126.07 30.97 Favored 'General case' 0 N--CA 1.434 -1.227 0 O-C-N 123.728 0.643 . . . . 72.400000000000006 109.629 -177.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 27.3 m -128.85 138.36 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-N 116.429 -0.351 . . . . 72.430000000000007 111.423 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . 0.537 ' HB3' ' HD2' ' B' ' 111' ' ' PRO 0.255 0.1 OUTLIER -140.01 169.68 11.46 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 105.61 -1.996 . . . . 74.5 105.61 174.636 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' B' ' 110' ' ' LEU . 89.6 Cg_endo -80.3 130.47 8.14 Favored 'Trans proline' 0 N--CA 1.425 -2.515 0 C-N-CA 121.412 1.408 . . . . 74.540000000000006 109.718 172.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.465 ' HE3' ' OG ' ' B' ' 38' ' ' SER . 15.0 ttpp . . . . . 0 C--N 1.29 -1.997 0 N-CA-C 104.723 -2.325 . . . . 60.149999999999999 104.723 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.66 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 7.1 mm-40 . . . . . 0 N--CA 1.444 -0.768 0 CA-C-O 119.976 -0.059 . . . . 75.340000000000003 111.067 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.0 pt -67.44 -34.99 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 112.413 0.523 . . . . 64.540000000000006 112.413 -176.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.498 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . 46.3 m-20 -59.52 -39.88 85.31 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.043 0.449 . . . . 64.140000000000001 110.014 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -76.18 -11.02 59.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.134 -0.939 . . . . 75.420000000000002 110.592 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.66 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 61.1 mmt-85 -98.16 5.44 48.52 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 109.052 -0.721 . . . . 72.329999999999998 109.052 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.476 ' HG ' ' HG2' ' A' ' 84' ' ' GLU . 46.9 t -109.93 164.61 12.43 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 113.677 0.992 . . . . 72.219999999999999 113.677 -174.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.98 162.18 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 114.937 -1.029 . . . . 61.229999999999997 110.017 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.545 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 28.5 t80 -110.34 124.64 52.06 Favored 'General case' 0 C--N 1.29 -2.01 0 C-N-CA 124.826 1.25 . . . . 74.219999999999999 107.722 177.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.8 t -111.07 116.43 52.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 N-CA-C 108.08 -1.081 . . . . 72.540000000000006 108.08 178.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.86 166.61 12.78 Favored Glycine 0 N--CA 1.417 -2.582 0 C-N-CA 119.909 -1.139 . . . . 71.239999999999995 112.092 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.8 t30 67.99 18.11 9.52 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 125.732 1.613 . . . . 74.420000000000002 113.449 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.533 ' O ' ' HA3' ' A' ' 79' ' ' GLY . 7.1 p -73.95 116.67 16.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.941 -0.762 . . . . 75.010000000000005 108.941 175.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -94.98 168.18 10.94 Favored 'General case' 0 C--O 1.255 1.373 0 CA-C-O 121.226 0.536 . . . . 74.010000000000005 111.851 -172.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.648 ' CE1' ' HB2' ' A' ' 77' ' ' PRO . 4.5 m-85 -64.77 96.44 0.18 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.405 -1.27 . . . . 73.239999999999995 110.935 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.42 -26.32 0.3 Allowed Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 109.949 -1.261 . . . . 45.329999999999998 109.949 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.5 m -84.14 135.06 34.53 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.222 -1.029 . . . . 71.219999999999999 108.222 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.1 p -105.84 170.8 7.69 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 119.755 -0.164 . . . . 75.329999999999998 111.095 -176.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.439 ' HB2' HD12 ' A' ' 66' ' ' ILE . . . -64.2 -50.55 67.65 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 117.828 0.286 . . . . 71.519999999999996 111.105 -177.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.402 ' HG2' ' CE2' ' B' ' 46' ' ' TYR . 78.8 mt-30 -59.03 -38.87 80.28 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.465 0.543 . . . . 74.319999999999993 112.465 176.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -64.53 -37.62 88.2 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.779 0.799 . . . . 74.120000000000005 109.43 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.5 mt -72.68 -47.35 48.04 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.996 -1.002 . . . . 65.329999999999998 110.955 177.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -61.39 -49.39 77.08 Favored 'General case' 0 C--O 1.204 -1.308 0 C-N-CA 123.295 0.638 . . . . 75.200000000000003 110.855 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.07 -44.09 78.59 Favored 'General case' 0 C--O 1.256 1.443 0 CA-C-O 121.269 0.557 . . . . 71.239999999999995 111.042 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -64.58 -39.98 94.7 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.268 -0.878 . . . . 74.129999999999995 110.858 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -82.1 -22.43 36.24 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 113.266 0.839 . . . . 72.099999999999994 113.266 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.2 t -70.31 -23.88 62.93 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.781 -0.645 . . . . 73.109999999999999 109.3 -177.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.9 m -58.96 -27.76 65.66 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-O 121.266 0.555 . . . . 65.209999999999994 109.861 172.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 58.9 m -94.12 5.39 51.87 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.023 0.529 . . . . 62.310000000000002 112.161 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.33 -166.81 27.58 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.306 -1.426 . . . . 73.319999999999993 114.259 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.2 t -98.83 123.0 42.8 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 120.896 0.379 . . . . 63.140000000000001 110.548 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.404 HG21 HD13 ' A' ' 63' ' ' ILE . 69.8 mt -83.41 134.28 27.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-O 121.606 0.717 . . . . 63.130000000000003 112.58 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.635 ' OD1' ' HB3' ' B' ' 73' ' ' PHE . 34.2 t30 -98.07 -45.08 6.37 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.443 -1.253 . . . . 72.040000000000006 110.254 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.463 ' HA ' ' HA ' ' B' ' 71' ' ' ASP . 49.4 mtp180 -155.57 165.03 37.83 Favored 'General case' 0 C--O 1.213 -0.86 0 N-CA-C 107.873 -1.158 . . . . 71.129999999999995 107.873 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.439 HD12 ' HB2' ' A' ' 50' ' ' ALA . 19.2 pt -146.08 144.38 20.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.237 -1.024 . . . . 71.0 108.237 171.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.57 ' OG1' ' HB2' ' A' ' 82' ' ' TYR . 39.7 p -122.43 137.2 54.95 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 105.414 -2.069 . . . . 64.219999999999999 105.414 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.445 HD12 ' O ' ' B' ' 68' ' ' ILE . 3.1 mp -129.26 112.54 25.46 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 105.705 -1.961 . . . . 73.430000000000007 105.705 173.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.473 ' HG ' ' CE2' ' A' ' 80' ' ' TYR 0.255 1.6 pt? -120.38 123.59 43.44 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 119.772 -0.771 . . . . 75.109999999999999 111.2 -179.228 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 73.4 m -117.83 136.47 53.4 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.204 -0.907 . . . . 51.509999999999998 109.592 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.599 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 4.0 p30 -120.24 143.43 48.3 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 119.928 -0.709 . . . . 75.510000000000005 110.011 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -124.85 5.31 8.07 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.336 -0.616 . . . . 62.310000000000002 109.336 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.609 ' HB3' ' OD1' ' B' ' 64' ' ' ASN . 36.9 p90 -64.52 -25.68 68.09 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 112.198 0.444 . . . . 62.0 112.198 -176.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.9 t -80.97 -8.47 59.77 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.151 0.5 . . . . 74.099999999999994 110.67 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.98 -55.19 0.57 Allowed Glycine 0 CA--C 1.494 -1.225 0 N-CA-C 110.427 -1.069 . . . . 60.409999999999997 110.427 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -96.63 133.81 24.09 Favored Pre-proline 0 C--N 1.295 -1.795 0 N-CA-C 107.482 -1.303 . . . . 74.510000000000005 107.482 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.648 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 74.2 Cg_endo -76.78 117.27 4.46 Favored 'Trans proline' 0 N--CA 1.426 -2.492 0 C-N-CA 120.613 0.875 . . . . 63.420000000000002 111.134 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm -100.77 147.11 26.43 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 115.552 -0.749 . . . . 73.209999999999994 109.283 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' A' ' 44' ' ' VAL . . . -122.38 137.01 11.11 Favored Glycine 0 N--CA 1.418 -2.558 0 C-N-CA 120.05 -1.071 . . . . 36.939999999999998 112.494 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.473 ' CE2' ' HG ' ' A' ' 69' ' ' LEU . 5.2 p90 -149.87 143.09 25.08 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 124.407 1.083 . . . . 71.230000000000004 109.338 176.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.32 153.95 45.43 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 116.509 -0.314 . . . . 72.150000000000006 111.825 -171.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.691 ' OH ' ' HA3' ' B' ' 21' ' ' GLY . 20.0 m-85 -116.78 125.1 51.11 Favored 'General case' 0 CA--C 1.461 -2.449 0 C-N-CA 122.864 0.466 . . . . 71.540000000000006 110.729 173.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.3 mm -103.69 110.7 30.83 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.536 0 N-CA-C 106.375 -1.713 . . . . 72.129999999999995 106.375 175.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.476 ' HG2' ' HG ' ' A' ' 38' ' ' SER . 29.2 mt-10 -96.88 121.08 38.36 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.325 -0.991 . . . . 63.420000000000002 108.325 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -99.43 170.98 8.24 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.218 0.533 . . . . 73.319999999999993 111.239 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.62 -41.01 22.09 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.474 -0.784 . . . . 73.340000000000003 110.637 173.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -101.81 146.99 27.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.06 0.457 . . . . 75.299999999999997 111.355 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.541 ' O ' HG21 ' A' ' 91' ' ' VAL . 0.8 OUTLIER -74.71 -34.05 62.51 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.077 -1.453 . . . . 75.319999999999993 107.077 -179.304 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.286 0.9 OUTLIER -65.98 -20.06 66.07 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.156 -0.929 . . . . 72.129999999999995 113.212 177.425 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.6 m -66.27 -36.6 83.41 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 109.824 -0.436 . . . . 71.040000000000006 109.824 174.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.541 HG21 ' O ' ' A' ' 88' ' ' ARG . 3.6 m -66.26 -40.42 86.81 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 N-CA-C 108.629 -0.878 . . . . 65.340000000000003 108.629 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -55.54 -38.52 69.39 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.435 0.694 . . . . 65.030000000000001 110.529 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.71 -37.92 65.0 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.838 -0.619 . . . . 61.229999999999997 111.421 177.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.85 -39.91 55.7 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.188 0.44 . . . . 53.030000000000001 112.188 -176.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 91' ' ' VAL . 33.0 m -55.41 -22.06 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 113.068 0.766 . . . . 54.399999999999999 113.068 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.31 -9.63 42.89 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 120.991 0.424 . . . . 41.409999999999997 110.37 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.56 ' C ' ' H ' ' A' ' 99' ' ' GLU . 68.3 mtm -99.17 5.98 46.58 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.153 0.797 . . . . 75.349999999999994 113.153 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -67.57 24.07 0.02 OUTLIER 'General case' 0 N--CA 1.528 3.43 0 C-N-CA 123.641 0.776 . . . . 74.230000000000004 112.578 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.56 ' H ' ' C ' ' A' ' 97' ' ' MET . 39.6 tt0 -156.21 -7.81 0.11 Allowed 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.805 -1.089 . . . . 71.420000000000002 109.171 -168.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.4 p -88.03 169.2 12.17 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.517 -0.765 . . . . 73.010000000000005 111.625 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.7 p -106.46 132.44 53.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-N 115.401 -0.818 . . . . 63.109999999999999 109.814 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -127.14 123.68 37.33 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.561 -0.903 . . . . 75.409999999999997 108.561 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.3 ttt-85 54.52 33.01 17.98 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-O 122.975 1.369 . . . . 75.129999999999995 111.003 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.0 14.62 69.08 Favored Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 114.224 -1.353 . . . . 74.319999999999993 114.449 176.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -136.12 148.82 48.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 118.043 0.922 . . . . 61.310000000000002 110.64 174.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.5 m -79.15 121.64 25.26 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.768 -0.827 . . . . 70.420000000000002 108.768 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 37.4 pt -102.32 172.13 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.18 0.514 . . . . 72.310000000000002 111.287 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -124.89 127.28 46.87 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.228 -1.027 . . . . 63.509999999999998 108.228 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 23.8 t -126.79 115.95 43.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 107.746 -1.205 . . . . 75.340000000000003 107.746 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.446 HD11 ' HB3' ' A' ' 40' ' ' TYR 0.283 0.0 OUTLIER -138.38 141.39 31.38 Favored Pre-proline 0 C--N 1.311 -1.073 0 C-N-CA 119.536 -0.865 . . . . 72.319999999999993 109.112 -179.533 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.01 140.0 44.32 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 122.326 2.017 . . . . 72.409999999999997 114.153 -171.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.498 ' HE3' ' HA ' ' A' ' 35' ' ' ASP . 32.8 ttpt . . . . . 0 N--CA 1.429 -1.5 0 N-CA-C 109.109 -0.7 . . . . 72.25 109.109 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.691 ' HA3' ' OH ' ' A' ' 82' ' ' TYR . . . . . . . . 0 C--O 1.239 0.436 0 N-CA-C 115.093 0.797 . . . . 54.420000000000002 115.093 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.65 -35.98 97.8 Favored 'Trans proline' 0 CA--C 1.558 1.724 0 C-N-CA 123.492 2.795 . . . . 71.25 114.762 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -47.52 123.57 8.26 Favored 'Trans proline' 0 C--N 1.4 3.27 0 C-N-CA 122.073 1.849 . . . . 75.409999999999997 113.041 174.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -91.03 141.52 26.56 Favored Pre-proline 0 C--N 1.294 -1.841 0 CA-C-N 114.56 -1.2 . . . . 63.140000000000001 108.874 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -49.3 117.73 3.1 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.998 2.465 . . . . 63.409999999999997 113.515 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 7.2 mp -58.04 -176.04 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.191 0 CA-C-N 113.98 -1.464 . . . . 71.010000000000005 110.453 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 20.3 m -66.58 142.93 57.32 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 107.254 -1.387 . . . . 63.009999999999998 107.254 171.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.564 ' O ' ' HE2' ' B' ' 32' ' ' LYS . . . -56.02 -42.84 77.07 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.577 -0.738 . . . . 65.109999999999999 110.68 176.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -68.4 -30.84 69.85 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 112.812 0.671 . . . . 74.409999999999997 112.812 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.411 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.7 OUTLIER -65.75 -39.74 91.38 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.636 -0.505 . . . . 62.299999999999997 109.636 171.673 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.448 ' HA ' HG12 ' B' ' 34' ' ' ILE . 57.3 mttm -70.19 -49.98 44.83 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 113.162 0.801 . . . . 53.229999999999997 113.162 -178.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.564 ' HE2' ' O ' ' B' ' 28' ' ' ALA . 0.3 OUTLIER -56.09 -39.15 71.7 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 120.146 -0.622 . . . . 75.209999999999994 112.639 -178.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 17.9 mt-10 -71.85 -41.61 67.91 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 118.945 -1.102 . . . . 74.230000000000004 112.629 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.448 HG12 ' HA ' ' B' ' 31' ' ' LYS . 35.1 pt -68.88 -35.46 69.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 C-N-CA 120.213 -0.595 . . . . 73.340000000000003 111.351 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -59.85 -44.08 94.31 Favored 'General case' 0 C--O 1.217 -0.625 0 N-CA-C 109.674 -0.491 . . . . 72.140000000000001 109.674 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 98.4 mttt -70.33 -18.22 63.08 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.269 -0.878 . . . . 65.239999999999995 112.298 -175.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' B' ' 33' ' ' GLU . 18.8 ptp180 -109.8 24.93 12.38 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-O 121.443 0.64 . . . . 71.040000000000006 111.383 -178.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' SER . . . . . 0.45 ' HB2' ' HD3' ' B' ' 112' ' ' LYS . 19.5 m -115.51 172.69 6.95 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.656 -0.702 . . . . 60.140000000000001 110.997 174.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.4 163.66 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 123.19 0.596 . . . . 74.25 110.573 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 36.0 t80 -111.97 125.61 54.25 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 125.596 1.559 . . . . 72.109999999999999 107.94 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 57.9 t -114.66 116.31 52.2 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 C-N-CA 123.651 0.78 . . . . 74.219999999999999 109.191 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.98 165.39 12.52 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 120.716 -0.754 . . . . 61.119999999999997 112.406 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 t30 57.81 20.43 6.53 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 126.241 1.816 . . . . 72.340000000000003 113.26 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.72 129.0 19.08 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 CA-C-O 121.396 0.617 . . . . 71.239999999999995 109.389 173.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.475 ' HA ' ' CZ ' ' B' ' 105' ' ' ARG . 20.8 t70 -61.35 139.23 58.22 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 114.674 -1.148 . . . . 64.299999999999997 109.274 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' TYR . . . . . 0.402 ' CE2' ' HG2' ' A' ' 51' ' ' GLN . 32.6 t80 -70.32 0.15 7.01 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.714 -0.676 . . . . 74.230000000000004 111.072 -174.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -107.6 -0.23 34.61 Favored Glycine 0 N--CA 1.421 -2.304 0 CA-C-N 115.799 -0.637 . . . . 71.230000000000004 112.148 175.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.9 t -80.51 146.27 31.42 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.599 -1.26 . . . . 71.420000000000002 107.599 176.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 71.7 p -105.52 172.58 6.72 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.982 -0.377 . . . . 73.030000000000001 109.982 -177.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.429 ' HB2' HD12 ' B' ' 66' ' ' ILE . . . -63.72 -50.4 69.29 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 120.57 0.224 . . . . 71.209999999999994 110.539 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -61.03 -35.99 78.36 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 111.838 0.311 . . . . 75.420000000000002 111.838 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -64.17 -43.65 94.49 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 109.61 -0.515 . . . . 65.209999999999994 109.61 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 52.0 mt -67.67 -48.14 67.48 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.208 -0.905 . . . . 73.140000000000001 112.042 176.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.423 ' HG2' HD13 ' B' ' 63' ' ' ILE . 0.6 OUTLIER -60.32 -49.16 78.71 Favored 'General case' 0 C--O 1.207 -1.132 0 C-N-CA 123.387 0.675 . . . . 75.209999999999994 110.809 -177.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.28 -43.25 78.62 Favored 'General case' 0 C--O 1.262 1.718 0 CA-C-O 121.215 0.531 . . . . 61.130000000000003 111.123 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -65.77 -39.25 90.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.479 -0.782 . . . . 74.219999999999999 110.718 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -82.45 -22.55 35.19 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 113.432 0.901 . . . . 75.150000000000006 113.432 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 36.1 t -69.23 -25.16 64.17 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.958 -0.565 . . . . 72.239999999999995 109.766 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.9 m -62.9 -24.97 68.09 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 120.387 -0.525 . . . . 74.310000000000002 110.511 173.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 58.4 m -96.55 3.73 52.46 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 122.744 0.418 . . . . 54.229999999999997 112.061 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.13 -171.72 32.73 Favored Glycine 0 C--O 1.222 -0.634 0 C-N-CA 119.281 -1.438 . . . . 65.409999999999997 114.456 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 21.7 m -98.86 119.38 37.52 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.707 -0.479 . . . . 51.409999999999997 109.707 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.423 HD13 ' HG2' ' B' ' 54' ' ' GLU . 50.8 mt -82.52 132.74 30.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 112.997 0.74 . . . . 73.450000000000003 112.997 -177.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . 0.609 ' OD1' ' HB3' ' A' ' 73' ' ' PHE . 46.1 t-20 -93.79 -51.29 4.97 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 125.315 1.446 . . . . 73.040000000000006 109.225 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.443 ' HD3' ' OE1' ' B' ' 84' ' ' GLU . 46.5 mtp180 -153.14 166.75 31.53 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.547 -1.279 . . . . 73.120000000000005 107.547 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.429 HD12 ' HB2' ' B' ' 50' ' ' ALA . 19.9 pt -147.13 144.28 19.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 108.059 -1.089 . . . . 75.319999999999993 108.059 171.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' THR . . . . . 0.574 ' OG1' ' HB2' ' B' ' 82' ' ' TYR . 36.9 p -121.71 136.88 54.93 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 105.387 -2.079 . . . . 55.100000000000001 105.387 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.445 ' O ' HD12 ' A' ' 68' ' ' ILE . 2.2 mp -129.25 113.08 26.93 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 N-CA-C 105.561 -2.014 . . . . 74.400000000000006 105.561 173.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.51 ' HG ' ' CE2' ' B' ' 80' ' ' TYR 0.274 1.5 pt? -120.72 123.03 41.72 Favored 'General case' 0 C--N 1.281 -2.387 0 C-N-CA 119.987 -0.685 . . . . 72.310000000000002 111.486 -179.497 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' CYS . . . . . 0.479 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 67.0 m -117.6 134.82 54.47 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.621 -0.718 . . . . 75.010000000000005 109.631 -177.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . 0.501 ' CG ' ' HZ2' ' B' ' 78' ' ' LYS . 3.5 p30 -115.11 140.38 49.11 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.878 -0.729 . . . . 74.439999999999998 109.871 177.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . 0.459 ' HZ2' ' HB3' ' B' ' 72' ' ' LYS . 7.6 mtpm? -112.5 7.67 19.06 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 116.126 -0.488 . . . . 73.349999999999994 110.365 -178.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.635 ' HB3' ' OD1' ' A' ' 64' ' ' ASN . 12.5 p90 -73.08 -11.2 60.46 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 121.524 0.678 . . . . 74.319999999999993 110.585 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' SER . . . . . 0.453 ' C ' ' H ' ' B' ' 76' ' ' HIS . 20.7 m -88.13 9.48 22.59 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.117 -0.947 . . . . 61.25 110.09 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.95 -51.0 4.39 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 109.607 -1.397 . . . . 72.439999999999998 109.607 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . 0.453 ' H ' ' C ' ' B' ' 74' ' ' SER . 95.1 m-70 -96.43 145.53 29.74 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 105.806 -1.924 . . . . 75.109999999999999 105.806 174.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.43 ' HB3' ' HG2' ' B' ' 72' ' ' LYS . 58.2 Cg_endo -77.43 118.1 4.52 Favored 'Trans proline' 0 N--CA 1.437 -1.81 0 C-N-CA 120.767 0.978 . . . . 65.420000000000002 110.623 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' LYS . . . . . 0.501 ' HZ2' ' CG ' ' B' ' 71' ' ' ASP . 28.8 mtmm -93.71 137.49 32.91 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 108.13 -1.063 . . . . 50.439999999999998 108.13 177.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -116.17 133.33 10.73 Favored Glycine 0 N--CA 1.413 -2.887 0 C-N-CA 119.974 -1.108 . . . . 62.0 111.773 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . 0.51 ' CE2' ' HG ' ' B' ' 69' ' ' LEU . 6.8 p90 -147.74 142.73 26.97 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 124.04 0.936 . . . . 75.129999999999995 109.42 175.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.08 154.37 45.91 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 116.397 -0.365 . . . . 74.230000000000004 111.728 -172.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' TYR . . . . . 0.574 ' HB2' ' OG1' ' B' ' 67' ' ' THR . 19.4 m-85 -117.25 124.96 50.31 Favored 'General case' 0 CA--C 1.467 -2.23 0 C-N-CA 122.78 0.432 . . . . 74.519999999999996 110.442 173.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 34.5 mm -102.75 110.11 28.5 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 106.635 -1.617 . . . . 74.040000000000006 106.635 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' GLU . . . . . 0.443 ' OE1' ' HD3' ' B' ' 65' ' ' ARG . 31.2 mt-10 -95.3 120.61 35.83 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.417 -0.957 . . . . 54.43 108.417 -178.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -99.09 162.2 13.2 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.413 0.625 . . . . 72.230000000000004 111.111 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.32 -11.37 56.48 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.509 -0.769 . . . . 65.200000000000003 109.983 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . 0.602 ' HB3' ' OG ' ' B' ' 90' ' ' SER . 43.2 tt0 -124.23 140.6 52.8 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.309 -0.405 . . . . 72.420000000000002 111.094 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.495 ' O ' HG21 ' B' ' 91' ' ' VAL . 0.6 OUTLIER -74.99 -34.91 62.02 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.64 -1.244 . . . . 74.030000000000001 107.64 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.13 -28.38 69.6 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.512 -0.921 . . . . 75.420000000000002 108.512 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' SER . . . . . 0.602 ' OG ' ' HB3' ' B' ' 87' ' ' GLU . 70.2 m -63.46 -36.34 83.43 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 116.19 -0.459 . . . . 71.239999999999995 111.025 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . 0.495 HG21 ' O ' ' B' ' 88' ' ' ARG . 3.6 m -67.18 -40.13 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.519 0 N-CA-C 108.551 -0.907 . . . . 61.130000000000003 108.551 179.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -56.96 -37.68 71.9 Favored 'General case' 0 N--CA 1.455 -0.225 0 O-C-N 123.828 0.705 . . . . 75.049999999999997 110.9 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.9 -37.18 64.76 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.753 -0.658 . . . . 61.329999999999998 111.48 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.83 -41.15 53.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.506 . . . . 73.510000000000005 111.87 -176.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . 0.483 HG12 ' O ' ' B' ' 91' ' ' VAL . 32.8 m -55.23 -21.46 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 112.905 0.705 . . . . 72.299999999999997 112.905 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.07 -13.77 62.25 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.805 0.812 . . . . 72.239999999999995 111.14 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 68.2 mtm -97.2 9.69 41.5 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.418 -0.81 . . . . 72.430000000000007 110.011 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . 0.703 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 6.1 p-10 -36.27 -46.81 0.55 Allowed 'General case' 0 C--O 1.204 -1.31 0 N-CA-C 115.694 1.739 . . . . 63.210000000000001 115.694 -176.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -128.47 41.89 3.41 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 118.585 -1.246 . . . . 73.299999999999997 110.792 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 40.8 p -79.62 176.87 9.32 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.88 -0.6 . . . . 74.400000000000006 110.794 175.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.04 132.96 55.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.139 0.495 . . . . 74.120000000000005 109.876 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -140.49 125.82 18.78 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.482 -0.781 . . . . 74.409999999999997 109.004 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . 0.263 20.7 ttt180 50.49 54.78 10.56 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 122.295 1.045 . . . . 74.349999999999994 113.747 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.89 -7.5 42.38 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 114.341 -1.3 . . . . 36.939999999999998 115.568 176.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.475 ' CZ ' ' HA ' ' B' ' 45' ' ' ASP . 10.2 ptt180 -136.7 159.89 40.48 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 114.35 1.241 . . . . 74.400000000000006 114.35 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 34.5 m -87.12 120.93 28.91 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.169 -0.923 . . . . 61.539999999999999 109.931 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 39.5 pt -101.78 172.01 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 116.204 -0.453 . . . . 73.319999999999993 110.413 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' LYS . . . . . 0.703 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 56.1 tptt -125.84 129.39 49.29 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.828 -0.804 . . . . 71.019999999999996 108.828 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 18.0 t -124.54 121.58 61.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 107.653 -1.24 . . . . 64.439999999999998 107.653 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.295 0.4 OUTLIER -140.09 135.05 16.02 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 106.25 -1.759 . . . . 73.209999999999994 106.25 -170.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.33 143.53 53.2 Favored 'Trans proline' 0 CA--C 1.551 1.363 0 C-N-CA 121.885 1.723 . . . . 71.310000000000002 113.93 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.45 ' HD3' ' HB2' ' B' ' 38' ' ' SER . 66.0 tttt . . . . . 0 C--N 1.323 -0.57 0 C-N-CA 123.54 0.736 . . . . 70.219999999999999 110.436 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 120.546 0.212 . . . . 72.319999999999993 111.513 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.3 pt -71.09 -36.74 64.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.966 -0.561 . . . . 64.140000000000001 111.904 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.507 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 29.9 m-20 -76.17 -19.14 58.73 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.712 0.634 . . . . 75.040000000000006 112.712 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -66.96 -26.42 66.81 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.361 0.6 . . . . 70.340000000000003 110.339 174.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -96.89 16.03 20.51 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.153 -0.684 . . . . 72.010000000000005 109.153 -177.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.519 ' OG ' ' HG3' ' A' ' 84' ' ' GLU . 14.9 m -103.5 163.01 12.56 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 115.542 -0.754 . . . . 62.439999999999998 110.48 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.2 m -131.64 164.16 35.29 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 115.469 -0.787 . . . . 75.439999999999998 109.883 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.525 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 23.7 t80 -110.87 126.03 54.25 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 107.44 -1.318 . . . . 73.109999999999999 107.44 175.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.0 t -115.89 111.99 37.8 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 N-CA-C 107.753 -1.203 . . . . 53.340000000000003 107.753 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 43' ' ' ASN . . . -105.6 172.03 18.89 Favored Glycine 0 CA--C 1.478 -2.256 0 N-CA-C 109.706 -1.358 . . . . 37.909999999999997 109.706 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.692 ' OD1' ' HG3' ' A' ' 105' ' ' ARG . 26.2 t-20 69.42 -11.05 0.51 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.356 0.662 . . . . 64.150000000000006 112.395 -178.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 44' ' ' VAL . 8.7 p -70.19 91.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 107.372 -1.344 . . . . 71.310000000000002 107.372 176.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.38 10.5 m-20 -74.43 168.02 20.53 Favored 'General case' 0 CA--C 1.457 -2.618 0 N-CA-C 116.341 1.978 . . . . 61.149999999999999 116.341 -166.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.56 ' HH ' ' CD ' ' B' ' 54' ' ' GLU . 62.8 t80 -39.33 -34.49 0.2 Allowed 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 128.231 2.612 . . . . 73.299999999999997 114.791 -173.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.66 -1.53 85.37 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.435 -0.888 . . . . 74.319999999999993 114.075 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 103' ' ' ARG . 19.7 m -75.26 133.33 41.37 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 117.677 0.738 . . . . 71.0 111.041 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.596 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 12.6 p -92.22 155.89 17.68 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 115.583 -0.735 . . . . 74.129999999999995 111.046 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.505 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -65.54 -47.82 74.58 Favored 'General case' 0 C--O 1.212 -0.904 0 C-N-CA 122.641 0.376 . . . . 71.420000000000002 110.831 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -56.81 -53.43 57.89 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.519 0.728 . . . . 63.009999999999998 112.529 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.61 -36.75 83.75 Favored 'General case' 0 C--O 1.25 1.128 0 CA-C-O 121.397 0.617 . . . . 55.509999999999998 111.348 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.596 ' HB2' ' O ' ' A' ' 49' ' ' THR . 2.9 tt -72.17 -46.56 55.86 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.78 -1.1 . . . . 74.319999999999993 108.493 -176.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.436 ' CD ' ' HZ2' ' B' ' 72' ' ' LYS . 35.9 tt0 -58.26 -48.3 80.86 Favored 'General case' 0 C--O 1.207 -1.158 0 C-N-CA 123.482 0.713 . . . . 74.120000000000005 111.039 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.92 -38.23 69.99 Favored 'General case' 0 C--O 1.258 1.551 0 CA-C-O 121.268 0.556 . . . . 61.439999999999998 110.752 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -65.39 -40.3 93.27 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.117 -0.947 . . . . 75.040000000000006 110.189 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -83.04 -21.33 33.83 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 113.751 1.019 . . . . 74.209999999999994 113.751 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.8 t -60.47 -33.69 72.94 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.988 -0.745 . . . . 72.549999999999997 108.988 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.9 m -59.04 -27.8 65.82 Favored 'General case' 0 CA--C 1.565 1.536 0 CA-C-N 115.789 -0.641 . . . . 63.210000000000001 111.807 174.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 67.5 m -92.0 -0.85 57.48 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.36 0.874 . . . . 73.030000000000001 113.36 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.69 -169.96 30.53 Favored Glycine 0 C--N 1.319 -0.399 0 C-N-CA 118.951 -1.595 . . . . 74.099999999999994 114.562 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.4 m -94.56 116.78 29.19 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 123.205 0.602 . . . . 71.010000000000005 110.479 -175.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 85.1 mt -89.23 130.1 39.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 C-N-CA 123.015 0.526 . . . . 74.150000000000006 112.368 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -99.34 -40.41 7.92 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.686 -0.688 . . . . 71.430000000000007 111.106 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' B' ' 71' ' ' ASP . 55.6 mtp180 -150.55 160.9 43.47 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 107.91 -1.145 . . . . 73.310000000000002 107.91 -177.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.505 HD11 ' HB1' ' A' ' 50' ' ' ALA . 26.4 pt -145.14 137.97 21.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.382 -1.34 . . . . 75.340000000000003 107.382 173.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.9 m -125.61 120.89 32.03 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 107.604 -1.258 . . . . 64.049999999999997 107.604 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.408 ' O ' HD13 ' B' ' 68' ' ' ILE . 2.8 mp -118.18 118.45 58.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 106.218 -1.771 . . . . 74.230000000000004 106.218 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.512 ' N ' HD21 ' A' ' 69' ' ' LEU 0.26 1.2 pt? -121.9 125.59 46.76 Favored 'General case' 0 C--N 1.285 -2.22 0 C-N-CA 120.257 -0.577 . . . . 60.210000000000001 111.967 179.156 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 73.1 m -117.37 136.0 53.47 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.734 -0.839 . . . . 71.420000000000002 108.734 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 2.5 p30 -131.07 153.52 49.22 Favored 'General case' 0 CA--C 1.495 -1.141 0 C-N-CA 119.146 -1.022 . . . . 62.140000000000001 112.033 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.402 ' HE3' ' OE1' ' B' ' 54' ' ' GLU . 97.9 mttt -121.54 18.33 11.26 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 124.048 0.843 . . . . 72.099999999999994 110.883 176.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -69.03 -21.18 64.13 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 119.049 -1.06 . . . . 72.409999999999997 112.98 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.7 p -91.8 10.61 27.82 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.405 0.621 . . . . 73.340000000000003 110.471 174.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.63 -47.87 1.4 Allowed Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.552 -0.619 . . . . 62.350000000000001 111.552 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -97.27 136.83 21.24 Favored Pre-proline 0 C--N 1.301 -1.543 0 CA-C-N 115.512 -0.344 . . . . 72.329999999999998 110.23 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.463 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 31.7 Cg_endo -69.0 118.61 5.78 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.616 1.544 . . . . 71.140000000000001 110.364 175.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 34.6 mtmm -113.33 149.74 33.55 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.337 -0.616 . . . . 73.439999999999998 109.337 -178.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -120.38 134.8 10.56 Favored Glycine 0 N--CA 1.423 -2.195 0 C-N-CA 119.847 -1.168 . . . . 73.230000000000004 112.791 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.469 ' CE2' ' HG ' ' A' ' 69' ' ' LEU . 17.6 p90 -152.85 144.42 23.42 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 124.326 1.05 . . . . 74.109999999999999 109.644 175.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.23 155.89 45.97 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.035 0.445 . . . . 64.010000000000005 111.811 -173.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -115.14 130.09 56.84 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.183 -1.414 . . . . 74.040000000000006 107.183 174.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.403 HG22 HG21 ' A' ' 66' ' ' ILE . 40.9 mm -112.39 112.88 42.38 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 108.454 -0.943 . . . . 73.230000000000004 108.454 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.519 ' HG3' ' OG ' ' A' ' 38' ' ' SER . 1.9 mp0 -88.08 118.96 28.01 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 122.61 0.364 . . . . 73.420000000000002 110.801 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -103.82 163.69 12.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.486 0.66 . . . . 73.219999999999999 111.602 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.27 -23.91 47.07 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.135 -0.938 . . . . 73.400000000000006 112.098 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -125.67 150.37 47.67 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 113.541 0.941 . . . . 74.120000000000005 113.541 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.526 ' O ' HG23 ' A' ' 91' ' ' VAL . 21.7 mmm180 -70.52 -29.3 65.77 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.248 -0.887 . . . . 73.310000000000002 108.986 173.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.95 -35.38 73.04 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.03 -0.532 . . . . 71.510000000000005 110.188 176.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.8 m -64.64 -36.91 85.8 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 116.745 -0.207 . . . . 73.209999999999994 111.077 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.544 ' O ' HG12 ' A' ' 95' ' ' VAL . 3.7 m -64.79 -39.26 85.05 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.885 0 C-N-CA 119.509 -0.876 . . . . 74.299999999999997 109.001 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -60.07 -34.96 74.16 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.069 0.461 . . . . 74.299999999999997 111.783 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.74 -37.54 65.05 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.905 -0.589 . . . . 73.530000000000001 110.351 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.14 -44.76 59.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.138 -0.483 . . . . 74.25 110.741 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 91' ' ' VAL . 14.8 m -61.09 -23.33 29.6 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.019 0 CA-C-N 116.456 -0.338 . . . . 75.109999999999999 111.8 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.01 -16.0 63.11 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.664 0.745 . . . . 75.430000000000007 110.431 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 25.2 ttp -104.89 9.22 34.78 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.835 -1.075 . . . . 72.019999999999996 109.134 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 4.5 p-10 -37.4 -49.52 1.01 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 113.812 1.041 . . . . 73.230000000000004 113.812 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -115.44 104.17 11.5 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-O 121.744 0.783 . . . . 70.239999999999995 110.268 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.5 t -145.15 173.62 11.77 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 114.712 -1.131 . . . . 71.409999999999997 108.644 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.14 115.76 48.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.827 0.822 . . . . 71.150000000000006 110.301 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -122.58 117.71 26.48 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.034 -1.099 . . . . 75.409999999999997 108.034 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.445 ' CZ ' ' HA ' ' A' ' 48' ' ' SER . 54.3 mtt180 62.26 33.6 16.52 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.79 0.836 . . . . 74.010000000000005 112.841 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.37 -2.64 81.19 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 114.7 -1.136 . . . . 72.420000000000002 114.137 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.692 ' HG3' ' OD1' ' A' ' 43' ' ' ASN . 18.0 ptp180 -130.21 154.84 47.15 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 117.479 0.64 . . . . 74.099999999999994 111.293 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.6 m -83.65 120.96 26.63 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 116.063 -0.517 . . . . 71.439999999999998 111.277 -174.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.564 ' HA ' ' HB3' ' A' ' 43' ' ' ASN . 40.3 pt -99.83 172.13 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 C-N-CA 120.595 -0.442 . . . . 63.200000000000003 111.968 -174.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 54.1 tptt -131.4 126.65 35.7 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.094 -0.957 . . . . 72.420000000000002 109.572 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 35.9 t -127.93 128.69 69.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.368 -0.605 . . . . 74.310000000000002 109.368 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.513 ' HB2' ' HD2' ' A' ' 111' ' ' PRO 0.295 0.0 OUTLIER -148.45 161.94 31.91 Favored Pre-proline 0 C--N 1.303 -1.433 0 CA-C-O 117.604 -1.189 . . . . 75.040000000000006 108.301 174.15 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.513 ' HD2' ' HB2' ' A' ' 110' ' ' LEU . 50.4 Cg_endo -67.73 149.47 78.76 Favored 'Trans proline' 0 C--N 1.357 1.02 0 CA-C-N 121.833 1.69 . . . . 54.219999999999999 109.122 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt . . . . . 0 C--N 1.319 -0.725 0 N-CA-C 107.332 -1.359 . . . . 71.450000000000003 107.332 -179.586 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.643 0 N-CA-C 110.325 -1.11 . . . . 71.019999999999996 110.325 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.459 ' HG2' ' HD3' ' B' ' 23' ' ' PRO . 2.2 Cg_endo -40.84 -51.21 3.76 Favored 'Trans proline' 0 CA--C 1.561 1.87 0 C-N-CA 124.158 3.239 . . . . 71.230000000000004 113.791 172.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.459 ' HD3' ' HG2' ' B' ' 22' ' ' PRO . 1.5 Cg_endo -82.96 123.59 3.64 Favored 'Trans proline' 0 C--N 1.375 1.97 0 CA-C-N 120.825 1.33 . . . . 53.109999999999999 109.763 173.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -62.29 150.39 84.85 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 115.613 -0.721 . . . . 61.140000000000001 111.447 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.38 109.86 0.44 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.476 2.784 . . . . 73.239999999999995 112.914 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.422 ' H ' HD13 ' B' ' 26' ' ' LEU . 0.0 OUTLIER -107.67 148.63 29.13 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.986 -1.116 . . . . 72.010000000000005 107.986 175.421 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.46 ' HB3' ' OE2' ' B' ' 30' ' ' GLU . 40.1 t -61.04 145.86 49.26 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.206 0.817 . . . . 75.340000000000003 113.206 -170.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.661 ' O ' ' HG2' ' B' ' 32' ' ' LYS . . . -49.5 -35.25 19.31 Favored 'General case' 0 C--O 1.196 -1.732 0 CA-C-N 114.638 -1.165 . . . . 74.319999999999993 110.95 172.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -66.26 -34.95 79.17 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.104 0.409 . . . . 75.540000000000006 112.104 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.486 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.7 OUTLIER -66.76 -35.23 79.61 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 109.096 -0.705 . . . . 60.43 109.096 172.409 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -69.82 -37.23 76.15 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.512 -0.767 . . . . 62.409999999999997 110.947 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.69 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 30.6 mmmt -57.63 -46.87 83.59 Favored 'General case' 0 C--O 1.204 -1.333 0 N-CA-C 109.85 -0.426 . . . . 74.319999999999993 109.85 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -66.23 -47.94 72.16 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.102 -0.499 . . . . 64.019999999999996 111.516 -175.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.486 HG12 ' O ' ' B' ' 30' ' ' GLU . 16.1 pt -70.97 -36.11 62.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.766 -0.652 . . . . 71.239999999999995 112.143 -178.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -76.48 -20.14 57.29 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.093 0.775 . . . . 75.519999999999996 113.093 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.69 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 95.9 mttt -67.09 -25.04 66.03 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.783 0.802 . . . . 73.430000000000007 109.64 174.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.612 ' HD3' ' O ' ' B' ' 86' ' ' ALA . 97.3 mtt180 -97.93 13.9 29.11 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.59 -1.186 . . . . 65.219999999999999 109.284 -174.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' SER . . . . . 0.512 ' OG ' ' HE3' ' B' ' 112' ' ' LYS . 43.6 t -107.15 169.41 8.58 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 115.029 -0.987 . . . . 65.430000000000007 110.533 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.49 164.25 33.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 123.651 0.781 . . . . 65.230000000000004 110.244 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . 0.577 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 18.6 t80 -110.17 125.83 53.45 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 107.741 -1.207 . . . . 75.140000000000001 107.741 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.07 112.42 39.51 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 N-CA-C 107.636 -1.246 . . . . 75.25 107.636 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.29 163.2 13.68 Favored Glycine 0 N--CA 1.421 -2.305 0 C-N-CA 120.041 -1.076 . . . . 74.209999999999994 113.46 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 7.9 t30 56.56 22.79 6.97 Favored 'General case' 0 CA--C 1.564 1.507 0 C-N-CA 125.983 1.713 . . . . 52.530000000000001 112.802 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 10.6 p -57.5 134.67 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 109.116 -0.698 . . . . 73.209999999999994 109.116 174.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -66.25 141.5 58.01 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.061 -0.718 . . . . 64.140000000000001 109.061 -177.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -64.51 -10.77 27.98 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-O 121.558 0.694 . . . . 75.420000000000002 109.892 -176.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.47 -10.09 58.4 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-N 115.677 -0.692 . . . . 54.119999999999997 113.026 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.5 m -98.21 79.7 2.59 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-N 118.685 1.242 . . . . 60.409999999999997 110.994 176.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' THR . . . . . 0.431 ' OG1' HG21 ' A' ' 49' ' ' THR . 22.6 p -71.06 -177.48 1.68 Allowed 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 113.632 0.975 . . . . 75.109999999999999 113.632 175.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.455 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -51.13 -51.5 52.93 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 115.01 1.485 . . . . 65.109999999999999 115.01 -164.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -58.21 -53.52 57.29 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 112.825 0.676 . . . . 64.329999999999998 112.825 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -63.5 -40.59 97.48 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-O 121.568 0.699 . . . . 64.019999999999996 111.02 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 2.7 tt -67.73 -46.76 71.24 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.901 -1.045 . . . . 74.129999999999995 109.298 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.56 ' CD ' ' HH ' ' A' ' 46' ' ' TYR . 29.5 tt0 -58.84 -48.28 81.9 Favored 'General case' 0 C--O 1.206 -1.206 0 C-N-CA 122.474 0.31 . . . . 62.210000000000001 111.422 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.64 -37.63 68.48 Favored 'General case' 0 C--O 1.262 1.726 0 CA-C-O 121.389 0.614 . . . . 74.420000000000002 110.757 -178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -64.92 -40.73 95.51 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.133 -0.94 . . . . 74.430000000000007 110.23 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -83.33 -21.94 33.03 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.715 1.006 . . . . 75.409999999999997 113.715 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 40.5 t -62.93 -32.66 74.01 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 123.812 0.845 . . . . 73.120000000000005 110.06 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 18.2 m -62.42 -24.88 67.65 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-N 116.15 -0.477 . . . . 62.219999999999999 111.197 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 58.8 m -96.04 5.93 50.01 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 112.903 0.705 . . . . 62.240000000000002 112.903 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.24 -177.29 30.12 Favored Glycine 0 C--N 1.32 -0.345 0 C-N-CA 118.823 -1.656 . . . . 62.340000000000003 114.433 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 20.1 m -96.0 114.95 26.71 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.384 0.611 . . . . 71.209999999999994 110.287 -177.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.427 HD12 ' HG3' ' B' ' 54' ' ' GLU . 62.4 mt -85.55 131.44 34.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.789 -0.641 . . . . 71.239999999999995 111.866 -176.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . 0.408 HD22 ' HB1' ' B' ' 86' ' ' ALA . 1.0 OUTLIER -99.04 -41.65 7.46 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.406 -0.816 . . . . 62.039999999999999 111.514 177.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -151.32 160.9 43.55 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 107.886 -1.153 . . . . 63.009999999999998 107.886 -177.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.455 HD11 ' HB1' ' B' ' 50' ' ' ALA . 23.6 pt -145.32 138.23 21.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.379 -1.341 . . . . 70.540000000000006 107.379 172.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 54.0 m -125.64 120.77 31.64 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 107.577 -1.268 . . . . 71.450000000000003 107.577 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.408 HD13 ' O ' ' A' ' 68' ' ' ILE . 3.2 mp -117.83 116.82 52.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 106.612 -1.625 . . . . 70.420000000000002 106.612 -177.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.407 ' HG ' ' CE2' ' B' ' 80' ' ' TYR 0.275 1.1 pt? -120.9 124.5 45.11 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 120.211 -0.595 . . . . 73.329999999999998 112.33 179.78 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 66.4 m -117.51 134.56 54.72 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 108.859 -0.793 . . . . 75.140000000000001 108.859 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 2.8 p30 -125.54 143.2 51.12 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.575 -0.85 . . . . 61.409999999999997 108.822 177.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . 0.436 ' HZ2' ' CD ' ' A' ' 54' ' ' GLU . 35.4 ttmt -118.72 15.53 13.57 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.124 -0.695 . . . . 64.540000000000006 109.124 -177.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -70.4 -11.28 60.81 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.317 0.579 . . . . 75.140000000000001 111.954 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 50.5 m -89.87 3.48 52.85 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.63 -0.713 . . . . 72.310000000000002 110.135 174.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.76 -47.89 2.05 Favored Glycine 0 CA--C 1.498 -1.018 0 N-CA-C 110.28 -1.128 . . . . 74.319999999999993 110.28 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -96.09 135.09 22.92 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 106.648 -1.612 . . . . 72.239999999999995 106.648 175.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.62 118.36 5.29 Favored 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 120.716 0.944 . . . . 62.32 110.609 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 32.9 mtmm -96.76 144.12 27.04 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 109.287 -0.635 . . . . 63.229999999999997 109.287 -178.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -119.42 132.01 9.31 Favored Glycine 0 N--CA 1.415 -2.728 0 C-N-CA 120.123 -1.037 . . . . 65.450000000000003 112.063 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . 0.407 ' CE2' ' HG ' ' B' ' 69' ' ' LEU . 16.7 p90 -150.79 143.91 24.76 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 123.959 0.904 . . . . 72.530000000000001 109.641 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.36 156.48 45.82 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.078 0.466 . . . . 75.019999999999996 111.613 -173.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' TYR . . . . . 0.431 ' CG ' ' HE2' ' B' ' 112' ' ' LYS . 27.2 m-85 -115.99 130.83 56.99 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.526 -1.287 . . . . 74.319999999999993 107.526 174.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.415 HG22 HG21 ' B' ' 66' ' ' ILE . 35.8 mm -114.51 110.74 33.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.621 -0.881 . . . . 74.349999999999994 108.621 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -86.24 119.34 26.41 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.48 -0.327 . . . . 75.450000000000003 110.988 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.25 165.21 11.2 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.909 0.385 . . . . 73.329999999999998 109.997 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.612 ' O ' ' HD3' ' B' ' 37' ' ' ARG . . . -79.46 -34.56 41.39 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.34 -0.391 . . . . 60.0 112.018 176.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -111.18 150.46 29.47 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.137 0.494 . . . . 73.409999999999997 112.282 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.574 ' O ' HG23 ' B' ' 91' ' ' VAL . 21.2 mmm180 -68.95 -28.8 66.97 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.411 -0.813 . . . . 74.540000000000006 109.533 172.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -63.7 -29.33 70.57 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.633 -0.712 . . . . 73.049999999999997 111.143 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 19.5 m -67.74 -36.36 80.42 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 116.664 -0.244 . . . . 75.409999999999997 110.491 177.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . 0.574 HG23 ' O ' ' B' ' 88' ' ' ARG . 3.6 m -64.24 -39.53 85.84 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.775 0 N-CA-C 108.802 -0.814 . . . . 75.109999999999999 108.802 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -57.08 -37.22 71.57 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.513 0.561 . . . . 65.310000000000002 112.513 175.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.55 -35.93 65.57 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.947 -0.569 . . . . 73.120000000000005 110.526 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.46 -42.72 52.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.869 -0.605 . . . . 64.439999999999998 110.942 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . 0.492 HG12 ' O ' ' B' ' 91' ' ' VAL . 19.2 m -62.11 -23.36 31.5 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.962 0 N-CA-C 111.896 0.332 . . . . 73.420000000000002 111.896 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.7 -16.19 63.3 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.28 0.562 . . . . 44.020000000000003 110.442 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 16.5 ttm -101.3 3.03 40.35 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 123.994 0.918 . . . . 73.239999999999995 109.013 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . 0.602 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 4.2 p-10 -35.85 -50.36 0.65 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 116.291 1.96 . . . . 71.5 116.291 -172.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -115.77 93.49 4.29 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 118.204 -1.398 . . . . 75.030000000000001 110.945 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 13.1 t -135.2 172.8 12.49 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.145 -1.389 . . . . 62.140000000000001 109.925 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.0 p -101.58 128.63 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 108.876 -0.787 . . . . 74.209999999999994 108.876 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -130.51 119.63 22.88 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.941 -0.763 . . . . 73.120000000000005 108.941 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 31.0 ttm-85 50.71 33.42 8.29 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.612 1.565 . . . . 73.450000000000003 112.151 -175.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 99.57 -2.93 57.51 Favored Glycine 0 C--N 1.296 -1.64 0 CA-C-N 114.439 -1.255 . . . . 63.119999999999997 114.345 172.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -131.77 149.18 52.55 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 118.171 0.986 . . . . 75.319999999999993 112.162 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 25.7 m -75.5 124.86 27.91 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.994 -0.548 . . . . 71.5 110.929 -174.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 43.1 pt -102.83 171.56 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.016 0.436 . . . . 73.310000000000002 110.832 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' LYS . . . . . 0.602 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 55.0 tptt -135.41 131.93 36.87 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.0 -1.111 . . . . 71.540000000000006 108.0 178.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 28.0 t -127.28 134.35 66.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.608 -0.515 . . . . 75.420000000000002 109.608 -177.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . 0.543 ' HB3' ' HD2' ' B' ' 111' ' ' PRO 0.262 0.1 OUTLIER -144.13 170.0 9.2 Favored Pre-proline 0 C--O 1.215 -0.76 0 N-CA-C 105.292 -2.114 . . . . 75.400000000000006 105.292 174.167 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' B' ' 110' ' ' LEU . 73.6 Cg_endo -73.53 151.51 47.44 Favored 'Trans proline' 0 CA--C 1.552 1.422 0 C-N-CA 122.015 1.81 . . . . 65.510000000000005 110.114 171.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.512 ' HE3' ' OG ' ' B' ' 38' ' ' SER . 35.1 ttmt . . . . . 0 C--N 1.317 -0.808 0 CA-C-O 121.007 0.432 . . . . 63.509999999999998 110.742 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 . . . . . 0 CA--C 1.511 -0.528 0 CA-C-O 121.2 0.524 . . . . 61.030000000000001 110.971 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . 0.26 15.5 pt -70.94 -35.65 60.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 113.204 0.816 . . . . 74.329999999999998 113.204 -178.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -61.43 -41.4 97.12 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.207 1.003 . . . . 73.030000000000001 109.416 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.457 ' CG ' ' HG2' ' A' ' 88' ' ' ARG . 28.3 ttmt -58.51 -25.51 62.47 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 125.18 1.392 . . . . 73.420000000000002 112.767 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -119.52 10.38 11.8 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 112.389 0.514 . . . . 65.299999999999997 112.389 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.0 t -98.32 154.7 17.63 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.253 0.549 . . . . 52.350000000000001 111.778 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.508 HG13 ' CG2' ' A' ' 91' ' ' VAL . 0.2 OUTLIER -140.64 161.9 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 C-N-CA 124.062 0.945 . . . . 42.100000000000001 111.719 176.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.635 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 25.7 t80 -112.49 126.5 55.38 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 107.642 -1.244 . . . . 74.5 107.642 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 59.7 t -113.32 110.35 31.87 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 N-CA-C 107.082 -1.451 . . . . 65.129999999999995 107.082 176.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.36 165.92 12.84 Favored Glycine 0 C--N 1.291 -1.958 0 C-N-CA 119.512 -1.328 . . . . 52.039999999999999 114.272 -175.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.451 ' O ' ' HD3' ' A' ' 105' ' ' ARG . 9.8 t30 64.58 24.72 13.08 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.121 1.368 . . . . 72.140000000000001 112.193 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.0 p -106.07 95.38 3.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-O 122.058 0.932 . . . . 71.409999999999997 110.451 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.455 ' HA ' ' HA3' ' A' ' 79' ' ' GLY . 4.9 m-20 -106.3 137.9 43.43 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 118.563 -0.732 . . . . 73.109999999999999 109.903 -169.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.54 ' CE1' ' HB2' ' A' ' 77' ' ' PRO 0.394 50.2 m-85 42.02 -60.52 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 121.247 3.795 . . . . 74.530000000000001 121.247 169.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.8 -20.46 62.03 Favored Glycine 0 N--CA 1.466 0.635 0 N-CA-C 115.073 0.789 . . . . 62.310000000000002 115.073 -173.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.9 m -95.69 134.7 38.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 117.477 0.638 . . . . 63.229999999999997 109.893 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 47.9 p -98.85 176.34 5.64 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 109.173 -0.677 . . . . 74.010000000000005 109.173 -177.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.439 ' HB1' HD13 ' A' ' 66' ' ' ILE . . . -60.2 -44.35 95.2 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 110.061 -0.348 . . . . 65.409999999999997 110.061 176.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -57.18 -46.29 82.95 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 116.547 -0.297 . . . . 75.530000000000001 110.621 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -56.44 -42.72 78.57 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.239 0.542 . . . . 62.119999999999997 111.446 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.4 mt -73.38 -49.3 27.93 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.267 -0.879 . . . . 64.519999999999996 111.696 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.412 ' CD ' ' HZ3' ' B' ' 72' ' ' LYS . 0.9 OUTLIER -64.18 -49.47 71.91 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.953 -0.567 . . . . 62.439999999999998 110.965 -176.207 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.31 -42.35 91.17 Favored 'General case' 0 C--O 1.267 2.001 0 CA-C-O 121.442 0.639 . . . . 44.310000000000002 111.752 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -66.42 -34.75 78.66 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.877 -0.602 . . . . 73.230000000000004 109.61 -176.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . 0.25 49.3 m-85 -82.31 -20.95 36.39 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 113.499 0.926 . . . . 74.549999999999997 113.499 175.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.0 m -61.05 -32.62 72.25 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.257 -0.646 . . . . 73.450000000000003 109.257 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 m -58.65 -30.74 67.56 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.945 -0.57 . . . . 52.520000000000003 110.618 174.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 61.0 m -97.71 -1.27 43.86 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 112.536 0.569 . . . . 73.430000000000007 112.536 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.428 ' HA3' ' HB3' ' A' ' 90' ' ' SER . . . 168.16 -174.18 43.01 Favored Glycine 0 C--O 1.223 -0.546 0 C-N-CA 118.379 -1.867 . . . . 74.049999999999997 116.0 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.4 p -70.55 -71.7 0.24 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.938 0.895 . . . . 71.140000000000001 112.428 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.481 HG22 HD11 ' A' ' 63' ' ' ILE 0.3 73.7 mt 99.77 113.12 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 C-N-CA 126.71 2.004 . . . . 54.530000000000001 112.669 177.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.528 ' OD1' ' HB1' ' A' ' 86' ' ' ALA . 3.7 m-20 -106.81 -28.24 10.25 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-N 114.354 -1.293 . . . . 74.450000000000003 112.57 -177.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.428 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 75.3 mtt180 -151.61 155.45 38.44 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.788 -0.819 . . . . 61.539999999999999 108.788 174.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.446 HG23 HG21 ' A' ' 83' ' ' ILE . 20.5 pt -144.02 137.25 23.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 105.428 -2.064 . . . . 72.530000000000001 105.428 169.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 58.5 m -125.09 125.21 43.41 Favored 'General case' 0 C--N 1.262 -3.224 0 N-CA-C 107.708 -1.219 . . . . 73.400000000000006 107.708 -177.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mp -122.0 118.32 55.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 106.188 -1.782 . . . . 72.329999999999998 106.188 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.298 0.9 OUTLIER -121.53 133.19 55.02 Favored 'General case' 0 C--N 1.278 -2.525 0 C-N-CA 120.047 -0.661 . . . . 74.200000000000003 111.942 177.058 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 79.3 m -116.67 124.99 51.08 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.211 -1.033 . . . . 74.420000000000002 108.211 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.505 ' HB2' ' CD2' ' A' ' 73' ' ' PHE . 2.9 p-10 -112.12 138.43 48.8 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 119.047 -1.061 . . . . 64.200000000000003 112.131 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -117.13 7.48 13.04 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 114.763 -1.108 . . . . 72.319999999999993 110.239 173.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.505 ' CD2' ' HB2' ' A' ' 71' ' ' ASP . 37.3 p90 -69.58 -15.93 63.31 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.93 0.871 . . . . 75.049999999999997 109.637 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.2 m -86.92 6.98 29.31 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 114.727 -1.124 . . . . 73.340000000000003 109.515 175.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.34 -53.99 4.44 Favored Glycine 0 CA--C 1.503 -0.661 0 N-CA-C 110.596 -1.001 . . . . 64.230000000000004 110.596 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -96.24 138.15 21.59 Favored Pre-proline 0 C--N 1.298 -1.646 0 CA-C-N 114.27 -0.965 . . . . 71.129999999999995 108.774 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.54 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 46.9 Cg_endo -71.62 118.43 5.65 Favored 'Trans proline' 0 C--O 1.247 0.951 0 C-N-CA 122.203 1.936 . . . . 73.230000000000004 112.719 -177.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 29.1 mtmm -113.21 165.54 12.31 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 109.07 -0.715 . . . . 73.120000000000005 109.07 175.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 45' ' ' ASP . . . -138.2 146.0 17.66 Favored Glycine 0 N--CA 1.42 -2.403 0 C-N-CA 120.235 -0.983 . . . . 63.409999999999997 113.405 175.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -154.08 145.22 22.83 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.569 -0.816 . . . . 74.019999999999996 109.674 175.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 67' ' ' THR . . . -132.74 152.72 51.68 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.482 -0.326 . . . . 74.519999999999996 110.882 -172.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.41 ' CZ ' ' HD1' ' A' ' 40' ' ' TYR . 77.3 m-85 -123.9 131.56 53.6 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.556 -0.905 . . . . 75.430000000000007 108.556 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.446 HG21 HG23 ' A' ' 66' ' ' ILE . 23.4 mm -115.38 120.6 65.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 109.227 -0.657 . . . . 64.430000000000007 109.227 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 65' ' ' ARG . 1.9 mp0 -100.14 121.59 41.67 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.882 -0.414 . . . . 74.510000000000005 109.882 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -98.81 161.83 13.43 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.699 -0.228 . . . . 74.519999999999996 110.796 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.528 ' HB1' ' OD1' ' A' ' 64' ' ' ASN . . . -85.16 -29.89 24.4 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.802 -0.359 . . . . 74.329999999999998 111.231 175.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.465 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 5.6 mp0 -97.81 142.94 28.96 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.639 -0.504 . . . . 73.209999999999994 109.639 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.457 ' HG2' ' CG ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -71.17 -30.79 66.88 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 105.882 -1.896 . . . . 73.540000000000006 105.882 176.08 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -67.57 -35.55 79.22 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.583 -1.189 . . . . 74.25 110.605 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 87' ' ' GLU . 50.1 m -70.93 -36.81 72.79 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 120.696 0.284 . . . . 72.010000000000005 111.742 -177.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.508 ' CG2' HG13 ' A' ' 39' ' ' VAL . 14.5 p -65.99 -37.22 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 109.257 -0.645 . . . . 60.43 109.257 177.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -65.29 -31.58 72.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.518 -0.764 . . . . 63.100000000000001 110.035 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.5 -31.57 63.8 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.854 -0.612 . . . . 75.230000000000004 110.845 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.61 -43.94 53.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.039 -0.528 . . . . 65.519999999999996 110.451 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 20.5 m -58.25 -22.41 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 112.942 0.719 . . . . 74.120000000000005 112.942 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.46 -13.15 61.73 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.372 0.606 . . . . 71.0 110.415 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 47.7 ttp -103.4 9.46 37.8 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.007 -0.738 . . . . 73.209999999999994 109.007 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.489 ' HA ' ' HB ' ' A' ' 109' ' ' VAL . 5.5 p-10 -37.37 -57.09 0.93 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 115.016 1.487 . . . . 62.439999999999998 115.016 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -110.09 85.12 2.05 Favored 'General case' 0 N--CA 1.397 -3.117 0 CA-C-O 122.167 0.984 . . . . 74.409999999999997 109.419 -174.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.2 p -129.6 167.47 17.9 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 113.849 -1.523 . . . . 74.049999999999997 111.904 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.2 p -110.73 106.18 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.163 0 CA-C-O 121.855 0.836 . . . . 74.209999999999994 109.017 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -105.69 126.23 51.91 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.115 -0.948 . . . . 73.439999999999998 108.543 -176.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 41.4 ttt-85 52.29 32.91 11.68 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 124.731 1.212 . . . . 72.140000000000001 111.348 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.72 -4.88 76.34 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 115.107 -0.951 . . . . 60.399999999999999 114.288 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.451 ' HD3' ' O ' ' A' ' 43' ' ' ASN . 4.6 ptp180 -121.88 138.41 54.41 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 117.593 0.696 . . . . 64.430000000000007 111.218 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 45.6 m -76.12 122.13 23.84 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-O 120.803 0.335 . . . . 54.340000000000003 110.761 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 44.6 pt -101.78 171.87 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.909 -0.587 . . . . 73.519999999999996 111.119 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 15.0 mmmt -125.1 131.13 53.35 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-N 114.952 -1.022 . . . . 72.510000000000005 109.245 176.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 24.7 t -127.47 116.19 42.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 108.361 -0.978 . . . . 70.019999999999996 108.361 174.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.425 ' CD1' ' HD2' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -146.99 156.4 47.29 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 106.912 -1.514 . . . . 62.329999999999998 106.912 177.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -62.61 129.3 25.97 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 121.841 1.694 . . . . 63.100000000000001 113.373 -175.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.423 -1.808 0 N-CA-C 103.155 -2.905 . . . . 72.120000000000005 103.155 173.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.461 0 N-CA-C 110.828 -0.909 . . . . 55.32 110.828 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.567 ' HG3' ' CZ ' ' A' ' 40' ' ' TYR . 2.3 Cg_endo -43.64 -51.82 5.82 Favored 'Trans proline' 0 CA--C 1.556 1.588 0 C-N-CA 123.418 2.745 . . . . 75.540000000000006 113.268 176.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.92 123.62 9.47 Favored 'Trans proline' 0 C--N 1.38 2.196 0 N-CA-C 108.132 -1.526 . . . . 75.510000000000005 108.132 171.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.5 160.12 83.08 Favored Pre-proline 0 C--N 1.288 -2.093 0 CA-C-N 115.287 -0.87 . . . . 73.120000000000005 109.784 -177.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.94 101.27 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 122.381 2.054 . . . . 75.010000000000005 111.457 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.519 ' H ' HD13 ' B' ' 26' ' ' LEU . 0.0 OUTLIER -72.49 171.98 11.35 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 114.21 -1.359 . . . . 75.129999999999995 111.42 178.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.503 ' HB3' ' OE1' ' B' ' 30' ' ' GLU . 34.3 t -65.08 145.99 55.59 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.704 0.764 . . . . 72.049999999999997 112.276 -173.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.23 -40.87 25.89 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.85 -1.523 . . . . 53.030000000000001 111.673 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -75.93 -30.25 58.64 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 113.746 1.017 . . . . 74.430000000000007 113.746 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.503 ' OE1' ' HB3' ' B' ' 27' ' ' SER . 1.1 mp0 -60.73 -34.61 74.67 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 120.32 -0.552 . . . . 74.329999999999998 109.814 171.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -66.18 -50.71 62.95 Favored 'General case' 0 C--O 1.199 -1.553 0 CA-C-N 115.81 -0.632 . . . . 65.439999999999998 109.756 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.686 ' HE2' ' N ' ' B' ' 32' ' ' LYS . 0.4 OUTLIER -61.43 -29.71 70.11 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 119.839 -0.744 . . . . 75.349999999999994 112.123 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.476 ' O ' ' HG2' ' B' ' 36' ' ' LYS . 9.4 tp10 -69.23 -44.72 71.43 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 108.558 -0.905 . . . . 71.329999999999998 108.558 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . 0.25 11.8 pt -71.95 -35.21 53.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 112.608 0.596 . . . . 71.519999999999996 112.608 177.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -58.41 -43.63 88.73 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.323 0.582 . . . . 73.150000000000006 110.616 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' B' ' 33' ' ' GLU . 15.0 ptpt -68.88 -18.34 64.12 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.457 0.54 . . . . 73.299999999999997 112.457 -173.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.642 ' HD2' ' O ' ' B' ' 85' ' ' PHE . 21.7 ptt180 -118.83 15.91 13.48 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.596 0.591 . . . . 71.019999999999996 112.596 -178.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 47.3 t -102.35 154.87 18.65 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.274 0.559 . . . . 44.299999999999997 111.738 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.555 HG13 ' CG2' ' B' ' 91' ' ' VAL . 0.3 OUTLIER -140.31 164.01 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 C-N-CA 124.287 1.035 . . . . 75.200000000000003 112.072 178.554 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . 0.62 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 30.7 t80 -115.71 127.39 55.1 Favored 'General case' 0 CA--C 1.48 -1.726 0 CA-C-N 114.557 -1.201 . . . . 74.400000000000006 107.76 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.36 109.65 29.31 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 N-CA-C 107.256 -1.387 . . . . 72.400000000000006 107.256 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -109.41 170.13 14.23 Favored Glycine 0 N--CA 1.435 -1.415 0 C-N-CA 120.257 -0.973 . . . . 51.549999999999997 112.602 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.2 t30 63.96 -0.66 0.77 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 126.213 1.805 . . . . 73.319999999999993 112.54 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.515 ' CG1' ' HA ' ' B' ' 80' ' ' TYR . 3.6 p -58.39 130.89 22.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 108.913 -0.773 . . . . 74.439999999999998 108.913 175.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -76.09 153.26 36.46 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 115.694 -0.685 . . . . 75.519999999999996 111.624 -173.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -50.55 -34.1 24.26 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 126.172 1.789 . . . . 75.439999999999998 111.214 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.7 3.99 78.73 Favored Glycine 0 CA--C 1.501 -0.842 0 C-N-CA 119.897 -1.144 . . . . 72.019999999999996 113.72 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 36.8 t -73.06 118.84 16.5 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 105.137 -2.172 . . . . 63.009999999999998 105.137 172.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.49 166.92 12.29 Favored 'General case' 0 N--CA 1.405 -2.701 0 N-CA-C 109.201 -0.666 . . . . 65.430000000000007 109.201 -169.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.432 ' HB1' HD13 ' B' ' 66' ' ' ILE . . . -56.08 -45.5 79.35 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 117.911 0.323 . . . . 72.299999999999997 111.439 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -57.18 -44.84 83.94 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.525 0.516 . . . . 60.109999999999999 111.042 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -57.17 -45.1 83.95 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 121.167 0.508 . . . . 71.239999999999995 111.348 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . 0.416 HD23 HG23 ' B' ' 44' ' ' VAL . 80.5 mt -72.2 -49.2 37.32 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.399 -0.818 . . . . 70.030000000000001 111.585 -177.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -63.2 -49.4 74.39 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 116.105 -0.498 . . . . 63.329999999999998 111.151 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.46 97.77 Favored 'General case' 0 C--O 1.267 2.014 0 CA-C-O 121.522 0.677 . . . . 70.540000000000006 111.812 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -66.39 -34.43 77.95 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.821 -0.627 . . . . 75.420000000000002 109.697 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -82.48 -21.36 35.59 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 113.678 0.992 . . . . 73.200000000000003 113.678 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 71.8 m -61.88 -30.69 71.04 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 116.379 -0.373 . . . . 62.439999999999998 110.295 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 17.4 m -58.69 -31.14 67.94 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 115.895 -0.593 . . . . 74.430000000000007 110.265 175.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 63.0 m -91.44 6.47 45.35 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 113.474 0.916 . . . . 41.409999999999997 113.474 -177.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.23 -159.93 26.25 Favored Glycine 0 N--CA 1.469 0.856 0 C-N-CA 118.914 -1.613 . . . . 70.319999999999993 115.108 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 12.9 m -101.48 123.26 45.24 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.021 0.439 . . . . 75.5 110.406 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 57.6 mt -92.04 134.91 28.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 123.583 0.753 . . . . 61.329999999999998 112.073 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . 0.494 ' ND2' ' HB2' ' B' ' 86' ' ' ALA . 0.8 OUTLIER -103.98 -33.15 8.92 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.711 0.805 . . . . 64.239999999999995 112.021 176.462 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.408 ' HB2' ' HB2' ' B' ' 84' ' ' GLU . 82.8 mtt180 -151.86 156.87 41.02 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.218 -0.66 . . . . 64.239999999999995 109.218 178.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.432 HD13 ' HB1' ' B' ' 50' ' ' ALA . 17.7 pt -143.61 138.15 25.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 105.824 -1.917 . . . . 64.409999999999997 105.824 168.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 53.8 m -125.29 125.73 44.0 Favored 'General case' 0 C--N 1.269 -2.926 0 N-CA-C 107.668 -1.234 . . . . 70.219999999999999 107.668 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.8 mp -122.78 117.54 52.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 106.337 -1.727 . . . . 73.310000000000002 106.337 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.288 0.9 OUTLIER -121.03 132.52 54.95 Favored 'General case' 0 C--N 1.283 -2.288 0 C-N-CA 120.028 -0.669 . . . . 62.140000000000001 111.8 177.774 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 70.6 m -116.98 123.01 45.88 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 108.73 -0.841 . . . . 74.120000000000005 108.73 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . 0.565 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 2.8 p30 -110.2 132.09 54.48 Favored 'General case' 0 C--O 1.208 -1.11 0 C-N-CA 119.913 -0.715 . . . . 73.239999999999995 110.115 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . 0.412 ' HZ3' ' CD ' ' A' ' 54' ' ' GLU . 37.9 ttmt -118.9 10.8 12.38 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.937 -1.134 . . . . 72.0 107.937 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.491 ' CD2' ' HB2' ' B' ' 71' ' ' ASP . 4.1 p90 -56.86 -17.41 9.3 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 115.902 1.816 . . . . 74.319999999999993 115.902 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 30.6 m -110.32 9.73 23.58 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 118.242 0.473 . . . . 75.0 111.61 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.39 -55.63 0.52 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.257 -0.973 . . . . 75.319999999999993 112.368 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -96.16 129.72 33.03 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 109.956 -0.387 . . . . 72.439999999999998 109.956 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 92.0 Cg_endo -77.04 119.61 5.12 Favored 'Trans proline' 0 N--CA 1.441 -1.617 0 C-N-CA 121.8 1.667 . . . . 74.329999999999998 111.932 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 30.1 mtmm -102.32 164.45 11.67 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 108.199 -1.037 . . . . 65.420000000000002 108.199 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -134.28 141.16 12.43 Favored Glycine 0 N--CA 1.423 -2.226 0 C-N-CA 119.658 -1.258 . . . . 73.439999999999998 113.027 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . 0.515 ' HA ' ' CG1' ' B' ' 44' ' ' VAL . 19.5 p90 -150.71 143.34 24.47 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.183 -0.509 . . . . 75.030000000000001 110.117 173.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.45 152.33 51.55 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.419 -0.355 . . . . 74.299999999999997 110.872 -172.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' TYR . . . . . 0.564 ' CD2' ' HG3' ' B' ' 112' ' ' LYS . 88.1 m-85 -124.15 130.05 51.88 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 108.944 -0.762 . . . . 71.109999999999999 108.944 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 23.5 mm -113.27 121.6 65.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 109.004 -0.739 . . . . 73.200000000000003 109.004 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' GLU . . . . . 0.408 ' HB2' ' HB2' ' B' ' 65' ' ' ARG . 1.2 mp0 -100.14 119.68 38.71 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.463 -0.569 . . . . 63.240000000000002 109.463 176.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.642 ' O ' ' HD2' ' B' ' 37' ' ' ARG . 96.5 m-85 -94.48 162.32 13.86 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 110.274 -0.269 . . . . 73.310000000000002 110.274 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.494 ' HB2' ' ND2' ' B' ' 64' ' ' ASN . . . -81.41 -34.58 31.5 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.305 -0.407 . . . . 42.399999999999999 110.608 174.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . 0.409 ' HB2' ' OG ' ' B' ' 90' ' ' SER . 9.7 mp0 -99.96 147.95 25.02 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.199 -0.6 . . . . 73.120000000000005 111.472 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.466 ' O ' HG13 ' B' ' 91' ' ' VAL . 0.0 OUTLIER -74.16 -31.64 62.79 Favored 'General case' 0 C--O 1.212 -0.891 0 N-CA-C 106.215 -1.772 . . . . 73.519999999999996 106.215 177.438 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -71.69 -29.18 64.3 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 120.479 -0.488 . . . . 74.349999999999994 111.885 177.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' SER . . . . . 0.409 ' OG ' ' HB2' ' B' ' 87' ' ' GLU . 49.4 m -71.49 -36.98 71.31 Favored 'General case' 0 N--CA 1.439 -0.99 0 O-C-N 122.224 -0.297 . . . . 73.530000000000001 111.349 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . 0.555 ' CG2' HG13 ' B' ' 39' ' ' VAL . 14.5 p -65.87 -37.69 80.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 108.64 -0.874 . . . . 73.340000000000003 108.64 177.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -63.77 -33.56 75.94 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.394 -0.821 . . . . 65.540000000000006 109.816 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.12 -31.3 64.21 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.829 -0.623 . . . . 75.140000000000001 110.539 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.67 -44.71 48.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.979 -0.555 . . . . 74.540000000000006 110.396 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 21.1 m -58.61 -22.46 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 112.41 0.522 . . . . 74.040000000000006 112.41 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.76 -18.49 63.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.897 0.855 . . . . 64.129999999999995 111.034 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 43.8 ttp -98.87 11.94 37.26 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 114.34 -1.3 . . . . 73.349999999999994 109.213 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . 0.472 ' HA ' ' HB ' ' B' ' 109' ' ' VAL . 9.8 t70 -35.11 -61.23 0.44 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 117.037 2.236 . . . . 63.119999999999997 117.037 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -115.74 34.98 4.65 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 119.542 1.065 . . . . 73.109999999999999 110.631 -174.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 76.4 p -77.72 -175.22 3.8 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.735 -0.666 . . . . 74.129999999999995 111.106 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -103.0 135.42 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 N-CA-C 109.334 -0.617 . . . . 71.299999999999997 109.334 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -142.23 128.19 19.53 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.596 -0.89 . . . . 74.450000000000003 108.596 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 57.2 ttt-85 56.3 32.99 21.46 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.277 1.031 . . . . 72.349999999999994 110.377 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.57 5.5 89.87 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.127 -0.942 . . . . 74.25 114.462 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -129.27 166.11 20.07 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 117.867 0.834 . . . . 61.420000000000002 109.976 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 32.4 m -90.99 122.74 33.91 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.785 -0.45 . . . . 63.32 109.785 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 39.7 pt -101.21 173.38 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 120.739 0.304 . . . . 74.030000000000001 111.763 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -130.86 120.76 24.14 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.241 -1.022 . . . . 70.329999999999998 108.241 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 42.3 t -127.0 116.04 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 123.361 0.413 . . . . 73.420000000000002 109.922 -177.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' B' ' 40' ' ' TYR . 0.0 OUTLIER -146.45 155.88 49.48 Favored Pre-proline 0 C--N 1.314 -0.963 0 N-CA-C 107.263 -1.384 . . . . 74.349999999999994 107.263 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.73 134.38 46.85 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.67 2.247 . . . . 72.349999999999994 113.151 -175.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.564 ' HG3' ' CD2' ' B' ' 82' ' ' TYR . 3.2 tmmm? . . . . . 0 C--N 1.29 -1.984 0 N-CA-C 106.831 -1.544 . . . . 74.140000000000001 106.831 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 . . . . . 0 C--O 1.214 -0.764 0 N-CA-C 111.389 0.144 . . . . 75.329999999999998 111.389 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.9 pt -66.64 -34.22 68.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.08 0.467 . . . . 75.040000000000006 110.742 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.24 -40.01 89.91 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.65 1.18 . . . . 55.509999999999998 110.985 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -64.2 -21.0 66.41 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.596 0.712 . . . . 73.439999999999998 110.492 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.502 ' HD3' ' O ' ' A' ' 86' ' ' ALA . 90.9 mtt180 -109.64 16.48 22.12 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.35 -0.841 . . . . 71.409999999999997 109.657 -174.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 46.9 m -101.05 158.4 16.04 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 121.471 0.653 . . . . 74.540000000000006 111.762 178.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.5 m -134.58 163.56 36.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.583 -0.735 . . . . 73.200000000000003 109.684 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.696 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 23.3 t80 -109.49 128.13 54.94 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.545 -1.28 . . . . 73.319999999999993 107.545 174.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.9 t -120.94 109.28 24.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 107.843 -1.169 . . . . 72.239999999999995 107.843 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.65 170.99 15.87 Favored Glycine 0 C--N 1.293 -1.842 0 C-N-CA 119.785 -1.198 . . . . 40.350000000000001 113.783 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t30 67.55 17.31 9.98 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 125.297 1.439 . . . . 63.240000000000002 112.163 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.443 ' O ' ' HA3' ' A' ' 79' ' ' GLY . 14.5 p -72.16 141.58 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 109.257 -0.646 . . . . 71.120000000000005 109.257 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -107.24 165.27 11.5 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 112.077 0.399 . . . . 53.340000000000003 112.077 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -59.31 -26.51 65.06 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.316 0.646 . . . . 74.510000000000005 111.948 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.94 -16.57 80.58 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.36 -0.696 . . . . 53.450000000000003 111.36 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 24.7 m -95.8 125.96 40.73 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 107.342 -1.355 . . . . 72.340000000000003 107.342 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.449 HG22 ' CB ' ' B' ' 49' ' ' THR 0.253 3.6 p -126.31 179.31 5.34 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 114.527 1.306 . . . . 75.349999999999994 114.527 -172.023 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.86 -52.65 64.28 Favored 'General case' 0 C--O 1.213 -0.818 0 N-CA-C 114.459 1.281 . . . . 54.340000000000003 114.459 -168.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.25 28.1 pt20 -64.37 -32.14 73.63 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 119.103 -1.039 . . . . 72.120000000000005 112.941 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -59.9 -44.93 93.97 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.101 -0.703 . . . . 51.140000000000001 109.101 176.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 69.8 mt -73.04 -48.54 35.17 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.562 -1.199 . . . . 71.5 111.214 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.34 -49.62 74.86 Favored 'General case' 0 C--O 1.198 -1.625 0 CA-C-N 116.197 -0.456 . . . . 73.109999999999999 111.429 -177.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.6 -41.73 86.48 Favored 'General case' 0 C--O 1.257 1.482 0 CA-C-O 121.434 0.635 . . . . 64.129999999999995 111.98 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -68.02 -39.2 83.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.995 -1.002 . . . . 73.140000000000001 110.023 -176.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -82.23 -21.52 36.29 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.213 0.82 . . . . 65.150000000000006 113.213 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.3 t -68.83 -24.29 64.36 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.988 -0.745 . . . . 72.430000000000007 108.988 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.2 m -60.28 -33.92 73.02 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.521 0.677 . . . . 71.439999999999998 109.526 172.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 63.4 m -90.33 5.05 48.91 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.515 -0.766 . . . . 73.329999999999998 112.373 -177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.83 -168.62 29.96 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 118.688 -1.72 . . . . 73.340000000000003 115.08 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.9 m -97.96 122.73 41.43 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.315 -0.624 . . . . 74.010000000000005 109.315 -176.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.5 mt -91.46 131.23 39.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 113.018 0.747 . . . . 74.310000000000002 113.018 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -100.05 -40.95 7.37 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.162 -0.926 . . . . 71.120000000000005 110.905 176.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -149.91 158.91 44.64 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 108.837 -0.801 . . . . 75.120000000000005 108.837 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 27.3 pt -144.95 140.82 23.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 106.941 -1.503 . . . . 61.329999999999998 106.941 169.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.0 m -125.25 125.35 43.44 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 106.498 -1.667 . . . . 74.329999999999998 106.498 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.606 HD11 ' O ' ' B' ' 68' ' ' ILE . 3.4 mp -122.12 118.57 55.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.812 -1.551 . . . . 72.420000000000002 106.812 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.263 1.2 pt? -120.09 122.81 41.9 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 120.206 -0.597 . . . . 63.350000000000001 111.111 178.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.413 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 64.2 m -116.85 132.63 56.65 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.271 -1.011 . . . . 74.140000000000001 108.271 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.505 ' CG ' ' HZ1' ' A' ' 78' ' ' LYS . 3.6 p-10 -118.74 138.18 52.84 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 119.559 -0.856 . . . . 62.299999999999997 112.005 -176.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -117.59 13.25 14.28 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.297 -0.865 . . . . 63.100000000000001 109.631 173.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.453 ' CD2' ' HB2' ' A' ' 71' ' ' ASP . 13.9 p90 -65.8 -23.53 66.72 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.428 0.632 . . . . 72.420000000000002 110.395 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.1 t -83.49 0.55 45.91 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.781 -0.645 . . . . 65.400000000000006 110.151 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.92 -58.72 1.05 Allowed Glycine 0 N--CA 1.438 -1.213 0 N-CA-C 110.533 -1.027 . . . . 44.32 110.533 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -95.13 130.35 32.81 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 108.703 -0.851 . . . . 73.219999999999999 108.703 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 24.3 Cg_endo -62.32 119.28 6.31 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 123.028 2.486 . . . . 72.129999999999995 114.183 -175.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.505 ' HZ1' ' CG ' ' A' ' 71' ' ' ASP . 25.2 mtmm -104.43 -168.92 1.55 Allowed 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.582 -1.266 . . . . 75.349999999999994 107.582 171.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 44' ' ' VAL . . . -172.33 141.79 6.47 Favored Glycine 0 N--CA 1.407 -3.299 0 C-N-CA 119.792 -1.194 . . . . 71.230000000000004 112.726 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -151.57 145.47 25.15 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 123.813 0.845 . . . . 72.310000000000002 109.033 175.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.91 159.46 42.14 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-O 120.925 0.393 . . . . 50.100000000000001 111.178 -172.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -123.06 123.34 40.62 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.988 -0.745 . . . . 63.299999999999997 108.988 175.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.4 mm -103.06 119.93 52.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 106.624 -1.621 . . . . 73.030000000000001 106.624 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 38' ' ' SER . 35.0 mt-10 -107.12 119.31 39.03 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.068 0.461 . . . . 53.109999999999999 110.049 -176.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -100.58 167.48 10.33 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.389 0.614 . . . . 72.040000000000006 112.468 -174.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.502 ' O ' ' HD3' ' A' ' 37' ' ' ARG . . . -83.85 -33.26 24.89 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.184 -0.916 . . . . 72.400000000000006 111.665 174.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.411 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 4.5 mp0 -104.55 143.66 32.74 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 110.119 -0.326 . . . . 62.32 110.119 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.461 ' O ' HG21 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -73.04 -29.66 63.15 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 106.005 -1.85 . . . . 75.420000000000002 106.005 177.174 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -60.48 -28.07 68.06 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.989 -1.459 . . . . 71.150000000000006 110.425 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.411 ' OG ' ' HB2' ' A' ' 87' ' ' GLU . 26.8 m -67.35 -36.38 81.28 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 116.553 -0.294 . . . . 62.030000000000001 110.922 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 88' ' ' ARG . 3.2 m -64.06 -39.05 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 N-CA-C 108.429 -0.952 . . . . 74.140000000000001 108.429 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -55.89 -39.6 71.8 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.929 0.768 . . . . 75.340000000000003 110.585 177.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.23 -37.43 63.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.891 -0.595 . . . . 62.329999999999998 111.452 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.56 -45.24 62.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.945 0.402 . . . . 54.240000000000002 111.357 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 91' ' ' VAL . 28.6 m -56.97 -22.15 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 113.16 0.8 . . . . 73.400000000000006 113.16 178.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.69 -17.73 64.81 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.277 0.561 . . . . 72.430000000000007 110.806 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.492 ' O ' HG22 ' A' ' 100' ' ' THR . 66.2 mtm -99.58 8.11 44.71 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.754 -0.657 . . . . 73.030000000000001 110.676 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -41.75 -42.33 2.57 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 115.476 1.658 . . . . 61.310000000000002 115.476 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -107.36 16.33 24.05 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 118.737 0.699 . . . . 64.340000000000003 112.439 -177.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.492 HG22 ' O ' ' A' ' 97' ' ' MET . 7.3 t -81.79 175.38 10.49 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 118.809 -1.156 . . . . 73.439999999999998 109.865 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.3 m -108.8 118.91 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 CA-C-O 121.652 0.739 . . . . 64.340000000000003 110.884 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -92.06 117.79 30.18 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 107.494 -1.298 . . . . 75.349999999999994 107.494 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 50.03 32.85 6.12 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.801 1.241 . . . . 73.209999999999994 112.135 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 99.5 -4.97 58.45 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 114.855 0.702 . . . . 61.229999999999997 114.855 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -118.67 137.02 53.6 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 118.209 1.004 . . . . 72.510000000000005 110.68 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.6 m -70.26 119.09 13.93 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.131 0.491 . . . . 74.0 110.38 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 45.7 pt -103.51 172.65 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 CA-C-N 116.054 -0.521 . . . . 70.430000000000007 110.223 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.43 ' HA ' ' HD2' ' A' ' 108' ' ' LYS . 19.8 mmmt -123.94 129.41 50.91 Favored 'General case' 0 CA--C 1.472 -2.03 0 CA-C-N 115.739 -0.664 . . . . 75.420000000000002 109.621 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 22.7 t -127.77 122.81 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 108.651 -0.87 . . . . 75.099999999999994 108.651 176.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.445 ' HB2' ' HD2' ' A' ' 111' ' ' PRO . 0.0 OUTLIER -146.73 155.35 48.48 Favored Pre-proline 0 C--N 1.292 -1.913 0 N-CA-C 107.464 -1.31 . . . . 74.120000000000005 107.464 175.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 110' ' ' LEU . 49.7 Cg_endo -66.29 140.92 60.42 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.134 1.223 . . . . 62.130000000000003 110.061 -175.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt . . . . . 0 C--N 1.326 -0.417 0 CA-C-O 121.249 0.547 . . . . 75.010000000000005 111.038 -175.768 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.762 0 N-CA-C 111.045 -0.822 . . . . 73.439999999999998 111.045 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -51.13 -45.04 39.09 Favored 'Trans proline' 0 CA--C 1.566 2.105 0 C-N-CA 123.542 2.828 . . . . 74.549999999999997 114.884 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -54.51 150.53 34.29 Favored 'Trans proline' 0 C--N 1.394 2.952 0 C-N-CA 121.839 1.692 . . . . 73.409999999999997 111.937 176.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -73.16 139.25 79.06 Favored Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 116.368 -0.378 . . . . 70.239999999999995 110.806 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -69.79 140.95 43.81 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.744 2.296 . . . . 74.200000000000003 113.517 -176.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.494 HD21 ' HB3' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -90.13 177.86 6.33 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.911 -1.041 . . . . 72.310000000000002 111.033 173.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 46.2 t -59.7 144.67 47.42 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 112.712 0.634 . . . . 71.239999999999995 112.712 -175.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.03 -37.74 54.56 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.994 -1.003 . . . . 64.230000000000004 111.024 171.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -76.43 -28.49 56.63 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 113.116 0.784 . . . . 70.140000000000001 113.116 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.51 ' O ' HG12 ' B' ' 34' ' ' ILE . 3.7 tp10 -64.5 -39.3 93.53 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 106.276 -1.75 . . . . 75.540000000000006 106.276 175.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -64.87 -44.32 90.08 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 114.424 -1.262 . . . . 73.439999999999998 108.697 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.607 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 0.1 OUTLIER -57.2 -47.57 80.95 Favored 'General case' 0 N--CA 1.413 -2.309 0 C-N-CA 123.597 0.759 . . . . 73.310000000000002 111.745 179.095 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 80.4 mm-40 -68.42 -44.57 74.7 Favored 'General case' 0 CA--C 1.505 -0.751 0 O-C-N 123.068 0.23 . . . . 72.120000000000005 111.363 -177.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.51 HG12 ' O ' ' B' ' 30' ' ' GLU . 11.3 pt -66.35 -34.93 73.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 O-C-N 123.376 0.422 . . . . 74.209999999999994 110.428 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -65.6 -42.07 92.04 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.49 0.716 . . . . 75.400000000000006 109.91 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 99.1 mttt -61.07 -24.19 66.03 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.613 -0.721 . . . . 72.409999999999997 110.777 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.527 ' HD3' ' O ' ' B' ' 86' ' ' ALA . 67.6 mtt180 -106.89 17.05 23.62 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.561 -0.745 . . . . 71.329999999999998 110.12 -174.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' B' ' 84' ' ' GLU . 26.2 m -106.43 169.08 8.73 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.176 0.512 . . . . 55.130000000000003 111.976 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 28.1 m -139.91 164.74 22.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 124.129 0.972 . . . . 74.230000000000004 110.211 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . 0.698 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 28.6 t80 -109.73 129.03 55.65 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.669 -1.234 . . . . 75.040000000000006 107.669 174.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.445 HG21 ' CZ ' ' B' ' 57' ' ' PHE . 97.5 t -122.18 111.93 32.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 108.451 -0.944 . . . . 73.109999999999999 108.451 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.93 171.22 16.66 Favored Glycine 0 C--N 1.289 -2.044 0 C-N-CA 120.022 -1.085 . . . . 64.120000000000005 113.558 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 61.4 t30 65.95 23.67 11.22 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.144 1.778 . . . . 75.129999999999995 112.754 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 14.1 p -65.83 130.95 31.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.838 -0.801 . . . . 72.430000000000007 108.838 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -99.95 161.37 13.65 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.39 -0.823 . . . . 63.350000000000001 111.393 -175.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' TYR . . . . . 0.756 ' CE1' ' HB2' ' B' ' 77' ' ' PRO . 17.7 m-85 -71.47 92.06 1.08 Allowed 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.489 -0.778 . . . . 71.409999999999997 109.793 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 164.75 -23.2 0.16 Allowed Glycine 0 N--CA 1.419 -2.446 0 CA-C-N 114.353 -1.294 . . . . 60.039999999999999 110.03 -177.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 40.3 m -79.47 128.54 33.48 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 109.097 -0.705 . . . . 71.450000000000003 109.097 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' THR . . . . . 0.449 ' CB ' HG22 ' A' ' 49' ' ' THR . 82.7 p -92.45 170.2 9.95 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 108.575 -0.898 . . . . 74.310000000000002 108.575 177.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.455 ' HB3' HD13 ' B' ' 66' ' ' ILE . . . -61.27 -44.07 97.83 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 110.274 -0.269 . . . . 74.209999999999994 110.274 175.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -62.36 -36.35 81.97 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.444 0.535 . . . . 65.230000000000004 112.444 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -56.64 -45.72 81.43 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.622 0.725 . . . . 71.109999999999999 109.727 176.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 57.0 mt -69.97 -48.24 59.05 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.664 -1.153 . . . . 64.049999999999997 111.642 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -62.1 -49.41 76.03 Favored 'General case' 0 C--O 1.199 -1.603 0 C-N-CA 122.831 0.452 . . . . 61.130000000000003 111.503 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.43 96.34 Favored 'General case' 0 C--O 1.252 1.23 0 CA-C-O 120.936 0.398 . . . . 53.240000000000002 110.651 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -66.37 -39.59 89.21 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.145 -0.48 . . . . 70.319999999999993 110.172 -176.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.445 ' CZ ' HG21 ' B' ' 41' ' ' VAL . 52.8 m-85 -82.18 -21.6 36.43 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 113.556 0.947 . . . . 71.319999999999993 113.556 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 23.2 t -70.09 -23.56 63.08 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.452 -0.944 . . . . 74.0 108.452 -178.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.3 m -58.66 -31.18 67.93 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-O 121.234 0.54 . . . . 74.340000000000003 109.773 172.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 69.5 m -95.3 10.72 35.15 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.809 -0.632 . . . . 73.340000000000003 112.567 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 143.42 -172.4 24.81 Favored Glycine 0 N--CA 1.462 0.388 0 C-N-CA 119.67 -1.252 . . . . 37.149999999999999 113.992 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 36.0 t -97.03 127.26 42.83 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 109.787 -0.449 . . . . 71.239999999999995 109.787 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 71.1 mt -90.62 133.62 31.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 115.789 -0.642 . . . . 73.239999999999995 112.661 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . 0.49 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 95.8 m-20 -101.39 -35.46 9.2 Favored 'General case' 0 C--O 1.206 -1.203 0 CA-C-N 115.488 -0.778 . . . . 71.230000000000004 111.68 176.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -153.19 159.72 42.72 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.885 -0.783 . . . . 75.230000000000004 108.885 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.455 HD13 ' HB3' ' B' ' 50' ' ' ALA . 24.6 pt -145.37 139.39 21.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.112 -1.44 . . . . 72.310000000000002 107.112 170.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 90.7 m -125.43 123.71 39.87 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 107.638 -1.245 . . . . 74.239999999999995 107.638 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.606 ' O ' HD11 ' A' ' 68' ' ' ILE . 2.3 mp -119.63 121.23 65.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 106.078 -1.823 . . . . 73.319999999999993 106.078 -177.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.298 1.2 pt? -121.06 122.85 40.97 Favored 'General case' 0 C--N 1.28 -2.434 0 C-N-CA 120.21 -0.596 . . . . 70.439999999999998 111.881 176.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' CYS . . . . . 0.404 ' HA ' ' HA2' ' B' ' 79' ' ' GLY . 64.6 m -116.74 130.99 57.06 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.939 -1.134 . . . . 73.109999999999999 107.939 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 3.5 p-10 -121.15 144.16 48.72 Favored 'General case' 0 C--O 1.201 -1.475 0 C-N-CA 119.756 -0.778 . . . . 61.310000000000002 110.627 -176.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -121.69 5.16 10.03 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.199 -0.667 . . . . 64.019999999999996 109.199 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.428 ' CD2' ' HB2' ' B' ' 71' ' ' ASP . 34.5 p90 -67.31 -26.52 66.56 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-O 121.132 0.492 . . . . 64.140000000000001 109.836 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 41.0 m -66.15 -18.8 65.58 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.555 -0.748 . . . . 75.239999999999995 111.758 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.34 -51.76 0.76 Allowed Glycine 0 CA--C 1.482 -2.028 0 N-CA-C 108.308 -1.917 . . . . 74.140000000000001 108.308 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 53.9 m170 -97.14 148.92 35.11 Favored Pre-proline 0 CA--C 1.479 -1.77 0 N-CA-C 105.851 -1.907 . . . . 73.349999999999994 105.851 173.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.756 ' HB2' ' CE1' ' B' ' 46' ' ' TYR . 74.5 Cg_endo -80.49 116.51 3.27 Favored 'Trans proline' 0 N--CA 1.417 -3.016 0 N-CA-C 108.955 -1.209 . . . . 75.430000000000007 108.955 173.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' LYS . . . . . 0.462 ' HZ1' ' CG ' ' B' ' 71' ' ' ASP . 23.9 mtmm -104.83 -168.52 1.49 Allowed 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 108.643 -0.873 . . . . 62.140000000000001 108.643 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' B' ' 70' ' ' CYS . . . -168.38 139.77 5.85 Favored Glycine 0 N--CA 1.403 -3.559 0 C-N-CA 119.7 -1.238 . . . . 54.119999999999997 113.17 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -150.12 144.67 25.86 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 114.662 -0.769 . . . . 73.530000000000001 109.344 174.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.44 159.91 41.07 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-O 120.716 0.293 . . . . 64.25 110.763 -172.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -123.0 125.55 45.45 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.427 -0.953 . . . . 74.200000000000003 108.427 174.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 44.6 mm -103.87 120.46 54.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 106.752 -1.573 . . . . 72.5 106.752 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' B' ' 38' ' ' SER . 34.3 mt-10 -107.4 118.73 37.5 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.079 0.466 . . . . 74.120000000000005 110.025 -175.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -99.93 166.73 10.92 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.998 0.74 . . . . 63.32 112.998 -173.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.527 ' O ' ' HD3' ' B' ' 37' ' ' ARG . . . -77.57 -36.84 51.64 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.641 -1.163 . . . . 61.450000000000003 111.378 174.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -109.08 146.82 33.37 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.15 0.5 . . . . 61.140000000000001 112.029 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.474 ' O ' HG21 ' B' ' 91' ' ' VAL . 0.6 OUTLIER -73.93 -29.77 62.21 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 106.407 -1.701 . . . . 72.530000000000001 106.407 178.759 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -64.15 -24.08 67.55 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 114.773 -1.103 . . . . 71.140000000000001 110.667 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 19.8 m -68.33 -36.28 79.04 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 116.394 -0.366 . . . . 75.239999999999995 110.314 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . 0.474 HG21 ' O ' ' B' ' 88' ' ' ARG . 3.1 m -64.49 -38.99 84.03 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.071 0 N-CA-C 108.373 -0.973 . . . . 74.349999999999994 108.373 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.3 -38.56 74.19 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 123.769 0.668 . . . . 72.329999999999998 110.601 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.27 -35.4 63.76 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.054 -0.521 . . . . 74.329999999999998 111.3 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.77 -45.24 59.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.911 0.386 . . . . 54.149999999999999 111.056 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . 0.4 HG13 ' O ' ' B' ' 91' ' ' VAL . 26.0 m -57.79 -21.58 16.74 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 N-CA-C 112.935 0.717 . . . . 70.329999999999998 112.935 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.25 -15.4 63.16 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 121.581 0.705 . . . . 71.109999999999999 110.62 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 67.3 mtm -103.35 12.27 35.61 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.536 -0.756 . . . . 74.239999999999995 109.662 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . 0.603 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 2.1 p-10 -36.21 -43.45 0.35 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.249 1.574 . . . . 65.040000000000006 115.249 -176.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -130.09 61.76 1.58 Allowed 'General case' 0 N--CA 1.421 -1.918 0 C-N-CA 118.665 -1.214 . . . . 73.430000000000007 111.129 174.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 15.0 t -89.84 173.84 8.03 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 113.914 -1.493 . . . . 74.400000000000006 109.995 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.35 128.77 63.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.261 0.553 . . . . 63.149999999999999 109.841 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -140.68 126.11 18.84 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.647 -1.242 . . . . 74.519999999999996 107.647 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . 0.366 12.6 ptm85 50.37 55.03 10.11 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.114 1.524 . . . . 73.340000000000003 115.114 -176.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.72 -4.4 9.73 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 114.616 -1.175 . . . . 74.430000000000007 115.484 177.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -127.76 161.89 27.91 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 117.897 0.849 . . . . 72.549999999999997 110.666 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 37.1 m -95.64 128.37 42.45 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 109.53 -0.544 . . . . 62.119999999999997 109.53 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 35.8 pt -102.49 171.69 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 120.922 -0.311 . . . . 54.119999999999997 111.075 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' LYS . . . . . 0.603 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 41.7 tptt -131.04 126.8 36.83 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 109.394 -0.595 . . . . 73.329999999999998 109.394 -176.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . 0.698 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 18.1 t -126.88 131.58 70.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.112 -0.699 . . . . 72.140000000000001 109.112 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . 0.567 ' HB3' ' HD2' ' B' ' 111' ' ' PRO 0.266 0.2 OUTLIER -136.26 168.42 17.26 Favored Pre-proline 0 CA--C 1.502 -0.894 0 N-CA-C 105.493 -2.04 . . . . 71.129999999999995 105.493 172.387 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' B' ' 110' ' ' LEU . 95.3 Cg_endo -76.55 148.75 29.82 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.363 1.375 . . . . 62.310000000000002 109.887 171.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 72.3 tttt . . . . . 0 C--N 1.292 -1.92 0 N-CA-C 106.217 -1.771 . . . . 63.530000000000001 106.217 178.12 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 11.3 mm-40 . . . . . 0 C--O 1.209 -1.053 0 N-CA-C 112.3 0.482 . . . . 72.349999999999994 112.3 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.9 pt -65.37 -35.59 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 112.934 0.716 . . . . 72.200000000000003 112.934 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -71.15 -29.5 65.29 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 119.878 -0.729 . . . . 71.099999999999994 110.778 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -73.69 -15.91 61.21 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.525 0.73 . . . . 74.540000000000006 110.067 176.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 98.3 mtt180 -104.9 12.02 32.95 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.303 -0.862 . . . . 71.230000000000004 109.019 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.425 ' HB3' ' HE2' ' A' ' 112' ' ' LYS . 33.0 t -107.21 156.65 18.61 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 121.58 0.705 . . . . 74.049999999999997 110.853 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.544 ' CG1' ' HB ' ' A' ' 91' ' ' VAL . 34.3 m -136.23 164.58 31.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.359 -0.837 . . . . 70.530000000000001 109.66 -177.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.599 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 22.4 t80 -110.18 127.0 54.69 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 107.847 -1.168 . . . . 75.150000000000006 107.847 176.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 58.0 t -121.31 112.73 36.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 107.518 -1.29 . . . . 75.420000000000002 107.518 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -117.81 172.71 14.48 Favored Glycine 0 C--N 1.294 -1.789 0 C-N-CA 118.978 -1.582 . . . . 73.400000000000006 114.036 -176.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.7 t30 60.41 20.86 10.49 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 125.749 1.62 . . . . 71.549999999999997 112.198 -176.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.87 139.92 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 121.093 0.473 . . . . 73.420000000000002 110.039 176.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -82.83 156.03 23.85 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.672 -0.862 . . . . 74.109999999999999 108.672 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -68.63 -18.62 64.33 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.741 0.781 . . . . 72.140000000000001 109.235 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.4 -15.7 81.18 Favored Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 115.055 -0.975 . . . . 74.099999999999994 112.296 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.4 m -87.1 127.34 35.13 Favored 'General case' 0 N--CA 1.411 -2.388 0 N-CA-C 108.011 -1.107 . . . . 63.240000000000002 108.011 176.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.3 p -105.49 178.67 4.49 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.613 -0.514 . . . . 74.150000000000006 109.613 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.508 ' HB3' HD11 ' A' ' 66' ' ' ILE . . . -60.7 -46.07 91.79 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.753 -0.462 . . . . 54.240000000000002 109.753 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -58.41 -36.25 73.29 Favored 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 115.596 -0.729 . . . . 75.129999999999995 111.305 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -67.45 -40.61 85.43 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.206 0.526 . . . . 62.140000000000001 110.463 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.6 mt -66.49 -47.94 71.43 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 115.165 -0.925 . . . . 60.240000000000002 111.744 -177.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.449 ' CD ' ' HZ3' ' B' ' 72' ' ' LYS . 36.2 mt-10 -60.62 -46.39 90.46 Favored 'General case' 0 C--O 1.181 -2.528 0 N-CA-C 113.645 0.98 . . . . 55.310000000000002 113.645 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.38 -47.83 75.23 Favored 'General case' 0 C--O 1.271 2.189 0 CA-C-O 121.662 0.744 . . . . 73.430000000000007 111.455 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -63.86 -43.01 97.38 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.851 -1.068 . . . . 74.010000000000005 110.568 -178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -82.13 -22.21 36.27 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 114.843 1.423 . . . . 63.009999999999998 114.843 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.4 t -67.07 -26.97 67.0 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.284 -0.636 . . . . 53.420000000000002 109.284 -177.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.2 m -59.1 -24.94 63.38 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 120.534 -0.466 . . . . 71.400000000000006 111.004 173.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 76.7 m -95.72 7.2 46.96 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.876 1.065 . . . . 74.120000000000005 113.876 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.38 -147.25 18.4 Favored Glycine 0 C--O 1.238 0.35 0 C-N-CA 118.51 -1.805 . . . . 60.0 115.067 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 52.8 p -112.95 122.97 49.23 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.021 0.438 . . . . 62.5 111.541 -175.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.3 mt -89.39 130.52 38.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-O 121.21 0.528 . . . . 73.230000000000004 112.03 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -92.68 -48.95 6.33 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.043 -0.981 . . . . 70.530000000000001 109.055 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -155.83 163.78 39.37 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.613 -0.884 . . . . 74.409999999999997 108.613 -176.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.508 HD11 ' HB3' ' A' ' 50' ' ' ALA . 31.3 pt -145.87 144.51 20.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 109.185 -0.672 . . . . 64.430000000000007 109.185 176.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.4 m -125.71 126.03 43.96 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 107.334 -1.358 . . . . 75.120000000000005 107.334 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.8 mp -122.48 122.89 67.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.113 -1.44 . . . . 71.329999999999998 107.113 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.286 1.0 OUTLIER -121.0 128.37 52.64 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 120.207 -0.597 . . . . 71.030000000000001 111.918 176.143 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 62.6 m -114.36 125.38 53.8 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.543 -1.28 . . . . 72.450000000000003 107.543 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' A' ' 78' ' ' LYS . 2.2 p-10 -110.64 130.43 55.57 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 118.462 -1.295 . . . . 55.240000000000002 112.013 -177.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -107.49 13.03 27.26 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.368 -1.345 . . . . 72.409999999999997 107.368 170.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -61.47 -36.63 80.98 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 113.921 -1.491 . . . . 75.340000000000003 108.508 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.5 t -81.68 7.78 11.57 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-N 115.495 -0.775 . . . . 73.129999999999995 111.154 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.74 -47.95 3.25 Favored Glycine 0 N--CA 1.462 0.418 0 O-C-N 121.615 -0.678 . . . . 74.140000000000001 111.429 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -95.77 137.28 21.89 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 106.737 -1.579 . . . . 74.439999999999998 106.737 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.34 117.01 4.66 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 CA-C-N 119.313 0.79 . . . . 72.409999999999997 110.706 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.431 ' HB2' ' OD1' ' A' ' 71' ' ' ASP . 13.0 mmmm -104.96 -176.47 3.09 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 115.0 -1.0 . . . . 75.219999999999999 108.663 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.54 137.59 4.91 Favored Glycine 0 N--CA 1.41 -3.061 0 C-N-CA 119.596 -1.288 . . . . 52.329999999999998 112.785 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.461 ' HH ' ' HG3' ' B' ' 23' ' ' PRO . 10.3 p90 -154.43 143.29 20.96 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 123.931 0.892 . . . . 73.150000000000006 109.27 173.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.26 151.8 50.04 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-O 120.9 0.381 . . . . 62.219999999999999 110.574 -172.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -118.82 115.68 24.93 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 108.386 -0.968 . . . . 72.099999999999994 108.386 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 40.0 mm -97.57 122.03 48.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.223 -1.029 . . . . 74.530000000000001 108.223 -176.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -102.38 119.79 39.41 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.195 -0.669 . . . . 61.130000000000003 109.195 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.26 156.47 16.41 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-O 121.062 0.458 . . . . 75.230000000000004 110.533 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.22 -27.84 56.95 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.156 -0.475 . . . . 60.409999999999997 110.051 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -112.48 136.86 51.49 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.826 -0.625 . . . . 73.010000000000005 110.848 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -69.72 -32.12 70.51 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.815 -1.18 . . . . 70.310000000000002 107.815 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -67.68 -21.67 65.33 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 115.807 -0.633 . . . . 75.230000000000004 111.498 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.3 m -67.85 -36.04 79.61 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.739 -0.467 . . . . 62.530000000000001 109.739 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.544 ' HB ' ' CG1' ' A' ' 39' ' ' VAL . 2.2 m -67.15 -38.57 81.37 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 N-CA-C 108.354 -0.98 . . . . 73.209999999999994 108.354 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -61.36 -35.55 77.76 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.439 -0.801 . . . . 70.230000000000004 110.735 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.31 -31.65 62.56 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.079 -0.509 . . . . 64.120000000000005 110.826 175.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 97' ' ' MET . . . -76.46 -42.93 42.08 Favored 'General case' 0 C--O 1.205 -1.269 0 CA-C-N 115.999 -0.546 . . . . 75.439999999999998 111.094 -177.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 91' ' ' VAL . 19.9 m -56.09 -21.37 11.37 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.957 0 N-CA-C 113.458 0.91 . . . . 75.019999999999996 113.458 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.07 -10.54 58.12 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-O 121.933 0.873 . . . . 65.349999999999994 110.235 176.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.48 ' HA ' ' OG1' ' A' ' 100' ' ' THR . 18.7 mtp -101.62 9.65 40.93 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 125.111 1.364 . . . . 71.200000000000003 109.866 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 12.4 t70 -35.73 -57.95 0.63 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 115.703 1.742 . . . . 74.239999999999995 115.703 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -116.99 30.39 7.36 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 122.327 1.06 . . . . 64.510000000000005 109.329 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.48 ' OG1' ' HA ' ' A' ' 97' ' ' MET . 89.8 m -74.71 167.39 21.89 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.915 -1.039 . . . . 75.299999999999997 110.195 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.25 133.12 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 CA-C-O 121.356 0.598 . . . . 50.310000000000002 110.143 -173.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -133.23 127.79 34.49 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.476 -0.784 . . . . 74.040000000000006 109.059 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 57.05 32.64 22.02 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 122.303 1.049 . . . . 73.209999999999994 110.484 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.19 5.85 87.45 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.012 -0.995 . . . . 75.549999999999997 113.444 177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -124.88 145.75 49.66 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 117.086 0.443 . . . . 71.430000000000007 110.137 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.5 m -79.31 119.74 22.79 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 110.018 -0.364 . . . . 63.109999999999999 110.018 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 45.9 pt -102.72 171.11 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 109.758 -0.46 . . . . 72.430000000000007 109.758 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 22.5 mmmt -118.02 130.15 56.0 Favored 'General case' 0 CA--C 1.472 -2.05 0 N-CA-C 108.883 -0.784 . . . . 75.400000000000006 108.883 176.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 41.1 t -125.59 111.79 28.53 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 107.304 -1.369 . . . . 70.329999999999998 107.304 172.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.401 HD12 ' HB3' ' A' ' 40' ' ' TYR 0.266 0.0 OUTLIER -138.9 146.75 51.27 Favored Pre-proline 0 N--CA 1.432 -1.345 0 C-N-CA 119.215 -0.994 . . . . 73.230000000000004 108.363 178.103 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -76.53 137.29 18.29 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.614 1.543 . . . . 63.009999999999998 112.217 -173.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.425 ' HE2' ' HB3' ' A' ' 38' ' ' SER . 37.6 ttpt . . . . . 0 N--CA 1.426 -1.657 0 N-CA-C 108.498 -0.927 . . . . 71.209999999999994 108.498 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.221 0 N-CA-C 116.021 1.168 . . . . 73.409999999999997 116.021 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.555 ' HG3' ' CE1' ' A' ' 40' ' ' TYR . 2.8 Cg_endo -41.69 -52.91 3.59 Favored 'Trans proline' 0 C--N 1.366 1.451 1 C-N-CA 125.475 4.117 . . . . 64.209999999999994 118.287 -173.658 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.461 ' HG3' ' HH ' ' A' ' 80' ' ' TYR . 32.9 Cg_endo -58.63 123.7 14.16 Favored 'Trans proline' 0 C--N 1.379 2.179 0 CA-C-N 120.802 1.322 . . . . 73.319999999999993 111.557 -174.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -59.79 136.47 90.07 Favored Pre-proline 0 N--CA 1.435 -1.216 0 CA-C-N 115.573 -0.74 . . . . 75.319999999999993 110.356 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.52 103.08 0.09 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 123.237 2.625 . . . . 75.319999999999993 114.149 -172.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.501 ' H ' HD13 ' B' ' 26' ' ' LEU . 0.0 OUTLIER -70.56 170.84 11.32 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 114.973 -1.012 . . . . 74.200000000000003 109.876 174.376 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 47.6 t -59.42 143.47 49.7 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.53 0.681 . . . . 73.549999999999997 112.707 -173.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.503 ' O ' ' HE2' ' B' ' 32' ' ' LYS . . . -52.73 -36.25 57.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.328 -1.306 . . . . 74.409999999999997 111.703 176.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -60.98 -49.2 78.42 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.555 -0.535 . . . . 63.32 109.555 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.52 -36.51 80.75 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-N 115.997 -0.547 . . . . 72.409999999999997 112.09 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.546 ' HA ' HG12 ' B' ' 34' ' ' ILE 0.516 5.3 ptpt -71.48 -35.43 70.82 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 115.049 1.5 . . . . 73.430000000000007 115.049 -179.146 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.503 ' HE2' ' O ' ' B' ' 28' ' ' ALA . 45.6 mtmt -64.41 -40.94 96.74 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.04 0.447 . . . . 54.009999999999998 111.066 174.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.549 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 38.6 mm-40 -71.07 -42.98 68.68 Favored 'General case' 0 C--O 1.211 -0.929 0 CA-C-N 115.622 -0.717 . . . . 73.409999999999997 112.768 -177.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.546 HG12 ' HA ' ' B' ' 31' ' ' LYS . 13.6 pt -64.79 -35.53 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 112.843 0.682 . . . . 73.540000000000006 112.843 -176.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -72.91 -23.69 60.73 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 119.994 -0.682 . . . . 70.010000000000005 111.329 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -77.1 -14.99 59.72 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.709 0.804 . . . . 74.439999999999998 109.741 174.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.549 ' HG3' ' O ' ' B' ' 33' ' ' GLU . 89.7 mtt180 -109.22 14.1 24.01 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 115.218 -0.901 . . . . 74.519999999999996 108.883 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 49.6 m -101.31 153.71 19.41 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.191 -0.913 . . . . 72.549999999999997 110.937 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.512 ' CG1' ' HB ' ' B' ' 91' ' ' VAL . 35.7 m -133.3 163.85 36.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.321 -0.854 . . . . 61.240000000000002 109.273 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . 0.532 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 35.0 t80 -110.9 124.47 52.16 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 107.623 -1.251 . . . . 73.420000000000002 107.623 177.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 59.1 t -122.91 110.1 25.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 107.923 -1.14 . . . . 73.310000000000002 107.923 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' B' ' 43' ' ' ASN . . . -133.88 109.02 0.77 Allowed Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 115.547 -3.216 . . . . 63.439999999999998 116.42 -177.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' B' ' 42' ' ' GLY . 62.0 t30 166.41 26.35 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 125.868 1.667 . . . . 75.209999999999994 108.011 157.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 12.0 p -69.67 136.22 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 115.208 -0.905 . . . . 75.030000000000001 109.921 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -111.9 167.09 10.65 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.666 -0.697 . . . . 63.520000000000003 110.788 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' TYR . . . . . 0.512 ' CE1' ' HB2' ' B' ' 77' ' ' PRO . 5.5 m-85 -69.25 101.55 1.52 Allowed 'General case' 0 CA--C 1.496 -1.13 0 CA-C-O 121.629 0.728 . . . . 73.400000000000006 109.796 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . 0.473 ' HA3' ' NH1' ' B' ' 103' ' ' ARG . . . 159.7 -33.58 0.45 Allowed Glycine 0 N--CA 1.413 -2.879 0 N-CA-C 109.218 -1.553 . . . . 43.340000000000003 109.218 -175.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.459 ' OG ' ' HE2' ' B' ' 102' ' ' PHE . 18.3 m -90.78 135.14 33.92 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 108.361 -0.977 . . . . 73.040000000000006 108.361 176.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 82.0 p -105.45 178.83 4.45 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 116.219 -0.446 . . . . 71.439999999999998 109.972 -177.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.508 ' HB3' HD11 ' B' ' 66' ' ' ILE . . . -61.98 -41.98 98.63 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.265 -1.013 . . . . 74.120000000000005 108.265 175.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -58.29 -35.41 71.77 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 114.949 -1.023 . . . . 74.319999999999993 111.392 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -69.55 -41.3 76.1 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 121.087 0.47 . . . . 75.400000000000006 110.472 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 61.2 mt -63.94 -47.82 78.98 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.348 -0.842 . . . . 73.219999999999999 112.244 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.421 ' HG2' HD13 ' B' ' 63' ' ' ILE . 31.0 mt-10 -60.14 -47.31 86.43 Favored 'General case' 0 C--O 1.182 -2.467 0 N-CA-C 113.796 1.036 . . . . 43.420000000000002 113.796 177.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.54 -48.02 75.38 Favored 'General case' 0 C--O 1.266 1.952 0 CA-C-N 118.413 0.551 . . . . 71.230000000000004 110.408 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -64.08 -41.57 97.27 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.549 -0.751 . . . . 74.129999999999995 110.719 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.436 ' CZ ' HG21 ' B' ' 41' ' ' VAL . 54.2 m-85 -82.51 -21.78 35.33 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 114.95 1.463 . . . . 72.140000000000001 114.95 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 48.5 t -66.89 -27.96 67.93 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.6 -0.518 . . . . 74.299999999999997 109.6 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.8 m -58.61 -31.55 68.17 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-O 121.003 0.43 . . . . 73.129999999999995 110.19 173.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 85.9 m -91.79 1.76 56.95 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.32 0.859 . . . . 64.239999999999995 113.32 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.65 -159.11 28.11 Favored Glycine 0 C--O 1.243 0.663 0 C-N-CA 118.033 -2.032 . . . . 37.810000000000002 116.383 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 17.5 m -106.05 116.21 31.54 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.053 -0.574 . . . . 75.510000000000005 110.592 -175.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.421 HD13 ' HG2' ' B' ' 54' ' ' GLU . 77.4 mt -84.18 132.16 32.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 121.594 0.712 . . . . 73.040000000000006 112.617 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -94.82 -49.07 5.75 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.635 -1.166 . . . . 65.219999999999999 109.281 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -155.93 164.32 38.64 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.659 -0.867 . . . . 74.400000000000006 108.659 -176.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.508 HD11 ' HB3' ' B' ' 50' ' ' ALA . 31.3 pt -145.98 144.59 20.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 109.002 -0.74 . . . . 72.409999999999997 109.002 176.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 58.5 m -125.47 125.71 43.74 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.263 -1.384 . . . . 74.329999999999998 107.263 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.7 mp -122.43 122.63 66.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 106.881 -1.526 . . . . 74.209999999999994 106.881 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.262 1.4 pt? -121.09 128.32 52.47 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.98 -0.688 . . . . 65.310000000000002 111.611 176.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 64.3 m -113.92 125.62 54.25 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.734 -1.21 . . . . 74.200000000000003 107.734 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -112.01 130.04 56.0 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 118.895 -1.122 . . . . 71.239999999999995 112.284 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . 0.449 ' HZ3' ' CD ' ' A' ' 54' ' ' GLU . 97.9 mttt -106.85 10.98 30.52 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.086 -1.079 . . . . 71.340000000000003 108.086 172.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -59.82 -33.69 72.09 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 113.733 -1.576 . . . . 74.140000000000001 107.892 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' SER . . . . . 0.404 ' C ' ' H ' ' B' ' 76' ' ' HIS . 24.8 m -82.35 8.31 11.68 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 115.087 -0.961 . . . . 53.200000000000003 111.799 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.2 -49.1 3.93 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-O 121.872 0.706 . . . . 72.209999999999994 111.388 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . 0.404 ' H ' ' C ' ' B' ' 74' ' ' SER . 40.7 m-70 -95.01 131.63 29.81 Favored Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 105.37 -2.085 . . . . 54.43 105.37 176.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.512 ' HB2' ' CE1' ' B' ' 46' ' ' TYR . 19.7 Cg_endo -63.42 116.67 3.77 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.212 1.275 . . . . 63.350000000000001 111.691 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -103.8 -178.61 3.71 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.239 -0.891 . . . . 64.230000000000004 109.303 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.55 136.44 4.22 Favored Glycine 0 N--CA 1.412 -2.945 0 C-N-CA 119.66 -1.257 . . . . 75.420000000000002 113.1 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -152.24 144.8 24.17 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 123.976 0.91 . . . . 75.129999999999995 109.756 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.98 151.48 49.05 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-O 121.001 0.429 . . . . 73.239999999999995 110.41 -172.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -118.83 115.93 25.46 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 108.129 -1.063 . . . . 74.25 108.129 176.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.402 HG23 HG23 ' B' ' 66' ' ' ILE . 40.7 mm -97.2 122.18 48.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 108.151 -1.055 . . . . 73.010000000000005 108.151 -177.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -101.97 119.46 38.83 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.067 -0.716 . . . . 71.329999999999998 109.067 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -98.02 155.66 17.0 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 116.279 -0.419 . . . . 72.439999999999998 109.972 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.97 -30.28 55.92 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.277 0.56 . . . . 74.239999999999995 109.644 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . 0.503 ' HB2' ' OG ' ' B' ' 90' ' ' SER . 35.6 mt-10 -105.14 136.71 44.14 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.862 -0.608 . . . . 74.099999999999994 109.627 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -72.52 -32.32 66.05 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.349 -1.352 . . . . 70.200000000000003 107.349 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -66.54 -22.42 66.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.429 -0.805 . . . . 72.340000000000003 111.357 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' SER . . . . . 0.503 ' OG ' ' HB2' ' B' ' 87' ' ' GLU . 49.6 m -67.48 -36.01 80.29 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.976 -0.379 . . . . 75.549999999999997 109.976 176.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . 0.512 ' HB ' ' CG1' ' B' ' 39' ' ' VAL . 2.0 m -67.01 -38.4 81.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 N-CA-C 108.121 -1.066 . . . . 73.319999999999993 108.121 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.34 -37.48 83.46 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.405 -0.816 . . . . 55.439999999999998 110.219 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.34 -30.92 63.66 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.195 0.521 . . . . 73.150000000000006 110.835 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.13 -44.79 36.75 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-N 116.086 -0.506 . . . . 73.510000000000005 111.352 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 25.7 m -55.46 -21.63 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.924 0.89 . . . . 74.239999999999995 112.819 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.62 -8.96 52.04 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.306 0.574 . . . . 62.25 110.481 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 32.9 mtm -105.02 12.97 31.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.495 -0.775 . . . . 75.340000000000003 110.583 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -39.55 -44.32 1.42 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.195 1.183 . . . . 74.400000000000006 114.195 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -110.05 95.14 5.4 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 121.545 0.688 . . . . 72.120000000000005 110.274 172.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' B' ' 106' ' ' THR . 6.7 p -132.11 156.08 46.99 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.119 -0.946 . . . . 72.209999999999994 111.934 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.68 127.14 65.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 121.095 0.474 . . . . 71.230000000000004 109.904 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' PHE . . . . . 0.459 ' HE2' ' OG ' ' B' ' 48' ' ' SER . 43.1 t80 -143.18 126.22 16.35 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.708 -1.59 . . . . 75.420000000000002 106.708 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' ARG . . . . . 0.473 ' NH1' ' HA3' ' B' ' 47' ' ' GLY . 72.9 mtp85 62.59 33.36 15.88 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.208 0.603 . . . . 72.209999999999994 111.101 -175.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.08 14.56 66.17 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 115.524 -0.762 . . . . 73.239999999999995 113.141 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -130.81 143.93 51.09 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 122.404 -0.468 . . . . 70.129999999999995 110.126 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' B' ' 100' ' ' THR . 53.5 m -83.0 126.68 32.8 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 120.777 0.322 . . . . 75.420000000000002 110.356 -177.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 38.7 pt -100.87 167.26 2.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 109.227 -0.657 . . . . 60.240000000000002 109.227 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 44.9 tptt -121.26 124.99 45.98 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.577 -0.898 . . . . 73.0 108.577 -175.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 35.6 t -122.01 119.19 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 108.413 -0.958 . . . . 75.150000000000006 108.413 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.327 0.3 OUTLIER -143.53 137.37 14.45 Favored Pre-proline 0 C--N 1.285 -2.197 0 N-CA-C 106.454 -1.684 . . . . 72.239999999999995 106.454 -169.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -77.18 130.11 10.9 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 120.771 1.311 . . . . 71.299999999999997 110.446 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt . . . . . 0 C--N 1.317 -0.821 0 C-N-CA 120.08 -0.648 . . . . 74.140000000000001 110.597 -174.124 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 120.728 0.299 . . . . 75.430000000000007 110.431 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.479 HD13 HG23 ' A' ' 34' ' ' ILE . 13.2 pt -71.63 -35.97 57.88 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 CA-C-N 115.578 -0.737 . . . . 71.129999999999995 110.747 176.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -58.98 -42.61 90.38 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 120.831 0.348 . . . . 74.340000000000003 110.169 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -60.26 -26.8 66.73 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.889 0.876 . . . . 71.5 111.804 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.444 ' HD3' ' O ' ' A' ' 86' ' ' ALA . 15.8 ptp180 -112.55 21.91 15.15 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.672 0.748 . . . . 74.299999999999997 109.93 -176.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 56.9 m -113.83 170.83 7.97 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.372 -0.831 . . . . 62.210000000000001 110.78 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.88 162.14 31.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.421 0.629 . . . . 74.109999999999999 111.567 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.574 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -96.33 125.58 40.93 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 105.996 -1.853 . . . . 65.519999999999996 105.996 169.548 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.451 ' N ' ' HD1' ' A' ' 40' ' ' TYR . 94.4 t -128.37 106.54 14.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 107.247 -1.39 . . . . 72.400000000000006 107.247 173.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -151.89 113.06 0.56 Allowed Glycine 0 N--CA 1.423 -2.216 0 C-N-CA 116.174 -2.917 . . . . 74.450000000000003 117.783 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.497 ' HB3' ' HA ' ' A' ' 107' ' ' ILE . 9.3 t30 176.18 23.85 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 103.346 -2.835 . . . . 73.430000000000007 103.346 161.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.418 ' CG2' ' HB2' ' A' ' 48' ' ' SER . 7.1 p -107.76 100.82 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-N 113.03 -1.895 . . . . 72.540000000000006 110.816 -173.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -92.16 170.44 9.82 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.861 -1.063 . . . . 71.140000000000001 108.165 -175.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -28.08 -32.97 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 117.465 2.395 . . . . 72.049999999999997 117.465 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.94 -32.7 42.24 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.743 -0.265 . . . . 61.140000000000001 113.152 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.418 ' HB2' ' CG2' ' A' ' 44' ' ' VAL . 41.4 m -109.93 154.08 23.61 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 109.641 -0.503 . . . . 74.25 109.641 176.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 63.7 p -121.83 178.6 4.8 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 112.046 0.387 . . . . 74.400000000000006 112.046 -171.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 53' ' ' LEU . . . -63.15 -44.27 95.97 Favored 'General case' 0 C--O 1.215 -0.76 0 C-N-CA 123.636 0.775 . . . . 71.530000000000001 111.636 -177.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -58.13 -38.36 76.38 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.871 0.367 . . . . 72.439999999999998 111.517 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -64.17 -32.69 74.35 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.525 0.678 . . . . 64.219999999999999 109.608 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 62.8 mt -69.87 -46.08 66.3 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 114.185 -1.37 . . . . 72.409999999999997 110.595 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -57.89 -50.12 74.4 Favored 'General case' 0 C--O 1.191 -1.988 0 C-N-CA 120.944 -0.302 . . . . 75.519999999999996 111.211 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.33 -48.3 79.33 Favored 'General case' 0 C--O 1.263 1.809 0 CA-C-O 121.653 0.74 . . . . 73.019999999999996 112.458 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -69.56 -40.78 76.59 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.775 -1.102 . . . . 73.230000000000004 111.119 -175.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.405 ' CZ ' HG23 ' A' ' 41' ' ' VAL . 61.8 m-85 -82.63 -22.66 34.62 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 114.592 1.33 . . . . 74.409999999999997 114.592 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.5 t -71.26 -23.53 62.0 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.655 -0.498 . . . . 74.439999999999998 109.655 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.0 t -57.98 -31.63 67.1 Favored 'General case' 0 CA--C 1.558 1.255 0 N-CA-C 108.944 -0.762 . . . . 64.319999999999993 108.944 172.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 90' ' ' SER . 60.7 m -90.51 -0.35 57.63 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 112.751 0.649 . . . . 70.299999999999997 112.751 -177.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.64 -169.86 29.15 Favored Glycine 0 C--O 1.229 -0.18 0 C-N-CA 119.505 -1.331 . . . . 53.119999999999997 114.436 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.0 m -95.68 123.21 39.14 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 121.15 0.5 . . . . 71.209999999999994 110.453 -177.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 72.7 mt -91.56 124.84 44.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.777 -0.647 . . . . 61.340000000000003 110.875 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.495 ' ND2' ' HA ' ' A' ' 86' ' ' ALA . 65.8 m-80 -91.47 -35.54 14.28 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-O 121.077 0.465 . . . . 74.329999999999998 111.835 177.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.473 ' HD2' ' OE2' ' A' ' 84' ' ' GLU 0.266 0.0 OUTLIER -157.21 152.97 26.86 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.708 -1.219 . . . . 73.200000000000003 107.708 -167.489 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.404 HD13 ' HB3' ' A' ' 50' ' ' ALA . 34.5 pt -148.21 143.86 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 CA-C-N 118.451 0.569 . . . . 73.219999999999999 109.908 174.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.3 m -126.26 123.87 39.08 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.747 -1.205 . . . . 72.439999999999998 107.747 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.47 HD12 ' O ' ' B' ' 68' ' ' ILE . 2.2 mp -120.95 121.26 64.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 106.041 -1.837 . . . . 71.209999999999994 106.041 -176.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -120.55 130.15 54.1 Favored 'General case' 0 C--N 1.275 -2.642 0 C-N-CA 120.199 -0.6 . . . . 75.430000000000007 112.032 179.067 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 69.1 m -112.07 111.79 22.96 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.998 -1.112 . . . . 63.43 107.998 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -102.16 120.22 40.09 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 108.408 -0.96 . . . . 65.329999999999998 108.408 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.482 ' HE2' ' HB3' ' A' ' 77' ' ' PRO . 38.9 ttmt -111.0 15.65 21.6 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.059 -0.719 . . . . 74.420000000000002 109.059 -178.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -67.75 -18.0 64.74 Favored 'General case' 0 C--N 1.35 0.607 0 CA-C-O 121.341 0.591 . . . . 70.540000000000006 111.187 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.8 m -78.29 -7.28 57.02 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.913 -0.585 . . . . 70.430000000000007 110.654 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.26 -51.05 1.28 Allowed Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 109.308 -1.517 . . . . 70.540000000000006 109.308 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -96.38 134.42 23.51 Favored Pre-proline 0 C--N 1.287 -2.111 0 N-CA-C 105.677 -1.972 . . . . 74.540000000000006 105.677 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.482 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 41.5 Cg_endo -66.3 118.05 5.2 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.274 1.316 . . . . 73.349999999999994 112.232 -175.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -100.66 141.53 33.4 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.368 -0.833 . . . . 74.420000000000002 108.865 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 44' ' ' VAL . . . -127.76 140.51 11.88 Favored Glycine 0 N--CA 1.41 -3.045 0 C-N-CA 119.738 -1.22 . . . . 51.119999999999997 112.73 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . 0.25 3.1 p90 -156.65 146.92 21.29 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 123.745 0.818 . . . . 74.030000000000001 110.07 175.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.48 155.06 47.8 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-O 121.489 0.661 . . . . 74.439999999999998 109.233 -172.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.583 ' CD2' ' HD3' ' A' ' 112' ' ' LYS . 84.8 m-85 -121.27 115.89 23.84 Favored 'General case' 0 C--N 1.263 -3.172 0 N-CA-C 108.231 -1.026 . . . . 72.409999999999997 108.231 175.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 35.9 mm -95.9 119.04 43.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.318 -1.364 . . . . 64.409999999999997 107.318 -176.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.473 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 31.7 mt-10 -101.95 117.94 35.87 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.527 -0.546 . . . . 64.299999999999997 109.527 -174.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -102.23 169.56 8.64 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 121.986 0.898 . . . . 75.5 113.326 -173.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.495 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . . . -74.41 -38.82 62.97 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.36 -1.291 . . . . 62.409999999999997 112.45 174.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -126.03 159.07 33.71 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.552 -0.859 . . . . 74.030000000000001 113.145 -175.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.448 ' O ' HG21 ' A' ' 91' ' ' VAL . 11.4 mmm180 -66.44 -31.32 72.0 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 114.487 -1.233 . . . . 75.120000000000005 108.687 173.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -57.66 -39.35 76.85 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 114.133 -1.394 . . . . 71.129999999999995 109.951 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 60' ' ' CYS . 15.0 m -67.71 -38.38 83.54 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.978 -0.555 . . . . 73.540000000000006 111.148 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 88' ' ' ARG . 3.2 m -68.22 -39.15 80.7 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.224 0 C-N-CA 119.733 -0.787 . . . . 75.209999999999994 108.978 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -58.43 -38.62 77.84 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.614 0.766 . . . . 73.129999999999995 110.202 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.47 -38.07 63.02 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.667 -0.697 . . . . 71.430000000000007 111.187 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.17 -45.24 57.64 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 116.243 -0.435 . . . . 60.25 111.706 -176.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 91' ' ' VAL . 25.8 m -57.32 -22.16 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.286 0.634 . . . . 74.099999999999994 112.669 177.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.41 -14.03 62.68 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.444 0.64 . . . . 72.239999999999995 110.256 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 60.1 mtm -100.38 11.49 39.3 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.718 -0.673 . . . . 53.240000000000002 110.231 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -36.71 -49.54 0.78 Allowed 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 115.356 1.613 . . . . 62.210000000000001 115.356 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -107.25 25.5 11.33 Favored 'General case' 0 CA--C 1.556 1.186 0 CA-C-O 120.908 0.385 . . . . 74.109999999999999 111.627 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 67.7 p -84.0 172.41 12.06 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 119.417 -0.913 . . . . 71.109999999999999 111.571 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 106' ' ' THR . 8.3 p -102.95 135.91 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.912 0 N-CA-C 109.019 -0.734 . . . . 74.109999999999999 109.019 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -123.78 118.18 26.58 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.626 -0.509 . . . . 73.530000000000001 109.626 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 103' ' ' ARG . 43.4 mtp180 45.3 32.34 0.98 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.834 1.653 . . . . 72.230000000000004 113.568 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.27 -10.55 33.59 Favored Glycine 0 CA--C 1.522 0.49 0 CA-C-N 115.264 -0.88 . . . . 72.409999999999997 113.896 174.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.418 ' HD3' ' O ' ' A' ' 43' ' ' ASN . 3.8 ptp180 -124.25 132.53 53.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 117.059 0.429 . . . . 54.039999999999999 111.779 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 101' ' ' VAL . 87.6 m -71.35 121.56 18.75 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.101 -0.499 . . . . 75.329999999999998 110.478 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.497 ' HA ' ' HB3' ' A' ' 43' ' ' ASN . 33.2 pt -103.02 172.13 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 115.787 -0.642 . . . . 73.109999999999999 111.593 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -118.71 126.67 52.42 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.582 -0.896 . . . . 60.539999999999999 108.582 177.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 23.4 t -125.62 121.52 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 108.045 -1.095 . . . . 73.129999999999995 108.045 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . 0.253 0.0 OUTLIER -142.59 153.47 61.93 Favored Pre-proline 0 C--O 1.208 -1.125 0 N-CA-C 107.693 -1.225 . . . . 65.310000000000002 107.693 174.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.33 149.67 28.01 Favored 'Trans proline' 0 CA--C 1.507 -0.861 0 CA-C-N 120.721 1.293 . . . . 61.399999999999999 112.634 -175.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.583 ' HD3' ' CD2' ' A' ' 82' ' ' TYR . 47.3 mtmt . . . . . 0 N--CA 1.409 -2.519 0 N-CA-C 105.765 -1.939 . . . . 62.409999999999997 105.765 172.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.29 0 N-CA-C 114.329 0.492 . . . . 42.539999999999999 114.329 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.548 ' HG2' ' CE2' ' A' ' 40' ' ' TYR . 43.4 Cg_exo -55.04 -49.6 16.01 Favored 'Trans proline' 0 CA--C 1.578 2.702 0 C-N-CA 123.896 3.064 . . . . 75.239999999999995 115.564 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -54.29 138.25 72.32 Favored 'Trans proline' 0 C--N 1.398 3.144 0 CA-C-N 121.302 1.501 . . . . 63.130000000000003 109.635 173.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -64.08 122.23 76.27 Favored Pre-proline 0 N--CA 1.434 -1.249 0 C-N-CA 120.572 -0.451 . . . . 72.319999999999993 111.589 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -67.89 125.9 13.81 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.938 2.425 . . . . 70.510000000000005 110.664 -175.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.527 ' O ' ' HE3' ' B' ' 31' ' ' LYS 0.348 0.0 OUTLIER -77.73 171.43 14.97 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.812 -0.755 . . . . 71.120000000000005 112.014 -179.66 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.528 ' HB2' ' OE1' ' B' ' 30' ' ' GLU . 68.4 m -70.23 145.5 51.34 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 115.033 1.494 . . . . 70.519999999999996 115.033 -171.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.459 ' O ' ' HE2' ' B' ' 32' ' ' LYS . . . -53.71 -45.7 70.52 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 114.864 -1.062 . . . . 71.329999999999998 113.428 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' B' ' 33' ' ' GLU . 8.6 mm-40 -63.15 -41.96 99.36 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 122.078 -0.389 . . . . 61.399999999999999 110.635 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.528 ' OE1' ' HB2' ' B' ' 27' ' ' SER . 3.6 mp0 -56.26 -39.21 72.25 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 109.86 -0.422 . . . . 73.400000000000006 109.86 172.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.527 ' HE3' ' O ' ' B' ' 26' ' ' LEU . 98.7 mttt -69.39 -41.7 76.11 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.616 -0.72 . . . . 70.219999999999999 111.776 -177.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.684 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 0.4 OUTLIER -70.42 -35.61 73.51 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 118.977 -1.089 . . . . 72.140000000000001 111.349 176.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' B' ' 29' ' ' GLU . 17.6 mt-10 -68.31 -37.7 80.87 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 120.126 -0.63 . . . . 55.520000000000003 111.569 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.407 HG12 ' O ' ' B' ' 30' ' ' GLU . 15.4 pt -70.78 -34.63 57.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 C-N-CA 120.545 -0.462 . . . . 63.43 110.368 176.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' B' ' 31' ' ' LYS . 0.9 OUTLIER -64.82 -37.09 86.44 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.732 -0.84 . . . . 72.109999999999999 108.732 -177.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.684 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 95.8 mttt -62.02 -28.82 69.85 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.932 -1.031 . . . . 74.400000000000006 110.679 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.471 ' HD2' ' O ' ' B' ' 86' ' ' ALA . 71.7 mtm180 -106.29 18.13 22.44 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.601 -0.727 . . . . 64.329999999999998 111.221 -176.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 44.3 m -110.23 170.56 8.0 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 116.237 -0.438 . . . . 71.120000000000005 110.544 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 30.5 m -137.41 164.66 28.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.171 0.51 . . . . 74.439999999999998 111.47 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . 0.579 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 0.8 OUTLIER -106.46 120.78 42.81 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 126.41 1.884 . . . . 75.420000000000002 106.273 175.608 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.512 HG23 ' CZ ' ' B' ' 57' ' ' PHE . 100.0 t -124.79 106.68 16.95 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 N-CA-C 107.742 -1.207 . . . . 73.200000000000003 107.742 177.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.66 113.2 0.58 Allowed Glycine 0 N--CA 1.423 -2.228 0 C-N-CA 116.318 -2.849 . . . . 64.109999999999999 117.724 -175.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.504 ' HB3' ' HA ' ' B' ' 107' ' ' ILE . 9.2 t30 176.22 23.76 0.0 OUTLIER 'General case' 0 C--O 1.209 -1.042 0 N-CA-C 105.41 -2.07 . . . . 73.219999999999999 105.41 160.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.475 ' O ' ' HA3' ' B' ' 79' ' ' GLY . 5.7 p -103.53 96.18 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-N 113.746 -1.57 . . . . 64.140000000000001 108.903 -178.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' B' ' 77' ' ' PRO . 6.0 m-20 -106.98 102.67 12.01 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.558 -1.645 . . . . 70.519999999999996 106.558 -170.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 51.21 -177.96 0.02 OUTLIER 'General case' 0 C--O 1.248 1.018 0 N-CA-C 114.935 1.457 . . . . 63.409999999999997 114.935 -173.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.22 -59.55 4.97 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 111.176 -0.77 . . . . 62.439999999999998 111.176 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.2 m -88.83 155.28 19.64 Favored 'General case' 0 N--CA 1.421 -1.875 0 N-CA-C 109.358 -0.608 . . . . 73.040000000000006 109.358 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 44.6 p -119.64 178.91 4.39 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 120.713 -0.395 . . . . 75.109999999999999 111.391 -174.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.47 ' HB3' HD13 ' B' ' 66' ' ' ILE . . . -64.53 -40.68 96.05 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 123.21 0.604 . . . . 74.319999999999993 109.904 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -58.39 -41.21 84.38 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 116.167 -0.47 . . . . 64.430000000000007 111.989 174.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -59.9 -35.88 75.8 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.637 0.732 . . . . 72.349999999999994 109.656 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.65 -45.68 74.62 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.838 -1.074 . . . . 74.319999999999993 111.354 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -58.17 -50.82 72.19 Favored 'General case' 0 C--O 1.189 -2.13 0 C-N-CA 120.751 -0.38 . . . . 72.420000000000002 111.856 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.8 -48.25 80.25 Favored 'General case' 0 C--O 1.257 1.463 0 CA-C-O 120.937 0.398 . . . . 71.329999999999998 111.537 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -68.82 -40.22 79.6 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.675 -0.693 . . . . 74.25 111.192 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.512 ' CZ ' HG23 ' B' ' 41' ' ' VAL . 63.1 m-85 -83.36 -22.68 32.75 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 114.976 1.472 . . . . 73.329999999999998 114.976 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 35.7 t -72.24 -26.63 62.09 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 110.06 -0.348 . . . . 70.239999999999995 110.06 -177.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 20.4 m -64.49 -27.18 68.8 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 119.498 -0.881 . . . . 37.359999999999999 109.428 174.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . 0.456 ' SG ' ' HE1' ' B' ' 97' ' ' MET . 57.3 m -95.58 9.21 40.99 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.681 -0.69 . . . . 64.239999999999995 112.04 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.92 -167.37 32.71 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 118.619 -1.753 . . . . 74.329999999999998 115.815 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 20.4 m -108.17 116.29 31.69 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.302 -0.629 . . . . 51.439999999999998 109.302 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 64.9 mt -91.11 123.4 43.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.063 0.458 . . . . 73.420000000000002 111.579 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -95.79 -34.43 11.89 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.596 -0.729 . . . . 71.019999999999996 111.944 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.523 ' HD2' ' OE1' ' B' ' 84' ' ' GLU 0.253 0.0 OUTLIER -157.87 153.41 26.29 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.593 -1.262 . . . . 70.219999999999999 107.593 -169.922 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.47 HD13 ' HB3' ' B' ' 50' ' ' ALA . 35.0 pt -148.33 144.0 18.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 109.115 -0.698 . . . . 70.129999999999995 109.115 174.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 36.3 m -125.45 124.41 41.35 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.58 -1.637 . . . . 72.239999999999995 106.58 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.47 ' O ' HD12 ' A' ' 68' ' ' ILE . 1.1 mp -121.85 121.55 64.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 106.11 -1.811 . . . . 72.329999999999998 106.11 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.71 130.59 54.13 Favored 'General case' 0 C--N 1.277 -2.566 0 C-N-CA 120.337 -0.545 . . . . 72.349999999999994 112.27 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 85.5 m -112.52 111.86 23.0 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.243 -1.021 . . . . 54.520000000000003 108.243 178.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -101.18 116.39 32.72 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.211 -1.033 . . . . 73.129999999999995 108.211 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -112.37 4.77 17.81 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.324 -0.551 . . . . 42.43 110.6 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -80.49 -6.64 58.47 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 119.308 -0.957 . . . . 74.340000000000003 110.727 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 33.7 t -80.93 7.82 9.76 Favored 'General case' 0 CA--C 1.557 1.249 0 CA-C-N 114.89 -1.05 . . . . 74.530000000000001 108.716 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.57 -58.87 2.59 Favored Glycine 0 CA--C 1.492 -1.392 0 N-CA-C 110.371 -1.092 . . . . 72.230000000000004 110.371 178.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -97.11 137.38 21.24 Favored Pre-proline 0 C--N 1.284 -2.253 0 N-CA-C 108.687 -0.857 . . . . 74.239999999999995 108.687 175.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.406 ' O ' ' HB3' ' B' ' 45' ' ' ASP . 15.7 Cg_endo -61.21 117.89 4.72 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.662 1.575 . . . . 63.509999999999998 111.54 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -108.7 140.66 41.78 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 108.67 -0.863 . . . . 64.319999999999993 108.67 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' B' ' 44' ' ' VAL . . . -128.37 138.16 10.18 Favored Glycine 0 N--CA 1.411 -3.025 0 C-N-CA 120.495 -0.86 . . . . 55.310000000000002 112.469 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -154.51 147.01 24.05 Favored 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 123.695 0.798 . . . . 73.349999999999994 109.74 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -138.57 152.83 48.51 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-N 115.969 -0.559 . . . . 64.409999999999997 110.78 -172.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' B' ' 40' ' ' TYR . 59.8 m-85 -118.47 115.3 24.34 Favored 'General case' 0 C--N 1.266 -3.062 0 N-CA-C 108.515 -0.92 . . . . 74.439999999999998 108.515 175.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.404 ' HA ' HG21 ' B' ' 66' ' ' ILE . 37.7 mm -95.3 118.72 42.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.668 -1.604 . . . . 74.200000000000003 106.668 -176.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' GLU . . . . . 0.523 ' OE1' ' HD2' ' B' ' 65' ' ' ARG . 32.3 mt-10 -102.78 117.79 35.42 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.308 -0.627 . . . . 75.209999999999994 109.308 -174.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -103.88 168.62 9.01 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.738 0.78 . . . . 73.510000000000005 112.261 -174.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.471 ' O ' ' HD2' ' B' ' 37' ' ' ARG . . . -81.01 -34.56 32.83 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.635 -1.166 . . . . 70.439999999999998 111.793 174.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -112.75 149.94 32.27 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 113.186 0.81 . . . . 74.420000000000002 113.186 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.417 ' O ' HG21 ' B' ' 91' ' ' VAL . 10.5 mmm180 -67.71 -31.16 70.91 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 107.542 -1.281 . . . . 71.25 107.542 168.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -56.79 -41.45 77.74 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 113.838 -1.528 . . . . 75.030000000000001 109.713 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 18.2 m -65.69 -39.5 91.35 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 116.06 -0.518 . . . . 72.230000000000004 111.356 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . 0.428 ' O ' HG13 ' B' ' 95' ' ' VAL . 3.1 m -67.91 -38.73 80.53 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.354 0 C-N-CA 119.493 -0.883 . . . . 71.420000000000002 108.803 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.71 -38.76 79.01 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.678 0.791 . . . . 71.200000000000003 110.296 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.37 -36.96 63.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.624 -0.716 . . . . 63.240000000000002 111.223 177.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.4 -45.1 48.92 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 116.285 -0.416 . . . . 63.310000000000002 111.447 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . 0.428 HG13 ' O ' ' B' ' 91' ' ' VAL . 25.6 m -58.56 -21.98 19.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 C-N-CA 123.778 0.831 . . . . 71.239999999999995 112.358 177.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.31 -14.49 62.96 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.106 0.479 . . . . 75.430000000000007 110.229 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' MET . . . . . 0.456 ' HE1' ' SG ' ' B' ' 60' ' ' CYS . 72.0 mtm -99.26 13.65 32.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.542 -0.754 . . . . 72.310000000000002 110.152 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -36.27 -56.28 0.77 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 114.294 1.22 . . . . 74.409999999999997 114.294 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -107.1 91.6 3.73 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.541 0.686 . . . . 74.230000000000004 110.224 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 33.4 p -135.13 169.19 17.82 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.959 -1.019 . . . . 74.530000000000001 111.64 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 11.7 p -102.58 138.76 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 N-CA-C 108.866 -0.79 . . . . 74.409999999999997 108.866 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' PHE . . . . . 0.462 ' O ' ' HG2' ' B' ' 105' ' ' ARG . 57.3 t80 -141.15 116.44 10.03 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 107.632 -1.248 . . . . 75.340000000000003 107.632 177.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 56.31 33.62 22.6 Favored 'General case' 0 CA--C 1.559 1.324 0 CA-C-O 122.684 1.231 . . . . 71.409999999999997 111.039 -176.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.18 2.54 87.9 Favored Glycine 0 C--N 1.314 -0.666 0 CA-C-N 114.754 -1.112 . . . . 75.129999999999995 114.259 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' B' ' 102' ' ' PHE . 4.1 ptp180 -120.02 137.28 54.19 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.419 -0.586 . . . . 61.340000000000003 109.419 177.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 28.0 m -78.39 120.92 23.82 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.529 -0.545 . . . . 74.450000000000003 109.529 -176.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . 0.504 ' HA ' ' HB3' ' B' ' 43' ' ' ASN . 41.2 pt -102.3 167.22 2.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 120.403 -0.519 . . . . 74.329999999999998 111.618 -177.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -118.76 126.13 51.18 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.014 -0.994 . . . . 71.430000000000007 109.185 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 21.5 t -124.17 122.37 64.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 N-CA-C 107.969 -1.123 . . . . 73.140000000000001 107.969 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.306 0.1 OUTLIER -146.76 144.03 19.63 Favored Pre-proline 0 C--N 1.284 -2.251 0 N-CA-C 105.729 -1.952 . . . . 75.209999999999994 105.729 -172.38 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -66.0 136.19 43.75 Favored 'Trans proline' 0 C--N 1.357 1.019 0 CA-C-N 121.657 1.627 . . . . 71.409999999999997 111.832 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 86.3 tttt . . . . . 0 N--CA 1.48 1.072 0 C-N-CA 123.244 0.617 . . . . 62.549999999999997 111.21 -171.715 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 . . . . . 0 C--O 1.211 -0.934 0 N-CA-C 111.652 0.241 . . . . 65.239999999999995 111.652 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.451 HD12 HG21 ' A' ' 34' ' ' ILE . 12.8 pt -70.33 -35.32 62.09 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.182 0 C-N-CA 120.981 -0.288 . . . . 65.329999999999998 110.945 178.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -73.06 -32.02 64.76 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.731 0.777 . . . . 73.25 109.717 -176.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -71.51 -19.17 62.22 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 115.042 -0.981 . . . . 72.209999999999994 110.298 176.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 98.2 mtt180 -107.56 9.2 29.51 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.784 -0.644 . . . . 74.200000000000003 110.4 -177.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.2 m -95.36 149.81 20.95 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.587 0.708 . . . . 75.450000000000003 109.96 177.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.4 m -128.33 160.93 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 CA-C-N 115.028 -0.987 . . . . 75.430000000000007 109.779 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 18.5 t80 -105.63 121.07 43.23 Favored 'General case' 0 C--N 1.269 -2.898 0 C-N-CA 124.896 1.278 . . . . 74.510000000000005 108.072 176.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.6 t -113.9 108.92 26.73 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 107.809 -1.182 . . . . 61.149999999999999 107.809 176.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.31 165.36 12.76 Favored Glycine 0 C--N 1.296 -1.67 0 C-N-CA 119.596 -1.288 . . . . 63.140000000000001 113.711 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.6 t30 57.75 20.57 6.57 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.976 1.711 . . . . 64.340000000000003 113.374 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.3 p -62.41 133.26 28.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 CA-C-O 121.497 0.665 . . . . 61.329999999999998 109.301 174.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.415 ' HB3' ' HD2' ' A' ' 103' ' ' ARG . 15.0 t70 -80.73 153.93 27.56 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.235 -1.024 . . . . 75.519999999999996 108.235 -177.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -65.55 -17.08 64.3 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.386 0.612 . . . . 75.319999999999993 109.523 -174.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.54 -22.17 71.27 Favored Glycine 0 N--CA 1.439 -1.117 0 CA-C-N 115.905 -0.589 . . . . 64.430000000000007 112.944 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.5 m -92.29 145.0 24.83 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 119.296 -0.962 . . . . 72.310000000000002 111.483 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.2 p -124.28 179.83 4.74 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.831 -1.077 . . . . 73.329999999999998 109.197 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.88 -50.28 72.98 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 112.634 0.605 . . . . 73.420000000000002 112.634 -174.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -58.55 -43.03 89.18 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.452 0.538 . . . . 74.400000000000006 112.452 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.49 -44.36 97.22 Favored 'General case' 0 C--O 1.254 1.328 0 CA-C-O 121.762 0.791 . . . . 73.219999999999999 109.414 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 76.2 mt -68.31 -46.06 71.32 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-N 114.733 -1.121 . . . . 75.439999999999998 112.037 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.424 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 38.5 mt-10 -58.6 -47.89 82.81 Favored 'General case' 0 C--O 1.203 -1.366 0 N-CA-C 113.09 0.774 . . . . 61.130000000000003 113.09 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.7 -47.66 76.44 Favored 'General case' 0 C--O 1.276 2.496 0 CA-C-O 120.89 0.376 . . . . 50.039999999999999 110.779 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -64.29 -34.89 79.16 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 120.103 -0.639 . . . . 73.140000000000001 110.928 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -81.45 -21.63 38.67 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.812 1.042 . . . . 75.230000000000004 113.812 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.2 m -64.55 -26.62 68.5 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 121.067 0.46 . . . . 42.009999999999998 110.006 -178.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.0 m -57.7 -32.58 67.52 Favored 'General case' 0 CA--C 1.567 1.62 0 CA-C-N 116.065 -0.516 . . . . 61.030000000000001 110.455 172.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.1 m -91.21 4.5 52.12 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 113.599 0.963 . . . . 74.510000000000005 113.599 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.21 -164.97 27.52 Favored Glycine 0 CA--C 1.511 -0.191 0 C-N-CA 118.944 -1.598 . . . . 74.329999999999998 113.978 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.7 m -101.72 121.94 42.98 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.228 -0.286 . . . . 73.200000000000003 110.228 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.424 ' CD1' ' HA ' ' A' ' 54' ' ' GLU . 47.5 mt -78.97 127.98 38.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 121.715 0.769 . . . . 71.450000000000003 112.262 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.447 ' OD1' ' HA ' ' B' ' 73' ' ' PHE . 34.0 t-20 -87.03 -47.12 9.19 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.371 -1.286 . . . . 71.349999999999994 108.766 177.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.519 ' HB2' ' OE1' ' A' ' 84' ' ' GLU . 50.1 mtm180 -155.39 165.02 37.91 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.168 -0.679 . . . . 74.040000000000006 109.168 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.1 tt -149.18 133.35 8.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 122.966 0.506 . . . . 75.219999999999999 111.557 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.0 m -125.65 131.77 52.57 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.674 -1.232 . . . . 71.310000000000002 107.674 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.413 HD11 ' O ' ' B' ' 68' ' ' ILE . 2.3 mp -128.66 124.16 60.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 107.335 -1.357 . . . . 75.400000000000006 107.335 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.458 HD23 ' O ' ' A' ' 80' ' ' TYR . 1.6 pt? -120.67 131.95 54.85 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.959 -0.696 . . . . 75.519999999999996 111.643 176.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 66.7 m -117.36 127.43 54.04 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 108.867 -0.79 . . . . 64.349999999999994 108.867 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 3.1 p30 -104.73 119.31 38.69 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 119.298 -0.961 . . . . 71.549999999999997 109.09 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 41.2 ttmt -110.06 -4.11 16.04 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 120.072 -0.651 . . . . 71.150000000000006 112.084 -175.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.578 ' HB3' ' OD1' ' B' ' 64' ' ' ASN . 50.7 p90 -58.1 -20.29 38.86 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 119.447 -0.901 . . . . 74.450000000000003 111.188 176.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 28.5 t -79.22 -3.66 46.86 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.165 0.586 . . . . 61.450000000000003 111.42 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.0 -61.16 0.8 Allowed Glycine 0 CA--C 1.496 -1.126 0 N-CA-C 109.748 -1.341 . . . . 64.329999999999998 109.748 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -95.23 120.49 63.96 Favored Pre-proline 0 CA--C 1.484 -1.575 0 N-CA-C 106.689 -1.597 . . . . 70.530000000000001 106.689 173.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 65.6 Cg_endo -68.9 119.34 6.34 Favored 'Trans proline' 0 N--CA 1.442 -1.553 0 C-N-CA 121.841 1.694 . . . . 74.209999999999994 111.5 -176.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 32.6 mtmm -95.9 151.92 18.98 Favored 'General case' 0 CA--C 1.472 -2.021 0 N-CA-C 107.619 -1.252 . . . . 75.400000000000006 107.619 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.05 144.24 15.47 Favored Glycine 0 N--CA 1.405 -3.432 0 C-N-CA 118.743 -1.694 . . . . 37.579999999999998 113.492 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.458 ' O ' HD23 ' A' ' 69' ' ' LEU . 44.0 p90 -152.14 146.32 25.4 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.479 -0.86 . . . . 64.030000000000001 109.018 172.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.11 154.08 50.91 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 120.691 0.282 . . . . 71.200000000000003 111.416 -171.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -126.74 122.67 35.51 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.613 -0.884 . . . . 73.409999999999997 108.613 175.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.468 HD11 HG23 ' A' ' 83' ' ' ILE . 76.1 mt -122.71 134.17 66.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 116.139 -0.482 . . . . 70.120000000000005 110.886 -174.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.519 ' OE1' ' HB2' ' A' ' 65' ' ' ARG . 2.9 mp0 -102.02 134.48 45.18 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.921 -0.77 . . . . 74.400000000000006 108.921 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -102.44 160.26 14.71 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.841 -0.429 . . . . 71.200000000000003 109.841 173.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.87 -37.69 87.88 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.944 0.402 . . . . 73.200000000000003 111.395 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -110.58 149.77 29.91 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.144 -0.48 . . . . 70.230000000000004 111.403 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.77 -30.02 61.32 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.242 -1.392 . . . . 70.340000000000003 107.242 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -67.46 -21.18 65.55 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.395 -0.82 . . . . 73.239999999999995 111.28 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.7 m -70.49 -35.22 73.12 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 109.451 -0.574 . . . . 72.540000000000006 109.451 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.2 m -65.63 -37.99 81.28 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 N-CA-C 108.209 -1.034 . . . . 65.120000000000005 108.209 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -56.49 -38.58 71.94 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.923 -0.58 . . . . 73.409999999999997 110.435 177.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.85 -31.49 63.2 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.598 0.713 . . . . 62.100000000000001 111.347 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.39 -44.88 34.2 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.715 -0.675 . . . . 71.120000000000005 110.795 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.7 m -62.36 -21.65 27.47 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.772 0 C-N-CA 122.656 0.383 . . . . 73.109999999999999 111.991 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.91 -10.33 52.31 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.639 0.733 . . . . 73.099999999999994 110.047 174.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 35.4 mtm -102.73 11.23 37.92 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.586 -0.734 . . . . 73.549999999999997 110.302 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -46.52 -46.85 19.46 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.525 0.565 . . . . 63.109999999999999 112.525 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -95.44 93.28 7.12 Favored 'General case' 0 N--CA 1.437 -1.1 0 O-C-N 121.708 -0.62 . . . . 74.549999999999997 109.496 174.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 21.9 p -148.88 160.01 43.65 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 122.594 0.357 . . . . 72.150000000000006 110.817 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.2 p -107.78 126.01 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 109.03 -0.73 . . . . 75.030000000000001 109.03 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -133.49 119.58 19.74 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 108.441 -0.948 . . . . 75.109999999999999 108.441 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.415 ' HD2' ' HB3' ' A' ' 45' ' ' ASP . 48.6 ttm-85 55.26 54.27 8.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.957 0.884 . . . . 75.430000000000007 112.411 -177.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.24 -8.44 17.64 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 114.54 -1.209 . . . . 65.530000000000001 115.888 176.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -130.88 156.58 44.8 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 118.044 0.922 . . . . 73.530000000000001 110.997 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.4 m -84.3 125.25 32.09 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 120.985 0.421 . . . . 64.540000000000006 110.483 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 47.6 pt -101.76 172.07 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 116.079 -0.509 . . . . 70.120000000000005 110.011 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.42 134.43 47.11 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.191 -0.913 . . . . 74.540000000000006 109.874 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.609 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 28.0 t -124.74 126.0 70.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.992 -1.114 . . . . 53.210000000000001 107.992 177.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 40' ' ' TYR . 97.0 mt -134.89 161.63 62.51 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 108.616 -0.883 . . . . 64.439999999999998 108.616 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.53 140.5 24.11 Favored 'Trans proline' 0 N--CA 1.44 -1.658 0 N-CA-C 107.977 -1.586 . . . . 60.049999999999997 107.977 171.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 64.7 tttm . . . . . 0 N--CA 1.428 -1.538 0 C-N-CA 119.891 -0.723 . . . . 72.230000000000004 110.835 179.002 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.2 0 N-CA-C 110.002 -1.239 . . . . 41.329999999999998 110.002 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.57 ' N ' ' HD2' ' B' ' 23' ' ' PRO . 52.7 Cg_exo -54.36 -40.24 83.75 Favored 'Trans proline' 0 CA--C 1.586 3.092 0 C-N-CA 123.409 2.739 . . . . 73.230000000000004 115.855 177.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' B' ' 22' ' ' PRO . 16.8 Cg_exo -30.21 126.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.411 3.866 0 C-N-CA 124.822 3.681 . . . . 74.319999999999993 115.85 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -61.3 140.84 94.48 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 124.157 0.983 . . . . 74.430000000000007 112.888 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -40.94 149.54 0.17 Allowed 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 125.039 3.826 . . . . 62.219999999999999 117.595 -177.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.442 HD23 ' HB2' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -134.39 164.64 26.98 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 105.542 -2.022 . . . . 73.439999999999998 105.542 177.603 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.443 ' HB3' ' OE1' ' B' ' 30' ' ' GLU . 45.8 t -76.01 144.79 40.69 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 118.264 -1.375 . . . . 73.25 112.576 -172.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.43 -32.9 8.38 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.034 -1.439 . . . . 53.520000000000003 111.62 173.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -71.45 -35.04 70.77 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 112.982 0.734 . . . . 64.519999999999996 112.982 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.509 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.9 OUTLIER -59.17 -37.85 78.36 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 109.03 -0.73 . . . . 71.120000000000005 109.03 172.6 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' B' ' 35' ' ' ASP . 65.1 mttm -63.29 -42.22 99.06 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 115.403 -0.817 . . . . 74.430000000000007 111.232 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.647 ' HE2' ' N ' ' B' ' 32' ' ' LYS . 0.5 OUTLIER -64.54 -44.47 90.71 Favored 'General case' 0 C--O 1.204 -1.3 0 C-N-CA 119.817 -0.753 . . . . 72.319999999999993 111.553 176.228 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -65.07 -42.27 94.33 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.782 -0.367 . . . . 52.109999999999999 111.346 -175.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.509 HG12 ' O ' ' B' ' 30' ' ' GLU . 11.7 pt -70.96 -34.68 56.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 116.254 -0.43 . . . . 75.430000000000007 111.482 178.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' B' ' 31' ' ' LYS . 3.8 m-20 -68.03 -41.32 82.29 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.971 0.509 . . . . 74.310000000000002 111.786 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -68.44 -23.53 64.62 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.14 -0.936 . . . . 74.120000000000005 110.519 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -101.89 10.54 39.7 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.641 -0.708 . . . . 64.549999999999997 110.947 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 16.3 t -105.24 155.1 19.38 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-O 121.317 0.58 . . . . 74.409999999999997 110.622 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 32.5 m -131.05 164.13 35.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.423 -0.808 . . . . 74.239999999999995 110.777 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . 0.613 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 22.5 t80 -109.54 122.81 48.25 Favored 'General case' 0 C--N 1.281 -2.394 0 C-N-CA 125.712 1.605 . . . . 73.349999999999994 108.031 176.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 46.6 t -115.95 112.92 41.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 107.759 -1.2 . . . . 73.129999999999995 107.759 176.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.3 175.81 16.51 Favored Glycine 0 C--N 1.306 -1.102 0 C-N-CA 119.806 -1.188 . . . . 53.32 113.732 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 10.7 t30 62.68 1.75 0.84 Allowed 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 126.462 1.905 . . . . 65.140000000000001 115.001 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.01 105.64 16.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.042 -1.036 . . . . 72.540000000000006 110.561 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -114.92 130.67 56.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 118.694 -0.669 . . . . 73.409999999999997 109.526 -171.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' TYR . . . . . 0.732 ' CE1' ' HB2' ' B' ' 77' ' ' PRO 0.344 13.6 m-85 52.11 -52.76 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 121.213 3.783 . . . . 74.409999999999997 121.213 170.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.74 -36.32 89.37 Favored Glycine 0 C--N 1.312 -0.777 0 N-CA-C 114.25 0.46 . . . . 72.140000000000001 114.25 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -91.44 147.84 22.74 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.095 0.474 . . . . 73.209999999999994 109.977 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 66.6 p -119.31 178.56 4.49 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.703 -0.68 . . . . 73.010000000000005 109.518 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.32 -50.29 74.22 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.021 0.378 . . . . 51.439999999999998 112.021 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -58.53 -40.81 83.97 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 120.972 0.415 . . . . 71.109999999999999 111.122 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -63.06 -47.74 81.64 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-N 115.665 -0.698 . . . . 74.329999999999998 109.766 -178.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 81.3 mt -62.36 -46.21 89.7 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-N 115.384 -0.826 . . . . 75.430000000000007 112.248 177.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -58.38 -47.69 83.03 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 112.636 0.606 . . . . 74.540000000000006 112.636 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.74 -45.44 78.01 Favored 'General case' 0 C--O 1.264 1.818 0 CA-C-O 121.463 0.649 . . . . 73.120000000000005 112.595 -176.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -67.35 -35.7 79.9 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.499 -0.773 . . . . 73.209999999999994 110.455 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -81.11 -22.94 38.74 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.052 0.76 . . . . 74.030000000000001 113.052 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' B' ' 61' ' ' GLY . 68.6 m -67.09 -28.73 68.42 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 116.428 -0.351 . . . . 63.140000000000001 110.829 -177.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 16.0 m -59.33 -30.56 68.46 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.059 0.457 . . . . 72.120000000000005 110.845 175.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 71.4 m -106.73 -0.16 23.75 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 113.449 0.907 . . . . 74.319999999999993 113.449 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . 0.614 ' O ' ' HA ' ' B' ' 58' ' ' SER . . . 178.07 164.83 31.93 Favored Glycine 0 C--O 1.215 -1.075 0 C-N-CA 118.844 -1.646 . . . . 60.149999999999999 114.144 -177.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 40.1 m -98.92 120.92 40.17 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.829 -0.804 . . . . 71.120000000000005 108.829 177.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.407 HD13 HG21 ' B' ' 63' ' ' ILE . 84.7 mt -82.16 129.44 37.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 114.717 1.377 . . . . 54.039999999999999 114.717 -173.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . 0.578 ' OD1' ' HB3' ' A' ' 73' ' ' PHE . 31.1 t-20 -88.22 -46.21 9.43 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.598 1.559 . . . . 72.400000000000006 109.265 177.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -156.05 166.04 34.65 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.556 -0.535 . . . . 71.349999999999994 109.556 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 1.3 tt -149.76 134.51 9.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 115.869 -0.605 . . . . 74.310000000000002 111.478 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 28.2 m -125.76 133.16 52.15 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.527 -1.286 . . . . 71.299999999999997 107.527 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.413 ' O ' HD11 ' A' ' 68' ' ' ILE . 1.5 mp -130.25 125.04 59.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 107.052 -1.462 . . . . 71.129999999999995 107.052 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.463 ' N ' HD21 ' B' ' 69' ' ' LEU 0.255 1.3 pt? -121.11 132.21 54.73 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.169 -0.612 . . . . 75.450000000000003 111.657 175.692 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 86.1 m -117.3 126.71 53.17 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.326 -0.99 . . . . 63.32 108.326 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 3.1 p-10 -113.13 134.46 54.54 Favored 'General case' 0 CA--C 1.489 -1.394 0 C-N-CA 119.328 -0.949 . . . . 61.409999999999997 110.759 -177.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' B' ' 77' ' ' PRO . 35.8 ttmt -119.49 14.26 12.75 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 105.698 -1.964 . . . . 61.100000000000001 105.698 176.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.447 ' HA ' ' OD1' ' A' ' 64' ' ' ASN . 62.0 t80 -43.75 -37.93 2.95 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 127.418 2.287 . . . . 74.25 113.27 177.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 49.8 m -110.37 22.24 15.73 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 120.891 0.377 . . . . 75.120000000000005 111.865 -177.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.83 -51.96 1.31 Allowed Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.366 -0.921 . . . . 74.349999999999994 112.857 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -95.4 119.16 65.84 Favored Pre-proline 0 C--N 1.311 -1.083 0 C-N-CA 120.586 -0.446 . . . . 72.430000000000007 110.385 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.732 ' HB2' ' CE1' ' B' ' 46' ' ' TYR . 57.3 Cg_endo -70.18 118.64 5.8 Favored 'Trans proline' 0 C--N 1.32 -0.97 0 C-N-CA 122.727 2.285 . . . . 53.32 113.335 -175.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 32.4 mtmm -113.83 166.25 11.75 Favored 'General case' 0 C--O 1.211 -0.963 0 CA-C-N 115.616 -0.72 . . . . 70.140000000000001 109.426 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -138.89 146.98 18.87 Favored Glycine 0 N--CA 1.421 -2.319 0 C-N-CA 120.042 -1.075 . . . . 45.43 114.177 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -153.16 146.3 24.66 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.467 -0.867 . . . . 74.140000000000001 108.891 172.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.38 154.12 48.95 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 120.946 0.403 . . . . 65.340000000000003 111.46 -172.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -127.64 121.07 29.5 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.863 -0.792 . . . . 74.030000000000001 108.863 175.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 71.2 mt -121.2 136.02 59.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 116.344 -0.389 . . . . 53.399999999999999 110.101 -174.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' GLU . . . . . . . . . . . . 0.387 1.3 pm0 -110.82 132.63 54.03 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.81 1.041 . . . . 65.209999999999994 113.81 174.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -97.99 162.02 13.44 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.473 -0.785 . . . . 73.140000000000001 111.755 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.69 -38.26 81.08 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.24 -0.891 . . . . 74.109999999999999 112.119 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' B' ' 88' ' ' ARG . 0.3 OUTLIER -120.67 156.42 31.77 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 120.045 -0.662 . . . . 73.230000000000004 111.122 178.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.508 ' H ' ' CD ' ' B' ' 87' ' ' GLU . 0.8 OUTLIER -75.22 -32.32 61.11 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 107.157 -1.423 . . . . 74.299999999999997 107.157 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -63.82 -22.77 67.07 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.527 -0.76 . . . . 61.020000000000003 110.857 176.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 16.0 m -71.07 -35.66 71.96 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 109.315 -0.624 . . . . 75.040000000000006 109.315 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 2.1 m -66.53 -37.12 78.92 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.157 0 N-CA-C 108.601 -0.888 . . . . 65.230000000000004 108.601 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -57.38 -38.46 74.27 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.353 0.597 . . . . 74.230000000000004 110.367 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.73 -33.0 64.15 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.458 -0.792 . . . . 73.420000000000002 110.043 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' B' ' 97' ' ' MET . . . -75.45 -43.67 48.31 Favored 'General case' 0 C--O 1.209 -1.049 0 CA-C-O 121.082 0.468 . . . . 74.140000000000001 110.562 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 24.7 m -63.24 -20.61 26.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 112.325 0.491 . . . . 74.140000000000001 112.325 176.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.95 -12.17 61.42 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 121.873 0.844 . . . . 53.130000000000003 109.882 174.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' B' ' 94' ' ' ALA . 40.0 mtp -99.66 10.18 41.8 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.583 -1.19 . . . . 62.409999999999997 109.51 178.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . 0.672 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 6.9 p-10 -36.57 -45.41 0.51 Allowed 'General case' 0 C--O 1.206 -1.218 0 N-CA-C 115.564 1.691 . . . . 74.140000000000001 115.564 -176.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -124.52 49.41 1.82 Allowed 'General case' 0 C--O 1.241 0.614 0 CA-C-N 119.98 1.264 . . . . 75.349999999999994 112.258 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 31.7 p -81.54 177.26 9.04 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.761 -0.654 . . . . 72.140000000000001 112.363 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 8.7 p -108.06 136.37 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-O 121.156 0.503 . . . . 63.210000000000001 110.174 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -139.17 120.92 15.35 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.77 -1.567 . . . . 73.239999999999995 106.77 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 53.71 33.27 16.35 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.315 0.857 . . . . 61.219999999999999 113.315 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.59 1.49 87.57 Favored Glycine 0 C--N 1.314 -0.647 0 CA-C-N 115.828 -0.624 . . . . 62.439999999999998 113.7 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -120.81 157.19 30.29 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.073 -0.714 . . . . 71.439999999999998 109.073 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 52.1 m -91.61 120.3 32.27 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 109.166 -0.679 . . . . 72.400000000000006 109.166 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 pp -102.14 164.67 3.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 119.668 -0.813 . . . . 74.420000000000002 111.089 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 108' ' ' LYS . . . . . 0.672 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 16.4 tptm -125.69 125.13 42.55 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.985 -0.746 . . . . 63.439999999999998 108.985 -169.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 22.9 t -121.16 131.37 73.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 110.046 -0.353 . . . . 74.040000000000006 110.046 -175.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . 0.411 ' HB2' ' HB3' ' B' ' 40' ' ' TYR . 96.9 mt -138.77 163.71 44.72 Favored Pre-proline 0 C--O 1.211 -0.924 0 C-N-CA 123.533 0.733 . . . . 65.040000000000006 109.34 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.31 142.38 26.87 Favored 'Trans proline' 0 CA--C 1.554 1.513 0 C-N-CA 122.506 2.137 . . . . 52.119999999999997 108.924 171.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt . . . . . 0 CA--C 1.564 1.508 0 N-CA-C 114.04 1.126 . . . . 74.150000000000006 114.04 -171.875 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 . . . . . 0 CA--C 1.532 0.255 0 N-CA-C 112.262 0.468 . . . . 72.430000000000007 112.262 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.0 pt -70.37 -36.1 65.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 112.926 0.714 . . . . 71.099999999999994 112.926 -175.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.95 -39.16 74.03 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-O 120.985 0.422 . . . . 73.010000000000005 111.422 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -57.35 -37.27 72.33 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 112.711 0.634 . . . . 73.230000000000004 112.711 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.407 ' HA ' HG13 ' A' ' 91' ' ' VAL . 4.9 ptp180 -114.44 14.74 17.91 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 114.492 1.293 . . . . 70.219999999999999 114.492 -165.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 62.7 p -104.21 158.19 16.61 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.219 1.192 . . . . 54.439999999999998 114.219 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.599 ' CG1' HG23 ' A' ' 91' ' ' VAL . 16.2 m -140.36 164.92 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 113.118 0.785 . . . . 64.549999999999997 113.118 -177.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.608 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 16.0 t80 -113.04 127.84 56.33 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 126.576 1.951 . . . . 75.230000000000004 108.448 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.28 114.41 43.8 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 N-CA-C 107.591 -1.263 . . . . 71.120000000000005 107.591 176.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.26 168.0 12.89 Favored Glycine 0 N--CA 1.425 -2.075 0 C-N-CA 119.729 -1.224 . . . . 72.409999999999997 113.909 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . 0.255 10.0 t30 60.63 67.07 0.86 Allowed 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 126.025 1.73 . . . . 72.349999999999994 114.988 -178.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 p -120.65 135.21 61.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 114.597 -1.183 . . . . 55.399999999999999 109.743 171.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -112.81 167.02 10.83 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.902 -1.518 . . . . 74.239999999999995 106.902 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -59.93 103.65 0.23 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 122.083 0.944 . . . . 75.140000000000001 113.029 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -179.51 -44.32 0.08 OUTLIER Glycine 0 N--CA 1.42 -2.428 0 N-CA-C 107.163 -2.375 . . . . 75.25 107.163 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 73.3 m -94.16 150.44 20.32 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.06 -0.57 . . . . 55.329999999999998 109.609 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.9 p -124.67 179.18 5.08 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.497 -0.774 . . . . 52.549999999999997 109.027 -178.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.25 -45.38 94.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.072 0.463 . . . . 61.240000000000002 109.837 -178.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -58.66 -39.18 79.89 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.61 -0.723 . . . . 72.030000000000001 111.431 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -67.48 -37.95 83.66 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-O 121.692 0.758 . . . . 64.109999999999999 109.09 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.4 mt -66.33 -46.22 77.6 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 114.569 -1.196 . . . . 63.520000000000003 111.454 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.444 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 35.3 mt-10 -58.38 -47.32 84.23 Favored 'General case' 0 C--O 1.187 -2.185 0 N-CA-C 113.002 0.741 . . . . 73.140000000000001 113.002 178.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.03 -47.42 74.77 Favored 'General case' 0 C--O 1.267 2.016 0 CA-C-O 121.006 0.431 . . . . 75.200000000000003 111.857 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -66.2 -39.17 89.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.987 -0.552 . . . . 74.340000000000003 110.666 -176.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -82.28 -22.63 35.64 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.883 1.068 . . . . 74.519999999999996 113.883 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.7 t -67.38 -30.89 70.79 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 123.377 0.671 . . . . 74.140000000000001 109.692 -176.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.0 m -62.06 -21.07 64.64 Favored 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 120.332 -0.547 . . . . 73.209999999999994 111.035 175.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 90' ' ' SER . 77.3 m -96.59 4.89 51.7 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 112.687 0.625 . . . . 71.340000000000003 112.687 178.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.28 -172.02 26.19 Favored Glycine 0 CA--C 1.503 -0.676 0 C-N-CA 119.215 -1.469 . . . . 53.229999999999997 114.325 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.2 m -94.67 118.54 31.87 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.273 0.559 . . . . 65.510000000000005 110.618 -177.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 54' ' ' GLU . 51.2 mt -76.34 132.67 32.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.313 -0.858 . . . . 71.030000000000001 111.314 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -97.33 -46.47 6.08 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.948 -1.023 . . . . 73.420000000000002 110.172 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.459 HH22 HD12 ' B' ' 69' ' ' LEU . 38.8 mtp180 -155.85 162.62 40.42 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.191 -1.411 . . . . 74.450000000000003 107.191 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.405 HG22 HD13 ' A' ' 66' ' ' ILE . 29.0 pt -147.93 144.24 19.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 108.775 -0.824 . . . . 74.329999999999998 108.775 173.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.4 m -125.44 130.24 51.44 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.426 -1.324 . . . . 72.349999999999994 107.426 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.449 ' N ' HD13 ' A' ' 68' ' ' ILE . 1.8 mp -129.32 120.43 51.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 106.527 -1.657 . . . . 65.209999999999994 106.527 -178.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.286 1.3 pt? -122.09 134.24 54.77 Favored 'General case' 0 C--N 1.283 -2.324 0 C-N-CA 119.635 -0.826 . . . . 61.43 112.629 177.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 60.9 m -117.03 126.84 53.48 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.777 -0.823 . . . . 74.109999999999999 108.777 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -112.44 130.07 56.11 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 107.404 -1.332 . . . . 65.209999999999994 107.404 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -128.94 13.38 6.28 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 120.111 -0.636 . . . . 73.120000000000005 110.294 -176.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -63.08 -20.51 65.42 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.22 1.192 . . . . 64.519999999999996 114.22 -171.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 52.1 m -96.16 9.62 40.35 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.211 0.449 . . . . 74.420000000000002 112.211 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.42 -56.08 0.48 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.012 -1.089 . . . . 42.119999999999997 113.09 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 42.2 m-70 -95.11 133.35 26.34 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 108.834 -0.802 . . . . 61.549999999999997 108.834 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 76' ' ' HIS . 2.0 Cg_endo -76.82 117.57 4.54 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 C-N-CA 121.302 1.335 . . . . 71.040000000000006 110.503 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -100.28 140.51 34.43 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 108.253 -1.017 . . . . 52.049999999999997 108.253 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -129.63 147.85 18.1 Favored Glycine 0 N--CA 1.397 -3.904 0 C-N-CA 119.313 -1.423 . . . . 64.349999999999994 112.417 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -149.8 143.47 25.39 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 114.109 -1.046 . . . . 74.329999999999998 109.087 174.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.81 150.19 52.19 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 116.255 -0.43 . . . . 72.329999999999998 110.611 -171.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -120.87 117.53 27.6 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 109.141 -0.688 . . . . 72.239999999999995 109.141 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.484 ' O ' HG22 ' A' ' 39' ' ' VAL . 34.3 mm -99.72 127.49 52.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.281 -1.377 . . . . 65.230000000000004 107.281 -178.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -113.15 124.25 52.12 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.762 -0.829 . . . . 72.340000000000003 108.762 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -98.24 165.67 11.76 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 111.602 0.223 . . . . 74.0 111.602 -177.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.05 -33.47 57.25 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.265 -0.425 . . . . 74.519999999999996 111.99 176.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -121.05 162.11 20.54 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 113.393 0.886 . . . . 54.43 113.393 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.417 ' O ' HG11 ' A' ' 91' ' ' VAL . 16.5 mmm180 -66.39 -33.71 76.32 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 114.45 -1.25 . . . . 74.129999999999995 111.692 174.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -66.91 -29.28 69.11 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.61 -0.436 . . . . 71.120000000000005 111.47 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 60' ' ' CYS . 9.6 m -71.01 -42.08 70.04 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-O 120.723 0.296 . . . . 37.490000000000002 110.533 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.599 HG23 ' CG1' ' A' ' 39' ' ' VAL . 0.2 OUTLIER -67.64 -39.49 82.31 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 N-CA-C 110.313 -0.254 . . . . 73.439999999999998 110.313 176.649 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -61.69 -37.21 83.27 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.354 0.597 . . . . 65.019999999999996 110.267 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.37 -31.29 62.33 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.804 -0.635 . . . . 73.340000000000003 110.829 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.88 -44.77 38.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.652 0.263 . . . . 54.049999999999997 111.161 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.5 m -57.74 -22.48 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 112.508 0.558 . . . . 73.519999999999996 112.508 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.2 -11.59 61.01 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 120.988 0.423 . . . . 75.430000000000007 110.05 176.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 64.9 mtm -102.75 10.78 38.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.224 -0.444 . . . . 75.409999999999997 110.293 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.607 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 4.7 p-10 -37.71 -48.71 1.09 Allowed 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.848 1.055 . . . . 73.450000000000003 113.848 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -114.72 99.92 7.87 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-O 121.975 0.893 . . . . 73.200000000000003 109.803 175.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 106' ' ' THR . 17.5 p -138.91 167.02 22.94 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.146 -1.388 . . . . 73.549999999999997 110.829 -178.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.0 p -113.85 105.55 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 CA-C-O 122.191 0.996 . . . . 62.0 109.494 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.55 ' O ' ' HG2' ' A' ' 105' ' ' ARG . 89.9 t80 -113.95 124.9 53.3 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.822 -1.081 . . . . 74.420000000000002 108.396 -176.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 20.6 ttt85 54.41 47.89 21.86 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 122.255 1.026 . . . . 73.549999999999997 110.131 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.57 8.0 55.14 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 113.769 -1.56 . . . . 73.099999999999994 115.146 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.55 ' HG2' ' O ' ' A' ' 102' ' ' PHE . 15.1 ptp180 -131.92 145.88 51.77 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 118.101 0.951 . . . . 55.109999999999999 111.135 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 100' ' ' THR . 27.8 m -77.76 120.18 22.31 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 120.903 0.382 . . . . 73.319999999999993 110.049 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 39.7 pt -102.55 171.25 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 109.596 -0.52 . . . . 73.349999999999994 109.596 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 42.0 tptt -134.73 130.8 36.8 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.894 -0.78 . . . . 71.140000000000001 108.894 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 17.7 t -121.13 127.81 75.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.043 -0.725 . . . . 73.299999999999997 109.043 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 89.7 mt -132.08 160.94 65.71 Favored Pre-proline 0 C--O 1.199 -1.605 0 N-CA-C 108.749 -0.834 . . . . 65.239999999999995 108.749 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -77.65 140.74 19.03 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.031 1.821 . . . . 75.409999999999997 110.869 173.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp . . . . . 0 N--CA 1.423 -1.776 0 N-CA-C 104.928 -2.249 . . . . 51.229999999999997 104.928 173.684 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.159 0 N-CA-C 107.872 -2.091 . . . . 71.239999999999995 107.872 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -53.95 -40.29 81.49 Favored 'Trans proline' 0 CA--C 1.574 2.501 0 C-N-CA 122.744 2.296 . . . . 72.349999999999994 113.887 172.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.69 136.12 60.55 Favored 'Trans proline' 0 C--N 1.394 2.964 0 C-N-CA 121.301 1.334 . . . . 72.109999999999999 111.379 173.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -66.54 141.11 96.86 Favored Pre-proline 0 C--N 1.31 -1.14 0 CA-C-N 115.289 -0.868 . . . . 74.239999999999995 110.892 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -59.06 116.45 3.27 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 122.7 2.267 . . . . 63.299999999999997 111.112 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.509 ' H ' HD13 ' B' ' 26' ' ' LEU . 0.0 OUTLIER -67.14 160.75 26.15 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.751 -1.113 . . . . 51.210000000000001 112.068 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.511 ' HB3' ' OE1' ' B' ' 30' ' ' GLU . 29.6 t -82.04 164.68 21.25 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.507 0.67 . . . . 74.099999999999994 112.332 -173.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.4 -38.68 63.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.5 -1.227 . . . . 52.530000000000001 112.617 -178.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -69.47 -36.38 76.51 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 120.706 -0.398 . . . . 72.549999999999997 111.551 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.511 ' OE1' ' HB3' ' B' ' 27' ' ' SER . 3.6 mp0 -62.37 -35.23 78.51 Favored 'General case' 0 CA--C 1.503 -0.832 0 O-C-N 123.481 0.488 . . . . 73.340000000000003 110.645 175.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -66.03 -51.35 59.04 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 123.302 0.377 . . . . 75.239999999999995 110.466 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.488 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 47.9 mtmt -53.93 -35.52 61.78 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 114.141 1.163 . . . . 53.439999999999998 114.141 176.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.526 ' O ' ' HD3' ' B' ' 37' ' ' ARG . 24.5 mm-40 -70.25 -47.55 60.84 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.198 0.444 . . . . 74.340000000000003 112.198 174.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.456 HG12 ' O ' ' B' ' 30' ' ' GLU . 10.3 pt -70.92 -35.7 60.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 112.934 0.716 . . . . 71.420000000000002 112.934 -176.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.32 -35.49 65.2 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.229 0.537 . . . . 72.400000000000006 111.21 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 97.9 mttt -63.3 -35.07 79.14 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.126 -0.943 . . . . 74.010000000000005 112.685 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.526 ' HD3' ' O ' ' B' ' 33' ' ' GLU . 11.3 mtp180 -111.3 5.41 19.81 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 114.727 1.38 . . . . 73.140000000000001 114.727 -164.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' SER . . . . . 0.578 ' HB2' ' O ' ' B' ' 112' ' ' LYS . 15.5 m -96.97 154.98 16.98 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 112.906 0.706 . . . . 75.099999999999994 112.906 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 11.4 m -139.54 164.99 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.609 1.163 . . . . 73.420000000000002 112.522 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . 0.659 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 18.4 t80 -113.51 126.88 55.8 Favored 'General case' 0 CA--C 1.489 -1.372 0 C-N-CA 126.624 1.97 . . . . 73.420000000000002 108.592 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 66.2 t -121.03 114.25 42.72 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 N-CA-C 108.303 -0.999 . . . . 63.409999999999997 108.303 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.27 174.05 15.28 Favored Glycine 0 N--CA 1.421 -2.311 0 C-N-CA 119.514 -1.327 . . . . 54.329999999999998 113.176 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.5 t30 64.65 21.28 12.38 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.95 1.7 . . . . 63.539999999999999 112.877 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 8.7 p -69.81 123.68 24.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.092 -0.707 . . . . 74.319999999999993 109.092 173.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -82.39 159.71 22.95 Favored 'General case' 0 C--O 1.253 1.281 0 CA-C-N 115.48 -0.782 . . . . 75.0 109.675 -174.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -76.24 91.07 3.17 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-O 121.743 0.782 . . . . 74.030000000000001 108.945 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 168.2 -18.92 0.08 OUTLIER Glycine 0 N--CA 1.41 -3.048 0 CA-C-N 114.694 -1.139 . . . . 53.310000000000002 110.543 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -84.19 143.3 29.71 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 107.799 -1.185 . . . . 74.299999999999997 107.799 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 77.8 p -99.89 170.19 8.7 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 110.296 -0.261 . . . . 74.420000000000002 110.296 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.408 ' HB3' HD12 ' B' ' 66' ' ' ILE . . . -67.05 -39.85 87.01 Favored 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 108.87 -0.789 . . . . 73.040000000000006 108.87 175.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -57.43 -44.55 84.75 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.553 -1.203 . . . . 72.120000000000005 110.961 174.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.05 -47.89 77.05 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.384 0.611 . . . . 64.439999999999998 110.86 174.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 41.2 mt -58.76 -47.04 86.05 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 114.493 -1.23 . . . . 63.420000000000002 112.52 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.458 ' HA ' ' CD1' ' B' ' 63' ' ' ILE . 93.9 mt-10 -58.85 -47.87 83.37 Favored 'General case' 0 C--O 1.183 -2.431 0 N-CA-C 112.57 0.582 . . . . 72.109999999999999 112.57 177.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.13 -47.73 74.63 Favored 'General case' 0 C--O 1.27 2.142 0 N-CA-C 112.334 0.494 . . . . 74.319999999999993 112.334 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -67.16 -38.39 85.4 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.02 -0.536 . . . . 61.32 110.598 -176.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -82.61 -22.0 34.93 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.686 0.995 . . . . 71.420000000000002 113.686 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 37.8 t -64.55 -32.22 73.78 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 123.693 0.797 . . . . 75.200000000000003 109.454 -178.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.8 m -59.6 -24.34 63.71 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-N 116.271 -0.422 . . . . 74.340000000000003 110.978 174.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . 0.484 ' O ' ' HA ' ' B' ' 90' ' ' SER . 68.8 m -88.1 -4.0 58.82 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.435 0.531 . . . . 74.329999999999998 112.435 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.94 -159.67 26.57 Favored Glycine 0 C--N 1.318 -0.425 0 C-N-CA 119.394 -1.384 . . . . 61.520000000000003 114.08 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 50.7 m -94.6 119.09 32.71 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 121.091 0.472 . . . . 73.120000000000005 112.102 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.458 ' CD1' ' HA ' ' B' ' 54' ' ' GLU . 68.0 mt -78.67 128.24 38.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.692 -0.686 . . . . 70.150000000000006 111.625 177.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . 0.491 ' OD1' ' HG3' ' B' ' 65' ' ' ARG . 19.0 t-20 -90.66 -50.23 6.03 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.797 -1.092 . . . . 71.230000000000004 108.529 -177.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.491 ' HG3' ' OD1' ' B' ' 64' ' ' ASN . 41.2 mtp180 -155.31 164.79 38.28 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 107.41 -1.33 . . . . 75.019999999999996 107.41 -177.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.42 HG22 HD13 ' B' ' 66' ' ' ILE . 28.9 pt -148.34 144.29 18.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.407 -0.96 . . . . 74.150000000000006 108.407 173.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 61.5 m -125.65 130.58 51.9 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 107.055 -1.461 . . . . 73.040000000000006 107.055 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.419 ' N ' HD13 ' B' ' 68' ' ' ILE . 1.9 mp -129.32 119.9 49.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 106.657 -1.609 . . . . 70.329999999999998 106.657 -178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.459 HD12 HH22 ' A' ' 65' ' ' ARG 0.264 1.5 pt? -121.77 134.14 54.92 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 119.701 -0.799 . . . . 74.010000000000005 112.272 177.749 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 61.9 m -117.11 125.72 51.7 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.52 -0.918 . . . . 63.43 108.52 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 10.3 t70 -105.74 127.18 52.93 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.624 -1.25 . . . . 72.230000000000004 107.624 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -127.01 17.56 7.24 Favored 'General case' 0 N--CA 1.423 -1.799 0 C-N-CA 120.719 -0.393 . . . . 73.129999999999995 110.138 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . 0.255 1.4 p90 -70.25 -16.25 63.01 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 118.367 -1.333 . . . . 74.239999999999995 112.672 -177.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 46.0 m -94.42 17.89 12.21 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.203 -0.453 . . . . 71.319999999999993 110.393 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.42 -63.76 1.95 Allowed Glycine 0 CA--C 1.492 -1.354 0 C-N-CA 120.75 -0.738 . . . . 51.509999999999998 111.569 176.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . 0.255 89.6 m-70 -96.4 125.07 48.91 Favored Pre-proline 0 C--N 1.291 -1.975 0 C-N-CA 120.414 -0.514 . . . . 63.350000000000001 110.852 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 98.6 Cg_endo -73.6 135.72 22.39 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.944 2.429 . . . . 54.350000000000001 115.051 -171.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -112.12 146.13 38.56 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 124.883 1.273 . . . . 73.340000000000003 107.842 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.8 148.03 17.86 Favored Glycine 0 N--CA 1.412 -2.961 0 C-N-CA 119.142 -1.504 . . . . 73.319999999999993 112.968 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -151.48 143.37 23.82 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 114.362 -0.919 . . . . 74.5 109.736 172.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.13 151.61 51.69 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 116.169 -0.468 . . . . 61.5 110.657 -172.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' TYR . . . . . 0.721 ' CD1' ' HE2' ' B' ' 112' ' ' LYS . 89.9 m-85 -122.32 116.52 24.21 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 109.253 -0.647 . . . . 64.420000000000002 109.253 177.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.418 HG23 HG21 ' B' ' 66' ' ' ILE . 34.3 mm -98.86 127.21 51.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 107.31 -1.367 . . . . 63.299999999999997 107.31 -178.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' B' ' 38' ' ' SER . 29.3 mt-10 -112.36 125.62 54.4 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 108.836 -0.801 . . . . 72.530000000000001 108.836 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -100.07 162.38 13.01 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.432 0.634 . . . . 64.099999999999994 112.245 -177.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.45 -29.77 53.0 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.328 -0.851 . . . . 71.319999999999993 111.387 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -122.67 150.0 43.28 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 112.9 0.704 . . . . 54.149999999999999 112.9 -175.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.41 ' HD3' ' HB3' ' B' ' 36' ' ' LYS . 14.4 mmm180 -63.08 -34.89 78.56 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.116 0.566 . . . . 75.540000000000006 110.676 175.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -62.73 -32.15 73.22 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.577 -0.738 . . . . 71.349999999999994 110.913 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' B' ' 60' ' ' CYS . 15.1 m -71.15 -41.4 70.47 Favored 'General case' 0 N--CA 1.433 -1.313 0 O-C-N 122.335 -0.228 . . . . 75.549999999999997 110.949 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.05 -38.98 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 C-N-CA 120.727 -0.389 . . . . 74.019999999999996 111.016 176.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -63.01 -36.68 84.36 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.476 0.655 . . . . 72.109999999999999 109.579 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.49 -31.03 63.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.797 -0.638 . . . . 71.239999999999995 111.789 178.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.05 -44.95 36.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.584 -0.734 . . . . 73.329999999999998 110.763 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 33.1 m -58.75 -22.29 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 112.334 0.494 . . . . 75.400000000000006 112.334 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.91 -14.91 63.28 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 121.51 0.671 . . . . 72.299999999999997 111.331 176.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 65.6 mtm -100.54 12.74 36.66 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.334 -0.848 . . . . 73.230000000000004 109.951 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . 0.714 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 3.0 p-10 -35.6 -51.98 0.66 Allowed 'General case' 0 C--O 1.178 -2.659 0 N-CA-C 115.51 1.67 . . . . 61.43 115.51 -174.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' B' ' 107' ' ' ILE . 19.0 tt0 -129.36 40.52 3.59 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 117.794 -1.562 . . . . 75.299999999999997 110.323 -178.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 47.6 p -75.63 -173.54 2.21 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.573 -1.194 . . . . 72.530000000000001 111.445 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.58 136.14 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 O-C-N 122.098 -0.376 . . . . 73.5 110.4 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -138.23 128.5 25.99 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 122.992 0.517 . . . . 74.239999999999995 109.924 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 50.17 32.45 6.02 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 124.998 1.319 . . . . 64.230000000000004 112.689 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.11 2.74 60.65 Favored Glycine 0 C--N 1.315 -0.617 0 CA-C-N 114.771 -1.104 . . . . 60.219999999999999 114.756 173.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -134.16 158.64 43.14 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 118.002 0.901 . . . . 72.340000000000003 111.169 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 68.4 m -85.47 119.85 26.27 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.338 -0.616 . . . . 54.340000000000003 109.338 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' B' ' 99' ' ' GLU . 42.1 pt -102.86 172.2 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 109.648 -0.501 . . . . 73.099999999999994 109.648 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 108' ' ' LYS . . . . . 0.714 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 0.1 OUTLIER -131.18 132.06 44.46 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.618 -1.253 . . . . 65.109999999999999 107.618 -179.654 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 21.2 t -121.67 130.82 74.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 108.099 -1.074 . . . . 74.450000000000003 108.099 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 90.1 mt -136.49 162.68 54.82 Favored Pre-proline 0 C--O 1.19 -2.046 0 N-CA-C 108.871 -0.789 . . . . 70.219999999999999 108.871 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -73.77 147.53 39.86 Favored 'Trans proline' 0 CA--C 1.564 1.98 0 C-N-CA 122.733 2.289 . . . . 70.319999999999993 110.564 173.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.721 ' HE2' ' CD1' ' B' ' 82' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.56 1.331 0 N-CA-C 109.633 -0.506 . . . . 70.310000000000002 109.633 -172.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 . . . . . 0 N--CA 1.445 -0.693 0 N-CA-C 113.786 1.032 . . . . 74.230000000000004 113.786 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.424 HG23 HD11 ' A' ' 34' ' ' ILE . 23.1 pt -69.33 -33.99 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.771 0.319 . . . . 75.340000000000003 111.457 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -62.32 -38.54 89.85 Favored 'General case' 0 C--O 1.203 -1.387 0 CA-C-N 115.611 -0.722 . . . . 72.219999999999999 111.521 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -70.35 -16.1 62.94 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 120.521 0.201 . . . . 63.329999999999998 111.17 -175.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.448 ' HA ' ' CG1' ' A' ' 91' ' ' VAL . 3.9 ptp180 -113.39 16.65 18.87 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 112.384 0.513 . . . . 74.030000000000001 112.384 -173.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.442 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 43.9 t -99.9 159.67 14.9 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-O 121.535 0.683 . . . . 65.299999999999997 111.607 177.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.456 ' CG1' HG21 ' A' ' 91' ' ' VAL . 5.5 m -139.7 164.12 24.16 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.942 0 C-N-CA 124.492 1.117 . . . . 73.340000000000003 110.686 176.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.664 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 16.4 t80 -118.9 128.39 54.38 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 125.236 1.415 . . . . 74.409999999999997 108.009 178.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 60.8 t -116.58 116.7 53.06 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 107.929 -1.137 . . . . 71.209999999999994 107.929 178.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.08 176.47 17.09 Favored Glycine 0 C--N 1.294 -1.771 0 C-N-CA 119.831 -1.176 . . . . 72.329999999999998 113.567 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.43 ' ND2' ' HD3' ' A' ' 105' ' ' ARG . 7.1 t30 68.51 8.52 6.73 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.759 1.624 . . . . 72.019999999999996 113.405 177.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.4 p -91.15 104.45 15.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.634 0.731 . . . . 73.329999999999998 109.766 176.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -116.79 102.98 9.87 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 106.985 -1.487 . . . . 75.120000000000005 106.985 -172.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 49.26 -175.78 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.594 1.331 . . . . 64.510000000000005 114.594 -172.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.69 -56.78 5.04 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.868 -0.682 . . . . 45.520000000000003 111.96 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.6 m -86.14 143.56 27.96 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 121.107 0.479 . . . . 61.100000000000001 110.071 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 61.7 p -114.79 178.82 4.14 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.199 -0.667 . . . . 74.030000000000001 109.199 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.428 ' HB1' HD13 ' A' ' 66' ' ' ILE . . . -58.91 -43.24 91.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.163 0.506 . . . . 64.230000000000004 109.777 178.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -56.96 -44.93 83.09 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 115.304 -0.862 . . . . 65.299999999999997 111.814 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -61.12 -42.49 98.64 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.513 0.673 . . . . 72.109999999999999 110.57 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.4 mt -69.89 -47.36 62.83 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 114.755 -1.111 . . . . 74.5 111.623 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.464 ' HB2' ' OH ' ' B' ' 46' ' ' TYR . 21.5 tt0 -59.15 -50.6 73.42 Favored 'General case' 0 C--O 1.194 -1.836 0 C-N-CA 121.108 -0.237 . . . . 72.239999999999995 111.486 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.32 79.67 Favored 'General case' 0 C--O 1.265 1.878 0 CA-C-O 121.763 0.792 . . . . 74.299999999999997 110.999 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -67.31 -38.45 84.99 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.209 -1.36 . . . . 71.129999999999995 110.107 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . 0.278 46.5 m-85 -82.48 -21.14 35.67 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 114.516 1.302 . . . . 64.239999999999995 114.516 177.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 71.4 m -64.81 -28.81 69.82 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 109.523 -0.547 . . . . 75.420000000000002 109.523 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.8 m -58.48 -25.23 62.09 Favored 'General case' 0 CA--C 1.56 1.351 0 CA-C-N 115.815 -0.63 . . . . 74.329999999999998 110.09 173.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 61.1 m -107.63 3.24 24.58 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 112.859 0.689 . . . . 71.329999999999998 112.859 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 58' ' ' SER . . . 173.51 177.54 42.81 Favored Glycine 0 N--CA 1.466 0.683 0 C-N-CA 118.551 -1.785 . . . . 38.159999999999997 115.159 -177.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.8 m -78.25 -61.09 2.11 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 122.389 0.276 . . . . 74.0 111.159 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 85' ' ' PHE 0.264 56.2 mt 99.85 117.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 126.11 1.764 . . . . 61.32 113.261 175.729 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.458 ' ND2' ' HA ' ' A' ' 86' ' ' ALA . 80.2 m-20 -98.59 -39.18 8.83 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 115.275 -0.875 . . . . 73.120000000000005 111.692 177.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -151.45 159.52 44.16 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.816 -0.809 . . . . 75.530000000000001 108.816 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.428 HD13 ' HB1' ' A' ' 50' ' ' ALA . 17.1 pt -148.32 144.48 18.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.073 -1.455 . . . . 75.540000000000006 107.073 171.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.553 ' OG1' ' HB2' ' A' ' 82' ' ' TYR . 43.0 p -123.49 138.74 54.51 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 106.018 -1.845 . . . . 63.43 106.018 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.461 HD12 ' O ' ' B' ' 68' ' ' ILE . 2.9 mp -129.89 116.4 37.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 106.371 -1.714 . . . . 74.310000000000002 106.371 175.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -120.55 125.66 48.38 Favored 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 120.078 -0.649 . . . . 53.439999999999998 111.037 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 82.9 m -115.61 133.55 55.93 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.19 -0.67 . . . . 75.400000000000006 109.19 -177.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -119.07 127.97 53.89 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 118.63 -1.228 . . . . 74.109999999999999 110.513 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -121.32 12.14 10.88 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.549 -0.908 . . . . 75.439999999999998 108.549 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -62.64 -22.04 66.13 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.273 0.471 . . . . 72.430000000000007 112.273 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.5 t -90.72 5.11 49.51 Favored 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 115.98 -0.554 . . . . 73.430000000000007 110.668 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.48 -56.25 0.48 Allowed Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.702 -0.761 . . . . 54.420000000000002 111.977 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -96.26 136.48 21.98 Favored Pre-proline 0 C--N 1.304 -1.394 0 N-CA-C 110.149 -0.315 . . . . 74.400000000000006 110.149 176.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -79.54 119.0 3.98 Favored 'Trans proline' 0 N--CA 1.441 -1.593 0 C-N-CA 121.774 1.649 . . . . 71.209999999999994 113.051 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -105.34 -163.82 0.98 Allowed 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.785 -1.098 . . . . 64.349999999999994 108.742 175.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.64 162.56 25.72 Favored Glycine 0 N--CA 1.412 -2.936 0 C-N-CA 119.591 -1.29 . . . . 73.239999999999995 114.453 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -158.53 153.91 25.84 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 113.641 -1.279 . . . . 75.049999999999997 108.988 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.92 152.95 50.79 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 120.386 0.136 . . . . 43.229999999999997 111.106 -173.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.553 ' HB2' ' OG1' ' A' ' 67' ' ' THR . 27.0 m-85 -118.22 130.05 55.85 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.572 -0.529 . . . . 74.450000000000003 109.572 174.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 32.8 mm -111.4 112.49 40.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 109.086 -0.709 . . . . 75.239999999999995 109.086 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.418 ' HG3' ' CB ' ' A' ' 38' ' ' SER . 4.1 mp0 -94.84 120.24 34.74 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.147 0.499 . . . . 65.230000000000004 110.943 176.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 99.1 m-85 -92.78 164.12 13.47 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.791 -0.448 . . . . 74.239999999999995 109.791 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.458 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . . . -85.02 -17.97 35.86 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.111 0.482 . . . . 63.100000000000001 109.969 174.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.428 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 0.7 OUTLIER -117.24 141.85 47.78 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 115.407 -0.815 . . . . 72.0 111.171 -178.313 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -75.57 -29.39 59.33 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 108.362 -0.977 . . . . 71.109999999999999 108.362 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -67.71 -24.79 65.43 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.76 -0.587 . . . . 74.319999999999993 110.713 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.428 ' OG ' ' HB2' ' A' ' 87' ' ' GLU . 20.1 m -71.69 -37.1 70.74 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 112.092 0.404 . . . . 74.140000000000001 112.092 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.456 HG21 ' CG1' ' A' ' 39' ' ' VAL . 0.2 OUTLIER -65.87 -38.46 82.21 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 C-N-CA 120.095 -0.642 . . . . 72.109999999999999 109.507 173.871 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.434 ' O ' HG21 ' A' ' 95' ' ' VAL . 19.7 t70 -59.08 -37.59 77.46 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.291 0.567 . . . . 65.099999999999994 110.239 175.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.52 -31.76 63.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.101 -0.499 . . . . 72.519999999999996 111.429 177.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.34 -41.17 49.22 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.117 -0.492 . . . . 71.109999999999999 111.161 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 92' ' ' ASP . 30.9 m -60.95 -21.99 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 112.716 0.636 . . . . 65.430000000000007 112.716 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.13 -10.92 60.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.525 0.678 . . . . 40.329999999999998 110.455 176.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 8.8 ttp -111.37 8.2 21.22 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.978 -1.119 . . . . 75.510000000000005 107.978 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.572 ' HB2' ' O ' ' A' ' 109' ' ' VAL . 0.5 OUTLIER -44.31 -44.15 7.91 Favored 'General case' 0 CA--C 1.473 -1.982 0 N-CA-C 114.431 1.271 . . . . 60.409999999999997 114.431 -176.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -122.89 98.66 6.01 Favored 'General case' 0 N--CA 1.389 -3.481 0 CA-C-O 122.511 1.148 . . . . 70.219999999999999 110.061 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 106' ' ' THR . 19.7 p -140.02 173.25 11.71 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 113.187 -1.824 . . . . 73.400000000000006 111.122 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.0 p -111.51 112.58 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.804 0 CA-C-O 122.316 1.055 . . . . 73.150000000000006 110.036 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -121.48 126.55 49.52 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.355 -1.293 . . . . 74.420000000000002 107.643 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.7 ttt-85 58.81 33.15 22.87 Favored 'General case' 0 CA--C 1.558 1.259 0 CA-C-O 122.054 0.93 . . . . 75.299999999999997 109.759 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.47 1.56 86.5 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.3 -0.864 . . . . 72.439999999999998 113.898 178.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.43 ' HD3' ' ND2' ' A' ' 43' ' ' ASN . 13.1 ptp180 -126.13 153.7 44.19 Favored 'General case' 0 C--N 1.314 -0.974 0 O-C-N 122.25 -0.559 . . . . 74.319999999999993 110.289 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 100' ' ' THR . 27.2 m -79.75 119.74 23.07 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.447 -0.575 . . . . 62.240000000000002 109.447 -178.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 pp -102.82 159.0 4.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 C-N-CA 119.601 -0.839 . . . . 72.230000000000004 109.815 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 57.7 tptt -123.56 129.89 51.86 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.321 -0.622 . . . . 65.239999999999995 109.321 -170.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.664 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 21.7 t -118.53 128.13 75.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 108.728 -0.842 . . . . 62.130000000000003 108.728 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.5 mt -125.51 141.36 38.77 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 108.999 -0.741 . . . . 74.319999999999993 108.999 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.07 136.96 18.88 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.546 1.497 . . . . 72.340000000000003 111.811 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.465 ' HZ1' ' HB2' ' A' ' 112' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.276 -2.59 0 N-CA-C 104.075 -2.565 . . . . 73.340000000000003 104.075 170.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.452 ' HA3' ' OH ' ' A' ' 82' ' ' TYR . . . . . . . . 0 CA--C 1.504 -0.628 0 CA-C-O 120.032 -0.315 . . . . 63.200000000000003 113.291 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.428 ' N ' ' HD2' ' B' ' 23' ' ' PRO . 54.1 Cg_exo -52.35 -44.44 46.65 Favored 'Trans proline' 0 CA--C 1.565 2.027 0 C-N-CA 123.792 2.995 . . . . 72.010000000000005 115.508 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' B' ' 22' ' ' PRO . 11.3 Cg_endo -53.78 146.72 44.01 Favored 'Trans proline' 0 C--N 1.389 2.696 0 C-N-CA 121.757 1.638 . . . . 70.030000000000001 112.349 177.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 15.3 pm0 -70.37 150.36 95.79 Favored Pre-proline 0 C--N 1.303 -1.436 0 CA-C-N 115.172 -0.922 . . . . 75.019999999999996 111.012 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.23 119.31 6.31 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.569 2.179 . . . . 71.030000000000001 112.144 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.446 ' H ' HD13 ' B' ' 26' ' ' LEU . 0.0 OUTLIER -77.03 168.5 19.98 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.168 -0.924 . . . . 64.400000000000006 110.69 176.271 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.607 ' HB3' ' OE1' ' B' ' 30' ' ' GLU . 47.4 t -68.12 147.06 52.84 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.612 0.967 . . . . 63.229999999999997 113.612 -173.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.712 ' O ' ' HG2' ' B' ' 32' ' ' LYS . . . -48.22 -46.22 35.01 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-N 114.001 -1.454 . . . . 64.140000000000001 111.949 177.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.411 ' HA ' ' CG ' ' B' ' 32' ' ' LYS . 69.9 mm-40 -63.65 -36.2 83.05 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.996 0.739 . . . . 74.219999999999999 112.996 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.607 ' OE1' ' HB3' ' B' ' 27' ' ' SER . 2.0 mp0 -63.12 -35.84 81.62 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.467 -0.493 . . . . 74.049999999999997 110.127 173.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -68.03 -43.59 78.39 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.032 -0.531 . . . . 75.150000000000006 109.581 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.712 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 28.9 mmmt -55.03 -47.36 74.84 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.628 0.771 . . . . 64.439999999999998 110.329 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -70.33 -46.28 64.49 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.341 -0.845 . . . . 54.219999999999999 111.745 -175.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.413 HG12 ' O ' ' B' ' 30' ' ' GLU . 17.1 pt -69.72 -35.02 63.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.927 0.394 . . . . 74.420000000000002 111.569 -175.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.87 -44.36 96.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.768 -0.651 . . . . 74.540000000000006 111.825 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' B' ' 32' ' ' LYS . 12.3 ptpt -68.47 -10.64 56.78 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 112.48 0.548 . . . . 62.200000000000003 112.48 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.428 ' HD3' ' O ' ' B' ' 86' ' ' ALA . 92.3 mtt180 -107.3 9.51 29.97 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.966 0.412 . . . . 73.200000000000003 110.871 -176.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' SER . . . . . 0.463 ' OG ' ' HG2' ' B' ' 84' ' ' GLU . 24.3 m -103.01 162.39 12.97 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 114.226 1.195 . . . . 74.430000000000007 114.226 -175.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.439 HG23 ' O ' ' B' ' 83' ' ' ILE . 12.1 m -141.22 164.45 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.551 1.14 . . . . 75.239999999999995 111.907 176.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . 0.571 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 17.6 t80 -119.11 130.96 55.85 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 126.109 1.764 . . . . 74.340000000000003 107.999 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.422 HG21 ' CE2' ' B' ' 57' ' ' PHE . 58.1 t -119.42 117.58 54.48 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 C-N-CA 123.945 0.898 . . . . 64.430000000000007 108.81 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.77 166.13 14.78 Favored Glycine 0 C--N 1.293 -1.806 0 C-N-CA 120.205 -0.998 . . . . 63.539999999999999 111.961 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 60.3 t30 66.29 20.36 11.03 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.738 1.615 . . . . 73.239999999999995 113.152 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 11.3 p -64.32 133.33 29.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 O-C-N 121.544 -0.723 . . . . 75.0 109.651 177.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.469 ' HB3' ' HG ' ' B' ' 48' ' ' SER . 21.7 t70 -72.43 141.34 48.65 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 108.294 -1.002 . . . . 74.519999999999996 108.294 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' TYR . . . . . 0.464 ' OH ' ' HB2' ' A' ' 54' ' ' GLU . 4.6 t80 -56.92 -28.15 61.73 Favored 'General case' 0 CA--C 1.551 0.996 0 O-C-N 124.187 0.929 . . . . 71.400000000000006 109.754 -178.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.33 0.77 81.51 Favored Glycine 0 N--CA 1.427 -1.924 0 CA-C-N 115.787 -0.642 . . . . 65.109999999999999 113.366 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.469 ' HG ' ' HB3' ' B' ' 45' ' ' ASP . 18.6 m -78.99 135.33 36.88 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 107.781 -1.192 . . . . 71.549999999999997 107.781 176.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 63.6 p -94.38 169.97 9.83 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 119.115 -1.034 . . . . 71.540000000000006 110.457 -176.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.509 ' HB1' HD13 ' B' ' 66' ' ' ILE . . . -60.47 -38.61 84.79 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.506 -0.924 . . . . 72.310000000000002 108.506 174.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -57.26 -46.68 82.82 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.191 -0.913 . . . . 51.530000000000001 111.242 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -58.55 -47.49 84.06 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.669 0.747 . . . . 43.399999999999999 110.183 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 66.2 mt -64.88 -48.03 75.69 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.645 -1.162 . . . . 71.329999999999998 112.344 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -59.7 -50.71 72.79 Favored 'General case' 0 C--O 1.206 -1.231 0 N-CA-C 111.656 0.243 . . . . 73.219999999999999 111.656 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.53 -45.42 81.15 Favored 'General case' 0 C--O 1.269 2.106 0 CA-C-O 121.631 0.729 . . . . 70.239999999999995 111.127 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -66.78 -39.21 87.73 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.457 -1.247 . . . . 63.310000000000002 109.942 -174.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' B' ' 41' ' ' VAL 0.259 46.4 m-85 -82.09 -21.47 36.77 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 114.617 1.339 . . . . 75.109999999999999 114.617 177.235 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 68.2 m -64.57 -28.03 69.36 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.166 0.508 . . . . 72.329999999999998 109.784 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 18.8 m -58.42 -28.94 65.7 Favored 'General case' 0 CA--C 1.557 1.248 0 CA-C-N 115.892 -0.595 . . . . 74.239999999999995 110.837 173.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 82.2 m -95.89 3.17 53.83 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 113.616 0.969 . . . . 61.329999999999998 113.616 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.9 -169.67 27.27 Favored Glycine 0 N--CA 1.464 0.515 0 C-N-CA 118.662 -1.733 . . . . 52.149999999999999 115.244 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 27.1 m -93.73 127.88 39.67 Favored 'General case' 0 C--O 1.216 -0.68 0 C-N-CA 123.391 0.677 . . . . 71.319999999999993 110.372 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 85.5 mt -97.88 132.04 43.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 124.023 0.929 . . . . 72.040000000000006 113.284 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . 0.481 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 75.5 m-20 -100.03 -38.69 8.47 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.84 0.856 . . . . 72.239999999999995 112.304 176.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -151.76 160.36 43.61 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.096 -0.705 . . . . 71.310000000000002 109.096 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.509 HD13 ' HB1' ' B' ' 50' ' ' ALA . 20.1 pt -148.52 144.52 18.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.094 -1.447 . . . . 75.230000000000004 107.094 172.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' THR . . . . . 0.566 ' OG1' ' HB2' ' B' ' 82' ' ' TYR . 43.4 p -123.98 139.7 53.7 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 105.936 -1.876 . . . . 64.120000000000005 105.936 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.461 ' O ' HD12 ' A' ' 68' ' ' ILE . 2.4 mp -130.61 118.41 42.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 106.009 -1.848 . . . . 64.019999999999996 106.009 175.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.293 1.0 OUTLIER -121.39 125.56 47.24 Favored 'General case' 0 C--N 1.28 -2.44 0 C-N-CA 120.348 -0.541 . . . . 74.129999999999995 111.977 177.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 68.7 m -116.53 133.5 55.94 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.198 -0.667 . . . . 63.219999999999999 109.198 -176.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -122.52 133.82 54.57 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 118.701 -1.2 . . . . 74.040000000000006 111.426 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -116.74 17.36 15.2 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.551 -1.648 . . . . 75.200000000000003 106.551 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -44.64 -35.03 2.41 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.811 2.044 . . . . 74.319999999999993 112.847 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 39.9 m -115.24 26.29 10.21 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 111.773 0.286 . . . . 74.409999999999997 111.773 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.27 -60.22 0.49 Allowed Glycine 0 C--O 1.236 0.276 0 C-N-CA 120.617 -0.802 . . . . 64.209999999999994 114.054 175.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -84.78 141.91 38.81 Favored Pre-proline 0 C--N 1.31 -1.147 0 N-CA-C 110.176 -0.305 . . . . 73.530000000000001 110.176 -177.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -78.88 118.04 4.03 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 121.177 1.251 . . . . 74.040000000000006 111.854 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -112.43 -166.47 1.08 Allowed 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 109.207 -0.664 . . . . 75.439999999999998 109.207 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 171.58 159.41 17.74 Favored Glycine 0 N--CA 1.414 -2.768 0 C-N-CA 119.652 -1.261 . . . . 63.25 114.16 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -154.64 152.14 29.62 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 125.06 1.344 . . . . 70.530000000000001 109.091 176.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.08 153.93 51.17 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 122.001 0.121 . . . . 72.430000000000007 110.982 -173.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' TYR . . . . . 0.566 ' HB2' ' OG1' ' B' ' 67' ' ' THR . 30.8 m-85 -119.95 127.0 52.26 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 110.047 -0.353 . . . . 75.450000000000003 110.047 174.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.439 ' O ' HG23 ' B' ' 39' ' ' VAL . 23.8 mm -107.97 118.74 56.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 107.497 -1.297 . . . . 64.109999999999999 107.497 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' GLU . . . . . 0.463 ' HG2' ' OG ' ' B' ' 38' ' ' SER . 61.6 mt-10 -105.73 119.63 39.64 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.249 0.547 . . . . 71.150000000000006 110.235 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -95.81 162.0 13.78 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.671 -0.695 . . . . 71.5 112.285 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.481 ' HA ' ' ND2' ' B' ' 64' ' ' ASN . . . -79.03 -32.04 44.86 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.771 -1.104 . . . . 72.239999999999995 111.168 175.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.39 146.4 34.5 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 120.06 -0.656 . . . . 65.549999999999997 110.26 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -74.69 -26.67 59.99 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 108.015 -1.105 . . . . 73.430000000000007 108.015 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -72.51 -20.28 61.39 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 119.723 -0.791 . . . . 71.200000000000003 111.625 177.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 21.9 m -69.46 -37.35 77.28 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 110.505 -0.183 . . . . 62.399999999999999 110.505 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . 0.438 HG21 ' CG1' ' B' ' 39' ' ' VAL . 0.2 OUTLIER -67.08 -39.05 82.43 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 C-N-CA 120.427 -0.509 . . . . 61.200000000000003 109.905 175.173 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.93 -37.08 75.88 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.213 0.53 . . . . 74.140000000000001 110.716 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.42 -31.41 62.3 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.033 -0.53 . . . . 62.149999999999999 111.173 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.73 -43.02 48.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.197 -0.456 . . . . 63.539999999999999 111.167 -178.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 33.6 m -57.11 -22.24 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 112.724 0.638 . . . . 73.340000000000003 112.724 177.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.4 -15.74 63.85 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.219 0.533 . . . . 71.200000000000003 110.515 176.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 11.2 mtm -98.71 15.64 24.63 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.654 0.782 . . . . 75.209999999999994 111.436 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 6.0 t70 -33.85 -52.25 0.42 Allowed 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 114.807 1.41 . . . . 75.549999999999997 114.807 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -123.91 64.42 1.05 Allowed 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 118.778 -1.169 . . . . 71.430000000000007 111.182 174.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 10.8 t -97.72 -177.63 3.85 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.772 -1.104 . . . . 65.430000000000007 110.087 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 9.7 p -108.6 134.5 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 CA-C-O 121.254 0.55 . . . . 51.030000000000001 109.652 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -130.31 115.83 17.48 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.073 -0.714 . . . . 73.510000000000005 109.073 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 40.0 mtp-105 49.98 32.24 5.49 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.471 1.508 . . . . 75.230000000000004 112.23 -178.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.66 -6.32 62.7 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.502 -0.772 . . . . 73.310000000000002 112.879 175.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.437 ' HD3' ' HB2' ' B' ' 45' ' ' ASP . 30.2 mtp180 -110.14 133.56 53.09 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.808 -0.442 . . . . 71.310000000000002 109.808 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 14.4 m -75.57 120.51 21.08 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.044 -1.095 . . . . 72.239999999999995 108.044 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 41.6 pt -103.13 172.08 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-O 121.475 0.655 . . . . 74.219999999999999 112.262 -178.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 108' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 57.6 tptt -125.93 126.44 44.37 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.667 -1.151 . . . . 74.430000000000007 107.97 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 48.5 t -117.71 122.06 68.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.904 -0.776 . . . . 74.030000000000001 108.904 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . 0.436 ' HB2' ' HB3' ' B' ' 40' ' ' TYR . 95.8 mt -121.53 145.19 42.12 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 108.918 -0.771 . . . . 70.120000000000005 108.918 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.55 130.84 13.07 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.857 1.705 . . . . 75.219999999999999 109.66 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.452 ' HB3' ' HB2' ' B' ' 38' ' ' SER . 25.7 ttpp . . . . . 0 CA--C 1.5 -0.981 0 C-N-CA 119.981 -0.688 . . . . 64.120000000000005 112.368 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 . . . . . 0 N--CA 1.415 -2.196 0 N-CA-C 112.74 0.644 . . . . 72.140000000000001 112.74 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.422 HG23 HH21 ' A' ' 37' ' ' ARG . 15.8 pt -65.94 -34.33 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 120.46 -0.496 . . . . 71.319999999999993 110.827 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -61.16 -42.6 98.85 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.779 -0.823 . . . . 72.129999999999995 108.779 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -78.64 -26.79 45.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.363 -0.835 . . . . 72.25 112.386 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.422 HH21 HG23 ' A' ' 34' ' ' ILE . 89.3 mtm180 -89.71 12.96 15.46 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 123.068 0.547 . . . . 64.349999999999994 111.943 -177.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.3 t -96.64 145.21 25.96 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.277 0.561 . . . . 75.329999999999998 111.403 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.485 ' CG1' ' HB ' ' A' ' 91' ' ' VAL . 28.3 m -128.17 160.02 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.764 0 CA-C-N 115.839 -0.619 . . . . 72.209999999999994 110.487 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.582 ' CZ ' ' HG3' ' B' ' 22' ' ' PRO . 15.1 t80 -110.4 121.21 44.75 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 107.692 -1.225 . . . . 73.230000000000004 107.692 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.718 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 66.6 t -121.55 108.8 23.1 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 N-CA-C 107.404 -1.332 . . . . 71.319999999999993 107.404 173.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.18 172.03 17.42 Favored Glycine 0 C--N 1.284 -2.359 0 C-N-CA 118.813 -1.661 . . . . 64.439999999999998 112.825 -176.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.3 t30 61.64 34.1 17.79 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 124.269 1.028 . . . . 71.450000000000003 110.421 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.486 ' HA ' ' NH1' ' A' ' 105' ' ' ARG . 7.4 p -90.89 14.11 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.706 0 CA-C-N 115.03 -0.986 . . . . 64.420000000000002 111.231 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -36.62 112.27 0.18 Allowed 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 127.929 2.492 . . . . 70.219999999999999 114.69 -177.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . 0.524 32.1 m-85 50.11 -43.91 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.846 1 N-CA-C 122.467 4.247 . . . . 74.329999999999998 122.467 173.418 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.84 0.18 46.49 Favored Glycine 0 C--N 1.306 -1.108 0 CA-C-N 119.145 0.884 . . . . 38.299999999999997 113.32 -175.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.481 ' OG ' ' HE2' ' A' ' 102' ' ' PHE . 49.6 m -129.48 137.31 50.76 Favored 'General case' 0 N--CA 1.409 -2.497 0 O-C-N 122.45 -0.441 . . . . 64.140000000000001 110.046 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 47.1 p -125.25 179.34 5.12 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.238 -1.023 . . . . 64.310000000000002 108.238 -176.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.96 -49.77 76.38 Favored 'General case' 0 C--O 1.207 -1.159 0 CA-C-N 118.349 0.522 . . . . 63.200000000000003 111.134 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -58.26 -41.12 83.54 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.888 0.699 . . . . 63.299999999999997 112.888 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -62.93 -44.64 95.52 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.941 0.877 . . . . 63.310000000000002 110.1 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.4 mt -73.0 -46.72 50.59 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.497 -1.229 . . . . 73.239999999999995 112.482 -175.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.507 ' HG3' ' OH ' ' B' ' 46' ' ' TYR . 6.1 tm-20 -57.48 -48.68 78.57 Favored 'General case' 0 C--O 1.196 -1.711 0 C-N-CA 122.804 0.442 . . . . 74.349999999999994 110.441 -176.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.22 -42.73 77.74 Favored 'General case' 0 C--O 1.267 2.008 0 CA-C-O 121.724 0.773 . . . . 43.020000000000003 110.747 176.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -68.08 -43.59 78.22 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.248 -0.887 . . . . 74.25 111.335 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.544 ' CD2' HG12 ' A' ' 83' ' ' ILE . 65.9 m-85 -80.15 -22.98 41.44 Favored 'General case' 0 C--O 1.225 -0.218 0 O-C-N 121.91 -0.494 . . . . 73.010000000000005 111.435 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.9 t -69.46 -24.14 63.76 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.9 -0.778 . . . . 43.350000000000001 108.9 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.8 m -63.27 -22.57 66.96 Favored 'General case' 0 CA--C 1.568 1.641 0 CA-C-N 116.121 -0.49 . . . . 55.109999999999999 110.78 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 78.7 m -97.03 7.43 46.67 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.821 0.674 . . . . 74.25 112.821 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 142.97 -161.79 27.52 Favored Glycine 0 C--O 1.221 -0.682 0 C-N-CA 119.45 -1.357 . . . . 65.239999999999995 113.838 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.3 m -99.26 129.81 45.51 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.404 -0.591 . . . . 73.450000000000003 109.404 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.4 HD12 ' HB2' ' A' ' 57' ' ' PHE . 72.0 mt -85.23 133.3 29.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 113.084 0.772 . . . . 73.5 113.084 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.483 ' OD1' ' HG3' ' A' ' 65' ' ' ARG . 24.1 t-20 -94.7 -48.19 6.17 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.865 1.266 . . . . 74.340000000000003 108.234 178.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.483 ' HG3' ' OD1' ' A' ' 64' ' ' ASN . 98.9 mtt180 -148.57 158.84 44.4 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.506 -0.77 . . . . 72.530000000000001 109.003 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.5 tt -149.31 127.6 2.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 C-N-CA 123.198 0.599 . . . . 63.119999999999997 110.138 173.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.2 m -125.08 133.65 52.81 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.627 -1.249 . . . . 63.409999999999997 107.627 -173.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.471 HD11 ' O ' ' B' ' 68' ' ' ILE . 2.0 mp -131.03 120.6 47.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 106.646 -1.613 . . . . 63.439999999999998 106.646 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.401 HD23 ' O ' ' A' ' 80' ' ' TYR . 1.6 pt? -120.63 134.33 55.29 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.871 -0.332 . . . . 72.010000000000005 110.14 178.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 80.8 m -116.58 126.51 53.38 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.642 -0.873 . . . . 73.239999999999995 108.642 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.558 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 4.3 p30 -105.29 126.6 52.29 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.403 -0.519 . . . . 73.540000000000006 111.108 -177.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -119.47 2.53 11.25 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 112.62 0.6 . . . . 61.229999999999997 112.62 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.648 ' HB3' ' OD1' ' B' ' 64' ' ' ASN . 41.8 p90 -56.96 -27.67 61.49 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 113.924 1.083 . . . . 74.140000000000001 113.924 -176.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.0 t -97.24 10.87 38.31 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.259 0.552 . . . . 64.400000000000006 110.191 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.35 -55.78 0.55 Allowed Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 121.072 -0.585 . . . . 42.409999999999997 112.677 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.3 m80 -95.5 125.56 49.12 Favored Pre-proline 0 C--N 1.308 -1.237 0 C-N-CA 120.964 -0.294 . . . . 75.219999999999999 110.946 -177.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.558 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 26.5 Cg_endo -67.88 119.59 6.59 Favored 'Trans proline' 0 C--O 1.247 0.94 0 C-N-CA 122.829 2.353 . . . . 71.450000000000003 112.744 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.45 ' HB2' ' OD2' ' A' ' 71' ' ' ASP . 28.1 mtmm -113.21 -160.37 0.72 Allowed 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.796 -1.187 . . . . 72.140000000000001 107.796 172.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 179.04 153.15 11.23 Favored Glycine 0 N--CA 1.423 -2.225 0 C-N-CA 119.145 -1.502 . . . . 63.219999999999999 114.786 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.416 ' HH ' ' HG2' ' B' ' 23' ' ' PRO . 24.9 m-85 -136.22 153.31 51.26 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.628 -1.99 . . . . 71.510000000000005 105.628 174.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.64 131.19 42.99 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.588 -0.893 . . . . 72.150000000000006 108.588 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -115.39 120.45 39.63 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.594 -1.261 . . . . 72.340000000000003 107.594 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.544 HG12 ' CD2' ' A' ' 57' ' ' PHE . 1.1 mp -113.76 129.05 70.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 108.894 -0.78 . . . . 72.120000000000005 108.894 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -99.6 124.43 44.79 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.2 -1.408 . . . . 74.239999999999995 107.2 174.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -94.03 155.93 16.86 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 121.248 -0.181 . . . . 74.230000000000004 110.628 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.29 -32.05 72.78 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.427 -0.352 . . . . 43.439999999999998 111.427 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.86 148.34 44.17 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.777 -0.769 . . . . 74.109999999999999 110.163 175.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -70.76 -27.09 63.67 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.319 -0.855 . . . . 75.239999999999995 109.608 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -62.49 -33.91 75.81 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.921 -0.582 . . . . 71.230000000000004 110.521 174.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.5 m -66.75 -35.94 81.28 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 116.048 -0.524 . . . . 55.439999999999998 110.902 -177.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.493 ' O ' HG11 ' A' ' 95' ' ' VAL . 1.5 m -68.95 -37.69 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 108.435 -0.95 . . . . 72.340000000000003 108.435 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.629 ' O ' HG21 ' A' ' 95' ' ' VAL . 9.9 t70 -68.02 -30.52 69.77 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.722 0.772 . . . . 64.329999999999998 109.499 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.01 -31.24 64.36 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.667 -0.697 . . . . 73.310000000000002 110.088 175.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.85 -36.17 59.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.889 -0.596 . . . . 53.329999999999998 111.453 -177.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.629 HG21 ' O ' ' A' ' 92' ' ' ASP . 11.2 m -53.86 -21.63 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 112.597 0.592 . . . . 74.140000000000001 112.597 178.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.75 -12.2 44.6 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.304 0.573 . . . . 64.219999999999999 110.991 177.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.562 ' HA ' ' OG1' ' A' ' 100' ' ' THR . 68.0 mtm -100.43 5.43 44.25 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 116.1 -0.5 . . . . 64.319999999999993 111.092 178.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.479 ' HA ' ' H ' ' A' ' 109' ' ' VAL . 0.4 OUTLIER -48.4 -49.02 36.53 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.569 1.322 . . . . 74.349999999999994 114.569 -177.171 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -101.97 12.82 36.29 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-O 121.887 0.851 . . . . 72.230000000000004 110.539 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.562 ' OG1' ' HA ' ' A' ' 97' ' ' MET . 62.9 m -72.24 151.93 42.53 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.917 -0.583 . . . . 74.299999999999997 109.984 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -101.56 134.34 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 N-CA-C 108.559 -0.904 . . . . 73.519999999999996 108.559 -177.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.481 ' HE2' ' OG ' ' A' ' 48' ' ' SER . 82.6 t80 -130.12 118.81 22.05 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 115.654 -0.703 . . . . 74.349999999999994 109.17 -173.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 54.55 32.06 16.18 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.717 1.006 . . . . 64.019999999999996 113.717 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.71 -5.47 73.33 Favored Glycine 0 N--CA 1.461 0.352 0 CA-C-N 115.227 -0.897 . . . . 64.150000000000006 113.406 174.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.486 ' NH1' ' HA ' ' A' ' 44' ' ' VAL . 21.9 ptt85 -121.52 145.49 47.9 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 122.846 0.458 . . . . 74.430000000000007 110.301 178.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.2 m -82.61 122.24 27.86 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.545 -0.909 . . . . 64.439999999999998 108.545 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 41.3 pt -101.44 171.52 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 N-CA-C 108.44 -0.948 . . . . 75.430000000000007 108.44 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.718 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 22.9 mmmt -121.91 128.23 51.32 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 109.685 -0.487 . . . . 71.150000000000006 109.685 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.479 ' H ' ' HA ' ' A' ' 98' ' ' ASP . 60.5 t -117.48 112.16 37.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 105.127 -2.175 . . . . 62.520000000000003 105.127 173.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 tt -140.41 129.97 13.38 Favored Pre-proline 0 C--N 1.274 -2.681 0 N-CA-C 105.146 -2.168 . . . . 75.310000000000002 105.146 -172.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -55.12 136.81 74.81 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 121.584 1.523 . . . . 72.409999999999997 109.736 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.25 24.2 ttpp . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 122.615 1.197 . . . . 71.430000000000007 112.204 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.776 0 CA-C-O 119.879 -0.4 . . . . 71.200000000000003 113.417 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.582 ' HG3' ' CZ ' ' A' ' 40' ' ' TYR . 0.9 OUTLIER -40.54 -57.27 1.3 Allowed 'Trans proline' 0 CA--C 1.573 2.47 0 C-N-CA 124.797 3.665 . . . . 71.030000000000001 116.192 -178.794 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.458 ' HD3' ' HG2' ' B' ' 22' ' ' PRO . 4.8 Cg_exo -83.95 165.61 13.31 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 121.95 1.767 . . . . 64.400000000000006 110.734 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -103.91 145.38 30.53 Favored Pre-proline 0 C--N 1.283 -2.31 0 N-CA-C 109.382 -0.599 . . . . 65.010000000000005 109.382 176.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -46.78 127.6 12.23 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.266 2.644 . . . . 43.539999999999999 113.841 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.559 ' H ' HD13 ' B' ' 26' ' ' LEU . 0.0 OUTLIER -61.61 -167.97 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 114.47 -1.241 . . . . 65.540000000000006 113.837 178.754 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.56 ' O ' ' HG3' ' B' ' 31' ' ' LYS . 47.0 t -54.19 143.51 22.56 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.765 0.793 . . . . 52.439999999999998 112.583 -176.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.477 ' O ' ' HE2' ' B' ' 32' ' ' LYS . . . -60.89 -43.74 98.06 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.16 -1.382 . . . . 72.430000000000007 111.709 178.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -66.92 -33.02 74.68 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 111.715 0.265 . . . . 52.329999999999998 111.715 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.453 ' HB3' HD23 ' B' ' 26' ' ' LEU . 10.8 tp10 -62.64 -34.89 77.97 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 107.631 -1.248 . . . . 52.039999999999999 107.631 177.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' B' ' 27' ' ' SER . 92.6 mttt -70.07 -50.43 41.11 Favored 'General case' 0 C--O 1.203 -1.359 0 CA-C-N 115.341 -0.845 . . . . 72.319999999999993 111.101 -174.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.477 ' HE2' ' O ' ' B' ' 28' ' ' ALA . 0.2 OUTLIER -57.66 -37.42 73.36 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 120.106 -0.637 . . . . 72.150000000000006 112.062 -177.455 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.687 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 7.1 mm-40 -71.14 -47.41 58.04 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.074 -0.512 . . . . 72.030000000000001 110.635 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.469 HG12 ' HA ' ' B' ' 31' ' ' LYS . 21.4 pt -64.83 -34.65 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 122.975 0.172 . . . . 63.149999999999999 111.211 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -60.63 -42.66 97.33 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-O 121.183 0.516 . . . . 74.349999999999994 109.807 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.418 ' O ' ' HD3' ' B' ' 88' ' ' ARG . 98.4 mttt -78.38 -25.87 46.38 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.153 0.798 . . . . 75.310000000000002 113.153 -176.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.687 ' HG2' ' O ' ' B' ' 33' ' ' GLU . 14.7 ptp180 -108.29 31.96 5.17 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.704 0.764 . . . . 74.540000000000006 112.2 -174.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' SER . . . . . 0.412 ' HB3' ' O ' ' B' ' 112' ' ' LYS . 35.2 t -95.55 155.78 16.6 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.092 -1.447 . . . . 75.519999999999996 107.092 172.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.5 ' CG1' ' HB ' ' B' ' 91' ' ' VAL . 26.8 m -135.49 158.39 40.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.931 -0.48 . . . . 75.319999999999993 110.11 176.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 22.1 t80 -107.73 119.82 40.51 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 107.354 -1.35 . . . . 71.549999999999997 107.354 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 67.3 t -122.0 107.57 20.14 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 N-CA-C 106.806 -1.553 . . . . 61.420000000000002 106.806 173.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.86 171.49 19.99 Favored Glycine 0 C--N 1.276 -2.802 0 C-N-CA 118.29 -1.909 . . . . 75.420000000000002 112.712 -176.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.6 t30 66.57 28.66 9.26 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.289 1.436 . . . . 72.329999999999998 112.208 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 14.7 p -58.49 134.5 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-O 121.412 0.625 . . . . 71.25 109.862 175.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -73.69 146.32 44.57 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.479 -0.782 . . . . 73.219999999999999 109.547 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' TYR . . . . . 0.507 ' OH ' ' HG3' ' A' ' 54' ' ' GLU . 45.8 t80 -61.71 -19.24 62.17 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.794 0.838 . . . . 72.420000000000002 110.93 -176.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.32 -0.53 55.75 Favored Glycine 0 N--CA 1.427 -1.924 0 CA-C-N 116.01 -0.541 . . . . 73.010000000000005 112.551 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 34.0 m -84.64 133.36 34.41 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.895 -0.78 . . . . 74.420000000000002 108.895 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 62.0 p -113.02 178.73 4.18 Favored 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 119.74 -0.784 . . . . 75.340000000000003 111.132 -177.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.8 -43.36 99.01 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.741 -0.663 . . . . 53.409999999999997 110.984 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -58.62 -43.13 89.58 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 111.724 0.268 . . . . 74.349999999999994 111.724 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -60.34 -47.93 83.93 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.912 0.863 . . . . 71.319999999999993 109.614 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 69.4 mt -68.73 -47.32 66.61 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-N 114.271 -1.331 . . . . 74.439999999999998 112.816 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -57.34 -48.85 77.92 Favored 'General case' 0 C--O 1.205 -1.284 0 C-N-CA 122.872 0.469 . . . . 64.200000000000003 110.569 -176.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.34 -42.72 78.2 Favored 'General case' 0 C--O 1.258 1.522 0 CA-C-O 121.286 0.565 . . . . 70.239999999999995 110.631 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -69.1 -42.03 76.67 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.363 -0.835 . . . . 73.200000000000003 111.201 -176.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.516 ' CD2' HG13 ' B' ' 83' ' ' ILE . 66.2 m-85 -80.52 -23.17 40.23 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.454 -0.499 . . . . 72.230000000000004 111.114 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 32.9 t -71.37 -24.54 62.1 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.435 -0.58 . . . . 75.450000000000003 109.435 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 23.8 m -63.95 -27.01 68.85 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.1 0.476 . . . . 71.099999999999994 110.005 176.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 63.5 m -97.43 7.51 46.38 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.574 0.583 . . . . 74.329999999999998 112.574 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.09 -165.18 29.78 Favored Glycine 0 CA--C 1.507 -0.461 0 C-N-CA 118.169 -1.967 . . . . 74.319999999999993 115.783 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 14.7 m -98.18 123.99 42.53 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.862 -0.669 . . . . 72.310000000000002 109.442 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 61.9 mt -88.72 131.83 35.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 113.223 0.823 . . . . 73.540000000000006 113.223 -178.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . 0.648 ' OD1' ' HB3' ' A' ' 73' ' ' PHE . 18.8 t-20 -99.73 -45.25 5.82 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 124.5 1.12 . . . . 54.520000000000003 109.955 177.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.431 ' HB2' ' HB2' ' B' ' 84' ' ' GLU . 98.3 mtt180 -147.46 158.47 43.99 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.181 -0.674 . . . . 70.219999999999999 109.181 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.467 HD11 HG21 ' B' ' 66' ' ' ILE . 0.8 OUTLIER -148.93 127.49 3.19 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 C-N-CA 123.658 0.783 . . . . 65.219999999999999 109.972 174.006 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 38.6 m -125.93 133.21 51.92 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.065 -0.971 . . . . 72.519999999999996 108.61 -175.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.471 ' O ' HD11 ' A' ' 68' ' ' ILE . 1.2 mp -129.9 122.34 54.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 106.353 -1.721 . . . . 75.329999999999998 106.353 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.407 HD23 ' N ' ' B' ' 69' ' ' LEU . 1.7 pt? -121.71 135.25 54.95 Favored 'General case' 0 C--N 1.287 -2.151 0 C-N-CA 120.6 -0.44 . . . . 62.299999999999997 110.468 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 64.5 m -115.87 127.08 54.74 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.03 -1.1 . . . . 72.140000000000001 108.03 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . 0.421 ' OD2' ' HB2' ' B' ' 78' ' ' LYS . 3.7 p30 -107.8 127.52 53.78 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.258 -0.645 . . . . 72.450000000000003 109.258 -177.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . 0.449 ' HE3' ' HB3' ' B' ' 77' ' ' PRO . 44.9 mtpt -124.1 10.88 8.81 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 120.732 -0.387 . . . . 63.210000000000001 110.015 -178.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -61.51 -22.7 65.34 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 113.893 1.072 . . . . 74.409999999999997 113.893 -177.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 19.8 m -97.81 14.08 28.25 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.025 0.44 . . . . 62.219999999999999 109.99 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.22 -44.37 3.09 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 111.275 -0.73 . . . . 75.299999999999997 111.275 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -91.37 125.62 57.44 Favored Pre-proline 0 CA--C 1.505 -0.762 0 N-CA-C 110.011 -0.366 . . . . 70.109999999999999 110.011 178.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.449 ' HB3' ' HE3' ' B' ' 72' ' ' LYS . 69.3 Cg_endo -76.57 119.55 5.24 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.905 2.404 . . . . 70.439999999999998 112.843 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' LYS . . . . . 0.421 ' HB2' ' OD2' ' B' ' 71' ' ' ASP . 24.6 mtmm -118.77 -160.82 0.81 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.094 -1.076 . . . . 70.329999999999998 108.094 175.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 178.79 158.26 20.95 Favored Glycine 0 N--CA 1.416 -2.698 0 C-N-CA 119.193 -1.48 . . . . 62.310000000000002 114.226 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -136.17 153.95 51.1 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 105.784 -1.932 . . . . 73.010000000000005 105.784 173.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.37 130.33 40.57 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 109.935 -0.394 . . . . 73.010000000000005 109.935 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -114.03 122.39 46.77 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.912 -1.144 . . . . 72.150000000000006 107.912 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.516 HG13 ' CD2' ' B' ' 57' ' ' PHE . 4.6 mm -114.03 129.38 70.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.106 -1.072 . . . . 74.019999999999996 108.106 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' B' ' 65' ' ' ARG . 1.3 mp0 -99.48 120.74 40.11 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.54 -1.281 . . . . 74.319999999999993 107.54 173.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -88.9 152.8 21.52 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 108.515 -0.92 . . . . 71.340000000000003 108.515 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.63 -24.23 64.53 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 110.239 -0.282 . . . . 71.430000000000007 110.239 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -120.91 147.09 45.9 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.924 -0.58 . . . . 73.109999999999999 110.675 -178.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.418 ' HD3' ' O ' ' B' ' 36' ' ' LYS . 0.0 OUTLIER -72.59 -34.14 67.21 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.0 -0.741 . . . . 73.430000000000007 109.0 177.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -59.46 -35.26 73.71 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.204 -0.907 . . . . 75.150000000000006 110.465 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 30.8 m -65.78 -36.26 83.02 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.931 -0.577 . . . . 72.25 110.555 -178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . 0.509 ' O ' HG11 ' B' ' 95' ' ' VAL . 1.4 m -69.12 -37.46 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 108.906 -0.775 . . . . 73.519999999999996 108.906 -178.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . 0.651 ' O ' HG21 ' B' ' 95' ' ' VAL . 7.2 t70 -68.49 -31.05 70.04 Favored 'General case' 0 C--O 1.215 -0.763 0 CA-C-O 121.67 0.748 . . . . 65.329999999999998 109.066 -178.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.99 -31.15 64.32 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.842 -0.617 . . . . 73.209999999999994 109.868 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.32 -35.55 61.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.796 -0.638 . . . . 73.510000000000005 111.481 -178.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . 0.651 HG21 ' O ' ' B' ' 92' ' ' ASP . 10.4 m -54.31 -21.18 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 112.582 0.586 . . . . 70.310000000000002 112.582 178.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.57 -13.97 61.73 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.213 0.53 . . . . 43.409999999999997 110.835 177.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 67.1 mtm -96.9 12.98 30.37 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 116.263 -0.426 . . . . 44.350000000000001 110.627 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -35.41 -58.36 0.58 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.283 1.033 . . . . 63.409999999999997 113.082 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -112.02 98.95 7.7 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 118.553 -1.259 . . . . 63.039999999999999 109.14 170.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 75.4 m -139.44 150.85 45.71 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.526 -1.215 . . . . 74.439999999999998 109.941 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.05 122.59 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-O 121.481 0.657 . . . . 74.319999999999993 110.302 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -120.36 124.89 46.64 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.736 -0.839 . . . . 74.219999999999999 108.736 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 61.0 ttt-85 47.9 31.5 2.36 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 125.566 1.546 . . . . 71.030000000000001 112.044 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 100.4 -6.36 57.67 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 115.666 -0.697 . . . . 38.299999999999997 114.35 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -121.91 150.97 41.23 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 117.838 0.819 . . . . 73.099999999999994 111.304 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 30.0 m -82.07 121.58 26.74 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 116.431 -0.35 . . . . 74.329999999999998 110.232 -176.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 45.8 pt -101.2 170.66 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 120.577 -0.449 . . . . 60.25 110.151 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 108' ' ' LYS . . . . . 0.595 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 46.7 tptt -128.81 121.61 28.69 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.955 -1.128 . . . . 72.109999999999999 107.955 -176.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 95.6 t -115.19 114.42 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 N-CA-C 107.374 -1.343 . . . . 72.310000000000002 107.374 -178.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 3.6 tt -138.83 131.12 15.67 Favored Pre-proline 0 C--N 1.292 -1.925 0 N-CA-C 105.938 -1.875 . . . . 71.040000000000006 105.938 -173.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -53.57 133.51 53.95 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.871 1.714 . . . . 74.030000000000001 112.888 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' B' ' 38' ' ' SER . 45.1 tttm . . . . . 0 N--CA 1.389 -3.485 0 N-CA-C 106.495 -1.668 . . . . 65.329999999999998 106.495 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 41.3 mm-40 . . . . . 0 N--CA 1.469 0.475 0 N-CA-C 112.236 0.458 . . . . 74.340000000000003 112.236 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 21.2 pt -67.42 -35.17 72.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.177 0.513 . . . . 63.0 111.541 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -68.9 -24.02 64.26 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.881 -0.6 . . . . 74.030000000000001 110.471 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -77.92 -32.03 51.42 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.2 0.524 . . . . 75.310000000000002 110.746 176.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 96.5 mtt180 -94.49 10.8 33.14 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.605 0.717 . . . . 71.349999999999994 110.56 -171.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.477 ' HB3' ' HG2' ' A' ' 84' ' ' GLU . 13.6 p -112.16 169.4 8.89 Favored 'General case' 0 N--CA 1.401 -2.887 0 CA-C-N 115.424 -0.807 . . . . 74.209999999999994 111.771 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 27.3 m -135.32 158.62 40.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 116.155 -0.475 . . . . 75.549999999999997 110.912 -175.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.661 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 46.7 t80 -99.0 121.78 41.4 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 124.572 1.149 . . . . 74.5 108.665 175.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 58.2 t -115.07 113.53 43.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 107.639 -1.245 . . . . 71.349999999999994 107.639 174.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.23 170.23 14.0 Favored Glycine 0 C--N 1.305 -1.182 0 C-N-CA 120.052 -1.07 . . . . 41.530000000000001 113.769 -177.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.448 ' O ' ' HD3' ' A' ' 105' ' ' ARG . 65.4 t30 68.71 21.49 7.81 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 126.425 1.89 . . . . 74.030000000000001 112.505 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.512 ' O ' ' HA3' ' A' ' 79' ' ' GLY . 7.4 p -91.63 103.65 14.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 O-C-N 121.203 -0.936 . . . . 71.109999999999999 110.99 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -86.71 166.74 15.06 Favored 'General case' 0 C--O 1.261 1.686 0 N-CA-C 108.391 -0.966 . . . . 63.439999999999998 108.391 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -50.81 131.77 26.28 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 123.41 0.444 . . . . 73.129999999999995 109.825 174.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 137.89 -38.49 1.7 Allowed Glycine 0 N--CA 1.427 -1.945 0 N-CA-C 110.1 -1.2 . . . . 75.319999999999993 110.1 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.4 m -84.08 131.97 34.75 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 108.131 -1.063 . . . . 74.329999999999998 108.131 176.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.0 p -94.1 162.86 13.7 Favored 'General case' 0 N--CA 1.418 -2.066 0 N-CA-C 109.678 -0.49 . . . . 72.25 109.678 -179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' HB3' HD11 ' A' ' 66' ' ' ILE . . . -65.9 -41.64 91.2 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 109.902 -0.407 . . . . 71.329999999999998 109.902 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.514 HE21 ' N ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -61.06 -37.31 82.22 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 120.21 -0.596 . . . . 63.109999999999999 112.254 178.824 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.514 ' N ' HE21 ' A' ' 51' ' ' GLN 0.279 1.9 p30 -73.57 -28.21 61.73 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 119.368 -0.933 . . . . 63.43 110.87 178.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.3 mt -62.61 -46.37 88.59 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 115.431 -0.804 . . . . 71.129999999999995 110.076 172.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -58.45 -47.43 84.03 Favored 'General case' 0 C--O 1.189 -2.124 0 N-CA-C 112.957 0.725 . . . . 72.439999999999998 112.957 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.59 -47.37 73.43 Favored 'General case' 0 C--O 1.27 2.136 0 CA-C-O 120.957 0.408 . . . . 75.409999999999997 111.054 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -64.04 -43.04 96.77 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.147 -0.933 . . . . 74.530000000000001 110.825 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -82.65 -25.6 32.94 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 116.081 1.882 . . . . 71.329999999999998 116.081 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.5 m -69.89 -28.07 65.32 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-O 120.761 0.315 . . . . 61.399999999999999 110.932 -176.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.1 m -59.34 -26.53 65.11 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 120.412 -0.515 . . . . 75.409999999999997 110.886 173.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 79.0 m -105.99 9.24 32.63 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.013 0.746 . . . . 73.310000000000002 113.013 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' A' ' 90' ' ' SER . . . 163.46 176.5 35.49 Favored Glycine 0 CA--C 1.502 -0.74 0 C-N-CA 118.176 -1.964 . . . . 71.349999999999994 115.484 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.5 m -100.66 116.47 32.64 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.107 -0.546 . . . . 75.209999999999994 110.109 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.4 mt -83.78 128.29 38.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 115.352 -0.84 . . . . 51.240000000000002 112.862 -176.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.493 HD22 ' HA ' ' A' ' 86' ' ' ALA . 89.2 m-20 -87.25 -45.55 10.52 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 115.424 -0.807 . . . . 74.030000000000001 109.621 175.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.514 ' HD3' ' OE1' ' A' ' 84' ' ' GLU . 53.8 mtp180 -159.27 165.96 32.35 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.242 -1.392 . . . . 75.150000000000006 107.242 -173.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.482 HD11 ' HB3' ' A' ' 50' ' ' ALA . 22.4 pt -146.19 141.94 21.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.193 -1.04 . . . . 75.030000000000001 108.193 174.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.6 m -125.32 125.41 43.45 Favored 'General case' 0 C--N 1.269 -2.933 0 N-CA-C 107.217 -1.401 . . . . 73.239999999999995 107.217 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.9 mp -120.46 115.88 48.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 105.541 -2.022 . . . . 74.239999999999995 105.541 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.556 HD11 ' NH2' ' B' ' 65' ' ' ARG . 1.0 OUTLIER -121.09 128.87 53.0 Favored 'General case' 0 C--N 1.283 -2.292 0 C-N-CA 120.348 -0.541 . . . . 64.420000000000002 112.096 -178.477 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 66.1 m -117.37 133.6 55.79 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.805 -0.634 . . . . 64.430000000000007 109.795 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -118.41 144.48 45.9 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 120.343 -0.543 . . . . 64.510000000000005 110.743 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -111.64 12.04 21.17 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.25 0.548 . . . . 64.319999999999993 111.208 174.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.602 ' CE2' ' HB3' ' B' ' 64' ' ' ASN . 30.5 m-85 -66.75 -20.73 66.02 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.633 -0.712 . . . . 75.310000000000002 111.275 175.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 76' ' ' HIS . 20.6 t -86.13 3.87 40.84 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.71 -0.677 . . . . 71.129999999999995 109.658 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.1 -44.26 3.29 Favored Glycine 0 CA--C 1.502 -0.776 0 N-CA-C 110.149 -1.181 . . . . 63.350000000000001 110.149 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.469 ' H ' ' C ' ' A' ' 74' ' ' SER . 45.1 m80 -96.81 147.16 32.51 Favored Pre-proline 0 C--N 1.292 -1.909 0 N-CA-C 105.915 -1.883 . . . . 73.439999999999998 105.915 177.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -75.44 116.57 4.54 Favored 'Trans proline' 0 N--CA 1.432 -2.125 0 N-CA-C 108.792 -1.272 . . . . 64.400000000000006 108.792 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 24.7 mtmm -108.05 156.93 18.71 Favored 'General case' 0 CA--C 1.461 -2.449 0 N-CA-C 107.73 -1.211 . . . . 73.329999999999998 107.73 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 44' ' ' VAL . . . -136.34 145.25 17.16 Favored Glycine 1 N--CA 1.395 -4.035 0 C-N-CA 119.167 -1.492 . . . . 61.210000000000001 112.226 176.724 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -146.2 143.55 29.32 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 108.31 -0.996 . . . . 74.310000000000002 108.31 174.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.09 144.37 51.31 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-O 120.777 0.322 . . . . 63.439999999999998 110.577 -173.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.727 ' CD1' ' HD2' ' A' ' 112' ' ' LYS . 68.7 m-85 -115.83 115.54 26.43 Favored 'General case' 0 N--CA 1.409 -2.482 0 CA-C-N 115.908 -0.587 . . . . 74.409999999999997 109.599 177.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.406 HG21 HG22 ' A' ' 66' ' ' ILE . 33.0 mm -99.85 119.51 48.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 107.632 -1.248 . . . . 73.140000000000001 107.632 -177.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.514 ' OE1' ' HD3' ' A' ' 65' ' ' ARG . 43.5 mt-10 -96.18 119.96 35.61 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.793 -0.363 . . . . 75.030000000000001 110.583 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -99.66 153.14 19.32 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.09 0.472 . . . . 63.229999999999997 110.136 177.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.493 ' HA ' HD22 ' A' ' 64' ' ' ASN . . . -64.13 -37.18 86.53 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.667 -0.697 . . . . 70.109999999999999 111.515 177.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -116.94 145.38 43.65 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.502 -0.772 . . . . 63.140000000000001 112.905 -176.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.535 ' O ' HG23 ' A' ' 91' ' ' VAL . 17.5 mmm180 -62.34 -33.16 74.18 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.381 -0.827 . . . . 75.439999999999998 109.549 171.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -62.81 -32.41 73.6 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.217 -0.901 . . . . 72.409999999999997 110.449 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.436 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . 47.3 m -67.75 -36.86 81.31 Favored 'General case' 0 N--CA 1.426 -1.67 0 O-C-N 122.383 -0.198 . . . . 71.219999999999999 110.546 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 88' ' ' ARG . 2.9 m -64.92 -39.18 84.81 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.886 0 C-N-CA 119.656 -0.818 . . . . 73.230000000000004 109.877 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -60.22 -36.3 77.4 Favored 'General case' 0 CA--C 1.502 -0.902 0 O-C-N 123.361 0.413 . . . . 75.510000000000005 111.935 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.73 -36.67 65.21 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.055 0.455 . . . . 54.229999999999997 110.298 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.07 -45.32 57.95 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.887 -0.597 . . . . 52.340000000000003 111.574 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 91' ' ' VAL . 22.1 m -55.39 -21.58 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 113.101 0.778 . . . . 74.519999999999996 113.101 177.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.97 -19.04 65.73 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.293 0.568 . . . . 75.319999999999993 110.461 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 56.9 mtm -96.19 9.43 41.0 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.653 -0.703 . . . . 63.100000000000001 110.173 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.428 ' HA ' HG13 ' A' ' 109' ' ' VAL . 2.7 p-10 -41.97 -41.71 2.59 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.825 0.676 . . . . 73.329999999999998 112.825 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -102.22 101.49 11.79 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 119.668 -0.813 . . . . 63.549999999999997 109.539 170.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.7 p -140.61 148.27 40.65 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.276 -0.874 . . . . 71.129999999999995 110.309 174.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.1 p -113.57 93.14 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 CA-C-O 122.764 1.269 . . . . 62.310000000000002 108.981 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -112.36 128.81 56.4 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 114.058 -1.428 . . . . 74.420000000000002 107.553 -173.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 61.1 33.18 19.59 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.27 1.028 . . . . 71.530000000000001 109.566 -175.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.59 -2.4 63.32 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 114.768 -1.105 . . . . 75.150000000000006 114.5 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.448 ' HD3' ' O ' ' A' ' 43' ' ' ASN . 5.5 ptp180 -113.0 141.14 47.18 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 122.058 -0.672 . . . . 73.310000000000002 109.523 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.0 m -83.68 119.72 25.12 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 108.322 -0.992 . . . . 74.340000000000003 108.322 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 33.3 pt -101.7 172.16 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 109.619 -0.512 . . . . 75.549999999999997 109.619 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 55.3 tptt -132.89 132.32 41.93 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.644 -0.873 . . . . 72.25 108.644 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 5.0 p -128.18 123.17 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 O-C-N 123.355 0.41 . . . . 71.409999999999997 110.498 175.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . 0.289 0.0 OUTLIER -141.95 146.79 42.05 Favored Pre-proline 0 N--CA 1.431 -1.383 0 N-CA-C 108.99 -0.744 . . . . 74.299999999999997 108.99 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.95 131.01 21.43 Favored 'Trans proline' 0 C--O 1.244 0.818 0 C-N-CA 122.099 1.866 . . . . 72.239999999999995 114.017 -171.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.727 ' HD2' ' CD1' ' A' ' 82' ' ' TYR . 48.3 mtpt . . . . . 0 C--N 1.313 -0.997 0 CA-C-N 114.484 -1.235 . . . . 75.530000000000001 112.735 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.798 0 N-CA-C 114.056 0.382 . . . . 50.530000000000001 114.056 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -50.52 -44.3 40.56 Favored 'Trans proline' 0 CA--C 1.553 1.444 0 C-N-CA 124.326 3.351 . . . . 74.409999999999997 115.339 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -46.47 133.03 16.24 Favored 'Trans proline' 0 C--N 1.396 3.029 0 C-N-CA 122.301 2.001 . . . . 72.530000000000001 112.94 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -65.87 140.4 97.21 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 115.835 -0.62 . . . . 63.299999999999997 110.957 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.16 119.46 6.53 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 122.746 2.297 . . . . 74.109999999999999 113.283 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.508 ' H ' HD12 ' B' ' 26' ' ' LEU . 0.0 OUTLIER -79.91 176.0 10.12 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.034 -0.985 . . . . 62.109999999999999 110.394 177.462 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.564 ' HB3' ' OE1' ' B' ' 30' ' ' GLU . 41.2 t -67.71 144.54 55.4 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.927 0.714 . . . . 73.310000000000002 112.927 -173.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.99 -35.53 34.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.371 -1.286 . . . . 71.140000000000001 111.349 173.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -65.43 -45.33 84.28 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 116.392 -0.367 . . . . 60.229999999999997 110.923 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.564 ' OE1' ' HB3' ' B' ' 27' ' ' SER . 2.8 mp0 -64.19 -38.68 91.91 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 120.776 -0.37 . . . . 72.430000000000007 110.974 176.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.1 -41.95 98.73 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.493 0.663 . . . . 75.140000000000001 109.294 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.536 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 0.0 OUTLIER -72.27 -38.0 68.93 Favored 'General case' 0 N--CA 1.384 -3.739 0 CA-C-N 115.225 -0.898 . . . . 72.040000000000006 112.59 -178.438 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -71.24 -41.36 70.21 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.311 0.486 . . . . 73.109999999999999 112.311 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.455 HG12 ' O ' ' B' ' 30' ' ' GLU . 15.7 pt -70.01 -35.42 64.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.367 -0.379 . . . . 74.420000000000002 110.983 -177.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.488 ' CG ' ' HZ2' ' B' ' 112' ' ' LYS . 12.5 t70 -69.38 -27.37 65.25 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.686 -0.688 . . . . 75.0 109.378 -177.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 99.3 mttt -71.18 -34.26 70.76 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.631 -0.713 . . . . 73.230000000000004 111.133 176.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -99.77 19.65 15.6 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.051 0.929 . . . . 75.239999999999995 110.33 -175.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 68.6 m -96.55 158.33 15.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.192 -1.367 . . . . 75.310000000000002 108.554 173.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' B' ' 82' ' ' TYR . 28.2 m -131.74 157.64 43.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.458 -0.571 . . . . 74.299999999999997 109.458 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . 0.635 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 40.7 t80 -103.93 119.07 38.16 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.041 -1.096 . . . . 74.420000000000002 108.041 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 58.5 t -112.02 109.79 29.84 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 107.414 -1.328 . . . . 74.299999999999997 107.414 175.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -113.44 173.96 15.42 Favored Glycine 0 N--CA 1.438 -1.197 0 C-N-CA 120.621 -0.799 . . . . 62.240000000000002 112.788 -176.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 7.4 t30 61.01 9.01 2.13 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 126.002 1.721 . . . . 51.109999999999999 111.542 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 5.6 p -84.33 90.84 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 106.394 -1.706 . . . . 72.450000000000003 106.394 173.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -82.14 84.93 6.88 Favored 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 115.474 1.657 . . . . 53.32 115.474 -165.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' TYR . . . . . 0.576 ' HA ' ' SG ' ' B' ' 70' ' ' CYS . 7.6 t80 70.68 -69.54 0.18 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 113.658 -1.61 . . . . 75.040000000000006 113.986 163.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.08 -4.53 22.35 Favored Glycine 0 N--CA 1.468 0.786 0 N-CA-C 116.432 1.333 . . . . 75.5 116.432 -170.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 71.2 m -71.22 130.34 41.18 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 117.989 0.894 . . . . 70.420000000000002 110.515 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 36.1 p -79.83 151.71 30.11 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.185 -0.462 . . . . 74.329999999999998 111.556 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.471 ' HB3' HD11 ' B' ' 66' ' ' ILE . . . -69.29 -41.56 76.66 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.437 0.695 . . . . 72.230000000000004 111.573 -175.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -41.8 81.7 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.868 -0.605 . . . . 75.430000000000007 111.587 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -69.04 -34.64 75.52 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.837 -0.62 . . . . 64.120000000000005 110.994 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 21.3 mt -61.51 -46.45 89.93 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-N 115.485 -0.779 . . . . 74.25 111.638 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -58.64 -47.05 85.72 Favored 'General case' 0 C--O 1.194 -1.827 0 N-CA-C 113.501 0.926 . . . . 75.530000000000001 113.501 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.64 -47.66 73.22 Favored 'General case' 0 C--O 1.268 2.029 0 CA-C-N 118.041 0.382 . . . . 70.099999999999994 111.185 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -64.26 -42.14 96.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.373 -0.831 . . . . 71.040000000000006 111.007 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -82.8 -25.63 32.53 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 115.903 1.816 . . . . 62.140000000000001 115.903 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 69.5 m -69.78 -25.0 63.59 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 120.651 0.262 . . . . 75.299999999999997 110.673 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 21.4 m -58.44 -27.25 64.18 Favored 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 120.432 -0.507 . . . . 74.120000000000005 110.764 172.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 68.2 m -99.94 7.36 44.88 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.741 1.015 . . . . 70.420000000000002 113.741 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.41 -167.96 32.54 Favored Glycine 0 CA--C 1.5 -0.856 0 C-N-CA 118.24 -1.933 . . . . 71.510000000000005 115.242 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 14.6 m -101.54 120.72 40.75 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 123.127 0.571 . . . . 71.430000000000007 110.087 -176.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 64.3 mt -87.52 125.82 41.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.07 0.462 . . . . 53.030000000000001 112.178 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . 0.602 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 90.5 m-20 -85.65 -46.85 10.37 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.959 0.885 . . . . 75.129999999999995 110.084 177.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.556 ' NH2' HD11 ' A' ' 69' ' ' LEU . 49.6 mtp180 -158.7 165.73 33.67 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.613 -1.625 . . . . 65.409999999999997 106.613 -172.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.471 HD11 ' HB3' ' B' ' 50' ' ' ALA . 23.2 pt -146.08 142.09 21.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.142 -1.059 . . . . 74.519999999999996 108.142 175.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 91.5 m -125.31 125.73 43.96 Favored 'General case' 0 C--N 1.272 -2.784 0 N-CA-C 107.351 -1.351 . . . . 72.109999999999999 107.351 -178.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mp -120.4 116.69 50.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 105.162 -2.162 . . . . 74.340000000000003 105.162 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.433 HD11 ' NH2' ' A' ' 65' ' ' ARG 0.256 1.0 OUTLIER -121.36 129.86 53.29 Favored 'General case' 0 C--N 1.277 -2.577 0 C-N-CA 120.308 -0.557 . . . . 73.129999999999995 112.106 -178.935 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' CYS . . . . . 0.576 ' SG ' ' HA ' ' B' ' 46' ' ' TYR . 63.1 m -118.02 131.7 56.45 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 115.484 -0.78 . . . . 55.420000000000002 109.446 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 4.5 p-10 -113.5 137.83 51.0 Favored 'General case' 0 CA--C 1.492 -1.282 0 C-N-CA 119.681 -0.808 . . . . 72.319999999999993 109.696 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -120.16 12.44 11.85 Favored 'General case' 0 N--CA 1.423 -1.81 0 C-N-CA 119.69 -0.804 . . . . 73.519999999999996 108.97 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -69.79 -22.33 63.33 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 108.48 -0.933 . . . . 74.299999999999997 108.48 176.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 40.3 m -75.71 4.27 8.15 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 114.809 -1.087 . . . . 55.210000000000001 110.367 175.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.12 -52.99 4.8 Favored Glycine 0 CA--C 1.496 -1.116 0 N-CA-C 110.5 -1.04 . . . . 65.340000000000003 110.5 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -95.38 122.74 58.71 Favored Pre-proline 0 C--N 1.287 -2.148 0 N-CA-C 106.952 -1.499 . . . . 72.0 106.952 174.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 59.4 Cg_endo -68.37 119.79 6.78 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 122.068 1.846 . . . . 62.450000000000003 111.903 -175.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' LYS . . . . . 0.428 ' HZ3' ' CG ' ' B' ' 71' ' ' ASP . 27.7 mtmm -106.22 162.92 13.23 Favored 'General case' 0 CA--C 1.476 -1.888 0 N-CA-C 108.285 -1.006 . . . . 74.310000000000002 108.285 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -133.97 144.55 16.53 Favored Glycine 0 N--CA 1.407 -3.257 0 C-N-CA 119.498 -1.334 . . . . 64.310000000000002 112.14 175.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -148.68 143.28 26.37 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.622 -0.881 . . . . 75.030000000000001 108.622 172.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.79 144.55 51.53 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 120.851 0.358 . . . . 44.130000000000003 110.734 -172.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' TYR . . . . . 0.463 ' HA ' ' O ' ' B' ' 39' ' ' VAL . 72.6 m-85 -115.31 115.65 26.99 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 115.852 -0.613 . . . . 70.5 109.455 176.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.4 HG21 HG22 ' B' ' 66' ' ' ILE . 33.1 mm -100.37 118.52 47.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 107.425 -1.324 . . . . 70.230000000000004 107.425 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' GLU . . . . . 0.419 ' OE1' ' HD3' ' B' ' 65' ' ' ARG . 46.5 mt-10 -95.6 119.21 33.7 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.667 -0.413 . . . . 72.349999999999994 110.331 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -97.4 153.71 17.93 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.005 0.431 . . . . 71.120000000000005 110.855 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.417 ' HA ' HD22 ' B' ' 64' ' ' ASN . . . -61.14 -30.31 70.31 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.492 -0.776 . . . . 73.019999999999996 112.046 177.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -131.27 157.82 42.27 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.477 0.656 . . . . 74.209999999999994 112.3 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.578 ' O ' HG23 ' B' ' 91' ' ' VAL . 19.8 mmm180 -68.29 -33.36 74.2 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.535 -1.212 . . . . 74.310000000000002 109.941 172.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -65.26 -28.6 69.46 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.312 -0.404 . . . . 73.120000000000005 111.461 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 39.9 m -68.77 -37.23 79.18 Favored 'General case' 0 N--CA 1.433 -1.298 0 O-C-N 122.273 -0.267 . . . . 75.040000000000006 110.36 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . 0.578 HG23 ' O ' ' B' ' 88' ' ' ARG . 3.6 m -65.89 -38.48 82.25 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 N-CA-C 108.894 -0.78 . . . . 72.409999999999997 108.894 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -62.76 -35.83 81.1 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.549 0.74 . . . . 73.340000000000003 109.424 -177.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.38 -37.8 63.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.762 -0.654 . . . . 65.310000000000002 110.858 177.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.0 -45.23 61.72 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.951 -0.568 . . . . 51.32 111.659 -176.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . 0.48 HG13 ' O ' ' B' ' 91' ' ' VAL . 25.5 m -54.53 -21.86 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 113.191 0.812 . . . . 63.329999999999998 113.191 178.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.97 -12.42 61.64 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.107 0.48 . . . . 63.25 110.862 177.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 60.6 mtm -100.03 9.72 42.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.171 -0.468 . . . . 54.200000000000003 110.707 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -46.91 -34.5 5.52 Favored 'General case' 0 C--O 1.201 -1.483 0 N-CA-C 115.549 1.685 . . . . 70.319999999999993 115.549 -177.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -100.52 29.62 4.34 Favored 'General case' 0 CA--C 1.58 2.104 0 CA-C-N 119.81 1.187 . . . . 74.319999999999993 111.941 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 43.4 p -88.95 160.17 17.28 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.259 -0.9 . . . . 73.140000000000001 111.815 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' B' ' 106' ' ' THR . 14.9 p -97.16 139.61 19.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.465 -0.569 . . . . 74.209999999999994 109.465 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -138.92 122.84 17.76 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 109.185 -0.672 . . . . 73.209999999999994 109.185 -176.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 62.5 ttp85 54.44 32.51 16.8 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 125.279 1.431 . . . . 74.319999999999993 111.292 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.81 -7.6 63.1 Favored Glycine 0 C--N 1.305 -1.166 0 CA-C-N 115.035 -0.984 . . . . 41.210000000000001 114.741 175.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -132.8 153.58 51.12 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 117.862 0.831 . . . . 74.230000000000004 110.218 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 106' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' B' ' 101' ' ' VAL . 56.8 m -77.89 126.46 30.88 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 120.595 0.236 . . . . 54.100000000000001 111.015 -174.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 2.4 pp -102.83 172.58 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 120.456 -0.497 . . . . 71.040000000000006 111.202 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 108' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 56.7 tptt -129.58 132.71 46.86 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.67 -0.863 . . . . 65.140000000000001 108.67 -178.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' B' ' 40' ' ' TYR 0.276 6.2 p -127.4 126.94 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-O 121.638 0.732 . . . . 72.439999999999998 110.277 175.333 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.321 0.3 OUTLIER -143.1 137.08 14.51 Favored Pre-proline 0 C--N 1.285 -2.202 0 N-CA-C 105.916 -1.883 . . . . 72.450000000000003 105.916 -168.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.2 136.75 22.65 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 121.775 1.65 . . . . 74.549999999999997 112.862 -177.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.488 ' HZ2' ' CG ' ' B' ' 35' ' ' ASP . 59.3 tttm . . . . . 0 N--CA 1.432 -1.366 0 CA-C-N 115.641 -0.709 . . . . 73.430000000000007 110.28 -176.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 N--CA 1.437 -1.109 0 CA-C-O 120.46 0.172 . . . . 73.450000000000003 111.072 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 20.4 pt -71.35 -37.95 67.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 112.386 0.513 . . . . 72.450000000000003 112.386 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.23 -32.2 73.75 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.931 0.492 . . . . 75.420000000000002 111.489 -177.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -56.73 -26.2 56.51 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.461 0.648 . . . . 73.120000000000005 111.206 177.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 -115.9 15.79 16.24 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-N 115.871 -0.604 . . . . 75.239999999999995 111.258 -172.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.564 ' OG ' ' HE2' ' A' ' 112' ' ' LYS . 10.3 t -95.66 143.95 26.5 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 121.569 0.7 . . . . 74.439999999999998 110.168 -177.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.452 HG23 ' CG2' ' A' ' 91' ' ' VAL . 13.7 t -127.36 148.42 32.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 115.663 -0.698 . . . . 74.420000000000002 109.459 -175.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.663 ' CZ ' ' HG3' ' B' ' 22' ' ' PRO . 35.7 t80 -96.32 124.86 40.47 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.907 -1.145 . . . . 64.209999999999994 107.907 169.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.1 t -118.51 112.18 37.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.438 -1.319 . . . . 54.539999999999999 107.438 174.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.66 164.04 12.65 Favored Glycine 0 C--N 1.289 -2.066 0 C-N-CA 119.637 -1.268 . . . . 75.540000000000006 113.836 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.478 HD22 ' HB2' ' A' ' 105' ' ' ARG . 12.3 t30 55.79 32.28 19.22 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.487 1.515 . . . . 71.310000000000002 112.905 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.0 p -55.92 132.48 19.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 121.479 0.657 . . . . 64.409999999999997 109.564 172.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -69.33 140.96 54.36 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 114.994 -1.003 . . . . 72.319999999999993 108.852 -174.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.51 ' CD2' ' HB2' ' A' ' 77' ' ' PRO . 0.7 OUTLIER -74.95 93.82 2.74 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 108.33 -0.989 . . . . 55.020000000000003 108.33 -179.52 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.76 -20.73 1.15 Allowed Glycine 0 N--CA 1.414 -2.821 0 N-CA-C 109.037 -1.625 . . . . 74.209999999999994 109.037 -174.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.509 ' OG ' ' HD3' ' A' ' 103' ' ' ARG . 73.1 m -91.89 78.52 5.36 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-O 121.951 0.881 . . . . 73.319999999999993 109.614 177.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.443 HG23 ' HB ' ' B' ' 49' ' ' THR . 51.5 p -65.39 -178.03 0.47 Allowed 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 114.429 -1.259 . . . . 64.239999999999995 113.15 177.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.492 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -51.22 -48.5 62.04 Favored 'General case' 0 C--O 1.202 -1.404 0 CA-C-N 115.12 -0.946 . . . . 61.549999999999997 112.152 -173.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -60.45 -38.81 85.36 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.711 0.634 . . . . 75.319999999999993 112.711 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -39.89 95.1 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 107.657 -1.238 . . . . 65.420000000000002 107.657 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.5 mt -71.97 -43.31 65.35 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 113.934 -1.484 . . . . 74.310000000000002 111.43 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 51.0 mt-10 -57.62 -48.93 78.08 Favored 'General case' 0 C--O 1.181 -2.509 0 CA-C-O 119.396 -0.335 . . . . 73.420000000000002 110.848 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.93 -48.28 80.37 Favored 'General case' 0 C--O 1.264 1.862 0 CA-C-O 121.341 0.591 . . . . 64.510000000000005 111.356 -177.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -66.33 -38.88 88.7 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.324 -0.853 . . . . 74.450000000000003 110.95 -176.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -81.37 -22.39 38.4 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 113.793 1.035 . . . . 72.519999999999996 113.793 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.8 t -68.74 -25.42 64.73 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.679 -0.86 . . . . 71.230000000000004 108.679 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.6 m -62.01 -28.51 69.63 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 116.026 -0.534 . . . . 73.230000000000004 110.004 174.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 61.1 m -95.68 0.27 52.43 Favored 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 112.917 0.71 . . . . 54.439999999999998 112.917 178.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.37 -159.32 28.07 Favored Glycine 0 C--O 1.22 -0.745 0 C-N-CA 118.865 -1.636 . . . . 62.039999999999999 115.424 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.9 m -112.85 127.95 56.32 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 122.523 0.329 . . . . 53.43 110.899 -175.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.475 ' CD1' ' HA ' ' A' ' 54' ' ' GLU . 75.3 mt -89.14 134.15 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 N-CA-C 113.186 0.81 . . . . 74.209999999999994 113.186 -177.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -101.54 -44.41 5.6 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.537 1.135 . . . . 54.240000000000002 111.869 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.481 ' HG3' ' HB2' ' B' ' 73' ' ' PHE . 26.7 mtp180 -145.15 152.82 40.63 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 108.266 -1.012 . . . . 63.43 108.266 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.411 HG12 HD11 ' A' ' 68' ' ' ILE . 1.1 tt -149.03 132.47 7.64 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-N 115.782 -0.644 . . . . 73.019999999999996 109.895 177.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.3 m -124.73 129.17 49.97 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.136 -1.431 . . . . 73.430000000000007 107.136 -176.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.411 HD11 HG12 ' A' ' 66' ' ' ILE . 1.8 mp -128.18 119.93 52.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 106.384 -1.71 . . . . 73.200000000000003 106.384 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.573 ' HG ' ' CE1' ' A' ' 80' ' ' TYR 0.352 1.0 OUTLIER -120.75 130.99 54.26 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 119.672 -0.811 . . . . 75.329999999999998 112.13 176.344 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.508 ' HB2' HG23 ' B' ' 66' ' ' ILE . 66.4 m -113.43 118.64 35.09 Favored 'General case' 0 N--CA 1.411 -2.402 0 C-N-CA 124.461 1.105 . . . . 72.430000000000007 108.754 -176.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' B' ' 65' ' ' ARG . 9.5 t0 -116.23 118.23 32.22 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 122.77 0.428 . . . . 73.5 109.968 -176.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 39.0 ttmt -114.65 16.48 17.51 Favored 'General case' 0 C--N 1.274 -2.686 0 C-N-CA 123.646 0.778 . . . . 61.210000000000001 110.632 -174.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -63.07 -23.7 67.57 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 119.481 -0.888 . . . . 73.129999999999995 112.773 -176.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.0 t -92.39 11.5 25.87 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.396 0.617 . . . . 75.340000000000003 110.831 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.18 -52.66 1.62 Allowed Glycine 0 CA--C 1.5 -0.888 0 C-N-CA 120.474 -0.87 . . . . 65.150000000000006 111.319 178.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -89.98 126.88 55.84 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 107.748 -1.205 . . . . 61.130000000000003 107.748 175.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.51 ' HB2' ' CD2' ' A' ' 46' ' ' TYR . 73.4 Cg_endo -72.58 118.71 5.71 Favored 'Trans proline' 0 N--CA 1.436 -1.878 0 C-N-CA 121.586 1.524 . . . . 72.549999999999997 112.225 -176.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -89.78 173.15 8.42 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 114.842 -1.072 . . . . 73.349999999999994 109.175 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.15 137.52 4.83 Favored Glycine 1 N--CA 1.386 -4.667 0 C-N-CA 120.361 -0.923 . . . . 37.770000000000003 111.106 -178.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.573 ' CE1' ' HG ' ' A' ' 69' ' ' LEU 0.263 0.0 OUTLIER -150.49 143.53 24.79 Favored 'General case' 0 C--N 1.273 -2.74 0 CA-C-N 114.906 -0.647 . . . . 74.310000000000002 110.032 173.642 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.45 147.56 52.56 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.68 -0.691 . . . . 65.129999999999995 109.568 -173.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -122.66 119.15 29.9 Favored 'General case' 0 C--N 1.273 -2.733 0 N-CA-C 108.198 -1.038 . . . . 73.010000000000005 108.198 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.6 mm -108.93 136.0 46.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 107.775 -1.194 . . . . 70.349999999999994 107.775 -175.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.429 ' OE2' ' HD3' ' A' ' 65' ' ' ARG . 41.7 mt-10 -113.82 124.88 53.31 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.098 -0.704 . . . . 74.120000000000005 109.098 176.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -97.11 164.25 12.58 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 111.806 0.298 . . . . 74.120000000000005 111.806 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.69 -41.98 59.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.234 0.54 . . . . 61.509999999999998 110.659 174.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.43 ' HB3' ' ND2' ' A' ' 89' ' ' ASN . 27.9 mm-40 -101.6 144.56 30.19 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.298 0.57 . . . . 54.399999999999999 112.134 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.453 ' O ' HG12 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -74.77 -25.4 59.05 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.178 -1.416 . . . . 75.430000000000007 107.178 179.397 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.43 ' ND2' ' HB3' ' A' ' 87' ' ' GLU . 9.0 p30 -72.43 -20.96 61.32 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.266 -0.574 . . . . 72.430000000000007 111.085 178.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 m -71.58 -39.89 70.29 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 122.208 -0.307 . . . . 54.119999999999997 110.561 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.498 ' O ' HG13 ' A' ' 95' ' ' VAL . 2.8 p -67.52 -39.38 82.32 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 C-N-CA 120.295 -0.562 . . . . 52.420000000000002 109.88 178.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -61.84 -32.5 72.83 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.766 -0.652 . . . . 75.129999999999995 110.149 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.89 -35.23 64.67 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.209 -0.451 . . . . 60.420000000000002 111.255 176.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.29 -38.09 56.62 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 116.216 -0.447 . . . . 73.140000000000001 111.239 -175.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.498 HG13 ' O ' ' A' ' 91' ' ' VAL . 14.4 m -56.84 -21.76 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 114.043 1.127 . . . . 73.099999999999994 114.043 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.49 -11.57 60.94 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.934 0.873 . . . . 62.130000000000003 110.385 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 7.1 ttp -101.25 5.36 42.47 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.855 -1.066 . . . . 70.209999999999994 108.546 -176.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.535 ' HA ' HG21 ' A' ' 109' ' ' VAL . 1.3 p-10 -37.7 -42.11 0.54 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.799 1.407 . . . . 72.099999999999994 114.799 -177.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -117.42 104.53 11.19 Favored 'General case' 0 N--CA 1.408 -2.539 0 CA-C-O 121.841 0.829 . . . . 72.129999999999995 109.777 174.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.5 t -147.49 165.2 31.0 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 114.01 -1.45 . . . . 72.299999999999997 108.451 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.7 110.58 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-O 122.244 1.021 . . . . 73.030000000000001 109.551 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -107.31 123.58 48.54 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.792 -1.094 . . . . 62.5 109.416 -173.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.509 ' HD3' ' OG ' ' A' ' 48' ' ' SER . 42.8 mtp-105 44.5 31.34 0.59 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.287 1.435 . . . . 75.430000000000007 114.632 -176.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 104.23 -4.34 44.5 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 114.984 -1.007 . . . . 74.129999999999995 113.342 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.478 ' HB2' HD22 ' A' ' 43' ' ' ASN . 1.3 ptp180 -130.02 139.97 50.94 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 113.182 0.808 . . . . 70.239999999999995 113.182 176.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 31.9 m -72.05 122.61 21.21 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.439 -0.801 . . . . 74.310000000000002 111.088 -177.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 43.6 pt -102.53 170.74 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 120.844 0.354 . . . . 70.010000000000005 110.765 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 27.0 mmmt -127.01 122.86 35.67 Favored 'General case' 0 CA--C 1.486 -1.487 0 C-N-CA 124.159 0.984 . . . . 74.530000000000001 109.632 176.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 32.9 m -128.31 115.95 40.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-O 121.048 0.451 . . . . 60.43 109.89 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.15 160.13 43.79 Favored Pre-proline 0 C--N 1.289 -2.064 0 N-CA-C 108.758 -0.83 . . . . 64.019999999999996 108.758 -177.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.438 ' HD3' HG12 ' A' ' 95' ' ' VAL . 72.0 Cg_endo -80.43 139.94 13.23 Favored 'Trans proline' 0 N--CA 1.436 -1.884 0 C-N-CA 121.118 1.212 . . . . 64.209999999999994 111.335 -173.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.564 ' HE2' ' OG ' ' A' ' 38' ' ' SER . 33.3 mtmt . . . . . 0 N--CA 1.406 -2.651 0 N-CA-C 106.533 -1.655 . . . . 65.329999999999998 106.533 175.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.365 0 CA-C-O 120.196 -0.224 . . . . 37.770000000000003 113.162 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.663 ' HG3' ' CZ ' ' A' ' 40' ' ' TYR . 6.6 Cg_endo -43.1 -55.55 2.75 Favored 'Trans proline' 0 CA--C 1.6 3.801 0 C-N-CA 124.657 3.571 . . . . 75.430000000000007 115.607 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.455 ' HD3' ' HG2' ' B' ' 22' ' ' PRO . 19.8 Cg_endo -91.4 167.5 3.45 Favored 'Trans proline' 0 C--N 1.364 1.358 0 C-N-CA 122.498 2.132 . . . . 72.230000000000004 111.729 177.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -124.96 155.52 70.43 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-O 118.991 -0.528 . . . . 74.349999999999994 110.372 176.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -27.82 115.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.167 1 C-N-CA 125.967 4.445 . . . . 45.43 116.623 -176.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.486 ' H ' HD13 ' B' ' 26' ' ' LEU . 0.0 OUTLIER -78.12 172.04 14.14 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.302 -1.317 . . . . 63.020000000000003 112.174 175.728 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 19.6 m -69.19 147.81 50.78 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 113.798 1.036 . . . . 73.030000000000001 113.798 -175.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.706 ' O ' ' HG2' ' B' ' 32' ' ' LYS . . . -53.74 -46.68 70.93 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 114.992 -1.004 . . . . 72.349999999999994 110.458 174.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.548 ' HA ' ' CG ' ' B' ' 32' ' ' LYS . 68.5 mm-40 -68.95 -29.41 67.64 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 112.988 0.736 . . . . 72.109999999999999 112.988 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.507 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.4 OUTLIER -61.39 -37.61 84.04 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.502 -0.479 . . . . 64.109999999999999 110.608 172.116 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -63.12 -50.26 71.15 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 107.651 -1.241 . . . . 73.420000000000002 107.651 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.706 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 10.4 mmmm -52.06 -47.05 65.33 Favored 'General case' 0 C--O 1.214 -0.771 0 C-N-CA 124.459 1.103 . . . . 73.129999999999995 110.764 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -66.3 -49.87 65.57 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 114.005 1.113 . . . . 74.400000000000006 114.005 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.507 HG12 ' O ' ' B' ' 30' ' ' GLU . 28.6 pt -70.52 -36.17 64.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 111.969 0.359 . . . . 71.129999999999995 111.969 -174.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -63.04 -36.37 83.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.809 -0.632 . . . . 72.120000000000005 111.449 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.647 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 98.5 mttt -56.69 -25.26 53.59 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.474 0.654 . . . . 74.129999999999995 110.795 177.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.561 ' HD3' ' O ' ' B' ' 85' ' ' PHE . 70.1 mtt85 -112.37 14.11 20.35 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 115.515 -0.766 . . . . 74.120000000000005 111.857 -172.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 42.4 m -93.89 143.45 26.33 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.474 0.654 . . . . 72.209999999999994 110.946 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.435 HG23 ' CG2' ' B' ' 91' ' ' VAL . 14.7 t -129.85 152.71 37.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.714 -0.847 . . . . 74.209999999999994 108.714 -178.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . 0.622 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 18.9 t80 -105.33 123.42 47.83 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 107.117 -1.438 . . . . 73.230000000000004 107.117 173.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 48.9 t -116.76 111.58 35.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 107.364 -1.347 . . . . 71.319999999999993 107.364 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . 0.447 ' O ' ' HB ' ' B' ' 107' ' ' ILE . . . -112.9 169.7 13.08 Favored Glycine 0 C--N 1.291 -1.941 0 C-N-CA 119.463 -1.351 . . . . 74.319999999999993 114.127 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 64.7 t30 62.98 17.32 9.99 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 126.059 1.743 . . . . 73.230000000000004 113.267 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 p -62.08 131.59 27.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.264 0.554 . . . . 71.400000000000006 109.943 176.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -75.43 156.72 35.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.52 -0.764 . . . . 70.049999999999997 109.067 -176.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -68.92 -18.16 64.07 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-O 121.808 0.813 . . . . 72.129999999999995 109.839 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.18 -12.73 80.37 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 115.559 -0.746 . . . . 37.770000000000003 111.808 178.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 25.1 m -87.23 133.07 33.71 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 108.45 -0.945 . . . . 75.230000000000004 108.45 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' THR . . . . . 0.468 ' H ' ' HB2' ' B' ' 52' ' ' ASP . 63.2 p -111.9 178.87 4.18 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 116.178 -0.464 . . . . 74.109999999999999 111.565 -172.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.425 ' O ' ' HG3' ' B' ' 54' ' ' GLU . . . -63.11 -48.12 79.9 Favored 'General case' 0 C--O 1.2 -1.549 0 N-CA-C 109.954 -0.387 . . . . 71.030000000000001 109.954 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -59.12 -39.59 82.77 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 111.946 0.35 . . . . 75.319999999999993 111.946 176.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.468 ' HB2' ' H ' ' B' ' 49' ' ' THR . 0.8 OUTLIER -55.94 -46.28 78.58 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.818 0.818 . . . . 74.040000000000006 109.765 173.715 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 99.2 mt -68.35 -43.88 76.51 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.369 -1.287 . . . . 72.299999999999997 112.149 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.479 ' HA ' ' CD1' ' B' ' 63' ' ' ILE . 48.3 mt-10 -57.97 -50.11 74.51 Favored 'General case' 0 C--O 1.183 -2.432 0 C-N-CA 120.645 -0.422 . . . . 75.030000000000001 111.061 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.44 -48.1 77.73 Favored 'General case' 0 C--O 1.25 1.081 0 O-C-N 123.554 0.534 . . . . 62.219999999999999 111.643 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -67.3 -37.66 83.72 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.486 -0.779 . . . . 72.109999999999999 110.868 -175.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -82.58 -22.88 34.68 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.647 0.98 . . . . 75.030000000000001 113.647 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 38.9 t -67.78 -27.96 67.19 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.891 -0.781 . . . . 51.009999999999998 108.891 -177.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 21.8 m -60.06 -25.4 65.34 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 115.806 -0.633 . . . . 74.019999999999996 110.673 174.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 77.1 m -102.1 2.97 38.14 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.092 0.775 . . . . 75.019999999999996 113.092 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.66 -167.6 29.82 Favored Glycine 0 N--CA 1.461 0.321 0 C-N-CA 119.058 -1.544 . . . . 72.310000000000002 114.977 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 19.4 t -105.86 127.92 53.43 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-O 120.857 0.36 . . . . 51.450000000000003 110.548 -176.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.479 ' CD1' ' HA ' ' B' ' 54' ' ' GLU . 74.2 mt -87.04 133.51 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 113.519 0.933 . . . . 74.099999999999994 113.519 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 94.2 m-20 -103.88 -35.94 7.98 Favored 'General case' 0 C--O 1.172 -3.022 0 CA-C-N 115.823 -0.626 . . . . 71.299999999999997 111.757 174.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 43.3 mtp180 -149.02 152.29 36.01 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.622 -0.881 . . . . 72.200000000000003 108.622 178.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.508 HG23 ' HB2' ' A' ' 70' ' ' CYS . 0.3 OUTLIER -149.51 131.39 5.65 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.698 0 C-N-CA 124.024 0.93 . . . . 72.129999999999995 109.886 177.231 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' B' ' 81' ' ' ALA . 74.1 m -124.79 128.68 49.11 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 106.964 -1.495 . . . . 75.209999999999994 106.964 -176.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.16 121.76 60.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 106.098 -1.816 . . . . 64.120000000000005 106.098 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.389 1.2 pt? -120.7 132.35 55.03 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 119.311 -0.956 . . . . 73.0 112.64 175.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 63.7 m -114.43 118.19 33.13 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 107.527 -1.286 . . . . 72.230000000000004 107.527 -178.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 8.8 t70 -110.75 115.33 29.37 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 118.788 -1.165 . . . . 64.420000000000002 109.276 -176.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -112.63 3.74 16.82 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.191 -1.411 . . . . 64.439999999999998 107.191 -178.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.481 ' HB2' ' HG3' ' A' ' 65' ' ' ARG . 65.7 t80 -56.96 -21.72 32.47 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 126.551 1.94 . . . . 72.239999999999995 113.755 -178.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 43.4 m -109.84 13.81 23.42 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.014 0.435 . . . . 74.230000000000004 111.005 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.27 -64.85 0.29 Allowed Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.779 -0.724 . . . . 71.299999999999997 112.128 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -96.4 129.63 32.89 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 109.83 -0.433 . . . . 70.019999999999996 109.83 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 84.1 Cg_endo -75.4 118.58 5.22 Favored 'Trans proline' 0 N--CA 1.435 -1.957 0 C-N-CA 121.39 1.393 . . . . 74.219999999999999 112.714 -178.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -94.16 -179.59 4.99 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 125.278 1.431 . . . . 75.439999999999998 109.578 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.35 135.58 3.94 Favored Glycine 0 N--CA 1.403 -3.503 0 C-N-CA 119.177 -1.487 . . . . 63.25 113.407 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . 0.266 0.2 OUTLIER -151.23 145.49 25.42 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 114.616 -0.792 . . . . 75.530000000000001 109.97 172.307 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' B' ' 67' ' ' THR . . . -130.75 148.2 52.5 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.553 -0.748 . . . . 71.340000000000003 110.265 -174.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' TYR . . . . . 0.427 ' CZ ' ' HD1' ' B' ' 40' ' ' TYR . 81.6 m-85 -123.16 116.63 23.75 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.816 -0.809 . . . . 63.329999999999998 108.816 177.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 11.4 mm -107.47 133.9 50.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 107.791 -1.188 . . . . 73.109999999999999 107.791 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' B' ' 37' ' ' ARG . 53.4 mt-10 -112.2 125.31 54.0 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.171 -1.048 . . . . 75.340000000000003 108.171 175.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.561 ' O ' ' HD3' ' B' ' 37' ' ' ARG . 89.4 m-85 -96.54 167.23 11.27 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 112.032 0.382 . . . . 64.400000000000006 112.032 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.424 ' HA ' ' ND2' ' B' ' 64' ' ' ASN . . . -81.92 -37.17 27.2 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.923 -0.58 . . . . 75.310000000000002 110.811 174.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . 0.534 ' HB2' ' OG ' ' B' ' 90' ' ' SER . 6.9 mp0 -98.73 141.84 31.03 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.462 -0.57 . . . . 61.219999999999999 109.462 178.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.42 ' O ' HG12 ' B' ' 91' ' ' VAL . 0.4 OUTLIER -75.25 -26.86 59.17 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 106.762 -1.57 . . . . 72.540000000000006 106.762 177.359 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . 0.433 ' ND2' ' HB3' ' B' ' 87' ' ' GLU . 9.1 p30 -70.97 -21.79 62.28 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.641 -0.709 . . . . 63.119999999999997 111.278 177.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' SER . . . . . 0.534 ' OG ' ' HB2' ' B' ' 87' ' ' GLU . 51.4 m -71.95 -37.19 70.02 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 111.957 0.354 . . . . 73.420000000000002 111.957 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . 0.435 ' CG2' HG23 ' B' ' 39' ' ' VAL . 2.2 p -67.83 -41.24 84.85 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 C-N-CA 119.407 -0.917 . . . . 74.230000000000004 109.489 175.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -59.16 -33.68 71.19 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.994 -0.548 . . . . 72.209999999999994 110.502 178.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.53 -34.24 65.12 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.209 -0.45 . . . . 45.130000000000003 111.848 176.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.86 -39.55 50.71 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-O 120.701 0.286 . . . . 74.510000000000005 111.163 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 19.9 m -56.25 -21.81 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 113.1 0.778 . . . . 74.319999999999993 113.1 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.99 -11.24 60.73 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.567 0.699 . . . . 73.140000000000001 110.819 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 19.9 mtm -93.88 -0.49 55.68 Favored 'General case' 0 C--O 1.175 -2.83 0 CA-C-O 117.872 -1.061 . . . . 75.150000000000006 110.994 175.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . 0.573 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 2.2 p-10 -35.82 -46.27 0.44 Allowed 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 115.372 1.619 . . . . 62.329999999999998 115.372 -168.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -93.63 85.33 4.84 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.052 -1.462 . . . . 73.25 107.052 169.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 100' ' ' THR . . . . . 0.556 ' HB ' ' CG1' ' B' ' 107' ' ' ILE . 1.3 m -95.7 137.72 34.37 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 119.979 -0.688 . . . . 63.530000000000001 109.404 -175.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 3.7 p -99.91 103.81 15.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 107.664 -1.236 . . . . 54.140000000000001 107.664 173.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -134.08 123.68 24.89 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.79 -1.095 . . . . 72.25 109.48 -173.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 58.29 33.48 23.18 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 122.405 1.098 . . . . 55.340000000000003 111.356 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.54 2.4 84.77 Favored Glycine 0 C--N 1.317 -0.475 0 CA-C-N 114.827 -1.079 . . . . 75.219999999999999 112.522 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -109.7 163.57 13.36 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 109.551 -0.537 . . . . 75.329999999999998 109.551 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 106' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' B' ' 100' ' ' THR . 62.0 m -108.36 118.73 37.54 Favored 'General case' 0 N--CA 1.404 -2.755 0 N-CA-C 106.985 -1.487 . . . . 75.5 106.985 172.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . 0.556 ' CG1' ' HB ' ' B' ' 100' ' ' THR . 46.3 pt -103.45 171.61 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 C-N-CA 119.792 -0.763 . . . . 74.430000000000007 109.293 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 108' ' ' LYS . . . . . 0.573 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 26.7 mmmt -125.2 125.62 43.92 Favored 'General case' 0 CA--C 1.479 -1.782 0 O-C-N 123.652 0.595 . . . . 74.420000000000002 110.019 -177.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 33.9 m -128.12 115.78 39.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 123.786 0.679 . . . . 74.219999999999999 109.739 176.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.2 158.56 47.74 Favored Pre-proline 0 C--N 1.294 -1.819 0 N-CA-C 108.762 -0.829 . . . . 73.049999999999997 108.762 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.23 146.43 25.14 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 121.498 1.465 . . . . 74.150000000000006 114.001 -172.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.436 ' HA ' ' HZ3' ' B' ' 112' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.286 -2.162 0 N-CA-C 107.19 -1.411 . . . . 55.200000000000003 107.19 176.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 111.841 0.312 . . . . 72.420000000000002 111.841 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.458 HD11 HG21 ' A' ' 34' ' ' ILE . 29.4 pt -71.07 -33.91 53.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.01 0.433 . . . . 70.409999999999997 111.556 -178.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.85 -34.67 69.97 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.572 1.149 . . . . 73.530000000000001 110.372 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -77.96 -16.46 58.14 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.591 -1.186 . . . . 71.219999999999999 111.035 -177.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -123.89 18.21 9.36 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 114.209 1.189 . . . . 73.010000000000005 114.209 -164.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.532 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 33.0 m -96.2 150.72 20.22 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 120.092 -0.643 . . . . 45.200000000000003 110.365 176.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 83' ' ' ILE . 33.2 m -140.02 164.11 23.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.125 0.488 . . . . 74.319999999999993 110.271 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.702 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 13.3 t80 -110.48 134.86 51.95 Favored 'General case' 0 C--N 1.284 -2.244 0 C-N-CA 124.974 1.31 . . . . 75.109999999999999 108.736 177.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.408 HG23 HG12 ' A' ' 109' ' ' VAL . 61.4 t -121.94 118.18 54.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.499 -1.297 . . . . 74.209999999999994 107.499 174.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.421 ' HA3' ' HH ' ' A' ' 40' ' ' TYR . . . -111.16 166.33 12.26 Favored Glycine 0 C--N 1.286 -2.232 0 C-N-CA 119.276 -1.44 . . . . 73.200000000000003 113.688 -178.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.451 ' ND2' ' HB3' ' A' ' 105' ' ' ARG . 66.3 t30 56.3 27.42 11.83 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 126.137 1.775 . . . . 70.140000000000001 113.558 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.6 p -61.55 138.64 21.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 N-CA-C 108.94 -0.763 . . . . 64.200000000000003 108.94 173.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.62 150.39 39.65 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.419 -0.586 . . . . 75.5 109.419 -173.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.472 ' CD1' ' HB2' ' A' ' 77' ' ' PRO . 78.3 t80 -65.36 -14.2 60.3 Favored 'General case' 0 CA--C 1.558 1.285 0 CA-C-O 121.586 0.708 . . . . 70.340000000000003 110.232 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.53 -7.39 59.15 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 116.003 -0.544 . . . . 73.120000000000005 112.921 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.4 m -80.03 133.97 36.18 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 117.424 0.612 . . . . 75.439999999999998 110.087 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.0 p -97.62 170.71 8.83 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 120.944 -0.303 . . . . 73.230000000000004 111.069 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.457 ' HB3' HD11 ' A' ' 66' ' ' ILE . . . -62.28 -45.22 94.23 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.594 -0.521 . . . . 75.209999999999994 109.594 175.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.82 -44.9 86.72 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.084 0.554 . . . . 64.409999999999997 109.885 176.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -55.91 -43.69 77.54 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.119 0.485 . . . . 54.32 111.55 176.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.3 mt -70.86 -47.55 58.71 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.522 -0.763 . . . . 74.109999999999999 111.71 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.35 -48.0 83.31 Favored 'General case' 0 C--O 1.204 -1.326 0 C-N-CA 123.424 0.69 . . . . 63.549999999999997 110.85 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.35 -42.57 96.01 Favored 'General case' 0 C--O 1.259 1.601 0 CA-C-O 121.523 0.678 . . . . 54.240000000000002 111.151 176.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -64.26 -41.89 96.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.41 -0.813 . . . . 61.350000000000001 110.428 -175.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -81.21 -20.51 40.95 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 113.289 0.848 . . . . 70.420000000000002 113.289 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.0 t -65.85 -26.63 67.74 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.712 -0.676 . . . . 74.140000000000001 109.481 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.4 m -60.19 -33.73 72.63 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-O 121.362 0.601 . . . . 75.319999999999993 110.023 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.427 ' SG ' ' SD ' ' A' ' 97' ' ' MET . 72.6 m -92.97 4.32 54.19 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 113.699 1.0 . . . . 70.140000000000001 113.699 -177.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.44 -169.92 33.39 Favored Glycine 0 CA--C 1.497 -1.053 0 C-N-CA 118.627 -1.749 . . . . 74.099999999999994 114.623 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.9 m -102.64 127.63 49.67 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.295 -0.631 . . . . 74.0 109.295 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.6 mt -95.6 130.05 44.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 113.788 1.033 . . . . 74.450000000000003 113.788 -175.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -91.53 -44.76 8.89 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-N 115.355 -0.839 . . . . 74.209999999999994 110.908 176.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -151.46 159.51 44.16 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 115.324 -0.853 . . . . 74.530000000000001 109.669 -173.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' A' ' 50' ' ' ALA . 28.2 pt -148.34 143.52 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 107.766 -1.198 . . . . 73.420000000000002 107.766 173.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.3 m -126.2 132.21 51.82 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 106.969 -1.493 . . . . 75.219999999999999 106.969 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.453 HD11 ' N ' ' A' ' 68' ' ' ILE . 2.4 mp -127.78 123.34 60.84 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 N-CA-C 106.085 -1.82 . . . . 50.140000000000001 106.085 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.411 ' HB3' ' HA ' ' B' ' 67' ' ' THR 0.345 1.0 OUTLIER -121.17 125.39 47.06 Favored 'General case' 0 C--N 1.273 -2.76 0 C-N-CA 120.073 -0.651 . . . . 72.450000000000003 112.588 175.861 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 81.8 m -116.73 128.61 55.49 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.784 -0.821 . . . . 74.040000000000006 108.784 -177.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.579 ' HA ' ' HA ' ' B' ' 65' ' ' ARG . 2.8 p-10 -121.35 152.14 39.32 Favored 'General case' 0 C--O 1.19 -2.056 0 C-N-CA 119.647 -0.821 . . . . 70.219999999999999 110.554 -177.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -127.06 15.81 7.32 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 108.63 -0.878 . . . . 62.310000000000002 108.63 175.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.405 ' HB3' ' HB3' ' B' ' 64' ' ' ASN . 37.7 p90 -66.84 -20.57 65.96 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 119.864 -0.734 . . . . 65.219999999999999 111.453 -177.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.6 m -86.82 9.16 19.97 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 116.162 -0.472 . . . . 74.549999999999997 110.833 176.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.33 -46.15 3.19 Favored Glycine 0 CA--C 1.501 -0.811 0 N-CA-C 111.084 -0.806 . . . . 52.130000000000003 111.084 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -95.5 129.2 35.52 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 106.779 -1.563 . . . . 71.040000000000006 106.779 176.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 72.2 Cg_endo -72.61 119.27 6.01 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 121.55 1.5 . . . . 61.450000000000003 111.404 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.41 ' HZ3' ' CG ' ' A' ' 71' ' ' ASP . 29.7 mtmm -110.71 -165.61 1.01 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.4 -0.818 . . . . 74.010000000000005 109.589 -176.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.18 148.58 11.31 Favored Glycine 0 N--CA 1.407 -3.267 0 C-N-CA 120.367 -0.92 . . . . 72.230000000000004 113.166 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -149.61 143.53 25.6 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 124.512 1.125 . . . . 75.239999999999995 109.236 172.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.37 156.1 47.25 Favored 'General case' 0 C--O 1.192 -1.959 0 CA-C-O 120.664 0.269 . . . . 64.120000000000005 110.927 -172.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -124.24 124.63 42.85 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.482 -0.562 . . . . 73.299999999999997 109.482 176.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.433 HG22 HG22 ' A' ' 66' ' ' ILE . 29.1 mm -108.94 124.88 65.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 109.224 -0.658 . . . . 74.040000000000006 109.224 -177.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -102.35 119.57 39.03 Favored 'General case' 0 C--O 1.25 1.112 0 N-CA-C 108.605 -0.887 . . . . 72.329999999999998 108.605 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -98.1 157.29 16.23 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.431 0.634 . . . . 73.209999999999994 112.708 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.19 -43.09 83.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.217 -0.902 . . . . 65.25 112.339 176.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -112.89 155.92 23.85 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 121.222 0.534 . . . . 75.439999999999998 111.836 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.478 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -69.91 -35.0 74.23 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.271 -1.011 . . . . 72.340000000000003 108.271 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -21.42 66.84 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 115.759 -0.655 . . . . 50.240000000000002 112.109 -177.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.9 m -68.21 -36.28 79.29 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 109.82 -0.437 . . . . 75.129999999999995 109.82 176.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.515 ' O ' HG13 ' A' ' 95' ' ' VAL . 3.1 m -69.31 -40.03 79.68 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.054 0 N-CA-C 108.97 -0.752 . . . . 74.439999999999998 108.97 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -56.87 -35.95 69.49 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.765 0.793 . . . . 73.120000000000005 110.032 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.34 -36.2 63.64 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.62 -0.718 . . . . 63.310000000000002 111.472 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.45 -42.49 43.71 Favored 'General case' 0 C--O 1.204 -1.309 0 CA-C-N 115.733 -0.667 . . . . 61.549999999999997 111.319 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 91' ' ' VAL . 23.8 m -56.69 -22.45 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 112.756 0.65 . . . . 73.25 112.756 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.34 -9.27 52.61 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.523 0.678 . . . . 38.149999999999999 110.469 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.427 ' SD ' ' SG ' ' A' ' 60' ' ' CYS . 37.8 mtp -105.67 4.52 30.22 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.176 -0.92 . . . . 73.530000000000001 110.405 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 1.6 p-10 -44.54 -36.89 3.21 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 114.884 1.439 . . . . 72.25 114.884 -176.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -115.33 92.29 3.88 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.341 -0.944 . . . . 72.439999999999998 109.537 171.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.9 p -138.45 172.31 13.08 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.263 -1.335 . . . . 55.299999999999997 110.649 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.4 p -119.75 126.28 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-O 121.412 0.625 . . . . 74.109999999999999 110.527 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -128.16 124.03 35.82 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 108.358 -0.978 . . . . 75.140000000000001 108.358 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 49.37 33.15 5.1 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.543 1.537 . . . . 73.450000000000003 111.204 -174.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.78 0.74 87.56 Favored Glycine 0 C--N 1.308 -1.016 0 CA-C-N 115.153 -0.93 . . . . 62.509999999999998 113.39 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.451 ' HB3' ' ND2' ' A' ' 43' ' ' ASN . 58.3 mtt180 -106.6 140.46 39.44 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.395 -0.594 . . . . 71.230000000000004 109.395 175.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.1 m -80.5 119.2 22.86 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.705 -1.22 . . . . 70.230000000000004 107.705 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 38.3 pt -101.49 169.46 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 C-N-CA 120.451 -0.5 . . . . 64.349999999999994 110.527 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 53.9 tptt -134.99 134.2 40.25 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.462 -0.79 . . . . 73.140000000000001 109.67 -177.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.702 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 16.0 m -127.17 126.84 68.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 O-C-N 123.044 0.215 . . . . 74.230000000000004 111.055 174.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . 0.255 0.0 OUTLIER -145.83 144.61 22.63 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 109.2 -0.667 . . . . 74.030000000000001 109.2 176.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -62.82 139.87 76.89 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 123.191 2.594 . . . . 74.239999999999995 113.782 -175.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 38' ' ' SER . 39.7 mtpt . . . . . 0 C--N 1.314 -0.935 0 CA-C-N 115.981 -0.554 . . . . 73.049999999999997 111.761 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.042 0 N-CA-C 115.695 1.038 . . . . 63.140000000000001 115.695 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.611 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 1.6 Cg_endo -40.12 -53.79 2.38 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 125.079 3.852 . . . . 74.109999999999999 114.505 -177.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.432 ' HD3' ' HG2' ' B' ' 22' ' ' PRO . 22.1 Cg_endo -93.17 122.81 0.48 Allowed 'Trans proline' 0 N--CA 1.416 -3.074 0 N-CA-C 108.442 -1.407 . . . . 64.299999999999997 108.442 170.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -69.02 135.8 89.55 Favored Pre-proline 0 C--N 1.313 -1.012 0 C-N-CA 120.145 -0.622 . . . . 72.140000000000001 109.884 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -28.73 104.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.385 2.485 1 C-N-CA 125.354 4.036 . . . . 75.129999999999995 113.57 -174.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.437 ' H ' HD12 ' B' ' 26' ' ' LEU 0.283 0.0 OUTLIER -52.64 153.16 3.28 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 113.333 -1.758 . . . . 64.340000000000003 115.079 -176.954 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.501 ' O ' ' HG3' ' B' ' 31' ' ' LYS . 14.8 m -60.46 163.83 4.94 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 125.687 1.595 . . . . 64.530000000000001 113.35 -177.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.5 75.74 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.021 -0.536 . . . . 73.439999999999998 112.393 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -73.21 -31.07 63.94 Favored 'General case' 0 CA--C 1.49 -1.352 0 CA-C-O 120.974 0.416 . . . . 72.349999999999994 111.851 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.423 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.4 OUTLIER -60.4 -33.92 73.18 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.228 -0.896 . . . . 75.430000000000007 110.457 173.313 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' B' ' 27' ' ' SER . 95.7 mttt -69.58 -51.56 34.18 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.397 -0.594 . . . . 73.329999999999998 109.397 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.44 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 0.7 OUTLIER -53.97 -47.32 71.49 Favored 'General case' 0 C--N 1.359 1.014 0 N-CA-C 113.516 0.932 . . . . 70.340000000000003 113.516 179.474 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 11.2 mm-40 -64.81 -44.39 90.06 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.471 0.545 . . . . 75.329999999999998 112.471 -174.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.473 HD11 HH12 ' B' ' 65' ' ' ARG . 24.3 pt -70.47 -33.33 53.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.196 0.522 . . . . 73.140000000000001 110.793 -178.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -56.92 -38.41 72.83 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.182 1.393 . . . . 73.25 111.311 -177.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 90.0 mttt -75.86 -25.26 56.03 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.639 -1.164 . . . . 72.310000000000002 112.327 -176.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' B' ' 33' ' ' GLU . 20.5 ptt180 -118.72 25.69 10.07 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 114.047 1.129 . . . . 73.519999999999996 114.047 -168.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 37.1 m -96.69 148.44 22.87 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 116.642 -0.254 . . . . 72.239999999999995 111.268 175.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 29.3 m -139.97 165.29 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-O 121.09 0.471 . . . . 72.010000000000005 111.541 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . 0.677 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 9.7 t80 -114.29 132.18 56.26 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 125.68 1.592 . . . . 72.319999999999993 108.721 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 59.1 t -119.51 118.4 57.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 124.568 1.147 . . . . 75.109999999999999 108.124 174.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.38 172.51 14.33 Favored Glycine 0 C--N 1.293 -1.849 0 C-N-CA 119.339 -1.41 . . . . 72.430000000000007 113.387 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 65.7 t30 63.99 8.52 3.99 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 126.211 1.804 . . . . 72.150000000000006 114.597 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.64 126.49 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-O 121.577 0.704 . . . . 74.400000000000006 109.747 175.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.99 156.72 25.78 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.475 -0.784 . . . . 55.439999999999998 111.399 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' TYR . . . . . 0.562 ' CD2' ' HB2' ' B' ' 77' ' ' PRO . 9.4 t80 -75.36 86.3 2.53 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 106.314 -1.735 . . . . 75.329999999999998 106.314 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.83 -27.62 0.07 OUTLIER Glycine 0 N--CA 1.419 -2.481 0 N-CA-C 109.728 -1.349 . . . . 65.0 109.728 -174.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 26.6 t -84.44 148.15 26.72 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 106.749 -1.574 . . . . 74.430000000000007 106.749 173.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 50.5 p -111.74 178.07 4.44 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 110.242 -0.281 . . . . 71.319999999999993 110.242 -177.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.456 ' HB3' HD11 ' B' ' 66' ' ' ILE . . . -62.31 -47.74 82.94 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 110.19 -0.3 . . . . 75.209999999999994 110.19 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -57.48 -44.02 84.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.208 -0.451 . . . . 72.340000000000003 110.534 177.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -60.36 -40.01 89.26 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-O 121.68 0.753 . . . . 63.450000000000003 109.789 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 56.0 mt -72.64 -47.31 48.6 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.086 -0.961 . . . . 73.319999999999993 112.288 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.54 -48.68 80.7 Favored 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 123.269 0.628 . . . . 72.349999999999994 110.727 -178.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.32 -42.77 87.51 Favored 'General case' 0 C--O 1.255 1.347 0 CA-C-O 121.252 0.548 . . . . 72.409999999999997 110.925 176.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -64.14 -41.58 97.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.556 -0.747 . . . . 70.120000000000005 110.496 -176.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.405 ' CZ ' HG13 ' B' ' 109' ' ' VAL 0.268 51.7 m-85 -81.83 -20.77 38.31 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 113.747 1.017 . . . . 73.209999999999994 113.747 178.451 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 33.4 t -66.67 -24.18 66.24 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.537 -0.912 . . . . 72.25 108.537 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 15.6 m -58.94 -31.91 69.12 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 115.934 -0.575 . . . . 61.420000000000002 110.155 172.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 74.7 m -93.89 7.33 45.4 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.973 0.731 . . . . 74.219999999999999 112.973 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.72 -148.51 20.22 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 118.242 -1.933 . . . . 64.209999999999994 115.698 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 15.6 m -110.94 124.48 52.2 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.73 -0.47 . . . . 70.340000000000003 109.73 -176.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 63.8 mt -94.69 130.55 43.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 113.642 0.978 . . . . 65.019999999999996 113.642 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 93.0 m-20 -94.82 -43.55 8.17 Favored 'General case' 0 C--O 1.197 -1.658 0 CA-C-N 115.208 -0.906 . . . . 73.0 110.827 175.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.579 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 67.4 mtt180 -152.45 157.44 41.19 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 109.399 -0.593 . . . . 71.439999999999998 109.399 -175.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.456 HD11 ' HB3' ' B' ' 50' ' ' ALA . 23.2 pt -147.3 142.87 20.11 Favored 'Isoleucine or valine' 0 C--O 1.191 -2.002 0 N-CA-C 106.77 -1.567 . . . . 73.329999999999998 106.77 173.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' THR . . . . . 0.411 ' HA ' ' HB3' ' A' ' 69' ' ' LEU . 61.8 m -126.4 131.64 51.69 Favored 'General case' 0 C--N 1.272 -2.769 0 N-CA-C 106.914 -1.513 . . . . 74.019999999999996 106.914 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 3.0 mp -127.25 120.54 55.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 106.697 -1.594 . . . . 65.099999999999994 106.697 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.282 1.1 pt? -120.49 127.75 52.5 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 120.065 -0.654 . . . . 50.549999999999997 111.62 177.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 80.1 m -116.91 130.23 56.57 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.217 -0.902 . . . . 63.210000000000001 109.342 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . 0.66 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 4.0 p30 -111.57 127.76 55.83 Favored 'General case' 0 C--O 1.216 -0.682 0 C-N-CA 119.497 -0.881 . . . . 72.349999999999994 110.488 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' B' ' 72' ' ' LYS . 33.2 ttmt -123.45 4.4 9.04 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.193 0.52 . . . . 71.230000000000004 109.931 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.459 ' CE2' ' HB2' ' B' ' 71' ' ' ASP . 53.3 p90 -64.04 -6.97 7.22 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 113.831 1.049 . . . . 70.299999999999997 113.831 -174.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 42.8 m -106.56 6.38 29.99 Favored 'General case' 0 C--N 1.313 -1.009 0 O-C-N 121.782 -0.574 . . . . 73.219999999999999 111.24 175.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.6 -61.86 0.3 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.835 -0.698 . . . . 70.209999999999994 111.745 -178.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -96.26 129.65 33.06 Favored Pre-proline 0 C--N 1.305 -1.337 0 N-CA-C 109.757 -0.46 . . . . 75.129999999999995 109.757 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.66 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 96.2 Cg_endo -79.32 126.69 7.03 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.639 2.226 . . . . 63.450000000000003 113.561 -177.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -107.35 -167.7 1.3 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.897 -1.149 . . . . 73.030000000000001 107.897 176.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.54 147.74 11.7 Favored Glycine 0 N--CA 1.415 -2.758 0 C-N-CA 119.791 -1.195 . . . . 44.25 113.576 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -151.64 144.79 24.62 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 124.502 1.121 . . . . 73.239999999999995 108.81 172.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -134.05 155.21 50.42 Favored 'General case' 0 C--O 1.194 -1.863 0 CA-C-O 120.681 0.277 . . . . 63.020000000000003 111.199 -172.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' TYR . . . . . 0.408 ' CD2' ' HD3' ' B' ' 112' ' ' LYS . 51.7 m-85 -124.32 124.09 41.63 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.279 -0.637 . . . . 61.340000000000003 109.279 176.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.452 HG22 HG22 ' B' ' 66' ' ' ILE . 30.4 mm -107.9 124.79 64.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 109.038 -0.727 . . . . 71.239999999999995 109.038 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -103.57 119.4 38.82 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.739 -1.208 . . . . 72.409999999999997 107.739 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -94.89 162.73 13.63 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 110.331 -0.248 . . . . 75.310000000000002 110.331 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.479 ' HA ' ' ND2' ' B' ' 64' ' ' ASN . . . -83.63 -21.24 32.57 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.101 0.477 . . . . 44.420000000000002 111.343 175.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . 0.449 ' HB2' ' OG ' ' B' ' 90' ' ' SER . 27.9 mt-10 -119.39 145.23 46.39 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 116.187 -0.46 . . . . 73.409999999999997 109.763 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.452 ' O ' HG22 ' B' ' 91' ' ' VAL . 0.5 OUTLIER -72.03 -34.29 68.68 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 107.203 -1.406 . . . . 71.310000000000002 107.203 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -59.31 -32.17 69.82 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.719 -1.128 . . . . 75.519999999999996 108.996 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' SER . . . . . 0.449 ' OG ' ' HB2' ' B' ' 87' ' ' GLU . 23.3 m -63.46 -35.94 82.11 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.757 -0.656 . . . . 75.409999999999997 110.955 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . 0.538 ' O ' HG13 ' B' ' 95' ' ' VAL . 3.1 m -69.35 -39.41 78.87 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.192 0 C-N-CA 119.302 -0.959 . . . . 73.109999999999999 108.678 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -57.72 -37.75 74.07 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.082 0.468 . . . . 73.299999999999997 110.811 176.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.46 -34.06 65.18 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.936 -0.575 . . . . 71.430000000000007 110.437 178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.6 -44.65 33.48 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 116.785 -0.189 . . . . 60.030000000000001 111.154 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . 0.538 HG13 ' O ' ' B' ' 91' ' ' VAL . 22.0 m -56.65 -22.85 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 112.68 0.622 . . . . 73.430000000000007 112.68 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.1 -9.33 45.5 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.349 0.595 . . . . 75.239999999999995 110.651 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 56.5 mtm -104.69 10.2 34.83 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.757 -0.656 . . . . 74.150000000000006 110.984 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . 0.264 4.1 p-10 -44.46 -44.95 8.88 Favored 'General case' 0 C--O 1.204 -1.298 0 N-CA-C 114.91 1.448 . . . . 72.140000000000001 114.91 -176.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -110.84 71.38 0.74 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-N 119.822 1.192 . . . . 74.420000000000002 112.146 167.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 47.4 p -115.84 168.43 10.06 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.115 -0.493 . . . . 73.310000000000002 111.771 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 9.6 p -100.64 136.42 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-O 121.41 0.624 . . . . 74.239999999999995 109.52 -177.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -132.39 109.91 10.18 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 107.961 -1.126 . . . . 62.229999999999997 107.961 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 49.53 32.21 4.68 Favored 'General case' 0 CA--C 1.563 1.46 0 C-N-CA 125.4 1.48 . . . . 65.219999999999999 112.628 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.22 -9.58 39.2 Favored Glycine 0 C--N 1.318 -0.428 0 C-N-CA 120.674 -0.774 . . . . 38.149999999999999 113.741 174.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -116.4 151.85 35.14 Favored 'General case' 0 C--O 1.206 -1.215 0 CA-C-N 117.135 0.467 . . . . 53.340000000000003 109.883 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 92.9 m -86.87 120.14 27.84 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.835 -1.172 . . . . 75.120000000000005 107.835 174.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 2.6 pp -102.13 166.74 2.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 119.691 -0.804 . . . . 62.439999999999998 110.267 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 108' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 54.3 tptt -125.37 132.99 52.7 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.734 -0.469 . . . . 72.510000000000005 109.734 -172.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . 0.677 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 15.7 m -127.0 128.79 70.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.277 0.56 . . . . 65.150000000000006 111.301 176.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.333 0.4 OUTLIER -147.01 133.43 9.71 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 106.279 -1.749 . . . . 63.310000000000002 106.279 -169.802 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.5 141.78 87.81 Favored 'Trans proline' 0 N--CA 1.486 1.038 0 C-N-CA 122.504 2.136 . . . . 64.439999999999998 113.068 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.408 ' HD3' ' CD2' ' B' ' 82' ' ' TYR . 22.6 ttpp . . . . . 0 N--CA 1.431 -1.407 0 N-CA-C 109.138 -0.69 . . . . 65.439999999999998 109.138 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 N--CA 1.44 -0.972 0 N-CA-C 113.759 1.022 . . . . 73.209999999999994 113.759 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.4 pt -63.06 -33.69 62.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.641 -0.424 . . . . 74.200000000000003 110.511 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.44 -38.45 81.15 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 108.949 -0.76 . . . . 62.340000000000003 108.949 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -66.01 -42.0 90.28 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 114.468 1.284 . . . . 55.420000000000002 114.468 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.626 ' HG3' ' O ' ' A' ' 85' ' ' PHE . 3.4 ptm180 -102.85 19.18 19.82 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 111.797 0.295 . . . . 75.400000000000006 111.797 -169.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.9 p -110.52 167.12 10.45 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.658 0.985 . . . . 37.490000000000002 113.658 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.7 m -140.3 164.95 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.277 1.031 . . . . 74.340000000000003 112.023 -177.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.635 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 27.9 t80 -109.89 127.03 54.47 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 124.882 1.273 . . . . 72.25 108.469 176.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.7 t -115.58 112.01 38.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 107.812 -1.181 . . . . 75.409999999999997 107.812 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.42 ' HA3' ' CZ ' ' A' ' 40' ' ' TYR . . . -121.62 -177.34 15.48 Favored Glycine 0 N--CA 1.435 -1.385 0 C-N-CA 119.556 -1.307 . . . . 73.319999999999993 114.738 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.3 t30 72.7 -7.35 1.45 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.062 2.145 . . . . 73.230000000000004 112.475 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.78 103.55 4.13 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.929 0 CA-C-O 121.488 0.661 . . . . 63.109999999999999 109.866 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -81.06 83.57 6.71 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 114.162 1.171 . . . . 72.209999999999994 114.162 -168.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.466 ' CD1' ' HB2' ' A' ' 77' ' ' PRO . 63.6 t80 68.22 -20.52 0.14 Allowed 'General case' 0 CA--C 1.577 1.989 0 N-CA-C 115.526 1.676 . . . . 73.120000000000005 115.526 163.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.27 5.35 45.15 Favored Glycine 0 C--O 1.241 0.577 0 N-CA-C 116.912 1.525 . . . . 51.020000000000003 116.912 -169.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.417 ' HG ' ' HG ' ' A' ' 53' ' ' LEU . 14.2 t -87.65 147.74 25.12 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 119.318 1.559 . . . . 73.329999999999998 109.885 176.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.408 HG21 HG22 ' B' ' 49' ' ' THR . 82.6 p -97.37 158.92 15.22 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.007 -0.542 . . . . 71.329999999999998 111.207 -176.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.425 ' HB3' HD11 ' A' ' 66' ' ' ILE . . . -65.16 -48.25 74.19 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 122.557 0.343 . . . . 54.310000000000002 110.835 -177.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.01 -40.3 80.46 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.333 0.494 . . . . 72.329999999999998 112.333 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.9 -38.06 76.18 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.216 0.531 . . . . 72.120000000000005 110.515 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.417 ' HG ' ' HG ' ' A' ' 48' ' ' SER . 40.2 mt -68.77 -47.2 66.82 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.381 -0.827 . . . . 64.25 111.209 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -61.92 -48.19 81.54 Favored 'General case' 0 C--O 1.202 -1.433 0 CA-C-N 115.755 -0.657 . . . . 72.239999999999995 110.875 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.65 -43.99 80.86 Favored 'General case' 0 C--O 1.26 1.609 0 CA-C-O 121.789 0.804 . . . . 52.439999999999998 111.256 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -64.77 -38.51 91.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.667 -1.152 . . . . 74.439999999999998 110.355 -176.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -82.33 -21.64 35.94 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.496 0.925 . . . . 74.5 113.496 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.7 t -70.63 -23.88 62.61 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.845 -0.616 . . . . 74.409999999999997 109.78 -176.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.8 m -59.97 -27.27 66.69 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-O 121.055 0.455 . . . . 75.200000000000003 110.36 173.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 62.7 m -92.66 7.93 41.32 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 112.568 0.581 . . . . 73.019999999999996 112.568 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.67 -169.82 25.04 Favored Glycine 0 CA--C 1.505 -0.538 0 C-N-CA 119.559 -1.305 . . . . 74.340000000000003 113.28 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.1 m -96.08 126.44 41.32 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 121.614 0.721 . . . . 71.140000000000001 110.156 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.5 mt -85.02 134.38 27.16 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.398 0 CA-C-N 114.938 -1.028 . . . . 75.310000000000002 112.462 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.432 ' OD1' ' HB3' ' B' ' 73' ' ' PHE . 50.9 t-20 -89.72 -54.24 4.15 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.633 -1.167 . . . . 73.439999999999998 108.51 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.423 ' HG3' ' OD1' ' A' ' 64' ' ' ASN . 66.0 mtp180 -154.34 164.17 39.02 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 106.624 -1.621 . . . . 74.239999999999995 106.624 -176.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.443 HG13 HD11 ' A' ' 68' ' ' ILE . 31.4 pt -143.59 142.59 24.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 107.166 -1.42 . . . . 73.310000000000002 107.166 172.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.7 m -124.81 125.14 43.54 Favored 'General case' 0 C--N 1.273 -2.726 0 N-CA-C 107.912 -1.144 . . . . 63.140000000000001 107.912 -177.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.443 HD11 HG13 ' A' ' 66' ' ' ILE . 3.0 mp -123.57 116.39 48.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 106.139 -1.8 . . . . 74.219999999999999 106.139 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.465 ' HG ' ' CE1' ' A' ' 80' ' ' TYR 0.286 0.8 OUTLIER -121.43 128.79 52.53 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 120.376 -0.53 . . . . 62.439999999999998 112.372 179.525 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 74.3 m -117.48 130.61 56.56 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 109.031 -0.729 . . . . 72.450000000000003 109.031 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.483 ' HA ' ' HA ' ' B' ' 65' ' ' ARG . 3.1 p30 -118.63 146.49 44.61 Favored 'General case' 0 CA--C 1.484 -1.588 0 C-N-CA 120.024 -0.67 . . . . 73.319999999999993 110.691 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -120.1 11.1 11.58 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.681 -0.859 . . . . 74.409999999999997 108.681 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.586 ' HB3' ' OD1' ' B' ' 64' ' ' ASN . 10.8 p90 -66.82 -19.95 65.84 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 120.325 -0.55 . . . . 75.439999999999998 110.958 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 31.2 t -79.59 -1.21 36.95 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 115.111 -0.95 . . . . 55.009999999999998 110.045 178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.47 -51.39 1.58 Allowed Glycine 0 CA--C 1.491 -1.458 0 N-CA-C 110.093 -1.203 . . . . 73.200000000000003 110.093 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -96.08 133.48 25.1 Favored Pre-proline 0 C--N 1.29 -2.004 0 N-CA-C 106.683 -1.599 . . . . 75.519999999999996 106.683 175.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.466 ' HB2' ' CD1' ' A' ' 46' ' ' TYR . 63.3 Cg_endo -71.06 118.76 5.86 Favored 'Trans proline' 0 N--CA 1.44 -1.652 0 C-N-CA 121.081 1.188 . . . . 70.329999999999998 111.001 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm -101.07 158.35 16.08 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.594 -1.184 . . . . 74.400000000000006 109.607 -175.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.25 138.69 10.07 Favored Glycine 0 N--CA 1.418 -2.531 0 C-N-CA 120.497 -0.859 . . . . 62.5 112.581 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.465 ' CE1' ' HG ' ' A' ' 69' ' ' LEU . 12.6 p90 -154.79 144.18 21.27 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 123.905 0.882 . . . . 70.349999999999994 110.32 174.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.75 150.03 52.21 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 116.026 -0.533 . . . . 74.25 109.658 -172.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.646 ' CD2' ' HD3' ' A' ' 112' ' ' LYS . 90.2 m-85 -126.74 130.85 51.14 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.738 -0.838 . . . . 72.340000000000003 108.738 177.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.1 mm -108.78 117.08 53.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 109.301 -0.629 . . . . 73.109999999999999 109.301 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -93.17 119.24 32.14 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.716 -0.846 . . . . 65.329999999999998 108.716 176.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.626 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 95.6 m-85 -96.02 161.95 13.76 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 112.753 0.649 . . . . 74.010000000000005 112.753 -178.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.0 -15.55 60.65 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 115.264 -0.88 . . . . 74.319999999999993 111.424 174.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.5 161.33 42.33 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 118.504 -1.279 . . . . 73.140000000000001 111.857 177.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.548 ' O ' HG11 ' A' ' 91' ' ' VAL . 6.4 mmm180 -64.21 -34.95 79.27 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 114.338 -1.301 . . . . 74.530000000000001 110.843 173.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -61.24 -33.52 73.65 Favored 'General case' 0 CA--C 1.509 -0.61 0 C-N-CA 120.13 -0.628 . . . . 72.109999999999999 111.036 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.0 m -69.67 -40.28 76.49 Favored 'General case' 0 N--CA 1.42 -1.952 0 O-C-N 122.299 -0.251 . . . . 73.150000000000006 111.213 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.548 HG11 ' O ' ' A' ' 88' ' ' ARG 0.266 0.2 OUTLIER -65.63 -47.31 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 120.586 -0.446 . . . . 73.200000000000003 111.954 176.626 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.13 -32.41 68.12 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.192 0.52 . . . . 63.310000000000002 111.727 176.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.08 -36.51 64.29 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.204 0.526 . . . . 52.340000000000003 111.884 177.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.68 -43.76 45.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.688 -0.687 . . . . 71.349999999999994 111.943 -176.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.2 m -50.92 -22.42 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 113.025 0.75 . . . . 74.230000000000004 113.025 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.24 -11.45 50.18 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.919 0.39 . . . . 63.409999999999997 111.438 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 68.5 mtm -99.48 7.41 45.42 Favored 'General case' 0 C--O 1.216 -0.695 0 CA-C-N 116.29 -0.414 . . . . 72.409999999999997 110.929 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.51 ' HA ' HG12 ' A' ' 109' ' ' VAL . 3.6 p-10 -42.86 -41.33 3.24 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.707 1.373 . . . . 73.439999999999998 114.707 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -111.83 100.34 8.84 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.792 -0.818 . . . . 73.329999999999998 108.792 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 106' ' ' THR . 11.2 t -151.08 166.3 31.19 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.899 -0.591 . . . . 74.420000000000002 109.451 -177.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.89 118.61 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-O 121.825 0.821 . . . . 61.119999999999997 109.647 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -134.28 121.58 21.48 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.002 -0.999 . . . . 74.420000000000002 108.762 -177.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 54.0 54.84 9.1 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 114.538 1.31 . . . . 74.319999999999993 114.538 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.53 3.16 53.2 Favored Glycine 0 N--CA 1.468 0.829 0 CA-C-N 114.901 -1.045 . . . . 70.540000000000006 115.642 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -135.29 157.0 48.01 Favored 'General case' 0 C--N 1.298 -1.63 0 CA-C-N 117.399 0.6 . . . . 75.129999999999995 111.349 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 100' ' ' THR . 33.9 m -88.31 120.01 29.27 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.834 -1.543 . . . . 65.439999999999998 106.834 175.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 44.8 pt -101.69 171.14 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 119.31 -0.956 . . . . 75.530000000000001 110.709 -176.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 55.4 tptt -129.33 125.75 37.4 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.163 -0.68 . . . . 71.010000000000005 109.163 -176.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 12.1 p -129.78 121.85 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-O 121.158 0.504 . . . . 62.140000000000001 111.61 178.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.89 159.91 42.01 Favored Pre-proline 0 C--N 1.294 -1.827 0 N-CA-C 107.085 -1.45 . . . . 75.219999999999999 107.085 -178.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.71 134.12 52.24 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.279 1.986 . . . . 75.420000000000002 113.508 -175.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.646 ' HD3' ' CD2' ' A' ' 82' ' ' TYR . 35.5 ttpt . . . . . 0 N--CA 1.428 -1.535 0 N-CA-C 105.46 -2.052 . . . . 65.219999999999999 105.46 173.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.827 0 N-CA-C 111.787 -0.525 . . . . 71.530000000000001 111.787 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.477 ' HG2' ' HD3' ' B' ' 23' ' ' PRO . 2.0 Cg_endo -47.51 -56.91 2.66 Favored 'Trans proline' 0 CA--C 1.582 2.895 0 C-N-CA 122.478 2.119 . . . . 73.329999999999998 111.464 171.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.477 ' HD3' ' HG2' ' B' ' 22' ' ' PRO . 11.8 Cg_endo -89.52 136.37 2.72 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 121.406 1.404 . . . . 60.310000000000002 109.161 169.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -100.69 139.2 20.4 Favored Pre-proline 0 C--N 1.288 -2.073 0 C-N-CA 119.403 -0.919 . . . . 73.400000000000006 109.93 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -29.55 124.07 0.06 OUTLIER 'Trans proline' 0 C--N 1.361 1.216 1 C-N-CA 125.674 4.249 . . . . 52.350000000000001 114.069 -175.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.565 HD11 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -56.09 169.34 0.4 Allowed 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.384 -0.826 . . . . 53.219999999999999 113.053 178.542 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.473 ' O ' ' HG3' ' B' ' 31' ' ' LYS . 8.4 t -74.57 165.03 25.89 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.38 0.61 . . . . 45.219999999999999 111.925 -172.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.15 -46.41 65.43 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 114.685 -1.143 . . . . 62.439999999999998 113.873 -175.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -65.02 -39.39 93.31 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 112.001 0.371 . . . . 74.129999999999995 112.001 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.484 ' O ' HG12 ' B' ' 34' ' ' ILE . 4.0 mp0 -60.02 -34.82 73.88 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 116.064 -0.516 . . . . 75.109999999999999 110.301 174.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' B' ' 27' ' ' SER . 97.5 mttt -65.37 -41.39 93.82 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.521 -0.548 . . . . 75.409999999999997 109.521 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.591 ' HE2' ' N ' ' B' ' 32' ' ' LYS . 0.5 OUTLIER -63.46 -46.73 84.89 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 120.796 -0.362 . . . . 62.409999999999997 111.138 176.188 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -71.75 -37.86 70.49 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 113.915 1.08 . . . . 74.409999999999997 113.915 -174.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.484 HG12 ' O ' ' B' ' 30' ' ' GLU . 17.9 pt -67.3 -34.04 66.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 C-N-CA 120.136 -0.626 . . . . 64.439999999999998 110.649 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -68.73 -44.82 73.02 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.892 -1.151 . . . . 62.509999999999998 107.892 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' B' ' 32' ' ' LYS . 33.6 ttmt -63.01 -36.16 82.64 Favored 'General case' 0 CA--C 1.558 1.254 0 CA-C-N 114.235 -1.348 . . . . 71.420000000000002 111.864 -177.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -102.0 14.05 33.03 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.33 0.863 . . . . 75.430000000000007 113.33 -174.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' SER . . . . . 0.585 ' OG ' ' HE2' ' B' ' 112' ' ' LYS . 39.1 t -103.03 163.81 11.99 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 113.238 0.829 . . . . 74.219999999999999 113.238 -177.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.427 ' CG1' HG23 ' B' ' 91' ' ' VAL . 11.8 m -137.25 163.49 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 124.502 1.121 . . . . 71.400000000000006 111.475 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . 0.685 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 29.1 t80 -111.6 125.6 54.11 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 125.248 1.419 . . . . 70.340000000000003 108.433 177.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 58.1 t -112.78 110.59 32.77 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 106.953 -1.499 . . . . 73.25 106.953 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.95 171.36 13.86 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 119.551 -1.309 . . . . 73.219999999999999 113.61 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 65.4 t30 65.79 9.21 5.84 Favored 'General case' 0 C--O 1.213 -0.852 0 C-N-CA 126.321 1.848 . . . . 75.010000000000005 111.459 -177.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.14 118.6 6.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.386 -0.968 . . . . 62.100000000000001 108.386 174.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -68.38 145.47 54.11 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.328 -0.851 . . . . 74.140000000000001 111.405 -173.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -61.45 90.2 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 114.626 -1.17 . . . . 72.150000000000006 108.016 177.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.39 -16.77 0.35 Allowed Glycine 0 N--CA 1.426 -2.005 0 CA-C-N 115.334 -0.848 . . . . 61.32 112.521 -175.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 68.0 m -72.29 148.62 45.25 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 118.026 0.913 . . . . 64.310000000000002 109.244 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' THR . . . . . 0.408 HG22 HG21 ' A' ' 49' ' ' THR . 59.3 p -99.63 162.5 12.98 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.735 -0.386 . . . . 74.200000000000003 111.327 -177.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.419 ' HB3' HD11 ' B' ' 66' ' ' ILE . . . -65.1 -45.35 85.53 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 122.712 0.405 . . . . 74.540000000000006 109.981 178.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.9 -49.94 74.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.667 -0.697 . . . . 75.340000000000003 110.129 178.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -61.31 -40.64 94.93 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 121.038 0.447 . . . . 73.510000000000005 110.742 -177.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 45.5 mt -65.44 -47.56 75.75 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.574 -0.739 . . . . 64.129999999999995 111.895 177.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.22 -48.6 77.6 Favored 'General case' 0 C--O 1.2 -1.55 0 C-N-CA 122.612 0.365 . . . . 74.030000000000001 110.781 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.35 -41.23 75.77 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 120.87 0.367 . . . . 71.299999999999997 110.842 178.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -67.96 -37.59 81.75 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.881 -0.6 . . . . 75.430000000000007 110.156 -176.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -82.25 -21.97 36.04 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 113.386 0.884 . . . . 63.509999999999998 113.386 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 25.7 t -71.92 -24.45 61.64 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.813 -0.63 . . . . 75.439999999999998 109.532 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 28.1 m -62.46 -26.29 68.44 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.255 0.55 . . . . 72.409999999999997 109.803 172.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 63.5 m -110.08 15.33 22.55 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.242 -0.436 . . . . 72.400000000000006 111.383 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.98 173.77 39.64 Favored Glycine 0 C--O 1.216 -1.026 0 C-N-CA 118.29 -1.909 . . . . 53.109999999999999 115.197 -177.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 10.2 p -73.23 -69.39 0.42 Allowed 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.015 0.436 . . . . 60.030000000000001 111.718 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . 0.358 57.5 mt 102.71 112.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 C-N-CA 127.302 2.241 . . . . 64.430000000000007 111.839 177.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . 0.586 ' OD1' ' HB3' ' A' ' 73' ' ' PHE . 32.5 t30 -90.66 -49.9 6.22 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 113.604 -1.634 . . . . 72.349999999999994 109.548 -177.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 65.1 mtp180 -154.58 162.88 40.93 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 106.841 -1.541 . . . . 74.230000000000004 106.841 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.438 HD12 HG22 ' B' ' 66' ' ' ILE . 24.4 pt -144.0 142.14 24.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 106.676 -1.601 . . . . 74.530000000000001 106.676 172.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 34.2 m -125.17 125.01 43.01 Favored 'General case' 0 C--N 1.27 -2.869 0 N-CA-C 107.86 -1.163 . . . . 74.430000000000007 107.86 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.4 mp -122.72 116.18 48.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.18 -1.785 . . . . 70.420000000000002 106.18 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.519 ' HG ' ' CE1' ' B' ' 80' ' ' TYR 0.272 0.9 OUTLIER -121.19 128.86 52.87 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-O 121.031 0.444 . . . . 64.450000000000003 112.006 179.584 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 75.2 m -117.21 133.6 55.8 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.653 -0.869 . . . . 73.219999999999999 108.653 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 4.1 p30 -117.58 134.53 54.77 Favored 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 119.281 -0.968 . . . . 71.239999999999995 110.433 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -124.26 5.94 8.45 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.1 0.476 . . . . 64.150000000000006 109.95 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.432 ' HB3' ' OD1' ' A' ' 64' ' ' ASN . 53.8 p90 -60.47 -25.96 66.43 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.16 0.8 . . . . 75.310000000000002 113.16 -177.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 41.9 m -87.92 6.57 35.06 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 120.865 -0.334 . . . . 63.5 111.095 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.04 -58.17 0.42 Allowed Glycine 0 N--CA 1.437 -1.274 0 N-CA-C 111.445 -0.662 . . . . 52.119999999999997 111.445 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -95.41 127.6 41.44 Favored Pre-proline 0 C--N 1.307 -1.257 0 N-CA-C 109.574 -0.528 . . . . 74.340000000000003 109.574 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 96.8 Cg_endo -76.56 122.78 6.63 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.759 2.306 . . . . 75.200000000000003 112.805 -177.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -106.15 159.27 16.21 Favored 'General case' 0 CA--C 1.484 -1.579 0 CA-C-N 115.263 -0.881 . . . . 75.439999999999998 111.477 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -132.56 136.43 8.73 Favored Glycine 0 N--CA 1.422 -2.266 0 C-N-CA 120.571 -0.823 . . . . 37.490000000000002 113.252 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . 0.519 ' CE1' ' HG ' ' B' ' 69' ' ' LEU . 11.7 p90 -152.68 143.55 22.93 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 124.24 1.016 . . . . 63.409999999999997 110.198 174.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.49 150.34 52.17 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 116.168 -0.469 . . . . 62.340000000000003 109.971 -173.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' TYR . . . . . 0.783 ' CD1' ' HD3' ' B' ' 112' ' ' LYS . 96.1 m-85 -126.53 129.9 49.52 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.995 -0.743 . . . . 65.450000000000003 108.995 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.421 HG23 HG21 ' B' ' 66' ' ' ILE . 34.2 mm -108.75 115.47 49.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 109.358 -0.608 . . . . 75.450000000000003 109.358 -177.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -91.51 119.19 31.24 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.546 -0.538 . . . . 62.149999999999999 109.546 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -98.78 156.67 16.74 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.956 -0.465 . . . . 72.140000000000001 109.761 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.35 -17.9 44.02 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.277 0.561 . . . . 73.120000000000005 110.379 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . 0.42 ' HB3' ' OD1' ' B' ' 89' ' ' ASN . 28.6 mt-10 -124.47 140.96 52.46 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.579 -0.737 . . . . 75.25 111.111 -177.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -63.71 -33.72 76.27 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.34 0.59 . . . . 75.010000000000005 110.454 172.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . 0.42 ' OD1' ' HB3' ' B' ' 87' ' ' GLU . 2.8 p-10 -61.94 -32.22 72.62 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.564 -0.744 . . . . 73.230000000000004 112.278 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' SER . . . . . 0.411 ' OG ' ' HB2' ' B' ' 87' ' ' GLU . 15.2 m -67.85 -41.24 83.21 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 120.834 0.35 . . . . 54.409999999999997 110.655 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . 0.427 HG23 ' CG1' ' B' ' 39' ' ' VAL 0.325 0.4 OUTLIER -65.87 -44.7 92.63 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 112.722 0.638 . . . . 74.430000000000007 112.722 178.667 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -59.51 -33.03 70.84 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.942 0.401 . . . . 64.109999999999999 112.006 174.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.79 -37.22 65.01 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 120.819 0.343 . . . . 65.230000000000004 110.521 177.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.12 -44.38 54.03 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.075 0.398 . . . . 63.299999999999997 112.075 -176.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . 0.401 HG11 ' O ' ' B' ' 91' ' ' VAL . 29.7 m -51.65 -22.42 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 113.632 0.975 . . . . 61.0 113.632 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.2 -17.56 63.66 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.988 0.423 . . . . 65.319999999999993 111.439 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 60.2 mtm -95.47 6.86 47.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.33 -0.395 . . . . 73.209999999999994 110.932 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . 0.595 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 5.2 p-10 -39.27 -47.62 1.71 Allowed 'General case' 0 C--O 1.204 -1.324 0 N-CA-C 114.925 1.454 . . . . 70.420000000000002 114.925 -176.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -113.37 92.62 4.06 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 119.267 0.94 . . . . 73.299999999999997 109.718 176.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 100' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' B' ' 106' ' ' THR . 31.6 p -142.16 173.59 11.38 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.671 -1.15 . . . . 71.040000000000006 110.989 -178.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.16 129.33 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.761 0 CA-C-O 121.559 0.695 . . . . 72.150000000000006 110.036 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -135.57 121.59 20.02 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.897 -1.149 . . . . 72.209999999999994 107.897 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 48.1 ttt-85 60.01 33.42 21.36 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 122.155 0.979 . . . . 70.430000000000007 111.23 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.38 -5.23 80.71 Favored Glycine 0 C--N 1.317 -0.491 0 CA-C-N 114.847 -1.069 . . . . 72.129999999999995 114.507 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -129.47 156.9 43.37 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 117.827 0.814 . . . . 73.230000000000004 111.458 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 106' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' B' ' 100' ' ' THR . 62.9 m -80.76 120.49 24.71 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 116.352 -0.385 . . . . 75.140000000000001 110.282 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 44.5 pt -102.06 171.99 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.983 -0.377 . . . . 71.510000000000005 109.983 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 108' ' ' LYS . . . . . 0.595 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 55.6 tptt -134.06 127.47 32.27 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.803 -0.814 . . . . 75.209999999999994 108.803 -178.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . 0.685 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 8.3 p -129.25 122.66 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-O 121.07 0.462 . . . . 64.319999999999993 111.684 177.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.37 159.59 41.52 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 107.026 -1.472 . . . . 74.140000000000001 107.026 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.96 131.03 35.1 Favored 'Trans proline' 0 N--CA 1.48 0.719 0 C-N-CA 122.476 2.117 . . . . 71.010000000000005 113.039 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.783 ' HD3' ' CD1' ' B' ' 82' ' ' TYR . 37.1 ttpt . . . . . 0 CA--C 1.501 -0.907 0 N-CA-C 108.93 -0.767 . . . . 60.229999999999997 108.93 178.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 112.416 0.525 . . . . 70.349999999999994 112.416 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 34' ' ' ILE . 20.2 pt -70.32 -34.36 58.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.425 -0.807 . . . . 70.010000000000005 112.697 -174.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -67.5 -31.57 71.78 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.227 0.537 . . . . 75.040000000000006 110.689 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -70.03 -24.19 63.23 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.688 -0.687 . . . . 74.150000000000006 111.072 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -109.3 16.96 22.01 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.598 -0.728 . . . . 74.219999999999999 109.806 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.4 t -107.88 159.72 16.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 121.699 0.761 . . . . 63.119999999999997 112.204 -177.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.595 HG11 ' CG2' ' A' ' 91' ' ' VAL . 0.2 OUTLIER -140.42 163.7 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 C-N-CA 124.678 1.191 . . . . 70.439999999999998 112.195 -179.445 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.61 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 23.1 t80 -105.75 128.27 53.59 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 126.216 1.806 . . . . 74.310000000000002 107.195 176.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 65.5 t -118.87 116.08 50.0 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 107.539 -1.282 . . . . 61.119999999999997 107.539 177.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.82 167.46 13.05 Favored Glycine 0 C--N 1.297 -1.626 0 C-N-CA 120.033 -1.08 . . . . 74.109999999999999 114.247 -177.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.7 t30 59.87 62.24 1.72 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.431 1.892 . . . . 64.439999999999998 114.751 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.4 p -114.44 131.19 67.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.926 -1.034 . . . . 64.319999999999993 110.363 173.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.33 163.39 15.36 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.231 -1.396 . . . . 63.240000000000002 107.231 178.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -55.84 123.78 15.38 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.871 0.843 . . . . 75.239999999999995 112.311 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.12 -42.37 0.73 Allowed Glycine 0 N--CA 1.412 -2.948 0 N-CA-C 107.46 -2.256 . . . . 63.520000000000003 107.46 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.3 m -92.64 136.02 33.59 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 108.179 -1.045 . . . . 70.099999999999994 108.179 174.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.1 p -112.17 179.04 4.11 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.373 -0.603 . . . . 72.219999999999999 109.373 -178.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.472 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -61.73 -39.25 90.9 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.291 -0.633 . . . . 61.340000000000003 109.291 176.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -58.08 -46.5 85.38 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.401 -0.818 . . . . 55.240000000000002 111.489 174.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -58.53 -40.35 82.71 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.505 0.669 . . . . 54.509999999999998 110.071 178.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.2 mt -69.94 -48.27 59.08 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.704 -1.135 . . . . 73.319999999999993 111.265 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.5 -50.26 74.28 Favored 'General case' 0 C--O 1.193 -1.893 0 O-C-N 123.119 0.262 . . . . 62.340000000000003 111.704 -178.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.27 -42.57 91.53 Favored 'General case' 0 C--O 1.248 1.025 0 CA-C-O 121.083 0.468 . . . . 74.310000000000002 110.78 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -67.22 -39.78 86.29 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.748 -0.66 . . . . 72.200000000000003 110.39 -175.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -82.03 -21.44 36.98 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 112.928 0.714 . . . . 73.439999999999998 112.928 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.9 t -70.35 -24.37 62.97 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.181 -0.674 . . . . 75.150000000000006 109.181 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.7 m -60.15 -30.34 69.24 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-O 120.977 0.418 . . . . 74.129999999999995 110.104 173.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 63.8 m -90.65 1.67 56.6 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 112.782 0.66 . . . . 64.230000000000004 112.782 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 147.38 -162.48 28.65 Favored Glycine 0 N--CA 1.462 0.427 0 C-N-CA 119.282 -1.437 . . . . 71.420000000000002 114.164 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.3 t -104.63 132.41 50.9 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.857 -0.423 . . . . 75.129999999999995 109.857 -177.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 72.0 mt -97.84 135.66 31.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.354 0.597 . . . . 52.140000000000001 112.581 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.537 ' HB3' ' CE2' ' B' ' 73' ' ' PHE . 79.5 m-20 -96.42 -42.05 8.3 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.236 -0.893 . . . . 73.530000000000001 111.909 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 43.8 mtt180 -153.57 161.83 41.84 Favored 'General case' 0 CA--C 1.486 -1.494 0 CA-C-N 115.71 -0.677 . . . . 74.219999999999999 109.699 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.472 HD11 ' HB1' ' A' ' 50' ' ' ALA . 29.3 pt -148.35 142.73 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 107.665 -1.235 . . . . 64.420000000000002 107.665 173.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.3 m -125.15 127.34 46.68 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 106.886 -1.524 . . . . 50.43 106.886 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.443 HD11 ' N ' ' A' ' 68' ' ' ILE . 2.1 mp -125.71 122.7 62.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 106.269 -1.752 . . . . 74.299999999999997 106.269 -177.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.406 HD23 ' N ' ' A' ' 69' ' ' LEU 0.253 1.3 pt? -121.24 126.36 49.41 Favored 'General case' 0 C--N 1.28 -2.421 0 C-N-CA 120.277 -0.569 . . . . 73.209999999999994 111.545 176.299 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 66.2 m -116.44 134.59 54.69 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.124 -0.695 . . . . 73.230000000000004 109.124 -177.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.458 ' CB ' ' HG2' ' B' ' 65' ' ' ARG . 2.0 p30 -126.65 152.91 46.08 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 119.773 -0.771 . . . . 70.439999999999998 113.034 -177.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.519 ' HE2' ' HB3' ' A' ' 77' ' ' PRO . 0.5 OUTLIER -121.93 18.81 10.95 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.817 -0.629 . . . . 70.109999999999999 109.722 169.256 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -67.78 -21.89 65.23 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 118.942 -1.103 . . . . 75.109999999999999 109.421 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.8 m -84.44 2.26 41.65 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.405 -0.816 . . . . 74.299999999999997 110.382 174.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.61 -44.13 2.27 Favored Glycine 0 CA--C 1.507 -0.423 0 N-CA-C 110.997 -0.841 . . . . 37.990000000000002 110.997 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -97.18 144.21 27.49 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 108.234 -1.024 . . . . 74.420000000000002 108.234 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.519 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 55.8 Cg_endo -65.43 116.85 4.13 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 123.168 2.579 . . . . 72.420000000000002 110.464 175.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.433 ' HZ3' ' CG ' ' A' ' 71' ' ' ASP . 21.6 mtmm -122.86 -162.56 1.03 Allowed 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.571 -1.27 . . . . 73.099999999999994 107.571 175.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 172.39 159.16 18.28 Favored Glycine 1 N--CA 1.396 -4.011 0 C-N-CA 119.631 -1.271 . . . . 44.43 113.516 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -151.41 147.78 27.31 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 125.12 1.368 . . . . 73.209999999999994 109.319 176.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.12 150.6 49.16 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.046 0.451 . . . . 73.430000000000007 110.327 -171.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.424 ' CZ ' ' HD1' ' A' ' 40' ' ' TYR . 39.9 m-85 -118.77 121.81 40.96 Favored 'General case' 0 C--N 1.28 -2.43 0 C-N-CA 123.596 0.758 . . . . 75.230000000000004 110.326 176.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.4 mm -105.65 127.86 60.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 107.712 -1.218 . . . . 60.200000000000003 107.712 -178.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -110.39 119.28 38.68 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.544 -0.539 . . . . 64.310000000000002 109.544 178.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -95.22 162.67 13.6 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.562 0.696 . . . . 74.019999999999996 112.079 -177.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.495 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . . . -80.22 -28.47 38.57 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.915 -1.038 . . . . 72.510000000000005 111.942 176.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.8 150.1 43.28 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.583 -0.847 . . . . 74.239999999999995 112.022 -178.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.562 ' O ' HG12 ' A' ' 91' ' ' VAL . 8.9 mmm180 -69.04 -32.71 72.41 Favored 'General case' 0 C--O 1.215 -0.719 0 C-N-CA 123.264 0.626 . . . . 70.439999999999998 109.791 177.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -66.9 -28.83 68.63 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.463 -0.895 . . . . 75.109999999999999 110.807 177.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.7 m -70.22 -39.41 75.14 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 109.818 -0.438 . . . . 74.239999999999995 109.818 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.595 ' CG2' HG11 ' A' ' 39' ' ' VAL . 8.3 p -66.19 -38.84 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.652 -0.499 . . . . 71.430000000000007 109.652 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -66.98 -30.04 70.05 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-O 120.93 0.395 . . . . 72.450000000000003 111.697 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.75 -33.02 64.12 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.541 -0.54 . . . . 64.409999999999997 109.541 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.93 -45.07 52.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.735 -0.666 . . . . 73.409999999999997 111.089 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.0 m -57.21 -22.07 16.2 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 N-CA-C 112.762 0.653 . . . . 63.140000000000001 112.762 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.04 -20.06 66.05 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.607 0.718 . . . . 73.420000000000002 110.887 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 69.0 mtm -94.92 7.91 44.47 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.174 -0.921 . . . . 74.530000000000001 110.24 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.654 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 5.1 p-10 -40.23 -45.66 2.11 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 113.814 1.042 . . . . 74.420000000000002 113.814 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -118.94 116.6 26.81 Favored 'General case' 0 N--CA 1.405 -2.679 0 N-CA-C 108.158 -1.053 . . . . 70.349999999999994 108.158 172.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 106' ' ' THR . 8.2 t -168.9 -179.77 3.82 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.103 -0.953 . . . . 54.450000000000003 108.621 -177.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.48 125.73 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-O 121.533 0.683 . . . . 72.25 110.364 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -130.51 128.96 42.24 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.297 -1.001 . . . . 73.439999999999998 108.297 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 54.45 33.03 17.85 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.763 1.225 . . . . 73.430000000000007 110.487 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.01 -1.81 88.66 Favored Glycine 0 C--N 1.311 -0.831 0 CA-C-N 114.765 -1.107 . . . . 74.530000000000001 114.25 177.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -122.31 152.46 40.08 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 117.589 0.694 . . . . 64.219999999999999 111.318 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 100' ' ' THR . 30.8 m -81.98 120.72 25.6 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 110.263 -0.273 . . . . 71.030000000000001 110.263 -178.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 40.0 pt -103.1 172.09 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 116.329 -0.396 . . . . 63.399999999999999 110.48 176.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 57.6 tptt -129.49 133.55 47.34 Favored 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 109.233 -0.655 . . . . 64.420000000000002 109.233 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.61 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 23.6 t -127.23 114.52 37.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.002 -0.74 . . . . 75.219999999999999 109.002 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.417 HD11 ' CG ' ' B' ' 22' ' ' PRO 0.258 0.0 OUTLIER -143.35 146.24 35.32 Favored Pre-proline 0 C--O 1.211 -0.953 0 C-N-CA 119.277 -0.969 . . . . 74.519999999999996 109.432 179.168 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.445 ' HA ' HG12 ' A' ' 39' ' ' VAL . 67.4 Cg_exo -52.08 137.53 53.79 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 123.386 2.724 . . . . 73.519999999999996 113.692 -173.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt . . . . . 0 C--O 1.248 0.981 0 CA-C-O 121.2 0.524 . . . . 74.340000000000003 111.886 -176.459 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.277 0 CA-C-O 120.177 -0.235 . . . . 70.129999999999995 113.615 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.417 ' CG ' HD11 ' A' ' 110' ' ' LEU . 53.8 Cg_exo -53.17 -40.3 77.61 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 124.568 3.512 . . . . 72.430000000000007 116.88 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.8 136.05 74.12 Favored 'Trans proline' 0 C--N 1.391 2.768 0 CA-C-N 121.365 1.523 . . . . 71.349999999999994 110.377 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -60.47 134.3 91.38 Favored Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 123.56 0.538 . . . . 64.219999999999999 111.59 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -57.88 179.6 0.15 Allowed 'Trans proline' 0 C--O 1.244 0.817 0 C-N-CA 123.484 2.789 . . . . 74.510000000000005 114.069 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -148.8 159.65 43.96 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 113.598 -1.637 . . . . 62.219999999999999 107.397 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 39.1 t -57.26 145.47 31.74 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 113.768 1.025 . . . . 70.109999999999999 113.768 -171.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.78 -38.89 67.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.451 -1.25 . . . . 37.990000000000002 111.142 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -64.79 -34.9 79.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.442 -0.345 . . . . 71.099999999999994 110.279 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.418 ' HB2' HD21 ' B' ' 26' ' ' LEU . 17.9 mm-40 -65.43 -35.31 80.55 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 116.207 -0.451 . . . . 75.030000000000001 110.008 177.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -72.66 -47.02 50.92 Favored 'General case' 0 CA--C 1.483 -1.611 0 CA-C-N 115.427 -0.806 . . . . 73.140000000000001 110.862 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 50.3 mtpt -54.87 -43.06 72.8 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 115.861 -0.609 . . . . 74.409999999999997 111.767 176.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 0.3 OUTLIER -65.89 -41.13 91.93 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.819 0.847 . . . . 71.099999999999994 111.439 -178.517 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . 0.277 11.7 pt -71.27 -34.66 54.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 113.131 0.789 . . . . 75.319999999999993 113.131 -175.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.544 ' OD1' ' HE2' ' B' ' 112' ' ' LYS . 62.7 m-20 -64.01 -41.62 97.4 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-O 121.312 0.577 . . . . 74.049999999999997 109.851 -179.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 84.0 mttt -60.27 -27.28 67.14 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.377 0.671 . . . . 75.299999999999997 111.63 -177.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' B' ' 33' ' ' GLU . 20.4 mtm180 -104.46 15.41 28.21 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 115.901 -0.591 . . . . 75.099999999999994 110.336 -174.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' SER . . . . . 0.708 ' OG ' ' HD3' ' B' ' 112' ' ' LYS . 77.7 p -114.89 169.26 9.22 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 113.915 1.08 . . . . 73.439999999999998 113.915 -177.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.46 164.64 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 124.93 1.292 . . . . 73.129999999999995 113.24 -174.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 30.4 t80 -105.59 125.98 51.61 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 127.125 2.17 . . . . 74.420000000000002 106.719 178.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 59.9 t -117.12 115.48 48.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 108.184 -1.043 . . . . 73.120000000000005 108.184 176.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.25 166.18 13.31 Favored Glycine 0 C--N 1.3 -1.471 0 C-N-CA 120.166 -1.016 . . . . 63.420000000000002 113.125 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 56.1 t30 62.6 65.75 0.82 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.4 1.48 . . . . 74.319999999999993 113.454 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.2 118.15 7.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.319 -0.855 . . . . 64.299999999999997 111.864 175.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -80.8 167.18 20.23 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 106.498 -1.668 . . . . 74.340000000000003 106.498 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' TYR . . . . . 0.582 ' HB3' ' SG ' ' B' ' 70' ' ' CYS . 48.3 p90 -75.33 5.24 5.88 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.145 0.498 . . . . 75.239999999999995 112.04 -178.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.34 -24.84 74.4 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.417 -1.073 . . . . 75.329999999999998 110.417 174.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 28.2 m -91.84 145.75 24.31 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 106.275 -1.75 . . . . 62.43 106.275 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 43.6 p -103.79 174.5 5.84 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 118.988 -1.085 . . . . 73.409999999999997 111.665 -173.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.488 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -64.7 -38.4 90.86 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 108.593 -0.892 . . . . 41.32 108.593 175.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -58.56 -42.46 87.95 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.379 -0.828 . . . . 74.340000000000003 111.06 176.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -59.05 -46.38 88.39 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.32 0.581 . . . . 74.400000000000006 110.027 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 55.6 mt -65.26 -48.6 72.65 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.898 -1.047 . . . . 73.239999999999995 111.969 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.456 ' HG2' HD11 ' B' ' 63' ' ' ILE . 0.8 OUTLIER -62.24 -49.09 77.11 Favored 'General case' 0 C--O 1.195 -1.801 0 N-CA-C 111.983 0.364 . . . . 70.409999999999997 111.983 -177.825 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.84 -41.51 87.11 Favored 'General case' 0 C--O 1.26 1.635 0 CA-C-O 121.531 0.681 . . . . 71.299999999999997 112.309 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -67.93 -41.22 82.93 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.918 -1.037 . . . . 74.329999999999998 109.967 -175.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -82.19 -22.07 36.17 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.395 0.517 . . . . 74.430000000000007 112.395 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 29.1 t -71.36 -23.86 61.98 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 109.163 -0.68 . . . . 75.420000000000002 109.163 -178.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 38.7 m -64.26 -18.93 65.03 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 115.821 -0.627 . . . . 74.409999999999997 109.808 175.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 56.0 m -107.38 10.03 29.69 Favored 'General case' 0 CA--C 1.556 1.211 0 N-CA-C 112.013 0.375 . . . . 74.439999999999998 112.013 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 147.89 -168.45 28.76 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 119.577 -1.297 . . . . 72.340000000000003 114.511 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 57.6 p -107.19 126.64 52.66 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 121.519 0.676 . . . . 61.32 110.502 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.456 HD11 ' HG2' ' B' ' 54' ' ' GLU . 78.9 mt -90.93 135.27 27.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.305 -0.862 . . . . 72.510000000000005 113.112 -175.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -93.03 -40.3 10.61 Favored 'General case' 0 CA--C 1.49 -1.344 0 CA-C-N 116.27 -0.423 . . . . 74.409999999999997 110.49 177.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.458 ' HG2' ' CB ' ' A' ' 71' ' ' ASP . 47.9 mtt180 -154.84 161.0 41.62 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 116.27 -0.423 . . . . 72.219999999999999 110.026 -177.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.488 HD11 ' HB1' ' B' ' 50' ' ' ALA . 26.7 pt -147.31 143.2 20.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 107.319 -1.363 . . . . 74.099999999999994 107.319 172.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 66.0 m -125.81 124.88 41.94 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 106.76 -1.57 . . . . 65.310000000000002 106.76 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.4 mp -124.33 120.2 58.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 106.926 -1.509 . . . . 71.109999999999999 106.926 -177.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.4 HD22 ' O ' ' B' ' 80' ' ' TYR 0.251 1.3 pt? -120.74 127.82 52.35 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.999 -0.68 . . . . 54.229999999999997 111.426 177.209 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' B' ' 46' ' ' TYR . 69.3 m -116.59 133.79 55.6 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.081 -0.711 . . . . 73.400000000000006 109.081 -177.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . 0.595 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 4.1 p-10 -119.65 137.72 53.71 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 118.704 -1.198 . . . . 71.430000000000007 113.519 -176.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -104.81 10.38 34.53 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.78 0.8 . . . . 73.450000000000003 109.714 171.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.537 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 19.7 m-85 -73.42 -2.38 22.13 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.263 -0.88 . . . . 74.140000000000001 112.221 175.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 25.2 m -110.92 13.06 22.18 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 114.633 -1.167 . . . . 71.230000000000004 108.779 176.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.51 -55.76 5.03 Favored Glycine 0 C--N 1.343 0.958 0 N-CA-C 110.735 -0.946 . . . . 73.549999999999997 110.735 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -97.22 136.46 21.43 Favored Pre-proline 0 C--N 1.288 -2.09 0 CA-C-N 114.272 -0.964 . . . . 72.299999999999997 108.655 175.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.595 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 51.5 Cg_endo -69.55 118.31 5.6 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 121.603 1.535 . . . . 72.319999999999993 111.752 -178.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm -112.22 -157.56 0.62 Allowed 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 106.998 -1.482 . . . . 73.129999999999995 106.998 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 171.59 158.6 15.95 Favored Glycine 0 N--CA 1.409 -3.165 0 C-N-CA 119.071 -1.538 . . . . 62.020000000000003 114.232 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . 0.4 ' O ' HD22 ' B' ' 69' ' ' LEU . 2.8 p90 -149.5 144.3 26.2 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 125.468 1.507 . . . . 74.349999999999994 109.134 177.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.43 150.17 51.78 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 112.082 0.401 . . . . 64.329999999999998 112.082 -172.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' TYR . . . . . 0.486 ' CZ ' ' HD1' ' B' ' 40' ' ' TYR . 26.4 m-85 -117.72 120.44 37.97 Favored 'General case' 0 C--N 1.286 -2.164 0 C-N-CA 123.398 0.679 . . . . 64.439999999999998 111.092 177.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 24.9 mm -106.5 124.36 61.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 108.337 -0.986 . . . . 74.329999999999998 108.337 -178.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' GLU . . . . . 0.419 ' HG2' ' CB ' ' B' ' 38' ' ' SER . 30.8 mt-10 -109.14 119.29 39.09 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 110.172 -0.307 . . . . 52.329999999999998 110.172 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -97.61 166.58 11.43 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.529 0.566 . . . . 74.430000000000007 112.529 -176.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.09 -34.39 26.15 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.321 -0.854 . . . . 61.43 112.265 175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -114.26 149.84 35.27 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 120.95 0.405 . . . . 74.25 111.295 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.563 ' O ' HG12 ' B' ' 91' ' ' VAL . 19.4 mtp180 -74.87 -28.68 60.75 Favored 'General case' 0 CA--C 1.463 -2.372 0 CA-C-O 122.301 1.048 . . . . 72.120000000000005 111.796 176.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -61.31 -32.27 72.13 Favored 'General case' 1 C--N 1.234 -4.419 0 CA-C-N 114.178 -1.373 . . . . 71.420000000000002 110.503 172.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 16.5 m -71.24 -37.88 71.97 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 110.267 -0.272 . . . . 73.150000000000006 110.267 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . 0.563 HG12 ' O ' ' B' ' 88' ' ' ARG . 7.5 p -66.85 -38.78 82.14 Favored 'Isoleucine or valine' 0 C--N 1.348 0.527 0 C-N-CA 120.313 -0.555 . . . . 60.520000000000003 109.505 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -67.35 -30.43 70.23 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-O 121.101 0.477 . . . . 73.310000000000002 111.677 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.1 -32.23 64.83 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.185 0.517 . . . . 75.109999999999999 109.83 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.9 -44.87 46.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.761 -0.654 . . . . 61.420000000000002 111.28 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 30.2 m -57.53 -23.26 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 112.553 0.575 . . . . 55.200000000000003 112.553 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.37 -17.28 64.68 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.23 0.538 . . . . 74.530000000000001 110.078 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 69.1 mtm -95.46 7.63 45.65 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.122 -0.49 . . . . 72.319999999999993 111.719 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.1 -36.54 18.98 Favored 'General case' 0 C--O 1.201 -1.449 0 N-CA-C 114.312 1.227 . . . . 75.209999999999994 114.312 -177.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -105.08 17.83 23.41 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-N 119.349 0.977 . . . . 71.439999999999998 112.053 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 76.4 p -81.28 172.11 14.01 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 119.276 -0.97 . . . . 73.109999999999999 112.561 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.96 122.88 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 CA-C-O 121.746 0.784 . . . . 64.120000000000005 111.248 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -117.77 122.96 44.83 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.317 -0.994 . . . . 70.420000000000002 108.317 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 53.32 32.74 14.19 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.033 0.753 . . . . 73.219999999999999 113.033 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.22 4.6 83.77 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.93 -0.652 . . . . 63.009999999999998 114.115 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -125.86 151.39 46.92 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 117.533 0.666 . . . . 74.530000000000001 110.065 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 55.2 m -83.34 121.33 27.0 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 109.672 -0.492 . . . . 73.430000000000007 109.672 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 39.6 pt -102.05 172.54 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.175 -0.676 . . . . 71.129999999999995 109.175 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 108' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 56.3 tptt -128.48 132.59 48.38 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.681 -0.859 . . . . 73.540000000000006 108.681 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 20.9 t -126.5 120.21 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 107.999 -1.111 . . . . 72.030000000000001 107.999 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.322 0.3 OUTLIER -145.28 133.28 10.56 Favored Pre-proline 0 C--O 1.192 -1.97 0 N-CA-C 107.841 -1.17 . . . . 72.200000000000003 107.841 -167.449 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.16 151.95 48.02 Favored 'Trans proline' 0 N--CA 1.507 2.299 0 C-N-CA 123.504 2.803 . . . . 75.450000000000003 116.303 -177.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.708 ' HD3' ' OG ' ' B' ' 38' ' ' SER . 76.2 tttt . . . . . 0 CA--C 1.557 1.24 0 C-N-CA 125.326 1.45 . . . . 62.43 109.84 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 N--CA 1.439 -0.98 0 N-CA-C 113.291 0.848 . . . . 70.230000000000004 113.291 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.7 pt -70.31 -35.77 64.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 C-N-CA 119.722 -0.791 . . . . 42.140000000000001 111.863 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.46 -29.32 69.42 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.232 0.539 . . . . 72.25 111.263 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -77.76 -10.75 59.7 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.895 -0.593 . . . . 73.230000000000004 111.649 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -118.09 18.74 13.8 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.163 -0.471 . . . . 74.230000000000004 110.711 -174.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -94.83 139.09 31.77 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.928 -0.767 . . . . 72.239999999999995 108.928 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.514 HG21 ' O ' ' A' ' 83' ' ' ILE . 32.1 m -126.18 160.76 33.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 109.616 -0.512 . . . . 64.430000000000007 109.616 178.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.516 ' CD2' ' HG2' ' B' ' 22' ' ' PRO . 38.4 t80 -114.56 123.08 48.47 Favored 'General case' 0 C--N 1.274 -2.693 0 C-N-CA 125.159 1.384 . . . . 75.230000000000004 108.343 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 97.1 t -112.45 108.28 25.12 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.877 0 N-CA-C 107.087 -1.449 . . . . 71.209999999999994 107.087 177.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.07 163.07 20.15 Favored Glycine 0 C--N 1.284 -2.359 0 C-N-CA 119.62 -1.276 . . . . 72.450000000000003 112.231 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.5 t30 57.7 21.12 7.0 Favored 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 125.779 1.632 . . . . 72.430000000000007 113.562 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 p -54.39 135.44 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-O 121.38 0.61 . . . . 62.420000000000002 109.849 175.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.36 148.92 40.84 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 108.081 -1.081 . . . . 73.510000000000005 108.081 -176.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -70.24 -15.88 62.97 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.076 0.941 . . . . 64.0 109.189 -176.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.44 -11.62 83.01 Favored Glycine 0 N--CA 1.427 -1.955 0 CA-C-N 115.383 -0.826 . . . . 37.640000000000001 112.323 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.6 m -74.5 122.28 22.81 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-O 121.56 0.695 . . . . 63.43 110.069 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.1 p -100.86 171.73 7.49 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.309 -0.86 . . . . 74.239999999999995 108.903 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.02 -50.13 75.27 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 118.142 0.428 . . . . 71.319999999999993 111.194 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -57.49 -42.03 81.9 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.725 0.639 . . . . 73.230000000000004 112.725 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -67.09 -41.2 86.71 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.227 0.537 . . . . 70.200000000000003 110.315 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.2 mt -71.37 -48.37 50.46 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.707 -0.679 . . . . 75.120000000000005 111.815 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.443 ' HG3' ' OH ' ' B' ' 46' ' ' TYR . 14.2 tm-20 -59.73 -49.07 79.15 Favored 'General case' 0 C--O 1.208 -1.1 0 C-N-CA 123.547 0.739 . . . . 71.409999999999997 111.317 -178.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.35 -42.82 87.72 Favored 'General case' 0 C--O 1.27 2.165 0 CA-C-O 121.51 0.672 . . . . 65.019999999999996 111.214 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -63.63 -43.51 96.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.741 -1.118 . . . . 72.030000000000001 110.517 -175.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -81.36 -21.4 39.11 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 113.73 1.011 . . . . 75.409999999999997 113.73 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 69.4 m -66.59 -24.58 66.36 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 120.969 0.414 . . . . 55.43 110.885 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.1 m -58.62 -26.3 63.56 Favored 'General case' 0 CA--C 1.562 1.413 0 CA-C-O 121.144 0.497 . . . . 74.519999999999996 110.562 173.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 59.7 m -91.0 -2.78 57.65 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 112.945 0.72 . . . . 74.409999999999997 112.945 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.42 -161.86 27.95 Favored Glycine 0 C--N 1.317 -0.48 0 C-N-CA 119.456 -1.354 . . . . 52.409999999999997 113.913 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.1 m -97.26 120.26 37.3 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.562 0.696 . . . . 45.039999999999999 111.382 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.2 mt -82.01 129.53 37.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 115.001 -0.999 . . . . 71.519999999999996 111.168 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.489 ' OD1' ' HA ' ' B' ' 73' ' ' PHE . 48.4 t30 -93.54 -36.95 12.16 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.029 -0.987 . . . . 72.439999999999998 109.777 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.523 ' HD2' ' OE1' ' A' ' 84' ' ' GLU . 99.4 mtt180 -157.34 162.43 39.1 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.391 -0.822 . . . . 72.25 109.51 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.412 HG21 HG23 ' A' ' 83' ' ' ILE . 34.7 pt -142.68 137.81 28.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 107.259 -1.385 . . . . 73.340000000000003 107.259 171.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' B' ' 68' ' ' ILE . 49.9 m -126.54 130.96 51.58 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 107.55 -1.278 . . . . 74.109999999999999 107.55 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' B' ' 67' ' ' THR . 16.2 mt -125.87 118.11 50.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.315 -1.365 . . . . 51.350000000000001 107.315 -177.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' B' ' 66' ' ' ILE 0.342 0.9 OUTLIER -121.59 125.5 46.89 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 119.944 -0.702 . . . . 44.520000000000003 112.795 176.798 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 66.1 m -116.38 130.63 56.87 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.923 -1.14 . . . . 73.120000000000005 107.923 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.572 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 3.8 p-10 -115.78 137.14 52.37 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 119.196 -1.002 . . . . 72.450000000000003 112.377 -176.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -110.61 12.54 22.7 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.679 -0.691 . . . . 63.539999999999999 110.13 173.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.499 ' CD2' ' HB2' ' A' ' 71' ' ' ASP . 13.7 p90 -72.66 -9.97 59.24 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.789 0.804 . . . . 75.319999999999993 109.447 176.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.431 ' C ' ' H ' ' A' ' 76' ' ' HIS . 37.7 m -94.22 8.87 40.17 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 114.357 -1.292 . . . . 63.399999999999999 109.47 176.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.28 -54.42 4.53 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 110.492 -1.043 . . . . 55.130000000000003 110.492 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.431 ' H ' ' C ' ' A' ' 74' ' ' SER . 72.4 m-70 -95.61 131.26 29.81 Favored Pre-proline 0 C--N 1.299 -1.587 0 N-CA-C 106.772 -1.566 . . . . 70.219999999999999 106.772 176.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 33.3 Cg_endo -66.7 118.36 5.48 Favored 'Trans proline' 0 C--O 1.243 0.748 0 C-N-CA 121.536 1.491 . . . . 75.209999999999994 112.557 -177.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.453 ' HZ1' ' CG ' ' A' ' 71' ' ' ASP . 25.0 mtmm -100.09 -169.39 1.73 Allowed 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.959 -1.126 . . . . 53.409999999999997 107.959 174.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.05 139.8 6.11 Favored Glycine 0 N--CA 1.41 -3.1 0 C-N-CA 119.727 -1.225 . . . . 75.219999999999999 112.763 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -151.12 143.31 24.07 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.797 -0.816 . . . . 72.230000000000004 108.797 172.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.08 152.01 50.0 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 116.747 -0.206 . . . . 71.430000000000007 111.23 -173.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.423 ' CE1' ' HD1' ' A' ' 40' ' ' TYR . 95.6 m-85 -120.4 115.63 23.89 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 109.044 -0.724 . . . . 75.310000000000002 109.044 174.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.514 ' O ' HG21 ' A' ' 39' ' ' VAL . 38.6 mm -101.65 121.27 52.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.515 -1.291 . . . . 71.109999999999999 107.515 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.523 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 33.7 mt-10 -106.07 123.09 47.45 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 120.242 -0.583 . . . . 64.530000000000001 109.5 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -94.45 156.64 16.38 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 112.525 0.565 . . . . 74.329999999999998 112.525 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.06 -36.32 55.99 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.515 -0.766 . . . . 61.520000000000003 110.404 176.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -103.01 146.23 28.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.771 0.319 . . . . 71.430000000000007 110.185 175.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.436 ' O ' HG21 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.77 -32.34 62.03 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.103 -1.443 . . . . 74.150000000000006 107.103 178.606 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -60.46 -31.48 70.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.283 -1.326 . . . . 75.109999999999999 110.338 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 31.5 m -64.41 -36.64 84.83 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 116.235 -0.439 . . . . 64.450000000000003 110.503 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.436 HG21 ' O ' ' A' ' 88' ' ' ARG . 2.3 m -67.68 -38.3 80.13 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.533 0 C-N-CA 119.61 -0.836 . . . . 70.420000000000002 109.241 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -58.3 -36.1 72.81 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.064 0.459 . . . . 74.209999999999994 111.59 176.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.34 -32.8 64.77 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.929 0.395 . . . . 73.099999999999994 110.658 177.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.36 -40.63 50.61 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 116.174 -0.466 . . . . 71.409999999999997 111.627 -177.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.7 m -55.76 -21.85 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 113.117 0.784 . . . . 73.239999999999995 113.117 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.08 -14.44 61.74 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 121.586 0.708 . . . . 74.530000000000001 110.535 176.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 28.3 mtp -98.17 8.1 45.29 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 124.471 1.108 . . . . 62.340000000000003 110.771 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 4.5 p-10 -36.57 -53.47 0.88 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.904 1.076 . . . . 72.299999999999997 113.904 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -118.87 106.14 12.2 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-O 121.704 0.764 . . . . 65.120000000000005 109.451 175.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.0 t -150.1 173.02 14.35 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 114.811 -1.086 . . . . 74.019999999999996 109.275 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.87 131.99 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.221 0 N-CA-C 108.754 -0.832 . . . . 63.32 108.754 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -138.32 113.64 9.47 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 107.289 -1.374 . . . . 72.150000000000006 107.289 -177.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 37.5 mtp85 56.1 33.31 21.72 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.906 0.882 . . . . 74.319999999999993 112.127 -175.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.06 -10.18 71.77 Favored Glycine 0 C--N 1.312 -0.795 0 CA-C-N 115.215 -0.902 . . . . 37.640000000000001 113.191 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -99.31 143.81 29.15 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.839 -0.801 . . . . 73.5 108.839 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.0 m -86.41 119.72 26.98 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.934 -1.506 . . . . 54.530000000000001 106.934 174.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 47.8 pt -102.01 171.35 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 120.15 -0.62 . . . . 70.439999999999998 110.976 -177.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 57.6 tptt -127.87 125.98 40.71 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.138 -0.937 . . . . 73.310000000000002 108.731 -177.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.9 t -114.32 115.53 49.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 106.275 -1.75 . . . . 75.019999999999996 106.275 177.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . 0.272 2.5 tt -138.87 128.56 14.52 Favored Pre-proline 0 C--O 1.196 -1.72 0 N-CA-C 106.972 -1.492 . . . . 74.239999999999995 106.972 -170.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.66 127.71 15.07 Favored 'Trans proline' 0 C--N 1.355 0.884 0 CA-C-N 121.485 1.566 . . . . 62.200000000000003 109.771 175.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.312 -1.058 0 CA-C-O 121.584 0.707 . . . . 75.230000000000004 110.744 -170.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.738 0 N-CA-C 109.717 -1.353 . . . . 75.109999999999999 109.717 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.516 ' HG2' ' CD2' ' A' ' 40' ' ' TYR . 76.3 Cg_exo -52.9 -37.98 78.33 Favored 'Trans proline' 0 CA--C 1.566 2.103 0 C-N-CA 122.742 2.295 . . . . 62.520000000000003 114.225 172.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -55.1 129.67 36.57 Favored 'Trans proline' 0 C--N 1.397 3.081 0 C-N-CA 121.499 1.466 . . . . 71.319999999999993 110.99 172.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -54.16 141.5 50.51 Favored Pre-proline 0 C--N 1.302 -1.487 0 CA-C-N 114.257 -1.338 . . . . 75.109999999999999 111.277 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.86 114.15 2.3 Favored 'Trans proline' 0 N--CA 1.443 -1.467 0 C-N-CA 122.098 1.866 . . . . 72.230000000000004 111.045 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 6.1 mp -61.83 165.83 4.97 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.821 -1.081 . . . . 74.540000000000006 109.882 176.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.421 ' O ' ' HG2' ' B' ' 31' ' ' LYS . 25.2 m -58.93 144.94 43.2 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.278 -0.638 . . . . 64.099999999999994 109.278 176.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' B' ' 31' ' ' LYS . . . -52.49 -44.18 65.48 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 123.569 0.543 . . . . 71.439999999999998 111.775 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -71.31 -30.98 66.88 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.828 0.677 . . . . 71.420000000000002 112.828 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.523 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.5 OUTLIER -60.57 -34.58 74.4 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 109.653 -0.499 . . . . 74.200000000000003 109.653 170.013 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' B' ' 28' ' ' ALA . 25.2 mmmt -65.84 -46.89 76.83 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 115.58 -0.736 . . . . 70.409999999999997 109.956 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.546 ' HE2' ' N ' ' B' ' 32' ' ' LYS . 0.5 OUTLIER -53.7 -46.36 70.71 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.8 -0.36 . . . . 73.030000000000001 110.734 176.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.77 -45.76 70.54 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.314 0.857 . . . . 63.420000000000002 113.314 -174.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.523 HG12 ' O ' ' B' ' 30' ' ' GLU . 26.3 pt -69.58 -35.37 65.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 C-N-CA 120.751 -0.38 . . . . 73.420000000000002 111.828 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.9 -35.09 79.23 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.915 0.388 . . . . 75.310000000000002 110.781 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 55.1 mtmt -75.12 -11.08 60.01 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.393 0.516 . . . . 73.209999999999994 112.393 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -118.23 18.37 13.76 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.328 0.585 . . . . 71.439999999999998 110.918 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' B' ' 84' ' ' GLU . 82.8 p -98.9 156.5 16.86 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 115.897 -0.592 . . . . 53.549999999999997 111.444 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.415 HG21 ' O ' ' B' ' 83' ' ' ILE . 31.2 m -137.08 163.89 31.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.931 0.396 . . . . 70.25 110.562 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . 0.503 ' HD1' ' CE1' ' B' ' 82' ' ' TYR . 38.7 t80 -115.57 123.03 47.44 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 126.118 1.767 . . . . 72.409999999999997 107.936 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 85.8 t -112.45 108.02 24.46 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.939 0 N-CA-C 107.461 -1.311 . . . . 72.519999999999996 107.461 176.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . 0.503 ' O ' ' HB ' ' B' ' 107' ' ' ILE . . . -98.83 164.97 20.87 Favored Glycine 0 C--N 1.289 -2.037 0 C-N-CA 119.697 -1.24 . . . . 75.540000000000006 112.201 -177.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 64.0 t30 60.29 18.45 7.99 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.639 1.176 . . . . 75.400000000000006 112.875 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 8.0 p -61.49 132.19 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 109.162 -0.681 . . . . 65.239999999999995 109.162 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.38 143.95 56.83 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.61 -0.723 . . . . 61.219999999999999 109.879 -176.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' TYR . . . . . 0.46 ' CD1' ' HB2' ' B' ' 77' ' ' PRO . 71.7 t80 -55.07 -21.98 14.51 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 124.878 1.271 . . . . 74.430000000000007 111.999 -177.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.26 10.84 54.76 Favored Glycine 0 N--CA 1.422 -2.267 0 C-N-CA 120.562 -0.828 . . . . 54.130000000000003 113.761 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 12.8 m -75.0 122.32 23.33 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 118.492 1.146 . . . . 70.0 108.687 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 61.8 p -96.57 167.62 11.03 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 111.663 0.245 . . . . 72.299999999999997 111.663 -175.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.96 -51.15 70.92 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 112.853 0.686 . . . . 71.010000000000005 112.853 -175.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -57.53 -38.4 74.63 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 112.473 0.545 . . . . 75.400000000000006 112.473 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -69.49 -42.21 75.1 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.082 0.468 . . . . 74.349999999999994 109.973 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.41 -48.56 55.53 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.646 -0.706 . . . . 70.239999999999995 112.036 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 tm-20 -59.91 -49.74 76.51 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.198 0.599 . . . . 72.540000000000006 111.289 -177.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.41 -42.07 81.57 Favored 'General case' 0 C--O 1.27 2.154 0 CA-C-O 121.602 0.715 . . . . 70.409999999999997 111.355 177.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -64.59 -42.79 95.35 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 114.879 -1.055 . . . . 70.409999999999997 110.761 -175.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -81.68 -21.43 38.1 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 113.571 0.952 . . . . 74.219999999999999 113.571 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 75.4 m -64.74 -26.09 68.21 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 116.36 -0.382 . . . . 72.219999999999999 110.946 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.4 m -58.17 -26.85 63.24 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-O 121.038 0.447 . . . . 64.200000000000003 110.524 174.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . 0.451 ' SG ' ' HA ' ' B' ' 94' ' ' ALA . 61.7 m -92.05 -0.61 57.46 Favored 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 112.885 0.698 . . . . 55.329999999999998 112.885 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.35 -154.83 26.21 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 119.054 -1.546 . . . . 65.310000000000002 114.681 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 44.1 m -105.27 117.97 35.37 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.033 0.444 . . . . 74.209999999999994 111.229 -176.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.441 HG23 HD13 ' B' ' 63' ' ' ILE . 67.3 mt -79.46 130.72 35.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.743 -0.662 . . . . 74.430000000000007 112.655 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . 0.536 ' OD1' ' HG3' ' B' ' 65' ' ' ARG . 23.6 t-20 -91.16 -41.91 10.75 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.186 0.995 . . . . 75.239999999999995 108.356 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.536 ' HG3' ' OD1' ' B' ' 64' ' ' ASN . 99.2 mtt180 -158.05 163.52 37.62 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.842 0.857 . . . . 70.530000000000001 109.125 -177.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 69' ' ' LEU . 34.8 pt -142.43 137.67 28.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 107.099 -1.445 . . . . 74.209999999999994 107.099 170.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 33.4 m -126.74 131.18 51.4 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 107.069 -1.456 . . . . 73.209999999999994 107.069 -178.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 67' ' ' THR . 17.1 mt -125.91 117.47 49.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 107.128 -1.434 . . . . 73.019999999999996 107.128 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.308 0.9 OUTLIER -121.49 125.88 47.91 Favored 'General case' 0 C--N 1.283 -2.313 0 C-N-CA 120.21 -0.596 . . . . 70.209999999999994 112.241 177.296 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 77.1 m -116.27 129.15 56.13 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 108.302 -0.999 . . . . 64.420000000000002 108.302 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . 0.657 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 4.8 p-10 -110.63 126.78 54.84 Favored 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 119.48 -0.888 . . . . 60.109999999999999 111.021 -177.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -113.49 15.2 19.1 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.039 -1.467 . . . . 74.010000000000005 107.039 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.489 ' HA ' ' OD1' ' A' ' 64' ' ' ASN . 30.8 t80 -44.72 -44.3 9.09 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.511 2.324 . . . . 71.340000000000003 112.096 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 24.1 m -100.82 18.99 18.04 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 116.208 -0.451 . . . . 71.430000000000007 111.558 -175.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.1 -53.17 2.52 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.095 -1.05 . . . . 75.340000000000003 111.388 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -91.55 119.89 68.4 Favored Pre-proline 0 CA--C 1.497 -1.085 0 N-CA-C 109.367 -0.605 . . . . 71.319999999999993 109.367 177.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 75.3 Cg_endo -77.81 121.1 5.33 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 122.522 2.148 . . . . 64.129999999999995 113.682 -174.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' LYS . . . . . 0.475 ' HZ1' ' CG ' ' B' ' 71' ' ' ASP . 25.8 mtmm -99.98 -167.16 1.42 Allowed 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.397 -0.964 . . . . 55.100000000000001 108.397 177.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.93 140.71 6.67 Favored Glycine 0 N--CA 1.408 -3.2 0 C-N-CA 120.252 -0.975 . . . . 73.129999999999995 112.663 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -151.73 143.44 23.65 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.509 -0.923 . . . . 75.540000000000006 108.509 171.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.33 152.19 50.81 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-O 121.023 0.44 . . . . 75.340000000000003 110.022 -173.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' TYR . . . . . 0.642 ' CD1' ' HD3' ' B' ' 112' ' ' LYS . 96.4 m-85 -121.31 115.21 22.54 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.411 -0.588 . . . . 72.549999999999997 109.411 175.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.415 ' O ' HG21 ' B' ' 39' ' ' VAL . 40.5 mm -100.12 122.8 52.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 106.904 -1.517 . . . . 72.329999999999998 106.904 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' GLU . . . . . 0.53 ' OE1' ' HD2' ' B' ' 65' ' ' ARG . 31.1 mt-10 -107.73 124.15 49.59 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.165 -0.68 . . . . 70.409999999999997 109.165 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -96.83 154.1 17.49 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 112.893 0.701 . . . . 73.010000000000005 112.893 -177.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.69 -40.47 72.89 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.147 -0.933 . . . . 71.420000000000002 110.251 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -105.76 147.94 28.04 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 116.005 -0.543 . . . . 74.209999999999994 111.471 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.471 ' O ' HG21 ' B' ' 91' ' ' VAL . 0.0 OUTLIER -74.26 -33.56 63.34 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.398 -1.334 . . . . 73.040000000000006 107.398 -179.762 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -63.03 -25.42 68.37 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 115.494 -0.775 . . . . 64.150000000000006 111.425 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 42.9 m -66.11 -36.89 84.37 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 110.243 -0.28 . . . . 73.409999999999997 110.243 177.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' VAL . . . . . 0.471 HG21 ' O ' ' B' ' 88' ' ' ARG . 3.2 m -67.83 -38.67 80.54 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 N-CA-C 109.003 -0.74 . . . . 64.109999999999999 109.003 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -56.87 -38.08 72.25 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.169 0.509 . . . . 73.450000000000003 111.576 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.69 -31.58 63.5 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.061 0.457 . . . . 65.430000000000007 111.083 177.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 94' ' ' ALA . . . . . 0.451 ' HA ' ' SG ' ' B' ' 60' ' ' CYS . . . -76.32 -40.8 50.49 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.192 -0.458 . . . . 75.450000000000003 111.454 -178.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 22.0 m -56.58 -21.77 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 113.0 0.741 . . . . 62.409999999999997 113.0 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.75 -18.85 65.42 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.292 0.567 . . . . 63.020000000000003 110.189 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 48.1 mtm -95.06 13.54 24.85 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.699 -0.682 . . . . 64.239999999999995 110.872 177.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . 0.457 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 11.1 t70 -33.8 -55.09 0.47 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.471 1.508 . . . . 64.230000000000004 113.683 -178.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . 0.411 ' HG3' ' OD1' ' B' ' 98' ' ' ASP . 45.6 mt-10 -124.83 62.33 1.15 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.166 -1.013 . . . . 74.299999999999997 112.775 171.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 35.0 p -91.69 174.75 7.19 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.297 -0.865 . . . . 72.200000000000003 111.72 174.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.4 p -101.67 137.81 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 109.122 -0.695 . . . . 74.010000000000005 109.122 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -142.72 118.61 10.58 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.532 -0.914 . . . . 75.0 108.532 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 45.3 mtp180 55.68 33.22 20.87 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.509 1.123 . . . . 75.129999999999995 113.539 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.53 -0.87 65.88 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.038 -0.983 . . . . 71.310000000000002 114.191 174.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -130.81 160.62 33.84 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.176 -0.676 . . . . 72.420000000000002 109.176 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 85.7 m -92.52 126.98 37.84 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.188 -0.671 . . . . 64.319999999999993 109.188 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' B' ' 42' ' ' GLY . 0.2 OUTLIER -102.8 172.3 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 118.198 -1.401 . . . . 63.200000000000003 110.334 177.485 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 108' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 56.8 tptt -119.21 124.72 47.46 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.641 -1.244 . . . . 55.530000000000001 107.641 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . 0.424 ' HB ' ' HA ' ' B' ' 98' ' ' ASP . 47.1 t -113.91 113.97 45.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 107.065 -1.458 . . . . 73.129999999999995 107.065 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.273 3.0 tt -139.66 128.53 13.61 Favored Pre-proline 0 C--O 1.187 -2.195 0 N-CA-C 106.454 -1.684 . . . . 70.200000000000003 106.454 -170.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.35 129.54 28.66 Favored 'Trans proline' 0 CA--C 1.551 1.37 0 CA-C-N 121.499 1.571 . . . . 74.019999999999996 112.056 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.642 ' HD3' ' CD1' ' B' ' 82' ' ' TYR . 36.0 ttpt . . . . . 0 C--O 1.218 -0.59 0 CA-C-N 116.199 -0.455 . . . . 75.209999999999994 111.039 -174.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.295 0 N-CA-C 109.947 -0.39 . . . . 73.329999999999998 109.947 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.8 tt -101.17 130.23 50.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 109.786 -0.45 . . . . 71.310000000000002 109.786 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.38 121.78 18.63 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 109.999 -0.371 . . . . 51.039999999999999 109.999 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -66.23 108.17 1.3 Allowed 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 122.591 2.194 . . . . 61.43 111.808 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.8 p -107.93 94.01 4.84 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.173 0.511 . . . . 74.099999999999994 110.086 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 85.3 mtp 62.9 -170.91 0.17 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.258 -0.883 . . . . 73.239999999999995 109.843 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 60.93 -168.26 0.18 Allowed 'General case' 0 C--O 1.241 0.644 0 C-N-CA 122.785 0.434 . . . . 71.340000000000003 111.84 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.7 m 70.4 5.03 5.18 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-O 122.085 0.945 . . . . 75.340000000000003 111.198 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -90.99 107.87 19.48 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.541 0.686 . . . . 72.230000000000004 110.473 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -153.04 96.02 2.03 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.793 0.806 . . . . 52.43 111.51 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.9 m -120.97 24.12 10.34 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.702 -1.135 . . . . 72.25 110.02 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.402 ' H ' ' HD2' ' A' ' 12' ' ' LYS 0.263 0.0 OUTLIER -78.38 69.59 4.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.937 0.875 . . . . 74.099999999999994 113.025 -178.274 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 27.3 ttt -148.27 102.99 3.4 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 107.641 -1.244 . . . . 62.43 107.641 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.1 m -109.29 -19.55 13.26 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 116.207 -0.451 . . . . 74.329999999999998 111.588 -175.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 76.08 -46.01 0.53 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.203 1.001 . . . . 72.239999999999995 110.137 -173.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.93 69.46 1.32 Allowed Glycine 0 CA--C 1.5 -0.87 0 CA-C-N 116.343 -0.389 . . . . 54.119999999999997 113.442 173.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -118.31 -30.29 5.29 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 120.607 0.242 . . . . 61.030000000000001 110.545 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.463 ' O ' ' HE2' ' B' ' 108' ' ' LYS . 98.3 m-85 65.13 18.32 11.4 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 122.096 0.95 . . . . 75.25 109.579 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -161.0 30.84 0.14 Allowed 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 126.48 1.912 . . . . 64.409999999999997 109.184 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -43.78 -61.56 1.38 Allowed 'General case' 0 C--N 1.348 0.535 0 O-C-N 124.653 1.221 . . . . 74.299999999999997 110.649 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.95 -177.44 50.1 Favored Glycine 0 N--CA 1.401 -3.665 0 C-N-CA 120.772 -0.727 . . . . 50.109999999999999 111.765 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.497 ' HA ' ' OH ' ' B' ' 82' ' ' TYR . 95.3 Cg_exo -48.32 -33.96 23.68 Favored 'Trans proline' 0 CA--C 1.586 3.098 0 C-N-CA 123.56 2.84 . . . . 73.049999999999997 117.814 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -90.45 167.66 4.2 Favored 'Trans proline' 0 N--CA 1.413 -3.253 0 N-CA-C 118.313 2.39 . . . . 54.5 118.313 -172.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.547 ' HG2' ' OH ' ' B' ' 80' ' ' TYR . 76.9 mt-30 -134.87 146.93 60.77 Favored Pre-proline 0 N--CA 1.411 -2.386 0 CA-C-N 110.842 -2.89 . . . . 75.209999999999994 104.27 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.65 99.69 0.97 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 CA-C-N 120.158 1.092 . . . . 73.409999999999997 113.148 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.406 ' CD2' HD12 ' A' ' 34' ' ' ILE . 6.1 mp -139.38 136.99 35.32 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.622 -0.881 . . . . 75.120000000000005 108.622 176.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.3 t -75.85 160.06 30.33 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.782 -1.192 . . . . 73.030000000000001 107.782 173.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.2 -40.26 23.69 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 123.198 0.599 . . . . 43.240000000000002 112.23 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.293 49.4 mt-10 -75.33 -30.39 60.28 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 114.731 1.382 . . . . 73.420000000000002 114.731 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -58.19 -34.95 70.92 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 108.742 -0.836 . . . . 63.25 108.742 169.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -73.22 -37.98 66.23 Favored 'General case' 0 N--CA 1.416 -2.16 0 CA-C-N 114.711 -1.132 . . . . 63.100000000000001 111.256 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.521 ' HA ' ' NZ ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -69.2 -43.97 73.05 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 120.045 -0.662 . . . . 62.32 110.139 -178.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.525 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 7.8 mm-40 -62.74 -37.88 88.3 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 116.27 -0.423 . . . . 71.439999999999998 111.163 -177.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.406 HD12 ' CD2' ' A' ' 26' ' ' LEU . 19.4 pt -70.89 -35.91 61.89 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 C-N-CA 120.763 -0.375 . . . . 63.210000000000001 111.863 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.316 2.1 p30 -76.53 -27.84 56.11 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 118.929 -1.108 . . . . 71.329999999999998 112.208 178.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -65.6 -19.3 65.86 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-O 121.364 0.602 . . . . 74.430000000000007 111.318 174.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 12.6 ptp180 -125.06 25.87 7.13 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-O 122.07 0.938 . . . . 71.340000000000003 109.624 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.553 ' OG ' ' HG2' ' A' ' 84' ' ' GLU . 39.6 t -104.2 157.23 17.27 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.332 -1.304 . . . . 62.109999999999999 110.331 177.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.464 HG23 HG21 ' A' ' 91' ' ' VAL . 17.0 t -131.07 157.04 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 N-CA-C 107.963 -1.125 . . . . 73.219999999999999 107.963 -177.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.679 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 25.6 t80 -107.19 125.63 51.36 Favored 'General case' 0 C--N 1.279 -2.5 0 N-CA-C 106.398 -1.705 . . . . 74.409999999999997 106.398 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.445 ' HA ' HG11 ' A' ' 109' ' ' VAL . 62.6 t -116.7 107.8 23.38 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.137 0 N-CA-C 106.656 -1.609 . . . . 75.299999999999997 106.656 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.483 ' HA3' ' CZ ' ' A' ' 40' ' ' TYR . . . -117.04 172.56 14.3 Favored Glycine 0 C--N 1.275 -2.812 0 C-N-CA 117.734 -2.174 . . . . 75.450000000000003 113.652 -176.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.1 t30 57.73 11.67 1.4 Allowed 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 125.003 1.321 . . . . 74.099999999999994 112.92 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.7 p -55.45 142.79 9.38 Favored 'Isoleucine or valine' 0 C--O 1.246 0.906 0 CA-C-O 121.376 0.608 . . . . 74.349999999999994 109.858 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -77.6 150.05 34.71 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 107.737 -1.209 . . . . 60.43 107.737 -177.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -62.12 -20.85 64.5 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 123.886 0.741 . . . . 74.25 110.075 -176.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.16 -23.61 71.51 Favored Glycine 0 N--CA 1.424 -2.163 0 CA-C-N 115.52 -0.763 . . . . 37.920000000000002 112.82 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 72.9 m -100.97 75.6 1.69 Allowed 'General case' 0 N--CA 1.427 -1.594 0 C-N-CA 118.667 -1.213 . . . . 61.32 113.264 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.9 p -71.71 -178.0 2.1 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 116.199 -0.455 . . . . 53.420000000000002 111.93 170.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.02 -51.09 32.95 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.469 1.285 . . . . 71.239999999999995 114.469 -165.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.523 ' HG2' ' CE2' ' B' ' 46' ' ' TYR . 50.5 mt-30 -56.77 -51.88 67.19 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.441 0.534 . . . . 73.450000000000003 112.441 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -68.48 -39.19 81.44 Favored 'General case' 0 C--O 1.256 1.407 0 CA-C-O 121.591 0.71 . . . . 73.299999999999997 110.657 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.21 -46.69 73.09 Favored 'General case' 0 C--O 1.259 1.583 0 CA-C-N 114.673 -1.148 . . . . 74.239999999999995 109.061 -175.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -58.9 -40.94 86.0 Favored 'General case' 0 C--O 1.187 -2.191 0 N-CA-C 112.331 0.493 . . . . 64.109999999999999 112.331 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.56 -44.04 72.56 Favored 'General case' 0 C--O 1.266 1.926 0 CA-C-O 121.285 0.564 . . . . 64.299999999999997 111.717 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -64.82 -40.65 95.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.197 -0.911 . . . . 73.439999999999998 110.386 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -82.34 -22.76 35.42 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.028 1.122 . . . . 70.010000000000005 114.028 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.0 t -68.64 -24.69 64.58 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.01 -0.737 . . . . 72.150000000000006 109.01 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.0 m -66.31 -22.68 66.29 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 120.605 -0.438 . . . . 73.129999999999995 111.099 173.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 67.6 m -97.19 7.74 45.96 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.42 0.526 . . . . 71.329999999999998 112.42 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.21 -163.41 27.78 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 119.055 -1.545 . . . . 52.329999999999998 114.286 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.7 p -106.12 127.44 53.2 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.219 0.533 . . . . 73.109999999999999 111.236 -177.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.3 mt -86.87 133.93 28.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.683 -0.69 . . . . 53.350000000000001 112.14 -177.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.518 ' OD1' ' HG3' ' A' ' 65' ' ' ARG . 24.0 t-20 -96.99 -47.99 5.58 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.389 -0.823 . . . . 71.409999999999997 109.695 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.518 ' HG3' ' OD1' ' A' ' 64' ' ' ASN . 54.1 mtp180 -151.58 159.44 44.09 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.359 -0.978 . . . . 74.450000000000003 108.359 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 30.5 pt -146.36 141.87 21.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 107.921 -1.14 . . . . 72.439999999999998 107.921 174.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.0 m -127.37 125.4 40.63 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 107.38 -1.341 . . . . 74.340000000000003 107.38 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.469 HD13 ' O ' ' B' ' 68' ' ' ILE . 2.9 mp -122.37 125.45 72.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.272 -1.381 . . . . 61.039999999999999 107.272 -176.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.415 HD13 ' NH2' ' B' ' 65' ' ' ARG . 1.6 pt? -119.68 130.35 55.0 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 120.309 -0.556 . . . . 74.040000000000006 110.925 176.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.675 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 62.7 m -116.69 127.61 54.58 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.934 -0.576 . . . . 73.329999999999998 109.459 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -109.86 128.86 55.6 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.986 -0.686 . . . . 64.140000000000001 111.057 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' B' ' 64' ' ' ASN . 52.0 mttm -99.84 8.9 43.82 Favored 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 123.438 0.695 . . . . 75.450000000000003 110.213 173.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.599 ' CE2' ' HD2' ' B' ' 65' ' ' ARG . 7.6 m-85 -57.7 -25.87 60.93 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 121.58 0.705 . . . . 74.140000000000001 109.361 170.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.456 ' C ' ' H ' ' A' ' 76' ' ' HIS . 19.4 m -89.49 6.48 40.71 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 114.913 -1.04 . . . . 62.0 111.229 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.84 -52.94 4.67 Favored Glycine 0 N--CA 1.475 1.3 0 N-CA-C 110.488 -1.045 . . . . 65.019999999999996 110.488 -177.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.456 ' H ' ' C ' ' A' ' 74' ' ' SER . 53.9 m80 -96.7 130.88 29.26 Favored Pre-proline 0 C--N 1.289 -2.043 0 N-CA-C 106.867 -1.531 . . . . 75.299999999999997 106.867 174.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.69 120.32 7.25 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 122.007 1.805 . . . . 75.200000000000003 111.252 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.675 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 15.1 mtmm -102.97 152.93 20.74 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.324 -1.361 . . . . 62.409999999999997 107.324 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.439 ' C ' ' HD1' ' A' ' 80' ' ' TYR . . . -120.48 137.28 12.02 Favored Glycine 0 N--CA 1.417 -2.632 0 C-N-CA 119.027 -1.558 . . . . 62.299999999999997 112.979 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.439 ' HD1' ' C ' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -129.06 142.23 50.97 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 102.743 -3.058 . . . . 72.219999999999999 102.743 172.373 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -140.47 141.89 35.37 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-N 119.042 0.837 . . . . 63.210000000000001 110.63 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.432 ' CD1' ' HD3' ' A' ' 112' ' ' LYS . 44.0 m-85 -110.07 117.2 33.1 Favored 'General case' 0 C--N 1.275 -2.632 0 N-CA-C 107.241 -1.392 . . . . 75.109999999999999 107.241 175.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 25.1 mm -102.98 121.17 53.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 107.347 -1.353 . . . . 74.310000000000002 107.347 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.553 ' HG2' ' OG ' ' A' ' 38' ' ' SER . 28.7 mt-10 -108.16 119.53 39.76 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.512 -0.922 . . . . 73.329999999999998 108.512 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -93.38 165.47 12.76 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.529 0.681 . . . . 75.409999999999997 112.819 -175.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.76 -37.81 64.9 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.065 -0.97 . . . . 74.299999999999997 111.011 174.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -118.63 158.61 25.15 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.126 1.158 . . . . 71.519999999999996 114.126 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -71.93 -26.47 62.31 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 114.701 -1.136 . . . . 54.450000000000003 110.778 175.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -60.21 -41.98 94.2 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.859 -0.61 . . . . 73.230000000000004 110.034 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.0 m -69.73 -39.7 76.65 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 115.603 -0.726 . . . . 40.100000000000001 111.765 -173.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.464 HG21 HG23 ' A' ' 39' ' ' VAL . 8.3 p -64.86 -39.22 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 120.33 -0.548 . . . . 75.340000000000003 109.807 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.68 -34.66 74.27 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.715 0.769 . . . . 73.019999999999996 109.928 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.75 -31.8 63.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.261 -0.881 . . . . 63.329999999999998 110.581 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.33 -45.05 33.96 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.088 -0.506 . . . . 51.229999999999997 110.57 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.1 m -59.44 -21.72 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 113.277 0.843 . . . . 73.019999999999996 113.277 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.97 -17.43 64.67 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.446 0.641 . . . . 75.120000000000005 110.61 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 71.8 mtm -94.98 9.96 37.4 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.562 -0.745 . . . . 70.299999999999997 110.129 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 2.2 p-10 -37.45 -47.53 0.89 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 116.418 2.007 . . . . 74.239999999999995 116.418 -174.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -115.47 30.68 7.2 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 118.95 0.795 . . . . 72.239999999999995 110.622 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.7 t -69.36 164.94 21.79 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-O 121.38 0.61 . . . . 72.230000000000004 110.056 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -109.13 132.13 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.936 0 N-CA-C 107.968 -1.123 . . . . 74.340000000000003 107.968 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -138.04 126.27 23.04 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 116.153 -0.476 . . . . 75.400000000000006 110.23 -174.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 55.54 32.44 19.09 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.845 1.258 . . . . 64.120000000000005 111.256 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.25 -10.58 72.59 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 114.237 -1.347 . . . . 61.020000000000003 113.202 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -113.16 150.65 31.93 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.828 -0.434 . . . . 74.209999999999994 109.828 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.4 m -86.6 123.16 31.48 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.252 -1.018 . . . . 72.450000000000003 108.252 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 44.4 pt -101.6 171.61 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.782 -0.767 . . . . 72.310000000000002 109.541 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 55.6 tptt -132.36 124.76 29.37 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.674 -0.491 . . . . 75.340000000000003 109.674 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 30.2 m -127.78 123.88 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 121.337 0.589 . . . . 75.209999999999994 111.317 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.57 163.69 26.45 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 106.65 -1.611 . . . . 71.519999999999996 106.65 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.83 149.2 86.84 Favored 'Trans proline' 0 N--CA 1.478 0.6 0 C-N-CA 121.839 1.692 . . . . 54.420000000000002 112.046 -174.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.475 ' HE3' ' OG ' ' A' ' 38' ' ' SER . 25.5 ttpp -73.11 84.25 1.32 Allowed 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 122.518 1.151 . . . . 74.040000000000006 112.109 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.458 ' HD3' ' HA ' ' A' ' 113' ' ' ARG 0.564 24.0 mmt180 43.42 79.25 0.04 OUTLIER 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 119.717 3.229 . . . . 72.400000000000006 119.717 -178.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 23.5 m -116.79 84.82 2.21 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 105.5 -2.037 . . . . 63.219999999999999 105.5 169.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -141.16 176.37 8.89 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.799 -1.186 . . . . 75.030000000000001 107.799 -174.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -114.0 103.35 55.21 Favored Pre-proline 0 C--N 1.307 -1.254 0 CA-C-O 121.558 0.694 . . . . 64.120000000000005 110.763 177.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -87.93 16.54 1.88 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.711 2.274 . . . . 51.43 110.578 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 150.78 -142.84 9.93 Favored Glycine 0 N--CA 1.423 -2.2 0 N-CA-C 107.386 -2.286 . . . . 44.140000000000001 107.386 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.46 ' O ' HD12 ' A' ' 119' ' ' ILE . 2.5 pp -82.71 135.77 24.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 117.844 0.822 . . . . 75.040000000000006 110.992 176.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 52.4 m -145.8 114.2 6.7 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.343 0.592 . . . . 73.129999999999995 110.382 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 48.2 m -149.01 135.66 19.58 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.308 -0.997 . . . . 55.32 108.308 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 43.4 m -66.81 -42.88 85.19 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 123.523 0.514 . . . . 64.209999999999994 110.275 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -123.23 132.26 53.97 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.07 -1.085 . . . . 73.140000000000001 108.07 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.168 0 C-N-CA 120.401 -0.52 . . . . 74.010000000000005 111.021 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.795 0 N-CA-C 109.414 -0.587 . . . . 64.519999999999996 109.414 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 63.7 mt -107.49 110.38 31.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 109.195 -0.668 . . . . 73.099999999999994 109.195 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.09 101.33 49.94 Favored Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 116.283 -0.417 . . . . 73.230000000000004 109.917 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -80.99 -16.1 10.15 Favored 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 122.286 1.991 . . . . 61.450000000000003 112.709 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 23.2 p -157.44 135.58 11.01 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 116.344 -0.389 . . . . 74.329999999999998 110.194 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 26.2 mmt -92.54 103.88 16.24 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.804 -0.813 . . . . 72.150000000000006 108.804 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -108.6 116.63 32.35 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.202 -0.453 . . . . 73.120000000000005 111.118 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 67.2 m -143.02 95.8 2.83 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.484 0.659 . . . . 71.030000000000001 109.595 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 10.6 t -134.38 178.23 7.14 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 115.596 -0.729 . . . . 72.019999999999996 109.107 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -99.95 146.66 26.43 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.859 -0.423 . . . . 73.450000000000003 109.859 -177.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 20.4 m -81.03 108.62 14.86 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 110.095 -0.335 . . . . 75.340000000000003 110.095 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -101.66 145.23 29.37 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.181 -0.674 . . . . 63.240000000000002 109.181 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 15.0 tpt -67.13 143.32 56.69 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 123.461 0.475 . . . . 72.109999999999999 110.745 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.426 ' O ' ' HB3' ' B' ' 18' ' ' TYR . 15.5 m -99.44 -57.64 2.11 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-O 120.842 0.353 . . . . 70.209999999999994 111.425 -177.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.9 131.52 43.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.928 0.394 . . . . 75.409999999999997 111.923 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.1 -69.34 0.23 Allowed Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 121.022 -0.609 . . . . 65.329999999999998 112.412 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.26 -30.43 18.49 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.082 -0.647 . . . . 73.409999999999997 112.714 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . 0.432 ' HB2' ' CD ' ' B' ' 117' ' ' PRO . 93.3 t80 -90.41 -79.57 0.35 Allowed 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 120.443 -0.503 . . . . 73.5 110.106 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 5.2 t -69.86 99.6 1.41 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 113.936 1.087 . . . . 73.530000000000001 113.936 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -98.07 3.52 49.27 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 105.48 -2.044 . . . . 71.439999999999998 105.48 171.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.41 -149.61 19.53 Favored Glycine 0 N--CA 1.42 -2.375 0 CA-C-N 113.226 -1.806 . . . . 73.010000000000005 109.655 -176.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.477 ' N ' ' HD2' ' B' ' 23' ' ' PRO . 33.1 Cg_exo -58.36 -43.09 49.35 Favored 'Trans proline' 0 CA--C 1.574 2.505 0 C-N-CA 123.055 2.503 . . . . 71.109999999999999 114.169 174.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' B' ' 22' ' ' PRO . 7.1 Cg_endo -53.43 154.98 13.73 Favored 'Trans proline' 0 C--N 1.397 3.099 0 C-N-CA 122.525 2.15 . . . . 73.230000000000004 112.008 175.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -84.26 133.02 45.86 Favored Pre-proline 0 N--CA 1.41 -2.467 0 N-CA-C 107.697 -1.223 . . . . 71.209999999999994 107.697 177.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -61.39 138.6 77.58 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.351 2.034 . . . . 72.25 112.128 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.557 HD11 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -68.79 176.19 3.18 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.71 -0.677 . . . . 71.349999999999994 110.555 175.393 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 15.7 m -53.68 143.02 21.48 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.097 0.777 . . . . 52.140000000000001 113.097 -170.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.56 -43.21 75.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.758 -1.11 . . . . 72.140000000000001 112.13 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . 0.319 49.2 mt-10 -76.8 -29.66 56.09 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.966 1.099 . . . . 74.420000000000002 113.966 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.457 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.4 OUTLIER -57.02 -35.62 69.47 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.847 -0.797 . . . . 74.010000000000005 108.847 169.174 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -72.33 -39.64 68.04 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.097 -0.956 . . . . 61.130000000000003 110.715 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.655 ' HE2' ' N ' ' B' ' 32' ' ' LYS . 0.0 OUTLIER -65.38 -45.92 82.18 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 112.109 0.411 . . . . 75.150000000000006 112.109 178.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -64.5 -35.48 81.07 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 123.279 0.362 . . . . 74.239999999999995 111.773 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.457 HG12 ' O ' ' B' ' 30' ' ' GLU 0.301 20.0 pt -70.78 -34.04 54.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 112.401 0.519 . . . . 55.229999999999997 112.401 179.484 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.518 ' HB3' ' HA ' ' B' ' 113' ' ' ARG . 44.4 m-20 -67.51 -43.34 81.1 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 121.941 0.877 . . . . 73.230000000000004 109.055 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -60.88 -19.8 60.85 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.957 -1.019 . . . . 75.340000000000003 111.141 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -112.21 11.64 20.28 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.353 -0.61 . . . . 72.450000000000003 109.353 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' SER . . . . . 0.508 ' OG ' ' HE3' ' B' ' 112' ' ' LYS . 31.4 t -99.08 151.17 21.25 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.679 0.752 . . . . 75.310000000000002 111.876 -177.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.427 HG23 HG21 ' B' ' 91' ' ' VAL . 10.5 t -129.09 158.9 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.079 0 N-CA-C 106.718 -1.586 . . . . 61.32 106.718 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . 0.671 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 36.7 t80 -110.0 125.44 52.9 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 106.353 -1.721 . . . . 73.319999999999993 106.353 174.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.443 ' HA ' HG11 ' B' ' 109' ' ' VAL . 59.9 t -117.22 106.91 21.01 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.098 0 N-CA-C 106.97 -1.493 . . . . 61.530000000000001 106.97 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.27 173.72 15.07 Favored Glycine 0 C--N 1.275 -2.842 0 C-N-CA 118.164 -1.97 . . . . 74.120000000000005 112.415 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.0 t30 62.25 6.0 1.72 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 124.842 1.257 . . . . 44.310000000000002 112.948 -177.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.9 p -61.57 131.24 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 107.274 -1.38 . . . . 55.43 107.274 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.511 ' OD1' ' HD2' ' B' ' 103' ' ' ARG . 3.6 p-10 -87.53 167.38 14.0 Favored 'General case' 0 N--CA 1.419 -1.977 0 C-N-CA 118.596 -1.242 . . . . 62.020000000000003 111.194 -172.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' TYR . . . . . 0.523 ' CE2' ' HG2' ' A' ' 51' ' ' GLN . 49.2 t80 -63.81 -12.19 33.58 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 113.981 -1.463 . . . . 72.420000000000002 111.189 -174.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.37 -23.6 67.69 Favored Glycine 0 N--CA 1.42 -2.431 0 CA-C-N 115.937 -0.574 . . . . 72.549999999999997 112.555 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.7 t -90.04 152.04 21.36 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 119.381 -0.927 . . . . 71.120000000000005 108.537 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' THR . . . . . 0.518 ' O ' ' HB2' ' B' ' 53' ' ' LEU . 32.8 p -133.21 178.33 6.98 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.883 -0.784 . . . . 74.120000000000005 108.883 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.495 ' HB3' HD13 ' B' ' 66' ' ' ILE . . . -57.15 -46.61 82.57 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.576 0.954 . . . . 61.310000000000002 113.576 -172.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -57.59 -52.2 66.39 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.088 0.47 . . . . 71.510000000000005 111.442 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -64.82 -40.04 94.56 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-N 115.518 -0.765 . . . . 54.020000000000003 110.767 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . 0.518 ' HB2' ' O ' ' B' ' 49' ' ' THR . 1.0 OUTLIER -67.3 -47.05 71.74 Favored 'General case' 0 C--O 1.255 1.386 0 CA-C-N 114.875 -1.057 . . . . 60.439999999999998 109.135 -177.3 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -58.93 -42.63 90.21 Favored 'General case' 0 C--O 1.188 -2.17 0 C-N-CA 120.671 -0.412 . . . . 73.239999999999995 111.932 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.1 -43.5 70.45 Favored 'General case' 0 C--O 1.266 1.955 0 O-C-N 123.196 0.31 . . . . 37.920000000000002 110.842 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -65.13 -41.51 94.76 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.073 -0.651 . . . . 71.319999999999993 110.534 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -82.32 -23.65 35.03 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 113.891 1.071 . . . . 72.200000000000003 113.891 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 34.5 t -71.26 -24.08 62.1 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 123.658 0.783 . . . . 74.030000000000001 108.947 -177.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 38.7 m -67.26 -24.71 65.82 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 115.56 -0.746 . . . . 73.5 109.899 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 61.5 m -106.59 14.37 27.11 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.554 0.576 . . . . 54.420000000000002 112.554 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . 0.435 ' HA3' ' OG ' ' B' ' 90' ' ' SER . . . 151.17 -174.96 30.29 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 118.953 -1.594 . . . . 75.340000000000003 115.158 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 46.7 m -105.35 120.0 40.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.422 0.629 . . . . 71.040000000000006 110.947 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 67.7 mt -83.23 131.28 34.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.609 -0.723 . . . . 71.510000000000005 112.553 -176.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 72' ' ' LYS . 43.3 t-20 -99.47 -42.32 7.0 Favored 'General case' 0 C--O 1.208 -1.1 0 CA-C-N 115.615 -0.72 . . . . 70.519999999999996 110.478 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.599 ' HD2' ' CE2' ' A' ' 73' ' ' PHE . 55.6 mtp180 -151.57 160.34 43.71 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.318 -0.993 . . . . 71.420000000000002 108.318 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.495 HD13 ' HB3' ' B' ' 50' ' ' ALA . 18.0 pt -148.23 141.47 18.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 107.869 -1.16 . . . . 50.119999999999997 107.869 176.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 47.9 m -127.73 126.44 41.83 Favored 'General case' 0 C--N 1.268 -2.942 0 N-CA-C 107.96 -1.126 . . . . 74.430000000000007 107.96 177.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.469 ' O ' HD13 ' A' ' 68' ' ' ILE . 2.3 mp -121.83 127.42 75.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 106.567 -1.642 . . . . 64.140000000000001 106.567 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -120.99 132.0 54.64 Favored 'General case' 0 C--N 1.286 -2.19 0 C-N-CA 119.801 -0.76 . . . . 74.439999999999998 110.52 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' CYS . . . . . 0.581 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 63.1 m -116.6 127.5 54.53 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 109.35 -0.611 . . . . 73.310000000000002 109.35 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -107.29 131.5 54.14 Favored 'General case' 0 CA--C 1.474 -1.956 0 C-N-CA 119.09 -1.044 . . . . 63.140000000000001 108.857 177.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' B' ' 77' ' ' PRO . 40.1 ttmt -125.16 7.42 7.87 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 109.158 -0.682 . . . . 74.340000000000003 109.158 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -69.64 -18.32 63.58 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.418 0.627 . . . . 72.099999999999994 110.247 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 22.5 p -84.26 1.98 42.2 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 114.85 -1.068 . . . . 71.549999999999997 109.955 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.46 -44.05 2.46 Favored Glycine 0 N--CA 1.439 -1.135 0 N-CA-C 110.733 -0.947 . . . . 60.420000000000002 110.733 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -95.85 128.1 38.74 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 108.096 -1.076 . . . . 70.209999999999994 108.096 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.474 ' HB3' ' HE2' ' B' ' 72' ' ' LYS . 94.2 Cg_endo -78.32 119.0 4.43 Favored 'Trans proline' 0 N--CA 1.434 -1.99 0 C-N-CA 121.298 1.332 . . . . 52.240000000000002 110.535 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' LYS . . . . . 0.581 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 1.2 mtpt -116.57 163.52 15.96 Favored 'General case' 0 CA--C 1.471 -2.095 0 CA-C-N 114.798 -1.092 . . . . 71.010000000000005 110.324 -174.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . 0.42 ' C ' ' HD1' ' B' ' 80' ' ' TYR . . . -134.2 137.84 9.61 Favored Glycine 0 N--CA 1.428 -1.838 0 C-N-CA 119.585 -1.293 . . . . 61.100000000000001 113.853 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . 0.547 ' OH ' ' HG2' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -130.77 142.6 50.41 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 102.794 -3.039 . . . . 74.430000000000007 102.794 172.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.81 141.79 36.7 Favored 'General case' 0 C--N 1.279 -2.467 0 CA-C-N 118.939 0.79 . . . . 63.420000000000002 110.486 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' TYR . . . . . 0.508 ' CD1' ' HG3' ' B' ' 112' ' ' LYS . 27.9 m-85 -109.51 117.18 33.31 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 106.793 -1.558 . . . . 71.340000000000003 106.793 175.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 33.0 mm -102.7 121.43 53.81 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 107.674 -1.232 . . . . 74.420000000000002 107.674 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' B' ' 38' ' ' SER . 31.1 mt-10 -108.07 119.3 39.09 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.704 -0.85 . . . . 72.420000000000002 108.704 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -95.31 164.58 12.77 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.408 0.623 . . . . 72.409999999999997 112.3 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.91 -30.33 31.93 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.194 -0.912 . . . . 62.350000000000001 111.864 176.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.02 147.62 42.18 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 114.79 1.404 . . . . 75.0 114.79 177.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.599 ' O ' HG12 ' B' ' 91' ' ' VAL . 20.4 mmm180 -64.25 -27.44 69.05 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.428 1.091 . . . . 73.230000000000004 110.279 175.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -58.44 -42.16 86.7 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.765 -0.652 . . . . 73.530000000000001 109.771 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' SER . . . . . 0.435 ' OG ' ' HA3' ' B' ' 61' ' ' GLY . 50.1 m -71.58 -37.32 71.04 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 113.082 0.771 . . . . 62.409999999999997 113.082 -173.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . 0.599 HG12 ' O ' ' B' ' 88' ' ' ARG . 12.3 p -65.48 -38.58 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 109.15 -0.685 . . . . 64.040000000000006 109.15 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -69.37 -35.81 76.2 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.612 0.72 . . . . 71.0 109.847 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.25 -31.85 64.36 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.374 -0.83 . . . . 63.310000000000002 110.554 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.31 -45.45 32.28 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.297 -0.41 . . . . 71.019999999999996 111.103 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 33.7 m -58.77 -22.23 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 112.874 0.694 . . . . 61.420000000000002 112.874 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.63 -13.0 61.7 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.371 0.605 . . . . 73.540000000000006 110.796 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 69.6 mtm -99.83 12.81 35.76 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.428 -0.805 . . . . 74.129999999999995 110.75 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . 0.446 ' HA ' HG22 ' B' ' 109' ' ' VAL . 3.9 p-10 -47.72 -40.47 20.46 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.054 0.761 . . . . 74.310000000000002 113.054 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -104.48 108.22 19.53 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 108.2 -1.037 . . . . 72.219999999999999 108.2 170.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 11.5 t -163.38 169.34 19.12 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.49 -0.93 . . . . 74.120000000000005 108.49 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.77 125.21 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 CA-C-O 121.606 0.717 . . . . 73.319999999999993 109.572 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' PHE . . . . . 0.407 ' O ' ' HG2' ' B' ' 105' ' ' ARG . 83.5 t80 -129.64 129.03 43.81 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.628 -0.879 . . . . 74.430000000000007 108.628 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . 0.511 ' HD2' ' OD1' ' B' ' 45' ' ' ASP . 24.2 ttm-85 55.57 31.91 18.09 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.541 1.136 . . . . 75.230000000000004 110.514 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.29 5.62 87.04 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 114.497 -1.229 . . . . 61.43 114.083 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' B' ' 102' ' ' PHE . 12.8 ptm180 -129.11 148.31 51.04 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 117.558 0.679 . . . . 73.450000000000003 110.262 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 37.2 m -80.76 120.98 25.34 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.725 -0.472 . . . . 74.310000000000002 109.725 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 34.7 pt -102.43 171.1 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 C-N-CA 120.352 -0.539 . . . . 73.439999999999998 110.393 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . 0.463 ' HE2' ' O ' ' A' ' 18' ' ' TYR . 53.7 tptt -128.61 125.16 37.6 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 109.267 -0.642 . . . . 75.150000000000006 109.267 -178.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.671 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 33.2 m -127.66 124.4 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-O 121.203 0.525 . . . . 73.299999999999997 111.727 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.02 164.05 24.11 Favored Pre-proline 0 C--O 1.197 -1.71 0 N-CA-C 106.916 -1.513 . . . . 71.349999999999994 106.916 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -66.45 143.82 70.96 Favored 'Trans proline' 0 CA--C 1.568 2.195 0 C-N-CA 122.182 1.921 . . . . 73.439999999999998 114.328 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.529 ' HD2' ' N ' ' B' ' 113' ' ' ARG . 0.9 OUTLIER -114.02 144.68 42.7 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 123.125 0.57 . . . . 73.129999999999995 109.83 -177.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.529 ' N ' ' HD2' ' B' ' 112' ' ' LYS . 56.4 ttp180 -149.7 129.04 12.9 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.701 0.63 . . . . 73.409999999999997 112.701 177.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' THR . . . . . 0.483 HG23 ' OD1' ' B' ' 35' ' ' ASP . 12.8 t -108.83 177.19 4.85 Favored 'General case' 0 CA--C 1.558 1.282 0 N-CA-C 108.667 -0.864 . . . . 75.239999999999995 108.667 174.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -156.26 163.02 40.05 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.654 -1.239 . . . . 72.329999999999998 107.654 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -109.6 145.07 31.16 Favored Pre-proline 0 N--CA 1.47 0.544 0 CA-C-N 118.674 0.67 . . . . 75.239999999999995 112.256 -176.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' PRO . . . . . 0.432 ' CD ' ' HB2' ' B' ' 18' ' ' TYR . 2.3 Cg_endo -87.71 -16.6 2.94 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 122.905 2.403 . . . . 62.039999999999999 111.625 173.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . 131.68 130.95 3.2 Favored Glycine 0 N--CA 1.439 -1.135 0 N-CA-C 110.897 -0.881 . . . . 70.109999999999999 110.897 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 21.0 pt -121.94 120.76 62.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 120.862 0.363 . . . . 74.409999999999997 111.181 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 61.0 m -153.83 142.8 21.18 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.308 -0.245 . . . . 75.329999999999998 110.781 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 49.8 m -121.57 121.44 37.43 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.22 -0.659 . . . . 74.319999999999993 109.22 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 33.4 m -88.95 124.73 34.52 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.398 -0.593 . . . . 74.439999999999998 109.398 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -75.86 -78.65 0.11 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.72 0.295 . . . . 74.299999999999997 111.062 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.437 -1.106 0 CA-C-O 118.042 -0.98 . . . . 53.310000000000002 111.069 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.75 0 N-CA-C 109.411 -0.589 . . . . 74.25 109.411 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.524 ' O ' HD12 ' A' ' 2' ' ' ILE . 2.4 pp -81.4 137.61 20.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 112.275 0.472 . . . . 74.540000000000006 112.275 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.7 119.9 75.43 Favored Pre-proline 0 C--N 1.297 -1.715 0 N-CA-C 107.271 -1.381 . . . . 62.399999999999999 107.271 173.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -49.39 118.11 3.41 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.426 2.751 . . . . 64.25 112.889 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 50.0 t -154.49 148.41 25.62 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.717 -0.674 . . . . 74.409999999999997 109.268 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 27.6 ttt -145.65 140.26 27.18 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.253 -1.017 . . . . 51.329999999999998 108.253 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -98.01 138.11 35.81 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.028 0.442 . . . . 73.329999999999998 110.408 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.3 p -88.99 96.42 10.72 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 115.554 -0.748 . . . . 72.140000000000001 112.04 -177.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.2 m -95.32 101.89 13.65 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.274 -1.009 . . . . 64.329999999999998 108.274 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -111.2 91.73 3.77 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 113.61 0.967 . . . . 74.450000000000003 113.61 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.8 p -100.73 134.18 44.09 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.606 -1.627 . . . . 54.149999999999999 106.606 173.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.457 ' HE2' ' CG ' ' B' ' 25' ' ' PRO . 3.4 tmtm? -143.4 132.7 23.27 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.109 -1.036 . . . . 75.140000000000001 109.877 -171.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.8 mtt -62.21 113.19 2.73 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.075 -0.713 . . . . 74.230000000000004 109.075 174.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.8 m -71.64 -79.04 0.07 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 114.566 1.321 . . . . 74.040000000000006 114.566 -171.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 51.81 92.26 0.02 OUTLIER 'General case' 0 C--O 1.256 1.412 0 C-N-CA 123.902 0.881 . . . . 71.230000000000004 112.085 -173.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.04 164.73 29.25 Favored Glycine 1 N--CA 1.385 -4.704 0 C-N-CA 120.018 -1.087 . . . . 73.120000000000005 110.989 -176.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 76.98 86.28 0.08 Allowed 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 125.234 1.414 . . . . 72.019999999999996 112.813 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -124.79 -58.84 1.47 Allowed 'General case' 0 C--O 1.216 -0.695 0 CA-C-N 114.759 -1.109 . . . . 72.430000000000007 109.277 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.2 m -64.95 106.4 1.23 Allowed 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.863 -0.608 . . . . 74.450000000000003 109.84 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.433 ' OE2' ' HA ' ' A' ' 25' ' ' PRO . 46.2 mt-10 -113.97 13.38 18.24 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-O 121.368 0.604 . . . . 74.530000000000001 109.821 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.511 ' HA3' ' OH ' ' B' ' 82' ' ' TYR . . . 76.7 -125.66 7.66 Favored Glycine 0 N--CA 1.496 2.671 0 CA-C-N 114.864 -1.062 . . . . 53.399999999999999 112.663 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -52.5 -53.95 6.01 Favored 'Trans proline' 0 CA--C 1.564 2.008 0 C-N-CA 122.529 2.153 . . . . 73.530000000000001 112.592 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.94 140.96 47.2 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 121.194 1.262 . . . . 72.099999999999994 110.116 173.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.05 154.54 63.97 Favored Pre-proline 0 C--N 1.292 -1.918 0 N-CA-C 107.524 -1.287 . . . . 74.430000000000007 107.524 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.433 ' HA ' ' OE2' ' A' ' 20' ' ' GLU . 11.5 Cg_endo -57.85 128.45 29.05 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 122.119 1.879 . . . . 62.0 110.353 178.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.485 HD13 ' H ' ' A' ' 26' ' ' LEU 0.289 0.0 OUTLIER -71.28 178.17 3.5 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 120.275 -0.57 . . . . 74.349999999999994 111.31 179.006 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.473 ' HB2' ' OE1' ' A' ' 30' ' ' GLU . 58.5 m -64.4 144.47 57.15 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 113.888 1.069 . . . . 73.530000000000001 113.888 -171.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' A' ' 32' ' ' LYS . . . -53.51 -46.54 70.13 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 114.505 -1.225 . . . . 63.109999999999999 112.82 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -67.24 -31.2 71.39 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 112.974 0.731 . . . . 74.530000000000001 112.974 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.473 ' OE1' ' HB2' ' A' ' 27' ' ' SER . 0.8 OUTLIER -65.52 -38.45 89.69 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.568 -0.287 . . . . 70.099999999999994 110.299 174.601 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -69.59 -35.26 75.17 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.886 -0.597 . . . . 72.209999999999994 110.163 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 28' ' ' ALA . 59.1 mtpt -67.74 -39.72 84.19 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 113.662 0.986 . . . . 63.32 113.662 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -70.59 -38.51 74.02 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 120.54 -0.464 . . . . 71.400000000000006 111.06 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 30' ' ' GLU . 13.8 pt -70.77 -33.42 52.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.705 -0.68 . . . . 65.129999999999995 110.566 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.446 ' OD1' ' HB2' ' A' ' 115' ' ' ASN . 4.7 t70 -56.13 -44.57 79.28 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.46 1.104 . . . . 74.0 109.654 175.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 99.6 mttt -55.56 -29.67 59.41 Favored 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 115.19 -0.914 . . . . 74.540000000000006 112.888 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' A' ' 86' ' ' ALA . 17.4 ptp180 -119.53 18.03 12.83 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 121.45 0.643 . . . . 63.219999999999999 111.566 -172.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.433 ' OG ' ' HG2' ' A' ' 84' ' ' GLU . 47.2 t -107.57 169.15 8.76 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.788 -0.642 . . . . 72.019999999999996 111.249 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.509 ' CG1' HG23 ' A' ' 91' ' ' VAL . 11.2 m -140.33 163.72 23.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 124.496 1.118 . . . . 71.219999999999999 111.488 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.417 ' CE2' ' HG2' ' B' ' 22' ' ' PRO . 21.4 t80 -116.26 129.7 56.41 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 125.227 1.411 . . . . 72.439999999999998 109.608 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 63.0 t -109.12 117.49 54.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.744 -1.206 . . . . 62.340000000000003 107.744 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.04 163.75 12.13 Favored Glycine 0 N--CA 1.426 -2.01 0 C-N-CA 119.522 -1.323 . . . . 60.210000000000001 113.055 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.9 t30 63.38 13.06 6.76 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.895 1.678 . . . . 63.450000000000003 112.883 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.9 p -64.49 137.62 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.452 0.644 . . . . 71.420000000000002 109.533 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -91.09 159.02 16.32 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.394 -0.821 . . . . 65.25 111.435 -174.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 77' ' ' PRO . 4.5 m-85 -61.09 -19.16 61.12 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 114.951 -1.022 . . . . 72.120000000000005 112.013 178.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.86 -24.11 77.34 Favored Glycine 0 N--CA 1.428 -1.856 0 CA-C-N 115.88 -0.6 . . . . 73.5 111.727 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.5 m -86.32 140.01 30.46 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 120.581 -0.447 . . . . 74.519999999999996 109.844 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 76.0 p -109.15 173.25 6.4 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.119 -0.492 . . . . 72.230000000000004 110.778 -176.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.19 -45.27 77.42 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 110.062 -0.348 . . . . 72.510000000000005 110.062 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -58.49 -42.28 87.22 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.472 -0.331 . . . . 73.099999999999994 111.229 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.474 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 1.4 t70 -64.35 -37.9 89.13 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.689 0.757 . . . . 72.340000000000003 109.02 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 33.7 mt -68.51 -47.93 65.71 Favored 'General case' 0 C--O 1.249 1.038 0 CA-C-N 114.965 -1.016 . . . . 75.400000000000006 111.096 177.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -60.81 -49.8 76.03 Favored 'General case' 0 C--O 1.198 -1.654 0 CA-C-N 116.355 -0.384 . . . . 64.439999999999998 111.144 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.49 -40.08 77.84 Favored 'General case' 0 C--O 1.258 1.53 0 CA-C-O 121.367 0.603 . . . . 75.25 111.184 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -69.02 -41.09 78.2 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.154 -0.93 . . . . 61.140000000000001 110.715 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -82.66 -22.85 34.46 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 113.055 0.761 . . . . 75.319999999999993 113.055 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.7 m -72.11 -21.23 61.51 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-N 115.19 -0.914 . . . . 75.349999999999994 110.979 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.1 m -57.68 -17.78 16.92 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.388 -0.369 . . . . 53.200000000000003 111.161 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.86 ' SG ' ' HA ' ' A' ' 90' ' ' SER . 44.1 t -94.4 -76.56 0.48 Allowed 'General case' 0 N--CA 1.417 -2.08 0 CA-C-O 120.789 0.328 . . . . 54.210000000000001 110.638 175.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -130.06 -143.33 5.38 Favored Glycine 0 CA--C 1.508 -0.351 0 C-N-CA 120.257 -0.973 . . . . 54.450000000000003 115.217 -176.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.0 m -105.13 121.51 43.96 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 122.437 0.295 . . . . 74.040000000000006 110.991 -173.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 61.2 mt -85.22 129.27 38.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 116.028 -0.533 . . . . 64.310000000000002 112.014 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -93.4 -44.75 8.12 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.51 0.724 . . . . 75.439999999999998 111.504 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -149.12 159.55 44.14 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.216 -0.902 . . . . 75.140000000000001 110.27 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.435 HG21 HD13 ' A' ' 66' ' ' ILE . 39.4 pt -145.34 135.0 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.994 0 N-CA-C 106.753 -1.573 . . . . 73.319999999999993 106.753 170.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.0 m -124.78 123.8 40.75 Favored 'General case' 0 C--N 1.272 -2.799 0 N-CA-C 106.112 -1.81 . . . . 75.510000000000005 106.112 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.6 mp -121.24 117.39 52.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 106.562 -1.644 . . . . 72.329999999999998 106.562 -175.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.35 0.9 OUTLIER -121.32 129.83 53.31 Favored 'General case' 0 C--N 1.274 -2.676 0 C-N-CA 120.127 -0.629 . . . . 74.329999999999998 112.558 177.763 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.504 ' HB2' HG12 ' B' ' 66' ' ' ILE . 81.0 m -116.55 121.21 41.1 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 115.647 -0.706 . . . . 74.349999999999994 109.256 -177.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.555 ' HA ' ' HA ' ' B' ' 65' ' ' ARG . 1.1 t70 -117.48 125.45 50.92 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 123.757 0.823 . . . . 70.140000000000001 110.586 -173.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.458 ' HE2' ' HB3' ' A' ' 77' ' ' PRO . 39.6 ttmt -115.9 16.73 16.17 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.224 -0.658 . . . . 73.5 109.224 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.426 ' HD1' ' N ' ' A' ' 74' ' ' SER . 0.0 OUTLIER -63.61 -23.15 67.26 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 119.934 -0.706 . . . . 74.5 112.817 -175.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.426 ' N ' ' HD1' ' A' ' 73' ' ' PHE . 14.9 m -81.79 -0.9 45.32 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.154 -0.475 . . . . 62.32 111.134 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.9 -40.57 2.38 Favored Glycine 0 CA--C 1.5 -0.881 0 N-CA-C 110.095 -1.202 . . . . 75.329999999999998 110.095 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -95.14 130.28 33.0 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 107.923 -1.14 . . . . 65.430000000000007 107.923 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.458 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 36.8 Cg_endo -70.74 118.07 5.49 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.387 1.392 . . . . 72.319999999999993 110.505 177.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -108.61 151.45 26.11 Favored 'General case' 0 CA--C 1.476 -1.898 0 CA-C-N 116.242 -0.436 . . . . 72.200000000000003 109.943 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.42 140.07 11.5 Favored Glycine 0 N--CA 1.409 -3.159 0 C-N-CA 120.517 -0.849 . . . . 72.209999999999994 111.025 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -151.41 144.13 24.37 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.788 -0.449 . . . . 73.510000000000005 109.788 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.42 154.81 49.89 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.968 -0.382 . . . . 74.420000000000002 109.968 -173.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -122.39 120.57 34.37 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 108.544 -0.91 . . . . 75.230000000000004 108.544 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.5 mm -101.73 119.22 49.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 107.17 -1.418 . . . . 74.140000000000001 107.17 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.433 ' HG2' ' OG ' ' A' ' 38' ' ' SER . 32.9 mt-10 -104.97 120.47 41.53 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.157 -0.682 . . . . 55.109999999999999 109.157 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -100.38 165.44 11.45 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 121.378 0.609 . . . . 65.140000000000001 112.055 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.456 ' O ' ' HD3' ' A' ' 37' ' ' ARG . . . -81.16 -32.37 33.67 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.728 -1.124 . . . . 51.240000000000002 110.965 175.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -123.5 160.67 26.46 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 113.246 0.832 . . . . 74.030000000000001 113.246 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -69.54 -32.48 71.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.359 -1.291 . . . . 75.239999999999995 112.279 174.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -60.74 -36.56 79.19 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.948 -0.301 . . . . 73.510000000000005 110.702 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.86 ' HA ' ' SG ' ' A' ' 60' ' ' CYS . 14.8 m -63.33 -45.2 92.34 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 116.574 -0.284 . . . . 61.350000000000001 111.403 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.509 HG23 ' CG1' ' A' ' 39' ' ' VAL . 0.6 OUTLIER -65.7 -43.2 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 119.317 -0.373 . . . . 73.340000000000003 111.71 177.54 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.2 -35.28 75.04 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.687 0.625 . . . . 73.239999999999995 112.687 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.557 ' HB2' ' SG ' ' A' ' 60' ' ' CYS . . . -75.34 -37.89 60.46 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.122 0.486 . . . . 64.209999999999994 110.954 177.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.51 -40.64 76.83 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 116.086 -0.507 . . . . 73.219999999999999 111.861 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 91' ' ' VAL . 24.5 m -56.64 -22.16 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 112.282 0.475 . . . . 62.310000000000002 112.282 177.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.89 -19.38 62.62 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-O 120.894 0.378 . . . . 64.510000000000005 110.043 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 32.4 mtm -88.46 7.68 31.67 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.202 0.601 . . . . 75.400000000000006 111.935 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 7.3 t70 -33.39 -54.11 0.41 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 116.938 2.199 . . . . 55.329999999999998 116.938 -178.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -124.42 45.37 2.53 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 120.495 1.498 . . . . 74.329999999999998 110.125 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 42.9 m -84.95 162.37 19.44 Favored 'General case' 0 CA--C 1.571 1.759 0 CA-C-N 114.3 -1.318 . . . . 63.200000000000003 109.752 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.0 p -99.71 137.86 25.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 O-C-N 121.465 -0.772 . . . . 72.200000000000003 110.646 -174.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -151.2 117.87 5.77 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.467 -0.938 . . . . 65.219999999999999 108.467 -177.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.381 83.2 mtt85 59.99 55.09 3.92 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 116.078 1.881 . . . . 71.230000000000004 116.078 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.99 -13.05 1.45 Allowed Glycine 0 N--CA 1.469 0.856 0 CA-C-N 114.806 -1.088 . . . . 44.200000000000003 114.893 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -119.39 161.08 21.09 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-O 121.012 0.434 . . . . 71.450000000000003 110.383 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.9 m -94.59 127.81 40.78 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 108.366 -0.975 . . . . 72.219999999999999 108.366 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 48.2 pt -101.37 171.27 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.334 0 C-N-CA 119.782 -0.767 . . . . 75.25 109.949 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 55.1 tptt -125.88 129.35 49.17 Favored 'General case' 0 N--CA 1.409 -2.522 0 CA-C-N 114.791 -1.095 . . . . 64.109999999999999 108.809 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.456 ' HB ' ' HA ' ' A' ' 98' ' ' ASP . 47.3 t -119.95 112.25 36.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 107.658 -1.238 . . . . 72.409999999999997 107.658 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 72.8 mt -112.4 152.59 44.67 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 109.017 -0.734 . . . . 75.200000000000003 109.017 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.42 ' HA ' HG13 ' A' ' 39' ' ' VAL . 3.3 Cg_exo -75.44 129.9 12.36 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 N-CA-C 107.892 -1.618 . . . . 52.409999999999997 107.892 171.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -76.35 112.66 13.09 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 107.584 -1.265 . . . . 71.239999999999995 107.584 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -149.72 156.91 42.66 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 115.671 -0.695 . . . . 74.439999999999998 110.774 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 13.8 m 70.37 17.52 6.94 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-O 122.031 0.92 . . . . 75.519999999999996 109.607 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.446 ' HB2' ' OD1' ' A' ' 35' ' ' ASP . 0.8 OUTLIER -91.49 16.23 10.75 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.733 -0.604 . . . . 73.209999999999994 109.923 178.444 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.45 ' SD ' ' HE3' ' A' ' 32' ' ' LYS . 54.6 mtm -60.35 122.2 65.46 Favored Pre-proline 0 C--O 1.24 0.579 0 CA-C-N 115.195 -0.911 . . . . 75.430000000000007 109.754 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -55.68 141.17 84.49 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 123.075 2.517 . . . . 63.210000000000001 112.508 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -93.4 -155.49 31.95 Favored Glycine 0 N--CA 1.434 -1.457 0 CA-C-N 115.608 -0.723 . . . . 45.240000000000002 111.355 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . 0.316 2.1 pp -76.74 94.5 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 114.025 1.12 . . . . 73.129999999999995 114.025 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.4 t -152.57 100.07 2.52 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.897 -1.047 . . . . 75.219999999999999 108.279 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.3 t -155.83 96.79 1.77 Allowed 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.219 0.533 . . . . 61.32 110.647 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.0 t -131.58 16.27 4.88 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.198 -1.038 . . . . 74.099999999999994 108.198 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -143.82 131.15 20.87 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 114.564 -1.198 . . . . 65.349999999999994 108.62 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 . . . . . 0 C--N 1.303 -1.44 0 N-CA-C 109.652 -0.499 . . . . 74.219999999999999 109.652 -178.056 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.967 0 N-CA-C 109.295 -0.632 . . . . 61.219999999999999 109.295 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 50.4 mm -90.57 110.75 22.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 109.156 -0.683 . . . . 72.510000000000005 109.156 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -135.91 106.05 9.7 Favored Pre-proline 0 C--N 1.301 -1.537 0 CA-C-N 115.821 -0.627 . . . . 73.129999999999995 109.681 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.71 130.66 22.47 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.349 2.033 . . . . 74.319999999999993 112.179 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 19.2 p -98.68 6.99 46.62 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.324 0.583 . . . . 73.140000000000001 110.616 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -80.51 156.48 26.5 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.486 -0.779 . . . . 72.120000000000005 110.853 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . 0.476 ' HB3' ' O ' ' B' ' 113' ' ' ARG . 0.0 OUTLIER -142.37 171.52 13.95 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.573 -0.74 . . . . 73.129999999999995 110.001 177.602 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 57.1 m -77.2 116.97 18.28 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 120.988 0.423 . . . . 54.130000000000003 110.943 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 88.2 m -57.5 133.79 55.53 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.608 0.763 . . . . 75.310000000000002 110.143 176.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -75.71 132.77 40.74 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.728 0.64 . . . . 64.439999999999998 112.728 -175.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 18.7 m -66.22 -28.86 69.06 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 109.249 -0.648 . . . . 43.240000000000002 109.249 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 61.6 tttp 177.43 -64.81 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 125.613 1.565 . . . . 63.329999999999998 107.516 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 25.9 mmt 63.54 86.22 0.12 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.656 -1.156 . . . . 74.319999999999993 113.772 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 11.2 t 171.05 -29.79 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 125.106 1.363 . . . . 74.439999999999998 107.781 173.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.95 178.75 10.0 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.954 -1.499 . . . . 73.049999999999997 106.954 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.23 -56.09 3.96 Favored Glycine 0 C--N 1.312 -0.781 0 C-N-CA 120.693 -0.765 . . . . 64.219999999999999 112.534 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.48 119.48 34.05 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.894 -0.41 . . . . 38.289999999999999 109.894 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -121.9 -66.41 1.04 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.28 -0.568 . . . . 72.439999999999998 110.804 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.458 ' HB ' ' CB ' ' B' ' 25' ' ' PRO . 10.1 t -140.32 155.85 46.65 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.201 -0.6 . . . . 73.519999999999996 111.129 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -76.0 -23.36 55.23 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.027 -0.988 . . . . 74.540000000000006 110.665 176.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.97 -140.62 5.89 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 120.848 -0.692 . . . . 51.229999999999997 112.141 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.438 ' N ' ' HD2' ' B' ' 23' ' ' PRO . 72.1 Cg_exo -49.74 -44.9 34.19 Favored 'Trans proline' 0 CA--C 1.567 2.125 0 C-N-CA 123.871 3.048 . . . . 73.019999999999996 116.031 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' B' ' 22' ' ' PRO . 10.3 Cg_endo -53.84 142.2 63.82 Favored 'Trans proline' 0 C--N 1.395 2.975 0 C-N-CA 121.96 1.774 . . . . 75.049999999999997 111.36 176.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -54.16 129.16 58.84 Favored Pre-proline 0 C--O 1.241 0.63 0 N-CA-C 113.454 0.909 . . . . 71.420000000000002 113.454 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.458 ' CB ' ' HB ' ' B' ' 19' ' ' THR . 5.7 Cg_exo -59.99 135.51 63.38 Favored 'Trans proline' 0 CA--C 1.501 -1.155 0 C-N-CA 123.641 2.894 . . . . 55.020000000000003 114.139 -177.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.452 HD22 ' O ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -113.92 125.89 54.54 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 107.037 -1.468 . . . . 73.109999999999999 107.037 173.346 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 32.8 t -71.84 173.94 7.58 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 113.479 0.918 . . . . 72.019999999999996 113.479 -168.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.512 ' O ' ' HG3' ' B' ' 32' ' ' LYS . . . -49.0 -46.17 43.54 Favored 'General case' 0 C--O 1.21 -0.982 0 CA-C-N 114.491 -1.231 . . . . 72.299999999999997 112.288 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -68.0 -33.01 73.8 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 112.054 0.39 . . . . 72.329999999999998 112.054 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.444 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.9 OUTLIER -65.71 -39.42 91.2 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.446 -0.576 . . . . 60.020000000000003 109.446 172.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -67.06 -36.87 82.98 Favored 'General case' 0 C--O 1.207 -1.149 0 CA-C-N 115.573 -0.739 . . . . 74.010000000000005 110.087 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' B' ' 28' ' ' ALA . 59.9 mtpt -66.35 -40.24 89.69 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 113.497 0.925 . . . . 75.530000000000001 113.497 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -70.08 -39.77 75.39 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 120.299 -0.56 . . . . 73.5 111.281 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.444 HG12 ' O ' ' B' ' 30' ' ' GLU . 11.1 pt -70.57 -32.99 51.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.785 -0.643 . . . . 63.210000000000001 110.328 178.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.516 ' OD2' ' HB2' ' B' ' 113' ' ' ARG . 10.4 t70 -56.35 -42.96 78.6 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.827 1.251 . . . . 72.400000000000006 109.699 176.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 97.7 mttt -57.64 -33.28 68.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.05 -0.977 . . . . 64.219999999999999 112.015 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -102.89 2.55 35.42 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 123.713 0.805 . . . . 73.420000000000002 111.23 -172.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 71.1 p -104.33 162.94 12.79 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 114.51 1.3 . . . . 62.229999999999997 114.51 -175.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 13.9 m -133.4 163.61 37.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.674 -1.148 . . . . 43.509999999999998 111.08 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . 0.437 ' CD2' HD12 ' B' ' 110' ' ' LEU . 23.1 t80 -116.17 130.53 56.84 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 125.281 1.432 . . . . 74.109999999999999 109.346 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 71.7 t -109.89 120.49 61.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 124.766 1.226 . . . . 41.109999999999999 109.06 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -118.59 169.38 13.44 Favored Glycine 0 N--CA 1.427 -1.95 0 C-N-CA 120.139 -1.029 . . . . 41.119999999999997 112.453 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 60.6 t30 65.97 12.54 8.5 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 126.451 1.901 . . . . 75.230000000000004 112.834 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -72.09 117.43 15.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 108.218 -1.03 . . . . 63.200000000000003 108.218 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -77.04 162.0 27.86 Favored 'General case' 0 C--O 1.253 1.288 0 C-N-CA 119.941 -0.703 . . . . 73.129999999999995 111.611 -173.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -69.01 98.52 0.97 Allowed 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 107.21 -1.404 . . . . 74.349999999999994 107.21 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 159.15 -26.08 0.36 Allowed Glycine 0 N--CA 1.417 -2.574 0 C-N-CA 120.539 -0.838 . . . . 61.210000000000001 112.051 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.7 t -77.18 149.46 35.57 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.7 -1.222 . . . . 74.25 107.7 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 25.2 p -99.55 167.54 10.53 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.444 -0.502 . . . . 74.120000000000005 110.883 -173.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.403 ' HB3' HD12 ' B' ' 66' ' ' ILE . . . -71.04 -41.78 70.34 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 109.102 -0.703 . . . . 74.150000000000006 109.102 177.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -57.39 -44.16 84.25 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.136 -0.484 . . . . 75.340000000000003 111.094 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.88 -45.95 78.45 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.133 0.492 . . . . 64.219999999999999 110.381 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 74.6 mt -64.26 -47.68 78.69 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.094 -0.957 . . . . 73.430000000000007 111.862 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -62.92 -50.85 69.22 Favored 'General case' 0 C--O 1.199 -1.59 0 C-N-CA 120.498 -0.481 . . . . 73.430000000000007 111.372 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.97 -40.08 72.73 Favored 'General case' 0 C--O 1.257 1.467 0 CA-C-O 121.594 0.711 . . . . 73.239999999999995 111.454 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -69.35 -41.56 76.45 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.78 -1.1 . . . . 73.450000000000003 110.542 -176.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -83.06 -23.19 33.27 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.903 0.705 . . . . 73.340000000000003 112.903 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 67.1 m -71.32 -22.72 61.89 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 115.472 -0.785 . . . . 71.540000000000006 109.534 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 58.3 m -65.84 -18.12 65.12 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.739 -0.664 . . . . 62.299999999999997 109.96 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . 0.574 ' O ' ' HA ' ' B' ' 90' ' ' SER . 70.3 m -115.29 19.18 15.74 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 116.245 -0.434 . . . . 54.25 111.669 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . 0.418 ' HA3' ' OG ' ' B' ' 90' ' ' SER . . . 149.03 -162.64 28.99 Favored Glycine 0 N--CA 1.46 0.284 0 C-N-CA 118.282 -1.913 . . . . 72.040000000000006 116.034 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 15.1 m -111.1 115.1 28.86 Favored 'General case' 0 C--O 1.25 1.092 0 C-N-CA 123.018 0.527 . . . . 71.140000000000001 110.399 -175.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 65.5 mt -80.73 130.85 35.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.668 0.747 . . . . 71.450000000000003 112.995 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -100.31 -43.81 6.14 Favored 'General case' 0 C--O 1.21 -1.001 0 N-CA-C 107.09 -1.448 . . . . 61.25 107.09 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.555 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 86.4 mtt180 -153.64 161.88 41.76 Favored 'General case' 0 C--O 1.21 -1.014 0 C-N-CA 123.732 0.813 . . . . 75.409999999999997 110.384 176.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' B' ' 82' ' ' TYR . 31.9 pt -144.79 137.81 22.15 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.495 0 N-CA-C 106.656 -1.609 . . . . 73.319999999999993 106.656 169.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' B' ' 81' ' ' ALA . 53.3 m -125.75 120.82 31.64 Favored 'General case' 0 C--N 1.273 -2.745 0 N-CA-C 106.912 -1.514 . . . . 63.329999999999998 106.912 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mp -117.08 116.72 52.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 106.278 -1.749 . . . . 72.310000000000002 106.278 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.306 1.5 pt? -122.12 132.69 54.61 Favored 'General case' 0 C--N 1.275 -2.669 0 C-N-CA 119.666 -0.814 . . . . 73.040000000000006 111.531 176.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 73.5 m -116.68 120.5 38.82 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 115.108 -0.951 . . . . 54.43 108.592 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . 0.407 ' HB2' ' CE2' ' B' ' 73' ' ' PHE . 2.4 p-10 -106.14 121.66 44.62 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 116.513 -2.075 . . . . 71.430000000000007 111.061 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . 0.407 ' HG2' ' HB3' ' B' ' 77' ' ' PRO . 43.8 mtpt -118.05 -6.79 10.91 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.446 -1.252 . . . . 74.099999999999994 111.157 -176.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.407 ' CE2' ' HB2' ' B' ' 71' ' ' ASP . 52.6 p90 -69.93 -17.2 63.31 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.556 0.693 . . . . 71.239999999999995 109.837 -177.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 20.1 m -81.21 -1.78 46.12 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.283 -0.871 . . . . 71.310000000000002 109.692 176.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.26 -59.66 0.37 Allowed Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 110.979 -0.849 . . . . 65.239999999999995 110.979 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . 0.428 ' HA ' ' HD3' ' B' ' 77' ' ' PRO . 72.5 m80 -96.5 131.15 28.9 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 110.167 -0.308 . . . . 74.450000000000003 110.167 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' B' ' 76' ' ' HIS . 13.6 Cg_exo -72.87 119.28 5.98 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.589 2.193 . . . . 51.450000000000003 112.616 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 37.1 mtmm -112.31 154.83 25.08 Favored 'General case' 0 CA--C 1.48 -1.732 0 N-CA-C 108.069 -1.086 . . . . 72.299999999999997 108.069 174.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.56 141.13 12.29 Favored Glycine 0 N--CA 1.411 -3.027 0 C-N-CA 119.612 -1.28 . . . . 74.310000000000002 112.325 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -154.61 145.33 22.4 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.001 -0.599 . . . . 74.519999999999996 109.634 175.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' B' ' 67' ' ' THR . . . -137.69 154.98 49.59 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 116.216 -0.447 . . . . 72.150000000000006 110.381 -172.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' B' ' 66' ' ' ILE . 49.1 m-85 -123.61 119.08 28.82 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.624 -0.88 . . . . 70.450000000000003 108.624 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.481 HG23 HG23 ' B' ' 66' ' ' ILE . 19.5 mm -101.66 119.94 50.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 107.07 -1.456 . . . . 75.420000000000002 107.07 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -107.19 125.55 51.25 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 108.579 -0.897 . . . . 64.530000000000001 108.579 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -106.7 164.52 12.02 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 120.994 0.426 . . . . 73.25 110.471 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.95 -18.72 23.31 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.743 -0.662 . . . . 72.319999999999993 111.097 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -127.24 142.06 51.57 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.297 -0.411 . . . . 74.409999999999997 111.118 -176.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -61.29 -34.4 75.15 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.116 0.784 . . . . 63.329999999999998 113.116 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -56.84 -37.16 70.89 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.537 -0.301 . . . . 74.109999999999999 111.103 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' B' ' 60' ' ' CYS . 15.0 m -62.92 -43.91 97.5 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 111.766 0.284 . . . . 74.329999999999998 111.766 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . 0.492 ' O ' HG13 ' B' ' 95' ' ' VAL 0.3 0.7 OUTLIER -67.31 -42.9 88.18 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 C-N-CA 120.426 -0.51 . . . . 65.510000000000005 111.924 177.515 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -59.55 -36.29 75.88 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.491 -0.484 . . . . 75.25 112.291 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.19 -35.68 63.97 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.802 0.334 . . . . 74.230000000000004 111.402 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.57 -38.42 62.68 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.254 -0.43 . . . . 75.040000000000006 111.958 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . 0.492 HG13 ' O ' ' B' ' 91' ' ' VAL . 28.0 m -58.94 -23.3 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 112.175 0.435 . . . . 72.430000000000007 112.175 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.24 -9.89 58.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.419 0.628 . . . . 54.130000000000003 111.142 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 8.0 ttp -103.23 7.05 38.52 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.383 -0.969 . . . . 61.229999999999997 108.383 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . 0.439 ' HA ' ' HB ' ' B' ' 109' ' ' VAL . 4.1 p-10 -41.24 -56.79 2.3 Favored 'General case' 0 C--O 1.209 -1.062 0 N-CA-C 113.463 0.912 . . . . 61.039999999999999 113.463 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -101.7 97.12 7.57 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 118.474 0.579 . . . . 71.450000000000003 109.735 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 26.0 p -145.83 165.04 30.05 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.212 -0.904 . . . . 74.209999999999994 110.537 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 p -107.63 119.46 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-O 121.359 0.599 . . . . 73.299999999999997 109.968 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -131.91 127.77 37.13 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.688 -0.687 . . . . 72.129999999999995 109.255 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 48.6 ttt-85 62.17 33.2 17.02 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 122.547 1.165 . . . . 74.430000000000007 110.229 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.41 5.98 86.45 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 114.073 -1.421 . . . . 70.140000000000001 114.899 175.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -136.92 155.72 49.39 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 117.76 0.78 . . . . 71.109999999999999 111.077 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 46.8 m -78.49 123.92 27.57 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.921 -0.77 . . . . 63.140000000000001 108.921 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 41.4 pt -101.38 171.35 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 C-N-CA 119.969 -0.692 . . . . 74.510000000000005 109.643 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -124.43 137.48 54.44 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 106.858 -1.534 . . . . 55.0 106.858 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' B' ' 98' ' ' ASP . 24.9 t -127.33 122.72 60.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.636 -1.246 . . . . 72.519999999999996 107.636 174.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . 0.437 HD12 ' CD2' ' B' ' 40' ' ' TYR . 73.9 mt -121.08 150.1 52.75 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 109.308 -0.627 . . . . 74.0 109.308 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.454 ' HG2' ' HB2' ' B' ' 115' ' ' ASN . 1.1 Cg_endo -81.63 135.28 9.05 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 C-N-CA 121.778 1.652 . . . . 75.010000000000005 108.16 170.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -73.87 -28.62 61.66 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.484 -0.887 . . . . 74.239999999999995 109.477 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.516 ' HB2' ' OD2' ' B' ' 35' ' ' ASP . 4.3 tpp180 -119.9 -79.06 0.6 Allowed 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 113.254 0.835 . . . . 72.150000000000006 113.254 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 4.3 p -122.67 139.41 53.97 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 113.14 0.792 . . . . 72.329999999999998 113.14 -172.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' ASN . . . . . 0.454 ' HB2' ' HG2' ' B' ' 111' ' ' PRO . 7.2 t30 -107.44 -18.65 13.8 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.987 -1.006 . . . . 70.540000000000006 108.353 174.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' MET . . . . . 0.42 ' HA ' ' HD3' ' B' ' 117' ' ' PRO . 50.2 ttm -84.45 118.0 70.07 Favored Pre-proline 0 N--CA 1.443 -0.777 0 CA-C-N 115.085 -0.961 . . . . 73.310000000000002 108.478 177.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' B' ' 116' ' ' MET . 1.8 Cg_endo -81.37 -69.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.136 1.89 . . . . 74.310000000000002 113.588 -177.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . 80.93 29.91 40.48 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 110.976 -0.85 . . . . 73.409999999999997 110.976 -177.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 67.0 mt -57.46 -44.54 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 122.748 0.419 . . . . 75.430000000000007 110.304 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 15.8 m 67.54 7.66 5.77 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.392 1.077 . . . . 73.239999999999995 111.574 177.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 26.3 t -133.17 -177.64 4.61 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 107.777 -1.194 . . . . 71.310000000000002 107.777 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 9.8 t -136.29 150.23 48.81 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.067 -0.716 . . . . 74.219999999999999 109.067 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -101.22 140.27 35.75 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.497 -1.298 . . . . 73.420000000000002 107.497 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.294 -1.82 0 N-CA-C 108.622 -0.881 . . . . 73.120000000000005 108.622 -175.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.569 0 N-CA-C 109.994 -0.373 . . . . 60.43 109.994 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.7 tt -89.9 110.55 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 108.67 -0.863 . . . . 73.530000000000001 108.67 176.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -95.98 114.33 63.93 Favored Pre-proline 0 C--N 1.311 -1.1 0 CA-C-N 115.48 -0.782 . . . . 74.25 111.035 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.66 147.92 46.17 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.202 1.935 . . . . 73.239999999999995 110.035 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 20.0 p -101.39 87.91 3.33 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.801 -0.759 . . . . 73.209999999999994 113.023 -176.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -76.61 145.7 38.72 Favored 'General case' 0 C--O 1.249 1.046 0 N-CA-C 107.005 -1.479 . . . . 73.010000000000005 107.005 174.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -165.3 110.42 0.9 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.285 0.564 . . . . 72.430000000000007 110.811 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.9 t -87.78 87.38 7.35 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-O 122.554 1.168 . . . . 70.420000000000002 109.846 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.6 p -102.66 101.16 11.27 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 114.939 -1.028 . . . . 72.0 109.783 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 55.5 m80 -142.57 140.67 31.82 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.501 -0.926 . . . . 73.329999999999998 108.501 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.467 ' HA ' ' HD2' ' A' ' 78' ' ' LYS . 24.1 m -79.36 100.91 7.83 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-O 121.137 0.494 . . . . 64.310000000000002 110.369 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -74.45 113.45 11.7 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.257 -0.883 . . . . 71.219999999999999 112.15 -177.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.4 mpt? 30.77 91.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 126.53 1.932 . . . . 73.510000000000005 114.614 174.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.444 ' O ' ' HB3' ' B' ' 23' ' ' PRO . 12.2 t -152.72 140.48 19.99 Favored 'General case' 0 N--CA 1.417 -2.115 0 C-N-CA 120.253 -0.579 . . . . 71.040000000000006 110.39 -177.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.34 159.44 38.79 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 116.649 -0.25 . . . . 75.099999999999994 110.357 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.433 ' HA3' ' NH1' ' B' ' 65' ' ' ARG . . . -172.28 -141.67 3.5 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 109.663 -1.375 . . . . 45.109999999999999 109.663 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -173.69 148.58 1.51 Allowed 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 123.007 0.523 . . . . 75.519999999999996 110.69 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -118.64 151.5 37.81 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.554 -0.535 . . . . 64.140000000000001 109.554 176.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.9 m -144.53 142.67 30.38 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.1 -0.704 . . . . 74.430000000000007 109.1 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.537 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 41.9 mt-10 -63.16 -31.31 72.42 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 114.951 1.463 . . . . 72.540000000000006 114.951 -175.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.21 -118.13 5.24 Favored Glycine 0 N--CA 1.474 1.22 0 C-N-CA 120.959 -0.639 . . . . 42.439999999999998 112.829 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -56.32 -47.47 24.09 Favored 'Trans proline' 0 CA--C 1.57 2.277 0 C-N-CA 123.528 2.818 . . . . 62.130000000000003 115.504 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.537 ' HD2' ' O ' ' A' ' 20' ' ' GLU . 75.2 Cg_exo -54.0 133.8 56.71 Favored 'Trans proline' 0 C--N 1.396 3.041 0 C-N-CA 121.652 1.568 . . . . 61.140000000000001 111.087 176.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -73.31 142.33 81.63 Favored Pre-proline 0 C--N 1.303 -1.445 0 CA-C-N 116.042 -0.526 . . . . 74.230000000000004 111.336 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.73 117.57 5.16 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.561 2.174 . . . . 72.519999999999996 112.5 -177.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.591 HD11 ' H ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -72.96 176.2 5.94 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.348 -0.842 . . . . 73.409999999999997 111.189 178.32 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.6 t -58.76 144.75 42.81 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 113.02 0.748 . . . . 60.420000000000002 113.02 -174.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 31' ' ' LYS . . . -54.2 -34.08 59.74 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.633 -1.167 . . . . 60.140000000000001 111.311 173.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -72.27 -34.83 68.5 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 119.399 -0.92 . . . . 74.310000000000002 109.648 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.493 ' O ' HG12 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -63.54 -36.02 82.4 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.565 -0.531 . . . . 73.409999999999997 109.565 174.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 28' ' ' ALA . 74.7 mmtt -59.13 -47.82 83.89 Favored 'General case' 0 C--O 1.208 -1.12 0 N-CA-C 108.819 -0.808 . . . . 70.219999999999999 108.819 177.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -60.2 -46.11 90.84 Favored 'General case' 0 C--O 1.209 -1.056 0 N-CA-C 113.46 0.911 . . . . 74.299999999999997 113.46 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -69.58 -41.01 76.39 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.102 -0.639 . . . . 72.540000000000006 112.259 -176.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 30' ' ' GLU . 27.9 pt -70.12 -35.87 65.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 120.513 -0.475 . . . . 72.450000000000003 111.059 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.665 ' OD1' ' HE3' ' A' ' 112' ' ' LYS . 30.0 t70 -68.44 -39.27 81.57 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.397 0.679 . . . . 64.239999999999995 110.563 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -66.61 -14.5 62.48 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.709 -0.678 . . . . 72.409999999999997 112.295 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -112.73 12.69 19.7 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 110.003 -0.369 . . . . 71.010000000000005 110.003 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.49 ' OG ' ' HB3' ' A' ' 112' ' ' LYS . 97.5 p -97.02 157.32 15.96 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.639 0.733 . . . . 75.140000000000001 112.392 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.466 HG23 HG21 ' A' ' 91' ' ' VAL . 49.0 t -127.82 151.53 34.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 114.912 -1.04 . . . . 75.109999999999999 108.401 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.653 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 24.4 t80 -104.4 127.66 52.12 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 125.055 1.342 . . . . 72.430000000000007 107.847 174.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.6 t -115.44 116.43 52.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 107.927 -1.138 . . . . 75.430000000000007 107.927 177.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.26 164.34 12.09 Favored Glycine 0 C--N 1.29 -1.987 0 C-N-CA 119.669 -1.253 . . . . 75.209999999999994 112.946 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 t30 68.75 25.02 6.46 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 125.677 1.591 . . . . 74.299999999999997 113.163 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.7 p -78.56 119.82 28.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 118.457 -1.297 . . . . 72.420000000000002 108.489 174.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -110.87 149.66 30.29 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.995 -1.113 . . . . 70.140000000000001 107.995 -173.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -51.45 115.58 1.67 Allowed 'General case' 0 CA--C 1.496 -1.102 0 CA-C-O 122.287 1.041 . . . . 74.329999999999998 112.128 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.19 -33.47 0.93 Allowed Glycine 0 N--CA 1.406 -3.318 0 N-CA-C 107.116 -2.393 . . . . 63.100000000000001 107.116 -174.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.5 m -102.61 141.85 34.75 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 108.327 -0.99 . . . . 74.329999999999998 108.327 173.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.6 p -115.88 178.73 4.2 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 120.4 0.143 . . . . 75.200000000000003 111.148 -176.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.422 ' HB3' HD13 ' A' ' 66' ' ' ILE . . . -64.64 -40.39 95.37 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 122.88 0.472 . . . . 75.319999999999993 110.542 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.54 -43.19 84.19 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 116.039 -0.528 . . . . 75.319999999999993 109.792 176.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -60.57 -38.8 85.78 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.382 0.61 . . . . 45.539999999999999 109.924 176.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.25 -46.94 75.38 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.187 -0.915 . . . . 53.509999999999998 111.066 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -58.75 -50.71 72.92 Favored 'General case' 0 C--O 1.19 -2.047 0 C-N-CA 120.434 -0.507 . . . . 70.129999999999995 111.762 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.8 -48.27 78.32 Favored 'General case' 0 C--O 1.271 2.187 0 CA-C-O 121.595 0.712 . . . . 71.340000000000003 111.795 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -67.31 -40.47 86.0 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.848 -1.069 . . . . 73.109999999999999 110.609 -175.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -81.57 -22.9 37.5 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 114.365 1.246 . . . . 54.219999999999999 114.365 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.1 m -69.85 -24.41 63.43 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.391 -0.368 . . . . 72.349999999999994 110.144 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.4 m -59.18 -31.22 68.8 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 119.908 -0.717 . . . . 74.340000000000003 109.674 172.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 60.9 m -85.92 3.05 43.64 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 112.909 0.707 . . . . 55.210000000000001 112.909 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.94 -158.09 26.15 Favored Glycine 0 N--CA 1.463 0.479 0 C-N-CA 119.528 -1.32 . . . . 65.519999999999996 114.138 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.1 m -105.46 126.03 51.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.925 0.393 . . . . 72.150000000000006 110.981 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 63.3 mt -91.74 127.28 44.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 115.633 -0.712 . . . . 65.510000000000005 111.885 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.555 ' ND2' ' HA ' ' A' ' 86' ' ' ALA . 90.3 m-20 -89.23 -42.1 11.82 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 121.325 0.583 . . . . 72.239999999999995 111.276 175.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -153.32 161.23 42.57 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.716 -0.675 . . . . 73.140000000000001 110.03 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.445 HD11 HG21 ' A' ' 66' ' ' ILE . 35.0 pt -146.0 139.69 21.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 107.562 -1.273 . . . . 74.510000000000005 107.562 172.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.4 m -124.74 125.98 44.93 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 106.295 -1.743 . . . . 72.109999999999999 106.295 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mp -123.27 117.69 52.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 105.883 -1.895 . . . . 51.229999999999997 105.883 -177.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.288 1.0 OUTLIER -120.38 128.46 53.25 Favored 'General case' 0 C--N 1.284 -2.28 0 C-N-CA 120.443 -0.503 . . . . 74.129999999999995 112.175 179.031 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 78.3 m -115.31 129.31 56.57 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 115.759 -0.655 . . . . 64.230000000000004 110.1 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.408 ' CG ' ' HG1' ' A' ' 14' ' ' THR . 17.0 t70 -114.69 125.33 53.61 Favored 'General case' 0 CA--C 1.492 -1.285 0 N-CA-C 112.174 0.435 . . . . 64.019999999999996 112.174 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -122.12 9.56 9.91 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 109.078 -0.712 . . . . 73.150000000000006 109.078 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.437 ' HB3' ' HB3' ' B' ' 64' ' ' ASN . 0.1 OUTLIER -64.79 -16.76 63.48 Favored 'General case' 0 C--N 1.361 1.095 0 N-CA-C 113.438 0.903 . . . . 71.329999999999998 113.438 -175.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.3 t -100.14 16.57 23.72 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-O 121.542 0.687 . . . . 70.129999999999995 109.847 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.64 -53.1 1.01 Allowed Glycine 0 CA--C 1.497 -1.066 0 C-N-CA 120.324 -0.941 . . . . 53.130000000000003 111.909 176.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -88.19 132.33 39.92 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 109.061 -0.718 . . . . 72.109999999999999 109.061 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -80.17 117.74 3.55 Favored 'Trans proline' 0 N--CA 1.431 -2.164 0 C-N-CA 121.329 1.353 . . . . 70.439999999999998 110.001 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' A' ' 11' ' ' SER . 34.2 mtmm -115.19 162.7 16.69 Favored 'General case' 0 CA--C 1.466 -2.268 0 C-N-CA 123.9 0.88 . . . . 74.049999999999997 108.692 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -144.13 149.99 22.03 Favored Glycine 0 N--CA 1.411 -3.027 0 C-N-CA 118.914 -1.612 . . . . 37.68 113.481 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -146.99 144.32 29.09 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 114.199 -1.0 . . . . 64.140000000000001 108.451 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.17 152.49 50.85 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 110.302 -0.258 . . . . 70.400000000000006 110.302 -172.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.451 ' CZ ' ' HD1' ' A' ' 40' ' ' TYR . 69.1 m-85 -121.5 123.51 42.19 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 109.679 -0.489 . . . . 75.409999999999997 109.679 176.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.41 HG23 HG23 ' A' ' 66' ' ' ILE . 22.9 mm -102.35 121.05 52.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 107.433 -1.321 . . . . 72.420000000000002 107.433 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -103.0 119.3 38.6 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.516 -0.55 . . . . 75.319999999999993 109.516 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -96.38 158.94 15.2 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.458 0.647 . . . . 74.319999999999993 112.637 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.555 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . . . -67.0 -46.98 72.9 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.671 -1.149 . . . . 71.409999999999997 112.054 177.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -119.74 156.93 29.61 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 113.316 0.858 . . . . 73.040000000000006 113.316 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -61.98 -28.36 69.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.606 -1.179 . . . . 72.129999999999995 112.22 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.351 2.0 p-10 -71.26 -24.48 62.18 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 113.605 0.965 . . . . 50.399999999999999 113.605 177.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -72.35 -41.58 66.3 Favored 'General case' 0 N--CA 1.433 -1.294 0 O-C-N 122.204 -0.31 . . . . 74.430000000000007 111.344 177.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.466 HG21 HG23 ' A' ' 39' ' ' VAL . 7.6 p -63.42 -39.88 86.96 Favored 'Isoleucine or valine' 0 C--N 1.354 0.79 0 N-CA-C 109.646 -0.501 . . . . 72.409999999999997 109.646 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -62.98 -34.84 78.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.583 -0.735 . . . . 72.430000000000007 110.155 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.15 -38.68 63.65 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.878 -0.601 . . . . 64.329999999999998 112.252 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.88 -40.18 65.81 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 116.049 -0.523 . . . . 74.329999999999998 110.923 -176.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 91' ' ' VAL . 30.0 m -59.43 -22.13 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 113.071 0.767 . . . . 70.409999999999997 113.071 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.15 -9.87 58.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 122.192 0.996 . . . . 71.409999999999997 110.709 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.404 ' HG2' ' OG1' ' A' ' 100' ' ' THR . 8.5 ttp -104.51 7.77 35.37 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.416 -1.266 . . . . 60.229999999999997 108.406 -176.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.567 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 2.8 p-10 -36.53 -50.92 0.82 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 116.645 2.091 . . . . 72.310000000000002 116.645 -175.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -123.69 55.58 1.25 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 119.999 1.272 . . . . 73.510000000000005 112.942 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.404 ' OG1' ' HG2' ' A' ' 97' ' ' MET . 41.5 p -92.97 -175.71 3.97 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.119 -1.401 . . . . 71.200000000000003 110.837 174.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.95 126.07 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 121.322 0.582 . . . . 61.5 110.58 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -111.12 118.76 36.87 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.079 -0.712 . . . . 72.019999999999996 109.079 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 43.42 31.67 0.43 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.562 1.545 . . . . 75.420000000000002 113.7 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.59 -8.84 37.65 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.837 -0.697 . . . . 37.68 114.395 175.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -123.41 146.08 48.27 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 118.112 0.956 . . . . 75.549999999999997 110.033 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.7 m -78.41 118.87 20.99 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 120.551 -0.46 . . . . 75.049999999999997 110.014 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 pp -104.51 169.98 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 116.305 -0.407 . . . . 73.409999999999997 110.938 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 57.8 tptt -130.49 131.16 44.99 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.708 -0.849 . . . . 74.209999999999994 108.708 -176.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 36.0 m -126.47 135.33 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 120.975 0.417 . . . . 63.439999999999998 110.511 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.8 mt -131.03 148.53 70.64 Favored Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 108.981 -0.748 . . . . 60.229999999999997 108.981 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.415 ' HB3' HG11 ' A' ' 95' ' ' VAL . 55.5 Cg_endo -79.5 135.29 11.66 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 121.126 1.217 . . . . 61.100000000000001 109.341 175.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.665 ' HE3' ' OD1' ' A' ' 35' ' ' ASP . 37.3 ttpt -84.28 68.46 10.19 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 118.03 -1.468 . . . . 73.439999999999998 109.731 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.419 ' C ' ' H ' ' A' ' 115' ' ' ASN . 1.6 ppt_? -176.53 26.99 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.253 -1.794 . . . . 70.400000000000006 112.134 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.8 m -80.66 23.5 0.52 Allowed 'General case' 0 CA--C 1.559 1.297 0 CA-C-O 121.637 0.732 . . . . 64.349999999999994 110.157 -175.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.419 ' H ' ' C ' ' A' ' 113' ' ' ARG . 41.6 t30 72.92 -62.19 0.48 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.8 1.24 . . . . 73.540000000000006 113.757 173.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.411 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 25.2 mmt -63.22 -50.22 76.18 Favored Pre-proline 0 C--N 1.316 -0.886 0 C-N-CA 120.897 -0.321 . . . . 73.150000000000006 111.536 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.411 ' HD3' ' HB2' ' A' ' 116' ' ' MET . 3.1 Cg_exo -81.31 97.67 0.98 Allowed 'Trans proline' 0 N--CA 1.441 -1.587 0 N-CA-C 108.951 -1.211 . . . . 61.140000000000001 108.951 170.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 158.77 -165.73 34.18 Favored Glycine 0 N--CA 1.435 -1.368 0 N-CA-C 110.237 -1.145 . . . . 72.340000000000003 110.237 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 51.0 mm -109.53 -63.48 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 117.267 0.533 . . . . 64.420000000000002 109.772 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.7 t 65.94 -87.15 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.429 1.092 . . . . 70.439999999999998 111.243 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.6 t 174.22 -173.36 0.06 Allowed 'General case' 0 C--O 1.248 0.984 0 N-CA-C 106.912 -1.514 . . . . 64.319999999999993 106.912 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.9 t -159.03 133.09 7.64 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-O 120.648 0.261 . . . . 73.530000000000001 110.734 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.2 t70 68.83 -40.04 0.43 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.911 1.684 . . . . 72.439999999999998 114.285 176.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.539 ' NE ' ' HA ' ' A' ' 124' ' ' ARG . 1.8 tpm_? . . . . . 0 C--N 1.3 -1.575 0 N-CA-C 109.858 -0.423 . . . . 72.299999999999997 109.858 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.685 0 N-CA-C 109.858 -0.423 . . . . 61.25 109.858 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 48.8 mm -108.07 130.06 61.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.509 -0.923 . . . . 72.430000000000007 108.509 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.2 140.54 34.57 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 109.181 -0.674 . . . . 72.109999999999999 109.181 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.65 115.81 2.34 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.799 2.333 . . . . 73.209999999999994 110.976 177.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 45.6 t -82.1 96.8 7.9 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.852 -0.613 . . . . 73.340000000000003 110.54 -175.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 25.3 mmt -97.51 103.33 15.26 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.876 -0.602 . . . . 71.329999999999998 110.143 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -102.57 -20.97 14.26 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.208 -0.905 . . . . 52.450000000000003 109.068 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 11.4 p -73.85 107.77 6.28 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 115.376 -0.829 . . . . 61.420000000000002 111.873 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -154.89 -177.25 6.38 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 107.68 -1.23 . . . . 71.319999999999993 107.68 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -146.62 138.67 24.78 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 122.588 0.355 . . . . 74.430000000000007 110.104 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 39.5 p -106.63 156.59 18.45 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 116.143 -0.48 . . . . 73.420000000000002 110.419 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -138.42 88.4 2.3 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.535 0.683 . . . . 65.049999999999997 111.686 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -176.59 151.51 0.94 Allowed 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 114.754 -1.112 . . . . 64.019999999999996 109.6 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 33.5 p -112.24 -70.46 0.81 Allowed 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.198 0.523 . . . . 75.120000000000005 110.231 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.77 -42.26 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.09 -1.448 . . . . 75.219999999999999 107.09 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.86 109.49 0.44 Allowed Glycine 0 N--CA 1.426 -1.993 0 CA-C-N 114.416 -1.265 . . . . 74.109999999999999 110.066 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -102.16 108.04 19.3 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.23 -0.655 . . . . 64.140000000000001 109.23 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -133.28 -16.31 2.44 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.389 0.885 . . . . 75.430000000000007 113.389 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 36.4 p -88.08 70.98 9.36 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 114.305 1.224 . . . . 74.129999999999995 114.305 -178.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -94.49 -47.48 6.54 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 103.468 -2.79 . . . . 65.230000000000004 103.468 170.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 162.64 -131.02 2.39 Favored Glycine 0 N--CA 1.411 -2.98 0 N-CA-C 107.606 -2.197 . . . . 60.130000000000003 107.606 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.517 ' HG2' ' CE2' ' A' ' 40' ' ' TYR . 57.9 Cg_exo -55.75 -36.31 94.9 Favored 'Trans proline' 0 CA--C 1.58 2.817 0 C-N-CA 123.08 2.52 . . . . 73.340000000000003 115.258 174.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.444 ' HB3' ' O ' ' A' ' 14' ' ' THR . 78.1 Cg_exo -53.73 158.74 7.83 Favored 'Trans proline' 0 C--N 1.405 3.518 0 C-N-CA 121.952 1.768 . . . . 74.299999999999997 114.033 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -89.6 167.24 18.0 Favored Pre-proline 0 C--N 1.309 -1.178 0 CA-C-N 115.021 -0.99 . . . . 72.420000000000002 109.712 -177.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -77.35 159.75 32.7 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 121.208 1.272 . . . . 70.329999999999998 112.596 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.73 162.23 38.97 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.322 -0.854 . . . . 73.239999999999995 109.131 176.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.539 ' HB2' ' HG2' ' B' ' 30' ' ' GLU . 71.2 m -65.44 143.74 57.51 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 115.088 1.514 . . . . 55.240000000000002 115.088 -171.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' B' ' 31' ' ' LYS . . . -55.72 -34.65 65.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.043 -1.435 . . . . 71.430000000000007 112.699 174.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . 0.274 6.0 mt-10 -72.89 -29.22 63.0 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 113.327 0.862 . . . . 71.5 113.327 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.539 ' HG2' ' HB2' ' B' ' 27' ' ' SER . 2.3 mm-40 -67.87 -35.39 78.46 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.085 -1.08 . . . . 72.340000000000003 108.085 172.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' B' ' 28' ' ' ALA . 74.7 mmtt -60.81 -48.41 81.93 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.151 -0.932 . . . . 64.230000000000004 108.955 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -54.24 -49.39 69.59 Favored 'General case' 0 C--N 1.363 1.156 0 N-CA-C 112.752 0.649 . . . . 62.25 112.752 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -70.63 -42.51 70.78 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 112.825 0.676 . . . . 65.409999999999997 112.825 -170.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.494 HG12 ' O ' ' B' ' 30' ' ' GLU . 24.2 pt -68.9 -35.6 70.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.018 0.437 . . . . 74.329999999999998 110.31 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -67.53 -43.22 81.32 Favored 'General case' 0 C--O 1.201 -1.476 0 CA-C-N 115.533 -0.758 . . . . 73.0 110.418 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.435 ' HA ' ' CB ' ' B' ' 113' ' ' ARG . 53.3 mtpt -63.24 -14.32 48.0 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.226 1.011 . . . . 72.409999999999997 113.388 -178.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -118.57 20.86 12.83 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 121.598 0.713 . . . . 72.150000000000006 110.644 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' SER . . . . . 0.459 ' HB2' ' HB3' ' B' ' 112' ' ' LYS . 40.1 m -97.91 160.42 14.31 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.288 -0.869 . . . . 73.310000000000002 111.719 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.436 HG23 HG21 ' B' ' 91' ' ' VAL . 46.2 t -129.9 154.64 40.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.772 -0.825 . . . . 74.519999999999996 108.772 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . 0.648 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 30.0 t80 -108.49 125.58 51.95 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 125.214 1.405 . . . . 71.510000000000005 107.953 175.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 59.6 t -113.33 117.45 55.45 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.442 0 N-CA-C 108.431 -0.952 . . . . 64.340000000000003 108.431 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.93 173.8 15.33 Favored Glycine 0 N--CA 1.433 -1.555 0 C-N-CA 119.963 -1.113 . . . . 74.129999999999995 112.671 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 t30 67.97 22.53 8.53 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.697 1.599 . . . . 72.120000000000005 112.139 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 13.2 p -95.09 128.44 46.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 O-C-N 121.628 -0.67 . . . . 75.430000000000007 110.106 175.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -116.08 167.17 11.22 Favored 'General case' 0 CA--C 1.483 -1.596 0 N-CA-C 108.456 -0.942 . . . . 74.109999999999999 108.456 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -51.33 128.14 21.59 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.817 0.818 . . . . 73.129999999999995 110.694 173.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.96 -41.78 1.1 Allowed Glycine 0 N--CA 1.415 -2.748 0 N-CA-C 107.41 -2.276 . . . . 61.409999999999997 107.41 -172.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.2 m -95.76 140.23 30.85 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.046 -1.094 . . . . 72.310000000000002 108.046 174.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 74.0 p -111.3 177.62 4.6 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.693 -0.403 . . . . 72.040000000000006 110.499 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.421 ' HB3' HD13 ' B' ' 66' ' ' ILE . . . -66.88 -39.05 87.38 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.996 -0.372 . . . . 70.030000000000001 109.996 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.73 -44.05 85.73 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.848 -0.615 . . . . 73.150000000000006 109.997 175.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -56.99 -44.67 82.96 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.577 0.703 . . . . 73.019999999999996 109.525 175.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 78.3 mt -60.9 -47.76 84.92 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 114.597 -1.183 . . . . 75.129999999999995 112.16 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -58.89 -50.84 72.52 Favored 'General case' 0 C--O 1.198 -1.614 0 C-N-CA 120.412 -0.515 . . . . 63.130000000000003 112.126 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.67 -48.38 77.72 Favored 'General case' 0 C--O 1.265 1.9 0 CA-C-O 121.629 0.728 . . . . 65.140000000000001 111.783 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -66.73 -41.05 88.51 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.707 -1.133 . . . . 74.519999999999996 110.662 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -81.59 -23.09 37.31 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 114.229 1.196 . . . . 65.340000000000003 114.229 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 66.7 m -70.61 -24.16 62.69 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.307 -0.406 . . . . 54.229999999999997 109.964 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.3 m -58.79 -29.01 66.5 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-O 121.096 0.475 . . . . 65.129999999999995 109.94 172.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 60.0 m -92.27 6.37 47.03 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 113.07 0.767 . . . . 52.229999999999997 113.07 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 142.84 -158.38 27.1 Favored Glycine 0 C--O 1.226 -0.397 0 C-N-CA 119.143 -1.503 . . . . 61.130000000000003 114.371 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 49.9 m -106.21 125.79 51.43 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 122.444 -0.445 . . . . 72.450000000000003 111.241 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.465 HD12 HG23 ' B' ' 63' ' ' ILE . 71.3 mt -91.42 127.15 43.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 116.029 -0.532 . . . . 75.299999999999997 112.401 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . 0.637 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 87.3 m-20 -89.06 -43.54 11.02 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-N 116.029 -0.532 . . . . 73.430000000000007 110.792 175.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.433 ' NH1' ' HA3' ' A' ' 16' ' ' GLY . 40.0 mtt180 -150.96 161.25 43.08 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.869 -0.605 . . . . 75.129999999999995 110.524 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.447 HG23 HG23 ' B' ' 83' ' ' ILE . 38.2 pt -146.17 140.15 20.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 107.65 -1.241 . . . . 73.219999999999999 107.65 172.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 85.3 m -124.91 126.41 45.48 Favored 'General case' 0 C--N 1.273 -2.73 0 N-CA-C 106.786 -1.561 . . . . 53.130000000000003 106.786 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.439 HD11 HG13 ' B' ' 66' ' ' ILE . 2.6 mp -124.28 116.71 48.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 105.817 -1.92 . . . . 74.450000000000003 105.817 -177.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.469 ' N ' HD22 ' B' ' 69' ' ' LEU . 1.3 pt? -120.56 129.37 53.75 Favored 'General case' 0 C--N 1.283 -2.287 0 C-N-CA 120.216 -0.594 . . . . 65.319999999999993 110.996 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 79.4 m -116.22 129.57 56.36 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.383 -0.599 . . . . 73.329999999999998 109.383 -177.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -109.43 124.71 51.47 Favored 'General case' 0 CA--C 1.482 -1.665 0 N-CA-C 112.595 0.591 . . . . 64.319999999999993 112.595 -178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -119.76 3.01 11.14 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 114.973 -1.012 . . . . 70.540000000000006 111.358 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -69.42 -22.44 63.67 Favored 'General case' 0 C--N 1.364 1.216 0 C-N-CA 119.084 -1.046 . . . . 73.019999999999996 110.67 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 35.2 t -88.97 15.01 9.23 Favored 'General case' 0 CA--C 1.56 1.345 0 CA-C-N 115.242 -0.89 . . . . 62.119999999999997 109.599 177.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.75 -61.2 2.74 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.91 -0.586 . . . . 63.229999999999997 112.046 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . 0.434 ' HA ' ' HD3' ' B' ' 77' ' ' PRO . 37.0 m80 -85.87 129.32 54.87 Favored Pre-proline 0 C--O 1.252 1.216 0 C-N-CA 120.836 -0.346 . . . . 74.129999999999995 110.19 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' B' ' 76' ' ' HIS . 9.2 Cg_exo -72.01 117.47 5.16 Favored 'Trans proline' 0 CA--C 1.504 -1.019 0 C-N-CA 121.975 1.783 . . . . 75.049999999999997 110.699 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 35.0 mtmm -118.34 159.36 23.54 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 107.666 -1.235 . . . . 65.120000000000005 107.666 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -138.94 152.13 22.06 Favored Glycine 0 N--CA 1.411 -3.023 0 C-N-CA 119.055 -1.545 . . . . 73.510000000000005 113.312 177.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -149.64 144.99 26.51 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.273 -1.01 . . . . 72.239999999999995 108.273 173.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.22 152.83 51.17 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 116.56 -0.291 . . . . 70.219999999999999 110.604 -171.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' TYR . . . . . 0.421 ' CZ ' ' HD1' ' B' ' 40' ' ' TYR . 78.2 m-85 -122.45 124.17 42.99 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 109.517 -0.549 . . . . 74.0 109.517 175.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.447 HG23 HG23 ' B' ' 66' ' ' ILE . 23.2 mm -102.97 120.07 52.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.488 -1.301 . . . . 63.149999999999999 107.488 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -102.31 119.15 38.34 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.549 -0.908 . . . . 73.319999999999993 108.549 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -93.84 160.04 14.92 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 112.734 0.642 . . . . 75.329999999999998 112.734 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.637 ' HA ' ' ND2' ' B' ' 64' ' ' ASN . . . -66.61 -43.56 84.47 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.067 -0.969 . . . . 72.150000000000006 112.224 176.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -127.0 160.04 32.3 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.381 0.882 . . . . 73.310000000000002 113.381 -176.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -63.89 -24.98 67.95 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.517 1.127 . . . . 73.109999999999999 112.787 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -63.48 -39.3 94.09 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.457 -0.942 . . . . 72.510000000000005 108.457 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 18.6 m -68.97 -38.68 79.5 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.314 -0.857 . . . . 73.400000000000006 112.074 -172.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . 0.436 HG21 HG23 ' B' ' 39' ' ' VAL . 7.5 p -65.01 -40.6 89.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 109.201 -0.666 . . . . 75.049999999999997 109.201 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.0 -34.33 77.76 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.549 0.69 . . . . 60.299999999999997 110.271 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.86 -37.68 64.68 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.73 -0.668 . . . . 74.519999999999996 111.111 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.1 -38.78 61.05 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 120.635 -0.426 . . . . 61.240000000000002 111.176 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . 0.439 HG11 ' HB3' ' B' ' 111' ' ' PRO . 30.1 m -59.66 -22.47 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 112.787 0.662 . . . . 71.049999999999997 112.787 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.87 -9.17 50.07 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.145 0.497 . . . . 60.049999999999997 110.177 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 22.7 mtm -97.51 4.0 50.54 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 112.843 0.683 . . . . 75.329999999999998 112.843 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . 0.454 ' HA ' HG22 ' B' ' 109' ' ' VAL . 2.3 p30 -43.86 -38.18 3.2 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 116.77 2.137 . . . . 71.430000000000007 116.77 -174.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -117.09 28.03 8.76 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 119.629 1.104 . . . . 74.340000000000003 111.405 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 73.6 p -84.41 177.46 8.13 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 121.245 -0.909 . . . . 61.520000000000003 111.55 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 13.0 p -101.27 145.73 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 N-CA-C 109.387 -0.598 . . . . 65.010000000000005 109.387 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -143.85 121.75 12.01 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.381 -0.97 . . . . 74.530000000000001 108.381 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 56.9 ttt-85 52.01 33.59 12.19 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 124.529 1.132 . . . . 72.340000000000003 111.868 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.65 1.57 70.95 Favored Glycine 0 C--N 1.313 -0.725 0 CA-C-N 115.188 -0.914 . . . . 71.109999999999999 114.33 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -126.94 157.9 38.24 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 117.544 0.672 . . . . 72.319999999999993 109.806 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 41.8 m -88.43 120.21 29.59 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.086 -1.079 . . . . 62.049999999999997 108.086 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 43.4 pt -101.83 172.0 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 C-N-CA 119.737 -0.785 . . . . 70.150000000000006 110.484 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -128.65 127.16 41.65 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.957 -0.757 . . . . 61.299999999999997 108.957 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.648 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 27.0 m -126.6 134.52 66.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 O-C-N 123.441 0.463 . . . . 71.530000000000001 111.018 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 96.4 mt -128.31 148.28 67.19 Favored Pre-proline 0 C--N 1.298 -1.642 0 N-CA-C 109.206 -0.665 . . . . 70.329999999999998 109.206 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.439 ' HB3' HG11 ' B' ' 95' ' ' VAL . 53.2 Cg_endo -79.28 133.82 11.05 Favored 'Trans proline' 0 N--CA 1.439 -1.711 0 C-N-CA 121.493 1.462 . . . . 74.150000000000006 111.22 175.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.459 ' HB3' ' HB2' ' B' ' 38' ' ' SER . 27.9 ttpp -100.17 131.48 46.09 Favored 'General case' 0 N--CA 1.41 -2.446 0 N-CA-C 105.75 -1.945 . . . . 71.439999999999998 105.75 173.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.435 ' CB ' ' HA ' ' B' ' 36' ' ' LYS . 5.1 ppt_? -168.92 172.21 7.82 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.755 0.312 . . . . 73.209999999999994 111.613 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 24.8 p -119.95 154.43 34.49 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.177 -1.045 . . . . 74.409999999999997 108.177 175.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -121.08 122.14 39.41 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.39 -0.524 . . . . 73.120000000000005 109.809 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -149.74 115.19 3.51 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 115.344 -0.844 . . . . 64.540000000000006 109.037 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.09 91.23 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.99 1.793 . . . . 72.310000000000002 111.294 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . 124.32 156.72 9.53 Favored Glycine 0 N--CA 1.431 -1.645 0 N-CA-C 110.952 -0.859 . . . . 72.5 110.952 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . 0.415 ' N ' HD13 ' B' ' 119' ' ' ILE . 2.5 mp -98.51 -35.96 5.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.842 -0.799 . . . . 71.409999999999997 108.842 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 29.8 m 72.35 14.76 5.37 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.643 1.177 . . . . 63.119999999999997 112.22 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 25.9 t -92.97 98.99 11.71 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.149 -0.685 . . . . 74.439999999999998 109.149 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 24.6 p -83.42 89.95 7.12 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-O 121.712 0.768 . . . . 73.299999999999997 112.026 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -99.39 -169.48 1.76 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.686 -1.143 . . . . 71.420000000000002 109.622 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . 0.471 ' HD2' ' O ' ' B' ' 124' ' ' ARG 0.271 6.1 ppt_? . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 112.024 0.379 . . . . 72.129999999999995 112.024 177.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.244 0 CA-C-O 120.906 0.384 . . . . 62.329999999999998 110.259 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.8 mm -87.48 132.55 32.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.942 -0.762 . . . . 74.239999999999995 108.942 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.73 118.43 54.5 Favored Pre-proline 0 N--CA 1.44 -0.965 0 N-CA-C 108.87 -0.789 . . . . 61.420000000000002 108.87 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -49.56 108.46 0.2 Allowed 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 123.274 2.649 . . . . 74.239999999999995 112.603 -177.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 65.4 m -94.39 116.54 28.92 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 108.072 -1.085 . . . . 71.519999999999996 108.072 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 15.4 tpt -76.58 84.9 3.26 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 121.595 0.712 . . . . 74.0 109.408 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.6 96.23 0.75 Allowed 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 106.462 -1.681 . . . . 75.329999999999998 106.462 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.6 m -129.29 101.26 5.91 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.647 -1.612 . . . . 75.140000000000001 106.647 178.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.3 m -55.06 107.62 0.32 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 113.977 1.103 . . . . 74.430000000000007 113.977 -171.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -109.06 101.52 10.58 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 107.253 -1.388 . . . . 72.019999999999996 107.253 172.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.2 p -90.81 119.64 31.19 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 120.868 0.366 . . . . 62.119999999999997 110.977 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -78.77 75.38 5.28 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 108.998 -0.742 . . . . 72.349999999999994 108.998 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 52.0 ttm -119.25 83.67 2.07 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-O 121.666 0.746 . . . . 73.430000000000007 109.617 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.1 m -120.07 113.14 20.04 Favored 'General case' 0 N--CA 1.41 -2.459 0 CA-C-N 114.214 -1.357 . . . . 74.420000000000002 107.694 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.75 -24.83 56.12 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.968 -1.123 . . . . 71.019999999999996 107.968 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.402 ' HA3' ' HA ' ' B' ' 43' ' ' ASN . . . 130.12 -107.16 0.76 Allowed Glycine 0 N--CA 1.41 -3.056 0 CA-C-N 114.489 -1.232 . . . . 50.149999999999999 110.272 177.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 166.6 75.03 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 105.935 -1.876 . . . . 62.210000000000001 105.935 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -59.05 -69.35 0.2 Allowed 'General case' 0 C--N 1.318 -0.764 0 O-C-N 123.865 0.728 . . . . 74.400000000000006 110.594 -171.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 t -130.85 80.21 1.93 Allowed 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 122.514 1.149 . . . . 73.310000000000002 112.084 176.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -93.24 -29.46 15.68 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 106.984 -1.487 . . . . 70.5 106.984 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.25 178.46 49.47 Favored Glycine 1 N--CA 1.389 -4.493 0 N-CA-C 109.075 -1.61 . . . . 55.409999999999997 109.075 -173.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.573 ' HA ' ' OH ' ' B' ' 82' ' ' TYR . 71.7 Cg_exo -47.07 -38.59 24.7 Favored 'Trans proline' 0 CA--C 1.587 3.135 0 C-N-CA 122.896 2.398 . . . . 71.209999999999994 116.287 174.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -93.41 168.27 2.25 Favored 'Trans proline' 0 N--CA 1.417 -3.003 0 N-CA-C 117.478 2.068 . . . . 71.409999999999997 117.478 -173.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.574 ' HG2' ' OH ' ' B' ' 80' ' ' TYR . 29.7 mt-30 -128.8 146.2 59.43 Favored Pre-proline 0 N--CA 1.417 -2.111 0 N-CA-C 103.961 -2.607 . . . . 55.240000000000002 103.961 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.47 102.04 1.46 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 121.633 1.556 . . . . 64.219999999999999 114.205 -176.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.403 HD11 ' HZ1' ' A' ' 31' ' ' LYS . 3.9 mp -146.08 145.52 30.58 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.858 -0.793 . . . . 75.540000000000006 108.858 177.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.3 t -79.45 160.69 26.5 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 109.046 -0.724 . . . . 52.200000000000003 109.046 173.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.7 -42.0 33.56 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 123.53 0.732 . . . . 72.140000000000001 112.009 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -67.2 -36.04 80.9 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.64 0.607 . . . . 71.310000000000002 112.64 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.466 ' O ' HG12 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -57.38 -36.1 70.82 Favored 'General case' 0 CA--C 1.496 -1.1 0 C-N-CA 120.318 -0.553 . . . . 53.210000000000001 109.881 171.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.403 ' HZ1' HD11 ' A' ' 26' ' ' LEU . 1.0 OUTLIER -66.71 -40.41 88.45 Favored 'General case' 0 C--O 1.192 -1.958 0 C-N-CA 119.821 -0.751 . . . . 71.329999999999998 111.584 -179.514 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.687 ' HE2' ' N ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -66.08 -38.04 87.27 Favored 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 119.716 -0.794 . . . . 74.329999999999998 111.824 178.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -65.66 -46.33 79.53 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.138 0.494 . . . . 55.420000000000002 111.62 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.539 HD13 ' NH2' ' A' ' 65' ' ' ARG . 12.7 pt -70.82 -33.77 53.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.656 -0.702 . . . . 70.040000000000006 110.679 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -66.0 -38.83 89.48 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.837 0.855 . . . . 74.439999999999998 108.887 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -57.4 -30.72 65.15 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.278 -0.874 . . . . 75.340000000000003 110.859 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.407 ' HD2' ' O ' ' A' ' 85' ' ' PHE . 54.2 mtm180 -104.09 18.82 21.27 Favored 'General case' 0 N--CA 1.419 -2.013 0 CA-C-N 114.842 -1.072 . . . . 71.140000000000001 111.856 -175.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.0 m -95.87 146.44 24.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.605 0.717 . . . . 72.5 111.152 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.7 m -127.95 160.69 37.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.932 -0.766 . . . . 74.030000000000001 108.932 176.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 28.1 t80 -109.14 126.06 52.83 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.497 -0.927 . . . . 74.109999999999999 108.497 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.423 ' HA ' HG13 ' A' ' 109' ' ' VAL . 61.3 t -114.49 111.82 37.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.841 -1.17 . . . . 65.420000000000002 107.841 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.2 171.62 13.87 Favored Glycine 0 C--N 1.304 -1.243 0 C-N-CA 120.267 -0.968 . . . . 52.420000000000002 113.215 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.466 ' ND2' ' HB3' ' A' ' 105' ' ' ARG . 4.8 t30 58.65 24.89 12.61 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 125.391 1.477 . . . . 44.340000000000003 110.037 -178.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 p -92.63 9.17 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.418 0 CA-C-N 114.524 -1.216 . . . . 61.439999999999998 110.069 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.556 ' OD2' ' HA ' ' A' ' 78' ' ' LYS . 6.0 m-20 -37.07 106.84 0.05 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 128.235 2.614 . . . . 72.030000000000001 113.617 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.432 ' C ' ' H ' ' A' ' 48' ' ' SER 0.4 41.3 m-85 50.11 162.81 0.0 OUTLIER 'General case' 0 C--N 1.351 0.643 0 N-CA-C 118.116 2.636 . . . . 75.540000000000006 118.116 179.436 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.423 ' HA3' ' NH1' ' A' ' 103' ' ' ARG . . . 80.94 -36.97 2.33 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.284 -0.871 . . . . 70.140000000000001 111.462 -177.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.432 ' H ' ' C ' ' A' ' 46' ' ' TYR . 19.4 m -76.84 118.27 19.28 Favored 'General case' 0 N--CA 1.415 -2.218 0 C-N-CA 124.733 1.213 . . . . 70.329999999999998 109.866 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.7 p -100.59 162.99 12.56 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.6 -0.519 . . . . 71.349999999999994 109.6 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.439 ' HB1' HD13 ' A' ' 66' ' ' ILE . . . -65.81 -50.25 65.31 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.171 0.434 . . . . 63.240000000000002 112.171 -175.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -57.79 -38.74 76.04 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 116.824 -0.171 . . . . 60.32 111.091 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.72 -37.67 76.61 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.018 0.437 . . . . 73.200000000000003 110.347 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 44.1 mt -68.22 -47.58 67.45 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.362 -0.835 . . . . 51.32 110.803 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -61.9 -48.24 81.34 Favored 'General case' 0 C--O 1.2 -1.538 0 CA-C-N 115.738 -0.665 . . . . 72.230000000000004 110.069 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.48 -41.18 84.71 Favored 'General case' 0 C--O 1.248 1.0 0 CA-C-O 121.036 0.446 . . . . 62.149999999999999 110.663 177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -65.82 -39.68 91.1 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.852 -0.613 . . . . 73.349999999999994 110.307 -175.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -82.33 -21.53 35.97 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 112.967 0.729 . . . . 72.549999999999997 112.967 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.9 t -70.11 -24.11 63.15 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.651 -0.704 . . . . 72.239999999999995 109.324 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.4 m -62.25 -30.24 70.97 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 109.197 -0.668 . . . . 71.530000000000001 109.197 173.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 57.5 m -96.1 11.83 32.83 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.772 -0.649 . . . . 72.319999999999993 112.378 -178.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.96 -167.58 30.58 Favored Glycine 0 N--CA 1.464 0.526 0 C-N-CA 118.609 -1.758 . . . . 61.32 115.386 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.4 m -104.32 115.06 29.72 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.212 -0.662 . . . . 70.329999999999998 109.212 -176.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.3 mt -91.11 131.8 37.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 112.537 0.569 . . . . 75.140000000000001 112.537 -176.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.418 HD22 ' HB1' ' A' ' 86' ' ' ALA . 1.0 OUTLIER -95.64 -40.47 9.39 Favored 'General case' 0 C--O 1.204 -1.296 0 CA-C-N 115.26 -0.882 . . . . 54.229999999999997 111.915 176.515 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.539 ' NH2' HD13 ' A' ' 34' ' ' ILE . 73.2 mtm180 -155.86 161.16 40.64 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.763 -0.458 . . . . 75.109999999999999 109.763 -177.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.47 HG21 HD11 ' A' ' 66' ' ' ILE . 23.0 pt -146.51 141.42 20.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.1 -1.074 . . . . 71.409999999999997 108.1 174.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.9 m -126.23 129.24 48.56 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 106.478 -1.675 . . . . 73.0 106.478 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.6 mp -125.06 121.4 60.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 106.878 -1.527 . . . . 73.340000000000003 106.878 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -120.62 134.61 55.26 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 120.528 -0.469 . . . . 72.099999999999994 112.123 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 83.6 m -117.5 122.66 44.31 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.892 -0.781 . . . . 60.219999999999999 108.892 176.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.454 ' HA ' ' HG2' ' B' ' 65' ' ' ARG . 2.5 p30 -113.55 128.87 56.6 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 119.734 -0.786 . . . . 72.010000000000005 112.287 -178.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' B' ' 64' ' ' ASN . 38.4 mttm -95.8 4.05 53.22 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.73 -0.668 . . . . 73.120000000000005 111.516 175.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -64.34 -6.25 6.68 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.38 0.881 . . . . 74.450000000000003 113.38 172.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.461 ' C ' ' H ' ' A' ' 76' ' ' HIS . 25.7 t -95.91 0.56 52.12 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.947 -0.76 . . . . 72.420000000000002 108.947 176.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.37 -48.78 3.63 Favored Glycine 0 CA--C 1.506 -0.521 0 N-CA-C 109.187 -1.565 . . . . 64.120000000000005 109.187 -175.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.461 ' H ' ' C ' ' A' ' 74' ' ' SER . 40.8 m80 -96.96 147.94 33.66 Favored Pre-proline 0 C--N 1.291 -1.961 0 N-CA-C 105.916 -1.883 . . . . 73.239999999999995 105.916 173.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.83 118.32 5.02 Favored 'Trans proline' 0 N--CA 1.443 -1.474 0 C-N-CA 120.679 0.919 . . . . 64.239999999999995 110.448 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.572 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 30.1 mtmm -96.59 149.22 22.02 Favored 'General case' 0 CA--C 1.483 -1.597 0 C-N-CA 119.873 -0.731 . . . . 72.439999999999998 109.262 175.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.9 135.13 8.32 Favored Glycine 0 N--CA 1.409 -3.105 0 C-N-CA 120.327 -0.94 . . . . 52.109999999999999 112.636 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . 0.349 1.3 p90 -150.8 144.77 25.28 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 124.382 1.073 . . . . 74.25 111.092 175.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.49 154.36 49.9 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.893 -0.594 . . . . 60.329999999999998 110.659 -171.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -120.36 124.49 45.66 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.325 -0.991 . . . . 74.239999999999995 108.325 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 27.2 mm -108.48 127.59 64.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.823 -1.177 . . . . 74.439999999999998 107.823 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -108.94 120.84 43.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.582 0.23 . . . . 63.439999999999998 111.039 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.407 ' O ' ' HD2' ' A' ' 37' ' ' ARG . 94.0 m-85 -98.89 162.88 12.85 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.98 0.419 . . . . 74.0 111.875 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.418 ' HB1' HD22 ' A' ' 64' ' ' ASN . . . -76.79 -37.88 55.01 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.264 0.626 . . . . 72.200000000000003 111.747 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.435 ' HG2' ' OG ' ' A' ' 90' ' ' SER . 0.2 OUTLIER -113.47 138.5 50.02 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 112.509 0.559 . . . . 73.430000000000007 112.509 179.422 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.411 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -57.79 -34.31 69.49 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 123.623 0.769 . . . . 73.040000000000006 111.26 179.051 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -66.65 -21.14 66.11 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 116.019 -0.537 . . . . 70.030000000000001 112.239 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.435 ' OG ' ' HG2' ' A' ' 87' ' ' GLU . 71.4 m -69.15 -36.13 77.09 Favored 'General case' 0 N--CA 1.414 -2.241 0 C-N-CA 120.635 -0.426 . . . . 64.040000000000006 111.263 176.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 88' ' ' ARG . 3.0 m -64.69 -41.22 91.62 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.85 0 C-N-CA 119.239 -0.984 . . . . 72.129999999999995 108.56 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.484 ' HA ' HG22 ' A' ' 95' ' ' VAL . 9.7 m-20 -61.99 -31.13 71.46 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 116.299 -0.41 . . . . 74.349999999999994 111.292 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.31 -39.81 62.64 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.172 -0.467 . . . . 71.319999999999993 111.225 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.83 -41.85 59.13 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-N 116.222 -0.445 . . . . 70.310000000000002 111.338 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.484 HG22 ' HA ' ' A' ' 92' ' ' ASP . 22.6 m -56.21 -22.18 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 111.98 0.363 . . . . 62.549999999999997 111.98 177.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.78 -13.86 62.47 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.367 0.603 . . . . 55.299999999999997 111.067 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 47.4 mtm -99.36 9.76 42.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.568 -0.742 . . . . 51.25 109.79 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 2.9 p-10 -37.67 -45.59 0.8 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 114.456 1.28 . . . . 70.120000000000005 114.456 -177.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -114.67 97.4 6.25 Favored 'General case' 0 N--CA 1.424 -1.741 0 C-N-CA 120.033 -0.667 . . . . 62.340000000000003 110.033 174.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.8 p -142.64 165.71 26.65 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.02 -0.991 . . . . 63.509999999999998 110.775 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.3 p -104.53 119.68 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-O 121.636 0.731 . . . . 60.119999999999997 110.171 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -113.47 116.64 29.91 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.858 -1.164 . . . . 75.219999999999999 107.858 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.423 ' NH1' ' HA3' ' A' ' 47' ' ' GLY . 7.1 ptm180 43.09 32.08 0.41 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 126.548 1.939 . . . . 72.450000000000003 114.147 -177.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.19 -12.02 33.91 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.007 -0.997 . . . . 70.219999999999999 113.87 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.466 ' HB3' ' ND2' ' A' ' 43' ' ' ASN . 65.1 mtt180 -112.42 138.74 48.72 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 117.37 0.585 . . . . 62.43 109.933 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 39.2 m -79.18 120.19 23.33 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.766 -1.198 . . . . 74.140000000000001 107.766 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.2 pt -101.57 171.44 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 C-N-CA 120.464 -0.495 . . . . 74.530000000000001 110.723 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 54.7 tptt -133.91 125.75 28.94 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 115.123 -0.944 . . . . 73.510000000000005 108.772 -177.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 27.7 m -128.82 132.49 67.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 O-C-N 123.238 0.336 . . . . 61.109999999999999 110.948 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.444 ' HB2' ' HD2' ' A' ' 111' ' ' PRO 0.25 0.0 OUTLIER -148.24 158.79 40.81 Favored Pre-proline 0 C--N 1.292 -1.929 0 N-CA-C 108.561 -0.903 . . . . 64.120000000000005 108.561 176.26 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 110' ' ' LEU . 91.8 Cg_endo -76.09 130.28 12.07 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 CA-C-N 120.45 1.196 . . . . 53.350000000000001 110.641 -176.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.5 110.36 18.62 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 104.874 -2.269 . . . . 74.239999999999995 104.874 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -93.97 135.92 34.8 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.373 -0.831 . . . . 74.510000000000005 112.5 -162.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.0 m -69.76 147.98 49.76 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.782 -1.099 . . . . 73.540000000000006 110.252 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.452 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 7.1 t30 -147.72 129.12 14.86 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.568 -0.901 . . . . 75.230000000000004 108.568 177.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 50.9 ttm -99.44 102.71 17.26 Favored Pre-proline 0 C--N 1.307 -1.266 0 N-CA-C 109.038 -0.726 . . . . 75.230000000000004 109.038 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 115' ' ' ASN . 2.7 Cg_exo -77.73 -16.38 14.72 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.524 2.149 . . . . 75.099999999999994 111.63 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.36 -117.13 3.44 Favored Glycine 0 N--CA 1.426 -1.991 0 N-CA-C 110.038 -1.225 . . . . 51.439999999999998 110.038 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 24.8 pt -101.34 106.0 18.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 121.69 0.757 . . . . 73.409999999999997 110.382 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.2 m -122.27 5.66 9.69 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.495 -0.775 . . . . 75.340000000000003 110.605 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 60.4 m 63.55 109.66 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.818 0.847 . . . . 64.209999999999994 111.346 -174.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 60.1 p -64.3 -47.84 77.95 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.7 0.762 . . . . 74.230000000000004 110.204 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -162.53 146.86 11.89 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.099 -1.815 . . . . 74.409999999999997 106.099 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 . . . . . 0 C--N 1.299 -1.61 0 C-N-CA 119.333 -0.947 . . . . 74.219999999999999 109.727 -179.16 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.671 0 N-CA-C 109.087 -0.708 . . . . 37.93 109.087 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.449 HD11 ' H ' ' B' ' 2' ' ' ILE . 0.2 OUTLIER -74.81 136.21 25.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 O-C-N 123.338 0.399 . . . . 63.149999999999999 110.816 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -113.08 144.32 30.9 Favored Pre-proline 0 C--N 1.306 -1.313 0 CA-C-N 115.962 -0.563 . . . . 61.340000000000003 109.55 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.14 104.9 0.53 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.46 2.107 . . . . 71.030000000000001 111.32 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 79.3 m -148.38 177.44 9.44 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.788 -0.819 . . . . 75.439999999999998 108.788 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 66.2 mtt -92.58 152.38 19.63 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.98 -0.378 . . . . 62.310000000000002 109.98 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -83.74 136.31 34.22 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.961 -0.563 . . . . 72.430000000000007 109.68 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 9.2 t -95.43 142.27 27.99 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.779 -0.823 . . . . 71.25 108.779 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 27.9 m -69.5 100.54 1.43 Allowed 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 123.047 0.539 . . . . 71.430000000000007 110.169 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -135.91 -40.84 0.68 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.241 -0.436 . . . . 73.430000000000007 110.847 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 50.3 m 65.87 142.3 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.295 1.038 . . . . 70.5 112.6 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -76.08 108.07 8.74 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.603 -0.888 . . . . 73.420000000000002 108.603 177.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 13.0 tmm? -83.04 107.02 15.33 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.405 -0.961 . . . . 71.439999999999998 108.405 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 12.6 t -140.8 -173.28 3.66 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.702 -0.851 . . . . 75.430000000000007 108.702 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -128.89 169.47 14.57 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.54 0.21 . . . . 62.119999999999997 111.159 -176.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.87 -25.53 52.84 Favored Glycine 0 C--N 1.336 0.539 0 O-C-N 124.054 0.846 . . . . 60.119999999999997 114.093 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.62 -40.97 69.44 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.591 0.756 . . . . 52.439999999999998 112.572 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -80.11 -35.5 36.71 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.096 0.474 . . . . 73.010000000000005 111.219 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 22.0 p -77.03 -172.49 2.37 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 114.54 1.311 . . . . 73.530000000000001 114.54 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . 0.422 ' OE2' ' HA ' ' B' ' 25' ' ' PRO . 30.9 mt-10 -59.89 16.35 0.01 OUTLIER 'General case' 0 CA--C 1.594 2.655 0 C-N-CA 127.779 2.432 . . . . 72.310000000000002 116.94 -171.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.04 -126.81 20.98 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 114.363 0.505 . . . . 74.439999999999998 114.363 177.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -53.36 -52.66 8.15 Favored 'Trans proline' 0 CA--C 1.559 1.73 0 C-N-CA 123.609 2.873 . . . . 74.120000000000005 114.181 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.12 141.65 48.43 Favored 'Trans proline' 0 C--N 1.376 1.979 0 CA-C-N 120.813 1.326 . . . . 75.340000000000003 108.83 172.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -84.21 146.35 47.91 Favored Pre-proline 0 C--N 1.284 -2.276 0 C-N-CA 119.818 -0.753 . . . . 74.150000000000006 109.102 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.422 ' HA ' ' OE2' ' B' ' 20' ' ' GLU . 18.3 Cg_endo -60.69 131.08 35.93 Favored 'Trans proline' 0 N--CA 1.438 -1.777 0 C-N-CA 122.275 1.983 . . . . 72.209999999999994 111.71 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.533 ' H ' HD13 ' B' ' 26' ' ' LEU 0.25 0.0 OUTLIER -70.09 178.7 2.64 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.598 -0.728 . . . . 73.209999999999994 110.764 176.815 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 13.8 m -57.47 144.6 36.06 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 113.441 0.904 . . . . 74.209999999999994 113.441 -171.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.495 ' O ' ' HE2' ' B' ' 32' ' ' LYS . . . -56.5 -44.68 80.91 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.919 -1.037 . . . . 72.200000000000003 110.733 174.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -60.51 -45.91 92.05 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.638 -0.256 . . . . 72.010000000000005 111.082 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.478 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.5 OUTLIER -55.83 -35.32 66.26 Favored 'General case' 0 C--O 1.22 -0.485 0 O-C-N 123.276 0.36 . . . . 63.439999999999998 110.583 174.101 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.474 ' HE2' ' O ' ' B' ' 26' ' ' LEU . 43.2 mttm -70.83 -35.47 72.48 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.757 -0.656 . . . . 74.209999999999994 112.399 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.568 ' O ' ' HB2' ' B' ' 36' ' ' LYS . 0.4 OUTLIER -69.76 -38.99 76.94 Favored 'General case' 0 C--O 1.211 -0.953 0 C-N-CA 119.651 -0.82 . . . . 74.129999999999995 111.35 174.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.536 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 5.9 mm-40 -64.8 -46.26 82.77 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.869 0.366 . . . . 72.120000000000005 111.06 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.478 HG12 ' O ' ' B' ' 30' ' ' GLU . 16.2 pt -70.72 -34.67 57.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.87 -0.605 . . . . 74.120000000000005 111.401 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -70.95 -35.12 72.05 Favored 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 108.69 -0.855 . . . . 75.099999999999994 108.69 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.568 ' HB2' ' O ' ' B' ' 32' ' ' LYS . 31.8 ttmt -62.71 -31.34 72.24 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 124.987 1.315 . . . . 74.209999999999994 110.234 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.536 ' HG2' ' O ' ' B' ' 33' ' ' GLU . 10.5 ptt180 -115.35 31.78 6.48 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.567 0.699 . . . . 74.349999999999994 112.004 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' SER . . . . . 0.465 ' OG ' ' HE3' ' B' ' 112' ' ' LYS . 25.4 t -100.9 163.07 12.47 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.307 -0.861 . . . . 74.219999999999999 109.945 174.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.458 ' HA ' ' H ' ' B' ' 112' ' ' LYS . 35.0 m -134.69 164.05 35.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 122.984 0.514 . . . . 53.109999999999999 110.732 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . 0.536 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 34.7 t80 -109.63 125.2 52.34 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.309 -0.997 . . . . 74.409999999999997 108.309 177.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.414 ' HA ' HG13 ' B' ' 109' ' ' VAL . 61.8 t -116.03 112.88 41.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 108.836 -0.801 . . . . 72.219999999999999 108.836 175.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.21 173.54 18.15 Favored Glycine 0 N--CA 1.426 -2.024 0 N-CA-C 110.822 -0.911 . . . . 63.539999999999999 110.822 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.409 ' HB3' ' HA ' ' B' ' 107' ' ' ILE . 25.7 t-20 80.96 -19.28 0.44 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.102 1.361 . . . . 63.509999999999998 113.022 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.5 p -55.39 117.8 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.833 0.825 . . . . 74.019999999999996 111.074 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -69.98 153.57 43.06 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.874 -1.057 . . . . 75.219999999999999 113.104 -174.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -49.46 -32.33 11.71 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 127.859 2.464 . . . . 74.120000000000005 110.817 176.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.31 0.26 71.39 Favored Glycine 0 N--CA 1.429 -1.796 0 CA-C-O 119.292 -0.727 . . . . 51.109999999999999 114.067 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 29.1 t -75.61 147.0 39.92 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 118.703 1.252 . . . . 73.099999999999994 109.877 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 36.8 p -98.52 157.56 16.15 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 116.002 -0.545 . . . . 74.319999999999993 112.228 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.465 ' HB1' HD13 ' B' ' 66' ' ' ILE . . . -72.6 -47.64 46.24 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.865 0.866 . . . . 71.129999999999995 112.274 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -34.49 72.31 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 119.523 -0.871 . . . . 73.010000000000005 112.533 -178.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -68.8 -39.12 80.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.109 -0.496 . . . . 75.209999999999994 110.343 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 55.7 mt -65.46 -47.7 75.24 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.657 -0.701 . . . . 73.319999999999993 111.29 176.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -49.11 78.29 Favored 'General case' 0 C--O 1.207 -1.168 0 CA-C-N 116.213 -0.448 . . . . 73.109999999999999 110.001 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.75 -40.71 80.32 Favored 'General case' 0 C--O 1.263 1.783 0 CA-C-O 122.015 0.912 . . . . 63.43 112.059 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -66.09 -40.61 90.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.608 -1.178 . . . . 73.549999999999997 109.854 -175.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -82.41 -21.84 35.61 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 112.833 0.679 . . . . 73.120000000000005 112.833 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 47.1 t -68.58 -24.59 64.62 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.4 -0.818 . . . . 71.140000000000001 110.226 -176.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 32.7 m -63.63 -20.44 65.68 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 120.06 -0.656 . . . . 71.25 110.963 174.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 58.6 m -106.02 17.23 23.91 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 111.852 0.316 . . . . 65.049999999999997 111.852 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.54 177.06 20.0 Favored Glycine 0 C--O 1.226 -0.353 0 C-N-CA 119.904 -1.141 . . . . 71.510000000000005 113.603 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 23.9 t -93.34 121.09 34.37 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.265 -1.013 . . . . 73.5 108.265 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 76.8 mt -87.53 133.84 29.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-O 121.413 0.625 . . . . 74.219999999999999 112.139 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . 0.493 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 68.6 m-20 -97.4 -38.71 9.51 Favored 'General case' 0 C--O 1.206 -1.202 0 CA-C-N 115.173 -0.922 . . . . 55.039999999999999 112.676 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.526 ' HB2' ' OE1' ' B' ' 84' ' ' GLU . 71.7 mtm180 -157.39 161.74 39.01 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.12 -0.696 . . . . 72.5 109.12 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.465 HD13 ' HB1' ' B' ' 50' ' ' ALA . 24.1 pt -146.68 140.91 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 N-CA-C 107.875 -1.157 . . . . 72.530000000000001 107.875 175.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 68.8 m -126.32 127.97 46.39 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.922 -1.14 . . . . 75.430000000000007 107.922 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.43 HD12 ' N ' ' B' ' 68' ' ' ILE . 1.9 mp -124.5 121.43 61.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 106.599 -1.63 . . . . 72.049999999999997 106.599 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.435 HD23 ' N ' ' B' ' 69' ' ' LEU . 1.4 pt? -121.36 135.33 55.1 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 120.458 -0.497 . . . . 74.230000000000004 111.289 178.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 73.1 m -116.9 121.76 42.38 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.192 -1.04 . . . . 74.400000000000006 108.192 176.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . 0.632 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 3.4 p30 -111.7 128.38 56.06 Favored 'General case' 0 C--O 1.212 -0.88 0 C-N-CA 119.261 -0.976 . . . . 71.329999999999998 111.873 -177.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -121.97 5.11 9.88 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.81 -0.632 . . . . 73.5 109.646 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.436 ' CD1' ' HD3' ' A' ' 65' ' ' ARG . 28.3 p90 -59.28 -16.92 24.52 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 114.191 1.182 . . . . 72.310000000000002 114.191 -175.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 38.4 p -96.96 4.19 51.67 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 120.855 0.36 . . . . 71.239999999999995 111.407 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.25 -60.1 0.35 Allowed Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 111.581 -0.608 . . . . 75.329999999999998 111.581 -177.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -96.73 129.17 33.53 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 112.009 0.374 . . . . 72.099999999999994 112.009 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.632 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 91.9 Cg_endo -78.41 126.42 7.57 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.546 2.164 . . . . 73.409999999999997 113.933 -177.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 32.9 mtmm -109.86 165.23 11.87 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 123.683 0.793 . . . . 73.430000000000007 109.753 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -134.11 135.68 8.15 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 119.925 -1.131 . . . . 71.019999999999996 113.808 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . 0.574 ' OH ' ' HG2' ' A' ' 24' ' ' GLN 0.436 0.4 OUTLIER -150.02 143.96 25.5 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 124.755 1.222 . . . . 72.439999999999998 112.083 173.853 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.94 154.89 50.32 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.086 -0.506 . . . . 73.109999999999999 110.504 -172.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' TYR . . . . . 0.573 ' OH ' ' HA ' ' A' ' 22' ' ' PRO . 29.5 m-85 -122.43 126.83 48.77 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.978 -1.119 . . . . 73.200000000000003 107.978 177.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.404 HG22 HG23 ' B' ' 66' ' ' ILE . 28.5 mm -109.66 127.41 66.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 107.594 -1.261 . . . . 73.120000000000005 107.594 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' GLU . . . . . 0.526 ' OE1' ' HB2' ' B' ' 65' ' ' ARG . 45.2 mt-10 -107.82 121.33 44.53 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 110.331 -0.248 . . . . 73.109999999999999 110.331 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -98.47 162.14 13.31 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.201 0.524 . . . . 74.420000000000002 112.018 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.493 ' HA ' ' ND2' ' B' ' 64' ' ' ASN . . . -69.18 -36.7 77.6 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.253 -0.885 . . . . 70.200000000000003 112.075 176.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.94 157.75 30.54 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.485 0.659 . . . . 75.409999999999997 111.341 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.69 -35.3 78.57 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 114.76 -1.109 . . . . 75.200000000000003 111.5 175.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -60.38 -32.15 71.03 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 123.525 0.516 . . . . 75.109999999999999 110.15 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 14.7 m -63.48 -37.06 85.87 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 116.4 -0.364 . . . . 74.209999999999994 111.212 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . 0.589 ' O ' HG11 ' B' ' 95' ' ' VAL . 3.0 m -67.47 -40.21 84.04 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 C-N-CA 119.582 -0.847 . . . . 64.120000000000005 108.984 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -63.0 -30.89 71.95 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.961 0.41 . . . . 75.140000000000001 110.933 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.73 -40.25 63.69 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.22 -0.445 . . . . 74.010000000000005 110.546 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.97 -40.41 63.02 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-N 116.409 -0.359 . . . . 54.130000000000003 111.401 -177.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . 0.589 HG11 ' O ' ' B' ' 91' ' ' VAL . 16.6 m -58.24 -21.66 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 112.873 0.694 . . . . 63.100000000000001 112.873 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.91 -15.94 63.84 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.44 0.638 . . . . 45.130000000000003 109.759 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 34.0 mtp -94.68 6.26 49.43 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 123.954 0.902 . . . . 72.140000000000001 110.021 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 2.0 p-10 -38.87 -46.65 1.32 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.455 1.28 . . . . 73.430000000000007 114.455 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -113.19 99.05 7.52 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 118.998 0.817 . . . . 71.439999999999998 109.931 171.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' B' ' 106' ' ' THR . 19.0 p -139.65 167.44 22.1 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.064 -0.971 . . . . 73.400000000000006 111.462 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' B' ' 105' ' ' ARG . 7.4 p -102.64 125.27 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 CA-C-O 121.671 0.748 . . . . 73.099999999999994 109.907 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -135.44 120.4 18.65 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.941 -1.133 . . . . 73.340000000000003 107.941 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 56.41 32.61 20.94 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.554 1.142 . . . . 74.109999999999999 112.31 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.71 4.5 82.62 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 114.661 -1.154 . . . . 63.119999999999997 113.488 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' B' ' 101' ' ' VAL . 99.2 mtt180 -120.89 162.85 19.14 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 117.224 0.512 . . . . 71.010000000000005 109.929 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' B' ' 100' ' ' THR . 62.9 m -94.12 120.52 34.48 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.067 -1.086 . . . . 71.430000000000007 108.067 175.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . 0.409 ' HA ' ' HB3' ' B' ' 43' ' ' ASN . 40.8 pt -100.68 170.45 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.116 -1.034 . . . . 73.140000000000001 110.164 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 55.5 tptt -133.1 126.07 30.97 Favored 'General case' 0 N--CA 1.434 -1.227 0 O-C-N 123.728 0.643 . . . . 72.400000000000006 109.629 -177.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 27.3 m -128.85 138.36 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-N 116.429 -0.351 . . . . 72.430000000000007 111.423 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . 0.537 ' HB3' ' HD2' ' B' ' 111' ' ' PRO 0.255 0.1 OUTLIER -140.01 169.68 11.46 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 105.61 -1.996 . . . . 74.5 105.61 174.636 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' B' ' 110' ' ' LEU . 89.6 Cg_endo -80.3 130.47 8.14 Favored 'Trans proline' 0 N--CA 1.425 -2.515 0 C-N-CA 121.412 1.408 . . . . 74.540000000000006 109.718 172.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.465 ' HE3' ' OG ' ' B' ' 38' ' ' SER . 15.0 ttpp -98.31 108.61 21.34 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 104.723 -2.325 . . . . 60.149999999999999 104.723 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -148.94 134.46 18.61 Favored 'General case' 0 CA--C 1.496 -1.097 0 C-N-CA 118.542 -1.263 . . . . 74.209999999999994 112.861 -166.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 36.6 p -111.17 85.13 2.06 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 106.954 -1.499 . . . . 74.430000000000007 106.954 164.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -73.15 95.53 2.09 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 114.896 -1.047 . . . . 61.009999999999998 110.914 -173.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 85.9 mtp -132.72 143.09 47.24 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 107.585 -1.265 . . . . 63.539999999999999 107.585 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -70.11 157.56 59.32 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 122.421 2.08 . . . . 63.32 112.369 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -103.21 161.34 16.36 Favored Glycine 0 N--CA 1.432 -1.616 0 N-CA-C 109.77 -1.332 . . . . 41.140000000000001 109.77 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 14.1 tt -88.2 83.91 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 CA-C-O 122.711 1.243 . . . . 73.109999999999999 111.348 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 37.7 m -135.91 128.48 30.64 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.921 -1.511 . . . . 53.210000000000001 106.921 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 61.1 p -68.73 107.27 2.95 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.976 0.417 . . . . 74.200000000000003 112.011 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 26.2 m -80.25 86.36 5.65 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.691 -1.226 . . . . 70.349999999999994 107.691 176.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -151.45 154.62 36.94 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.253 -1.017 . . . . 55.549999999999997 108.253 -174.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.301 -1.542 0 CA-C-O 119.451 -0.309 . . . . 73.049999999999997 111.592 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.462 0 CA-C-O 120.702 0.287 . . . . 63.109999999999999 110.996 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.496 HD13 ' O ' ' A' ' 2' ' ' ILE . 2.4 pp -102.05 136.71 32.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 120.852 0.358 . . . . 74.519999999999996 110.674 175.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.82 124.77 27.75 Favored Pre-proline 0 C--N 1.297 -1.697 0 CA-C-N 116.525 -0.307 . . . . 61.229999999999997 110.338 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.29 100.84 1.05 Allowed 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 122.077 1.851 . . . . 53.140000000000001 109.825 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 72.1 m -125.42 79.54 1.82 Allowed 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.702 -0.681 . . . . 74.540000000000006 110.223 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -91.42 -46.12 8.18 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.726 -1.213 . . . . 70.310000000000002 107.726 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 48.81 76.52 0.12 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.305 1.442 . . . . 54.299999999999997 113.426 176.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.1 m -128.36 85.23 2.31 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.738 0.78 . . . . 62.530000000000001 109.475 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.5 p -145.7 137.25 25.07 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.674 -1.148 . . . . 43.43 109.598 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -140.54 148.16 40.59 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.712 -0.477 . . . . 62.420000000000002 109.712 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.2 p -97.16 -49.11 5.1 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.027 0.442 . . . . 62.240000000000002 110.254 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt 65.51 -160.39 0.27 Allowed 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.232 -0.895 . . . . 64.049999999999997 110.847 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.477 ' HB2' ' CA ' ' B' ' 23' ' ' PRO . 0.0 OUTLIER -110.23 128.87 55.73 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 113.855 1.057 . . . . 75.150000000000006 113.855 -172.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 p -151.6 123.9 8.28 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.613 1.565 . . . . 62.140000000000001 109.337 173.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.94 166.7 11.32 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 112.424 0.527 . . . . 73.120000000000005 112.424 -175.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.518 ' HA3' ' NH1' ' B' ' 65' ' ' ARG . . . -166.6 -44.26 0.02 OUTLIER Glycine 0 CA--C 1.532 1.111 0 C-N-CA 120.747 -0.74 . . . . 61.240000000000002 113.955 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.14 120.18 41.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 117.738 0.769 . . . . 71.25 112.401 -175.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -92.14 -31.23 15.57 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 116.109 -0.496 . . . . 74.140000000000001 112.056 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 t -109.12 -177.5 3.32 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 121.967 -0.458 . . . . 72.209999999999994 110.5 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -111.36 -13.19 13.95 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.485 -1.302 . . . . 52.5 107.485 174.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.606 ' HA3' ' OH ' ' B' ' 82' ' ' TYR . . . 86.33 -136.31 14.04 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.561 -1.199 . . . . 64.400000000000006 114.751 175.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.44 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 52.4 Cg_exo -55.75 -39.4 91.32 Favored 'Trans proline' 0 CA--C 1.564 1.976 0 C-N-CA 124.368 3.378 . . . . 73.329999999999998 116.481 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 22' ' ' PRO . 9.5 Cg_endo -53.82 130.89 41.4 Favored 'Trans proline' 0 C--N 1.394 2.957 0 CA-C-N 121.194 1.462 . . . . 72.319999999999993 111.1 176.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -62.81 129.84 93.38 Favored Pre-proline 0 C--N 1.316 -0.891 0 CA-C-N 116.001 -0.545 . . . . 73.209999999999994 111.884 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -72.14 120.64 6.93 Favored 'Trans proline' 0 N--CA 1.438 -1.749 0 C-N-CA 122.27 1.98 . . . . 72.329999999999998 111.365 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.575 HD11 ' H ' ' A' ' 26' ' ' LEU 0.28 0.0 OUTLIER -74.12 172.25 12.06 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.399 -0.819 . . . . 72.140000000000001 112.18 176.913 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.483 ' HB3' ' OE1' ' A' ' 30' ' ' GLU . 37.7 t -67.2 158.29 31.69 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.71 1.004 . . . . 72.230000000000004 113.71 -171.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.55 ' O ' ' HE2' ' A' ' 32' ' ' LYS . . . -54.14 -47.14 72.23 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 115.038 -0.983 . . . . 64.200000000000003 111.371 176.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -69.56 -30.25 68.0 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.338 0.496 . . . . 75.120000000000005 112.338 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.483 ' OE1' ' HB3' ' A' ' 27' ' ' SER . 1.4 mp0 -66.03 -38.9 89.59 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 120.326 -0.55 . . . . 74.430000000000007 109.883 170.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.453 ' HA ' HG12 ' A' ' 34' ' ' ILE . 58.3 mttm -68.98 -49.61 56.35 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 112.908 0.707 . . . . 75.409999999999997 112.908 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.55 ' HE2' ' O ' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -58.95 -35.13 72.62 Favored 'General case' 0 C--O 1.215 -0.737 0 C-N-CA 120.092 -0.643 . . . . 75.25 112.132 -178.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.66 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 7.1 mm-40 -70.27 -49.86 45.52 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.93 -0.308 . . . . 75.340000000000003 111.067 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 30' ' ' GLU . 34.0 pt -67.44 -34.99 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 112.413 0.523 . . . . 64.540000000000006 112.413 -176.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.498 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . 46.3 m-20 -59.52 -39.88 85.31 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.043 0.449 . . . . 64.140000000000001 110.014 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 97.1 mttt -76.18 -11.02 59.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.134 -0.939 . . . . 75.420000000000002 110.592 -177.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.66 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 61.1 mmt-85 -98.16 5.44 48.52 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 109.052 -0.721 . . . . 72.329999999999998 109.052 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.476 ' HG ' ' HG2' ' A' ' 84' ' ' GLU . 46.9 t -109.93 164.61 12.43 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 113.677 0.992 . . . . 72.219999999999999 113.677 -174.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.98 162.18 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 114.937 -1.029 . . . . 61.229999999999997 110.017 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.545 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 28.5 t80 -110.34 124.64 52.06 Favored 'General case' 0 C--N 1.29 -2.01 0 C-N-CA 124.826 1.25 . . . . 74.219999999999999 107.722 177.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.8 t -111.07 116.43 52.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 N-CA-C 108.08 -1.081 . . . . 72.540000000000006 108.08 178.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.86 166.61 12.78 Favored Glycine 0 N--CA 1.417 -2.582 0 C-N-CA 119.909 -1.139 . . . . 71.239999999999995 112.092 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.8 t30 67.99 18.11 9.52 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 125.732 1.613 . . . . 74.420000000000002 113.449 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.533 ' O ' ' HA3' ' A' ' 79' ' ' GLY . 7.1 p -73.95 116.67 16.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.941 -0.762 . . . . 75.010000000000005 108.941 175.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -94.98 168.18 10.94 Favored 'General case' 0 C--O 1.255 1.373 0 CA-C-O 121.226 0.536 . . . . 74.010000000000005 111.851 -172.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.648 ' CE1' ' HB2' ' A' ' 77' ' ' PRO . 4.5 m-85 -64.77 96.44 0.18 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.405 -1.27 . . . . 73.239999999999995 110.935 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.42 -26.32 0.3 Allowed Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 109.949 -1.261 . . . . 45.329999999999998 109.949 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.5 m -84.14 135.06 34.53 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.222 -1.029 . . . . 71.219999999999999 108.222 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.1 p -105.84 170.8 7.69 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 119.755 -0.164 . . . . 75.329999999999998 111.095 -176.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.439 ' HB2' HD12 ' A' ' 66' ' ' ILE . . . -64.2 -50.55 67.65 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 117.828 0.286 . . . . 71.519999999999996 111.105 -177.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.402 ' HG2' ' CE2' ' B' ' 46' ' ' TYR . 78.8 mt-30 -59.03 -38.87 80.28 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.465 0.543 . . . . 74.319999999999993 112.465 176.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -64.53 -37.62 88.2 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.779 0.799 . . . . 74.120000000000005 109.43 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.5 mt -72.68 -47.35 48.04 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.996 -1.002 . . . . 65.329999999999998 110.955 177.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -61.39 -49.39 77.08 Favored 'General case' 0 C--O 1.204 -1.308 0 C-N-CA 123.295 0.638 . . . . 75.200000000000003 110.855 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.07 -44.09 78.59 Favored 'General case' 0 C--O 1.256 1.443 0 CA-C-O 121.269 0.557 . . . . 71.239999999999995 111.042 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -64.58 -39.98 94.7 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.268 -0.878 . . . . 74.129999999999995 110.858 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -82.1 -22.43 36.24 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 113.266 0.839 . . . . 72.099999999999994 113.266 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.2 t -70.31 -23.88 62.93 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.781 -0.645 . . . . 73.109999999999999 109.3 -177.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.9 m -58.96 -27.76 65.66 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-O 121.266 0.555 . . . . 65.209999999999994 109.861 172.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 58.9 m -94.12 5.39 51.87 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.023 0.529 . . . . 62.310000000000002 112.161 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.33 -166.81 27.58 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.306 -1.426 . . . . 73.319999999999993 114.259 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.2 t -98.83 123.0 42.8 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 120.896 0.379 . . . . 63.140000000000001 110.548 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.404 HG21 HD13 ' A' ' 63' ' ' ILE . 69.8 mt -83.41 134.28 27.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-O 121.606 0.717 . . . . 63.130000000000003 112.58 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.635 ' OD1' ' HB3' ' B' ' 73' ' ' PHE . 34.2 t30 -98.07 -45.08 6.37 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.443 -1.253 . . . . 72.040000000000006 110.254 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.463 ' HA ' ' HA ' ' B' ' 71' ' ' ASP . 49.4 mtp180 -155.57 165.03 37.83 Favored 'General case' 0 C--O 1.213 -0.86 0 N-CA-C 107.873 -1.158 . . . . 71.129999999999995 107.873 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.439 HD12 ' HB2' ' A' ' 50' ' ' ALA . 19.2 pt -146.08 144.38 20.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.237 -1.024 . . . . 71.0 108.237 171.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.57 ' OG1' ' HB2' ' A' ' 82' ' ' TYR . 39.7 p -122.43 137.2 54.95 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 105.414 -2.069 . . . . 64.219999999999999 105.414 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.445 HD12 ' O ' ' B' ' 68' ' ' ILE . 3.1 mp -129.26 112.54 25.46 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 105.705 -1.961 . . . . 73.430000000000007 105.705 173.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.473 ' HG ' ' CE2' ' A' ' 80' ' ' TYR 0.255 1.6 pt? -120.38 123.59 43.44 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 119.772 -0.771 . . . . 75.109999999999999 111.2 -179.228 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 73.4 m -117.83 136.47 53.4 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.204 -0.907 . . . . 51.509999999999998 109.592 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.599 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 4.0 p30 -120.24 143.43 48.3 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 119.928 -0.709 . . . . 75.510000000000005 110.011 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -124.85 5.31 8.07 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.336 -0.616 . . . . 62.310000000000002 109.336 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.609 ' HB3' ' OD1' ' B' ' 64' ' ' ASN . 36.9 p90 -64.52 -25.68 68.09 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 112.198 0.444 . . . . 62.0 112.198 -176.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.9 t -80.97 -8.47 59.77 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.151 0.5 . . . . 74.099999999999994 110.67 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.98 -55.19 0.57 Allowed Glycine 0 CA--C 1.494 -1.225 0 N-CA-C 110.427 -1.069 . . . . 60.409999999999997 110.427 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -96.63 133.81 24.09 Favored Pre-proline 0 C--N 1.295 -1.795 0 N-CA-C 107.482 -1.303 . . . . 74.510000000000005 107.482 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.648 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 74.2 Cg_endo -76.78 117.27 4.46 Favored 'Trans proline' 0 N--CA 1.426 -2.492 0 C-N-CA 120.613 0.875 . . . . 63.420000000000002 111.134 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm -100.77 147.11 26.43 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 115.552 -0.749 . . . . 73.209999999999994 109.283 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' A' ' 44' ' ' VAL . . . -122.38 137.01 11.11 Favored Glycine 0 N--CA 1.418 -2.558 0 C-N-CA 120.05 -1.071 . . . . 36.939999999999998 112.494 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.473 ' CE2' ' HG ' ' A' ' 69' ' ' LEU . 5.2 p90 -149.87 143.09 25.08 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 124.407 1.083 . . . . 71.230000000000004 109.338 176.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.32 153.95 45.43 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 116.509 -0.314 . . . . 72.150000000000006 111.825 -171.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.691 ' OH ' ' HA3' ' B' ' 21' ' ' GLY . 20.0 m-85 -116.78 125.1 51.11 Favored 'General case' 0 CA--C 1.461 -2.449 0 C-N-CA 122.864 0.466 . . . . 71.540000000000006 110.729 173.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.3 mm -103.69 110.7 30.83 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.536 0 N-CA-C 106.375 -1.713 . . . . 72.129999999999995 106.375 175.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.476 ' HG2' ' HG ' ' A' ' 38' ' ' SER . 29.2 mt-10 -96.88 121.08 38.36 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.325 -0.991 . . . . 63.420000000000002 108.325 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -99.43 170.98 8.24 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.218 0.533 . . . . 73.319999999999993 111.239 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.62 -41.01 22.09 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.474 -0.784 . . . . 73.340000000000003 110.637 173.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -101.81 146.99 27.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.06 0.457 . . . . 75.299999999999997 111.355 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.541 ' O ' HG21 ' A' ' 91' ' ' VAL . 0.8 OUTLIER -74.71 -34.05 62.51 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.077 -1.453 . . . . 75.319999999999993 107.077 -179.304 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.286 0.9 OUTLIER -65.98 -20.06 66.07 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.156 -0.929 . . . . 72.129999999999995 113.212 177.425 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.6 m -66.27 -36.6 83.41 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 109.824 -0.436 . . . . 71.040000000000006 109.824 174.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.541 HG21 ' O ' ' A' ' 88' ' ' ARG . 3.6 m -66.26 -40.42 86.81 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 N-CA-C 108.629 -0.878 . . . . 65.340000000000003 108.629 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -55.54 -38.52 69.39 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.435 0.694 . . . . 65.030000000000001 110.529 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.71 -37.92 65.0 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.838 -0.619 . . . . 61.229999999999997 111.421 177.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.85 -39.91 55.7 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.188 0.44 . . . . 53.030000000000001 112.188 -176.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 91' ' ' VAL . 33.0 m -55.41 -22.06 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 113.068 0.766 . . . . 54.399999999999999 113.068 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.31 -9.63 42.89 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 120.991 0.424 . . . . 41.409999999999997 110.37 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.56 ' C ' ' H ' ' A' ' 99' ' ' GLU . 68.3 mtm -99.17 5.98 46.58 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.153 0.797 . . . . 75.349999999999994 113.153 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -67.57 24.07 0.02 OUTLIER 'General case' 0 N--CA 1.528 3.43 0 C-N-CA 123.641 0.776 . . . . 74.230000000000004 112.578 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.56 ' H ' ' C ' ' A' ' 97' ' ' MET . 39.6 tt0 -156.21 -7.81 0.11 Allowed 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.805 -1.089 . . . . 71.420000000000002 109.171 -168.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.4 p -88.03 169.2 12.17 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.517 -0.765 . . . . 73.010000000000005 111.625 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.7 p -106.46 132.44 53.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-N 115.401 -0.818 . . . . 63.109999999999999 109.814 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -127.14 123.68 37.33 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.561 -0.903 . . . . 75.409999999999997 108.561 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.3 ttt-85 54.52 33.01 17.98 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-O 122.975 1.369 . . . . 75.129999999999995 111.003 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.0 14.62 69.08 Favored Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 114.224 -1.353 . . . . 74.319999999999993 114.449 176.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -136.12 148.82 48.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 118.043 0.922 . . . . 61.310000000000002 110.64 174.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.5 m -79.15 121.64 25.26 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.768 -0.827 . . . . 70.420000000000002 108.768 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 37.4 pt -102.32 172.13 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.18 0.514 . . . . 72.310000000000002 111.287 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -124.89 127.28 46.87 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.228 -1.027 . . . . 63.509999999999998 108.228 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 23.8 t -126.79 115.95 43.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 107.746 -1.205 . . . . 75.340000000000003 107.746 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.446 HD11 ' HB3' ' A' ' 40' ' ' TYR 0.283 0.0 OUTLIER -138.38 141.39 31.38 Favored Pre-proline 0 C--N 1.311 -1.073 0 C-N-CA 119.536 -0.865 . . . . 72.319999999999993 109.112 -179.533 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.01 140.0 44.32 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 122.326 2.017 . . . . 72.409999999999997 114.153 -171.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.498 ' HE3' ' HA ' ' A' ' 35' ' ' ASP . 32.8 ttpt -84.81 136.94 33.46 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 109.109 -0.7 . . . . 72.25 109.109 177.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -113.38 164.54 13.45 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.411 -0.959 . . . . 63.240000000000002 108.411 175.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 35' ' ' ASP . 13.2 t -104.2 110.95 23.35 Favored 'General case' 0 N--CA 1.404 -2.727 0 N-CA-C 106.871 -1.529 . . . . 75.430000000000007 106.871 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -77.55 87.02 3.88 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.993 0.902 . . . . 62.450000000000003 111.193 -173.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.433 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 0.2 OUTLIER -123.01 -49.61 0.04 OUTLIER Pre-proline 0 C--N 1.303 -1.423 0 CA-C-N 113.773 -1.558 . . . . 73.030000000000001 110.002 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.433 ' HD3' ' HB2' ' A' ' 116' ' ' MET . 2.9 Cg_endo -89.77 31.27 0.38 Allowed 'Trans proline' 0 C--N 1.388 2.637 0 C-N-CA 122.361 2.041 . . . . 64.129999999999995 110.954 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -92.55 38.21 3.22 Favored Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 115.815 -0.63 . . . . 73.349999999999994 112.172 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 mp 63.42 99.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 124.379 1.072 . . . . 60.329999999999998 112.314 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.9 m -88.66 -25.8 22.19 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.656 -0.702 . . . . 64.099999999999994 109.956 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 53.1 m 65.94 -178.23 0.19 Allowed 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.184 0.994 . . . . 65.549999999999997 111.89 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.5 p -95.49 103.7 15.58 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 121.091 0.472 . . . . 74.549999999999997 110.504 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -80.01 107.84 13.11 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 108.884 -0.784 . . . . 74.140000000000001 108.884 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 . . . . . 0 C--N 1.302 -1.479 0 N-CA-C 109.448 -0.575 . . . . 73.129999999999995 109.448 -178.101 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.454 0 CA-C-O 120.978 0.418 . . . . 74.340000000000003 110.367 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 50.3 mm -117.5 110.97 32.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 108.678 -0.86 . . . . 74.439999999999998 108.678 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -126.92 94.53 39.36 Favored Pre-proline 0 C--N 1.312 -1.042 0 CA-C-O 120.959 0.409 . . . . 73.349999999999994 111.161 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -94.83 -163.8 0.1 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 123.061 2.507 . . . . 74.200000000000003 110.111 176.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 42.0 t -76.51 108.43 9.48 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.225 -1.028 . . . . 74.420000000000002 108.225 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 66.3 mtt -81.34 93.06 6.49 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.791 -0.641 . . . . 74.129999999999995 111.722 -174.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -111.19 -6.51 14.56 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.49 -0.777 . . . . 63.43 109.459 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 26.3 m -87.86 94.13 9.67 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.298 -0.865 . . . . 72.129999999999995 109.301 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 51.6 m -151.7 139.28 19.64 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.035 -0.728 . . . . 63.329999999999998 109.035 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -105.85 101.76 11.25 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.592 0.71 . . . . 75.430000000000007 110.244 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 21.8 p -80.94 162.56 23.83 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.753 -1.112 . . . . 64.150000000000006 110.94 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' B' ' 12' ' ' LYS . 11.0 mptt -104.17 88.66 3.05 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.139 -0.482 . . . . 74.129999999999995 110.012 -177.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' MET . . . . . 0.424 ' C ' ' H ' ' B' ' 15' ' ' ALA . 65.7 mtt -90.56 140.37 29.82 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.801 -0.636 . . . . 72.200000000000003 109.785 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 84.9 m 75.51 -29.02 0.18 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.643 0.777 . . . . 73.299999999999997 111.379 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.424 ' H ' ' C ' ' B' ' 13' ' ' MET . . . -78.71 -61.45 2.01 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 109.104 -0.702 . . . . 72.319999999999993 109.104 175.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.43 -173.11 23.68 Favored Glycine 0 N--CA 1.433 -1.552 0 C-N-CA 120.838 -0.696 . . . . 62.5 112.705 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.65 -154.65 0.48 Allowed 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.583 -0.895 . . . . 63.530000000000001 108.583 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -91.81 -3.16 56.44 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.758 -0.83 . . . . 74.049999999999997 108.758 174.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.486 ' HB ' ' HD2' ' A' ' 112' ' ' LYS . 28.8 m 60.54 101.56 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.788 1.235 . . . . 75.319999999999993 113.994 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -69.74 -13.44 62.29 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 121.135 -0.226 . . . . 71.409999999999997 110.648 174.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.691 ' HA3' ' OH ' ' A' ' 82' ' ' TYR . . . 94.08 -124.6 7.94 Favored Glycine 0 C--N 1.344 1.009 0 N-CA-C 115.093 0.797 . . . . 54.420000000000002 115.093 170.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.65 -35.98 97.8 Favored 'Trans proline' 0 CA--C 1.558 1.724 0 C-N-CA 123.492 2.795 . . . . 71.25 114.762 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.477 ' CA ' ' HB2' ' A' ' 13' ' ' MET . 58.6 Cg_exo -47.52 123.57 8.26 Favored 'Trans proline' 0 C--N 1.4 3.27 0 C-N-CA 122.073 1.849 . . . . 75.409999999999997 113.041 174.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -91.03 141.52 26.56 Favored Pre-proline 0 C--N 1.294 -1.841 0 CA-C-N 114.56 -1.2 . . . . 63.140000000000001 108.874 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -49.3 117.73 3.1 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.998 2.465 . . . . 63.409999999999997 113.515 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 7.2 mp -58.04 -176.04 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.191 0 CA-C-N 113.98 -1.464 . . . . 71.010000000000005 110.453 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 20.3 m -66.58 142.93 57.32 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 107.254 -1.387 . . . . 63.009999999999998 107.254 171.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.564 ' O ' ' HE2' ' B' ' 32' ' ' LYS . . . -56.02 -42.84 77.07 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.577 -0.738 . . . . 65.109999999999999 110.68 176.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -68.4 -30.84 69.85 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 112.812 0.671 . . . . 74.409999999999997 112.812 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.411 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.7 OUTLIER -65.75 -39.74 91.38 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.636 -0.505 . . . . 62.299999999999997 109.636 171.673 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.448 ' HA ' HG12 ' B' ' 34' ' ' ILE . 57.3 mttm -70.19 -49.98 44.83 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 113.162 0.801 . . . . 53.229999999999997 113.162 -178.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.564 ' HE2' ' O ' ' B' ' 28' ' ' ALA . 0.3 OUTLIER -56.09 -39.15 71.7 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 120.146 -0.622 . . . . 75.209999999999994 112.639 -178.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 17.9 mt-10 -71.85 -41.61 67.91 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 118.945 -1.102 . . . . 74.230000000000004 112.629 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.448 HG12 ' HA ' ' B' ' 31' ' ' LYS . 35.1 pt -68.88 -35.46 69.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 C-N-CA 120.213 -0.595 . . . . 73.340000000000003 111.351 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -59.85 -44.08 94.31 Favored 'General case' 0 C--O 1.217 -0.625 0 N-CA-C 109.674 -0.491 . . . . 72.140000000000001 109.674 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 98.4 mttt -70.33 -18.22 63.08 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.269 -0.878 . . . . 65.239999999999995 112.298 -175.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' B' ' 33' ' ' GLU . 18.8 ptp180 -109.8 24.93 12.38 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-O 121.443 0.64 . . . . 71.040000000000006 111.383 -178.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' SER . . . . . 0.45 ' HB2' ' HD3' ' B' ' 112' ' ' LYS . 19.5 m -115.51 172.69 6.95 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.656 -0.702 . . . . 60.140000000000001 110.997 174.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.4 163.66 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 123.19 0.596 . . . . 74.25 110.573 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 36.0 t80 -111.97 125.61 54.25 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 125.596 1.559 . . . . 72.109999999999999 107.94 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 57.9 t -114.66 116.31 52.2 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 C-N-CA 123.651 0.78 . . . . 74.219999999999999 109.191 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.98 165.39 12.52 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 120.716 -0.754 . . . . 61.119999999999997 112.406 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 t30 57.81 20.43 6.53 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 126.241 1.816 . . . . 72.340000000000003 113.26 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.72 129.0 19.08 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 CA-C-O 121.396 0.617 . . . . 71.239999999999995 109.389 173.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.475 ' HA ' ' CZ ' ' B' ' 105' ' ' ARG . 20.8 t70 -61.35 139.23 58.22 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 114.674 -1.148 . . . . 64.299999999999997 109.274 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' TYR . . . . . 0.402 ' CE2' ' HG2' ' A' ' 51' ' ' GLN . 32.6 t80 -70.32 0.15 7.01 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.714 -0.676 . . . . 74.230000000000004 111.072 -174.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -107.6 -0.23 34.61 Favored Glycine 0 N--CA 1.421 -2.304 0 CA-C-N 115.799 -0.637 . . . . 71.230000000000004 112.148 175.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.9 t -80.51 146.27 31.42 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.599 -1.26 . . . . 71.420000000000002 107.599 176.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 71.7 p -105.52 172.58 6.72 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.982 -0.377 . . . . 73.030000000000001 109.982 -177.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.429 ' HB2' HD12 ' B' ' 66' ' ' ILE . . . -63.72 -50.4 69.29 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 120.57 0.224 . . . . 71.209999999999994 110.539 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -61.03 -35.99 78.36 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 111.838 0.311 . . . . 75.420000000000002 111.838 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -64.17 -43.65 94.49 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 109.61 -0.515 . . . . 65.209999999999994 109.61 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 52.0 mt -67.67 -48.14 67.48 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.208 -0.905 . . . . 73.140000000000001 112.042 176.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.423 ' HG2' HD13 ' B' ' 63' ' ' ILE . 0.6 OUTLIER -60.32 -49.16 78.71 Favored 'General case' 0 C--O 1.207 -1.132 0 C-N-CA 123.387 0.675 . . . . 75.209999999999994 110.809 -177.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.28 -43.25 78.62 Favored 'General case' 0 C--O 1.262 1.718 0 CA-C-O 121.215 0.531 . . . . 61.130000000000003 111.123 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -65.77 -39.25 90.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.479 -0.782 . . . . 74.219999999999999 110.718 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -82.45 -22.55 35.19 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 113.432 0.901 . . . . 75.150000000000006 113.432 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 36.1 t -69.23 -25.16 64.17 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.958 -0.565 . . . . 72.239999999999995 109.766 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.9 m -62.9 -24.97 68.09 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 120.387 -0.525 . . . . 74.310000000000002 110.511 173.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 58.4 m -96.55 3.73 52.46 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 122.744 0.418 . . . . 54.229999999999997 112.061 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.13 -171.72 32.73 Favored Glycine 0 C--O 1.222 -0.634 0 C-N-CA 119.281 -1.438 . . . . 65.409999999999997 114.456 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 21.7 m -98.86 119.38 37.52 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.707 -0.479 . . . . 51.409999999999997 109.707 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.423 HD13 ' HG2' ' B' ' 54' ' ' GLU . 50.8 mt -82.52 132.74 30.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 112.997 0.74 . . . . 73.450000000000003 112.997 -177.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . 0.609 ' OD1' ' HB3' ' A' ' 73' ' ' PHE . 46.1 t-20 -93.79 -51.29 4.97 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 125.315 1.446 . . . . 73.040000000000006 109.225 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.518 ' NH1' ' HA3' ' A' ' 16' ' ' GLY . 46.5 mtp180 -153.14 166.75 31.53 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.547 -1.279 . . . . 73.120000000000005 107.547 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.429 HD12 ' HB2' ' B' ' 50' ' ' ALA . 19.9 pt -147.13 144.28 19.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 108.059 -1.089 . . . . 75.319999999999993 108.059 171.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' THR . . . . . 0.574 ' OG1' ' HB2' ' B' ' 82' ' ' TYR . 36.9 p -121.71 136.88 54.93 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 105.387 -2.079 . . . . 55.100000000000001 105.387 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.445 ' O ' HD12 ' A' ' 68' ' ' ILE . 2.2 mp -129.25 113.08 26.93 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 N-CA-C 105.561 -2.014 . . . . 74.400000000000006 105.561 173.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.51 ' HG ' ' CE2' ' B' ' 80' ' ' TYR 0.274 1.5 pt? -120.72 123.03 41.72 Favored 'General case' 0 C--N 1.281 -2.387 0 C-N-CA 119.987 -0.685 . . . . 72.310000000000002 111.486 -179.497 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' CYS . . . . . 0.479 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 67.0 m -117.6 134.82 54.47 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.621 -0.718 . . . . 75.010000000000005 109.631 -177.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . 0.501 ' CG ' ' HZ2' ' B' ' 78' ' ' LYS . 3.5 p30 -115.11 140.38 49.11 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.878 -0.729 . . . . 74.439999999999998 109.871 177.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . 0.459 ' HZ2' ' HB3' ' B' ' 72' ' ' LYS . 7.6 mtpm? -112.5 7.67 19.06 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 116.126 -0.488 . . . . 73.349999999999994 110.365 -178.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.635 ' HB3' ' OD1' ' A' ' 64' ' ' ASN . 12.5 p90 -73.08 -11.2 60.46 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 121.524 0.678 . . . . 74.319999999999993 110.585 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.453 ' C ' ' H ' ' B' ' 76' ' ' HIS . 20.7 m -88.13 9.48 22.59 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.117 -0.947 . . . . 61.25 110.09 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.95 -51.0 4.39 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 109.607 -1.397 . . . . 72.439999999999998 109.607 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . 0.453 ' H ' ' C ' ' B' ' 74' ' ' SER . 95.1 m-70 -96.43 145.53 29.74 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 105.806 -1.924 . . . . 75.109999999999999 105.806 174.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.43 ' HB3' ' HG2' ' B' ' 72' ' ' LYS . 58.2 Cg_endo -77.43 118.1 4.52 Favored 'Trans proline' 0 N--CA 1.437 -1.81 0 C-N-CA 120.767 0.978 . . . . 65.420000000000002 110.623 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' LYS . . . . . 0.501 ' HZ2' ' CG ' ' B' ' 71' ' ' ASP . 28.8 mtmm -93.71 137.49 32.91 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 108.13 -1.063 . . . . 50.439999999999998 108.13 177.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -116.17 133.33 10.73 Favored Glycine 0 N--CA 1.413 -2.887 0 C-N-CA 119.974 -1.108 . . . . 62.0 111.773 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . 0.51 ' CE2' ' HG ' ' B' ' 69' ' ' LEU . 6.8 p90 -147.74 142.73 26.97 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 124.04 0.936 . . . . 75.129999999999995 109.42 175.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.08 154.37 45.91 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 116.397 -0.365 . . . . 74.230000000000004 111.728 -172.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' TYR . . . . . 0.606 ' OH ' ' HA3' ' A' ' 21' ' ' GLY . 19.4 m-85 -117.25 124.96 50.31 Favored 'General case' 0 CA--C 1.467 -2.23 0 C-N-CA 122.78 0.432 . . . . 74.519999999999996 110.442 173.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 34.5 mm -102.75 110.11 28.5 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 106.635 -1.617 . . . . 74.040000000000006 106.635 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' GLU . . . . . 0.443 ' OE1' ' HD3' ' B' ' 65' ' ' ARG . 31.2 mt-10 -95.3 120.61 35.83 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.417 -0.957 . . . . 54.43 108.417 -178.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -99.09 162.2 13.2 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.413 0.625 . . . . 72.230000000000004 111.111 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.32 -11.37 56.48 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.509 -0.769 . . . . 65.200000000000003 109.983 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . 0.602 ' HB3' ' OG ' ' B' ' 90' ' ' SER . 43.2 tt0 -124.23 140.6 52.8 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.309 -0.405 . . . . 72.420000000000002 111.094 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.495 ' O ' HG21 ' B' ' 91' ' ' VAL . 0.6 OUTLIER -74.99 -34.91 62.02 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.64 -1.244 . . . . 74.030000000000001 107.64 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.13 -28.38 69.6 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.512 -0.921 . . . . 75.420000000000002 108.512 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' SER . . . . . 0.602 ' OG ' ' HB3' ' B' ' 87' ' ' GLU . 70.2 m -63.46 -36.34 83.43 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 116.19 -0.459 . . . . 71.239999999999995 111.025 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . 0.495 HG21 ' O ' ' B' ' 88' ' ' ARG . 3.6 m -67.18 -40.13 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.519 0 N-CA-C 108.551 -0.907 . . . . 61.130000000000003 108.551 179.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -56.96 -37.68 71.9 Favored 'General case' 0 N--CA 1.455 -0.225 0 O-C-N 123.828 0.705 . . . . 75.049999999999997 110.9 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.9 -37.18 64.76 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.753 -0.658 . . . . 61.329999999999998 111.48 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.83 -41.15 53.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.506 . . . . 73.510000000000005 111.87 -176.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . 0.483 HG12 ' O ' ' B' ' 91' ' ' VAL . 32.8 m -55.23 -21.46 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 112.905 0.705 . . . . 72.299999999999997 112.905 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.07 -13.77 62.25 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.805 0.812 . . . . 72.239999999999995 111.14 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 68.2 mtm -97.2 9.69 41.5 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.418 -0.81 . . . . 72.430000000000007 110.011 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . 0.703 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 6.1 p-10 -36.27 -46.81 0.55 Allowed 'General case' 0 C--O 1.204 -1.31 0 N-CA-C 115.694 1.739 . . . . 63.210000000000001 115.694 -176.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -128.47 41.89 3.41 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 118.585 -1.246 . . . . 73.299999999999997 110.792 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 40.8 p -79.62 176.87 9.32 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.88 -0.6 . . . . 74.400000000000006 110.794 175.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.04 132.96 55.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.139 0.495 . . . . 74.120000000000005 109.876 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -140.49 125.82 18.78 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.482 -0.781 . . . . 74.409999999999997 109.004 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . 0.263 20.7 ttt180 50.49 54.78 10.56 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 122.295 1.045 . . . . 74.349999999999994 113.747 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.89 -7.5 42.38 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 114.341 -1.3 . . . . 36.939999999999998 115.568 176.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.475 ' CZ ' ' HA ' ' B' ' 45' ' ' ASP . 10.2 ptt180 -136.7 159.89 40.48 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 114.35 1.241 . . . . 74.400000000000006 114.35 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 34.5 m -87.12 120.93 28.91 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.169 -0.923 . . . . 61.539999999999999 109.931 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 39.5 pt -101.78 172.01 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 116.204 -0.453 . . . . 73.319999999999993 110.413 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . 0.703 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 56.1 tptt -125.84 129.39 49.29 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.828 -0.804 . . . . 71.019999999999996 108.828 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 18.0 t -124.54 121.58 61.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 107.653 -1.24 . . . . 64.439999999999998 107.653 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.295 0.4 OUTLIER -140.09 135.05 16.02 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 106.25 -1.759 . . . . 73.209999999999994 106.25 -170.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.33 143.53 53.2 Favored 'Trans proline' 0 CA--C 1.551 1.363 0 C-N-CA 121.885 1.723 . . . . 71.310000000000002 113.93 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.45 ' HD3' ' HB2' ' B' ' 38' ' ' SER . 66.0 tttt -91.08 148.53 22.32 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 123.54 0.736 . . . . 70.219999999999999 110.436 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -158.4 135.83 10.18 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 105.061 -2.2 . . . . 63.219999999999999 105.061 168.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 62.1 m -147.29 110.2 4.73 Favored 'General case' 0 N--CA 1.421 -1.902 0 C-N-CA 119.085 -1.046 . . . . 72.319999999999993 113.177 -172.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' ASN . . . . . 0.435 ' O ' ' HD3' ' B' ' 117' ' ' PRO . 2.7 t-20 60.05 111.96 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 115.669 1.729 . . . . 74.200000000000003 115.669 168.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -107.34 96.14 15.19 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 108.188 -1.042 . . . . 70.209999999999994 108.188 171.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' B' ' 115' ' ' ASN . 13.4 Cg_exo -69.95 -174.8 1.02 Allowed 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 122.853 2.368 . . . . 62.310000000000002 112.205 -177.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.63 105.5 1.74 Allowed Glycine 0 N--CA 1.427 -1.958 0 C-N-CA 120.94 -0.647 . . . . 63.119999999999997 111.505 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 66.0 mt -64.11 -43.35 97.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.481 -0.933 . . . . 71.400000000000006 108.481 177.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 32.4 t -149.93 115.37 5.5 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 115.11 -0.95 . . . . 71.099999999999994 109.233 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 32.4 t -83.94 -43.04 15.65 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.406 -1.331 . . . . 70.329999999999998 107.406 177.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 10.2 t -156.72 132.04 9.24 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 107.87 -1.159 . . . . 72.450000000000003 107.87 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -78.65 -37.11 42.83 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 108.485 -0.931 . . . . 75.510000000000005 108.485 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 . . . . . 0 N--CA 1.423 -1.803 0 CA-C-N 114.637 -1.165 . . . . 62.439999999999998 109.061 175.001 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.55 0 N-CA-C 109.82 -0.437 . . . . 64.219999999999999 109.82 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.5 mm -99.59 118.96 46.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.516 -0.55 . . . . 74.430000000000007 109.516 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.08 89.2 6.09 Favored Pre-proline 0 C--N 1.308 -1.237 0 CA-C-N 116.188 -0.46 . . . . 73.239999999999995 110.037 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -85.4 12.47 3.05 Favored 'Trans proline' 0 C--O 1.242 0.679 0 C-N-CA 123.354 2.702 . . . . 74.439999999999998 112.114 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.2 t 68.75 90.57 0.09 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.277 1.431 . . . . 63.439999999999998 113.255 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -124.33 129.52 50.87 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.094 -1.076 . . . . 72.340000000000003 108.094 173.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -79.27 93.82 5.34 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.998 -1.112 . . . . 74.239999999999995 107.998 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.9 p -78.56 4.34 13.67 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 113.735 1.013 . . . . 61.25 113.735 -173.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.5 t -76.51 126.77 31.58 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 106.857 -1.535 . . . . 55.539999999999999 106.857 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -135.28 116.82 14.8 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 116.216 -0.447 . . . . 72.310000000000002 110.891 -171.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.7 t -95.62 -90.89 0.23 Allowed 'General case' 0 N--CA 1.403 -2.797 0 N-CA-C 107.026 -1.472 . . . . 72.109999999999999 107.026 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.495 ' HD2' ' SD ' ' A' ' 13' ' ' MET . 0.3 OUTLIER 43.74 89.68 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 124.759 1.223 . . . . 74.109999999999999 109.073 177.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.495 ' SD ' ' HD2' ' A' ' 12' ' ' LYS . 1.2 mpt? 82.05 75.61 0.03 OUTLIER 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 124.907 1.283 . . . . 74.439999999999998 108.211 -163.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.4 m -71.9 -30.67 65.62 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 113.921 -1.491 . . . . 70.319999999999993 110.739 -176.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 69.23 129.16 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 124.713 1.205 . . . . 61.310000000000002 112.304 -178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 169.51 153.4 8.47 Favored Glycine 0 N--CA 1.41 -3.048 0 N-CA-C 109.346 -1.502 . . . . 72.329999999999998 109.346 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.17 -74.79 0.08 Allowed 'General case' 0 C--N 1.308 -1.213 0 O-C-N 123.845 0.38 . . . . 43.109999999999999 110.716 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.559 ' OH ' ' HA ' ' B' ' 114' ' ' THR . 78.9 t80 -170.6 110.18 0.36 Allowed 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 113.313 0.857 . . . . 72.340000000000003 113.313 177.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.472 ' OG1' ' HA ' ' A' ' 25' ' ' PRO . 53.9 m -170.16 120.03 0.61 Allowed 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 106.079 -1.823 . . . . 72.129999999999995 106.079 170.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 59.76 26.71 15.89 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 122.367 1.08 . . . . 74.200000000000003 109.711 -176.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.39 -118.34 4.77 Favored Glycine 0 N--CA 1.432 -1.613 0 CA-C-N 113.449 -1.705 . . . . 60.130000000000003 111.357 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.98 -26.95 50.8 Favored 'Trans proline' 0 CA--C 1.597 3.626 0 C-N-CA 124.178 3.252 . . . . 65.450000000000003 118.752 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.56 167.64 7.88 Favored 'Trans proline' 0 C--N 1.389 2.7 0 C-N-CA 122.516 2.144 . . . . 71.209999999999994 114.48 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -62.5 139.99 96.7 Favored Pre-proline 0 C--O 1.238 0.461 0 CA-C-N 115.731 -0.668 . . . . 74.209999999999994 110.914 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.472 ' HA ' ' OG1' ' A' ' 19' ' ' THR . 94.3 Cg_endo -80.02 132.33 9.42 Favored 'Trans proline' 0 N--CA 1.437 -1.845 0 C-N-CA 122.158 1.905 . . . . 65.439999999999998 112.973 -179.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.31 142.72 41.89 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 114.766 -1.107 . . . . 74.519999999999996 108.178 174.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.3 t -67.86 155.26 39.77 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 123.317 0.386 . . . . 70.219999999999999 111.502 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.675 ' O ' ' HG2' ' A' ' 32' ' ' LYS . . . -49.34 -33.08 12.53 Favored 'General case' 0 C--O 1.188 -2.166 0 CA-C-N 115.641 -0.709 . . . . 44.520000000000003 110.748 172.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -66.57 -33.77 76.41 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.819 0.674 . . . . 74.120000000000005 112.819 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.514 ' O ' HG12 ' A' ' 34' ' ' ILE . 1.5 mp0 -67.27 -35.9 80.47 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 108.782 -0.822 . . . . 71.209999999999994 108.782 171.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 28' ' ' ALA . 55.8 mmtt -63.67 -45.23 91.05 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-N 114.766 -1.106 . . . . 61.509999999999998 108.543 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.723 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 30.5 mmmt -56.42 -47.16 79.63 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 116.204 -0.453 . . . . 74.5 110.628 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -67.18 -46.32 74.31 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.306 -0.406 . . . . 72.319999999999993 111.513 -174.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 30' ' ' GLU . 15.3 pt -71.09 -36.74 64.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.966 -0.561 . . . . 64.140000000000001 111.904 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.507 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 29.9 m-20 -76.17 -19.14 58.73 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.712 0.634 . . . . 75.040000000000006 112.712 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.723 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 97.3 mttt -66.96 -26.42 66.81 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.361 0.6 . . . . 70.340000000000003 110.339 174.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -96.89 16.03 20.51 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.153 -0.684 . . . . 72.010000000000005 109.153 -177.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.519 ' OG ' ' HG3' ' A' ' 84' ' ' GLU . 14.9 m -103.5 163.01 12.56 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 115.542 -0.754 . . . . 62.439999999999998 110.48 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.2 m -131.64 164.16 35.29 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 115.469 -0.787 . . . . 75.439999999999998 109.883 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.525 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 23.7 t80 -110.87 126.03 54.25 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 107.44 -1.318 . . . . 73.109999999999999 107.44 175.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.0 t -115.89 111.99 37.8 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 N-CA-C 107.753 -1.203 . . . . 53.340000000000003 107.753 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 43' ' ' ASN . . . -105.6 172.03 18.89 Favored Glycine 0 CA--C 1.478 -2.256 0 N-CA-C 109.706 -1.358 . . . . 37.909999999999997 109.706 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.692 ' OD1' ' HG3' ' A' ' 105' ' ' ARG . 26.2 t-20 69.42 -11.05 0.51 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.356 0.662 . . . . 64.150000000000006 112.395 -178.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 44' ' ' VAL . 8.7 p -70.19 91.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 107.372 -1.344 . . . . 71.310000000000002 107.372 176.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.38 10.5 m-20 -74.43 168.02 20.53 Favored 'General case' 0 CA--C 1.457 -2.618 0 N-CA-C 116.341 1.978 . . . . 61.149999999999999 116.341 -166.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.56 ' HH ' ' CD ' ' B' ' 54' ' ' GLU . 62.8 t80 -39.33 -34.49 0.2 Allowed 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 128.231 2.612 . . . . 73.299999999999997 114.791 -173.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.66 -1.53 85.37 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.435 -0.888 . . . . 74.319999999999993 114.075 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 103' ' ' ARG . 19.7 m -75.26 133.33 41.37 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 117.677 0.738 . . . . 71.0 111.041 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.596 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 12.6 p -92.22 155.89 17.68 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 115.583 -0.735 . . . . 74.129999999999995 111.046 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.505 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -65.54 -47.82 74.58 Favored 'General case' 0 C--O 1.212 -0.904 0 C-N-CA 122.641 0.376 . . . . 71.420000000000002 110.831 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -56.81 -53.43 57.89 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.519 0.728 . . . . 63.009999999999998 112.529 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.61 -36.75 83.75 Favored 'General case' 0 C--O 1.25 1.128 0 CA-C-O 121.397 0.617 . . . . 55.509999999999998 111.348 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.596 ' HB2' ' O ' ' A' ' 49' ' ' THR . 2.9 tt -72.17 -46.56 55.86 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.78 -1.1 . . . . 74.319999999999993 108.493 -176.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.436 ' CD ' ' HZ2' ' B' ' 72' ' ' LYS . 35.9 tt0 -58.26 -48.3 80.86 Favored 'General case' 0 C--O 1.207 -1.158 0 C-N-CA 123.482 0.713 . . . . 74.120000000000005 111.039 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.92 -38.23 69.99 Favored 'General case' 0 C--O 1.258 1.551 0 CA-C-O 121.268 0.556 . . . . 61.439999999999998 110.752 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -65.39 -40.3 93.27 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.117 -0.947 . . . . 75.040000000000006 110.189 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -83.04 -21.33 33.83 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 113.751 1.019 . . . . 74.209999999999994 113.751 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.8 t -60.47 -33.69 72.94 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.988 -0.745 . . . . 72.549999999999997 108.988 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.9 m -59.04 -27.8 65.82 Favored 'General case' 0 CA--C 1.565 1.536 0 CA-C-N 115.789 -0.641 . . . . 63.210000000000001 111.807 174.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 67.5 m -92.0 -0.85 57.48 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.36 0.874 . . . . 73.030000000000001 113.36 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.69 -169.96 30.53 Favored Glycine 0 C--N 1.319 -0.399 0 C-N-CA 118.951 -1.595 . . . . 74.099999999999994 114.562 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.4 m -94.56 116.78 29.19 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 123.205 0.602 . . . . 71.010000000000005 110.479 -175.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 85.1 mt -89.23 130.1 39.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 C-N-CA 123.015 0.526 . . . . 74.150000000000006 112.368 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -99.34 -40.41 7.92 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.686 -0.688 . . . . 71.430000000000007 111.106 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' B' ' 71' ' ' ASP . 55.6 mtp180 -150.55 160.9 43.47 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 107.91 -1.145 . . . . 73.310000000000002 107.91 -177.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.505 HD11 ' HB1' ' A' ' 50' ' ' ALA . 26.4 pt -145.14 137.97 21.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.382 -1.34 . . . . 75.340000000000003 107.382 173.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.9 m -125.61 120.89 32.03 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 107.604 -1.258 . . . . 64.049999999999997 107.604 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.408 ' O ' HD13 ' B' ' 68' ' ' ILE . 2.8 mp -118.18 118.45 58.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 106.218 -1.771 . . . . 74.230000000000004 106.218 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.512 ' N ' HD21 ' A' ' 69' ' ' LEU 0.26 1.2 pt? -121.9 125.59 46.76 Favored 'General case' 0 C--N 1.285 -2.22 0 C-N-CA 120.257 -0.577 . . . . 60.210000000000001 111.967 179.156 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 73.1 m -117.37 136.0 53.47 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.734 -0.839 . . . . 71.420000000000002 108.734 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 2.5 p30 -131.07 153.52 49.22 Favored 'General case' 0 CA--C 1.495 -1.141 0 C-N-CA 119.146 -1.022 . . . . 62.140000000000001 112.033 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.402 ' HE3' ' OE1' ' B' ' 54' ' ' GLU . 97.9 mttt -121.54 18.33 11.26 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 124.048 0.843 . . . . 72.099999999999994 110.883 176.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -69.03 -21.18 64.13 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 119.049 -1.06 . . . . 72.409999999999997 112.98 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.7 p -91.8 10.61 27.82 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.405 0.621 . . . . 73.340000000000003 110.471 174.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.63 -47.87 1.4 Allowed Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.552 -0.619 . . . . 62.350000000000001 111.552 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -97.27 136.83 21.24 Favored Pre-proline 0 C--N 1.301 -1.543 0 CA-C-N 115.512 -0.344 . . . . 72.329999999999998 110.23 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.463 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 31.7 Cg_endo -69.0 118.61 5.78 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.616 1.544 . . . . 71.140000000000001 110.364 175.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 34.6 mtmm -113.33 149.74 33.55 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.337 -0.616 . . . . 73.439999999999998 109.337 -178.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -120.38 134.8 10.56 Favored Glycine 0 N--CA 1.423 -2.195 0 C-N-CA 119.847 -1.168 . . . . 73.230000000000004 112.791 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.469 ' CE2' ' HG ' ' A' ' 69' ' ' LEU . 17.6 p90 -152.85 144.42 23.42 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 124.326 1.05 . . . . 74.109999999999999 109.644 175.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.23 155.89 45.97 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.035 0.445 . . . . 64.010000000000005 111.811 -173.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -115.14 130.09 56.84 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.183 -1.414 . . . . 74.040000000000006 107.183 174.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.403 HG22 HG21 ' A' ' 66' ' ' ILE . 40.9 mm -112.39 112.88 42.38 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 108.454 -0.943 . . . . 73.230000000000004 108.454 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.519 ' HG3' ' OG ' ' A' ' 38' ' ' SER . 1.9 mp0 -88.08 118.96 28.01 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 122.61 0.364 . . . . 73.420000000000002 110.801 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -103.82 163.69 12.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.486 0.66 . . . . 73.219999999999999 111.602 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.27 -23.91 47.07 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.135 -0.938 . . . . 73.400000000000006 112.098 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -125.67 150.37 47.67 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 113.541 0.941 . . . . 74.120000000000005 113.541 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.526 ' O ' HG23 ' A' ' 91' ' ' VAL . 21.7 mmm180 -70.52 -29.3 65.77 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.248 -0.887 . . . . 73.310000000000002 108.986 173.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.95 -35.38 73.04 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.03 -0.532 . . . . 71.510000000000005 110.188 176.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.8 m -64.64 -36.91 85.8 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 116.745 -0.207 . . . . 73.209999999999994 111.077 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.544 ' O ' HG12 ' A' ' 95' ' ' VAL . 3.7 m -64.79 -39.26 85.05 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.885 0 C-N-CA 119.509 -0.876 . . . . 74.299999999999997 109.001 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -60.07 -34.96 74.16 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.069 0.461 . . . . 74.299999999999997 111.783 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.74 -37.54 65.05 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.905 -0.589 . . . . 73.530000000000001 110.351 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.14 -44.76 59.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.138 -0.483 . . . . 74.25 110.741 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 91' ' ' VAL . 14.8 m -61.09 -23.33 29.6 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.019 0 CA-C-N 116.456 -0.338 . . . . 75.109999999999999 111.8 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.01 -16.0 63.11 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.664 0.745 . . . . 75.430000000000007 110.431 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 25.2 ttp -104.89 9.22 34.78 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.835 -1.075 . . . . 72.019999999999996 109.134 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 4.5 p-10 -37.4 -49.52 1.01 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 113.812 1.041 . . . . 73.230000000000004 113.812 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -115.44 104.17 11.5 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-O 121.744 0.783 . . . . 70.239999999999995 110.268 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.5 t -145.15 173.62 11.77 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 114.712 -1.131 . . . . 71.409999999999997 108.644 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.14 115.76 48.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.827 0.822 . . . . 71.150000000000006 110.301 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -122.58 117.71 26.48 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.034 -1.099 . . . . 75.409999999999997 108.034 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.445 ' CZ ' ' HA ' ' A' ' 48' ' ' SER . 54.3 mtt180 62.26 33.6 16.52 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.79 0.836 . . . . 74.010000000000005 112.841 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.37 -2.64 81.19 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 114.7 -1.136 . . . . 72.420000000000002 114.137 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.692 ' HG3' ' OD1' ' A' ' 43' ' ' ASN . 18.0 ptp180 -130.21 154.84 47.15 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 117.479 0.64 . . . . 74.099999999999994 111.293 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.6 m -83.65 120.96 26.63 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 116.063 -0.517 . . . . 71.439999999999998 111.277 -174.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.564 ' HA ' ' HB3' ' A' ' 43' ' ' ASN . 40.3 pt -99.83 172.13 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 C-N-CA 120.595 -0.442 . . . . 63.200000000000003 111.968 -174.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 54.1 tptt -131.4 126.65 35.7 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.094 -0.957 . . . . 72.420000000000002 109.572 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 35.9 t -127.93 128.69 69.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.368 -0.605 . . . . 74.310000000000002 109.368 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.513 ' HB2' ' HD2' ' A' ' 111' ' ' PRO 0.295 0.0 OUTLIER -148.45 161.94 31.91 Favored Pre-proline 0 C--N 1.303 -1.433 0 CA-C-O 117.604 -1.189 . . . . 75.040000000000006 108.301 174.15 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.513 ' HD2' ' HB2' ' A' ' 110' ' ' LEU . 50.4 Cg_endo -67.73 149.47 78.76 Favored 'Trans proline' 0 C--N 1.357 1.02 0 CA-C-N 121.833 1.69 . . . . 54.219999999999999 109.122 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -70.04 93.19 0.78 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.332 -1.359 . . . . 71.450000000000003 107.332 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.473 ' HD3' ' OD1' ' A' ' 115' ' ' ASN 0.262 0.9 OUTLIER -75.26 137.92 41.53 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 118.581 2.808 . . . . 64.129999999999995 118.581 -163.813 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 32.5 p -103.0 -11.92 17.82 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 113.373 -1.739 . . . . 73.319999999999993 107.991 172.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.473 ' OD1' ' HD3' ' A' ' 113' ' ' ARG . 19.3 m120 70.74 -68.21 0.22 Allowed 'General case' 0 C--N 1.351 0.666 0 C-N-CA 125.936 1.695 . . . . 72.150000000000006 113.513 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 25.2 mmt -109.38 107.81 59.74 Favored Pre-proline 0 C--N 1.308 -1.204 0 CA-C-N 116.218 -0.446 . . . . 65.549999999999997 111.501 -176.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -88.08 -1.72 7.09 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.565 2.176 . . . . 72.420000000000002 111.194 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -108.03 -54.48 0.63 Allowed Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 110.86 -0.896 . . . . 64.340000000000003 110.86 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.9 mm -72.42 97.42 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.022 0.439 . . . . 72.430000000000007 110.879 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.9 t -177.19 155.65 1.17 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.143 -1.799 . . . . 64.230000000000004 106.143 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 49.4 m -130.38 98.13 4.61 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.295 0.569 . . . . 73.109999999999999 110.738 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.4 m -77.17 85.05 3.64 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 121.71 0.767 . . . . 74.209999999999994 110.399 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 170.72 -25.95 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 125.722 1.609 . . . . 73.450000000000003 107.028 -177.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 . . . . . 0 C--O 1.248 1.005 0 CA-C-N 114.912 -1.04 . . . . 74.129999999999995 109.739 -178.59 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.381 0 CA-C-O 121.375 0.607 . . . . 45.520000000000003 109.886 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.408 HD13 ' N ' ' B' ' 2' ' ' ILE . 2.5 mp -91.04 133.31 33.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 107.858 -1.164 . . . . 74.019999999999996 107.858 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -130.77 125.2 21.27 Favored Pre-proline 0 C--N 1.303 -1.451 0 CA-C-N 116.775 -0.193 . . . . 74.120000000000005 110.938 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -61.3 -51.01 4.84 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.387 2.058 . . . . 74.439999999999998 109.354 175.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 76.9 m -161.33 123.07 2.93 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 105.01 -2.219 . . . . 74.219999999999999 105.01 175.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' MET . . . . . 0.408 ' HE2' ' SD ' ' B' ' 116' ' ' MET . 0.0 OUTLIER -112.26 97.79 6.87 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 119.407 -0.917 . . . . 74.549999999999997 113.26 -178.089 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 56.53 -86.81 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.924 1.69 . . . . 62.119999999999997 113.658 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 41.6 p -94.79 97.12 9.82 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 120.895 0.379 . . . . 64.109999999999999 110.807 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 98.4 m -78.44 96.93 5.5 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.179 0.514 . . . . 75.519999999999996 109.907 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -85.76 83.27 7.9 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 108.415 -0.957 . . . . 74.030000000000001 108.415 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 41.6 m -151.41 157.53 42.52 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.827 -1.175 . . . . 75.319999999999993 107.827 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -89.2 -17.69 28.59 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.446 -0.576 . . . . 64.209999999999994 109.446 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 64.9 mtt 70.54 -59.27 0.53 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.862 1.265 . . . . 65.530000000000001 112.315 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 39.1 m -68.45 -40.6 81.05 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 108.874 -0.787 . . . . 73.219999999999999 108.874 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.85 94.21 4.95 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 109.195 -0.668 . . . . 72.319999999999993 109.195 174.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.7 -60.12 0.29 Allowed Glycine 0 CA--C 1.484 -1.867 0 N-CA-C 109.429 -1.468 . . . . 74.510000000000005 109.429 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 88.24 4.56 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 106.997 -1.483 . . . . 74.109999999999999 106.997 172.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -64.16 128.23 34.88 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.4 -0.818 . . . . 74.430000000000007 111.482 -175.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 40.8 m -89.0 112.21 23.09 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 109.073 -0.714 . . . . 75.349999999999994 109.073 177.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -84.3 1.86 42.93 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 122.099 0.952 . . . . 71.430000000000007 110.396 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.65 -100.98 2.31 Favored Glycine 0 C--N 1.3 -1.419 0 CA-C-N 114.015 -1.448 . . . . 71.019999999999996 110.325 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.459 ' HG2' ' HD3' ' B' ' 23' ' ' PRO . 2.2 Cg_endo -40.84 -51.21 3.76 Favored 'Trans proline' 0 CA--C 1.561 1.87 0 C-N-CA 124.158 3.239 . . . . 71.230000000000004 113.791 172.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.459 ' HD3' ' HG2' ' B' ' 22' ' ' PRO . 1.5 Cg_endo -82.96 123.59 3.64 Favored 'Trans proline' 0 C--N 1.375 1.97 0 CA-C-N 120.825 1.33 . . . . 53.109999999999999 109.763 173.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -62.29 150.39 84.85 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 115.613 -0.721 . . . . 61.140000000000001 111.447 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.38 109.86 0.44 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.476 2.784 . . . . 73.239999999999995 112.914 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.422 ' H ' HD13 ' B' ' 26' ' ' LEU . 0.0 OUTLIER -107.67 148.63 29.13 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.986 -1.116 . . . . 72.010000000000005 107.986 175.421 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.46 ' HB3' ' OE2' ' B' ' 30' ' ' GLU . 40.1 t -61.04 145.86 49.26 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.206 0.817 . . . . 75.340000000000003 113.206 -170.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.661 ' O ' ' HG2' ' B' ' 32' ' ' LYS . . . -49.5 -35.25 19.31 Favored 'General case' 0 C--O 1.196 -1.732 0 CA-C-N 114.638 -1.165 . . . . 74.319999999999993 110.95 172.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -66.26 -34.95 79.17 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.104 0.409 . . . . 75.540000000000006 112.104 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.486 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.7 OUTLIER -66.76 -35.23 79.61 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 109.096 -0.705 . . . . 60.43 109.096 172.409 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -69.82 -37.23 76.15 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.512 -0.767 . . . . 62.409999999999997 110.947 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.69 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 30.6 mmmt -57.63 -46.87 83.59 Favored 'General case' 0 C--O 1.204 -1.333 0 N-CA-C 109.85 -0.426 . . . . 74.319999999999993 109.85 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -66.23 -47.94 72.16 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.102 -0.499 . . . . 64.019999999999996 111.516 -175.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.486 HG12 ' O ' ' B' ' 30' ' ' GLU . 16.1 pt -70.97 -36.11 62.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.766 -0.652 . . . . 71.239999999999995 112.143 -178.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -76.48 -20.14 57.29 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.093 0.775 . . . . 75.519999999999996 113.093 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.69 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 95.9 mttt -67.09 -25.04 66.03 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.783 0.802 . . . . 73.430000000000007 109.64 174.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.612 ' HD3' ' O ' ' B' ' 86' ' ' ALA . 97.3 mtt180 -97.93 13.9 29.11 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.59 -1.186 . . . . 65.219999999999999 109.284 -174.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' SER . . . . . 0.512 ' OG ' ' HE3' ' B' ' 112' ' ' LYS . 43.6 t -107.15 169.41 8.58 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 115.029 -0.987 . . . . 65.430000000000007 110.533 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.49 164.25 33.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 123.651 0.781 . . . . 65.230000000000004 110.244 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . 0.577 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 18.6 t80 -110.17 125.83 53.45 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 107.741 -1.207 . . . . 75.140000000000001 107.741 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.07 112.42 39.51 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 N-CA-C 107.636 -1.246 . . . . 75.25 107.636 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.29 163.2 13.68 Favored Glycine 0 N--CA 1.421 -2.305 0 C-N-CA 120.041 -1.076 . . . . 74.209999999999994 113.46 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 7.9 t30 56.56 22.79 6.97 Favored 'General case' 0 CA--C 1.564 1.507 0 C-N-CA 125.983 1.713 . . . . 52.530000000000001 112.802 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 10.6 p -57.5 134.67 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 109.116 -0.698 . . . . 73.209999999999994 109.116 174.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -66.25 141.5 58.01 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.061 -0.718 . . . . 64.140000000000001 109.061 -177.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -64.51 -10.77 27.98 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-O 121.558 0.694 . . . . 75.420000000000002 109.892 -176.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.47 -10.09 58.4 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-N 115.677 -0.692 . . . . 54.119999999999997 113.026 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.5 m -98.21 79.7 2.59 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-N 118.685 1.242 . . . . 60.409999999999997 110.994 176.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' THR . . . . . 0.431 ' OG1' HG21 ' A' ' 49' ' ' THR . 22.6 p -71.06 -177.48 1.68 Allowed 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 113.632 0.975 . . . . 75.109999999999999 113.632 175.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.455 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -51.13 -51.5 52.93 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 115.01 1.485 . . . . 65.109999999999999 115.01 -164.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -58.21 -53.52 57.29 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 112.825 0.676 . . . . 64.329999999999998 112.825 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -63.5 -40.59 97.48 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-O 121.568 0.699 . . . . 64.019999999999996 111.02 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 2.7 tt -67.73 -46.76 71.24 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.901 -1.045 . . . . 74.129999999999995 109.298 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.56 ' CD ' ' HH ' ' A' ' 46' ' ' TYR . 29.5 tt0 -58.84 -48.28 81.9 Favored 'General case' 0 C--O 1.206 -1.206 0 C-N-CA 122.474 0.31 . . . . 62.210000000000001 111.422 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.64 -37.63 68.48 Favored 'General case' 0 C--O 1.262 1.726 0 CA-C-O 121.389 0.614 . . . . 74.420000000000002 110.757 -178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -64.92 -40.73 95.51 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.133 -0.94 . . . . 74.430000000000007 110.23 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -83.33 -21.94 33.03 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.715 1.006 . . . . 75.409999999999997 113.715 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 40.5 t -62.93 -32.66 74.01 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 123.812 0.845 . . . . 73.120000000000005 110.06 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 18.2 m -62.42 -24.88 67.65 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-N 116.15 -0.477 . . . . 62.219999999999999 111.197 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 58.8 m -96.04 5.93 50.01 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 112.903 0.705 . . . . 62.240000000000002 112.903 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.24 -177.29 30.12 Favored Glycine 0 C--N 1.32 -0.345 0 C-N-CA 118.823 -1.656 . . . . 62.340000000000003 114.433 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 20.1 m -96.0 114.95 26.71 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.384 0.611 . . . . 71.209999999999994 110.287 -177.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.427 HD12 ' HG3' ' B' ' 54' ' ' GLU . 62.4 mt -85.55 131.44 34.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.789 -0.641 . . . . 71.239999999999995 111.866 -176.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . 0.408 HD22 ' HB1' ' B' ' 86' ' ' ALA . 1.0 OUTLIER -99.04 -41.65 7.46 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.406 -0.816 . . . . 62.039999999999999 111.514 177.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -151.32 160.9 43.55 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 107.886 -1.153 . . . . 63.009999999999998 107.886 -177.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.455 HD11 ' HB1' ' B' ' 50' ' ' ALA . 23.6 pt -145.32 138.23 21.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.379 -1.341 . . . . 70.540000000000006 107.379 172.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 54.0 m -125.64 120.77 31.64 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 107.577 -1.268 . . . . 71.450000000000003 107.577 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.408 HD13 ' O ' ' A' ' 68' ' ' ILE . 3.2 mp -117.83 116.82 52.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 106.612 -1.625 . . . . 70.420000000000002 106.612 -177.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.407 ' HG ' ' CE2' ' B' ' 80' ' ' TYR 0.275 1.1 pt? -120.9 124.5 45.11 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 120.211 -0.595 . . . . 73.329999999999998 112.33 179.78 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 66.4 m -117.51 134.56 54.72 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 108.859 -0.793 . . . . 75.140000000000001 108.859 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 2.8 p30 -125.54 143.2 51.12 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.575 -0.85 . . . . 61.409999999999997 108.822 177.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . 0.436 ' HZ2' ' CD ' ' A' ' 54' ' ' GLU . 35.4 ttmt -118.72 15.53 13.57 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.124 -0.695 . . . . 64.540000000000006 109.124 -177.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -70.4 -11.28 60.81 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.317 0.579 . . . . 75.140000000000001 111.954 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 50.5 m -89.87 3.48 52.85 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.63 -0.713 . . . . 72.310000000000002 110.135 174.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.76 -47.89 2.05 Favored Glycine 0 CA--C 1.498 -1.018 0 N-CA-C 110.28 -1.128 . . . . 74.319999999999993 110.28 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -96.09 135.09 22.92 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 106.648 -1.612 . . . . 72.239999999999995 106.648 175.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.62 118.36 5.29 Favored 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 120.716 0.944 . . . . 62.32 110.609 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 32.9 mtmm -96.76 144.12 27.04 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 109.287 -0.635 . . . . 63.229999999999997 109.287 -178.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -119.42 132.01 9.31 Favored Glycine 0 N--CA 1.415 -2.728 0 C-N-CA 120.123 -1.037 . . . . 65.450000000000003 112.063 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . 0.407 ' CE2' ' HG ' ' B' ' 69' ' ' LEU . 16.7 p90 -150.79 143.91 24.76 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 123.959 0.904 . . . . 72.530000000000001 109.641 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.36 156.48 45.82 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.078 0.466 . . . . 75.019999999999996 111.613 -173.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' TYR . . . . . 0.431 ' CG ' ' HE2' ' B' ' 112' ' ' LYS . 27.2 m-85 -115.99 130.83 56.99 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.526 -1.287 . . . . 74.319999999999993 107.526 174.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.415 HG22 HG21 ' B' ' 66' ' ' ILE . 35.8 mm -114.51 110.74 33.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.621 -0.881 . . . . 74.349999999999994 108.621 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -86.24 119.34 26.41 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.48 -0.327 . . . . 75.450000000000003 110.988 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.25 165.21 11.2 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.909 0.385 . . . . 73.329999999999998 109.997 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.612 ' O ' ' HD3' ' B' ' 37' ' ' ARG . . . -79.46 -34.56 41.39 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.34 -0.391 . . . . 60.0 112.018 176.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -111.18 150.46 29.47 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.137 0.494 . . . . 73.409999999999997 112.282 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.574 ' O ' HG23 ' B' ' 91' ' ' VAL . 21.2 mmm180 -68.95 -28.8 66.97 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.411 -0.813 . . . . 74.540000000000006 109.533 172.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -63.7 -29.33 70.57 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.633 -0.712 . . . . 73.049999999999997 111.143 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 19.5 m -67.74 -36.36 80.42 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 116.664 -0.244 . . . . 75.409999999999997 110.491 177.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . 0.574 HG23 ' O ' ' B' ' 88' ' ' ARG . 3.6 m -64.24 -39.53 85.84 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.775 0 N-CA-C 108.802 -0.814 . . . . 75.109999999999999 108.802 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -57.08 -37.22 71.57 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.513 0.561 . . . . 65.310000000000002 112.513 175.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.55 -35.93 65.57 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.947 -0.569 . . . . 73.120000000000005 110.526 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.46 -42.72 52.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.869 -0.605 . . . . 64.439999999999998 110.942 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . 0.492 HG12 ' O ' ' B' ' 91' ' ' VAL . 19.2 m -62.11 -23.36 31.5 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.962 0 N-CA-C 111.896 0.332 . . . . 73.420000000000002 111.896 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.7 -16.19 63.3 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.28 0.562 . . . . 44.020000000000003 110.442 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 16.5 ttm -101.3 3.03 40.35 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 123.994 0.918 . . . . 73.239999999999995 109.013 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . 0.602 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 4.2 p-10 -35.85 -50.36 0.65 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 116.291 1.96 . . . . 71.5 116.291 -172.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -115.77 93.49 4.29 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 118.204 -1.398 . . . . 75.030000000000001 110.945 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 13.1 t -135.2 172.8 12.49 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.145 -1.389 . . . . 62.140000000000001 109.925 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.0 p -101.58 128.63 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 108.876 -0.787 . . . . 74.209999999999994 108.876 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -130.51 119.63 22.88 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.941 -0.763 . . . . 73.120000000000005 108.941 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 31.0 ttm-85 50.71 33.42 8.29 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.612 1.565 . . . . 73.450000000000003 112.151 -175.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 99.57 -2.93 57.51 Favored Glycine 0 C--N 1.296 -1.64 0 CA-C-N 114.439 -1.255 . . . . 63.119999999999997 114.345 172.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -131.77 149.18 52.55 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 118.171 0.986 . . . . 75.319999999999993 112.162 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 25.7 m -75.5 124.86 27.91 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.994 -0.548 . . . . 71.5 110.929 -174.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 43.1 pt -102.83 171.56 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.016 0.436 . . . . 73.310000000000002 110.832 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . 0.602 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 55.0 tptt -135.41 131.93 36.87 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.0 -1.111 . . . . 71.540000000000006 108.0 178.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 28.0 t -127.28 134.35 66.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.608 -0.515 . . . . 75.420000000000002 109.608 -177.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . 0.543 ' HB3' ' HD2' ' B' ' 111' ' ' PRO 0.262 0.1 OUTLIER -144.13 170.0 9.2 Favored Pre-proline 0 C--O 1.215 -0.76 0 N-CA-C 105.292 -2.114 . . . . 75.400000000000006 105.292 174.167 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' B' ' 110' ' ' LEU . 73.6 Cg_endo -73.53 151.51 47.44 Favored 'Trans proline' 0 CA--C 1.552 1.422 0 C-N-CA 122.015 1.81 . . . . 65.510000000000005 110.114 171.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.512 ' HE3' ' OG ' ' B' ' 38' ' ' SER . 35.1 ttmt -86.77 140.77 29.4 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.007 0.432 . . . . 63.509999999999998 110.742 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -143.88 125.34 14.82 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.337 -1.357 . . . . 74.310000000000002 107.337 172.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' THR . . . . . 0.559 ' HA ' ' OH ' ' A' ' 18' ' ' TYR . 85.5 m -146.85 115.25 6.69 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 112.795 0.665 . . . . 43.329999999999998 112.795 -175.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' ASN . . . . . 0.421 HD21 ' HA ' ' B' ' 115' ' ' ASN . 11.9 m120 45.42 106.94 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 117.064 2.246 . . . . 72.409999999999997 117.064 169.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' MET . . . . . 0.408 ' SD ' ' HE2' ' B' ' 6' ' ' MET . 0.1 OUTLIER -88.65 117.75 68.65 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 106.75 -1.574 . . . . 73.219999999999999 106.75 175.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -79.65 102.92 1.53 Allowed 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.038 1.825 . . . . 64.340000000000003 111.167 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.8 57.72 4.78 Favored Glycine 0 N--CA 1.439 -1.122 0 CA-C-N 115.797 -0.638 . . . . 37.909999999999997 112.217 -177.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 10.2 tt -152.26 130.78 2.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.773 -0.825 . . . . 73.5 108.773 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 56.3 m -152.54 158.52 42.65 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.425 -0.954 . . . . 61.509999999999998 108.425 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 35.1 m -79.81 103.98 10.09 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.97 -0.752 . . . . 62.340000000000003 108.97 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 62.3 m -105.49 119.04 38.11 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 116.274 -0.421 . . . . 70.400000000000006 110.169 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -150.73 -56.0 0.16 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.185 -0.672 . . . . 74.040000000000006 109.185 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 . . . . . 0 N--CA 1.43 -1.441 0 CA-C-N 115.644 -0.707 . . . . 74.200000000000003 111.667 -176.348 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.56 0 N-CA-C 109.387 -0.597 . . . . 71.510000000000005 109.387 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 66.7 mt -81.51 112.86 20.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 121.167 0.508 . . . . 74.209999999999994 110.516 -177.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.07 117.0 15.77 Favored Pre-proline 0 C--N 1.298 -1.641 0 N-CA-C 107.932 -1.136 . . . . 72.420000000000002 107.932 177.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -65.82 99.53 0.39 Allowed 'Trans proline' 0 C--O 1.241 0.646 0 C-N-CA 122.286 1.991 . . . . 70.030000000000001 112.637 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 66.9 m -116.79 94.63 4.68 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 108.782 -0.822 . . . . 61.450000000000003 108.782 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.407 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 81.8 mtp -127.83 131.38 49.53 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.699 -0.852 . . . . 74.120000000000005 108.699 -177.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -122.52 119.57 31.29 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.019 0.438 . . . . 75.519999999999996 110.849 -177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 59.7 m -152.86 150.14 29.01 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.215 -0.448 . . . . 61.039999999999999 109.869 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.0 m 74.91 -73.03 0.1 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.586 1.154 . . . . 64.439999999999998 112.658 175.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.457 ' HA ' ' HD3' ' A' ' 108' ' ' LYS 0.342 16.3 p80 44.81 81.04 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.244 1.572 . . . . 75.030000000000001 115.244 -176.131 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.4 m -82.58 161.42 22.27 Favored 'General case' 0 C--O 1.247 0.954 0 CA-C-N 115.462 -0.79 . . . . 74.519999999999996 109.799 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.434 ' HB2' ' SD ' ' A' ' 13' ' ' MET . 63.6 pttt -168.59 157.58 8.77 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 111.748 0.277 . . . . 74.439999999999998 111.748 -176.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.434 ' SD ' ' HB2' ' A' ' 12' ' ' LYS . 1.5 mpt? 54.01 113.77 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.703 1.742 . . . . 73.129999999999995 115.703 173.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 t -163.32 162.73 25.25 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-N 116.39 -0.368 . . . . 75.140000000000001 111.42 178.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.537 ' HA ' ' HB ' ' A' ' 114' ' ' THR . . . -150.37 128.66 12.05 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.262 0.625 . . . . 53.100000000000001 110.798 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 158.27 129.0 1.05 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 121.02 -0.61 . . . . 73.140000000000001 112.967 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -170.49 103.82 0.27 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.908 0.883 . . . . 74.140000000000001 109.735 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -146.2 -26.88 0.43 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 117.341 2.349 . . . . 75.420000000000002 117.341 -174.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' B' ' 17' ' ' ALA . 24.9 m -133.48 138.0 45.94 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 120.822 1.646 . . . . 72.209999999999994 112.556 -169.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -126.07 -78.43 0.59 Allowed 'General case' 0 CA--C 1.557 1.244 0 N-CA-C 110.313 -0.254 . . . . 74.230000000000004 110.313 174.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.74 -139.73 3.48 Favored Glycine 0 N--CA 1.473 1.162 0 N-CA-C 111.275 -0.73 . . . . 54.520000000000003 111.275 176.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -51.0 -49.93 15.49 Favored 'Trans proline' 0 CA--C 1.556 1.612 0 C-N-CA 122.672 2.248 . . . . 52.32 112.212 174.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.11 135.86 65.2 Favored 'Trans proline' 0 C--N 1.388 2.609 0 N-CA-C 108.584 -1.352 . . . . 74.310000000000002 108.584 170.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -78.88 159.06 74.43 Favored Pre-proline 0 C--N 1.296 -1.726 0 C-N-CA 120.78 -0.368 . . . . 71.209999999999994 111.744 -173.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -70.23 58.13 1.75 Allowed 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 123.217 2.611 . . . . 64.109999999999999 113.463 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.423 ' HB3' ' H ' ' A' ' 27' ' ' SER . 5.5 mp 36.3 -166.04 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 117.068 2.247 . . . . 73.109999999999999 117.068 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.423 ' H ' ' HB3' ' A' ' 26' ' ' LEU . 10.9 m -90.44 150.76 21.69 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 114.191 -1.368 . . . . 64.120000000000005 107.484 174.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.494 ' HA ' ' HE3' ' A' ' 31' ' ' LYS . . . -51.92 -47.0 64.87 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.663 0.616 . . . . 73.409999999999997 112.663 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -76.26 -30.37 57.83 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 113.941 1.089 . . . . 71.310000000000002 113.941 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.33 -35.22 73.44 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 120.381 -0.528 . . . . 74.420000000000002 110.04 172.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.494 ' HE3' ' HA ' ' A' ' 28' ' ' ALA . 48.5 mtmt -66.22 -45.83 79.34 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 115.187 -0.915 . . . . 73.420000000000002 111.841 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.717 ' HE2' ' N ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -64.94 -30.99 72.02 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 119.644 -0.822 . . . . 63.229999999999997 112.576 177.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -64.4 -47.05 80.65 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.2 0.524 . . . . 61.030000000000001 110.971 174.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . 0.26 15.5 pt -70.94 -35.65 60.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 113.204 0.816 . . . . 74.329999999999998 113.204 -178.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -61.43 -41.4 97.12 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.207 1.003 . . . . 73.030000000000001 109.416 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.457 ' CG ' ' HG2' ' A' ' 88' ' ' ARG . 28.3 ttmt -58.51 -25.51 62.47 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 125.18 1.392 . . . . 73.420000000000002 112.767 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -119.52 10.38 11.8 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 112.389 0.514 . . . . 65.299999999999997 112.389 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.0 t -98.32 154.7 17.63 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.253 0.549 . . . . 52.350000000000001 111.778 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.508 HG13 ' CG2' ' A' ' 91' ' ' VAL . 0.2 OUTLIER -140.64 161.9 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 C-N-CA 124.062 0.945 . . . . 42.100000000000001 111.719 176.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.635 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 25.7 t80 -112.49 126.5 55.38 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 107.642 -1.244 . . . . 74.5 107.642 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 59.7 t -113.32 110.35 31.87 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 N-CA-C 107.082 -1.451 . . . . 65.129999999999995 107.082 176.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.36 165.92 12.84 Favored Glycine 0 C--N 1.291 -1.958 0 C-N-CA 119.512 -1.328 . . . . 52.039999999999999 114.272 -175.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.451 ' O ' ' HD3' ' A' ' 105' ' ' ARG . 9.8 t30 64.58 24.72 13.08 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.121 1.368 . . . . 72.140000000000001 112.193 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.0 p -106.07 95.38 3.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-O 122.058 0.932 . . . . 71.409999999999997 110.451 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.455 ' HA ' ' HA3' ' A' ' 79' ' ' GLY . 4.9 m-20 -106.3 137.9 43.43 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 118.563 -0.732 . . . . 73.109999999999999 109.903 -169.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.54 ' CE1' ' HB2' ' A' ' 77' ' ' PRO 0.394 50.2 m-85 42.02 -60.52 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 121.247 3.795 . . . . 74.530000000000001 121.247 169.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.8 -20.46 62.03 Favored Glycine 0 N--CA 1.466 0.635 0 N-CA-C 115.073 0.789 . . . . 62.310000000000002 115.073 -173.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.9 m -95.69 134.7 38.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 117.477 0.638 . . . . 63.229999999999997 109.893 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 47.9 p -98.85 176.34 5.64 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 109.173 -0.677 . . . . 74.010000000000005 109.173 -177.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.439 ' HB1' HD13 ' A' ' 66' ' ' ILE . . . -60.2 -44.35 95.2 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 110.061 -0.348 . . . . 65.409999999999997 110.061 176.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -57.18 -46.29 82.95 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 116.547 -0.297 . . . . 75.530000000000001 110.621 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -56.44 -42.72 78.57 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.239 0.542 . . . . 62.119999999999997 111.446 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.4 mt -73.38 -49.3 27.93 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.267 -0.879 . . . . 64.519999999999996 111.696 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.412 ' CD ' ' HZ3' ' B' ' 72' ' ' LYS . 0.9 OUTLIER -64.18 -49.47 71.91 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.953 -0.567 . . . . 62.439999999999998 110.965 -176.207 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.31 -42.35 91.17 Favored 'General case' 0 C--O 1.267 2.001 0 CA-C-O 121.442 0.639 . . . . 44.310000000000002 111.752 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -66.42 -34.75 78.66 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.877 -0.602 . . . . 73.230000000000004 109.61 -176.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . 0.25 49.3 m-85 -82.31 -20.95 36.39 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 113.499 0.926 . . . . 74.549999999999997 113.499 175.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.0 m -61.05 -32.62 72.25 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.257 -0.646 . . . . 73.450000000000003 109.257 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 m -58.65 -30.74 67.56 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.945 -0.57 . . . . 52.520000000000003 110.618 174.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 61.0 m -97.71 -1.27 43.86 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 112.536 0.569 . . . . 73.430000000000007 112.536 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.428 ' HA3' ' HB3' ' A' ' 90' ' ' SER . . . 168.16 -174.18 43.01 Favored Glycine 0 C--O 1.223 -0.546 0 C-N-CA 118.379 -1.867 . . . . 74.049999999999997 116.0 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.4 p -70.55 -71.7 0.24 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.938 0.895 . . . . 71.140000000000001 112.428 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.481 HG22 HD11 ' A' ' 63' ' ' ILE 0.3 73.7 mt 99.77 113.12 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 C-N-CA 126.71 2.004 . . . . 54.530000000000001 112.669 177.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.528 ' OD1' ' HB1' ' A' ' 86' ' ' ALA . 3.7 m-20 -106.81 -28.24 10.25 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-N 114.354 -1.293 . . . . 74.450000000000003 112.57 -177.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.428 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 75.3 mtt180 -151.61 155.45 38.44 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.788 -0.819 . . . . 61.539999999999999 108.788 174.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.446 HG23 HG21 ' A' ' 83' ' ' ILE . 20.5 pt -144.02 137.25 23.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 105.428 -2.064 . . . . 72.530000000000001 105.428 169.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 58.5 m -125.09 125.21 43.41 Favored 'General case' 0 C--N 1.262 -3.224 0 N-CA-C 107.708 -1.219 . . . . 73.400000000000006 107.708 -177.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mp -122.0 118.32 55.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 106.188 -1.782 . . . . 72.329999999999998 106.188 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.298 0.9 OUTLIER -121.53 133.19 55.02 Favored 'General case' 0 C--N 1.278 -2.525 0 C-N-CA 120.047 -0.661 . . . . 74.200000000000003 111.942 177.058 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 79.3 m -116.67 124.99 51.08 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.211 -1.033 . . . . 74.420000000000002 108.211 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.505 ' HB2' ' CD2' ' A' ' 73' ' ' PHE . 2.9 p-10 -112.12 138.43 48.8 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 119.047 -1.061 . . . . 64.200000000000003 112.131 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -117.13 7.48 13.04 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 114.763 -1.108 . . . . 72.319999999999993 110.239 173.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.505 ' CD2' ' HB2' ' A' ' 71' ' ' ASP . 37.3 p90 -69.58 -15.93 63.31 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.93 0.871 . . . . 75.049999999999997 109.637 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.2 m -86.92 6.98 29.31 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 114.727 -1.124 . . . . 73.340000000000003 109.515 175.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.34 -53.99 4.44 Favored Glycine 0 CA--C 1.503 -0.661 0 N-CA-C 110.596 -1.001 . . . . 64.230000000000004 110.596 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -96.24 138.15 21.59 Favored Pre-proline 0 C--N 1.298 -1.646 0 CA-C-N 114.27 -0.965 . . . . 71.129999999999995 108.774 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.54 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 46.9 Cg_endo -71.62 118.43 5.65 Favored 'Trans proline' 0 C--O 1.247 0.951 0 C-N-CA 122.203 1.936 . . . . 73.230000000000004 112.719 -177.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 29.1 mtmm -113.21 165.54 12.31 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 109.07 -0.715 . . . . 73.120000000000005 109.07 175.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 45' ' ' ASP . . . -138.2 146.0 17.66 Favored Glycine 0 N--CA 1.42 -2.403 0 C-N-CA 120.235 -0.983 . . . . 63.409999999999997 113.405 175.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -154.08 145.22 22.83 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.569 -0.816 . . . . 74.019999999999996 109.674 175.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 67' ' ' THR . . . -132.74 152.72 51.68 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.482 -0.326 . . . . 74.519999999999996 110.882 -172.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.41 ' CZ ' ' HD1' ' A' ' 40' ' ' TYR . 77.3 m-85 -123.9 131.56 53.6 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.556 -0.905 . . . . 75.430000000000007 108.556 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.446 HG21 HG23 ' A' ' 66' ' ' ILE . 23.4 mm -115.38 120.6 65.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 109.227 -0.657 . . . . 64.430000000000007 109.227 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 65' ' ' ARG . 1.9 mp0 -100.14 121.59 41.67 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.882 -0.414 . . . . 74.510000000000005 109.882 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -98.81 161.83 13.43 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.699 -0.228 . . . . 74.519999999999996 110.796 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.528 ' HB1' ' OD1' ' A' ' 64' ' ' ASN . . . -85.16 -29.89 24.4 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.802 -0.359 . . . . 74.329999999999998 111.231 175.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.465 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 5.6 mp0 -97.81 142.94 28.96 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.639 -0.504 . . . . 73.209999999999994 109.639 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.457 ' HG2' ' CG ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -71.17 -30.79 66.88 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 105.882 -1.896 . . . . 73.540000000000006 105.882 176.08 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -67.57 -35.55 79.22 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.583 -1.189 . . . . 74.25 110.605 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 87' ' ' GLU . 50.1 m -70.93 -36.81 72.79 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 120.696 0.284 . . . . 72.010000000000005 111.742 -177.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.508 ' CG2' HG13 ' A' ' 39' ' ' VAL . 14.5 p -65.99 -37.22 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 109.257 -0.645 . . . . 60.43 109.257 177.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -65.29 -31.58 72.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.518 -0.764 . . . . 63.100000000000001 110.035 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.5 -31.57 63.8 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.854 -0.612 . . . . 75.230000000000004 110.845 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.61 -43.94 53.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.039 -0.528 . . . . 65.519999999999996 110.451 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 20.5 m -58.25 -22.41 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 112.942 0.719 . . . . 74.120000000000005 112.942 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.46 -13.15 61.73 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.372 0.606 . . . . 71.0 110.415 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 47.7 ttp -103.4 9.46 37.8 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.007 -0.738 . . . . 73.209999999999994 109.007 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.489 ' HA ' ' HB ' ' A' ' 109' ' ' VAL . 5.5 p-10 -37.37 -57.09 0.93 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 115.016 1.487 . . . . 62.439999999999998 115.016 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 6' ' ' MET . 35.8 tt0 -110.09 85.12 2.05 Favored 'General case' 0 N--CA 1.397 -3.117 0 CA-C-O 122.167 0.984 . . . . 74.409999999999997 109.419 -174.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.2 p -129.6 167.47 17.9 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 113.849 -1.523 . . . . 74.049999999999997 111.904 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.2 p -110.73 106.18 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.163 0 CA-C-O 121.855 0.836 . . . . 74.209999999999994 109.017 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -105.69 126.23 51.91 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.115 -0.948 . . . . 73.439999999999998 108.543 -176.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 41.4 ttt-85 52.29 32.91 11.68 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 124.731 1.212 . . . . 72.140000000000001 111.348 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.72 -4.88 76.34 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 115.107 -0.951 . . . . 60.399999999999999 114.288 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.451 ' HD3' ' O ' ' A' ' 43' ' ' ASN . 4.6 ptp180 -121.88 138.41 54.41 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 117.593 0.696 . . . . 64.430000000000007 111.218 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 45.6 m -76.12 122.13 23.84 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-O 120.803 0.335 . . . . 54.340000000000003 110.761 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 44.6 pt -101.78 171.87 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.909 -0.587 . . . . 73.519999999999996 111.119 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 15.0 mmmt -125.1 131.13 53.35 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-N 114.952 -1.022 . . . . 72.510000000000005 109.245 176.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 24.7 t -127.47 116.19 42.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 108.361 -0.978 . . . . 70.019999999999996 108.361 174.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.425 ' CD1' ' HD2' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -146.99 156.4 47.29 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 106.912 -1.514 . . . . 62.329999999999998 106.912 177.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -62.61 129.3 25.97 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 121.841 1.694 . . . . 63.100000000000001 113.373 -175.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.03 100.48 13.29 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 103.155 -2.905 . . . . 72.120000000000005 103.155 173.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.473 ' HE ' ' HB2' ' A' ' 116' ' ' MET . 2.7 tmt_? -160.73 93.91 1.02 Allowed 'General case' 0 C--N 1.272 -2.787 0 N-CA-C 106.638 -1.615 . . . . 75.120000000000005 106.638 -164.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.537 ' HB ' ' HA ' ' A' ' 15' ' ' ALA . 40.6 p -106.27 -76.7 0.6 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.528 -1.669 . . . . 64.530000000000001 111.42 -170.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -79.71 110.9 15.49 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 102.842 -3.022 . . . . 73.340000000000003 102.842 170.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.473 ' HB2' ' HE ' ' A' ' 113' ' ' ARG . 24.7 ptt? -137.72 162.3 55.33 Favored Pre-proline 0 C--N 1.272 -2.776 0 N-CA-C 114.812 1.412 . . . . 73.140000000000001 114.812 -159.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -61.18 137.29 70.19 Favored 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 122.83 2.353 . . . . 61.240000000000002 109.386 169.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 108.47 35.47 2.45 Favored Glycine 0 C--N 1.299 -1.517 0 N-CA-C 110.298 -1.121 . . . . 53.020000000000003 110.298 -175.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . 0.29 9.7 tt 42.06 79.49 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 125.953 1.701 . . . . 75.129999999999995 115.118 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 55.6 p -95.24 -22.35 17.86 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.77 -0.65 . . . . 73.010000000000005 109.343 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.1 m 63.72 -163.36 0.27 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.331 -0.849 . . . . 75.549999999999997 110.742 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.2 m 75.23 88.53 0.09 Allowed 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.097 0.959 . . . . 73.340000000000003 112.452 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -161.41 -46.23 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 114.142 -1.39 . . . . 64.239999999999995 108.472 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 . . . . . 0 C--N 1.313 -1.01 0 CA-C-N 115.169 -0.923 . . . . 73.030000000000001 110.212 176.788 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 110.469 -0.197 . . . . 74.140000000000001 110.469 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 2.3 mp -97.71 134.61 35.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.918 -0.771 . . . . 70.549999999999997 108.918 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.99 101.4 9.43 Favored Pre-proline 0 C--N 1.312 -1.03 0 N-CA-C 110.276 -0.268 . . . . 73.230000000000004 110.276 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -75.94 121.46 6.23 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 122.327 2.018 . . . . 72.129999999999995 111.491 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 54.1 t -146.15 103.38 3.72 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.849 -0.614 . . . . 72.430000000000007 109.784 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 22.5 ptp -146.77 144.12 29.15 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.788 0.328 . . . . 74.010000000000005 110.887 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . 0.423 ' HB2' ' NH1' ' B' ' 113' ' ' ARG . 27.1 mt-30 -118.58 116.18 26.09 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.974 -1.491 . . . . 75.349999999999994 106.974 174.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 8.8 t -79.82 144.94 33.07 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.356 0.598 . . . . 75.400000000000006 110.855 -174.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 11.4 t -168.82 173.55 7.06 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 107.019 -1.475 . . . . 75.040000000000006 107.019 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -128.21 100.41 5.83 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.945 -0.391 . . . . 62.509999999999998 109.945 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t -143.67 -167.59 2.62 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.906 -1.146 . . . . 62.119999999999997 107.906 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -84.98 164.63 18.18 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.626 -0.509 . . . . 72.329999999999998 109.626 -177.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 25.8 ptm -95.01 3.31 55.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.131 0.491 . . . . 73.129999999999995 110.023 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 29.6 p -74.77 84.61 2.15 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 121.611 0.719 . . . . 75.129999999999995 110.757 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.437 ' HA ' ' OG1' ' A' ' 19' ' ' THR . . . -113.51 117.71 32.42 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.257 -0.883 . . . . 64.010000000000005 109.87 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.64 34.92 0.75 Allowed Glycine 0 C--N 1.294 -1.757 0 N-CA-C 110.944 -0.863 . . . . 40.399999999999999 110.944 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.516 ' O ' ' HB ' ' A' ' 19' ' ' THR . . . 67.11 -83.71 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 124.401 1.08 . . . . 63.340000000000003 109.783 -175.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -139.64 -75.56 0.35 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.511 0.196 . . . . 73.340000000000003 111.244 175.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 10.2 t 166.85 30.45 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.775 -1.194 . . . . 73.230000000000004 107.775 -171.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -59.95 -82.97 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 114.704 1.372 . . . . 73.239999999999995 114.704 -166.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.09 -91.25 0.23 Allowed Glycine 0 C--N 1.28 -2.575 0 C-N-CA 119.016 -1.564 . . . . 55.32 110.828 -171.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.567 ' HG3' ' CZ ' ' A' ' 40' ' ' TYR . 2.3 Cg_endo -43.64 -51.82 5.82 Favored 'Trans proline' 0 CA--C 1.556 1.588 0 C-N-CA 123.418 2.745 . . . . 75.540000000000006 113.268 176.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.92 123.62 9.47 Favored 'Trans proline' 0 C--N 1.38 2.196 0 N-CA-C 108.132 -1.526 . . . . 75.510000000000005 108.132 171.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.5 160.12 83.08 Favored Pre-proline 0 C--N 1.288 -2.093 0 CA-C-N 115.287 -0.87 . . . . 73.120000000000005 109.784 -177.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.94 101.27 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 122.381 2.054 . . . . 75.010000000000005 111.457 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.519 ' H ' HD13 ' B' ' 26' ' ' LEU . 0.0 OUTLIER -72.49 171.98 11.35 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 114.21 -1.359 . . . . 75.129999999999995 111.42 178.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.503 ' HB3' ' OE1' ' B' ' 30' ' ' GLU . 34.3 t -65.08 145.99 55.59 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.704 0.764 . . . . 72.049999999999997 112.276 -173.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.23 -40.87 25.89 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.85 -1.523 . . . . 53.030000000000001 111.673 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -75.93 -30.25 58.64 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 113.746 1.017 . . . . 74.430000000000007 113.746 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.503 ' OE1' ' HB3' ' B' ' 27' ' ' SER . 1.1 mp0 -60.73 -34.61 74.67 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 120.32 -0.552 . . . . 74.329999999999998 109.814 171.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -66.18 -50.71 62.95 Favored 'General case' 0 C--O 1.199 -1.553 0 CA-C-N 115.81 -0.632 . . . . 65.439999999999998 109.756 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.686 ' HE2' ' N ' ' B' ' 32' ' ' LYS . 0.4 OUTLIER -61.43 -29.71 70.11 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 119.839 -0.744 . . . . 75.349999999999994 112.123 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.476 ' O ' ' HG2' ' B' ' 36' ' ' LYS . 9.4 tp10 -69.23 -44.72 71.43 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 108.558 -0.905 . . . . 71.329999999999998 108.558 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . 0.25 11.8 pt -71.95 -35.21 53.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 112.608 0.596 . . . . 71.519999999999996 112.608 177.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.47 ' HB3' ' CB ' ' B' ' 113' ' ' ARG . 9.6 m-20 -58.41 -43.63 88.73 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.323 0.582 . . . . 73.150000000000006 110.616 177.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' B' ' 33' ' ' GLU . 15.0 ptpt -68.88 -18.34 64.12 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.457 0.54 . . . . 73.299999999999997 112.457 -173.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.642 ' HD2' ' O ' ' B' ' 85' ' ' PHE . 21.7 ptt180 -118.83 15.91 13.48 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.596 0.591 . . . . 71.019999999999996 112.596 -178.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 47.3 t -102.35 154.87 18.65 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.274 0.559 . . . . 44.299999999999997 111.738 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.555 HG13 ' CG2' ' B' ' 91' ' ' VAL . 0.3 OUTLIER -140.31 164.01 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 C-N-CA 124.287 1.035 . . . . 75.200000000000003 112.072 178.554 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . 0.62 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 30.7 t80 -115.71 127.39 55.1 Favored 'General case' 0 CA--C 1.48 -1.726 0 CA-C-N 114.557 -1.201 . . . . 74.400000000000006 107.76 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.36 109.65 29.31 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 N-CA-C 107.256 -1.387 . . . . 72.400000000000006 107.256 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -109.41 170.13 14.23 Favored Glycine 0 N--CA 1.435 -1.415 0 C-N-CA 120.257 -0.973 . . . . 51.549999999999997 112.602 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.2 t30 63.96 -0.66 0.77 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 126.213 1.805 . . . . 73.319999999999993 112.54 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.515 ' CG1' ' HA ' ' B' ' 80' ' ' TYR . 3.6 p -58.39 130.89 22.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 108.913 -0.773 . . . . 74.439999999999998 108.913 175.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -76.09 153.26 36.46 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 115.694 -0.685 . . . . 75.519999999999996 111.624 -173.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -50.55 -34.1 24.26 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 126.172 1.789 . . . . 75.439999999999998 111.214 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.7 3.99 78.73 Favored Glycine 0 CA--C 1.501 -0.842 0 C-N-CA 119.897 -1.144 . . . . 72.019999999999996 113.72 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 36.8 t -73.06 118.84 16.5 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 105.137 -2.172 . . . . 63.009999999999998 105.137 172.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.49 166.92 12.29 Favored 'General case' 0 N--CA 1.405 -2.701 0 N-CA-C 109.201 -0.666 . . . . 65.430000000000007 109.201 -169.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.432 ' HB1' HD13 ' B' ' 66' ' ' ILE . . . -56.08 -45.5 79.35 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 117.911 0.323 . . . . 72.299999999999997 111.439 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -57.18 -44.84 83.94 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.525 0.516 . . . . 60.109999999999999 111.042 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -57.17 -45.1 83.95 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 121.167 0.508 . . . . 71.239999999999995 111.348 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . 0.416 HD23 HG23 ' B' ' 44' ' ' VAL . 80.5 mt -72.2 -49.2 37.32 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.399 -0.818 . . . . 70.030000000000001 111.585 -177.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -63.2 -49.4 74.39 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 116.105 -0.498 . . . . 63.329999999999998 111.151 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.46 97.77 Favored 'General case' 0 C--O 1.267 2.014 0 CA-C-O 121.522 0.677 . . . . 70.540000000000006 111.812 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -66.39 -34.43 77.95 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.821 -0.627 . . . . 75.420000000000002 109.697 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -82.48 -21.36 35.59 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 113.678 0.992 . . . . 73.200000000000003 113.678 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 71.8 m -61.88 -30.69 71.04 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 116.379 -0.373 . . . . 62.439999999999998 110.295 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 17.4 m -58.69 -31.14 67.94 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 115.895 -0.593 . . . . 74.430000000000007 110.265 175.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 63.0 m -91.44 6.47 45.35 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 113.474 0.916 . . . . 41.409999999999997 113.474 -177.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.23 -159.93 26.25 Favored Glycine 0 N--CA 1.469 0.856 0 C-N-CA 118.914 -1.613 . . . . 70.319999999999993 115.108 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 12.9 m -101.48 123.26 45.24 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.021 0.439 . . . . 75.5 110.406 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 57.6 mt -92.04 134.91 28.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 123.583 0.753 . . . . 61.329999999999998 112.073 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . 0.494 ' ND2' ' HB2' ' B' ' 86' ' ' ALA . 0.8 OUTLIER -103.98 -33.15 8.92 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.711 0.805 . . . . 64.239999999999995 112.021 176.462 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.408 ' HB2' ' HB2' ' B' ' 84' ' ' GLU . 82.8 mtt180 -151.86 156.87 41.02 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.218 -0.66 . . . . 64.239999999999995 109.218 178.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.432 HD13 ' HB1' ' B' ' 50' ' ' ALA . 17.7 pt -143.61 138.15 25.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 105.824 -1.917 . . . . 64.409999999999997 105.824 168.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 53.8 m -125.29 125.73 44.0 Favored 'General case' 0 C--N 1.269 -2.926 0 N-CA-C 107.668 -1.234 . . . . 70.219999999999999 107.668 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.8 mp -122.78 117.54 52.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 106.337 -1.727 . . . . 73.310000000000002 106.337 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.288 0.9 OUTLIER -121.03 132.52 54.95 Favored 'General case' 0 C--N 1.283 -2.288 0 C-N-CA 120.028 -0.669 . . . . 62.140000000000001 111.8 177.774 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 70.6 m -116.98 123.01 45.88 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 108.73 -0.841 . . . . 74.120000000000005 108.73 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . 0.565 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 2.8 p30 -110.2 132.09 54.48 Favored 'General case' 0 C--O 1.208 -1.11 0 C-N-CA 119.913 -0.715 . . . . 73.239999999999995 110.115 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . 0.412 ' HZ3' ' CD ' ' A' ' 54' ' ' GLU . 37.9 ttmt -118.9 10.8 12.38 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.937 -1.134 . . . . 72.0 107.937 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.491 ' CD2' ' HB2' ' B' ' 71' ' ' ASP . 4.1 p90 -56.86 -17.41 9.3 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 115.902 1.816 . . . . 74.319999999999993 115.902 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 30.6 m -110.32 9.73 23.58 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 118.242 0.473 . . . . 75.0 111.61 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.39 -55.63 0.52 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.257 -0.973 . . . . 75.319999999999993 112.368 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -96.16 129.72 33.03 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 109.956 -0.387 . . . . 72.439999999999998 109.956 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 92.0 Cg_endo -77.04 119.61 5.12 Favored 'Trans proline' 0 N--CA 1.441 -1.617 0 C-N-CA 121.8 1.667 . . . . 74.329999999999998 111.932 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 30.1 mtmm -102.32 164.45 11.67 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 108.199 -1.037 . . . . 65.420000000000002 108.199 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -134.28 141.16 12.43 Favored Glycine 0 N--CA 1.423 -2.226 0 C-N-CA 119.658 -1.258 . . . . 73.439999999999998 113.027 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . 0.515 ' HA ' ' CG1' ' B' ' 44' ' ' VAL . 19.5 p90 -150.71 143.34 24.47 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.183 -0.509 . . . . 75.030000000000001 110.117 173.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.45 152.33 51.55 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.419 -0.355 . . . . 74.299999999999997 110.872 -172.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' TYR . . . . . 0.564 ' CD2' ' HG3' ' B' ' 112' ' ' LYS . 88.1 m-85 -124.15 130.05 51.88 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 108.944 -0.762 . . . . 71.109999999999999 108.944 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 23.5 mm -113.27 121.6 65.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 109.004 -0.739 . . . . 73.200000000000003 109.004 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' GLU . . . . . 0.408 ' HB2' ' HB2' ' B' ' 65' ' ' ARG . 1.2 mp0 -100.14 119.68 38.71 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.463 -0.569 . . . . 63.240000000000002 109.463 176.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.642 ' O ' ' HD2' ' B' ' 37' ' ' ARG . 96.5 m-85 -94.48 162.32 13.86 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 110.274 -0.269 . . . . 73.310000000000002 110.274 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.494 ' HB2' ' ND2' ' B' ' 64' ' ' ASN . . . -81.41 -34.58 31.5 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.305 -0.407 . . . . 42.399999999999999 110.608 174.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . 0.409 ' HB2' ' OG ' ' B' ' 90' ' ' SER . 9.7 mp0 -99.96 147.95 25.02 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.199 -0.6 . . . . 73.120000000000005 111.472 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.466 ' O ' HG13 ' B' ' 91' ' ' VAL . 0.0 OUTLIER -74.16 -31.64 62.79 Favored 'General case' 0 C--O 1.212 -0.891 0 N-CA-C 106.215 -1.772 . . . . 73.519999999999996 106.215 177.438 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -71.69 -29.18 64.3 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 120.479 -0.488 . . . . 74.349999999999994 111.885 177.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' SER . . . . . 0.409 ' OG ' ' HB2' ' B' ' 87' ' ' GLU . 49.4 m -71.49 -36.98 71.31 Favored 'General case' 0 N--CA 1.439 -0.99 0 O-C-N 122.224 -0.297 . . . . 73.530000000000001 111.349 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . 0.555 ' CG2' HG13 ' B' ' 39' ' ' VAL . 14.5 p -65.87 -37.69 80.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 108.64 -0.874 . . . . 73.340000000000003 108.64 177.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -63.77 -33.56 75.94 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.394 -0.821 . . . . 65.540000000000006 109.816 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.12 -31.3 64.21 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.829 -0.623 . . . . 75.140000000000001 110.539 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.67 -44.71 48.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.979 -0.555 . . . . 74.540000000000006 110.396 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 21.1 m -58.61 -22.46 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 112.41 0.522 . . . . 74.040000000000006 112.41 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.76 -18.49 63.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.897 0.855 . . . . 64.129999999999995 111.034 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 43.8 ttp -98.87 11.94 37.26 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 114.34 -1.3 . . . . 73.349999999999994 109.213 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . 0.472 ' HA ' ' HB ' ' B' ' 109' ' ' VAL . 9.8 t70 -35.11 -61.23 0.44 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 117.037 2.236 . . . . 63.119999999999997 117.037 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -115.74 34.98 4.65 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 119.542 1.065 . . . . 73.109999999999999 110.631 -174.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 76.4 p -77.72 -175.22 3.8 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.735 -0.666 . . . . 74.129999999999995 111.106 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -103.0 135.42 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 N-CA-C 109.334 -0.617 . . . . 71.299999999999997 109.334 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -142.23 128.19 19.53 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.596 -0.89 . . . . 74.450000000000003 108.596 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 57.2 ttt-85 56.3 32.99 21.46 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.277 1.031 . . . . 72.349999999999994 110.377 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.57 5.5 89.87 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.127 -0.942 . . . . 74.25 114.462 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -129.27 166.11 20.07 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 117.867 0.834 . . . . 61.420000000000002 109.976 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 32.4 m -90.99 122.74 33.91 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.785 -0.45 . . . . 63.32 109.785 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 39.7 pt -101.21 173.38 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 120.739 0.304 . . . . 74.030000000000001 111.763 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -130.86 120.76 24.14 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.241 -1.022 . . . . 70.329999999999998 108.241 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 42.3 t -127.0 116.04 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 123.361 0.413 . . . . 73.420000000000002 109.922 -177.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' B' ' 40' ' ' TYR . 0.0 OUTLIER -146.45 155.88 49.48 Favored Pre-proline 0 C--N 1.314 -0.963 0 N-CA-C 107.263 -1.384 . . . . 74.349999999999994 107.263 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.73 134.38 46.85 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.67 2.247 . . . . 72.349999999999994 113.151 -175.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.564 ' HG3' ' CD2' ' B' ' 82' ' ' TYR . 3.2 tmmm? -105.54 123.73 48.38 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 106.831 -1.544 . . . . 74.140000000000001 106.831 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.47 ' CB ' ' HB3' ' B' ' 35' ' ' ASP . 13.7 ptm180 -166.55 162.2 16.53 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-O 121.331 0.586 . . . . 64.349999999999994 112.149 -177.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 30.8 p -104.81 -172.53 2.12 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 114.09 -1.414 . . . . 61.340000000000003 108.508 173.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' ASN . . . . . 0.476 ' O ' ' HD3' ' B' ' 117' ' ' PRO . 27.8 t-20 -150.56 150.89 31.8 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.778 -0.453 . . . . 71.400000000000006 109.778 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 26.7 ttt -107.48 93.24 9.59 Favored Pre-proline 0 C--N 1.314 -0.959 0 N-CA-C 109.396 -0.594 . . . . 74.420000000000002 109.396 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' B' ' 115' ' ' ASN . 51.6 Cg_endo -94.7 15.61 1.14 Allowed 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.798 2.332 . . . . 55.25 111.85 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.16 66.84 3.55 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.936 -0.575 . . . . 65.340000000000003 112.021 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 23.1 pt -131.53 128.29 60.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 109.298 -0.631 . . . . 64.120000000000005 109.298 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 25.0 t -117.55 88.67 2.96 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 120.399 -0.52 . . . . 74.040000000000006 110.363 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 39.2 m 52.26 25.25 3.26 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.355 1.062 . . . . 64.450000000000003 112.947 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 22.4 m -89.1 84.41 6.56 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 120.996 0.426 . . . . 70.239999999999995 110.501 -175.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -168.36 142.14 3.21 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.624 -0.716 . . . . 74.430000000000007 109.455 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 . . . . . 0 C--N 1.311 -1.089 0 O-C-N 123.246 0.341 . . . . 75.120000000000005 110.67 178.853 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.556 0 N-CA-C 109.578 -0.527 . . . . 75.319999999999993 109.578 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.4 HD11 ' N ' ' A' ' 2' ' ' ILE . 2.7 mp -83.97 110.19 18.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 109.3 -0.63 . . . . 71.209999999999994 109.3 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -117.34 98.95 52.43 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 108.942 -0.762 . . . . 73.439999999999998 108.942 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -88.12 96.62 0.4 Allowed 'Trans proline' 0 N--CA 1.427 -2.434 0 C-N-CA 122.308 2.005 . . . . 73.049999999999997 111.312 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 58.8 m -95.37 102.81 14.64 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.04 -0.726 . . . . 72.319999999999993 109.04 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.539 ' HG3' ' O ' ' B' ' 74' ' ' SER . 26.8 ttt -121.39 93.33 3.98 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.893 -0.78 . . . . 42.210000000000001 108.893 -177.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -128.83 116.09 18.92 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.691 -0.686 . . . . 64.409999999999997 111.785 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 t -90.46 -7.71 52.36 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.933 -0.766 . . . . 75.209999999999994 108.933 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.428 HG22 ' HA ' ' A' ' 23' ' ' PRO . 88.6 m 70.96 89.06 0.1 Allowed 'General case' 0 C--O 1.244 0.794 0 CA-C-N 114.626 -1.17 . . . . 75.200000000000003 111.458 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -100.71 77.3 1.87 Allowed 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.969 0.89 . . . . 73.329999999999998 110.395 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.8 p -177.29 -177.45 0.71 Allowed 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 113.686 -1.597 . . . . 74.400000000000006 107.066 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -159.79 138.44 10.61 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.701 -0.481 . . . . 63.520000000000003 109.701 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -128.92 -67.9 0.77 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.651 -1.611 . . . . 71.239999999999995 106.651 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.3 m 50.9 30.91 5.59 Favored 'General case' 0 CA--C 1.583 2.221 0 C-N-CA 124.407 1.083 . . . . 74.519999999999996 113.749 168.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.48 -25.41 57.34 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.374 -0.829 . . . . 53.439999999999998 110.731 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.75 50.08 0.98 Allowed Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.276 -0.964 . . . . 72.230000000000004 113.385 176.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.0 86.47 2.28 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 109.699 -0.482 . . . . 61.100000000000001 109.699 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.44 ' H ' HG23 ' B' ' 14' ' ' THR . 96.0 m-85 62.39 25.08 14.96 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.96 0.904 . . . . 73.409999999999997 109.388 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.9 m -91.26 149.27 21.83 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 114.138 -1.392 . . . . 74.0 110.122 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.425 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 4.5 mm-40 -94.26 27.48 2.88 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 107.032 -1.47 . . . . 73.420000000000002 107.032 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.88 -109.5 2.86 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 109.718 -1.353 . . . . 42.210000000000001 109.718 -170.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.603 ' HG3' ' CZ ' ' B' ' 40' ' ' TYR . 2.1 Cg_endo -51.67 -53.54 6.86 Favored 'Trans proline' 0 CA--C 1.574 2.513 0 C-N-CA 123.418 2.746 . . . . 60.409999999999997 114.387 174.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.441 ' HD3' ' HG2' ' A' ' 22' ' ' PRO . 11.7 Cg_exo -70.36 133.83 25.34 Favored 'Trans proline' 0 C--N 1.386 2.526 0 CA-C-N 120.96 1.379 . . . . 62.539999999999999 110.753 173.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.8 pm0 -73.04 161.76 77.82 Favored Pre-proline 0 C--N 1.297 -1.688 0 CA-C-N 115.023 -0.989 . . . . 75.019999999999996 109.107 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.79 100.26 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.537 1.491 . . . . 71.310000000000002 109.236 173.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.452 ' HG ' ' H ' ' A' ' 27' ' ' SER . 0.5 OUTLIER -65.52 -84.83 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.457 -0.792 . . . . 61.439999999999998 111.999 -176.419 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.479 ' HB3' ' HB2' ' A' ' 30' ' ' GLU . 29.3 t -140.43 143.71 35.75 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 120.409 -0.516 . . . . 72.0 110.381 172.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.81 -40.37 75.85 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 124.006 0.816 . . . . 72.420000000000002 109.51 171.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.28 39.7 mt-10 -76.65 -29.24 56.33 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 113.992 1.108 . . . . 73.010000000000005 113.992 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.517 ' O ' HG12 ' A' ' 34' ' ' ILE . 14.7 tp10 -64.12 -38.91 92.77 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 106.385 -1.709 . . . . 70.400000000000006 106.385 175.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -64.82 -45.16 87.36 Favored 'General case' 0 C--O 1.199 -1.591 0 CA-C-N 114.713 -1.131 . . . . 75.230000000000004 108.813 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.568 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -56.79 -46.99 81.18 Favored 'General case' 0 N--CA 1.42 -1.936 0 C-N-CA 123.514 0.726 . . . . 74.099999999999994 111.686 178.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -68.41 -44.45 75.0 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 121.028 -0.269 . . . . 75.329999999999998 111.389 -177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 30' ' ' GLU . 12.9 pt -66.64 -34.22 68.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.08 0.467 . . . . 75.040000000000006 110.742 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.24 -40.01 89.91 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.65 1.18 . . . . 55.509999999999998 110.985 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.568 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 98.6 mttt -64.2 -21.0 66.41 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.596 0.712 . . . . 73.439999999999998 110.492 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.502 ' HD3' ' O ' ' A' ' 86' ' ' ALA . 90.9 mtt180 -109.64 16.48 22.12 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.35 -0.841 . . . . 71.409999999999997 109.657 -174.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 46.9 m -101.05 158.4 16.04 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 121.471 0.653 . . . . 74.540000000000006 111.762 178.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.5 m -134.58 163.56 36.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.583 -0.735 . . . . 73.200000000000003 109.684 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.696 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 23.3 t80 -109.49 128.13 54.94 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.545 -1.28 . . . . 73.319999999999993 107.545 174.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.9 t -120.94 109.28 24.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 107.843 -1.169 . . . . 72.239999999999995 107.843 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.65 170.99 15.87 Favored Glycine 0 C--N 1.293 -1.842 0 C-N-CA 119.785 -1.198 . . . . 40.350000000000001 113.783 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t30 67.55 17.31 9.98 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 125.297 1.439 . . . . 63.240000000000002 112.163 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.443 ' O ' ' HA3' ' A' ' 79' ' ' GLY . 14.5 p -72.16 141.58 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 109.257 -0.646 . . . . 71.120000000000005 109.257 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -107.24 165.27 11.5 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 112.077 0.399 . . . . 53.340000000000003 112.077 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -59.31 -26.51 65.06 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.316 0.646 . . . . 74.510000000000005 111.948 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.94 -16.57 80.58 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.36 -0.696 . . . . 53.450000000000003 111.36 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 24.7 m -95.8 125.96 40.73 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 107.342 -1.355 . . . . 72.340000000000003 107.342 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.449 HG22 ' CB ' ' B' ' 49' ' ' THR 0.253 3.6 p -126.31 179.31 5.34 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 114.527 1.306 . . . . 75.349999999999994 114.527 -172.023 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.86 -52.65 64.28 Favored 'General case' 0 C--O 1.213 -0.818 0 N-CA-C 114.459 1.281 . . . . 54.340000000000003 114.459 -168.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.25 28.1 pt20 -64.37 -32.14 73.63 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 119.103 -1.039 . . . . 72.120000000000005 112.941 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -59.9 -44.93 93.97 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.101 -0.703 . . . . 51.140000000000001 109.101 176.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 69.8 mt -73.04 -48.54 35.17 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.562 -1.199 . . . . 71.5 111.214 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.34 -49.62 74.86 Favored 'General case' 0 C--O 1.198 -1.625 0 CA-C-N 116.197 -0.456 . . . . 73.109999999999999 111.429 -177.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.6 -41.73 86.48 Favored 'General case' 0 C--O 1.257 1.482 0 CA-C-O 121.434 0.635 . . . . 64.129999999999995 111.98 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -68.02 -39.2 83.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.995 -1.002 . . . . 73.140000000000001 110.023 -176.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -82.23 -21.52 36.29 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.213 0.82 . . . . 65.150000000000006 113.213 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.3 t -68.83 -24.29 64.36 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.988 -0.745 . . . . 72.430000000000007 108.988 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.2 m -60.28 -33.92 73.02 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.521 0.677 . . . . 71.439999999999998 109.526 172.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 63.4 m -90.33 5.05 48.91 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.515 -0.766 . . . . 73.329999999999998 112.373 -177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.83 -168.62 29.96 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 118.688 -1.72 . . . . 73.340000000000003 115.08 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.9 m -97.96 122.73 41.43 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.315 -0.624 . . . . 74.010000000000005 109.315 -176.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.5 mt -91.46 131.23 39.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 113.018 0.747 . . . . 74.310000000000002 113.018 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -100.05 -40.95 7.37 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.162 -0.926 . . . . 71.120000000000005 110.905 176.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -149.91 158.91 44.64 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 108.837 -0.801 . . . . 75.120000000000005 108.837 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 27.3 pt -144.95 140.82 23.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 106.941 -1.503 . . . . 61.329999999999998 106.941 169.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.0 m -125.25 125.35 43.44 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 106.498 -1.667 . . . . 74.329999999999998 106.498 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.606 HD11 ' O ' ' B' ' 68' ' ' ILE . 3.4 mp -122.12 118.57 55.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.812 -1.551 . . . . 72.420000000000002 106.812 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.263 1.2 pt? -120.09 122.81 41.9 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 120.206 -0.597 . . . . 63.350000000000001 111.111 178.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.413 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 64.2 m -116.85 132.63 56.65 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.271 -1.011 . . . . 74.140000000000001 108.271 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.505 ' CG ' ' HZ1' ' A' ' 78' ' ' LYS . 3.6 p-10 -118.74 138.18 52.84 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 119.559 -0.856 . . . . 62.299999999999997 112.005 -176.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -117.59 13.25 14.28 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.297 -0.865 . . . . 63.100000000000001 109.631 173.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.453 ' CD2' ' HB2' ' A' ' 71' ' ' ASP . 13.9 p90 -65.8 -23.53 66.72 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.428 0.632 . . . . 72.420000000000002 110.395 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.1 t -83.49 0.55 45.91 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.781 -0.645 . . . . 65.400000000000006 110.151 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.92 -58.72 1.05 Allowed Glycine 0 N--CA 1.438 -1.213 0 N-CA-C 110.533 -1.027 . . . . 44.32 110.533 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -95.13 130.35 32.81 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 108.703 -0.851 . . . . 73.219999999999999 108.703 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 24.3 Cg_endo -62.32 119.28 6.31 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 123.028 2.486 . . . . 72.129999999999995 114.183 -175.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.505 ' HZ1' ' CG ' ' A' ' 71' ' ' ASP . 25.2 mtmm -104.43 -168.92 1.55 Allowed 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.582 -1.266 . . . . 75.349999999999994 107.582 171.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 44' ' ' VAL . . . -172.33 141.79 6.47 Favored Glycine 0 N--CA 1.407 -3.299 0 C-N-CA 119.792 -1.194 . . . . 71.230000000000004 112.726 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.508 ' HH ' ' HG3' ' B' ' 20' ' ' GLU . 13.5 p90 -151.57 145.47 25.15 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 123.813 0.845 . . . . 72.310000000000002 109.033 175.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.91 159.46 42.14 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-O 120.925 0.393 . . . . 50.100000000000001 111.178 -172.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -123.06 123.34 40.62 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.988 -0.745 . . . . 63.299999999999997 108.988 175.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.4 mm -103.06 119.93 52.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 106.624 -1.621 . . . . 73.030000000000001 106.624 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 38' ' ' SER . 35.0 mt-10 -107.12 119.31 39.03 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.068 0.461 . . . . 53.109999999999999 110.049 -176.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -100.58 167.48 10.33 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.389 0.614 . . . . 72.040000000000006 112.468 -174.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.502 ' O ' ' HD3' ' A' ' 37' ' ' ARG . . . -83.85 -33.26 24.89 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.184 -0.916 . . . . 72.400000000000006 111.665 174.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.411 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 4.5 mp0 -104.55 143.66 32.74 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 110.119 -0.326 . . . . 62.32 110.119 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.461 ' O ' HG21 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -73.04 -29.66 63.15 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 106.005 -1.85 . . . . 75.420000000000002 106.005 177.174 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -60.48 -28.07 68.06 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.989 -1.459 . . . . 71.150000000000006 110.425 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.411 ' OG ' ' HB2' ' A' ' 87' ' ' GLU . 26.8 m -67.35 -36.38 81.28 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 116.553 -0.294 . . . . 62.030000000000001 110.922 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 88' ' ' ARG . 3.2 m -64.06 -39.05 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 N-CA-C 108.429 -0.952 . . . . 74.140000000000001 108.429 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -55.89 -39.6 71.8 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.929 0.768 . . . . 75.340000000000003 110.585 177.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.23 -37.43 63.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.891 -0.595 . . . . 62.329999999999998 111.452 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.56 -45.24 62.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.945 0.402 . . . . 54.240000000000002 111.357 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 91' ' ' VAL . 28.6 m -56.97 -22.15 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 113.16 0.8 . . . . 73.400000000000006 113.16 178.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.69 -17.73 64.81 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.277 0.561 . . . . 72.430000000000007 110.806 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.492 ' O ' HG22 ' A' ' 100' ' ' THR . 66.2 mtm -99.58 8.11 44.71 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.754 -0.657 . . . . 73.030000000000001 110.676 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -41.75 -42.33 2.57 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 115.476 1.658 . . . . 61.310000000000002 115.476 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -107.36 16.33 24.05 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 118.737 0.699 . . . . 64.340000000000003 112.439 -177.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.492 HG22 ' O ' ' A' ' 97' ' ' MET . 7.3 t -81.79 175.38 10.49 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 118.809 -1.156 . . . . 73.439999999999998 109.865 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.3 m -108.8 118.91 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 CA-C-O 121.652 0.739 . . . . 64.340000000000003 110.884 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -92.06 117.79 30.18 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 107.494 -1.298 . . . . 75.349999999999994 107.494 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 50.03 32.85 6.12 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.801 1.241 . . . . 73.209999999999994 112.135 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 99.5 -4.97 58.45 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 114.855 0.702 . . . . 61.229999999999997 114.855 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -118.67 137.02 53.6 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 118.209 1.004 . . . . 72.510000000000005 110.68 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.6 m -70.26 119.09 13.93 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.131 0.491 . . . . 74.0 110.38 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 45.7 pt -103.51 172.65 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 CA-C-N 116.054 -0.521 . . . . 70.430000000000007 110.223 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.43 ' HA ' ' HD2' ' A' ' 108' ' ' LYS . 19.8 mmmt -123.94 129.41 50.91 Favored 'General case' 0 CA--C 1.472 -2.03 0 CA-C-N 115.739 -0.664 . . . . 75.420000000000002 109.621 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 22.7 t -127.77 122.81 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 108.651 -0.87 . . . . 75.099999999999994 108.651 176.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.445 ' HB2' ' HD2' ' A' ' 111' ' ' PRO . 0.0 OUTLIER -146.73 155.35 48.48 Favored Pre-proline 0 C--N 1.292 -1.913 0 N-CA-C 107.464 -1.31 . . . . 74.120000000000005 107.464 175.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 110' ' ' LEU . 49.7 Cg_endo -66.29 140.92 60.42 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.134 1.223 . . . . 62.130000000000003 110.061 -175.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -61.06 106.33 0.58 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.249 0.547 . . . . 75.010000000000005 111.038 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -123.15 -171.16 2.24 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.345 -0.843 . . . . 74.400000000000006 109.797 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.0 m 78.76 69.68 0.04 OUTLIER 'General case' 0 C--O 1.246 0.901 0 CA-C-O 122.911 1.339 . . . . 73.549999999999997 109.99 -176.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -168.6 103.6 0.42 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 112.714 -2.039 . . . . 75.519999999999996 106.979 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 27.4 ttt -102.46 119.19 56.91 Favored Pre-proline 0 C--N 1.3 -1.547 0 CA-C-N 116.205 -0.452 . . . . 73.430000000000007 111.498 -176.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -71.94 100.12 1.05 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.001 1.801 . . . . 63.25 109.599 174.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.56 87.71 1.55 Allowed Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 115.745 -0.661 . . . . 61.149999999999999 113.311 -175.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 21.6 pt -128.22 87.58 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-O 121.962 0.887 . . . . 63.420000000000002 109.484 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.1 m -84.26 144.82 28.65 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.344 -0.844 . . . . 70.439999999999998 112.571 -172.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 50.5 m -148.33 103.08 3.4 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.604 -0.726 . . . . 71.319999999999993 109.356 175.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 43.0 m -107.48 -30.9 8.38 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.979 -0.555 . . . . 65.140000000000001 110.584 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.3 t70 73.21 -47.31 0.66 Allowed 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 124.141 0.976 . . . . 72.400000000000006 113.469 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 . . . . . 0 C--N 1.308 -1.223 0 N-CA-C 110.006 -0.368 . . . . 74.519999999999996 110.006 -179.432 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.496 0 N-CA-C 110.007 -0.368 . . . . 55.200000000000003 110.007 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 47.1 mm -123.14 110.19 25.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 108.978 -0.749 . . . . 71.239999999999995 108.978 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -144.82 85.4 8.37 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 109.867 -0.419 . . . . 71.430000000000007 109.867 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -80.63 -10.28 13.19 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 122.945 2.43 . . . . 72.209999999999994 112.092 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 70.9 m 59.47 90.18 0.06 Allowed 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.973 0.909 . . . . 71.340000000000003 111.674 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 24.1 mmt -82.32 101.13 10.36 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.023 -0.732 . . . . 74.150000000000006 109.023 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -125.9 100.28 6.31 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.502 -0.555 . . . . 64.099999999999994 109.502 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 50.2 m -73.45 97.27 2.52 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 115.764 -0.653 . . . . 75.150000000000006 110.693 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 23.5 p -137.18 -67.91 0.49 Allowed 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.045 -0.724 . . . . 70.439999999999998 109.045 175.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 62.75 19.73 11.63 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 121.879 0.847 . . . . 74.420000000000002 110.369 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 32.4 t -172.89 174.62 3.51 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.198 -1.408 . . . . 54.439999999999998 107.198 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -108.13 98.5 8.05 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.67 -1.233 . . . . 73.299999999999997 107.67 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 64.1 mtt -106.85 110.76 23.0 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.317 -0.401 . . . . 65.450000000000003 110.243 -175.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.45 ' HB ' ' HD2' ' B' ' 117' ' ' PRO . 8.9 t -133.26 136.19 45.38 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.388 0.613 . . . . 74.219999999999999 111.706 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.69 178.33 8.25 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.538 -0.755 . . . . 63.420000000000002 109.966 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.06 -75.11 0.79 Allowed Glycine 0 N--CA 1.443 -0.842 0 O-C-N 123.596 0.56 . . . . 64.299999999999997 113.298 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.41 104.73 4.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.061 0.457 . . . . 71.319999999999993 111.344 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -150.74 91.71 1.76 Allowed 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.104 -0.702 . . . . 74.120000000000005 109.104 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 48.9 m -135.59 139.77 44.11 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.211 -0.663 . . . . 75.409999999999997 109.211 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . 0.508 ' HG3' ' HH ' ' A' ' 80' ' ' TYR . 2.4 mp0 -51.89 -28.35 15.9 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 114.201 1.186 . . . . 74.530000000000001 114.201 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.11 -130.72 10.08 Favored Glycine 0 CA--C 1.502 -0.762 0 N-CA-C 111.045 -0.822 . . . . 73.439999999999998 111.045 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -51.13 -45.04 39.09 Favored 'Trans proline' 0 CA--C 1.566 2.105 0 C-N-CA 123.542 2.828 . . . . 74.549999999999997 114.884 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.452 ' HD2' ' O ' ' B' ' 20' ' ' GLU . 62.1 Cg_exo -54.51 150.53 34.29 Favored 'Trans proline' 0 C--N 1.394 2.952 0 C-N-CA 121.839 1.692 . . . . 73.409999999999997 111.937 176.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -73.16 139.25 79.06 Favored Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 116.368 -0.378 . . . . 70.239999999999995 110.806 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -69.79 140.95 43.81 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.744 2.296 . . . . 74.200000000000003 113.517 -176.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.494 HD21 ' HB3' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -90.13 177.86 6.33 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.911 -1.041 . . . . 72.310000000000002 111.033 173.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 46.2 t -59.7 144.67 47.42 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 112.712 0.634 . . . . 71.239999999999995 112.712 -175.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.03 -37.74 54.56 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.994 -1.003 . . . . 64.230000000000004 111.024 171.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -76.43 -28.49 56.63 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 113.116 0.784 . . . . 70.140000000000001 113.116 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.51 ' O ' HG12 ' B' ' 34' ' ' ILE . 3.7 tp10 -64.5 -39.3 93.53 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 106.276 -1.75 . . . . 75.540000000000006 106.276 175.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -64.87 -44.32 90.08 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 114.424 -1.262 . . . . 73.439999999999998 108.697 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.607 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 0.1 OUTLIER -57.2 -47.57 80.95 Favored 'General case' 0 N--CA 1.413 -2.309 0 C-N-CA 123.597 0.759 . . . . 73.310000000000002 111.745 179.095 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 80.4 mm-40 -68.42 -44.57 74.7 Favored 'General case' 0 CA--C 1.505 -0.751 0 O-C-N 123.068 0.23 . . . . 72.120000000000005 111.363 -177.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.51 HG12 ' O ' ' B' ' 30' ' ' GLU . 11.3 pt -66.35 -34.93 73.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 O-C-N 123.376 0.422 . . . . 74.209999999999994 110.428 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -65.6 -42.07 92.04 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.49 0.716 . . . . 75.400000000000006 109.91 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 99.1 mttt -61.07 -24.19 66.03 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.613 -0.721 . . . . 72.409999999999997 110.777 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.527 ' HD3' ' O ' ' B' ' 86' ' ' ALA . 67.6 mtt180 -106.89 17.05 23.62 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.561 -0.745 . . . . 71.329999999999998 110.12 -174.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' B' ' 84' ' ' GLU . 26.2 m -106.43 169.08 8.73 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.176 0.512 . . . . 55.130000000000003 111.976 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 28.1 m -139.91 164.74 22.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 124.129 0.972 . . . . 74.230000000000004 110.211 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . 0.698 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 28.6 t80 -109.73 129.03 55.65 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.669 -1.234 . . . . 75.040000000000006 107.669 174.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.445 HG21 ' CZ ' ' B' ' 57' ' ' PHE . 97.5 t -122.18 111.93 32.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 108.451 -0.944 . . . . 73.109999999999999 108.451 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.93 171.22 16.66 Favored Glycine 0 C--N 1.289 -2.044 0 C-N-CA 120.022 -1.085 . . . . 64.120000000000005 113.558 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 61.4 t30 65.95 23.67 11.22 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.144 1.778 . . . . 75.129999999999995 112.754 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 14.1 p -65.83 130.95 31.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.838 -0.801 . . . . 72.430000000000007 108.838 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -99.95 161.37 13.65 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.39 -0.823 . . . . 63.350000000000001 111.393 -175.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' TYR . . . . . 0.756 ' CE1' ' HB2' ' B' ' 77' ' ' PRO . 17.7 m-85 -71.47 92.06 1.08 Allowed 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.489 -0.778 . . . . 71.409999999999997 109.793 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 164.75 -23.2 0.16 Allowed Glycine 0 N--CA 1.419 -2.446 0 CA-C-N 114.353 -1.294 . . . . 60.039999999999999 110.03 -177.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 40.3 m -79.47 128.54 33.48 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 109.097 -0.705 . . . . 71.450000000000003 109.097 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' THR . . . . . 0.449 ' CB ' HG22 ' A' ' 49' ' ' THR . 82.7 p -92.45 170.2 9.95 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 108.575 -0.898 . . . . 74.310000000000002 108.575 177.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.455 ' HB3' HD13 ' B' ' 66' ' ' ILE . . . -61.27 -44.07 97.83 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 110.274 -0.269 . . . . 74.209999999999994 110.274 175.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -62.36 -36.35 81.97 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.444 0.535 . . . . 65.230000000000004 112.444 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -56.64 -45.72 81.43 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.622 0.725 . . . . 71.109999999999999 109.727 176.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 57.0 mt -69.97 -48.24 59.05 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.664 -1.153 . . . . 64.049999999999997 111.642 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -62.1 -49.41 76.03 Favored 'General case' 0 C--O 1.199 -1.603 0 C-N-CA 122.831 0.452 . . . . 61.130000000000003 111.503 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.43 96.34 Favored 'General case' 0 C--O 1.252 1.23 0 CA-C-O 120.936 0.398 . . . . 53.240000000000002 110.651 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -66.37 -39.59 89.21 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.145 -0.48 . . . . 70.319999999999993 110.172 -176.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.445 ' CZ ' HG21 ' B' ' 41' ' ' VAL . 52.8 m-85 -82.18 -21.6 36.43 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 113.556 0.947 . . . . 71.319999999999993 113.556 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 23.2 t -70.09 -23.56 63.08 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.452 -0.944 . . . . 74.0 108.452 -178.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.3 m -58.66 -31.18 67.93 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-O 121.234 0.54 . . . . 74.340000000000003 109.773 172.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 69.5 m -95.3 10.72 35.15 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.809 -0.632 . . . . 73.340000000000003 112.567 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 143.42 -172.4 24.81 Favored Glycine 0 N--CA 1.462 0.388 0 C-N-CA 119.67 -1.252 . . . . 37.149999999999999 113.992 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 36.0 t -97.03 127.26 42.83 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 109.787 -0.449 . . . . 71.239999999999995 109.787 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 71.1 mt -90.62 133.62 31.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 115.789 -0.642 . . . . 73.239999999999995 112.661 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . 0.49 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 95.8 m-20 -101.39 -35.46 9.2 Favored 'General case' 0 C--O 1.206 -1.203 0 CA-C-N 115.488 -0.778 . . . . 71.230000000000004 111.68 176.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -153.19 159.72 42.72 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.885 -0.783 . . . . 75.230000000000004 108.885 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.455 HD13 ' HB3' ' B' ' 50' ' ' ALA . 24.6 pt -145.37 139.39 21.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.112 -1.44 . . . . 72.310000000000002 107.112 170.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 90.7 m -125.43 123.71 39.87 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 107.638 -1.245 . . . . 74.239999999999995 107.638 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.606 ' O ' HD11 ' A' ' 68' ' ' ILE . 2.3 mp -119.63 121.23 65.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 106.078 -1.823 . . . . 73.319999999999993 106.078 -177.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.298 1.2 pt? -121.06 122.85 40.97 Favored 'General case' 0 C--N 1.28 -2.434 0 C-N-CA 120.21 -0.596 . . . . 70.439999999999998 111.881 176.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' CYS . . . . . 0.404 ' HA ' ' HA2' ' B' ' 79' ' ' GLY . 64.6 m -116.74 130.99 57.06 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.939 -1.134 . . . . 73.109999999999999 107.939 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 3.5 p-10 -121.15 144.16 48.72 Favored 'General case' 0 C--O 1.201 -1.475 0 C-N-CA 119.756 -0.778 . . . . 61.310000000000002 110.627 -176.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -121.69 5.16 10.03 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.199 -0.667 . . . . 64.019999999999996 109.199 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.428 ' CD2' ' HB2' ' B' ' 71' ' ' ASP . 34.5 p90 -67.31 -26.52 66.56 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-O 121.132 0.492 . . . . 64.140000000000001 109.836 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.539 ' O ' ' HG3' ' A' ' 6' ' ' MET . 41.0 m -66.15 -18.8 65.58 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.555 -0.748 . . . . 75.239999999999995 111.758 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.34 -51.76 0.76 Allowed Glycine 0 CA--C 1.482 -2.028 0 N-CA-C 108.308 -1.917 . . . . 74.140000000000001 108.308 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 53.9 m170 -97.14 148.92 35.11 Favored Pre-proline 0 CA--C 1.479 -1.77 0 N-CA-C 105.851 -1.907 . . . . 73.349999999999994 105.851 173.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.756 ' HB2' ' CE1' ' B' ' 46' ' ' TYR . 74.5 Cg_endo -80.49 116.51 3.27 Favored 'Trans proline' 0 N--CA 1.417 -3.016 0 N-CA-C 108.955 -1.209 . . . . 75.430000000000007 108.955 173.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' LYS . . . . . 0.462 ' HZ1' ' CG ' ' B' ' 71' ' ' ASP . 23.9 mtmm -104.83 -168.52 1.49 Allowed 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 108.643 -0.873 . . . . 62.140000000000001 108.643 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' B' ' 70' ' ' CYS . . . -168.38 139.77 5.85 Favored Glycine 0 N--CA 1.403 -3.559 0 C-N-CA 119.7 -1.238 . . . . 54.119999999999997 113.17 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -150.12 144.67 25.86 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 114.662 -0.769 . . . . 73.530000000000001 109.344 174.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.44 159.91 41.07 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-O 120.716 0.293 . . . . 64.25 110.763 -172.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -123.0 125.55 45.45 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.427 -0.953 . . . . 74.200000000000003 108.427 174.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 44.6 mm -103.87 120.46 54.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 106.752 -1.573 . . . . 72.5 106.752 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' B' ' 38' ' ' SER . 34.3 mt-10 -107.4 118.73 37.5 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.079 0.466 . . . . 74.120000000000005 110.025 -175.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -99.93 166.73 10.92 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.998 0.74 . . . . 63.32 112.998 -173.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.527 ' O ' ' HD3' ' B' ' 37' ' ' ARG . . . -77.57 -36.84 51.64 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.641 -1.163 . . . . 61.450000000000003 111.378 174.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -109.08 146.82 33.37 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.15 0.5 . . . . 61.140000000000001 112.029 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.474 ' O ' HG21 ' B' ' 91' ' ' VAL . 0.6 OUTLIER -73.93 -29.77 62.21 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 106.407 -1.701 . . . . 72.530000000000001 106.407 178.759 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -64.15 -24.08 67.55 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 114.773 -1.103 . . . . 71.140000000000001 110.667 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 19.8 m -68.33 -36.28 79.04 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 116.394 -0.366 . . . . 75.239999999999995 110.314 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . 0.474 HG21 ' O ' ' B' ' 88' ' ' ARG . 3.1 m -64.49 -38.99 84.03 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.071 0 N-CA-C 108.373 -0.973 . . . . 74.349999999999994 108.373 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.3 -38.56 74.19 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 123.769 0.668 . . . . 72.329999999999998 110.601 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.27 -35.4 63.76 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.054 -0.521 . . . . 74.329999999999998 111.3 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.77 -45.24 59.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.911 0.386 . . . . 54.149999999999999 111.056 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . 0.4 HG13 ' O ' ' B' ' 91' ' ' VAL . 26.0 m -57.79 -21.58 16.74 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 N-CA-C 112.935 0.717 . . . . 70.329999999999998 112.935 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.25 -15.4 63.16 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 121.581 0.705 . . . . 71.109999999999999 110.62 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 67.3 mtm -103.35 12.27 35.61 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.536 -0.756 . . . . 74.239999999999995 109.662 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . 0.603 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 2.1 p-10 -36.21 -43.45 0.35 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.249 1.574 . . . . 65.040000000000006 115.249 -176.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -130.09 61.76 1.58 Allowed 'General case' 0 N--CA 1.421 -1.918 0 C-N-CA 118.665 -1.214 . . . . 73.430000000000007 111.129 174.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 15.0 t -89.84 173.84 8.03 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 113.914 -1.493 . . . . 74.400000000000006 109.995 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.35 128.77 63.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.261 0.553 . . . . 63.149999999999999 109.841 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -140.68 126.11 18.84 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.647 -1.242 . . . . 74.519999999999996 107.647 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . 0.366 12.6 ptm85 50.37 55.03 10.11 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.114 1.524 . . . . 73.340000000000003 115.114 -176.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.72 -4.4 9.73 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 114.616 -1.175 . . . . 74.430000000000007 115.484 177.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -127.76 161.89 27.91 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 117.897 0.849 . . . . 72.549999999999997 110.666 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 37.1 m -95.64 128.37 42.45 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 109.53 -0.544 . . . . 62.119999999999997 109.53 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 35.8 pt -102.49 171.69 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 120.922 -0.311 . . . . 54.119999999999997 111.075 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . 0.603 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 41.7 tptt -131.04 126.8 36.83 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 109.394 -0.595 . . . . 73.329999999999998 109.394 -176.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.698 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 18.1 t -126.88 131.58 70.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.112 -0.699 . . . . 72.140000000000001 109.112 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . 0.567 ' HB3' ' HD2' ' B' ' 111' ' ' PRO 0.266 0.2 OUTLIER -136.26 168.42 17.26 Favored Pre-proline 0 CA--C 1.502 -0.894 0 N-CA-C 105.493 -2.04 . . . . 71.129999999999995 105.493 172.387 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' B' ' 110' ' ' LEU . 95.3 Cg_endo -76.55 148.75 29.82 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.363 1.375 . . . . 62.310000000000002 109.887 171.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -89.72 124.25 34.45 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.217 -1.771 . . . . 63.530000000000001 106.217 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.444 ' C ' ' HG1' ' B' ' 114' ' ' THR . 0.0 OUTLIER -132.7 78.09 1.78 Allowed 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.958 -1.497 . . . . 53.240000000000002 106.958 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' THR . . . . . 0.533 HG23 ' H ' ' B' ' 115' ' ' ASN . 4.4 m -154.08 -142.24 0.11 Allowed 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 107.428 -1.323 . . . . 70.150000000000006 107.428 -175.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' ASN . . . . . 0.533 ' H ' HG23 ' B' ' 114' ' ' THR . 7.4 t30 165.31 179.13 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 103.873 -2.639 . . . . 64.030000000000001 103.873 174.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 28.0 ttt -126.85 71.22 74.41 Favored Pre-proline 0 C--N 1.297 -1.706 0 C-N-CA 118.995 -1.082 . . . . 71.540000000000006 110.713 172.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' B' ' 14' ' ' THR . 74.0 Cg_endo -107.65 24.56 0.07 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.837 0 C-N-CA 123.644 2.896 . . . . 75.230000000000004 109.566 175.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.04 -9.38 63.22 Favored Glycine 0 CA--C 1.493 -1.308 0 CA-C-N 115.501 -0.772 . . . . 53.109999999999999 112.02 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 60.4 mt -79.2 86.87 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.017 0 N-CA-C 107.289 -1.375 . . . . 64.040000000000006 107.289 175.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 42.6 m -148.06 111.97 5.12 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.735 -0.839 . . . . 75.439999999999998 108.735 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 53.4 m -152.38 127.15 9.54 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.721 -0.474 . . . . 72.030000000000001 109.721 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 38.7 m -85.78 93.24 8.83 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-O 121.554 0.692 . . . . 73.109999999999999 109.546 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -87.54 78.1 8.64 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.938 0.875 . . . . 74.319999999999993 109.404 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . 0.469 ' C ' ' HE ' ' B' ' 124' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.494 -1.195 0 N-CA-C 106.883 -1.525 . . . . 74.349999999999994 106.883 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.572 0 N-CA-C 110.025 -0.361 . . . . 72.450000000000003 110.025 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.3 pt -80.96 135.56 24.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 120.857 0.361 . . . . 74.409999999999997 110.051 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.83 112.11 9.65 Favored Pre-proline 0 C--N 1.305 -1.354 0 CA-C-N 116.477 -0.329 . . . . 43.210000000000001 110.857 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.82 104.05 1.84 Allowed 'Trans proline' 0 N--CA 1.44 -1.658 0 C-N-CA 121.81 1.673 . . . . 62.350000000000001 110.173 176.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 58.0 m -106.76 115.72 30.69 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.481 -0.781 . . . . 62.140000000000001 109.198 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.533 ' HG2' ' OE1' ' A' ' 99' ' ' GLU . 1.6 mpt? -84.69 88.05 7.33 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.181 0.515 . . . . 63.240000000000002 111.927 -176.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -97.35 102.79 14.63 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.703 -1.592 . . . . 75.519999999999996 106.703 177.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.3 t -163.49 172.21 14.78 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.341 -0.985 . . . . 63.539999999999999 108.341 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -168.49 -178.82 3.65 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 107.923 -1.14 . . . . 75.420000000000002 107.923 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.416 ' CB ' ' HG ' ' A' ' 110' ' ' LEU . 8.2 p80 -124.66 153.33 42.44 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.045 -0.724 . . . . 72.329999999999998 109.045 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.7 m -76.26 94.61 3.58 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 109.877 -0.416 . . . . 73.239999999999995 109.877 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -75.03 91.27 2.52 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 122.242 1.02 . . . . 72.120000000000005 111.871 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.6 ttp -165.66 151.44 9.27 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.739 -1.573 . . . . 64.200000000000003 106.944 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.8 m -57.53 116.9 3.65 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.559 -0.534 . . . . 72.239999999999995 109.559 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.79 -33.64 76.07 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 115.99 -0.55 . . . . 53.119999999999997 112.143 -176.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.7 -179.47 16.24 Favored Glycine 0 N--CA 1.429 -1.802 0 C-N-CA 120.407 -0.901 . . . . 74.140000000000001 111.721 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -108.64 158.67 17.38 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 109.977 -0.379 . . . . 74.349999999999994 109.977 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -108.21 136.32 48.06 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.092 -0.706 . . . . 75.349999999999994 109.092 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.0 m -74.84 97.17 3.24 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.943 -0.571 . . . . 73.409999999999997 109.861 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -70.83 159.1 35.2 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.536 -0.913 . . . . 71.299999999999997 108.536 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.91 -108.06 0.97 Allowed Glycine 0 C--N 1.306 -1.101 0 C-N-CA 120.491 -0.862 . . . . 61.420000000000002 113.861 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.462 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 8.6 Cg_endo -75.82 -20.78 14.97 Favored 'Trans proline' 0 CA--C 1.589 3.26 0 N-CA-C 119.179 2.723 . . . . 70.219999999999999 119.179 -177.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 22' ' ' PRO . 11.7 Cg_endo -52.74 124.48 15.45 Favored 'Trans proline' 0 C--N 1.403 3.429 0 CA-C-N 122.85 2.053 . . . . 71.409999999999997 113.575 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -59.71 150.55 66.82 Favored Pre-proline 0 C--O 1.245 0.849 0 CA-C-N 115.256 -0.884 . . . . 63.229999999999997 112.591 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -55.37 121.62 10.25 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.675 2.917 . . . . 62.409999999999997 116.097 -176.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.49 HD11 ' H ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -102.93 164.1 11.82 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.272 -1.751 . . . . 71.510000000000005 106.272 165.738 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.449 ' HB3' ' OE2' ' A' ' 30' ' ' GLU . 46.1 t -59.99 143.79 50.87 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 113.234 0.827 . . . . 73.209999999999994 113.234 -172.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.427 ' O ' ' HE2' ' A' ' 32' ' ' LYS . . . -53.39 -33.18 52.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.1 -1.409 . . . . 71.120000000000005 110.801 174.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -66.75 -38.58 86.91 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 116.672 -0.24 . . . . 73.519999999999996 111.253 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.449 ' OE2' ' HB3' ' A' ' 27' ' ' SER . 0.6 OUTLIER -65.08 -34.82 79.33 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 116.449 -0.341 . . . . 73.019999999999996 110.909 174.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -67.13 -45.47 77.04 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.022 0.439 . . . . 53.299999999999997 110.36 -176.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 28' ' ' ALA . 46.6 mtmt -61.2 -42.64 98.94 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.936 -0.575 . . . . 70.430000000000007 112.07 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 11.3 mm-40 -71.27 -40.66 70.8 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-N 116.045 -0.525 . . . . 72.349999999999994 112.3 -176.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.9 pt -65.37 -35.59 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 112.934 0.716 . . . . 72.200000000000003 112.934 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -71.15 -29.5 65.29 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 119.878 -0.729 . . . . 71.099999999999994 110.778 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -73.69 -15.91 61.21 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.525 0.73 . . . . 74.540000000000006 110.067 176.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 98.3 mtt180 -104.9 12.02 32.95 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.303 -0.862 . . . . 71.230000000000004 109.019 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.425 ' HB3' ' HE2' ' A' ' 112' ' ' LYS . 33.0 t -107.21 156.65 18.61 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 121.58 0.705 . . . . 74.049999999999997 110.853 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.544 ' CG1' ' HB ' ' A' ' 91' ' ' VAL . 34.3 m -136.23 164.58 31.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.359 -0.837 . . . . 70.530000000000001 109.66 -177.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.599 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 22.4 t80 -110.18 127.0 54.69 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 107.847 -1.168 . . . . 75.150000000000006 107.847 176.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 58.0 t -121.31 112.73 36.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 107.518 -1.29 . . . . 75.420000000000002 107.518 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -117.81 172.71 14.48 Favored Glycine 0 C--N 1.294 -1.789 0 C-N-CA 118.978 -1.582 . . . . 73.400000000000006 114.036 -176.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.7 t30 60.41 20.86 10.49 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 125.749 1.62 . . . . 71.549999999999997 112.198 -176.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.87 139.92 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 121.093 0.473 . . . . 73.420000000000002 110.039 176.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -82.83 156.03 23.85 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.672 -0.862 . . . . 74.109999999999999 108.672 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -68.63 -18.62 64.33 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.741 0.781 . . . . 72.140000000000001 109.235 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.4 -15.7 81.18 Favored Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 115.055 -0.975 . . . . 74.099999999999994 112.296 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.4 m -87.1 127.34 35.13 Favored 'General case' 0 N--CA 1.411 -2.388 0 N-CA-C 108.011 -1.107 . . . . 63.240000000000002 108.011 176.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.3 p -105.49 178.67 4.49 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.613 -0.514 . . . . 74.150000000000006 109.613 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.508 ' HB3' HD11 ' A' ' 66' ' ' ILE . . . -60.7 -46.07 91.79 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.753 -0.462 . . . . 54.240000000000002 109.753 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -58.41 -36.25 73.29 Favored 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 115.596 -0.729 . . . . 75.129999999999995 111.305 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -67.45 -40.61 85.43 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.206 0.526 . . . . 62.140000000000001 110.463 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.6 mt -66.49 -47.94 71.43 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 115.165 -0.925 . . . . 60.240000000000002 111.744 -177.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.449 ' CD ' ' HZ3' ' B' ' 72' ' ' LYS . 36.2 mt-10 -60.62 -46.39 90.46 Favored 'General case' 0 C--O 1.181 -2.528 0 N-CA-C 113.645 0.98 . . . . 55.310000000000002 113.645 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.38 -47.83 75.23 Favored 'General case' 0 C--O 1.271 2.189 0 CA-C-O 121.662 0.744 . . . . 73.430000000000007 111.455 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -63.86 -43.01 97.38 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.851 -1.068 . . . . 74.010000000000005 110.568 -178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -82.13 -22.21 36.27 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 114.843 1.423 . . . . 63.009999999999998 114.843 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.4 t -67.07 -26.97 67.0 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.284 -0.636 . . . . 53.420000000000002 109.284 -177.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.2 m -59.1 -24.94 63.38 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 120.534 -0.466 . . . . 71.400000000000006 111.004 173.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 76.7 m -95.72 7.2 46.96 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.876 1.065 . . . . 74.120000000000005 113.876 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.38 -147.25 18.4 Favored Glycine 0 C--O 1.238 0.35 0 C-N-CA 118.51 -1.805 . . . . 60.0 115.067 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 52.8 p -112.95 122.97 49.23 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.021 0.438 . . . . 62.5 111.541 -175.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.3 mt -89.39 130.52 38.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-O 121.21 0.528 . . . . 73.230000000000004 112.03 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -92.68 -48.95 6.33 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.043 -0.981 . . . . 70.530000000000001 109.055 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -155.83 163.78 39.37 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.613 -0.884 . . . . 74.409999999999997 108.613 -176.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.508 HD11 ' HB3' ' A' ' 50' ' ' ALA . 31.3 pt -145.87 144.51 20.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 109.185 -0.672 . . . . 64.430000000000007 109.185 176.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.4 m -125.71 126.03 43.96 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 107.334 -1.358 . . . . 75.120000000000005 107.334 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.8 mp -122.48 122.89 67.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.113 -1.44 . . . . 71.329999999999998 107.113 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.286 1.0 OUTLIER -121.0 128.37 52.64 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 120.207 -0.597 . . . . 71.030000000000001 111.918 176.143 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 62.6 m -114.36 125.38 53.8 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.543 -1.28 . . . . 72.450000000000003 107.543 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' A' ' 78' ' ' LYS . 2.2 p-10 -110.64 130.43 55.57 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 118.462 -1.295 . . . . 55.240000000000002 112.013 -177.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -107.49 13.03 27.26 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.368 -1.345 . . . . 72.409999999999997 107.368 170.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -61.47 -36.63 80.98 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 113.921 -1.491 . . . . 75.340000000000003 108.508 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.5 t -81.68 7.78 11.57 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-N 115.495 -0.775 . . . . 73.129999999999995 111.154 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.74 -47.95 3.25 Favored Glycine 0 N--CA 1.462 0.418 0 O-C-N 121.615 -0.678 . . . . 74.140000000000001 111.429 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -95.77 137.28 21.89 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 106.737 -1.579 . . . . 74.439999999999998 106.737 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.34 117.01 4.66 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 CA-C-N 119.313 0.79 . . . . 72.409999999999997 110.706 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.431 ' HB2' ' OD1' ' A' ' 71' ' ' ASP . 13.0 mmmm -104.96 -176.47 3.09 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 115.0 -1.0 . . . . 75.219999999999999 108.663 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.54 137.59 4.91 Favored Glycine 0 N--CA 1.41 -3.061 0 C-N-CA 119.596 -1.288 . . . . 52.329999999999998 112.785 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.461 ' HH ' ' HG3' ' B' ' 23' ' ' PRO . 10.3 p90 -154.43 143.29 20.96 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 123.931 0.892 . . . . 73.150000000000006 109.27 173.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.26 151.8 50.04 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-O 120.9 0.381 . . . . 62.219999999999999 110.574 -172.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -118.82 115.68 24.93 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 108.386 -0.968 . . . . 72.099999999999994 108.386 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 40.0 mm -97.57 122.03 48.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.223 -1.029 . . . . 74.530000000000001 108.223 -176.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -102.38 119.79 39.41 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.195 -0.669 . . . . 61.130000000000003 109.195 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.26 156.47 16.41 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-O 121.062 0.458 . . . . 75.230000000000004 110.533 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.22 -27.84 56.95 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.156 -0.475 . . . . 60.409999999999997 110.051 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -112.48 136.86 51.49 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.826 -0.625 . . . . 73.010000000000005 110.848 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -69.72 -32.12 70.51 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.815 -1.18 . . . . 70.310000000000002 107.815 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -67.68 -21.67 65.33 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 115.807 -0.633 . . . . 75.230000000000004 111.498 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.3 m -67.85 -36.04 79.61 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.739 -0.467 . . . . 62.530000000000001 109.739 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.544 ' HB ' ' CG1' ' A' ' 39' ' ' VAL . 2.2 m -67.15 -38.57 81.37 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 N-CA-C 108.354 -0.98 . . . . 73.209999999999994 108.354 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -61.36 -35.55 77.76 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.439 -0.801 . . . . 70.230000000000004 110.735 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.31 -31.65 62.56 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.079 -0.509 . . . . 64.120000000000005 110.826 175.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 97' ' ' MET . . . -76.46 -42.93 42.08 Favored 'General case' 0 C--O 1.205 -1.269 0 CA-C-N 115.999 -0.546 . . . . 75.439999999999998 111.094 -177.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 91' ' ' VAL . 19.9 m -56.09 -21.37 11.37 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.957 0 N-CA-C 113.458 0.91 . . . . 75.019999999999996 113.458 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.07 -10.54 58.12 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-O 121.933 0.873 . . . . 65.349999999999994 110.235 176.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.48 ' HA ' ' OG1' ' A' ' 100' ' ' THR . 18.7 mtp -101.62 9.65 40.93 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 125.111 1.364 . . . . 71.200000000000003 109.866 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 12.4 t70 -35.73 -57.95 0.63 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 115.703 1.742 . . . . 74.239999999999995 115.703 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.533 ' OE1' ' HG2' ' A' ' 6' ' ' MET . 42.0 tt0 -116.99 30.39 7.36 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 122.327 1.06 . . . . 64.510000000000005 109.329 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.48 ' OG1' ' HA ' ' A' ' 97' ' ' MET . 89.8 m -74.71 167.39 21.89 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.915 -1.039 . . . . 75.299999999999997 110.195 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.25 133.12 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 CA-C-O 121.356 0.598 . . . . 50.310000000000002 110.143 -173.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -133.23 127.79 34.49 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.476 -0.784 . . . . 74.040000000000006 109.059 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 57.05 32.64 22.02 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 122.303 1.049 . . . . 73.209999999999994 110.484 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.19 5.85 87.45 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.012 -0.995 . . . . 75.549999999999997 113.444 177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -124.88 145.75 49.66 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 117.086 0.443 . . . . 71.430000000000007 110.137 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.5 m -79.31 119.74 22.79 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 110.018 -0.364 . . . . 63.109999999999999 110.018 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 45.9 pt -102.72 171.11 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 109.758 -0.46 . . . . 72.430000000000007 109.758 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 22.5 mmmt -118.02 130.15 56.0 Favored 'General case' 0 CA--C 1.472 -2.05 0 N-CA-C 108.883 -0.784 . . . . 75.400000000000006 108.883 176.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 41.1 t -125.59 111.79 28.53 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 107.304 -1.369 . . . . 70.329999999999998 107.304 172.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.416 ' HG ' ' CB ' ' A' ' 10' ' ' HIS 0.266 0.0 OUTLIER -138.9 146.75 51.27 Favored Pre-proline 0 N--CA 1.432 -1.345 0 C-N-CA 119.215 -0.994 . . . . 73.230000000000004 108.363 178.103 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -76.53 137.29 18.29 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.614 1.543 . . . . 63.009999999999998 112.217 -173.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.425 ' HE2' ' HB3' ' A' ' 38' ' ' SER . 37.6 ttpt -83.39 86.56 7.05 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 108.498 -0.927 . . . . 71.209999999999994 108.498 -177.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -178.74 179.89 0.68 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.158 -0.928 . . . . 75.040000000000006 111.831 -172.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.5 t -100.89 157.26 16.86 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 115.405 -0.816 . . . . 64.540000000000006 109.118 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -139.9 156.42 46.7 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.628 -1.249 . . . . 74.310000000000002 107.628 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 27.3 ttt -57.01 112.41 4.56 Favored Pre-proline 0 CA--C 1.536 0.408 0 O-C-N 123.616 0.572 . . . . 63.530000000000001 111.36 -177.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.89 -29.9 14.68 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.52 2.147 . . . . 61.210000000000001 112.241 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.38 -64.44 3.23 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.742 -0.742 . . . . 42.310000000000002 111.707 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.5 pt -86.15 7.0 2.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.35 0.595 . . . . 71.510000000000005 111.068 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.1 t -149.39 162.69 39.59 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 107.264 -1.384 . . . . 75.150000000000006 107.264 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 62.4 p -148.24 -161.18 1.28 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.87 -0.789 . . . . 74.040000000000006 108.87 -176.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.6 p -74.71 0.26 15.8 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 112.447 0.536 . . . . 62.140000000000001 112.447 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -78.56 104.32 9.08 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 109.15 -0.685 . . . . 64.510000000000005 109.15 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.489 0 CA-C-N 115.927 -0.579 . . . . 75.430000000000007 112.294 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.558 0 CA-C-O 120.621 0.248 . . . . 73.230000000000004 110.522 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 51.0 mm -97.94 129.39 48.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.42 -0.955 . . . . 73.239999999999995 108.42 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.78 91.8 32.39 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 111.967 0.358 . . . . 42.310000000000002 111.967 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -98.62 178.73 0.35 Allowed 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 123.058 2.505 . . . . 71.430000000000007 110.857 176.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 21.8 p -101.61 -2.96 29.22 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.178 0.514 . . . . 54.340000000000003 110.718 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 20.9 ptp -90.28 107.5 19.18 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.424 0.63 . . . . 61.43 111.545 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -138.02 97.4 3.4 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.511 -0.768 . . . . 63.140000000000001 110.758 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 42.5 m -72.68 -28.82 62.93 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.113 -0.494 . . . . 75.319999999999993 111.058 -178.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 19.6 m -73.98 81.0 1.69 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 116.493 -0.321 . . . . 64.010000000000005 111.491 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 13.5 m170 176.38 -32.7 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 127.8 2.44 . . . . 74.209999999999994 110.192 177.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 54.1 p -64.68 134.7 54.78 Favored 'General case' 0 C--O 1.244 0.779 0 O-C-N 123.283 0.364 . . . . 74.349999999999994 111.185 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . 0.457 ' HZ1' ' CG ' ' B' ' 35' ' ' ASP . 58.6 mttp -72.36 95.64 1.77 Allowed 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.122 -0.695 . . . . 74.219999999999999 109.122 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -48.12 -44.49 32.0 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.798 1.036 . . . . 55.119999999999997 113.798 -174.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 70.1 m 68.76 95.34 0.07 Allowed 'General case' 0 CA--C 1.55 0.973 0 CA-C-O 122.286 1.041 . . . . 61.049999999999997 113.342 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.4 -159.44 0.99 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 105.394 -2.076 . . . . 75.120000000000005 105.394 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.6 -38.18 70.47 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 109.951 -1.26 . . . . 74.140000000000001 109.951 174.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.59 94.41 8.07 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 107.042 -1.466 . . . . 72.540000000000006 107.042 171.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . 0.449 ' CE2' ' HB3' ' B' ' 20' ' ' GLU . 66.1 t80 -101.0 -19.58 15.77 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.54 -0.755 . . . . 72.129999999999995 111.555 -174.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 30.7 m 57.92 -59.6 0.03 OUTLIER 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 114.451 1.278 . . . . 72.150000000000006 114.451 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . 0.449 ' HB3' ' CE2' ' B' ' 18' ' ' TYR . 41.6 tt0 -54.9 -26.96 39.34 Favored 'General case' 0 CA--C 1.572 1.815 0 C-N-CA 126.168 1.787 . . . . 55.32 111.869 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.33 -120.86 5.37 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 116.021 1.168 . . . . 73.409999999999997 116.021 171.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.555 ' HG3' ' CE1' ' A' ' 40' ' ' TYR . 2.8 Cg_endo -41.69 -52.91 3.59 Favored 'Trans proline' 0 C--N 1.366 1.451 1 C-N-CA 125.475 4.117 . . . . 64.209999999999994 118.287 -173.658 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.461 ' HG3' ' HH ' ' A' ' 80' ' ' TYR . 32.9 Cg_endo -58.63 123.7 14.16 Favored 'Trans proline' 0 C--N 1.379 2.179 0 CA-C-N 120.802 1.322 . . . . 73.319999999999993 111.557 -174.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -59.79 136.47 90.07 Favored Pre-proline 0 N--CA 1.435 -1.216 0 CA-C-N 115.573 -0.74 . . . . 75.319999999999993 110.356 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.52 103.08 0.09 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 123.237 2.625 . . . . 75.319999999999993 114.149 -172.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.501 ' H ' HD13 ' B' ' 26' ' ' LEU . 0.0 OUTLIER -70.56 170.84 11.32 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 114.973 -1.012 . . . . 74.200000000000003 109.876 174.376 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 47.6 t -59.42 143.47 49.7 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.53 0.681 . . . . 73.549999999999997 112.707 -173.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.503 ' O ' ' HE2' ' B' ' 32' ' ' LYS . . . -52.73 -36.25 57.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.328 -1.306 . . . . 74.409999999999997 111.703 176.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -60.98 -49.2 78.42 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.555 -0.535 . . . . 63.32 109.555 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.52 -36.51 80.75 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-N 115.997 -0.547 . . . . 72.409999999999997 112.09 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.546 ' HA ' HG12 ' B' ' 34' ' ' ILE 0.516 5.3 ptpt -71.48 -35.43 70.82 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 115.049 1.5 . . . . 73.430000000000007 115.049 -179.146 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.503 ' HE2' ' O ' ' B' ' 28' ' ' ALA . 45.6 mtmt -64.41 -40.94 96.74 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.04 0.447 . . . . 54.009999999999998 111.066 174.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.549 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 38.6 mm-40 -71.07 -42.98 68.68 Favored 'General case' 0 C--O 1.211 -0.929 0 CA-C-N 115.622 -0.717 . . . . 73.409999999999997 112.768 -177.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.546 HG12 ' HA ' ' B' ' 31' ' ' LYS . 13.6 pt -64.79 -35.53 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 112.843 0.682 . . . . 73.540000000000006 112.843 -176.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.457 ' CG ' ' HZ1' ' B' ' 12' ' ' LYS . 11.1 m-20 -72.91 -23.69 60.73 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 119.994 -0.682 . . . . 70.010000000000005 111.329 177.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -77.1 -14.99 59.72 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.709 0.804 . . . . 74.439999999999998 109.741 174.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.549 ' HG3' ' O ' ' B' ' 33' ' ' GLU . 89.7 mtt180 -109.22 14.1 24.01 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 115.218 -0.901 . . . . 74.519999999999996 108.883 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 49.6 m -101.31 153.71 19.41 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.191 -0.913 . . . . 72.549999999999997 110.937 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.512 ' CG1' ' HB ' ' B' ' 91' ' ' VAL . 35.7 m -133.3 163.85 36.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.321 -0.854 . . . . 61.240000000000002 109.273 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . 0.532 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 35.0 t80 -110.9 124.47 52.16 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 107.623 -1.251 . . . . 73.420000000000002 107.623 177.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 59.1 t -122.91 110.1 25.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 107.923 -1.14 . . . . 73.310000000000002 107.923 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' B' ' 43' ' ' ASN . . . -133.88 109.02 0.77 Allowed Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 115.547 -3.216 . . . . 63.439999999999998 116.42 -177.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' B' ' 42' ' ' GLY . 62.0 t30 166.41 26.35 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 125.868 1.667 . . . . 75.209999999999994 108.011 157.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 12.0 p -69.67 136.22 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 115.208 -0.905 . . . . 75.030000000000001 109.921 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -111.9 167.09 10.65 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.666 -0.697 . . . . 63.520000000000003 110.788 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' TYR . . . . . 0.512 ' CE1' ' HB2' ' B' ' 77' ' ' PRO . 5.5 m-85 -69.25 101.55 1.52 Allowed 'General case' 0 CA--C 1.496 -1.13 0 CA-C-O 121.629 0.728 . . . . 73.400000000000006 109.796 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . 0.473 ' HA3' ' NH1' ' B' ' 103' ' ' ARG . . . 159.7 -33.58 0.45 Allowed Glycine 0 N--CA 1.413 -2.879 0 N-CA-C 109.218 -1.553 . . . . 43.340000000000003 109.218 -175.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.459 ' OG ' ' HE2' ' B' ' 102' ' ' PHE . 18.3 m -90.78 135.14 33.92 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 108.361 -0.977 . . . . 73.040000000000006 108.361 176.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 82.0 p -105.45 178.83 4.45 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 116.219 -0.446 . . . . 71.439999999999998 109.972 -177.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.508 ' HB3' HD11 ' B' ' 66' ' ' ILE . . . -61.98 -41.98 98.63 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.265 -1.013 . . . . 74.120000000000005 108.265 175.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -58.29 -35.41 71.77 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 114.949 -1.023 . . . . 74.319999999999993 111.392 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -69.55 -41.3 76.1 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 121.087 0.47 . . . . 75.400000000000006 110.472 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 61.2 mt -63.94 -47.82 78.98 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.348 -0.842 . . . . 73.219999999999999 112.244 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.421 ' HG2' HD13 ' B' ' 63' ' ' ILE . 31.0 mt-10 -60.14 -47.31 86.43 Favored 'General case' 0 C--O 1.182 -2.467 0 N-CA-C 113.796 1.036 . . . . 43.420000000000002 113.796 177.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.54 -48.02 75.38 Favored 'General case' 0 C--O 1.266 1.952 0 CA-C-N 118.413 0.551 . . . . 71.230000000000004 110.408 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -64.08 -41.57 97.27 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.549 -0.751 . . . . 74.129999999999995 110.719 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.436 ' CZ ' HG21 ' B' ' 41' ' ' VAL . 54.2 m-85 -82.51 -21.78 35.33 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 114.95 1.463 . . . . 72.140000000000001 114.95 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 48.5 t -66.89 -27.96 67.93 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.6 -0.518 . . . . 74.299999999999997 109.6 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.8 m -58.61 -31.55 68.17 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-O 121.003 0.43 . . . . 73.129999999999995 110.19 173.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 85.9 m -91.79 1.76 56.95 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.32 0.859 . . . . 64.239999999999995 113.32 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.65 -159.11 28.11 Favored Glycine 0 C--O 1.243 0.663 0 C-N-CA 118.033 -2.032 . . . . 37.810000000000002 116.383 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 17.5 m -106.05 116.21 31.54 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.053 -0.574 . . . . 75.510000000000005 110.592 -175.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.421 HD13 ' HG2' ' B' ' 54' ' ' GLU . 77.4 mt -84.18 132.16 32.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 121.594 0.712 . . . . 73.040000000000006 112.617 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -94.82 -49.07 5.75 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.635 -1.166 . . . . 65.219999999999999 109.281 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -155.93 164.32 38.64 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.659 -0.867 . . . . 74.400000000000006 108.659 -176.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.508 HD11 ' HB3' ' B' ' 50' ' ' ALA . 31.3 pt -145.98 144.59 20.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 109.002 -0.74 . . . . 72.409999999999997 109.002 176.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 58.5 m -125.47 125.71 43.74 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.263 -1.384 . . . . 74.329999999999998 107.263 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.7 mp -122.43 122.63 66.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 106.881 -1.526 . . . . 74.209999999999994 106.881 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.262 1.4 pt? -121.09 128.32 52.47 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.98 -0.688 . . . . 65.310000000000002 111.611 176.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 64.3 m -113.92 125.62 54.25 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.734 -1.21 . . . . 74.200000000000003 107.734 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -112.01 130.04 56.0 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 118.895 -1.122 . . . . 71.239999999999995 112.284 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . 0.449 ' HZ3' ' CD ' ' A' ' 54' ' ' GLU . 97.9 mttt -106.85 10.98 30.52 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.086 -1.079 . . . . 71.340000000000003 108.086 172.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -59.82 -33.69 72.09 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 113.733 -1.576 . . . . 74.140000000000001 107.892 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.404 ' C ' ' H ' ' B' ' 76' ' ' HIS . 24.8 m -82.35 8.31 11.68 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 115.087 -0.961 . . . . 53.200000000000003 111.799 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.2 -49.1 3.93 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-O 121.872 0.706 . . . . 72.209999999999994 111.388 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . 0.404 ' H ' ' C ' ' B' ' 74' ' ' SER . 40.7 m-70 -95.01 131.63 29.81 Favored Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 105.37 -2.085 . . . . 54.43 105.37 176.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.512 ' HB2' ' CE1' ' B' ' 46' ' ' TYR . 19.7 Cg_endo -63.42 116.67 3.77 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.212 1.275 . . . . 63.350000000000001 111.691 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -103.8 -178.61 3.71 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.239 -0.891 . . . . 64.230000000000004 109.303 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.55 136.44 4.22 Favored Glycine 0 N--CA 1.412 -2.945 0 C-N-CA 119.66 -1.257 . . . . 75.420000000000002 113.1 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -152.24 144.8 24.17 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 123.976 0.91 . . . . 75.129999999999995 109.756 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.98 151.48 49.05 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-O 121.001 0.429 . . . . 73.239999999999995 110.41 -172.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -118.83 115.93 25.46 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 108.129 -1.063 . . . . 74.25 108.129 176.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.402 HG23 HG23 ' B' ' 66' ' ' ILE . 40.7 mm -97.2 122.18 48.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 108.151 -1.055 . . . . 73.010000000000005 108.151 -177.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -101.97 119.46 38.83 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.067 -0.716 . . . . 71.329999999999998 109.067 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -98.02 155.66 17.0 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 116.279 -0.419 . . . . 72.439999999999998 109.972 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.97 -30.28 55.92 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.277 0.56 . . . . 74.239999999999995 109.644 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . 0.503 ' HB2' ' OG ' ' B' ' 90' ' ' SER . 35.6 mt-10 -105.14 136.71 44.14 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.862 -0.608 . . . . 74.099999999999994 109.627 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -72.52 -32.32 66.05 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.349 -1.352 . . . . 70.200000000000003 107.349 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -66.54 -22.42 66.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.429 -0.805 . . . . 72.340000000000003 111.357 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' SER . . . . . 0.503 ' OG ' ' HB2' ' B' ' 87' ' ' GLU . 49.6 m -67.48 -36.01 80.29 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.976 -0.379 . . . . 75.549999999999997 109.976 176.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . 0.512 ' HB ' ' CG1' ' B' ' 39' ' ' VAL . 2.0 m -67.01 -38.4 81.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 N-CA-C 108.121 -1.066 . . . . 73.319999999999993 108.121 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.34 -37.48 83.46 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.405 -0.816 . . . . 55.439999999999998 110.219 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.34 -30.92 63.66 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.195 0.521 . . . . 73.150000000000006 110.835 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.13 -44.79 36.75 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-N 116.086 -0.506 . . . . 73.510000000000005 111.352 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 25.7 m -55.46 -21.63 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.924 0.89 . . . . 74.239999999999995 112.819 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.62 -8.96 52.04 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.306 0.574 . . . . 62.25 110.481 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 32.9 mtm -105.02 12.97 31.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.495 -0.775 . . . . 75.340000000000003 110.583 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -39.55 -44.32 1.42 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.195 1.183 . . . . 74.400000000000006 114.195 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -110.05 95.14 5.4 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 121.545 0.688 . . . . 72.120000000000005 110.274 172.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' B' ' 106' ' ' THR . 6.7 p -132.11 156.08 46.99 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.119 -0.946 . . . . 72.209999999999994 111.934 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.68 127.14 65.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 121.095 0.474 . . . . 71.230000000000004 109.904 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' PHE . . . . . 0.459 ' HE2' ' OG ' ' B' ' 48' ' ' SER . 43.1 t80 -143.18 126.22 16.35 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.708 -1.59 . . . . 75.420000000000002 106.708 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . 0.473 ' NH1' ' HA3' ' B' ' 47' ' ' GLY . 72.9 mtp85 62.59 33.36 15.88 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.208 0.603 . . . . 72.209999999999994 111.101 -175.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.08 14.56 66.17 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 115.524 -0.762 . . . . 73.239999999999995 113.141 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -130.81 143.93 51.09 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 122.404 -0.468 . . . . 70.129999999999995 110.126 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' B' ' 100' ' ' THR . 53.5 m -83.0 126.68 32.8 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 120.777 0.322 . . . . 75.420000000000002 110.356 -177.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 38.7 pt -100.87 167.26 2.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 109.227 -0.657 . . . . 60.240000000000002 109.227 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 44.9 tptt -121.26 124.99 45.98 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.577 -0.898 . . . . 73.0 108.577 -175.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 35.6 t -122.01 119.19 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 108.413 -0.958 . . . . 75.150000000000006 108.413 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.327 0.3 OUTLIER -143.53 137.37 14.45 Favored Pre-proline 0 C--N 1.285 -2.197 0 N-CA-C 106.454 -1.684 . . . . 72.239999999999995 106.454 -169.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -77.18 130.11 10.9 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 120.771 1.311 . . . . 71.299999999999997 110.446 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -69.4 -42.06 75.61 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.08 -0.648 . . . . 74.140000000000001 110.597 -174.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.427 ' HG2' ' H ' ' B' ' 114' ' ' THR . 30.0 ttm-85 68.6 171.33 0.29 Allowed 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.044 0.938 . . . . 71.299999999999997 111.765 174.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' THR . . . . . 0.427 ' H ' ' HG2' ' B' ' 113' ' ' ARG . 28.8 m -160.75 169.68 22.28 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 104.326 -2.472 . . . . 74.019999999999996 104.326 -177.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -72.56 141.12 48.43 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-O 121.015 0.436 . . . . 63.350000000000001 111.122 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 94.7 mmm -77.38 116.3 56.62 Favored Pre-proline 0 C--N 1.31 -1.124 0 CA-C-N 115.272 -0.876 . . . . 70.140000000000001 109.219 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.35 14.9 0.86 Allowed 'Trans proline' 0 N--CA 1.478 0.581 0 C-N-CA 123.165 2.576 . . . . 62.0 113.584 -177.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.04 -135.32 32.09 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 121.311 -0.471 . . . . 61.140000000000001 112.2 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 34.9 pt -130.72 -175.51 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 109.678 -0.49 . . . . 72.239999999999995 109.678 -178.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 33.8 m 69.14 79.87 0.2 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 114.209 1.189 . . . . 61.409999999999997 114.209 175.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 18.9 p -92.31 -69.14 0.76 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.663 -1.236 . . . . 64.109999999999999 107.663 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 24.1 p -144.01 -52.39 0.33 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.765 -1.198 . . . . 70.450000000000003 107.765 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 33.4 t70 64.3 107.78 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.861 1.264 . . . . 62.539999999999999 111.664 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 . . . . . 0 C--N 1.301 -1.533 0 CA-C-O 118.636 -0.697 . . . . 60.200000000000003 110.106 -176.954 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.299 0 CA-C-O 121.099 0.476 . . . . 71.120000000000005 110.204 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.9 mm -106.95 135.85 44.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 109.042 -0.725 . . . . 73.310000000000002 109.042 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.85 99.74 49.04 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 110.172 -0.307 . . . . 72.019999999999996 110.172 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.99 101.8 1.55 Allowed 'Trans proline' 0 N--CA 1.442 -1.508 0 C-N-CA 122.103 1.868 . . . . 62.340000000000003 110.54 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 23.8 p -91.33 -42.37 10.4 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.536 -0.756 . . . . 73.040000000000006 109.667 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 63.0 mtm 61.05 22.62 12.87 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.047 0.939 . . . . 65.420000000000002 111.051 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -90.5 94.61 9.79 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.252 0.549 . . . . 73.519999999999996 109.772 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 99.0 m -145.87 132.19 19.56 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.77 -0.65 . . . . 73.040000000000006 110.951 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.2 p -106.56 153.51 22.23 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.227 -1.027 . . . . 73.430000000000007 108.227 175.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 -137.14 137.28 39.05 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.846 -0.742 . . . . 74.299999999999997 112.677 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' A' ' 12' ' ' LYS . 28.9 t 59.5 91.08 0.05 OUTLIER 'General case' 0 C--O 1.246 0.912 0 C-N-CA 125.306 1.442 . . . . 74.120000000000005 113.524 175.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 11' ' ' SER . 20.3 mtmm 171.59 126.2 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.092 0 C-N-CA 126.953 2.101 . . . . 65.200000000000003 110.305 175.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -120.4 23.43 10.88 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.926 -1.139 . . . . 72.129999999999995 107.926 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.3 p -68.79 97.71 0.85 Allowed 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 114.991 -1.004 . . . . 71.219999999999999 113.366 -176.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.38 127.81 14.98 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.1 -0.955 . . . . 72.409999999999997 109.151 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.93 86.16 0.08 OUTLIER Glycine 0 C--N 1.3 -1.47 0 C-N-CA 120.486 -0.864 . . . . 54.130000000000003 111.4 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -119.42 27.45 8.78 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 120.695 0.283 . . . . 62.030000000000001 110.902 -177.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.584 ' CE1' ' HA ' ' B' ' 15' ' ' ALA . 47.1 t80 -106.5 115.22 29.84 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.499 0.666 . . . . 70.019999999999996 111.162 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.4 m -148.38 -84.84 0.1 Allowed 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 106.721 -1.585 . . . . 61.399999999999999 106.721 170.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 60.75 -77.88 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 125.0 1.32 . . . . 74.239999999999995 114.125 173.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.28 -124.65 7.68 Favored Glycine 0 N--CA 1.429 -1.826 0 N-CA-C 109.449 -1.46 . . . . 70.099999999999994 109.449 -175.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.584 ' HG2' ' CE2' ' B' ' 40' ' ' TYR . 52.1 Cg_exo -56.88 -41.66 72.94 Favored 'Trans proline' 0 CA--C 1.576 2.625 0 C-N-CA 123.407 2.738 . . . . 73.230000000000004 114.963 176.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 22' ' ' PRO . 7.4 Cg_endo -56.49 144.92 82.51 Favored 'Trans proline' 0 C--N 1.395 2.979 0 C-N-CA 121.473 1.449 . . . . 51.520000000000003 110.569 171.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -70.05 124.34 90.52 Favored Pre-proline 0 C--N 1.316 -0.887 0 C-N-CA 120.327 -0.549 . . . . 61.039999999999999 111.458 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -68.59 121.97 8.92 Favored 'Trans proline' 0 N--CA 1.435 -1.927 0 C-N-CA 122.243 1.962 . . . . 64.129999999999995 110.343 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.57 HD11 ' H ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -73.94 169.94 16.42 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.601 -0.727 . . . . 72.0 110.876 -179.482 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.7 t -63.27 143.84 57.46 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.462 0.648 . . . . 72.140000000000001 112.412 -170.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.17 -41.05 64.81 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 114.686 -1.143 . . . . 70.209999999999994 113.157 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.265 27.3 mt-10 -66.25 -37.79 86.35 Favored 'General case' 0 CA--C 1.494 -1.188 0 C-N-CA 118.683 -1.207 . . . . 75.25 112.52 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.492 ' O ' HG12 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -58.07 -37.78 75.12 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 123.597 0.561 . . . . 74.030000000000001 109.532 172.102 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -67.65 -42.46 82.2 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.487 -0.779 . . . . 64.230000000000004 111.76 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.722 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -71.21 -36.06 71.75 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 118.772 -1.171 . . . . 73.140000000000001 111.412 177.26 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -63.6 -40.8 97.85 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.728 0.299 . . . . 75.430000000000007 110.431 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.492 HG12 ' O ' ' A' ' 30' ' ' GLU . 13.2 pt -71.63 -35.97 57.88 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 CA-C-N 115.578 -0.737 . . . . 71.129999999999995 110.747 176.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -58.98 -42.61 90.38 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 120.831 0.348 . . . . 74.340000000000003 110.169 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.722 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 88.9 mttt -60.26 -26.8 66.73 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.889 0.876 . . . . 71.5 111.804 -176.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.444 ' HD3' ' O ' ' A' ' 86' ' ' ALA . 15.8 ptp180 -112.55 21.91 15.15 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.672 0.748 . . . . 74.299999999999997 109.93 -176.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 56.9 m -113.83 170.83 7.97 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.372 -0.831 . . . . 62.210000000000001 110.78 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.88 162.14 31.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.421 0.629 . . . . 74.109999999999999 111.567 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.574 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -96.33 125.58 40.93 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 105.996 -1.853 . . . . 65.519999999999996 105.996 169.548 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.451 ' N ' ' HD1' ' A' ' 40' ' ' TYR . 94.4 t -128.37 106.54 14.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 107.247 -1.39 . . . . 72.400000000000006 107.247 173.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -151.89 113.06 0.56 Allowed Glycine 0 N--CA 1.423 -2.216 0 C-N-CA 116.174 -2.917 . . . . 74.450000000000003 117.783 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.497 ' HB3' ' HA ' ' A' ' 107' ' ' ILE . 9.3 t30 176.18 23.85 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 103.346 -2.835 . . . . 73.430000000000007 103.346 161.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.418 ' CG2' ' HB2' ' A' ' 48' ' ' SER . 7.1 p -107.76 100.82 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-N 113.03 -1.895 . . . . 72.540000000000006 110.816 -173.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -92.16 170.44 9.82 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.861 -1.063 . . . . 71.140000000000001 108.165 -175.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -28.08 -32.97 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 117.465 2.395 . . . . 72.049999999999997 117.465 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.94 -32.7 42.24 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.743 -0.265 . . . . 61.140000000000001 113.152 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.418 ' HB2' ' CG2' ' A' ' 44' ' ' VAL . 41.4 m -109.93 154.08 23.61 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 109.641 -0.503 . . . . 74.25 109.641 176.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 63.7 p -121.83 178.6 4.8 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 112.046 0.387 . . . . 74.400000000000006 112.046 -171.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 53' ' ' LEU . . . -63.15 -44.27 95.97 Favored 'General case' 0 C--O 1.215 -0.76 0 C-N-CA 123.636 0.775 . . . . 71.530000000000001 111.636 -177.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -58.13 -38.36 76.38 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.871 0.367 . . . . 72.439999999999998 111.517 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -64.17 -32.69 74.35 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.525 0.678 . . . . 64.219999999999999 109.608 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 62.8 mt -69.87 -46.08 66.3 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 114.185 -1.37 . . . . 72.409999999999997 110.595 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -57.89 -50.12 74.4 Favored 'General case' 0 C--O 1.191 -1.988 0 C-N-CA 120.944 -0.302 . . . . 75.519999999999996 111.211 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.33 -48.3 79.33 Favored 'General case' 0 C--O 1.263 1.809 0 CA-C-O 121.653 0.74 . . . . 73.019999999999996 112.458 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -69.56 -40.78 76.59 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.775 -1.102 . . . . 73.230000000000004 111.119 -175.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.405 ' CZ ' HG23 ' A' ' 41' ' ' VAL . 61.8 m-85 -82.63 -22.66 34.62 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 114.592 1.33 . . . . 74.409999999999997 114.592 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.5 t -71.26 -23.53 62.0 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.655 -0.498 . . . . 74.439999999999998 109.655 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.0 t -57.98 -31.63 67.1 Favored 'General case' 0 CA--C 1.558 1.255 0 N-CA-C 108.944 -0.762 . . . . 64.319999999999993 108.944 172.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 90' ' ' SER . 60.7 m -90.51 -0.35 57.63 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 112.751 0.649 . . . . 70.299999999999997 112.751 -177.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.64 -169.86 29.15 Favored Glycine 0 C--O 1.229 -0.18 0 C-N-CA 119.505 -1.331 . . . . 53.119999999999997 114.436 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.0 m -95.68 123.21 39.14 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 121.15 0.5 . . . . 71.209999999999994 110.453 -177.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 72.7 mt -91.56 124.84 44.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.777 -0.647 . . . . 61.340000000000003 110.875 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.495 ' ND2' ' HA ' ' A' ' 86' ' ' ALA . 65.8 m-80 -91.47 -35.54 14.28 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-O 121.077 0.465 . . . . 74.329999999999998 111.835 177.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.473 ' HD2' ' OE2' ' A' ' 84' ' ' GLU 0.266 0.0 OUTLIER -157.21 152.97 26.86 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.708 -1.219 . . . . 73.200000000000003 107.708 -167.489 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.404 HD13 ' HB3' ' A' ' 50' ' ' ALA . 34.5 pt -148.21 143.86 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 CA-C-N 118.451 0.569 . . . . 73.219999999999999 109.908 174.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.3 m -126.26 123.87 39.08 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.747 -1.205 . . . . 72.439999999999998 107.747 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.47 HD12 ' O ' ' B' ' 68' ' ' ILE . 2.2 mp -120.95 121.26 64.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 106.041 -1.837 . . . . 71.209999999999994 106.041 -176.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -120.55 130.15 54.1 Favored 'General case' 0 C--N 1.275 -2.642 0 C-N-CA 120.199 -0.6 . . . . 75.430000000000007 112.032 179.067 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 69.1 m -112.07 111.79 22.96 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.998 -1.112 . . . . 63.43 107.998 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -102.16 120.22 40.09 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 108.408 -0.96 . . . . 65.329999999999998 108.408 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.482 ' HE2' ' HB3' ' A' ' 77' ' ' PRO . 38.9 ttmt -111.0 15.65 21.6 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.059 -0.719 . . . . 74.420000000000002 109.059 -178.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -67.75 -18.0 64.74 Favored 'General case' 0 C--N 1.35 0.607 0 CA-C-O 121.341 0.591 . . . . 70.540000000000006 111.187 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.8 m -78.29 -7.28 57.02 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.913 -0.585 . . . . 70.430000000000007 110.654 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.26 -51.05 1.28 Allowed Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 109.308 -1.517 . . . . 70.540000000000006 109.308 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -96.38 134.42 23.51 Favored Pre-proline 0 C--N 1.287 -2.111 0 N-CA-C 105.677 -1.972 . . . . 74.540000000000006 105.677 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.482 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 41.5 Cg_endo -66.3 118.05 5.2 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.274 1.316 . . . . 73.349999999999994 112.232 -175.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -100.66 141.53 33.4 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.368 -0.833 . . . . 74.420000000000002 108.865 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 44' ' ' VAL . . . -127.76 140.51 11.88 Favored Glycine 0 N--CA 1.41 -3.045 0 C-N-CA 119.738 -1.22 . . . . 51.119999999999997 112.73 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . 0.25 3.1 p90 -156.65 146.92 21.29 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 123.745 0.818 . . . . 74.030000000000001 110.07 175.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.48 155.06 47.8 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-O 121.489 0.661 . . . . 74.439999999999998 109.233 -172.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.583 ' CD2' ' HD3' ' A' ' 112' ' ' LYS . 84.8 m-85 -121.27 115.89 23.84 Favored 'General case' 0 C--N 1.263 -3.172 0 N-CA-C 108.231 -1.026 . . . . 72.409999999999997 108.231 175.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 35.9 mm -95.9 119.04 43.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.318 -1.364 . . . . 64.409999999999997 107.318 -176.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.473 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 31.7 mt-10 -101.95 117.94 35.87 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.527 -0.546 . . . . 64.299999999999997 109.527 -174.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -102.23 169.56 8.64 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 121.986 0.898 . . . . 75.5 113.326 -173.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.495 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . . . -74.41 -38.82 62.97 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.36 -1.291 . . . . 62.409999999999997 112.45 174.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -126.03 159.07 33.71 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.552 -0.859 . . . . 74.030000000000001 113.145 -175.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.448 ' O ' HG21 ' A' ' 91' ' ' VAL . 11.4 mmm180 -66.44 -31.32 72.0 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 114.487 -1.233 . . . . 75.120000000000005 108.687 173.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -57.66 -39.35 76.85 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 114.133 -1.394 . . . . 71.129999999999995 109.951 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 60' ' ' CYS . 15.0 m -67.71 -38.38 83.54 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.978 -0.555 . . . . 73.540000000000006 111.148 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 88' ' ' ARG . 3.2 m -68.22 -39.15 80.7 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.224 0 C-N-CA 119.733 -0.787 . . . . 75.209999999999994 108.978 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -58.43 -38.62 77.84 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.614 0.766 . . . . 73.129999999999995 110.202 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.47 -38.07 63.02 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.667 -0.697 . . . . 71.430000000000007 111.187 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.17 -45.24 57.64 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 116.243 -0.435 . . . . 60.25 111.706 -176.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 91' ' ' VAL . 25.8 m -57.32 -22.16 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.286 0.634 . . . . 74.099999999999994 112.669 177.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.41 -14.03 62.68 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.444 0.64 . . . . 72.239999999999995 110.256 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 60.1 mtm -100.38 11.49 39.3 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.718 -0.673 . . . . 53.240000000000002 110.231 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -36.71 -49.54 0.78 Allowed 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 115.356 1.613 . . . . 62.210000000000001 115.356 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -107.25 25.5 11.33 Favored 'General case' 0 CA--C 1.556 1.186 0 CA-C-O 120.908 0.385 . . . . 74.109999999999999 111.627 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 67.7 p -84.0 172.41 12.06 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 119.417 -0.913 . . . . 71.109999999999999 111.571 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 106' ' ' THR . 8.3 p -102.95 135.91 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.912 0 N-CA-C 109.019 -0.734 . . . . 74.109999999999999 109.019 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -123.78 118.18 26.58 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.626 -0.509 . . . . 73.530000000000001 109.626 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 103' ' ' ARG . 43.4 mtp180 45.3 32.34 0.98 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.834 1.653 . . . . 72.230000000000004 113.568 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.27 -10.55 33.59 Favored Glycine 0 CA--C 1.522 0.49 0 CA-C-N 115.264 -0.88 . . . . 72.409999999999997 113.896 174.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.418 ' HD3' ' O ' ' A' ' 43' ' ' ASN . 3.8 ptp180 -124.25 132.53 53.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 117.059 0.429 . . . . 54.039999999999999 111.779 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 101' ' ' VAL . 87.6 m -71.35 121.56 18.75 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.101 -0.499 . . . . 75.329999999999998 110.478 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.497 ' HA ' ' HB3' ' A' ' 43' ' ' ASN . 33.2 pt -103.02 172.13 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 115.787 -0.642 . . . . 73.109999999999999 111.593 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -118.71 126.67 52.42 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.582 -0.896 . . . . 60.539999999999999 108.582 177.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 23.4 t -125.62 121.52 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 108.045 -1.095 . . . . 73.129999999999995 108.045 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . 0.253 0.0 OUTLIER -142.59 153.47 61.93 Favored Pre-proline 0 C--O 1.208 -1.125 0 N-CA-C 107.693 -1.225 . . . . 65.310000000000002 107.693 174.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.33 149.67 28.01 Favored 'Trans proline' 0 CA--C 1.507 -0.861 0 CA-C-N 120.721 1.293 . . . . 61.399999999999999 112.634 -175.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.583 ' HD3' ' CD2' ' A' ' 82' ' ' TYR . 47.3 mtmt -84.07 125.57 32.24 Favored 'General case' 0 N--CA 1.409 -2.519 0 N-CA-C 105.765 -1.939 . . . . 62.409999999999997 105.765 172.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -130.06 131.15 45.68 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 120.217 -0.593 . . . . 73.310000000000002 111.131 -170.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.9 t -141.32 -156.09 0.65 Allowed 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 107.279 -1.378 . . . . 71.409999999999997 107.279 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.661 ' O ' ' HE2' ' A' ' 36' ' ' LYS . 39.2 m-80 -43.37 156.26 0.05 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 126.224 1.81 . . . . 62.509999999999998 113.684 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.488 ' N ' ' HE1' ' A' ' 116' ' ' MET . 0.0 OUTLIER -77.05 164.52 58.48 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.829 -0.623 . . . . 71.400000000000006 111.086 -177.424 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -66.79 123.72 11.39 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.866 1.711 . . . . 54.409999999999997 107.936 169.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 101.3 93.22 2.17 Favored Glycine 0 C--N 1.298 -1.547 0 N-CA-C 107.974 -2.05 . . . . 71.430000000000007 107.974 -171.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 66.2 mt 74.7 86.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 124.479 1.112 . . . . 75.299999999999997 108.142 -171.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 11.5 t -100.8 53.5 0.86 Allowed 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 114.85 -1.068 . . . . 72.120000000000005 108.374 -173.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.6 t 78.81 178.88 0.12 Allowed 'General case' 0 C--N 1.35 0.629 0 C-N-CA 125.219 1.407 . . . . 73.319999999999993 109.01 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.1 p -82.14 -65.98 0.95 Allowed 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.159 0.504 . . . . 60.299999999999997 109.761 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.0 t70 169.36 -60.13 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 126.664 1.986 . . . . 74.530000000000001 105.829 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.2 ptt85 . . . . . 0 C--N 1.297 -1.717 0 CA-C-N 113.837 -1.529 . . . . 72.010000000000005 110.148 177.758 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 109.651 -0.5 . . . . 73.140000000000001 109.651 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 51.1 mm -93.89 110.72 23.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 109.296 -0.631 . . . . 62.5 109.296 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.06 107.11 59.05 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 116.056 -0.52 . . . . 73.409999999999997 110.066 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.29 130.32 13.94 Favored 'Trans proline' 0 C--O 1.247 0.967 0 C-N-CA 122.399 2.066 . . . . 62.009999999999998 111.551 178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 28.1 p -133.19 141.2 47.97 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.265 -0.643 . . . . 62.549999999999997 109.265 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 25.2 ptm -99.0 106.56 18.83 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.734 0.778 . . . . 42.310000000000002 110.489 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -91.28 111.34 22.78 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 115.681 -0.69 . . . . 74.329999999999998 110.685 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 35.4 p -104.33 -178.13 3.57 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 107.772 -1.196 . . . . 73.0 107.772 175.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 40.7 p -77.36 98.73 5.32 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 119.732 -0.787 . . . . 52.439999999999998 109.579 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -126.6 97.23 4.94 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-O 122.098 0.951 . . . . 73.310000000000002 110.875 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 40.5 t -157.49 110.59 2.49 Favored 'General case' 0 C--N 1.278 -2.5 0 N-CA-C 105.711 -1.959 . . . . 70.530000000000001 105.711 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -168.0 175.19 6.85 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.454 -0.339 . . . . 74.409999999999997 110.245 -172.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 86.5 mtp 66.99 102.45 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.651 1.181 . . . . 75.519999999999996 113.654 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 25.3 m -116.44 34.84 4.82 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 106.41 -1.7 . . . . 72.329999999999998 106.41 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.584 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . -76.51 127.82 33.58 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.124 -1.398 . . . . 75.129999999999995 111.291 -176.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.63 11.71 30.16 Favored Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 120.555 -0.831 . . . . 41.340000000000003 111.754 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.96 83.64 5.22 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.409 0.623 . . . . 64.340000000000003 110.472 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -118.82 171.25 8.35 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.253 -0.885 . . . . 74.409999999999997 109.205 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 19.6 m -87.34 136.11 33.06 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 120.225 -0.59 . . . . 65.25 110.954 -176.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -131.28 -48.09 0.99 Allowed 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 104.671 -2.344 . . . . 63.520000000000003 104.671 173.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.4 -124.36 9.77 Favored Glycine 0 N--CA 1.422 -2.29 0 CA-C-N 114.63 -1.168 . . . . 42.539999999999999 114.329 172.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.548 ' HG2' ' CE2' ' A' ' 40' ' ' TYR . 43.4 Cg_exo -55.04 -49.6 16.01 Favored 'Trans proline' 0 CA--C 1.578 2.702 0 C-N-CA 123.896 3.064 . . . . 75.239999999999995 115.564 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -54.29 138.25 72.32 Favored 'Trans proline' 0 C--N 1.398 3.144 0 CA-C-N 121.302 1.501 . . . . 63.130000000000003 109.635 173.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -64.08 122.23 76.27 Favored Pre-proline 0 N--CA 1.434 -1.249 0 C-N-CA 120.572 -0.451 . . . . 72.319999999999993 111.589 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -67.89 125.9 13.81 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.938 2.425 . . . . 70.510000000000005 110.664 -175.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.527 ' O ' ' HE3' ' B' ' 31' ' ' LYS 0.348 0.0 OUTLIER -77.73 171.43 14.97 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.812 -0.755 . . . . 71.120000000000005 112.014 -179.66 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.528 ' HB2' ' OE1' ' B' ' 30' ' ' GLU . 68.4 m -70.23 145.5 51.34 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 115.033 1.494 . . . . 70.519999999999996 115.033 -171.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.459 ' O ' ' HE2' ' B' ' 32' ' ' LYS . . . -53.71 -45.7 70.52 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 114.864 -1.062 . . . . 71.329999999999998 113.428 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' B' ' 33' ' ' GLU . 8.6 mm-40 -63.15 -41.96 99.36 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 122.078 -0.389 . . . . 61.399999999999999 110.635 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.528 ' OE1' ' HB2' ' B' ' 27' ' ' SER . 3.6 mp0 -56.26 -39.21 72.25 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 109.86 -0.422 . . . . 73.400000000000006 109.86 172.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.527 ' HE3' ' O ' ' B' ' 26' ' ' LEU . 98.7 mttt -69.39 -41.7 76.11 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.616 -0.72 . . . . 70.219999999999999 111.776 -177.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.684 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 0.4 OUTLIER -70.42 -35.61 73.51 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 118.977 -1.089 . . . . 72.140000000000001 111.349 176.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' B' ' 29' ' ' GLU . 17.6 mt-10 -68.31 -37.7 80.87 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 120.126 -0.63 . . . . 55.520000000000003 111.569 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.407 HG12 ' O ' ' B' ' 30' ' ' GLU . 15.4 pt -70.78 -34.63 57.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 C-N-CA 120.545 -0.462 . . . . 63.43 110.368 176.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' B' ' 31' ' ' LYS . 0.9 OUTLIER -64.82 -37.09 86.44 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.732 -0.84 . . . . 72.109999999999999 108.732 -177.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.684 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 95.8 mttt -62.02 -28.82 69.85 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.932 -1.031 . . . . 74.400000000000006 110.679 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.471 ' HD2' ' O ' ' B' ' 86' ' ' ALA . 71.7 mtm180 -106.29 18.13 22.44 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.601 -0.727 . . . . 64.329999999999998 111.221 -176.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 44.3 m -110.23 170.56 8.0 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 116.237 -0.438 . . . . 71.120000000000005 110.544 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 30.5 m -137.41 164.66 28.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.171 0.51 . . . . 74.439999999999998 111.47 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . 0.584 ' CE2' ' HG2' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -106.46 120.78 42.81 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 126.41 1.884 . . . . 75.420000000000002 106.273 175.608 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.512 HG23 ' CZ ' ' B' ' 57' ' ' PHE . 100.0 t -124.79 106.68 16.95 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 N-CA-C 107.742 -1.207 . . . . 73.200000000000003 107.742 177.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.66 113.2 0.58 Allowed Glycine 0 N--CA 1.423 -2.228 0 C-N-CA 116.318 -2.849 . . . . 64.109999999999999 117.724 -175.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.504 ' HB3' ' HA ' ' B' ' 107' ' ' ILE . 9.2 t30 176.22 23.76 0.0 OUTLIER 'General case' 0 C--O 1.209 -1.042 0 N-CA-C 105.41 -2.07 . . . . 73.219999999999999 105.41 160.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.475 ' O ' ' HA3' ' B' ' 79' ' ' GLY . 5.7 p -103.53 96.18 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-N 113.746 -1.57 . . . . 64.140000000000001 108.903 -178.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' B' ' 77' ' ' PRO . 6.0 m-20 -106.98 102.67 12.01 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.558 -1.645 . . . . 70.519999999999996 106.558 -170.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 51.21 -177.96 0.02 OUTLIER 'General case' 0 C--O 1.248 1.018 0 N-CA-C 114.935 1.457 . . . . 63.409999999999997 114.935 -173.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.22 -59.55 4.97 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 111.176 -0.77 . . . . 62.439999999999998 111.176 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.2 m -88.83 155.28 19.64 Favored 'General case' 0 N--CA 1.421 -1.875 0 N-CA-C 109.358 -0.608 . . . . 73.040000000000006 109.358 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 44.6 p -119.64 178.91 4.39 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 120.713 -0.395 . . . . 75.109999999999999 111.391 -174.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.47 ' HB3' HD13 ' B' ' 66' ' ' ILE . . . -64.53 -40.68 96.05 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 123.21 0.604 . . . . 74.319999999999993 109.904 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -58.39 -41.21 84.38 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 116.167 -0.47 . . . . 64.430000000000007 111.989 174.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -59.9 -35.88 75.8 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.637 0.732 . . . . 72.349999999999994 109.656 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.65 -45.68 74.62 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.838 -1.074 . . . . 74.319999999999993 111.354 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -58.17 -50.82 72.19 Favored 'General case' 0 C--O 1.189 -2.13 0 C-N-CA 120.751 -0.38 . . . . 72.420000000000002 111.856 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.8 -48.25 80.25 Favored 'General case' 0 C--O 1.257 1.463 0 CA-C-O 120.937 0.398 . . . . 71.329999999999998 111.537 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -68.82 -40.22 79.6 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.675 -0.693 . . . . 74.25 111.192 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.512 ' CZ ' HG23 ' B' ' 41' ' ' VAL . 63.1 m-85 -83.36 -22.68 32.75 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 114.976 1.472 . . . . 73.329999999999998 114.976 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 35.7 t -72.24 -26.63 62.09 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 110.06 -0.348 . . . . 70.239999999999995 110.06 -177.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 20.4 m -64.49 -27.18 68.8 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 119.498 -0.881 . . . . 37.359999999999999 109.428 174.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . 0.456 ' SG ' ' HE1' ' B' ' 97' ' ' MET . 57.3 m -95.58 9.21 40.99 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.681 -0.69 . . . . 64.239999999999995 112.04 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.92 -167.37 32.71 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 118.619 -1.753 . . . . 74.329999999999998 115.815 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 20.4 m -108.17 116.29 31.69 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.302 -0.629 . . . . 51.439999999999998 109.302 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 64.9 mt -91.11 123.4 43.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.063 0.458 . . . . 73.420000000000002 111.579 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -95.79 -34.43 11.89 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.596 -0.729 . . . . 71.019999999999996 111.944 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.523 ' HD2' ' OE1' ' B' ' 84' ' ' GLU 0.253 0.0 OUTLIER -157.87 153.41 26.29 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.593 -1.262 . . . . 70.219999999999999 107.593 -169.922 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.47 HD13 ' HB3' ' B' ' 50' ' ' ALA . 35.0 pt -148.33 144.0 18.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 109.115 -0.698 . . . . 70.129999999999995 109.115 174.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 36.3 m -125.45 124.41 41.35 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.58 -1.637 . . . . 72.239999999999995 106.58 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.47 ' O ' HD12 ' A' ' 68' ' ' ILE . 1.1 mp -121.85 121.55 64.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 106.11 -1.811 . . . . 72.329999999999998 106.11 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.71 130.59 54.13 Favored 'General case' 0 C--N 1.277 -2.566 0 C-N-CA 120.337 -0.545 . . . . 72.349999999999994 112.27 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 85.5 m -112.52 111.86 23.0 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.243 -1.021 . . . . 54.520000000000003 108.243 178.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -101.18 116.39 32.72 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.211 -1.033 . . . . 73.129999999999995 108.211 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -112.37 4.77 17.81 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.324 -0.551 . . . . 42.43 110.6 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -80.49 -6.64 58.47 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 119.308 -0.957 . . . . 74.340000000000003 110.727 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 33.7 t -80.93 7.82 9.76 Favored 'General case' 0 CA--C 1.557 1.249 0 CA-C-N 114.89 -1.05 . . . . 74.530000000000001 108.716 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.57 -58.87 2.59 Favored Glycine 0 CA--C 1.492 -1.392 0 N-CA-C 110.371 -1.092 . . . . 72.230000000000004 110.371 178.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -97.11 137.38 21.24 Favored Pre-proline 0 C--N 1.284 -2.253 0 N-CA-C 108.687 -0.857 . . . . 74.239999999999995 108.687 175.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.406 ' O ' ' HB3' ' B' ' 45' ' ' ASP . 15.7 Cg_endo -61.21 117.89 4.72 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.662 1.575 . . . . 63.509999999999998 111.54 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -108.7 140.66 41.78 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 108.67 -0.863 . . . . 64.319999999999993 108.67 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' B' ' 44' ' ' VAL . . . -128.37 138.16 10.18 Favored Glycine 0 N--CA 1.411 -3.025 0 C-N-CA 120.495 -0.86 . . . . 55.310000000000002 112.469 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -154.51 147.01 24.05 Favored 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 123.695 0.798 . . . . 73.349999999999994 109.74 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -138.57 152.83 48.51 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-N 115.969 -0.559 . . . . 64.409999999999997 110.78 -172.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' B' ' 40' ' ' TYR . 59.8 m-85 -118.47 115.3 24.34 Favored 'General case' 0 C--N 1.266 -3.062 0 N-CA-C 108.515 -0.92 . . . . 74.439999999999998 108.515 175.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.404 ' HA ' HG21 ' B' ' 66' ' ' ILE . 37.7 mm -95.3 118.72 42.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.668 -1.604 . . . . 74.200000000000003 106.668 -176.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' GLU . . . . . 0.523 ' OE1' ' HD2' ' B' ' 65' ' ' ARG . 32.3 mt-10 -102.78 117.79 35.42 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.308 -0.627 . . . . 75.209999999999994 109.308 -174.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -103.88 168.62 9.01 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.738 0.78 . . . . 73.510000000000005 112.261 -174.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.471 ' O ' ' HD2' ' B' ' 37' ' ' ARG . . . -81.01 -34.56 32.83 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.635 -1.166 . . . . 70.439999999999998 111.793 174.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -112.75 149.94 32.27 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 113.186 0.81 . . . . 74.420000000000002 113.186 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.417 ' O ' HG21 ' B' ' 91' ' ' VAL . 10.5 mmm180 -67.71 -31.16 70.91 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 107.542 -1.281 . . . . 71.25 107.542 168.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -56.79 -41.45 77.74 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 113.838 -1.528 . . . . 75.030000000000001 109.713 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 18.2 m -65.69 -39.5 91.35 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 116.06 -0.518 . . . . 72.230000000000004 111.356 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . 0.428 ' O ' HG13 ' B' ' 95' ' ' VAL . 3.1 m -67.91 -38.73 80.53 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.354 0 C-N-CA 119.493 -0.883 . . . . 71.420000000000002 108.803 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.71 -38.76 79.01 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.678 0.791 . . . . 71.200000000000003 110.296 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.37 -36.96 63.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.624 -0.716 . . . . 63.240000000000002 111.223 177.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.4 -45.1 48.92 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 116.285 -0.416 . . . . 63.310000000000002 111.447 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . 0.428 HG13 ' O ' ' B' ' 91' ' ' VAL . 25.6 m -58.56 -21.98 19.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 C-N-CA 123.778 0.831 . . . . 71.239999999999995 112.358 177.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.31 -14.49 62.96 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.106 0.479 . . . . 75.430000000000007 110.229 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' MET . . . . . 0.456 ' HE1' ' SG ' ' B' ' 60' ' ' CYS . 72.0 mtm -99.26 13.65 32.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.542 -0.754 . . . . 72.310000000000002 110.152 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -36.27 -56.28 0.77 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 114.294 1.22 . . . . 74.409999999999997 114.294 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -107.1 91.6 3.73 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.541 0.686 . . . . 74.230000000000004 110.224 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 33.4 p -135.13 169.19 17.82 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.959 -1.019 . . . . 74.530000000000001 111.64 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 11.7 p -102.58 138.76 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 N-CA-C 108.866 -0.79 . . . . 74.409999999999997 108.866 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' PHE . . . . . 0.462 ' O ' ' HG2' ' B' ' 105' ' ' ARG . 57.3 t80 -141.15 116.44 10.03 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 107.632 -1.248 . . . . 75.340000000000003 107.632 177.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 56.31 33.62 22.6 Favored 'General case' 0 CA--C 1.559 1.324 0 CA-C-O 122.684 1.231 . . . . 71.409999999999997 111.039 -176.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.18 2.54 87.9 Favored Glycine 0 C--N 1.314 -0.666 0 CA-C-N 114.754 -1.112 . . . . 75.129999999999995 114.259 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' B' ' 102' ' ' PHE . 4.1 ptp180 -120.02 137.28 54.19 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.419 -0.586 . . . . 61.340000000000003 109.419 177.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 28.0 m -78.39 120.92 23.82 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.529 -0.545 . . . . 74.450000000000003 109.529 -176.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . 0.504 ' HA ' ' HB3' ' B' ' 43' ' ' ASN . 41.2 pt -102.3 167.22 2.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 120.403 -0.519 . . . . 74.329999999999998 111.618 -177.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -118.76 126.13 51.18 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.014 -0.994 . . . . 71.430000000000007 109.185 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 21.5 t -124.17 122.37 64.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 N-CA-C 107.969 -1.123 . . . . 73.140000000000001 107.969 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.306 0.1 OUTLIER -146.76 144.03 19.63 Favored Pre-proline 0 C--N 1.284 -2.251 0 N-CA-C 105.729 -1.952 . . . . 75.209999999999994 105.729 -172.38 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.472 ' O ' HG21 ' B' ' 114' ' ' THR . 17.4 Cg_endo -66.0 136.19 43.75 Favored 'Trans proline' 0 C--N 1.357 1.019 0 CA-C-N 121.657 1.627 . . . . 71.409999999999997 111.832 -177.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -55.67 -50.65 69.68 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.244 0.617 . . . . 62.549999999999997 111.21 -171.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -83.81 75.63 10.07 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.827 -0.624 . . . . 71.430000000000007 110.141 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' THR . . . . . 0.472 HG21 ' O ' ' B' ' 111' ' ' PRO . 1.1 p -95.98 90.0 5.41 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.891 0.853 . . . . 75.540000000000006 112.109 176.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -164.42 140.76 6.2 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.739 -1.578 . . . . 65.25 106.739 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 26.7 ttt -64.16 109.46 2.75 Favored Pre-proline 0 C--N 1.321 -0.643 0 O-C-N 123.935 0.772 . . . . 73.409999999999997 110.425 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -88.25 -175.14 1.27 Allowed 'Trans proline' 0 N--CA 1.442 -1.501 0 C-N-CA 122.275 1.983 . . . . 73.329999999999998 112.441 -177.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -98.43 91.58 1.14 Allowed Glycine 0 N--CA 1.429 -1.8 0 N-CA-C 110.067 -1.213 . . . . 64.239999999999995 110.067 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 13.1 tt -150.81 150.05 13.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.573 -0.899 . . . . 54.530000000000001 108.573 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 31.6 t -77.72 -54.87 5.85 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.812 -1.181 . . . . 72.120000000000005 107.812 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 31.5 t 66.8 166.46 0.22 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.308 1.043 . . . . 74.430000000000007 112.173 176.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 9.4 t -171.05 155.22 4.36 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.287 -1.005 . . . . 73.230000000000004 108.287 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -156.11 148.65 23.76 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 109.353 -0.61 . . . . 62.130000000000003 109.353 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . 0.405 ' HD2' ' C ' ' B' ' 124' ' ' ARG . 4.5 tmm_? . . . . . 0 C--N 1.287 -2.117 0 N-CA-C 107.272 -1.381 . . . . 73.209999999999994 107.272 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.585 0 N-CA-C 109.643 -0.502 . . . . 43.030000000000001 109.643 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.3 mp -85.11 110.64 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 107.497 -1.297 . . . . 71.209999999999994 107.497 177.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -115.0 123.25 32.14 Favored Pre-proline 0 N--CA 1.426 -1.652 0 CA-C-N 116.442 -0.344 . . . . 74.129999999999995 111.389 -176.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -75.03 141.41 26.52 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.476 2.117 . . . . 61.009999999999998 110.147 174.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 45.9 t -84.4 93.51 8.29 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.602 -0.888 . . . . 70.329999999999998 108.602 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 84.8 mtp -82.59 107.87 15.56 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.677 -0.692 . . . . 72.430000000000007 109.716 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -138.52 117.35 12.35 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.66 0.743 . . . . 72.329999999999998 111.359 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.9 t -163.1 144.81 9.91 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 106.197 -1.779 . . . . 75.200000000000003 106.197 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.419 ' HA ' ' OD2' ' B' ' 92' ' ' ASP . 57.5 m -68.8 91.62 0.46 Allowed 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 121.584 0.706 . . . . 61.140000000000001 111.238 -177.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -104.42 -5.32 21.78 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.599 0.714 . . . . 72.310000000000002 109.305 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.2 t -85.52 96.22 9.55 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 107.632 -1.247 . . . . 70.439999999999998 107.632 176.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -78.79 -75.26 0.24 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.728 -0.669 . . . . 72.329999999999998 111.001 -176.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 16.2 tpt -174.92 131.69 0.32 Allowed 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 106.646 -1.613 . . . . 63.340000000000003 106.646 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -161.92 175.23 12.08 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.029 0.442 . . . . 74.120000000000005 110.135 -177.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.07 -18.35 21.08 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.948 -1.13 . . . . 51.240000000000002 107.948 175.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.84 156.31 28.29 Favored Glycine 0 N--CA 1.42 -2.368 0 CA-C-N 114.627 -1.169 . . . . 52.43 111.401 -178.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.12 99.86 12.07 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.521 -0.918 . . . . 61.229999999999997 108.521 176.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -134.49 169.9 16.58 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 112.884 0.698 . . . . 74.519999999999996 112.884 -176.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.428 ' C ' ' H ' ' A' ' 21' ' ' GLY . 31.1 m 70.17 70.05 0.22 Allowed 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.445 -1.252 . . . . 74.450000000000003 109.96 -177.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 72.98 -39.15 0.44 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 113.971 -1.468 . . . . 73.140000000000001 112.654 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 19' ' ' THR . . . 76.74 -109.95 2.91 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 119.275 -0.736 . . . . 63.420000000000002 113.039 177.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.411 ' HD2' ' HA3' ' A' ' 21' ' ' GLY . 1.7 Cg_endo -37.6 -53.78 1.36 Allowed 'Trans proline' 0 CA--C 1.561 1.846 1 C-N-CA 125.52 4.147 . . . . 43.020000000000003 117.11 179.404 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.67 147.26 95.74 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 121.475 1.45 . . . . 72.319999999999993 111.281 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -68.35 142.17 94.31 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 109.24 -0.652 . . . . 62.450000000000003 109.24 -175.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.56 102.83 0.1 OUTLIER 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.913 2.408 . . . . 51.119999999999997 112.374 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.551 ' H ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.17 168.53 17.6 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 114.997 -1.001 . . . . 72.549999999999997 112.026 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.1 t -79.22 153.59 29.86 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-O 121.211 0.529 . . . . 75.510000000000005 110.839 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.89 -33.99 8.3 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.66 -1.154 . . . . 75.120000000000005 111.609 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -70.71 -36.29 73.17 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 113.078 0.77 . . . . 73.549999999999997 113.078 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.545 ' O ' HG12 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -59.5 -36.37 75.95 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 109.023 -0.732 . . . . 65.239999999999995 109.023 173.109 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.604 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 66.1 mttm -63.32 -42.63 99.0 Favored 'General case' 0 C--O 1.196 -1.721 0 O-C-N 123.823 0.702 . . . . 74.540000000000006 111.08 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.702 ' HE2' ' N ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -64.44 -44.62 90.59 Favored 'General case' 0 C--O 1.202 -1.403 0 C-N-CA 119.677 -0.809 . . . . 63.039999999999999 111.679 177.254 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -65.81 -42.83 90.17 Favored 'General case' 0 C--O 1.211 -0.934 0 C-N-CA 120.645 -0.422 . . . . 65.239999999999995 111.652 -174.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 30' ' ' GLU . 12.8 pt -70.33 -35.32 62.09 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.182 0 C-N-CA 120.981 -0.288 . . . . 65.329999999999998 110.945 178.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.604 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 7.0 t70 -73.06 -32.02 64.76 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.731 0.777 . . . . 73.25 109.717 -176.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.458 ' HA ' ' HG2' ' A' ' 113' ' ' ARG . 52.9 mtpt -71.51 -19.17 62.22 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 115.042 -0.981 . . . . 72.209999999999994 110.298 176.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 84' ' ' GLU . 98.2 mtt180 -107.56 9.2 29.51 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.784 -0.644 . . . . 74.200000000000003 110.4 -177.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.2 m -95.36 149.81 20.95 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.587 0.708 . . . . 75.450000000000003 109.96 177.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.4 m -128.33 160.93 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 CA-C-N 115.028 -0.987 . . . . 75.430000000000007 109.779 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 18.5 t80 -105.63 121.07 43.23 Favored 'General case' 0 C--N 1.269 -2.898 0 C-N-CA 124.896 1.278 . . . . 74.510000000000005 108.072 176.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.6 t -113.9 108.92 26.73 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 107.809 -1.182 . . . . 61.149999999999999 107.809 176.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.31 165.36 12.76 Favored Glycine 0 C--N 1.296 -1.67 0 C-N-CA 119.596 -1.288 . . . . 63.140000000000001 113.711 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.6 t30 57.75 20.57 6.57 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.976 1.711 . . . . 64.340000000000003 113.374 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.3 p -62.41 133.26 28.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 CA-C-O 121.497 0.665 . . . . 61.329999999999998 109.301 174.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.415 ' HB3' ' HD2' ' A' ' 103' ' ' ARG . 15.0 t70 -80.73 153.93 27.56 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.235 -1.024 . . . . 75.519999999999996 108.235 -177.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -65.55 -17.08 64.3 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.386 0.612 . . . . 75.319999999999993 109.523 -174.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.54 -22.17 71.27 Favored Glycine 0 N--CA 1.439 -1.117 0 CA-C-N 115.905 -0.589 . . . . 64.430000000000007 112.944 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.5 m -92.29 145.0 24.83 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 119.296 -0.962 . . . . 72.310000000000002 111.483 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.2 p -124.28 179.83 4.74 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.831 -1.077 . . . . 73.329999999999998 109.197 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.88 -50.28 72.98 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 112.634 0.605 . . . . 73.420000000000002 112.634 -174.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -58.55 -43.03 89.18 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.452 0.538 . . . . 74.400000000000006 112.452 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.49 -44.36 97.22 Favored 'General case' 0 C--O 1.254 1.328 0 CA-C-O 121.762 0.791 . . . . 73.219999999999999 109.414 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 76.2 mt -68.31 -46.06 71.32 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-N 114.733 -1.121 . . . . 75.439999999999998 112.037 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.424 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 38.5 mt-10 -58.6 -47.89 82.81 Favored 'General case' 0 C--O 1.203 -1.366 0 N-CA-C 113.09 0.774 . . . . 61.130000000000003 113.09 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.7 -47.66 76.44 Favored 'General case' 0 C--O 1.276 2.496 0 CA-C-O 120.89 0.376 . . . . 50.039999999999999 110.779 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -64.29 -34.89 79.16 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 120.103 -0.639 . . . . 73.140000000000001 110.928 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -81.45 -21.63 38.67 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.812 1.042 . . . . 75.230000000000004 113.812 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.2 m -64.55 -26.62 68.5 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 121.067 0.46 . . . . 42.009999999999998 110.006 -178.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.0 m -57.7 -32.58 67.52 Favored 'General case' 0 CA--C 1.567 1.62 0 CA-C-N 116.065 -0.516 . . . . 61.030000000000001 110.455 172.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.1 m -91.21 4.5 52.12 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 113.599 0.963 . . . . 74.510000000000005 113.599 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.21 -164.97 27.52 Favored Glycine 0 CA--C 1.511 -0.191 0 C-N-CA 118.944 -1.598 . . . . 74.329999999999998 113.978 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.7 m -101.72 121.94 42.98 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.228 -0.286 . . . . 73.200000000000003 110.228 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.424 ' CD1' ' HA ' ' A' ' 54' ' ' GLU . 47.5 mt -78.97 127.98 38.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 121.715 0.769 . . . . 71.450000000000003 112.262 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.447 ' OD1' ' HA ' ' B' ' 73' ' ' PHE . 34.0 t-20 -87.03 -47.12 9.19 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.371 -1.286 . . . . 71.349999999999994 108.766 177.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.519 ' HB2' ' OE1' ' A' ' 84' ' ' GLU . 50.1 mtm180 -155.39 165.02 37.91 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.168 -0.679 . . . . 74.040000000000006 109.168 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.1 tt -149.18 133.35 8.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 122.966 0.506 . . . . 75.219999999999999 111.557 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.0 m -125.65 131.77 52.57 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.674 -1.232 . . . . 71.310000000000002 107.674 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.413 HD11 ' O ' ' B' ' 68' ' ' ILE . 2.3 mp -128.66 124.16 60.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 107.335 -1.357 . . . . 75.400000000000006 107.335 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.458 HD23 ' O ' ' A' ' 80' ' ' TYR . 1.6 pt? -120.67 131.95 54.85 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.959 -0.696 . . . . 75.519999999999996 111.643 176.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 66.7 m -117.36 127.43 54.04 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 108.867 -0.79 . . . . 64.349999999999994 108.867 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 3.1 p30 -104.73 119.31 38.69 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 119.298 -0.961 . . . . 71.549999999999997 109.09 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 41.2 ttmt -110.06 -4.11 16.04 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 120.072 -0.651 . . . . 71.150000000000006 112.084 -175.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.578 ' HB3' ' OD1' ' B' ' 64' ' ' ASN . 50.7 p90 -58.1 -20.29 38.86 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 119.447 -0.901 . . . . 74.450000000000003 111.188 176.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 28.5 t -79.22 -3.66 46.86 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.165 0.586 . . . . 61.450000000000003 111.42 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.0 -61.16 0.8 Allowed Glycine 0 CA--C 1.496 -1.126 0 N-CA-C 109.748 -1.341 . . . . 64.329999999999998 109.748 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -95.23 120.49 63.96 Favored Pre-proline 0 CA--C 1.484 -1.575 0 N-CA-C 106.689 -1.597 . . . . 70.530000000000001 106.689 173.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 65.6 Cg_endo -68.9 119.34 6.34 Favored 'Trans proline' 0 N--CA 1.442 -1.553 0 C-N-CA 121.841 1.694 . . . . 74.209999999999994 111.5 -176.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 32.6 mtmm -95.9 151.92 18.98 Favored 'General case' 0 CA--C 1.472 -2.021 0 N-CA-C 107.619 -1.252 . . . . 75.400000000000006 107.619 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.05 144.24 15.47 Favored Glycine 0 N--CA 1.405 -3.432 0 C-N-CA 118.743 -1.694 . . . . 37.579999999999998 113.492 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.458 ' O ' HD23 ' A' ' 69' ' ' LEU . 44.0 p90 -152.14 146.32 25.4 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.479 -0.86 . . . . 64.030000000000001 109.018 172.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.11 154.08 50.91 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 120.691 0.282 . . . . 71.200000000000003 111.416 -171.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -126.74 122.67 35.51 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.613 -0.884 . . . . 73.409999999999997 108.613 175.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.468 HD11 HG23 ' A' ' 83' ' ' ILE . 76.1 mt -122.71 134.17 66.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 116.139 -0.482 . . . . 70.120000000000005 110.886 -174.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.519 ' OE1' ' HB2' ' A' ' 65' ' ' ARG . 2.9 mp0 -102.02 134.48 45.18 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.921 -0.77 . . . . 74.400000000000006 108.921 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -102.44 160.26 14.71 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.841 -0.429 . . . . 71.200000000000003 109.841 173.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.87 -37.69 87.88 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.944 0.402 . . . . 73.200000000000003 111.395 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -110.58 149.77 29.91 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.144 -0.48 . . . . 70.230000000000004 111.403 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.77 -30.02 61.32 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.242 -1.392 . . . . 70.340000000000003 107.242 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -67.46 -21.18 65.55 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.395 -0.82 . . . . 73.239999999999995 111.28 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.7 m -70.49 -35.22 73.12 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 109.451 -0.574 . . . . 72.540000000000006 109.451 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.2 m -65.63 -37.99 81.28 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 N-CA-C 108.209 -1.034 . . . . 65.120000000000005 108.209 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -56.49 -38.58 71.94 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.923 -0.58 . . . . 73.409999999999997 110.435 177.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.85 -31.49 63.2 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.598 0.713 . . . . 62.100000000000001 111.347 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.39 -44.88 34.2 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.715 -0.675 . . . . 71.120000000000005 110.795 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.7 m -62.36 -21.65 27.47 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.772 0 C-N-CA 122.656 0.383 . . . . 73.109999999999999 111.991 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.91 -10.33 52.31 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.639 0.733 . . . . 73.099999999999994 110.047 174.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 35.4 mtm -102.73 11.23 37.92 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.586 -0.734 . . . . 73.549999999999997 110.302 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -46.52 -46.85 19.46 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.525 0.565 . . . . 63.109999999999999 112.525 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -95.44 93.28 7.12 Favored 'General case' 0 N--CA 1.437 -1.1 0 O-C-N 121.708 -0.62 . . . . 74.549999999999997 109.496 174.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 21.9 p -148.88 160.01 43.65 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 122.594 0.357 . . . . 72.150000000000006 110.817 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.2 p -107.78 126.01 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 109.03 -0.73 . . . . 75.030000000000001 109.03 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -133.49 119.58 19.74 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 108.441 -0.948 . . . . 75.109999999999999 108.441 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.415 ' HD2' ' HB3' ' A' ' 45' ' ' ASP . 48.6 ttm-85 55.26 54.27 8.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.957 0.884 . . . . 75.430000000000007 112.411 -177.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.24 -8.44 17.64 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 114.54 -1.209 . . . . 65.530000000000001 115.888 176.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -130.88 156.58 44.8 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 118.044 0.922 . . . . 73.530000000000001 110.997 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.4 m -84.3 125.25 32.09 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 120.985 0.421 . . . . 64.540000000000006 110.483 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 47.6 pt -101.76 172.07 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 116.079 -0.509 . . . . 70.120000000000005 110.011 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.42 134.43 47.11 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.191 -0.913 . . . . 74.540000000000006 109.874 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.609 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 28.0 t -124.74 126.0 70.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.992 -1.114 . . . . 53.210000000000001 107.992 177.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 40' ' ' TYR . 97.0 mt -134.89 161.63 62.51 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 108.616 -0.883 . . . . 64.439999999999998 108.616 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.53 140.5 24.11 Favored 'Trans proline' 0 N--CA 1.44 -1.658 0 N-CA-C 107.977 -1.586 . . . . 60.049999999999997 107.977 171.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -69.02 -29.65 67.87 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 119.891 -0.723 . . . . 72.230000000000004 110.835 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.458 ' HG2' ' HA ' ' A' ' 36' ' ' LYS 0.32 0.0 OUTLIER -87.92 112.78 22.91 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 119.408 -0.917 . . . . 74.140000000000001 111.504 171.58 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.6 p -145.45 164.46 31.51 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.41 -0.814 . . . . 70.019999999999996 109.21 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -156.78 99.06 1.83 Allowed 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.741 -0.466 . . . . 71.519999999999996 109.741 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 28.1 ttt -114.73 103.46 54.82 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 109.428 -0.582 . . . . 75.150000000000006 109.428 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.83 124.34 10.56 Favored 'Trans proline' 0 C--O 1.242 0.712 0 C-N-CA 122.538 2.159 . . . . 63.520000000000003 111.562 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -92.05 -120.81 2.69 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.866 -0.894 . . . . 64.530000000000001 110.866 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.9 tt -154.3 103.97 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 121.588 0.709 . . . . 74.540000000000006 111.611 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.8 m -144.08 106.3 4.37 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.02 -0.733 . . . . 73.099999999999994 109.02 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 50.6 m -85.8 106.84 17.33 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 121.321 0.582 . . . . 75.120000000000005 110.45 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 57.7 m -151.3 94.77 2.07 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.555 -0.906 . . . . 70.230000000000004 108.555 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -149.45 153.18 36.89 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.941 -0.572 . . . . 71.019999999999996 109.743 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 . . . . . 0 C--N 1.296 -1.734 0 CA-C-N 115.437 -0.801 . . . . 75.430000000000007 110.162 -177.817 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.505 0 CA-C-O 121.539 0.685 . . . . 50.140000000000001 109.906 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 48.0 mm -96.22 136.47 26.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 115.226 -0.897 . . . . 74.319999999999993 109.291 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.61 129.24 24.6 Favored Pre-proline 0 C--N 1.308 -1.198 0 N-CA-C 109.547 -0.538 . . . . 62.310000000000002 109.547 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -74.64 96.18 0.98 Allowed 'Trans proline' 0 C--O 1.249 1.037 0 C-N-CA 122.105 1.87 . . . . 75.230000000000004 110.973 177.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 62.7 m -148.41 95.55 2.47 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.298 -1.001 . . . . 71.209999999999994 108.298 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.68 113.66 21.45 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.933 -0.576 . . . . 63.149999999999999 111.038 -176.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -136.61 78.28 1.69 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.385 1.088 . . . . 62.030000000000001 111.872 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 3.5 p -139.22 112.22 7.97 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 113.886 -1.507 . . . . 54.310000000000002 108.731 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 71.9 p 65.67 107.0 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.042 1.737 . . . . 70.099999999999994 110.987 -173.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -67.79 154.55 41.29 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 116.112 -0.494 . . . . 75.409999999999997 111.343 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 13.4 p -68.76 -43.43 75.83 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 116.166 -0.47 . . . . 42.43 110.571 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -89.3 132.22 35.02 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 107.885 -1.154 . . . . 75.239999999999995 107.885 175.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' MET . . . . . 0.427 ' HE2' ' HB2' ' B' ' 15' ' ' ALA . 18.0 ptm -159.55 139.74 11.92 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.57 -0.452 . . . . 63.399999999999999 111.903 -174.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 54.9 p -88.37 30.98 0.84 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.871 0.868 . . . . 73.439999999999998 110.749 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.427 ' HB2' ' HE2' ' B' ' 13' ' ' MET . . . -56.34 147.3 21.6 Favored 'General case' 0 CA--C 1.504 -0.819 0 C-N-CA 124.592 1.157 . . . . 74.129999999999995 113.544 -176.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 148.25 -169.16 28.94 Favored Glycine 0 N--CA 1.412 -2.959 0 CA-C-N 115.322 -0.853 . . . . 64.530000000000001 111.995 175.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.97 92.24 8.27 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.667 -0.864 . . . . 60.409999999999997 108.667 177.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . 0.484 ' C ' ' H ' ' B' ' 20' ' ' GLU . 92.7 m-85 -134.97 -162.77 1.29 Allowed 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 115.062 -0.972 . . . . 75.329999999999998 109.615 -178.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 42.4 p 50.94 -23.19 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.701 0 N-CA-C 116.712 2.115 . . . . 72.530000000000001 116.712 -170.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . 0.484 ' H ' ' C ' ' B' ' 18' ' ' TYR . 39.5 mt-10 -74.45 82.63 1.96 Allowed 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 108.179 -1.045 . . . . 71.430000000000007 108.179 178.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.81 -150.6 19.08 Favored Glycine 0 C--N 1.33 0.237 0 CA-C-N 114.176 -1.375 . . . . 41.329999999999998 110.002 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.57 ' N ' ' HD2' ' B' ' 23' ' ' PRO . 52.7 Cg_exo -54.36 -40.24 83.75 Favored 'Trans proline' 0 CA--C 1.586 3.092 0 C-N-CA 123.409 2.739 . . . . 73.230000000000004 115.855 177.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' B' ' 22' ' ' PRO . 16.8 Cg_exo -30.21 126.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.411 3.866 0 C-N-CA 124.822 3.681 . . . . 74.319999999999993 115.85 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . 0.43 ' O ' ' HB3' ' B' ' 18' ' ' TYR . 15.2 mm100 -61.3 140.84 94.48 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 124.157 0.983 . . . . 74.430000000000007 112.888 -177.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -40.94 149.54 0.17 Allowed 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 125.039 3.826 . . . . 62.219999999999999 117.595 -177.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.442 HD23 ' HB2' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -134.39 164.64 26.98 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 105.542 -2.022 . . . . 73.439999999999998 105.542 177.603 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.443 ' HB3' ' OE1' ' B' ' 30' ' ' GLU . 45.8 t -76.01 144.79 40.69 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 118.264 -1.375 . . . . 73.25 112.576 -172.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.43 -32.9 8.38 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.034 -1.439 . . . . 53.520000000000003 111.62 173.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -71.45 -35.04 70.77 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 112.982 0.734 . . . . 64.519999999999996 112.982 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.509 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.9 OUTLIER -59.17 -37.85 78.36 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 109.03 -0.73 . . . . 71.120000000000005 109.03 172.6 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' B' ' 35' ' ' ASP . 65.1 mttm -63.29 -42.22 99.06 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 115.403 -0.817 . . . . 74.430000000000007 111.232 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.647 ' HE2' ' N ' ' B' ' 32' ' ' LYS . 0.5 OUTLIER -64.54 -44.47 90.71 Favored 'General case' 0 C--O 1.204 -1.3 0 C-N-CA 119.817 -0.753 . . . . 72.319999999999993 111.553 176.228 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -65.07 -42.27 94.33 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.782 -0.367 . . . . 52.109999999999999 111.346 -175.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.509 HG12 ' O ' ' B' ' 30' ' ' GLU . 11.7 pt -70.96 -34.68 56.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 116.254 -0.43 . . . . 75.430000000000007 111.482 178.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' B' ' 31' ' ' LYS . 3.8 m-20 -68.03 -41.32 82.29 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.971 0.509 . . . . 74.310000000000002 111.786 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -68.44 -23.53 64.62 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.14 -0.936 . . . . 74.120000000000005 110.519 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -101.89 10.54 39.7 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.641 -0.708 . . . . 64.549999999999997 110.947 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 16.3 t -105.24 155.1 19.38 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-O 121.317 0.58 . . . . 74.409999999999997 110.622 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 32.5 m -131.05 164.13 35.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.423 -0.808 . . . . 74.239999999999995 110.777 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . 0.613 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 22.5 t80 -109.54 122.81 48.25 Favored 'General case' 0 C--N 1.281 -2.394 0 C-N-CA 125.712 1.605 . . . . 73.349999999999994 108.031 176.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 46.6 t -115.95 112.92 41.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 107.759 -1.2 . . . . 73.129999999999995 107.759 176.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.3 175.81 16.51 Favored Glycine 0 C--N 1.306 -1.102 0 C-N-CA 119.806 -1.188 . . . . 53.32 113.732 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 10.7 t30 62.68 1.75 0.84 Allowed 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 126.462 1.905 . . . . 65.140000000000001 115.001 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.01 105.64 16.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.042 -1.036 . . . . 72.540000000000006 110.561 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -114.92 130.67 56.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 118.694 -0.669 . . . . 73.409999999999997 109.526 -171.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' TYR . . . . . 0.732 ' CE1' ' HB2' ' B' ' 77' ' ' PRO 0.344 13.6 m-85 52.11 -52.76 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 121.213 3.783 . . . . 74.409999999999997 121.213 170.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.74 -36.32 89.37 Favored Glycine 0 C--N 1.312 -0.777 0 N-CA-C 114.25 0.46 . . . . 72.140000000000001 114.25 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -91.44 147.84 22.74 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.095 0.474 . . . . 73.209999999999994 109.977 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 66.6 p -119.31 178.56 4.49 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.703 -0.68 . . . . 73.010000000000005 109.518 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.32 -50.29 74.22 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.021 0.378 . . . . 51.439999999999998 112.021 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -58.53 -40.81 83.97 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 120.972 0.415 . . . . 71.109999999999999 111.122 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -63.06 -47.74 81.64 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-N 115.665 -0.698 . . . . 74.329999999999998 109.766 -178.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 81.3 mt -62.36 -46.21 89.7 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-N 115.384 -0.826 . . . . 75.430000000000007 112.248 177.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -58.38 -47.69 83.03 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 112.636 0.606 . . . . 74.540000000000006 112.636 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.74 -45.44 78.01 Favored 'General case' 0 C--O 1.264 1.818 0 CA-C-O 121.463 0.649 . . . . 73.120000000000005 112.595 -176.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -67.35 -35.7 79.9 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.499 -0.773 . . . . 73.209999999999994 110.455 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -81.11 -22.94 38.74 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.052 0.76 . . . . 74.030000000000001 113.052 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' B' ' 61' ' ' GLY . 68.6 m -67.09 -28.73 68.42 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 116.428 -0.351 . . . . 63.140000000000001 110.829 -177.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 16.0 m -59.33 -30.56 68.46 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.059 0.457 . . . . 72.120000000000005 110.845 175.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 71.4 m -106.73 -0.16 23.75 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 113.449 0.907 . . . . 74.319999999999993 113.449 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . 0.614 ' O ' ' HA ' ' B' ' 58' ' ' SER . . . 178.07 164.83 31.93 Favored Glycine 0 C--O 1.215 -1.075 0 C-N-CA 118.844 -1.646 . . . . 60.149999999999999 114.144 -177.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 40.1 m -98.92 120.92 40.17 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.829 -0.804 . . . . 71.120000000000005 108.829 177.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.407 HD13 HG21 ' B' ' 63' ' ' ILE . 84.7 mt -82.16 129.44 37.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 114.717 1.377 . . . . 54.039999999999999 114.717 -173.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . 0.578 ' OD1' ' HB3' ' A' ' 73' ' ' PHE . 31.1 t-20 -88.22 -46.21 9.43 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.598 1.559 . . . . 72.400000000000006 109.265 177.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -156.05 166.04 34.65 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.556 -0.535 . . . . 71.349999999999994 109.556 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 1.3 tt -149.76 134.51 9.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 115.869 -0.605 . . . . 74.310000000000002 111.478 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 28.2 m -125.76 133.16 52.15 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.527 -1.286 . . . . 71.299999999999997 107.527 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.413 ' O ' HD11 ' A' ' 68' ' ' ILE . 1.5 mp -130.25 125.04 59.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 107.052 -1.462 . . . . 71.129999999999995 107.052 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.463 ' N ' HD21 ' B' ' 69' ' ' LEU 0.255 1.3 pt? -121.11 132.21 54.73 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.169 -0.612 . . . . 75.450000000000003 111.657 175.692 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 86.1 m -117.3 126.71 53.17 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.326 -0.99 . . . . 63.32 108.326 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 3.1 p-10 -113.13 134.46 54.54 Favored 'General case' 0 CA--C 1.489 -1.394 0 C-N-CA 119.328 -0.949 . . . . 61.409999999999997 110.759 -177.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' B' ' 77' ' ' PRO . 35.8 ttmt -119.49 14.26 12.75 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 105.698 -1.964 . . . . 61.100000000000001 105.698 176.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.447 ' HA ' ' OD1' ' A' ' 64' ' ' ASN . 62.0 t80 -43.75 -37.93 2.95 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 127.418 2.287 . . . . 74.25 113.27 177.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 49.8 m -110.37 22.24 15.73 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 120.891 0.377 . . . . 75.120000000000005 111.865 -177.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.83 -51.96 1.31 Allowed Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.366 -0.921 . . . . 74.349999999999994 112.857 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -95.4 119.16 65.84 Favored Pre-proline 0 C--N 1.311 -1.083 0 C-N-CA 120.586 -0.446 . . . . 72.430000000000007 110.385 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.732 ' HB2' ' CE1' ' B' ' 46' ' ' TYR . 57.3 Cg_endo -70.18 118.64 5.8 Favored 'Trans proline' 0 C--N 1.32 -0.97 0 C-N-CA 122.727 2.285 . . . . 53.32 113.335 -175.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 32.4 mtmm -113.83 166.25 11.75 Favored 'General case' 0 C--O 1.211 -0.963 0 CA-C-N 115.616 -0.72 . . . . 70.140000000000001 109.426 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -138.89 146.98 18.87 Favored Glycine 0 N--CA 1.421 -2.319 0 C-N-CA 120.042 -1.075 . . . . 45.43 114.177 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -153.16 146.3 24.66 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.467 -0.867 . . . . 74.140000000000001 108.891 172.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.38 154.12 48.95 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 120.946 0.403 . . . . 65.340000000000003 111.46 -172.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -127.64 121.07 29.5 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.863 -0.792 . . . . 74.030000000000001 108.863 175.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 71.2 mt -121.2 136.02 59.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 116.344 -0.389 . . . . 53.399999999999999 110.101 -174.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' GLU . . . . . . . . . . . . 0.387 1.3 pm0 -110.82 132.63 54.03 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.81 1.041 . . . . 65.209999999999994 113.81 174.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -97.99 162.02 13.44 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.473 -0.785 . . . . 73.140000000000001 111.755 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.69 -38.26 81.08 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.24 -0.891 . . . . 74.109999999999999 112.119 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' B' ' 88' ' ' ARG . 0.3 OUTLIER -120.67 156.42 31.77 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 120.045 -0.662 . . . . 73.230000000000004 111.122 178.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.508 ' H ' ' CD ' ' B' ' 87' ' ' GLU . 0.8 OUTLIER -75.22 -32.32 61.11 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 107.157 -1.423 . . . . 74.299999999999997 107.157 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -63.82 -22.77 67.07 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.527 -0.76 . . . . 61.020000000000003 110.857 176.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 16.0 m -71.07 -35.66 71.96 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 109.315 -0.624 . . . . 75.040000000000006 109.315 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 2.1 m -66.53 -37.12 78.92 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.157 0 N-CA-C 108.601 -0.888 . . . . 65.230000000000004 108.601 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . 0.419 ' OD2' ' HA ' ' A' ' 9' ' ' THR . 23.1 t70 -57.38 -38.46 74.27 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.353 0.597 . . . . 74.230000000000004 110.367 177.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.73 -33.0 64.15 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.458 -0.792 . . . . 73.420000000000002 110.043 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' B' ' 97' ' ' MET . . . -75.45 -43.67 48.31 Favored 'General case' 0 C--O 1.209 -1.049 0 CA-C-O 121.082 0.468 . . . . 74.140000000000001 110.562 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 24.7 m -63.24 -20.61 26.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 112.325 0.491 . . . . 74.140000000000001 112.325 176.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.95 -12.17 61.42 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 121.873 0.844 . . . . 53.130000000000003 109.882 174.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' B' ' 94' ' ' ALA . 40.0 mtp -99.66 10.18 41.8 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.583 -1.19 . . . . 62.409999999999997 109.51 178.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . 0.672 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 6.9 p-10 -36.57 -45.41 0.51 Allowed 'General case' 0 C--O 1.206 -1.218 0 N-CA-C 115.564 1.691 . . . . 74.140000000000001 115.564 -176.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -124.52 49.41 1.82 Allowed 'General case' 0 C--O 1.241 0.614 0 CA-C-N 119.98 1.264 . . . . 75.349999999999994 112.258 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 31.7 p -81.54 177.26 9.04 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.761 -0.654 . . . . 72.140000000000001 112.363 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 8.7 p -108.06 136.37 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-O 121.156 0.503 . . . . 63.210000000000001 110.174 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -139.17 120.92 15.35 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.77 -1.567 . . . . 73.239999999999995 106.77 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 53.71 33.27 16.35 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.315 0.857 . . . . 61.219999999999999 113.315 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.59 1.49 87.57 Favored Glycine 0 C--N 1.314 -0.647 0 CA-C-N 115.828 -0.624 . . . . 62.439999999999998 113.7 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -120.81 157.19 30.29 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.073 -0.714 . . . . 71.439999999999998 109.073 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 52.1 m -91.61 120.3 32.27 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 109.166 -0.679 . . . . 72.400000000000006 109.166 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 pp -102.14 164.67 3.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 119.668 -0.813 . . . . 74.420000000000002 111.089 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . 0.672 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 16.4 tptm -125.69 125.13 42.55 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.985 -0.746 . . . . 63.439999999999998 108.985 -169.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 22.9 t -121.16 131.37 73.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 110.046 -0.353 . . . . 74.040000000000006 110.046 -175.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . 0.411 ' HB2' ' HB3' ' B' ' 40' ' ' TYR . 96.9 mt -138.77 163.71 44.72 Favored Pre-proline 0 C--O 1.211 -0.924 0 C-N-CA 123.533 0.733 . . . . 65.040000000000006 109.34 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.31 142.38 26.87 Favored 'Trans proline' 0 CA--C 1.554 1.513 0 C-N-CA 122.506 2.137 . . . . 52.119999999999997 108.924 171.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.515 ' HG2' ' HD2' ' B' ' 113' ' ' ARG . 35.6 ttpt -85.27 -57.57 3.02 Favored 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 114.04 1.126 . . . . 74.150000000000006 114.04 -171.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.515 ' HD2' ' HG2' ' B' ' 112' ' ' LYS . 4.2 mpt_? -133.52 148.86 51.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.743 -1.223 . . . . 74.409999999999997 112.235 175.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 20.9 m -151.72 26.75 0.65 Allowed 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 107.212 -1.403 . . . . 71.319999999999993 107.212 174.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -149.99 173.76 13.47 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 107.172 -1.418 . . . . 54.119999999999997 107.172 -178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 65.1 mtt 74.02 103.64 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 125.397 1.479 . . . . 72.549999999999997 113.588 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' PRO . . . . . 0.427 ' HA ' ' HD3' ' B' ' 32' ' ' LYS . 63.7 Cg_endo -94.26 -172.29 0.28 Allowed 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 123.213 2.609 . . . . 73.540000000000006 112.234 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -153.04 167.53 31.74 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.883 -0.887 . . . . 62.240000000000002 110.883 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 12.8 tt -156.13 128.72 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.394 0.616 . . . . 65.310000000000002 112.046 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 35.7 t -136.25 94.35 3.02 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.304 -1.739 . . . . 52.539999999999999 106.304 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 23.2 t -94.43 -55.82 3.03 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.021 -0.536 . . . . 71.129999999999995 110.867 -174.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 48.8 m 64.29 95.35 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.621 0.769 . . . . 74.530000000000001 111.709 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -135.94 140.97 44.42 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 115.829 -0.623 . . . . 65.310000000000002 110.117 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 . . . . . 0 C--N 1.304 -1.391 0 N-CA-C 108.907 -0.775 . . . . 74.430000000000007 108.907 179.182 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.53 0 N-CA-C 109.659 -0.497 . . . . 70.439999999999998 109.659 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 27.9 pt -120.72 128.03 76.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.118 0.485 . . . . 74.420000000000002 110.366 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -102.27 121.44 50.21 Favored Pre-proline 0 C--N 1.286 -2.168 0 N-CA-C 108.053 -1.091 . . . . 73.530000000000001 108.053 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.02 120.24 7.94 Favored 'Trans proline' 0 C--O 1.245 0.846 0 C-N-CA 122.349 2.032 . . . . 60.25 110.767 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 63.3 m -101.96 116.8 33.47 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.742 -0.663 . . . . 64.510000000000005 110.362 -177.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -96.97 122.34 39.85 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.415 -0.587 . . . . 72.340000000000003 109.415 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -82.91 101.71 11.2 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.917 -0.713 . . . . 74.450000000000003 109.78 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.6 p -59.23 124.47 20.1 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.85 -1.068 . . . . 73.310000000000002 112.081 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -88.27 130.41 35.11 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-O 121.496 0.665 . . . . 71.209999999999994 109.602 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -131.65 92.64 3.19 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.461 -0.79 . . . . 63.219999999999999 110.719 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.1 t -78.57 146.83 34.0 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.606 -1.179 . . . . 60.240000000000002 110.323 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -85.8 97.36 10.13 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 109.177 -0.675 . . . . 72.109999999999999 109.177 177.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.4 ptm -72.46 109.22 6.0 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.615 -1.254 . . . . 72.299999999999997 107.615 174.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -81.51 137.6 35.57 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.838 -1.074 . . . . 73.200000000000003 113.43 -168.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.65 91.63 8.34 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 114.863 -1.062 . . . . 55.100000000000001 108.198 171.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.46 75.44 2.0 Favored Glycine 0 CA--C 1.495 -1.194 0 N-CA-C 110.035 -1.226 . . . . 65.120000000000005 110.035 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -100.89 133.55 45.21 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 122.699 0.4 . . . . 73.340000000000003 111.235 -176.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.577 ' HB3' ' O ' ' A' ' 24' ' ' GLN . 90.7 m-85 -79.62 77.63 6.21 Favored 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 108.213 -1.032 . . . . 74.319999999999993 108.213 175.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.478 HG22 ' NH2' ' A' ' 65' ' ' ARG . 26.5 m -105.35 -71.89 0.73 Allowed 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 115.664 1.727 . . . . 63.130000000000003 115.664 -177.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.518 ' O ' ' HG2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -149.99 149.38 30.28 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.982 -1.118 . . . . 63.229999999999997 107.982 -167.351 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.63 -133.01 11.49 Favored Glycine 0 C--N 1.317 -0.523 0 N-CA-C 110.527 -1.029 . . . . 73.129999999999995 110.527 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -51.18 -50.37 14.12 Favored 'Trans proline' 0 CA--C 1.566 2.123 0 C-N-CA 122.465 2.11 . . . . 71.010000000000005 113.116 174.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.518 ' HG2' ' O ' ' A' ' 20' ' ' GLU . 3.9 Cg_endo -54.58 134.97 64.78 Favored 'Trans proline' 0 C--N 1.397 3.121 0 C-N-CA 121.697 1.598 . . . . 72.439999999999998 110.913 171.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.577 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 16.2 mm100 -84.37 163.01 49.35 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-N 116.19 -0.459 . . . . 72.409999999999997 110.571 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.87 125.16 18.2 Favored 'Trans proline' 0 C--O 1.247 0.968 0 C-N-CA 122.681 2.254 . . . . 74.329999999999998 113.816 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.53 HD13 ' O ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -68.24 166.14 16.99 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.607 -1.178 . . . . 75.239999999999995 112.498 177.258 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.4 t -73.48 157.37 36.93 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 113.624 0.972 . . . . 74.549999999999997 113.624 -172.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.71 -45.7 74.07 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.338 -1.301 . . . . 74.219999999999999 112.39 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -58.67 -44.08 90.08 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.175 0.19 . . . . 72.430000000000007 110.686 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.475 ' O ' HG12 ' A' ' 34' ' ' ILE . 0.5 OUTLIER -59.33 -36.24 75.31 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 116.401 -0.363 . . . . 75.329999999999998 111.905 177.713 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -65.62 -51.79 56.93 Favored 'General case' 0 CA--C 1.5 -0.966 0 O-C-N 123.324 0.39 . . . . 73.010000000000005 110.056 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 47.7 mtmt -53.6 -34.87 59.94 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 113.925 1.083 . . . . 75.340000000000003 113.925 177.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -70.96 -49.18 48.28 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.262 0.468 . . . . 72.430000000000007 112.262 174.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 30' ' ' GLU . 16.0 pt -70.37 -36.1 65.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 112.926 0.714 . . . . 71.099999999999994 112.926 -175.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.95 -39.16 74.03 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-O 120.985 0.422 . . . . 73.010000000000005 111.422 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 99.0 mttt -57.35 -37.27 72.33 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 112.711 0.634 . . . . 73.230000000000004 112.711 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.407 ' HA ' HG13 ' A' ' 91' ' ' VAL . 4.9 ptp180 -114.44 14.74 17.91 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 114.492 1.293 . . . . 70.219999999999999 114.492 -165.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 62.7 p -104.21 158.19 16.61 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.219 1.192 . . . . 54.439999999999998 114.219 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.599 ' CG1' HG23 ' A' ' 91' ' ' VAL . 16.2 m -140.36 164.92 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 113.118 0.785 . . . . 64.549999999999997 113.118 -177.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.608 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 16.0 t80 -113.04 127.84 56.33 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 126.576 1.951 . . . . 75.230000000000004 108.448 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.28 114.41 43.8 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 N-CA-C 107.591 -1.263 . . . . 71.120000000000005 107.591 176.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.26 168.0 12.89 Favored Glycine 0 N--CA 1.425 -2.075 0 C-N-CA 119.729 -1.224 . . . . 72.409999999999997 113.909 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . 0.255 10.0 t30 60.63 67.07 0.86 Allowed 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 126.025 1.73 . . . . 72.349999999999994 114.988 -178.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 p -120.65 135.21 61.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 114.597 -1.183 . . . . 55.399999999999999 109.743 171.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -112.81 167.02 10.83 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.902 -1.518 . . . . 74.239999999999995 106.902 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -59.93 103.65 0.23 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 122.083 0.944 . . . . 75.140000000000001 113.029 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -179.51 -44.32 0.08 OUTLIER Glycine 0 N--CA 1.42 -2.428 0 N-CA-C 107.163 -2.375 . . . . 75.25 107.163 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 73.3 m -94.16 150.44 20.32 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.06 -0.57 . . . . 55.329999999999998 109.609 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.9 p -124.67 179.18 5.08 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.497 -0.774 . . . . 52.549999999999997 109.027 -178.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.25 -45.38 94.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.072 0.463 . . . . 61.240000000000002 109.837 -178.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -58.66 -39.18 79.89 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.61 -0.723 . . . . 72.030000000000001 111.431 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -67.48 -37.95 83.66 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-O 121.692 0.758 . . . . 64.109999999999999 109.09 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.4 mt -66.33 -46.22 77.6 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 114.569 -1.196 . . . . 63.520000000000003 111.454 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.444 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 35.3 mt-10 -58.38 -47.32 84.23 Favored 'General case' 0 C--O 1.187 -2.185 0 N-CA-C 113.002 0.741 . . . . 73.140000000000001 113.002 178.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.03 -47.42 74.77 Favored 'General case' 0 C--O 1.267 2.016 0 CA-C-O 121.006 0.431 . . . . 75.200000000000003 111.857 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -66.2 -39.17 89.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.987 -0.552 . . . . 74.340000000000003 110.666 -176.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -82.28 -22.63 35.64 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.883 1.068 . . . . 74.519999999999996 113.883 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.7 t -67.38 -30.89 70.79 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 123.377 0.671 . . . . 74.140000000000001 109.692 -176.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.0 m -62.06 -21.07 64.64 Favored 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 120.332 -0.547 . . . . 73.209999999999994 111.035 175.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 90' ' ' SER . 77.3 m -96.59 4.89 51.7 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 112.687 0.625 . . . . 71.340000000000003 112.687 178.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.28 -172.02 26.19 Favored Glycine 0 CA--C 1.503 -0.676 0 C-N-CA 119.215 -1.469 . . . . 53.229999999999997 114.325 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.2 m -94.67 118.54 31.87 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.273 0.559 . . . . 65.510000000000005 110.618 -177.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 54' ' ' GLU . 51.2 mt -76.34 132.67 32.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.313 -0.858 . . . . 71.030000000000001 111.314 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -97.33 -46.47 6.08 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.948 -1.023 . . . . 73.420000000000002 110.172 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.478 ' NH2' HG22 ' A' ' 19' ' ' THR . 38.8 mtp180 -155.85 162.62 40.42 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.191 -1.411 . . . . 74.450000000000003 107.191 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.405 HG22 HD13 ' A' ' 66' ' ' ILE . 29.0 pt -147.93 144.24 19.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 108.775 -0.824 . . . . 74.329999999999998 108.775 173.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.4 m -125.44 130.24 51.44 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.426 -1.324 . . . . 72.349999999999994 107.426 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.449 ' N ' HD13 ' A' ' 68' ' ' ILE . 1.8 mp -129.32 120.43 51.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 106.527 -1.657 . . . . 65.209999999999994 106.527 -178.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.286 1.3 pt? -122.09 134.24 54.77 Favored 'General case' 0 C--N 1.283 -2.324 0 C-N-CA 119.635 -0.826 . . . . 61.43 112.629 177.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 60.9 m -117.03 126.84 53.48 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.777 -0.823 . . . . 74.109999999999999 108.777 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -112.44 130.07 56.11 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 107.404 -1.332 . . . . 65.209999999999994 107.404 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -128.94 13.38 6.28 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 120.111 -0.636 . . . . 73.120000000000005 110.294 -176.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -63.08 -20.51 65.42 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.22 1.192 . . . . 64.519999999999996 114.22 -171.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 52.1 m -96.16 9.62 40.35 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.211 0.449 . . . . 74.420000000000002 112.211 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.42 -56.08 0.48 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.012 -1.089 . . . . 42.119999999999997 113.09 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 42.2 m-70 -95.11 133.35 26.34 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 108.834 -0.802 . . . . 61.549999999999997 108.834 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 76' ' ' HIS . 2.0 Cg_endo -76.82 117.57 4.54 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 C-N-CA 121.302 1.335 . . . . 71.040000000000006 110.503 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -100.28 140.51 34.43 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 108.253 -1.017 . . . . 52.049999999999997 108.253 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -129.63 147.85 18.1 Favored Glycine 0 N--CA 1.397 -3.904 0 C-N-CA 119.313 -1.423 . . . . 64.349999999999994 112.417 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -149.8 143.47 25.39 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 114.109 -1.046 . . . . 74.329999999999998 109.087 174.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.81 150.19 52.19 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 116.255 -0.43 . . . . 72.329999999999998 110.611 -171.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -120.87 117.53 27.6 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 109.141 -0.688 . . . . 72.239999999999995 109.141 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.484 ' O ' HG22 ' A' ' 39' ' ' VAL . 34.3 mm -99.72 127.49 52.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.281 -1.377 . . . . 65.230000000000004 107.281 -178.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -113.15 124.25 52.12 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.762 -0.829 . . . . 72.340000000000003 108.762 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -98.24 165.67 11.76 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 111.602 0.223 . . . . 74.0 111.602 -177.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.05 -33.47 57.25 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.265 -0.425 . . . . 74.519999999999996 111.99 176.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -121.05 162.11 20.54 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 113.393 0.886 . . . . 54.43 113.393 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.417 ' O ' HG11 ' A' ' 91' ' ' VAL . 16.5 mmm180 -66.39 -33.71 76.32 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 114.45 -1.25 . . . . 74.129999999999995 111.692 174.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -66.91 -29.28 69.11 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.61 -0.436 . . . . 71.120000000000005 111.47 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 60' ' ' CYS . 9.6 m -71.01 -42.08 70.04 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-O 120.723 0.296 . . . . 37.490000000000002 110.533 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.599 HG23 ' CG1' ' A' ' 39' ' ' VAL . 0.2 OUTLIER -67.64 -39.49 82.31 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 N-CA-C 110.313 -0.254 . . . . 73.439999999999998 110.313 176.649 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -61.69 -37.21 83.27 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.354 0.597 . . . . 65.019999999999996 110.267 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.37 -31.29 62.33 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.804 -0.635 . . . . 73.340000000000003 110.829 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.88 -44.77 38.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.652 0.263 . . . . 54.049999999999997 111.161 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.5 m -57.74 -22.48 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 112.508 0.558 . . . . 73.519999999999996 112.508 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.2 -11.59 61.01 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 120.988 0.423 . . . . 75.430000000000007 110.05 176.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 64.9 mtm -102.75 10.78 38.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.224 -0.444 . . . . 75.409999999999997 110.293 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.607 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 4.7 p-10 -37.71 -48.71 1.09 Allowed 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.848 1.055 . . . . 73.450000000000003 113.848 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -114.72 99.92 7.87 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-O 121.975 0.893 . . . . 73.200000000000003 109.803 175.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 106' ' ' THR . 17.5 p -138.91 167.02 22.94 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.146 -1.388 . . . . 73.549999999999997 110.829 -178.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.0 p -113.85 105.55 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 CA-C-O 122.191 0.996 . . . . 62.0 109.494 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.55 ' O ' ' HG2' ' A' ' 105' ' ' ARG . 89.9 t80 -113.95 124.9 53.3 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.822 -1.081 . . . . 74.420000000000002 108.396 -176.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 20.6 ttt85 54.41 47.89 21.86 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 122.255 1.026 . . . . 73.549999999999997 110.131 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.57 8.0 55.14 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 113.769 -1.56 . . . . 73.099999999999994 115.146 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.55 ' HG2' ' O ' ' A' ' 102' ' ' PHE . 15.1 ptp180 -131.92 145.88 51.77 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 118.101 0.951 . . . . 55.109999999999999 111.135 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 100' ' ' THR . 27.8 m -77.76 120.18 22.31 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 120.903 0.382 . . . . 73.319999999999993 110.049 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 39.7 pt -102.55 171.25 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 109.596 -0.52 . . . . 73.349999999999994 109.596 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 42.0 tptt -134.73 130.8 36.8 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.894 -0.78 . . . . 71.140000000000001 108.894 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 17.7 t -121.13 127.81 75.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.043 -0.725 . . . . 73.299999999999997 109.043 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 89.7 mt -132.08 160.94 65.71 Favored Pre-proline 0 C--O 1.199 -1.605 0 N-CA-C 108.749 -0.834 . . . . 65.239999999999995 108.749 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -77.65 140.74 19.03 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.031 1.821 . . . . 75.409999999999997 110.869 173.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -107.02 109.22 21.05 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 104.928 -2.249 . . . . 51.229999999999997 104.928 173.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.566 ' O ' ' HD2' ' A' ' 113' ' ' ARG . 5.7 ppt_? -161.87 137.45 7.55 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 113.946 1.091 . . . . 74.349999999999994 113.946 -170.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 39.1 m -91.79 84.17 5.37 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 122.249 1.023 . . . . 74.109999999999999 108.82 171.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -125.58 142.96 51.23 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.16 -1.793 . . . . 71.420000000000002 106.16 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 47.3 ttm 71.06 135.82 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.809 0 O-C-N 124.544 1.153 . . . . 73.239999999999995 110.095 -176.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -58.41 106.4 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.001 1.801 . . . . 74.150000000000006 111.12 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.36 17.93 0.3 Allowed Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.872 -0.68 . . . . 71.5 112.311 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.3 tt -91.72 134.19 30.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 108.103 -1.073 . . . . 54.039999999999999 108.103 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.7 t -94.05 90.08 6.28 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.643 -0.823 . . . . 63.25 110.995 -177.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.2 m -160.91 -84.29 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.725 -0.67 . . . . 73.310000000000002 109.852 177.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.1 t 174.35 32.31 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 106.871 -1.529 . . . . 73.439999999999998 106.871 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.9 t70 75.07 142.64 0.07 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 114.489 -1.232 . . . . 64.140000000000001 111.816 -174.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 . . . . . 0 C--O 1.25 1.114 0 CA-C-O 121.977 0.894 . . . . 64.420000000000002 110.211 -177.428 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.585 0 N-CA-C 110.041 -0.355 . . . . 74.409999999999997 110.041 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 49.5 mm -85.49 119.32 33.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 109.115 -0.698 . . . . 72.340000000000003 109.115 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -117.19 94.63 45.47 Favored Pre-proline 0 C--N 1.309 -1.195 0 CA-C-N 116.621 -0.263 . . . . 52.439999999999998 110.56 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -85.65 142.49 8.07 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 122.192 1.928 . . . . 61.149999999999999 112.415 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 10.1 p -75.53 106.78 7.26 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.881 -0.6 . . . . 63.240000000000002 110.307 177.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 85.1 mtp -122.82 103.1 8.42 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.547 -0.752 . . . . 64.439999999999998 109.204 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 62.52 34.58 15.17 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.598 0.759 . . . . 63.310000000000002 110.574 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 61.6 m -69.84 102.71 2.01 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.305 -0.862 . . . . 64.040000000000006 110.473 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -95.64 147.94 23.06 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 115.711 -0.677 . . . . 64.340000000000003 109.186 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . 0.406 ' O ' ' HE2' ' B' ' 13' ' ' MET . 65.2 t-80 -113.61 -29.34 7.18 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.516 -0.473 . . . . 62.119999999999997 110.384 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 31.5 t -97.57 144.09 27.61 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.215 -0.661 . . . . 74.010000000000005 109.215 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 65.51 78.47 0.27 Allowed 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.975 0.91 . . . . 74.340000000000003 111.766 -178.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' MET . . . . . 0.406 ' HE2' ' O ' ' B' ' 10' ' ' HIS . 63.9 mtt -111.04 -159.68 0.69 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.444 -1.253 . . . . 75.129999999999995 107.968 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 24.8 p -57.29 -34.63 68.89 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 120.996 0.427 . . . . 73.019999999999996 110.253 175.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.45 102.38 6.84 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.697 -0.853 . . . . 54.210000000000001 108.697 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.9 -33.39 2.73 Favored Glycine 0 C--N 1.299 -1.497 0 N-CA-C 108.979 -1.648 . . . . 60.409999999999997 108.979 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.23 -47.31 10.21 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.874 -1.158 . . . . 74.340000000000003 107.874 173.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -132.18 151.61 51.71 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.792 -1.095 . . . . 75.109999999999999 110.695 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 9.8 t -152.27 -168.83 3.18 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 105.839 -1.912 . . . . 74.209999999999994 105.839 176.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -74.64 -49.86 19.87 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.029 -1.1 . . . . 72.109999999999999 108.029 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 160.0 -113.01 0.55 Allowed Glycine 0 CA--C 1.495 -1.159 0 N-CA-C 107.872 -2.091 . . . . 71.239999999999995 107.872 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -53.95 -40.29 81.49 Favored 'Trans proline' 0 CA--C 1.574 2.501 0 C-N-CA 122.744 2.296 . . . . 72.349999999999994 113.887 172.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.69 136.12 60.55 Favored 'Trans proline' 0 C--N 1.394 2.964 0 C-N-CA 121.301 1.334 . . . . 72.109999999999999 111.379 173.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -66.54 141.11 96.86 Favored Pre-proline 0 C--N 1.31 -1.14 0 CA-C-N 115.289 -0.868 . . . . 74.239999999999995 110.892 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -59.06 116.45 3.27 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 122.7 2.267 . . . . 63.299999999999997 111.112 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.509 ' H ' HD13 ' B' ' 26' ' ' LEU . 0.0 OUTLIER -67.14 160.75 26.15 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.751 -1.113 . . . . 51.210000000000001 112.068 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.511 ' HB3' ' OE1' ' B' ' 30' ' ' GLU . 29.6 t -82.04 164.68 21.25 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.507 0.67 . . . . 74.099999999999994 112.332 -173.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.4 -38.68 63.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.5 -1.227 . . . . 52.530000000000001 112.617 -178.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -69.47 -36.38 76.51 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 120.706 -0.398 . . . . 72.549999999999997 111.551 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.511 ' OE1' ' HB3' ' B' ' 27' ' ' SER . 3.6 mp0 -62.37 -35.23 78.51 Favored 'General case' 0 CA--C 1.503 -0.832 0 O-C-N 123.481 0.488 . . . . 73.340000000000003 110.645 175.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -66.03 -51.35 59.04 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 123.302 0.377 . . . . 75.239999999999995 110.466 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.488 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 47.9 mtmt -53.93 -35.52 61.78 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 114.141 1.163 . . . . 53.439999999999998 114.141 176.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.526 ' O ' ' HD3' ' B' ' 37' ' ' ARG . 24.5 mm-40 -70.25 -47.55 60.84 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.198 0.444 . . . . 74.340000000000003 112.198 174.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.46 HD13 ' HA ' ' B' ' 115' ' ' ASN . 10.3 pt -70.92 -35.7 60.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 112.934 0.716 . . . . 71.420000000000002 112.934 -176.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.32 -35.49 65.2 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.229 0.537 . . . . 72.400000000000006 111.21 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 97.9 mttt -63.3 -35.07 79.14 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.126 -0.943 . . . . 74.010000000000005 112.685 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.526 ' HD3' ' O ' ' B' ' 33' ' ' GLU . 11.3 mtp180 -111.3 5.41 19.81 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 114.727 1.38 . . . . 73.140000000000001 114.727 -164.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' SER . . . . . 0.578 ' HB2' ' O ' ' B' ' 112' ' ' LYS . 15.5 m -96.97 154.98 16.98 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 112.906 0.706 . . . . 75.099999999999994 112.906 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 11.4 m -139.54 164.99 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.609 1.163 . . . . 73.420000000000002 112.522 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . 0.659 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 18.4 t80 -113.51 126.88 55.8 Favored 'General case' 0 CA--C 1.489 -1.372 0 C-N-CA 126.624 1.97 . . . . 73.420000000000002 108.592 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 66.2 t -121.03 114.25 42.72 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 N-CA-C 108.303 -0.999 . . . . 63.409999999999997 108.303 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.27 174.05 15.28 Favored Glycine 0 N--CA 1.421 -2.311 0 C-N-CA 119.514 -1.327 . . . . 54.329999999999998 113.176 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.5 t30 64.65 21.28 12.38 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.95 1.7 . . . . 63.539999999999999 112.877 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 8.7 p -69.81 123.68 24.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.092 -0.707 . . . . 74.319999999999993 109.092 173.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -82.39 159.71 22.95 Favored 'General case' 0 C--O 1.253 1.281 0 CA-C-N 115.48 -0.782 . . . . 75.0 109.675 -174.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -76.24 91.07 3.17 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-O 121.743 0.782 . . . . 74.030000000000001 108.945 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 168.2 -18.92 0.08 OUTLIER Glycine 0 N--CA 1.41 -3.048 0 CA-C-N 114.694 -1.139 . . . . 53.310000000000002 110.543 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -84.19 143.3 29.71 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 107.799 -1.185 . . . . 74.299999999999997 107.799 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 77.8 p -99.89 170.19 8.7 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 110.296 -0.261 . . . . 74.420000000000002 110.296 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.408 ' HB3' HD12 ' B' ' 66' ' ' ILE . . . -67.05 -39.85 87.01 Favored 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 108.87 -0.789 . . . . 73.040000000000006 108.87 175.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -57.43 -44.55 84.75 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.553 -1.203 . . . . 72.120000000000005 110.961 174.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.05 -47.89 77.05 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.384 0.611 . . . . 64.439999999999998 110.86 174.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 41.2 mt -58.76 -47.04 86.05 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 114.493 -1.23 . . . . 63.420000000000002 112.52 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.458 ' HA ' ' CD1' ' B' ' 63' ' ' ILE . 93.9 mt-10 -58.85 -47.87 83.37 Favored 'General case' 0 C--O 1.183 -2.431 0 N-CA-C 112.57 0.582 . . . . 72.109999999999999 112.57 177.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.13 -47.73 74.63 Favored 'General case' 0 C--O 1.27 2.142 0 N-CA-C 112.334 0.494 . . . . 74.319999999999993 112.334 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -67.16 -38.39 85.4 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.02 -0.536 . . . . 61.32 110.598 -176.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -82.61 -22.0 34.93 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.686 0.995 . . . . 71.420000000000002 113.686 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 37.8 t -64.55 -32.22 73.78 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 123.693 0.797 . . . . 75.200000000000003 109.454 -178.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.8 m -59.6 -24.34 63.71 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-N 116.271 -0.422 . . . . 74.340000000000003 110.978 174.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . 0.484 ' O ' ' HA ' ' B' ' 90' ' ' SER . 68.8 m -88.1 -4.0 58.82 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.435 0.531 . . . . 74.329999999999998 112.435 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.94 -159.67 26.57 Favored Glycine 0 C--N 1.318 -0.425 0 C-N-CA 119.394 -1.384 . . . . 61.520000000000003 114.08 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 50.7 m -94.6 119.09 32.71 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 121.091 0.472 . . . . 73.120000000000005 112.102 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.458 ' CD1' ' HA ' ' B' ' 54' ' ' GLU . 68.0 mt -78.67 128.24 38.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.692 -0.686 . . . . 70.150000000000006 111.625 177.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . 0.491 ' OD1' ' HG3' ' B' ' 65' ' ' ARG . 19.0 t-20 -90.66 -50.23 6.03 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.797 -1.092 . . . . 71.230000000000004 108.529 -177.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.491 ' HG3' ' OD1' ' B' ' 64' ' ' ASN . 41.2 mtp180 -155.31 164.79 38.28 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 107.41 -1.33 . . . . 75.019999999999996 107.41 -177.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.42 HG22 HD13 ' B' ' 66' ' ' ILE . 28.9 pt -148.34 144.29 18.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.407 -0.96 . . . . 74.150000000000006 108.407 173.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 61.5 m -125.65 130.58 51.9 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 107.055 -1.461 . . . . 73.040000000000006 107.055 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.419 ' N ' HD13 ' B' ' 68' ' ' ILE . 1.9 mp -129.32 119.9 49.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 106.657 -1.609 . . . . 70.329999999999998 106.657 -178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.459 HD12 HH22 ' A' ' 65' ' ' ARG 0.264 1.5 pt? -121.77 134.14 54.92 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 119.701 -0.799 . . . . 74.010000000000005 112.272 177.749 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 61.9 m -117.11 125.72 51.7 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.52 -0.918 . . . . 63.43 108.52 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 10.3 t70 -105.74 127.18 52.93 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.624 -1.25 . . . . 72.230000000000004 107.624 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -127.01 17.56 7.24 Favored 'General case' 0 N--CA 1.423 -1.799 0 C-N-CA 120.719 -0.393 . . . . 73.129999999999995 110.138 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . 0.255 1.4 p90 -70.25 -16.25 63.01 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 118.367 -1.333 . . . . 74.239999999999995 112.672 -177.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 46.0 m -94.42 17.89 12.21 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.203 -0.453 . . . . 71.319999999999993 110.393 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.42 -63.76 1.95 Allowed Glycine 0 CA--C 1.492 -1.354 0 C-N-CA 120.75 -0.738 . . . . 51.509999999999998 111.569 176.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . 0.255 89.6 m-70 -96.4 125.07 48.91 Favored Pre-proline 0 C--N 1.291 -1.975 0 C-N-CA 120.414 -0.514 . . . . 63.350000000000001 110.852 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 98.6 Cg_endo -73.6 135.72 22.39 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.944 2.429 . . . . 54.350000000000001 115.051 -171.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -112.12 146.13 38.56 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 124.883 1.273 . . . . 73.340000000000003 107.842 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.8 148.03 17.86 Favored Glycine 0 N--CA 1.412 -2.961 0 C-N-CA 119.142 -1.504 . . . . 73.319999999999993 112.968 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . 0.427 ' OH ' ' HB ' ' A' ' 19' ' ' THR . 31.0 p90 -151.48 143.37 23.82 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 114.362 -0.919 . . . . 74.5 109.736 172.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.13 151.61 51.69 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 116.169 -0.468 . . . . 61.5 110.657 -172.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' TYR . . . . . 0.721 ' CD1' ' HE2' ' B' ' 112' ' ' LYS . 89.9 m-85 -122.32 116.52 24.21 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 109.253 -0.647 . . . . 64.420000000000002 109.253 177.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.418 HG23 HG21 ' B' ' 66' ' ' ILE . 34.3 mm -98.86 127.21 51.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 107.31 -1.367 . . . . 63.299999999999997 107.31 -178.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' B' ' 38' ' ' SER . 29.3 mt-10 -112.36 125.62 54.4 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 108.836 -0.801 . . . . 72.530000000000001 108.836 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -100.07 162.38 13.01 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.432 0.634 . . . . 64.099999999999994 112.245 -177.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.45 -29.77 53.0 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.328 -0.851 . . . . 71.319999999999993 111.387 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -122.67 150.0 43.28 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 112.9 0.704 . . . . 54.149999999999999 112.9 -175.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.41 ' HD3' ' HB3' ' B' ' 36' ' ' LYS . 14.4 mmm180 -63.08 -34.89 78.56 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.116 0.566 . . . . 75.540000000000006 110.676 175.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -62.73 -32.15 73.22 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.577 -0.738 . . . . 71.349999999999994 110.913 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' B' ' 60' ' ' CYS . 15.1 m -71.15 -41.4 70.47 Favored 'General case' 0 N--CA 1.433 -1.313 0 O-C-N 122.335 -0.228 . . . . 75.549999999999997 110.949 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.05 -38.98 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 C-N-CA 120.727 -0.389 . . . . 74.019999999999996 111.016 176.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -63.01 -36.68 84.36 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.476 0.655 . . . . 72.109999999999999 109.579 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.49 -31.03 63.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.797 -0.638 . . . . 71.239999999999995 111.789 178.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.05 -44.95 36.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.584 -0.734 . . . . 73.329999999999998 110.763 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 33.1 m -58.75 -22.29 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 112.334 0.494 . . . . 75.400000000000006 112.334 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.91 -14.91 63.28 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 121.51 0.671 . . . . 72.299999999999997 111.331 176.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 65.6 mtm -100.54 12.74 36.66 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.334 -0.848 . . . . 73.230000000000004 109.951 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . 0.714 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 3.0 p-10 -35.6 -51.98 0.66 Allowed 'General case' 0 C--O 1.178 -2.659 0 N-CA-C 115.51 1.67 . . . . 61.43 115.51 -174.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' B' ' 107' ' ' ILE . 19.0 tt0 -129.36 40.52 3.59 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 117.794 -1.562 . . . . 75.299999999999997 110.323 -178.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 47.6 p -75.63 -173.54 2.21 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.573 -1.194 . . . . 72.530000000000001 111.445 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.58 136.14 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 O-C-N 122.098 -0.376 . . . . 73.5 110.4 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -138.23 128.5 25.99 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 122.992 0.517 . . . . 74.239999999999995 109.924 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 50.17 32.45 6.02 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 124.998 1.319 . . . . 64.230000000000004 112.689 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.11 2.74 60.65 Favored Glycine 0 C--N 1.315 -0.617 0 CA-C-N 114.771 -1.104 . . . . 60.219999999999999 114.756 173.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -134.16 158.64 43.14 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 118.002 0.901 . . . . 72.340000000000003 111.169 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 68.4 m -85.47 119.85 26.27 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.338 -0.616 . . . . 54.340000000000003 109.338 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' B' ' 99' ' ' GLU . 42.1 pt -102.86 172.2 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 109.648 -0.501 . . . . 73.099999999999994 109.648 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . 0.714 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 0.1 OUTLIER -131.18 132.06 44.46 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.618 -1.253 . . . . 65.109999999999999 107.618 -179.654 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 21.2 t -121.67 130.82 74.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 108.099 -1.074 . . . . 74.450000000000003 108.099 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 90.1 mt -136.49 162.68 54.82 Favored Pre-proline 0 C--O 1.19 -2.046 0 N-CA-C 108.871 -0.789 . . . . 70.219999999999999 108.871 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -73.77 147.53 39.86 Favored 'Trans proline' 0 CA--C 1.564 1.98 0 C-N-CA 122.733 2.289 . . . . 70.319999999999993 110.564 173.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.721 ' HE2' ' CD1' ' B' ' 82' ' ' TYR . 0.0 OUTLIER -157.61 -173.21 4.28 Favored 'General case' 0 CA--C 1.56 1.331 0 N-CA-C 109.633 -0.506 . . . . 70.310000000000002 109.633 -172.372 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.519 ' H ' ' HD2' ' B' ' 112' ' ' LYS . 0.3 OUTLIER -153.24 127.96 9.46 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.541 0.736 . . . . 71.040000000000006 110.653 175.575 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 47.8 m -111.04 -83.28 0.57 Allowed 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 118.532 -1.267 . . . . 73.120000000000005 111.361 176.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' ASN . . . . . 0.46 ' HA ' HD13 ' B' ' 34' ' ' ILE . 34.0 m-20 179.68 -164.84 0.06 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.704 1.202 . . . . 71.430000000000007 110.456 -176.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' MET . . . . . 0.422 ' H ' ' HB3' ' B' ' 115' ' ' ASN . 23.1 ptm -153.44 157.26 32.81 Favored Pre-proline 0 N--CA 1.441 -0.891 0 N-CA-C 106.099 -1.815 . . . . 71.219999999999999 106.099 174.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -92.77 -162.62 0.1 Allowed 'Trans proline' 0 N--CA 1.439 -1.689 0 C-N-CA 122.178 1.919 . . . . 54.119999999999997 114.099 -173.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -162.4 -164.87 18.35 Favored Glycine 0 N--CA 1.423 -2.227 0 N-CA-C 107.515 -2.234 . . . . 74.310000000000002 107.515 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 11.1 tt -64.1 107.56 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.87 0 CA-C-O 122.168 0.985 . . . . 60.509999999999998 112.363 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 36.1 p -93.27 118.53 31.38 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.694 -1.139 . . . . 63.329999999999998 108.493 176.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 5.4 p -69.76 106.44 3.11 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 113.231 0.826 . . . . 74.099999999999994 113.231 -177.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 9.7 t -142.46 28.14 1.67 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 106.276 -1.75 . . . . 54.140000000000001 106.276 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -69.45 156.36 38.98 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 113.647 -1.615 . . . . 74.109999999999999 111.531 -176.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 . . . . . 0 C--N 1.304 -1.371 0 N-CA-C 108.268 -1.012 . . . . 73.329999999999998 108.268 179.409 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.835 0 N-CA-C 109.286 -0.635 . . . . 73.510000000000005 109.286 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.459 HD13 ' O ' ' A' ' 2' ' ' ILE . 2.3 pp -120.05 129.33 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 112.919 0.711 . . . . 64.129999999999995 112.919 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.71 92.23 31.4 Favored Pre-proline 0 C--N 1.302 -1.478 0 CA-C-N 115.476 -0.784 . . . . 53.420000000000002 109.64 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.85 113.82 3.51 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.671 2.247 . . . . 75.129999999999995 110.953 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.6 p -90.72 103.09 15.83 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 110.275 -0.269 . . . . 62.43 110.275 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.2 ttt -168.79 144.64 3.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.001 0.429 . . . . 72.349999999999994 110.779 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -144.9 152.31 40.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.754 -1.572 . . . . 70.310000000000002 106.754 176.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.488 ' HA ' ' OE1' ' A' ' 99' ' ' GLU . 15.1 t -146.71 142.85 28.26 Favored 'General case' 0 N--CA 1.422 -1.841 0 C-N-CA 118.399 -1.321 . . . . 70.219999999999999 113.858 -177.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.1 p -140.49 -176.62 4.7 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 126.799 2.04 . . . . 62.200000000000003 106.642 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -149.26 112.64 4.98 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 118.479 0.581 . . . . 74.120000000000005 110.875 175.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.6 p -89.57 -89.93 0.15 Allowed 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 116.0 -0.545 . . . . 71.450000000000003 112.201 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -164.16 155.14 15.57 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.771 -0.455 . . . . 70.400000000000006 109.771 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -132.8 95.14 3.52 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.956 -0.757 . . . . 60.119999999999997 108.956 177.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.2 m -154.38 140.43 18.36 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.327 -0.397 . . . . 73.230000000000004 112.053 -173.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 72.4 -175.57 0.17 Allowed 'General case' 0 C--O 1.262 1.736 0 N-CA-C 115.798 1.777 . . . . 61.200000000000003 115.798 167.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.62 115.62 3.11 Favored Glycine 0 N--CA 1.422 -2.252 0 CA-C-N 113.883 -1.508 . . . . 62.119999999999997 111.753 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' B' ' 19' ' ' THR . . . -87.81 -174.71 4.86 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.013 -0.736 . . . . 73.400000000000006 109.013 175.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.443 ' HE2' ' NH1' ' A' ' 65' ' ' ARG . 69.7 t80 -148.89 126.69 11.82 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 120.643 -0.423 . . . . 74.329999999999998 110.74 -175.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.6 m -102.82 154.42 19.21 Favored 'General case' 0 CA--C 1.56 1.356 0 CA-C-N 115.99 -0.55 . . . . 71.349999999999994 110.087 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -130.69 -72.27 0.57 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 120.85 0.357 . . . . 74.409999999999997 110.041 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.5 ' HA3' ' OH ' ' B' ' 82' ' ' TYR . . . 118.62 -141.69 16.27 Favored Glycine 0 N--CA 1.469 0.891 0 CA-C-N 116.379 -0.373 . . . . 54.240000000000002 112.528 177.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.522 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 62.3 Cg_exo -51.9 -43.08 54.36 Favored 'Trans proline' 0 CA--C 1.567 2.149 0 C-N-CA 124.306 3.337 . . . . 51.549999999999997 116.579 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 22' ' ' PRO . 2.4 Cg_endo -43.13 142.36 2.49 Favored 'Trans proline' 0 C--N 1.404 3.458 0 C-N-CA 123.689 2.926 . . . . 73.409999999999997 113.607 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -53.77 134.52 56.07 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 115.831 -0.622 . . . . 74.239999999999995 111.107 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.87 -176.04 2.8 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 122.722 2.281 . . . . 75.150000000000006 113.322 -175.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.03 166.12 26.25 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 114.568 -1.196 . . . . 71.019999999999996 109.732 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.431 ' HB3' ' OE1' ' A' ' 30' ' ' GLU . 23.3 t -82.56 164.22 20.99 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 120.681 0.277 . . . . 73.5 111.584 -172.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.714 ' O ' ' HG2' ' A' ' 32' ' ' LYS . . . -48.75 -46.71 41.57 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 115.56 -0.745 . . . . 73.329999999999998 112.226 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.435 ' HA ' ' CG ' ' A' ' 32' ' ' LYS . 17.0 mm-40 -63.62 -32.88 74.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.793 0.664 . . . . 72.340000000000003 112.793 -178.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.535 ' O ' HG12 ' A' ' 34' ' ' ILE . 1.9 mp0 -63.88 -37.74 88.5 Favored 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 120.683 -0.407 . . . . 61.32 110.202 173.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -68.12 -44.76 75.41 Favored 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 124.003 0.814 . . . . 74.209999999999994 109.403 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.714 ' HG2' ' O ' ' A' ' 28' ' ' ALA . 29.3 mmmt -53.69 -48.27 69.68 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 123.197 0.599 . . . . 63.32 109.97 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 18.6 mt-10 -72.29 -42.1 65.89 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 113.786 1.032 . . . . 74.230000000000004 113.786 -175.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 30' ' ' GLU . 23.1 pt -69.33 -33.99 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.771 0.319 . . . . 75.340000000000003 111.457 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -62.32 -38.54 89.85 Favored 'General case' 0 C--O 1.203 -1.387 0 CA-C-N 115.611 -0.722 . . . . 72.219999999999999 111.521 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -70.35 -16.1 62.94 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 120.521 0.201 . . . . 63.329999999999998 111.17 -175.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.448 ' HA ' ' CG1' ' A' ' 91' ' ' VAL . 3.9 ptp180 -113.39 16.65 18.87 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 112.384 0.513 . . . . 74.030000000000001 112.384 -173.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.442 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 43.9 t -99.9 159.67 14.9 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-O 121.535 0.683 . . . . 65.299999999999997 111.607 177.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.456 ' CG1' HG21 ' A' ' 91' ' ' VAL . 5.5 m -139.7 164.12 24.16 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.942 0 C-N-CA 124.492 1.117 . . . . 73.340000000000003 110.686 176.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.664 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 16.4 t80 -118.9 128.39 54.38 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 125.236 1.415 . . . . 74.409999999999997 108.009 178.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 60.8 t -116.58 116.7 53.06 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 107.929 -1.137 . . . . 71.209999999999994 107.929 178.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.08 176.47 17.09 Favored Glycine 0 C--N 1.294 -1.771 0 C-N-CA 119.831 -1.176 . . . . 72.329999999999998 113.567 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.43 ' ND2' ' HD3' ' A' ' 105' ' ' ARG . 7.1 t30 68.51 8.52 6.73 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.759 1.624 . . . . 72.019999999999996 113.405 177.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.4 p -91.15 104.45 15.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.634 0.731 . . . . 73.329999999999998 109.766 176.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -116.79 102.98 9.87 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 106.985 -1.487 . . . . 75.120000000000005 106.985 -172.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 49.26 -175.78 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.594 1.331 . . . . 64.510000000000005 114.594 -172.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.69 -56.78 5.04 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.868 -0.682 . . . . 45.520000000000003 111.96 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.6 m -86.14 143.56 27.96 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 121.107 0.479 . . . . 61.100000000000001 110.071 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 61.7 p -114.79 178.82 4.14 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.199 -0.667 . . . . 74.030000000000001 109.199 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.428 ' HB1' HD13 ' A' ' 66' ' ' ILE . . . -58.91 -43.24 91.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.163 0.506 . . . . 64.230000000000004 109.777 178.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -56.96 -44.93 83.09 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 115.304 -0.862 . . . . 65.299999999999997 111.814 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -61.12 -42.49 98.64 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.513 0.673 . . . . 72.109999999999999 110.57 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.4 mt -69.89 -47.36 62.83 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 114.755 -1.111 . . . . 74.5 111.623 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.464 ' HB2' ' OH ' ' B' ' 46' ' ' TYR . 21.5 tt0 -59.15 -50.6 73.42 Favored 'General case' 0 C--O 1.194 -1.836 0 C-N-CA 121.108 -0.237 . . . . 72.239999999999995 111.486 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.32 79.67 Favored 'General case' 0 C--O 1.265 1.878 0 CA-C-O 121.763 0.792 . . . . 74.299999999999997 110.999 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -67.31 -38.45 84.99 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.209 -1.36 . . . . 71.129999999999995 110.107 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . 0.278 46.5 m-85 -82.48 -21.14 35.67 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 114.516 1.302 . . . . 64.239999999999995 114.516 177.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 71.4 m -64.81 -28.81 69.82 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 109.523 -0.547 . . . . 75.420000000000002 109.523 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.8 m -58.48 -25.23 62.09 Favored 'General case' 0 CA--C 1.56 1.351 0 CA-C-N 115.815 -0.63 . . . . 74.329999999999998 110.09 173.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 61.1 m -107.63 3.24 24.58 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 112.859 0.689 . . . . 71.329999999999998 112.859 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 58' ' ' SER . . . 173.51 177.54 42.81 Favored Glycine 0 N--CA 1.466 0.683 0 C-N-CA 118.551 -1.785 . . . . 38.159999999999997 115.159 -177.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.8 m -78.25 -61.09 2.11 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 122.389 0.276 . . . . 74.0 111.159 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 85' ' ' PHE 0.264 56.2 mt 99.85 117.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 126.11 1.764 . . . . 61.32 113.261 175.729 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.458 ' ND2' ' HA ' ' A' ' 86' ' ' ALA . 80.2 m-20 -98.59 -39.18 8.83 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 115.275 -0.875 . . . . 73.120000000000005 111.692 177.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.443 ' NH1' ' HE2' ' A' ' 18' ' ' TYR . 96.6 mtt180 -151.45 159.52 44.16 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.816 -0.809 . . . . 75.530000000000001 108.816 -177.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.428 HD13 ' HB1' ' A' ' 50' ' ' ALA . 17.1 pt -148.32 144.48 18.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.073 -1.455 . . . . 75.540000000000006 107.073 171.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.553 ' OG1' ' HB2' ' A' ' 82' ' ' TYR . 43.0 p -123.49 138.74 54.51 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 106.018 -1.845 . . . . 63.43 106.018 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.461 HD12 ' O ' ' B' ' 68' ' ' ILE . 2.9 mp -129.89 116.4 37.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 106.371 -1.714 . . . . 74.310000000000002 106.371 175.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -120.55 125.66 48.38 Favored 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 120.078 -0.649 . . . . 53.439999999999998 111.037 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 82.9 m -115.61 133.55 55.93 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.19 -0.67 . . . . 75.400000000000006 109.19 -177.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -119.07 127.97 53.89 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 118.63 -1.228 . . . . 74.109999999999999 110.513 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -121.32 12.14 10.88 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.549 -0.908 . . . . 75.439999999999998 108.549 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -62.64 -22.04 66.13 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.273 0.471 . . . . 72.430000000000007 112.273 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.5 t -90.72 5.11 49.51 Favored 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 115.98 -0.554 . . . . 73.430000000000007 110.668 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.48 -56.25 0.48 Allowed Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.702 -0.761 . . . . 54.420000000000002 111.977 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -96.26 136.48 21.98 Favored Pre-proline 0 C--N 1.304 -1.394 0 N-CA-C 110.149 -0.315 . . . . 74.400000000000006 110.149 176.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -79.54 119.0 3.98 Favored 'Trans proline' 0 N--CA 1.441 -1.593 0 C-N-CA 121.774 1.649 . . . . 71.209999999999994 113.051 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -105.34 -163.82 0.98 Allowed 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.785 -1.098 . . . . 64.349999999999994 108.742 175.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.64 162.56 25.72 Favored Glycine 0 N--CA 1.412 -2.936 0 C-N-CA 119.591 -1.29 . . . . 73.239999999999995 114.453 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -158.53 153.91 25.84 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 113.641 -1.279 . . . . 75.049999999999997 108.988 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.92 152.95 50.79 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 120.386 0.136 . . . . 43.229999999999997 111.106 -173.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.553 ' HB2' ' OG1' ' A' ' 67' ' ' THR . 27.0 m-85 -118.22 130.05 55.85 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.572 -0.529 . . . . 74.450000000000003 109.572 174.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 32.8 mm -111.4 112.49 40.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 109.086 -0.709 . . . . 75.239999999999995 109.086 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.418 ' HG3' ' CB ' ' A' ' 38' ' ' SER . 4.1 mp0 -94.84 120.24 34.74 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.147 0.499 . . . . 65.230000000000004 110.943 176.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 99.1 m-85 -92.78 164.12 13.47 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.791 -0.448 . . . . 74.239999999999995 109.791 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.458 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . . . -85.02 -17.97 35.86 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.111 0.482 . . . . 63.100000000000001 109.969 174.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.428 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 0.7 OUTLIER -117.24 141.85 47.78 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 115.407 -0.815 . . . . 72.0 111.171 -178.313 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -75.57 -29.39 59.33 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 108.362 -0.977 . . . . 71.109999999999999 108.362 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -67.71 -24.79 65.43 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.76 -0.587 . . . . 74.319999999999993 110.713 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.428 ' OG ' ' HB2' ' A' ' 87' ' ' GLU . 20.1 m -71.69 -37.1 70.74 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 112.092 0.404 . . . . 74.140000000000001 112.092 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.456 HG21 ' CG1' ' A' ' 39' ' ' VAL . 0.2 OUTLIER -65.87 -38.46 82.21 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 C-N-CA 120.095 -0.642 . . . . 72.109999999999999 109.507 173.871 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.434 ' O ' HG21 ' A' ' 95' ' ' VAL . 19.7 t70 -59.08 -37.59 77.46 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.291 0.567 . . . . 65.099999999999994 110.239 175.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.52 -31.76 63.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.101 -0.499 . . . . 72.519999999999996 111.429 177.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.34 -41.17 49.22 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.117 -0.492 . . . . 71.109999999999999 111.161 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 92' ' ' ASP . 30.9 m -60.95 -21.99 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 112.716 0.636 . . . . 65.430000000000007 112.716 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.13 -10.92 60.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.525 0.678 . . . . 40.329999999999998 110.455 176.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 8.8 ttp -111.37 8.2 21.22 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.978 -1.119 . . . . 75.510000000000005 107.978 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.572 ' HB2' ' O ' ' A' ' 109' ' ' VAL . 0.5 OUTLIER -44.31 -44.15 7.91 Favored 'General case' 0 CA--C 1.473 -1.982 0 N-CA-C 114.431 1.271 . . . . 60.409999999999997 114.431 -176.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.488 ' OE1' ' HA ' ' A' ' 8' ' ' THR . 34.6 tt0 -122.89 98.66 6.01 Favored 'General case' 0 N--CA 1.389 -3.481 0 CA-C-O 122.511 1.148 . . . . 70.219999999999999 110.061 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 106' ' ' THR . 19.7 p -140.02 173.25 11.71 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 113.187 -1.824 . . . . 73.400000000000006 111.122 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.0 p -111.51 112.58 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.804 0 CA-C-O 122.316 1.055 . . . . 73.150000000000006 110.036 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -121.48 126.55 49.52 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.355 -1.293 . . . . 74.420000000000002 107.643 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.7 ttt-85 58.81 33.15 22.87 Favored 'General case' 0 CA--C 1.558 1.259 0 CA-C-O 122.054 0.93 . . . . 75.299999999999997 109.759 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.47 1.56 86.5 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.3 -0.864 . . . . 72.439999999999998 113.898 178.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.43 ' HD3' ' ND2' ' A' ' 43' ' ' ASN . 13.1 ptp180 -126.13 153.7 44.19 Favored 'General case' 0 C--N 1.314 -0.974 0 O-C-N 122.25 -0.559 . . . . 74.319999999999993 110.289 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 100' ' ' THR . 27.2 m -79.75 119.74 23.07 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.447 -0.575 . . . . 62.240000000000002 109.447 -178.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 pp -102.82 159.0 4.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 C-N-CA 119.601 -0.839 . . . . 72.230000000000004 109.815 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 57.7 tptt -123.56 129.89 51.86 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.321 -0.622 . . . . 65.239999999999995 109.321 -170.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.664 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 21.7 t -118.53 128.13 75.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 108.728 -0.842 . . . . 62.130000000000003 108.728 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.5 mt -125.51 141.36 38.77 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 108.999 -0.741 . . . . 74.319999999999993 108.999 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.07 136.96 18.88 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.546 1.497 . . . . 72.340000000000003 111.811 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.465 ' HZ1' ' HB2' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -97.72 120.19 37.66 Favored 'General case' 0 C--N 1.276 -2.59 0 N-CA-C 104.075 -2.565 . . . . 73.340000000000003 104.075 170.564 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 166.69 -37.86 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.279 -1.748 . . . . 73.209999999999994 106.279 -174.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 23.3 p -91.54 99.79 12.66 Favored 'General case' 0 N--CA 1.405 -2.677 0 CA-C-N 114.225 -1.352 . . . . 63.219999999999999 110.567 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -81.52 -24.42 36.66 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.18 -1.415 . . . . 65.239999999999995 107.18 176.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 66.6 mtt -142.01 147.15 43.35 Favored Pre-proline 0 N--CA 1.441 -0.886 0 N-CA-C 106.114 -1.81 . . . . 73.040000000000006 106.114 174.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.52 139.17 52.64 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 122.154 1.903 . . . . 74.420000000000002 112.418 -177.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 85.57 -68.74 3.37 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.042 -0.599 . . . . 42.25 111.932 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 11.2 tt -137.91 143.32 33.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.361 -0.977 . . . . 63.539999999999999 108.361 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 54.0 m -120.07 103.02 8.94 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 121.272 0.558 . . . . 73.25 111.864 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.9 m -107.2 108.52 19.99 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 106.761 -1.57 . . . . 72.310000000000002 106.761 173.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 44.9 m -64.19 143.8 57.61 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 123.243 0.617 . . . . 73.519999999999996 111.28 -175.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -62.82 129.15 39.2 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.79 0.805 . . . . 74.519999999999996 112.58 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 . . . . . 0 C--N 1.298 -1.653 0 CA-C-N 114.27 -1.332 . . . . 74.329999999999998 110.854 -178.833 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.801 0 CA-C-O 121.35 0.595 . . . . 61.009999999999998 110.272 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 49.0 mm -107.5 121.95 61.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 115.599 -0.728 . . . . 73.510000000000005 109.484 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.88 114.7 55.73 Favored Pre-proline 0 C--N 1.31 -1.145 0 N-CA-C 109.295 -0.631 . . . . 63.5 109.295 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.19 109.42 1.54 Allowed 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.804 2.336 . . . . 72.340000000000003 112.593 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 26.3 p -154.13 134.9 13.68 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.347 -0.983 . . . . 54.100000000000001 108.347 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -95.68 96.19 8.84 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.873 -0.331 . . . . 71.019999999999996 110.287 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -81.3 76.09 8.24 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 122.136 0.969 . . . . 74.540000000000006 110.238 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 6.9 t -168.7 83.74 0.16 Allowed 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 113.579 -1.646 . . . . 72.150000000000006 107.388 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 24.0 p -100.51 169.03 9.35 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.81 -1.086 . . . . 75.420000000000002 111.263 -176.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 175.93 -176.6 0.12 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 105.606 -1.998 . . . . 72.549999999999997 105.606 -177.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 32.8 m -61.23 160.48 10.39 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 108.949 -0.76 . . . . 72.219999999999999 108.949 172.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -60.23 104.13 0.29 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 113.745 1.017 . . . . 74.219999999999999 113.745 -176.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -110.33 75.84 0.95 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.812 0.815 . . . . 64.140000000000001 109.939 169.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 91.5 m -107.1 112.21 25.01 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.82 -1.082 . . . . 61.549999999999997 109.667 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.79 159.74 33.03 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.294 -1.002 . . . . 50.310000000000002 108.294 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.15 -44.95 6.43 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 110.851 -0.9 . . . . 38.159999999999997 110.851 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.85 97.96 7.72 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.693 -0.854 . . . . 73.120000000000005 108.693 177.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -52.51 -24.67 8.51 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 115.267 1.58 . . . . 74.409999999999997 115.267 -177.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 12.3 t -172.83 -13.29 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.067 0.46 . . . . 64.230000000000004 110.243 178.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -56.67 -52.54 64.51 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.06 0.944 . . . . 73.319999999999993 112.098 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.452 ' HA3' ' OH ' ' A' ' 82' ' ' TYR . . . 104.29 -119.8 6.41 Favored Glycine 0 CA--C 1.504 -0.628 0 C-N-CA 120.214 -0.993 . . . . 63.200000000000003 113.291 175.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.428 ' N ' ' HD2' ' B' ' 23' ' ' PRO . 54.1 Cg_exo -52.35 -44.44 46.65 Favored 'Trans proline' 0 CA--C 1.565 2.027 0 C-N-CA 123.792 2.995 . . . . 72.010000000000005 115.508 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' B' ' 22' ' ' PRO . 11.3 Cg_endo -53.78 146.72 44.01 Favored 'Trans proline' 0 C--N 1.389 2.696 0 C-N-CA 121.757 1.638 . . . . 70.030000000000001 112.349 177.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 15.3 pm0 -70.37 150.36 95.79 Favored Pre-proline 0 C--N 1.303 -1.436 0 CA-C-N 115.172 -0.922 . . . . 75.019999999999996 111.012 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.23 119.31 6.31 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.569 2.179 . . . . 71.030000000000001 112.144 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.446 ' H ' HD13 ' B' ' 26' ' ' LEU . 0.0 OUTLIER -77.03 168.5 19.98 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.168 -0.924 . . . . 64.400000000000006 110.69 176.271 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.607 ' HB3' ' OE1' ' B' ' 30' ' ' GLU . 47.4 t -68.12 147.06 52.84 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.612 0.967 . . . . 63.229999999999997 113.612 -173.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.712 ' O ' ' HG2' ' B' ' 32' ' ' LYS . . . -48.22 -46.22 35.01 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-N 114.001 -1.454 . . . . 64.140000000000001 111.949 177.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.411 ' HA ' ' CG ' ' B' ' 32' ' ' LYS . 69.9 mm-40 -63.65 -36.2 83.05 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.996 0.739 . . . . 74.219999999999999 112.996 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.607 ' OE1' ' HB3' ' B' ' 27' ' ' SER . 2.0 mp0 -63.12 -35.84 81.62 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.467 -0.493 . . . . 74.049999999999997 110.127 173.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -68.03 -43.59 78.39 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.032 -0.531 . . . . 75.150000000000006 109.581 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.712 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 28.9 mmmt -55.03 -47.36 74.84 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.628 0.771 . . . . 64.439999999999998 110.329 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -70.33 -46.28 64.49 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.341 -0.845 . . . . 54.219999999999999 111.745 -175.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.413 HG12 ' O ' ' B' ' 30' ' ' GLU . 17.1 pt -69.72 -35.02 63.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.927 0.394 . . . . 74.420000000000002 111.569 -175.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.87 -44.36 96.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.768 -0.651 . . . . 74.540000000000006 111.825 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' B' ' 32' ' ' LYS . 12.3 ptpt -68.47 -10.64 56.78 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 112.48 0.548 . . . . 62.200000000000003 112.48 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.428 ' HD3' ' O ' ' B' ' 86' ' ' ALA . 92.3 mtt180 -107.3 9.51 29.97 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.966 0.412 . . . . 73.200000000000003 110.871 -176.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' SER . . . . . 0.463 ' OG ' ' HG2' ' B' ' 84' ' ' GLU . 24.3 m -103.01 162.39 12.97 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 114.226 1.195 . . . . 74.430000000000007 114.226 -175.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.439 HG23 ' O ' ' B' ' 83' ' ' ILE . 12.1 m -141.22 164.45 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.551 1.14 . . . . 75.239999999999995 111.907 176.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . 0.571 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 17.6 t80 -119.11 130.96 55.85 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 126.109 1.764 . . . . 74.340000000000003 107.999 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.422 HG21 ' CE2' ' B' ' 57' ' ' PHE . 58.1 t -119.42 117.58 54.48 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 C-N-CA 123.945 0.898 . . . . 64.430000000000007 108.81 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.77 166.13 14.78 Favored Glycine 0 C--N 1.293 -1.806 0 C-N-CA 120.205 -0.998 . . . . 63.539999999999999 111.961 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 60.3 t30 66.29 20.36 11.03 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.738 1.615 . . . . 73.239999999999995 113.152 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 11.3 p -64.32 133.33 29.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 O-C-N 121.544 -0.723 . . . . 75.0 109.651 177.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.469 ' HB3' ' HG ' ' B' ' 48' ' ' SER . 21.7 t70 -72.43 141.34 48.65 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 108.294 -1.002 . . . . 74.519999999999996 108.294 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' TYR . . . . . 0.464 ' OH ' ' HB2' ' A' ' 54' ' ' GLU . 4.6 t80 -56.92 -28.15 61.73 Favored 'General case' 0 CA--C 1.551 0.996 0 O-C-N 124.187 0.929 . . . . 71.400000000000006 109.754 -178.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.33 0.77 81.51 Favored Glycine 0 N--CA 1.427 -1.924 0 CA-C-N 115.787 -0.642 . . . . 65.109999999999999 113.366 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.469 ' HG ' ' HB3' ' B' ' 45' ' ' ASP . 18.6 m -78.99 135.33 36.88 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 107.781 -1.192 . . . . 71.549999999999997 107.781 176.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 63.6 p -94.38 169.97 9.83 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 119.115 -1.034 . . . . 71.540000000000006 110.457 -176.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.509 ' HB1' HD13 ' B' ' 66' ' ' ILE . . . -60.47 -38.61 84.79 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.506 -0.924 . . . . 72.310000000000002 108.506 174.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -57.26 -46.68 82.82 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.191 -0.913 . . . . 51.530000000000001 111.242 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -58.55 -47.49 84.06 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.669 0.747 . . . . 43.399999999999999 110.183 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 66.2 mt -64.88 -48.03 75.69 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.645 -1.162 . . . . 71.329999999999998 112.344 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -59.7 -50.71 72.79 Favored 'General case' 0 C--O 1.206 -1.231 0 N-CA-C 111.656 0.243 . . . . 73.219999999999999 111.656 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.53 -45.42 81.15 Favored 'General case' 0 C--O 1.269 2.106 0 CA-C-O 121.631 0.729 . . . . 70.239999999999995 111.127 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -66.78 -39.21 87.73 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.457 -1.247 . . . . 63.310000000000002 109.942 -174.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' B' ' 41' ' ' VAL 0.259 46.4 m-85 -82.09 -21.47 36.77 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 114.617 1.339 . . . . 75.109999999999999 114.617 177.235 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 68.2 m -64.57 -28.03 69.36 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.166 0.508 . . . . 72.329999999999998 109.784 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 18.8 m -58.42 -28.94 65.7 Favored 'General case' 0 CA--C 1.557 1.248 0 CA-C-N 115.892 -0.595 . . . . 74.239999999999995 110.837 173.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 82.2 m -95.89 3.17 53.83 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 113.616 0.969 . . . . 61.329999999999998 113.616 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.9 -169.67 27.27 Favored Glycine 0 N--CA 1.464 0.515 0 C-N-CA 118.662 -1.733 . . . . 52.149999999999999 115.244 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 27.1 m -93.73 127.88 39.67 Favored 'General case' 0 C--O 1.216 -0.68 0 C-N-CA 123.391 0.677 . . . . 71.319999999999993 110.372 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 85.5 mt -97.88 132.04 43.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 124.023 0.929 . . . . 72.040000000000006 113.284 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . 0.481 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 75.5 m-20 -100.03 -38.69 8.47 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.84 0.856 . . . . 72.239999999999995 112.304 176.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -151.76 160.36 43.61 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.096 -0.705 . . . . 71.310000000000002 109.096 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.509 HD13 ' HB1' ' B' ' 50' ' ' ALA . 20.1 pt -148.52 144.52 18.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.094 -1.447 . . . . 75.230000000000004 107.094 172.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' THR . . . . . 0.566 ' OG1' ' HB2' ' B' ' 82' ' ' TYR . 43.4 p -123.98 139.7 53.7 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 105.936 -1.876 . . . . 64.120000000000005 105.936 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.461 ' O ' HD12 ' A' ' 68' ' ' ILE . 2.4 mp -130.61 118.41 42.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 106.009 -1.848 . . . . 64.019999999999996 106.009 175.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.293 1.0 OUTLIER -121.39 125.56 47.24 Favored 'General case' 0 C--N 1.28 -2.44 0 C-N-CA 120.348 -0.541 . . . . 74.129999999999995 111.977 177.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 68.7 m -116.53 133.5 55.94 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.198 -0.667 . . . . 63.219999999999999 109.198 -176.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -122.52 133.82 54.57 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 118.701 -1.2 . . . . 74.040000000000006 111.426 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -116.74 17.36 15.2 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.551 -1.648 . . . . 75.200000000000003 106.551 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -44.64 -35.03 2.41 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.811 2.044 . . . . 74.319999999999993 112.847 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 39.9 m -115.24 26.29 10.21 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 111.773 0.286 . . . . 74.409999999999997 111.773 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.27 -60.22 0.49 Allowed Glycine 0 C--O 1.236 0.276 0 C-N-CA 120.617 -0.802 . . . . 64.209999999999994 114.054 175.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -84.78 141.91 38.81 Favored Pre-proline 0 C--N 1.31 -1.147 0 N-CA-C 110.176 -0.305 . . . . 73.530000000000001 110.176 -177.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -78.88 118.04 4.03 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 121.177 1.251 . . . . 74.040000000000006 111.854 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -112.43 -166.47 1.08 Allowed 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 109.207 -0.664 . . . . 75.439999999999998 109.207 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 171.58 159.41 17.74 Favored Glycine 0 N--CA 1.414 -2.768 0 C-N-CA 119.652 -1.261 . . . . 63.25 114.16 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -154.64 152.14 29.62 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 125.06 1.344 . . . . 70.530000000000001 109.091 176.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.08 153.93 51.17 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 122.001 0.121 . . . . 72.430000000000007 110.982 -173.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' TYR . . . . . 0.566 ' HB2' ' OG1' ' B' ' 67' ' ' THR . 30.8 m-85 -119.95 127.0 52.26 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 110.047 -0.353 . . . . 75.450000000000003 110.047 174.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.439 ' O ' HG23 ' B' ' 39' ' ' VAL . 23.8 mm -107.97 118.74 56.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 107.497 -1.297 . . . . 64.109999999999999 107.497 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' GLU . . . . . 0.463 ' HG2' ' OG ' ' B' ' 38' ' ' SER . 61.6 mt-10 -105.73 119.63 39.64 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.249 0.547 . . . . 71.150000000000006 110.235 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -95.81 162.0 13.78 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.671 -0.695 . . . . 71.5 112.285 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.481 ' HA ' ' ND2' ' B' ' 64' ' ' ASN . . . -79.03 -32.04 44.86 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.771 -1.104 . . . . 72.239999999999995 111.168 175.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.39 146.4 34.5 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 120.06 -0.656 . . . . 65.549999999999997 110.26 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -74.69 -26.67 59.99 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 108.015 -1.105 . . . . 73.430000000000007 108.015 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -72.51 -20.28 61.39 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 119.723 -0.791 . . . . 71.200000000000003 111.625 177.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 21.9 m -69.46 -37.35 77.28 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 110.505 -0.183 . . . . 62.399999999999999 110.505 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . 0.438 HG21 ' CG1' ' B' ' 39' ' ' VAL . 0.2 OUTLIER -67.08 -39.05 82.43 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 C-N-CA 120.427 -0.509 . . . . 61.200000000000003 109.905 175.173 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.93 -37.08 75.88 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.213 0.53 . . . . 74.140000000000001 110.716 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.42 -31.41 62.3 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.033 -0.53 . . . . 62.149999999999999 111.173 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.73 -43.02 48.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.197 -0.456 . . . . 63.539999999999999 111.167 -178.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 33.6 m -57.11 -22.24 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 112.724 0.638 . . . . 73.340000000000003 112.724 177.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.4 -15.74 63.85 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.219 0.533 . . . . 71.200000000000003 110.515 176.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 11.2 mtm -98.71 15.64 24.63 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.654 0.782 . . . . 75.209999999999994 111.436 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 6.0 t70 -33.85 -52.25 0.42 Allowed 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 114.807 1.41 . . . . 75.549999999999997 114.807 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -123.91 64.42 1.05 Allowed 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 118.778 -1.169 . . . . 71.430000000000007 111.182 174.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 10.8 t -97.72 -177.63 3.85 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.772 -1.104 . . . . 65.430000000000007 110.087 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 9.7 p -108.6 134.5 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 CA-C-O 121.254 0.55 . . . . 51.030000000000001 109.652 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -130.31 115.83 17.48 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.073 -0.714 . . . . 73.510000000000005 109.073 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 40.0 mtp-105 49.98 32.24 5.49 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.471 1.508 . . . . 75.230000000000004 112.23 -178.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.66 -6.32 62.7 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.502 -0.772 . . . . 73.310000000000002 112.879 175.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.437 ' HD3' ' HB2' ' B' ' 45' ' ' ASP . 30.2 mtp180 -110.14 133.56 53.09 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.808 -0.442 . . . . 71.310000000000002 109.808 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 14.4 m -75.57 120.51 21.08 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.044 -1.095 . . . . 72.239999999999995 108.044 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 41.6 pt -103.13 172.08 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-O 121.475 0.655 . . . . 74.219999999999999 112.262 -178.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 57.6 tptt -125.93 126.44 44.37 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.667 -1.151 . . . . 74.430000000000007 107.97 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 48.5 t -117.71 122.06 68.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.904 -0.776 . . . . 74.030000000000001 108.904 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . 0.436 ' HB2' ' HB3' ' B' ' 40' ' ' TYR . 95.8 mt -121.53 145.19 42.12 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 108.918 -0.771 . . . . 70.120000000000005 108.918 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.55 130.84 13.07 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.857 1.705 . . . . 75.219999999999999 109.66 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.452 ' HB3' ' HB2' ' B' ' 38' ' ' SER . 25.7 ttpp -86.11 135.93 33.42 Favored 'General case' 0 CA--C 1.5 -0.981 0 C-N-CA 119.981 -0.688 . . . . 64.120000000000005 112.368 -178.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -139.18 136.28 34.89 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 106.635 -1.617 . . . . 73.340000000000003 106.635 171.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 14.9 t -73.95 -175.66 2.23 Favored 'General case' 0 N--CA 1.413 -2.299 0 CA-C-O 122.192 0.996 . . . . 74.209999999999994 110.607 -176.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -143.28 135.63 27.2 Favored 'General case' 0 N--CA 1.394 -3.275 0 N-CA-C 108.132 -1.062 . . . . 62.219999999999999 108.132 -174.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 46.3 ttm -156.17 105.12 2.06 Favored Pre-proline 0 N--CA 1.428 -1.548 0 N-CA-C 109.318 -0.623 . . . . 75.299999999999997 109.318 -176.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.7 164.21 16.61 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.434 2.089 . . . . 61.32 110.46 175.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.14 57.03 4.63 Favored Glycine 0 C--N 1.313 -0.742 0 C-N-CA 120.777 -0.725 . . . . 61.299999999999997 113.01 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . 0.301 2.0 pp 49.39 178.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 126.876 2.071 . . . . 75.120000000000005 115.839 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 49.4 m -134.22 119.84 19.28 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.186 -1.042 . . . . 71.219999999999999 108.186 175.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 36.5 t -163.45 128.92 3.08 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 108.713 -0.847 . . . . 74.5 108.713 -177.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 86.7 m -143.3 101.02 3.73 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.622 -0.881 . . . . 61.32 108.622 175.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -81.39 144.46 31.42 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.927 -1.138 . . . . 72.510000000000005 107.927 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . 0.536 ' C ' ' HE ' ' B' ' 124' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.374 0 N-CA-C 107.66 -1.237 . . . . 73.019999999999996 107.66 -174.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.497 0 CA-C-O 121.131 0.491 . . . . 71.349999999999994 110.838 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.7 mm -83.26 112.69 21.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 115.852 -0.613 . . . . 74.230000000000004 109.738 178.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.87 125.82 6.39 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 108.365 -0.976 . . . . 72.319999999999993 108.365 178.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -66.95 103.96 0.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 121.828 1.685 . . . . 51.210000000000001 111.236 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 46.0 t -90.97 105.99 18.21 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.469 -0.567 . . . . 73.540000000000006 109.469 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 65.2 mtt -136.13 146.45 46.95 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.94 -0.573 . . . . 72.120000000000005 109.61 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -77.45 101.18 6.29 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.47 -0.567 . . . . 75.129999999999995 109.47 176.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.9 p -78.83 98.27 6.26 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 115.315 -0.857 . . . . 64.209999999999994 111.265 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -164.15 94.85 0.75 Allowed 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 115.195 -0.911 . . . . 62.439999999999998 109.191 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -93.23 131.84 37.96 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.94 -0.573 . . . . 73.409999999999997 110.137 -177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.0 t -60.97 109.03 0.96 Allowed 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 108.497 -0.927 . . . . 71.530000000000001 108.497 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -127.18 112.72 15.46 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.472 -1.307 . . . . 63.340000000000003 107.472 -177.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.8 ptp -126.71 142.43 51.54 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.782 -0.644 . . . . 73.430000000000007 111.558 -175.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.2 m -148.0 151.62 36.07 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.003 -1.48 . . . . 73.200000000000003 107.003 -178.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.21 86.76 6.16 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 119.991 -0.683 . . . . 63.310000000000002 109.566 175.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.43 68.89 3.38 Favored Glycine 0 CA--C 1.497 -1.038 0 N-CA-C 111.039 -0.825 . . . . 63.32 111.039 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.74 -162.73 1.33 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.913 -0.773 . . . . 70.120000000000005 108.913 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 65.39 84.81 0.15 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.946 0.899 . . . . 73.010000000000005 111.7 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.0 m 149.22 -72.82 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 129.851 3.26 . . . . 72.340000000000003 105.464 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 44.4 -175.66 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.699 1.6 . . . . 75.400000000000006 114.469 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.617 ' HA2' ' CE1' ' B' ' 40' ' ' TYR . . . 116.49 -149.91 18.68 Favored Glycine 0 N--CA 1.402 -3.577 0 N-CA-C 106.846 -2.502 . . . . 61.420000000000002 106.846 177.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.629 ' HA ' ' OH ' ' B' ' 82' ' ' TYR . 56.7 Cg_exo -50.26 -34.36 39.86 Favored 'Trans proline' 0 CA--C 1.601 3.849 0 C-N-CA 122.479 2.119 . . . . 71.409999999999997 115.264 171.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -106.8 170.01 0.12 Allowed 'Trans proline' 0 C--N 1.375 1.93 0 N-CA-C 117.35 2.019 . . . . 71.450000000000003 117.35 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.501 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 21.8 mm-40 -109.44 120.78 44.37 Favored Pre-proline 0 N--CA 1.418 -2.028 0 CA-C-N 112.26 -2.245 . . . . 74.239999999999995 106.781 177.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.14 123.07 8.55 Favored 'Trans proline' 0 C--O 1.244 0.821 0 C-N-CA 122.622 2.215 . . . . 73.239999999999995 112.229 -177.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 24' ' ' GLN . 0.4 OUTLIER -160.5 175.31 12.88 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 114.515 -1.22 . . . . 72.409999999999997 112.708 -174.361 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.3 t -89.73 156.35 18.59 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.36 -0.836 . . . . 71.420000000000002 110.167 178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.41 ' O ' ' HE2' ' A' ' 32' ' ' LYS . . . -51.76 -44.32 63.29 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 112.609 0.596 . . . . 74.319999999999993 112.609 177.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -64.65 -30.19 71.21 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 112.104 0.409 . . . . 75.319999999999993 112.104 178.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -64.81 -34.22 77.85 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.498 -1.297 . . . . 73.5 107.498 176.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.448 ' HA ' HG12 ' A' ' 34' ' ' ILE . 95.7 mttt -69.83 -50.55 41.7 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.05 -0.977 . . . . 72.439999999999998 110.766 -174.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.491 ' HE2' ' N ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -57.2 -39.5 75.54 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 119.889 -0.725 . . . . 73.219999999999999 111.75 -178.49 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -72.58 -40.42 66.61 Favored 'General case' 0 N--CA 1.415 -2.196 0 C-N-CA 119.203 -0.999 . . . . 72.140000000000001 112.74 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.448 HG12 ' HA ' ' A' ' 31' ' ' LYS . 15.8 pt -65.94 -34.33 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 120.46 -0.496 . . . . 71.319999999999993 110.827 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -61.16 -42.6 98.85 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.779 -0.823 . . . . 72.129999999999995 108.779 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -78.64 -26.79 45.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.363 -0.835 . . . . 72.25 112.386 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.422 HH21 HG23 ' A' ' 34' ' ' ILE . 89.3 mtm180 -89.71 12.96 15.46 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 123.068 0.547 . . . . 64.349999999999994 111.943 -177.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.3 t -96.64 145.21 25.96 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.277 0.561 . . . . 75.329999999999998 111.403 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.485 ' CG1' ' HB ' ' A' ' 91' ' ' VAL . 28.3 m -128.17 160.02 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.764 0 CA-C-N 115.839 -0.619 . . . . 72.209999999999994 110.487 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.582 ' CZ ' ' HG3' ' B' ' 22' ' ' PRO . 15.1 t80 -110.4 121.21 44.75 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 107.692 -1.225 . . . . 73.230000000000004 107.692 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.718 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 66.6 t -121.55 108.8 23.1 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 N-CA-C 107.404 -1.332 . . . . 71.319999999999993 107.404 173.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.18 172.03 17.42 Favored Glycine 0 C--N 1.284 -2.359 0 C-N-CA 118.813 -1.661 . . . . 64.439999999999998 112.825 -176.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.3 t30 61.64 34.1 17.79 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 124.269 1.028 . . . . 71.450000000000003 110.421 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.486 ' HA ' ' NH1' ' A' ' 105' ' ' ARG . 7.4 p -90.89 14.11 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.706 0 CA-C-N 115.03 -0.986 . . . . 64.420000000000002 111.231 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -36.62 112.27 0.18 Allowed 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 127.929 2.492 . . . . 70.219999999999999 114.69 -177.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . 0.524 32.1 m-85 50.11 -43.91 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.846 1 N-CA-C 122.467 4.247 . . . . 74.329999999999998 122.467 173.418 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.84 0.18 46.49 Favored Glycine 0 C--N 1.306 -1.108 0 CA-C-N 119.145 0.884 . . . . 38.299999999999997 113.32 -175.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.481 ' OG ' ' HE2' ' A' ' 102' ' ' PHE . 49.6 m -129.48 137.31 50.76 Favored 'General case' 0 N--CA 1.409 -2.497 0 O-C-N 122.45 -0.441 . . . . 64.140000000000001 110.046 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 47.1 p -125.25 179.34 5.12 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.238 -1.023 . . . . 64.310000000000002 108.238 -176.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.96 -49.77 76.38 Favored 'General case' 0 C--O 1.207 -1.159 0 CA-C-N 118.349 0.522 . . . . 63.200000000000003 111.134 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -58.26 -41.12 83.54 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.888 0.699 . . . . 63.299999999999997 112.888 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -62.93 -44.64 95.52 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.941 0.877 . . . . 63.310000000000002 110.1 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.4 mt -73.0 -46.72 50.59 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.497 -1.229 . . . . 73.239999999999995 112.482 -175.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.507 ' HG3' ' OH ' ' B' ' 46' ' ' TYR . 6.1 tm-20 -57.48 -48.68 78.57 Favored 'General case' 0 C--O 1.196 -1.711 0 C-N-CA 122.804 0.442 . . . . 74.349999999999994 110.441 -176.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.22 -42.73 77.74 Favored 'General case' 0 C--O 1.267 2.008 0 CA-C-O 121.724 0.773 . . . . 43.020000000000003 110.747 176.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -68.08 -43.59 78.22 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.248 -0.887 . . . . 74.25 111.335 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.544 ' CD2' HG12 ' A' ' 83' ' ' ILE . 65.9 m-85 -80.15 -22.98 41.44 Favored 'General case' 0 C--O 1.225 -0.218 0 O-C-N 121.91 -0.494 . . . . 73.010000000000005 111.435 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.9 t -69.46 -24.14 63.76 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.9 -0.778 . . . . 43.350000000000001 108.9 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.8 m -63.27 -22.57 66.96 Favored 'General case' 0 CA--C 1.568 1.641 0 CA-C-N 116.121 -0.49 . . . . 55.109999999999999 110.78 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 78.7 m -97.03 7.43 46.67 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.821 0.674 . . . . 74.25 112.821 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 142.97 -161.79 27.52 Favored Glycine 0 C--O 1.221 -0.682 0 C-N-CA 119.45 -1.357 . . . . 65.239999999999995 113.838 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.3 m -99.26 129.81 45.51 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.404 -0.591 . . . . 73.450000000000003 109.404 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.4 HD12 ' HB2' ' A' ' 57' ' ' PHE . 72.0 mt -85.23 133.3 29.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 113.084 0.772 . . . . 73.5 113.084 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.483 ' OD1' ' HG3' ' A' ' 65' ' ' ARG . 24.1 t-20 -94.7 -48.19 6.17 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.865 1.266 . . . . 74.340000000000003 108.234 178.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.483 ' HG3' ' OD1' ' A' ' 64' ' ' ASN . 98.9 mtt180 -148.57 158.84 44.4 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.506 -0.77 . . . . 72.530000000000001 109.003 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.5 tt -149.31 127.6 2.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 C-N-CA 123.198 0.599 . . . . 63.119999999999997 110.138 173.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.2 m -125.08 133.65 52.81 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.627 -1.249 . . . . 63.409999999999997 107.627 -173.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.471 HD11 ' O ' ' B' ' 68' ' ' ILE . 2.0 mp -131.03 120.6 47.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 106.646 -1.613 . . . . 63.439999999999998 106.646 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.401 HD23 ' O ' ' A' ' 80' ' ' TYR . 1.6 pt? -120.63 134.33 55.29 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.871 -0.332 . . . . 72.010000000000005 110.14 178.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 80.8 m -116.58 126.51 53.38 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.642 -0.873 . . . . 73.239999999999995 108.642 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.558 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 4.3 p30 -105.29 126.6 52.29 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.403 -0.519 . . . . 73.540000000000006 111.108 -177.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -119.47 2.53 11.25 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 112.62 0.6 . . . . 61.229999999999997 112.62 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.648 ' HB3' ' OD1' ' B' ' 64' ' ' ASN . 41.8 p90 -56.96 -27.67 61.49 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 113.924 1.083 . . . . 74.140000000000001 113.924 -176.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.0 t -97.24 10.87 38.31 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.259 0.552 . . . . 64.400000000000006 110.191 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.35 -55.78 0.55 Allowed Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 121.072 -0.585 . . . . 42.409999999999997 112.677 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.3 m80 -95.5 125.56 49.12 Favored Pre-proline 0 C--N 1.308 -1.237 0 C-N-CA 120.964 -0.294 . . . . 75.219999999999999 110.946 -177.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.558 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 26.5 Cg_endo -67.88 119.59 6.59 Favored 'Trans proline' 0 C--O 1.247 0.94 0 C-N-CA 122.829 2.353 . . . . 71.450000000000003 112.744 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.45 ' HB2' ' OD2' ' A' ' 71' ' ' ASP . 28.1 mtmm -113.21 -160.37 0.72 Allowed 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.796 -1.187 . . . . 72.140000000000001 107.796 172.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 179.04 153.15 11.23 Favored Glycine 0 N--CA 1.423 -2.225 0 C-N-CA 119.145 -1.502 . . . . 63.219999999999999 114.786 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.416 ' HH ' ' HG2' ' B' ' 23' ' ' PRO . 24.9 m-85 -136.22 153.31 51.26 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.628 -1.99 . . . . 71.510000000000005 105.628 174.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.64 131.19 42.99 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.588 -0.893 . . . . 72.150000000000006 108.588 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -115.39 120.45 39.63 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.594 -1.261 . . . . 72.340000000000003 107.594 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.544 HG12 ' CD2' ' A' ' 57' ' ' PHE . 1.1 mp -113.76 129.05 70.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 108.894 -0.78 . . . . 72.120000000000005 108.894 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -99.6 124.43 44.79 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.2 -1.408 . . . . 74.239999999999995 107.2 174.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -94.03 155.93 16.86 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 121.248 -0.181 . . . . 74.230000000000004 110.628 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.29 -32.05 72.78 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.427 -0.352 . . . . 43.439999999999998 111.427 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.86 148.34 44.17 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.777 -0.769 . . . . 74.109999999999999 110.163 175.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -70.76 -27.09 63.67 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.319 -0.855 . . . . 75.239999999999995 109.608 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -62.49 -33.91 75.81 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.921 -0.582 . . . . 71.230000000000004 110.521 174.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.5 m -66.75 -35.94 81.28 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 116.048 -0.524 . . . . 55.439999999999998 110.902 -177.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.493 ' O ' HG11 ' A' ' 95' ' ' VAL . 1.5 m -68.95 -37.69 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 108.435 -0.95 . . . . 72.340000000000003 108.435 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.629 ' O ' HG21 ' A' ' 95' ' ' VAL . 9.9 t70 -68.02 -30.52 69.77 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.722 0.772 . . . . 64.329999999999998 109.499 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.01 -31.24 64.36 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.667 -0.697 . . . . 73.310000000000002 110.088 175.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.85 -36.17 59.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.889 -0.596 . . . . 53.329999999999998 111.453 -177.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.629 HG21 ' O ' ' A' ' 92' ' ' ASP . 11.2 m -53.86 -21.63 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 112.597 0.592 . . . . 74.140000000000001 112.597 178.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.75 -12.2 44.6 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.304 0.573 . . . . 64.219999999999999 110.991 177.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.562 ' HA ' ' OG1' ' A' ' 100' ' ' THR . 68.0 mtm -100.43 5.43 44.25 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 116.1 -0.5 . . . . 64.319999999999993 111.092 178.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.479 ' HA ' ' H ' ' A' ' 109' ' ' VAL . 0.4 OUTLIER -48.4 -49.02 36.53 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.569 1.322 . . . . 74.349999999999994 114.569 -177.171 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -101.97 12.82 36.29 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-O 121.887 0.851 . . . . 72.230000000000004 110.539 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.562 ' OG1' ' HA ' ' A' ' 97' ' ' MET . 62.9 m -72.24 151.93 42.53 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.917 -0.583 . . . . 74.299999999999997 109.984 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -101.56 134.34 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 N-CA-C 108.559 -0.904 . . . . 73.519999999999996 108.559 -177.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.481 ' HE2' ' OG ' ' A' ' 48' ' ' SER . 82.6 t80 -130.12 118.81 22.05 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 115.654 -0.703 . . . . 74.349999999999994 109.17 -173.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 54.55 32.06 16.18 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.717 1.006 . . . . 64.019999999999996 113.717 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.71 -5.47 73.33 Favored Glycine 0 N--CA 1.461 0.352 0 CA-C-N 115.227 -0.897 . . . . 64.150000000000006 113.406 174.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.486 ' NH1' ' HA ' ' A' ' 44' ' ' VAL . 21.9 ptt85 -121.52 145.49 47.9 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 122.846 0.458 . . . . 74.430000000000007 110.301 178.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.2 m -82.61 122.24 27.86 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.545 -0.909 . . . . 64.439999999999998 108.545 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 41.3 pt -101.44 171.52 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 N-CA-C 108.44 -0.948 . . . . 75.430000000000007 108.44 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.718 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 22.9 mmmt -121.91 128.23 51.32 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 109.685 -0.487 . . . . 71.150000000000006 109.685 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.479 ' H ' ' HA ' ' A' ' 98' ' ' ASP . 60.5 t -117.48 112.16 37.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 105.127 -2.175 . . . . 62.520000000000003 105.127 173.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 tt -140.41 129.97 13.38 Favored Pre-proline 0 C--N 1.274 -2.681 0 N-CA-C 105.146 -2.168 . . . . 75.310000000000002 105.146 -172.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -55.12 136.81 74.81 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 121.584 1.523 . . . . 72.409999999999997 109.736 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.25 24.2 ttpp -79.33 65.68 4.57 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 122.615 1.197 . . . . 71.430000000000007 112.204 -178.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.432 ' C ' ' H ' ' A' ' 115' ' ' ASN . 34.8 mmt180 35.51 -99.31 0.02 OUTLIER 'General case' 0 C--O 1.246 0.887 0 CA-C-N 111.543 -2.571 . . . . 75.219999999999999 115.512 -178.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 62.2 m 71.01 -47.4 0.66 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.943 1.697 . . . . 73.019999999999996 109.272 -175.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.432 ' H ' ' C ' ' A' ' 113' ' ' ARG . 27.7 t-20 -75.72 104.4 6.26 Favored 'General case' 0 N--CA 1.418 -2.03 0 C-N-CA 125.651 1.58 . . . . 61.049999999999997 109.299 175.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.461 ' HA ' ' HE1' ' A' ' 116' ' ' MET . 1.5 mmt -115.65 161.38 30.63 Favored Pre-proline 0 C--N 1.291 -1.968 0 N-CA-C 108.629 -0.878 . . . . 62.520000000000003 108.629 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.18 -15.85 46.92 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.755 2.303 . . . . 71.530000000000001 111.88 177.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -133.32 177.77 18.72 Favored Glycine 0 N--CA 1.437 -1.25 0 N-CA-C 109.442 -1.463 . . . . 62.229999999999997 109.442 176.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 27.3 pt -91.99 106.78 18.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 117.646 0.723 . . . . 74.209999999999994 110.533 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.2 t -89.76 127.2 35.92 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.6 -0.727 . . . . 63.549999999999997 109.681 -177.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 39.6 p -101.11 98.16 8.62 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.496 -0.32 . . . . 73.120000000000005 110.222 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.6 m -81.76 120.71 25.49 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.536 -0.542 . . . . 71.409999999999997 109.536 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.4 t70 64.57 92.7 0.07 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.851 0.861 . . . . 73.409999999999997 112.345 -178.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 . . . . . 0 C--N 1.306 -1.29 0 CA-C-N 115.262 -0.881 . . . . 62.340000000000003 109.659 -178.867 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.726 0 CA-C-O 120.618 0.247 . . . . 75.519999999999996 110.342 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 64.3 mt -92.97 110.74 23.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 107.895 -1.15 . . . . 72.209999999999994 107.895 177.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.37 134.9 33.54 Favored Pre-proline 0 C--N 1.298 -1.662 0 CA-C-N 115.88 -0.6 . . . . 74.510000000000005 110.515 -176.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.37 101.68 0.44 Allowed 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 122.156 1.904 . . . . 74.140000000000001 110.419 176.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 61.0 m -85.01 172.89 10.95 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.447 -0.797 . . . . 75.409999999999997 109.606 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -76.36 -178.24 4.49 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.719 -0.474 . . . . 71.409999999999997 109.719 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -80.09 85.76 5.62 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 119.883 -0.727 . . . . 73.209999999999994 111.927 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 95.4 m -97.54 102.06 13.74 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 107.503 -1.295 . . . . 73.099999999999994 107.503 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.535 ' HA ' ' NH2' ' B' ' 113' ' ' ARG . 12.6 t -143.04 164.77 29.2 Favored 'General case' 0 N--CA 1.407 -2.594 0 C-N-CA 119.946 -0.702 . . . . 65.299999999999997 111.312 -176.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -136.2 22.09 3.23 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.978 -1.49 . . . . 71.5 106.978 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 79.1 p -80.2 171.59 14.88 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.317 -0.856 . . . . 74.340000000000003 112.723 -176.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 58.5 tttm 175.38 168.83 0.33 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 102.648 -3.093 . . . . 73.409999999999997 102.648 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 64.3 mtt -67.97 93.04 0.4 Allowed 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 120.029 1.286 . . . . 64.310000000000002 108.484 172.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 14.5 p -112.15 171.5 7.47 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 114.492 -1.231 . . . . 71.239999999999995 109.425 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -126.91 100.38 6.13 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 113.449 0.907 . . . . 72.409999999999997 113.449 -175.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.448 ' HA3' ' OD1' ' B' ' 35' ' ' ASP . . . -76.42 -42.23 23.25 Favored Glycine 0 CA--C 1.491 -1.431 0 N-CA-C 106.53 -2.628 . . . . 61.310000000000002 106.53 169.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.6 85.28 5.65 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 106.749 -1.574 . . . . 65.129999999999995 106.749 169.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -69.58 170.18 11.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.827 -1.079 . . . . 72.310000000000002 108.975 -175.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 49.2 p -68.73 81.83 0.28 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.589 0.709 . . . . 75.129999999999995 109.439 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . 0.554 ' O ' ' HD2' ' B' ' 22' ' ' PRO . 27.7 tt0 -70.29 -24.87 63.11 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 113.925 -1.489 . . . . 72.310000000000002 110.782 -177.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.52 -106.03 2.98 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.768 -0.651 . . . . 71.200000000000003 113.417 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.582 ' HG3' ' CZ ' ' A' ' 40' ' ' TYR . 0.9 OUTLIER -40.54 -57.27 1.3 Allowed 'Trans proline' 0 CA--C 1.573 2.47 0 C-N-CA 124.797 3.665 . . . . 71.030000000000001 116.192 -178.794 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.531 ' HG2' ' OE2' ' B' ' 20' ' ' GLU . 4.8 Cg_exo -83.95 165.61 13.31 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 121.95 1.767 . . . . 64.400000000000006 110.734 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -103.91 145.38 30.53 Favored Pre-proline 0 C--N 1.283 -2.31 0 N-CA-C 109.382 -0.599 . . . . 65.010000000000005 109.382 176.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -46.78 127.6 12.23 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.266 2.644 . . . . 43.539999999999999 113.841 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.559 ' H ' HD13 ' B' ' 26' ' ' LEU . 0.0 OUTLIER -61.61 -167.97 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 114.47 -1.241 . . . . 65.540000000000006 113.837 178.754 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.56 ' O ' ' HG3' ' B' ' 31' ' ' LYS . 47.0 t -54.19 143.51 22.56 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.765 0.793 . . . . 52.439999999999998 112.583 -176.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.477 ' O ' ' HE2' ' B' ' 32' ' ' LYS . . . -60.89 -43.74 98.06 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.16 -1.382 . . . . 72.430000000000007 111.709 178.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -66.92 -33.02 74.68 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 111.715 0.265 . . . . 52.329999999999998 111.715 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.453 ' HB3' HD23 ' B' ' 26' ' ' LEU . 10.8 tp10 -62.64 -34.89 77.97 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 107.631 -1.248 . . . . 52.039999999999999 107.631 177.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' B' ' 27' ' ' SER . 92.6 mttt -70.07 -50.43 41.11 Favored 'General case' 0 C--O 1.203 -1.359 0 CA-C-N 115.341 -0.845 . . . . 72.319999999999993 111.101 -174.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.477 ' HE2' ' O ' ' B' ' 28' ' ' ALA . 0.2 OUTLIER -57.66 -37.42 73.36 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 120.106 -0.637 . . . . 72.150000000000006 112.062 -177.455 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.687 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 7.1 mm-40 -71.14 -47.41 58.04 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.074 -0.512 . . . . 72.030000000000001 110.635 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.469 HG12 ' HA ' ' B' ' 31' ' ' LYS . 21.4 pt -64.83 -34.65 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 122.975 0.172 . . . . 63.149999999999999 111.211 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.579 ' HB3' ' O ' ' B' ' 114' ' ' THR . 67.8 m-20 -60.63 -42.66 97.33 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-O 121.183 0.516 . . . . 74.349999999999994 109.807 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.418 ' O ' ' HD3' ' B' ' 88' ' ' ARG . 98.4 mttt -78.38 -25.87 46.38 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.153 0.798 . . . . 75.310000000000002 113.153 -176.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.687 ' HG2' ' O ' ' B' ' 33' ' ' GLU . 14.7 ptp180 -108.29 31.96 5.17 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.704 0.764 . . . . 74.540000000000006 112.2 -174.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' SER . . . . . 0.412 ' HB3' ' O ' ' B' ' 112' ' ' LYS . 35.2 t -95.55 155.78 16.6 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.092 -1.447 . . . . 75.519999999999996 107.092 172.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.5 ' CG1' ' HB ' ' B' ' 91' ' ' VAL . 26.8 m -135.49 158.39 40.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.931 -0.48 . . . . 75.319999999999993 110.11 176.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . 0.617 ' CE1' ' HA2' ' A' ' 21' ' ' GLY . 22.1 t80 -107.73 119.82 40.51 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 107.354 -1.35 . . . . 71.549999999999997 107.354 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 67.3 t -122.0 107.57 20.14 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 N-CA-C 106.806 -1.553 . . . . 61.420000000000002 106.806 173.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.86 171.49 19.99 Favored Glycine 0 C--N 1.276 -2.802 0 C-N-CA 118.29 -1.909 . . . . 75.420000000000002 112.712 -176.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.6 t30 66.57 28.66 9.26 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.289 1.436 . . . . 72.329999999999998 112.208 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 14.7 p -58.49 134.5 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-O 121.412 0.625 . . . . 71.25 109.862 175.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -73.69 146.32 44.57 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.479 -0.782 . . . . 73.219999999999999 109.547 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' TYR . . . . . 0.507 ' OH ' ' HG3' ' A' ' 54' ' ' GLU . 45.8 t80 -61.71 -19.24 62.17 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.794 0.838 . . . . 72.420000000000002 110.93 -176.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.32 -0.53 55.75 Favored Glycine 0 N--CA 1.427 -1.924 0 CA-C-N 116.01 -0.541 . . . . 73.010000000000005 112.551 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 34.0 m -84.64 133.36 34.41 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.895 -0.78 . . . . 74.420000000000002 108.895 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 62.0 p -113.02 178.73 4.18 Favored 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 119.74 -0.784 . . . . 75.340000000000003 111.132 -177.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.8 -43.36 99.01 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.741 -0.663 . . . . 53.409999999999997 110.984 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -58.62 -43.13 89.58 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 111.724 0.268 . . . . 74.349999999999994 111.724 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -60.34 -47.93 83.93 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.912 0.863 . . . . 71.319999999999993 109.614 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 69.4 mt -68.73 -47.32 66.61 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-N 114.271 -1.331 . . . . 74.439999999999998 112.816 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -57.34 -48.85 77.92 Favored 'General case' 0 C--O 1.205 -1.284 0 C-N-CA 122.872 0.469 . . . . 64.200000000000003 110.569 -176.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.34 -42.72 78.2 Favored 'General case' 0 C--O 1.258 1.522 0 CA-C-O 121.286 0.565 . . . . 70.239999999999995 110.631 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -69.1 -42.03 76.67 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.363 -0.835 . . . . 73.200000000000003 111.201 -176.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.516 ' CD2' HG13 ' B' ' 83' ' ' ILE . 66.2 m-85 -80.52 -23.17 40.23 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.454 -0.499 . . . . 72.230000000000004 111.114 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 32.9 t -71.37 -24.54 62.1 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.435 -0.58 . . . . 75.450000000000003 109.435 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 23.8 m -63.95 -27.01 68.85 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.1 0.476 . . . . 71.099999999999994 110.005 176.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 63.5 m -97.43 7.51 46.38 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.574 0.583 . . . . 74.329999999999998 112.574 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.09 -165.18 29.78 Favored Glycine 0 CA--C 1.507 -0.461 0 C-N-CA 118.169 -1.967 . . . . 74.319999999999993 115.783 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 14.7 m -98.18 123.99 42.53 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.862 -0.669 . . . . 72.310000000000002 109.442 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 61.9 mt -88.72 131.83 35.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 113.223 0.823 . . . . 73.540000000000006 113.223 -178.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . 0.648 ' OD1' ' HB3' ' A' ' 73' ' ' PHE . 18.8 t-20 -99.73 -45.25 5.82 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 124.5 1.12 . . . . 54.520000000000003 109.955 177.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.431 ' HB2' ' HB2' ' B' ' 84' ' ' GLU . 98.3 mtt180 -147.46 158.47 43.99 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.181 -0.674 . . . . 70.219999999999999 109.181 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.467 HD11 HG21 ' B' ' 66' ' ' ILE . 0.8 OUTLIER -148.93 127.49 3.19 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 C-N-CA 123.658 0.783 . . . . 65.219999999999999 109.972 174.006 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 38.6 m -125.93 133.21 51.92 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.065 -0.971 . . . . 72.519999999999996 108.61 -175.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.471 ' O ' HD11 ' A' ' 68' ' ' ILE . 1.2 mp -129.9 122.34 54.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 106.353 -1.721 . . . . 75.329999999999998 106.353 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.407 HD23 ' N ' ' B' ' 69' ' ' LEU . 1.7 pt? -121.71 135.25 54.95 Favored 'General case' 0 C--N 1.287 -2.151 0 C-N-CA 120.6 -0.44 . . . . 62.299999999999997 110.468 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 64.5 m -115.87 127.08 54.74 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.03 -1.1 . . . . 72.140000000000001 108.03 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . 0.45 ' HB3' ' NE2' ' A' ' 24' ' ' GLN . 3.7 p30 -107.8 127.52 53.78 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.258 -0.645 . . . . 72.450000000000003 109.258 -177.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . 0.449 ' HE3' ' HB3' ' B' ' 77' ' ' PRO . 44.9 mtpt -124.1 10.88 8.81 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 120.732 -0.387 . . . . 63.210000000000001 110.015 -178.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -61.51 -22.7 65.34 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 113.893 1.072 . . . . 74.409999999999997 113.893 -177.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 19.8 m -97.81 14.08 28.25 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.025 0.44 . . . . 62.219999999999999 109.99 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.22 -44.37 3.09 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 111.275 -0.73 . . . . 75.299999999999997 111.275 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -91.37 125.62 57.44 Favored Pre-proline 0 CA--C 1.505 -0.762 0 N-CA-C 110.011 -0.366 . . . . 70.109999999999999 110.011 178.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.449 ' HB3' ' HE3' ' B' ' 72' ' ' LYS . 69.3 Cg_endo -76.57 119.55 5.24 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.905 2.404 . . . . 70.439999999999998 112.843 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' LYS . . . . . 0.421 ' HB2' ' OD2' ' B' ' 71' ' ' ASP . 24.6 mtmm -118.77 -160.82 0.81 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.094 -1.076 . . . . 70.329999999999998 108.094 175.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 178.79 158.26 20.95 Favored Glycine 0 N--CA 1.416 -2.698 0 C-N-CA 119.193 -1.48 . . . . 62.310000000000002 114.226 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -136.17 153.95 51.1 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 105.784 -1.932 . . . . 73.010000000000005 105.784 173.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.37 130.33 40.57 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 109.935 -0.394 . . . . 73.010000000000005 109.935 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' TYR . . . . . 0.629 ' OH ' ' HA ' ' A' ' 22' ' ' PRO . 64.0 m-85 -114.03 122.39 46.77 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.912 -1.144 . . . . 72.150000000000006 107.912 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.516 HG13 ' CD2' ' B' ' 57' ' ' PHE . 4.6 mm -114.03 129.38 70.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.106 -1.072 . . . . 74.019999999999996 108.106 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' B' ' 65' ' ' ARG . 1.3 mp0 -99.48 120.74 40.11 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.54 -1.281 . . . . 74.319999999999993 107.54 173.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -88.9 152.8 21.52 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 108.515 -0.92 . . . . 71.340000000000003 108.515 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.63 -24.23 64.53 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 110.239 -0.282 . . . . 71.430000000000007 110.239 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -120.91 147.09 45.9 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.924 -0.58 . . . . 73.109999999999999 110.675 -178.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.418 ' HD3' ' O ' ' B' ' 36' ' ' LYS . 0.0 OUTLIER -72.59 -34.14 67.21 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.0 -0.741 . . . . 73.430000000000007 109.0 177.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -59.46 -35.26 73.71 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.204 -0.907 . . . . 75.150000000000006 110.465 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 30.8 m -65.78 -36.26 83.02 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.931 -0.577 . . . . 72.25 110.555 -178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . 0.509 ' O ' HG11 ' B' ' 95' ' ' VAL . 1.4 m -69.12 -37.46 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 108.906 -0.775 . . . . 73.519999999999996 108.906 -178.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . 0.651 ' O ' HG21 ' B' ' 95' ' ' VAL . 7.2 t70 -68.49 -31.05 70.04 Favored 'General case' 0 C--O 1.215 -0.763 0 CA-C-O 121.67 0.748 . . . . 65.329999999999998 109.066 -178.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.99 -31.15 64.32 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.842 -0.617 . . . . 73.209999999999994 109.868 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.32 -35.55 61.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.796 -0.638 . . . . 73.510000000000005 111.481 -178.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . 0.651 HG21 ' O ' ' B' ' 92' ' ' ASP . 10.4 m -54.31 -21.18 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 112.582 0.586 . . . . 70.310000000000002 112.582 178.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.57 -13.97 61.73 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.213 0.53 . . . . 43.409999999999997 110.835 177.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 67.1 mtm -96.9 12.98 30.37 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 116.263 -0.426 . . . . 44.350000000000001 110.627 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -35.41 -58.36 0.58 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.283 1.033 . . . . 63.409999999999997 113.082 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -112.02 98.95 7.7 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 118.553 -1.259 . . . . 63.039999999999999 109.14 170.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 75.4 m -139.44 150.85 45.71 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.526 -1.215 . . . . 74.439999999999998 109.941 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.05 122.59 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-O 121.481 0.657 . . . . 74.319999999999993 110.302 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -120.36 124.89 46.64 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.736 -0.839 . . . . 74.219999999999999 108.736 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 61.0 ttt-85 47.9 31.5 2.36 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 125.566 1.546 . . . . 71.030000000000001 112.044 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 100.4 -6.36 57.67 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 115.666 -0.697 . . . . 38.299999999999997 114.35 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -121.91 150.97 41.23 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 117.838 0.819 . . . . 73.099999999999994 111.304 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 30.0 m -82.07 121.58 26.74 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 116.431 -0.35 . . . . 74.329999999999998 110.232 -176.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 45.8 pt -101.2 170.66 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 120.577 -0.449 . . . . 60.25 110.151 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . 0.595 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 46.7 tptt -128.81 121.61 28.69 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.955 -1.128 . . . . 72.109999999999999 107.955 -176.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 95.6 t -115.19 114.42 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 N-CA-C 107.374 -1.343 . . . . 72.310000000000002 107.374 -178.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 3.6 tt -138.83 131.12 15.67 Favored Pre-proline 0 C--N 1.292 -1.925 0 N-CA-C 105.938 -1.875 . . . . 71.040000000000006 105.938 -173.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -53.57 133.51 53.95 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.871 1.714 . . . . 74.030000000000001 112.888 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' B' ' 38' ' ' SER . 45.1 tttm -109.94 103.6 12.39 Favored 'General case' 0 N--CA 1.389 -3.485 0 N-CA-C 106.495 -1.668 . . . . 65.329999999999998 106.495 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.535 ' NH2' ' HA ' ' B' ' 9' ' ' THR 0.358 3.4 ppt_? -115.57 98.68 6.85 Favored 'General case' 0 N--CA 1.409 -2.498 0 C-N-CA 117.57 -1.652 . . . . 72.420000000000002 108.825 -177.223 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' THR . . . . . 0.579 ' O ' ' HB3' ' B' ' 35' ' ' ASP . 23.4 m -80.29 161.72 24.95 Favored 'General case' 0 C--N 1.27 -2.853 0 CA-C-N 112.275 -2.238 . . . . 74.129999999999995 108.378 -173.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -161.11 107.67 1.43 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.63 -0.428 . . . . 72.109999999999999 109.95 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 47.4 ttm -104.11 104.21 42.46 Favored Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 109.214 -0.662 . . . . 64.25 109.214 176.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -81.63 103.71 1.4 Allowed 'Trans proline' 0 N--CA 1.442 -1.556 0 C-N-CA 121.792 1.661 . . . . 73.010000000000005 109.556 175.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -151.32 60.62 0.41 Allowed Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 119.768 -1.205 . . . . 63.340000000000003 113.24 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 32.8 pt -88.6 150.26 3.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 109.12 -0.696 . . . . 71.239999999999995 109.12 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 47.7 m -76.63 107.41 8.91 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.195 0.521 . . . . 73.420000000000002 109.878 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 23.7 p -106.09 150.82 25.42 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 108.603 -0.888 . . . . 74.209999999999994 108.603 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 9.0 t -66.15 140.24 58.19 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.11 0.481 . . . . 73.329999999999998 109.888 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -85.38 116.86 23.95 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.215 -0.661 . . . . 54.310000000000002 109.215 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 . . . . . 0 C--N 1.301 -1.508 0 N-CA-C 108.484 -0.932 . . . . 75.329999999999998 108.484 -179.59 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.104 0 CA-C-O 120.65 0.262 . . . . 70.329999999999998 110.949 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.9 pt -94.58 110.75 24.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.589 0.709 . . . . 75.439999999999998 111.27 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.81 136.18 15.1 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 108.395 -0.965 . . . . 75.420000000000002 108.395 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -61.98 109.21 0.76 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.359 2.039 . . . . 70.400000000000006 111.126 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.2 p -119.3 10.59 12.01 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.637 0.732 . . . . 73.530000000000001 109.737 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.14 153.74 18.24 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 115.374 -0.83 . . . . 72.010000000000005 110.396 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -133.47 106.29 7.38 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 105.058 -2.201 . . . . 65.329999999999998 105.058 174.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 79.9 p 71.53 111.95 0.06 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.155 1.782 . . . . 63.409999999999997 110.796 -171.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.4 m -58.89 133.5 56.09 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.055 -0.521 . . . . 70.099999999999994 111.299 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -80.58 128.44 33.61 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.618 -0.882 . . . . 74.420000000000002 108.618 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.4 t -74.3 166.85 22.76 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-O 120.877 0.37 . . . . 73.540000000000006 111.7 -176.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp 67.74 -70.97 0.11 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.499 1.52 . . . . 74.140000000000001 111.238 -175.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 27.4 ttt -125.44 120.75 31.88 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.43 -1.322 . . . . 74.150000000000006 107.43 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.0 p -78.93 -29.36 44.1 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 112.772 0.656 . . . . 62.439999999999998 112.772 -173.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -126.94 -167.24 1.7 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.204 0.526 . . . . 52.439999999999998 111.166 -176.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 165.37 -143.65 8.63 Favored Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 107.546 -2.222 . . . . 74.420000000000002 107.546 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.489 ' HA ' ' CZ ' ' A' ' 65' ' ' ARG . . . 72.88 151.36 0.11 Allowed 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.528 0.936 . . . . 51.039999999999999 113.528 174.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.63 ' CD1' ' HG2' ' A' ' 117' ' ' PRO . 55.7 m-85 -94.27 -163.85 1.1 Allowed 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 105.878 -1.897 . . . . 74.299999999999997 105.878 175.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.591 ' OG1' ' HA ' ' A' ' 25' ' ' PRO . 34.6 m -111.15 75.3 0.91 Allowed 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 107.717 -1.216 . . . . 72.400000000000006 107.717 171.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.508 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -100.64 102.27 13.36 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 115.357 -0.838 . . . . 73.120000000000005 111.603 178.28 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.45 -132.6 14.75 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 115.526 -0.761 . . . . 63.310000000000002 113.37 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.34 -41.83 69.87 Favored 'Trans proline' 0 CA--C 1.572 2.376 0 C-N-CA 124.267 3.311 . . . . 74.129999999999995 117.36 -178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.508 ' HD2' ' O ' ' A' ' 20' ' ' GLU . 43.2 Cg_exo -43.06 151.06 0.29 Allowed 'Trans proline' 0 C--N 1.403 3.421 0 C-N-CA 123.204 2.603 . . . . 75.109999999999999 113.819 177.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -76.88 136.77 66.41 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 116.182 -0.463 . . . . 74.140000000000001 112.077 -174.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.591 ' HA ' ' OG1' ' A' ' 19' ' ' THR . 27.8 Cg_endo -63.04 132.18 35.67 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.121 2.547 . . . . 63.200000000000003 113.605 -177.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.4 172.26 7.31 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.18 -0.918 . . . . 74.200000000000003 111.602 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.1 t -73.34 146.78 44.99 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.845 -0.616 . . . . 73.530000000000001 112.412 -176.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.97 -34.08 8.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.638 -1.164 . . . . 61.43 111.2 172.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -59.87 -47.1 87.13 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.394 0.678 . . . . 62.310000000000002 109.201 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.553 ' O ' HG12 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -64.05 -41.75 97.27 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 116.673 -0.24 . . . . 75.409999999999997 111.179 177.287 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.18 -42.24 98.23 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.699 0.761 . . . . 75.310000000000002 109.356 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.528 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -70.97 -37.68 72.77 Favored 'General case' 0 N--CA 1.379 -3.98 0 CA-C-N 114.771 -1.104 . . . . 74.120000000000005 112.589 -178.54 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 41.3 mm-40 -71.17 -44.13 66.11 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.236 0.458 . . . . 74.340000000000003 112.236 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 30' ' ' GLU . 21.2 pt -67.42 -35.17 72.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.177 0.513 . . . . 63.0 111.541 -177.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -68.9 -24.02 64.26 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.881 -0.6 . . . . 74.030000000000001 110.471 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 99.7 mttt -77.92 -32.03 51.42 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.2 0.524 . . . . 75.310000000000002 110.746 176.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 96.5 mtt180 -94.49 10.8 33.14 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.605 0.717 . . . . 71.349999999999994 110.56 -171.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.477 ' HB3' ' HG2' ' A' ' 84' ' ' GLU . 13.6 p -112.16 169.4 8.89 Favored 'General case' 0 N--CA 1.401 -2.887 0 CA-C-N 115.424 -0.807 . . . . 74.209999999999994 111.771 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 27.3 m -135.32 158.62 40.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 116.155 -0.475 . . . . 75.549999999999997 110.912 -175.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.661 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 46.7 t80 -99.0 121.78 41.4 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 124.572 1.149 . . . . 74.5 108.665 175.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 58.2 t -115.07 113.53 43.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 107.639 -1.245 . . . . 71.349999999999994 107.639 174.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.23 170.23 14.0 Favored Glycine 0 C--N 1.305 -1.182 0 C-N-CA 120.052 -1.07 . . . . 41.530000000000001 113.769 -177.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.448 ' O ' ' HD3' ' A' ' 105' ' ' ARG . 65.4 t30 68.71 21.49 7.81 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 126.425 1.89 . . . . 74.030000000000001 112.505 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.512 ' O ' ' HA3' ' A' ' 79' ' ' GLY . 7.4 p -91.63 103.65 14.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 O-C-N 121.203 -0.936 . . . . 71.109999999999999 110.99 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -86.71 166.74 15.06 Favored 'General case' 0 C--O 1.261 1.686 0 N-CA-C 108.391 -0.966 . . . . 63.439999999999998 108.391 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -50.81 131.77 26.28 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 123.41 0.444 . . . . 73.129999999999995 109.825 174.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 137.89 -38.49 1.7 Allowed Glycine 0 N--CA 1.427 -1.945 0 N-CA-C 110.1 -1.2 . . . . 75.319999999999993 110.1 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.4 m -84.08 131.97 34.75 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 108.131 -1.063 . . . . 74.329999999999998 108.131 176.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.0 p -94.1 162.86 13.7 Favored 'General case' 0 N--CA 1.418 -2.066 0 N-CA-C 109.678 -0.49 . . . . 72.25 109.678 -179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' HB3' HD11 ' A' ' 66' ' ' ILE . . . -65.9 -41.64 91.2 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 109.902 -0.407 . . . . 71.329999999999998 109.902 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.514 HE21 ' N ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -61.06 -37.31 82.22 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 120.21 -0.596 . . . . 63.109999999999999 112.254 178.824 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.514 ' N ' HE21 ' A' ' 51' ' ' GLN 0.279 1.9 p30 -73.57 -28.21 61.73 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 119.368 -0.933 . . . . 63.43 110.87 178.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.3 mt -62.61 -46.37 88.59 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 115.431 -0.804 . . . . 71.129999999999995 110.076 172.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -58.45 -47.43 84.03 Favored 'General case' 0 C--O 1.189 -2.124 0 N-CA-C 112.957 0.725 . . . . 72.439999999999998 112.957 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.59 -47.37 73.43 Favored 'General case' 0 C--O 1.27 2.136 0 CA-C-O 120.957 0.408 . . . . 75.409999999999997 111.054 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -64.04 -43.04 96.77 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.147 -0.933 . . . . 74.530000000000001 110.825 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -82.65 -25.6 32.94 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 116.081 1.882 . . . . 71.329999999999998 116.081 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.5 m -69.89 -28.07 65.32 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-O 120.761 0.315 . . . . 61.399999999999999 110.932 -176.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.1 m -59.34 -26.53 65.11 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 120.412 -0.515 . . . . 75.409999999999997 110.886 173.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 79.0 m -105.99 9.24 32.63 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.013 0.746 . . . . 73.310000000000002 113.013 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' A' ' 90' ' ' SER . . . 163.46 176.5 35.49 Favored Glycine 0 CA--C 1.502 -0.74 0 C-N-CA 118.176 -1.964 . . . . 71.349999999999994 115.484 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.5 m -100.66 116.47 32.64 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.107 -0.546 . . . . 75.209999999999994 110.109 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.4 mt -83.78 128.29 38.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 115.352 -0.84 . . . . 51.240000000000002 112.862 -176.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.493 HD22 ' HA ' ' A' ' 86' ' ' ALA . 89.2 m-20 -87.25 -45.55 10.52 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 115.424 -0.807 . . . . 74.030000000000001 109.621 175.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.514 ' HD3' ' OE1' ' A' ' 84' ' ' GLU . 53.8 mtp180 -159.27 165.96 32.35 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.242 -1.392 . . . . 75.150000000000006 107.242 -173.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.482 HD11 ' HB3' ' A' ' 50' ' ' ALA . 22.4 pt -146.19 141.94 21.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.193 -1.04 . . . . 75.030000000000001 108.193 174.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.6 m -125.32 125.41 43.45 Favored 'General case' 0 C--N 1.269 -2.933 0 N-CA-C 107.217 -1.401 . . . . 73.239999999999995 107.217 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.9 mp -120.46 115.88 48.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 105.541 -2.022 . . . . 74.239999999999995 105.541 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.556 HD11 ' NH2' ' B' ' 65' ' ' ARG . 1.0 OUTLIER -121.09 128.87 53.0 Favored 'General case' 0 C--N 1.283 -2.292 0 C-N-CA 120.348 -0.541 . . . . 64.420000000000002 112.096 -178.477 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 66.1 m -117.37 133.6 55.79 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.805 -0.634 . . . . 64.430000000000007 109.795 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -118.41 144.48 45.9 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 120.343 -0.543 . . . . 64.510000000000005 110.743 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -111.64 12.04 21.17 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.25 0.548 . . . . 64.319999999999993 111.208 174.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.602 ' CE2' ' HB3' ' B' ' 64' ' ' ASN . 30.5 m-85 -66.75 -20.73 66.02 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.633 -0.712 . . . . 75.310000000000002 111.275 175.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 76' ' ' HIS . 20.6 t -86.13 3.87 40.84 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.71 -0.677 . . . . 71.129999999999995 109.658 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.1 -44.26 3.29 Favored Glycine 0 CA--C 1.502 -0.776 0 N-CA-C 110.149 -1.181 . . . . 63.350000000000001 110.149 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.469 ' H ' ' C ' ' A' ' 74' ' ' SER . 45.1 m80 -96.81 147.16 32.51 Favored Pre-proline 0 C--N 1.292 -1.909 0 N-CA-C 105.915 -1.883 . . . . 73.439999999999998 105.915 177.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -75.44 116.57 4.54 Favored 'Trans proline' 0 N--CA 1.432 -2.125 0 N-CA-C 108.792 -1.272 . . . . 64.400000000000006 108.792 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 24.7 mtmm -108.05 156.93 18.71 Favored 'General case' 0 CA--C 1.461 -2.449 0 N-CA-C 107.73 -1.211 . . . . 73.329999999999998 107.73 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 44' ' ' VAL . . . -136.34 145.25 17.16 Favored Glycine 1 N--CA 1.395 -4.035 0 C-N-CA 119.167 -1.492 . . . . 61.210000000000001 112.226 176.724 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -146.2 143.55 29.32 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 108.31 -0.996 . . . . 74.310000000000002 108.31 174.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.09 144.37 51.31 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-O 120.777 0.322 . . . . 63.439999999999998 110.577 -173.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.727 ' CD1' ' HD2' ' A' ' 112' ' ' LYS . 68.7 m-85 -115.83 115.54 26.43 Favored 'General case' 0 N--CA 1.409 -2.482 0 CA-C-N 115.908 -0.587 . . . . 74.409999999999997 109.599 177.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.406 HG21 HG22 ' A' ' 66' ' ' ILE . 33.0 mm -99.85 119.51 48.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 107.632 -1.248 . . . . 73.140000000000001 107.632 -177.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.514 ' OE1' ' HD3' ' A' ' 65' ' ' ARG . 43.5 mt-10 -96.18 119.96 35.61 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.793 -0.363 . . . . 75.030000000000001 110.583 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -99.66 153.14 19.32 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.09 0.472 . . . . 63.229999999999997 110.136 177.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.493 ' HA ' HD22 ' A' ' 64' ' ' ASN . . . -64.13 -37.18 86.53 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.667 -0.697 . . . . 70.109999999999999 111.515 177.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -116.94 145.38 43.65 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.502 -0.772 . . . . 63.140000000000001 112.905 -176.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.535 ' O ' HG23 ' A' ' 91' ' ' VAL . 17.5 mmm180 -62.34 -33.16 74.18 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.381 -0.827 . . . . 75.439999999999998 109.549 171.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -62.81 -32.41 73.6 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.217 -0.901 . . . . 72.409999999999997 110.449 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.436 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . 47.3 m -67.75 -36.86 81.31 Favored 'General case' 0 N--CA 1.426 -1.67 0 O-C-N 122.383 -0.198 . . . . 71.219999999999999 110.546 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 88' ' ' ARG . 2.9 m -64.92 -39.18 84.81 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.886 0 C-N-CA 119.656 -0.818 . . . . 73.230000000000004 109.877 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -60.22 -36.3 77.4 Favored 'General case' 0 CA--C 1.502 -0.902 0 O-C-N 123.361 0.413 . . . . 75.510000000000005 111.935 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.73 -36.67 65.21 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.055 0.455 . . . . 54.229999999999997 110.298 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.07 -45.32 57.95 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.887 -0.597 . . . . 52.340000000000003 111.574 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 91' ' ' VAL . 22.1 m -55.39 -21.58 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 113.101 0.778 . . . . 74.519999999999996 113.101 177.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.97 -19.04 65.73 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.293 0.568 . . . . 75.319999999999993 110.461 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 56.9 mtm -96.19 9.43 41.0 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.653 -0.703 . . . . 63.100000000000001 110.173 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.428 ' HA ' HG13 ' A' ' 109' ' ' VAL . 2.7 p-10 -41.97 -41.71 2.59 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.825 0.676 . . . . 73.329999999999998 112.825 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -102.22 101.49 11.79 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 119.668 -0.813 . . . . 63.549999999999997 109.539 170.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.7 p -140.61 148.27 40.65 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.276 -0.874 . . . . 71.129999999999995 110.309 174.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.1 p -113.57 93.14 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 CA-C-O 122.764 1.269 . . . . 62.310000000000002 108.981 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -112.36 128.81 56.4 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 114.058 -1.428 . . . . 74.420000000000002 107.553 -173.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 61.1 33.18 19.59 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.27 1.028 . . . . 71.530000000000001 109.566 -175.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.59 -2.4 63.32 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 114.768 -1.105 . . . . 75.150000000000006 114.5 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.448 ' HD3' ' O ' ' A' ' 43' ' ' ASN . 5.5 ptp180 -113.0 141.14 47.18 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 122.058 -0.672 . . . . 73.310000000000002 109.523 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.0 m -83.68 119.72 25.12 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 108.322 -0.992 . . . . 74.340000000000003 108.322 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 33.3 pt -101.7 172.16 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 109.619 -0.512 . . . . 75.549999999999997 109.619 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 55.3 tptt -132.89 132.32 41.93 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.644 -0.873 . . . . 72.25 108.644 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 5.0 p -128.18 123.17 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 O-C-N 123.355 0.41 . . . . 71.409999999999997 110.498 175.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . 0.289 0.0 OUTLIER -141.95 146.79 42.05 Favored Pre-proline 0 N--CA 1.431 -1.383 0 N-CA-C 108.99 -0.744 . . . . 74.299999999999997 108.99 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.95 131.01 21.43 Favored 'Trans proline' 0 C--O 1.244 0.818 0 C-N-CA 122.099 1.866 . . . . 72.239999999999995 114.017 -171.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.727 ' HD2' ' CD1' ' A' ' 82' ' ' TYR . 48.3 mtpt -76.15 152.89 36.58 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.484 -1.235 . . . . 75.530000000000001 112.735 -177.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -167.96 160.86 12.49 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 115.584 -0.735 . . . . 74.019999999999996 112.348 173.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.447 ' O ' HG21 ' A' ' 114' ' ' THR . 25.3 m 68.76 18.48 8.65 Favored 'General case' 0 CA--C 1.568 1.638 0 C-N-CA 125.096 1.358 . . . . 72.540000000000006 114.514 169.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -97.95 122.58 41.24 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.571 -1.331 . . . . 75.430000000000007 108.607 173.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 27.1 ttt -122.95 95.37 46.3 Favored Pre-proline 0 C--N 1.29 -1.982 0 N-CA-C 109.027 -0.731 . . . . 75.230000000000004 109.027 177.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.63 ' HG2' ' CD1' ' A' ' 18' ' ' TYR . 50.8 Cg_exo -58.79 111.42 0.88 Allowed 'Trans proline' 0 C--O 1.247 0.939 0 C-N-CA 122.722 2.282 . . . . 55.350000000000001 111.677 178.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.41 -20.52 0.02 OUTLIER Glycine 0 N--CA 1.432 -1.615 0 CA-C-N 114.769 -1.105 . . . . 75.340000000000003 110.91 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 mp 74.55 -11.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.385 0 C-N-CA 123.254 0.622 . . . . 74.530000000000001 112.311 175.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 47.3 m 57.57 69.25 0.76 Allowed 'General case' 0 C--O 1.245 0.822 0 CA-C-O 122.283 1.04 . . . . 60.219999999999999 108.284 -171.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 50.1 m -93.26 103.36 15.62 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 114.668 -1.151 . . . . 74.150000000000006 113.503 -171.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.7 m -92.2 -16.72 25.85 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 105.588 -2.004 . . . . 74.450000000000003 105.588 169.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -59.67 128.52 37.37 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 112.335 -2.211 . . . . 75.099999999999994 112.677 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 . . . . . 0 C--O 1.248 1.019 0 N-CA-C 109.485 -0.561 . . . . 64.129999999999995 109.485 175.403 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.698 0 N-CA-C 109.775 -0.454 . . . . 52.130000000000003 109.775 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 32.3 pt -94.03 120.55 43.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 121.305 0.574 . . . . 74.219999999999999 111.45 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.79 142.45 10.05 Favored Pre-proline 0 C--N 1.308 -1.229 0 N-CA-C 109.068 -0.715 . . . . 73.140000000000001 109.068 178.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -82.08 11.56 3.1 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.604 2.203 . . . . 73.25 112.261 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 52.4 t -95.35 100.44 12.22 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.363 0.602 . . . . 74.019999999999996 112.28 -177.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -132.43 101.38 5.32 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 105.293 -2.114 . . . . 64.120000000000005 105.293 172.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -137.65 100.88 4.32 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.654 -0.418 . . . . 63.340000000000003 111.148 -175.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 55.8 m -125.16 81.41 1.96 Allowed 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.966 -1.124 . . . . 64.239999999999995 107.966 174.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 12.9 p -87.63 92.1 8.98 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 114.211 1.189 . . . . 71.319999999999993 114.211 -173.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 17.8 p80 175.96 151.49 0.14 Allowed 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 125.877 1.671 . . . . 75.400000000000006 107.257 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 20.3 p -72.2 148.15 45.84 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.03 0.443 . . . . 65.319999999999993 111.287 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -107.5 170.12 8.17 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.952 -0.567 . . . . 72.200000000000003 110.177 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -79.15 79.03 5.6 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.616 0.722 . . . . 73.340000000000003 112.281 -176.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 86.0 m -157.7 100.86 1.79 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.141 -0.936 . . . . 73.200000000000003 108.495 176.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.5 148.08 9.2 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 108.43 -0.952 . . . . 71.030000000000001 108.43 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.407 ' HA3' ' HB2' ' B' ' 24' ' ' GLN . . . -143.63 -158.9 7.75 Favored Glycine 0 N--CA 1.415 -2.704 0 N-CA-C 111.058 -0.817 . . . . 74.200000000000003 111.058 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.97 68.45 10.02 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 113.035 0.754 . . . . 65.010000000000005 113.035 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . 0.251 94.3 m-85 74.19 -161.24 0.08 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 114.442 1.275 . . . . 74.299999999999997 114.442 173.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 5.2 t -92.7 170.57 9.61 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 113.803 1.038 . . . . 62.130000000000003 113.803 -165.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . 0.293 31.1 tt0 48.03 140.69 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 129.662 3.185 . . . . 74.299999999999997 117.96 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.14 -145.96 30.13 Favored Glycine 0 CA--C 1.501 -0.798 0 CA-C-N 113.874 -1.512 . . . . 50.530000000000001 114.056 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -50.52 -44.3 40.56 Favored 'Trans proline' 0 CA--C 1.553 1.444 0 C-N-CA 124.326 3.351 . . . . 74.409999999999997 115.339 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -46.47 133.03 16.24 Favored 'Trans proline' 0 C--N 1.396 3.029 0 C-N-CA 122.301 2.001 . . . . 72.530000000000001 112.94 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . 0.407 ' HB2' ' HA3' ' B' ' 16' ' ' GLY . 16.0 mm100 -65.87 140.4 97.21 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 115.835 -0.62 . . . . 63.299999999999997 110.957 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.16 119.46 6.53 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 122.746 2.297 . . . . 74.109999999999999 113.283 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.508 ' H ' HD12 ' B' ' 26' ' ' LEU . 0.0 OUTLIER -79.91 176.0 10.12 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.034 -0.985 . . . . 62.109999999999999 110.394 177.462 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.564 ' HB3' ' OE1' ' B' ' 30' ' ' GLU . 41.2 t -67.71 144.54 55.4 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.927 0.714 . . . . 73.310000000000002 112.927 -173.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.99 -35.53 34.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.371 -1.286 . . . . 71.140000000000001 111.349 173.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -65.43 -45.33 84.28 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 116.392 -0.367 . . . . 60.229999999999997 110.923 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.564 ' OE1' ' HB3' ' B' ' 27' ' ' SER . 2.8 mp0 -64.19 -38.68 91.91 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 120.776 -0.37 . . . . 72.430000000000007 110.974 176.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.1 -41.95 98.73 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.493 0.663 . . . . 75.140000000000001 109.294 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.536 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 0.0 OUTLIER -72.27 -38.0 68.93 Favored 'General case' 0 N--CA 1.384 -3.739 0 CA-C-N 115.225 -0.898 . . . . 72.040000000000006 112.59 -178.438 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -71.24 -41.36 70.21 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.311 0.486 . . . . 73.109999999999999 112.311 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.455 HG12 ' O ' ' B' ' 30' ' ' GLU . 15.7 pt -70.01 -35.42 64.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.367 -0.379 . . . . 74.420000000000002 110.983 -177.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.639 ' OD2' ' HB2' ' B' ' 113' ' ' ARG . 12.5 t70 -69.38 -27.37 65.25 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.686 -0.688 . . . . 75.0 109.378 -177.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 99.3 mttt -71.18 -34.26 70.76 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.631 -0.713 . . . . 73.230000000000004 111.133 176.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -99.77 19.65 15.6 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.051 0.929 . . . . 75.239999999999995 110.33 -175.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 68.6 m -96.55 158.33 15.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.192 -1.367 . . . . 75.310000000000002 108.554 173.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' B' ' 82' ' ' TYR . 28.2 m -131.74 157.64 43.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.458 -0.571 . . . . 74.299999999999997 109.458 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . 0.635 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 40.7 t80 -103.93 119.07 38.16 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.041 -1.096 . . . . 74.420000000000002 108.041 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 58.5 t -112.02 109.79 29.84 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 107.414 -1.328 . . . . 74.299999999999997 107.414 175.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -113.44 173.96 15.42 Favored Glycine 0 N--CA 1.438 -1.197 0 C-N-CA 120.621 -0.799 . . . . 62.240000000000002 112.788 -176.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 7.4 t30 61.01 9.01 2.13 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 126.002 1.721 . . . . 51.109999999999999 111.542 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 5.6 p -84.33 90.84 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 106.394 -1.706 . . . . 72.450000000000003 106.394 173.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -82.14 84.93 6.88 Favored 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 115.474 1.657 . . . . 53.32 115.474 -165.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' TYR . . . . . 0.576 ' HA ' ' SG ' ' B' ' 70' ' ' CYS . 7.6 t80 70.68 -69.54 0.18 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 113.658 -1.61 . . . . 75.040000000000006 113.986 163.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.08 -4.53 22.35 Favored Glycine 0 N--CA 1.468 0.786 0 N-CA-C 116.432 1.333 . . . . 75.5 116.432 -170.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 71.2 m -71.22 130.34 41.18 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 117.989 0.894 . . . . 70.420000000000002 110.515 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 36.1 p -79.83 151.71 30.11 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.185 -0.462 . . . . 74.329999999999998 111.556 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.471 ' HB3' HD11 ' B' ' 66' ' ' ILE . . . -69.29 -41.56 76.66 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.437 0.695 . . . . 72.230000000000004 111.573 -175.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -41.8 81.7 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.868 -0.605 . . . . 75.430000000000007 111.587 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -69.04 -34.64 75.52 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.837 -0.62 . . . . 64.120000000000005 110.994 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 21.3 mt -61.51 -46.45 89.93 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-N 115.485 -0.779 . . . . 74.25 111.638 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -58.64 -47.05 85.72 Favored 'General case' 0 C--O 1.194 -1.827 0 N-CA-C 113.501 0.926 . . . . 75.530000000000001 113.501 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.64 -47.66 73.22 Favored 'General case' 0 C--O 1.268 2.029 0 CA-C-N 118.041 0.382 . . . . 70.099999999999994 111.185 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -64.26 -42.14 96.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.373 -0.831 . . . . 71.040000000000006 111.007 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -82.8 -25.63 32.53 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 115.903 1.816 . . . . 62.140000000000001 115.903 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 69.5 m -69.78 -25.0 63.59 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 120.651 0.262 . . . . 75.299999999999997 110.673 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 21.4 m -58.44 -27.25 64.18 Favored 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 120.432 -0.507 . . . . 74.120000000000005 110.764 172.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 68.2 m -99.94 7.36 44.88 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.741 1.015 . . . . 70.420000000000002 113.741 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.41 -167.96 32.54 Favored Glycine 0 CA--C 1.5 -0.856 0 C-N-CA 118.24 -1.933 . . . . 71.510000000000005 115.242 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 14.6 m -101.54 120.72 40.75 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 123.127 0.571 . . . . 71.430000000000007 110.087 -176.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 64.3 mt -87.52 125.82 41.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.07 0.462 . . . . 53.030000000000001 112.178 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . 0.602 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 90.5 m-20 -85.65 -46.85 10.37 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.959 0.885 . . . . 75.129999999999995 110.084 177.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.556 ' NH2' HD11 ' A' ' 69' ' ' LEU . 49.6 mtp180 -158.7 165.73 33.67 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.613 -1.625 . . . . 65.409999999999997 106.613 -172.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.471 HD11 ' HB3' ' B' ' 50' ' ' ALA . 23.2 pt -146.08 142.09 21.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.142 -1.059 . . . . 74.519999999999996 108.142 175.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 91.5 m -125.31 125.73 43.96 Favored 'General case' 0 C--N 1.272 -2.784 0 N-CA-C 107.351 -1.351 . . . . 72.109999999999999 107.351 -178.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mp -120.4 116.69 50.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 105.162 -2.162 . . . . 74.340000000000003 105.162 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.433 HD11 ' NH2' ' A' ' 65' ' ' ARG 0.256 1.0 OUTLIER -121.36 129.86 53.29 Favored 'General case' 0 C--N 1.277 -2.577 0 C-N-CA 120.308 -0.557 . . . . 73.129999999999995 112.106 -178.935 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' CYS . . . . . 0.576 ' SG ' ' HA ' ' B' ' 46' ' ' TYR . 63.1 m -118.02 131.7 56.45 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 115.484 -0.78 . . . . 55.420000000000002 109.446 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 4.5 p-10 -113.5 137.83 51.0 Favored 'General case' 0 CA--C 1.492 -1.282 0 C-N-CA 119.681 -0.808 . . . . 72.319999999999993 109.696 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -120.16 12.44 11.85 Favored 'General case' 0 N--CA 1.423 -1.81 0 C-N-CA 119.69 -0.804 . . . . 73.519999999999996 108.97 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -69.79 -22.33 63.33 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 108.48 -0.933 . . . . 74.299999999999997 108.48 176.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 40.3 m -75.71 4.27 8.15 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 114.809 -1.087 . . . . 55.210000000000001 110.367 175.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.12 -52.99 4.8 Favored Glycine 0 CA--C 1.496 -1.116 0 N-CA-C 110.5 -1.04 . . . . 65.340000000000003 110.5 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -95.38 122.74 58.71 Favored Pre-proline 0 C--N 1.287 -2.148 0 N-CA-C 106.952 -1.499 . . . . 72.0 106.952 174.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 59.4 Cg_endo -68.37 119.79 6.78 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 122.068 1.846 . . . . 62.450000000000003 111.903 -175.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' LYS . . . . . 0.428 ' HZ3' ' CG ' ' B' ' 71' ' ' ASP . 27.7 mtmm -106.22 162.92 13.23 Favored 'General case' 0 CA--C 1.476 -1.888 0 N-CA-C 108.285 -1.006 . . . . 74.310000000000002 108.285 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -133.97 144.55 16.53 Favored Glycine 0 N--CA 1.407 -3.257 0 C-N-CA 119.498 -1.334 . . . . 64.310000000000002 112.14 175.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -148.68 143.28 26.37 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.622 -0.881 . . . . 75.030000000000001 108.622 172.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.79 144.55 51.53 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 120.851 0.358 . . . . 44.130000000000003 110.734 -172.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' TYR . . . . . 0.463 ' HA ' ' O ' ' B' ' 39' ' ' VAL . 72.6 m-85 -115.31 115.65 26.99 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 115.852 -0.613 . . . . 70.5 109.455 176.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.4 HG21 HG22 ' B' ' 66' ' ' ILE . 33.1 mm -100.37 118.52 47.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 107.425 -1.324 . . . . 70.230000000000004 107.425 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' GLU . . . . . 0.419 ' OE1' ' HD3' ' B' ' 65' ' ' ARG . 46.5 mt-10 -95.6 119.21 33.7 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.667 -0.413 . . . . 72.349999999999994 110.331 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -97.4 153.71 17.93 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.005 0.431 . . . . 71.120000000000005 110.855 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.417 ' HA ' HD22 ' B' ' 64' ' ' ASN . . . -61.14 -30.31 70.31 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.492 -0.776 . . . . 73.019999999999996 112.046 177.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -131.27 157.82 42.27 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.477 0.656 . . . . 74.209999999999994 112.3 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.578 ' O ' HG23 ' B' ' 91' ' ' VAL . 19.8 mmm180 -68.29 -33.36 74.2 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.535 -1.212 . . . . 74.310000000000002 109.941 172.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -65.26 -28.6 69.46 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.312 -0.404 . . . . 73.120000000000005 111.461 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 39.9 m -68.77 -37.23 79.18 Favored 'General case' 0 N--CA 1.433 -1.298 0 O-C-N 122.273 -0.267 . . . . 75.040000000000006 110.36 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . 0.578 HG23 ' O ' ' B' ' 88' ' ' ARG . 3.6 m -65.89 -38.48 82.25 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 N-CA-C 108.894 -0.78 . . . . 72.409999999999997 108.894 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -62.76 -35.83 81.1 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.549 0.74 . . . . 73.340000000000003 109.424 -177.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.38 -37.8 63.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.762 -0.654 . . . . 65.310000000000002 110.858 177.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.0 -45.23 61.72 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.951 -0.568 . . . . 51.32 111.659 -176.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . 0.48 HG13 ' O ' ' B' ' 91' ' ' VAL . 25.5 m -54.53 -21.86 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 113.191 0.812 . . . . 63.329999999999998 113.191 178.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.97 -12.42 61.64 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.107 0.48 . . . . 63.25 110.862 177.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 60.6 mtm -100.03 9.72 42.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.171 -0.468 . . . . 54.200000000000003 110.707 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -46.91 -34.5 5.52 Favored 'General case' 0 C--O 1.201 -1.483 0 N-CA-C 115.549 1.685 . . . . 70.319999999999993 115.549 -177.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -100.52 29.62 4.34 Favored 'General case' 0 CA--C 1.58 2.104 0 CA-C-N 119.81 1.187 . . . . 74.319999999999993 111.941 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 43.4 p -88.95 160.17 17.28 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.259 -0.9 . . . . 73.140000000000001 111.815 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' B' ' 106' ' ' THR . 14.9 p -97.16 139.61 19.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.465 -0.569 . . . . 74.209999999999994 109.465 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -138.92 122.84 17.76 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 109.185 -0.672 . . . . 73.209999999999994 109.185 -176.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 62.5 ttp85 54.44 32.51 16.8 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 125.279 1.431 . . . . 74.319999999999993 111.292 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.81 -7.6 63.1 Favored Glycine 0 C--N 1.305 -1.166 0 CA-C-N 115.035 -0.984 . . . . 41.210000000000001 114.741 175.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -132.8 153.58 51.12 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 117.862 0.831 . . . . 74.230000000000004 110.218 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' B' ' 101' ' ' VAL . 56.8 m -77.89 126.46 30.88 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 120.595 0.236 . . . . 54.100000000000001 111.015 -174.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 2.4 pp -102.83 172.58 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 120.456 -0.497 . . . . 71.040000000000006 111.202 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 56.7 tptt -129.58 132.71 46.86 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.67 -0.863 . . . . 65.140000000000001 108.67 -178.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' B' ' 40' ' ' TYR 0.276 6.2 p -127.4 126.94 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-O 121.638 0.732 . . . . 72.439999999999998 110.277 175.333 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.321 0.3 OUTLIER -143.1 137.08 14.51 Favored Pre-proline 0 C--N 1.285 -2.202 0 N-CA-C 105.916 -1.883 . . . . 72.450000000000003 105.916 -168.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.574 ' HB2' ' OG1' ' B' ' 114' ' ' THR . 58.2 Cg_endo -74.2 136.75 22.65 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 121.775 1.65 . . . . 74.549999999999997 112.862 -177.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.488 ' HZ2' ' CG ' ' B' ' 35' ' ' ASP . 59.3 tttm -92.81 146.45 23.64 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 115.641 -0.709 . . . . 73.430000000000007 110.28 -176.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.639 ' HB2' ' OD2' ' B' ' 35' ' ' ASP . 9.2 tpt180 54.82 32.41 17.59 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.371 1.081 . . . . 73.109999999999999 110.138 175.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' THR . . . . . 0.574 ' OG1' ' HB2' ' B' ' 111' ' ' PRO . 95.5 m -80.08 84.57 5.78 Favored 'General case' 0 N--CA 1.399 -3.0 0 CA-C-O 122.352 1.072 . . . . 71.439999999999998 112.9 -175.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -108.47 92.78 4.2 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 103.705 -2.702 . . . . 74.450000000000003 103.705 169.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 24.1 ttt -120.28 139.54 28.72 Favored Pre-proline 0 C--N 1.284 -2.279 0 CA-C-N 115.053 -0.976 . . . . 74.310000000000002 110.715 -169.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -67.85 99.58 0.56 Allowed 'Trans proline' 0 N--CA 1.445 -1.362 0 N-CA-C 108.117 -1.532 . . . . 72.530000000000001 108.117 170.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.65 -176.81 33.9 Favored Glycine 0 N--CA 1.431 -1.68 0 CA-C-N 115.391 -0.822 . . . . 73.340000000000003 113.612 -174.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 2.0 mp 70.44 108.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.772 0 C-N-CA 124.174 0.99 . . . . 70.109999999999999 110.966 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 39.5 p -62.05 133.99 56.03 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 114.954 -1.021 . . . . 63.420000000000002 109.958 178.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 20.3 p -72.05 95.02 1.56 Allowed 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 120.914 0.388 . . . . 71.299999999999997 111.159 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 40.8 p -128.82 102.12 6.41 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.315 0.579 . . . . 72.319999999999993 110.912 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -111.47 123.82 51.0 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.423 -0.584 . . . . 75.340000000000003 109.423 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 . . . . . 0 C--N 1.307 -1.249 0 CA-C-O 118.663 -0.684 . . . . 72.200000000000003 110.544 -178.349 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.845 0 N-CA-C 109.67 -0.493 . . . . 75.5 109.67 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.415 ' N ' HD12 ' A' ' 2' ' ' ILE . 2.4 mp -86.05 117.66 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 107.7 -1.222 . . . . 64.140000000000001 107.7 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -123.99 135.69 26.62 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 116.21 -0.45 . . . . 70.510000000000005 110.128 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.8 103.58 0.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.26 1.974 . . . . 74.25 111.033 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.1 p -155.69 147.42 23.09 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.365 -0.834 . . . . 71.129999999999995 109.162 -177.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 27.5 ttt -139.68 104.48 4.92 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.43 -0.582 . . . . 71.219999999999999 109.43 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -138.86 101.86 4.41 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.888 0.852 . . . . 74.439999999999998 110.485 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.5 m -145.2 83.64 1.68 Allowed 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.785 -0.82 . . . . 70.230000000000004 108.785 178.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.6 p -143.43 81.81 1.72 Allowed 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.419 -0.81 . . . . 75.519999999999996 112.611 -178.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -138.52 88.03 2.27 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.499 -1.297 . . . . 75.049999999999997 107.499 174.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.1 p -139.46 2.62 2.05 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 112.682 0.623 . . . . 60.409999999999997 112.682 -176.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 11.2 mptt -107.13 94.63 5.2 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.37 0.605 . . . . 74.450000000000003 109.796 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.482 ' O ' ' HB2' ' B' ' 22' ' ' PRO . 12.2 tpt -126.99 -55.72 1.37 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.161 -1.051 . . . . 61.009999999999998 108.161 -177.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.7 m -72.07 131.89 43.47 Favored 'General case' 0 C--O 1.252 1.215 0 N-CA-C 108.803 -0.814 . . . . 73.010000000000005 108.803 177.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.539 ' HA ' ' NZ ' ' A' ' 78' ' ' LYS . . . -132.55 -82.97 0.49 Allowed 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 115.601 1.704 . . . . 63.299999999999997 115.601 -171.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.89 -155.72 16.08 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.851 -1.166 . . . . 72.409999999999997 112.75 -176.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.52 -170.37 1.71 Allowed 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.621 0.724 . . . . 53.439999999999998 112.679 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -126.33 122.97 36.95 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 124.28 1.032 . . . . 74.439999999999998 108.223 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.8 m -142.55 141.34 32.02 Favored 'General case' 0 CA--C 1.553 1.085 0 O-C-N 123.403 0.439 . . . . 73.430000000000007 110.859 -171.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -156.49 -172.25 4.0 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 105.252 -2.129 . . . . 64.420000000000002 105.252 175.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -126.65 -99.62 1.11 Allowed Glycine 0 C--N 1.312 -0.771 0 N-CA-C 110.294 -1.123 . . . . 64.030000000000001 110.294 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.451 ' HD2' ' OH ' ' B' ' 82' ' ' TYR . 10.3 Cg_endo -53.68 -39.17 84.33 Favored 'Trans proline' 0 CA--C 1.577 2.672 0 C-N-CA 122.793 2.328 . . . . 74.540000000000006 116.273 176.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.5 138.61 19.72 Favored 'Trans proline' 0 C--N 1.392 2.861 0 CA-C-N 121.64 1.621 . . . . 73.310000000000002 113.034 -176.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -135.34 165.69 34.5 Favored Pre-proline 0 C--N 1.297 -1.688 0 N-CA-C 106.816 -1.549 . . . . 72.430000000000007 106.816 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -50.26 112.27 0.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.461 2.107 . . . . 73.239999999999995 112.373 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.56 ' H ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -61.72 -160.98 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 126.759 2.023 . . . . 72.310000000000002 114.203 178.467 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.528 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 42.7 m -60.5 145.67 47.63 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 121.969 -0.457 . . . . 73.099999999999994 111.157 -178.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.718 ' O ' ' HG2' ' A' ' 32' ' ' LYS . . . -54.94 -49.16 72.05 Favored 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 114.688 1.366 . . . . 50.25 114.688 -172.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.519 ' OE2' ' HG3' ' A' ' 32' ' ' LYS . 32.7 mm-40 -73.34 -29.93 63.0 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 113.295 0.85 . . . . 70.519999999999996 113.295 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -60.87 -37.63 82.8 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.104 -0.332 . . . . 73.219999999999999 110.104 171.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 27' ' ' SER . 94.5 mttt -62.1 -50.86 70.25 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 108.312 -0.995 . . . . 72.310000000000002 108.312 179.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.718 ' HG2' ' O ' ' A' ' 28' ' ' ALA . 10.4 mmmm -53.05 -47.04 68.72 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-N 114.677 -1.147 . . . . 72.540000000000006 110.114 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -71.09 -45.88 62.89 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.864 -1.062 . . . . 73.450000000000003 111.072 -172.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 20.4 pt -71.35 -37.95 67.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 112.386 0.513 . . . . 72.450000000000003 112.386 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.482 ' OD2' ' HA ' ' A' ' 114' ' ' THR . 31.8 t70 -65.23 -32.2 73.75 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.931 0.492 . . . . 75.420000000000002 111.489 -177.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.691 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 98.2 mttt -56.73 -26.2 56.51 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.461 0.648 . . . . 73.120000000000005 111.206 177.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 -115.9 15.79 16.24 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-N 115.871 -0.604 . . . . 75.239999999999995 111.258 -172.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.564 ' OG ' ' HE2' ' A' ' 112' ' ' LYS . 10.3 t -95.66 143.95 26.5 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 121.569 0.7 . . . . 74.439999999999998 110.168 -177.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.452 HG23 ' CG2' ' A' ' 91' ' ' VAL . 13.7 t -127.36 148.42 32.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 115.663 -0.698 . . . . 74.420000000000002 109.459 -175.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.663 ' CZ ' ' HG3' ' B' ' 22' ' ' PRO . 35.7 t80 -96.32 124.86 40.47 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.907 -1.145 . . . . 64.209999999999994 107.907 169.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.1 t -118.51 112.18 37.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.438 -1.319 . . . . 54.539999999999999 107.438 174.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.66 164.04 12.65 Favored Glycine 0 C--N 1.289 -2.066 0 C-N-CA 119.637 -1.268 . . . . 75.540000000000006 113.836 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.478 HD22 ' HB2' ' A' ' 105' ' ' ARG . 12.3 t30 55.79 32.28 19.22 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.487 1.515 . . . . 71.310000000000002 112.905 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.0 p -55.92 132.48 19.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 121.479 0.657 . . . . 64.409999999999997 109.564 172.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -69.33 140.96 54.36 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 114.994 -1.003 . . . . 72.319999999999993 108.852 -174.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.51 ' CD2' ' HB2' ' A' ' 77' ' ' PRO . 0.7 OUTLIER -74.95 93.82 2.74 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 108.33 -0.989 . . . . 55.020000000000003 108.33 -179.52 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.76 -20.73 1.15 Allowed Glycine 0 N--CA 1.414 -2.821 0 N-CA-C 109.037 -1.625 . . . . 74.209999999999994 109.037 -174.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.509 ' OG ' ' HD3' ' A' ' 103' ' ' ARG . 73.1 m -91.89 78.52 5.36 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-O 121.951 0.881 . . . . 73.319999999999993 109.614 177.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.443 HG23 ' HB ' ' B' ' 49' ' ' THR . 51.5 p -65.39 -178.03 0.47 Allowed 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 114.429 -1.259 . . . . 64.239999999999995 113.15 177.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.492 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -51.22 -48.5 62.04 Favored 'General case' 0 C--O 1.202 -1.404 0 CA-C-N 115.12 -0.946 . . . . 61.549999999999997 112.152 -173.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -60.45 -38.81 85.36 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.711 0.634 . . . . 75.319999999999993 112.711 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -39.89 95.1 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 107.657 -1.238 . . . . 65.420000000000002 107.657 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.5 mt -71.97 -43.31 65.35 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 113.934 -1.484 . . . . 74.310000000000002 111.43 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 51.0 mt-10 -57.62 -48.93 78.08 Favored 'General case' 0 C--O 1.181 -2.509 0 CA-C-O 119.396 -0.335 . . . . 73.420000000000002 110.848 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.93 -48.28 80.37 Favored 'General case' 0 C--O 1.264 1.862 0 CA-C-O 121.341 0.591 . . . . 64.510000000000005 111.356 -177.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -66.33 -38.88 88.7 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.324 -0.853 . . . . 74.450000000000003 110.95 -176.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -81.37 -22.39 38.4 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 113.793 1.035 . . . . 72.519999999999996 113.793 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.8 t -68.74 -25.42 64.73 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.679 -0.86 . . . . 71.230000000000004 108.679 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.6 m -62.01 -28.51 69.63 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 116.026 -0.534 . . . . 73.230000000000004 110.004 174.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 61.1 m -95.68 0.27 52.43 Favored 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 112.917 0.71 . . . . 54.439999999999998 112.917 178.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.37 -159.32 28.07 Favored Glycine 0 C--O 1.22 -0.745 0 C-N-CA 118.865 -1.636 . . . . 62.039999999999999 115.424 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.9 m -112.85 127.95 56.32 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 122.523 0.329 . . . . 53.43 110.899 -175.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.475 ' CD1' ' HA ' ' A' ' 54' ' ' GLU . 75.3 mt -89.14 134.15 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 N-CA-C 113.186 0.81 . . . . 74.209999999999994 113.186 -177.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -101.54 -44.41 5.6 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.537 1.135 . . . . 54.240000000000002 111.869 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.481 ' HG3' ' HB2' ' B' ' 73' ' ' PHE . 26.7 mtp180 -145.15 152.82 40.63 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 108.266 -1.012 . . . . 63.43 108.266 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.411 HG12 HD11 ' A' ' 68' ' ' ILE . 1.1 tt -149.03 132.47 7.64 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-N 115.782 -0.644 . . . . 73.019999999999996 109.895 177.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.3 m -124.73 129.17 49.97 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.136 -1.431 . . . . 73.430000000000007 107.136 -176.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.411 HD11 HG12 ' A' ' 66' ' ' ILE . 1.8 mp -128.18 119.93 52.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 106.384 -1.71 . . . . 73.200000000000003 106.384 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.573 ' HG ' ' CE1' ' A' ' 80' ' ' TYR 0.352 1.0 OUTLIER -120.75 130.99 54.26 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 119.672 -0.811 . . . . 75.329999999999998 112.13 176.344 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.508 ' HB2' HG23 ' B' ' 66' ' ' ILE . 66.4 m -113.43 118.64 35.09 Favored 'General case' 0 N--CA 1.411 -2.402 0 C-N-CA 124.461 1.105 . . . . 72.430000000000007 108.754 -176.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' B' ' 65' ' ' ARG . 9.5 t0 -116.23 118.23 32.22 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 122.77 0.428 . . . . 73.5 109.968 -176.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 39.0 ttmt -114.65 16.48 17.51 Favored 'General case' 0 C--N 1.274 -2.686 0 C-N-CA 123.646 0.778 . . . . 61.210000000000001 110.632 -174.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -63.07 -23.7 67.57 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 119.481 -0.888 . . . . 73.129999999999995 112.773 -176.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.0 t -92.39 11.5 25.87 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.396 0.617 . . . . 75.340000000000003 110.831 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.18 -52.66 1.62 Allowed Glycine 0 CA--C 1.5 -0.888 0 C-N-CA 120.474 -0.87 . . . . 65.150000000000006 111.319 178.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -89.98 126.88 55.84 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 107.748 -1.205 . . . . 61.130000000000003 107.748 175.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.51 ' HB2' ' CD2' ' A' ' 46' ' ' TYR . 73.4 Cg_endo -72.58 118.71 5.71 Favored 'Trans proline' 0 N--CA 1.436 -1.878 0 C-N-CA 121.586 1.524 . . . . 72.549999999999997 112.225 -176.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.539 ' NZ ' ' HA ' ' A' ' 15' ' ' ALA . 23.7 mtmt -89.78 173.15 8.42 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 114.842 -1.072 . . . . 73.349999999999994 109.175 178.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.15 137.52 4.83 Favored Glycine 1 N--CA 1.386 -4.667 0 C-N-CA 120.361 -0.923 . . . . 37.770000000000003 111.106 -178.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.573 ' CE1' ' HG ' ' A' ' 69' ' ' LEU 0.263 0.0 OUTLIER -150.49 143.53 24.79 Favored 'General case' 0 C--N 1.273 -2.74 0 CA-C-N 114.906 -0.647 . . . . 74.310000000000002 110.032 173.642 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.45 147.56 52.56 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.68 -0.691 . . . . 65.129999999999995 109.568 -173.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -122.66 119.15 29.9 Favored 'General case' 0 C--N 1.273 -2.733 0 N-CA-C 108.198 -1.038 . . . . 73.010000000000005 108.198 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.6 mm -108.93 136.0 46.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 107.775 -1.194 . . . . 70.349999999999994 107.775 -175.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.429 ' OE2' ' HD3' ' A' ' 65' ' ' ARG . 41.7 mt-10 -113.82 124.88 53.31 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.098 -0.704 . . . . 74.120000000000005 109.098 176.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -97.11 164.25 12.58 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 111.806 0.298 . . . . 74.120000000000005 111.806 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.69 -41.98 59.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.234 0.54 . . . . 61.509999999999998 110.659 174.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.43 ' HB3' ' ND2' ' A' ' 89' ' ' ASN . 27.9 mm-40 -101.6 144.56 30.19 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.298 0.57 . . . . 54.399999999999999 112.134 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.453 ' O ' HG12 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -74.77 -25.4 59.05 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.178 -1.416 . . . . 75.430000000000007 107.178 179.397 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.43 ' ND2' ' HB3' ' A' ' 87' ' ' GLU . 9.0 p30 -72.43 -20.96 61.32 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.266 -0.574 . . . . 72.430000000000007 111.085 178.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 m -71.58 -39.89 70.29 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 122.208 -0.307 . . . . 54.119999999999997 110.561 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.498 ' O ' HG13 ' A' ' 95' ' ' VAL . 2.8 p -67.52 -39.38 82.32 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 C-N-CA 120.295 -0.562 . . . . 52.420000000000002 109.88 178.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -61.84 -32.5 72.83 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.766 -0.652 . . . . 75.129999999999995 110.149 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.89 -35.23 64.67 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.209 -0.451 . . . . 60.420000000000002 111.255 176.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.29 -38.09 56.62 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 116.216 -0.447 . . . . 73.140000000000001 111.239 -175.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.498 HG13 ' O ' ' A' ' 91' ' ' VAL . 14.4 m -56.84 -21.76 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 114.043 1.127 . . . . 73.099999999999994 114.043 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.49 -11.57 60.94 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.934 0.873 . . . . 62.130000000000003 110.385 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 7.1 ttp -101.25 5.36 42.47 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.855 -1.066 . . . . 70.209999999999994 108.546 -176.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.535 ' HA ' HG21 ' A' ' 109' ' ' VAL . 1.3 p-10 -37.7 -42.11 0.54 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.799 1.407 . . . . 72.099999999999994 114.799 -177.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -117.42 104.53 11.19 Favored 'General case' 0 N--CA 1.408 -2.539 0 CA-C-O 121.841 0.829 . . . . 72.129999999999995 109.777 174.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.5 t -147.49 165.2 31.0 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 114.01 -1.45 . . . . 72.299999999999997 108.451 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.7 110.58 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-O 122.244 1.021 . . . . 73.030000000000001 109.551 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -107.31 123.58 48.54 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.792 -1.094 . . . . 62.5 109.416 -173.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.509 ' HD3' ' OG ' ' A' ' 48' ' ' SER . 42.8 mtp-105 44.5 31.34 0.59 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.287 1.435 . . . . 75.430000000000007 114.632 -176.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 104.23 -4.34 44.5 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 114.984 -1.007 . . . . 74.129999999999995 113.342 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.478 ' HB2' HD22 ' A' ' 43' ' ' ASN . 1.3 ptp180 -130.02 139.97 50.94 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 113.182 0.808 . . . . 70.239999999999995 113.182 176.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 31.9 m -72.05 122.61 21.21 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.439 -0.801 . . . . 74.310000000000002 111.088 -177.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 43.6 pt -102.53 170.74 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 120.844 0.354 . . . . 70.010000000000005 110.765 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 27.0 mmmt -127.01 122.86 35.67 Favored 'General case' 0 CA--C 1.486 -1.487 0 C-N-CA 124.159 0.984 . . . . 74.530000000000001 109.632 176.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 32.9 m -128.31 115.95 40.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-O 121.048 0.451 . . . . 60.43 109.89 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.478 HD21 ' NH1' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -146.15 160.13 43.79 Favored Pre-proline 0 C--N 1.289 -2.064 0 N-CA-C 108.758 -0.83 . . . . 64.019999999999996 108.758 -177.186 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.438 ' HD3' HG12 ' A' ' 95' ' ' VAL . 72.0 Cg_endo -80.43 139.94 13.23 Favored 'Trans proline' 0 N--CA 1.436 -1.884 0 C-N-CA 121.118 1.212 . . . . 64.209999999999994 111.335 -173.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.564 ' HE2' ' OG ' ' A' ' 38' ' ' SER . 33.3 mtmt -77.92 135.91 37.93 Favored 'General case' 0 N--CA 1.406 -2.651 0 N-CA-C 106.533 -1.655 . . . . 65.329999999999998 106.533 175.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.478 ' NH1' HD21 ' A' ' 110' ' ' LEU . 10.2 mpt_? -78.45 -64.73 1.1 Allowed 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 113.336 0.865 . . . . 74.239999999999995 113.336 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.482 ' HA ' ' OD2' ' A' ' 35' ' ' ASP . 20.4 p -148.85 98.07 2.8 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.863 0.319 . . . . 74.420000000000002 111.863 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.484 ' HB2' ' HB ' ' B' ' 19' ' ' THR . 39.1 t30 -157.89 107.3 2.09 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 121.669 0.747 . . . . 73.310000000000002 112.418 173.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 23.9 ptp -67.36 125.19 90.75 Favored Pre-proline 0 C--N 1.304 -1.386 0 CA-C-N 114.302 -1.317 . . . . 73.109999999999999 111.331 -178.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -94.32 174.95 1.33 Allowed 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.615 2.21 . . . . 70.219999999999999 111.942 176.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -102.3 148.2 17.49 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 111.788 -0.525 . . . . 40.149999999999999 111.788 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 10.8 tt -148.71 171.04 2.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 107.844 -1.169 . . . . 75.230000000000004 107.844 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.2 m -70.51 99.66 1.66 Allowed 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.573 -0.529 . . . . 64.439999999999998 109.573 175.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.5 m -79.52 96.66 6.17 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 115.803 -0.635 . . . . 65.030000000000001 110.132 -178.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.7 t -137.97 137.85 38.35 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 109.611 -0.515 . . . . 74.120000000000005 109.611 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -172.36 -72.24 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.801 -0.636 . . . . 71.25 109.342 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 . . . . . 0 C--N 1.31 -1.127 0 CA-C-N 115.618 -0.719 . . . . 74.319999999999993 109.28 -179.456 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.421 0 CA-C-O 121.563 0.697 . . . . 71.129999999999995 109.791 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 22.6 pt -99.73 110.35 26.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 115.115 -0.948 . . . . 55.149999999999999 111.41 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . 0.422 ' HB2' ' HD2' ' B' ' 4' ' ' PRO . . . -151.36 173.75 4.14 Favored Pre-proline 0 C--N 1.302 -1.472 0 N-CA-C 107.445 -1.317 . . . . 54.109999999999999 107.445 -178.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' B' ' 3' ' ' ALA . 52.9 Cg_exo -26.58 120.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.393 2.885 0 C-N-CA 124.982 3.788 . . . . 75.150000000000006 114.337 175.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 12.2 p -57.02 98.33 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 114.775 1.398 . . . . 72.120000000000005 114.775 -175.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -169.44 156.33 6.7 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.488 -1.301 . . . . 52.020000000000003 107.488 176.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -91.48 148.8 22.04 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.622 -0.431 . . . . 54.340000000000003 109.925 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 28.2 p -75.15 85.48 2.38 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 121.613 0.721 . . . . 73.140000000000001 111.364 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 5.2 t -144.16 135.92 26.06 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.095 -1.076 . . . . 73.5 108.095 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -89.43 76.63 7.46 Favored 'General case' 0 CA--C 1.494 -1.211 0 CA-C-O 121.713 0.768 . . . . 70.400000000000006 109.846 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 22.0 p -146.44 93.86 2.36 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 114.51 -1.223 . . . . 65.010000000000005 109.969 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -108.15 -41.51 4.89 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.203 -0.908 . . . . 74.310000000000002 109.256 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 27.9 ttt -143.15 82.22 1.74 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.705 -0.68 . . . . 74.239999999999995 109.753 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 5.3 t -158.84 95.92 1.32 Allowed 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 114.869 -1.06 . . . . 75.530000000000001 109.425 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.07 134.12 35.54 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.754 -0.657 . . . . 72.200000000000003 109.682 -178.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.52 -48.17 4.0 Favored Glycine 0 C--N 1.306 -1.093 0 CA-C-N 116.518 -0.31 . . . . 74.030000000000001 112.679 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.02 99.76 7.82 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.101 0.477 . . . . 74.109999999999999 111.829 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -135.89 -57.11 0.77 Allowed 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 106.55 -1.648 . . . . 74.430000000000007 106.55 176.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' A' ' 115' ' ' ASN 0.524 49.3 m 88.83 66.44 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 118.521 2.785 . . . . 71.329999999999998 118.521 169.548 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . 0.418 ' O ' ' HD2' ' B' ' 22' ' ' PRO . 0.1 OUTLIER -108.13 -30.72 8.25 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 102.445 -3.168 . . . . 75.200000000000003 102.445 163.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.16 -100.73 2.14 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 112.483 -2.144 . . . . 37.770000000000003 113.162 170.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.663 ' HG3' ' CZ ' ' A' ' 40' ' ' TYR . 6.6 Cg_endo -43.1 -55.55 2.75 Favored 'Trans proline' 0 CA--C 1.6 3.801 0 C-N-CA 124.657 3.571 . . . . 75.430000000000007 115.607 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.455 ' HD3' ' HG2' ' B' ' 22' ' ' PRO . 19.8 Cg_endo -91.4 167.5 3.45 Favored 'Trans proline' 0 C--N 1.364 1.358 0 C-N-CA 122.498 2.132 . . . . 72.230000000000004 111.729 177.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -124.96 155.52 70.43 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-O 118.991 -0.528 . . . . 74.349999999999994 110.372 176.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -27.82 115.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.167 1 C-N-CA 125.967 4.445 . . . . 45.43 116.623 -176.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.486 ' H ' HD13 ' B' ' 26' ' ' LEU . 0.0 OUTLIER -78.12 172.04 14.14 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.302 -1.317 . . . . 63.020000000000003 112.174 175.728 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 19.6 m -69.19 147.81 50.78 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 113.798 1.036 . . . . 73.030000000000001 113.798 -175.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.706 ' O ' ' HG2' ' B' ' 32' ' ' LYS . . . -53.74 -46.68 70.93 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 114.992 -1.004 . . . . 72.349999999999994 110.458 174.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.548 ' HA ' ' CG ' ' B' ' 32' ' ' LYS . 68.5 mm-40 -68.95 -29.41 67.64 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 112.988 0.736 . . . . 72.109999999999999 112.988 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.507 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.4 OUTLIER -61.39 -37.61 84.04 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.502 -0.479 . . . . 64.109999999999999 110.608 172.116 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -63.12 -50.26 71.15 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 107.651 -1.241 . . . . 73.420000000000002 107.651 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.706 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 10.4 mmmm -52.06 -47.05 65.33 Favored 'General case' 0 C--O 1.214 -0.771 0 C-N-CA 124.459 1.103 . . . . 73.129999999999995 110.764 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -66.3 -49.87 65.57 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 114.005 1.113 . . . . 74.400000000000006 114.005 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.507 HG12 ' O ' ' B' ' 30' ' ' GLU . 28.6 pt -70.52 -36.17 64.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 111.969 0.359 . . . . 71.129999999999995 111.969 -174.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.598 ' OD2' ' HD2' ' B' ' 113' ' ' ARG . 7.6 t70 -63.04 -36.37 83.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.809 -0.632 . . . . 72.120000000000005 111.449 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.647 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 98.5 mttt -56.69 -25.26 53.59 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.474 0.654 . . . . 74.129999999999995 110.795 177.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.561 ' HD3' ' O ' ' B' ' 85' ' ' PHE . 70.1 mtt85 -112.37 14.11 20.35 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 115.515 -0.766 . . . . 74.120000000000005 111.857 -172.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 42.4 m -93.89 143.45 26.33 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.474 0.654 . . . . 72.209999999999994 110.946 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.435 HG23 ' CG2' ' B' ' 91' ' ' VAL . 14.7 t -129.85 152.71 37.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.714 -0.847 . . . . 74.209999999999994 108.714 -178.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . 0.622 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 18.9 t80 -105.33 123.42 47.83 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 107.117 -1.438 . . . . 73.230000000000004 107.117 173.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 48.9 t -116.76 111.58 35.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 107.364 -1.347 . . . . 71.319999999999993 107.364 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . 0.447 ' O ' ' HB ' ' B' ' 107' ' ' ILE . . . -112.9 169.7 13.08 Favored Glycine 0 C--N 1.291 -1.941 0 C-N-CA 119.463 -1.351 . . . . 74.319999999999993 114.127 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 64.7 t30 62.98 17.32 9.99 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 126.059 1.743 . . . . 73.230000000000004 113.267 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 p -62.08 131.59 27.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.264 0.554 . . . . 71.400000000000006 109.943 176.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -75.43 156.72 35.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.52 -0.764 . . . . 70.049999999999997 109.067 -176.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -68.92 -18.16 64.07 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-O 121.808 0.813 . . . . 72.129999999999995 109.839 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.18 -12.73 80.37 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 115.559 -0.746 . . . . 37.770000000000003 111.808 178.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 25.1 m -87.23 133.07 33.71 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 108.45 -0.945 . . . . 75.230000000000004 108.45 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' THR . . . . . 0.468 ' H ' ' HB2' ' B' ' 52' ' ' ASP . 63.2 p -111.9 178.87 4.18 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 116.178 -0.464 . . . . 74.109999999999999 111.565 -172.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.425 ' O ' ' HG3' ' B' ' 54' ' ' GLU . . . -63.11 -48.12 79.9 Favored 'General case' 0 C--O 1.2 -1.549 0 N-CA-C 109.954 -0.387 . . . . 71.030000000000001 109.954 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -59.12 -39.59 82.77 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 111.946 0.35 . . . . 75.319999999999993 111.946 176.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.468 ' HB2' ' H ' ' B' ' 49' ' ' THR . 0.8 OUTLIER -55.94 -46.28 78.58 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.818 0.818 . . . . 74.040000000000006 109.765 173.715 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 99.2 mt -68.35 -43.88 76.51 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.369 -1.287 . . . . 72.299999999999997 112.149 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.479 ' HA ' ' CD1' ' B' ' 63' ' ' ILE . 48.3 mt-10 -57.97 -50.11 74.51 Favored 'General case' 0 C--O 1.183 -2.432 0 C-N-CA 120.645 -0.422 . . . . 75.030000000000001 111.061 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.44 -48.1 77.73 Favored 'General case' 0 C--O 1.25 1.081 0 O-C-N 123.554 0.534 . . . . 62.219999999999999 111.643 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -67.3 -37.66 83.72 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.486 -0.779 . . . . 72.109999999999999 110.868 -175.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -82.58 -22.88 34.68 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.647 0.98 . . . . 75.030000000000001 113.647 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 38.9 t -67.78 -27.96 67.19 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.891 -0.781 . . . . 51.009999999999998 108.891 -177.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 21.8 m -60.06 -25.4 65.34 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 115.806 -0.633 . . . . 74.019999999999996 110.673 174.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 77.1 m -102.1 2.97 38.14 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.092 0.775 . . . . 75.019999999999996 113.092 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.66 -167.6 29.82 Favored Glycine 0 N--CA 1.461 0.321 0 C-N-CA 119.058 -1.544 . . . . 72.310000000000002 114.977 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 19.4 t -105.86 127.92 53.43 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-O 120.857 0.36 . . . . 51.450000000000003 110.548 -176.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.479 ' CD1' ' HA ' ' B' ' 54' ' ' GLU . 74.2 mt -87.04 133.51 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 113.519 0.933 . . . . 74.099999999999994 113.519 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 94.2 m-20 -103.88 -35.94 7.98 Favored 'General case' 0 C--O 1.172 -3.022 0 CA-C-N 115.823 -0.626 . . . . 71.299999999999997 111.757 174.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 43.3 mtp180 -149.02 152.29 36.01 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.622 -0.881 . . . . 72.200000000000003 108.622 178.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.508 HG23 ' HB2' ' A' ' 70' ' ' CYS . 0.3 OUTLIER -149.51 131.39 5.65 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.698 0 C-N-CA 124.024 0.93 . . . . 72.129999999999995 109.886 177.231 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' B' ' 81' ' ' ALA . 74.1 m -124.79 128.68 49.11 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 106.964 -1.495 . . . . 75.209999999999994 106.964 -176.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.16 121.76 60.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 106.098 -1.816 . . . . 64.120000000000005 106.098 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.389 1.2 pt? -120.7 132.35 55.03 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 119.311 -0.956 . . . . 73.0 112.64 175.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 63.7 m -114.43 118.19 33.13 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 107.527 -1.286 . . . . 72.230000000000004 107.527 -178.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 8.8 t70 -110.75 115.33 29.37 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 118.788 -1.165 . . . . 64.420000000000002 109.276 -176.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -112.63 3.74 16.82 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.191 -1.411 . . . . 64.439999999999998 107.191 -178.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.481 ' HB2' ' HG3' ' A' ' 65' ' ' ARG . 65.7 t80 -56.96 -21.72 32.47 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 126.551 1.94 . . . . 72.239999999999995 113.755 -178.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 43.4 m -109.84 13.81 23.42 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.014 0.435 . . . . 74.230000000000004 111.005 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.27 -64.85 0.29 Allowed Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.779 -0.724 . . . . 71.299999999999997 112.128 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -96.4 129.63 32.89 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 109.83 -0.433 . . . . 70.019999999999996 109.83 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 84.1 Cg_endo -75.4 118.58 5.22 Favored 'Trans proline' 0 N--CA 1.435 -1.957 0 C-N-CA 121.39 1.393 . . . . 74.219999999999999 112.714 -178.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -94.16 -179.59 4.99 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 125.278 1.431 . . . . 75.439999999999998 109.578 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.35 135.58 3.94 Favored Glycine 0 N--CA 1.403 -3.503 0 C-N-CA 119.177 -1.487 . . . . 63.25 113.407 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . 0.266 0.2 OUTLIER -151.23 145.49 25.42 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 114.616 -0.792 . . . . 75.530000000000001 109.97 172.307 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' B' ' 67' ' ' THR . . . -130.75 148.2 52.5 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.553 -0.748 . . . . 71.340000000000003 110.265 -174.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' TYR . . . . . 0.451 ' OH ' ' HD2' ' A' ' 22' ' ' PRO . 81.6 m-85 -123.16 116.63 23.75 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.816 -0.809 . . . . 63.329999999999998 108.816 177.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 11.4 mm -107.47 133.9 50.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 107.791 -1.188 . . . . 73.109999999999999 107.791 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' B' ' 37' ' ' ARG . 53.4 mt-10 -112.2 125.31 54.0 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.171 -1.048 . . . . 75.340000000000003 108.171 175.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.561 ' O ' ' HD3' ' B' ' 37' ' ' ARG . 89.4 m-85 -96.54 167.23 11.27 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 112.032 0.382 . . . . 64.400000000000006 112.032 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.424 ' HA ' ' ND2' ' B' ' 64' ' ' ASN . . . -81.92 -37.17 27.2 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.923 -0.58 . . . . 75.310000000000002 110.811 174.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . 0.534 ' HB2' ' OG ' ' B' ' 90' ' ' SER . 6.9 mp0 -98.73 141.84 31.03 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.462 -0.57 . . . . 61.219999999999999 109.462 178.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.42 ' O ' HG12 ' B' ' 91' ' ' VAL . 0.4 OUTLIER -75.25 -26.86 59.17 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 106.762 -1.57 . . . . 72.540000000000006 106.762 177.359 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . 0.433 ' ND2' ' HB3' ' B' ' 87' ' ' GLU . 9.1 p30 -70.97 -21.79 62.28 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.641 -0.709 . . . . 63.119999999999997 111.278 177.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' SER . . . . . 0.534 ' OG ' ' HB2' ' B' ' 87' ' ' GLU . 51.4 m -71.95 -37.19 70.02 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 111.957 0.354 . . . . 73.420000000000002 111.957 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . 0.435 ' CG2' HG23 ' B' ' 39' ' ' VAL . 2.2 p -67.83 -41.24 84.85 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 C-N-CA 119.407 -0.917 . . . . 74.230000000000004 109.489 175.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -59.16 -33.68 71.19 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.994 -0.548 . . . . 72.209999999999994 110.502 178.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.53 -34.24 65.12 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.209 -0.45 . . . . 45.130000000000003 111.848 176.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.86 -39.55 50.71 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-O 120.701 0.286 . . . . 74.510000000000005 111.163 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 19.9 m -56.25 -21.81 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 113.1 0.778 . . . . 74.319999999999993 113.1 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.99 -11.24 60.73 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.567 0.699 . . . . 73.140000000000001 110.819 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 19.9 mtm -93.88 -0.49 55.68 Favored 'General case' 0 C--O 1.175 -2.83 0 CA-C-O 117.872 -1.061 . . . . 75.150000000000006 110.994 175.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . 0.573 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 2.2 p-10 -35.82 -46.27 0.44 Allowed 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 115.372 1.619 . . . . 62.329999999999998 115.372 -168.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -93.63 85.33 4.84 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.052 -1.462 . . . . 73.25 107.052 169.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' THR . . . . . 0.556 ' HB ' ' CG1' ' B' ' 107' ' ' ILE . 1.3 m -95.7 137.72 34.37 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 119.979 -0.688 . . . . 63.530000000000001 109.404 -175.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 3.7 p -99.91 103.81 15.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 107.664 -1.236 . . . . 54.140000000000001 107.664 173.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -134.08 123.68 24.89 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.79 -1.095 . . . . 72.25 109.48 -173.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 58.29 33.48 23.18 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 122.405 1.098 . . . . 55.340000000000003 111.356 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.54 2.4 84.77 Favored Glycine 0 C--N 1.317 -0.475 0 CA-C-N 114.827 -1.079 . . . . 75.219999999999999 112.522 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -109.7 163.57 13.36 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 109.551 -0.537 . . . . 75.329999999999998 109.551 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' B' ' 100' ' ' THR . 62.0 m -108.36 118.73 37.54 Favored 'General case' 0 N--CA 1.404 -2.755 0 N-CA-C 106.985 -1.487 . . . . 75.5 106.985 172.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . 0.556 ' CG1' ' HB ' ' B' ' 100' ' ' THR . 46.3 pt -103.45 171.61 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 C-N-CA 119.792 -0.763 . . . . 74.430000000000007 109.293 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . 0.573 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 26.7 mmmt -125.2 125.62 43.92 Favored 'General case' 0 CA--C 1.479 -1.782 0 O-C-N 123.652 0.595 . . . . 74.420000000000002 110.019 -177.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 33.9 m -128.12 115.78 39.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 123.786 0.679 . . . . 74.219999999999999 109.739 176.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.2 158.56 47.74 Favored Pre-proline 0 C--N 1.294 -1.819 0 N-CA-C 108.762 -0.829 . . . . 73.049999999999997 108.762 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.23 146.43 25.14 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 121.498 1.465 . . . . 74.150000000000006 114.001 -172.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.436 ' HA ' ' HZ3' ' B' ' 112' ' ' LYS . 0.2 OUTLIER -108.15 138.12 44.97 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.19 -1.411 . . . . 55.200000000000003 107.19 176.15 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.598 ' HD2' ' OD2' ' B' ' 35' ' ' ASP . 18.7 tpt180 -167.03 133.22 2.24 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.845 -0.342 . . . . 70.219999999999999 110.91 -175.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 10.0 t -156.63 161.52 39.9 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.064 0.946 . . . . 74.140000000000001 109.544 175.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 68.14 111.86 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.424 0 C-N-CA 124.445 1.098 . . . . 74.530000000000001 113.406 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 49.4 ttm -152.64 114.37 2.81 Favored Pre-proline 0 N--CA 1.477 0.917 0 O-C-N 121.716 -0.615 . . . . 65.109999999999999 111.417 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -91.91 -38.12 0.04 OUTLIER 'Trans proline' 0 CA--C 1.562 1.899 0 C-N-CA 122.405 2.07 . . . . 62.240000000000002 113.196 175.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . 94.19 26.06 15.12 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.849 -0.691 . . . . 60.030000000000001 112.531 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 2.3 pp -140.64 179.67 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 122.963 0.505 . . . . 75.430000000000007 111.059 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 76.0 p 61.06 89.96 0.07 Allowed 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.941 1.296 . . . . 74.209999999999994 113.162 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 27.8 p -140.54 155.66 46.54 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.127 -0.942 . . . . 37.770000000000003 110.011 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 34.7 p -64.67 117.41 7.4 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 122.52 0.328 . . . . 75.200000000000003 110.639 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -66.85 -54.87 18.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.909 0.385 . . . . 75.430000000000007 110.319 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 . . . . . 0 C--N 1.307 -1.251 0 N-CA-C 108.838 -0.801 . . . . 71.400000000000006 108.838 176.715 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.637 0 N-CA-C 109.757 -0.46 . . . . 64.299999999999997 109.757 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.1 pt -110.09 136.26 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 121.605 0.717 . . . . 74.209999999999994 112.029 -177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -150.15 153.65 35.53 Favored Pre-proline 0 C--N 1.291 -1.973 0 N-CA-C 106.066 -1.828 . . . . 64.310000000000002 106.066 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -56.55 127.88 27.77 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.61 1.54 . . . . 74.439999999999998 109.952 177.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 65.0 m -72.24 116.25 12.45 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.905 -0.589 . . . . 74.5 109.916 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 65.1 mtt 64.58 79.07 0.26 Allowed 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.618 0.767 . . . . 72.010000000000005 111.398 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -81.43 124.06 29.11 Favored 'General case' 0 CA--C 1.486 -1.514 0 CA-C-N 115.37 -0.832 . . . . 75.129999999999995 109.779 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.9 p -81.9 95.93 7.5 Favored 'General case' 0 N--CA 1.41 -2.452 0 N-CA-C 108.953 -0.758 . . . . 52.130000000000003 108.953 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.436 HG23 ' OD2' ' A' ' 92' ' ' ASP . 40.9 p -105.61 -70.13 0.79 Allowed 'General case' 0 N--CA 1.416 -2.175 0 N-CA-C 108.858 -0.794 . . . . 72.25 108.858 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 57.3 22.83 8.15 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.397 1.079 . . . . 63.43 110.085 177.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.3 t -86.16 79.41 9.12 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-O 121.911 0.862 . . . . 74.439999999999998 110.74 -175.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -126.59 83.64 2.19 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.268 -1.382 . . . . 64.329999999999998 107.268 174.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 14.9 tpt -159.85 156.69 27.83 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.725 -1.213 . . . . 63.439999999999998 107.725 -175.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.0 m -132.97 89.69 2.65 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-O 121.739 0.78 . . . . 75.310000000000002 110.14 175.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.422 ' HB3' ' HG2' ' A' ' 112' ' ' LYS . . . -115.03 115.02 26.15 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 115.071 -0.968 . . . . 74.099999999999994 108.52 178.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.75 -121.39 0.48 Allowed Glycine 0 N--CA 1.427 -1.937 0 CA-C-N 115.602 -0.726 . . . . 74.329999999999998 114.139 -175.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.74 -173.75 3.79 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.321 0.581 . . . . 72.510000000000005 112.339 -170.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -133.86 -166.19 1.75 Allowed 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 105.153 -2.166 . . . . 73.420000000000002 105.153 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.6 t -137.85 139.05 39.71 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 120.028 1.285 . . . . 65.310000000000002 111.026 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -75.4 -177.16 3.44 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 115.028 1.492 . . . . 75.319999999999993 115.028 178.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.0 -113.97 2.9 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 113.587 -1.642 . . . . 65.430000000000007 110.85 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.64 -42.84 60.93 Favored 'Trans proline' 0 CA--C 1.575 2.527 0 C-N-CA 123.744 2.963 . . . . 72.209999999999994 116.835 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.58 143.39 74.97 Favored 'Trans proline' 0 C--N 1.39 2.715 0 CA-C-N 121.443 1.551 . . . . 44.030000000000001 113.594 -178.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -101.42 170.8 6.04 Favored Pre-proline 0 C--N 1.295 -1.77 0 CA-C-N 114.255 -1.339 . . . . 72.219999999999999 109.037 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.401 ' C ' HD11 ' A' ' 26' ' ' LEU . 59.5 Cg_exo -57.5 -156.17 0.01 OUTLIER 'Trans proline' 0 CA--C 1.561 1.846 0 C-N-CA 122.577 2.184 . . . . 65.140000000000001 113.926 174.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.401 HD11 ' C ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -134.68 -167.53 2.0 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 104.321 -2.474 . . . . 75.150000000000006 104.321 -173.338 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.552 ' HB3' ' OE1' ' A' ' 30' ' ' GLU . 20.9 t -73.57 155.12 39.46 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 108.085 -1.08 . . . . 73.420000000000002 108.085 173.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.48 -47.55 57.09 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 113.716 1.006 . . . . 74.439999999999998 113.716 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -64.86 -39.24 93.24 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.906 0.384 . . . . 63.520000000000003 111.472 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.565 ' O ' HG12 ' A' ' 34' ' ' ILE . 4.5 mp0 -59.91 -35.27 74.51 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 115.749 -0.66 . . . . 74.310000000000002 111.396 177.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -67.6 -50.67 57.09 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.551 0.691 . . . . 74.019999999999996 109.367 -178.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.479 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 37.0 mtpt -61.48 -38.79 88.56 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 114.687 1.366 . . . . 73.430000000000007 114.687 -177.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -69.47 -43.45 73.18 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 111.841 0.312 . . . . 72.420000000000002 111.841 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 30' ' ' GLU . 29.4 pt -71.07 -33.91 53.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.01 0.433 . . . . 70.409999999999997 111.556 -178.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.85 -34.67 69.97 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.572 1.149 . . . . 73.530000000000001 110.372 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 91.6 mttt -77.96 -16.46 58.14 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.591 -1.186 . . . . 71.219999999999999 111.035 -177.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -123.89 18.21 9.36 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 114.209 1.189 . . . . 73.010000000000005 114.209 -164.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.532 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 33.0 m -96.2 150.72 20.22 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 120.092 -0.643 . . . . 45.200000000000003 110.365 176.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 83' ' ' ILE . 33.2 m -140.02 164.11 23.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.125 0.488 . . . . 74.319999999999993 110.271 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.702 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 13.3 t80 -110.48 134.86 51.95 Favored 'General case' 0 C--N 1.284 -2.244 0 C-N-CA 124.974 1.31 . . . . 75.109999999999999 108.736 177.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.408 HG23 HG12 ' A' ' 109' ' ' VAL . 61.4 t -121.94 118.18 54.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.499 -1.297 . . . . 74.209999999999994 107.499 174.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.421 ' HA3' ' HH ' ' A' ' 40' ' ' TYR . . . -111.16 166.33 12.26 Favored Glycine 0 C--N 1.286 -2.232 0 C-N-CA 119.276 -1.44 . . . . 73.200000000000003 113.688 -178.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.451 ' ND2' ' HB3' ' A' ' 105' ' ' ARG . 66.3 t30 56.3 27.42 11.83 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 126.137 1.775 . . . . 70.140000000000001 113.558 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.6 p -61.55 138.64 21.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 N-CA-C 108.94 -0.763 . . . . 64.200000000000003 108.94 173.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.62 150.39 39.65 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.419 -0.586 . . . . 75.5 109.419 -173.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.472 ' CD1' ' HB2' ' A' ' 77' ' ' PRO . 78.3 t80 -65.36 -14.2 60.3 Favored 'General case' 0 CA--C 1.558 1.285 0 CA-C-O 121.586 0.708 . . . . 70.340000000000003 110.232 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.53 -7.39 59.15 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 116.003 -0.544 . . . . 73.120000000000005 112.921 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.4 m -80.03 133.97 36.18 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 117.424 0.612 . . . . 75.439999999999998 110.087 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.0 p -97.62 170.71 8.83 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 120.944 -0.303 . . . . 73.230000000000004 111.069 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.457 ' HB3' HD11 ' A' ' 66' ' ' ILE . . . -62.28 -45.22 94.23 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.594 -0.521 . . . . 75.209999999999994 109.594 175.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.82 -44.9 86.72 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.084 0.554 . . . . 64.409999999999997 109.885 176.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -55.91 -43.69 77.54 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.119 0.485 . . . . 54.32 111.55 176.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.3 mt -70.86 -47.55 58.71 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.522 -0.763 . . . . 74.109999999999999 111.71 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.35 -48.0 83.31 Favored 'General case' 0 C--O 1.204 -1.326 0 C-N-CA 123.424 0.69 . . . . 63.549999999999997 110.85 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.35 -42.57 96.01 Favored 'General case' 0 C--O 1.259 1.601 0 CA-C-O 121.523 0.678 . . . . 54.240000000000002 111.151 176.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -64.26 -41.89 96.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.41 -0.813 . . . . 61.350000000000001 110.428 -175.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -81.21 -20.51 40.95 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 113.289 0.848 . . . . 70.420000000000002 113.289 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.0 t -65.85 -26.63 67.74 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.712 -0.676 . . . . 74.140000000000001 109.481 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.4 m -60.19 -33.73 72.63 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-O 121.362 0.601 . . . . 75.319999999999993 110.023 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.427 ' SG ' ' SD ' ' A' ' 97' ' ' MET . 72.6 m -92.97 4.32 54.19 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 113.699 1.0 . . . . 70.140000000000001 113.699 -177.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.44 -169.92 33.39 Favored Glycine 0 CA--C 1.497 -1.053 0 C-N-CA 118.627 -1.749 . . . . 74.099999999999994 114.623 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.9 m -102.64 127.63 49.67 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.295 -0.631 . . . . 74.0 109.295 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.6 mt -95.6 130.05 44.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 113.788 1.033 . . . . 74.450000000000003 113.788 -175.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -91.53 -44.76 8.89 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-N 115.355 -0.839 . . . . 74.209999999999994 110.908 176.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -151.46 159.51 44.16 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 115.324 -0.853 . . . . 74.530000000000001 109.669 -173.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' A' ' 50' ' ' ALA . 28.2 pt -148.34 143.52 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 107.766 -1.198 . . . . 73.420000000000002 107.766 173.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.3 m -126.2 132.21 51.82 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 106.969 -1.493 . . . . 75.219999999999999 106.969 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.453 HD11 ' N ' ' A' ' 68' ' ' ILE . 2.4 mp -127.78 123.34 60.84 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 N-CA-C 106.085 -1.82 . . . . 50.140000000000001 106.085 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.411 ' HB3' ' HA ' ' B' ' 67' ' ' THR 0.345 1.0 OUTLIER -121.17 125.39 47.06 Favored 'General case' 0 C--N 1.273 -2.76 0 C-N-CA 120.073 -0.651 . . . . 72.450000000000003 112.588 175.861 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 81.8 m -116.73 128.61 55.49 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.784 -0.821 . . . . 74.040000000000006 108.784 -177.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.579 ' HA ' ' HA ' ' B' ' 65' ' ' ARG . 2.8 p-10 -121.35 152.14 39.32 Favored 'General case' 0 C--O 1.19 -2.056 0 C-N-CA 119.647 -0.821 . . . . 70.219999999999999 110.554 -177.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -127.06 15.81 7.32 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 108.63 -0.878 . . . . 62.310000000000002 108.63 175.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.405 ' HB3' ' HB3' ' B' ' 64' ' ' ASN . 37.7 p90 -66.84 -20.57 65.96 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 119.864 -0.734 . . . . 65.219999999999999 111.453 -177.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.6 m -86.82 9.16 19.97 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 116.162 -0.472 . . . . 74.549999999999997 110.833 176.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.33 -46.15 3.19 Favored Glycine 0 CA--C 1.501 -0.811 0 N-CA-C 111.084 -0.806 . . . . 52.130000000000003 111.084 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -95.5 129.2 35.52 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 106.779 -1.563 . . . . 71.040000000000006 106.779 176.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 72.2 Cg_endo -72.61 119.27 6.01 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 121.55 1.5 . . . . 61.450000000000003 111.404 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.41 ' HZ3' ' CG ' ' A' ' 71' ' ' ASP . 29.7 mtmm -110.71 -165.61 1.01 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.4 -0.818 . . . . 74.010000000000005 109.589 -176.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.18 148.58 11.31 Favored Glycine 0 N--CA 1.407 -3.267 0 C-N-CA 120.367 -0.92 . . . . 72.230000000000004 113.166 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -149.61 143.53 25.6 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 124.512 1.125 . . . . 75.239999999999995 109.236 172.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.37 156.1 47.25 Favored 'General case' 0 C--O 1.192 -1.959 0 CA-C-O 120.664 0.269 . . . . 64.120000000000005 110.927 -172.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -124.24 124.63 42.85 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.482 -0.562 . . . . 73.299999999999997 109.482 176.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.433 HG22 HG22 ' A' ' 66' ' ' ILE . 29.1 mm -108.94 124.88 65.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 109.224 -0.658 . . . . 74.040000000000006 109.224 -177.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -102.35 119.57 39.03 Favored 'General case' 0 C--O 1.25 1.112 0 N-CA-C 108.605 -0.887 . . . . 72.329999999999998 108.605 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -98.1 157.29 16.23 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.431 0.634 . . . . 73.209999999999994 112.708 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.19 -43.09 83.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.217 -0.902 . . . . 65.25 112.339 176.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -112.89 155.92 23.85 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 121.222 0.534 . . . . 75.439999999999998 111.836 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.478 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -69.91 -35.0 74.23 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.271 -1.011 . . . . 72.340000000000003 108.271 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -21.42 66.84 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 115.759 -0.655 . . . . 50.240000000000002 112.109 -177.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.9 m -68.21 -36.28 79.29 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 109.82 -0.437 . . . . 75.129999999999995 109.82 176.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.515 ' O ' HG13 ' A' ' 95' ' ' VAL . 3.1 m -69.31 -40.03 79.68 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.054 0 N-CA-C 108.97 -0.752 . . . . 74.439999999999998 108.97 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.436 ' OD2' HG23 ' A' ' 9' ' ' THR . 3.6 m-20 -56.87 -35.95 69.49 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.765 0.793 . . . . 73.120000000000005 110.032 176.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.34 -36.2 63.64 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.62 -0.718 . . . . 63.310000000000002 111.472 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.45 -42.49 43.71 Favored 'General case' 0 C--O 1.204 -1.309 0 CA-C-N 115.733 -0.667 . . . . 61.549999999999997 111.319 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 91' ' ' VAL . 23.8 m -56.69 -22.45 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 112.756 0.65 . . . . 73.25 112.756 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.34 -9.27 52.61 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.523 0.678 . . . . 38.149999999999999 110.469 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.427 ' SD ' ' SG ' ' A' ' 60' ' ' CYS . 37.8 mtp -105.67 4.52 30.22 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.176 -0.92 . . . . 73.530000000000001 110.405 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 1.6 p-10 -44.54 -36.89 3.21 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 114.884 1.439 . . . . 72.25 114.884 -176.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -115.33 92.29 3.88 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.341 -0.944 . . . . 72.439999999999998 109.537 171.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.9 p -138.45 172.31 13.08 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.263 -1.335 . . . . 55.299999999999997 110.649 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.4 p -119.75 126.28 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-O 121.412 0.625 . . . . 74.109999999999999 110.527 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -128.16 124.03 35.82 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 108.358 -0.978 . . . . 75.140000000000001 108.358 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 49.37 33.15 5.1 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.543 1.537 . . . . 73.450000000000003 111.204 -174.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.78 0.74 87.56 Favored Glycine 0 C--N 1.308 -1.016 0 CA-C-N 115.153 -0.93 . . . . 62.509999999999998 113.39 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.451 ' HB3' ' ND2' ' A' ' 43' ' ' ASN . 58.3 mtt180 -106.6 140.46 39.44 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.395 -0.594 . . . . 71.230000000000004 109.395 175.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.1 m -80.5 119.2 22.86 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.705 -1.22 . . . . 70.230000000000004 107.705 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 38.3 pt -101.49 169.46 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 C-N-CA 120.451 -0.5 . . . . 64.349999999999994 110.527 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 53.9 tptt -134.99 134.2 40.25 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.462 -0.79 . . . . 73.140000000000001 109.67 -177.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.702 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 16.0 m -127.17 126.84 68.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 O-C-N 123.044 0.215 . . . . 74.230000000000004 111.055 174.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . 0.255 0.0 OUTLIER -145.83 144.61 22.63 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 109.2 -0.667 . . . . 74.030000000000001 109.2 176.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -62.82 139.87 76.89 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 123.191 2.594 . . . . 74.239999999999995 113.782 -175.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 38' ' ' SER . 39.7 mtpt -145.73 173.96 11.63 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.981 -0.554 . . . . 73.049999999999997 111.761 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -99.44 -32.37 11.17 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.783 -1.192 . . . . 65.129999999999995 107.783 175.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.1 m 75.41 -69.83 0.16 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.259 -1.337 . . . . 74.450000000000003 113.328 171.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.5 t30 176.49 -30.72 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 112.009 0.374 . . . . 75.340000000000003 112.009 -174.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 57.4 mtt 74.13 57.47 0.3 Allowed Pre-proline 0 N--CA 1.484 1.265 0 O-C-N 124.455 1.097 . . . . 73.109999999999999 108.26 -172.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.446 ' HB3' HD13 ' B' ' 69' ' ' LEU . 0.2 OUTLIER -19.44 -80.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.384 2.439 1 C-N-CA 126.181 4.587 . . . . 75.329999999999998 118.762 -168.519 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 171.3 -177.57 44.12 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 119.042 -1.551 . . . . 74.420000000000002 113.052 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.437 HG12 ' N ' ' A' ' 120' ' ' SER . 11.2 tt -173.02 177.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 105.332 -2.099 . . . . 74.310000000000002 105.332 -175.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.437 ' N ' HG12 ' A' ' 119' ' ' ILE . 29.5 m -77.13 92.48 3.79 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 105.48 -2.044 . . . . 75.519999999999996 105.48 168.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 49.6 m -53.78 130.54 37.21 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 114.314 1.228 . . . . 72.109999999999999 114.314 -172.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.7 t -164.3 155.04 15.14 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 105.802 -1.925 . . . . 62.109999999999999 105.802 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -148.78 -72.36 0.19 Allowed 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 120.588 -0.445 . . . . 72.010000000000005 111.888 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 . . . . . 0 C--N 1.309 -1.19 0 N-CA-C 109.506 -0.553 . . . . 74.019999999999996 109.506 -177.709 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.514 0 CA-C-O 121.713 0.768 . . . . 73.319999999999993 109.978 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 67.7 mt -83.79 121.39 36.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 115.075 -0.966 . . . . 54.530000000000001 109.192 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -161.0 129.09 2.85 Favored Pre-proline 0 C--N 1.316 -0.888 0 N-CA-C 110.158 -0.312 . . . . 65.530000000000001 110.158 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.57 104.44 1.81 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.596 2.197 . . . . 71.310000000000002 111.592 178.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 50.1 t -80.05 147.46 31.47 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.258 -0.645 . . . . 63.439999999999998 109.258 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' MET . . . . . 0.629 ' SD ' ' HB ' ' B' ' 9' ' ' THR . 24.7 ptt? -149.7 135.72 18.79 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.145 -0.687 . . . . 65.239999999999995 109.145 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -64.57 -60.05 3.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.576 0.703 . . . . 54.020000000000003 109.109 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 8.4 t -149.0 122.47 9.09 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 115.36 -0.836 . . . . 73.230000000000004 109.405 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.629 ' HB ' ' SD ' ' B' ' 6' ' ' MET . 62.2 m -150.06 87.96 1.5 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.583 0.706 . . . . 73.150000000000006 110.711 176.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -150.16 90.52 1.68 Allowed 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.024 -0.989 . . . . 65.230000000000004 108.994 174.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 34.2 t -133.76 152.83 51.98 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 108.096 -1.076 . . . . 75.010000000000005 108.096 -176.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -71.07 163.93 26.6 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.282 -1.007 . . . . 75.209999999999994 108.282 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 27.9 ttt -69.45 86.65 0.44 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.984 0.897 . . . . 63.409999999999997 111.878 -174.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 46.2 m -148.4 -75.57 0.17 Allowed 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.894 -1.048 . . . . 74.230000000000004 109.023 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . 67.59 -31.05 0.17 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.562 1.319 . . . . 70.540000000000006 114.562 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.43 -93.86 0.16 Allowed Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 110.506 -1.038 . . . . 38.149999999999999 110.506 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.02 101.79 12.01 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.318 -0.623 . . . . 73.420000000000002 109.318 177.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . 0.442 ' O ' ' HG3' ' B' ' 25' ' ' PRO . 25.7 p90 -137.71 -5.2 1.75 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.033 -0.531 . . . . 65.310000000000002 110.098 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.429 HG23 ' NZ ' ' A' ' 112' ' ' LYS . 61.4 m -75.63 82.38 2.63 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 114.571 1.323 . . . . 70.420000000000002 114.571 -175.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . 0.477 ' OE2' ' HG2' ' B' ' 23' ' ' PRO . 30.8 tt0 -133.85 126.85 31.35 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 102.938 -2.986 . . . . 74.010000000000005 102.938 176.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.78 -79.56 1.21 Allowed Glycine 0 CA--C 1.531 1.042 0 N-CA-C 115.695 1.038 . . . . 63.140000000000001 115.695 -169.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.611 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 1.6 Cg_endo -40.12 -53.79 2.38 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 125.079 3.852 . . . . 74.109999999999999 114.505 -177.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.477 ' HG2' ' OE2' ' B' ' 20' ' ' GLU . 22.1 Cg_endo -93.17 122.81 0.48 Allowed 'Trans proline' 0 N--CA 1.416 -3.074 0 N-CA-C 108.442 -1.407 . . . . 64.299999999999997 108.442 170.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -69.02 135.8 89.55 Favored Pre-proline 0 C--N 1.313 -1.012 0 C-N-CA 120.145 -0.622 . . . . 72.140000000000001 109.884 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.442 ' HG3' ' O ' ' B' ' 18' ' ' TYR . 73.3 Cg_exo -28.73 104.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.385 2.485 1 C-N-CA 125.354 4.036 . . . . 75.129999999999995 113.57 -174.587 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.437 ' H ' HD12 ' B' ' 26' ' ' LEU 0.283 0.0 OUTLIER -52.64 153.16 3.28 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 113.333 -1.758 . . . . 64.340000000000003 115.079 -176.954 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.501 ' O ' ' HG3' ' B' ' 31' ' ' LYS . 14.8 m -60.46 163.83 4.94 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 125.687 1.595 . . . . 64.530000000000001 113.35 -177.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.5 75.74 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.021 -0.536 . . . . 73.439999999999998 112.393 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -73.21 -31.07 63.94 Favored 'General case' 0 CA--C 1.49 -1.352 0 CA-C-O 120.974 0.416 . . . . 72.349999999999994 111.851 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.423 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.4 OUTLIER -60.4 -33.92 73.18 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.228 -0.896 . . . . 75.430000000000007 110.457 173.313 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' B' ' 27' ' ' SER . 95.7 mttt -69.58 -51.56 34.18 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.397 -0.594 . . . . 73.329999999999998 109.397 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.44 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 0.7 OUTLIER -53.97 -47.32 71.49 Favored 'General case' 0 C--N 1.359 1.014 0 N-CA-C 113.516 0.932 . . . . 70.340000000000003 113.516 179.474 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 11.2 mm-40 -64.81 -44.39 90.06 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.471 0.545 . . . . 75.329999999999998 112.471 -174.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.473 HD11 HH12 ' B' ' 65' ' ' ARG . 24.3 pt -70.47 -33.33 53.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.196 0.522 . . . . 73.140000000000001 110.793 -178.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -56.92 -38.41 72.83 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.182 1.393 . . . . 73.25 111.311 -177.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 90.0 mttt -75.86 -25.26 56.03 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.639 -1.164 . . . . 72.310000000000002 112.327 -176.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' B' ' 33' ' ' GLU . 20.5 ptt180 -118.72 25.69 10.07 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 114.047 1.129 . . . . 73.519999999999996 114.047 -168.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 37.1 m -96.69 148.44 22.87 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 116.642 -0.254 . . . . 72.239999999999995 111.268 175.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 29.3 m -139.97 165.29 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-O 121.09 0.471 . . . . 72.010000000000005 111.541 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . 0.677 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 9.7 t80 -114.29 132.18 56.26 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 125.68 1.592 . . . . 72.319999999999993 108.721 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 59.1 t -119.51 118.4 57.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 124.568 1.147 . . . . 75.109999999999999 108.124 174.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.38 172.51 14.33 Favored Glycine 0 C--N 1.293 -1.849 0 C-N-CA 119.339 -1.41 . . . . 72.430000000000007 113.387 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 65.7 t30 63.99 8.52 3.99 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 126.211 1.804 . . . . 72.150000000000006 114.597 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.64 126.49 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-O 121.577 0.704 . . . . 74.400000000000006 109.747 175.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.99 156.72 25.78 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.475 -0.784 . . . . 55.439999999999998 111.399 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' TYR . . . . . 0.562 ' CD2' ' HB2' ' B' ' 77' ' ' PRO . 9.4 t80 -75.36 86.3 2.53 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 106.314 -1.735 . . . . 75.329999999999998 106.314 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.83 -27.62 0.07 OUTLIER Glycine 0 N--CA 1.419 -2.481 0 N-CA-C 109.728 -1.349 . . . . 65.0 109.728 -174.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 26.6 t -84.44 148.15 26.72 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 106.749 -1.574 . . . . 74.430000000000007 106.749 173.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 50.5 p -111.74 178.07 4.44 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 110.242 -0.281 . . . . 71.319999999999993 110.242 -177.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.456 ' HB3' HD11 ' B' ' 66' ' ' ILE . . . -62.31 -47.74 82.94 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 110.19 -0.3 . . . . 75.209999999999994 110.19 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -57.48 -44.02 84.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.208 -0.451 . . . . 72.340000000000003 110.534 177.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -60.36 -40.01 89.26 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-O 121.68 0.753 . . . . 63.450000000000003 109.789 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 56.0 mt -72.64 -47.31 48.6 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.086 -0.961 . . . . 73.319999999999993 112.288 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.54 -48.68 80.7 Favored 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 123.269 0.628 . . . . 72.349999999999994 110.727 -178.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.32 -42.77 87.51 Favored 'General case' 0 C--O 1.255 1.347 0 CA-C-O 121.252 0.548 . . . . 72.409999999999997 110.925 176.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -64.14 -41.58 97.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.556 -0.747 . . . . 70.120000000000005 110.496 -176.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.405 ' CZ ' HG13 ' B' ' 109' ' ' VAL 0.268 51.7 m-85 -81.83 -20.77 38.31 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 113.747 1.017 . . . . 73.209999999999994 113.747 178.451 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 33.4 t -66.67 -24.18 66.24 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.537 -0.912 . . . . 72.25 108.537 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 15.6 m -58.94 -31.91 69.12 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 115.934 -0.575 . . . . 61.420000000000002 110.155 172.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 74.7 m -93.89 7.33 45.4 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.973 0.731 . . . . 74.219999999999999 112.973 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.72 -148.51 20.22 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 118.242 -1.933 . . . . 64.209999999999994 115.698 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 15.6 m -110.94 124.48 52.2 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.73 -0.47 . . . . 70.340000000000003 109.73 -176.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 63.8 mt -94.69 130.55 43.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 113.642 0.978 . . . . 65.019999999999996 113.642 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 93.0 m-20 -94.82 -43.55 8.17 Favored 'General case' 0 C--O 1.197 -1.658 0 CA-C-N 115.208 -0.906 . . . . 73.0 110.827 175.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.579 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 67.4 mtt180 -152.45 157.44 41.19 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 109.399 -0.593 . . . . 71.439999999999998 109.399 -175.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.456 HD11 ' HB3' ' B' ' 50' ' ' ALA . 23.2 pt -147.3 142.87 20.11 Favored 'Isoleucine or valine' 0 C--O 1.191 -2.002 0 N-CA-C 106.77 -1.567 . . . . 73.329999999999998 106.77 173.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' THR . . . . . 0.411 ' HA ' ' HB3' ' A' ' 69' ' ' LEU . 61.8 m -126.4 131.64 51.69 Favored 'General case' 0 C--N 1.272 -2.769 0 N-CA-C 106.914 -1.513 . . . . 74.019999999999996 106.914 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 3.0 mp -127.25 120.54 55.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 106.697 -1.594 . . . . 65.099999999999994 106.697 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.446 HD13 ' HB3' ' A' ' 117' ' ' PRO 0.282 1.1 pt? -120.49 127.75 52.5 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 120.065 -0.654 . . . . 50.549999999999997 111.62 177.131 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 80.1 m -116.91 130.23 56.57 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.217 -0.902 . . . . 63.210000000000001 109.342 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . 0.66 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 4.0 p30 -111.57 127.76 55.83 Favored 'General case' 0 C--O 1.216 -0.682 0 C-N-CA 119.497 -0.881 . . . . 72.349999999999994 110.488 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' B' ' 72' ' ' LYS . 33.2 ttmt -123.45 4.4 9.04 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.193 0.52 . . . . 71.230000000000004 109.931 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.459 ' CE2' ' HB2' ' B' ' 71' ' ' ASP . 53.3 p90 -64.04 -6.97 7.22 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 113.831 1.049 . . . . 70.299999999999997 113.831 -174.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 42.8 m -106.56 6.38 29.99 Favored 'General case' 0 C--N 1.313 -1.009 0 O-C-N 121.782 -0.574 . . . . 73.219999999999999 111.24 175.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.6 -61.86 0.3 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.835 -0.698 . . . . 70.209999999999994 111.745 -178.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -96.26 129.65 33.06 Favored Pre-proline 0 C--N 1.305 -1.337 0 N-CA-C 109.757 -0.46 . . . . 75.129999999999995 109.757 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.66 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 96.2 Cg_endo -79.32 126.69 7.03 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.639 2.226 . . . . 63.450000000000003 113.561 -177.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -107.35 -167.7 1.3 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.897 -1.149 . . . . 73.030000000000001 107.897 176.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.54 147.74 11.7 Favored Glycine 0 N--CA 1.415 -2.758 0 C-N-CA 119.791 -1.195 . . . . 44.25 113.576 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -151.64 144.79 24.62 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 124.502 1.121 . . . . 73.239999999999995 108.81 172.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -134.05 155.21 50.42 Favored 'General case' 0 C--O 1.194 -1.863 0 CA-C-O 120.681 0.277 . . . . 63.020000000000003 111.199 -172.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' TYR . . . . . 0.408 ' CD2' ' HD3' ' B' ' 112' ' ' LYS . 51.7 m-85 -124.32 124.09 41.63 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.279 -0.637 . . . . 61.340000000000003 109.279 176.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.452 HG22 HG22 ' B' ' 66' ' ' ILE . 30.4 mm -107.9 124.79 64.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 109.038 -0.727 . . . . 71.239999999999995 109.038 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -103.57 119.4 38.82 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.739 -1.208 . . . . 72.409999999999997 107.739 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -94.89 162.73 13.63 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 110.331 -0.248 . . . . 75.310000000000002 110.331 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.479 ' HA ' ' ND2' ' B' ' 64' ' ' ASN . . . -83.63 -21.24 32.57 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.101 0.477 . . . . 44.420000000000002 111.343 175.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . 0.449 ' HB2' ' OG ' ' B' ' 90' ' ' SER . 27.9 mt-10 -119.39 145.23 46.39 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 116.187 -0.46 . . . . 73.409999999999997 109.763 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.452 ' O ' HG22 ' B' ' 91' ' ' VAL . 0.5 OUTLIER -72.03 -34.29 68.68 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 107.203 -1.406 . . . . 71.310000000000002 107.203 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -59.31 -32.17 69.82 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.719 -1.128 . . . . 75.519999999999996 108.996 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' SER . . . . . 0.449 ' OG ' ' HB2' ' B' ' 87' ' ' GLU . 23.3 m -63.46 -35.94 82.11 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.757 -0.656 . . . . 75.409999999999997 110.955 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . 0.538 ' O ' HG13 ' B' ' 95' ' ' VAL . 3.1 m -69.35 -39.41 78.87 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.192 0 C-N-CA 119.302 -0.959 . . . . 73.109999999999999 108.678 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -57.72 -37.75 74.07 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.082 0.468 . . . . 73.299999999999997 110.811 176.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.46 -34.06 65.18 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.936 -0.575 . . . . 71.430000000000007 110.437 178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.6 -44.65 33.48 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 116.785 -0.189 . . . . 60.030000000000001 111.154 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . 0.538 HG13 ' O ' ' B' ' 91' ' ' VAL . 22.0 m -56.65 -22.85 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 112.68 0.622 . . . . 73.430000000000007 112.68 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.1 -9.33 45.5 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.349 0.595 . . . . 75.239999999999995 110.651 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 56.5 mtm -104.69 10.2 34.83 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.757 -0.656 . . . . 74.150000000000006 110.984 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . 0.264 4.1 p-10 -44.46 -44.95 8.88 Favored 'General case' 0 C--O 1.204 -1.298 0 N-CA-C 114.91 1.448 . . . . 72.140000000000001 114.91 -176.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -110.84 71.38 0.74 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-N 119.822 1.192 . . . . 74.420000000000002 112.146 167.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 47.4 p -115.84 168.43 10.06 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.115 -0.493 . . . . 73.310000000000002 111.771 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 9.6 p -100.64 136.42 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-O 121.41 0.624 . . . . 74.239999999999995 109.52 -177.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -132.39 109.91 10.18 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 107.961 -1.126 . . . . 62.229999999999997 107.961 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 49.53 32.21 4.68 Favored 'General case' 0 CA--C 1.563 1.46 0 C-N-CA 125.4 1.48 . . . . 65.219999999999999 112.628 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.22 -9.58 39.2 Favored Glycine 0 C--N 1.318 -0.428 0 C-N-CA 120.674 -0.774 . . . . 38.149999999999999 113.741 174.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -116.4 151.85 35.14 Favored 'General case' 0 C--O 1.206 -1.215 0 CA-C-N 117.135 0.467 . . . . 53.340000000000003 109.883 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 92.9 m -86.87 120.14 27.84 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.835 -1.172 . . . . 75.120000000000005 107.835 174.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 2.6 pp -102.13 166.74 2.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 119.691 -0.804 . . . . 62.439999999999998 110.267 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 54.3 tptt -125.37 132.99 52.7 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.734 -0.469 . . . . 72.510000000000005 109.734 -172.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.677 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 15.7 m -127.0 128.79 70.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.277 0.56 . . . . 65.150000000000006 111.301 176.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.333 0.4 OUTLIER -147.01 133.43 9.71 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 106.279 -1.749 . . . . 63.310000000000002 106.279 -169.802 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.5 141.78 87.81 Favored 'Trans proline' 0 N--CA 1.486 1.038 0 C-N-CA 122.504 2.136 . . . . 64.439999999999998 113.068 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.408 ' HD3' ' CD2' ' B' ' 82' ' ' TYR . 22.6 ttpp -120.42 144.87 47.71 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 109.138 -0.69 . . . . 65.439999999999998 109.138 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -106.25 162.68 13.45 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 107.227 -1.398 . . . . 73.420000000000002 107.227 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 54.3 m -134.33 -41.85 0.79 Allowed 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 112.49 0.552 . . . . 72.450000000000003 112.49 -176.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' ASN . . . . . 0.566 HD21 ' N ' ' B' ' 116' ' ' MET . 0.2 OUTLIER -89.07 134.99 33.8 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 123.592 0.757 . . . . 72.299999999999997 110.202 -173.725 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' MET . . . . . 0.566 ' N ' HD21 ' B' ' 115' ' ' ASN . 26.5 ptt? -144.19 167.96 13.8 Favored Pre-proline 0 C--N 1.304 -1.387 0 N-CA-C 105.952 -1.87 . . . . 74.439999999999998 105.952 174.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -48.03 -40.74 33.7 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 122.6 2.2 . . . . 73.129999999999995 112.361 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.71 -144.49 29.07 Favored Glycine 0 N--CA 1.436 -1.33 0 CA-C-N 115.94 -0.573 . . . . 65.129999999999995 112.054 176.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 55.4 mt 69.29 3.9 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 C-N-CA 124.175 0.99 . . . . 75.150000000000006 110.205 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 37.8 m 63.67 96.87 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.233 1.013 . . . . 65.25 111.009 -177.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 4.8 p -70.19 85.91 0.56 Allowed 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 113.913 1.079 . . . . 72.510000000000005 113.913 -176.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 24.7 m -126.16 16.07 7.84 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.047 -1.464 . . . . 74.400000000000006 107.047 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -118.49 127.47 53.67 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 113.824 -1.534 . . . . 71.129999999999995 110.132 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? . . . . . 0 C--N 1.305 -1.356 0 N-CA-C 107.243 -1.392 . . . . 64.340000000000003 107.243 178.35 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.932 0 N-CA-C 109.05 -0.722 . . . . 73.420000000000002 109.05 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.48 ' O ' HD12 ' A' ' 2' ' ' ILE . 2.5 pp -89.2 137.63 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 110.205 -0.294 . . . . 74.540000000000006 110.205 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.26 113.51 11.69 Favored Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 108.048 -1.093 . . . . 75.120000000000005 108.048 176.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.77 109.9 1.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.806 2.337 . . . . 71.340000000000003 113.295 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 63.1 m -80.51 -56.4 4.2 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 106.332 -1.729 . . . . 51.340000000000003 106.332 172.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 64.9 mtt 50.47 -159.22 0.08 Allowed 'General case' 0 C--N 1.353 0.738 0 CA-C-N 115.144 -0.934 . . . . 74.329999999999998 112.391 175.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 76.52 -19.44 0.42 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.403 1.081 . . . . 72.420000000000002 112.618 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.4 p -76.67 90.58 3.39 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 108.806 -0.813 . . . . 74.25 108.806 174.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.7 t -115.39 3.11 14.08 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 115.815 -0.63 . . . . 71.340000000000003 111.482 -174.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.613 ' HB2' ' O ' ' B' ' 25' ' ' PRO . 38.6 m80 65.16 -68.35 0.11 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.052 1.341 . . . . 65.349999999999994 112.341 178.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.4 t -166.11 114.95 0.95 Allowed 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 122.792 0.437 . . . . 70.329999999999998 110.804 -177.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -151.02 159.12 44.76 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 110.028 -0.36 . . . . 52.100000000000001 110.028 173.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -160.31 94.64 1.09 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.834 -0.802 . . . . 72.439999999999998 108.834 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.3 m 62.3 87.28 0.1 Allowed 'General case' 0 C--O 1.246 0.881 0 CA-C-O 121.925 0.869 . . . . 73.230000000000004 111.053 -175.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.07 153.06 29.01 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.393 -0.821 . . . . 54.32 111.568 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 177.08 -104.38 0.19 Allowed Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 110.337 -1.105 . . . . 64.530000000000001 110.337 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -155.98 146.5 21.82 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.685 -0.487 . . . . 65.150000000000006 109.685 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -118.08 -159.95 0.77 Allowed 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.84 -0.8 . . . . 74.510000000000005 108.84 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.2 t -80.58 152.13 28.73 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 108.973 -0.751 . . . . 62.5 108.973 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.74 -39.95 6.46 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 116.593 -0.276 . . . . 71.420000000000002 110.365 177.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 160.83 -129.81 2.22 Favored Glycine 0 N--CA 1.453 -0.223 0 N-CA-C 110.485 -1.046 . . . . 37.490000000000002 110.485 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.66 -38.56 55.91 Favored 'Trans proline' 0 CA--C 1.58 2.817 0 C-N-CA 123.938 3.092 . . . . 71.030000000000001 116.247 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -49.94 167.66 0.2 Allowed 'Trans proline' 0 C--N 1.395 2.997 0 C-N-CA 123.054 2.502 . . . . 73.420000000000002 114.064 175.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -70.8 138.49 85.52 Favored Pre-proline 0 C--N 1.309 -1.154 0 CA-C-N 115.906 -0.588 . . . . 62.049999999999997 112.476 -176.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -79.15 106.16 2.02 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 122.645 2.23 . . . . 73.239999999999995 110.647 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.547 HD11 ' H ' ' A' ' 26' ' ' LEU 0.304 0.0 OUTLIER -73.07 153.5 40.81 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 112.498 0.555 . . . . 74.420000000000002 112.498 -179.953 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -71.97 160.68 32.1 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.56 -0.745 . . . . 61.43 112.155 -173.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.48 -43.74 35.15 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 114.825 -1.08 . . . . 73.099999999999994 112.953 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -67.2 -34.19 76.98 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 119.674 -0.81 . . . . 72.120000000000005 113.036 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.519 ' O ' HG12 ' A' ' 34' ' ' ILE . 0.5 OUTLIER -60.04 -34.9 74.03 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 109.854 -0.424 . . . . 64.519999999999996 109.854 173.337 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -66.1 -40.18 90.57 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 123.639 0.587 . . . . 73.430000000000007 109.708 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.631 ' HE2' ' N ' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -64.92 -45.81 84.3 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 120.799 -0.361 . . . . 74.200000000000003 111.01 175.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -71.46 -41.08 69.86 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 113.759 1.022 . . . . 73.209999999999994 113.759 -174.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.519 HG12 ' O ' ' A' ' 30' ' ' GLU . 15.4 pt -63.06 -33.69 62.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.641 -0.424 . . . . 74.200000000000003 110.511 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.44 -38.45 81.15 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 108.949 -0.76 . . . . 62.340000000000003 108.949 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -66.01 -42.0 90.28 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 114.468 1.284 . . . . 55.420000000000002 114.468 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.626 ' HG3' ' O ' ' A' ' 85' ' ' PHE . 3.4 ptm180 -102.85 19.18 19.82 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 111.797 0.295 . . . . 75.400000000000006 111.797 -169.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.9 p -110.52 167.12 10.45 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.658 0.985 . . . . 37.490000000000002 113.658 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.7 m -140.3 164.95 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.277 1.031 . . . . 74.340000000000003 112.023 -177.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.635 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 27.9 t80 -109.89 127.03 54.47 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 124.882 1.273 . . . . 72.25 108.469 176.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.7 t -115.58 112.01 38.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 107.812 -1.181 . . . . 75.409999999999997 107.812 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.42 ' HA3' ' CZ ' ' A' ' 40' ' ' TYR . . . -121.62 -177.34 15.48 Favored Glycine 0 N--CA 1.435 -1.385 0 C-N-CA 119.556 -1.307 . . . . 73.319999999999993 114.738 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.3 t30 72.7 -7.35 1.45 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.062 2.145 . . . . 73.230000000000004 112.475 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.78 103.55 4.13 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.929 0 CA-C-O 121.488 0.661 . . . . 63.109999999999999 109.866 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -81.06 83.57 6.71 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 114.162 1.171 . . . . 72.209999999999994 114.162 -168.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.466 ' CD1' ' HB2' ' A' ' 77' ' ' PRO . 63.6 t80 68.22 -20.52 0.14 Allowed 'General case' 0 CA--C 1.577 1.989 0 N-CA-C 115.526 1.676 . . . . 73.120000000000005 115.526 163.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.27 5.35 45.15 Favored Glycine 0 C--O 1.241 0.577 0 N-CA-C 116.912 1.525 . . . . 51.020000000000003 116.912 -169.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.417 ' HG ' ' HG ' ' A' ' 53' ' ' LEU . 14.2 t -87.65 147.74 25.12 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 119.318 1.559 . . . . 73.329999999999998 109.885 176.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.408 HG21 HG22 ' B' ' 49' ' ' THR . 82.6 p -97.37 158.92 15.22 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.007 -0.542 . . . . 71.329999999999998 111.207 -176.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.425 ' HB3' HD11 ' A' ' 66' ' ' ILE . . . -65.16 -48.25 74.19 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 122.557 0.343 . . . . 54.310000000000002 110.835 -177.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.01 -40.3 80.46 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.333 0.494 . . . . 72.329999999999998 112.333 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.9 -38.06 76.18 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.216 0.531 . . . . 72.120000000000005 110.515 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.417 ' HG ' ' HG ' ' A' ' 48' ' ' SER . 40.2 mt -68.77 -47.2 66.82 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.381 -0.827 . . . . 64.25 111.209 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -61.92 -48.19 81.54 Favored 'General case' 0 C--O 1.202 -1.433 0 CA-C-N 115.755 -0.657 . . . . 72.239999999999995 110.875 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.65 -43.99 80.86 Favored 'General case' 0 C--O 1.26 1.609 0 CA-C-O 121.789 0.804 . . . . 52.439999999999998 111.256 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -64.77 -38.51 91.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.667 -1.152 . . . . 74.439999999999998 110.355 -176.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -82.33 -21.64 35.94 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.496 0.925 . . . . 74.5 113.496 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.7 t -70.63 -23.88 62.61 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.845 -0.616 . . . . 74.409999999999997 109.78 -176.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.8 m -59.97 -27.27 66.69 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-O 121.055 0.455 . . . . 75.200000000000003 110.36 173.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 62.7 m -92.66 7.93 41.32 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 112.568 0.581 . . . . 73.019999999999996 112.568 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.67 -169.82 25.04 Favored Glycine 0 CA--C 1.505 -0.538 0 C-N-CA 119.559 -1.305 . . . . 74.340000000000003 113.28 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.1 m -96.08 126.44 41.32 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 121.614 0.721 . . . . 71.140000000000001 110.156 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.5 mt -85.02 134.38 27.16 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.398 0 CA-C-N 114.938 -1.028 . . . . 75.310000000000002 112.462 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.432 ' OD1' ' HB3' ' B' ' 73' ' ' PHE . 50.9 t-20 -89.72 -54.24 4.15 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.633 -1.167 . . . . 73.439999999999998 108.51 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.423 ' HG3' ' OD1' ' A' ' 64' ' ' ASN . 66.0 mtp180 -154.34 164.17 39.02 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 106.624 -1.621 . . . . 74.239999999999995 106.624 -176.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.443 HG13 HD11 ' A' ' 68' ' ' ILE . 31.4 pt -143.59 142.59 24.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 107.166 -1.42 . . . . 73.310000000000002 107.166 172.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.7 m -124.81 125.14 43.54 Favored 'General case' 0 C--N 1.273 -2.726 0 N-CA-C 107.912 -1.144 . . . . 63.140000000000001 107.912 -177.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.443 HD11 HG13 ' A' ' 66' ' ' ILE . 3.0 mp -123.57 116.39 48.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 106.139 -1.8 . . . . 74.219999999999999 106.139 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.465 ' HG ' ' CE1' ' A' ' 80' ' ' TYR 0.286 0.8 OUTLIER -121.43 128.79 52.53 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 120.376 -0.53 . . . . 62.439999999999998 112.372 179.525 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 74.3 m -117.48 130.61 56.56 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 109.031 -0.729 . . . . 72.450000000000003 109.031 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.483 ' HA ' ' HA ' ' B' ' 65' ' ' ARG . 3.1 p30 -118.63 146.49 44.61 Favored 'General case' 0 CA--C 1.484 -1.588 0 C-N-CA 120.024 -0.67 . . . . 73.319999999999993 110.691 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -120.1 11.1 11.58 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.681 -0.859 . . . . 74.409999999999997 108.681 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.586 ' HB3' ' OD1' ' B' ' 64' ' ' ASN . 10.8 p90 -66.82 -19.95 65.84 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 120.325 -0.55 . . . . 75.439999999999998 110.958 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 31.2 t -79.59 -1.21 36.95 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 115.111 -0.95 . . . . 55.009999999999998 110.045 178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.47 -51.39 1.58 Allowed Glycine 0 CA--C 1.491 -1.458 0 N-CA-C 110.093 -1.203 . . . . 73.200000000000003 110.093 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -96.08 133.48 25.1 Favored Pre-proline 0 C--N 1.29 -2.004 0 N-CA-C 106.683 -1.599 . . . . 75.519999999999996 106.683 175.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.466 ' HB2' ' CD1' ' A' ' 46' ' ' TYR . 63.3 Cg_endo -71.06 118.76 5.86 Favored 'Trans proline' 0 N--CA 1.44 -1.652 0 C-N-CA 121.081 1.188 . . . . 70.329999999999998 111.001 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm -101.07 158.35 16.08 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.594 -1.184 . . . . 74.400000000000006 109.607 -175.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.25 138.69 10.07 Favored Glycine 0 N--CA 1.418 -2.531 0 C-N-CA 120.497 -0.859 . . . . 62.5 112.581 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.465 ' CE1' ' HG ' ' A' ' 69' ' ' LEU . 12.6 p90 -154.79 144.18 21.27 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 123.905 0.882 . . . . 70.349999999999994 110.32 174.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.75 150.03 52.21 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 116.026 -0.533 . . . . 74.25 109.658 -172.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.646 ' CD2' ' HD3' ' A' ' 112' ' ' LYS . 90.2 m-85 -126.74 130.85 51.14 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.738 -0.838 . . . . 72.340000000000003 108.738 177.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.1 mm -108.78 117.08 53.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 109.301 -0.629 . . . . 73.109999999999999 109.301 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -93.17 119.24 32.14 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.716 -0.846 . . . . 65.329999999999998 108.716 176.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.626 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 95.6 m-85 -96.02 161.95 13.76 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 112.753 0.649 . . . . 74.010000000000005 112.753 -178.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.0 -15.55 60.65 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 115.264 -0.88 . . . . 74.319999999999993 111.424 174.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.5 161.33 42.33 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 118.504 -1.279 . . . . 73.140000000000001 111.857 177.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.548 ' O ' HG11 ' A' ' 91' ' ' VAL . 6.4 mmm180 -64.21 -34.95 79.27 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 114.338 -1.301 . . . . 74.530000000000001 110.843 173.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -61.24 -33.52 73.65 Favored 'General case' 0 CA--C 1.509 -0.61 0 C-N-CA 120.13 -0.628 . . . . 72.109999999999999 111.036 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.0 m -69.67 -40.28 76.49 Favored 'General case' 0 N--CA 1.42 -1.952 0 O-C-N 122.299 -0.251 . . . . 73.150000000000006 111.213 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.548 HG11 ' O ' ' A' ' 88' ' ' ARG 0.266 0.2 OUTLIER -65.63 -47.31 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 120.586 -0.446 . . . . 73.200000000000003 111.954 176.626 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.13 -32.41 68.12 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.192 0.52 . . . . 63.310000000000002 111.727 176.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.08 -36.51 64.29 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.204 0.526 . . . . 52.340000000000003 111.884 177.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.68 -43.76 45.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.688 -0.687 . . . . 71.349999999999994 111.943 -176.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.2 m -50.92 -22.42 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 113.025 0.75 . . . . 74.230000000000004 113.025 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.24 -11.45 50.18 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.919 0.39 . . . . 63.409999999999997 111.438 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 68.5 mtm -99.48 7.41 45.42 Favored 'General case' 0 C--O 1.216 -0.695 0 CA-C-N 116.29 -0.414 . . . . 72.409999999999997 110.929 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.51 ' HA ' HG12 ' A' ' 109' ' ' VAL . 3.6 p-10 -42.86 -41.33 3.24 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.707 1.373 . . . . 73.439999999999998 114.707 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -111.83 100.34 8.84 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.792 -0.818 . . . . 73.329999999999998 108.792 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 106' ' ' THR . 11.2 t -151.08 166.3 31.19 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.899 -0.591 . . . . 74.420000000000002 109.451 -177.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.89 118.61 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-O 121.825 0.821 . . . . 61.119999999999997 109.647 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -134.28 121.58 21.48 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.002 -0.999 . . . . 74.420000000000002 108.762 -177.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 54.0 54.84 9.1 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 114.538 1.31 . . . . 74.319999999999993 114.538 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.53 3.16 53.2 Favored Glycine 0 N--CA 1.468 0.829 0 CA-C-N 114.901 -1.045 . . . . 70.540000000000006 115.642 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -135.29 157.0 48.01 Favored 'General case' 0 C--N 1.298 -1.63 0 CA-C-N 117.399 0.6 . . . . 75.129999999999995 111.349 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 100' ' ' THR . 33.9 m -88.31 120.01 29.27 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.834 -1.543 . . . . 65.439999999999998 106.834 175.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 44.8 pt -101.69 171.14 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 119.31 -0.956 . . . . 75.530000000000001 110.709 -176.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 55.4 tptt -129.33 125.75 37.4 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.163 -0.68 . . . . 71.010000000000005 109.163 -176.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 12.1 p -129.78 121.85 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-O 121.158 0.504 . . . . 62.140000000000001 111.61 178.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.89 159.91 42.01 Favored Pre-proline 0 C--N 1.294 -1.827 0 N-CA-C 107.085 -1.45 . . . . 75.219999999999999 107.085 -178.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.71 134.12 52.24 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.279 1.986 . . . . 75.420000000000002 113.508 -175.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.646 ' HD3' ' CD2' ' A' ' 82' ' ' TYR . 35.5 ttpt -80.94 101.78 9.7 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 105.46 -2.052 . . . . 65.219999999999999 105.46 173.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -132.13 123.97 28.2 Favored 'General case' 0 C--N 1.288 -2.076 0 C-N-CA 119.895 -0.722 . . . . 72.5 112.174 -168.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 91.5 m -82.37 106.3 14.14 Favored 'General case' 0 N--CA 1.4 -2.966 0 N-CA-C 105.45 -2.056 . . . . 75.349999999999994 105.45 172.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -76.99 104.28 7.4 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.863 0.84 . . . . 71.329999999999998 112.063 -172.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 21.2 ptp -140.25 156.01 70.1 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 106.638 -1.615 . . . . 74.150000000000006 106.638 177.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -51.16 -46.95 28.17 Favored 'Trans proline' 0 C--O 1.24 0.582 0 C-N-CA 122.869 2.38 . . . . 65.049999999999997 112.183 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 169.48 -179.53 41.95 Favored Glycine 0 N--CA 1.425 -2.086 0 N-CA-C 110.106 -1.197 . . . . 62.140000000000001 110.106 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.421 HD11 ' N ' ' A' ' 119' ' ' ILE . 1.9 mp -82.12 82.32 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 108.962 -0.755 . . . . 64.349999999999994 108.962 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.8 t -174.47 -36.94 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.095 -1.446 . . . . 73.120000000000005 107.095 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 39.4 p -72.92 108.73 6.01 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 106.834 -1.543 . . . . 62.200000000000003 106.834 173.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.6 m 67.68 76.31 0.27 Allowed 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.0 -1.481 . . . . 70.409999999999997 107.0 -168.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -85.43 107.39 17.38 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-N 115.055 -0.975 . . . . 70.519999999999996 110.813 -174.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 . . . . . 0 C--N 1.296 -1.744 0 CA-C-N 115.0 -1.0 . . . . 72.150000000000006 108.83 177.191 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.595 0 N-CA-C 109.651 -0.5 . . . . 45.130000000000003 109.651 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.461 ' O ' HD13 ' B' ' 2' ' ' ILE . 2.4 pp -123.31 136.8 58.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 112.744 0.646 . . . . 73.439999999999998 112.744 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.34 152.09 18.03 Favored Pre-proline 0 C--N 1.293 -1.889 0 N-CA-C 106.28 -1.748 . . . . 72.400000000000006 106.28 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -52.56 117.25 3.48 Favored 'Trans proline' 0 C--O 1.246 0.903 0 C-N-CA 122.627 2.218 . . . . 63.009999999999998 111.835 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 13.3 p -77.99 -27.03 48.95 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.109 -0.496 . . . . 65.319999999999993 110.671 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -81.11 150.16 28.86 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.66 -0.7 . . . . 61.310000000000002 110.006 176.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -152.05 134.69 15.43 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 107.644 -1.243 . . . . 74.209999999999994 107.644 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 15.0 m -111.4 94.08 4.79 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.267 0.556 . . . . 72.450000000000003 110.177 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 23.0 p -137.48 147.64 45.42 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.776 -1.194 . . . . 74.099999999999994 107.776 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . 0.262 11.1 p80 -78.04 69.35 4.25 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.582 0.956 . . . . 72.439999999999998 113.582 -177.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 71.8 m -178.81 112.22 0.06 Allowed 'General case' 0 C--O 1.24 0.566 0 C-N-CA 128.255 2.622 . . . . 73.409999999999997 107.448 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -109.25 16.74 22.21 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.723 -0.843 . . . . 65.329999999999998 108.723 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.04 121.71 6.4 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.99 -1.004 . . . . 74.340000000000003 110.621 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 29.5 m -82.71 -28.48 30.48 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.874 0.845 . . . . 64.430000000000007 108.764 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.46 116.07 7.17 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 114.99 -1.005 . . . . 74.140000000000001 108.427 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.96 -80.82 0.05 OUTLIER Glycine 0 N--CA 1.427 -1.926 0 C-N-CA 120.423 -0.894 . . . . 53.32 111.429 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -101.61 103.83 14.66 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.257 0.551 . . . . 72.430000000000007 110.429 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -145.92 127.25 14.89 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.354 -1.35 . . . . 73.230000000000004 107.354 177.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 48.5 m -80.58 94.18 6.24 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 120.977 0.418 . . . . 70.040000000000006 111.819 -174.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . 0.657 ' HB2' ' O ' ' B' ' 23' ' ' PRO . 33.6 mt-10 -69.46 -33.28 72.69 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.923 -0.769 . . . . 51.130000000000003 108.923 175.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.31 -95.19 1.34 Allowed Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.749 -0.659 . . . . 71.530000000000001 111.787 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.509 ' HD2' ' O ' ' B' ' 20' ' ' GLU . 2.0 Cg_endo -47.51 -56.91 2.66 Favored 'Trans proline' 0 CA--C 1.582 2.895 0 C-N-CA 122.478 2.119 . . . . 73.329999999999998 111.464 171.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.657 ' O ' ' HB2' ' B' ' 20' ' ' GLU . 11.8 Cg_endo -89.52 136.37 2.72 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 121.406 1.404 . . . . 60.310000000000002 109.161 169.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -100.69 139.2 20.4 Favored Pre-proline 0 C--N 1.288 -2.073 0 C-N-CA 119.403 -0.919 . . . . 73.400000000000006 109.93 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.613 ' O ' ' HB2' ' A' ' 10' ' ' HIS . 39.1 Cg_exo -29.55 124.07 0.06 OUTLIER 'Trans proline' 0 C--N 1.361 1.216 1 C-N-CA 125.674 4.249 . . . . 52.350000000000001 114.069 -175.34 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.565 HD11 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -56.09 169.34 0.4 Allowed 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.384 -0.826 . . . . 53.219999999999999 113.053 178.542 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.473 ' O ' ' HG3' ' B' ' 31' ' ' LYS . 8.4 t -74.57 165.03 25.89 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.38 0.61 . . . . 45.219999999999999 111.925 -172.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.15 -46.41 65.43 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 114.685 -1.143 . . . . 62.439999999999998 113.873 -175.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -65.02 -39.39 93.31 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 112.001 0.371 . . . . 74.129999999999995 112.001 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.484 ' O ' HG12 ' B' ' 34' ' ' ILE . 4.0 mp0 -60.02 -34.82 73.88 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 116.064 -0.516 . . . . 75.109999999999999 110.301 174.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' B' ' 27' ' ' SER . 97.5 mttt -65.37 -41.39 93.82 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.521 -0.548 . . . . 75.409999999999997 109.521 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.591 ' HE2' ' N ' ' B' ' 32' ' ' LYS . 0.5 OUTLIER -63.46 -46.73 84.89 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 120.796 -0.362 . . . . 62.409999999999997 111.138 176.188 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -71.75 -37.86 70.49 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 113.915 1.08 . . . . 74.409999999999997 113.915 -174.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.484 HG12 ' O ' ' B' ' 30' ' ' GLU . 17.9 pt -67.3 -34.04 66.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 C-N-CA 120.136 -0.626 . . . . 64.439999999999998 110.649 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -68.73 -44.82 73.02 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.892 -1.151 . . . . 62.509999999999998 107.892 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' B' ' 32' ' ' LYS . 33.6 ttmt -63.01 -36.16 82.64 Favored 'General case' 0 CA--C 1.558 1.254 0 CA-C-N 114.235 -1.348 . . . . 71.420000000000002 111.864 -177.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -102.0 14.05 33.03 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.33 0.863 . . . . 75.430000000000007 113.33 -174.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' SER . . . . . 0.585 ' OG ' ' HE2' ' B' ' 112' ' ' LYS . 39.1 t -103.03 163.81 11.99 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 113.238 0.829 . . . . 74.219999999999999 113.238 -177.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.427 ' CG1' HG23 ' B' ' 91' ' ' VAL . 11.8 m -137.25 163.49 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 124.502 1.121 . . . . 71.400000000000006 111.475 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . 0.685 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 29.1 t80 -111.6 125.6 54.11 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 125.248 1.419 . . . . 70.340000000000003 108.433 177.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 58.1 t -112.78 110.59 32.77 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 106.953 -1.499 . . . . 73.25 106.953 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.95 171.36 13.86 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 119.551 -1.309 . . . . 73.219999999999999 113.61 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 65.4 t30 65.79 9.21 5.84 Favored 'General case' 0 C--O 1.213 -0.852 0 C-N-CA 126.321 1.848 . . . . 75.010000000000005 111.459 -177.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.14 118.6 6.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.386 -0.968 . . . . 62.100000000000001 108.386 174.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -68.38 145.47 54.11 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.328 -0.851 . . . . 74.140000000000001 111.405 -173.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -61.45 90.2 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 114.626 -1.17 . . . . 72.150000000000006 108.016 177.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.39 -16.77 0.35 Allowed Glycine 0 N--CA 1.426 -2.005 0 CA-C-N 115.334 -0.848 . . . . 61.32 112.521 -175.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 68.0 m -72.29 148.62 45.25 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 118.026 0.913 . . . . 64.310000000000002 109.244 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' THR . . . . . 0.408 HG22 HG21 ' A' ' 49' ' ' THR . 59.3 p -99.63 162.5 12.98 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.735 -0.386 . . . . 74.200000000000003 111.327 -177.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.419 ' HB3' HD11 ' B' ' 66' ' ' ILE . . . -65.1 -45.35 85.53 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 122.712 0.405 . . . . 74.540000000000006 109.981 178.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.9 -49.94 74.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.667 -0.697 . . . . 75.340000000000003 110.129 178.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -61.31 -40.64 94.93 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 121.038 0.447 . . . . 73.510000000000005 110.742 -177.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 45.5 mt -65.44 -47.56 75.75 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.574 -0.739 . . . . 64.129999999999995 111.895 177.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.22 -48.6 77.6 Favored 'General case' 0 C--O 1.2 -1.55 0 C-N-CA 122.612 0.365 . . . . 74.030000000000001 110.781 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.35 -41.23 75.77 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 120.87 0.367 . . . . 71.299999999999997 110.842 178.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -67.96 -37.59 81.75 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.881 -0.6 . . . . 75.430000000000007 110.156 -176.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -82.25 -21.97 36.04 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 113.386 0.884 . . . . 63.509999999999998 113.386 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 25.7 t -71.92 -24.45 61.64 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.813 -0.63 . . . . 75.439999999999998 109.532 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 28.1 m -62.46 -26.29 68.44 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.255 0.55 . . . . 72.409999999999997 109.803 172.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 63.5 m -110.08 15.33 22.55 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.242 -0.436 . . . . 72.400000000000006 111.383 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.98 173.77 39.64 Favored Glycine 0 C--O 1.216 -1.026 0 C-N-CA 118.29 -1.909 . . . . 53.109999999999999 115.197 -177.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 10.2 p -73.23 -69.39 0.42 Allowed 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.015 0.436 . . . . 60.030000000000001 111.718 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . 0.358 57.5 mt 102.71 112.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 C-N-CA 127.302 2.241 . . . . 64.430000000000007 111.839 177.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . 0.586 ' OD1' ' HB3' ' A' ' 73' ' ' PHE . 32.5 t30 -90.66 -49.9 6.22 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 113.604 -1.634 . . . . 72.349999999999994 109.548 -177.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 65.1 mtp180 -154.58 162.88 40.93 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 106.841 -1.541 . . . . 74.230000000000004 106.841 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.438 HD12 HG22 ' B' ' 66' ' ' ILE . 24.4 pt -144.0 142.14 24.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 106.676 -1.601 . . . . 74.530000000000001 106.676 172.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 34.2 m -125.17 125.01 43.01 Favored 'General case' 0 C--N 1.27 -2.869 0 N-CA-C 107.86 -1.163 . . . . 74.430000000000007 107.86 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.4 mp -122.72 116.18 48.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.18 -1.785 . . . . 70.420000000000002 106.18 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.519 ' HG ' ' CE1' ' B' ' 80' ' ' TYR 0.272 0.9 OUTLIER -121.19 128.86 52.87 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-O 121.031 0.444 . . . . 64.450000000000003 112.006 179.584 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 75.2 m -117.21 133.6 55.8 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.653 -0.869 . . . . 73.219999999999999 108.653 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 4.1 p30 -117.58 134.53 54.77 Favored 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 119.281 -0.968 . . . . 71.239999999999995 110.433 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -124.26 5.94 8.45 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.1 0.476 . . . . 64.150000000000006 109.95 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.432 ' HB3' ' OD1' ' A' ' 64' ' ' ASN . 53.8 p90 -60.47 -25.96 66.43 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.16 0.8 . . . . 75.310000000000002 113.16 -177.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 41.9 m -87.92 6.57 35.06 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 120.865 -0.334 . . . . 63.5 111.095 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.04 -58.17 0.42 Allowed Glycine 0 N--CA 1.437 -1.274 0 N-CA-C 111.445 -0.662 . . . . 52.119999999999997 111.445 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -95.41 127.6 41.44 Favored Pre-proline 0 C--N 1.307 -1.257 0 N-CA-C 109.574 -0.528 . . . . 74.340000000000003 109.574 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 96.8 Cg_endo -76.56 122.78 6.63 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.759 2.306 . . . . 75.200000000000003 112.805 -177.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -106.15 159.27 16.21 Favored 'General case' 0 CA--C 1.484 -1.579 0 CA-C-N 115.263 -0.881 . . . . 75.439999999999998 111.477 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -132.56 136.43 8.73 Favored Glycine 0 N--CA 1.422 -2.266 0 C-N-CA 120.571 -0.823 . . . . 37.490000000000002 113.252 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . 0.519 ' CE1' ' HG ' ' B' ' 69' ' ' LEU . 11.7 p90 -152.68 143.55 22.93 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 124.24 1.016 . . . . 63.409999999999997 110.198 174.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.49 150.34 52.17 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 116.168 -0.469 . . . . 62.340000000000003 109.971 -173.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' TYR . . . . . 0.783 ' CD1' ' HD3' ' B' ' 112' ' ' LYS . 96.1 m-85 -126.53 129.9 49.52 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.995 -0.743 . . . . 65.450000000000003 108.995 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.421 HG23 HG21 ' B' ' 66' ' ' ILE . 34.2 mm -108.75 115.47 49.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 109.358 -0.608 . . . . 75.450000000000003 109.358 -177.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -91.51 119.19 31.24 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.546 -0.538 . . . . 62.149999999999999 109.546 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -98.78 156.67 16.74 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.956 -0.465 . . . . 72.140000000000001 109.761 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.35 -17.9 44.02 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.277 0.561 . . . . 73.120000000000005 110.379 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . 0.42 ' HB3' ' OD1' ' B' ' 89' ' ' ASN . 28.6 mt-10 -124.47 140.96 52.46 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.579 -0.737 . . . . 75.25 111.111 -177.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -63.71 -33.72 76.27 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.34 0.59 . . . . 75.010000000000005 110.454 172.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . 0.42 ' OD1' ' HB3' ' B' ' 87' ' ' GLU . 2.8 p-10 -61.94 -32.22 72.62 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.564 -0.744 . . . . 73.230000000000004 112.278 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' SER . . . . . 0.411 ' OG ' ' HB2' ' B' ' 87' ' ' GLU . 15.2 m -67.85 -41.24 83.21 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 120.834 0.35 . . . . 54.409999999999997 110.655 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . 0.427 HG23 ' CG1' ' B' ' 39' ' ' VAL 0.325 0.4 OUTLIER -65.87 -44.7 92.63 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 112.722 0.638 . . . . 74.430000000000007 112.722 178.667 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -59.51 -33.03 70.84 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.942 0.401 . . . . 64.109999999999999 112.006 174.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.79 -37.22 65.01 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 120.819 0.343 . . . . 65.230000000000004 110.521 177.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.12 -44.38 54.03 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.075 0.398 . . . . 63.299999999999997 112.075 -176.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . 0.401 HG11 ' O ' ' B' ' 91' ' ' VAL . 29.7 m -51.65 -22.42 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 113.632 0.975 . . . . 61.0 113.632 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.2 -17.56 63.66 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.988 0.423 . . . . 65.319999999999993 111.439 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 60.2 mtm -95.47 6.86 47.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.33 -0.395 . . . . 73.209999999999994 110.932 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . 0.595 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 5.2 p-10 -39.27 -47.62 1.71 Allowed 'General case' 0 C--O 1.204 -1.324 0 N-CA-C 114.925 1.454 . . . . 70.420000000000002 114.925 -176.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -113.37 92.62 4.06 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 119.267 0.94 . . . . 73.299999999999997 109.718 176.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' B' ' 106' ' ' THR . 31.6 p -142.16 173.59 11.38 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.671 -1.15 . . . . 71.040000000000006 110.989 -178.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.16 129.33 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.761 0 CA-C-O 121.559 0.695 . . . . 72.150000000000006 110.036 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -135.57 121.59 20.02 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.897 -1.149 . . . . 72.209999999999994 107.897 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 48.1 ttt-85 60.01 33.42 21.36 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 122.155 0.979 . . . . 70.430000000000007 111.23 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.38 -5.23 80.71 Favored Glycine 0 C--N 1.317 -0.491 0 CA-C-N 114.847 -1.069 . . . . 72.129999999999995 114.507 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -129.47 156.9 43.37 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 117.827 0.814 . . . . 73.230000000000004 111.458 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 106' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' B' ' 100' ' ' THR . 62.9 m -80.76 120.49 24.71 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 116.352 -0.385 . . . . 75.140000000000001 110.282 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 44.5 pt -102.06 171.99 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.983 -0.377 . . . . 71.510000000000005 109.983 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . 0.595 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 55.6 tptt -134.06 127.47 32.27 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.803 -0.814 . . . . 75.209999999999994 108.803 -178.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.685 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 8.3 p -129.25 122.66 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-O 121.07 0.462 . . . . 64.319999999999993 111.684 177.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.37 159.59 41.52 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 107.026 -1.472 . . . . 74.140000000000001 107.026 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.96 131.03 35.1 Favored 'Trans proline' 0 N--CA 1.48 0.719 0 C-N-CA 122.476 2.117 . . . . 71.010000000000005 113.039 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.783 ' HD3' ' CD1' ' B' ' 82' ' ' TYR . 37.1 ttpt -78.41 93.24 4.69 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 108.93 -0.767 . . . . 60.229999999999997 108.93 178.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 58.63 120.35 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.676 0 O-C-N 125.141 1.526 . . . . 75.230000000000004 111.78 -173.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 15.9 m -97.67 82.46 3.06 Favored 'General case' 0 N--CA 1.407 -2.591 0 C-N-CA 118.147 -1.421 . . . . 75.140000000000001 110.318 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -91.93 91.48 7.9 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.02 -1.104 . . . . 72.239999999999995 108.02 176.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 26.6 ttt -162.65 137.23 5.04 Favored Pre-proline 0 C--N 1.293 -1.88 0 N-CA-C 107.832 -1.174 . . . . 63.039999999999999 107.832 -174.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -65.78 109.61 1.5 Allowed 'Trans proline' 0 N--CA 1.441 -1.58 0 C-N-CA 121.235 1.29 . . . . 61.109999999999999 109.947 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.98 -45.55 95.89 Favored Glycine 0 CA--C 1.493 -1.312 0 N-CA-C 110.429 -1.069 . . . . 74.049999999999997 110.429 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 10.0 tt -79.25 127.37 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.062 0 N-CA-C 108.347 -0.983 . . . . 64.239999999999995 108.347 174.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 38.7 m -69.52 117.0 10.59 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 108.74 -0.837 . . . . 74.129999999999995 108.74 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 32.8 m -62.66 98.4 0.12 Allowed 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.838 0.828 . . . . 72.430000000000007 111.01 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 25.4 p -138.61 -165.46 1.82 Allowed 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 114.12 -1.4 . . . . 73.010000000000005 107.423 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -77.99 -25.77 48.26 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.063 0.459 . . . . 63.549999999999997 110.461 177.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? . . . . . 0 C--N 1.308 -1.214 0 N-CA-C 107.653 -1.24 . . . . 74.340000000000003 107.653 179.569 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.28 0 CA-C-O 120.744 0.307 . . . . 51.140000000000001 110.278 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.2 pt -116.02 137.47 49.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-O 120.931 0.396 . . . . 73.120000000000005 110.719 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.19 144.11 62.04 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 108.835 -0.802 . . . . 73.25 108.835 175.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -61.36 144.63 98.51 Favored 'Trans proline' 0 C--O 1.243 0.727 0 C-N-CA 122.537 2.158 . . . . 74.150000000000006 111.918 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 68.4 m -73.28 108.68 6.29 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 116.299 -0.409 . . . . 71.439999999999998 109.924 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 66.3 mtt -86.09 153.4 22.13 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.894 -0.594 . . . . 74.420000000000002 109.445 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -122.27 137.29 54.89 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.002 0.429 . . . . 75.340000000000003 111.342 -176.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 t -150.92 102.39 2.97 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.478 -0.934 . . . . 70.040000000000006 108.478 176.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p -88.27 132.9 34.21 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 116.017 -0.538 . . . . 74.409999999999997 111.67 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -90.73 165.18 13.81 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.003 -1.11 . . . . 72.540000000000006 108.003 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.4 t -82.19 152.97 26.2 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.056 -0.72 . . . . 71.239999999999995 109.056 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -87.6 168.7 12.8 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.07 -0.715 . . . . 74.299999999999997 109.07 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.3 mtt -71.79 94.31 1.39 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.399 0.619 . . . . 75.310000000000002 111.384 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.0 p -82.17 134.07 35.29 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.169 -0.923 . . . . 70.439999999999998 111.326 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -98.28 170.89 8.56 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.802 -0.636 . . . . 70.239999999999995 110.437 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.98 39.38 6.15 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 116.233 -0.439 . . . . 74.319999999999993 112.146 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -108.56 105.56 15.24 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 110.028 -0.36 . . . . 72.030000000000001 110.028 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -136.37 -53.29 0.73 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.49 -0.323 . . . . 73.200000000000003 111.539 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.9 t -134.6 145.73 48.92 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-O 121.277 0.561 . . . . 52.439999999999998 112.175 -177.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -137.11 -20.08 1.26 Allowed 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 125.208 1.403 . . . . 74.200000000000003 109.232 176.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.451 ' HA2' ' CE1' ' B' ' 40' ' ' TYR . . . 74.43 -167.06 54.79 Favored Glycine 0 N--CA 1.429 -1.77 0 CA-C-N 114.919 -1.037 . . . . 51.340000000000003 111.598 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.645 ' CA ' ' HH ' ' B' ' 82' ' ' TYR . 14.5 Cg_exo -57.74 -39.86 84.01 Favored 'Trans proline' 0 CA--C 1.564 1.998 0 C-N-CA 122.715 2.277 . . . . 75.230000000000004 117.384 -178.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -90.64 167.49 4.03 Favored 'Trans proline' 0 N--CA 1.416 -3.046 0 N-CA-C 115.93 1.473 . . . . 73.25 115.93 -169.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.498 ' HG2' ' NH1' ' A' ' 65' ' ' ARG . 19.3 mt-30 -93.93 117.26 67.18 Favored Pre-proline 0 N--CA 1.379 -3.976 0 N-CA-C 103.912 -2.625 . . . . 72.400000000000006 103.912 175.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.529 ' C ' HD12 ' A' ' 26' ' ' LEU . 74.2 Cg_endo -84.95 96.5 0.66 Allowed 'Trans proline' 0 C--O 1.249 1.047 0 C-N-CA 121.941 1.761 . . . . 73.230000000000004 112.636 -177.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.529 HD12 ' C ' ' A' ' 25' ' ' PRO . 4.7 mp -142.09 169.54 17.4 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.52 -1.218 . . . . 72.310000000000002 109.425 -178.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 68.6 m -74.43 148.79 40.8 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 108.337 -0.986 . . . . 64.430000000000007 108.337 170.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.29 -45.53 62.2 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 111.944 0.35 . . . . 70.310000000000002 111.944 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -61.47 -37.24 82.87 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.951 0.405 . . . . 75.140000000000001 111.449 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.472 ' HB3' HD23 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -61.75 -40.09 93.88 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.749 -0.66 . . . . 71.510000000000005 111.222 175.955 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -73.97 -38.96 64.01 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.723 -0.473 . . . . 72.409999999999997 109.723 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 51.6 mtpt -59.2 -41.9 89.64 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.586 0.587 . . . . 71.5 112.586 176.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -67.57 -40.84 84.86 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.416 0.525 . . . . 70.349999999999994 112.416 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 34' ' ' ILE . 20.2 pt -70.32 -34.36 58.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.425 -0.807 . . . . 70.010000000000005 112.697 -174.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -67.5 -31.57 71.78 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.227 0.537 . . . . 75.040000000000006 110.689 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 93.5 mttt -70.03 -24.19 63.23 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.688 -0.687 . . . . 74.150000000000006 111.072 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -109.3 16.96 22.01 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.598 -0.728 . . . . 74.219999999999999 109.806 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.4 t -107.88 159.72 16.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 121.699 0.761 . . . . 63.119999999999997 112.204 -177.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.595 HG11 ' CG2' ' A' ' 91' ' ' VAL . 0.2 OUTLIER -140.42 163.7 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 C-N-CA 124.678 1.191 . . . . 70.439999999999998 112.195 -179.445 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.61 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 23.1 t80 -105.75 128.27 53.59 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 126.216 1.806 . . . . 74.310000000000002 107.195 176.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 65.5 t -118.87 116.08 50.0 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 107.539 -1.282 . . . . 61.119999999999997 107.539 177.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.82 167.46 13.05 Favored Glycine 0 C--N 1.297 -1.626 0 C-N-CA 120.033 -1.08 . . . . 74.109999999999999 114.247 -177.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.7 t30 59.87 62.24 1.72 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.431 1.892 . . . . 64.439999999999998 114.751 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.4 p -114.44 131.19 67.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.926 -1.034 . . . . 64.319999999999993 110.363 173.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.33 163.39 15.36 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.231 -1.396 . . . . 63.240000000000002 107.231 178.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -55.84 123.78 15.38 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.871 0.843 . . . . 75.239999999999995 112.311 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.12 -42.37 0.73 Allowed Glycine 0 N--CA 1.412 -2.948 0 N-CA-C 107.46 -2.256 . . . . 63.520000000000003 107.46 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.3 m -92.64 136.02 33.59 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 108.179 -1.045 . . . . 70.099999999999994 108.179 174.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.1 p -112.17 179.04 4.11 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.373 -0.603 . . . . 72.219999999999999 109.373 -178.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.472 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -61.73 -39.25 90.9 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.291 -0.633 . . . . 61.340000000000003 109.291 176.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -58.08 -46.5 85.38 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.401 -0.818 . . . . 55.240000000000002 111.489 174.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -58.53 -40.35 82.71 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.505 0.669 . . . . 54.509999999999998 110.071 178.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.2 mt -69.94 -48.27 59.08 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.704 -1.135 . . . . 73.319999999999993 111.265 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.5 -50.26 74.28 Favored 'General case' 0 C--O 1.193 -1.893 0 O-C-N 123.119 0.262 . . . . 62.340000000000003 111.704 -178.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.27 -42.57 91.53 Favored 'General case' 0 C--O 1.248 1.025 0 CA-C-O 121.083 0.468 . . . . 74.310000000000002 110.78 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -67.22 -39.78 86.29 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.748 -0.66 . . . . 72.200000000000003 110.39 -175.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -82.03 -21.44 36.98 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 112.928 0.714 . . . . 73.439999999999998 112.928 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.9 t -70.35 -24.37 62.97 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.181 -0.674 . . . . 75.150000000000006 109.181 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.7 m -60.15 -30.34 69.24 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-O 120.977 0.418 . . . . 74.129999999999995 110.104 173.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 63.8 m -90.65 1.67 56.6 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 112.782 0.66 . . . . 64.230000000000004 112.782 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 147.38 -162.48 28.65 Favored Glycine 0 N--CA 1.462 0.427 0 C-N-CA 119.282 -1.437 . . . . 71.420000000000002 114.164 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.3 t -104.63 132.41 50.9 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.857 -0.423 . . . . 75.129999999999995 109.857 -177.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 72.0 mt -97.84 135.66 31.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.354 0.597 . . . . 52.140000000000001 112.581 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.537 ' HB3' ' CE2' ' B' ' 73' ' ' PHE . 79.5 m-20 -96.42 -42.05 8.3 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.236 -0.893 . . . . 73.530000000000001 111.909 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.498 ' NH1' ' HG2' ' A' ' 24' ' ' GLN . 43.8 mtt180 -153.57 161.83 41.84 Favored 'General case' 0 CA--C 1.486 -1.494 0 CA-C-N 115.71 -0.677 . . . . 74.219999999999999 109.699 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.472 HD11 ' HB1' ' A' ' 50' ' ' ALA . 29.3 pt -148.35 142.73 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 107.665 -1.235 . . . . 64.420000000000002 107.665 173.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.3 m -125.15 127.34 46.68 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 106.886 -1.524 . . . . 50.43 106.886 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.443 HD11 ' N ' ' A' ' 68' ' ' ILE . 2.1 mp -125.71 122.7 62.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 106.269 -1.752 . . . . 74.299999999999997 106.269 -177.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.406 HD23 ' N ' ' A' ' 69' ' ' LEU 0.253 1.3 pt? -121.24 126.36 49.41 Favored 'General case' 0 C--N 1.28 -2.421 0 C-N-CA 120.277 -0.569 . . . . 73.209999999999994 111.545 176.299 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 66.2 m -116.44 134.59 54.69 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.124 -0.695 . . . . 73.230000000000004 109.124 -177.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.458 ' CB ' ' HG2' ' B' ' 65' ' ' ARG . 2.0 p30 -126.65 152.91 46.08 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 119.773 -0.771 . . . . 70.439999999999998 113.034 -177.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.519 ' HE2' ' HB3' ' A' ' 77' ' ' PRO . 0.5 OUTLIER -121.93 18.81 10.95 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.817 -0.629 . . . . 70.109999999999999 109.722 169.256 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -67.78 -21.89 65.23 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 118.942 -1.103 . . . . 75.109999999999999 109.421 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.8 m -84.44 2.26 41.65 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.405 -0.816 . . . . 74.299999999999997 110.382 174.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.61 -44.13 2.27 Favored Glycine 0 CA--C 1.507 -0.423 0 N-CA-C 110.997 -0.841 . . . . 37.990000000000002 110.997 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -97.18 144.21 27.49 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 108.234 -1.024 . . . . 74.420000000000002 108.234 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.519 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 55.8 Cg_endo -65.43 116.85 4.13 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 123.168 2.579 . . . . 72.420000000000002 110.464 175.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.433 ' HZ3' ' CG ' ' A' ' 71' ' ' ASP . 21.6 mtmm -122.86 -162.56 1.03 Allowed 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.571 -1.27 . . . . 73.099999999999994 107.571 175.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 172.39 159.16 18.28 Favored Glycine 1 N--CA 1.396 -4.011 0 C-N-CA 119.631 -1.271 . . . . 44.43 113.516 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -151.41 147.78 27.31 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 125.12 1.368 . . . . 73.209999999999994 109.319 176.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.12 150.6 49.16 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.046 0.451 . . . . 73.430000000000007 110.327 -171.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.424 ' CZ ' ' HD1' ' A' ' 40' ' ' TYR . 39.9 m-85 -118.77 121.81 40.96 Favored 'General case' 0 C--N 1.28 -2.43 0 C-N-CA 123.596 0.758 . . . . 75.230000000000004 110.326 176.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.4 mm -105.65 127.86 60.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 107.712 -1.218 . . . . 60.200000000000003 107.712 -178.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -110.39 119.28 38.68 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.544 -0.539 . . . . 64.310000000000002 109.544 178.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -95.22 162.67 13.6 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.562 0.696 . . . . 74.019999999999996 112.079 -177.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.495 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . . . -80.22 -28.47 38.57 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.915 -1.038 . . . . 72.510000000000005 111.942 176.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.8 150.1 43.28 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.583 -0.847 . . . . 74.239999999999995 112.022 -178.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.562 ' O ' HG12 ' A' ' 91' ' ' VAL . 8.9 mmm180 -69.04 -32.71 72.41 Favored 'General case' 0 C--O 1.215 -0.719 0 C-N-CA 123.264 0.626 . . . . 70.439999999999998 109.791 177.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -66.9 -28.83 68.63 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.463 -0.895 . . . . 75.109999999999999 110.807 177.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.7 m -70.22 -39.41 75.14 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 109.818 -0.438 . . . . 74.239999999999995 109.818 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.595 ' CG2' HG11 ' A' ' 39' ' ' VAL . 8.3 p -66.19 -38.84 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.652 -0.499 . . . . 71.430000000000007 109.652 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -66.98 -30.04 70.05 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-O 120.93 0.395 . . . . 72.450000000000003 111.697 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.75 -33.02 64.12 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.541 -0.54 . . . . 64.409999999999997 109.541 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.93 -45.07 52.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.735 -0.666 . . . . 73.409999999999997 111.089 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.0 m -57.21 -22.07 16.2 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 N-CA-C 112.762 0.653 . . . . 63.140000000000001 112.762 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.04 -20.06 66.05 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.607 0.718 . . . . 73.420000000000002 110.887 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 69.0 mtm -94.92 7.91 44.47 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.174 -0.921 . . . . 74.530000000000001 110.24 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.654 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 5.1 p-10 -40.23 -45.66 2.11 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 113.814 1.042 . . . . 74.420000000000002 113.814 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -118.94 116.6 26.81 Favored 'General case' 0 N--CA 1.405 -2.679 0 N-CA-C 108.158 -1.053 . . . . 70.349999999999994 108.158 172.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 106' ' ' THR . 8.2 t -168.9 -179.77 3.82 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.103 -0.953 . . . . 54.450000000000003 108.621 -177.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.48 125.73 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-O 121.533 0.683 . . . . 72.25 110.364 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -130.51 128.96 42.24 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.297 -1.001 . . . . 73.439999999999998 108.297 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 54.45 33.03 17.85 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.763 1.225 . . . . 73.430000000000007 110.487 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.01 -1.81 88.66 Favored Glycine 0 C--N 1.311 -0.831 0 CA-C-N 114.765 -1.107 . . . . 74.530000000000001 114.25 177.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -122.31 152.46 40.08 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 117.589 0.694 . . . . 64.219999999999999 111.318 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 100' ' ' THR . 30.8 m -81.98 120.72 25.6 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 110.263 -0.273 . . . . 71.030000000000001 110.263 -178.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 40.0 pt -103.1 172.09 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 116.329 -0.396 . . . . 63.399999999999999 110.48 176.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 57.6 tptt -129.49 133.55 47.34 Favored 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 109.233 -0.655 . . . . 64.420000000000002 109.233 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.61 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 23.6 t -127.23 114.52 37.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.002 -0.74 . . . . 75.219999999999999 109.002 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.417 HD11 ' CG ' ' B' ' 22' ' ' PRO 0.258 0.0 OUTLIER -143.35 146.24 35.32 Favored Pre-proline 0 C--O 1.211 -0.953 0 C-N-CA 119.277 -0.969 . . . . 74.519999999999996 109.432 179.168 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.445 ' HA ' HG12 ' A' ' 39' ' ' VAL . 67.4 Cg_exo -52.08 137.53 53.79 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 123.386 2.724 . . . . 73.519999999999996 113.692 -173.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -67.93 97.93 0.71 Allowed 'General case' 0 C--O 1.248 0.981 0 CA-C-O 121.2 0.524 . . . . 74.340000000000003 111.886 -176.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.456 ' O ' ' HB ' ' A' ' 114' ' ' THR . 40.2 ptt180 173.81 -164.13 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 126.145 1.778 . . . . 71.299999999999997 106.993 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 113' ' ' ARG . 86.3 m 80.53 143.87 0.08 Allowed 'General case' 0 CA--C 1.543 0.69 0 O-C-N 123.865 0.728 . . . . 73.439999999999998 110.968 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 78.2 14.61 1.46 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.414 1.086 . . . . 75.319999999999993 110.504 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 25.9 ttt -88.13 128.24 54.36 Favored Pre-proline 0 C--N 1.311 -1.092 0 CA-C-N 115.246 -0.888 . . . . 44.240000000000002 109.106 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -59.63 150.56 75.69 Favored 'Trans proline' 0 C--O 1.249 1.027 0 C-N-CA 122.415 2.077 . . . . 65.129999999999995 111.281 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -156.15 -152.84 6.38 Favored Glycine 0 N--CA 1.427 -1.925 0 C-N-CA 120.584 -0.817 . . . . 72.430000000000007 111.791 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.45 ' O ' HD12 ' A' ' 119' ' ' ILE 0.264 2.3 pp -57.77 114.1 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 114.134 1.161 . . . . 71.150000000000006 114.134 -178.88 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.2 t -173.69 122.25 0.34 Allowed 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.216 -1.401 . . . . 73.409999999999997 107.216 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.7 p -83.27 84.75 7.38 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 121.683 0.754 . . . . 71.129999999999995 111.065 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.1 p -81.68 149.3 28.57 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.274 -0.875 . . . . 75.510000000000005 112.247 -177.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -121.12 109.08 14.58 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.394 -0.965 . . . . 74.120000000000005 108.394 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? . . . . . 0 C--N 1.305 -1.334 0 N-CA-C 108.742 -0.836 . . . . 72.329999999999998 108.742 -177.667 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.651 0 N-CA-C 109.185 -0.672 . . . . 73.319999999999993 109.185 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 66.1 mt -123.17 112.52 34.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 109.085 -0.709 . . . . 63.219999999999999 109.085 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.91 156.62 54.1 Favored Pre-proline 0 C--N 1.308 -1.216 0 N-CA-C 109.398 -0.593 . . . . 73.430000000000007 109.398 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -63.46 118.28 5.21 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.437 2.091 . . . . 62.310000000000002 111.198 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 26.2 p 52.79 83.44 0.06 Allowed 'General case' 0 C--O 1.246 0.886 0 C-N-CA 124.749 1.22 . . . . 63.32 112.434 -177.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 65.5 mtm -83.57 82.82 8.13 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.255 -0.884 . . . . 73.319999999999993 110.953 -178.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . 0.42 ' C ' ' HG1' ' B' ' 8' ' ' THR . 8.9 tt0 -158.96 -71.09 0.08 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.867 -1.06 . . . . 53.140000000000001 109.188 176.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.42 ' HG1' ' C ' ' B' ' 7' ' ' GLN . 56.6 m -157.5 151.46 24.41 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.62 -0.511 . . . . 74.109999999999999 109.62 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 34.7 m 74.89 108.16 0.07 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.59 1.33 . . . . 70.340000000000003 114.59 173.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -129.21 119.72 24.52 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.924 -0.769 . . . . 74.010000000000005 108.924 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 49.5 m 53.26 86.74 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.522 1.304 . . . . 75.010000000000005 114.522 176.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -178.29 166.16 1.87 Allowed 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 124.514 1.125 . . . . 64.430000000000007 109.629 176.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 27.5 ttt -68.5 88.67 0.34 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.707 1.003 . . . . 65.540000000000006 113.707 -175.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 16.7 p -162.38 150.96 14.82 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 126.147 1.779 . . . . 74.129999999999995 106.685 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.6 95.39 2.33 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 118.045 0.384 . . . . 63.539999999999999 110.476 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.95 -117.36 11.13 Favored Glycine 0 C--O 1.245 0.832 0 N-CA-C 110.575 -1.01 . . . . 75.299999999999997 110.575 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.63 -0.73 57.6 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.104 0.478 . . . . 71.040000000000006 110.746 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . 0.443 ' C ' ' HG1' ' B' ' 19' ' ' THR . 91.4 t80 -81.31 128.81 34.22 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 121.371 0.605 . . . . 72.230000000000004 110.158 177.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.443 ' HG1' ' C ' ' B' ' 18' ' ' TYR . 59.6 m -164.31 171.49 14.77 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 103.752 -2.685 . . . . 74.129999999999995 103.752 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.89 -46.31 78.36 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 119.493 1.042 . . . . 64.230000000000004 109.398 177.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.79 -123.57 6.45 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 115.687 -0.688 . . . . 70.129999999999995 113.615 173.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.417 ' CG ' HD11 ' A' ' 110' ' ' LEU . 53.8 Cg_exo -53.17 -40.3 77.61 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 124.568 3.512 . . . . 72.430000000000007 116.88 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.8 136.05 74.12 Favored 'Trans proline' 0 C--N 1.391 2.768 0 CA-C-N 121.365 1.523 . . . . 71.349999999999994 110.377 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -60.47 134.3 91.38 Favored Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 123.56 0.538 . . . . 64.219999999999999 111.59 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -57.88 179.6 0.15 Allowed 'Trans proline' 0 C--O 1.244 0.817 0 C-N-CA 123.484 2.789 . . . . 74.510000000000005 114.069 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -148.8 159.65 43.96 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 113.598 -1.637 . . . . 62.219999999999999 107.397 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 39.1 t -57.26 145.47 31.74 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 113.768 1.025 . . . . 70.109999999999999 113.768 -171.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.78 -38.89 67.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.451 -1.25 . . . . 37.990000000000002 111.142 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -64.79 -34.9 79.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.442 -0.345 . . . . 71.099999999999994 110.279 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.418 ' HB2' HD21 ' B' ' 26' ' ' LEU . 17.9 mm-40 -65.43 -35.31 80.55 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 116.207 -0.451 . . . . 75.030000000000001 110.008 177.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -72.66 -47.02 50.92 Favored 'General case' 0 CA--C 1.483 -1.611 0 CA-C-N 115.427 -0.806 . . . . 73.140000000000001 110.862 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 50.3 mtpt -54.87 -43.06 72.8 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 115.861 -0.609 . . . . 74.409999999999997 111.767 176.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 0.3 OUTLIER -65.89 -41.13 91.93 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.819 0.847 . . . . 71.099999999999994 111.439 -178.517 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . 0.277 11.7 pt -71.27 -34.66 54.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 113.131 0.789 . . . . 75.319999999999993 113.131 -175.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.544 ' OD1' ' HE2' ' B' ' 112' ' ' LYS . 62.7 m-20 -64.01 -41.62 97.4 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-O 121.312 0.577 . . . . 74.049999999999997 109.851 -179.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.498 ' HZ3' ' C ' ' B' ' 116' ' ' MET . 84.0 mttt -60.27 -27.28 67.14 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.377 0.671 . . . . 75.299999999999997 111.63 -177.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' B' ' 33' ' ' GLU . 20.4 mtm180 -104.46 15.41 28.21 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 115.901 -0.591 . . . . 75.099999999999994 110.336 -174.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' SER . . . . . 0.708 ' OG ' ' HD3' ' B' ' 112' ' ' LYS . 77.7 p -114.89 169.26 9.22 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 113.915 1.08 . . . . 73.439999999999998 113.915 -177.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.46 164.64 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 124.93 1.292 . . . . 73.129999999999995 113.24 -174.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 30.4 t80 -105.59 125.98 51.61 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 127.125 2.17 . . . . 74.420000000000002 106.719 178.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 59.9 t -117.12 115.48 48.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 108.184 -1.043 . . . . 73.120000000000005 108.184 176.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.25 166.18 13.31 Favored Glycine 0 C--N 1.3 -1.471 0 C-N-CA 120.166 -1.016 . . . . 63.420000000000002 113.125 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 56.1 t30 62.6 65.75 0.82 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.4 1.48 . . . . 74.319999999999993 113.454 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.2 118.15 7.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.319 -0.855 . . . . 64.299999999999997 111.864 175.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -80.8 167.18 20.23 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 106.498 -1.668 . . . . 74.340000000000003 106.498 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' TYR . . . . . 0.582 ' HB3' ' SG ' ' B' ' 70' ' ' CYS . 48.3 p90 -75.33 5.24 5.88 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.145 0.498 . . . . 75.239999999999995 112.04 -178.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.34 -24.84 74.4 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.417 -1.073 . . . . 75.329999999999998 110.417 174.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 28.2 m -91.84 145.75 24.31 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 106.275 -1.75 . . . . 62.43 106.275 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 43.6 p -103.79 174.5 5.84 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 118.988 -1.085 . . . . 73.409999999999997 111.665 -173.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.488 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -64.7 -38.4 90.86 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 108.593 -0.892 . . . . 41.32 108.593 175.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -58.56 -42.46 87.95 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.379 -0.828 . . . . 74.340000000000003 111.06 176.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -59.05 -46.38 88.39 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.32 0.581 . . . . 74.400000000000006 110.027 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 55.6 mt -65.26 -48.6 72.65 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.898 -1.047 . . . . 73.239999999999995 111.969 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.456 ' HG2' HD11 ' B' ' 63' ' ' ILE . 0.8 OUTLIER -62.24 -49.09 77.11 Favored 'General case' 0 C--O 1.195 -1.801 0 N-CA-C 111.983 0.364 . . . . 70.409999999999997 111.983 -177.825 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.84 -41.51 87.11 Favored 'General case' 0 C--O 1.26 1.635 0 CA-C-O 121.531 0.681 . . . . 71.299999999999997 112.309 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -67.93 -41.22 82.93 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.918 -1.037 . . . . 74.329999999999998 109.967 -175.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -82.19 -22.07 36.17 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.395 0.517 . . . . 74.430000000000007 112.395 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 29.1 t -71.36 -23.86 61.98 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 109.163 -0.68 . . . . 75.420000000000002 109.163 -178.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 38.7 m -64.26 -18.93 65.03 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 115.821 -0.627 . . . . 74.409999999999997 109.808 175.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 56.0 m -107.38 10.03 29.69 Favored 'General case' 0 CA--C 1.556 1.211 0 N-CA-C 112.013 0.375 . . . . 74.439999999999998 112.013 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 147.89 -168.45 28.76 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 119.577 -1.297 . . . . 72.340000000000003 114.511 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 57.6 p -107.19 126.64 52.66 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 121.519 0.676 . . . . 61.32 110.502 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.456 HD11 ' HG2' ' B' ' 54' ' ' GLU . 78.9 mt -90.93 135.27 27.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.305 -0.862 . . . . 72.510000000000005 113.112 -175.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -93.03 -40.3 10.61 Favored 'General case' 0 CA--C 1.49 -1.344 0 CA-C-N 116.27 -0.423 . . . . 74.409999999999997 110.49 177.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.458 ' HG2' ' CB ' ' A' ' 71' ' ' ASP . 47.9 mtt180 -154.84 161.0 41.62 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 116.27 -0.423 . . . . 72.219999999999999 110.026 -177.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.488 HD11 ' HB1' ' B' ' 50' ' ' ALA . 26.7 pt -147.31 143.2 20.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 107.319 -1.363 . . . . 74.099999999999994 107.319 172.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 66.0 m -125.81 124.88 41.94 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 106.76 -1.57 . . . . 65.310000000000002 106.76 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.4 mp -124.33 120.2 58.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 106.926 -1.509 . . . . 71.109999999999999 106.926 -177.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.4 HD22 ' O ' ' B' ' 80' ' ' TYR 0.251 1.3 pt? -120.74 127.82 52.35 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.999 -0.68 . . . . 54.229999999999997 111.426 177.209 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' B' ' 46' ' ' TYR . 69.3 m -116.59 133.79 55.6 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.081 -0.711 . . . . 73.400000000000006 109.081 -177.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . 0.595 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 4.1 p-10 -119.65 137.72 53.71 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 118.704 -1.198 . . . . 71.430000000000007 113.519 -176.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -104.81 10.38 34.53 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.78 0.8 . . . . 73.450000000000003 109.714 171.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.537 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 19.7 m-85 -73.42 -2.38 22.13 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.263 -0.88 . . . . 74.140000000000001 112.221 175.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 25.2 m -110.92 13.06 22.18 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 114.633 -1.167 . . . . 71.230000000000004 108.779 176.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.51 -55.76 5.03 Favored Glycine 0 C--N 1.343 0.958 0 N-CA-C 110.735 -0.946 . . . . 73.549999999999997 110.735 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -97.22 136.46 21.43 Favored Pre-proline 0 C--N 1.288 -2.09 0 CA-C-N 114.272 -0.964 . . . . 72.299999999999997 108.655 175.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.595 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 51.5 Cg_endo -69.55 118.31 5.6 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 121.603 1.535 . . . . 72.319999999999993 111.752 -178.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm -112.22 -157.56 0.62 Allowed 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 106.998 -1.482 . . . . 73.129999999999995 106.998 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 171.59 158.6 15.95 Favored Glycine 0 N--CA 1.409 -3.165 0 C-N-CA 119.071 -1.538 . . . . 62.020000000000003 114.232 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . 0.4 ' O ' HD22 ' B' ' 69' ' ' LEU . 2.8 p90 -149.5 144.3 26.2 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 125.468 1.507 . . . . 74.349999999999994 109.134 177.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.43 150.17 51.78 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 112.082 0.401 . . . . 64.329999999999998 112.082 -172.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' TYR . . . . . 0.645 ' HH ' ' CA ' ' A' ' 22' ' ' PRO . 26.4 m-85 -117.72 120.44 37.97 Favored 'General case' 0 C--N 1.286 -2.164 0 C-N-CA 123.398 0.679 . . . . 64.439999999999998 111.092 177.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 24.9 mm -106.5 124.36 61.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 108.337 -0.986 . . . . 74.329999999999998 108.337 -178.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' GLU . . . . . 0.419 ' HG2' ' CB ' ' B' ' 38' ' ' SER . 30.8 mt-10 -109.14 119.29 39.09 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 110.172 -0.307 . . . . 52.329999999999998 110.172 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -97.61 166.58 11.43 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.529 0.566 . . . . 74.430000000000007 112.529 -176.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.09 -34.39 26.15 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.321 -0.854 . . . . 61.43 112.265 175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -114.26 149.84 35.27 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 120.95 0.405 . . . . 74.25 111.295 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.563 ' O ' HG12 ' B' ' 91' ' ' VAL . 19.4 mtp180 -74.87 -28.68 60.75 Favored 'General case' 0 CA--C 1.463 -2.372 0 CA-C-O 122.301 1.048 . . . . 72.120000000000005 111.796 176.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -61.31 -32.27 72.13 Favored 'General case' 1 C--N 1.234 -4.419 0 CA-C-N 114.178 -1.373 . . . . 71.420000000000002 110.503 172.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 16.5 m -71.24 -37.88 71.97 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 110.267 -0.272 . . . . 73.150000000000006 110.267 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . 0.563 HG12 ' O ' ' B' ' 88' ' ' ARG . 7.5 p -66.85 -38.78 82.14 Favored 'Isoleucine or valine' 0 C--N 1.348 0.527 0 C-N-CA 120.313 -0.555 . . . . 60.520000000000003 109.505 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -67.35 -30.43 70.23 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-O 121.101 0.477 . . . . 73.310000000000002 111.677 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.1 -32.23 64.83 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.185 0.517 . . . . 75.109999999999999 109.83 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.9 -44.87 46.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.761 -0.654 . . . . 61.420000000000002 111.28 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 30.2 m -57.53 -23.26 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 112.553 0.575 . . . . 55.200000000000003 112.553 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.37 -17.28 64.68 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.23 0.538 . . . . 74.530000000000001 110.078 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 69.1 mtm -95.46 7.63 45.65 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.122 -0.49 . . . . 72.319999999999993 111.719 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.1 -36.54 18.98 Favored 'General case' 0 C--O 1.201 -1.449 0 N-CA-C 114.312 1.227 . . . . 75.209999999999994 114.312 -177.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -105.08 17.83 23.41 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-N 119.349 0.977 . . . . 71.439999999999998 112.053 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 76.4 p -81.28 172.11 14.01 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 119.276 -0.97 . . . . 73.109999999999999 112.561 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.96 122.88 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 CA-C-O 121.746 0.784 . . . . 64.120000000000005 111.248 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -117.77 122.96 44.83 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.317 -0.994 . . . . 70.420000000000002 108.317 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 53.32 32.74 14.19 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.033 0.753 . . . . 73.219999999999999 113.033 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.22 4.6 83.77 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.93 -0.652 . . . . 63.009999999999998 114.115 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -125.86 151.39 46.92 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 117.533 0.666 . . . . 74.530000000000001 110.065 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 55.2 m -83.34 121.33 27.0 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 109.672 -0.492 . . . . 73.430000000000007 109.672 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 39.6 pt -102.05 172.54 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.175 -0.676 . . . . 71.129999999999995 109.175 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 56.3 tptt -128.48 132.59 48.38 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.681 -0.859 . . . . 73.540000000000006 108.681 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 20.9 t -126.5 120.21 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 107.999 -1.111 . . . . 72.030000000000001 107.999 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.322 0.3 OUTLIER -145.28 133.28 10.56 Favored Pre-proline 0 C--O 1.192 -1.97 0 N-CA-C 107.841 -1.17 . . . . 72.200000000000003 107.841 -167.449 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.16 151.95 48.02 Favored 'Trans proline' 0 N--CA 1.507 2.299 0 C-N-CA 123.504 2.803 . . . . 75.450000000000003 116.303 -177.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.708 ' HD3' ' OG ' ' B' ' 38' ' ' SER . 76.2 tttt -109.69 117.4 33.81 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 125.326 1.45 . . . . 62.43 109.84 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 61.7 168.99 0.11 Allowed 'General case' 0 N--CA 1.51 2.562 0 C-N-CA 124.308 1.043 . . . . 73.230000000000004 113.549 175.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 20.6 p -142.01 139.64 32.43 Favored 'General case' 0 CA--C 1.566 1.577 0 C-N-CA 124.117 0.967 . . . . 70.140000000000001 111.262 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 115' ' ' ASN . . . . . 0.447 ' HB3' ' HE2' ' B' ' 36' ' ' LYS . 3.7 t-20 177.78 151.52 0.23 Allowed 'General case' 0 N--CA 1.505 2.291 0 C-N-CA 123.656 0.782 . . . . 71.329999999999998 110.038 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 116' ' ' MET . . . . . 0.498 ' C ' ' HZ3' ' B' ' 36' ' ' LYS . 0.0 OUTLIER -81.11 144.34 54.39 Favored Pre-proline 0 N--CA 1.481 1.102 0 C-N-CA 122.777 0.431 . . . . 62.439999999999998 110.588 179.127 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 117' ' ' PRO . . . . . 0.496 ' HA ' ' NZ ' ' B' ' 36' ' ' LYS . 3.8 Cg_exo -76.27 161.75 34.67 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 123.97 3.113 . . . . 72.230000000000004 115.987 -174.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -145.13 -176.14 18.86 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 115.283 -0.871 . . . . 72.409999999999997 110.946 176.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 68.0 mt -137.45 141.93 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 117.654 0.727 . . . . 73.049999999999997 110.051 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 67.5 m -156.57 141.39 17.03 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.782 0.433 . . . . 72.540000000000006 110.354 178.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 31.7 m -142.79 168.4 19.8 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 110.247 -0.279 . . . . 62.240000000000002 110.247 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 78.0 m -144.68 124.34 13.3 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.884 0.373 . . . . 72.239999999999995 110.383 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -133.16 -170.18 2.42 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.503 -0.925 . . . . 74.230000000000004 108.503 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 . . . . . 0 N--CA 1.433 -1.324 0 N-CA-C 106.723 -1.584 . . . . 74.409999999999997 106.723 173.275 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.337 0 N-CA-C 109.126 -0.694 . . . . 52.450000000000003 109.126 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.2 mt -106.91 113.38 43.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 108.603 -0.888 . . . . 74.5 108.603 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -150.69 145.58 18.52 Favored Pre-proline 0 C--N 1.305 -1.34 0 N-CA-C 108.92 -0.771 . . . . 70.439999999999998 108.92 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.3 162.94 25.0 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 122.356 2.037 . . . . 75.230000000000004 111.763 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 72.6 m -77.28 158.05 30.44 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.991 -0.55 . . . . 74.319999999999993 109.963 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.4 127.74 32.48 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.904 -0.318 . . . . 75.120000000000005 110.467 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -151.74 6.12 0.45 Allowed 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.303 0.573 . . . . 60.329999999999998 111.976 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.8 t -117.43 135.42 53.91 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 106.279 -1.748 . . . . 73.25 106.279 174.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.0 p -141.85 172.88 12.08 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 111.897 0.332 . . . . 75.340000000000003 111.897 -172.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 76.7 t60 69.36 -55.07 0.58 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.264 1.426 . . . . 63.219999999999999 113.285 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.428 ' HB3' ' OG1' ' B' ' 14' ' ' THR . 49.8 m -89.48 138.84 31.11 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 116.24 -0.437 . . . . 71.420000000000002 110.289 -177.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.482 ' HD3' ' N ' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -161.52 -2.85 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.839 -0.619 . . . . 74.329999999999998 111.875 -173.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.7 mtt -70.99 102.91 2.53 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.659 0.742 . . . . 74.409999999999997 112.633 -176.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.8 m -154.45 -55.77 0.1 Allowed 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.526 -1.215 . . . . 54.340000000000003 108.629 175.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.511 ' HA ' ' OE2' ' A' ' 20' ' ' GLU . . . -158.83 167.57 29.1 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-N 116.453 -0.34 . . . . 62.109999999999999 110.649 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.29 -107.74 0.5 Allowed Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 110.44 -1.064 . . . . 74.409999999999997 110.44 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.41 26.95 0.93 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 122.182 0.991 . . . . 64.010000000000005 108.505 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -136.23 -15.95 1.67 Allowed 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 114.512 1.301 . . . . 74.109999999999999 114.512 -171.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.3 m -126.26 29.51 5.8 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.51 -1.663 . . . . 71.109999999999999 106.51 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.511 ' OE2' ' HA ' ' A' ' 15' ' ' ALA . 2.3 mp0 -100.85 97.03 7.68 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 116.396 1.999 . . . . 71.409999999999997 116.396 -169.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 50.05 -149.35 5.91 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 119.314 2.485 . . . . 55.450000000000003 119.314 167.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.444 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 78.8 Cg_exo -48.11 -45.56 25.14 Favored 'Trans proline' 0 C--N 1.365 1.415 1 C-N-CA 125.925 4.417 . . . . 64.219999999999999 118.388 -173.505 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.459 ' HG3' ' CE2' ' B' ' 80' ' ' TYR . 2.6 Cg_endo -42.35 129.49 4.75 Favored 'Trans proline' 0 C--N 1.391 2.781 0 C-N-CA 122.659 2.239 . . . . 74.519999999999996 112.388 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -58.79 139.31 86.54 Favored Pre-proline 0 C--O 1.247 0.968 0 CA-C-N 115.316 -0.856 . . . . 73.030000000000001 111.991 -177.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -72.1 103.28 1.47 Allowed 'Trans proline' 0 N--CA 1.432 -2.113 0 C-N-CA 122.112 1.874 . . . . 71.120000000000005 110.413 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.49 HD11 ' H ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -63.85 175.54 1.14 Allowed 'General case' 0 C--O 1.247 0.929 0 CA-C-N 115.158 -0.928 . . . . 72.319999999999993 111.671 177.812 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.9 m -53.35 143.43 18.9 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.879 0.696 . . . . 63.329999999999998 112.879 -172.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 31' ' ' LYS . . . -55.7 -46.13 77.72 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.721 -1.127 . . . . 73.400000000000006 112.189 -178.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -69.38 -31.76 70.35 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.467 -0.893 . . . . 65.319999999999993 112.923 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.63 -34.1 75.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.485 -0.325 . . . . 55.219999999999999 110.256 170.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -65.45 -47.41 76.25 Favored 'General case' 0 C--O 1.211 -0.964 0 N-CA-C 108.334 -0.987 . . . . 43.439999999999998 108.334 178.719 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.571 ' HE2' ' N ' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -53.4 -47.0 69.92 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-O 120.401 0.143 . . . . 74.299999999999997 110.798 177.746 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -70.45 -43.44 69.85 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 113.291 0.848 . . . . 70.230000000000004 113.291 -174.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.7 pt -70.31 -35.77 64.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 C-N-CA 119.722 -0.791 . . . . 42.140000000000001 111.863 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.46 -29.32 69.42 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.232 0.539 . . . . 72.25 111.263 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 54.0 mtmt -77.76 -10.75 59.7 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.895 -0.593 . . . . 73.230000000000004 111.649 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -118.09 18.74 13.8 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.163 -0.471 . . . . 74.230000000000004 110.711 -174.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -94.83 139.09 31.77 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.928 -0.767 . . . . 72.239999999999995 108.928 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.514 HG21 ' O ' ' A' ' 83' ' ' ILE . 32.1 m -126.18 160.76 33.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 109.616 -0.512 . . . . 64.430000000000007 109.616 178.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.516 ' CD2' ' HG2' ' B' ' 22' ' ' PRO . 38.4 t80 -114.56 123.08 48.47 Favored 'General case' 0 C--N 1.274 -2.693 0 C-N-CA 125.159 1.384 . . . . 75.230000000000004 108.343 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 97.1 t -112.45 108.28 25.12 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.877 0 N-CA-C 107.087 -1.449 . . . . 71.209999999999994 107.087 177.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.07 163.07 20.15 Favored Glycine 0 C--N 1.284 -2.359 0 C-N-CA 119.62 -1.276 . . . . 72.450000000000003 112.231 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.5 t30 57.7 21.12 7.0 Favored 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 125.779 1.632 . . . . 72.430000000000007 113.562 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 p -54.39 135.44 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-O 121.38 0.61 . . . . 62.420000000000002 109.849 175.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.36 148.92 40.84 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 108.081 -1.081 . . . . 73.510000000000005 108.081 -176.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -70.24 -15.88 62.97 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.076 0.941 . . . . 64.0 109.189 -176.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.44 -11.62 83.01 Favored Glycine 0 N--CA 1.427 -1.955 0 CA-C-N 115.383 -0.826 . . . . 37.640000000000001 112.323 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.6 m -74.5 122.28 22.81 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-O 121.56 0.695 . . . . 63.43 110.069 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.1 p -100.86 171.73 7.49 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.309 -0.86 . . . . 74.239999999999995 108.903 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.02 -50.13 75.27 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 118.142 0.428 . . . . 71.319999999999993 111.194 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -57.49 -42.03 81.9 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.725 0.639 . . . . 73.230000000000004 112.725 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -67.09 -41.2 86.71 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.227 0.537 . . . . 70.200000000000003 110.315 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.2 mt -71.37 -48.37 50.46 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.707 -0.679 . . . . 75.120000000000005 111.815 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.443 ' HG3' ' OH ' ' B' ' 46' ' ' TYR . 14.2 tm-20 -59.73 -49.07 79.15 Favored 'General case' 0 C--O 1.208 -1.1 0 C-N-CA 123.547 0.739 . . . . 71.409999999999997 111.317 -178.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.35 -42.82 87.72 Favored 'General case' 0 C--O 1.27 2.165 0 CA-C-O 121.51 0.672 . . . . 65.019999999999996 111.214 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -63.63 -43.51 96.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.741 -1.118 . . . . 72.030000000000001 110.517 -175.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -81.36 -21.4 39.11 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 113.73 1.011 . . . . 75.409999999999997 113.73 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 69.4 m -66.59 -24.58 66.36 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 120.969 0.414 . . . . 55.43 110.885 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.1 m -58.62 -26.3 63.56 Favored 'General case' 0 CA--C 1.562 1.413 0 CA-C-O 121.144 0.497 . . . . 74.519999999999996 110.562 173.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 59.7 m -91.0 -2.78 57.65 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 112.945 0.72 . . . . 74.409999999999997 112.945 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.42 -161.86 27.95 Favored Glycine 0 C--N 1.317 -0.48 0 C-N-CA 119.456 -1.354 . . . . 52.409999999999997 113.913 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.1 m -97.26 120.26 37.3 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.562 0.696 . . . . 45.039999999999999 111.382 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.2 mt -82.01 129.53 37.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 115.001 -0.999 . . . . 71.519999999999996 111.168 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.489 ' OD1' ' HA ' ' B' ' 73' ' ' PHE . 48.4 t30 -93.54 -36.95 12.16 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.029 -0.987 . . . . 72.439999999999998 109.777 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.523 ' HD2' ' OE1' ' A' ' 84' ' ' GLU . 99.4 mtt180 -157.34 162.43 39.1 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.391 -0.822 . . . . 72.25 109.51 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.412 HG21 HG23 ' A' ' 83' ' ' ILE . 34.7 pt -142.68 137.81 28.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 107.259 -1.385 . . . . 73.340000000000003 107.259 171.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' B' ' 68' ' ' ILE . 49.9 m -126.54 130.96 51.58 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 107.55 -1.278 . . . . 74.109999999999999 107.55 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' B' ' 67' ' ' THR . 16.2 mt -125.87 118.11 50.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.315 -1.365 . . . . 51.350000000000001 107.315 -177.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' B' ' 66' ' ' ILE 0.342 0.9 OUTLIER -121.59 125.5 46.89 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 119.944 -0.702 . . . . 44.520000000000003 112.795 176.798 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 66.1 m -116.38 130.63 56.87 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.923 -1.14 . . . . 73.120000000000005 107.923 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.572 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 3.8 p-10 -115.78 137.14 52.37 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 119.196 -1.002 . . . . 72.450000000000003 112.377 -176.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -110.61 12.54 22.7 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.679 -0.691 . . . . 63.539999999999999 110.13 173.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.499 ' CD2' ' HB2' ' A' ' 71' ' ' ASP . 13.7 p90 -72.66 -9.97 59.24 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.789 0.804 . . . . 75.319999999999993 109.447 176.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.431 ' C ' ' H ' ' A' ' 76' ' ' HIS . 37.7 m -94.22 8.87 40.17 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 114.357 -1.292 . . . . 63.399999999999999 109.47 176.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.28 -54.42 4.53 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 110.492 -1.043 . . . . 55.130000000000003 110.492 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.431 ' H ' ' C ' ' A' ' 74' ' ' SER . 72.4 m-70 -95.61 131.26 29.81 Favored Pre-proline 0 C--N 1.299 -1.587 0 N-CA-C 106.772 -1.566 . . . . 70.219999999999999 106.772 176.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 33.3 Cg_endo -66.7 118.36 5.48 Favored 'Trans proline' 0 C--O 1.243 0.748 0 C-N-CA 121.536 1.491 . . . . 75.209999999999994 112.557 -177.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.453 ' HZ1' ' CG ' ' A' ' 71' ' ' ASP . 25.0 mtmm -100.09 -169.39 1.73 Allowed 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.959 -1.126 . . . . 53.409999999999997 107.959 174.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.05 139.8 6.11 Favored Glycine 0 N--CA 1.41 -3.1 0 C-N-CA 119.727 -1.225 . . . . 75.219999999999999 112.763 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -151.12 143.31 24.07 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.797 -0.816 . . . . 72.230000000000004 108.797 172.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.08 152.01 50.0 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 116.747 -0.206 . . . . 71.430000000000007 111.23 -173.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.423 ' CE1' ' HD1' ' A' ' 40' ' ' TYR . 95.6 m-85 -120.4 115.63 23.89 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 109.044 -0.724 . . . . 75.310000000000002 109.044 174.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.514 ' O ' HG21 ' A' ' 39' ' ' VAL . 38.6 mm -101.65 121.27 52.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.515 -1.291 . . . . 71.109999999999999 107.515 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.523 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 33.7 mt-10 -106.07 123.09 47.45 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 120.242 -0.583 . . . . 64.530000000000001 109.5 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -94.45 156.64 16.38 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 112.525 0.565 . . . . 74.329999999999998 112.525 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.06 -36.32 55.99 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.515 -0.766 . . . . 61.520000000000003 110.404 176.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -103.01 146.23 28.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.771 0.319 . . . . 71.430000000000007 110.185 175.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.436 ' O ' HG21 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.77 -32.34 62.03 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.103 -1.443 . . . . 74.150000000000006 107.103 178.606 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -60.46 -31.48 70.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.283 -1.326 . . . . 75.109999999999999 110.338 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 31.5 m -64.41 -36.64 84.83 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 116.235 -0.439 . . . . 64.450000000000003 110.503 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.436 HG21 ' O ' ' A' ' 88' ' ' ARG . 2.3 m -67.68 -38.3 80.13 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.533 0 C-N-CA 119.61 -0.836 . . . . 70.420000000000002 109.241 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -58.3 -36.1 72.81 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.064 0.459 . . . . 74.209999999999994 111.59 176.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.34 -32.8 64.77 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.929 0.395 . . . . 73.099999999999994 110.658 177.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.36 -40.63 50.61 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 116.174 -0.466 . . . . 71.409999999999997 111.627 -177.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.7 m -55.76 -21.85 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 113.117 0.784 . . . . 73.239999999999995 113.117 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.08 -14.44 61.74 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 121.586 0.708 . . . . 74.530000000000001 110.535 176.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 28.3 mtp -98.17 8.1 45.29 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 124.471 1.108 . . . . 62.340000000000003 110.771 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 4.5 p-10 -36.57 -53.47 0.88 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.904 1.076 . . . . 72.299999999999997 113.904 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -118.87 106.14 12.2 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-O 121.704 0.764 . . . . 65.120000000000005 109.451 175.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.0 t -150.1 173.02 14.35 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 114.811 -1.086 . . . . 74.019999999999996 109.275 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.87 131.99 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.221 0 N-CA-C 108.754 -0.832 . . . . 63.32 108.754 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -138.32 113.64 9.47 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 107.289 -1.374 . . . . 72.150000000000006 107.289 -177.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 37.5 mtp85 56.1 33.31 21.72 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.906 0.882 . . . . 74.319999999999993 112.127 -175.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.06 -10.18 71.77 Favored Glycine 0 C--N 1.312 -0.795 0 CA-C-N 115.215 -0.902 . . . . 37.640000000000001 113.191 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -99.31 143.81 29.15 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.839 -0.801 . . . . 73.5 108.839 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.0 m -86.41 119.72 26.98 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.934 -1.506 . . . . 54.530000000000001 106.934 174.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 47.8 pt -102.01 171.35 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 120.15 -0.62 . . . . 70.439999999999998 110.976 -177.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 57.6 tptt -127.87 125.98 40.71 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.138 -0.937 . . . . 73.310000000000002 108.731 -177.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.9 t -114.32 115.53 49.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 106.275 -1.75 . . . . 75.019999999999996 106.275 177.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.48 HD22 ' HB3' ' A' ' 115' ' ' ASN 0.272 2.5 tt -138.87 128.56 14.52 Favored Pre-proline 0 C--O 1.196 -1.72 0 N-CA-C 106.972 -1.492 . . . . 74.239999999999995 106.972 -170.511 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.66 127.71 15.07 Favored 'Trans proline' 0 C--N 1.355 0.884 0 CA-C-N 121.485 1.566 . . . . 62.200000000000003 109.771 175.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 -7.01 58.24 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.584 0.707 . . . . 75.230000000000004 110.744 -170.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.503 ' O ' ' HD2' ' A' ' 113' ' ' ARG . 3.4 tmm_? -90.02 -33.98 16.14 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.861 -0.792 . . . . 74.109999999999999 108.861 175.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.7 m -84.24 -47.73 10.5 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.624 -0.716 . . . . 62.020000000000003 112.351 -172.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.48 ' HB3' HD22 ' A' ' 110' ' ' LEU . 38.1 t-20 -121.12 110.08 15.78 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.845 0.831 . . . . 55.229999999999997 112.236 -174.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 66.9 mtm -127.43 108.92 21.07 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 107.854 -1.165 . . . . 37.640000000000001 107.854 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.11 163.88 25.07 Favored 'Trans proline' 0 C--O 1.242 0.704 0 C-N-CA 122.953 2.435 . . . . 72.030000000000001 113.539 -176.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 139.27 -141.79 12.16 Favored Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 115.47 -0.786 . . . . 73.120000000000005 111.513 177.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.7 mm -107.32 146.87 13.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 106.893 -1.521 . . . . 63.219999999999999 106.893 178.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.8 m -65.92 96.9 0.32 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.115 0.483 . . . . 74.030000000000001 110.263 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.4 m -121.14 76.78 1.25 Allowed 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 121.966 0.889 . . . . 52.109999999999999 108.969 177.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.2 m -150.49 83.32 1.36 Allowed 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 107.169 -1.419 . . . . 73.519999999999996 107.169 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -161.13 148.01 14.96 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.895 -0.593 . . . . 71.299999999999997 109.627 -178.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 . . . . . 0 C--N 1.295 -1.789 0 CA-C-N 115.658 -0.701 . . . . 73.209999999999994 109.642 -178.793 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.271 0 CA-C-O 121.149 0.499 . . . . 62.32 110.213 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.439 ' O ' HD13 ' B' ' 2' ' ' ILE 0.303 2.3 pp -82.06 111.65 18.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 122.255 1.026 . . . . 65.319999999999993 113.347 179.736 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.42 165.38 18.31 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 107.928 -1.138 . . . . 54.329999999999998 107.928 -177.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -59.73 94.11 0.09 OUTLIER 'Trans proline' 0 C--N 1.364 1.354 0 C-N-CA 122.103 1.869 . . . . 54.149999999999999 110.793 175.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 45.8 t -162.56 161.68 26.94 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 107.097 -1.446 . . . . 52.409999999999997 107.097 -176.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 65.3 mtt 70.37 167.85 0.3 Allowed 'General case' 0 C--O 1.247 0.945 0 C-N-CA 124.301 1.04 . . . . 72.120000000000005 111.42 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -112.94 119.62 38.57 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.99 -0.55 . . . . 73.319999999999993 109.745 -178.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 34.6 p -81.21 105.79 12.69 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.745 0.783 . . . . 73.019999999999996 110.575 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 34.6 p -88.71 131.18 35.13 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 115.881 -0.599 . . . . 75.329999999999998 111.663 -177.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -97.51 -11.28 23.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.997 -0.547 . . . . 75.230000000000004 110.297 177.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.407 ' CB ' ' HA ' ' B' ' 115' ' ' ASN . 10.2 p -132.8 -176.12 4.0 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.87 -0.605 . . . . 75.310000000000002 111.126 -177.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -106.57 104.86 14.65 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.099 -1.074 . . . . 74.439999999999998 108.099 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 24.6 ttt -110.97 140.7 45.27 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.857 -0.61 . . . . 74.120000000000005 112.464 -173.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 11' ' ' SER . 5.9 t -89.83 140.91 29.13 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.775 -1.194 . . . . 62.439999999999998 107.775 171.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.98 115.25 18.54 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.046 0.45 . . . . 60.299999999999997 110.161 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.05 -87.29 0.22 Allowed Glycine 0 N--CA 1.428 -1.891 0 N-CA-C 110.704 -0.959 . . . . 37.640000000000001 110.704 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.77 150.23 32.73 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.369 -0.604 . . . . 71.310000000000002 109.369 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -85.76 124.92 32.81 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.559 -0.904 . . . . 75.319999999999993 108.559 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 9.5 t -146.25 142.61 28.53 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.397 0.617 . . . . 63.329999999999998 111.295 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . 0.437 ' HG3' ' HB3' ' A' ' 15' ' ' ALA . 1.1 mp0 -80.2 -26.89 38.98 Favored 'General case' 0 CA--C 1.566 1.561 0 CA-C-N 115.117 -0.947 . . . . 70.129999999999995 109.897 178.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.69 -125.24 1.45 Allowed Glycine 0 CA--C 1.502 -0.738 0 N-CA-C 109.717 -1.353 . . . . 75.109999999999999 109.717 178.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.516 ' HG2' ' CD2' ' A' ' 40' ' ' TYR . 76.3 Cg_exo -52.9 -37.98 78.33 Favored 'Trans proline' 0 CA--C 1.566 2.103 0 C-N-CA 122.742 2.295 . . . . 62.520000000000003 114.225 172.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -55.1 129.67 36.57 Favored 'Trans proline' 0 C--N 1.397 3.081 0 C-N-CA 121.499 1.466 . . . . 71.319999999999993 110.99 172.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -54.16 141.5 50.51 Favored Pre-proline 0 C--N 1.302 -1.487 0 CA-C-N 114.257 -1.338 . . . . 75.109999999999999 111.277 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.86 114.15 2.3 Favored 'Trans proline' 0 N--CA 1.443 -1.467 0 C-N-CA 122.098 1.866 . . . . 72.230000000000004 111.045 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 6.1 mp -61.83 165.83 4.97 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.821 -1.081 . . . . 74.540000000000006 109.882 176.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.421 ' O ' ' HG2' ' B' ' 31' ' ' LYS . 25.2 m -58.93 144.94 43.2 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.278 -0.638 . . . . 64.099999999999994 109.278 176.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' B' ' 31' ' ' LYS . . . -52.49 -44.18 65.48 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 123.569 0.543 . . . . 71.439999999999998 111.775 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -71.31 -30.98 66.88 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.828 0.677 . . . . 71.420000000000002 112.828 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.523 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.5 OUTLIER -60.57 -34.58 74.4 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 109.653 -0.499 . . . . 74.200000000000003 109.653 170.013 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' B' ' 28' ' ' ALA . 25.2 mmmt -65.84 -46.89 76.83 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 115.58 -0.736 . . . . 70.409999999999997 109.956 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.546 ' HE2' ' N ' ' B' ' 32' ' ' LYS . 0.5 OUTLIER -53.7 -46.36 70.71 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.8 -0.36 . . . . 73.030000000000001 110.734 176.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.77 -45.76 70.54 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.314 0.857 . . . . 63.420000000000002 113.314 -174.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.523 HG12 ' O ' ' B' ' 30' ' ' GLU . 26.3 pt -69.58 -35.37 65.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 C-N-CA 120.751 -0.38 . . . . 73.420000000000002 111.828 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.9 -35.09 79.23 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.915 0.388 . . . . 75.310000000000002 110.781 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 55.1 mtmt -75.12 -11.08 60.01 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.393 0.516 . . . . 73.209999999999994 112.393 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -118.23 18.37 13.76 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.328 0.585 . . . . 71.439999999999998 110.918 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' B' ' 84' ' ' GLU . 82.8 p -98.9 156.5 16.86 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 115.897 -0.592 . . . . 53.549999999999997 111.444 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.415 HG21 ' O ' ' B' ' 83' ' ' ILE . 31.2 m -137.08 163.89 31.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.931 0.396 . . . . 70.25 110.562 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . 0.503 ' HD1' ' CE1' ' B' ' 82' ' ' TYR . 38.7 t80 -115.57 123.03 47.44 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 126.118 1.767 . . . . 72.409999999999997 107.936 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 85.8 t -112.45 108.02 24.46 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.939 0 N-CA-C 107.461 -1.311 . . . . 72.519999999999996 107.461 176.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . 0.503 ' O ' ' HB ' ' B' ' 107' ' ' ILE . . . -98.83 164.97 20.87 Favored Glycine 0 C--N 1.289 -2.037 0 C-N-CA 119.697 -1.24 . . . . 75.540000000000006 112.201 -177.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 64.0 t30 60.29 18.45 7.99 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.639 1.176 . . . . 75.400000000000006 112.875 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 8.0 p -61.49 132.19 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 109.162 -0.681 . . . . 65.239999999999995 109.162 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.38 143.95 56.83 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.61 -0.723 . . . . 61.219999999999999 109.879 -176.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' TYR . . . . . 0.46 ' CD1' ' HB2' ' B' ' 77' ' ' PRO . 71.7 t80 -55.07 -21.98 14.51 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 124.878 1.271 . . . . 74.430000000000007 111.999 -177.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.26 10.84 54.76 Favored Glycine 0 N--CA 1.422 -2.267 0 C-N-CA 120.562 -0.828 . . . . 54.130000000000003 113.761 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 12.8 m -75.0 122.32 23.33 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 118.492 1.146 . . . . 70.0 108.687 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 61.8 p -96.57 167.62 11.03 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 111.663 0.245 . . . . 72.299999999999997 111.663 -175.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.96 -51.15 70.92 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 112.853 0.686 . . . . 71.010000000000005 112.853 -175.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -57.53 -38.4 74.63 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 112.473 0.545 . . . . 75.400000000000006 112.473 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -69.49 -42.21 75.1 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.082 0.468 . . . . 74.349999999999994 109.973 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.41 -48.56 55.53 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.646 -0.706 . . . . 70.239999999999995 112.036 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 tm-20 -59.91 -49.74 76.51 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.198 0.599 . . . . 72.540000000000006 111.289 -177.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.41 -42.07 81.57 Favored 'General case' 0 C--O 1.27 2.154 0 CA-C-O 121.602 0.715 . . . . 70.409999999999997 111.355 177.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -64.59 -42.79 95.35 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 114.879 -1.055 . . . . 70.409999999999997 110.761 -175.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -81.68 -21.43 38.1 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 113.571 0.952 . . . . 74.219999999999999 113.571 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 75.4 m -64.74 -26.09 68.21 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 116.36 -0.382 . . . . 72.219999999999999 110.946 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.4 m -58.17 -26.85 63.24 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-O 121.038 0.447 . . . . 64.200000000000003 110.524 174.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . 0.451 ' SG ' ' HA ' ' B' ' 94' ' ' ALA . 61.7 m -92.05 -0.61 57.46 Favored 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 112.885 0.698 . . . . 55.329999999999998 112.885 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.35 -154.83 26.21 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 119.054 -1.546 . . . . 65.310000000000002 114.681 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 44.1 m -105.27 117.97 35.37 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.033 0.444 . . . . 74.209999999999994 111.229 -176.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.441 HG23 HD13 ' B' ' 63' ' ' ILE . 67.3 mt -79.46 130.72 35.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.743 -0.662 . . . . 74.430000000000007 112.655 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . 0.536 ' OD1' ' HG3' ' B' ' 65' ' ' ARG . 23.6 t-20 -91.16 -41.91 10.75 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.186 0.995 . . . . 75.239999999999995 108.356 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.536 ' HG3' ' OD1' ' B' ' 64' ' ' ASN . 99.2 mtt180 -158.05 163.52 37.62 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.842 0.857 . . . . 70.530000000000001 109.125 -177.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 69' ' ' LEU . 34.8 pt -142.43 137.67 28.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 107.099 -1.445 . . . . 74.209999999999994 107.099 170.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 33.4 m -126.74 131.18 51.4 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 107.069 -1.456 . . . . 73.209999999999994 107.069 -178.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 67' ' ' THR . 17.1 mt -125.91 117.47 49.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 107.128 -1.434 . . . . 73.019999999999996 107.128 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.308 0.9 OUTLIER -121.49 125.88 47.91 Favored 'General case' 0 C--N 1.283 -2.313 0 C-N-CA 120.21 -0.596 . . . . 70.209999999999994 112.241 177.296 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 77.1 m -116.27 129.15 56.13 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 108.302 -0.999 . . . . 64.420000000000002 108.302 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . 0.657 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 4.8 p-10 -110.63 126.78 54.84 Favored 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 119.48 -0.888 . . . . 60.109999999999999 111.021 -177.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -113.49 15.2 19.1 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.039 -1.467 . . . . 74.010000000000005 107.039 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.489 ' HA ' ' OD1' ' A' ' 64' ' ' ASN . 30.8 t80 -44.72 -44.3 9.09 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.511 2.324 . . . . 71.340000000000003 112.096 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 24.1 m -100.82 18.99 18.04 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 116.208 -0.451 . . . . 71.430000000000007 111.558 -175.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.1 -53.17 2.52 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.095 -1.05 . . . . 75.340000000000003 111.388 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -91.55 119.89 68.4 Favored Pre-proline 0 CA--C 1.497 -1.085 0 N-CA-C 109.367 -0.605 . . . . 71.319999999999993 109.367 177.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 75.3 Cg_endo -77.81 121.1 5.33 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 122.522 2.148 . . . . 64.129999999999995 113.682 -174.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' LYS . . . . . 0.475 ' HZ1' ' CG ' ' B' ' 71' ' ' ASP . 25.8 mtmm -99.98 -167.16 1.42 Allowed 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.397 -0.964 . . . . 55.100000000000001 108.397 177.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.93 140.71 6.67 Favored Glycine 0 N--CA 1.408 -3.2 0 C-N-CA 120.252 -0.975 . . . . 73.129999999999995 112.663 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' TYR . . . . . 0.459 ' CE2' ' HG3' ' A' ' 23' ' ' PRO . 16.3 p90 -151.73 143.44 23.65 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.509 -0.923 . . . . 75.540000000000006 108.509 171.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.33 152.19 50.81 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-O 121.023 0.44 . . . . 75.340000000000003 110.022 -173.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' TYR . . . . . 0.642 ' CD1' ' HD3' ' B' ' 112' ' ' LYS . 96.4 m-85 -121.31 115.21 22.54 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.411 -0.588 . . . . 72.549999999999997 109.411 175.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.415 ' O ' HG21 ' B' ' 39' ' ' VAL . 40.5 mm -100.12 122.8 52.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 106.904 -1.517 . . . . 72.329999999999998 106.904 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' GLU . . . . . 0.53 ' OE1' ' HD2' ' B' ' 65' ' ' ARG . 31.1 mt-10 -107.73 124.15 49.59 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.165 -0.68 . . . . 70.409999999999997 109.165 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -96.83 154.1 17.49 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 112.893 0.701 . . . . 73.010000000000005 112.893 -177.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.69 -40.47 72.89 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.147 -0.933 . . . . 71.420000000000002 110.251 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -105.76 147.94 28.04 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 116.005 -0.543 . . . . 74.209999999999994 111.471 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.471 ' O ' HG21 ' B' ' 91' ' ' VAL . 0.0 OUTLIER -74.26 -33.56 63.34 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.398 -1.334 . . . . 73.040000000000006 107.398 -179.762 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -63.03 -25.42 68.37 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 115.494 -0.775 . . . . 64.150000000000006 111.425 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 42.9 m -66.11 -36.89 84.37 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 110.243 -0.28 . . . . 73.409999999999997 110.243 177.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . 0.471 HG21 ' O ' ' B' ' 88' ' ' ARG . 3.2 m -67.83 -38.67 80.54 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 N-CA-C 109.003 -0.74 . . . . 64.109999999999999 109.003 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -56.87 -38.08 72.25 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.169 0.509 . . . . 73.450000000000003 111.576 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.69 -31.58 63.5 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.061 0.457 . . . . 65.430000000000007 111.083 177.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . 0.451 ' HA ' ' SG ' ' B' ' 60' ' ' CYS . . . -76.32 -40.8 50.49 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.192 -0.458 . . . . 75.450000000000003 111.454 -178.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 22.0 m -56.58 -21.77 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 113.0 0.741 . . . . 62.409999999999997 113.0 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.75 -18.85 65.42 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.292 0.567 . . . . 63.020000000000003 110.189 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 48.1 mtm -95.06 13.54 24.85 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.699 -0.682 . . . . 64.239999999999995 110.872 177.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . 0.457 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 11.1 t70 -33.8 -55.09 0.47 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.471 1.508 . . . . 64.230000000000004 113.683 -178.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . 0.411 ' HG3' ' OD1' ' B' ' 98' ' ' ASP . 45.6 mt-10 -124.83 62.33 1.15 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.166 -1.013 . . . . 74.299999999999997 112.775 171.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 35.0 p -91.69 174.75 7.19 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.297 -0.865 . . . . 72.200000000000003 111.72 174.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.4 p -101.67 137.81 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 109.122 -0.695 . . . . 74.010000000000005 109.122 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -142.72 118.61 10.58 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.532 -0.914 . . . . 75.0 108.532 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 45.3 mtp180 55.68 33.22 20.87 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.509 1.123 . . . . 75.129999999999995 113.539 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.53 -0.87 65.88 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.038 -0.983 . . . . 71.310000000000002 114.191 174.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -130.81 160.62 33.84 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.176 -0.676 . . . . 72.420000000000002 109.176 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 85.7 m -92.52 126.98 37.84 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.188 -0.671 . . . . 64.319999999999993 109.188 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' B' ' 42' ' ' GLY . 0.2 OUTLIER -102.8 172.3 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 118.198 -1.401 . . . . 63.200000000000003 110.334 177.485 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 56.8 tptt -119.21 124.72 47.46 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.641 -1.244 . . . . 55.530000000000001 107.641 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.424 ' HB ' ' HA ' ' B' ' 98' ' ' ASP . 47.1 t -113.91 113.97 45.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 107.065 -1.458 . . . . 73.129999999999995 107.065 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.273 3.0 tt -139.66 128.53 13.61 Favored Pre-proline 0 C--O 1.187 -2.195 0 N-CA-C 106.454 -1.684 . . . . 70.200000000000003 106.454 -170.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.35 129.54 28.66 Favored 'Trans proline' 0 CA--C 1.551 1.37 0 CA-C-N 121.499 1.571 . . . . 74.019999999999996 112.056 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.642 ' HD3' ' CD1' ' B' ' 82' ' ' TYR . 36.0 ttpt -88.29 131.56 34.74 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 116.199 -0.455 . . . . 75.209999999999994 111.039 -174.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 45.28 -175.32 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 116.94 2.2 . . . . 74.349999999999994 116.94 173.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 88.5 m -162.71 95.07 0.88 Allowed 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 125.824 1.649 . . . . 73.140000000000001 106.84 173.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 115' ' ' ASN . . . . . 0.407 ' HA ' ' CB ' ' B' ' 11' ' ' SER . 16.4 t30 -78.19 99.63 6.3 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.776 0.798 . . . . 64.519999999999996 111.785 -177.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 50.1 ttm -156.07 95.22 2.38 Favored Pre-proline 0 C--N 1.312 -1.043 0 CA-C-N 114.723 -1.126 . . . . 51.130000000000003 111.034 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -94.89 -1.34 2.6 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 122.829 2.353 . . . . 55.520000000000003 110.712 172.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.34 -72.27 2.78 Favored Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 111.343 -0.703 . . . . 62.210000000000001 111.343 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 55.6 mt 59.68 89.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.247 0.929 0 C-N-CA 124.25 1.02 . . . . 71.0 110.444 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 16.4 m -105.23 111.4 24.13 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 115.4 -0.818 . . . . 60.109999999999999 109.438 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 25.5 p -132.76 85.09 2.19 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 121.319 0.58 . . . . 74.120000000000005 109.893 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 23.7 p -129.51 6.31 5.22 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.217 -0.901 . . . . 74.230000000000004 110.52 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 70.39 -47.0 0.63 Allowed 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 125.237 1.415 . . . . 75.25 111.629 -175.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 . . . . . 0 N--CA 1.416 -2.17 0 N-CA-C 106.692 -1.596 . . . . 71.219999999999999 106.692 174.294 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.493 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 7.8 mm-40 . . . . . 0 C--O 1.221 -0.401 0 CA-C-O 120.341 0.115 . . . . 71.44 111.163 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.4 pt -70.89 -35.91 61.89 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 C-N-CA 120.763 -0.375 . . . . 54.23 111.863 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.316 2.1 p30 -76.53 -27.84 56.11 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 118.929 -1.108 . . . . 64.51 112.208 178.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -65.6 -19.3 65.86 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-O 121.364 0.602 . . . . 74.43 111.318 174.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 12.6 ptp180 -125.06 25.87 7.13 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-O 122.07 0.938 . . . . 71.34 109.624 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.57 ' OG ' ' HG2' ' A' ' 84' ' ' GLU . 39.6 t -104.2 157.23 17.27 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.332 -1.304 . . . . 54.33 110.331 177.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.616 HG22 HG23 ' A' ' 91' ' ' VAL . 17.0 t -131.07 157.04 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 N-CA-C 107.963 -1.125 . . . . 73.22 107.963 -177.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.692 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 25.6 t80 -107.19 125.63 51.36 Favored 'General case' 0 C--N 1.279 -2.5 0 N-CA-C 106.398 -1.705 . . . . 74.41 106.398 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.517 ' HA ' HG12 ' A' ' 109' ' ' VAL . 62.6 t -116.7 107.8 23.38 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.137 0 N-CA-C 106.656 -1.609 . . . . 75.3 106.656 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.467 ' HA3' ' CZ ' ' A' ' 40' ' ' TYR . . . -117.04 172.56 14.3 Favored Glycine 0 C--N 1.275 -2.812 0 C-N-CA 117.734 -2.174 . . . . 75.45 113.652 -176.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 57.73 11.67 1.4 Allowed 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 125.003 1.321 . . . . 74.1 112.92 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.7 p -55.45 142.79 9.38 Favored 'Isoleucine or valine' 0 C--O 1.246 0.906 0 CA-C-O 121.376 0.608 . . . . 74.35 109.858 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -77.6 150.05 34.71 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 107.737 -1.209 . . . . 60.43 107.737 -177.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.416 ' CD2' ' HB2' ' A' ' 77' ' ' PRO . 32.3 t80 -62.12 -20.85 64.5 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 123.886 0.741 . . . . 74.25 110.075 -176.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.16 -23.61 71.51 Favored Glycine 0 N--CA 1.424 -2.163 0 CA-C-N 115.52 -0.763 . . . . 20.43 112.82 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 72.9 m -100.97 75.6 1.69 Allowed 'General case' 0 N--CA 1.427 -1.594 0 C-N-CA 118.667 -1.213 . . . . 61.32 113.264 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.9 p -71.71 -178.0 2.1 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 116.199 -0.455 . . . . 53.42 111.93 170.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.02 -51.09 32.95 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.469 1.285 . . . . 71.24 114.469 -165.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.533 ' HG2' ' CE2' ' B' ' 46' ' ' TYR . 50.5 mt-30 -56.77 -51.88 67.19 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.441 0.534 . . . . 73.45 112.441 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -68.48 -39.19 81.44 Favored 'General case' 0 C--O 1.256 1.407 0 CA-C-O 121.591 0.71 . . . . 73.3 110.657 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.21 -46.69 73.09 Favored 'General case' 0 C--O 1.259 1.583 0 CA-C-N 114.673 -1.148 . . . . 74.24 109.061 -175.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -58.9 -40.94 86.0 Favored 'General case' 0 C--O 1.187 -2.191 0 N-CA-C 112.331 0.493 . . . . 64.11 112.331 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.56 -44.04 72.56 Favored 'General case' 0 C--O 1.266 1.926 0 CA-C-O 121.285 0.564 . . . . 64.3 111.717 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -64.82 -40.65 95.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.197 -0.911 . . . . 73.44 110.386 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.412 ' HZ ' HG11 ' A' ' 109' ' ' VAL . 66.7 m-85 -82.34 -22.76 35.42 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.028 1.122 . . . . 70.01 114.028 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.0 t -68.64 -24.69 64.58 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.01 -0.737 . . . . 72.15 109.01 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.0 m -66.31 -22.68 66.29 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 120.605 -0.438 . . . . 73.13 111.099 173.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 67.6 m -97.19 7.74 45.96 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.42 0.526 . . . . 71.33 112.42 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.21 -163.41 27.78 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 119.055 -1.545 . . . . 52.33 114.286 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.7 p -106.12 127.44 53.2 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.219 0.533 . . . . 73.11 111.236 -177.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.3 mt -86.87 133.93 28.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.683 -0.69 . . . . 53.35 112.14 -177.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.534 ' OD1' ' HG3' ' A' ' 65' ' ' ARG . 24.0 t-20 -96.99 -47.99 5.58 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.389 -0.823 . . . . 71.41 109.695 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.534 ' HG3' ' OD1' ' A' ' 64' ' ' ASN . 54.1 mtp180 -151.58 159.44 44.09 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.359 -0.978 . . . . 74.45 108.359 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.444 HG22 HG23 ' A' ' 83' ' ' ILE . 30.5 pt -146.36 141.87 21.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 107.921 -1.14 . . . . 72.33 107.921 174.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.0 m -127.37 125.4 40.63 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 107.38 -1.341 . . . . 74.34 107.38 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' B' ' 67' ' ' THR . 2.9 mp -122.37 125.45 72.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.272 -1.381 . . . . 55.32 107.272 -176.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.499 HD12 ' NH2' ' B' ' 65' ' ' ARG . 1.6 pt? -119.68 130.35 55.0 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 120.309 -0.556 . . . . 74.04 110.925 176.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.693 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 62.7 m -116.69 127.61 54.58 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.934 -0.576 . . . . 71.13 109.459 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -109.86 128.86 55.6 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.986 -0.686 . . . . 64.14 111.057 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' B' ' 64' ' ' ASN . 52.0 mttm -99.84 8.9 43.82 Favored 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 123.438 0.695 . . . . 75.45 110.213 173.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.622 ' CE2' ' HD2' ' B' ' 65' ' ' ARG . 7.6 m-85 -57.7 -25.87 60.93 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 121.58 0.705 . . . . 74.14 109.361 170.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.4 m -89.49 6.48 40.71 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 114.913 -1.04 . . . . 62.0 111.229 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.84 -52.94 4.67 Favored Glycine 0 N--CA 1.475 1.3 0 N-CA-C 110.488 -1.045 . . . . 65.02 110.488 -177.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -96.7 130.88 29.26 Favored Pre-proline 0 C--N 1.289 -2.043 0 N-CA-C 106.867 -1.531 . . . . 75.3 106.867 174.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.416 ' HB2' ' CD2' ' A' ' 46' ' ' TYR . 55.7 Cg_endo -68.69 120.32 7.25 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 122.007 1.805 . . . . 75.2 111.252 -177.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.693 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 15.1 mtmm -102.97 152.93 20.74 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.324 -1.361 . . . . 62.41 107.324 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.436 ' C ' ' HD1' ' A' ' 80' ' ' TYR . . . -120.48 137.28 12.02 Favored Glycine 0 N--CA 1.417 -2.632 0 C-N-CA 119.027 -1.558 . . . . 62.3 112.979 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.436 ' HD1' ' C ' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -129.06 142.23 50.97 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 102.743 -3.058 . . . . 72.22 102.743 172.373 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -140.47 141.89 35.37 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-N 119.042 0.837 . . . . 63.21 110.63 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.442 ' CD1' ' HD3' ' A' ' 112' ' ' LYS . 44.0 m-85 -110.07 117.2 33.1 Favored 'General case' 0 C--N 1.275 -2.632 0 N-CA-C 107.241 -1.392 . . . . 75.11 107.241 175.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.444 HG23 HG22 ' A' ' 66' ' ' ILE . 25.1 mm -102.98 121.17 53.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 107.347 -1.353 . . . . 74.31 107.347 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.57 ' HG2' ' OG ' ' A' ' 38' ' ' SER . 28.7 mt-10 -108.16 119.53 39.76 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.512 -0.922 . . . . 73.33 108.512 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -93.38 165.47 12.76 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.529 0.681 . . . . 75.41 112.819 -175.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.76 -37.81 64.9 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.065 -0.97 . . . . 74.3 111.011 174.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -118.63 158.61 25.15 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.126 1.158 . . . . 71.52 114.126 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -71.93 -26.47 62.31 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 114.701 -1.136 . . . . 54.45 110.778 175.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -60.21 -41.98 94.2 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.859 -0.61 . . . . 73.23 110.034 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.0 m -69.73 -39.7 76.65 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 115.603 -0.726 . . . . 40.1 111.765 -173.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.616 HG23 HG22 ' A' ' 39' ' ' VAL . 8.3 p -64.86 -39.22 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 120.33 -0.548 . . . . 75.34 109.807 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.68 -34.66 74.27 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.715 0.769 . . . . 73.02 109.928 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.75 -31.8 63.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.261 -0.881 . . . . 63.33 110.581 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.33 -45.05 33.96 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.088 -0.506 . . . . 51.23 110.57 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.1 m -59.44 -21.72 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 113.277 0.843 . . . . 73.02 113.277 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.97 -17.43 64.67 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.446 0.641 . . . . 74.54 110.61 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 71.8 mtm -94.98 9.96 37.4 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.562 -0.745 . . . . 70.3 110.129 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.602 ' HA ' HG22 ' A' ' 109' ' ' VAL . 2.2 p-10 -37.45 -47.53 0.89 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 116.418 2.007 . . . . 74.24 116.418 -174.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -115.47 30.68 7.2 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 118.95 0.795 . . . . 72.24 110.622 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.7 t -69.36 164.94 21.79 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-O 121.38 0.61 . . . . 72.23 110.056 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -109.13 132.13 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.936 0 N-CA-C 107.968 -1.123 . . . . 74.34 107.968 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -138.04 126.27 23.04 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 116.153 -0.476 . . . . 75.4 110.23 -174.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 103' ' ' ARG . 20.0 ttt180 55.54 32.44 19.09 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.845 1.258 . . . . 64.12 111.256 178.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.25 -10.58 72.59 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 114.237 -1.347 . . . . 61.02 113.202 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -113.16 150.65 31.93 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.828 -0.434 . . . . 74.21 109.828 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.4 m -86.6 123.16 31.48 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.252 -1.018 . . . . 72.45 108.252 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 44.4 pt -101.6 171.61 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.782 -0.767 . . . . 72.31 109.541 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 55.6 tptt -132.36 124.76 29.37 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.674 -0.491 . . . . 75.34 109.674 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.692 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 30.2 m -127.78 123.88 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 121.337 0.589 . . . . 73.14 111.317 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.405 HD11 ' HG2' ' B' ' 22' ' ' PRO . 0.0 OUTLIER -147.57 163.69 26.45 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 106.65 -1.611 . . . . 71.52 106.65 179.375 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.83 149.2 86.84 Favored 'Trans proline' 0 N--CA 1.478 0.6 0 C-N-CA 121.839 1.692 . . . . 54.42 112.046 -174.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.509 ' HE3' ' OG ' ' A' ' 38' ' ' SER . 25.5 ttpp . . . . . 0 N--CA 1.437 -1.108 0 CA-C-O 122.518 1.151 . . . . 74.04 112.109 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.375 0 N-CA-C 109.655 -1.378 . . . . 73.01 109.655 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.479 ' N ' ' HD2' ' B' ' 23' ' ' PRO . 33.1 Cg_exo -58.36 -43.09 49.35 Favored 'Trans proline' 0 CA--C 1.574 2.505 0 C-N-CA 123.055 2.503 . . . . 71.11 114.169 174.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' B' ' 22' ' ' PRO . 7.1 Cg_endo -53.43 154.98 13.73 Favored 'Trans proline' 0 C--N 1.397 3.099 0 C-N-CA 122.525 2.15 . . . . 73.23 112.008 175.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' GLN . . . . . 0.448 ' H ' ' CD ' ' B' ' 24' ' ' GLN . 0.1 OUTLIER -84.26 133.02 45.86 Favored Pre-proline 0 N--CA 1.41 -2.467 0 N-CA-C 107.697 -1.223 . . . . 71.21 107.697 177.44 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' B' ' 24' ' ' GLN . 25.2 Cg_exo -61.39 138.6 77.58 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.351 2.034 . . . . 72.25 112.128 -175.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.758 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -68.79 176.19 3.18 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.71 -0.677 . . . . 63.31 110.555 175.393 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 15.7 m -53.68 143.02 21.48 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.097 0.777 . . . . 45.12 113.097 -170.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.56 -43.21 75.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.758 -1.11 . . . . 72.14 112.13 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . 0.319 49.2 mt-10 -76.8 -29.66 56.09 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.966 1.099 . . . . 74.42 113.966 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.458 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.4 OUTLIER -57.02 -35.62 69.47 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.847 -0.797 . . . . 74.01 108.847 169.174 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -72.33 -39.64 68.04 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.097 -0.956 . . . . 61.13 110.715 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.617 ' N ' ' HE2' ' B' ' 32' ' ' LYS . 0.0 OUTLIER -65.38 -45.92 82.18 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 112.109 0.411 . . . . 75.15 112.109 178.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -64.5 -35.48 81.07 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 123.279 0.362 . . . . 74.24 111.773 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.458 HG12 ' O ' ' B' ' 30' ' ' GLU 0.301 20.0 pt -70.78 -34.04 54.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 112.401 0.519 . . . . 55.23 112.401 179.484 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -67.51 -43.34 81.1 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 121.941 0.877 . . . . 73.23 109.055 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -60.88 -19.8 60.85 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.957 -1.019 . . . . 72.53 111.141 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -112.21 11.64 20.28 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.353 -0.61 . . . . 72.45 109.353 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.507 ' OG ' ' HE3' ' B' ' 112' ' ' LYS . 31.4 t -99.08 151.17 21.25 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.679 0.752 . . . . 75.31 111.876 -177.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.579 HG22 HG23 ' B' ' 91' ' ' VAL . 10.5 t -129.09 158.9 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.079 0 N-CA-C 106.718 -1.586 . . . . 61.32 106.718 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' TYR . . . . . 0.696 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 36.7 t80 -110.0 125.44 52.9 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 106.353 -1.721 . . . . 73.32 106.353 174.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.523 ' HA ' HG12 ' B' ' 109' ' ' VAL . 59.9 t -117.22 106.91 21.01 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.098 0 N-CA-C 106.97 -1.493 . . . . 55.2 106.97 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.27 173.72 15.07 Favored Glycine 0 C--N 1.275 -2.842 0 C-N-CA 118.164 -1.97 . . . . 74.12 112.415 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.0 t30 62.25 6.0 1.72 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 124.842 1.257 . . . . 44.31 112.948 -177.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.9 p -61.57 131.24 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 107.274 -1.38 . . . . 51.23 107.274 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.519 ' OD1' ' HD2' ' B' ' 103' ' ' ARG . 3.6 p-10 -87.53 167.38 14.0 Favored 'General case' 0 N--CA 1.419 -1.977 0 C-N-CA 118.596 -1.242 . . . . 54.12 111.194 -172.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' TYR . . . . . 0.533 ' CE2' ' HG2' ' A' ' 51' ' ' GLN . 49.2 t80 -63.81 -12.19 33.58 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 113.981 -1.463 . . . . 72.42 111.189 -174.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.37 -23.6 67.69 Favored Glycine 0 N--CA 1.42 -2.431 0 CA-C-N 115.937 -0.574 . . . . 72.55 112.555 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.7 t -90.04 152.04 21.36 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 119.381 -0.927 . . . . 71.12 108.537 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' THR . . . . . 0.537 ' O ' ' HB2' ' B' ' 53' ' ' LEU . 32.8 p -133.21 178.33 6.98 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.883 -0.784 . . . . 74.12 108.883 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.15 -46.61 82.57 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.576 0.954 . . . . 61.31 113.576 -172.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -57.59 -52.2 66.39 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.088 0.47 . . . . 71.51 111.442 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -64.82 -40.04 94.56 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-N 115.518 -0.765 . . . . 54.02 110.767 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.537 ' HB2' ' O ' ' B' ' 49' ' ' THR . 1.0 OUTLIER -67.3 -47.05 71.74 Favored 'General case' 0 C--O 1.255 1.386 0 CA-C-N 114.875 -1.057 . . . . 60.44 109.135 -177.3 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -58.93 -42.63 90.21 Favored 'General case' 0 C--O 1.188 -2.17 0 C-N-CA 120.671 -0.412 . . . . 73.24 111.932 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.1 -43.5 70.45 Favored 'General case' 0 C--O 1.266 1.955 0 O-C-N 123.196 0.31 . . . . 30.42 110.842 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -65.13 -41.51 94.76 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.073 -0.651 . . . . 71.32 110.534 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -82.32 -23.65 35.03 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 113.891 1.071 . . . . 72.2 113.891 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 34.5 t -71.26 -24.08 62.1 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 123.658 0.783 . . . . 74.03 108.947 -177.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 38.7 m -67.26 -24.71 65.82 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 115.56 -0.746 . . . . 73.5 109.899 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 61.5 m -106.59 14.37 27.11 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.554 0.576 . . . . 54.42 112.554 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' GLY . . . . . 0.444 ' HA3' ' OG ' ' B' ' 90' ' ' SER . . . 151.17 -174.96 30.29 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 118.953 -1.594 . . . . 75.34 115.158 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 46.7 m -105.35 120.0 40.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.422 0.629 . . . . 71.04 110.947 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 67.7 mt -83.23 131.28 34.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.609 -0.723 . . . . 71.51 112.553 -176.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 72' ' ' LYS . 43.3 t-20 -99.47 -42.32 7.0 Favored 'General case' 0 C--O 1.208 -1.1 0 CA-C-N 115.615 -0.72 . . . . 70.52 110.478 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.622 ' HD2' ' CE2' ' A' ' 73' ' ' PHE . 55.6 mtp180 -151.57 160.34 43.71 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.318 -0.993 . . . . 71.42 108.318 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 18.0 pt -148.23 141.47 18.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 107.869 -1.16 . . . . 50.12 107.869 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 47.9 m -127.73 126.44 41.83 Favored 'General case' 0 C--N 1.268 -2.942 0 N-CA-C 107.96 -1.126 . . . . 74.43 107.96 177.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 68' ' ' ILE . . . . . 0.468 ' O ' HD12 ' A' ' 68' ' ' ILE . 2.3 mp -121.83 127.42 75.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 106.567 -1.642 . . . . 64.14 106.567 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -120.99 132.0 54.64 Favored 'General case' 0 C--N 1.286 -2.19 0 C-N-CA 119.801 -0.76 . . . . 74.44 110.52 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 70' ' ' CYS . . . . . 0.6 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 63.1 m -116.6 127.5 54.53 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 109.35 -0.611 . . . . 73.31 109.35 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -107.29 131.5 54.14 Favored 'General case' 0 CA--C 1.474 -1.956 0 C-N-CA 119.09 -1.044 . . . . 63.14 108.857 177.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 72' ' ' LYS . . . . . 0.579 ' HE2' ' HB3' ' B' ' 77' ' ' PRO . 40.1 ttmt -125.16 7.42 7.87 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 109.158 -0.682 . . . . 74.34 109.158 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -69.64 -18.32 63.58 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.418 0.627 . . . . 72.1 110.247 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 22.5 p -84.26 1.98 42.2 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 114.85 -1.068 . . . . 71.55 109.955 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.46 -44.05 2.46 Favored Glycine 0 N--CA 1.439 -1.135 0 N-CA-C 110.733 -0.947 . . . . 60.42 110.733 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -95.85 128.1 38.74 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 108.096 -1.076 . . . . 70.21 108.096 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.579 ' HB3' ' HE2' ' B' ' 72' ' ' LYS . 94.2 Cg_endo -78.32 119.0 4.43 Favored 'Trans proline' 0 N--CA 1.434 -1.99 0 C-N-CA 121.298 1.332 . . . . 52.24 110.535 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 78' ' ' LYS . . . . . 0.6 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 1.2 mtpt -116.57 163.52 15.96 Favored 'General case' 0 CA--C 1.471 -2.095 0 CA-C-N 114.798 -1.092 . . . . 71.01 110.324 -174.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 79' ' ' GLY . . . . . 0.415 ' C ' ' HD1' ' B' ' 80' ' ' TYR . . . -134.2 137.84 9.61 Favored Glycine 0 N--CA 1.428 -1.838 0 C-N-CA 119.585 -1.293 . . . . 61.1 113.853 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 80' ' ' TYR . . . . . 0.415 ' HD1' ' C ' ' B' ' 79' ' ' GLY . 0.1 OUTLIER -130.77 142.6 50.41 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 102.794 -3.039 . . . . 74.32 102.794 172.0 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.81 141.79 36.7 Favored 'General case' 0 C--N 1.279 -2.467 0 CA-C-N 118.939 0.79 . . . . 63.42 110.486 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 82' ' ' TYR . . . . . 0.516 ' CD1' ' HG3' ' B' ' 112' ' ' LYS . 27.9 m-85 -109.51 117.18 33.31 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 106.793 -1.558 . . . . 71.34 106.793 175.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 33.0 mm -102.7 121.43 53.81 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 107.674 -1.232 . . . . 64.32 107.674 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' B' ' 38' ' ' SER . 31.1 mt-10 -108.07 119.3 39.09 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.704 -0.85 . . . . 72.42 108.704 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -95.31 164.58 12.77 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.408 0.623 . . . . 72.41 112.3 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.91 -30.33 31.93 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.194 -0.912 . . . . 53.0 111.864 176.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.02 147.62 42.18 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 114.79 1.404 . . . . 75.0 114.79 177.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.438 ' O ' HG12 ' B' ' 91' ' ' VAL . 20.4 mmm180 -64.25 -27.44 69.05 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.428 1.091 . . . . 73.23 110.279 175.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -58.44 -42.16 86.7 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.765 -0.652 . . . . 73.53 109.771 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' SER . . . . . 0.444 ' OG ' ' HA3' ' B' ' 61' ' ' GLY . 50.1 m -71.58 -37.32 71.04 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 113.082 0.771 . . . . 62.41 113.082 -173.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.579 HG23 HG22 ' B' ' 39' ' ' VAL . 12.3 p -65.48 -38.58 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 109.15 -0.685 . . . . 62.5 109.15 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -69.37 -35.81 76.2 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.612 0.72 . . . . 71.0 109.847 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.25 -31.85 64.36 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.374 -0.83 . . . . 63.31 110.554 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.31 -45.45 32.28 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.297 -0.41 . . . . 71.02 111.103 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 33.7 m -58.77 -22.23 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 112.874 0.694 . . . . 61.42 112.874 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.63 -13.0 61.7 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.371 0.605 . . . . 73.54 110.796 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 69.6 mtm -99.83 12.81 35.76 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.428 -0.805 . . . . 74.13 110.75 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 98' ' ' ASP . . . . . 0.551 ' HA ' HG22 ' B' ' 109' ' ' VAL . 3.9 p-10 -47.72 -40.47 20.46 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.054 0.761 . . . . 74.31 113.054 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -104.48 108.22 19.53 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 108.2 -1.037 . . . . 72.22 108.2 170.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 11.5 t -163.38 169.34 19.12 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.49 -0.93 . . . . 74.12 108.49 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.77 125.21 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 CA-C-O 121.606 0.717 . . . . 73.32 109.572 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 102' ' ' PHE . . . . . 0.428 ' O ' ' HG2' ' B' ' 105' ' ' ARG . 83.5 t80 -129.64 129.03 43.81 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.628 -0.879 . . . . 74.43 108.628 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 103' ' ' ARG . . . . . 0.519 ' HD2' ' OD1' ' B' ' 45' ' ' ASP . 24.2 ttm-85 55.57 31.91 18.09 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.541 1.136 . . . . 75.23 110.514 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.29 5.62 87.04 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 114.497 -1.229 . . . . 61.43 114.083 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' B' ' 102' ' ' PHE . 12.8 ptm180 -129.11 148.31 51.04 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 117.558 0.679 . . . . 73.45 110.262 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 37.2 m -80.76 120.98 25.34 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.725 -0.472 . . . . 74.31 109.725 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 34.7 pt -102.43 171.1 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 C-N-CA 120.352 -0.539 . . . . 73.44 110.393 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -128.61 125.16 37.6 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 109.267 -0.642 . . . . 75.15 109.267 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 109' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 33.2 m -127.66 124.4 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-O 121.203 0.525 . . . . 73.3 111.727 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.02 164.05 24.11 Favored Pre-proline 0 C--O 1.197 -1.71 0 N-CA-C 106.916 -1.513 . . . . 70.31 106.916 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -66.45 143.82 70.96 Favored 'Trans proline' 0 CA--C 1.568 2.195 0 C-N-CA 122.182 1.921 . . . . 73.44 114.328 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.516 ' HG3' ' CD1' ' B' ' 82' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.83 0 C-N-CA 123.125 0.57 . . . . 72.32 109.83 -177.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 120.964 0.411 . . . . 71.4 111.06 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.8 pt -70.77 -33.42 52.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.705 -0.68 . . . . 64.04 110.566 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -56.13 -44.57 79.28 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.46 1.104 . . . . 74.0 109.654 175.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -55.56 -29.67 59.41 Favored 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 115.19 -0.914 . . . . 74.54 112.888 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.49 ' HA ' HG11 ' A' ' 91' ' ' VAL . 17.4 ptp180 -119.53 18.03 12.83 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 121.45 0.643 . . . . 53.33 111.566 -172.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.447 ' OG ' ' HG2' ' A' ' 84' ' ' GLU . 47.2 t -107.57 169.15 8.76 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.788 -0.642 . . . . 72.02 111.249 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 111' ' ' PRO . 11.2 m -140.33 163.72 23.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 124.496 1.118 . . . . 55.22 111.488 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.423 ' HB3' ' HB2' ' A' ' 110' ' ' LEU . 21.4 t80 -116.26 129.7 56.41 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 125.227 1.411 . . . . 65.5 109.608 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 63.0 t -109.12 117.49 54.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.744 -1.206 . . . . 62.34 107.744 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.04 163.75 12.13 Favored Glycine 0 N--CA 1.426 -2.01 0 C-N-CA 119.522 -1.323 . . . . 60.21 113.055 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 63.38 13.06 6.76 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.895 1.678 . . . . 63.45 112.883 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.9 p -64.49 137.62 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.452 0.644 . . . . 71.42 109.533 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -91.09 159.02 16.32 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.394 -0.821 . . . . 53.22 111.435 -174.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.463 ' CE2' ' HB2' ' A' ' 77' ' ' PRO . 4.5 m-85 -61.09 -19.16 61.12 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 114.951 -1.022 . . . . 70.4 112.013 178.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.86 -24.11 77.34 Favored Glycine 0 N--CA 1.428 -1.856 0 CA-C-N 115.88 -0.6 . . . . 73.5 111.727 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.5 m -86.32 140.01 30.46 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 120.581 -0.447 . . . . 74.52 109.844 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.465 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 76.0 p -109.15 173.25 6.4 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.119 -0.492 . . . . 63.13 110.778 -176.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.424 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -67.19 -45.27 77.42 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 110.062 -0.348 . . . . 72.51 110.062 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -58.49 -42.28 87.22 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.472 -0.331 . . . . 73.1 111.229 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.465 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 1.4 t70 -64.35 -37.9 89.13 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.689 0.757 . . . . 72.34 109.02 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 33.7 mt -68.51 -47.93 65.71 Favored 'General case' 0 C--O 1.249 1.038 0 CA-C-N 114.965 -1.016 . . . . 75.4 111.096 177.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -60.81 -49.8 76.03 Favored 'General case' 0 C--O 1.198 -1.654 0 CA-C-N 116.355 -0.384 . . . . 63.22 111.144 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.49 -40.08 77.84 Favored 'General case' 0 C--O 1.258 1.53 0 CA-C-O 121.367 0.603 . . . . 75.25 111.184 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -69.02 -41.09 78.2 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.154 -0.93 . . . . 61.14 110.715 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -82.66 -22.85 34.46 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 113.055 0.761 . . . . 75.32 113.055 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.7 m -72.11 -21.23 61.51 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-N 115.19 -0.914 . . . . 75.35 110.979 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.1 m -57.68 -17.78 16.92 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.388 -0.369 . . . . 53.2 111.161 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.872 ' SG ' ' HA ' ' A' ' 90' ' ' SER . 44.1 t -94.4 -76.56 0.48 Allowed 'General case' 0 N--CA 1.417 -2.08 0 CA-C-O 120.789 0.328 . . . . 54.11 110.638 175.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -130.06 -143.33 5.38 Favored Glycine 0 CA--C 1.508 -0.351 0 C-N-CA 120.257 -0.973 . . . . 54.45 115.217 -176.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.0 m -105.13 121.51 43.96 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 122.437 0.295 . . . . 71.34 110.991 -173.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 61.2 mt -85.22 129.27 38.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 116.028 -0.533 . . . . 64.31 112.014 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -93.4 -44.75 8.12 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.51 0.724 . . . . 75.44 111.504 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -149.12 159.55 44.14 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.216 -0.902 . . . . 75.14 110.27 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.442 HD13 HG21 ' A' ' 66' ' ' ILE . 39.4 pt -145.34 135.0 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.994 0 N-CA-C 106.753 -1.573 . . . . 73.32 106.753 170.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.0 m -124.78 123.8 40.75 Favored 'General case' 0 C--N 1.272 -2.799 0 N-CA-C 106.112 -1.81 . . . . 75.11 106.112 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.6 mp -121.24 117.39 52.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 106.562 -1.644 . . . . 72.3 106.562 -175.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.35 0.9 OUTLIER -121.32 129.83 53.31 Favored 'General case' 0 C--N 1.274 -2.676 0 C-N-CA 120.127 -0.629 . . . . 74.33 112.558 177.763 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.576 ' HB2' HG12 ' B' ' 66' ' ' ILE . 81.0 m -116.55 121.21 41.1 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 115.647 -0.706 . . . . 74.35 109.256 -177.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.608 ' HA ' ' HA ' ' B' ' 65' ' ' ARG . 1.1 t70 -117.48 125.45 50.92 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 123.757 0.823 . . . . 70.14 110.586 -173.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.55 ' HE2' ' HB3' ' A' ' 77' ' ' PRO . 39.6 ttmt -115.9 16.73 16.17 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.224 -0.658 . . . . 73.5 109.224 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.423 ' HD1' ' N ' ' A' ' 74' ' ' SER . 0.0 OUTLIER -63.61 -23.15 67.26 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 119.934 -0.706 . . . . 74.5 112.817 -175.913 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.423 ' N ' ' HD1' ' A' ' 73' ' ' PHE . 14.9 m -81.79 -0.9 45.32 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.154 -0.475 . . . . 62.32 111.134 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.9 -40.57 2.38 Favored Glycine 0 CA--C 1.5 -0.881 0 N-CA-C 110.095 -1.202 . . . . 75.33 110.095 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -95.14 130.28 33.0 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 107.923 -1.14 . . . . 61.41 107.923 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.55 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 36.8 Cg_endo -70.74 118.07 5.49 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.387 1.392 . . . . 72.32 110.505 177.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 37.2 mtmm -108.61 151.45 26.11 Favored 'General case' 0 CA--C 1.476 -1.898 0 CA-C-N 116.242 -0.436 . . . . 72.2 109.943 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.42 140.07 11.5 Favored Glycine 0 N--CA 1.409 -3.159 0 C-N-CA 120.517 -0.849 . . . . 72.21 111.025 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -151.41 144.13 24.37 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.788 -0.449 . . . . 73.51 109.788 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.42 154.81 49.89 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.968 -0.382 . . . . 74.42 109.968 -173.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -122.39 120.57 34.37 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 108.544 -0.91 . . . . 73.2 108.544 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.5 mm -101.73 119.22 49.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 107.17 -1.418 . . . . 74.14 107.17 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.447 ' HG2' ' OG ' ' A' ' 38' ' ' SER . 32.9 mt-10 -104.97 120.47 41.53 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.157 -0.682 . . . . 55.11 109.157 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -100.38 165.44 11.45 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 121.378 0.609 . . . . 65.14 112.055 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.48 ' O ' ' HD3' ' A' ' 37' ' ' ARG . . . -81.16 -32.37 33.67 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.728 -1.124 . . . . 42.32 110.965 175.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -123.5 160.67 26.46 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 113.246 0.832 . . . . 74.03 113.246 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -69.54 -32.48 71.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.359 -1.291 . . . . 75.24 112.279 174.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -60.74 -36.56 79.19 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.948 -0.301 . . . . 73.51 110.702 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.872 ' HA ' ' SG ' ' A' ' 60' ' ' CYS . 14.8 m -63.33 -45.2 92.34 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 116.574 -0.284 . . . . 61.35 111.403 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.49 HG11 ' HA ' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -65.7 -43.2 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 119.317 -0.373 . . . . 73.34 111.71 177.54 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.2 -35.28 75.04 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.687 0.625 . . . . 72.03 112.687 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.579 ' HB3' ' SG ' ' A' ' 60' ' ' CYS . . . -75.34 -37.89 60.46 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.122 0.486 . . . . 64.21 110.954 177.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.51 -40.64 76.83 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 116.086 -0.507 . . . . 73.22 111.861 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 91' ' ' VAL . 24.5 m -56.64 -22.16 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 112.282 0.475 . . . . 62.31 112.282 177.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.89 -19.38 62.62 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-O 120.894 0.378 . . . . 64.51 110.043 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 32.4 mtm -88.46 7.68 31.67 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.202 0.601 . . . . 75.4 111.935 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.564 ' HA ' ' HB ' ' A' ' 109' ' ' VAL . 7.3 t70 -33.39 -54.11 0.41 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 116.938 2.199 . . . . 55.33 116.938 -178.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -124.42 45.37 2.53 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 120.495 1.498 . . . . 74.33 110.125 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 42.9 m -84.95 162.37 19.44 Favored 'General case' 0 CA--C 1.571 1.759 0 CA-C-N 114.3 -1.318 . . . . 63.2 109.752 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.0 p -99.71 137.86 25.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 O-C-N 121.465 -0.772 . . . . 72.2 110.646 -174.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -151.2 117.87 5.77 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.467 -0.938 . . . . 65.22 108.467 -177.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.381 83.2 mtt85 59.99 55.09 3.92 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 116.078 1.881 . . . . 71.23 116.078 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.99 -13.05 1.45 Allowed Glycine 0 N--CA 1.469 0.856 0 CA-C-N 114.806 -1.088 . . . . 44.2 114.893 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -119.39 161.08 21.09 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-O 121.012 0.434 . . . . 71.45 110.383 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.9 m -94.59 127.81 40.78 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 108.366 -0.975 . . . . 64.2 108.366 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 48.2 pt -101.37 171.27 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.334 0 C-N-CA 119.782 -0.767 . . . . 75.25 109.949 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 55.1 tptt -125.88 129.35 49.17 Favored 'General case' 0 N--CA 1.409 -2.522 0 CA-C-N 114.791 -1.095 . . . . 64.11 108.809 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.564 ' HB ' ' HA ' ' A' ' 98' ' ' ASP . 47.3 t -119.95 112.25 36.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 107.658 -1.238 . . . . 72.41 107.658 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 40' ' ' TYR . 72.8 mt -112.4 152.59 44.67 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 109.017 -0.734 . . . . 75.2 109.017 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.452 ' HA ' HG12 ' A' ' 39' ' ' VAL . 3.3 Cg_exo -75.44 129.9 12.36 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 N-CA-C 107.892 -1.618 . . . . 52.41 107.892 171.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.418 ' H ' ' HA ' ' A' ' 39' ' ' VAL . 87.1 tttt . . . . . 0 CA--C 1.487 -1.446 0 N-CA-C 107.584 -1.265 . . . . 71.24 107.584 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.411 0 N-CA-C 112.141 -0.384 . . . . 51.23 112.141 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.439 ' N ' ' HD2' ' B' ' 23' ' ' PRO . 72.1 Cg_exo -49.74 -44.9 34.19 Favored 'Trans proline' 0 CA--C 1.567 2.125 0 C-N-CA 123.871 3.048 . . . . 73.02 116.031 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' B' ' 22' ' ' PRO . 10.3 Cg_endo -53.84 142.2 63.82 Favored 'Trans proline' 0 C--N 1.395 2.975 0 C-N-CA 121.96 1.774 . . . . 75.05 111.36 176.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -54.16 129.16 58.84 Favored Pre-proline 0 C--O 1.241 0.63 0 N-CA-C 113.454 0.909 . . . . 71.42 113.454 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -59.99 135.51 63.38 Favored 'Trans proline' 0 CA--C 1.501 -1.155 0 C-N-CA 123.641 2.894 . . . . 55.02 114.139 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.512 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -113.92 125.89 54.54 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 107.037 -1.468 . . . . 73.11 107.037 173.346 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 32.8 t -71.84 173.94 7.58 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 113.479 0.918 . . . . 54.14 113.479 -168.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.511 ' O ' ' HG3' ' B' ' 32' ' ' LYS . . . -49.0 -46.17 43.54 Favored 'General case' 0 C--O 1.21 -0.982 0 CA-C-N 114.491 -1.231 . . . . 72.3 112.288 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -68.0 -33.01 73.8 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 112.054 0.39 . . . . 72.33 112.054 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.44 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.9 OUTLIER -65.71 -39.42 91.2 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.446 -0.576 . . . . 60.02 109.446 172.795 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -67.06 -36.87 82.98 Favored 'General case' 0 C--O 1.207 -1.149 0 CA-C-N 115.573 -0.739 . . . . 74.01 110.087 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' B' ' 28' ' ' ALA . 59.9 mtpt -66.35 -40.24 89.69 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 113.497 0.925 . . . . 75.53 113.497 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -70.08 -39.77 75.39 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 120.299 -0.56 . . . . 71.2 111.281 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.44 HG12 ' O ' ' B' ' 30' ' ' GLU . 11.1 pt -70.57 -32.99 51.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.785 -0.643 . . . . 63.21 110.328 178.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' B' ' 32' ' ' LYS . 10.4 t70 -56.35 -42.96 78.6 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.827 1.251 . . . . 72.4 109.699 176.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 97.7 mttt -57.64 -33.28 68.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.05 -0.977 . . . . 64.22 112.015 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -102.89 2.55 35.42 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 123.713 0.805 . . . . 73.11 111.23 -172.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 71.1 p -104.33 162.94 12.79 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 114.51 1.3 . . . . 62.23 114.51 -175.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 13.9 m -133.4 163.61 37.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.674 -1.148 . . . . 40.2 111.08 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' TYR . . . . . 0.486 ' CD2' HD12 ' B' ' 110' ' ' LEU . 23.1 t80 -116.17 130.53 56.84 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 125.281 1.432 . . . . 74.11 109.346 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 71.7 t -109.89 120.49 61.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 124.766 1.226 . . . . 41.11 109.06 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -118.59 169.38 13.44 Favored Glycine 0 N--CA 1.427 -1.95 0 C-N-CA 120.139 -1.029 . . . . 41.12 112.453 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 60.6 t30 65.97 12.54 8.5 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 126.451 1.901 . . . . 75.23 112.834 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -72.09 117.43 15.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 108.218 -1.03 . . . . 63.2 108.218 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -77.04 162.0 27.86 Favored 'General case' 0 C--O 1.253 1.288 0 C-N-CA 119.941 -0.703 . . . . 73.13 111.611 -173.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -69.01 98.52 0.97 Allowed 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 107.21 -1.404 . . . . 74.35 107.21 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 159.15 -26.08 0.36 Allowed Glycine 0 N--CA 1.417 -2.574 0 C-N-CA 120.539 -0.838 . . . . 61.21 112.051 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.7 t -77.18 149.46 35.57 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.7 -1.222 . . . . 72.23 107.7 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 25.2 p -99.55 167.54 10.53 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.444 -0.502 . . . . 74.12 110.883 -173.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.44 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -71.04 -41.78 70.34 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 109.102 -0.703 . . . . 74.15 109.102 177.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -57.39 -44.16 84.25 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.136 -0.484 . . . . 72.43 111.094 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.88 -45.95 78.45 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.133 0.492 . . . . 64.22 110.381 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 74.6 mt -64.26 -47.68 78.69 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.094 -0.957 . . . . 73.43 111.862 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.445 ' HG3' HD12 ' B' ' 63' ' ' ILE . 34.1 tt0 -62.92 -50.85 69.22 Favored 'General case' 0 C--O 1.199 -1.59 0 C-N-CA 120.498 -0.481 . . . . 73.43 111.372 -178.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.97 -40.08 72.73 Favored 'General case' 0 C--O 1.257 1.467 0 CA-C-O 121.594 0.711 . . . . 73.24 111.454 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -69.35 -41.56 76.45 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.78 -1.1 . . . . 73.45 110.542 -176.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -83.06 -23.19 33.27 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.903 0.705 . . . . 73.34 112.903 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 67.1 m -71.32 -22.72 61.89 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 115.472 -0.785 . . . . 62.21 109.534 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 58.3 m -65.84 -18.12 65.12 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.739 -0.664 . . . . 62.3 109.96 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' CYS . . . . . 0.565 ' O ' ' HA ' ' B' ' 90' ' ' SER . 70.3 m -115.29 19.18 15.74 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 116.245 -0.434 . . . . 54.25 111.669 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 61' ' ' GLY . . . . . 0.43 ' HA3' ' OG ' ' B' ' 90' ' ' SER . . . 149.03 -162.64 28.99 Favored Glycine 0 N--CA 1.46 0.284 0 C-N-CA 118.282 -1.913 . . . . 72.04 116.034 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 15.1 m -111.1 115.1 28.86 Favored 'General case' 0 C--O 1.25 1.092 0 C-N-CA 123.018 0.527 . . . . 71.14 110.399 -175.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.445 HD12 ' HG3' ' B' ' 54' ' ' GLU . 65.5 mt -80.73 130.85 35.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.668 0.747 . . . . 71.45 112.995 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -100.31 -43.81 6.14 Favored 'General case' 0 C--O 1.21 -1.001 0 N-CA-C 107.09 -1.448 . . . . 61.25 107.09 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.608 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 86.4 mtt180 -153.64 161.88 41.76 Favored 'General case' 0 C--O 1.21 -1.014 0 C-N-CA 123.732 0.813 . . . . 75.41 110.384 176.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.576 HG12 ' HB2' ' A' ' 70' ' ' CYS . 31.9 pt -144.79 137.81 22.15 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.495 0 N-CA-C 106.656 -1.609 . . . . 73.32 106.656 169.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 67' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' B' ' 81' ' ' ALA . 53.3 m -125.75 120.82 31.64 Favored 'General case' 0 C--N 1.273 -2.745 0 N-CA-C 106.912 -1.514 . . . . 63.03 106.912 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mp -117.08 116.72 52.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 106.278 -1.749 . . . . 72.31 106.278 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.306 1.5 pt? -122.12 132.69 54.61 Favored 'General case' 0 C--N 1.275 -2.669 0 C-N-CA 119.666 -0.814 . . . . 73.04 111.531 176.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 70' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 73.5 m -116.68 120.5 38.82 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 115.108 -0.951 . . . . 54.43 108.592 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.426 ' HB2' ' CE2' ' B' ' 73' ' ' PHE . 2.4 p-10 -106.14 121.66 44.62 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 116.513 -2.075 . . . . 71.43 111.061 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 72' ' ' LYS . . . . . 0.468 ' HE3' ' HG3' ' B' ' 77' ' ' PRO . 43.8 mtpt -118.05 -6.79 10.91 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.446 -1.252 . . . . 74.1 111.157 -176.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.426 ' CE2' ' HB2' ' B' ' 71' ' ' ASP . 52.6 p90 -69.93 -17.2 63.31 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.556 0.693 . . . . 63.25 109.837 -177.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 20.1 m -81.21 -1.78 46.12 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.283 -0.871 . . . . 71.31 109.692 176.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.26 -59.66 0.37 Allowed Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 110.979 -0.849 . . . . 65.24 110.979 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' HIS . . . . . 0.478 ' HA ' ' HD3' ' B' ' 77' ' ' PRO . 72.5 m80 -96.5 131.15 28.9 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 110.167 -0.308 . . . . 72.41 110.167 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' B' ' 76' ' ' HIS . 13.6 Cg_exo -72.87 119.28 5.98 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.589 2.193 . . . . 51.45 112.616 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 78' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 37.1 mtmm -112.31 154.83 25.08 Favored 'General case' 0 CA--C 1.48 -1.732 0 N-CA-C 108.069 -1.086 . . . . 71.0 108.069 174.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.56 141.13 12.29 Favored Glycine 0 N--CA 1.411 -3.027 0 C-N-CA 119.612 -1.28 . . . . 74.31 112.325 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -154.61 145.33 22.4 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.001 -0.599 . . . . 74.52 109.634 175.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' B' ' 67' ' ' THR . . . -137.69 154.98 49.59 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 116.216 -0.447 . . . . 53.3 110.381 -172.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 82' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' B' ' 66' ' ' ILE . 49.1 m-85 -123.61 119.08 28.82 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.624 -0.88 . . . . 70.31 108.624 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.53 HG23 HG22 ' B' ' 66' ' ' ILE . 19.5 mm -101.66 119.94 50.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 107.07 -1.456 . . . . 75.42 107.07 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -107.19 125.55 51.25 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 108.579 -0.897 . . . . 64.53 108.579 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -106.7 164.52 12.02 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 120.994 0.426 . . . . 72.22 110.471 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.95 -18.72 23.31 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.743 -0.662 . . . . 72.32 111.097 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -127.24 142.06 51.57 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.297 -0.411 . . . . 74.41 111.118 -176.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -61.29 -34.4 75.15 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.116 0.784 . . . . 63.33 113.116 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -56.84 -37.16 70.89 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.537 -0.301 . . . . 74.11 111.103 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 90' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' B' ' 60' ' ' CYS . 15.0 m -62.92 -43.91 97.5 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 111.766 0.284 . . . . 74.33 111.766 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.494 ' O ' HG13 ' B' ' 95' ' ' VAL 0.3 0.7 OUTLIER -67.31 -42.9 88.18 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 C-N-CA 120.426 -0.51 . . . . 65.51 111.924 177.515 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -59.55 -36.29 75.88 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.491 -0.484 . . . . 74.14 112.291 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.19 -35.68 63.97 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.802 0.334 . . . . 74.23 111.402 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.57 -38.42 62.68 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.254 -0.43 . . . . 75.04 111.958 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 95' ' ' VAL . . . . . 0.494 HG13 ' O ' ' B' ' 91' ' ' VAL . 28.0 m -58.94 -23.3 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 112.175 0.435 . . . . 72.43 112.175 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.24 -9.89 58.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.419 0.628 . . . . 52.14 111.142 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 8.0 ttp -103.23 7.05 38.52 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.383 -0.969 . . . . 61.23 108.383 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 98' ' ' ASP . . . . . 0.515 ' HA ' ' HB ' ' B' ' 109' ' ' VAL . 4.1 p-10 -41.24 -56.79 2.3 Favored 'General case' 0 C--O 1.209 -1.062 0 N-CA-C 113.463 0.912 . . . . 61.04 113.463 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -101.7 97.12 7.57 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 118.474 0.579 . . . . 71.45 109.735 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 26.0 p -145.83 165.04 30.05 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.212 -0.904 . . . . 74.21 110.537 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 p -107.63 119.46 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-O 121.359 0.599 . . . . 73.3 109.968 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -131.91 127.77 37.13 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.688 -0.687 . . . . 72.13 109.255 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 48.6 ttt-85 62.17 33.2 17.02 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 122.547 1.165 . . . . 74.43 110.229 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.41 5.98 86.45 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 114.073 -1.421 . . . . 70.14 114.899 175.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -136.92 155.72 49.39 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 117.76 0.78 . . . . 71.11 111.077 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 46.8 m -78.49 123.92 27.57 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.921 -0.77 . . . . 63.14 108.921 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 41.4 pt -101.38 171.35 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 C-N-CA 119.969 -0.692 . . . . 74.51 109.643 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -124.43 137.48 54.44 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 106.858 -1.534 . . . . 55.0 106.858 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 109' ' ' VAL . . . . . 0.515 ' HB ' ' HA ' ' B' ' 98' ' ' ASP . 24.9 t -127.33 122.72 60.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.636 -1.246 . . . . 65.43 107.636 174.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.486 HD12 ' CD2' ' B' ' 40' ' ' TYR . 73.9 mt -121.08 150.1 52.75 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 109.308 -0.627 . . . . 74.0 109.308 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -81.63 135.28 9.05 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 C-N-CA 121.778 1.652 . . . . 75.01 108.16 170.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt . . . . . 0 C--N 1.304 -1.374 0 C-N-CA 119.484 -0.887 . . . . 74.24 109.477 -179.107 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 . . . . . 0 C--O 1.22 -0.482 0 N-CA-C 112.259 0.466 . . . . 72.54 112.259 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.9 pt -70.12 -35.87 65.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 120.513 -0.475 . . . . 72.45 111.059 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.667 ' OD1' ' HE3' ' A' ' 112' ' ' LYS . 30.0 t70 -68.44 -39.27 81.57 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.397 0.679 . . . . 64.24 110.563 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -66.61 -14.5 62.48 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.709 -0.678 . . . . 72.41 112.295 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -112.73 12.69 19.7 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 110.003 -0.369 . . . . 61.41 110.003 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.515 ' OG ' ' HB3' ' A' ' 112' ' ' LYS . 97.5 p -97.02 157.32 15.96 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.639 0.733 . . . . 75.14 112.392 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.59 HG22 HG23 ' A' ' 91' ' ' VAL . 49.0 t -127.82 151.53 34.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 114.912 -1.04 . . . . 70.44 108.401 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.668 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 24.4 t80 -104.4 127.66 52.12 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 125.055 1.342 . . . . 72.43 107.847 174.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.408 ' HA ' HG12 ' A' ' 109' ' ' VAL . 60.6 t -115.44 116.43 52.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 107.927 -1.138 . . . . 75.43 107.927 177.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.26 164.34 12.09 Favored Glycine 0 C--N 1.29 -1.987 0 C-N-CA 119.669 -1.253 . . . . 75.21 112.946 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 t30 68.75 25.02 6.46 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 125.677 1.591 . . . . 74.3 113.163 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.7 p -78.56 119.82 28.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 118.457 -1.297 . . . . 72.42 108.489 174.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -110.87 149.66 30.29 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.995 -1.113 . . . . 70.14 107.995 -173.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -51.45 115.58 1.67 Allowed 'General case' 0 CA--C 1.496 -1.102 0 CA-C-O 122.287 1.041 . . . . 71.43 112.128 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.19 -33.47 0.93 Allowed Glycine 0 N--CA 1.406 -3.318 0 N-CA-C 107.116 -2.393 . . . . 63.1 107.116 -174.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.5 m -102.61 141.85 34.75 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 108.327 -0.99 . . . . 74.33 108.327 173.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.6 p -115.88 178.73 4.2 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 120.4 0.143 . . . . 75.2 111.148 -176.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.528 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -64.64 -40.39 95.37 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 122.88 0.472 . . . . 75.32 110.542 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.54 -43.19 84.19 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 116.039 -0.528 . . . . 75.32 109.792 176.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -60.57 -38.8 85.78 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.382 0.61 . . . . 45.54 109.924 176.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.25 -46.94 75.38 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.187 -0.915 . . . . 35.42 111.066 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -58.75 -50.71 72.92 Favored 'General case' 0 C--O 1.19 -2.047 0 C-N-CA 120.434 -0.507 . . . . 64.43 111.762 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.8 -48.27 78.32 Favored 'General case' 0 C--O 1.271 2.187 0 CA-C-O 121.595 0.712 . . . . 71.34 111.795 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -67.31 -40.47 86.0 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.848 -1.069 . . . . 72.44 110.609 -175.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.467 ' HZ ' HG11 ' A' ' 109' ' ' VAL . 43.8 m-85 -81.57 -22.9 37.5 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 114.365 1.246 . . . . 54.22 114.365 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.1 m -69.85 -24.41 63.43 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.391 -0.368 . . . . 72.35 110.144 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.4 m -59.18 -31.22 68.8 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 119.908 -0.717 . . . . 74.34 109.674 172.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 60.9 m -85.92 3.05 43.64 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 112.909 0.707 . . . . 55.21 112.909 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.94 -158.09 26.15 Favored Glycine 0 N--CA 1.463 0.479 0 C-N-CA 119.528 -1.32 . . . . 65.52 114.138 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.1 m -105.46 126.03 51.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.925 0.393 . . . . 72.15 110.981 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 63.3 mt -91.74 127.28 44.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 115.633 -0.712 . . . . 65.51 111.885 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.554 ' ND2' ' HA ' ' A' ' 86' ' ' ALA . 90.3 m-20 -89.23 -42.1 11.82 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 121.325 0.583 . . . . 72.24 111.276 175.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.432 ' HG2' ' HA ' ' B' ' 71' ' ' ASP . 77.1 mtt180 -153.32 161.23 42.57 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.716 -0.675 . . . . 73.14 110.03 -176.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.528 HD11 ' HB1' ' A' ' 50' ' ' ALA . 35.0 pt -146.0 139.69 21.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 107.562 -1.273 . . . . 74.51 107.562 172.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.4 m -124.74 125.98 44.93 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 106.295 -1.743 . . . . 72.11 106.295 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mp -123.27 117.69 52.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 105.883 -1.895 . . . . 51.23 105.883 -177.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.288 1.0 OUTLIER -120.38 128.46 53.25 Favored 'General case' 0 C--N 1.284 -2.28 0 C-N-CA 120.443 -0.503 . . . . 74.13 112.175 179.031 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 78.3 m -115.31 129.31 56.57 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 115.759 -0.655 . . . . 61.03 110.1 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.454 ' HA ' ' HG2' ' B' ' 65' ' ' ARG . 17.0 t70 -114.69 125.33 53.61 Favored 'General case' 0 CA--C 1.492 -1.285 0 N-CA-C 112.174 0.435 . . . . 64.02 112.174 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -122.12 9.56 9.91 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 109.078 -0.712 . . . . 73.15 109.078 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.498 ' HB3' ' HB3' ' B' ' 64' ' ' ASN . 0.1 OUTLIER -64.79 -16.76 63.48 Favored 'General case' 0 C--N 1.361 1.095 0 N-CA-C 113.438 0.903 . . . . 62.53 113.438 -175.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.3 t -100.14 16.57 23.72 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-O 121.542 0.687 . . . . 70.13 109.847 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.64 -53.1 1.01 Allowed Glycine 0 CA--C 1.497 -1.066 0 C-N-CA 120.324 -0.941 . . . . 53.13 111.909 176.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -88.19 132.33 39.92 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 109.061 -0.718 . . . . 72.11 109.061 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -80.17 117.74 3.55 Favored 'Trans proline' 0 N--CA 1.431 -2.164 0 C-N-CA 121.329 1.353 . . . . 70.44 110.001 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 34.2 mtmm -115.19 162.7 16.69 Favored 'General case' 0 CA--C 1.466 -2.268 0 C-N-CA 123.9 0.88 . . . . 74.05 108.692 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -144.13 149.99 22.03 Favored Glycine 0 N--CA 1.411 -3.027 0 C-N-CA 118.914 -1.612 . . . . 22.42 113.481 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -146.99 144.32 29.09 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 114.199 -1.0 . . . . 61.35 108.451 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.17 152.49 50.85 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 110.302 -0.258 . . . . 64.44 110.302 -172.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.448 ' CZ ' ' HD1' ' A' ' 40' ' ' TYR . 69.1 m-85 -121.5 123.51 42.19 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 109.679 -0.489 . . . . 63.42 109.679 176.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.451 HG23 HG22 ' A' ' 66' ' ' ILE . 22.9 mm -102.35 121.05 52.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 107.433 -1.321 . . . . 72.42 107.433 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -103.0 119.3 38.6 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.516 -0.55 . . . . 75.32 109.516 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -96.38 158.94 15.2 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.458 0.647 . . . . 74.32 112.637 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.554 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . . . -67.0 -46.98 72.9 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.671 -1.149 . . . . 71.41 112.054 177.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -119.74 156.93 29.61 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 113.316 0.858 . . . . 73.04 113.316 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -61.98 -28.36 69.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.606 -1.179 . . . . 72.13 112.22 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.351 2.0 p-10 -71.26 -24.48 62.18 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 113.605 0.965 . . . . 50.4 113.605 177.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -72.35 -41.58 66.3 Favored 'General case' 0 N--CA 1.433 -1.294 0 O-C-N 122.204 -0.31 . . . . 74.43 111.344 177.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.59 HG23 HG22 ' A' ' 39' ' ' VAL . 7.6 p -63.42 -39.88 86.96 Favored 'Isoleucine or valine' 0 C--N 1.354 0.79 0 N-CA-C 109.646 -0.501 . . . . 72.41 109.646 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -62.98 -34.84 78.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.583 -0.735 . . . . 72.43 110.155 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.15 -38.68 63.65 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.878 -0.601 . . . . 64.33 112.252 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.88 -40.18 65.81 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 116.049 -0.523 . . . . 74.33 110.923 -176.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.463 HG11 ' HB3' ' A' ' 111' ' ' PRO . 30.0 m -59.43 -22.13 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 113.071 0.767 . . . . 70.41 113.071 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.15 -9.87 58.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 122.192 0.996 . . . . 71.41 110.709 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 8.5 ttp -104.51 7.77 35.37 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.416 -1.266 . . . . 60.23 108.406 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.691 ' HA ' HG22 ' A' ' 109' ' ' VAL . 2.8 p-10 -36.53 -50.92 0.82 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 116.645 2.091 . . . . 63.1 116.645 -175.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -123.69 55.58 1.25 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 119.999 1.272 . . . . 73.51 112.942 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.5 p -92.97 -175.71 3.97 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.119 -1.401 . . . . 71.2 110.837 174.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.95 126.07 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 121.322 0.582 . . . . 61.5 110.58 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -111.12 118.76 36.87 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.079 -0.712 . . . . 72.02 109.079 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 43.42 31.67 0.43 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.562 1.545 . . . . 75.42 113.7 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.59 -8.84 37.65 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.837 -0.697 . . . . 34.31 114.395 175.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -123.41 146.08 48.27 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 118.112 0.956 . . . . 74.3 110.033 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.7 m -78.41 118.87 20.99 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 120.551 -0.46 . . . . 75.05 110.014 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 pp -104.51 169.98 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 116.305 -0.407 . . . . 73.41 110.938 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 57.8 tptt -130.49 131.16 44.99 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.708 -0.849 . . . . 74.21 108.708 -176.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.691 HG22 ' HA ' ' A' ' 98' ' ' ASP . 36.0 m -126.47 135.33 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 120.975 0.417 . . . . 63.44 110.511 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.8 mt -131.03 148.53 70.64 Favored Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 108.981 -0.748 . . . . 60.23 108.981 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.463 ' HB3' HG11 ' A' ' 95' ' ' VAL . 55.5 Cg_endo -79.5 135.29 11.66 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 121.126 1.217 . . . . 32.42 109.341 175.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.667 ' HE3' ' OD1' ' A' ' 35' ' ' ASP . 37.3 ttpt . . . . . 0 C--N 1.294 -1.811 0 C-N-CA 118.03 -1.468 . . . . 73.44 109.731 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.411 -2.98 0 N-CA-C 107.606 -2.197 . . . . 60.13 107.606 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.53 ' HG2' ' CE2' ' A' ' 40' ' ' TYR . 57.9 Cg_exo -55.75 -36.31 94.9 Favored 'Trans proline' 0 CA--C 1.58 2.817 0 C-N-CA 123.08 2.52 . . . . 73.34 115.258 174.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -53.73 158.74 7.83 Favored 'Trans proline' 0 C--N 1.405 3.518 0 C-N-CA 121.952 1.768 . . . . 74.3 114.033 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -89.6 167.24 18.0 Favored Pre-proline 0 C--N 1.309 -1.178 0 CA-C-N 115.021 -0.99 . . . . 72.42 109.712 -177.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -77.35 159.75 32.7 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 121.208 1.272 . . . . 52.51 112.596 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -146.73 162.23 38.97 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.322 -0.854 . . . . 73.24 109.131 176.419 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.657 ' HB2' ' HG2' ' B' ' 30' ' ' GLU . 71.2 m -65.44 143.74 57.51 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 115.088 1.514 . . . . 55.24 115.088 -171.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' B' ' 31' ' ' LYS . . . -55.72 -34.65 65.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.043 -1.435 . . . . 71.43 112.699 174.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . 0.274 6.0 mt-10 -72.89 -29.22 63.0 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 113.327 0.862 . . . . 71.5 113.327 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.657 ' HG2' ' HB2' ' B' ' 27' ' ' SER . 2.3 mm-40 -67.87 -35.39 78.46 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.085 -1.08 . . . . 72.34 108.085 172.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' B' ' 28' ' ' ALA . 74.7 mmtt -60.81 -48.41 81.93 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.151 -0.932 . . . . 64.23 108.955 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -54.24 -49.39 69.59 Favored 'General case' 0 C--N 1.363 1.156 0 N-CA-C 112.752 0.649 . . . . 62.25 112.752 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -70.63 -42.51 70.78 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 112.825 0.676 . . . . 65.31 112.825 -170.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.491 HG12 ' O ' ' B' ' 30' ' ' GLU . 24.2 pt -68.9 -35.6 70.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.018 0.437 . . . . 74.33 110.31 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -67.53 -43.22 81.32 Favored 'General case' 0 C--O 1.201 -1.476 0 CA-C-N 115.533 -0.758 . . . . 73.0 110.418 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -63.24 -14.32 48.0 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.226 1.011 . . . . 72.41 113.388 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -118.57 20.86 12.83 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 121.598 0.713 . . . . 72.15 110.644 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.523 ' HB2' ' HB3' ' B' ' 112' ' ' LYS . 40.1 m -97.91 160.42 14.31 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.288 -0.869 . . . . 73.31 111.719 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.558 HG22 HG23 ' B' ' 91' ' ' VAL . 46.2 t -129.9 154.64 40.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.772 -0.825 . . . . 74.52 108.772 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' TYR . . . . . 0.66 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 30.0 t80 -108.49 125.58 51.95 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 125.214 1.405 . . . . 71.51 107.953 175.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.403 ' HA ' HG12 ' B' ' 109' ' ' VAL . 59.6 t -113.33 117.45 55.45 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.442 0 N-CA-C 108.431 -0.952 . . . . 64.34 108.431 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.93 173.8 15.33 Favored Glycine 0 N--CA 1.433 -1.555 0 C-N-CA 119.963 -1.113 . . . . 74.13 112.671 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 t30 67.97 22.53 8.53 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.697 1.599 . . . . 72.12 112.139 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 13.2 p -95.09 128.44 46.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 O-C-N 121.628 -0.67 . . . . 75.43 110.106 175.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -116.08 167.17 11.22 Favored 'General case' 0 CA--C 1.483 -1.596 0 N-CA-C 108.456 -0.942 . . . . 74.11 108.456 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -51.33 128.14 21.59 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.817 0.818 . . . . 73.13 110.694 173.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.96 -41.78 1.1 Allowed Glycine 0 N--CA 1.415 -2.748 0 N-CA-C 107.41 -2.276 . . . . 61.41 107.41 -172.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.2 m -95.76 140.23 30.85 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.046 -1.094 . . . . 72.31 108.046 174.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 74.0 p -111.3 177.62 4.6 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.693 -0.403 . . . . 72.04 110.499 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.505 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -66.88 -39.05 87.38 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.996 -0.372 . . . . 70.03 109.996 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.73 -44.05 85.73 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.848 -0.615 . . . . 73.15 109.997 175.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -56.99 -44.67 82.96 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.577 0.703 . . . . 73.02 109.525 175.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' B' ' 50' ' ' ALA . 78.3 mt -60.9 -47.76 84.92 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 114.597 -1.183 . . . . 75.13 112.16 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -58.89 -50.84 72.52 Favored 'General case' 0 C--O 1.198 -1.614 0 C-N-CA 120.412 -0.515 . . . . 63.13 112.126 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.67 -48.38 77.72 Favored 'General case' 0 C--O 1.265 1.9 0 CA-C-O 121.629 0.728 . . . . 65.14 111.783 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -66.73 -41.05 88.51 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.707 -1.133 . . . . 74.52 110.662 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -81.59 -23.09 37.31 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 114.229 1.196 . . . . 65.34 114.229 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 66.7 m -70.61 -24.16 62.69 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.307 -0.406 . . . . 52.04 109.964 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.3 m -58.79 -29.01 66.5 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-O 121.096 0.475 . . . . 65.13 109.94 172.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 60.0 m -92.27 6.37 47.03 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 113.07 0.767 . . . . 52.23 113.07 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 142.84 -158.38 27.1 Favored Glycine 0 C--O 1.226 -0.397 0 C-N-CA 119.143 -1.503 . . . . 61.13 114.371 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 49.9 m -106.21 125.79 51.43 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 122.444 -0.445 . . . . 72.21 111.241 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 71.3 mt -91.42 127.15 43.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 116.029 -0.532 . . . . 73.24 112.401 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' ASN . . . . . 0.642 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 87.3 m-20 -89.06 -43.54 11.02 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-N 116.029 -0.532 . . . . 73.43 110.792 175.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.454 ' HG2' ' HA ' ' A' ' 71' ' ' ASP . 40.0 mtt180 -150.96 161.25 43.08 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.869 -0.605 . . . . 75.13 110.524 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.505 HD11 ' HB1' ' B' ' 50' ' ' ALA . 38.2 pt -146.17 140.15 20.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 107.65 -1.241 . . . . 65.42 107.65 172.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 85.3 m -124.91 126.41 45.48 Favored 'General case' 0 C--N 1.273 -2.73 0 N-CA-C 106.786 -1.561 . . . . 50.22 106.786 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.6 mp -124.28 116.71 48.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 105.817 -1.92 . . . . 74.45 105.817 -177.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -120.56 129.37 53.75 Favored 'General case' 0 C--N 1.283 -2.287 0 C-N-CA 120.216 -0.594 . . . . 65.32 110.996 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 70' ' ' CYS . . . . . 0.425 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 79.4 m -116.22 129.57 56.36 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.383 -0.599 . . . . 73.33 109.383 -177.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.432 ' HA ' ' HG2' ' A' ' 65' ' ' ARG . 8.0 t70 -109.43 124.71 51.47 Favored 'General case' 0 CA--C 1.482 -1.665 0 N-CA-C 112.595 0.591 . . . . 64.32 112.595 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -119.76 3.01 11.14 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 114.973 -1.012 . . . . 70.54 111.358 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.432 ' HB3' ' HB3' ' A' ' 64' ' ' ASN . 0.8 OUTLIER -69.42 -22.44 63.67 Favored 'General case' 0 C--N 1.364 1.216 0 C-N-CA 119.084 -1.046 . . . . 73.02 110.67 -176.75 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 35.2 t -88.97 15.01 9.23 Favored 'General case' 0 CA--C 1.56 1.345 0 CA-C-N 115.242 -0.89 . . . . 62.12 109.599 177.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.75 -61.2 2.74 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.91 -0.586 . . . . 63.23 112.046 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' HIS . . . . . 0.419 ' HA ' ' HD3' ' B' ' 77' ' ' PRO . 37.0 m80 -85.87 129.32 54.87 Favored Pre-proline 0 C--O 1.252 1.216 0 C-N-CA 120.836 -0.346 . . . . 74.13 110.19 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' B' ' 76' ' ' HIS . 9.2 Cg_exo -72.01 117.47 5.16 Favored 'Trans proline' 0 CA--C 1.504 -1.019 0 C-N-CA 121.975 1.783 . . . . 44.33 110.699 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 78' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 35.0 mtmm -118.34 159.36 23.54 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 107.666 -1.235 . . . . 65.12 107.666 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -138.94 152.13 22.06 Favored Glycine 0 N--CA 1.411 -3.023 0 C-N-CA 119.055 -1.545 . . . . 73.51 113.312 177.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -149.64 144.99 26.51 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.273 -1.01 . . . . 70.32 108.273 173.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.22 152.83 51.17 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 116.56 -0.291 . . . . 70.22 110.604 -171.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 82' ' ' TYR . . . . . 0.422 ' CZ ' ' HD1' ' B' ' 40' ' ' TYR . 78.2 m-85 -122.45 124.17 42.99 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 109.517 -0.549 . . . . 74.0 109.517 175.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.487 HG23 HG22 ' B' ' 66' ' ' ILE . 23.2 mm -102.97 120.07 52.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.488 -1.301 . . . . 63.15 107.488 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -102.31 119.15 38.34 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.549 -0.908 . . . . 73.32 108.549 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -93.84 160.04 14.92 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 112.734 0.642 . . . . 75.33 112.734 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.642 ' HA ' ' ND2' ' B' ' 64' ' ' ASN . . . -66.61 -43.56 84.47 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.067 -0.969 . . . . 72.15 112.224 176.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -127.0 160.04 32.3 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.381 0.882 . . . . 73.31 113.381 -176.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -63.89 -24.98 67.95 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.517 1.127 . . . . 64.25 112.787 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -63.48 -39.3 94.09 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.457 -0.942 . . . . 72.51 108.457 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 18.6 m -68.97 -38.68 79.5 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.314 -0.857 . . . . 60.23 112.074 -172.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.558 HG23 HG22 ' B' ' 39' ' ' VAL . 7.5 p -65.01 -40.6 89.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 109.201 -0.666 . . . . 74.43 109.201 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.0 -34.33 77.76 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.549 0.69 . . . . 60.3 110.271 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.86 -37.68 64.68 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.73 -0.668 . . . . 74.52 111.111 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.1 -38.78 61.05 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 120.635 -0.426 . . . . 61.24 111.176 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 95' ' ' VAL . . . . . 0.491 HG11 ' HB3' ' B' ' 111' ' ' PRO . 30.1 m -59.66 -22.47 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 112.787 0.662 . . . . 71.05 112.787 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.87 -9.17 50.07 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.145 0.497 . . . . 60.05 110.177 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 22.7 mtm -97.51 4.0 50.54 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 112.843 0.683 . . . . 75.33 112.843 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 98' ' ' ASP . . . . . 0.582 ' HA ' HG22 ' B' ' 109' ' ' VAL . 2.3 p30 -43.86 -38.18 3.2 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 116.77 2.137 . . . . 71.43 116.77 -174.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -117.09 28.03 8.76 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 119.629 1.104 . . . . 74.34 111.405 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 73.6 p -84.41 177.46 8.13 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 121.245 -0.909 . . . . 61.52 111.55 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 13.0 p -101.27 145.73 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 N-CA-C 109.387 -0.598 . . . . 65.01 109.387 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -143.85 121.75 12.01 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.381 -0.97 . . . . 70.23 108.381 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 56.9 ttt-85 52.01 33.59 12.19 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 124.529 1.132 . . . . 72.34 111.868 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.65 1.57 70.95 Favored Glycine 0 C--N 1.313 -0.725 0 CA-C-N 115.188 -0.914 . . . . 71.11 114.33 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -126.94 157.9 38.24 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 117.544 0.672 . . . . 53.11 109.806 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 41.8 m -88.43 120.21 29.59 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.086 -1.079 . . . . 62.05 108.086 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 43.4 pt -101.83 172.0 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 C-N-CA 119.737 -0.785 . . . . 70.15 110.484 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -128.65 127.16 41.65 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.957 -0.757 . . . . 61.3 108.957 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 109' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 27.0 m -126.6 134.52 66.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 O-C-N 123.441 0.463 . . . . 62.41 111.018 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 96.4 mt -128.31 148.28 67.19 Favored Pre-proline 0 C--N 1.298 -1.642 0 N-CA-C 109.206 -0.665 . . . . 63.53 109.206 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.491 ' HB3' HG11 ' B' ' 95' ' ' VAL . 53.2 Cg_endo -79.28 133.82 11.05 Favored 'Trans proline' 0 N--CA 1.439 -1.711 0 C-N-CA 121.493 1.462 . . . . 74.15 111.22 175.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.523 ' HB3' ' HB2' ' B' ' 38' ' ' SER . 27.9 ttpp . . . . . 0 N--CA 1.41 -2.446 0 N-CA-C 105.75 -1.945 . . . . 51.32 105.75 173.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.416 ' HB3' HH21 ' A' ' 37' ' ' ARG . 60.0 mm-40 . . . . . 0 C--O 1.224 -0.26 0 CA-C-O 121.138 0.494 . . . . 55.42 111.62 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.57 HD12 ' NH2' ' A' ' 65' ' ' ARG . 12.7 pt -70.82 -33.77 53.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.656 -0.702 . . . . 70.04 110.679 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.406 ' OD2' ' NZ ' ' A' ' 112' ' ' LYS . 13.9 t70 -66.0 -38.83 89.48 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.837 0.855 . . . . 74.44 108.887 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -57.4 -30.72 65.15 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.278 -0.874 . . . . 75.34 110.859 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.416 HH21 ' HB3' ' A' ' 33' ' ' GLU . 54.2 mtm180 -104.09 18.82 21.27 Favored 'General case' 0 N--CA 1.419 -2.013 0 CA-C-N 114.842 -1.072 . . . . 71.14 111.856 -175.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.0 m -95.87 146.44 24.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.605 0.717 . . . . 64.01 111.152 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.434 HG22 ' HB ' ' A' ' 83' ' ' ILE . 33.7 m -127.95 160.69 37.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.932 -0.766 . . . . 62.33 108.932 176.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.576 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 28.1 t80 -109.14 126.06 52.83 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.497 -0.927 . . . . 74.11 108.497 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.52 ' HA ' HG12 ' A' ' 109' ' ' VAL . 61.3 t -114.49 111.82 37.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.841 -1.17 . . . . 65.42 107.841 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.2 171.62 13.87 Favored Glycine 0 C--N 1.304 -1.243 0 C-N-CA 120.267 -0.968 . . . . 52.42 113.215 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.436 ' HA ' ' OD1' ' A' ' 45' ' ' ASP . 9.7 t-20 58.65 24.89 12.61 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 125.391 1.477 . . . . 40.2 110.037 -178.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 p -92.63 9.17 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.418 0 CA-C-N 114.524 -1.216 . . . . 61.44 110.069 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.54 ' OD2' ' HA ' ' A' ' 78' ' ' LYS . 6.0 m-20 -37.07 106.84 0.05 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 128.235 2.614 . . . . 72.03 113.617 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.415 ' C ' ' H ' ' A' ' 48' ' ' SER 0.4 41.3 m-85 50.11 162.81 0.0 OUTLIER 'General case' 0 C--N 1.351 0.643 0 N-CA-C 118.116 2.636 . . . . 75.54 118.116 179.436 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.438 ' HA3' ' NH1' ' A' ' 103' ' ' ARG . . . 80.94 -36.97 2.33 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.284 -0.871 . . . . 70.14 111.462 -177.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 46' ' ' TYR . 19.4 m -76.84 118.27 19.28 Favored 'General case' 0 N--CA 1.415 -2.218 0 C-N-CA 124.733 1.213 . . . . 70.33 109.866 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.7 p -100.59 162.99 12.56 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.6 -0.519 . . . . 71.35 109.6 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.487 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -65.81 -50.25 65.31 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.171 0.434 . . . . 63.24 112.171 -175.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -57.79 -38.74 76.04 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 116.824 -0.171 . . . . 60.32 111.091 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.72 -37.67 76.61 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.018 0.437 . . . . 73.2 110.347 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 44.1 mt -68.22 -47.58 67.45 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.362 -0.835 . . . . 51.32 110.803 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -61.9 -48.24 81.34 Favored 'General case' 0 C--O 1.2 -1.538 0 CA-C-N 115.738 -0.665 . . . . 72.23 110.069 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.48 -41.18 84.71 Favored 'General case' 0 C--O 1.248 1.0 0 CA-C-O 121.036 0.446 . . . . 40.44 110.663 177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -65.82 -39.68 91.1 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.852 -0.613 . . . . 73.35 110.307 -175.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -82.33 -21.53 35.97 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 112.967 0.729 . . . . 72.55 112.967 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.9 t -70.11 -24.11 63.15 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.651 -0.704 . . . . 72.24 109.324 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.4 m -62.25 -30.24 70.97 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 109.197 -0.668 . . . . 62.33 109.197 173.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 57.5 m -96.1 11.83 32.83 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.772 -0.649 . . . . 70.31 112.378 -178.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.96 -167.58 30.58 Favored Glycine 0 N--CA 1.464 0.526 0 C-N-CA 118.609 -1.758 . . . . 61.32 115.386 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 86' ' ' ALA . 7.4 m -104.32 115.06 29.72 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.212 -0.662 . . . . 70.33 109.212 -176.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.3 mt -91.11 131.8 37.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 112.537 0.569 . . . . 75.14 112.537 -176.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -95.64 -40.47 9.39 Favored 'General case' 0 C--O 1.204 -1.296 0 CA-C-N 115.26 -0.882 . . . . 54.23 111.915 176.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.57 ' NH2' HD12 ' A' ' 34' ' ' ILE . 73.2 mtm180 -155.86 161.16 40.64 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.763 -0.458 . . . . 75.11 109.763 -177.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.487 HD11 ' HB1' ' A' ' 50' ' ' ALA . 23.0 pt -146.51 141.42 20.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.1 -1.074 . . . . 71.41 108.1 174.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.9 m -126.23 129.24 48.56 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 106.478 -1.675 . . . . 72.12 106.478 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.6 mp -125.06 121.4 60.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 106.878 -1.527 . . . . 73.33 106.878 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -120.62 134.61 55.26 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 120.528 -0.469 . . . . 72.1 112.123 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 83.6 m -117.5 122.66 44.31 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.892 -0.781 . . . . 60.22 108.892 176.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.563 ' HA ' ' HG2' ' B' ' 65' ' ' ARG . 2.5 p30 -113.55 128.87 56.6 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 119.734 -0.786 . . . . 72.01 112.287 -178.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' B' ' 64' ' ' ASN . 38.4 mttm -95.8 4.05 53.22 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.73 -0.668 . . . . 73.12 111.516 175.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' B' ' 64' ' ' ASN . 45.5 m-85 -64.34 -6.25 6.68 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.38 0.881 . . . . 74.45 113.38 172.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.7 t -95.91 0.56 52.12 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.947 -0.76 . . . . 72.42 108.947 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.37 -48.78 3.63 Favored Glycine 0 CA--C 1.506 -0.521 0 N-CA-C 109.187 -1.565 . . . . 64.12 109.187 -175.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -96.96 147.94 33.66 Favored Pre-proline 0 C--N 1.291 -1.961 0 N-CA-C 105.916 -1.883 . . . . 73.24 105.916 173.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.83 118.32 5.02 Favored 'Trans proline' 0 N--CA 1.443 -1.474 0 C-N-CA 120.679 0.919 . . . . 64.24 110.448 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 30.1 mtmm -96.59 149.22 22.02 Favored 'General case' 0 CA--C 1.483 -1.597 0 C-N-CA 119.873 -0.731 . . . . 70.33 109.262 175.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 45' ' ' ASP . . . -128.9 135.13 8.32 Favored Glycine 0 N--CA 1.409 -3.105 0 C-N-CA 120.327 -0.94 . . . . 52.11 112.636 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . 0.349 1.3 p90 -150.8 144.77 25.28 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 124.382 1.073 . . . . 74.25 111.092 175.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.49 154.36 49.9 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.893 -0.594 . . . . 60.33 110.659 -171.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -120.36 124.49 45.66 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.325 -0.991 . . . . 74.24 108.325 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.434 ' HB ' HG22 ' A' ' 39' ' ' VAL . 27.2 mm -108.48 127.59 64.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.823 -1.177 . . . . 74.44 107.823 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -108.94 120.84 43.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.582 0.23 . . . . 63.44 111.039 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -98.89 162.88 12.85 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.98 0.419 . . . . 74.0 111.875 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' A' ' 62' ' ' SER . . . -76.79 -37.88 55.01 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.264 0.626 . . . . 64.21 111.747 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.434 ' HG2' ' OG ' ' A' ' 90' ' ' SER . 0.2 OUTLIER -113.47 138.5 50.02 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 112.509 0.559 . . . . 73.43 112.509 179.422 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.429 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -57.79 -34.31 69.49 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 123.623 0.769 . . . . 73.04 111.26 179.051 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -66.65 -21.14 66.11 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 116.019 -0.537 . . . . 70.03 112.239 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.434 ' OG ' ' HG2' ' A' ' 87' ' ' GLU . 71.4 m -69.15 -36.13 77.09 Favored 'General case' 0 N--CA 1.414 -2.241 0 C-N-CA 120.635 -0.426 . . . . 64.04 111.263 176.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 95' ' ' VAL . 3.0 m -64.69 -41.22 91.62 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.85 0 C-N-CA 119.239 -0.984 . . . . 72.13 108.56 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -61.99 -31.13 71.46 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 116.299 -0.41 . . . . 74.35 111.292 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.31 -39.81 62.64 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.172 -0.467 . . . . 71.32 111.225 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.83 -41.85 59.13 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-N 116.222 -0.445 . . . . 70.31 111.338 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 91' ' ' VAL . 22.6 m -56.21 -22.18 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 111.98 0.363 . . . . 62.55 111.98 177.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.78 -13.86 62.47 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.367 0.603 . . . . 55.3 111.067 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 47.4 mtm -99.36 9.76 42.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.568 -0.742 . . . . 51.25 109.79 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.588 ' HA ' HG22 ' A' ' 109' ' ' VAL . 2.9 p-10 -37.67 -45.59 0.8 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 114.456 1.28 . . . . 70.12 114.456 -177.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -114.67 97.4 6.25 Favored 'General case' 0 N--CA 1.424 -1.741 0 C-N-CA 120.033 -0.667 . . . . 62.34 110.033 174.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.8 p -142.64 165.71 26.65 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.02 -0.991 . . . . 63.51 110.775 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.3 p -104.53 119.68 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-O 121.636 0.731 . . . . 60.12 110.171 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -113.47 116.64 29.91 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.858 -1.164 . . . . 74.52 107.858 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.438 ' NH1' ' HA3' ' A' ' 47' ' ' GLY . 7.1 ptm180 43.09 32.08 0.41 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 126.548 1.939 . . . . 72.45 114.147 -177.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.19 -12.02 33.91 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.007 -0.997 . . . . 70.22 113.87 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.407 ' NH1' ' HB2' ' A' ' 45' ' ' ASP . 65.1 mtt180 -112.42 138.74 48.72 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 117.37 0.585 . . . . 62.43 109.933 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 39.2 m -79.18 120.19 23.33 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.766 -1.198 . . . . 74.14 107.766 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.41 ' HA ' ' HB3' ' A' ' 43' ' ' ASN . 42.2 pt -101.57 171.44 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 C-N-CA 120.464 -0.495 . . . . 74.53 110.723 -177.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 54.7 tptt -133.91 125.75 28.94 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 115.123 -0.944 . . . . 73.51 108.772 -177.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.588 HG22 ' HA ' ' A' ' 98' ' ' ASP . 27.7 m -128.82 132.49 67.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 O-C-N 123.238 0.336 . . . . 54.5 110.948 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.459 HD13 ' HB3' ' A' ' 40' ' ' TYR 0.25 0.0 OUTLIER -148.24 158.79 40.81 Favored Pre-proline 0 C--N 1.292 -1.929 0 N-CA-C 108.561 -0.903 . . . . 42.03 108.561 176.26 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 110' ' ' LEU . 91.8 Cg_endo -76.09 130.28 12.07 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 CA-C-N 120.45 1.196 . . . . 53.35 110.641 -176.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.406 ' NZ ' ' OD2' ' A' ' 35' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.423 -1.783 0 N-CA-C 104.874 -2.269 . . . . 74.24 104.874 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.19 0 N-CA-C 114.363 0.505 . . . . 74.44 114.363 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -53.36 -52.66 8.15 Favored 'Trans proline' 0 CA--C 1.559 1.73 0 C-N-CA 123.609 2.873 . . . . 74.12 114.181 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.12 141.65 48.43 Favored 'Trans proline' 0 C--N 1.376 1.979 0 CA-C-N 120.813 1.326 . . . . 75.34 108.83 172.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -84.21 146.35 47.91 Favored Pre-proline 0 C--N 1.284 -2.276 0 C-N-CA 119.818 -0.753 . . . . 74.15 109.102 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.69 131.08 35.93 Favored 'Trans proline' 0 N--CA 1.438 -1.777 0 C-N-CA 122.275 1.983 . . . . 72.21 111.71 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.747 HD13 ' H ' ' B' ' 26' ' ' LEU 0.25 0.0 OUTLIER -70.09 178.7 2.64 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.598 -0.728 . . . . 73.21 110.764 176.815 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 13.8 m -57.47 144.6 36.06 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 113.441 0.904 . . . . 74.21 113.441 -171.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.453 ' O ' ' HE2' ' B' ' 32' ' ' LYS . . . -56.5 -44.68 80.91 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.919 -1.037 . . . . 72.2 110.733 174.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -60.51 -45.91 92.05 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.638 -0.256 . . . . 72.01 111.082 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.464 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.5 OUTLIER -55.83 -35.32 66.26 Favored 'General case' 0 C--O 1.22 -0.485 0 O-C-N 123.276 0.36 . . . . 61.35 110.583 174.101 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' B' ' 26' ' ' LEU . 43.2 mttm -70.83 -35.47 72.48 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.757 -0.656 . . . . 74.21 112.399 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.59 ' O ' ' HB2' ' B' ' 36' ' ' LYS . 0.4 OUTLIER -69.76 -38.99 76.94 Favored 'General case' 0 C--O 1.211 -0.953 0 C-N-CA 119.651 -0.82 . . . . 74.13 111.35 174.791 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.539 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 5.9 mm-40 -64.8 -46.26 82.77 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.869 0.366 . . . . 72.12 111.06 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.464 HG12 ' O ' ' B' ' 30' ' ' GLU . 16.2 pt -70.72 -34.67 57.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.87 -0.605 . . . . 74.12 111.401 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -70.95 -35.12 72.05 Favored 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 108.69 -0.855 . . . . 75.1 108.69 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' B' ' 32' ' ' LYS . 31.8 ttmt -62.71 -31.34 72.24 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 124.987 1.315 . . . . 74.21 110.234 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' B' ' 33' ' ' GLU . 10.5 ptt180 -115.35 31.78 6.48 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.567 0.699 . . . . 74.35 112.004 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.446 ' OG ' ' HE3' ' B' ' 112' ' ' LYS . 25.4 t -100.9 163.07 12.47 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.307 -0.861 . . . . 74.22 109.945 174.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.524 ' HA ' ' H ' ' B' ' 112' ' ' LYS . 35.0 m -134.69 164.05 35.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 122.984 0.514 . . . . 42.52 110.732 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' TYR . . . . . 0.537 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 34.7 t80 -109.63 125.2 52.34 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.309 -0.997 . . . . 74.41 108.309 177.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.506 ' HA ' HG12 ' B' ' 109' ' ' VAL . 61.8 t -116.03 112.88 41.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 108.836 -0.801 . . . . 72.22 108.836 175.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.21 173.54 18.15 Favored Glycine 0 N--CA 1.426 -2.024 0 N-CA-C 110.822 -0.911 . . . . 63.54 110.822 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.465 ' HB3' ' HA ' ' B' ' 107' ' ' ILE . 25.7 t-20 80.96 -19.28 0.44 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.102 1.361 . . . . 54.52 113.022 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.403 HG21 HD11 ' B' ' 53' ' ' LEU . 7.5 p -55.39 117.8 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.833 0.825 . . . . 63.2 111.074 -177.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -69.98 153.57 43.06 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.874 -1.057 . . . . 75.22 113.104 -174.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' TYR . . . . . 0.401 ' CD2' ' HB2' ' B' ' 77' ' ' PRO . 60.6 t80 -49.46 -32.33 11.71 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 127.859 2.464 . . . . 74.12 110.817 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.31 0.26 71.39 Favored Glycine 0 N--CA 1.429 -1.796 0 CA-C-O 119.292 -0.727 . . . . 51.11 114.067 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 29.1 t -75.61 147.0 39.92 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 118.703 1.252 . . . . 72.34 109.877 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 36.8 p -98.52 157.56 16.15 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 116.002 -0.545 . . . . 74.32 112.228 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.52 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -72.6 -47.64 46.24 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.865 0.866 . . . . 71.13 112.274 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -34.49 72.31 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 119.523 -0.871 . . . . 73.01 112.533 -178.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -68.8 -39.12 80.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.109 -0.496 . . . . 75.21 110.343 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.403 HD11 HG21 ' B' ' 44' ' ' VAL . 55.7 mt -65.46 -47.7 75.24 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.657 -0.701 . . . . 73.32 111.29 176.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -49.11 78.29 Favored 'General case' 0 C--O 1.207 -1.168 0 CA-C-N 116.213 -0.448 . . . . 70.12 110.001 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.75 -40.71 80.32 Favored 'General case' 0 C--O 1.263 1.783 0 CA-C-O 122.015 0.912 . . . . 63.43 112.059 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -66.09 -40.61 90.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.608 -1.178 . . . . 73.55 109.854 -175.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -82.41 -21.84 35.61 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 112.833 0.679 . . . . 71.02 112.833 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 47.1 t -68.58 -24.59 64.62 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.4 -0.818 . . . . 70.4 110.226 -176.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 32.7 m -63.63 -20.44 65.68 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 120.06 -0.656 . . . . 71.25 110.963 174.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 58.6 m -106.02 17.23 23.91 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 111.852 0.316 . . . . 65.05 111.852 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.54 177.06 20.0 Favored Glycine 0 C--O 1.226 -0.353 0 C-N-CA 119.904 -1.141 . . . . 71.51 113.603 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 23.9 t -93.34 121.09 34.37 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.265 -1.013 . . . . 73.5 108.265 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 76.8 mt -87.53 133.84 29.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-O 121.413 0.625 . . . . 74.22 112.139 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 72' ' ' LYS . 9.4 m120 -97.4 -38.71 9.51 Favored 'General case' 0 C--O 1.206 -1.202 0 CA-C-N 115.173 -0.922 . . . . 55.04 112.676 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.563 ' HG2' ' HA ' ' A' ' 71' ' ' ASP . 71.7 mtm180 -157.39 161.74 39.01 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.12 -0.696 . . . . 72.5 109.12 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.52 HD11 ' HB1' ' B' ' 50' ' ' ALA . 24.1 pt -146.68 140.91 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 N-CA-C 107.875 -1.157 . . . . 65.34 107.875 175.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 68.8 m -126.32 127.97 46.39 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.922 -1.14 . . . . 75.43 107.922 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' ILE . . . . . 0.421 HD12 ' N ' ' B' ' 68' ' ' ILE . 1.9 mp -124.5 121.43 61.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 106.599 -1.63 . . . . 72.05 106.599 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.36 135.33 55.1 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 120.458 -0.497 . . . . 71.34 111.289 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 73.1 m -116.9 121.76 42.38 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.192 -1.04 . . . . 74.4 108.192 176.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.687 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 3.4 p30 -111.7 128.38 56.06 Favored 'General case' 0 C--O 1.212 -0.88 0 C-N-CA 119.261 -0.976 . . . . 71.33 111.873 -177.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -121.97 5.11 9.88 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.81 -0.632 . . . . 73.5 109.646 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.446 ' CD1' ' HD3' ' A' ' 65' ' ' ARG . 28.3 p90 -59.28 -16.92 24.52 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 114.191 1.182 . . . . 71.03 114.191 -175.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 38.4 p -96.96 4.19 51.67 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 120.855 0.36 . . . . 71.24 111.407 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.25 -60.1 0.35 Allowed Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 111.581 -0.608 . . . . 75.33 111.581 -177.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -96.73 129.17 33.53 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 112.009 0.374 . . . . 72.1 112.009 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.687 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 91.9 Cg_endo -78.41 126.42 7.57 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.546 2.164 . . . . 71.43 113.933 -177.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 78' ' ' LYS . . . . . 0.528 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 32.9 mtmm -109.86 165.23 11.87 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 123.683 0.793 . . . . 73.43 109.753 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -134.11 135.68 8.15 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 119.925 -1.131 . . . . 71.02 113.808 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . 0.436 0.4 OUTLIER -150.02 143.96 25.5 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 124.755 1.222 . . . . 72.44 112.083 173.853 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.94 154.89 50.32 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.086 -0.506 . . . . 50.03 110.504 -172.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 82' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -122.43 126.83 48.77 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.978 -1.119 . . . . 71.13 107.978 177.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.423 HG23 HG22 ' B' ' 66' ' ' ILE . 28.5 mm -109.66 127.41 66.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 107.594 -1.261 . . . . 73.12 107.594 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 84' ' ' GLU . . . . . 0.539 ' OE1' ' HB2' ' B' ' 65' ' ' ARG . 45.2 mt-10 -107.82 121.33 44.53 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 110.331 -0.248 . . . . 73.11 110.331 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -98.47 162.14 13.31 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.201 0.524 . . . . 74.42 112.018 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.18 -36.7 77.6 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.253 -0.885 . . . . 70.2 112.075 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.94 157.75 30.54 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.485 0.659 . . . . 75.41 111.341 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.69 -35.3 78.57 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 114.76 -1.109 . . . . 75.2 111.5 175.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -60.38 -32.15 71.03 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 123.525 0.516 . . . . 75.11 110.15 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 14.7 m -63.48 -37.06 85.87 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 116.4 -0.364 . . . . 74.21 111.212 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.596 ' O ' HG13 ' B' ' 95' ' ' VAL . 3.0 m -67.47 -40.21 84.04 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 C-N-CA 119.582 -0.847 . . . . 64.12 108.984 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -63.0 -30.89 71.95 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.961 0.41 . . . . 75.14 110.933 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.73 -40.25 63.69 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.22 -0.445 . . . . 74.01 110.546 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.97 -40.41 63.02 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-N 116.409 -0.359 . . . . 54.13 111.401 -177.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 95' ' ' VAL . . . . . 0.596 HG13 ' O ' ' B' ' 91' ' ' VAL . 16.6 m -58.24 -21.66 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 112.873 0.694 . . . . 63.1 112.873 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.91 -15.94 63.84 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.44 0.638 . . . . 45.13 109.759 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 34.0 mtp -94.68 6.26 49.43 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 123.954 0.902 . . . . 72.14 110.021 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 98' ' ' ASP . . . . . 0.548 ' HA ' HG22 ' B' ' 109' ' ' VAL . 2.0 p-10 -38.87 -46.65 1.32 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.455 1.28 . . . . 73.43 114.455 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -113.19 99.05 7.52 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 118.998 0.817 . . . . 71.44 109.931 171.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 100' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' B' ' 106' ' ' THR . 19.0 p -139.65 167.44 22.1 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.064 -0.971 . . . . 73.4 111.462 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 101' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' B' ' 105' ' ' ARG . 7.4 p -102.64 125.27 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 CA-C-O 121.671 0.748 . . . . 73.1 109.907 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 102' ' ' PHE . . . . . 0.4 ' HB3' HG23 ' B' ' 107' ' ' ILE . 74.2 t80 -135.44 120.4 18.65 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.941 -1.133 . . . . 73.34 107.941 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 56.41 32.61 20.94 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.554 1.142 . . . . 74.11 112.31 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.71 4.5 82.62 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 114.661 -1.154 . . . . 63.12 113.488 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' B' ' 101' ' ' VAL . 99.2 mtt180 -120.89 162.85 19.14 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 117.224 0.512 . . . . 71.01 109.929 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 106' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' B' ' 100' ' ' THR . 62.9 m -94.12 120.52 34.48 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.067 -1.086 . . . . 45.15 108.067 175.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 107' ' ' ILE . . . . . 0.465 ' HA ' ' HB3' ' B' ' 43' ' ' ASN . 40.8 pt -100.68 170.45 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.116 -1.034 . . . . 73.14 110.164 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 108' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 55.5 tptt -133.1 126.07 30.97 Favored 'General case' 0 N--CA 1.434 -1.227 0 O-C-N 123.728 0.643 . . . . 72.4 109.629 -177.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 109' ' ' VAL . . . . . 0.548 HG22 ' HA ' ' B' ' 98' ' ' ASP . 27.3 m -128.85 138.36 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-N 116.429 -0.351 . . . . 72.43 111.423 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.72 ' HB3' ' HD2' ' B' ' 111' ' ' PRO 0.255 0.1 OUTLIER -140.01 169.68 11.46 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 105.61 -1.996 . . . . 74.5 105.61 174.636 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.72 ' HD2' ' HB3' ' B' ' 110' ' ' LEU . 89.6 Cg_endo -80.3 130.47 8.14 Favored 'Trans proline' 0 N--CA 1.425 -2.515 0 C-N-CA 121.412 1.408 . . . . 74.54 109.718 172.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.524 ' H ' ' HA ' ' B' ' 39' ' ' VAL . 15.0 ttpp . . . . . 0 C--N 1.29 -1.997 0 N-CA-C 104.723 -2.325 . . . . 60.15 104.723 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.657 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 7.1 mm-40 . . . . . 0 N--CA 1.444 -0.768 0 CA-C-O 119.976 -0.059 . . . . 75.34 111.067 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.0 pt -67.44 -34.99 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 112.413 0.523 . . . . 64.54 112.413 -176.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.53 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . 46.3 m-20 -59.52 -39.88 85.31 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.043 0.449 . . . . 64.14 110.014 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -76.18 -11.02 59.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.134 -0.939 . . . . 75.42 110.592 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.657 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 61.1 mmt-85 -98.16 5.44 48.52 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 109.052 -0.721 . . . . 72.33 109.052 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.478 ' HB3' ' HE2' ' A' ' 112' ' ' LYS . 46.9 t -109.93 164.61 12.43 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 113.677 0.992 . . . . 71.11 113.677 -174.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.98 162.18 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 114.937 -1.029 . . . . 61.23 110.017 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.536 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 28.5 t80 -110.34 124.64 52.06 Favored 'General case' 0 C--N 1.29 -2.01 0 C-N-CA 124.826 1.25 . . . . 64.44 107.722 177.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.8 t -111.07 116.43 52.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 N-CA-C 108.08 -1.081 . . . . 64.51 108.08 178.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.86 166.61 12.78 Favored Glycine 0 N--CA 1.417 -2.582 0 C-N-CA 119.909 -1.139 . . . . 71.24 112.092 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.8 t30 67.99 18.11 9.52 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 125.732 1.613 . . . . 74.42 113.449 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.522 ' O ' ' HA3' ' A' ' 79' ' ' GLY . 7.1 p -73.95 116.67 16.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.941 -0.762 . . . . 75.01 108.941 175.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -94.98 168.18 10.94 Favored 'General case' 0 C--O 1.255 1.373 0 CA-C-O 121.226 0.536 . . . . 74.01 111.851 -172.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.661 ' CE1' ' HB2' ' A' ' 77' ' ' PRO . 4.5 m-85 -64.77 96.44 0.18 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.405 -1.27 . . . . 61.43 110.935 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.42 -26.32 0.3 Allowed Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 109.949 -1.261 . . . . 45.33 109.949 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.5 m -84.14 135.06 34.53 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.222 -1.029 . . . . 53.15 108.222 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.1 p -105.84 170.8 7.69 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 119.755 -0.164 . . . . 75.33 111.095 -176.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.481 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -64.2 -50.55 67.65 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 117.828 0.286 . . . . 71.52 111.105 -177.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.406 ' HG2' ' CE2' ' B' ' 46' ' ' TYR . 78.8 mt-30 -59.03 -38.87 80.28 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.465 0.543 . . . . 74.32 112.465 176.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -64.53 -37.62 88.2 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.779 0.799 . . . . 74.05 109.43 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.5 mt -72.68 -47.35 48.04 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.996 -1.002 . . . . 65.33 110.955 177.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -61.39 -49.39 77.08 Favored 'General case' 0 C--O 1.204 -1.308 0 C-N-CA 123.295 0.638 . . . . 34.3 110.855 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.07 -44.09 78.59 Favored 'General case' 0 C--O 1.256 1.443 0 CA-C-O 121.269 0.557 . . . . 71.24 111.042 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -64.58 -39.98 94.7 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.268 -0.878 . . . . 74.13 110.858 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -82.1 -22.43 36.24 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 113.266 0.839 . . . . 70.41 113.266 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.2 t -70.31 -23.88 62.93 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.781 -0.645 . . . . 73.11 109.3 -177.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.9 m -58.96 -27.76 65.66 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-O 121.266 0.555 . . . . 65.21 109.861 172.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 58.9 m -94.12 5.39 51.87 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.023 0.529 . . . . 55.23 112.161 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.33 -166.81 27.58 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.306 -1.426 . . . . 73.32 114.259 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.2 t -98.83 123.0 42.8 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 120.896 0.379 . . . . 52.44 110.548 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.8 mt -83.41 134.28 27.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-O 121.606 0.717 . . . . 50.53 112.58 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.652 ' OD1' ' HB3' ' B' ' 73' ' ' PHE . 34.2 t30 -98.07 -45.08 6.37 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.443 -1.253 . . . . 72.04 110.254 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' B' ' 71' ' ' ASP . 49.4 mtp180 -155.57 165.03 37.83 Favored 'General case' 0 C--O 1.213 -0.86 0 N-CA-C 107.873 -1.158 . . . . 71.13 107.873 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.481 HD11 ' HB1' ' A' ' 50' ' ' ALA . 19.2 pt -146.08 144.38 20.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.237 -1.024 . . . . 71.0 108.237 171.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.573 ' OG1' ' HB2' ' A' ' 82' ' ' TYR . 39.7 p -122.43 137.2 54.95 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 105.414 -2.069 . . . . 64.22 105.414 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.1 mp -129.26 112.54 25.46 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 105.705 -1.961 . . . . 73.43 105.705 173.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.457 ' HG ' ' CE2' ' A' ' 80' ' ' TYR 0.255 1.6 pt? -120.38 123.59 43.44 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 119.772 -0.771 . . . . 75.11 111.2 -179.228 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 73.4 m -117.83 136.47 53.4 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.204 -0.907 . . . . 44.41 109.592 -177.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.65 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 4.0 p30 -120.24 143.43 48.3 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 119.928 -0.709 . . . . 75.51 110.011 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -124.85 5.31 8.07 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.336 -0.616 . . . . 62.31 109.336 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.621 ' HB3' ' OD1' ' B' ' 64' ' ' ASN . 36.9 p90 -64.52 -25.68 68.09 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 112.198 0.444 . . . . 61.55 112.198 -176.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.9 t -80.97 -8.47 59.77 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.151 0.5 . . . . 74.1 110.67 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.98 -55.19 0.57 Allowed Glycine 0 CA--C 1.494 -1.225 0 N-CA-C 110.427 -1.069 . . . . 60.41 110.427 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -96.63 133.81 24.09 Favored Pre-proline 0 C--N 1.295 -1.795 0 N-CA-C 107.482 -1.303 . . . . 71.41 107.482 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.661 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 74.2 Cg_endo -76.78 117.27 4.46 Favored 'Trans proline' 0 N--CA 1.426 -2.492 0 C-N-CA 120.613 0.875 . . . . 63.42 111.134 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 29.5 mtmm -100.77 147.11 26.43 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 115.552 -0.749 . . . . 73.21 109.283 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 44' ' ' VAL . . . -122.38 137.01 11.11 Favored Glycine 0 N--CA 1.418 -2.558 0 C-N-CA 120.05 -1.071 . . . . 23.1 112.494 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.457 ' CE2' ' HG ' ' A' ' 69' ' ' LEU . 5.2 p90 -149.87 143.09 25.08 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 124.407 1.083 . . . . 71.23 109.338 176.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.32 153.95 45.43 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 116.509 -0.314 . . . . 72.15 111.825 -171.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.702 ' OH ' ' HA3' ' B' ' 21' ' ' GLY . 20.0 m-85 -116.78 125.1 51.11 Favored 'General case' 0 CA--C 1.461 -2.449 0 C-N-CA 122.864 0.466 . . . . 70.32 110.729 173.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.3 mm -103.69 110.7 30.83 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.536 0 N-CA-C 106.375 -1.713 . . . . 72.13 106.375 175.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.46 ' HG2' ' OG ' ' A' ' 38' ' ' SER . 29.2 mt-10 -96.88 121.08 38.36 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.325 -0.991 . . . . 63.42 108.325 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -99.43 170.98 8.24 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.218 0.533 . . . . 73.32 111.239 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.62 -41.01 22.09 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.474 -0.784 . . . . 73.34 110.637 173.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.405 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 40.7 mm-40 -101.81 146.99 27.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.06 0.457 . . . . 75.3 111.355 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.559 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.8 OUTLIER -74.71 -34.05 62.51 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.077 -1.453 . . . . 71.24 107.077 -179.304 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.286 0.9 OUTLIER -65.98 -20.06 66.07 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.156 -0.929 . . . . 72.13 113.212 177.425 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.405 ' OG ' ' HB2' ' A' ' 87' ' ' GLU . 22.6 m -66.27 -36.6 83.41 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 109.824 -0.436 . . . . 71.04 109.824 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 88' ' ' ARG . 3.6 m -66.26 -40.42 86.81 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 N-CA-C 108.629 -0.878 . . . . 65.34 108.629 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -55.54 -38.52 69.39 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.435 0.694 . . . . 65.03 110.529 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.71 -37.92 65.0 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.838 -0.619 . . . . 61.23 111.421 177.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.85 -39.91 55.7 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.188 0.44 . . . . 53.03 112.188 -176.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 91' ' ' VAL . 33.0 m -55.41 -22.06 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 113.068 0.766 . . . . 53.14 113.068 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.31 -9.63 42.89 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 120.991 0.424 . . . . 41.41 110.37 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.5 ' C ' ' H ' ' A' ' 99' ' ' GLU . 68.3 mtm -99.17 5.98 46.58 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.153 0.797 . . . . 75.35 113.153 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 109' ' ' VAL . 1.4 p-10 -67.57 24.07 0.02 OUTLIER 'General case' 0 N--CA 1.528 3.43 0 C-N-CA 123.641 0.776 . . . . 74.23 112.578 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.5 ' H ' ' C ' ' A' ' 97' ' ' MET . 39.6 tt0 -156.21 -7.81 0.11 Allowed 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.805 -1.089 . . . . 71.42 109.171 -168.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.4 p -88.03 169.2 12.17 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.517 -0.765 . . . . 73.01 111.625 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.7 p -106.46 132.44 53.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-N 115.401 -0.818 . . . . 61.23 109.814 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -127.14 123.68 37.33 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.561 -0.903 . . . . 75.41 108.561 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.3 ttt-85 54.52 33.01 17.98 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-O 122.975 1.369 . . . . 65.22 111.003 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.0 14.62 69.08 Favored Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 114.224 -1.353 . . . . 74.32 114.449 176.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -136.12 148.82 48.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 118.043 0.922 . . . . 61.31 110.64 174.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.5 m -79.15 121.64 25.26 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.768 -0.827 . . . . 33.32 108.768 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 37.4 pt -102.32 172.13 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.18 0.514 . . . . 72.31 111.287 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.409 ' HE3' ' HB3' ' A' ' 110' ' ' LEU . 55.1 tptt -124.89 127.28 46.87 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.228 -1.027 . . . . 63.51 108.228 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 23.8 t -126.79 115.95 43.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 107.746 -1.205 . . . . 75.34 107.746 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.477 HD13 ' HB3' ' A' ' 40' ' ' TYR 0.283 0.0 OUTLIER -138.38 141.39 31.38 Favored Pre-proline 0 C--N 1.311 -1.073 0 C-N-CA 119.536 -0.865 . . . . 72.32 109.112 -179.533 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.01 140.0 44.32 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 122.326 2.017 . . . . 63.1 114.153 -171.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.53 ' HE3' ' HA ' ' A' ' 35' ' ' ASP . 32.8 ttpt . . . . . 0 N--CA 1.429 -1.5 0 N-CA-C 109.109 -0.7 . . . . 72.25 109.109 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.702 ' HA3' ' OH ' ' A' ' 82' ' ' TYR . . . . . . . . 0 C--O 1.239 0.436 0 N-CA-C 115.093 0.797 . . . . 54.42 115.093 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.65 -35.98 97.8 Favored 'Trans proline' 0 CA--C 1.558 1.724 0 C-N-CA 123.492 2.795 . . . . 71.25 114.762 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -47.52 123.57 8.26 Favored 'Trans proline' 0 C--N 1.4 3.27 0 C-N-CA 122.073 1.849 . . . . 75.41 113.041 174.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -91.03 141.52 26.56 Favored Pre-proline 0 C--N 1.294 -1.841 0 CA-C-N 114.56 -1.2 . . . . 63.14 108.874 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -49.3 117.73 3.1 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.998 2.465 . . . . 63.41 113.515 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 7.2 mp -58.04 -176.04 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.191 0 CA-C-N 113.98 -1.464 . . . . 70.32 110.453 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 20.3 m -66.58 142.93 57.32 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 107.254 -1.387 . . . . 63.01 107.254 171.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.501 ' O ' ' HE2' ' B' ' 32' ' ' LYS . . . -56.02 -42.84 77.07 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.577 -0.738 . . . . 65.11 110.68 176.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -68.4 -30.84 69.85 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 112.812 0.671 . . . . 74.41 112.812 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.75 -39.74 91.38 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.636 -0.505 . . . . 62.3 109.636 171.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.483 ' HA ' HG12 ' B' ' 34' ' ' ILE . 57.3 mttm -70.19 -49.98 44.83 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 113.162 0.801 . . . . 53.23 113.162 -178.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.559 ' N ' ' HE2' ' B' ' 32' ' ' LYS . 0.3 OUTLIER -56.09 -39.15 71.7 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 120.146 -0.622 . . . . 75.21 112.639 -178.648 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 17.9 mt-10 -71.85 -41.61 67.91 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 118.945 -1.102 . . . . 74.23 112.629 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.483 HG12 ' HA ' ' B' ' 31' ' ' LYS . 35.1 pt -68.88 -35.46 69.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 C-N-CA 120.213 -0.595 . . . . 73.34 111.351 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -59.85 -44.08 94.31 Favored 'General case' 0 C--O 1.217 -0.625 0 N-CA-C 109.674 -0.491 . . . . 72.14 109.674 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 98.4 mttt -70.33 -18.22 63.08 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.269 -0.878 . . . . 65.24 112.298 -175.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' B' ' 33' ' ' GLU . 18.8 ptp180 -109.8 24.93 12.38 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-O 121.443 0.64 . . . . 71.04 111.383 -178.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.511 ' HB2' ' HD3' ' B' ' 112' ' ' LYS . 19.5 m -115.51 172.69 6.95 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.656 -0.702 . . . . 53.54 110.997 174.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.4 163.66 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 123.19 0.596 . . . . 74.25 110.573 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 36.0 t80 -111.97 125.61 54.25 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 125.596 1.559 . . . . 61.4 107.94 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 57.9 t -114.66 116.31 52.2 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 C-N-CA 123.651 0.78 . . . . 74.22 109.191 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.98 165.39 12.52 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 120.716 -0.754 . . . . 61.12 112.406 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 t30 57.81 20.43 6.53 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 126.241 1.816 . . . . 72.34 113.26 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.72 129.0 19.08 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 CA-C-O 121.396 0.617 . . . . 71.24 109.389 173.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.487 ' HA ' ' CZ ' ' B' ' 105' ' ' ARG . 20.8 t70 -61.35 139.23 58.22 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 114.674 -1.148 . . . . 52.43 109.274 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' TYR . . . . . 0.406 ' CE2' ' HG2' ' A' ' 51' ' ' GLN . 32.6 t80 -70.32 0.15 7.01 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.714 -0.676 . . . . 74.23 111.072 -174.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -107.6 -0.23 34.61 Favored Glycine 0 N--CA 1.421 -2.304 0 CA-C-N 115.799 -0.637 . . . . 71.23 112.148 175.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.9 t -80.51 146.27 31.42 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.599 -1.26 . . . . 63.1 107.599 176.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 71.7 p -105.52 172.58 6.72 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.982 -0.377 . . . . 73.03 109.982 -177.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.48 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -63.72 -50.4 69.29 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 120.57 0.224 . . . . 71.21 110.539 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -61.03 -35.99 78.36 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 111.838 0.311 . . . . 75.21 111.838 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -64.17 -43.65 94.49 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 109.61 -0.515 . . . . 65.21 109.61 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 52.0 mt -67.67 -48.14 67.48 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.208 -0.905 . . . . 73.14 112.042 176.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.32 -49.16 78.71 Favored 'General case' 0 C--O 1.207 -1.132 0 C-N-CA 123.387 0.675 . . . . 63.02 110.809 -177.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.28 -43.25 78.62 Favored 'General case' 0 C--O 1.262 1.718 0 CA-C-O 121.215 0.531 . . . . 55.31 111.123 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -65.77 -39.25 90.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.479 -0.782 . . . . 74.22 110.718 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -82.45 -22.55 35.19 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 113.432 0.901 . . . . 75.15 113.432 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 36.1 t -69.23 -25.16 64.17 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.958 -0.565 . . . . 72.24 109.766 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.9 m -62.9 -24.97 68.09 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 120.387 -0.525 . . . . 74.31 110.511 173.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 58.4 m -96.55 3.73 52.46 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 122.744 0.418 . . . . 51.32 112.061 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.13 -171.72 32.73 Favored Glycine 0 C--O 1.222 -0.634 0 C-N-CA 119.281 -1.438 . . . . 65.41 114.456 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 21.7 m -98.86 119.38 37.52 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.707 -0.479 . . . . 51.41 109.707 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 50.8 mt -82.52 132.74 30.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 112.997 0.74 . . . . 70.35 112.997 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' ASN . . . . . 0.621 ' OD1' ' HB3' ' A' ' 73' ' ' PHE . 46.1 t-20 -93.79 -51.29 4.97 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 125.315 1.446 . . . . 73.04 109.225 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.444 ' HD3' ' OE1' ' B' ' 84' ' ' GLU . 46.5 mtp180 -153.14 166.75 31.53 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.547 -1.279 . . . . 43.33 107.547 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.48 HD11 ' HB1' ' B' ' 50' ' ' ALA . 19.9 pt -147.13 144.28 19.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 108.059 -1.089 . . . . 75.32 108.059 171.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 67' ' ' THR . . . . . 0.577 ' OG1' ' HB2' ' B' ' 82' ' ' TYR . 36.9 p -121.71 136.88 54.93 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 105.387 -2.079 . . . . 55.1 105.387 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.2 mp -129.25 113.08 26.93 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 N-CA-C 105.561 -2.014 . . . . 74.4 105.561 173.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.498 ' HG ' ' CE2' ' B' ' 80' ' ' TYR 0.274 1.5 pt? -120.72 123.03 41.72 Favored 'General case' 0 C--N 1.281 -2.387 0 C-N-CA 119.987 -0.685 . . . . 72.31 111.486 -179.497 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 70' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 67.0 m -117.6 134.82 54.47 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.621 -0.718 . . . . 75.01 109.631 -177.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 3.5 p30 -115.11 140.38 49.11 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.878 -0.729 . . . . 74.44 109.871 177.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 72' ' ' LYS . . . . . 0.451 ' HG2' ' HB3' ' B' ' 77' ' ' PRO . 7.6 mtpm? -112.5 7.67 19.06 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 116.126 -0.488 . . . . 73.35 110.365 -178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.652 ' HB3' ' OD1' ' A' ' 64' ' ' ASN . 12.5 p90 -73.08 -11.2 60.46 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 121.524 0.678 . . . . 73.43 110.585 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 20.7 m -88.13 9.48 22.59 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.117 -0.947 . . . . 61.25 110.09 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.95 -51.0 4.39 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 109.607 -1.397 . . . . 72.44 109.607 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -96.43 145.53 29.74 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 105.806 -1.924 . . . . 72.32 105.806 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.451 ' HB3' ' HG2' ' B' ' 72' ' ' LYS . 58.2 Cg_endo -77.43 118.1 4.52 Favored 'Trans proline' 0 N--CA 1.437 -1.81 0 C-N-CA 120.767 0.978 . . . . 65.42 110.623 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 78' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 28.8 mtmm -93.71 137.49 32.91 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 108.13 -1.063 . . . . 50.44 108.13 177.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -116.17 133.33 10.73 Favored Glycine 0 N--CA 1.413 -2.887 0 C-N-CA 119.974 -1.108 . . . . 62.0 111.773 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' TYR . . . . . 0.498 ' CE2' ' HG ' ' B' ' 69' ' ' LEU . 6.8 p90 -147.74 142.73 26.97 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 124.04 0.936 . . . . 75.13 109.42 175.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.08 154.37 45.91 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 116.397 -0.365 . . . . 74.23 111.728 -172.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 82' ' ' TYR . . . . . 0.577 ' HB2' ' OG1' ' B' ' 67' ' ' THR . 19.4 m-85 -117.25 124.96 50.31 Favored 'General case' 0 CA--C 1.467 -2.23 0 C-N-CA 122.78 0.432 . . . . 72.2 110.442 173.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 34.5 mm -102.75 110.11 28.5 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 106.635 -1.617 . . . . 74.04 106.635 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' GLU . . . . . 0.444 ' OE1' ' HD3' ' B' ' 65' ' ' ARG . 31.2 mt-10 -95.3 120.61 35.83 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.417 -0.957 . . . . 54.43 108.417 -178.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.418 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 98.0 m-85 -99.09 162.2 13.2 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.413 0.625 . . . . 65.43 111.111 -177.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.32 -11.37 56.48 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.509 -0.769 . . . . 65.2 109.983 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 87' ' ' GLU . . . . . 0.605 ' HB3' ' OG ' ' B' ' 90' ' ' SER . 43.2 tt0 -124.23 140.6 52.8 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.309 -0.405 . . . . 54.11 111.094 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.507 ' O ' HG22 ' B' ' 91' ' ' VAL . 0.6 OUTLIER -74.99 -34.91 62.02 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.64 -1.244 . . . . 74.03 107.64 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 89' ' ' ASN . . . . . 0.42 ' H ' ' HG2' ' B' ' 87' ' ' GLU . 0.6 OUTLIER -62.13 -28.38 69.6 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.512 -0.921 . . . . 75.42 108.512 -179.742 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 90' ' ' SER . . . . . 0.605 ' OG ' ' HB3' ' B' ' 87' ' ' GLU . 70.2 m -63.46 -36.34 83.43 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 116.19 -0.459 . . . . 71.24 111.025 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.507 HG22 ' O ' ' B' ' 88' ' ' ARG . 3.6 m -67.18 -40.13 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.519 0 N-CA-C 108.551 -0.907 . . . . 61.13 108.551 179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -56.96 -37.68 71.9 Favored 'General case' 0 N--CA 1.455 -0.225 0 O-C-N 123.828 0.705 . . . . 75.05 110.9 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.9 -37.18 64.76 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.753 -0.658 . . . . 61.33 111.48 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.83 -41.15 53.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.506 . . . . 73.51 111.87 -176.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 95' ' ' VAL . . . . . 0.493 HG13 ' O ' ' B' ' 91' ' ' VAL . 32.8 m -55.23 -21.46 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 112.905 0.705 . . . . 72.3 112.905 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.07 -13.77 62.25 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.805 0.812 . . . . 72.24 111.14 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 68.2 mtm -97.2 9.69 41.5 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.418 -0.81 . . . . 72.43 110.011 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 98' ' ' ASP . . . . . 0.709 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 6.1 p-10 -36.27 -46.81 0.55 Allowed 'General case' 0 C--O 1.204 -1.31 0 N-CA-C 115.694 1.739 . . . . 63.21 115.694 -176.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -128.47 41.89 3.41 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 118.585 -1.246 . . . . 73.3 110.792 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 40.8 p -79.62 176.87 9.32 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.88 -0.6 . . . . 74.4 110.794 175.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.04 132.96 55.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.139 0.495 . . . . 74.12 109.876 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -140.49 125.82 18.78 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.482 -0.781 . . . . 74.41 109.004 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . 0.263 20.7 ttt180 50.49 54.78 10.56 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 122.295 1.045 . . . . 74.35 113.747 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.89 -7.5 42.38 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 114.341 -1.3 . . . . 12.14 115.568 176.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.487 ' CZ ' ' HA ' ' B' ' 45' ' ' ASP . 10.2 ptt180 -136.7 159.89 40.48 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 114.35 1.241 . . . . 74.4 114.35 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 34.5 m -87.12 120.93 28.91 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.169 -0.923 . . . . 61.54 109.931 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 39.5 pt -101.78 172.01 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 116.204 -0.453 . . . . 73.32 110.413 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 108' ' ' LYS . . . . . 0.709 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 56.1 tptt -125.84 129.39 49.29 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.828 -0.804 . . . . 71.02 108.828 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 109' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 18.0 t -124.54 121.58 61.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 107.653 -1.24 . . . . 64.44 107.653 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.295 0.4 OUTLIER -140.09 135.05 16.02 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 106.25 -1.759 . . . . 73.21 106.25 -170.597 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.33 143.53 53.2 Favored 'Trans proline' 0 CA--C 1.551 1.363 0 C-N-CA 121.885 1.723 . . . . 71.31 113.93 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.511 ' HD3' ' HB2' ' B' ' 38' ' ' SER . 66.0 tttt . . . . . 0 C--N 1.323 -0.57 0 C-N-CA 123.54 0.736 . . . . 70.22 110.436 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 120.546 0.212 . . . . 72.32 111.513 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.3 pt -71.09 -36.74 64.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.966 -0.561 . . . . 63.42 111.904 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.5 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 29.9 m-20 -76.17 -19.14 58.73 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.712 0.634 . . . . 75.04 112.712 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -66.96 -26.42 66.81 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.361 0.6 . . . . 70.34 110.339 174.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -96.89 16.03 20.51 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.153 -0.684 . . . . 72.01 109.153 -177.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.522 ' OG ' ' HG3' ' A' ' 84' ' ' GLU . 14.9 m -103.5 163.01 12.56 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 115.542 -0.754 . . . . 62.44 110.48 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 111' ' ' PRO . 27.2 m -131.64 164.16 35.29 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 115.469 -0.787 . . . . 73.34 109.883 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 23.7 t80 -110.87 126.03 54.25 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 107.44 -1.318 . . . . 73.11 107.44 175.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.0 t -115.89 111.99 37.8 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 N-CA-C 107.753 -1.203 . . . . 53.1 107.753 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.6 172.03 18.89 Favored Glycine 0 CA--C 1.478 -2.256 0 N-CA-C 109.706 -1.358 . . . . 32.44 109.706 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.687 ' OD1' ' HG3' ' A' ' 105' ' ' ARG . 26.2 t-20 69.42 -11.05 0.51 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.356 0.662 . . . . 64.15 112.395 -178.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.7 p -70.19 91.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 107.372 -1.344 . . . . 71.31 107.372 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.38 10.5 m-20 -74.43 168.02 20.53 Favored 'General case' 0 CA--C 1.457 -2.618 0 N-CA-C 116.341 1.978 . . . . 61.15 116.341 -166.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -39.33 -34.49 0.2 Allowed 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 128.231 2.612 . . . . 73.3 114.791 -173.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.66 -1.53 85.37 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.435 -0.888 . . . . 74.32 114.075 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.454 ' HA ' ' CZ ' ' A' ' 103' ' ' ARG . 19.7 m -75.26 133.33 41.37 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 117.677 0.738 . . . . 63.34 111.041 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.612 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 12.6 p -92.22 155.89 17.68 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 115.583 -0.735 . . . . 74.13 111.046 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.581 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -65.54 -47.82 74.58 Favored 'General case' 0 C--O 1.212 -0.904 0 C-N-CA 122.641 0.376 . . . . 71.42 110.831 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -56.81 -53.43 57.89 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.519 0.728 . . . . 63.01 112.529 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.61 -36.75 83.75 Favored 'General case' 0 C--O 1.25 1.128 0 CA-C-O 121.397 0.617 . . . . 55.51 111.348 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' A' ' 49' ' ' THR . 2.9 tt -72.17 -46.56 55.86 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.78 -1.1 . . . . 74.32 108.493 -176.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -58.26 -48.3 80.86 Favored 'General case' 0 C--O 1.207 -1.158 0 C-N-CA 123.482 0.713 . . . . 74.12 111.039 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.92 -38.23 69.99 Favored 'General case' 0 C--O 1.258 1.551 0 CA-C-O 121.268 0.556 . . . . 45.54 110.752 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -65.39 -40.3 93.27 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.117 -0.947 . . . . 75.04 110.189 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -83.04 -21.33 33.83 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 113.751 1.019 . . . . 74.21 113.751 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.8 t -60.47 -33.69 72.94 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.988 -0.745 . . . . 72.55 108.988 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.9 m -59.04 -27.8 65.82 Favored 'General case' 0 CA--C 1.565 1.536 0 CA-C-N 115.789 -0.641 . . . . 63.01 111.807 174.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 67.5 m -92.0 -0.85 57.48 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.36 0.874 . . . . 73.03 113.36 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.69 -169.96 30.53 Favored Glycine 0 C--N 1.319 -0.399 0 C-N-CA 118.951 -1.595 . . . . 74.1 114.562 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.4 m -94.56 116.78 29.19 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 123.205 0.602 . . . . 71.01 110.479 -175.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 85.1 mt -89.23 130.1 39.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 C-N-CA 123.015 0.526 . . . . 74.15 112.368 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.47 HD21 ' HB2' ' A' ' 86' ' ' ALA . 11.7 m120 -99.34 -40.41 7.92 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.686 -0.688 . . . . 71.43 111.106 177.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' B' ' 71' ' ' ASP . 55.6 mtp180 -150.55 160.9 43.47 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 107.91 -1.145 . . . . 73.31 107.91 -177.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.581 HD11 ' HB1' ' A' ' 50' ' ' ALA . 26.4 pt -145.14 137.97 21.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.382 -1.34 . . . . 74.32 107.382 173.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.9 m -125.61 120.89 32.03 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 107.604 -1.258 . . . . 64.05 107.604 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.402 ' O ' HD12 ' B' ' 68' ' ' ILE . 2.8 mp -118.18 118.45 58.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 106.218 -1.771 . . . . 74.23 106.218 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.45 ' HG ' ' CE2' ' A' ' 80' ' ' TYR 0.26 1.2 pt? -121.9 125.59 46.76 Favored 'General case' 0 C--N 1.285 -2.22 0 C-N-CA 120.257 -0.577 . . . . 60.21 111.967 179.156 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 73.1 m -117.37 136.0 53.47 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.734 -0.839 . . . . 71.42 108.734 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.502 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 2.5 p30 -131.07 153.52 49.22 Favored 'General case' 0 CA--C 1.495 -1.141 0 C-N-CA 119.146 -1.022 . . . . 61.13 112.033 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.411 ' HE3' ' OE1' ' B' ' 54' ' ' GLU . 97.9 mttt -121.54 18.33 11.26 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 124.048 0.843 . . . . 72.1 110.883 176.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -69.03 -21.18 64.13 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 119.049 -1.06 . . . . 51.44 112.98 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.7 p -91.8 10.61 27.82 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.405 0.621 . . . . 73.34 110.471 174.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.63 -47.87 1.4 Allowed Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.552 -0.619 . . . . 62.35 111.552 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -97.27 136.83 21.24 Favored Pre-proline 0 C--N 1.301 -1.543 0 CA-C-N 115.512 -0.344 . . . . 72.33 110.23 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 31.7 Cg_endo -69.0 118.61 5.78 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.616 1.544 . . . . 71.14 110.364 175.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 34.6 mtmm -113.33 149.74 33.55 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.337 -0.616 . . . . 70.21 109.337 -178.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -120.38 134.8 10.56 Favored Glycine 0 N--CA 1.423 -2.195 0 C-N-CA 119.847 -1.168 . . . . 73.23 112.791 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.45 ' CE2' ' HG ' ' A' ' 69' ' ' LEU . 17.6 p90 -152.85 144.42 23.42 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 124.326 1.05 . . . . 74.11 109.644 175.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.23 155.89 45.97 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.035 0.445 . . . . 64.01 111.811 -173.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -115.14 130.09 56.84 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.183 -1.414 . . . . 74.04 107.183 174.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.48 HG23 HG22 ' A' ' 66' ' ' ILE . 40.9 mm -112.39 112.88 42.38 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 108.454 -0.943 . . . . 73.23 108.454 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.522 ' HG3' ' OG ' ' A' ' 38' ' ' SER . 1.9 mp0 -88.08 118.96 28.01 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 122.61 0.364 . . . . 73.42 110.801 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -103.82 163.69 12.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.486 0.66 . . . . 73.22 111.602 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.47 ' HB2' HD21 ' A' ' 64' ' ' ASN . . . -78.27 -23.91 47.07 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.135 -0.938 . . . . 73.4 112.098 176.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -125.67 150.37 47.67 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 113.541 0.941 . . . . 74.12 113.541 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.555 ' O ' HG22 ' A' ' 91' ' ' VAL . 21.7 mmm180 -70.52 -29.3 65.77 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.248 -0.887 . . . . 73.31 108.986 173.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.95 -35.38 73.04 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.03 -0.532 . . . . 71.51 110.188 176.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.8 m -64.64 -36.91 85.8 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 116.745 -0.207 . . . . 73.21 111.077 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 88' ' ' ARG . 3.7 m -64.79 -39.26 85.05 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.885 0 C-N-CA 119.509 -0.876 . . . . 74.3 109.001 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.437 ' HA ' HG22 ' A' ' 95' ' ' VAL . 38.5 m-20 -60.07 -34.96 74.16 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.069 0.461 . . . . 74.3 111.783 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.74 -37.54 65.05 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.905 -0.589 . . . . 73.53 110.351 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.14 -44.76 59.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.138 -0.483 . . . . 65.15 110.741 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 91' ' ' VAL . 14.8 m -61.09 -23.33 29.6 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.019 0 CA-C-N 116.456 -0.338 . . . . 75.11 111.8 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.01 -16.0 63.11 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.664 0.745 . . . . 75.43 110.431 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 25.2 ttp -104.89 9.22 34.78 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.835 -1.075 . . . . 72.02 109.134 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 4.5 p-10 -37.4 -49.52 1.01 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 113.812 1.041 . . . . 73.23 113.812 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -115.44 104.17 11.5 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-O 121.744 0.783 . . . . 70.24 110.268 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 106' ' ' THR . 14.5 t -145.15 173.62 11.77 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 114.712 -1.131 . . . . 70.32 108.644 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.14 115.76 48.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.827 0.822 . . . . 71.15 110.301 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -122.58 117.71 26.48 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.034 -1.099 . . . . 75.41 108.034 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.454 ' CZ ' ' HA ' ' A' ' 48' ' ' SER . 54.3 mtt180 62.26 33.6 16.52 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.79 0.836 . . . . 74.01 112.841 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.37 -2.64 81.19 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 114.7 -1.136 . . . . 72.42 114.137 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.687 ' HG3' ' OD1' ' A' ' 43' ' ' ASN . 18.0 ptp180 -130.21 154.84 47.15 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 117.479 0.64 . . . . 74.1 111.293 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 100' ' ' THR . 88.6 m -83.65 120.96 26.63 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 116.063 -0.517 . . . . 71.44 111.277 -174.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.656 ' HA ' ' HB3' ' A' ' 43' ' ' ASN . 40.3 pt -99.83 172.13 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 C-N-CA 120.595 -0.442 . . . . 62.31 111.968 -174.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 54.1 tptt -131.4 126.65 35.7 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.094 -0.957 . . . . 72.42 109.572 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 35.9 t -127.93 128.69 69.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.368 -0.605 . . . . 74.31 109.368 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.542 ' HB2' ' HD2' ' A' ' 111' ' ' PRO 0.295 0.0 OUTLIER -148.45 161.94 31.91 Favored Pre-proline 0 C--N 1.303 -1.433 0 CA-C-O 117.604 -1.189 . . . . 75.04 108.301 174.15 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.542 ' HD2' ' HB2' ' A' ' 110' ' ' LEU . 50.4 Cg_endo -67.73 149.47 78.76 Favored 'Trans proline' 0 C--N 1.357 1.02 0 CA-C-N 121.833 1.69 . . . . 54.22 109.122 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.473 ' HE2' ' HB2' ' A' ' 38' ' ' SER . 35.8 ttpt . . . . . 0 C--N 1.319 -0.725 0 N-CA-C 107.332 -1.359 . . . . 71.45 107.332 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.643 0 N-CA-C 110.325 -1.11 . . . . 71.02 110.325 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.534 ' HG2' ' HD3' ' B' ' 23' ' ' PRO . 2.2 Cg_endo -40.84 -51.21 3.76 Favored 'Trans proline' 0 CA--C 1.561 1.87 0 C-N-CA 124.158 3.239 . . . . 71.23 113.791 172.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.534 ' HD3' ' HG2' ' B' ' 22' ' ' PRO . 1.5 Cg_endo -82.96 123.59 3.64 Favored 'Trans proline' 0 C--N 1.375 1.97 0 CA-C-N 120.825 1.33 . . . . 34.32 109.763 173.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -62.29 150.39 84.85 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 115.613 -0.721 . . . . 61.14 111.447 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.38 109.86 0.44 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.476 2.784 . . . . 73.24 112.914 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.557 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -107.67 148.63 29.13 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.986 -1.116 . . . . 65.14 107.986 175.421 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.477 ' HB3' ' OE2' ' B' ' 30' ' ' GLU . 40.1 t -61.04 145.86 49.26 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.206 0.817 . . . . 75.34 113.206 -170.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.653 ' O ' ' HG2' ' B' ' 32' ' ' LYS . . . -49.5 -35.25 19.31 Favored 'General case' 0 C--O 1.196 -1.732 0 CA-C-N 114.638 -1.165 . . . . 74.32 110.95 172.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.401 ' HA ' ' HG2' ' B' ' 32' ' ' LYS . 45.8 mt-10 -66.26 -34.95 79.17 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.104 0.409 . . . . 75.54 112.104 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.477 ' OE2' ' HB3' ' B' ' 27' ' ' SER . 0.7 OUTLIER -66.76 -35.23 79.61 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 109.096 -0.705 . . . . 60.43 109.096 172.409 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -69.82 -37.23 76.15 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.512 -0.767 . . . . 62.41 110.947 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.68 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 30.6 mmmt -57.63 -46.87 83.59 Favored 'General case' 0 C--O 1.204 -1.333 0 N-CA-C 109.85 -0.426 . . . . 74.32 109.85 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -66.23 -47.94 72.16 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.102 -0.499 . . . . 64.02 111.516 -175.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.473 HG12 ' O ' ' B' ' 30' ' ' GLU . 16.1 pt -70.97 -36.11 62.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.766 -0.652 . . . . 71.24 112.143 -178.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.434 ' HB3' ' HD2' ' B' ' 112' ' ' LYS . 29.0 m-20 -76.48 -20.14 57.29 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.093 0.775 . . . . 75.52 113.093 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.68 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 95.9 mttt -67.09 -25.04 66.03 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.783 0.802 . . . . 73.43 109.64 174.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.629 ' HD3' ' O ' ' B' ' 86' ' ' ALA . 97.3 mtt180 -97.93 13.9 29.11 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.59 -1.186 . . . . 64.03 109.284 -174.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.515 ' OG ' ' HE3' ' B' ' 112' ' ' LYS . 43.6 t -107.15 169.41 8.58 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 115.029 -0.987 . . . . 65.43 110.533 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.49 164.25 33.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 123.651 0.781 . . . . 65.23 110.244 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' TYR . . . . . 0.572 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 18.6 t80 -110.17 125.83 53.45 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 107.741 -1.207 . . . . 75.14 107.741 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.07 112.42 39.51 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 N-CA-C 107.636 -1.246 . . . . 75.25 107.636 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.29 163.2 13.68 Favored Glycine 0 N--CA 1.421 -2.305 0 C-N-CA 120.041 -1.076 . . . . 74.21 113.46 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.56 22.79 6.97 Favored 'General case' 0 CA--C 1.564 1.507 0 C-N-CA 125.983 1.713 . . . . 52.53 112.802 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 10.6 p -57.5 134.67 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 109.116 -0.698 . . . . 73.21 109.116 174.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -66.25 141.5 58.01 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.061 -0.718 . . . . 64.14 109.061 -177.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -64.51 -10.77 27.98 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-O 121.558 0.694 . . . . 70.32 109.892 -176.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.47 -10.09 58.4 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-N 115.677 -0.692 . . . . 54.12 113.026 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.5 m -98.21 79.7 2.59 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-N 118.685 1.242 . . . . 53.23 110.994 176.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' THR . . . . . 0.443 ' OG1' HG22 ' A' ' 49' ' ' THR . 22.6 p -71.06 -177.48 1.68 Allowed 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 113.632 0.975 . . . . 75.11 113.632 175.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.581 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -51.13 -51.5 52.93 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 115.01 1.485 . . . . 65.11 115.01 -164.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -58.21 -53.52 57.29 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 112.825 0.676 . . . . 64.33 112.825 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -63.5 -40.59 97.48 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-O 121.568 0.699 . . . . 54.32 111.02 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 2.7 tt -67.73 -46.76 71.24 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.901 -1.045 . . . . 74.13 109.298 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.411 ' OE1' ' HE3' ' A' ' 72' ' ' LYS . 29.5 tt0 -58.84 -48.28 81.9 Favored 'General case' 0 C--O 1.206 -1.206 0 C-N-CA 122.474 0.31 . . . . 62.21 111.422 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.64 -37.63 68.48 Favored 'General case' 0 C--O 1.262 1.726 0 CA-C-O 121.389 0.614 . . . . 74.42 110.757 -178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -64.92 -40.73 95.51 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.133 -0.94 . . . . 74.43 110.23 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -83.33 -21.94 33.03 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.715 1.006 . . . . 75.41 113.715 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 40.5 t -62.93 -32.66 74.01 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 123.812 0.845 . . . . 73.12 110.06 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 18.2 m -62.42 -24.88 67.65 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-N 116.15 -0.477 . . . . 54.34 111.197 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 58.8 m -96.04 5.93 50.01 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 112.903 0.705 . . . . 62.24 112.903 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.24 -177.29 30.12 Favored Glycine 0 C--N 1.32 -0.345 0 C-N-CA 118.823 -1.656 . . . . 62.34 114.433 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 20.1 m -96.0 114.95 26.71 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.384 0.611 . . . . 71.21 110.287 -177.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 62.4 mt -85.55 131.44 34.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.789 -0.641 . . . . 53.32 111.866 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -99.04 -41.65 7.46 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.406 -0.816 . . . . 62.04 111.514 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -151.32 160.9 43.55 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 107.886 -1.153 . . . . 63.01 107.886 -177.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.581 HD11 ' HB1' ' B' ' 50' ' ' ALA . 23.6 pt -145.32 138.23 21.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.379 -1.341 . . . . 64.24 107.379 172.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 54.0 m -125.64 120.77 31.64 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 107.577 -1.268 . . . . 71.45 107.577 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 68' ' ' ILE . 3.2 mp -117.83 116.82 52.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 106.612 -1.625 . . . . 62.21 106.612 -177.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.275 1.1 pt? -120.9 124.5 45.11 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 120.211 -0.595 . . . . 73.33 112.33 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 70' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 66.4 m -117.51 134.56 54.72 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 108.859 -0.793 . . . . 73.41 108.859 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 2.8 p30 -125.54 143.2 51.12 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.575 -0.85 . . . . 61.41 108.822 177.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -118.72 15.53 13.57 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.124 -0.695 . . . . 64.54 109.124 -177.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -70.4 -11.28 60.81 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.317 0.579 . . . . 75.14 111.954 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 50.5 m -89.87 3.48 52.85 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.63 -0.713 . . . . 72.31 110.135 174.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.76 -47.89 2.05 Favored Glycine 0 CA--C 1.498 -1.018 0 N-CA-C 110.28 -1.128 . . . . 74.32 110.28 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -96.09 135.09 22.92 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 106.648 -1.612 . . . . 72.24 106.648 175.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.62 118.36 5.29 Favored 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 120.716 0.944 . . . . 62.32 110.609 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 78' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 32.9 mtmm -96.76 144.12 27.04 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 109.287 -0.635 . . . . 63.23 109.287 -178.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -119.42 132.01 9.31 Favored Glycine 0 N--CA 1.415 -2.728 0 C-N-CA 120.123 -1.037 . . . . 65.45 112.063 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -150.79 143.91 24.76 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 123.959 0.904 . . . . 72.53 109.641 175.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.36 156.48 45.82 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.078 0.466 . . . . 75.02 111.613 -173.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 82' ' ' TYR . . . . . 0.444 ' CG ' ' HE2' ' B' ' 112' ' ' LYS . 27.2 m-85 -115.99 130.83 56.99 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.526 -1.287 . . . . 73.3 107.526 174.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.483 HG23 HG22 ' B' ' 66' ' ' ILE . 35.8 mm -114.51 110.74 33.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.621 -0.881 . . . . 74.35 108.621 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -86.24 119.34 26.41 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.48 -0.327 . . . . 75.45 110.988 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.25 165.21 11.2 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.909 0.385 . . . . 73.33 109.997 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.629 ' O ' ' HD3' ' B' ' 37' ' ' ARG . . . -79.46 -34.56 41.39 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.34 -0.391 . . . . 55.44 112.018 176.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -111.18 150.46 29.47 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.137 0.494 . . . . 73.41 112.282 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.597 ' O ' HG22 ' B' ' 91' ' ' VAL . 21.2 mmm180 -68.95 -28.8 66.97 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.411 -0.813 . . . . 74.54 109.533 172.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -63.7 -29.33 70.57 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.633 -0.712 . . . . 73.05 111.143 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 19.5 m -67.74 -36.36 80.42 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 116.664 -0.244 . . . . 71.13 110.491 177.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.597 HG22 ' O ' ' B' ' 88' ' ' ARG . 3.6 m -64.24 -39.53 85.84 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.775 0 N-CA-C 108.802 -0.814 . . . . 75.11 108.802 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.402 ' HA ' HG22 ' B' ' 95' ' ' VAL . 6.0 m-20 -57.08 -37.22 71.57 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.513 0.561 . . . . 65.31 112.513 175.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.55 -35.93 65.57 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.947 -0.569 . . . . 70.42 110.526 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.46 -42.72 52.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.869 -0.605 . . . . 64.44 110.942 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 95' ' ' VAL . . . . . 0.505 HG13 ' O ' ' B' ' 91' ' ' VAL . 19.2 m -62.11 -23.36 31.5 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.962 0 N-CA-C 111.896 0.332 . . . . 73.42 111.896 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.7 -16.19 63.3 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.28 0.562 . . . . 44.02 110.442 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 16.5 ttm -101.3 3.03 40.35 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 123.994 0.918 . . . . 73.24 109.013 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 98' ' ' ASP . . . . . 0.586 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 4.2 p-10 -35.85 -50.36 0.65 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 116.291 1.96 . . . . 71.5 116.291 -172.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -115.77 93.49 4.29 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 118.204 -1.398 . . . . 75.03 110.945 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 13.1 t -135.2 172.8 12.49 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.145 -1.389 . . . . 62.14 109.925 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.0 p -101.58 128.63 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 108.876 -0.787 . . . . 74.21 108.876 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -130.51 119.63 22.88 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.941 -0.763 . . . . 73.12 108.941 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 31.0 ttm-85 50.71 33.42 8.29 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.612 1.565 . . . . 73.45 112.151 -175.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 99.57 -2.93 57.51 Favored Glycine 0 C--N 1.296 -1.64 0 CA-C-N 114.439 -1.255 . . . . 63.12 114.345 172.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -131.77 149.18 52.55 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 118.171 0.986 . . . . 75.32 112.162 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 25.7 m -75.5 124.86 27.91 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.994 -0.548 . . . . 62.04 110.929 -174.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 43.1 pt -102.83 171.56 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.016 0.436 . . . . 73.31 110.832 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 108' ' ' LYS . . . . . 0.586 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 55.0 tptt -135.41 131.93 36.87 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.0 -1.111 . . . . 71.54 108.0 178.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 109' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 28.0 t -127.28 134.35 66.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.608 -0.515 . . . . 75.42 109.608 -177.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.686 ' HB3' ' HD2' ' B' ' 111' ' ' PRO 0.262 0.1 OUTLIER -144.13 170.0 9.2 Favored Pre-proline 0 C--O 1.215 -0.76 0 N-CA-C 105.292 -2.114 . . . . 75.4 105.292 174.167 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.686 ' HD2' ' HB3' ' B' ' 110' ' ' LEU . 73.6 Cg_endo -73.53 151.51 47.44 Favored 'Trans proline' 0 CA--C 1.552 1.422 0 C-N-CA 122.015 1.81 . . . . 65.51 110.114 171.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.515 ' HE3' ' OG ' ' B' ' 38' ' ' SER . 35.1 ttmt . . . . . 0 C--N 1.317 -0.808 0 CA-C-O 121.007 0.432 . . . . 63.51 110.742 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 . . . . . 0 CA--C 1.511 -0.528 0 CA-C-O 121.2 0.524 . . . . 61.03 110.971 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . 0.26 15.5 pt -70.94 -35.65 60.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 113.204 0.816 . . . . 74.33 113.204 -178.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -61.43 -41.4 97.12 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.207 1.003 . . . . 73.03 109.416 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.497 ' HG2' ' HG2' ' A' ' 88' ' ' ARG . 28.3 ttmt -58.51 -25.51 62.47 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 125.18 1.392 . . . . 73.42 112.767 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.437 ' HA ' HG11 ' A' ' 91' ' ' VAL . 88.5 mtm180 -119.52 10.38 11.8 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 112.389 0.514 . . . . 64.51 112.389 -175.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.0 t -98.32 154.7 17.63 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.253 0.549 . . . . 52.35 111.778 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.604 HG13 ' CG2' ' A' ' 91' ' ' VAL . 0.2 OUTLIER -140.64 161.9 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 C-N-CA 124.062 0.945 . . . . 31.31 111.719 176.905 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 25.7 t80 -112.49 126.5 55.38 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 107.642 -1.244 . . . . 72.44 107.642 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 59.7 t -113.32 110.35 31.87 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 N-CA-C 107.082 -1.451 . . . . 65.13 107.082 176.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.36 165.92 12.84 Favored Glycine 0 C--N 1.291 -1.958 0 C-N-CA 119.512 -1.328 . . . . 52.04 114.272 -175.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.464 ' O ' ' HD3' ' A' ' 105' ' ' ARG . 19.1 t-20 64.58 24.72 13.08 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.121 1.368 . . . . 72.14 112.193 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.431 HG21 HD21 ' A' ' 53' ' ' LEU . 8.0 p -106.07 95.38 3.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-O 122.058 0.932 . . . . 71.41 110.451 176.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.526 ' HA ' ' HA3' ' A' ' 79' ' ' GLY . 4.9 m-20 -106.3 137.9 43.43 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 118.563 -0.732 . . . . 73.11 109.903 -169.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.566 ' CE1' ' HB2' ' A' ' 77' ' ' PRO 0.394 50.2 m-85 42.02 -60.52 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 121.247 3.795 . . . . 74.53 121.247 169.824 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.8 -20.46 62.03 Favored Glycine 0 N--CA 1.466 0.635 0 N-CA-C 115.073 0.789 . . . . 62.31 115.073 -173.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.9 m -95.69 134.7 38.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 117.477 0.638 . . . . 63.23 109.893 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 47.9 p -98.85 176.34 5.64 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 109.173 -0.677 . . . . 74.01 109.173 -177.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.484 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -60.2 -44.35 95.2 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 110.061 -0.348 . . . . 65.41 110.061 176.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -57.18 -46.29 82.95 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 116.547 -0.297 . . . . 75.53 110.621 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -56.44 -42.72 78.57 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.239 0.542 . . . . 62.12 111.446 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.431 HD21 HG21 ' A' ' 44' ' ' VAL . 62.4 mt -73.38 -49.3 27.93 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.267 -0.879 . . . . 64.52 111.696 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.18 -49.47 71.91 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.953 -0.567 . . . . 62.44 110.965 -176.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.31 -42.35 91.17 Favored 'General case' 0 C--O 1.267 2.001 0 CA-C-O 121.442 0.639 . . . . 44.31 111.752 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -66.42 -34.75 78.66 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.877 -0.602 . . . . 73.23 109.61 -176.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . 0.25 49.3 m-85 -82.31 -20.95 36.39 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 113.499 0.926 . . . . 70.12 113.499 175.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.0 m -61.05 -32.62 72.25 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.257 -0.646 . . . . 73.45 109.257 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 m -58.65 -30.74 67.56 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.945 -0.57 . . . . 52.52 110.618 174.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 61.0 m -97.71 -1.27 43.86 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 112.536 0.569 . . . . 73.43 112.536 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' A' ' 90' ' ' SER . . . 168.16 -174.18 43.01 Favored Glycine 0 C--O 1.223 -0.546 0 C-N-CA 118.379 -1.867 . . . . 74.05 116.0 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.4 p -70.55 -71.7 0.24 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.938 0.895 . . . . 62.2 112.428 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.3 73.7 mt 99.77 113.12 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 C-N-CA 126.71 2.004 . . . . 54.53 112.669 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.516 ' OD1' ' HB2' ' A' ' 86' ' ' ALA . 3.7 m-20 -106.81 -28.24 10.25 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-N 114.354 -1.293 . . . . 74.45 112.57 -177.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.478 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 75.3 mtt180 -151.61 155.45 38.44 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.788 -0.819 . . . . 61.54 108.788 174.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.498 HG22 HG23 ' A' ' 83' ' ' ILE . 20.5 pt -144.02 137.25 23.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 105.428 -2.064 . . . . 72.53 105.428 169.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 58.5 m -125.09 125.21 43.41 Favored 'General case' 0 C--N 1.262 -3.224 0 N-CA-C 107.708 -1.219 . . . . 73.4 107.708 -177.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mp -122.0 118.32 55.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 106.188 -1.782 . . . . 72.33 106.188 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.41 HD23 ' N ' ' A' ' 69' ' ' LEU 0.298 0.9 OUTLIER -121.53 133.19 55.02 Favored 'General case' 0 C--N 1.278 -2.525 0 C-N-CA 120.047 -0.661 . . . . 74.2 111.942 177.058 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 79.3 m -116.67 124.99 51.08 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.211 -1.033 . . . . 74.42 108.211 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.517 ' HB2' ' CD2' ' A' ' 73' ' ' PHE . 2.9 p-10 -112.12 138.43 48.8 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 119.047 -1.061 . . . . 64.2 112.131 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -117.13 7.48 13.04 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 114.763 -1.108 . . . . 72.32 110.239 173.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.517 ' CD2' ' HB2' ' A' ' 71' ' ' ASP . 37.3 p90 -69.58 -15.93 63.31 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.93 0.871 . . . . 75.05 109.637 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.2 m -86.92 6.98 29.31 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 114.727 -1.124 . . . . 73.34 109.515 175.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.34 -53.99 4.44 Favored Glycine 0 CA--C 1.503 -0.661 0 N-CA-C 110.596 -1.001 . . . . 64.23 110.596 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -96.24 138.15 21.59 Favored Pre-proline 0 C--N 1.298 -1.646 0 CA-C-N 114.27 -0.965 . . . . 71.13 108.774 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.566 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 46.9 Cg_endo -71.62 118.43 5.65 Favored 'Trans proline' 0 C--O 1.247 0.951 0 C-N-CA 122.203 1.936 . . . . 73.23 112.719 -177.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 29.1 mtmm -113.21 165.54 12.31 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 109.07 -0.715 . . . . 72.21 109.07 175.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 45' ' ' ASP . . . -138.2 146.0 17.66 Favored Glycine 0 N--CA 1.42 -2.403 0 C-N-CA 120.235 -0.983 . . . . 63.41 113.405 175.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -154.08 145.22 22.83 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.569 -0.816 . . . . 71.04 109.674 175.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 67' ' ' THR . . . -132.74 152.72 51.68 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.482 -0.326 . . . . 74.52 110.882 -172.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.408 ' CZ ' ' HD1' ' A' ' 40' ' ' TYR . 77.3 m-85 -123.9 131.56 53.6 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.556 -0.905 . . . . 75.43 108.556 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.498 HG23 HG22 ' A' ' 66' ' ' ILE . 23.4 mm -115.38 120.6 65.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 109.227 -0.657 . . . . 61.3 109.227 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 65' ' ' ARG . 1.9 mp0 -100.14 121.59 41.67 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.882 -0.414 . . . . 74.51 109.882 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -98.81 161.83 13.43 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.699 -0.228 . . . . 73.0 110.796 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.516 ' HB2' ' OD1' ' A' ' 64' ' ' ASN . . . -85.16 -29.89 24.4 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.802 -0.359 . . . . 70.44 111.231 175.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.467 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 5.6 mp0 -97.81 142.94 28.96 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.639 -0.504 . . . . 73.21 109.639 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.497 ' HG2' ' HG2' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -71.17 -30.79 66.88 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 105.882 -1.896 . . . . 61.21 105.882 176.08 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -67.57 -35.55 79.22 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.583 -1.189 . . . . 74.25 110.605 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.467 ' OG ' ' HB2' ' A' ' 87' ' ' GLU . 50.1 m -70.93 -36.81 72.79 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 120.696 0.284 . . . . 72.01 111.742 -177.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.604 ' CG2' HG13 ' A' ' 39' ' ' VAL . 14.5 p -65.99 -37.22 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 109.257 -0.645 . . . . 60.43 109.257 177.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -65.29 -31.58 72.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.518 -0.764 . . . . 63.1 110.035 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.5 -31.57 63.8 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.854 -0.612 . . . . 75.23 110.845 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.61 -43.94 53.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.039 -0.528 . . . . 65.52 110.451 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 20.5 m -58.25 -22.41 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 112.942 0.719 . . . . 54.33 112.942 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.46 -13.15 61.73 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.372 0.606 . . . . 71.0 110.415 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 47.7 ttp -103.4 9.46 37.8 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.007 -0.738 . . . . 73.21 109.007 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.592 ' HA ' ' HB ' ' A' ' 109' ' ' VAL . 5.5 p-10 -37.37 -57.09 0.93 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 115.016 1.487 . . . . 62.44 115.016 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -110.09 85.12 2.05 Favored 'General case' 0 N--CA 1.397 -3.117 0 CA-C-O 122.167 0.984 . . . . 74.41 109.419 -174.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.2 p -129.6 167.47 17.9 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 113.849 -1.523 . . . . 70.04 111.904 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.2 p -110.73 106.18 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.163 0 CA-C-O 121.855 0.836 . . . . 74.21 109.017 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -105.69 126.23 51.91 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.115 -0.948 . . . . 73.44 108.543 -176.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 41.4 ttt-85 52.29 32.91 11.68 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 124.731 1.212 . . . . 72.14 111.348 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.72 -4.88 76.34 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 115.107 -0.951 . . . . 60.4 114.288 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.464 ' HD3' ' O ' ' A' ' 43' ' ' ASN . 4.6 ptp180 -121.88 138.41 54.41 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 117.593 0.696 . . . . 64.43 111.218 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 45.6 m -76.12 122.13 23.84 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-O 120.803 0.335 . . . . 53.44 110.761 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 44.6 pt -101.78 171.87 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.909 -0.587 . . . . 73.52 111.119 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 15.0 mmmt -125.1 131.13 53.35 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-N 114.952 -1.022 . . . . 72.51 109.245 176.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.609 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 24.7 t -127.47 116.19 42.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 108.361 -0.978 . . . . 70.02 108.361 174.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.426 ' CD1' ' HD2' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -146.99 156.4 47.29 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 106.912 -1.514 . . . . 60.24 106.912 177.808 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -62.61 129.3 25.97 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 121.841 1.694 . . . . 63.1 113.373 -175.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.423 -1.808 0 N-CA-C 103.155 -2.905 . . . . 72.12 103.155 173.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.461 0 N-CA-C 110.828 -0.909 . . . . 55.32 110.828 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.584 ' HG3' ' CZ ' ' A' ' 40' ' ' TYR . 2.3 Cg_endo -43.64 -51.82 5.82 Favored 'Trans proline' 0 CA--C 1.556 1.588 0 C-N-CA 123.418 2.745 . . . . 75.54 113.268 176.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.432 ' HD3' ' HG2' ' B' ' 22' ' ' PRO . 11.2 Cg_exo -71.92 123.62 9.47 Favored 'Trans proline' 0 C--N 1.38 2.196 0 N-CA-C 108.132 -1.526 . . . . 75.44 108.132 171.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' GLN . . . . . 0.422 ' CD ' ' H ' ' B' ' 24' ' ' GLN . 0.5 OUTLIER -73.5 160.12 83.08 Favored Pre-proline 0 C--N 1.288 -2.093 0 CA-C-N 115.287 -0.87 . . . . 73.12 109.784 -177.598 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.94 101.27 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 122.381 2.054 . . . . 75.01 111.457 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.747 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -72.49 171.98 11.35 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 114.21 -1.359 . . . . 75.13 111.42 178.924 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.522 ' HB3' ' OE1' ' B' ' 30' ' ' GLU . 34.3 t -65.08 145.99 55.59 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.704 0.764 . . . . 60.23 112.276 -173.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.23 -40.87 25.89 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.85 -1.523 . . . . 53.03 111.673 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -75.93 -30.25 58.64 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 113.746 1.017 . . . . 73.4 113.746 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.522 ' OE1' ' HB3' ' B' ' 27' ' ' SER . 1.1 mp0 -60.73 -34.61 74.67 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 120.32 -0.552 . . . . 74.33 109.814 171.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -66.18 -50.71 62.95 Favored 'General case' 0 C--O 1.199 -1.553 0 CA-C-N 115.81 -0.632 . . . . 65.44 109.756 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.687 ' N ' ' HE2' ' B' ' 32' ' ' LYS . 0.4 OUTLIER -61.43 -29.71 70.11 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 119.839 -0.744 . . . . 75.35 112.123 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' B' ' 36' ' ' LYS . 9.4 tp10 -69.23 -44.72 71.43 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 108.558 -0.905 . . . . 71.33 108.558 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . 0.25 11.8 pt -71.95 -35.21 53.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 112.608 0.596 . . . . 71.52 112.608 177.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -58.41 -43.63 88.73 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.323 0.582 . . . . 73.15 110.616 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' B' ' 33' ' ' GLU . 15.0 ptpt -68.88 -18.34 64.12 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.457 0.54 . . . . 73.3 112.457 -173.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.63 ' HD2' ' O ' ' B' ' 85' ' ' PHE . 21.7 ptt180 -118.83 15.91 13.48 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.596 0.591 . . . . 71.02 112.596 -178.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 47.3 t -102.35 154.87 18.65 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.274 0.559 . . . . 44.3 111.738 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.618 HG13 ' CG2' ' B' ' 91' ' ' VAL . 0.3 OUTLIER -140.31 164.01 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 C-N-CA 124.287 1.035 . . . . 75.2 112.072 178.554 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 40' ' ' TYR . . . . . 0.619 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 30.7 t80 -115.71 127.39 55.1 Favored 'General case' 0 CA--C 1.48 -1.726 0 CA-C-N 114.557 -1.201 . . . . 74.4 107.76 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.36 109.65 29.31 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 N-CA-C 107.256 -1.387 . . . . 43.12 107.256 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -109.41 170.13 14.23 Favored Glycine 0 N--CA 1.435 -1.415 0 C-N-CA 120.257 -0.973 . . . . 51.55 112.602 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.2 t30 63.96 -0.66 0.77 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 126.213 1.805 . . . . 73.32 112.54 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.548 HG21 HD21 ' B' ' 53' ' ' LEU . 3.6 p -58.39 130.89 22.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 108.913 -0.773 . . . . 74.44 108.913 175.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -76.09 153.26 36.46 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 115.694 -0.685 . . . . 75.52 111.624 -173.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -50.55 -34.1 24.26 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 126.172 1.789 . . . . 75.44 111.214 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.7 3.99 78.73 Favored Glycine 0 CA--C 1.501 -0.842 0 C-N-CA 119.897 -1.144 . . . . 72.02 113.72 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 36.8 t -73.06 118.84 16.5 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 105.137 -2.172 . . . . 63.01 105.137 172.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.49 166.92 12.29 Favored 'General case' 0 N--CA 1.405 -2.701 0 N-CA-C 109.201 -0.666 . . . . 61.53 109.201 -169.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.448 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -56.08 -45.5 79.35 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 117.911 0.323 . . . . 72.3 111.439 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' GLN . . . . . 0.4 ' H ' ' CD ' ' B' ' 51' ' ' GLN . 22.1 mp0 -57.18 -44.84 83.94 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.525 0.516 . . . . 53.42 111.042 178.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -57.17 -45.1 83.95 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 121.167 0.508 . . . . 71.24 111.348 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.548 HD21 HG21 ' B' ' 44' ' ' VAL . 80.5 mt -72.2 -49.2 37.32 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.399 -0.818 . . . . 70.03 111.585 -177.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -63.2 -49.4 74.39 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 116.105 -0.498 . . . . 63.33 111.151 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.46 97.77 Favored 'General case' 0 C--O 1.267 2.014 0 CA-C-O 121.522 0.677 . . . . 70.54 111.812 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -66.39 -34.43 77.95 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.821 -0.627 . . . . 75.42 109.697 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -82.48 -21.36 35.59 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 113.678 0.992 . . . . 71.12 113.678 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 71.8 m -61.88 -30.69 71.04 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 116.379 -0.373 . . . . 62.44 110.295 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 17.4 m -58.69 -31.14 67.94 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 115.895 -0.593 . . . . 74.43 110.265 175.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 63.0 m -91.44 6.47 45.35 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 113.474 0.916 . . . . 35.45 113.474 -177.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.23 -159.93 26.25 Favored Glycine 0 N--CA 1.469 0.856 0 C-N-CA 118.914 -1.613 . . . . 70.32 115.108 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 12.9 m -101.48 123.26 45.24 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.021 0.439 . . . . 75.5 110.406 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 57.6 mt -92.04 134.91 28.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 123.583 0.753 . . . . 53.51 112.073 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -103.98 -33.15 8.92 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.711 0.805 . . . . 64.24 112.021 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.452 ' HB2' ' HB2' ' B' ' 84' ' ' GLU . 82.8 mtt180 -151.86 156.87 41.02 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.218 -0.66 . . . . 64.24 109.218 178.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.514 HG22 HG23 ' B' ' 83' ' ' ILE . 17.7 pt -143.61 138.15 25.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 105.824 -1.917 . . . . 64.41 105.824 168.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 53.8 m -125.29 125.73 44.0 Favored 'General case' 0 C--N 1.269 -2.926 0 N-CA-C 107.668 -1.234 . . . . 70.22 107.668 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.8 mp -122.78 117.54 52.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 106.337 -1.727 . . . . 73.31 106.337 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.402 HD23 ' N ' ' B' ' 69' ' ' LEU 0.288 0.9 OUTLIER -121.03 132.52 54.95 Favored 'General case' 0 C--N 1.283 -2.288 0 C-N-CA 120.028 -0.669 . . . . 62.14 111.8 177.774 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' B' B ' 70' ' ' CYS . . . . . 0.493 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 70.6 m -116.98 123.01 45.88 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 108.73 -0.841 . . . . 72.14 108.73 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.606 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 2.8 p30 -110.2 132.09 54.48 Favored 'General case' 0 C--O 1.208 -1.11 0 C-N-CA 119.913 -0.715 . . . . 73.24 110.115 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -118.9 10.8 12.38 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.937 -1.134 . . . . 72.0 107.937 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.494 ' CD2' ' HB2' ' B' ' 71' ' ' ASP . 4.1 p90 -56.86 -17.41 9.3 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 115.902 1.816 . . . . 64.12 115.902 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 30.6 m -110.32 9.73 23.58 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 118.242 0.473 . . . . 72.21 111.61 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.39 -55.63 0.52 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.257 -0.973 . . . . 75.32 112.368 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -96.16 129.72 33.03 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 109.956 -0.387 . . . . 72.44 109.956 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.606 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 92.0 Cg_endo -77.04 119.61 5.12 Favored 'Trans proline' 0 N--CA 1.441 -1.617 0 C-N-CA 121.8 1.667 . . . . 74.33 111.932 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 30.1 mtmm -102.32 164.45 11.67 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 108.199 -1.037 . . . . 65.42 108.199 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -134.28 141.16 12.43 Favored Glycine 0 N--CA 1.423 -2.226 0 C-N-CA 119.658 -1.258 . . . . 73.44 113.027 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 80' ' ' TYR . . . . . 0.452 ' HA ' ' CG1' ' B' ' 44' ' ' VAL . 19.5 p90 -150.71 143.34 24.47 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.183 -0.509 . . . . 75.03 110.117 173.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.45 152.33 51.55 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.419 -0.355 . . . . 74.3 110.872 -172.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 82' ' ' TYR . . . . . 0.574 ' CD2' ' HG3' ' B' ' 112' ' ' LYS . 88.1 m-85 -124.15 130.05 51.88 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 108.944 -0.762 . . . . 71.11 108.944 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.514 HG23 HG22 ' B' ' 66' ' ' ILE . 23.5 mm -113.27 121.6 65.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 109.004 -0.739 . . . . 73.2 109.004 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 84' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' B' ' 65' ' ' ARG . 1.2 mp0 -100.14 119.68 38.71 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.463 -0.569 . . . . 44.35 109.463 176.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.63 ' O ' ' HD2' ' B' ' 37' ' ' ARG . 96.5 m-85 -94.48 162.32 13.86 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 110.274 -0.269 . . . . 73.31 110.274 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.41 -34.58 31.5 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.305 -0.407 . . . . 42.23 110.608 174.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 87' ' ' GLU . . . . . 0.409 ' HB2' ' OG ' ' B' ' 90' ' ' SER . 9.7 mp0 -99.96 147.95 25.02 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.199 -0.6 . . . . 73.12 111.472 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.522 ' O ' HG12 ' B' ' 91' ' ' VAL . 0.0 OUTLIER -74.16 -31.64 62.79 Favored 'General case' 0 C--O 1.212 -0.891 0 N-CA-C 106.215 -1.772 . . . . 73.52 106.215 177.438 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -71.69 -29.18 64.3 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 120.479 -0.488 . . . . 74.35 111.885 177.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 90' ' ' SER . . . . . 0.409 ' OG ' ' HB2' ' B' ' 87' ' ' GLU . 49.4 m -71.49 -36.98 71.31 Favored 'General case' 0 N--CA 1.439 -0.99 0 O-C-N 122.224 -0.297 . . . . 73.53 111.349 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.618 ' CG2' HG13 ' B' ' 39' ' ' VAL . 14.5 p -65.87 -37.69 80.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 108.64 -0.874 . . . . 73.34 108.64 177.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -63.77 -33.56 75.94 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.394 -0.821 . . . . 60.34 109.816 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.12 -31.3 64.21 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.829 -0.623 . . . . 75.14 110.539 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.67 -44.71 48.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.979 -0.555 . . . . 74.54 110.396 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 21.1 m -58.61 -22.46 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 112.41 0.522 . . . . 74.04 112.41 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.76 -18.49 63.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.897 0.855 . . . . 64.13 111.034 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 43.8 ttp -98.87 11.94 37.26 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 114.34 -1.3 . . . . 73.35 109.213 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 98' ' ' ASP . . . . . 0.56 ' HA ' ' HB ' ' B' ' 109' ' ' VAL . 9.8 t70 -35.11 -61.23 0.44 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 117.037 2.236 . . . . 63.12 117.037 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 99' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' B' ' 107' ' ' ILE . 35.7 tt0 -115.74 34.98 4.65 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 119.542 1.065 . . . . 73.11 110.631 -174.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 76.4 p -77.72 -175.22 3.8 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.735 -0.666 . . . . 74.13 111.106 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -103.0 135.42 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 N-CA-C 109.334 -0.617 . . . . 71.23 109.334 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -142.23 128.19 19.53 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.596 -0.89 . . . . 74.45 108.596 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 57.2 ttt-85 56.3 32.99 21.46 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.277 1.031 . . . . 72.31 110.377 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.57 5.5 89.87 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.127 -0.942 . . . . 74.25 114.462 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -129.27 166.11 20.07 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 117.867 0.834 . . . . 61.42 109.976 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 32.4 m -90.99 122.74 33.91 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.785 -0.45 . . . . 63.32 109.785 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' B' ' 99' ' ' GLU . 39.7 pt -101.21 173.38 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 120.739 0.304 . . . . 74.03 111.763 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -130.86 120.76 24.14 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.241 -1.022 . . . . 70.33 108.241 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' VAL . . . . . 0.619 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 42.3 t -127.0 116.04 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 123.361 0.413 . . . . 73.42 109.922 -177.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.472 HD13 ' HB3' ' B' ' 40' ' ' TYR . 0.0 OUTLIER -146.45 155.88 49.48 Favored Pre-proline 0 C--N 1.314 -0.963 0 N-CA-C 107.263 -1.384 . . . . 72.12 107.263 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.73 134.38 46.85 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.67 2.247 . . . . 72.35 113.151 -175.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.574 ' HG3' ' CD2' ' B' ' 82' ' ' TYR . 3.2 tmmm? . . . . . 0 C--N 1.29 -1.984 0 N-CA-C 106.831 -1.544 . . . . 74.14 106.831 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 . . . . . 0 C--O 1.214 -0.764 0 N-CA-C 111.389 0.144 . . . . 75.33 111.389 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.9 pt -66.64 -34.22 68.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.08 0.467 . . . . 75.04 110.742 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.24 -40.01 89.91 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.65 1.18 . . . . 55.51 110.985 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -64.2 -21.0 66.41 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.596 0.712 . . . . 73.44 110.492 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.522 ' HD3' ' O ' ' A' ' 86' ' ' ALA . 90.9 mtt180 -109.64 16.48 22.12 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.35 -0.841 . . . . 71.41 109.657 -174.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 46.9 m -101.05 158.4 16.04 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 121.471 0.653 . . . . 40.12 111.762 178.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.5 m -134.58 163.56 36.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.583 -0.735 . . . . 73.2 109.684 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.691 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 23.3 t80 -109.49 128.13 54.94 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.545 -1.28 . . . . 73.32 107.545 174.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.9 t -120.94 109.28 24.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 107.843 -1.169 . . . . 72.24 107.843 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.65 170.99 15.87 Favored Glycine 0 C--N 1.293 -1.842 0 C-N-CA 119.785 -1.198 . . . . 40.35 113.783 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t30 67.55 17.31 9.98 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 125.297 1.439 . . . . 63.24 112.163 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.439 ' O ' ' HA3' ' A' ' 79' ' ' GLY . 14.5 p -72.16 141.58 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 109.257 -0.646 . . . . 71.12 109.257 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -107.24 165.27 11.5 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 112.077 0.399 . . . . 53.34 112.077 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.408 ' CE1' ' HB3' ' A' ' 70' ' ' CYS . 21.7 m-85 -59.31 -26.51 65.06 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.316 0.646 . . . . 74.51 111.948 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.94 -16.57 80.58 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.36 -0.696 . . . . 53.45 111.36 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 24.7 m -95.8 125.96 40.73 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 107.342 -1.355 . . . . 72.34 107.342 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.48 HG21 ' HB ' ' B' ' 49' ' ' THR 0.253 3.6 p -126.31 179.31 5.34 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 114.527 1.306 . . . . 75.35 114.527 -172.023 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.463 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -56.86 -52.65 64.28 Favored 'General case' 0 C--O 1.213 -0.818 0 N-CA-C 114.459 1.281 . . . . 54.34 114.459 -168.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.25 28.1 pt20 -64.37 -32.14 73.63 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 119.103 -1.039 . . . . 72.12 112.941 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -59.9 -44.93 93.97 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.101 -0.703 . . . . 51.14 109.101 176.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 69.8 mt -73.04 -48.54 35.17 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.562 -1.199 . . . . 71.5 111.214 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.34 -49.62 74.86 Favored 'General case' 0 C--O 1.198 -1.625 0 CA-C-N 116.197 -0.456 . . . . 73.11 111.429 -177.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.6 -41.73 86.48 Favored 'General case' 0 C--O 1.257 1.482 0 CA-C-O 121.434 0.635 . . . . 64.13 111.98 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -68.02 -39.2 83.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.995 -1.002 . . . . 73.14 110.023 -176.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -82.23 -21.52 36.29 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.213 0.82 . . . . 65.15 113.213 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.3 t -68.83 -24.29 64.36 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.988 -0.745 . . . . 72.43 108.988 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.2 m -60.28 -33.92 73.02 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.521 0.677 . . . . 71.44 109.526 172.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 63.4 m -90.33 5.05 48.91 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.515 -0.766 . . . . 73.33 112.373 -177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.83 -168.62 29.96 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 118.688 -1.72 . . . . 73.34 115.08 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.436 ' HB2' ' HB3' ' A' ' 86' ' ' ALA . 9.9 m -97.96 122.73 41.43 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.315 -0.624 . . . . 74.01 109.315 -176.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.5 mt -91.46 131.23 39.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 113.018 0.747 . . . . 74.31 113.018 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -100.05 -40.95 7.37 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.162 -0.926 . . . . 71.12 110.905 176.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.431 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 88.6 mtt180 -149.91 158.91 44.64 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 108.837 -0.801 . . . . 75.12 108.837 -177.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.463 HD11 ' HB1' ' A' ' 50' ' ' ALA . 27.3 pt -144.95 140.82 23.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 106.941 -1.503 . . . . 61.33 106.941 169.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.0 m -125.25 125.35 43.44 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 106.498 -1.667 . . . . 74.33 106.498 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.458 HD12 ' O ' ' B' ' 68' ' ' ILE . 3.4 mp -122.12 118.57 55.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.812 -1.551 . . . . 72.32 106.812 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.263 1.2 pt? -120.09 122.81 41.9 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 120.206 -0.597 . . . . 63.35 111.111 178.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.445 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 64.2 m -116.85 132.63 56.65 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.271 -1.011 . . . . 74.14 108.271 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 3.6 p-10 -118.74 138.18 52.84 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 119.559 -0.856 . . . . 62.04 112.005 -176.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -117.59 13.25 14.28 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.297 -0.865 . . . . 63.1 109.631 173.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.46 ' CD2' ' HB2' ' A' ' 71' ' ' ASP . 13.9 p90 -65.8 -23.53 66.72 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.428 0.632 . . . . 64.13 110.395 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.1 t -83.49 0.55 45.91 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.781 -0.645 . . . . 65.4 110.151 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.92 -58.72 1.05 Allowed Glycine 0 N--CA 1.438 -1.213 0 N-CA-C 110.533 -1.027 . . . . 44.32 110.533 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -95.13 130.35 32.81 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 108.703 -0.851 . . . . 71.04 108.703 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 24.3 Cg_endo -62.32 119.28 6.31 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 123.028 2.486 . . . . 72.13 114.183 -175.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -104.43 -168.92 1.55 Allowed 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.582 -1.266 . . . . 75.35 107.582 171.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 70' ' ' CYS . . . -172.33 141.79 6.47 Favored Glycine 0 N--CA 1.407 -3.299 0 C-N-CA 119.792 -1.194 . . . . 71.23 112.726 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -151.57 145.47 25.15 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 123.813 0.845 . . . . 63.14 109.033 175.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.91 159.46 42.14 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-O 120.925 0.393 . . . . 50.1 111.178 -172.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -123.06 123.34 40.62 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.988 -0.745 . . . . 61.33 108.988 175.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.431 HG23 HG22 ' A' ' 66' ' ' ILE . 33.4 mm -103.06 119.93 52.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 106.624 -1.621 . . . . 73.03 106.624 177.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 38' ' ' SER . 35.0 mt-10 -107.12 119.31 39.03 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.068 0.461 . . . . 53.11 110.049 -176.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -100.58 167.48 10.33 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.389 0.614 . . . . 72.04 112.468 -174.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.522 ' O ' ' HD3' ' A' ' 37' ' ' ARG . . . -83.85 -33.26 24.89 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.184 -0.916 . . . . 72.4 111.665 174.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.421 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 4.5 mp0 -104.55 143.66 32.74 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 110.119 -0.326 . . . . 62.32 110.119 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.479 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -73.04 -29.66 63.15 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 106.005 -1.85 . . . . 75.42 106.005 177.174 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' A' ' 92' ' ' ASP . 13.9 m120 -60.48 -28.07 68.06 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.989 -1.459 . . . . 71.15 110.425 177.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 87' ' ' GLU . 26.8 m -67.35 -36.38 81.28 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 116.553 -0.294 . . . . 62.03 110.922 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 88' ' ' ARG . 3.2 m -64.06 -39.05 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 N-CA-C 108.429 -0.952 . . . . 74.14 108.429 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 89' ' ' ASN . 21.2 t70 -55.89 -39.6 71.8 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.929 0.768 . . . . 75.34 110.585 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.23 -37.43 63.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.891 -0.595 . . . . 62.33 111.452 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.56 -45.24 62.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.945 0.402 . . . . 54.24 111.357 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.485 HG11 ' HD3' ' A' ' 111' ' ' PRO . 28.6 m -56.97 -22.15 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 113.16 0.8 . . . . 73.4 113.16 178.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.69 -17.73 64.81 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.277 0.561 . . . . 72.43 110.806 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.51 ' O ' HG22 ' A' ' 100' ' ' THR . 66.2 mtm -99.58 8.11 44.71 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.754 -0.657 . . . . 73.03 110.676 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -41.75 -42.33 2.57 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 115.476 1.658 . . . . 61.31 115.476 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 41.9 tt0 -107.36 16.33 24.05 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 118.737 0.699 . . . . 64.34 112.439 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 97' ' ' MET . 7.3 t -81.79 175.38 10.49 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 118.809 -1.156 . . . . 73.44 109.865 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.3 m -108.8 118.91 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 CA-C-O 121.652 0.739 . . . . 64.34 110.884 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.479 ' HB2' HD13 ' A' ' 107' ' ' ILE . 61.0 t80 -92.06 117.79 30.18 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 107.494 -1.298 . . . . 74.34 107.494 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 50.03 32.85 6.12 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.801 1.241 . . . . 73.21 112.135 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 99.5 -4.97 58.45 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 114.855 0.702 . . . . 61.23 114.855 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -118.67 137.02 53.6 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 118.209 1.004 . . . . 72.51 110.68 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.6 m -70.26 119.09 13.93 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.131 0.491 . . . . 64.22 110.38 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 102' ' ' PHE . 45.7 pt -103.51 172.65 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 CA-C-N 116.054 -0.521 . . . . 70.43 110.223 177.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.427 ' HD2' ' HA ' ' A' ' 108' ' ' LYS . 19.8 mmmt -123.94 129.41 50.91 Favored 'General case' 0 CA--C 1.472 -2.03 0 CA-C-N 115.739 -0.664 . . . . 75.42 109.621 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.691 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 22.7 t -127.77 122.81 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 108.651 -0.87 . . . . 75.1 108.651 176.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.52 HD13 ' HB3' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -146.73 155.35 48.48 Favored Pre-proline 0 C--N 1.292 -1.913 0 N-CA-C 107.464 -1.31 . . . . 74.12 107.464 175.808 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.485 ' HD3' HG11 ' A' ' 95' ' ' VAL . 49.7 Cg_endo -66.29 140.92 60.42 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.134 1.223 . . . . 62.13 110.061 -175.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt . . . . . 0 C--N 1.326 -0.417 0 CA-C-O 121.249 0.547 . . . . 75.01 111.038 -175.768 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.762 0 N-CA-C 111.045 -0.822 . . . . 73.44 111.045 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -51.13 -45.04 39.09 Favored 'Trans proline' 0 CA--C 1.566 2.105 0 C-N-CA 123.542 2.828 . . . . 74.55 114.884 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -54.51 150.53 34.29 Favored 'Trans proline' 0 C--N 1.394 2.952 0 C-N-CA 121.839 1.692 . . . . 73.41 111.937 176.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -73.16 139.25 79.06 Favored Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 116.368 -0.378 . . . . 70.24 110.806 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -69.79 140.95 43.81 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.744 2.296 . . . . 74.2 113.517 -176.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.585 HD23 ' HB3' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -90.13 177.86 6.33 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.911 -1.041 . . . . 71.32 111.033 173.797 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 46.2 t -59.7 144.67 47.42 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 112.712 0.634 . . . . 51.34 112.712 -175.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.03 -37.74 54.56 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.994 -1.003 . . . . 64.23 111.024 171.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -76.43 -28.49 56.63 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 113.116 0.784 . . . . 70.14 113.116 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.585 ' HB3' HD23 ' B' ' 26' ' ' LEU . 3.7 tp10 -64.5 -39.3 93.53 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 106.276 -1.75 . . . . 73.51 106.276 175.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -64.87 -44.32 90.08 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 114.424 -1.262 . . . . 73.44 108.697 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.61 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 0.1 OUTLIER -57.2 -47.57 80.95 Favored 'General case' 0 N--CA 1.413 -2.309 0 C-N-CA 123.597 0.759 . . . . 71.33 111.745 179.095 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.409 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 80.4 mm-40 -68.42 -44.57 74.7 Favored 'General case' 0 CA--C 1.505 -0.751 0 O-C-N 123.068 0.23 . . . . 72.12 111.363 -177.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.502 HG12 ' O ' ' B' ' 30' ' ' GLU . 11.3 pt -66.35 -34.93 73.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 O-C-N 123.376 0.422 . . . . 72.12 110.428 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -65.6 -42.07 92.04 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.49 0.716 . . . . 75.4 109.91 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.61 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 99.1 mttt -61.07 -24.19 66.03 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.613 -0.721 . . . . 70.51 110.777 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.55 ' HD3' ' O ' ' B' ' 86' ' ' ALA . 67.6 mtt180 -106.89 17.05 23.62 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.561 -0.745 . . . . 71.33 110.12 -174.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.433 ' HB2' ' HB3' ' B' ' 112' ' ' LYS . 26.2 m -106.43 169.08 8.73 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.176 0.512 . . . . 55.13 111.976 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 28.1 m -139.91 164.74 22.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 124.129 0.972 . . . . 74.23 110.211 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' TYR . . . . . 0.69 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 28.6 t80 -109.73 129.03 55.65 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.669 -1.234 . . . . 75.04 107.669 174.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 97.5 t -122.18 111.93 32.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 108.451 -0.944 . . . . 73.11 108.451 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.93 171.22 16.66 Favored Glycine 0 C--N 1.289 -2.044 0 C-N-CA 120.022 -1.085 . . . . 64.12 113.558 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 61.4 t30 65.95 23.67 11.22 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.144 1.778 . . . . 73.25 112.754 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 14.1 p -65.83 130.95 31.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.838 -0.801 . . . . 72.43 108.838 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -99.95 161.37 13.65 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.39 -0.823 . . . . 63.35 111.393 -175.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' TYR . . . . . 0.764 ' CE1' ' HB2' ' B' ' 77' ' ' PRO . 17.7 m-85 -71.47 92.06 1.08 Allowed 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.489 -0.778 . . . . 71.01 109.793 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 164.75 -23.2 0.16 Allowed Glycine 0 N--CA 1.419 -2.446 0 CA-C-N 114.353 -1.294 . . . . 60.04 110.03 -177.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 40.3 m -79.47 128.54 33.48 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 109.097 -0.705 . . . . 70.12 109.097 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' THR . . . . . 0.48 ' HB ' HG21 ' A' ' 49' ' ' THR . 82.7 p -92.45 170.2 9.95 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 108.575 -0.898 . . . . 71.41 108.575 177.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.59 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -61.27 -44.07 97.83 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 110.274 -0.269 . . . . 74.21 110.274 175.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -62.36 -36.35 81.97 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.444 0.535 . . . . 65.23 112.444 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -56.64 -45.72 81.43 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.622 0.725 . . . . 71.04 109.727 176.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 57.0 mt -69.97 -48.24 59.05 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.664 -1.153 . . . . 54.54 111.642 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -62.1 -49.41 76.03 Favored 'General case' 0 C--O 1.199 -1.603 0 C-N-CA 122.831 0.452 . . . . 61.13 111.503 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.43 96.34 Favored 'General case' 0 C--O 1.252 1.23 0 CA-C-O 120.936 0.398 . . . . 43.54 110.651 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -66.37 -39.59 89.21 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.145 -0.48 . . . . 62.3 110.172 -176.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -82.18 -21.6 36.43 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 113.556 0.947 . . . . 71.32 113.556 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 23.2 t -70.09 -23.56 63.08 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.452 -0.944 . . . . 74.0 108.452 -178.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.3 m -58.66 -31.18 67.93 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-O 121.234 0.54 . . . . 54.53 109.773 172.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 69.5 m -95.3 10.72 35.15 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.809 -0.632 . . . . 73.34 112.567 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 143.42 -172.4 24.81 Favored Glycine 0 N--CA 1.462 0.388 0 C-N-CA 119.67 -1.252 . . . . 12.15 113.992 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 36.0 t -97.03 127.26 42.83 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 109.787 -0.449 . . . . 71.24 109.787 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 71.1 mt -90.62 133.62 31.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 115.789 -0.642 . . . . 73.24 112.661 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' ASN . . . . . 0.487 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 95.8 m-20 -101.39 -35.46 9.2 Favored 'General case' 0 C--O 1.206 -1.203 0 CA-C-N 115.488 -0.778 . . . . 71.23 111.68 176.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.437 ' HB2' ' HB2' ' B' ' 84' ' ' GLU . 94.0 mtt180 -153.19 159.72 42.72 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.885 -0.783 . . . . 75.23 108.885 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.59 HD11 ' HB1' ' B' ' 50' ' ' ALA . 24.6 pt -145.37 139.39 21.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.112 -1.44 . . . . 72.31 107.112 170.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 67' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 90.7 m -125.43 123.71 39.87 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 107.638 -1.245 . . . . 74.24 107.638 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 68' ' ' ILE . . . . . 0.458 ' O ' HD12 ' A' ' 68' ' ' ILE . 2.3 mp -119.63 121.23 65.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 106.078 -1.823 . . . . 73.32 106.078 -177.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 66' ' ' ILE 0.298 1.2 pt? -121.06 122.85 40.97 Favored 'General case' 0 C--N 1.28 -2.434 0 C-N-CA 120.21 -0.596 . . . . 70.44 111.881 176.508 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 70' ' ' CYS . . . . . 0.437 ' HA ' ' HA2' ' B' ' 79' ' ' GLY . 64.6 m -116.74 130.99 57.06 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.939 -1.134 . . . . 73.11 107.939 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.537 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 3.5 p-10 -121.15 144.16 48.72 Favored 'General case' 0 C--O 1.201 -1.475 0 C-N-CA 119.756 -0.778 . . . . 61.31 110.627 -176.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -121.69 5.16 10.03 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.199 -0.667 . . . . 64.02 109.199 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.441 ' CD2' ' HB2' ' B' ' 71' ' ' ASP . 34.5 p90 -67.31 -26.52 66.56 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-O 121.132 0.492 . . . . 63.33 109.836 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 41.0 m -66.15 -18.8 65.58 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.555 -0.748 . . . . 75.24 111.758 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.34 -51.76 0.76 Allowed Glycine 0 CA--C 1.482 -2.028 0 N-CA-C 108.308 -1.917 . . . . 74.14 108.308 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 53.9 m170 -97.14 148.92 35.11 Favored Pre-proline 0 CA--C 1.479 -1.77 0 N-CA-C 105.851 -1.907 . . . . 73.35 105.851 173.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.764 ' HB2' ' CE1' ' B' ' 46' ' ' TYR . 74.5 Cg_endo -80.49 116.51 3.27 Favored 'Trans proline' 0 N--CA 1.417 -3.016 0 N-CA-C 108.955 -1.209 . . . . 75.43 108.955 173.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 78' ' ' LYS . . . . . 0.44 ' HZ3' ' CG ' ' B' ' 71' ' ' ASP . 23.9 mtmm -104.83 -168.52 1.49 Allowed 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 108.643 -0.873 . . . . 62.14 108.643 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 79' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' B' ' 70' ' ' CYS . . . -168.38 139.77 5.85 Favored Glycine 0 N--CA 1.403 -3.559 0 C-N-CA 119.7 -1.238 . . . . 54.12 113.17 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -150.12 144.67 25.86 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 114.662 -0.769 . . . . 61.13 109.344 174.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.44 159.91 41.07 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-O 120.716 0.293 . . . . 64.25 110.763 -172.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 82' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -123.0 125.55 45.45 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.427 -0.953 . . . . 74.15 108.427 174.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.433 HG23 HG22 ' B' ' 66' ' ' ILE . 44.6 mm -103.87 120.46 54.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 106.752 -1.573 . . . . 72.5 106.752 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 84' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' B' ' 65' ' ' ARG . 34.3 mt-10 -107.4 118.73 37.5 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.079 0.466 . . . . 73.54 110.025 -175.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -99.93 166.73 10.92 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.998 0.74 . . . . 63.32 112.998 -173.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.55 ' O ' ' HD3' ' B' ' 37' ' ' ARG . . . -77.57 -36.84 51.64 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.641 -1.163 . . . . 52.33 111.378 174.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -109.08 146.82 33.37 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.15 0.5 . . . . 61.14 112.029 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.486 ' O ' HG22 ' B' ' 91' ' ' VAL . 0.6 OUTLIER -73.93 -29.77 62.21 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 106.407 -1.701 . . . . 72.53 106.407 178.759 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -64.15 -24.08 67.55 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 114.773 -1.103 . . . . 71.14 110.667 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 19.8 m -68.33 -36.28 79.04 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 116.394 -0.366 . . . . 62.34 110.314 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.486 HG22 ' O ' ' B' ' 88' ' ' ARG . 3.1 m -64.49 -38.99 84.03 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.071 0 N-CA-C 108.373 -0.973 . . . . 74.35 108.373 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.3 -38.56 74.19 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 123.769 0.668 . . . . 33.34 110.601 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.27 -35.4 63.76 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.054 -0.521 . . . . 74.33 111.3 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.77 -45.24 59.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.911 0.386 . . . . 54.15 111.056 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 95' ' ' VAL . . . . . 0.43 HG13 ' O ' ' B' ' 91' ' ' VAL . 26.0 m -57.79 -21.58 16.74 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 N-CA-C 112.935 0.717 . . . . 70.33 112.935 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.25 -15.4 63.16 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 121.581 0.705 . . . . 71.11 110.62 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 67.3 mtm -103.35 12.27 35.61 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.536 -0.756 . . . . 74.24 109.662 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 98' ' ' ASP . . . . . 0.614 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 2.1 p-10 -36.21 -43.45 0.35 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.249 1.574 . . . . 65.04 115.249 -176.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -130.09 61.76 1.58 Allowed 'General case' 0 N--CA 1.421 -1.918 0 C-N-CA 118.665 -1.214 . . . . 73.43 111.129 174.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 15.0 t -89.84 173.84 8.03 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 113.914 -1.493 . . . . 74.4 109.995 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.35 128.77 63.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.261 0.553 . . . . 45.42 109.841 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -140.68 126.11 18.84 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.647 -1.242 . . . . 74.52 107.647 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . 0.366 12.6 ptm85 50.37 55.03 10.11 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.114 1.524 . . . . 73.34 115.114 -176.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.72 -4.4 9.73 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 114.616 -1.175 . . . . 74.43 115.484 177.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -127.76 161.89 27.91 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 117.897 0.849 . . . . 72.55 110.666 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 37.1 m -95.64 128.37 42.45 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 109.53 -0.544 . . . . 62.12 109.53 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 35.8 pt -102.49 171.69 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 120.922 -0.311 . . . . 54.12 111.075 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 108' ' ' LYS . . . . . 0.614 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 41.7 tptt -131.04 126.8 36.83 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 109.394 -0.595 . . . . 73.33 109.394 -176.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 109' ' ' VAL . . . . . 0.69 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 18.1 t -126.88 131.58 70.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.112 -0.699 . . . . 72.14 109.112 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.659 ' HB3' ' HD2' ' B' ' 111' ' ' PRO 0.266 0.2 OUTLIER -136.26 168.42 17.26 Favored Pre-proline 0 CA--C 1.502 -0.894 0 N-CA-C 105.493 -2.04 . . . . 71.13 105.493 172.387 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.659 ' HD2' ' HB3' ' B' ' 110' ' ' LEU . 95.3 Cg_endo -76.55 148.75 29.82 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.363 1.375 . . . . 62.31 109.887 171.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' B' ' 38' ' ' SER . 72.3 tttt . . . . . 0 C--N 1.292 -1.92 0 N-CA-C 106.217 -1.771 . . . . 63.53 106.217 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.48 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 11.3 mm-40 . . . . . 0 C--O 1.209 -1.053 0 N-CA-C 112.3 0.482 . . . . 72.35 112.3 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.9 pt -65.37 -35.59 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 112.934 0.716 . . . . 72.2 112.934 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -71.15 -29.5 65.29 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 119.878 -0.729 . . . . 71.1 110.778 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -73.69 -15.91 61.21 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.525 0.73 . . . . 74.54 110.067 176.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 98.3 mtt180 -104.9 12.02 32.95 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.303 -0.862 . . . . 71.23 109.019 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.453 ' HB3' ' HE2' ' A' ' 112' ' ' LYS . 33.0 t -107.21 156.65 18.61 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 121.58 0.705 . . . . 74.05 110.853 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.514 ' CG1' ' HB ' ' A' ' 91' ' ' VAL . 34.3 m -136.23 164.58 31.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.359 -0.837 . . . . 70.53 109.66 -177.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.585 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 22.4 t80 -110.18 127.0 54.69 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 107.847 -1.168 . . . . 72.54 107.847 176.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 58.0 t -121.31 112.73 36.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 107.518 -1.29 . . . . 75.42 107.518 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -117.81 172.71 14.48 Favored Glycine 0 C--N 1.294 -1.789 0 C-N-CA 118.978 -1.582 . . . . 73.4 114.036 -176.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.7 t30 60.41 20.86 10.49 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 125.749 1.62 . . . . 71.55 112.198 -176.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.87 139.92 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 121.093 0.473 . . . . 62.53 110.039 176.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -82.83 156.03 23.85 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.672 -0.862 . . . . 74.11 108.672 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -68.63 -18.62 64.33 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.741 0.781 . . . . 72.14 109.235 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.4 -15.7 81.18 Favored Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 115.055 -0.975 . . . . 74.1 112.296 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.4 m -87.1 127.34 35.13 Favored 'General case' 0 N--CA 1.411 -2.388 0 N-CA-C 108.011 -1.107 . . . . 34.14 108.011 176.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.3 p -105.49 178.67 4.49 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.613 -0.514 . . . . 74.15 109.613 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.585 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -60.7 -46.07 91.79 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.753 -0.462 . . . . 45.23 109.753 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -58.41 -36.25 73.29 Favored 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 115.596 -0.729 . . . . 73.14 111.305 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -67.45 -40.61 85.43 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.206 0.526 . . . . 62.14 110.463 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.6 mt -66.49 -47.94 71.43 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 115.165 -0.925 . . . . 60.24 111.744 -177.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -60.62 -46.39 90.46 Favored 'General case' 0 C--O 1.181 -2.528 0 N-CA-C 113.645 0.98 . . . . 55.31 113.645 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.38 -47.83 75.23 Favored 'General case' 0 C--O 1.271 2.189 0 CA-C-O 121.662 0.744 . . . . 52.25 111.455 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -63.86 -43.01 97.38 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.851 -1.068 . . . . 74.01 110.568 -178.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -82.13 -22.21 36.27 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 114.843 1.423 . . . . 63.01 114.843 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.4 t -67.07 -26.97 67.0 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.284 -0.636 . . . . 53.42 109.284 -177.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.2 m -59.1 -24.94 63.38 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 120.534 -0.466 . . . . 71.4 111.004 173.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 76.7 m -95.72 7.2 46.96 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.876 1.065 . . . . 63.44 113.876 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.38 -147.25 18.4 Favored Glycine 0 C--O 1.238 0.35 0 C-N-CA 118.51 -1.805 . . . . 60.0 115.067 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 52.8 p -112.95 122.97 49.23 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.021 0.438 . . . . 62.5 111.541 -175.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.3 mt -89.39 130.52 38.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-O 121.21 0.528 . . . . 71.34 112.03 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -92.68 -48.95 6.33 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.043 -0.981 . . . . 70.53 109.055 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.42 ' HG2' ' HB2' ' B' ' 71' ' ' ASP . 79.2 mtm180 -155.83 163.78 39.37 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.613 -0.884 . . . . 74.41 108.613 -176.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.585 HD11 ' HB1' ' A' ' 50' ' ' ALA . 31.3 pt -145.87 144.51 20.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 109.185 -0.672 . . . . 64.11 109.185 176.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.4 m -125.71 126.03 43.96 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 107.334 -1.358 . . . . 75.12 107.334 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.8 mp -122.48 122.89 67.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.113 -1.44 . . . . 71.32 107.113 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.286 1.0 OUTLIER -121.0 128.37 52.64 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 120.207 -0.597 . . . . 71.03 111.918 176.143 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 62.6 m -114.36 125.38 53.8 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.543 -1.28 . . . . 72.45 107.543 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' A' ' 78' ' ' LYS . 2.2 p-10 -110.64 130.43 55.57 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 118.462 -1.295 . . . . 55.24 112.013 -177.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -107.49 13.03 27.26 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.368 -1.345 . . . . 72.41 107.368 170.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -61.47 -36.63 80.98 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 113.921 -1.491 . . . . 75.34 108.508 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.5 t -81.68 7.78 11.57 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-N 115.495 -0.775 . . . . 55.53 111.154 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.74 -47.95 3.25 Favored Glycine 0 N--CA 1.462 0.418 0 O-C-N 121.615 -0.678 . . . . 74.14 111.429 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -95.77 137.28 21.89 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 106.737 -1.579 . . . . 74.44 106.737 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.34 117.01 4.66 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 CA-C-N 119.313 0.79 . . . . 72.41 110.706 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.447 ' HB2' ' OD1' ' A' ' 71' ' ' ASP . 13.0 mmmm -104.96 -176.47 3.09 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 115.0 -1.0 . . . . 75.22 108.663 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.54 137.59 4.91 Favored Glycine 0 N--CA 1.41 -3.061 0 C-N-CA 119.596 -1.288 . . . . 52.33 112.785 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -154.43 143.29 20.96 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 123.931 0.892 . . . . 71.33 109.27 173.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.26 151.8 50.04 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-O 120.9 0.381 . . . . 62.22 110.574 -172.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 28.1 m-85 -118.82 115.68 24.93 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 108.386 -0.968 . . . . 72.1 108.386 176.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.479 HG23 HG22 ' A' ' 66' ' ' ILE . 40.0 mm -97.57 122.03 48.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.223 -1.029 . . . . 74.53 108.223 -176.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -102.38 119.79 39.41 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.195 -0.669 . . . . 55.42 109.195 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.26 156.47 16.41 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-O 121.062 0.458 . . . . 73.34 110.533 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.22 -27.84 56.95 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.156 -0.475 . . . . 51.54 110.051 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -112.48 136.86 51.49 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.826 -0.625 . . . . 54.02 110.848 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.464 ' O ' HG22 ' A' ' 91' ' ' VAL . 1.4 tmm_? -69.72 -32.12 70.51 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.815 -1.18 . . . . 70.31 107.815 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -67.68 -21.67 65.33 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 115.807 -0.633 . . . . 71.32 111.498 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.3 m -67.85 -36.04 79.61 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.739 -0.467 . . . . 62.53 109.739 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.514 ' HB ' ' CG1' ' A' ' 39' ' ' VAL . 2.2 m -67.15 -38.57 81.37 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 N-CA-C 108.354 -0.98 . . . . 73.21 108.354 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -61.36 -35.55 77.76 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.439 -0.801 . . . . 70.23 110.735 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.31 -31.65 62.56 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.079 -0.509 . . . . 64.12 110.826 175.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 97' ' ' MET . . . -76.46 -42.93 42.08 Favored 'General case' 0 C--O 1.205 -1.269 0 CA-C-N 115.999 -0.546 . . . . 75.44 111.094 -177.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 91' ' ' VAL . 19.9 m -56.09 -21.37 11.37 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.957 0 N-CA-C 113.458 0.91 . . . . 75.02 113.458 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.07 -10.54 58.12 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-O 121.933 0.873 . . . . 65.35 110.235 176.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.515 ' HA ' ' OG1' ' A' ' 100' ' ' THR . 18.7 mtp -101.62 9.65 40.93 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 125.111 1.364 . . . . 71.2 109.866 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 12.4 t70 -35.73 -57.95 0.63 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 115.703 1.742 . . . . 74.24 115.703 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -116.99 30.39 7.36 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 122.327 1.06 . . . . 64.51 109.329 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.515 ' OG1' ' HA ' ' A' ' 97' ' ' MET . 89.8 m -74.71 167.39 21.89 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.915 -1.039 . . . . 74.22 110.195 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.25 133.12 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 CA-C-O 121.356 0.598 . . . . 50.31 110.143 -173.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -133.23 127.79 34.49 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.476 -0.784 . . . . 70.42 109.059 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 103' ' ' ARG . 21.0 ttt180 57.05 32.64 22.02 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 122.303 1.049 . . . . 73.21 110.484 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.19 5.85 87.45 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.012 -0.995 . . . . 75.55 113.444 177.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -124.88 145.75 49.66 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 117.086 0.443 . . . . 71.43 110.137 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.5 m -79.31 119.74 22.79 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 110.018 -0.364 . . . . 61.25 110.018 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 45.9 pt -102.72 171.11 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 109.758 -0.46 . . . . 62.03 109.758 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 22.5 mmmt -118.02 130.15 56.0 Favored 'General case' 0 CA--C 1.472 -2.05 0 N-CA-C 108.883 -0.784 . . . . 75.4 108.883 176.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 41.1 t -125.59 111.79 28.53 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 107.304 -1.369 . . . . 70.33 107.304 172.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.43 HD13 ' CD2' ' A' ' 40' ' ' TYR 0.266 0.0 OUTLIER -138.9 146.75 51.27 Favored Pre-proline 0 N--CA 1.432 -1.345 0 C-N-CA 119.215 -0.994 . . . . 73.23 108.363 178.103 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -76.53 137.29 18.29 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.614 1.543 . . . . 63.01 112.217 -173.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.453 ' HE2' ' HB3' ' A' ' 38' ' ' SER . 37.6 ttpt . . . . . 0 N--CA 1.426 -1.657 0 N-CA-C 108.498 -0.927 . . . . 71.21 108.498 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.412 ' HA3' ' HD2' ' B' ' 22' ' ' PRO . . . . . . . . 0 CA--C 1.534 1.221 0 N-CA-C 116.021 1.168 . . . . 73.41 116.021 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.577 ' HG3' ' CE1' ' A' ' 40' ' ' TYR . 2.8 Cg_endo -41.69 -52.91 3.59 Favored 'Trans proline' 0 C--N 1.366 1.451 1 C-N-CA 125.475 4.117 . . . . 64.21 118.287 -173.658 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -58.63 123.7 14.16 Favored 'Trans proline' 0 C--N 1.379 2.179 0 CA-C-N 120.802 1.322 . . . . 73.32 111.557 -174.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -59.79 136.47 90.07 Favored Pre-proline 0 N--CA 1.435 -1.216 0 CA-C-N 115.573 -0.74 . . . . 75.32 110.356 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.52 103.08 0.09 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 123.237 2.625 . . . . 75.32 114.149 -172.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.69 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -70.56 170.84 11.32 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 114.973 -1.012 . . . . 74.2 109.876 174.376 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 47.6 t -59.42 143.47 49.7 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.53 0.681 . . . . 71.24 112.707 -173.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.5 ' O ' ' HE2' ' B' ' 32' ' ' LYS . . . -52.73 -36.25 57.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.328 -1.306 . . . . 74.41 111.703 176.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -60.98 -49.2 78.42 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.555 -0.535 . . . . 63.32 109.555 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.457 ' HB2' HD23 ' B' ' 26' ' ' LEU . 0.8 OUTLIER -61.52 -36.51 80.75 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-N 115.997 -0.547 . . . . 72.41 112.09 178.595 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.533 ' HA ' HG12 ' B' ' 34' ' ' ILE 0.516 5.3 ptpt -71.48 -35.43 70.82 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 115.049 1.5 . . . . 73.43 115.049 -179.146 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.5 ' HE2' ' O ' ' B' ' 28' ' ' ALA . 45.6 mtmt -64.41 -40.94 96.74 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.04 0.447 . . . . 54.01 111.066 174.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.548 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 38.6 mm-40 -71.07 -42.98 68.68 Favored 'General case' 0 C--O 1.211 -0.929 0 CA-C-N 115.622 -0.717 . . . . 73.41 112.768 -177.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.533 HG12 ' HA ' ' B' ' 31' ' ' LYS . 13.6 pt -64.79 -35.53 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 112.843 0.682 . . . . 73.54 112.843 -176.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -72.91 -23.69 60.73 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 119.994 -0.682 . . . . 70.01 111.329 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -77.1 -14.99 59.72 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.709 0.804 . . . . 74.44 109.741 174.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' B' ' 33' ' ' GLU . 89.7 mtt180 -109.22 14.1 24.01 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 115.218 -0.901 . . . . 74.52 108.883 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 49.6 m -101.31 153.71 19.41 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.191 -0.913 . . . . 71.21 110.937 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.495 ' CG1' ' HB ' ' B' ' 91' ' ' VAL . 35.7 m -133.3 163.85 36.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.321 -0.854 . . . . 61.24 109.273 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 35.0 t80 -110.9 124.47 52.16 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 107.623 -1.251 . . . . 73.42 107.623 177.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 59.1 t -122.91 110.1 25.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 107.923 -1.14 . . . . 73.31 107.923 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' B' ' 43' ' ' ASN . . . -133.88 109.02 0.77 Allowed Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 115.547 -3.216 . . . . 63.44 116.42 -177.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' B' ' 42' ' ' GLY . 62.0 t30 166.41 26.35 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 125.868 1.667 . . . . 75.21 108.011 157.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 12.0 p -69.67 136.22 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 115.208 -0.905 . . . . 75.03 109.921 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -111.9 167.09 10.65 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.666 -0.697 . . . . 63.52 110.788 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' TYR . . . . . 0.537 ' CE1' ' HB2' ' B' ' 77' ' ' PRO . 5.5 m-85 -69.25 101.55 1.52 Allowed 'General case' 0 CA--C 1.496 -1.13 0 CA-C-O 121.629 0.728 . . . . 73.4 109.796 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' GLY . . . . . 0.467 ' HA3' ' NH1' ' B' ' 103' ' ' ARG . . . 159.7 -33.58 0.45 Allowed Glycine 0 N--CA 1.413 -2.879 0 N-CA-C 109.218 -1.553 . . . . 43.34 109.218 -175.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.46 ' OG ' ' HE2' ' B' ' 102' ' ' PHE . 18.3 m -90.78 135.14 33.92 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 108.361 -0.977 . . . . 73.04 108.361 176.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 82.0 p -105.45 178.83 4.45 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 116.219 -0.446 . . . . 52.35 109.972 -177.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.623 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -61.98 -41.98 98.63 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.265 -1.013 . . . . 61.02 108.265 175.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -58.29 -35.41 71.77 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 114.949 -1.023 . . . . 74.32 111.392 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -69.55 -41.3 76.1 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 121.087 0.47 . . . . 75.4 110.472 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 61.2 mt -63.94 -47.82 78.98 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.348 -0.842 . . . . 73.22 112.244 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -60.14 -47.31 86.43 Favored 'General case' 0 C--O 1.182 -2.467 0 N-CA-C 113.796 1.036 . . . . 43.42 113.796 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.54 -48.02 75.38 Favored 'General case' 0 C--O 1.266 1.952 0 CA-C-N 118.413 0.551 . . . . 71.23 110.408 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -64.08 -41.57 97.27 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.549 -0.751 . . . . 74.13 110.719 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -82.51 -21.78 35.33 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 114.95 1.463 . . . . 71.3 114.95 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 48.5 t -66.89 -27.96 67.93 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.6 -0.518 . . . . 71.03 109.6 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.8 m -58.61 -31.55 68.17 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-O 121.003 0.43 . . . . 73.13 110.19 173.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 85.9 m -91.79 1.76 56.95 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.32 0.859 . . . . 64.24 113.32 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.65 -159.11 28.11 Favored Glycine 0 C--O 1.243 0.663 0 C-N-CA 118.033 -2.032 . . . . 35.35 116.383 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 17.5 m -106.05 116.21 31.54 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.053 -0.574 . . . . 75.51 110.592 -175.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 77.4 mt -84.18 132.16 32.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 121.594 0.712 . . . . 73.04 112.617 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -94.82 -49.07 5.75 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.635 -1.166 . . . . 65.22 109.281 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -155.93 164.32 38.64 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.659 -0.867 . . . . 74.4 108.659 -176.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.623 HD11 ' HB1' ' B' ' 50' ' ' ALA . 31.3 pt -145.98 144.59 20.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 109.002 -0.74 . . . . 71.11 109.002 176.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 58.5 m -125.47 125.71 43.74 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.263 -1.384 . . . . 74.33 107.263 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.7 mp -122.43 122.63 66.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 106.881 -1.526 . . . . 74.21 106.881 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.262 1.4 pt? -121.09 128.32 52.47 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.98 -0.688 . . . . 65.31 111.611 176.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 64.3 m -113.92 125.62 54.25 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.734 -1.21 . . . . 74.2 107.734 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.42 ' HB2' ' HG2' ' A' ' 65' ' ' ARG . 3.3 p-10 -112.01 130.04 56.0 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 118.895 -1.122 . . . . 71.24 112.284 -177.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 72' ' ' LYS . . . . . 0.413 ' HE3' ' OH ' ' B' ' 46' ' ' TYR . 97.9 mttt -106.85 10.98 30.52 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.086 -1.079 . . . . 71.34 108.086 172.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -59.82 -33.69 72.09 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 113.733 -1.576 . . . . 73.24 107.892 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 24.8 m -82.35 8.31 11.68 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 115.087 -0.961 . . . . 53.2 111.799 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.2 -49.1 3.93 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-O 121.872 0.706 . . . . 72.21 111.388 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -95.01 131.63 29.81 Favored Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 105.37 -2.085 . . . . 53.25 105.37 176.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.537 ' HB2' ' CE1' ' B' ' 46' ' ' TYR . 19.7 Cg_endo -63.42 116.67 3.77 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.212 1.275 . . . . 63.35 111.691 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 78' ' ' LYS . . . . . 0.408 ' HB2' ' OD1' ' B' ' 71' ' ' ASP . 13.4 mmmm -103.8 -178.61 3.71 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.239 -0.891 . . . . 64.23 109.303 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.55 136.44 4.22 Favored Glycine 0 N--CA 1.412 -2.945 0 C-N-CA 119.66 -1.257 . . . . 75.42 113.1 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -152.24 144.8 24.17 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 123.976 0.91 . . . . 75.13 109.756 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.98 151.48 49.05 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-O 121.001 0.429 . . . . 73.24 110.41 -172.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 82' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' B' ' 39' ' ' VAL . 28.1 m-85 -118.83 115.93 25.46 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 108.129 -1.063 . . . . 74.25 108.129 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.497 HG23 HG22 ' B' ' 66' ' ' ILE . 40.7 mm -97.2 122.18 48.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 108.151 -1.055 . . . . 73.01 108.151 -177.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -101.97 119.46 38.83 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.067 -0.716 . . . . 71.31 109.067 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -98.02 155.66 17.0 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 116.279 -0.419 . . . . 64.32 109.972 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.97 -30.28 55.92 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.277 0.56 . . . . 74.24 109.644 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' GLU . . . . . 0.513 ' HB2' ' OG ' ' B' ' 90' ' ' SER . 35.6 mt-10 -105.14 136.71 44.14 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.862 -0.608 . . . . 74.1 109.627 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.403 ' O ' HG22 ' B' ' 91' ' ' VAL . 1.5 tmm_? -72.52 -32.32 66.05 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.349 -1.352 . . . . 70.2 107.349 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -66.54 -22.42 66.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.429 -0.805 . . . . 72.34 111.357 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 90' ' ' SER . . . . . 0.513 ' OG ' ' HB2' ' B' ' 87' ' ' GLU . 49.6 m -67.48 -36.01 80.29 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.976 -0.379 . . . . 75.55 109.976 176.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.498 ' O ' HG13 ' B' ' 95' ' ' VAL . 2.0 m -67.01 -38.4 81.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 N-CA-C 108.121 -1.066 . . . . 73.32 108.121 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.34 -37.48 83.46 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.405 -0.816 . . . . 55.44 110.219 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.34 -30.92 63.66 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.195 0.521 . . . . 73.15 110.835 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.13 -44.79 36.75 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-N 116.086 -0.506 . . . . 73.51 111.352 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 95' ' ' VAL . . . . . 0.498 HG13 ' O ' ' B' ' 91' ' ' VAL . 25.7 m -55.46 -21.63 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.924 0.89 . . . . 74.24 112.819 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.62 -8.96 52.04 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.306 0.574 . . . . 62.25 110.481 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 32.9 mtm -105.02 12.97 31.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.495 -0.775 . . . . 75.34 110.583 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 98' ' ' ASP . . . . . 0.42 ' HA ' ' H ' ' B' ' 109' ' ' VAL . 3.7 p30 -39.55 -44.32 1.42 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.195 1.183 . . . . 74.4 114.195 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -110.05 95.14 5.4 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 121.545 0.688 . . . . 72.12 110.274 172.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 100' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' B' ' 106' ' ' THR . 6.7 p -132.11 156.08 46.99 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.119 -0.946 . . . . 64.34 111.934 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.68 127.14 65.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 121.095 0.474 . . . . 71.23 109.904 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 102' ' ' PHE . . . . . 0.46 ' HE2' ' OG ' ' B' ' 48' ' ' SER . 43.1 t80 -143.18 126.22 16.35 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.708 -1.59 . . . . 71.54 106.708 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 103' ' ' ARG . . . . . 0.467 ' NH1' ' HA3' ' B' ' 47' ' ' GLY . 72.9 mtp85 62.59 33.36 15.88 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.208 0.603 . . . . 72.21 111.101 -175.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.08 14.56 66.17 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 115.524 -0.762 . . . . 73.24 113.141 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -130.81 143.93 51.09 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 122.404 -0.468 . . . . 70.13 110.126 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 106' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' B' ' 100' ' ' THR . 53.5 m -83.0 126.68 32.8 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 120.777 0.322 . . . . 75.42 110.356 -177.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 107' ' ' ILE . . . . . 0.429 HG22 ' HB3' ' B' ' 43' ' ' ASN . 38.7 pt -100.87 167.26 2.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 109.227 -0.657 . . . . 60.24 109.227 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 108' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 44.9 tptt -121.26 124.99 45.98 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.577 -0.898 . . . . 73.0 108.577 -175.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 109' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 35.6 t -122.01 119.19 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 108.413 -0.958 . . . . 75.15 108.413 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.327 0.3 OUTLIER -143.53 137.37 14.45 Favored Pre-proline 0 C--N 1.285 -2.197 0 N-CA-C 106.454 -1.684 . . . . 72.01 106.454 -169.837 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -77.18 130.11 10.9 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 120.771 1.311 . . . . 71.3 110.446 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt . . . . . 0 C--N 1.317 -0.821 0 C-N-CA 120.08 -0.648 . . . . 74.14 110.597 -174.124 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 120.728 0.299 . . . . 75.43 110.431 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.2 pt -71.63 -35.97 57.88 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 CA-C-N 115.578 -0.737 . . . . 71.13 110.747 176.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -58.98 -42.61 90.38 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 120.831 0.348 . . . . 74.34 110.169 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -60.26 -26.8 66.73 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.889 0.876 . . . . 71.5 111.804 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.459 ' HD3' ' O ' ' A' ' 86' ' ' ALA . 15.8 ptp180 -112.55 21.91 15.15 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.672 0.748 . . . . 74.3 109.93 -176.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 56.9 m -113.83 170.83 7.97 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.372 -0.831 . . . . 62.21 110.78 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.88 162.14 31.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.421 0.629 . . . . 74.11 111.567 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.557 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -96.33 125.58 40.93 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 105.996 -1.853 . . . . 44.13 105.996 169.548 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.44 ' N ' ' HD1' ' A' ' 40' ' ' TYR . 94.4 t -128.37 106.54 14.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 107.247 -1.39 . . . . 72.4 107.247 173.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -151.89 113.06 0.56 Allowed Glycine 0 N--CA 1.423 -2.216 0 C-N-CA 116.174 -2.917 . . . . 74.45 117.783 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.579 ' HB3' ' HA ' ' A' ' 107' ' ' ILE . 9.3 t30 176.18 23.85 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 103.346 -2.835 . . . . 73.43 103.346 161.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.435 ' CG2' ' HB2' ' A' ' 48' ' ' SER . 7.1 p -107.76 100.82 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-N 113.03 -1.895 . . . . 72.54 110.816 -173.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.408 ' HA ' ' HA3' ' A' ' 79' ' ' GLY . 7.9 m-20 -92.16 170.44 9.82 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.861 -1.063 . . . . 71.14 108.165 -175.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -28.08 -32.97 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 117.465 2.395 . . . . 52.14 117.465 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.94 -32.7 42.24 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.743 -0.265 . . . . 61.14 113.152 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.435 ' HB2' ' CG2' ' A' ' 44' ' ' VAL . 41.4 m -109.93 154.08 23.61 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 109.641 -0.503 . . . . 61.2 109.641 176.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 63.7 p -121.83 178.6 4.8 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 112.046 0.387 . . . . 64.12 112.046 -171.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.497 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -63.15 -44.27 95.97 Favored 'General case' 0 C--O 1.215 -0.76 0 C-N-CA 123.636 0.775 . . . . 71.53 111.636 -177.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -58.13 -38.36 76.38 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.871 0.367 . . . . 72.33 111.517 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -64.17 -32.69 74.35 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.525 0.678 . . . . 64.22 109.608 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 62.8 mt -69.87 -46.08 66.3 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 114.185 -1.37 . . . . 72.41 110.595 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -57.89 -50.12 74.4 Favored 'General case' 0 C--O 1.191 -1.988 0 C-N-CA 120.944 -0.302 . . . . 75.52 111.211 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.33 -48.3 79.33 Favored 'General case' 0 C--O 1.263 1.809 0 CA-C-O 121.653 0.74 . . . . 63.53 112.458 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -69.56 -40.78 76.59 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.775 -1.102 . . . . 73.23 111.119 -175.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -82.63 -22.66 34.62 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 114.592 1.33 . . . . 74.13 114.592 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.5 t -71.26 -23.53 62.0 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.655 -0.498 . . . . 74.44 109.655 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.0 t -57.98 -31.63 67.1 Favored 'General case' 0 CA--C 1.558 1.255 0 N-CA-C 108.944 -0.762 . . . . 64.32 108.944 172.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 60.7 m -90.51 -0.35 57.63 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 112.751 0.649 . . . . 70.3 112.751 -177.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.64 -169.86 29.15 Favored Glycine 0 C--O 1.229 -0.18 0 C-N-CA 119.505 -1.331 . . . . 53.12 114.436 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.0 m -95.68 123.21 39.14 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 121.15 0.5 . . . . 55.51 110.453 -177.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 72.7 mt -91.56 124.84 44.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.777 -0.647 . . . . 61.34 110.875 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -91.47 -35.54 14.28 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-O 121.077 0.465 . . . . 74.33 111.835 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.481 ' HD2' ' OE2' ' A' ' 84' ' ' GLU 0.266 0.0 OUTLIER -157.21 152.97 26.86 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.708 -1.219 . . . . 73.2 107.708 -167.489 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.527 HG22 ' HA ' ' A' ' 83' ' ' ILE . 34.5 pt -148.21 143.86 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 CA-C-N 118.451 0.569 . . . . 73.22 109.908 174.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.3 m -126.26 123.87 39.08 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.747 -1.205 . . . . 72.44 107.747 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.598 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.2 mp -120.95 121.26 64.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 106.041 -1.837 . . . . 71.21 106.041 -176.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.41 ' N ' HD23 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -120.55 130.15 54.1 Favored 'General case' 0 C--N 1.275 -2.642 0 C-N-CA 120.199 -0.6 . . . . 75.43 112.032 179.067 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 69.1 m -112.07 111.79 22.96 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.998 -1.112 . . . . 63.12 107.998 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -102.16 120.22 40.09 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 108.408 -0.96 . . . . 65.33 108.408 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.545 ' HE2' ' HB3' ' A' ' 77' ' ' PRO . 38.9 ttmt -111.0 15.65 21.6 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.059 -0.719 . . . . 74.42 109.059 -178.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -67.75 -18.0 64.74 Favored 'General case' 0 C--N 1.35 0.607 0 CA-C-O 121.341 0.591 . . . . 70.54 111.187 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.8 m -78.29 -7.28 57.02 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.913 -0.585 . . . . 63.21 110.654 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.26 -51.05 1.28 Allowed Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 109.308 -1.517 . . . . 70.54 109.308 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -96.38 134.42 23.51 Favored Pre-proline 0 C--N 1.287 -2.111 0 N-CA-C 105.677 -1.972 . . . . 74.13 105.677 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.545 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 41.5 Cg_endo -66.3 118.05 5.2 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.274 1.316 . . . . 73.35 112.232 -175.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -100.66 141.53 33.4 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.368 -0.833 . . . . 74.42 108.865 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 44' ' ' VAL . . . -127.76 140.51 11.88 Favored Glycine 0 N--CA 1.41 -3.045 0 C-N-CA 119.738 -1.22 . . . . 51.12 112.73 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . 0.25 3.1 p90 -156.65 146.92 21.29 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 123.745 0.818 . . . . 74.03 110.07 175.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.598 ' HB2' HG23 ' A' ' 68' ' ' ILE . . . -139.48 155.06 47.8 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-O 121.489 0.661 . . . . 74.44 109.233 -172.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.603 ' CD2' ' HD3' ' A' ' 112' ' ' LYS . 84.8 m-85 -121.27 115.89 23.84 Favored 'General case' 0 C--N 1.263 -3.172 0 N-CA-C 108.231 -1.026 . . . . 63.13 108.231 175.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.527 ' HA ' HG22 ' A' ' 66' ' ' ILE . 35.9 mm -95.9 119.04 43.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.318 -1.364 . . . . 64.41 107.318 -176.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.481 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 31.7 mt-10 -101.95 117.94 35.87 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.527 -0.546 . . . . 64.3 109.527 -174.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -102.23 169.56 8.64 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 121.986 0.898 . . . . 75.5 113.326 -173.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.459 ' O ' ' HD3' ' A' ' 37' ' ' ARG . . . -74.41 -38.82 62.97 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.36 -1.291 . . . . 62.1 112.45 174.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -126.03 159.07 33.71 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.552 -0.859 . . . . 62.11 113.145 -175.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.453 ' O ' HG22 ' A' ' 91' ' ' VAL . 11.4 mmm180 -66.44 -31.32 72.0 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 114.487 -1.233 . . . . 75.12 108.687 173.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -57.66 -39.35 76.85 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 114.133 -1.394 . . . . 71.13 109.951 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.0 m -67.71 -38.38 83.54 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.978 -0.555 . . . . 73.54 111.148 -177.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 88' ' ' ARG . 3.2 m -68.22 -39.15 80.7 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.224 0 C-N-CA 119.733 -0.787 . . . . 75.21 108.978 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -58.43 -38.62 77.84 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.614 0.766 . . . . 73.13 110.202 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.47 -38.07 63.02 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.667 -0.697 . . . . 71.43 111.187 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.17 -45.24 57.64 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 116.243 -0.435 . . . . 60.25 111.706 -176.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 91' ' ' VAL . 25.8 m -57.32 -22.16 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.286 0.634 . . . . 74.1 112.669 177.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.41 -14.03 62.68 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.444 0.64 . . . . 72.24 110.256 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 60.1 mtm -100.38 11.49 39.3 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.718 -0.673 . . . . 53.24 110.231 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.452 ' HA ' ' HB ' ' A' ' 109' ' ' VAL . 6.4 p-10 -36.71 -49.54 0.78 Allowed 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 115.356 1.613 . . . . 62.21 115.356 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -107.25 25.5 11.33 Favored 'General case' 0 CA--C 1.556 1.186 0 CA-C-O 120.908 0.385 . . . . 74.11 111.627 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 67.7 p -84.0 172.41 12.06 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 119.417 -0.913 . . . . 71.11 111.571 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 106' ' ' THR . 8.3 p -102.95 135.91 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.912 0 N-CA-C 109.019 -0.734 . . . . 54.54 109.019 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -123.78 118.18 26.58 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.626 -0.509 . . . . 73.53 109.626 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 103' ' ' ARG . 43.4 mtp180 45.3 32.34 0.98 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.834 1.653 . . . . 64.54 113.568 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.27 -10.55 33.59 Favored Glycine 0 CA--C 1.522 0.49 0 CA-C-N 115.264 -0.88 . . . . 72.41 113.896 174.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.434 ' HD3' ' O ' ' A' ' 43' ' ' ASN . 3.8 ptp180 -124.25 132.53 53.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 117.059 0.429 . . . . 54.04 111.779 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 101' ' ' VAL . 87.6 m -71.35 121.56 18.75 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.101 -0.499 . . . . 75.33 110.478 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.579 ' HA ' ' HB3' ' A' ' 43' ' ' ASN . 33.2 pt -103.02 172.13 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 115.787 -0.642 . . . . 73.11 111.593 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.506 ' HE2' HD12 ' A' ' 110' ' ' LEU . 19.0 tptm -118.71 126.67 52.42 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.582 -0.896 . . . . 60.54 108.582 177.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 23.4 t -125.62 121.52 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 108.045 -1.095 . . . . 73.13 108.045 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.506 HD12 ' HE2' ' A' ' 108' ' ' LYS 0.253 0.0 OUTLIER -142.59 153.47 61.93 Favored Pre-proline 0 C--O 1.208 -1.125 0 N-CA-C 107.693 -1.225 . . . . 65.31 107.693 174.627 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.33 149.67 28.01 Favored 'Trans proline' 0 CA--C 1.507 -0.861 0 CA-C-N 120.721 1.293 . . . . 61.4 112.634 -175.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.603 ' HD3' ' CD2' ' A' ' 82' ' ' TYR . 47.3 mtmt . . . . . 0 N--CA 1.409 -2.519 0 N-CA-C 105.765 -1.939 . . . . 62.41 105.765 172.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.461 ' HA3' ' HD3' ' B' ' 22' ' ' PRO . . . . . . . . 0 N--CA 1.422 -2.29 0 N-CA-C 114.329 0.492 . . . . 42.54 114.329 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.53 ' HG2' ' CE2' ' A' ' 40' ' ' TYR . 43.4 Cg_exo -55.04 -49.6 16.01 Favored 'Trans proline' 0 CA--C 1.578 2.702 0 C-N-CA 123.896 3.064 . . . . 75.24 115.564 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -54.29 138.25 72.32 Favored 'Trans proline' 0 C--N 1.398 3.144 0 CA-C-N 121.302 1.501 . . . . 63.13 109.635 173.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -64.08 122.23 76.27 Favored Pre-proline 0 N--CA 1.434 -1.249 0 C-N-CA 120.572 -0.451 . . . . 72.32 111.589 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -67.89 125.9 13.81 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.938 2.425 . . . . 70.51 110.664 -175.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.71 HD13 ' H ' ' B' ' 26' ' ' LEU 0.348 0.0 OUTLIER -77.73 171.43 14.97 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.812 -0.755 . . . . 71.12 112.014 -179.66 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.587 ' HB2' ' OE1' ' B' ' 30' ' ' GLU . 68.4 m -70.23 145.5 51.34 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 115.033 1.494 . . . . 70.52 115.033 -171.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.71 -45.7 70.52 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 114.864 -1.062 . . . . 71.33 113.428 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' B' ' 33' ' ' GLU . 8.6 mm-40 -63.15 -41.96 99.36 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 122.078 -0.389 . . . . 61.4 110.635 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.587 ' OE1' ' HB2' ' B' ' 27' ' ' SER . 3.6 mp0 -56.26 -39.21 72.25 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 109.86 -0.422 . . . . 73.4 109.86 172.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.539 ' HE3' ' O ' ' B' ' 26' ' ' LEU . 98.7 mttt -69.39 -41.7 76.11 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.616 -0.72 . . . . 70.22 111.776 -177.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.687 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 0.4 OUTLIER -70.42 -35.61 73.51 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 118.977 -1.089 . . . . 72.14 111.349 176.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' B' ' 29' ' ' GLU . 17.6 mt-10 -68.31 -37.7 80.87 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 120.126 -0.63 . . . . 55.52 111.569 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 15.4 pt -70.78 -34.63 57.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 C-N-CA 120.545 -0.462 . . . . 63.43 110.368 176.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' B' ' 31' ' ' LYS . 0.9 OUTLIER -64.82 -37.09 86.44 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.732 -0.84 . . . . 70.23 108.732 -177.805 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.687 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 95.8 mttt -62.02 -28.82 69.85 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.932 -1.031 . . . . 74.4 110.679 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.504 ' HD2' ' O ' ' B' ' 86' ' ' ALA . 71.7 mtm180 -106.29 18.13 22.44 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.601 -0.727 . . . . 64.33 111.221 -176.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 44.3 m -110.23 170.56 8.0 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 116.237 -0.438 . . . . 71.12 110.544 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.442 ' HA ' ' H ' ' B' ' 112' ' ' LYS . 30.5 m -137.41 164.66 28.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.171 0.51 . . . . 72.34 111.47 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 0.8 OUTLIER -106.46 120.78 42.81 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 126.41 1.884 . . . . 72.41 106.273 175.608 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 100.0 t -124.79 106.68 16.95 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 N-CA-C 107.742 -1.207 . . . . 64.14 107.742 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.66 113.2 0.58 Allowed Glycine 0 N--CA 1.423 -2.228 0 C-N-CA 116.318 -2.849 . . . . 64.11 117.724 -175.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.635 ' HB3' ' HA ' ' B' ' 107' ' ' ILE . 9.2 t30 176.22 23.76 0.0 OUTLIER 'General case' 0 C--O 1.209 -1.042 0 N-CA-C 105.41 -2.07 . . . . 73.22 105.41 160.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.473 ' O ' ' HA3' ' B' ' 79' ' ' GLY . 5.7 p -103.53 96.18 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-N 113.746 -1.57 . . . . 64.14 108.903 -178.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' B' ' 77' ' ' PRO . 6.0 m-20 -106.98 102.67 12.01 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.558 -1.645 . . . . 70.52 106.558 -170.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 51.21 -177.96 0.02 OUTLIER 'General case' 0 C--O 1.248 1.018 0 N-CA-C 114.935 1.457 . . . . 55.53 114.935 -173.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.22 -59.55 4.97 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 111.176 -0.77 . . . . 62.44 111.176 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.2 m -88.83 155.28 19.64 Favored 'General case' 0 N--CA 1.421 -1.875 0 N-CA-C 109.358 -0.608 . . . . 73.04 109.358 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 44.6 p -119.64 178.91 4.39 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 120.713 -0.395 . . . . 75.11 111.391 -174.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.548 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -64.53 -40.68 96.05 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 123.21 0.604 . . . . 74.32 109.904 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -58.39 -41.21 84.38 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 116.167 -0.47 . . . . 63.25 111.989 174.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -59.9 -35.88 75.8 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.637 0.732 . . . . 72.35 109.656 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' B' ' 50' ' ' ALA . 86.6 mt -67.65 -45.68 74.62 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.838 -1.074 . . . . 74.32 111.354 178.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -58.17 -50.82 72.19 Favored 'General case' 0 C--O 1.189 -2.13 0 C-N-CA 120.751 -0.38 . . . . 72.42 111.856 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.8 -48.25 80.25 Favored 'General case' 0 C--O 1.257 1.463 0 CA-C-O 120.937 0.398 . . . . 71.33 111.537 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -68.82 -40.22 79.6 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.675 -0.693 . . . . 74.25 111.192 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -83.36 -22.68 32.75 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 114.976 1.472 . . . . 73.33 114.976 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 35.7 t -72.24 -26.63 62.09 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 110.06 -0.348 . . . . 53.25 110.06 -177.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 20.4 m -64.49 -27.18 68.8 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 119.498 -0.881 . . . . 34.32 109.428 174.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 57.3 m -95.58 9.21 40.99 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.681 -0.69 . . . . 64.24 112.04 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.92 -167.37 32.71 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 118.619 -1.753 . . . . 74.33 115.815 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 20.4 m -108.17 116.29 31.69 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.302 -0.629 . . . . 51.44 109.302 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 64.9 mt -91.11 123.4 43.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.063 0.458 . . . . 73.42 111.579 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -95.79 -34.43 11.89 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.596 -0.729 . . . . 71.02 111.944 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.526 ' HD2' ' OE1' ' B' ' 84' ' ' GLU 0.253 0.0 OUTLIER -157.87 153.41 26.29 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.593 -1.262 . . . . 70.22 107.593 -169.922 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.548 HD11 ' HB1' ' B' ' 50' ' ' ALA . 35.0 pt -148.33 144.0 18.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 109.115 -0.698 . . . . 70.13 109.115 174.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 36.3 m -125.45 124.41 41.35 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.58 -1.637 . . . . 72.24 106.58 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' ILE . . . . . 0.617 HG23 ' HB2' ' B' ' 81' ' ' ALA . 1.1 mp -121.85 121.55 64.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 106.11 -1.811 . . . . 61.22 106.11 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.71 130.59 54.13 Favored 'General case' 0 C--N 1.277 -2.566 0 C-N-CA 120.337 -0.545 . . . . 72.12 112.27 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 85.5 m -112.52 111.86 23.0 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.243 -1.021 . . . . 50.4 108.243 178.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -101.18 116.39 32.72 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.211 -1.033 . . . . 51.01 108.211 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' LYS . . . . . 0.422 ' HE3' ' HB3' ' B' ' 77' ' ' PRO . 46.7 mtpt -112.37 4.77 17.81 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.324 -0.551 . . . . 42.43 110.6 -177.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -80.49 -6.64 58.47 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 119.308 -0.957 . . . . 74.34 110.727 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 33.7 t -80.93 7.82 9.76 Favored 'General case' 0 CA--C 1.557 1.249 0 CA-C-N 114.89 -1.05 . . . . 70.04 108.716 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.57 -58.87 2.59 Favored Glycine 0 CA--C 1.492 -1.392 0 N-CA-C 110.371 -1.092 . . . . 72.23 110.371 178.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -97.11 137.38 21.24 Favored Pre-proline 0 C--N 1.284 -2.253 0 N-CA-C 108.687 -0.857 . . . . 74.24 108.687 175.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.422 ' HB3' ' HE3' ' B' ' 72' ' ' LYS . 15.7 Cg_endo -61.21 117.89 4.72 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.662 1.575 . . . . 63.51 111.54 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -108.7 140.66 41.78 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 108.67 -0.863 . . . . 64.32 108.67 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' B' ' 44' ' ' VAL . . . -128.37 138.16 10.18 Favored Glycine 0 N--CA 1.411 -3.025 0 C-N-CA 120.495 -0.86 . . . . 55.31 112.469 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -154.51 147.01 24.05 Favored 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 123.695 0.798 . . . . 73.35 109.74 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.617 ' HB2' HG23 ' B' ' 68' ' ' ILE . . . -138.57 152.83 48.51 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-N 115.969 -0.559 . . . . 64.41 110.78 -172.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 82' ' ' TYR . . . . . 0.462 ' CE2' ' HB2' ' B' ' 40' ' ' TYR . 59.8 m-85 -118.47 115.3 24.34 Favored 'General case' 0 C--N 1.266 -3.062 0 N-CA-C 108.515 -0.92 . . . . 74.44 108.515 175.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.535 ' HA ' HG22 ' B' ' 66' ' ' ILE . 37.7 mm -95.3 118.72 42.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.668 -1.604 . . . . 74.2 106.668 -176.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 84' ' ' GLU . . . . . 0.526 ' OE1' ' HD2' ' B' ' 65' ' ' ARG . 32.3 mt-10 -102.78 117.79 35.42 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.308 -0.627 . . . . 63.43 109.308 -174.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -103.88 168.62 9.01 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.738 0.78 . . . . 73.51 112.261 -174.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.504 ' O ' ' HD2' ' B' ' 37' ' ' ARG . . . -81.01 -34.56 32.83 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.635 -1.166 . . . . 70.44 111.793 174.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -112.75 149.94 32.27 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 113.186 0.81 . . . . 74.42 113.186 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.426 ' O ' HG22 ' B' ' 91' ' ' VAL . 10.5 mmm180 -67.71 -31.16 70.91 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 107.542 -1.281 . . . . 64.54 107.542 168.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -56.79 -41.45 77.74 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 113.838 -1.528 . . . . 75.03 109.713 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 18.2 m -65.69 -39.5 91.35 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 116.06 -0.518 . . . . 72.15 111.356 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.446 ' O ' HG13 ' B' ' 95' ' ' VAL . 3.1 m -67.91 -38.73 80.53 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.354 0 C-N-CA 119.493 -0.883 . . . . 71.42 108.803 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.71 -38.76 79.01 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.678 0.791 . . . . 71.2 110.296 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.37 -36.96 63.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.624 -0.716 . . . . 63.24 111.223 177.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.4 -45.1 48.92 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 116.285 -0.416 . . . . 63.31 111.447 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 95' ' ' VAL . . . . . 0.446 HG13 ' O ' ' B' ' 91' ' ' VAL . 25.6 m -58.56 -21.98 19.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 C-N-CA 123.778 0.831 . . . . 52.11 112.358 177.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.31 -14.49 62.96 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.106 0.479 . . . . 73.44 110.229 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 72.0 mtm -99.26 13.65 32.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.542 -0.754 . . . . 72.31 110.152 178.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -36.27 -56.28 0.77 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 114.294 1.22 . . . . 74.41 114.294 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -107.1 91.6 3.73 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.541 0.686 . . . . 74.23 110.224 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 33.4 p -135.13 169.19 17.82 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.959 -1.019 . . . . 74.53 111.64 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 11.7 p -102.58 138.76 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 N-CA-C 108.866 -0.79 . . . . 74.41 108.866 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 102' ' ' PHE . . . . . 0.483 ' O ' ' HG2' ' B' ' 105' ' ' ARG . 57.3 t80 -141.15 116.44 10.03 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 107.632 -1.248 . . . . 75.34 107.632 177.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 103' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' B' ' 103' ' ' ARG . 20.4 ttt180 56.31 33.62 22.6 Favored 'General case' 0 CA--C 1.559 1.324 0 CA-C-O 122.684 1.231 . . . . 71.41 111.039 -176.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.18 2.54 87.9 Favored Glycine 0 C--N 1.314 -0.666 0 CA-C-N 114.754 -1.112 . . . . 75.13 114.259 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' B' ' 102' ' ' PHE . 4.1 ptp180 -120.02 137.28 54.19 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.419 -0.586 . . . . 53.52 109.419 177.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 28.0 m -78.39 120.92 23.82 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.529 -0.545 . . . . 74.45 109.529 -176.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 107' ' ' ILE . . . . . 0.635 ' HA ' ' HB3' ' B' ' 43' ' ' ASN . 41.2 pt -102.3 167.22 2.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 120.403 -0.519 . . . . 74.33 111.618 -177.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -118.76 126.13 51.18 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.014 -0.994 . . . . 71.43 109.185 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 109' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 21.5 t -124.17 122.37 64.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 N-CA-C 107.969 -1.123 . . . . 73.0 107.969 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.553 HD13 ' HD2' ' B' ' 40' ' ' TYR 0.306 0.1 OUTLIER -146.76 144.03 19.63 Favored Pre-proline 0 C--N 1.284 -2.251 0 N-CA-C 105.729 -1.952 . . . . 75.21 105.729 -172.38 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -66.0 136.19 43.75 Favored 'Trans proline' 0 C--N 1.357 1.019 0 CA-C-N 121.657 1.627 . . . . 71.41 111.832 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.442 ' H ' ' HA ' ' B' ' 39' ' ' VAL . 86.3 tttt . . . . . 0 N--CA 1.48 1.072 0 C-N-CA 123.244 0.617 . . . . 62.55 111.21 -171.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.406 ' HA ' ' OE1' ' A' ' 33' ' ' GLU . 5.3 mm-40 . . . . . 0 C--O 1.211 -0.934 0 N-CA-C 111.652 0.241 . . . . 65.24 111.652 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.8 pt -70.33 -35.32 62.09 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.182 0 C-N-CA 120.981 -0.288 . . . . 65.33 110.945 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -73.06 -32.02 64.76 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.731 0.777 . . . . 73.25 109.717 -176.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -71.51 -19.17 62.22 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 115.042 -0.981 . . . . 72.21 110.298 176.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -107.56 9.2 29.51 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.784 -0.644 . . . . 74.2 110.4 -177.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 69.2 m -95.36 149.81 20.95 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.587 0.708 . . . . 75.45 109.96 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 32.4 m -128.33 160.93 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 CA-C-N 115.028 -0.987 . . . . 75.43 109.779 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.605 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 18.5 t80 -105.63 121.07 43.23 Favored 'General case' 0 C--N 1.269 -2.898 0 C-N-CA 124.896 1.278 . . . . 74.51 108.072 176.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.6 t -113.9 108.92 26.73 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 107.809 -1.182 . . . . 61.15 107.809 176.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.31 165.36 12.76 Favored Glycine 0 C--N 1.296 -1.67 0 C-N-CA 119.596 -1.288 . . . . 63.14 113.711 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.6 t30 57.75 20.57 6.57 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.976 1.711 . . . . 61.12 113.374 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.3 p -62.41 133.26 28.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 CA-C-O 121.497 0.665 . . . . 61.33 109.301 174.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.448 ' HB3' ' HD2' ' A' ' 103' ' ' ARG . 15.0 t70 -80.73 153.93 27.56 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.235 -1.024 . . . . 75.52 108.235 -177.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -65.55 -17.08 64.3 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.386 0.612 . . . . 75.32 109.523 -174.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.54 -22.17 71.27 Favored Glycine 0 N--CA 1.439 -1.117 0 CA-C-N 115.905 -0.589 . . . . 64.43 112.944 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.5 m -92.29 145.0 24.83 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 119.296 -0.962 . . . . 72.31 111.483 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.2 p -124.28 179.83 4.74 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.831 -1.077 . . . . 72.54 109.197 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.88 -50.28 72.98 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 112.634 0.605 . . . . 73.42 112.634 -174.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -58.55 -43.03 89.18 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.452 0.538 . . . . 72.53 112.452 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.49 -44.36 97.22 Favored 'General case' 0 C--O 1.254 1.328 0 CA-C-O 121.762 0.791 . . . . 73.22 109.414 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 76.2 mt -68.31 -46.06 71.32 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-N 114.733 -1.121 . . . . 75.44 112.037 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -58.6 -47.89 82.81 Favored 'General case' 0 C--O 1.203 -1.366 0 N-CA-C 113.09 0.774 . . . . 61.13 113.09 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.7 -47.66 76.44 Favored 'General case' 0 C--O 1.276 2.496 0 CA-C-O 120.89 0.376 . . . . 43.33 110.779 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -64.29 -34.89 79.16 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 120.103 -0.639 . . . . 73.14 110.928 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -81.45 -21.63 38.67 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.812 1.042 . . . . 75.23 113.812 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.2 m -64.55 -26.62 68.5 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 121.067 0.46 . . . . 42.01 110.006 -178.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.0 m -57.7 -32.58 67.52 Favored 'General case' 0 CA--C 1.567 1.62 0 CA-C-N 116.065 -0.516 . . . . 61.03 110.455 172.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.1 m -91.21 4.5 52.12 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 113.599 0.963 . . . . 62.11 113.599 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.21 -164.97 27.52 Favored Glycine 0 CA--C 1.511 -0.191 0 C-N-CA 118.944 -1.598 . . . . 74.33 113.978 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.7 m -101.72 121.94 42.98 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.228 -0.286 . . . . 73.2 110.228 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.5 mt -78.97 127.98 38.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 121.715 0.769 . . . . 62.23 112.262 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -87.03 -47.12 9.19 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.371 -1.286 . . . . 51.11 108.766 177.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.536 ' HB2' ' OE1' ' A' ' 84' ' ' GLU . 50.1 mtm180 -155.39 165.02 37.91 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.168 -0.679 . . . . 74.04 109.168 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.423 HG13 HG12 ' A' ' 83' ' ' ILE . 1.1 tt -149.18 133.35 8.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 122.966 0.506 . . . . 75.22 111.557 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.0 m -125.65 131.77 52.57 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.674 -1.232 . . . . 71.31 107.674 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mp -128.66 124.16 60.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 107.335 -1.357 . . . . 75.4 107.335 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.437 ' HB3' HG23 ' B' ' 67' ' ' THR . 1.6 pt? -120.67 131.95 54.85 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.959 -0.696 . . . . 75.52 111.643 176.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 66.7 m -117.36 127.43 54.04 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 108.867 -0.79 . . . . 64.35 108.867 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.535 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 3.1 p30 -104.73 119.31 38.69 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 119.298 -0.961 . . . . 71.55 109.09 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -110.06 -4.11 16.04 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 120.072 -0.651 . . . . 71.15 112.084 -175.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.585 ' HB3' ' OD1' ' B' ' 64' ' ' ASN . 50.7 p90 -58.1 -20.29 38.86 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 119.447 -0.901 . . . . 54.43 111.188 176.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 28.5 t -79.22 -3.66 46.86 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.165 0.586 . . . . 61.45 111.42 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.0 -61.16 0.8 Allowed Glycine 0 CA--C 1.496 -1.126 0 N-CA-C 109.748 -1.341 . . . . 64.33 109.748 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -95.23 120.49 63.96 Favored Pre-proline 0 CA--C 1.484 -1.575 0 N-CA-C 106.689 -1.597 . . . . 70.53 106.689 173.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 65.6 Cg_endo -68.9 119.34 6.34 Favored 'Trans proline' 0 N--CA 1.442 -1.553 0 C-N-CA 121.841 1.694 . . . . 74.21 111.5 -176.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 32.6 mtmm -95.9 151.92 18.98 Favored 'General case' 0 CA--C 1.472 -2.021 0 N-CA-C 107.619 -1.252 . . . . 75.24 107.619 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.05 144.24 15.47 Favored Glycine 0 N--CA 1.405 -3.432 0 C-N-CA 118.743 -1.694 . . . . 12.12 113.492 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -152.14 146.32 25.4 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.479 -0.86 . . . . 60.35 109.018 172.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.11 154.08 50.91 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 120.691 0.282 . . . . 71.2 111.416 -171.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.45 ' OH ' ' HA3' ' B' ' 21' ' ' GLY . 92.6 m-85 -126.74 122.67 35.51 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.613 -0.884 . . . . 64.14 108.613 175.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.423 HG12 HG13 ' A' ' 66' ' ' ILE . 76.1 mt -122.71 134.17 66.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 116.139 -0.482 . . . . 70.12 110.886 -174.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.536 ' OE1' ' HB2' ' A' ' 65' ' ' ARG . 2.9 mp0 -102.02 134.48 45.18 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.921 -0.77 . . . . 63.14 108.921 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -102.44 160.26 14.71 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.841 -0.429 . . . . 71.2 109.841 173.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.87 -37.69 87.88 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.944 0.402 . . . . 73.2 111.395 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -110.58 149.77 29.91 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.144 -0.48 . . . . 70.23 111.403 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.42 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.9 OUTLIER -74.77 -30.02 61.32 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.242 -1.392 . . . . 70.34 107.242 178.716 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -67.46 -21.18 65.55 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.395 -0.82 . . . . 73.24 111.28 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.7 m -70.49 -35.22 73.12 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 109.451 -0.574 . . . . 72.54 109.451 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 88' ' ' ARG . 2.2 m -65.63 -37.99 81.28 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 N-CA-C 108.209 -1.034 . . . . 65.12 108.209 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -56.49 -38.58 71.94 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.923 -0.58 . . . . 73.41 110.435 177.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.85 -31.49 63.2 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.598 0.713 . . . . 62.1 111.347 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.39 -44.88 34.2 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.715 -0.675 . . . . 71.12 110.795 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.7 m -62.36 -21.65 27.47 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.772 0 C-N-CA 122.656 0.383 . . . . 72.33 111.991 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.91 -10.33 52.31 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.639 0.733 . . . . 44.34 110.047 174.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 35.4 mtm -102.73 11.23 37.92 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.586 -0.734 . . . . 73.55 110.302 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -46.52 -46.85 19.46 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.525 0.565 . . . . 63.11 112.525 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -95.44 93.28 7.12 Favored 'General case' 0 N--CA 1.437 -1.1 0 O-C-N 121.708 -0.62 . . . . 74.55 109.496 174.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 21.9 p -148.88 160.01 43.65 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 122.594 0.357 . . . . 72.15 110.817 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.2 p -107.78 126.01 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 109.03 -0.73 . . . . 75.03 109.03 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -133.49 119.58 19.74 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 108.441 -0.948 . . . . 75.11 108.441 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.448 ' HD2' ' HB3' ' A' ' 45' ' ' ASP . 48.6 ttm-85 55.26 54.27 8.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.957 0.884 . . . . 75.43 112.411 -177.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.24 -8.44 17.64 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 114.54 -1.209 . . . . 65.53 115.888 176.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -130.88 156.58 44.8 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 118.044 0.922 . . . . 72.15 110.997 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.4 m -84.3 125.25 32.09 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 120.985 0.421 . . . . 64.54 110.483 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 47.6 pt -101.76 172.07 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 116.079 -0.509 . . . . 70.12 110.011 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.42 134.43 47.11 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.191 -0.913 . . . . 74.54 109.874 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 28.0 t -124.74 126.0 70.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.992 -1.114 . . . . 53.21 107.992 177.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.487 ' HB2' ' HB3' ' A' ' 40' ' ' TYR . 97.0 mt -134.89 161.63 62.51 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 108.616 -0.883 . . . . 64.44 108.616 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.53 140.5 24.11 Favored 'Trans proline' 0 N--CA 1.44 -1.658 0 N-CA-C 107.977 -1.586 . . . . 60.05 107.977 171.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 64.7 tttm . . . . . 0 N--CA 1.428 -1.538 0 C-N-CA 119.891 -0.723 . . . . 72.23 110.835 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.45 ' HA3' ' OH ' ' A' ' 82' ' ' TYR . . . . . . . . 0 C--O 1.235 0.2 0 N-CA-C 110.002 -1.239 . . . . 41.33 110.002 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.569 ' N ' ' HD2' ' B' ' 23' ' ' PRO . 52.7 Cg_exo -54.36 -40.24 83.75 Favored 'Trans proline' 0 CA--C 1.586 3.092 0 C-N-CA 123.409 2.739 . . . . 73.23 115.855 177.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' B' ' 22' ' ' PRO . 16.8 Cg_exo -30.21 126.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.411 3.866 0 C-N-CA 124.822 3.681 . . . . 74.05 115.85 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -61.3 140.84 94.48 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 124.157 0.983 . . . . 74.05 112.888 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -40.94 149.54 0.17 Allowed 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 125.039 3.826 . . . . 62.22 117.595 -177.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.61 HD23 ' HB2' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -134.39 164.64 26.98 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 105.542 -2.022 . . . . 73.44 105.542 177.603 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.45 ' HB3' ' OE1' ' B' ' 30' ' ' GLU . 45.8 t -76.01 144.79 40.69 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 118.264 -1.375 . . . . 53.04 112.576 -172.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.43 -32.9 8.38 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.034 -1.439 . . . . 53.52 111.62 173.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -71.45 -35.04 70.77 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 112.982 0.734 . . . . 64.52 112.982 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.61 ' HB2' HD23 ' B' ' 26' ' ' LEU . 0.9 OUTLIER -59.17 -37.85 78.36 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 109.03 -0.73 . . . . 71.12 109.03 172.6 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' B' ' 35' ' ' ASP . 65.1 mttm -63.29 -42.22 99.06 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 115.403 -0.817 . . . . 74.43 111.232 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.647 ' N ' ' HE2' ' B' ' 32' ' ' LYS . 0.5 OUTLIER -64.54 -44.47 90.71 Favored 'General case' 0 C--O 1.204 -1.3 0 C-N-CA 119.817 -0.753 . . . . 72.32 111.553 176.228 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -65.07 -42.27 94.33 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.782 -0.367 . . . . 52.11 111.346 -175.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.503 HG12 ' O ' ' B' ' 30' ' ' GLU . 11.7 pt -70.96 -34.68 56.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 116.254 -0.43 . . . . 75.43 111.482 178.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' B' ' 31' ' ' LYS . 3.8 m-20 -68.03 -41.32 82.29 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.971 0.509 . . . . 74.31 111.786 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -68.44 -23.53 64.62 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.14 -0.936 . . . . 74.12 110.519 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -101.89 10.54 39.7 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.641 -0.708 . . . . 64.55 110.947 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' B' ' 84' ' ' GLU . 16.3 t -105.24 155.1 19.38 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-O 121.317 0.58 . . . . 74.23 110.622 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.458 HG22 ' O ' ' B' ' 83' ' ' ILE . 32.5 m -131.05 164.13 35.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.423 -0.808 . . . . 74.24 110.777 -176.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 40' ' ' TYR . . . . . 0.615 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 22.5 t80 -109.54 122.81 48.25 Favored 'General case' 0 C--N 1.281 -2.394 0 C-N-CA 125.712 1.605 . . . . 73.35 108.031 176.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 46.6 t -115.95 112.92 41.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 107.759 -1.2 . . . . 73.13 107.759 176.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.3 175.81 16.51 Favored Glycine 0 C--N 1.306 -1.102 0 C-N-CA 119.806 -1.188 . . . . 53.32 113.732 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 62.68 1.75 0.84 Allowed 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 126.462 1.905 . . . . 64.21 115.001 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.01 105.64 16.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.042 -1.036 . . . . 72.54 110.561 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -114.92 130.67 56.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 118.694 -0.669 . . . . 73.41 109.526 -171.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 46' ' ' TYR . . . . . 0.74 ' CE1' ' HB2' ' B' ' 77' ' ' PRO 0.344 13.6 m-85 52.11 -52.76 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 121.213 3.783 . . . . 72.12 121.213 170.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.74 -36.32 89.37 Favored Glycine 0 C--N 1.312 -0.777 0 N-CA-C 114.25 0.46 . . . . 72.14 114.25 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -91.44 147.84 22.74 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.095 0.474 . . . . 71.23 109.977 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 66.6 p -119.31 178.56 4.49 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.703 -0.68 . . . . 73.01 109.518 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.32 -50.29 74.22 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.021 0.378 . . . . 51.44 112.021 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -58.53 -40.81 83.97 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 120.972 0.415 . . . . 71.11 111.122 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -63.06 -47.74 81.64 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-N 115.665 -0.698 . . . . 74.33 109.766 -178.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 81.3 mt -62.36 -46.21 89.7 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-N 115.384 -0.826 . . . . 75.43 112.248 177.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -58.38 -47.69 83.03 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 112.636 0.606 . . . . 74.54 112.636 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.74 -45.44 78.01 Favored 'General case' 0 C--O 1.264 1.818 0 CA-C-O 121.463 0.649 . . . . 73.12 112.595 -176.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -67.35 -35.7 79.9 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.499 -0.773 . . . . 73.21 110.455 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -81.11 -22.94 38.74 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.052 0.76 . . . . 74.03 113.052 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 58' ' ' SER . . . . . 0.61 ' HA ' ' O ' ' B' ' 61' ' ' GLY . 68.6 m -67.09 -28.73 68.42 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 116.428 -0.351 . . . . 62.01 110.829 -177.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 16.0 m -59.33 -30.56 68.46 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.059 0.457 . . . . 72.12 110.845 175.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 71.4 m -106.73 -0.16 23.75 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 113.449 0.907 . . . . 74.32 113.449 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 61' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' B' ' 58' ' ' SER . . . 178.07 164.83 31.93 Favored Glycine 0 C--O 1.215 -1.075 0 C-N-CA 118.844 -1.646 . . . . 60.15 114.144 -177.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 40.1 m -98.92 120.92 40.17 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.829 -0.804 . . . . 34.45 108.829 177.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 84.7 mt -82.16 129.44 37.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 114.717 1.377 . . . . 52.43 114.717 -173.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 64' ' ' ASN . . . . . 0.585 ' OD1' ' HB3' ' A' ' 73' ' ' PHE . 31.1 t-20 -88.22 -46.21 9.43 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.598 1.559 . . . . 72.4 109.265 177.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.485 ' HG2' ' HA ' ' A' ' 71' ' ' ASP . 52.5 mtm180 -156.05 166.04 34.65 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.556 -0.535 . . . . 71.35 109.556 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.402 HG13 HG12 ' B' ' 83' ' ' ILE . 1.3 tt -149.76 134.51 9.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 115.869 -0.605 . . . . 74.31 111.478 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 67' ' ' THR . . . . . 0.437 HG23 ' HB3' ' A' ' 69' ' ' LEU . 28.2 m -125.76 133.16 52.15 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.527 -1.286 . . . . 71.3 107.527 -178.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 68' ' ' ILE . . . . . 0.426 HD12 ' N ' ' B' ' 68' ' ' ILE . 1.5 mp -130.25 125.04 59.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 107.052 -1.462 . . . . 71.13 107.052 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.255 1.3 pt? -121.11 132.21 54.73 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.169 -0.612 . . . . 75.45 111.657 175.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 70' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 86.1 m -117.3 126.71 53.17 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.326 -0.99 . . . . 51.1 108.326 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.611 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 3.1 p-10 -113.13 134.46 54.54 Favored 'General case' 0 CA--C 1.489 -1.394 0 C-N-CA 119.328 -0.949 . . . . 61.41 110.759 -177.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 72' ' ' LYS . . . . . 0.499 ' HE2' ' HB3' ' B' ' 77' ' ' PRO . 35.8 ttmt -119.49 14.26 12.75 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 105.698 -1.964 . . . . 61.1 105.698 176.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -43.75 -37.93 2.95 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 127.418 2.287 . . . . 73.5 113.27 177.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 49.8 m -110.37 22.24 15.73 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 120.891 0.377 . . . . 75.12 111.865 -177.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.83 -51.96 1.31 Allowed Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.366 -0.921 . . . . 74.35 112.857 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -95.4 119.16 65.84 Favored Pre-proline 0 C--N 1.311 -1.083 0 C-N-CA 120.586 -0.446 . . . . 72.43 110.385 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.74 ' HB2' ' CE1' ' B' ' 46' ' ' TYR . 57.3 Cg_endo -70.18 118.64 5.8 Favored 'Trans proline' 0 C--N 1.32 -0.97 0 C-N-CA 122.727 2.285 . . . . 53.32 113.335 -175.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 78' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 32.4 mtmm -113.83 166.25 11.75 Favored 'General case' 0 C--O 1.211 -0.963 0 CA-C-N 115.616 -0.72 . . . . 70.14 109.426 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -138.89 146.98 18.87 Favored Glycine 0 N--CA 1.421 -2.319 0 C-N-CA 120.042 -1.075 . . . . 45.43 114.177 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -153.16 146.3 24.66 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.467 -0.867 . . . . 74.14 108.891 172.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.38 154.12 48.95 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 120.946 0.403 . . . . 55.55 111.46 -172.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 82' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -127.64 121.07 29.5 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.863 -0.792 . . . . 74.03 108.863 175.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.458 ' O ' HG22 ' B' ' 39' ' ' VAL . 71.2 mt -121.2 136.02 59.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 116.344 -0.389 . . . . 53.4 110.101 -174.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 84' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' B' ' 38' ' ' SER 0.387 1.3 pm0 -110.82 132.63 54.03 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.81 1.041 . . . . 65.21 113.81 174.635 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -97.99 162.02 13.44 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.473 -0.785 . . . . 73.14 111.755 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.69 -38.26 81.08 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.24 -0.891 . . . . 74.11 112.119 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 87' ' ' GLU . . . . . 0.493 ' CD ' ' H ' ' B' ' 88' ' ' ARG . 0.3 OUTLIER -120.67 156.42 31.77 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 120.045 -0.662 . . . . 73.23 111.122 178.623 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.493 ' H ' ' CD ' ' B' ' 87' ' ' GLU . 0.8 OUTLIER -75.22 -32.32 61.11 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 107.157 -1.423 . . . . 74.3 107.157 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -63.82 -22.77 67.07 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.527 -0.76 . . . . 61.02 110.857 176.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 16.0 m -71.07 -35.66 71.96 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 109.315 -0.624 . . . . 72.4 109.315 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.417 HG22 ' O ' ' B' ' 88' ' ' ARG . 2.1 m -66.53 -37.12 78.92 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.157 0 N-CA-C 108.601 -0.888 . . . . 65.23 108.601 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -57.38 -38.46 74.27 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.353 0.597 . . . . 74.23 110.367 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.73 -33.0 64.15 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.458 -0.792 . . . . 73.42 110.043 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 94' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' B' ' 97' ' ' MET . . . -75.45 -43.67 48.31 Favored 'General case' 0 C--O 1.209 -1.049 0 CA-C-O 121.082 0.468 . . . . 63.42 110.562 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 24.7 m -63.24 -20.61 26.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 112.325 0.491 . . . . 74.14 112.325 176.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.95 -12.17 61.42 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 121.873 0.844 . . . . 53.13 109.882 174.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 97' ' ' MET . . . . . 0.494 ' HB2' ' O ' ' B' ' 94' ' ' ALA . 40.0 mtp -99.66 10.18 41.8 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.583 -1.19 . . . . 62.41 109.51 178.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 98' ' ' ASP . . . . . 0.684 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 6.9 p-10 -36.57 -45.41 0.51 Allowed 'General case' 0 C--O 1.206 -1.218 0 N-CA-C 115.564 1.691 . . . . 74.14 115.564 -176.259 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -124.52 49.41 1.82 Allowed 'General case' 0 C--O 1.241 0.614 0 CA-C-N 119.98 1.264 . . . . 75.35 112.258 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 31.7 p -81.54 177.26 9.04 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.761 -0.654 . . . . 72.14 112.363 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 8.7 p -108.06 136.37 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-O 121.156 0.503 . . . . 63.21 110.174 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -139.17 120.92 15.35 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.77 -1.567 . . . . 73.24 106.77 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 53.71 33.27 16.35 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.315 0.857 . . . . 61.22 113.315 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.59 1.49 87.57 Favored Glycine 0 C--N 1.314 -0.647 0 CA-C-N 115.828 -0.624 . . . . 62.44 113.7 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -120.81 157.19 30.29 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.073 -0.714 . . . . 71.44 109.073 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 52.1 m -91.61 120.3 32.27 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 109.166 -0.679 . . . . 72.4 109.166 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 pp -102.14 164.67 3.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 119.668 -0.813 . . . . 74.42 111.089 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 108' ' ' LYS . . . . . 0.684 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 16.4 tptm -125.69 125.13 42.55 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.985 -0.746 . . . . 63.44 108.985 -169.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 109' ' ' VAL . . . . . 0.615 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 22.9 t -121.16 131.37 73.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 110.046 -0.353 . . . . 74.04 110.046 -175.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.44 ' HB2' ' HB3' ' B' ' 40' ' ' TYR . 96.9 mt -138.77 163.71 44.72 Favored Pre-proline 0 C--O 1.211 -0.924 0 C-N-CA 123.533 0.733 . . . . 65.04 109.34 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.31 142.38 26.87 Favored 'Trans proline' 0 CA--C 1.554 1.513 0 C-N-CA 122.506 2.137 . . . . 52.12 108.924 171.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt . . . . . 0 CA--C 1.564 1.508 0 N-CA-C 114.04 1.126 . . . . 74.15 114.04 -171.875 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 . . . . . 0 CA--C 1.532 0.255 0 N-CA-C 112.262 0.468 . . . . 72.43 112.262 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.0 pt -70.37 -36.1 65.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 112.926 0.714 . . . . 55.01 112.926 -175.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.95 -39.16 74.03 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-O 120.985 0.422 . . . . 73.01 111.422 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.408 ' HB3' ' HD3' ' A' ' 88' ' ' ARG . 99.0 mttt -57.35 -37.27 72.33 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 112.711 0.634 . . . . 73.23 112.711 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.566 ' HA ' HG11 ' A' ' 91' ' ' VAL . 4.9 ptp180 -114.44 14.74 17.91 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 114.492 1.293 . . . . 64.25 114.492 -165.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 62.7 p -104.21 158.19 16.61 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.219 1.192 . . . . 54.44 114.219 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.5 ' CG1' HG23 ' A' ' 91' ' ' VAL . 16.2 m -140.36 164.92 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 113.118 0.785 . . . . 64.55 113.118 -177.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.606 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 16.0 t80 -113.04 127.84 56.33 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 126.576 1.951 . . . . 75.23 108.448 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.28 114.41 43.8 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 N-CA-C 107.591 -1.263 . . . . 71.12 107.591 176.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.26 168.0 12.89 Favored Glycine 0 N--CA 1.425 -2.075 0 C-N-CA 119.729 -1.224 . . . . 72.41 113.909 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . 0.255 10.0 t30 60.63 67.07 0.86 Allowed 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 126.025 1.73 . . . . 72.35 114.988 -178.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 p -120.65 135.21 61.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 114.597 -1.183 . . . . 55.4 109.743 171.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -112.81 167.02 10.83 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.902 -1.518 . . . . 74.24 106.902 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -59.93 103.65 0.23 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 122.083 0.944 . . . . 75.14 113.029 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -179.51 -44.32 0.08 OUTLIER Glycine 0 N--CA 1.42 -2.428 0 N-CA-C 107.163 -2.375 . . . . 75.25 107.163 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 73.3 m -94.16 150.44 20.32 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.06 -0.57 . . . . 55.33 109.609 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.9 p -124.67 179.18 5.08 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.497 -0.774 . . . . 50.15 109.027 -178.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.669 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -61.25 -45.38 94.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.072 0.463 . . . . 61.24 109.837 -178.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -58.66 -39.18 79.89 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.61 -0.723 . . . . 72.03 111.431 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -67.48 -37.95 83.66 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-O 121.692 0.758 . . . . 64.11 109.09 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.4 mt -66.33 -46.22 77.6 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 114.569 -1.196 . . . . 63.52 111.454 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.426 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 35.3 mt-10 -58.38 -47.32 84.23 Favored 'General case' 0 C--O 1.187 -2.185 0 N-CA-C 113.002 0.741 . . . . 73.14 113.002 178.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.03 -47.42 74.77 Favored 'General case' 0 C--O 1.267 2.016 0 CA-C-O 121.006 0.431 . . . . 75.2 111.857 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -66.2 -39.17 89.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.987 -0.552 . . . . 65.41 110.666 -176.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -82.28 -22.63 35.64 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.883 1.068 . . . . 74.52 113.883 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.7 t -67.38 -30.89 70.79 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 123.377 0.671 . . . . 74.14 109.692 -176.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.0 m -62.06 -21.07 64.64 Favored 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 120.332 -0.547 . . . . 73.21 111.035 175.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 90' ' ' SER . 77.3 m -96.59 4.89 51.7 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 112.687 0.625 . . . . 71.34 112.687 178.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.28 -172.02 26.19 Favored Glycine 0 CA--C 1.503 -0.676 0 C-N-CA 119.215 -1.469 . . . . 53.23 114.325 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.2 m -94.67 118.54 31.87 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.273 0.559 . . . . 65.51 110.618 -177.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.426 ' CD1' ' HA ' ' A' ' 54' ' ' GLU . 51.2 mt -76.34 132.67 32.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.313 -0.858 . . . . 71.03 111.314 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -97.33 -46.47 6.08 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.948 -1.023 . . . . 73.42 110.172 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.479 HH22 HD12 ' B' ' 69' ' ' LEU . 38.8 mtp180 -155.85 162.62 40.42 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.191 -1.411 . . . . 61.04 107.191 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.669 HD11 ' HB1' ' A' ' 50' ' ' ALA . 29.0 pt -147.93 144.24 19.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 108.775 -0.824 . . . . 74.33 108.775 173.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.4 m -125.44 130.24 51.44 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.426 -1.324 . . . . 72.35 107.426 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.441 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.8 mp -129.32 120.43 51.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 106.527 -1.657 . . . . 65.21 106.527 -178.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.286 1.3 pt? -122.09 134.24 54.77 Favored 'General case' 0 C--N 1.283 -2.324 0 C-N-CA 119.635 -0.826 . . . . 61.43 112.629 177.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 60.9 m -117.03 126.84 53.48 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.777 -0.823 . . . . 74.11 108.777 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -112.44 130.07 56.11 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 107.404 -1.332 . . . . 65.21 107.404 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -128.94 13.38 6.28 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 120.111 -0.636 . . . . 73.12 110.294 -176.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -63.08 -20.51 65.42 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.22 1.192 . . . . 64.52 114.22 -171.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 52.1 m -96.16 9.62 40.35 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.211 0.449 . . . . 74.42 112.211 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.42 -56.08 0.48 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.012 -1.089 . . . . 42.12 113.09 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 42.2 m-70 -95.11 133.35 26.34 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 108.834 -0.802 . . . . 61.31 108.834 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 76' ' ' HIS . 2.0 Cg_endo -76.82 117.57 4.54 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 C-N-CA 121.302 1.335 . . . . 51.02 110.503 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -100.28 140.51 34.43 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 108.253 -1.017 . . . . 52.05 108.253 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -129.63 147.85 18.1 Favored Glycine 0 N--CA 1.397 -3.904 0 C-N-CA 119.313 -1.423 . . . . 64.35 112.417 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -149.8 143.47 25.39 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 114.109 -1.046 . . . . 74.33 109.087 174.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.81 150.19 52.19 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 116.255 -0.43 . . . . 72.33 110.611 -171.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -120.87 117.53 27.6 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 109.141 -0.688 . . . . 72.24 109.141 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.454 HG23 HG22 ' A' ' 66' ' ' ILE . 34.3 mm -99.72 127.49 52.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.281 -1.377 . . . . 65.23 107.281 -178.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -113.15 124.25 52.12 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.762 -0.829 . . . . 72.34 108.762 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -98.24 165.67 11.76 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 111.602 0.223 . . . . 74.0 111.602 -177.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.05 -33.47 57.25 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.265 -0.425 . . . . 74.52 111.99 176.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -121.05 162.11 20.54 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 113.393 0.886 . . . . 54.43 113.393 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.408 ' HD3' ' HB3' ' A' ' 36' ' ' LYS . 16.5 mmm180 -66.39 -33.71 76.32 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 114.45 -1.25 . . . . 74.05 111.692 174.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -66.91 -29.28 69.11 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.61 -0.436 . . . . 71.12 111.47 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 60' ' ' CYS . 9.6 m -71.01 -42.08 70.04 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-O 120.723 0.296 . . . . 32.34 110.533 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.566 HG11 ' HA ' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -67.64 -39.49 82.31 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 N-CA-C 110.313 -0.254 . . . . 73.44 110.313 176.649 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -61.69 -37.21 83.27 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.354 0.597 . . . . 65.02 110.267 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.37 -31.29 62.33 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.804 -0.635 . . . . 73.34 110.829 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.88 -44.77 38.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.652 0.263 . . . . 54.05 111.161 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.404 HG11 ' HG3' ' A' ' 111' ' ' PRO . 32.5 m -57.74 -22.48 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 112.508 0.558 . . . . 73.52 112.508 177.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.2 -11.59 61.01 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 120.988 0.423 . . . . 75.43 110.05 176.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 64.9 mtm -102.75 10.78 38.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.224 -0.444 . . . . 75.41 110.293 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.619 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 4.7 p-10 -37.71 -48.71 1.09 Allowed 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.848 1.055 . . . . 73.45 113.848 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -114.72 99.92 7.87 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-O 121.975 0.893 . . . . 73.2 109.803 175.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 106' ' ' THR . 17.5 p -138.91 167.02 22.94 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.146 -1.388 . . . . 73.55 110.829 -178.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.0 p -113.85 105.55 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 CA-C-O 122.191 0.996 . . . . 62.0 109.494 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.568 ' O ' ' HG2' ' A' ' 105' ' ' ARG . 89.9 t80 -113.95 124.9 53.3 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.822 -1.081 . . . . 74.42 108.396 -176.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 20.6 ttt85 54.41 47.89 21.86 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 122.255 1.026 . . . . 73.55 110.131 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.57 8.0 55.14 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 113.769 -1.56 . . . . 73.1 115.146 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 102' ' ' PHE . 15.1 ptp180 -131.92 145.88 51.77 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 118.101 0.951 . . . . 55.11 111.135 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 100' ' ' THR . 27.8 m -77.76 120.18 22.31 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 120.903 0.382 . . . . 72.14 110.049 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 39.7 pt -102.55 171.25 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 109.596 -0.52 . . . . 73.35 109.596 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.619 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 42.0 tptt -134.73 130.8 36.8 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.894 -0.78 . . . . 71.14 108.894 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 17.7 t -121.13 127.81 75.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.043 -0.725 . . . . 73.3 109.043 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 89.7 mt -132.08 160.94 65.71 Favored Pre-proline 0 C--O 1.199 -1.605 0 N-CA-C 108.749 -0.834 . . . . 63.13 108.749 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.404 ' HG3' HG11 ' A' ' 95' ' ' VAL . 8.1 Cg_exo -77.65 140.74 19.03 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.031 1.821 . . . . 75.41 110.869 173.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp . . . . . 0 N--CA 1.423 -1.776 0 N-CA-C 104.928 -2.249 . . . . 51.23 104.928 173.684 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.159 0 N-CA-C 107.872 -2.091 . . . . 71.24 107.872 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -53.95 -40.29 81.49 Favored 'Trans proline' 0 CA--C 1.574 2.501 0 C-N-CA 122.744 2.296 . . . . 72.35 113.887 172.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.69 136.12 60.55 Favored 'Trans proline' 0 C--N 1.394 2.964 0 C-N-CA 121.301 1.334 . . . . 72.11 111.379 173.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -66.54 141.11 96.86 Favored Pre-proline 0 C--N 1.31 -1.14 0 CA-C-N 115.289 -0.868 . . . . 74.24 110.892 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -59.06 116.45 3.27 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 122.7 2.267 . . . . 63.3 111.112 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.661 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -67.14 160.75 26.15 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.751 -1.113 . . . . 51.21 112.068 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.524 ' HB3' ' OE1' ' B' ' 30' ' ' GLU . 29.6 t -82.04 164.68 21.25 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.507 0.67 . . . . 74.1 112.332 -173.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.4 -38.68 63.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.5 -1.227 . . . . 52.53 112.617 -178.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -69.47 -36.38 76.51 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 120.706 -0.398 . . . . 72.24 111.551 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.524 ' OE1' ' HB3' ' B' ' 27' ' ' SER . 3.6 mp0 -62.37 -35.23 78.51 Favored 'General case' 0 CA--C 1.503 -0.832 0 O-C-N 123.481 0.488 . . . . 73.34 110.645 175.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -66.03 -51.35 59.04 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 123.302 0.377 . . . . 75.24 110.466 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.485 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 47.9 mtmt -53.93 -35.52 61.78 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 114.141 1.163 . . . . 53.44 114.141 176.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.538 ' O ' ' HD3' ' B' ' 37' ' ' ARG . 24.5 mm-40 -70.25 -47.55 60.84 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.198 0.444 . . . . 74.34 112.198 174.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.444 HG12 ' O ' ' B' ' 30' ' ' GLU . 10.3 pt -70.92 -35.7 60.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 112.934 0.716 . . . . 71.42 112.934 -176.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.32 -35.49 65.2 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.229 0.537 . . . . 72.4 111.21 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 97.9 mttt -63.3 -35.07 79.14 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.126 -0.943 . . . . 74.01 112.685 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.538 ' HD3' ' O ' ' B' ' 33' ' ' GLU . 11.3 mtp180 -111.3 5.41 19.81 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 114.727 1.38 . . . . 73.14 114.727 -164.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.583 ' HB2' ' O ' ' B' ' 112' ' ' LYS . 15.5 m -96.97 154.98 16.98 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 112.906 0.706 . . . . 75.1 112.906 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.5 ' CG1' HG23 ' B' ' 91' ' ' VAL . 11.4 m -139.54 164.99 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.609 1.163 . . . . 41.43 112.522 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 40' ' ' TYR . . . . . 0.65 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 18.4 t80 -113.51 126.88 55.8 Favored 'General case' 0 CA--C 1.489 -1.372 0 C-N-CA 126.624 1.97 . . . . 73.42 108.592 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 66.2 t -121.03 114.25 42.72 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 N-CA-C 108.303 -0.999 . . . . 62.23 108.303 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.27 174.05 15.28 Favored Glycine 0 N--CA 1.421 -2.311 0 C-N-CA 119.514 -1.327 . . . . 54.33 113.176 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.5 t30 64.65 21.28 12.38 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.95 1.7 . . . . 63.54 112.877 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 8.7 p -69.81 123.68 24.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.092 -0.707 . . . . 74.32 109.092 173.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -82.39 159.71 22.95 Favored 'General case' 0 C--O 1.253 1.281 0 CA-C-N 115.48 -0.782 . . . . 75.0 109.675 -174.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -76.24 91.07 3.17 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-O 121.743 0.782 . . . . 74.03 108.945 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 168.2 -18.92 0.08 OUTLIER Glycine 0 N--CA 1.41 -3.048 0 CA-C-N 114.694 -1.139 . . . . 53.31 110.543 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -84.19 143.3 29.71 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 107.799 -1.185 . . . . 74.3 107.799 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 77.8 p -99.89 170.19 8.7 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 110.296 -0.261 . . . . 72.24 110.296 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.677 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -67.05 -39.85 87.01 Favored 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 108.87 -0.789 . . . . 73.04 108.87 175.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -57.43 -44.55 84.75 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.553 -1.203 . . . . 72.12 110.961 174.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.05 -47.89 77.05 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.384 0.611 . . . . 64.44 110.86 174.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 41.2 mt -58.76 -47.04 86.05 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 114.493 -1.23 . . . . 63.42 112.52 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.45 ' HA ' ' CD1' ' B' ' 63' ' ' ILE . 93.9 mt-10 -58.85 -47.87 83.37 Favored 'General case' 0 C--O 1.183 -2.431 0 N-CA-C 112.57 0.582 . . . . 72.11 112.57 177.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.13 -47.73 74.63 Favored 'General case' 0 C--O 1.27 2.142 0 N-CA-C 112.334 0.494 . . . . 60.4 112.334 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -67.16 -38.39 85.4 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.02 -0.536 . . . . 61.32 110.598 -176.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -82.61 -22.0 34.93 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.686 0.995 . . . . 71.33 113.686 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 37.8 t -64.55 -32.22 73.78 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 123.693 0.797 . . . . 75.2 109.454 -178.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.8 m -59.6 -24.34 63.71 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-N 116.271 -0.422 . . . . 71.15 110.978 174.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 60' ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' B' ' 90' ' ' SER . 68.8 m -88.1 -4.0 58.82 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.435 0.531 . . . . 74.33 112.435 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.94 -159.67 26.57 Favored Glycine 0 C--N 1.318 -0.425 0 C-N-CA 119.394 -1.384 . . . . 61.52 114.08 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 50.7 m -94.6 119.09 32.71 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 121.091 0.472 . . . . 73.12 112.102 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.45 ' CD1' ' HA ' ' B' ' 54' ' ' GLU . 68.0 mt -78.67 128.24 38.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.692 -0.686 . . . . 70.15 111.625 177.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 64' ' ' ASN . . . . . 0.489 ' OD1' ' HG3' ' B' ' 65' ' ' ARG . 19.0 t-20 -90.66 -50.23 6.03 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.797 -1.092 . . . . 71.23 108.529 -177.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.489 ' HG3' ' OD1' ' B' ' 64' ' ' ASN . 41.2 mtp180 -155.31 164.79 38.28 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 107.41 -1.33 . . . . 75.02 107.41 -177.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.677 HD11 ' HB1' ' B' ' 50' ' ' ALA . 28.9 pt -148.34 144.29 18.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.407 -0.96 . . . . 74.15 108.407 173.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 61.5 m -125.65 130.58 51.9 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 107.055 -1.461 . . . . 73.04 107.055 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 68' ' ' ILE . . . . . 0.415 HD12 ' N ' ' B' ' 68' ' ' ILE . 1.9 mp -129.32 119.9 49.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 106.657 -1.609 . . . . 70.33 106.657 -178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.479 HD12 HH22 ' A' ' 65' ' ' ARG 0.264 1.5 pt? -121.77 134.14 54.92 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 119.701 -0.799 . . . . 74.01 112.272 177.749 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 61.9 m -117.11 125.72 51.7 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.52 -0.918 . . . . 63.15 108.52 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.532 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 10.3 t70 -105.74 127.18 52.93 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.624 -1.25 . . . . 72.23 107.624 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 72' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' B' ' 77' ' ' PRO . 40.2 ttmt -127.01 17.56 7.24 Favored 'General case' 0 N--CA 1.423 -1.799 0 C-N-CA 120.719 -0.393 . . . . 73.13 110.138 -177.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . 0.255 1.4 p90 -70.25 -16.25 63.01 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 118.367 -1.333 . . . . 65.12 112.672 -177.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 46.0 m -94.42 17.89 12.21 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.203 -0.453 . . . . 71.32 110.393 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.42 -63.76 1.95 Allowed Glycine 0 CA--C 1.492 -1.354 0 C-N-CA 120.75 -0.738 . . . . 51.51 111.569 176.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . 0.255 89.6 m-70 -96.4 125.07 48.91 Favored Pre-proline 0 C--N 1.291 -1.975 0 C-N-CA 120.414 -0.514 . . . . 63.35 110.852 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 98.6 Cg_endo -73.6 135.72 22.39 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.944 2.429 . . . . 54.35 115.051 -171.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -112.12 146.13 38.56 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 124.883 1.273 . . . . 73.34 107.842 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.8 148.03 17.86 Favored Glycine 0 N--CA 1.412 -2.961 0 C-N-CA 119.142 -1.504 . . . . 73.32 112.968 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -151.48 143.37 23.82 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 114.362 -0.919 . . . . 74.5 109.736 172.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.13 151.61 51.69 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 116.169 -0.468 . . . . 61.5 110.657 -172.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 82' ' ' TYR . . . . . 0.735 ' CD1' ' HE2' ' B' ' 112' ' ' LYS . 89.9 m-85 -122.32 116.52 24.21 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 109.253 -0.647 . . . . 63.25 109.253 177.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.491 HG23 HG22 ' B' ' 66' ' ' ILE . 34.3 mm -98.86 127.21 51.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 107.31 -1.367 . . . . 63.3 107.31 -178.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 84' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' B' ' 38' ' ' SER . 29.3 mt-10 -112.36 125.62 54.4 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 108.836 -0.801 . . . . 72.53 108.836 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -100.07 162.38 13.01 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.432 0.634 . . . . 64.1 112.245 -177.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.45 -29.77 53.0 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.328 -0.851 . . . . 71.32 111.387 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -122.67 150.0 43.28 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 112.9 0.704 . . . . 54.15 112.9 -175.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.469 ' HD3' ' HB3' ' B' ' 36' ' ' LYS . 14.4 mmm180 -63.08 -34.89 78.56 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.116 0.566 . . . . 75.54 110.676 175.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -62.73 -32.15 73.22 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.577 -0.738 . . . . 71.35 110.913 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 90' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' B' ' 60' ' ' CYS . 15.1 m -71.15 -41.4 70.47 Favored 'General case' 0 N--CA 1.433 -1.313 0 O-C-N 122.335 -0.228 . . . . 75.55 110.949 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.5 HG23 ' CG1' ' B' ' 39' ' ' VAL . 0.2 OUTLIER -68.05 -38.98 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 C-N-CA 120.727 -0.389 . . . . 74.02 111.016 176.832 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -63.01 -36.68 84.36 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.476 0.655 . . . . 72.11 109.579 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.49 -31.03 63.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.797 -0.638 . . . . 71.24 111.789 178.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.05 -44.95 36.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.584 -0.734 . . . . 73.33 110.763 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 33.1 m -58.75 -22.29 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 112.334 0.494 . . . . 75.4 112.334 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.91 -14.91 63.28 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 121.51 0.671 . . . . 53.31 111.331 176.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 65.6 mtm -100.54 12.74 36.66 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.334 -0.848 . . . . 73.23 109.951 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 98' ' ' ASP . . . . . 0.694 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 3.0 p-10 -35.6 -51.98 0.66 Allowed 'General case' 0 C--O 1.178 -2.659 0 N-CA-C 115.51 1.67 . . . . 61.43 115.51 -174.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 99' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' B' ' 107' ' ' ILE . 19.0 tt0 -129.36 40.52 3.59 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 117.794 -1.562 . . . . 55.1 110.323 -178.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 47.6 p -75.63 -173.54 2.21 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.573 -1.194 . . . . 63.44 111.445 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.58 136.14 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 O-C-N 122.098 -0.376 . . . . 73.5 110.4 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -138.23 128.5 25.99 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 122.992 0.517 . . . . 64.44 109.924 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 50.17 32.45 6.02 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 124.998 1.319 . . . . 64.23 112.689 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.11 2.74 60.65 Favored Glycine 0 C--N 1.315 -0.617 0 CA-C-N 114.771 -1.104 . . . . 60.22 114.756 173.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -134.16 158.64 43.14 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 118.002 0.901 . . . . 72.34 111.169 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 68.4 m -85.47 119.85 26.27 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.338 -0.616 . . . . 54.34 109.338 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 107' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' B' ' 99' ' ' GLU . 42.1 pt -102.86 172.2 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 109.648 -0.501 . . . . 73.1 109.648 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 108' ' ' LYS . . . . . 0.694 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 0.1 OUTLIER -131.18 132.06 44.46 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.618 -1.253 . . . . 65.11 107.618 -179.654 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 109' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 21.2 t -121.67 130.82 74.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 108.099 -1.074 . . . . 74.14 108.099 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 90.1 mt -136.49 162.68 54.82 Favored Pre-proline 0 C--O 1.19 -2.046 0 N-CA-C 108.871 -0.789 . . . . 70.22 108.871 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -73.77 147.53 39.86 Favored 'Trans proline' 0 CA--C 1.564 1.98 0 C-N-CA 122.733 2.289 . . . . 70.32 110.564 173.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.735 ' HE2' ' CD1' ' B' ' 82' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.56 1.331 0 N-CA-C 109.633 -0.506 . . . . 70.31 109.633 -172.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 . . . . . 0 N--CA 1.445 -0.693 0 N-CA-C 113.786 1.032 . . . . 74.23 113.786 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.1 pt -69.33 -33.99 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.771 0.319 . . . . 75.34 111.457 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -62.32 -38.54 89.85 Favored 'General case' 0 C--O 1.203 -1.387 0 CA-C-N 115.611 -0.722 . . . . 72.22 111.521 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -70.35 -16.1 62.94 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 120.521 0.201 . . . . 63.33 111.17 -175.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.483 ' HA ' ' CG1' ' A' ' 91' ' ' VAL . 3.9 ptp180 -113.39 16.65 18.87 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 112.384 0.513 . . . . 74.03 112.384 -173.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.547 ' HB2' ' HG3' ' A' ' 84' ' ' GLU . 43.9 t -99.9 159.67 14.9 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-O 121.535 0.683 . . . . 65.3 111.607 177.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.484 ' CG1' HG23 ' A' ' 91' ' ' VAL . 5.5 m -139.7 164.12 24.16 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.942 0 C-N-CA 124.492 1.117 . . . . 73.34 110.686 176.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.644 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 16.4 t80 -118.9 128.39 54.38 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 125.236 1.415 . . . . 74.41 108.009 178.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 60.8 t -116.58 116.7 53.06 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 107.929 -1.137 . . . . 71.21 107.929 178.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.08 176.47 17.09 Favored Glycine 0 C--N 1.294 -1.771 0 C-N-CA 119.831 -1.176 . . . . 72.33 113.567 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 68.51 8.52 6.73 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.759 1.624 . . . . 72.02 113.405 177.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.4 p -91.15 104.45 15.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.634 0.731 . . . . 73.33 109.766 176.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.407 ' CG ' ' HA ' ' A' ' 78' ' ' LYS . 28.6 m-20 -116.79 102.98 9.87 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 106.985 -1.487 . . . . 75.12 106.985 -172.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 49.26 -175.78 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.594 1.331 . . . . 54.03 114.594 -172.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.69 -56.78 5.04 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.868 -0.682 . . . . 45.52 111.96 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.6 m -86.14 143.56 27.96 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 121.107 0.479 . . . . 61.1 110.071 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 61.7 p -114.79 178.82 4.14 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.199 -0.667 . . . . 73.55 109.199 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.52 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -58.91 -43.24 91.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.163 0.506 . . . . 64.23 109.777 178.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -56.96 -44.93 83.09 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 115.304 -0.862 . . . . 65.3 111.814 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -61.12 -42.49 98.64 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.513 0.673 . . . . 72.11 110.57 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.4 mt -69.89 -47.36 62.83 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 114.755 -1.111 . . . . 74.5 111.623 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.501 ' HB2' ' OH ' ' B' ' 46' ' ' TYR . 21.5 tt0 -59.15 -50.6 73.42 Favored 'General case' 0 C--O 1.194 -1.836 0 C-N-CA 121.108 -0.237 . . . . 72.24 111.486 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.32 79.67 Favored 'General case' 0 C--O 1.265 1.878 0 CA-C-O 121.763 0.792 . . . . 74.3 110.999 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -67.31 -38.45 84.99 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.209 -1.36 . . . . 71.13 110.107 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . 0.278 46.5 m-85 -82.48 -21.14 35.67 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 114.516 1.302 . . . . 64.24 114.516 177.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 71.4 m -64.81 -28.81 69.82 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 109.523 -0.547 . . . . 62.41 109.523 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.8 m -58.48 -25.23 62.09 Favored 'General case' 0 CA--C 1.56 1.351 0 CA-C-N 115.815 -0.63 . . . . 74.24 110.09 173.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 61.1 m -107.63 3.24 24.58 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 112.859 0.689 . . . . 71.33 112.859 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 58' ' ' SER . . . 173.51 177.54 42.81 Favored Glycine 0 N--CA 1.466 0.683 0 C-N-CA 118.551 -1.785 . . . . 31.44 115.159 -177.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.8 m -78.25 -61.09 2.11 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 122.389 0.276 . . . . 74.0 111.159 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 85' ' ' PHE 0.264 56.2 mt 99.85 117.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 126.11 1.764 . . . . 61.32 113.261 175.729 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.46 ' ND2' ' HA ' ' A' ' 86' ' ' ALA . 80.2 m-20 -98.59 -39.18 8.83 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 115.275 -0.875 . . . . 73.12 111.692 177.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.425 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 96.6 mtt180 -151.45 159.52 44.16 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.816 -0.809 . . . . 75.53 108.816 -177.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.52 HD11 ' HB1' ' A' ' 50' ' ' ALA . 17.1 pt -148.32 144.48 18.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.073 -1.455 . . . . 75.54 107.073 171.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.534 ' OG1' ' HB2' ' A' ' 82' ' ' TYR . 43.0 p -123.49 138.74 54.51 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 106.018 -1.845 . . . . 63.43 106.018 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.465 HD12 ' O ' ' B' ' 68' ' ' ILE . 2.9 mp -129.89 116.4 37.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 106.371 -1.714 . . . . 74.31 106.371 175.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -120.55 125.66 48.38 Favored 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 120.078 -0.649 . . . . 53.44 111.037 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.435 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 82.9 m -115.61 133.55 55.93 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.19 -0.67 . . . . 75.4 109.19 -177.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -119.07 127.97 53.89 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 118.63 -1.228 . . . . 74.11 110.513 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 77' ' ' PRO . 36.7 ttmt -121.32 12.14 10.88 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.549 -0.908 . . . . 75.44 108.549 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -62.64 -22.04 66.13 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.273 0.471 . . . . 71.44 112.273 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.5 t -90.72 5.11 49.51 Favored 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 115.98 -0.554 . . . . 73.43 110.668 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.48 -56.25 0.48 Allowed Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.702 -0.761 . . . . 54.42 111.977 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -96.26 136.48 21.98 Favored Pre-proline 0 C--N 1.304 -1.394 0 N-CA-C 110.149 -0.315 . . . . 74.4 110.149 176.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.433 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 80.3 Cg_endo -79.54 119.0 3.98 Favored 'Trans proline' 0 N--CA 1.441 -1.593 0 C-N-CA 121.774 1.649 . . . . 71.21 113.051 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.407 ' HA ' ' CG ' ' A' ' 45' ' ' ASP . 37.1 mtmm -105.34 -163.82 0.98 Allowed 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.785 -1.098 . . . . 64.35 108.742 175.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 70' ' ' CYS . . . 173.64 162.56 25.72 Favored Glycine 0 N--CA 1.412 -2.936 0 C-N-CA 119.591 -1.29 . . . . 73.24 114.453 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -158.53 153.91 25.84 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 113.641 -1.279 . . . . 75.05 108.988 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.92 152.95 50.79 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 120.386 0.136 . . . . 41.11 111.106 -173.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.534 ' HB2' ' OG1' ' A' ' 67' ' ' THR . 27.0 m-85 -118.22 130.05 55.85 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.572 -0.529 . . . . 74.45 109.572 174.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.449 HG23 HG22 ' A' ' 66' ' ' ILE . 32.8 mm -111.4 112.49 40.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 109.086 -0.709 . . . . 75.24 109.086 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.547 ' HG3' ' HB2' ' A' ' 38' ' ' SER . 4.1 mp0 -94.84 120.24 34.74 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.147 0.499 . . . . 65.23 110.943 176.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 99.1 m-85 -92.78 164.12 13.47 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.791 -0.448 . . . . 74.24 109.791 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.46 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . . . -85.02 -17.97 35.86 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.111 0.482 . . . . 63.1 109.969 174.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.426 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 0.7 OUTLIER -117.24 141.85 47.78 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 115.407 -0.815 . . . . 72.0 111.171 -178.313 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -75.57 -29.39 59.33 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 108.362 -0.977 . . . . 71.11 108.362 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -67.71 -24.79 65.43 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.76 -0.587 . . . . 74.32 110.713 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.426 ' OG ' ' HB2' ' A' ' 87' ' ' GLU . 20.1 m -71.69 -37.1 70.74 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 112.092 0.404 . . . . 74.14 112.092 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.484 HG23 ' CG1' ' A' ' 39' ' ' VAL . 0.2 OUTLIER -65.87 -38.46 82.21 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 C-N-CA 120.095 -0.642 . . . . 64.55 109.507 173.871 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.08 -37.59 77.46 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.291 0.567 . . . . 65.1 110.239 175.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.52 -31.76 63.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.101 -0.499 . . . . 72.52 111.429 177.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.34 -41.17 49.22 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.117 -0.492 . . . . 71.11 111.161 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.409 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 30.9 m -60.95 -21.99 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 112.716 0.636 . . . . 64.15 112.716 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.13 -10.92 60.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.525 0.678 . . . . 40.33 110.455 176.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 8.8 ttp -111.37 8.2 21.22 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.978 -1.119 . . . . 75.51 107.978 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.698 ' HA ' ' HB ' ' A' ' 109' ' ' VAL . 0.5 OUTLIER -44.31 -44.15 7.91 Favored 'General case' 0 CA--C 1.473 -1.982 0 N-CA-C 114.431 1.271 . . . . 60.41 114.431 -176.973 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -122.89 98.66 6.01 Favored 'General case' 0 N--CA 1.389 -3.481 0 CA-C-O 122.511 1.148 . . . . 70.22 110.061 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 106' ' ' THR . 19.7 p -140.02 173.25 11.71 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 113.187 -1.824 . . . . 73.4 111.122 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.0 p -111.51 112.58 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.804 0 CA-C-O 122.316 1.055 . . . . 73.15 110.036 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -121.48 126.55 49.52 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.355 -1.293 . . . . 73.42 107.643 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.7 ttt-85 58.81 33.15 22.87 Favored 'General case' 0 CA--C 1.558 1.259 0 CA-C-O 122.054 0.93 . . . . 75.23 109.759 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.47 1.56 86.5 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.3 -0.864 . . . . 72.44 113.898 178.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -126.13 153.7 44.19 Favored 'General case' 0 C--N 1.314 -0.974 0 O-C-N 122.25 -0.559 . . . . 74.32 110.289 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 100' ' ' THR . 27.2 m -79.75 119.74 23.07 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.447 -0.575 . . . . 62.24 109.447 -178.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 pp -102.82 159.0 4.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 C-N-CA 119.601 -0.839 . . . . 64.42 109.815 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 57.7 tptt -123.56 129.89 51.86 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.321 -0.622 . . . . 65.24 109.321 -170.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.698 ' HB ' ' HA ' ' A' ' 98' ' ' ASP . 21.7 t -118.53 128.13 75.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 108.728 -0.842 . . . . 62.13 108.728 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 40' ' ' TYR . 93.5 mt -125.51 141.36 38.77 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 108.999 -0.741 . . . . 74.32 108.999 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.07 136.96 18.88 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.546 1.497 . . . . 72.34 111.811 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 38' ' ' SER . 0.3 OUTLIER . . . . . 0 C--N 1.276 -2.59 0 N-CA-C 104.075 -2.565 . . . . 73.34 104.075 170.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.473 ' HA3' ' OH ' ' A' ' 82' ' ' TYR . . . . . . . . 0 CA--C 1.504 -0.628 0 CA-C-O 120.032 -0.315 . . . . 63.2 113.291 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.439 ' N ' ' HD2' ' B' ' 23' ' ' PRO . 54.1 Cg_exo -52.35 -44.44 46.65 Favored 'Trans proline' 0 CA--C 1.565 2.027 0 C-N-CA 123.792 2.995 . . . . 50.32 115.508 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' B' ' 22' ' ' PRO . 11.3 Cg_endo -53.78 146.72 44.01 Favored 'Trans proline' 0 C--N 1.389 2.696 0 C-N-CA 121.757 1.638 . . . . 70.03 112.349 177.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 15.3 pm0 -70.37 150.36 95.79 Favored Pre-proline 0 C--N 1.303 -1.436 0 CA-C-N 115.172 -0.922 . . . . 75.02 111.012 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.23 119.31 6.31 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.569 2.179 . . . . 71.03 112.144 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.625 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -77.03 168.5 19.98 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.168 -0.924 . . . . 64.4 110.69 176.271 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.62 ' HB3' ' OE1' ' B' ' 30' ' ' GLU . 47.4 t -68.12 147.06 52.84 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.612 0.967 . . . . 63.23 113.612 -173.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.718 ' O ' ' HG2' ' B' ' 32' ' ' LYS . . . -48.22 -46.22 35.01 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-N 114.001 -1.454 . . . . 64.14 111.949 177.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.403 ' HA ' ' CG ' ' B' ' 32' ' ' LYS . 69.9 mm-40 -63.65 -36.2 83.05 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.996 0.739 . . . . 74.22 112.996 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.62 ' OE1' ' HB3' ' B' ' 27' ' ' SER . 2.0 mp0 -63.12 -35.84 81.62 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.467 -0.493 . . . . 72.33 110.127 173.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' B' ' 26' ' ' LEU . 97.5 mttt -68.03 -43.59 78.39 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.032 -0.531 . . . . 75.15 109.581 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.718 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 28.9 mmmt -55.03 -47.36 74.84 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.628 0.771 . . . . 64.44 110.329 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -70.33 -46.28 64.49 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.341 -0.845 . . . . 54.22 111.745 -175.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 17.1 pt -69.72 -35.02 63.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.927 0.394 . . . . 74.42 111.569 -175.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.87 -44.36 96.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.768 -0.651 . . . . 74.54 111.825 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.586 ' HG2' ' O ' ' B' ' 32' ' ' LYS . 12.3 ptpt -68.47 -10.64 56.78 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 112.48 0.548 . . . . 62.2 112.48 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.432 ' HD3' ' O ' ' B' ' 86' ' ' ALA . 92.3 mtt180 -107.3 9.51 29.97 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.966 0.412 . . . . 73.2 110.871 -176.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.514 ' HB2' ' HB3' ' B' ' 112' ' ' LYS . 24.3 m -103.01 162.39 12.97 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 114.226 1.195 . . . . 74.43 114.226 -175.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.462 ' CG1' HG23 ' B' ' 91' ' ' VAL . 12.1 m -141.22 164.45 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.551 1.14 . . . . 75.24 111.907 176.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 40' ' ' TYR . . . . . 0.562 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 17.6 t80 -119.11 130.96 55.85 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 126.109 1.764 . . . . 71.34 107.999 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 58.1 t -119.42 117.58 54.48 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 C-N-CA 123.945 0.898 . . . . 64.43 108.81 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.77 166.13 14.78 Favored Glycine 0 C--N 1.293 -1.806 0 C-N-CA 120.205 -0.998 . . . . 63.54 111.961 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 60.3 t30 66.29 20.36 11.03 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.738 1.615 . . . . 73.24 113.152 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 11.3 p -64.32 133.33 29.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 O-C-N 121.544 -0.723 . . . . 75.0 109.651 177.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.483 ' HB2' ' HD3' ' B' ' 105' ' ' ARG . 21.7 t70 -72.43 141.34 48.65 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 108.294 -1.002 . . . . 74.52 108.294 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 46' ' ' TYR . . . . . 0.501 ' OH ' ' HB2' ' A' ' 54' ' ' GLU . 4.6 t80 -56.92 -28.15 61.73 Favored 'General case' 0 CA--C 1.551 0.996 0 O-C-N 124.187 0.929 . . . . 71.4 109.754 -178.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.33 0.77 81.51 Favored Glycine 0 N--CA 1.427 -1.924 0 CA-C-N 115.787 -0.642 . . . . 65.11 113.366 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 18.6 m -78.99 135.33 36.88 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 107.781 -1.192 . . . . 71.55 107.781 176.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 63.6 p -94.38 169.97 9.83 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 119.115 -1.034 . . . . 71.54 110.457 -176.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.628 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -60.47 -38.61 84.79 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.506 -0.924 . . . . 44.31 108.506 174.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -57.26 -46.68 82.82 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.191 -0.913 . . . . 51.53 111.242 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -58.55 -47.49 84.06 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.669 0.747 . . . . 43.4 110.183 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 66.2 mt -64.88 -48.03 75.69 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.645 -1.162 . . . . 71.33 112.344 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -59.7 -50.71 72.79 Favored 'General case' 0 C--O 1.206 -1.231 0 N-CA-C 111.656 0.243 . . . . 73.22 111.656 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.53 -45.42 81.15 Favored 'General case' 0 C--O 1.269 2.106 0 CA-C-O 121.631 0.729 . . . . 70.24 111.127 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -66.78 -39.21 87.73 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.457 -1.247 . . . . 62.31 109.942 -174.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . 0.259 46.4 m-85 -82.09 -21.47 36.77 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 114.617 1.339 . . . . 70.51 114.617 177.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 68.2 m -64.57 -28.03 69.36 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.166 0.508 . . . . 72.33 109.784 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 18.8 m -58.42 -28.94 65.7 Favored 'General case' 0 CA--C 1.557 1.248 0 CA-C-N 115.892 -0.595 . . . . 74.24 110.837 173.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 82.2 m -95.89 3.17 53.83 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 113.616 0.969 . . . . 61.33 113.616 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.9 -169.67 27.27 Favored Glycine 0 N--CA 1.464 0.515 0 C-N-CA 118.662 -1.733 . . . . 52.15 115.244 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 27.1 m -93.73 127.88 39.67 Favored 'General case' 0 C--O 1.216 -0.68 0 C-N-CA 123.391 0.677 . . . . 71.32 110.372 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 85.5 mt -97.88 132.04 43.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 124.023 0.929 . . . . 72.04 113.284 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 64' ' ' ASN . . . . . 0.468 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 75.5 m-20 -100.03 -38.69 8.47 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.84 0.856 . . . . 72.24 112.304 176.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.433 ' HB2' ' HB2' ' B' ' 84' ' ' GLU . 95.3 mtt180 -151.76 160.36 43.61 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.096 -0.705 . . . . 71.31 109.096 -177.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.628 HD11 ' HB1' ' B' ' 50' ' ' ALA . 20.1 pt -148.52 144.52 18.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.094 -1.447 . . . . 75.0 107.094 172.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 67' ' ' THR . . . . . 0.546 ' OG1' ' HB2' ' B' ' 82' ' ' TYR . 43.4 p -123.98 139.7 53.7 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 105.936 -1.876 . . . . 63.01 105.936 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 68' ' ' ILE . . . . . 0.465 ' O ' HD12 ' A' ' 68' ' ' ILE . 2.4 mp -130.61 118.41 42.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 106.009 -1.848 . . . . 64.02 106.009 175.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.293 1.0 OUTLIER -121.39 125.56 47.24 Favored 'General case' 0 C--N 1.28 -2.44 0 C-N-CA 120.348 -0.541 . . . . 74.13 111.977 177.77 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 70' ' ' CYS . . . . . 0.467 ' HA ' ' HA2' ' B' ' 79' ' ' GLY . 68.7 m -116.53 133.5 55.94 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.198 -0.667 . . . . 63.22 109.198 -176.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 5.4 p-10 -122.52 133.82 54.57 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 118.701 -1.2 . . . . 74.04 111.426 -179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 72' ' ' LYS . . . . . 0.4 ' HE3' ' HG3' ' B' ' 77' ' ' PRO . 39.9 mtpt -116.74 17.36 15.2 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.551 -1.648 . . . . 75.2 106.551 178.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -44.64 -35.03 2.41 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.811 2.044 . . . . 74.32 112.847 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 39.9 m -115.24 26.29 10.21 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 111.773 0.286 . . . . 74.41 111.773 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.27 -60.22 0.49 Allowed Glycine 0 C--O 1.236 0.276 0 C-N-CA 120.617 -0.802 . . . . 64.21 114.054 175.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 76' ' ' HIS . . . . . 0.408 ' HA ' ' HD3' ' B' ' 77' ' ' PRO . 12.0 m170 -84.78 141.91 38.81 Favored Pre-proline 0 C--N 1.31 -1.147 0 N-CA-C 110.176 -0.305 . . . . 73.04 110.176 -177.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' B' ' 76' ' ' HIS . 3.0 Cg_exo -78.88 118.04 4.03 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 121.177 1.251 . . . . 74.04 111.854 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -112.43 -166.47 1.08 Allowed 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 109.207 -0.664 . . . . 75.44 109.207 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 79' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' B' ' 70' ' ' CYS . . . 171.58 159.41 17.74 Favored Glycine 0 N--CA 1.414 -2.768 0 C-N-CA 119.652 -1.261 . . . . 63.25 114.16 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -154.64 152.14 29.62 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 125.06 1.344 . . . . 70.53 109.091 176.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.08 153.93 51.17 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 122.001 0.121 . . . . 65.22 110.982 -173.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 82' ' ' TYR . . . . . 0.546 ' HB2' ' OG1' ' B' ' 67' ' ' THR . 30.8 m-85 -119.95 127.0 52.26 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 110.047 -0.353 . . . . 75.45 110.047 174.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.484 HG23 HG22 ' B' ' 66' ' ' ILE . 23.8 mm -107.97 118.74 56.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 107.497 -1.297 . . . . 64.11 107.497 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 84' ' ' GLU . . . . . 0.433 ' HB2' ' HB2' ' B' ' 65' ' ' ARG . 61.6 mt-10 -105.73 119.63 39.64 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.249 0.547 . . . . 71.15 110.235 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -95.81 162.0 13.78 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.671 -0.695 . . . . 71.5 112.285 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.468 ' HA ' ' ND2' ' B' ' 64' ' ' ASN . . . -79.03 -32.04 44.86 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.771 -1.104 . . . . 64.24 111.168 175.021 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.39 146.4 34.5 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 120.06 -0.656 . . . . 65.55 110.26 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -74.69 -26.67 59.99 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 108.015 -1.105 . . . . 73.43 108.015 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -72.51 -20.28 61.39 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 119.723 -0.791 . . . . 71.2 111.625 177.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 21.9 m -69.46 -37.35 77.28 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 110.505 -0.183 . . . . 62.4 110.505 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.462 HG23 ' CG1' ' B' ' 39' ' ' VAL . 0.2 OUTLIER -67.08 -39.05 82.43 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 C-N-CA 120.427 -0.509 . . . . 61.2 109.905 175.173 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.93 -37.08 75.88 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.213 0.53 . . . . 74.14 110.716 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.42 -31.41 62.3 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.033 -0.53 . . . . 62.15 111.173 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.73 -43.02 48.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.197 -0.456 . . . . 63.54 111.167 -178.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 33.6 m -57.11 -22.24 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 112.724 0.638 . . . . 73.34 112.724 177.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.4 -15.74 63.85 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.219 0.533 . . . . 71.2 110.515 176.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 11.2 mtm -98.71 15.64 24.63 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.654 0.782 . . . . 75.21 111.436 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 98' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 6.0 t70 -33.85 -52.25 0.42 Allowed 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 114.807 1.41 . . . . 75.55 114.807 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -123.91 64.42 1.05 Allowed 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 118.778 -1.169 . . . . 71.43 111.182 174.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 10.8 t -97.72 -177.63 3.85 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.772 -1.104 . . . . 65.43 110.087 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 9.7 p -108.6 134.5 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 CA-C-O 121.254 0.55 . . . . 51.03 109.652 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -130.31 115.83 17.48 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.073 -0.714 . . . . 61.43 109.073 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 40.0 mtp-105 49.98 32.24 5.49 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.471 1.508 . . . . 75.23 112.23 -178.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.66 -6.32 62.7 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.502 -0.772 . . . . 73.31 112.879 175.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.483 ' HD3' ' HB2' ' B' ' 45' ' ' ASP . 30.2 mtp180 -110.14 133.56 53.09 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.808 -0.442 . . . . 71.3 109.808 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 14.4 m -75.57 120.51 21.08 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.044 -1.095 . . . . 72.24 108.044 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 41.6 pt -103.13 172.08 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-O 121.475 0.655 . . . . 74.22 112.262 -178.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 108' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 57.6 tptt -125.93 126.44 44.37 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.667 -1.151 . . . . 74.43 107.97 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 109' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 48.5 t -117.71 122.06 68.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.904 -0.776 . . . . 74.03 108.904 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.46 ' HB2' ' HB3' ' B' ' 40' ' ' TYR . 95.8 mt -121.53 145.19 42.12 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 108.918 -0.771 . . . . 70.12 108.918 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.55 130.84 13.07 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.857 1.705 . . . . 75.22 109.66 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.514 ' HB3' ' HB2' ' B' ' 38' ' ' SER . 25.7 ttpp . . . . . 0 CA--C 1.5 -0.981 0 C-N-CA 119.981 -0.688 . . . . 64.12 112.368 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 . . . . . 0 N--CA 1.415 -2.196 0 N-CA-C 112.74 0.644 . . . . 72.14 112.74 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.438 HG23 HH21 ' A' ' 37' ' ' ARG . 15.8 pt -65.94 -34.33 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 120.46 -0.496 . . . . 71.32 110.827 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -61.16 -42.6 98.85 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.779 -0.823 . . . . 72.13 108.779 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -78.64 -26.79 45.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.363 -0.835 . . . . 72.25 112.386 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.438 HH21 HG23 ' A' ' 34' ' ' ILE . 89.3 mtm180 -89.71 12.96 15.46 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 123.068 0.547 . . . . 64.35 111.943 -177.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.3 t -96.64 145.21 25.96 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.277 0.561 . . . . 75.14 111.403 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.48 ' CG1' ' HB ' ' A' ' 91' ' ' VAL . 28.3 m -128.17 160.02 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.764 0 CA-C-N 115.839 -0.619 . . . . 72.21 110.487 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.572 ' CZ ' ' HG3' ' B' ' 22' ' ' PRO . 15.1 t80 -110.4 121.21 44.75 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 107.692 -1.225 . . . . 72.41 107.692 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.716 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 66.6 t -121.55 108.8 23.1 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 N-CA-C 107.404 -1.332 . . . . 70.5 107.404 173.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.18 172.03 17.42 Favored Glycine 0 C--N 1.284 -2.359 0 C-N-CA 118.813 -1.661 . . . . 64.44 112.825 -176.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.3 t30 61.64 34.1 17.79 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 124.269 1.028 . . . . 71.45 110.421 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.499 ' HA ' ' NH1' ' A' ' 105' ' ' ARG . 7.4 p -90.89 14.11 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.706 0 CA-C-N 115.03 -0.986 . . . . 64.42 111.231 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -36.62 112.27 0.18 Allowed 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 127.929 2.492 . . . . 64.45 114.69 -177.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . 0.524 32.1 m-85 50.11 -43.91 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.846 1 N-CA-C 122.467 4.247 . . . . 74.33 122.467 173.418 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.84 0.18 46.49 Favored Glycine 0 C--N 1.306 -1.108 0 CA-C-N 119.145 0.884 . . . . 30.0 113.32 -175.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.489 ' HB2' HG22 ' A' ' 44' ' ' VAL . 49.6 m -129.48 137.31 50.76 Favored 'General case' 0 N--CA 1.409 -2.497 0 O-C-N 122.45 -0.441 . . . . 64.14 110.046 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 47.1 p -125.25 179.34 5.12 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.238 -1.023 . . . . 64.31 108.238 -176.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.96 -49.77 76.38 Favored 'General case' 0 C--O 1.207 -1.159 0 CA-C-N 118.349 0.522 . . . . 63.2 111.134 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -58.26 -41.12 83.54 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.888 0.699 . . . . 63.3 112.888 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -62.93 -44.64 95.52 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.941 0.877 . . . . 63.31 110.1 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.45 ' HB3' ' HE2' ' A' ' 57' ' ' PHE . 63.4 mt -73.0 -46.72 50.59 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.497 -1.229 . . . . 73.24 112.482 -175.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.5 ' HG3' ' OH ' ' B' ' 46' ' ' TYR . 6.1 tm-20 -57.48 -48.68 78.57 Favored 'General case' 0 C--O 1.196 -1.711 0 C-N-CA 122.804 0.442 . . . . 74.35 110.441 -176.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.22 -42.73 77.74 Favored 'General case' 0 C--O 1.267 2.008 0 CA-C-O 121.724 0.773 . . . . 43.02 110.747 176.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -68.08 -43.59 78.22 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.248 -0.887 . . . . 71.2 111.335 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.609 ' CD2' HG12 ' A' ' 83' ' ' ILE . 65.9 m-85 -80.15 -22.98 41.44 Favored 'General case' 0 C--O 1.225 -0.218 0 O-C-N 121.91 -0.494 . . . . 71.25 111.435 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.9 t -69.46 -24.14 63.76 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.9 -0.778 . . . . 41.23 108.9 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.8 m -63.27 -22.57 66.96 Favored 'General case' 0 CA--C 1.568 1.641 0 CA-C-N 116.121 -0.49 . . . . 55.11 110.78 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 78.7 m -97.03 7.43 46.67 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.821 0.674 . . . . 74.25 112.821 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 142.97 -161.79 27.52 Favored Glycine 0 C--O 1.221 -0.682 0 C-N-CA 119.45 -1.357 . . . . 65.24 113.838 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.3 m -99.26 129.81 45.51 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.404 -0.591 . . . . 63.54 109.404 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.44 HD11 ' HB2' ' A' ' 57' ' ' PHE . 72.0 mt -85.23 133.3 29.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 113.084 0.772 . . . . 65.24 113.084 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.496 ' OD1' ' HG3' ' A' ' 65' ' ' ARG . 24.1 t-20 -94.7 -48.19 6.17 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.865 1.266 . . . . 64.44 108.234 178.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.496 ' HG3' ' OD1' ' A' ' 64' ' ' ASN . 98.9 mtt180 -148.57 158.84 44.4 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.506 -0.77 . . . . 72.21 109.003 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.417 ' HB ' HG13 ' A' ' 83' ' ' ILE . 1.5 tt -149.31 127.6 2.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 C-N-CA 123.198 0.599 . . . . 54.15 110.138 173.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 30.2 m -125.08 133.65 52.81 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.627 -1.249 . . . . 62.53 107.627 -173.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.0 mp -131.03 120.6 47.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 106.646 -1.613 . . . . 63.44 106.646 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.469 ' H ' HD23 ' A' ' 69' ' ' LEU . 1.6 pt? -120.63 134.33 55.29 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.871 -0.332 . . . . 72.01 110.14 178.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 80.8 m -116.58 126.51 53.38 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.642 -0.873 . . . . 73.24 108.642 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.603 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 4.3 p30 -105.29 126.6 52.29 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.403 -0.519 . . . . 73.54 111.108 -177.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.451 ' HG2' ' HB3' ' A' ' 77' ' ' PRO . 96.3 mttt -119.47 2.53 11.25 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 112.62 0.6 . . . . 61.23 112.62 177.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.664 ' HB3' ' OD1' ' B' ' 64' ' ' ASN . 41.8 p90 -56.96 -27.67 61.49 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 113.924 1.083 . . . . 74.14 113.924 -176.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.0 t -97.24 10.87 38.31 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.259 0.552 . . . . 64.4 110.191 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.35 -55.78 0.55 Allowed Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 121.072 -0.585 . . . . 42.41 112.677 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.3 m80 -95.5 125.56 49.12 Favored Pre-proline 0 C--N 1.308 -1.237 0 C-N-CA 120.964 -0.294 . . . . 75.22 110.946 -177.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.603 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 26.5 Cg_endo -67.88 119.59 6.59 Favored 'Trans proline' 0 C--O 1.247 0.94 0 C-N-CA 122.829 2.353 . . . . 63.4 112.744 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.453 ' HB2' ' OD2' ' A' ' 71' ' ' ASP . 28.1 mtmm -113.21 -160.37 0.72 Allowed 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.796 -1.187 . . . . 72.14 107.796 172.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 69' ' ' LEU . . . 179.04 153.15 11.23 Favored Glycine 0 N--CA 1.423 -2.225 0 C-N-CA 119.145 -1.502 . . . . 63.22 114.786 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.414 ' O ' HD23 ' A' ' 69' ' ' LEU . 24.9 m-85 -136.22 153.31 51.26 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.628 -1.99 . . . . 71.51 105.628 174.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.486 ' HB2' HG11 ' A' ' 44' ' ' VAL . . . -131.64 131.19 42.99 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.588 -0.893 . . . . 72.15 108.588 176.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -115.39 120.45 39.63 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.594 -1.261 . . . . 71.41 107.594 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.609 HG12 ' CD2' ' A' ' 57' ' ' PHE . 1.1 mp -113.76 129.05 70.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 108.894 -0.78 . . . . 71.33 108.894 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 65' ' ' ARG . 2.1 mp0 -99.6 124.43 44.79 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.2 -1.408 . . . . 74.24 107.2 174.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -94.03 155.93 16.86 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 121.248 -0.181 . . . . 74.23 110.628 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.29 -32.05 72.78 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.427 -0.352 . . . . 14.31 111.427 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.86 148.34 44.17 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.777 -0.769 . . . . 74.11 110.163 175.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -70.76 -27.09 63.67 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.319 -0.855 . . . . 75.24 109.608 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -62.49 -33.91 75.81 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.921 -0.582 . . . . 71.23 110.521 174.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.5 m -66.75 -35.94 81.28 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 116.048 -0.524 . . . . 53.5 110.902 -177.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.504 ' O ' HG13 ' A' ' 95' ' ' VAL . 1.5 m -68.95 -37.69 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 108.435 -0.95 . . . . 72.34 108.435 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.639 ' O ' HG22 ' A' ' 95' ' ' VAL . 9.9 t70 -68.02 -30.52 69.77 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.722 0.772 . . . . 64.33 109.499 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.01 -31.24 64.36 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.667 -0.697 . . . . 73.11 110.088 175.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.85 -36.17 59.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.889 -0.596 . . . . 53.21 111.453 -177.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 92' ' ' ASP . 11.2 m -53.86 -21.63 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 112.597 0.592 . . . . 74.14 112.597 178.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.75 -12.2 44.6 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.304 0.573 . . . . 54.23 110.991 177.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.565 ' HA ' ' OG1' ' A' ' 100' ' ' THR . 68.0 mtm -100.43 5.43 44.25 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 116.1 -0.5 . . . . 64.32 111.092 178.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.541 ' HA ' ' H ' ' A' ' 109' ' ' VAL . 0.4 OUTLIER -48.4 -49.02 36.53 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.569 1.322 . . . . 74.35 114.569 -177.171 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -101.97 12.82 36.29 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-O 121.887 0.851 . . . . 72.23 110.539 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.565 ' OG1' ' HA ' ' A' ' 97' ' ' MET . 62.9 m -72.24 151.93 42.53 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.917 -0.583 . . . . 73.14 109.984 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -101.56 134.34 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 N-CA-C 108.559 -0.904 . . . . 73.52 108.559 -177.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.48 ' HE2' ' OG ' ' A' ' 48' ' ' SER . 82.6 t80 -130.12 118.81 22.05 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 115.654 -0.703 . . . . 74.35 109.17 -173.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 54.55 32.06 16.18 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.717 1.006 . . . . 64.02 113.717 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.71 -5.47 73.33 Favored Glycine 0 N--CA 1.461 0.352 0 CA-C-N 115.227 -0.897 . . . . 64.15 113.406 174.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.499 ' NH1' ' HA ' ' A' ' 44' ' ' VAL . 21.9 ptt85 -121.52 145.49 47.9 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 122.846 0.458 . . . . 74.43 110.301 178.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.2 m -82.61 122.24 27.86 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.545 -0.909 . . . . 64.44 108.545 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 41.3 pt -101.44 171.52 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 N-CA-C 108.44 -0.948 . . . . 63.13 108.44 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.716 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 22.9 mmmt -121.91 128.23 51.32 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 109.685 -0.487 . . . . 71.15 109.685 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.541 ' H ' ' HA ' ' A' ' 98' ' ' ASP . 60.5 t -117.48 112.16 37.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 105.127 -2.175 . . . . 62.52 105.127 173.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 tt -140.41 129.97 13.38 Favored Pre-proline 0 C--N 1.274 -2.681 0 N-CA-C 105.146 -2.168 . . . . 75.31 105.146 -172.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -55.12 136.81 74.81 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 121.584 1.523 . . . . 72.41 109.736 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.25 24.2 ttpp . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 122.615 1.197 . . . . 71.43 112.204 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.776 0 CA-C-O 119.879 -0.4 . . . . 71.2 113.417 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.572 ' HG3' ' CZ ' ' A' ' 40' ' ' TYR . 0.9 OUTLIER -40.54 -57.27 1.3 Allowed 'Trans proline' 0 CA--C 1.573 2.47 0 C-N-CA 124.797 3.665 . . . . 54.15 116.192 -178.794 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.512 ' HD3' ' HG2' ' B' ' 22' ' ' PRO . 4.8 Cg_exo -83.95 165.61 13.31 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 121.95 1.767 . . . . 64.4 110.734 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -103.91 145.38 30.53 Favored Pre-proline 0 C--N 1.283 -2.31 0 N-CA-C 109.382 -0.599 . . . . 65.01 109.382 176.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -46.78 127.6 12.23 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.266 2.644 . . . . 43.54 113.841 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.802 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -61.61 -167.97 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 114.47 -1.241 . . . . 65.54 113.837 178.754 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.572 ' O ' ' HG3' ' B' ' 31' ' ' LYS . 47.0 t -54.19 143.51 22.56 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.765 0.793 . . . . 52.44 112.583 -176.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.423 ' O ' ' HE2' ' B' ' 32' ' ' LYS . . . -60.89 -43.74 98.06 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.16 -1.382 . . . . 72.43 111.709 178.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -66.92 -33.02 74.68 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 111.715 0.265 . . . . 52.33 111.715 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.64 ' HB3' HD23 ' B' ' 26' ' ' LEU . 10.8 tp10 -62.64 -34.89 77.97 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 107.631 -1.248 . . . . 52.04 107.631 177.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.572 ' HG3' ' O ' ' B' ' 27' ' ' SER . 92.6 mttt -70.07 -50.43 41.11 Favored 'General case' 0 C--O 1.203 -1.359 0 CA-C-N 115.341 -0.845 . . . . 72.32 111.101 -174.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.532 ' N ' ' HE2' ' B' ' 32' ' ' LYS . 0.2 OUTLIER -57.66 -37.42 73.36 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 120.106 -0.637 . . . . 72.15 112.062 -177.455 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.659 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 7.1 mm-40 -71.14 -47.41 58.04 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.074 -0.512 . . . . 72.03 110.635 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.509 HG12 ' HA ' ' B' ' 31' ' ' LYS . 21.4 pt -64.83 -34.65 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 122.975 0.172 . . . . 63.15 111.211 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -60.63 -42.66 97.33 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-O 121.183 0.516 . . . . 74.35 109.807 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.436 ' O ' ' HD3' ' B' ' 88' ' ' ARG . 98.4 mttt -78.38 -25.87 46.38 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.153 0.798 . . . . 75.31 113.153 -176.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.659 ' HG2' ' O ' ' B' ' 33' ' ' GLU . 14.7 ptp180 -108.29 31.96 5.17 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.704 0.764 . . . . 74.54 112.2 -174.009 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' B' ' 84' ' ' GLU . 35.2 t -95.55 155.78 16.6 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.092 -1.447 . . . . 63.21 107.092 172.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.495 ' CG1' ' HB ' ' B' ' 91' ' ' VAL . 26.8 m -135.49 158.39 40.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.931 -0.48 . . . . 75.32 110.11 176.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -107.73 119.82 40.51 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 107.354 -1.35 . . . . 63.41 107.354 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 67.3 t -122.0 107.57 20.14 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 N-CA-C 106.806 -1.553 . . . . 51.05 106.806 173.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.86 171.49 19.99 Favored Glycine 0 C--N 1.276 -2.802 0 C-N-CA 118.29 -1.909 . . . . 75.42 112.712 -176.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.6 t30 66.57 28.66 9.26 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.289 1.436 . . . . 72.33 112.208 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 14.7 p -58.49 134.5 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-O 121.412 0.625 . . . . 71.25 109.862 175.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -73.69 146.32 44.57 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.479 -0.782 . . . . 73.22 109.547 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 46' ' ' TYR . . . . . 0.5 ' OH ' ' HG3' ' A' ' 54' ' ' GLU . 45.8 t80 -61.71 -19.24 62.17 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.794 0.838 . . . . 72.42 110.93 -176.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.32 -0.53 55.75 Favored Glycine 0 N--CA 1.427 -1.924 0 CA-C-N 116.01 -0.541 . . . . 73.01 112.551 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 34.0 m -84.64 133.36 34.41 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.895 -0.78 . . . . 74.42 108.895 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 62.0 p -113.02 178.73 4.18 Favored 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 119.74 -0.784 . . . . 64.22 111.132 -177.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.8 -43.36 99.01 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.741 -0.663 . . . . 53.41 110.984 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -58.62 -43.13 89.58 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 111.724 0.268 . . . . 74.35 111.724 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -60.34 -47.93 83.93 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.912 0.863 . . . . 71.32 109.614 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.462 ' HB3' ' HE2' ' B' ' 57' ' ' PHE . 69.4 mt -68.73 -47.32 66.61 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-N 114.271 -1.331 . . . . 74.44 112.816 -177.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -57.34 -48.85 77.92 Favored 'General case' 0 C--O 1.205 -1.284 0 C-N-CA 122.872 0.469 . . . . 64.2 110.569 -176.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.34 -42.72 78.2 Favored 'General case' 0 C--O 1.258 1.522 0 CA-C-O 121.286 0.565 . . . . 70.24 110.631 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -69.1 -42.03 76.67 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.363 -0.835 . . . . 72.14 111.201 -176.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.572 ' CD2' HG13 ' B' ' 83' ' ' ILE . 66.2 m-85 -80.52 -23.17 40.23 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.454 -0.499 . . . . 70.24 111.114 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 32.9 t -71.37 -24.54 62.1 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.435 -0.58 . . . . 75.45 109.435 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 23.8 m -63.95 -27.01 68.85 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.1 0.476 . . . . 71.1 110.005 176.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 63.5 m -97.43 7.51 46.38 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.574 0.583 . . . . 74.33 112.574 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.09 -165.18 29.78 Favored Glycine 0 CA--C 1.507 -0.461 0 C-N-CA 118.169 -1.967 . . . . 74.32 115.783 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 14.7 m -98.18 123.99 42.53 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.862 -0.669 . . . . 72.31 109.442 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.45 HD11 ' HB2' ' B' ' 57' ' ' PHE . 61.9 mt -88.72 131.83 35.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 113.223 0.823 . . . . 73.54 113.223 -178.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 64' ' ' ASN . . . . . 0.664 ' OD1' ' HB3' ' A' ' 73' ' ' PHE . 18.8 t-20 -99.73 -45.25 5.82 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 124.5 1.12 . . . . 54.52 109.955 177.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.483 ' HB2' ' HB2' ' B' ' 84' ' ' GLU . 98.3 mtt180 -147.46 158.47 43.99 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.181 -0.674 . . . . 70.22 109.181 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -148.93 127.49 3.19 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 C-N-CA 123.658 0.783 . . . . 65.22 109.972 174.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 38.6 m -125.93 133.21 51.92 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.065 -0.971 . . . . 72.52 108.61 -175.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 68' ' ' ILE . . . . . 0.418 HD12 ' N ' ' B' ' 68' ' ' ILE . 1.2 mp -129.9 122.34 54.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 106.353 -1.721 . . . . 75.33 106.353 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.479 HD23 ' H ' ' B' ' 69' ' ' LEU . 1.7 pt? -121.71 135.25 54.95 Favored 'General case' 0 C--N 1.287 -2.151 0 C-N-CA 120.6 -0.44 . . . . 62.3 110.468 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 64.5 m -115.87 127.08 54.74 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.03 -1.1 . . . . 72.14 108.03 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 3.7 p30 -107.8 127.52 53.78 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.258 -0.645 . . . . 72.45 109.258 -177.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 72' ' ' LYS . . . . . 0.487 ' HE3' ' HB3' ' B' ' 77' ' ' PRO . 44.9 mtpt -124.1 10.88 8.81 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 120.732 -0.387 . . . . 63.21 110.015 -178.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -61.51 -22.7 65.34 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 113.893 1.072 . . . . 74.41 113.893 -177.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 19.8 m -97.81 14.08 28.25 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.025 0.44 . . . . 62.22 109.99 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.22 -44.37 3.09 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 111.275 -0.73 . . . . 75.3 111.275 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -91.37 125.62 57.44 Favored Pre-proline 0 CA--C 1.505 -0.762 0 N-CA-C 110.011 -0.366 . . . . 70.11 110.011 178.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.487 ' HB3' ' HE3' ' B' ' 72' ' ' LYS . 69.3 Cg_endo -76.57 119.55 5.24 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.905 2.404 . . . . 70.44 112.843 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 78' ' ' LYS . . . . . 0.43 ' HB2' ' OD2' ' B' ' 71' ' ' ASP . 24.6 mtmm -118.77 -160.82 0.81 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.094 -1.076 . . . . 70.33 108.094 175.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 178.79 158.26 20.95 Favored Glycine 0 N--CA 1.416 -2.698 0 C-N-CA 119.193 -1.48 . . . . 62.31 114.226 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 80' ' ' TYR . . . . . 0.405 ' O ' HD23 ' B' ' 69' ' ' LEU . 30.2 m-85 -136.17 153.95 51.1 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 105.784 -1.932 . . . . 73.01 105.784 173.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.37 130.33 40.57 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 109.935 -0.394 . . . . 73.01 109.935 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 82' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -114.03 122.39 46.77 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.912 -1.144 . . . . 54.33 107.912 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.572 HG13 ' CD2' ' B' ' 57' ' ' PHE . 4.6 mm -114.03 129.38 70.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.106 -1.072 . . . . 74.02 108.106 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 84' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' B' ' 65' ' ' ARG . 1.3 mp0 -99.48 120.74 40.11 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.54 -1.281 . . . . 74.32 107.54 173.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -88.9 152.8 21.52 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 108.515 -0.92 . . . . 71.34 108.515 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.63 -24.23 64.53 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 110.239 -0.282 . . . . 71.43 110.239 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -120.91 147.09 45.9 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.924 -0.58 . . . . 73.11 110.675 -178.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.436 ' HD3' ' O ' ' B' ' 36' ' ' LYS . 0.0 OUTLIER -72.59 -34.14 67.21 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.0 -0.741 . . . . 73.43 109.0 177.658 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -59.46 -35.26 73.71 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.204 -0.907 . . . . 74.43 110.465 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 30.8 m -65.78 -36.26 83.02 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.931 -0.577 . . . . 71.54 110.555 -178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.517 ' O ' HG13 ' B' ' 95' ' ' VAL . 1.4 m -69.12 -37.46 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 108.906 -0.775 . . . . 73.52 108.906 -178.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.662 ' O ' HG22 ' B' ' 95' ' ' VAL . 7.2 t70 -68.49 -31.05 70.04 Favored 'General case' 0 C--O 1.215 -0.763 0 CA-C-O 121.67 0.748 . . . . 65.33 109.066 -178.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.99 -31.15 64.32 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.842 -0.617 . . . . 73.21 109.868 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.32 -35.55 61.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.796 -0.638 . . . . 73.51 111.481 -178.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 95' ' ' VAL . . . . . 0.662 HG22 ' O ' ' B' ' 92' ' ' ASP . 10.4 m -54.31 -21.18 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 112.582 0.586 . . . . 70.31 112.582 178.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.57 -13.97 61.73 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.213 0.53 . . . . 43.41 110.835 177.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 67.1 mtm -96.9 12.98 30.37 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 116.263 -0.426 . . . . 44.03 110.627 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -35.41 -58.36 0.58 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.283 1.033 . . . . 63.41 113.082 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -112.02 98.95 7.7 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 118.553 -1.259 . . . . 63.04 109.14 170.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 75.4 m -139.44 150.85 45.71 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.526 -1.215 . . . . 74.44 109.941 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.05 122.59 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-O 121.481 0.657 . . . . 74.32 110.302 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -120.36 124.89 46.64 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.736 -0.839 . . . . 74.22 108.736 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 61.0 ttt-85 47.9 31.5 2.36 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 125.566 1.546 . . . . 71.03 112.044 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 100.4 -6.36 57.67 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 115.666 -0.697 . . . . 32.42 114.35 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -121.91 150.97 41.23 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 117.838 0.819 . . . . 73.1 111.304 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 30.0 m -82.07 121.58 26.74 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 116.431 -0.35 . . . . 74.33 110.232 -176.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 45.8 pt -101.2 170.66 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 120.577 -0.449 . . . . 60.25 110.151 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 108' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 46.7 tptt -128.81 121.61 28.69 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.955 -1.128 . . . . 72.11 107.955 -176.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 95.6 t -115.19 114.42 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 N-CA-C 107.374 -1.343 . . . . 72.31 107.374 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.411 HD23 ' HD2' ' B' ' 111' ' ' PRO . 3.6 tt -138.83 131.12 15.67 Favored Pre-proline 0 C--N 1.292 -1.925 0 N-CA-C 105.938 -1.875 . . . . 71.04 105.938 -173.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.411 ' HD2' HD23 ' B' ' 110' ' ' LEU . 73.6 Cg_exo -53.57 133.51 53.95 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.871 1.714 . . . . 74.03 112.888 178.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' B' ' 38' ' ' SER . 45.1 tttm . . . . . 0 N--CA 1.389 -3.485 0 N-CA-C 106.495 -1.668 . . . . 65.33 106.495 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 41.3 mm-40 . . . . . 0 N--CA 1.469 0.475 0 N-CA-C 112.236 0.458 . . . . 74.34 112.236 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 21.2 pt -67.42 -35.17 72.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.177 0.513 . . . . 63.0 111.541 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -68.9 -24.02 64.26 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.881 -0.6 . . . . 74.03 110.471 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -77.92 -32.03 51.42 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.2 0.524 . . . . 75.31 110.746 176.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 96.5 mtt180 -94.49 10.8 33.14 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.605 0.717 . . . . 71.35 110.56 -171.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.574 ' HB3' ' HG2' ' A' ' 84' ' ' GLU . 13.6 p -112.16 169.4 8.89 Favored 'General case' 0 N--CA 1.401 -2.887 0 CA-C-N 115.424 -0.807 . . . . 61.01 111.771 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 27.3 m -135.32 158.62 40.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 116.155 -0.475 . . . . 75.55 110.912 -175.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.673 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 46.7 t80 -99.0 121.78 41.4 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 124.572 1.149 . . . . 74.5 108.665 175.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 58.2 t -115.07 113.53 43.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 107.639 -1.245 . . . . 71.35 107.639 174.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.23 170.23 14.0 Favored Glycine 0 C--N 1.305 -1.182 0 C-N-CA 120.052 -1.07 . . . . 41.53 113.769 -177.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.471 ' O ' ' HD3' ' A' ' 105' ' ' ARG . 65.4 t30 68.71 21.49 7.81 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 126.425 1.89 . . . . 61.54 112.505 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.496 ' O ' ' HA3' ' A' ' 79' ' ' GLY . 7.4 p -91.63 103.65 14.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 O-C-N 121.203 -0.936 . . . . 71.11 110.99 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.404 ' HB2' ' NH2' ' A' ' 105' ' ' ARG . 2.3 m-20 -86.71 166.74 15.06 Favored 'General case' 0 C--O 1.261 1.686 0 N-CA-C 108.391 -0.966 . . . . 63.44 108.391 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -50.81 131.77 26.28 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 123.41 0.444 . . . . 73.13 109.825 174.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 137.89 -38.49 1.7 Allowed Glycine 0 N--CA 1.427 -1.945 0 N-CA-C 110.1 -1.2 . . . . 75.32 110.1 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.4 m -84.08 131.97 34.75 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 108.131 -1.063 . . . . 74.33 108.131 176.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.0 p -94.1 162.86 13.7 Favored 'General case' 0 N--CA 1.418 -2.066 0 N-CA-C 109.678 -0.49 . . . . 72.25 109.678 -179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.666 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -65.9 -41.64 91.2 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 109.902 -0.407 . . . . 71.33 109.902 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -37.31 82.22 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 120.21 -0.596 . . . . 63.11 112.254 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.279 1.9 p30 -73.57 -28.21 61.73 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 119.368 -0.933 . . . . 63.43 110.87 178.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.3 mt -62.61 -46.37 88.59 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 115.431 -0.804 . . . . 71.13 110.076 172.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -58.45 -47.43 84.03 Favored 'General case' 0 C--O 1.189 -2.124 0 N-CA-C 112.957 0.725 . . . . 72.44 112.957 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.59 -47.37 73.43 Favored 'General case' 0 C--O 1.27 2.136 0 CA-C-O 120.957 0.408 . . . . 75.41 111.054 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -64.04 -43.04 96.77 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.147 -0.933 . . . . 74.53 110.825 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -82.65 -25.6 32.94 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 116.081 1.882 . . . . 71.33 116.081 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.5 m -69.89 -28.07 65.32 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-O 120.761 0.315 . . . . 61.4 110.932 -176.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.1 m -59.34 -26.53 65.11 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 120.412 -0.515 . . . . 75.41 110.886 173.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 79.0 m -105.99 9.24 32.63 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.013 0.746 . . . . 71.5 113.013 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' A' ' 90' ' ' SER . . . 163.46 176.5 35.49 Favored Glycine 0 CA--C 1.502 -0.74 0 C-N-CA 118.176 -1.964 . . . . 71.35 115.484 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.5 m -100.66 116.47 32.64 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.107 -0.546 . . . . 75.21 110.109 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.4 mt -83.78 128.29 38.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 115.352 -0.84 . . . . 24.25 112.862 -176.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.536 HD21 ' HA ' ' A' ' 86' ' ' ALA . 89.2 m-20 -87.25 -45.55 10.52 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 115.424 -0.807 . . . . 74.03 109.621 175.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.519 ' HD3' ' OE1' ' A' ' 84' ' ' GLU . 53.8 mtp180 -159.27 165.96 32.35 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.242 -1.392 . . . . 75.15 107.242 -173.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.666 HD11 ' HB1' ' A' ' 50' ' ' ALA . 22.4 pt -146.19 141.94 21.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.193 -1.04 . . . . 75.03 108.193 174.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.6 m -125.32 125.41 43.45 Favored 'General case' 0 C--N 1.269 -2.933 0 N-CA-C 107.217 -1.401 . . . . 62.15 107.217 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.9 mp -120.46 115.88 48.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 105.541 -2.022 . . . . 74.24 105.541 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.574 HD12 ' NH2' ' B' ' 65' ' ' ARG . 1.0 OUTLIER -121.09 128.87 53.0 Favored 'General case' 0 C--N 1.283 -2.292 0 C-N-CA 120.348 -0.541 . . . . 53.32 112.096 -178.477 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 66.1 m -117.37 133.6 55.79 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.805 -0.634 . . . . 64.43 109.795 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -118.41 144.48 45.9 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 120.343 -0.543 . . . . 64.51 110.743 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -111.64 12.04 21.17 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.25 0.548 . . . . 64.32 111.208 174.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.614 ' CE2' ' HB3' ' B' ' 64' ' ' ASN . 30.5 m-85 -66.75 -20.73 66.02 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.633 -0.712 . . . . 75.31 111.275 175.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.6 t -86.13 3.87 40.84 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.71 -0.677 . . . . 65.13 109.658 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.1 -44.26 3.29 Favored Glycine 0 CA--C 1.502 -0.776 0 N-CA-C 110.149 -1.181 . . . . 63.35 110.149 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -96.81 147.16 32.51 Favored Pre-proline 0 C--N 1.292 -1.909 0 N-CA-C 105.915 -1.883 . . . . 73.44 105.915 177.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -75.44 116.57 4.54 Favored 'Trans proline' 0 N--CA 1.432 -2.125 0 N-CA-C 108.792 -1.272 . . . . 64.4 108.792 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 24.7 mtmm -108.05 156.93 18.71 Favored 'General case' 0 CA--C 1.461 -2.449 0 N-CA-C 107.73 -1.211 . . . . 73.33 107.73 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 44' ' ' VAL . . . -136.34 145.25 17.16 Favored Glycine 1 N--CA 1.395 -4.035 0 C-N-CA 119.167 -1.492 . . . . 61.21 112.226 176.724 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -146.2 143.55 29.32 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 108.31 -0.996 . . . . 74.31 108.31 174.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.09 144.37 51.31 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-O 120.777 0.322 . . . . 63.44 110.577 -173.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.741 ' CD1' ' HD2' ' A' ' 112' ' ' LYS . 68.7 m-85 -115.83 115.54 26.43 Favored 'General case' 0 N--CA 1.409 -2.482 0 CA-C-N 115.908 -0.587 . . . . 74.41 109.599 177.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.448 HG23 HG22 ' A' ' 66' ' ' ILE . 33.0 mm -99.85 119.51 48.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 107.632 -1.248 . . . . 73.14 107.632 -177.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.574 ' HG2' ' HB3' ' A' ' 38' ' ' SER . 43.5 mt-10 -96.18 119.96 35.61 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.793 -0.363 . . . . 75.03 110.583 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -99.66 153.14 19.32 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.09 0.472 . . . . 53.44 110.136 177.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.536 ' HA ' HD21 ' A' ' 64' ' ' ASN . . . -64.13 -37.18 86.53 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.667 -0.697 . . . . 70.11 111.515 177.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -116.94 145.38 43.65 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.502 -0.772 . . . . 63.14 112.905 -176.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.544 ' O ' HG22 ' A' ' 91' ' ' VAL . 17.5 mmm180 -62.34 -33.16 74.18 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.381 -0.827 . . . . 75.44 109.549 171.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -62.81 -32.41 73.6 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.217 -0.901 . . . . 72.41 110.449 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.467 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . 47.3 m -67.75 -36.86 81.31 Favored 'General case' 0 N--CA 1.426 -1.67 0 O-C-N 122.383 -0.198 . . . . 61.33 110.546 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 88' ' ' ARG . 2.9 m -64.92 -39.18 84.81 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.886 0 C-N-CA 119.656 -0.818 . . . . 73.23 109.877 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -60.22 -36.3 77.4 Favored 'General case' 0 CA--C 1.502 -0.902 0 O-C-N 123.361 0.413 . . . . 75.51 111.935 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.73 -36.67 65.21 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.055 0.455 . . . . 54.23 110.298 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.07 -45.32 57.95 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.887 -0.597 . . . . 52.34 111.574 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 91' ' ' VAL . 22.1 m -55.39 -21.58 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 113.101 0.778 . . . . 74.52 113.101 177.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.97 -19.04 65.73 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.293 0.568 . . . . 75.32 110.461 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 56.9 mtm -96.19 9.43 41.0 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.653 -0.703 . . . . 63.1 110.173 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.597 ' HA ' HG12 ' A' ' 109' ' ' VAL . 2.7 p-10 -41.97 -41.71 2.59 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.825 0.676 . . . . 73.33 112.825 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -102.22 101.49 11.79 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 119.668 -0.813 . . . . 63.55 109.539 170.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.7 p -140.61 148.27 40.65 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.276 -0.874 . . . . 61.34 110.309 174.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.1 p -113.57 93.14 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 CA-C-O 122.764 1.269 . . . . 62.31 108.981 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -112.36 128.81 56.4 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 114.058 -1.428 . . . . 74.42 107.553 -173.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 61.1 33.18 19.59 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.27 1.028 . . . . 71.53 109.566 -175.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.59 -2.4 63.32 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 114.768 -1.105 . . . . 75.15 114.5 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.471 ' HD3' ' O ' ' A' ' 43' ' ' ASN . 5.5 ptp180 -113.0 141.14 47.18 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 122.058 -0.672 . . . . 73.31 109.523 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.0 m -83.68 119.72 25.12 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 108.322 -0.992 . . . . 74.34 108.322 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 33.3 pt -101.7 172.16 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 109.619 -0.512 . . . . 75.55 109.619 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 55.3 tptt -132.89 132.32 41.93 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.644 -0.873 . . . . 62.22 108.644 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.673 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 5.0 p -128.18 123.17 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 O-C-N 123.355 0.41 . . . . 71.41 110.498 175.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . 0.289 0.0 OUTLIER -141.95 146.79 42.05 Favored Pre-proline 0 N--CA 1.431 -1.383 0 N-CA-C 108.99 -0.744 . . . . 74.3 108.99 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.46 ' HD3' HG11 ' A' ' 95' ' ' VAL . 37.2 Cg_endo -68.95 131.01 21.43 Favored 'Trans proline' 0 C--O 1.244 0.818 0 C-N-CA 122.099 1.866 . . . . 72.24 114.017 -171.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.741 ' HD2' ' CD1' ' A' ' 82' ' ' TYR . 48.3 mtpt . . . . . 0 C--N 1.313 -0.997 0 CA-C-N 114.484 -1.235 . . . . 75.53 112.735 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.798 0 N-CA-C 114.056 0.382 . . . . 50.53 114.056 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -50.52 -44.3 40.56 Favored 'Trans proline' 0 CA--C 1.553 1.444 0 C-N-CA 124.326 3.351 . . . . 74.41 115.339 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -46.47 133.03 16.24 Favored 'Trans proline' 0 C--N 1.396 3.029 0 C-N-CA 122.301 2.001 . . . . 72.53 112.94 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -65.87 140.4 97.21 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 115.835 -0.62 . . . . 63.3 110.957 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.16 119.46 6.53 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 122.746 2.297 . . . . 74.11 113.283 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.69 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -79.91 176.0 10.12 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.034 -0.985 . . . . 62.11 110.394 177.462 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.583 ' HB3' ' OE1' ' B' ' 30' ' ' GLU . 41.2 t -67.71 144.54 55.4 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.927 0.714 . . . . 54.35 112.927 -173.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.99 -35.53 34.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.371 -1.286 . . . . 71.14 111.349 173.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -65.43 -45.33 84.28 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 116.392 -0.367 . . . . 60.23 110.923 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.583 ' OE1' ' HB3' ' B' ' 27' ' ' SER . 2.8 mp0 -64.19 -38.68 91.91 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 120.776 -0.37 . . . . 72.43 110.974 176.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.1 -41.95 98.73 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.493 0.663 . . . . 75.14 109.294 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.532 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 0.0 OUTLIER -72.27 -38.0 68.93 Favored 'General case' 0 N--CA 1.384 -3.739 0 CA-C-N 115.225 -0.898 . . . . 72.04 112.59 -178.438 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -71.24 -41.36 70.21 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.311 0.486 . . . . 73.11 112.311 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.432 HG12 ' O ' ' B' ' 30' ' ' GLU . 15.7 pt -70.01 -35.42 64.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.367 -0.379 . . . . 74.42 110.983 -177.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -69.38 -27.37 65.25 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.686 -0.688 . . . . 75.0 109.378 -177.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 99.3 mttt -71.18 -34.26 70.76 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.631 -0.713 . . . . 51.01 111.133 176.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -99.77 19.65 15.6 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.051 0.929 . . . . 73.23 110.33 -175.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 68.6 m -96.55 158.33 15.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.192 -1.367 . . . . 75.31 108.554 173.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' B' ' 82' ' ' TYR . 28.2 m -131.74 157.64 43.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.458 -0.571 . . . . 74.3 109.458 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 40' ' ' TYR . . . . . 0.649 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 40.7 t80 -103.93 119.07 38.16 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.041 -1.096 . . . . 71.05 108.041 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 58.5 t -112.02 109.79 29.84 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 107.414 -1.328 . . . . 74.3 107.414 175.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -113.44 173.96 15.42 Favored Glycine 0 N--CA 1.438 -1.197 0 C-N-CA 120.621 -0.799 . . . . 62.24 112.788 -176.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 7.4 t30 61.01 9.01 2.13 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 126.002 1.721 . . . . 45.03 111.542 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 5.6 p -84.33 90.84 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 106.394 -1.706 . . . . 72.45 106.394 173.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -82.14 84.93 6.88 Favored 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 115.474 1.657 . . . . 53.32 115.474 -165.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 46' ' ' TYR . . . . . 0.565 ' HA ' ' SG ' ' B' ' 70' ' ' CYS . 7.6 t80 70.68 -69.54 0.18 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 113.658 -1.61 . . . . 73.34 113.986 163.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.08 -4.53 22.35 Favored Glycine 0 N--CA 1.468 0.786 0 N-CA-C 116.432 1.333 . . . . 75.5 116.432 -170.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 71.2 m -71.22 130.34 41.18 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 117.989 0.894 . . . . 70.42 110.515 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 36.1 p -79.83 151.71 30.11 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.185 -0.462 . . . . 54.4 111.556 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.63 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -69.29 -41.56 76.66 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.437 0.695 . . . . 72.23 111.573 -175.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -41.8 81.7 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.868 -0.605 . . . . 75.43 111.587 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -69.04 -34.64 75.52 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.837 -0.62 . . . . 64.12 110.994 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 21.3 mt -61.51 -46.45 89.93 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-N 115.485 -0.779 . . . . 74.25 111.638 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -58.64 -47.05 85.72 Favored 'General case' 0 C--O 1.194 -1.827 0 N-CA-C 113.501 0.926 . . . . 75.53 113.501 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.64 -47.66 73.22 Favored 'General case' 0 C--O 1.268 2.029 0 CA-C-N 118.041 0.382 . . . . 70.1 111.185 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -64.26 -42.14 96.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.373 -0.831 . . . . 70.41 111.007 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -82.8 -25.63 32.53 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 115.903 1.816 . . . . 53.14 115.903 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 69.5 m -69.78 -25.0 63.59 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 120.651 0.262 . . . . 71.51 110.673 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 21.4 m -58.44 -27.25 64.18 Favored 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 120.432 -0.507 . . . . 72.12 110.764 172.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 68.2 m -99.94 7.36 44.88 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.741 1.015 . . . . 70.42 113.741 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.41 -167.96 32.54 Favored Glycine 0 CA--C 1.5 -0.856 0 C-N-CA 118.24 -1.933 . . . . 71.51 115.242 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 14.6 m -101.54 120.72 40.75 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 123.127 0.571 . . . . 63.0 110.087 -176.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 64.3 mt -87.52 125.82 41.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.07 0.462 . . . . 53.03 112.178 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 64' ' ' ASN . . . . . 0.614 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 90.5 m-20 -85.65 -46.85 10.37 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.959 0.885 . . . . 75.13 110.084 177.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.574 ' NH2' HD12 ' A' ' 69' ' ' LEU . 49.6 mtp180 -158.7 165.73 33.67 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.613 -1.625 . . . . 65.41 106.613 -172.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.63 HD11 ' HB1' ' B' ' 50' ' ' ALA . 23.2 pt -146.08 142.09 21.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.142 -1.059 . . . . 74.52 108.142 175.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 91.5 m -125.31 125.73 43.96 Favored 'General case' 0 C--N 1.272 -2.784 0 N-CA-C 107.351 -1.351 . . . . 72.11 107.351 -178.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mp -120.4 116.69 50.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 105.162 -2.162 . . . . 74.34 105.162 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.444 HD12 ' NH2' ' A' ' 65' ' ' ARG 0.256 1.0 OUTLIER -121.36 129.86 53.29 Favored 'General case' 0 C--N 1.277 -2.577 0 C-N-CA 120.308 -0.557 . . . . 73.13 112.106 -178.935 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' B' B ' 70' ' ' CYS . . . . . 0.565 ' SG ' ' HA ' ' B' ' 46' ' ' TYR . 63.1 m -118.02 131.7 56.45 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 115.484 -0.78 . . . . 55.42 109.446 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.539 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 4.5 p-10 -113.5 137.83 51.0 Favored 'General case' 0 CA--C 1.492 -1.282 0 C-N-CA 119.681 -0.808 . . . . 72.32 109.696 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -120.16 12.44 11.85 Favored 'General case' 0 N--CA 1.423 -1.81 0 C-N-CA 119.69 -0.804 . . . . 73.52 108.97 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.408 ' CD2' ' HB2' ' B' ' 71' ' ' ASP . 38.3 p90 -69.79 -22.33 63.33 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 108.48 -0.933 . . . . 73.11 108.48 176.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 40.3 m -75.71 4.27 8.15 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 114.809 -1.087 . . . . 55.21 110.367 175.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.12 -52.99 4.8 Favored Glycine 0 CA--C 1.496 -1.116 0 N-CA-C 110.5 -1.04 . . . . 65.34 110.5 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -95.38 122.74 58.71 Favored Pre-proline 0 C--N 1.287 -2.148 0 N-CA-C 106.952 -1.499 . . . . 72.0 106.952 174.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 59.4 Cg_endo -68.37 119.79 6.78 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 122.068 1.846 . . . . 55.31 111.903 -175.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 78' ' ' LYS . . . . . 0.445 ' HZ3' ' CG ' ' B' ' 71' ' ' ASP . 27.7 mtmm -106.22 162.92 13.23 Favored 'General case' 0 CA--C 1.476 -1.888 0 N-CA-C 108.285 -1.006 . . . . 74.31 108.285 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -133.97 144.55 16.53 Favored Glycine 0 N--CA 1.407 -3.257 0 C-N-CA 119.498 -1.334 . . . . 64.31 112.14 175.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -148.68 143.28 26.37 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.622 -0.881 . . . . 75.03 108.622 172.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.79 144.55 51.53 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 120.851 0.358 . . . . 44.13 110.734 -172.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 82' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' B' ' 39' ' ' VAL . 72.6 m-85 -115.31 115.65 26.99 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 115.852 -0.613 . . . . 70.5 109.455 176.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.45 HG23 HG22 ' B' ' 66' ' ' ILE . 33.1 mm -100.37 118.52 47.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 107.425 -1.324 . . . . 70.23 107.425 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 84' ' ' GLU . . . . . 0.427 ' OE1' ' HD3' ' B' ' 65' ' ' ARG . 46.5 mt-10 -95.6 119.21 33.7 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.667 -0.413 . . . . 72.35 110.331 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -97.4 153.71 17.93 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.005 0.431 . . . . 65.53 110.855 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.456 ' HA ' HD21 ' B' ' 64' ' ' ASN . . . -61.14 -30.31 70.31 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.492 -0.776 . . . . 73.02 112.046 177.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -131.27 157.82 42.27 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.477 0.656 . . . . 74.21 112.3 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.59 ' O ' HG22 ' B' ' 91' ' ' VAL . 19.8 mmm180 -68.29 -33.36 74.2 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.535 -1.212 . . . . 74.31 109.941 172.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -65.26 -28.6 69.46 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.312 -0.404 . . . . 73.12 111.461 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 39.9 m -68.77 -37.23 79.18 Favored 'General case' 0 N--CA 1.433 -1.298 0 O-C-N 122.273 -0.267 . . . . 45.33 110.36 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.59 HG22 ' O ' ' B' ' 88' ' ' ARG . 3.6 m -65.89 -38.48 82.25 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 N-CA-C 108.894 -0.78 . . . . 72.41 108.894 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -62.76 -35.83 81.1 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.549 0.74 . . . . 73.34 109.424 -177.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.38 -37.8 63.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.762 -0.654 . . . . 65.31 110.858 177.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.0 -45.23 61.72 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.951 -0.568 . . . . 51.32 111.659 -176.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 95' ' ' VAL . . . . . 0.509 HG13 ' O ' ' B' ' 91' ' ' VAL . 25.5 m -54.53 -21.86 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 113.191 0.812 . . . . 52.01 113.191 178.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.97 -12.42 61.64 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.107 0.48 . . . . 63.13 110.862 177.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 60.6 mtm -100.03 9.72 42.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.171 -0.468 . . . . 54.2 110.707 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 98' ' ' ASP . . . . . 0.553 ' HA ' HG12 ' B' ' 109' ' ' VAL . 2.5 p-10 -46.91 -34.5 5.52 Favored 'General case' 0 C--O 1.201 -1.483 0 N-CA-C 115.549 1.685 . . . . 70.32 115.549 -177.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -100.52 29.62 4.34 Favored 'General case' 0 CA--C 1.58 2.104 0 CA-C-N 119.81 1.187 . . . . 74.32 111.941 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 43.4 p -88.95 160.17 17.28 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.259 -0.9 . . . . 73.12 111.815 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 101' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' B' ' 106' ' ' THR . 14.9 p -97.16 139.61 19.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.465 -0.569 . . . . 74.21 109.465 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -138.92 122.84 17.76 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 109.185 -0.672 . . . . 73.21 109.185 -176.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 62.5 ttp85 54.44 32.51 16.8 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 125.279 1.431 . . . . 74.32 111.292 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.81 -7.6 63.1 Favored Glycine 0 C--N 1.305 -1.166 0 CA-C-N 115.035 -0.984 . . . . 41.21 114.741 175.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -132.8 153.58 51.12 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 117.862 0.831 . . . . 74.23 110.218 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 106' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' B' ' 101' ' ' VAL . 56.8 m -77.89 126.46 30.88 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 120.595 0.236 . . . . 52.4 111.015 -174.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 2.4 pp -102.83 172.58 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 120.456 -0.497 . . . . 71.04 111.202 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 108' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 56.7 tptt -129.58 132.71 46.86 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.67 -0.863 . . . . 65.14 108.67 -178.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 109' ' ' VAL . . . . . 0.649 ' HA ' ' O ' ' B' ' 40' ' ' TYR 0.276 6.2 p -127.4 126.94 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-O 121.638 0.732 . . . . 72.44 110.277 175.333 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.321 0.3 OUTLIER -143.1 137.08 14.51 Favored Pre-proline 0 C--N 1.285 -2.202 0 N-CA-C 105.916 -1.883 . . . . 72.45 105.916 -168.638 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.433 ' HD3' HG11 ' B' ' 95' ' ' VAL . 58.2 Cg_endo -74.2 136.75 22.65 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 121.775 1.65 . . . . 72.15 112.862 -177.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 59.3 tttm . . . . . 0 N--CA 1.432 -1.366 0 CA-C-N 115.641 -0.709 . . . . 73.43 110.28 -176.325 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 N--CA 1.437 -1.109 0 CA-C-O 120.46 0.172 . . . . 73.45 111.072 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 20.4 pt -71.35 -37.95 67.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 112.386 0.513 . . . . 72.45 112.386 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.23 -32.2 73.75 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.931 0.492 . . . . 75.42 111.489 -177.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -56.73 -26.2 56.51 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.461 0.648 . . . . 73.12 111.206 177.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 -115.9 15.79 16.24 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-N 115.871 -0.604 . . . . 73.43 111.258 -172.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.563 ' OG ' ' HE2' ' A' ' 112' ' ' LYS . 10.3 t -95.66 143.95 26.5 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 121.569 0.7 . . . . 74.44 110.168 -177.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.723 HG22 HG23 ' A' ' 91' ' ' VAL . 13.7 t -127.36 148.42 32.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 115.663 -0.698 . . . . 51.52 109.459 -175.077 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.63 ' CZ ' ' HG3' ' B' ' 22' ' ' PRO . 35.7 t80 -96.32 124.86 40.47 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.907 -1.145 . . . . 62.31 107.907 169.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.1 t -118.51 112.18 37.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.438 -1.319 . . . . 54.54 107.438 174.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.66 164.04 12.65 Favored Glycine 0 C--N 1.289 -2.066 0 C-N-CA 119.637 -1.268 . . . . 75.54 113.836 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 55.79 32.28 19.22 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.487 1.515 . . . . 71.31 112.905 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.0 p -55.92 132.48 19.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 121.479 0.657 . . . . 64.41 109.564 172.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -69.33 140.96 54.36 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 114.994 -1.003 . . . . 72.32 108.852 -174.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.541 ' CD2' ' HB2' ' A' ' 77' ' ' PRO . 0.7 OUTLIER -74.95 93.82 2.74 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 108.33 -0.989 . . . . 54.33 108.33 -179.52 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.76 -20.73 1.15 Allowed Glycine 0 N--CA 1.414 -2.821 0 N-CA-C 109.037 -1.625 . . . . 74.21 109.037 -174.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.528 ' OG ' ' HD3' ' A' ' 103' ' ' ARG . 73.1 m -91.89 78.52 5.36 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-O 121.951 0.881 . . . . 73.32 109.614 177.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.582 HG21 ' HB ' ' B' ' 49' ' ' THR . 51.5 p -65.39 -178.03 0.47 Allowed 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 114.429 -1.259 . . . . 64.24 113.15 177.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.501 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -51.22 -48.5 62.04 Favored 'General case' 0 C--O 1.202 -1.404 0 CA-C-N 115.12 -0.946 . . . . 61.55 112.152 -173.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -60.45 -38.81 85.36 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.711 0.634 . . . . 75.32 112.711 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -39.89 95.1 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 107.657 -1.238 . . . . 65.42 107.657 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.5 mt -71.97 -43.31 65.35 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 113.934 -1.484 . . . . 74.31 111.43 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 51.0 mt-10 -57.62 -48.93 78.08 Favored 'General case' 0 C--O 1.181 -2.509 0 CA-C-O 119.396 -0.335 . . . . 73.42 110.848 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.93 -48.28 80.37 Favored 'General case' 0 C--O 1.264 1.862 0 CA-C-O 121.341 0.591 . . . . 64.51 111.356 -177.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -66.33 -38.88 88.7 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.324 -0.853 . . . . 74.45 110.95 -176.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -81.37 -22.39 38.4 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 113.793 1.035 . . . . 72.52 113.793 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.8 t -68.74 -25.42 64.73 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.679 -0.86 . . . . 64.34 108.679 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.6 m -62.01 -28.51 69.63 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 116.026 -0.534 . . . . 73.23 110.004 174.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 61.1 m -95.68 0.27 52.43 Favored 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 112.917 0.71 . . . . 54.44 112.917 178.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.37 -159.32 28.07 Favored Glycine 0 C--O 1.22 -0.745 0 C-N-CA 118.865 -1.636 . . . . 62.04 115.424 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.9 m -112.85 127.95 56.32 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 122.523 0.329 . . . . 53.43 110.899 -175.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.466 ' CD1' ' HA ' ' A' ' 54' ' ' GLU . 75.3 mt -89.14 134.15 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 N-CA-C 113.186 0.81 . . . . 74.21 113.186 -177.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -101.54 -44.41 5.6 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.537 1.135 . . . . 54.24 111.869 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.435 ' HD3' ' OE2' ' A' ' 84' ' ' GLU . 26.7 mtp180 -145.15 152.82 40.63 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 108.266 -1.012 . . . . 63.43 108.266 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.1 tt -149.03 132.47 7.64 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-N 115.782 -0.644 . . . . 71.3 109.895 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.3 m -124.73 129.17 49.97 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.136 -1.431 . . . . 53.44 107.136 -176.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 mp -128.18 119.93 52.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 106.384 -1.71 . . . . 73.2 106.384 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.58 ' HG ' ' CE1' ' A' ' 80' ' ' TYR 0.352 1.0 OUTLIER -120.75 130.99 54.26 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 119.672 -0.811 . . . . 74.4 112.13 176.344 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.553 ' HB2' HG23 ' B' ' 66' ' ' ILE . 66.4 m -113.43 118.64 35.09 Favored 'General case' 0 N--CA 1.411 -2.402 0 C-N-CA 124.461 1.105 . . . . 72.43 108.754 -176.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.517 ' HA ' ' HA ' ' B' ' 65' ' ' ARG . 9.5 t0 -116.23 118.23 32.22 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 122.77 0.428 . . . . 73.5 109.968 -176.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 39.0 ttmt -114.65 16.48 17.51 Favored 'General case' 0 C--N 1.274 -2.686 0 C-N-CA 123.646 0.778 . . . . 61.21 110.632 -174.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.4 ' HB3' ' HB3' ' B' ' 64' ' ' ASN . 0.7 OUTLIER -63.07 -23.7 67.57 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 119.481 -0.888 . . . . 73.13 112.773 -176.154 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.0 t -92.39 11.5 25.87 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.396 0.617 . . . . 75.34 110.831 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.18 -52.66 1.62 Allowed Glycine 0 CA--C 1.5 -0.888 0 C-N-CA 120.474 -0.87 . . . . 65.15 111.319 178.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -89.98 126.88 55.84 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 107.748 -1.205 . . . . 61.13 107.748 175.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.541 ' HB2' ' CD2' ' A' ' 46' ' ' TYR . 73.4 Cg_endo -72.58 118.71 5.71 Favored 'Trans proline' 0 N--CA 1.436 -1.878 0 C-N-CA 121.586 1.524 . . . . 72.55 112.225 -176.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -89.78 173.15 8.42 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 114.842 -1.072 . . . . 73.35 109.175 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.15 137.52 4.83 Favored Glycine 1 N--CA 1.386 -4.667 0 C-N-CA 120.361 -0.923 . . . . 25.22 111.106 -178.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.58 ' CE1' ' HG ' ' A' ' 69' ' ' LEU 0.263 0.0 OUTLIER -150.49 143.53 24.79 Favored 'General case' 0 C--N 1.273 -2.74 0 CA-C-N 114.906 -0.647 . . . . 74.22 110.032 173.642 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.45 147.56 52.56 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.68 -0.691 . . . . 65.13 109.568 -173.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 80.7 m-85 -122.66 119.15 29.9 Favored 'General case' 0 C--N 1.273 -2.733 0 N-CA-C 108.198 -1.038 . . . . 73.01 108.198 176.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.6 mm -108.93 136.0 46.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 107.775 -1.194 . . . . 70.35 107.775 -175.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.435 ' OE2' ' HD3' ' A' ' 65' ' ' ARG . 41.7 mt-10 -113.82 124.88 53.31 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.098 -0.704 . . . . 74.12 109.098 176.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -97.11 164.25 12.58 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 111.806 0.298 . . . . 74.04 111.806 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.69 -41.98 59.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.234 0.54 . . . . 61.51 110.659 174.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -101.6 144.56 30.19 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.298 0.57 . . . . 54.4 112.134 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.77 -25.4 59.05 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.178 -1.416 . . . . 75.43 107.178 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -72.43 -20.96 61.32 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.266 -0.574 . . . . 72.43 111.085 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 m -71.58 -39.89 70.29 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 122.208 -0.307 . . . . 54.12 110.561 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.723 HG23 HG22 ' A' ' 39' ' ' VAL . 2.8 p -67.52 -39.38 82.32 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 C-N-CA 120.295 -0.562 . . . . 52.42 109.88 178.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -61.84 -32.5 72.83 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.766 -0.652 . . . . 74.43 110.149 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.89 -35.23 64.67 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.209 -0.451 . . . . 60.42 111.255 176.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.29 -38.09 56.62 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 116.216 -0.447 . . . . 73.14 111.239 -175.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 91' ' ' VAL . 14.4 m -56.84 -21.76 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 114.043 1.127 . . . . 73.1 114.043 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.49 -11.57 60.94 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.934 0.873 . . . . 62.13 110.385 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 7.1 ttp -101.25 5.36 42.47 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.855 -1.066 . . . . 70.21 108.546 -176.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 1.3 p-10 -37.7 -42.11 0.54 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.799 1.407 . . . . 72.1 114.799 -177.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -117.42 104.53 11.19 Favored 'General case' 0 N--CA 1.408 -2.539 0 CA-C-O 121.841 0.829 . . . . 72.13 109.777 174.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.5 t -147.49 165.2 31.0 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 114.01 -1.45 . . . . 65.14 108.451 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 106' ' ' THR . 7.1 p -112.7 110.58 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-O 122.244 1.021 . . . . 73.03 109.551 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -107.31 123.58 48.54 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.792 -1.094 . . . . 62.5 109.416 -173.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.528 ' HD3' ' OG ' ' A' ' 48' ' ' SER . 42.8 mtp-105 44.5 31.34 0.59 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.287 1.435 . . . . 75.43 114.632 -176.088 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 104.23 -4.34 44.5 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 114.984 -1.007 . . . . 74.13 113.342 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -130.02 139.97 50.94 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 113.182 0.808 . . . . 70.24 113.182 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 101' ' ' VAL . 31.9 m -72.05 122.61 21.21 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.439 -0.801 . . . . 60.5 111.088 -177.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 43.6 pt -102.53 170.74 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 120.844 0.354 . . . . 70.01 110.765 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 27.0 mmmt -127.01 122.86 35.67 Favored 'General case' 0 CA--C 1.486 -1.487 0 C-N-CA 124.159 0.984 . . . . 74.53 109.632 176.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 32.9 m -128.31 115.95 40.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-O 121.048 0.451 . . . . 60.43 109.89 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.402 ' CD1' ' HD2' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -146.15 160.13 43.79 Favored Pre-proline 0 C--N 1.289 -2.064 0 N-CA-C 108.758 -0.83 . . . . 64.02 108.758 -177.186 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.43 139.94 13.23 Favored 'Trans proline' 0 N--CA 1.436 -1.884 0 C-N-CA 121.118 1.212 . . . . 64.21 111.335 -173.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.563 ' HE2' ' OG ' ' A' ' 38' ' ' SER . 33.3 mtmt . . . . . 0 N--CA 1.406 -2.651 0 N-CA-C 106.533 -1.655 . . . . 65.33 106.533 175.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.417 ' HA3' ' HD2' ' B' ' 22' ' ' PRO . . . . . . . . 0 N--CA 1.436 -1.365 0 CA-C-O 120.196 -0.224 . . . . 35.41 113.162 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.63 ' HG3' ' CZ ' ' A' ' 40' ' ' TYR . 6.6 Cg_endo -43.1 -55.55 2.75 Favored 'Trans proline' 0 CA--C 1.6 3.801 0 C-N-CA 124.657 3.571 . . . . 71.32 115.607 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.495 ' HD3' ' HG2' ' B' ' 22' ' ' PRO . 19.8 Cg_endo -91.4 167.5 3.45 Favored 'Trans proline' 0 C--N 1.364 1.358 0 C-N-CA 122.498 2.132 . . . . 72.23 111.729 177.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -124.96 155.52 70.43 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-O 118.991 -0.528 . . . . 74.35 110.372 176.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -27.82 115.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.167 1 C-N-CA 125.967 4.445 . . . . 45.43 116.623 -176.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.692 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -78.12 172.04 14.14 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.302 -1.317 . . . . 63.02 112.174 175.728 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 19.6 m -69.19 147.81 50.78 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 113.798 1.036 . . . . 73.03 113.798 -175.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.716 ' O ' ' HG2' ' B' ' 32' ' ' LYS . . . -53.74 -46.68 70.93 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 114.992 -1.004 . . . . 72.35 110.458 174.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.542 ' HA ' ' CG ' ' B' ' 32' ' ' LYS . 68.5 mm-40 -68.95 -29.41 67.64 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 112.988 0.736 . . . . 72.11 112.988 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.514 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.4 OUTLIER -61.39 -37.61 84.04 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.502 -0.479 . . . . 64.11 110.608 172.116 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -63.12 -50.26 71.15 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 107.651 -1.241 . . . . 73.42 107.651 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.716 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 10.4 mmmm -52.06 -47.05 65.33 Favored 'General case' 0 C--O 1.214 -0.771 0 C-N-CA 124.459 1.103 . . . . 73.13 110.764 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -66.3 -49.87 65.57 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 114.005 1.113 . . . . 74.4 114.005 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.514 HG12 ' O ' ' B' ' 30' ' ' GLU . 28.6 pt -70.52 -36.17 64.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 111.969 0.359 . . . . 63.34 111.969 -174.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -63.04 -36.37 83.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.809 -0.632 . . . . 64.01 111.449 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.655 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 98.5 mttt -56.69 -25.26 53.59 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.474 0.654 . . . . 74.13 110.795 177.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.574 ' HD3' ' O ' ' B' ' 85' ' ' PHE . 70.1 mtt85 -112.37 14.11 20.35 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 115.515 -0.766 . . . . 74.12 111.857 -172.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 42.4 m -93.89 143.45 26.33 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.474 0.654 . . . . 71.14 110.946 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.655 HG22 HG23 ' B' ' 91' ' ' VAL . 14.7 t -129.85 152.71 37.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.714 -0.847 . . . . 60.54 108.714 -178.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 40' ' ' TYR . . . . . 0.612 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 18.9 t80 -105.33 123.42 47.83 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 107.117 -1.438 . . . . 73.23 107.117 173.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 48.9 t -116.76 111.58 35.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 107.364 -1.347 . . . . 71.32 107.364 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 42' ' ' GLY . . . . . 0.431 ' O ' ' HB ' ' B' ' 107' ' ' ILE . . . -112.9 169.7 13.08 Favored Glycine 0 C--N 1.291 -1.941 0 C-N-CA 119.463 -1.351 . . . . 74.32 114.127 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 64.7 t30 62.98 17.32 9.99 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 126.059 1.743 . . . . 73.23 113.267 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.423 HG22 ' HB2' ' B' ' 48' ' ' SER . 11.9 p -62.08 131.59 27.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.264 0.554 . . . . 71.4 109.943 176.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -75.43 156.72 35.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.52 -0.764 . . . . 70.05 109.067 -176.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -68.92 -18.16 64.07 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-O 121.808 0.813 . . . . 72.13 109.839 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.18 -12.73 80.37 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 115.559 -0.746 . . . . 32.12 111.808 178.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.423 ' HB2' HG22 ' B' ' 44' ' ' VAL . 25.1 m -87.23 133.07 33.71 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 108.45 -0.945 . . . . 71.44 108.45 178.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 49' ' ' THR . . . . . 0.582 ' HB ' HG21 ' A' ' 49' ' ' THR . 63.2 p -111.9 178.87 4.18 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 116.178 -0.464 . . . . 74.11 111.565 -172.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.439 ' O ' ' HG3' ' B' ' 54' ' ' GLU . . . -63.11 -48.12 79.9 Favored 'General case' 0 C--O 1.2 -1.549 0 N-CA-C 109.954 -0.387 . . . . 71.03 109.954 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -59.12 -39.59 82.77 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 111.946 0.35 . . . . 75.32 111.946 176.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.526 ' HB2' ' H ' ' B' ' 49' ' ' THR . 0.8 OUTLIER -55.94 -46.28 78.58 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.818 0.818 . . . . 74.04 109.765 173.715 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 99.2 mt -68.35 -43.88 76.51 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.369 -1.287 . . . . 72.3 112.149 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.46 ' HA ' ' CD1' ' B' ' 63' ' ' ILE . 48.3 mt-10 -57.97 -50.11 74.51 Favored 'General case' 0 C--O 1.183 -2.432 0 C-N-CA 120.645 -0.422 . . . . 75.03 111.061 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.44 -48.1 77.73 Favored 'General case' 0 C--O 1.25 1.081 0 O-C-N 123.554 0.534 . . . . 62.22 111.643 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -67.3 -37.66 83.72 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.486 -0.779 . . . . 72.11 110.868 -175.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -82.58 -22.88 34.68 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.647 0.98 . . . . 75.03 113.647 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 38.9 t -67.78 -27.96 67.19 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.891 -0.781 . . . . 23.53 108.891 -177.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 21.8 m -60.06 -25.4 65.34 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 115.806 -0.633 . . . . 74.02 110.673 174.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 77.1 m -102.1 2.97 38.14 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.092 0.775 . . . . 52.4 113.092 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.66 -167.6 29.82 Favored Glycine 0 N--CA 1.461 0.321 0 C-N-CA 119.058 -1.544 . . . . 72.31 114.977 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 19.4 t -105.86 127.92 53.43 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-O 120.857 0.36 . . . . 40.45 110.548 -176.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.46 ' CD1' ' HA ' ' B' ' 54' ' ' GLU . 74.2 mt -87.04 133.51 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 113.519 0.933 . . . . 74.1 113.519 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 64' ' ' ASN . . . . . 0.419 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 94.2 m-20 -103.88 -35.94 7.98 Favored 'General case' 0 C--O 1.172 -3.022 0 CA-C-N 115.823 -0.626 . . . . 71.3 111.757 174.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 43.3 mtp180 -149.02 152.29 36.01 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.622 -0.881 . . . . 72.2 108.622 178.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.553 HG23 ' HB2' ' A' ' 70' ' ' CYS . 0.3 OUTLIER -149.51 131.39 5.65 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.698 0 C-N-CA 124.024 0.93 . . . . 72.13 109.886 177.231 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 67' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' B' ' 81' ' ' ALA . 74.1 m -124.79 128.68 49.11 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 106.964 -1.495 . . . . 75.21 106.964 -176.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.16 121.76 60.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 106.098 -1.816 . . . . 64.12 106.098 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.389 1.2 pt? -120.7 132.35 55.03 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 119.311 -0.956 . . . . 73.0 112.64 175.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 70' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 63.7 m -114.43 118.19 33.13 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 107.527 -1.286 . . . . 70.12 107.527 -178.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 8.8 t70 -110.75 115.33 29.37 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 118.788 -1.165 . . . . 64.42 109.276 -176.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -112.63 3.74 16.82 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.191 -1.411 . . . . 64.44 107.191 -178.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -56.96 -21.72 32.47 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 126.551 1.94 . . . . 72.24 113.755 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 43.4 m -109.84 13.81 23.42 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.014 0.435 . . . . 74.23 111.005 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.27 -64.85 0.29 Allowed Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.779 -0.724 . . . . 71.3 112.128 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -96.4 129.63 32.89 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 109.83 -0.433 . . . . 70.02 109.83 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 84.1 Cg_endo -75.4 118.58 5.22 Favored 'Trans proline' 0 N--CA 1.435 -1.957 0 C-N-CA 121.39 1.393 . . . . 74.22 112.714 -178.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 78' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 39.6 mtpt -94.16 -179.59 4.99 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 125.278 1.431 . . . . 75.44 109.578 175.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.35 135.58 3.94 Favored Glycine 0 N--CA 1.403 -3.503 0 C-N-CA 119.177 -1.487 . . . . 63.25 113.407 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . 0.266 0.2 OUTLIER -151.23 145.49 25.42 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 114.616 -0.792 . . . . 75.53 109.97 172.307 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' B' ' 67' ' ' THR . . . -130.75 148.2 52.5 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.553 -0.748 . . . . 71.34 110.265 -174.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 82' ' ' TYR . . . . . 0.429 ' CZ ' ' HD1' ' B' ' 40' ' ' TYR . 81.6 m-85 -123.16 116.63 23.75 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.816 -0.809 . . . . 63.33 108.816 177.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 11.4 mm -107.47 133.9 50.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 107.791 -1.188 . . . . 73.11 107.791 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 84' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' B' ' 37' ' ' ARG . 53.4 mt-10 -112.2 125.31 54.0 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.171 -1.048 . . . . 75.34 108.171 175.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.574 ' O ' ' HD3' ' B' ' 37' ' ' ARG . 89.4 m-85 -96.54 167.23 11.27 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 112.032 0.382 . . . . 64.4 112.032 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.419 ' HA ' ' ND2' ' B' ' 64' ' ' ASN . . . -81.92 -37.17 27.2 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.923 -0.58 . . . . 75.31 110.811 174.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 87' ' ' GLU . . . . . 0.541 ' HB2' ' OG ' ' B' ' 90' ' ' SER . 6.9 mp0 -98.73 141.84 31.03 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.462 -0.57 . . . . 61.22 109.462 178.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.25 -26.86 59.17 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 106.762 -1.57 . . . . 72.54 106.762 177.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -70.97 -21.79 62.28 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.641 -0.709 . . . . 63.12 111.278 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 90' ' ' SER . . . . . 0.541 ' OG ' ' HB2' ' B' ' 87' ' ' GLU . 51.4 m -71.95 -37.19 70.02 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 111.957 0.354 . . . . 73.42 111.957 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.655 HG23 HG22 ' B' ' 39' ' ' VAL . 2.2 p -67.83 -41.24 84.85 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 C-N-CA 119.407 -0.917 . . . . 61.22 109.489 175.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -59.16 -33.68 71.19 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.994 -0.548 . . . . 72.21 110.502 178.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.53 -34.24 65.12 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.209 -0.45 . . . . 45.13 111.848 176.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.86 -39.55 50.71 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-O 120.701 0.286 . . . . 74.51 111.163 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 95' ' ' VAL . . . . . 0.527 HG13 ' O ' ' B' ' 91' ' ' VAL . 19.9 m -56.25 -21.81 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 113.1 0.778 . . . . 44.0 113.1 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.99 -11.24 60.73 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.567 0.699 . . . . 73.14 110.819 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 19.9 mtm -93.88 -0.49 55.68 Favored 'General case' 0 C--O 1.175 -2.83 0 CA-C-O 117.872 -1.061 . . . . 75.15 110.994 175.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 98' ' ' ASP . . . . . 0.575 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 2.2 p-10 -35.82 -46.27 0.44 Allowed 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 115.372 1.619 . . . . 62.33 115.372 -168.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -93.63 85.33 4.84 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.052 -1.462 . . . . 70.24 107.052 169.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 100' ' ' THR . . . . . 0.627 ' HB ' HG12 ' B' ' 107' ' ' ILE . 1.3 m -95.7 137.72 34.37 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 119.979 -0.688 . . . . 63.53 109.404 -175.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 3.7 p -99.91 103.81 15.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 107.664 -1.236 . . . . 54.14 107.664 173.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -134.08 123.68 24.89 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.79 -1.095 . . . . 72.25 109.48 -173.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 58.29 33.48 23.18 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 122.405 1.098 . . . . 55.34 111.356 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.54 2.4 84.77 Favored Glycine 0 C--N 1.317 -0.475 0 CA-C-N 114.827 -1.079 . . . . 75.22 112.522 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -109.7 163.57 13.36 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 109.551 -0.537 . . . . 75.33 109.551 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 106' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' B' ' 100' ' ' THR . 62.0 m -108.36 118.73 37.54 Favored 'General case' 0 N--CA 1.404 -2.755 0 N-CA-C 106.985 -1.487 . . . . 61.42 106.985 172.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 107' ' ' ILE . . . . . 0.627 HG12 ' HB ' ' B' ' 100' ' ' THR . 46.3 pt -103.45 171.61 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 C-N-CA 119.792 -0.763 . . . . 74.43 109.293 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 108' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 26.7 mmmt -125.2 125.62 43.92 Favored 'General case' 0 CA--C 1.479 -1.782 0 O-C-N 123.652 0.595 . . . . 74.42 110.019 -177.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 109' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 33.9 m -128.12 115.78 39.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 123.786 0.679 . . . . 74.22 109.739 176.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.2 158.56 47.74 Favored Pre-proline 0 C--N 1.294 -1.819 0 N-CA-C 108.762 -0.829 . . . . 73.05 108.762 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.23 146.43 25.14 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 121.498 1.465 . . . . 74.15 114.001 -172.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.479 ' NZ ' ' HA ' ' B' ' 112' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.286 -2.162 0 N-CA-C 107.19 -1.411 . . . . 55.2 107.19 176.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 111.841 0.312 . . . . 72.42 111.841 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.4 pt -71.07 -33.91 53.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.01 0.433 . . . . 70.41 111.556 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.85 -34.67 69.97 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.572 1.149 . . . . 73.53 110.372 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -77.96 -16.46 58.14 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.591 -1.186 . . . . 71.2 111.035 -177.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.423 ' HG2' ' HA ' ' A' ' 88' ' ' ARG . 89.7 mtt180 -123.89 18.21 9.36 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 114.209 1.189 . . . . 73.01 114.209 -164.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.543 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 33.0 m -96.2 150.72 20.22 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 120.092 -0.643 . . . . 45.2 110.365 176.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 83' ' ' ILE . 33.2 m -140.02 164.11 23.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.125 0.488 . . . . 74.32 110.271 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.72 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 13.3 t80 -110.48 134.86 51.95 Favored 'General case' 0 C--N 1.284 -2.244 0 C-N-CA 124.974 1.31 . . . . 60.21 108.736 177.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.516 HG22 HG12 ' A' ' 109' ' ' VAL . 61.4 t -121.94 118.18 54.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.499 -1.297 . . . . 74.21 107.499 174.1 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -111.16 166.33 12.26 Favored Glycine 0 C--N 1.286 -2.232 0 C-N-CA 119.276 -1.44 . . . . 73.2 113.688 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.46 ' ND2' ' HB3' ' A' ' 105' ' ' ARG . 66.3 t30 56.3 27.42 11.83 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 126.137 1.775 . . . . 70.14 113.558 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.448 HG22 ' HB2' ' A' ' 48' ' ' SER . 14.6 p -61.55 138.64 21.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 N-CA-C 108.94 -0.763 . . . . 64.2 108.94 173.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.62 150.39 39.65 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.419 -0.586 . . . . 75.5 109.419 -173.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.494 ' CD1' ' HB2' ' A' ' 77' ' ' PRO . 78.3 t80 -65.36 -14.2 60.3 Favored 'General case' 0 CA--C 1.558 1.285 0 CA-C-O 121.586 0.708 . . . . 63.24 110.232 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.53 -7.39 59.15 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 116.003 -0.544 . . . . 73.12 112.921 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.448 ' HB2' HG22 ' A' ' 44' ' ' VAL . 26.4 m -80.03 133.97 36.18 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 117.424 0.612 . . . . 75.44 110.087 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.0 p -97.62 170.71 8.83 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 120.944 -0.303 . . . . 73.23 111.069 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.526 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -62.28 -45.22 94.23 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.594 -0.521 . . . . 75.21 109.594 175.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.82 -44.9 86.72 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.084 0.554 . . . . 41.31 109.885 176.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -55.91 -43.69 77.54 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.119 0.485 . . . . 54.32 111.55 176.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.3 mt -70.86 -47.55 58.71 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.522 -0.763 . . . . 74.11 111.71 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.35 -48.0 83.31 Favored 'General case' 0 C--O 1.204 -1.326 0 C-N-CA 123.424 0.69 . . . . 63.55 110.85 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.35 -42.57 96.01 Favored 'General case' 0 C--O 1.259 1.601 0 CA-C-O 121.523 0.678 . . . . 54.24 111.151 176.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -64.26 -41.89 96.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.41 -0.813 . . . . 61.35 110.428 -175.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -81.21 -20.51 40.95 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 113.289 0.848 . . . . 70.42 113.289 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.0 t -65.85 -26.63 67.74 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.712 -0.676 . . . . 71.34 109.481 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.4 m -60.19 -33.73 72.63 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-O 121.362 0.601 . . . . 75.32 110.023 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.427 ' SG ' ' SD ' ' A' ' 97' ' ' MET . 72.6 m -92.97 4.32 54.19 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 113.699 1.0 . . . . 70.14 113.699 -177.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.44 -169.92 33.39 Favored Glycine 0 CA--C 1.497 -1.053 0 C-N-CA 118.627 -1.749 . . . . 74.1 114.623 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.9 m -102.64 127.63 49.67 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.295 -0.631 . . . . 74.0 109.295 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.6 mt -95.6 130.05 44.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 113.788 1.033 . . . . 74.01 113.788 -175.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -91.53 -44.76 8.89 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-N 115.355 -0.839 . . . . 74.21 110.908 176.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.409 ' HD2' ' OE1' ' A' ' 84' ' ' GLU . 66.2 mtt180 -151.46 159.51 44.16 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 115.324 -0.853 . . . . 74.53 109.669 -173.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.526 HD11 ' HB1' ' A' ' 50' ' ' ALA . 28.2 pt -148.34 143.52 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 107.766 -1.198 . . . . 61.0 107.766 173.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.3 m -126.2 132.21 51.82 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 106.969 -1.493 . . . . 75.22 106.969 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 68' ' ' ILE . 2.4 mp -127.78 123.34 60.84 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 N-CA-C 106.085 -1.82 . . . . 33.15 106.085 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.46 ' HB3' ' HA ' ' B' ' 67' ' ' THR 0.345 1.0 OUTLIER -121.17 125.39 47.06 Favored 'General case' 0 C--N 1.273 -2.76 0 C-N-CA 120.073 -0.651 . . . . 72.45 112.588 175.861 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.406 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 81.8 m -116.73 128.61 55.49 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.784 -0.821 . . . . 71.11 108.784 -177.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.623 ' HA ' ' HA ' ' B' ' 65' ' ' ARG . 2.8 p-10 -121.35 152.14 39.32 Favored 'General case' 0 C--O 1.19 -2.056 0 C-N-CA 119.647 -0.821 . . . . 70.22 110.554 -177.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -127.06 15.81 7.32 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 108.63 -0.878 . . . . 62.31 108.63 175.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.468 ' HB3' ' HB3' ' B' ' 64' ' ' ASN . 37.7 p90 -66.84 -20.57 65.96 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 119.864 -0.734 . . . . 65.22 111.453 -177.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.6 m -86.82 9.16 19.97 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 116.162 -0.472 . . . . 74.55 110.833 176.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.33 -46.15 3.19 Favored Glycine 0 CA--C 1.501 -0.811 0 N-CA-C 111.084 -0.806 . . . . 52.13 111.084 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -95.5 129.2 35.52 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 106.779 -1.563 . . . . 50.14 106.779 176.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 72.2 Cg_endo -72.61 119.27 6.01 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 121.55 1.5 . . . . 61.45 111.404 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -110.71 -165.61 1.01 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.4 -0.818 . . . . 74.01 109.589 -176.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 70' ' ' CYS . . . -171.18 148.58 11.31 Favored Glycine 0 N--CA 1.407 -3.267 0 C-N-CA 120.367 -0.92 . . . . 72.23 113.166 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -149.61 143.53 25.6 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 124.512 1.125 . . . . 75.24 109.236 172.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.37 156.1 47.25 Favored 'General case' 0 C--O 1.192 -1.959 0 CA-C-O 120.664 0.269 . . . . 64.12 110.927 -172.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.441 ' HE2' ' HZ3' ' A' ' 112' ' ' LYS . 44.3 m-85 -124.24 124.63 42.85 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.482 -0.562 . . . . 62.31 109.482 176.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.48 HG23 HG22 ' A' ' 66' ' ' ILE . 29.1 mm -108.94 124.88 65.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 109.224 -0.658 . . . . 74.04 109.224 -177.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.409 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 32.0 tt0 -102.35 119.57 39.03 Favored 'General case' 0 C--O 1.25 1.112 0 N-CA-C 108.605 -0.887 . . . . 72.33 108.605 177.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -98.1 157.29 16.23 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.431 0.634 . . . . 73.21 112.708 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.19 -43.09 83.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.217 -0.902 . . . . 65.25 112.339 176.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -112.89 155.92 23.85 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 121.222 0.534 . . . . 74.21 111.836 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.494 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -69.91 -35.0 74.23 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.271 -1.011 . . . . 72.34 108.271 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -21.42 66.84 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 115.759 -0.655 . . . . 50.24 112.109 -177.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.9 m -68.21 -36.28 79.29 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 109.82 -0.437 . . . . 42.21 109.82 176.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 95' ' ' VAL . 3.1 m -69.31 -40.03 79.68 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.054 0 N-CA-C 108.97 -0.752 . . . . 74.44 108.97 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -56.87 -35.95 69.49 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.765 0.793 . . . . 73.12 110.032 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.34 -36.2 63.64 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.62 -0.718 . . . . 63.31 111.472 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.45 -42.49 43.71 Favored 'General case' 0 C--O 1.204 -1.309 0 CA-C-N 115.733 -0.667 . . . . 61.55 111.319 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 91' ' ' VAL . 23.8 m -56.69 -22.45 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 112.756 0.65 . . . . 72.02 112.756 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.34 -9.27 52.61 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.523 0.678 . . . . 35.11 110.469 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.427 ' SD ' ' SG ' ' A' ' 60' ' ' CYS . 37.8 mtp -105.67 4.52 30.22 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.176 -0.92 . . . . 73.53 110.405 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.515 ' HA ' HG22 ' A' ' 109' ' ' VAL . 1.6 p-10 -44.54 -36.89 3.21 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 114.884 1.439 . . . . 72.25 114.884 -176.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -115.33 92.29 3.88 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.341 -0.944 . . . . 72.44 109.537 171.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.9 p -138.45 172.31 13.08 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.263 -1.335 . . . . 45.12 110.649 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.4 p -119.75 126.28 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-O 121.412 0.625 . . . . 74.11 110.527 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -128.16 124.03 35.82 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 108.358 -0.978 . . . . 74.21 108.358 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 49.37 33.15 5.1 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.543 1.537 . . . . 73.45 111.204 -174.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.78 0.74 87.56 Favored Glycine 0 C--N 1.308 -1.016 0 CA-C-N 115.153 -0.93 . . . . 62.51 113.39 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.46 ' HB3' ' ND2' ' A' ' 43' ' ' ASN . 58.3 mtt180 -106.6 140.46 39.44 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.395 -0.594 . . . . 71.23 109.395 175.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.1 m -80.5 119.2 22.86 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.705 -1.22 . . . . 64.42 107.705 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 38.3 pt -101.49 169.46 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 C-N-CA 120.451 -0.5 . . . . 64.1 110.527 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 53.9 tptt -134.99 134.2 40.25 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.462 -0.79 . . . . 73.14 109.67 -177.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.72 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 16.0 m -127.17 126.84 68.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 O-C-N 123.044 0.215 . . . . 74.23 111.055 174.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . 0.255 0.0 OUTLIER -145.83 144.61 22.63 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 109.2 -0.667 . . . . 53.35 109.2 176.92 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -62.82 139.87 76.89 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 123.191 2.594 . . . . 74.24 113.782 -175.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 38' ' ' SER . 39.7 mtpt . . . . . 0 C--N 1.314 -0.935 0 CA-C-N 115.981 -0.554 . . . . 73.05 111.761 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.042 0 N-CA-C 115.695 1.038 . . . . 63.14 115.695 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.576 ' HD3' ' CZ ' ' A' ' 40' ' ' TYR . 1.6 Cg_endo -40.12 -53.79 2.38 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 125.079 3.852 . . . . 74.11 114.505 -177.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.495 ' HD3' ' HG2' ' B' ' 22' ' ' PRO . 22.1 Cg_endo -93.17 122.81 0.48 Allowed 'Trans proline' 0 N--CA 1.416 -3.074 0 N-CA-C 108.442 -1.407 . . . . 64.3 108.442 170.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -69.02 135.8 89.55 Favored Pre-proline 0 C--N 1.313 -1.012 0 C-N-CA 120.145 -0.622 . . . . 72.14 109.884 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -28.73 104.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.385 2.485 1 C-N-CA 125.354 4.036 . . . . 75.13 113.57 -174.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.539 HD13 ' H ' ' B' ' 26' ' ' LEU 0.283 0.0 OUTLIER -52.64 153.16 3.28 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 113.333 -1.758 . . . . 64.34 115.079 -176.954 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.513 ' O ' ' HG3' ' B' ' 31' ' ' LYS . 14.8 m -60.46 163.83 4.94 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 125.687 1.595 . . . . 44.34 113.35 -177.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.5 75.74 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.021 -0.536 . . . . 73.44 112.393 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -73.21 -31.07 63.94 Favored 'General case' 0 CA--C 1.49 -1.352 0 CA-C-O 120.974 0.416 . . . . 72.35 111.851 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.405 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.4 OUTLIER -60.4 -33.92 73.18 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.228 -0.896 . . . . 75.43 110.457 173.313 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' B' ' 27' ' ' SER . 95.7 mttt -69.58 -51.56 34.18 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.397 -0.594 . . . . 61.34 109.397 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 0.7 OUTLIER -53.97 -47.32 71.49 Favored 'General case' 0 C--N 1.359 1.014 0 N-CA-C 113.516 0.932 . . . . 70.34 113.516 179.474 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 11.2 mm-40 -64.81 -44.39 90.06 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.471 0.545 . . . . 75.33 112.471 -174.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.405 HG12 ' O ' ' B' ' 30' ' ' GLU . 24.3 pt -70.47 -33.33 53.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.196 0.522 . . . . 73.14 110.793 -178.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -56.92 -38.41 72.83 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.182 1.393 . . . . 50.34 111.311 -177.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 90.0 mttt -75.86 -25.26 56.03 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.639 -1.164 . . . . 72.12 112.327 -176.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' B' ' 33' ' ' GLU . 20.5 ptt180 -118.72 25.69 10.07 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 114.047 1.129 . . . . 73.52 114.047 -168.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 37.1 m -96.69 148.44 22.87 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 116.642 -0.254 . . . . 72.24 111.268 175.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.409 HG22 ' O ' ' B' ' 83' ' ' ILE . 29.3 m -139.97 165.29 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-O 121.09 0.471 . . . . 72.01 111.541 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 40' ' ' TYR . . . . . 0.697 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 9.7 t80 -114.29 132.18 56.26 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 125.68 1.592 . . . . 72.0 108.721 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 59.1 t -119.51 118.4 57.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 124.568 1.147 . . . . 75.11 108.124 174.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.38 172.51 14.33 Favored Glycine 0 C--N 1.293 -1.849 0 C-N-CA 119.339 -1.41 . . . . 72.43 113.387 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 65.7 t30 63.99 8.52 3.99 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 126.211 1.804 . . . . 72.15 114.597 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.64 126.49 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-O 121.577 0.704 . . . . 74.4 109.747 175.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.99 156.72 25.78 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.475 -0.784 . . . . 43.44 111.399 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 46' ' ' TYR . . . . . 0.592 ' CD2' ' HB2' ' B' ' 77' ' ' PRO . 9.4 t80 -75.36 86.3 2.53 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 106.314 -1.735 . . . . 75.05 106.314 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.83 -27.62 0.07 OUTLIER Glycine 0 N--CA 1.419 -2.481 0 N-CA-C 109.728 -1.349 . . . . 65.0 109.728 -174.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 26.6 t -84.44 148.15 26.72 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 106.749 -1.574 . . . . 65.21 106.749 173.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 50.5 p -111.74 178.07 4.44 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 110.242 -0.281 . . . . 71.32 110.242 -177.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.505 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -62.31 -47.74 82.94 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 110.19 -0.3 . . . . 73.33 110.19 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -57.48 -44.02 84.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.208 -0.451 . . . . 72.34 110.534 177.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -60.36 -40.01 89.26 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-O 121.68 0.753 . . . . 63.45 109.789 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 56.0 mt -72.64 -47.31 48.6 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.086 -0.961 . . . . 73.32 112.288 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.54 -48.68 80.7 Favored 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 123.269 0.628 . . . . 72.35 110.727 -178.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.32 -42.77 87.51 Favored 'General case' 0 C--O 1.255 1.347 0 CA-C-O 121.252 0.548 . . . . 62.2 110.925 176.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -64.14 -41.58 97.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.556 -0.747 . . . . 70.12 110.496 -176.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.421 ' CZ ' HG11 ' B' ' 109' ' ' VAL 0.268 51.7 m-85 -81.83 -20.77 38.31 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 113.747 1.017 . . . . 73.21 113.747 178.451 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 33.4 t -66.67 -24.18 66.24 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.537 -0.912 . . . . 72.25 108.537 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 15.6 m -58.94 -31.91 69.12 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 115.934 -0.575 . . . . 61.42 110.155 172.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 74.7 m -93.89 7.33 45.4 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.973 0.731 . . . . 71.4 112.973 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.72 -148.51 20.22 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 118.242 -1.933 . . . . 64.21 115.698 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 62' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' B' ' 86' ' ' ALA . 15.6 m -110.94 124.48 52.2 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.73 -0.47 . . . . 70.34 109.73 -176.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 63.8 mt -94.69 130.55 43.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 113.642 0.978 . . . . 65.02 113.642 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 64' ' ' ASN . . . . . 0.482 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 93.0 m-20 -94.82 -43.55 8.17 Favored 'General case' 0 C--O 1.197 -1.658 0 CA-C-N 115.208 -0.906 . . . . 73.0 110.827 175.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.623 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 67.4 mtt180 -152.45 157.44 41.19 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 109.399 -0.593 . . . . 71.44 109.399 -175.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.523 HG22 HG23 ' B' ' 83' ' ' ILE . 23.2 pt -147.3 142.87 20.11 Favored 'Isoleucine or valine' 0 C--O 1.191 -2.002 0 N-CA-C 106.77 -1.567 . . . . 73.33 106.77 173.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 67' ' ' THR . . . . . 0.46 ' HA ' ' HB3' ' A' ' 69' ' ' LEU . 61.8 m -126.4 131.64 51.69 Favored 'General case' 0 C--N 1.272 -2.769 0 N-CA-C 106.914 -1.513 . . . . 74.02 106.914 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 3.0 mp -127.25 120.54 55.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 106.697 -1.594 . . . . 65.1 106.697 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.282 1.1 pt? -120.49 127.75 52.5 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 120.065 -0.654 . . . . 50.55 111.62 177.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 80.1 m -116.91 130.23 56.57 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.217 -0.902 . . . . 63.21 109.342 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.702 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 4.0 p30 -111.57 127.76 55.83 Favored 'General case' 0 C--O 1.216 -0.682 0 C-N-CA 119.497 -0.881 . . . . 72.35 110.488 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 72' ' ' LYS . . . . . 0.442 ' O ' ' HG2' ' B' ' 72' ' ' LYS . 33.2 ttmt -123.45 4.4 9.04 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.193 0.52 . . . . 71.23 109.931 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' B' ' 71' ' ' ASP . 53.3 p90 -64.04 -6.97 7.22 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 113.831 1.049 . . . . 70.3 113.831 -174.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 42.8 m -106.56 6.38 29.99 Favored 'General case' 0 C--N 1.313 -1.009 0 O-C-N 121.782 -0.574 . . . . 73.22 111.24 175.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.6 -61.86 0.3 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.835 -0.698 . . . . 70.21 111.745 -178.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -96.26 129.65 33.06 Favored Pre-proline 0 C--N 1.305 -1.337 0 N-CA-C 109.757 -0.46 . . . . 75.13 109.757 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.702 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 96.2 Cg_endo -79.32 126.69 7.03 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.639 2.226 . . . . 63.45 113.561 -177.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -107.35 -167.7 1.3 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.897 -1.149 . . . . 73.03 107.897 176.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.54 147.74 11.7 Favored Glycine 0 N--CA 1.415 -2.758 0 C-N-CA 119.791 -1.195 . . . . 44.25 113.576 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -151.64 144.79 24.62 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 124.502 1.121 . . . . 71.13 108.81 172.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -134.05 155.21 50.42 Favored 'General case' 0 C--O 1.194 -1.863 0 CA-C-O 120.681 0.277 . . . . 63.02 111.199 -172.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 82' ' ' TYR . . . . . 0.425 ' CD2' ' HD3' ' B' ' 112' ' ' LYS . 51.7 m-85 -124.32 124.09 41.63 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.279 -0.637 . . . . 61.34 109.279 176.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.523 HG23 HG22 ' B' ' 66' ' ' ILE . 30.4 mm -107.9 124.79 64.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 109.038 -0.727 . . . . 71.24 109.038 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 84' ' ' GLU . . . . . 0.424 ' HB3' ' HB2' ' B' ' 65' ' ' ARG . 36.6 tt0 -103.57 119.4 38.82 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.739 -1.208 . . . . 72.41 107.739 176.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -94.89 162.73 13.63 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 110.331 -0.248 . . . . 75.31 110.331 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.482 ' HA ' ' ND2' ' B' ' 64' ' ' ASN . . . -83.63 -21.24 32.57 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.101 0.477 . . . . 35.42 111.343 175.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 87' ' ' GLU . . . . . 0.457 ' HB2' ' OG ' ' B' ' 90' ' ' SER . 27.9 mt-10 -119.39 145.23 46.39 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 116.187 -0.46 . . . . 73.41 109.763 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.463 ' O ' HG22 ' B' ' 91' ' ' VAL . 0.5 OUTLIER -72.03 -34.29 68.68 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 107.203 -1.406 . . . . 71.31 107.203 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -59.31 -32.17 69.82 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.719 -1.128 . . . . 75.52 108.996 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 90' ' ' SER . . . . . 0.457 ' OG ' ' HB2' ' B' ' 87' ' ' GLU . 23.3 m -63.46 -35.94 82.11 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.757 -0.656 . . . . 75.41 110.955 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.534 ' O ' HG13 ' B' ' 95' ' ' VAL . 3.1 m -69.35 -39.41 78.87 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.192 0 C-N-CA 119.302 -0.959 . . . . 73.11 108.678 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -57.72 -37.75 74.07 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.082 0.468 . . . . 73.3 110.811 176.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.46 -34.06 65.18 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.936 -0.575 . . . . 71.43 110.437 178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.6 -44.65 33.48 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 116.785 -0.189 . . . . 60.03 111.154 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 95' ' ' VAL . . . . . 0.534 HG13 ' O ' ' B' ' 91' ' ' VAL . 22.0 m -56.65 -22.85 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 112.68 0.622 . . . . 73.43 112.68 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.1 -9.33 45.5 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.349 0.595 . . . . 75.24 110.651 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 56.5 mtm -104.69 10.2 34.83 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.757 -0.656 . . . . 74.15 110.984 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . 0.264 4.1 p-10 -44.46 -44.95 8.88 Favored 'General case' 0 C--O 1.204 -1.298 0 N-CA-C 114.91 1.448 . . . . 72.14 114.91 -176.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -110.84 71.38 0.74 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-N 119.822 1.192 . . . . 74.42 112.146 167.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 47.4 p -115.84 168.43 10.06 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.115 -0.493 . . . . 53.23 111.771 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 9.6 p -100.64 136.42 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-O 121.41 0.624 . . . . 74.24 109.52 -177.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -132.39 109.91 10.18 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 107.961 -1.126 . . . . 61.15 107.961 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 49.53 32.21 4.68 Favored 'General case' 0 CA--C 1.563 1.46 0 C-N-CA 125.4 1.48 . . . . 65.22 112.628 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.22 -9.58 39.2 Favored Glycine 0 C--N 1.318 -0.428 0 C-N-CA 120.674 -0.774 . . . . 23.44 113.741 174.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -116.4 151.85 35.14 Favored 'General case' 0 C--O 1.206 -1.215 0 CA-C-N 117.135 0.467 . . . . 53.34 109.883 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 92.9 m -86.87 120.14 27.84 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.835 -1.172 . . . . 75.12 107.835 174.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 2.6 pp -102.13 166.74 2.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 119.691 -0.804 . . . . 62.44 110.267 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 108' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 54.3 tptt -125.37 132.99 52.7 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.734 -0.469 . . . . 72.51 109.734 -172.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 109' ' ' VAL . . . . . 0.697 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 15.7 m -127.0 128.79 70.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.277 0.56 . . . . 65.15 111.301 176.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.333 0.4 OUTLIER -147.01 133.43 9.71 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 106.279 -1.749 . . . . 63.31 106.279 -169.802 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.5 141.78 87.81 Favored 'Trans proline' 0 N--CA 1.486 1.038 0 C-N-CA 122.504 2.136 . . . . 62.44 113.068 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.425 ' HD3' ' CD2' ' B' ' 82' ' ' TYR . 22.6 ttpp . . . . . 0 N--CA 1.431 -1.407 0 N-CA-C 109.138 -0.69 . . . . 65.44 109.138 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 N--CA 1.44 -0.972 0 N-CA-C 113.759 1.022 . . . . 73.21 113.759 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.4 pt -63.06 -33.69 62.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.641 -0.424 . . . . 74.2 110.511 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.44 -38.45 81.15 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 108.949 -0.76 . . . . 61.22 108.949 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -66.01 -42.0 90.28 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 114.468 1.284 . . . . 55.42 114.468 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.673 ' HG3' ' O ' ' A' ' 85' ' ' PHE . 3.4 ptm180 -102.85 19.18 19.82 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 111.797 0.295 . . . . 75.4 111.797 -169.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.9 p -110.52 167.12 10.45 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.658 0.985 . . . . 34.05 113.658 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.404 ' CG1' HG23 ' A' ' 91' ' ' VAL . 9.7 m -140.3 164.95 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.277 1.031 . . . . 73.44 112.023 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.659 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 27.9 t80 -109.89 127.03 54.47 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 124.882 1.273 . . . . 72.25 108.469 176.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.7 t -115.58 112.01 38.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 107.812 -1.181 . . . . 75.41 107.812 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.427 ' HA3' ' CZ ' ' A' ' 40' ' ' TYR . . . -121.62 -177.34 15.48 Favored Glycine 0 N--CA 1.435 -1.385 0 C-N-CA 119.556 -1.307 . . . . 73.32 114.738 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.3 t30 72.7 -7.35 1.45 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.062 2.145 . . . . 61.33 112.475 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.78 103.55 4.13 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.929 0 CA-C-O 121.488 0.661 . . . . 63.11 109.866 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -81.06 83.57 6.71 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 114.162 1.171 . . . . 72.21 114.162 -168.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.55 ' H ' ' HA3' ' A' ' 79' ' ' GLY . 63.6 t80 68.22 -20.52 0.14 Allowed 'General case' 0 CA--C 1.577 1.989 0 N-CA-C 115.526 1.676 . . . . 73.12 115.526 163.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.27 5.35 45.15 Favored Glycine 0 C--O 1.241 0.577 0 N-CA-C 116.912 1.525 . . . . 51.02 116.912 -169.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.2 t -87.65 147.74 25.12 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 119.318 1.559 . . . . 70.32 109.885 176.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.549 HG22 HG22 ' B' ' 49' ' ' THR . 82.6 p -97.37 158.92 15.22 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.007 -0.542 . . . . 71.33 111.207 -176.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.484 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -65.16 -48.25 74.19 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 122.557 0.343 . . . . 54.31 110.835 -177.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.01 -40.3 80.46 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.333 0.494 . . . . 72.33 112.333 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.9 -38.06 76.18 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.216 0.531 . . . . 72.12 110.515 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.2 mt -68.77 -47.2 66.82 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.381 -0.827 . . . . 64.25 111.209 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -61.92 -48.19 81.54 Favored 'General case' 0 C--O 1.202 -1.433 0 CA-C-N 115.755 -0.657 . . . . 65.14 110.875 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.65 -43.99 80.86 Favored 'General case' 0 C--O 1.26 1.609 0 CA-C-O 121.789 0.804 . . . . 52.44 111.256 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -64.77 -38.51 91.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.667 -1.152 . . . . 74.44 110.355 -176.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -82.33 -21.64 35.94 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.496 0.925 . . . . 64.23 113.496 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.7 t -70.63 -23.88 62.61 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.845 -0.616 . . . . 74.41 109.78 -176.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.8 m -59.97 -27.27 66.69 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-O 121.055 0.455 . . . . 62.55 110.36 173.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 62.7 m -92.66 7.93 41.32 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 112.568 0.581 . . . . 73.02 112.568 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.67 -169.82 25.04 Favored Glycine 0 CA--C 1.505 -0.538 0 C-N-CA 119.559 -1.305 . . . . 74.34 113.28 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.1 m -96.08 126.44 41.32 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 121.614 0.721 . . . . 71.14 110.156 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.5 mt -85.02 134.38 27.16 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.398 0 CA-C-N 114.938 -1.028 . . . . 75.31 112.462 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.462 ' OD1' ' HG3' ' A' ' 65' ' ' ARG . 50.9 t-20 -89.72 -54.24 4.15 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.633 -1.167 . . . . 73.44 108.51 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.462 ' HG3' ' OD1' ' A' ' 64' ' ' ASN . 66.0 mtp180 -154.34 164.17 39.02 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 106.624 -1.621 . . . . 74.24 106.624 -176.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.484 HD11 ' HB1' ' A' ' 50' ' ' ALA . 31.4 pt -143.59 142.59 24.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 107.166 -1.42 . . . . 73.31 107.166 172.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.7 m -124.81 125.14 43.54 Favored 'General case' 0 C--N 1.273 -2.726 0 N-CA-C 107.912 -1.144 . . . . 63.14 107.912 -177.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.0 mp -123.57 116.39 48.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 106.139 -1.8 . . . . 74.22 106.139 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.461 ' HG ' ' CE1' ' A' ' 80' ' ' TYR 0.286 0.8 OUTLIER -121.43 128.79 52.53 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 120.376 -0.53 . . . . 62.44 112.372 179.525 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 74.3 m -117.48 130.61 56.56 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 109.031 -0.729 . . . . 72.45 109.031 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.557 ' HA ' ' HA ' ' B' ' 65' ' ' ARG . 3.1 p30 -118.63 146.49 44.61 Favored 'General case' 0 CA--C 1.484 -1.588 0 C-N-CA 120.024 -0.67 . . . . 73.32 110.691 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -120.1 11.1 11.58 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.681 -0.859 . . . . 74.41 108.681 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.596 ' HB3' ' OD1' ' B' ' 64' ' ' ASN . 10.8 p90 -66.82 -19.95 65.84 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 120.325 -0.55 . . . . 75.44 110.958 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 31.2 t -79.59 -1.21 36.95 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 115.111 -0.95 . . . . 55.01 110.045 178.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.47 -51.39 1.58 Allowed Glycine 0 CA--C 1.491 -1.458 0 N-CA-C 110.093 -1.203 . . . . 73.2 110.093 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -96.08 133.48 25.1 Favored Pre-proline 0 C--N 1.29 -2.004 0 N-CA-C 106.683 -1.599 . . . . 75.52 106.683 175.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.478 ' HB2' ' CD1' ' A' ' 46' ' ' TYR . 63.3 Cg_endo -71.06 118.76 5.86 Favored 'Trans proline' 0 N--CA 1.44 -1.652 0 C-N-CA 121.081 1.188 . . . . 44.42 111.001 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm -101.07 158.35 16.08 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.594 -1.184 . . . . 74.4 109.607 -175.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.55 ' HA3' ' H ' ' A' ' 46' ' ' TYR . . . -136.25 138.69 10.07 Favored Glycine 0 N--CA 1.418 -2.531 0 C-N-CA 120.497 -0.859 . . . . 62.5 112.581 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.461 ' CE1' ' HG ' ' A' ' 69' ' ' LEU . 12.6 p90 -154.79 144.18 21.27 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 123.905 0.882 . . . . 70.35 110.32 174.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.75 150.03 52.21 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 116.026 -0.533 . . . . 74.25 109.658 -172.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.656 ' CD2' ' HD3' ' A' ' 112' ' ' LYS . 90.2 m-85 -126.74 130.85 51.14 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.738 -0.838 . . . . 72.34 108.738 177.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.446 HG23 HG22 ' A' ' 66' ' ' ILE . 34.1 mm -108.78 117.08 53.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 109.301 -0.629 . . . . 63.23 109.301 -177.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -93.17 119.24 32.14 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.716 -0.846 . . . . 65.33 108.716 176.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.673 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 95.6 m-85 -96.02 161.95 13.76 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 112.753 0.649 . . . . 71.21 112.753 -178.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.0 -15.55 60.65 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 115.264 -0.88 . . . . 74.32 111.424 174.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.5 161.33 42.33 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 118.504 -1.279 . . . . 73.14 111.857 177.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -64.21 -34.95 79.27 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 114.338 -1.301 . . . . 74.53 110.843 173.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -61.24 -33.52 73.65 Favored 'General case' 0 CA--C 1.509 -0.61 0 C-N-CA 120.13 -0.628 . . . . 72.11 111.036 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.0 m -69.67 -40.28 76.49 Favored 'General case' 0 N--CA 1.42 -1.952 0 O-C-N 122.299 -0.251 . . . . 73.15 111.213 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.452 HG11 ' HA ' ' A' ' 37' ' ' ARG 0.266 0.2 OUTLIER -65.63 -47.31 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 120.586 -0.446 . . . . 52.11 111.954 176.626 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.13 -32.41 68.12 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.192 0.52 . . . . 63.31 111.727 176.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.08 -36.51 64.29 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.204 0.526 . . . . 52.34 111.884 177.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.68 -43.76 45.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.688 -0.687 . . . . 71.33 111.943 -176.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 91' ' ' VAL . 34.2 m -50.92 -22.42 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 113.025 0.75 . . . . 74.23 113.025 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.24 -11.45 50.18 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.919 0.39 . . . . 63.41 111.438 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 68.5 mtm -99.48 7.41 45.42 Favored 'General case' 0 C--O 1.216 -0.695 0 CA-C-N 116.29 -0.414 . . . . 72.41 110.929 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 3.6 p-10 -42.86 -41.33 3.24 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.707 1.373 . . . . 71.35 114.707 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -111.83 100.34 8.84 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.792 -0.818 . . . . 73.33 108.792 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 106' ' ' THR . 11.2 t -151.08 166.3 31.19 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.899 -0.591 . . . . 74.42 109.451 -177.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.89 118.61 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-O 121.825 0.821 . . . . 61.12 109.647 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -134.28 121.58 21.48 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.002 -0.999 . . . . 74.42 108.762 -177.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 54.0 54.84 9.1 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 114.538 1.31 . . . . 74.32 114.538 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.53 3.16 53.2 Favored Glycine 0 N--CA 1.468 0.829 0 CA-C-N 114.901 -1.045 . . . . 70.54 115.642 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -135.29 157.0 48.01 Favored 'General case' 0 C--N 1.298 -1.63 0 CA-C-N 117.399 0.6 . . . . 75.13 111.349 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 100' ' ' THR . 33.9 m -88.31 120.01 29.27 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.834 -1.543 . . . . 65.44 106.834 175.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 44.8 pt -101.69 171.14 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 119.31 -0.956 . . . . 73.52 110.709 -176.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 55.4 tptt -129.33 125.75 37.4 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.163 -0.68 . . . . 71.01 109.163 -176.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 12.1 p -129.78 121.85 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-O 121.158 0.504 . . . . 62.14 111.61 178.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.89 159.91 42.01 Favored Pre-proline 0 C--N 1.294 -1.827 0 N-CA-C 107.085 -1.45 . . . . 75.22 107.085 -178.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.71 134.12 52.24 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.279 1.986 . . . . 75.42 113.508 -175.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.656 ' HD3' ' CD2' ' A' ' 82' ' ' TYR . 35.5 ttpt . . . . . 0 N--CA 1.428 -1.535 0 N-CA-C 105.46 -2.052 . . . . 65.22 105.46 173.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.827 0 N-CA-C 111.787 -0.525 . . . . 71.53 111.787 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.547 ' HG2' ' HD3' ' B' ' 23' ' ' PRO . 2.0 Cg_endo -47.51 -56.91 2.66 Favored 'Trans proline' 0 CA--C 1.582 2.895 0 C-N-CA 122.478 2.119 . . . . 73.33 111.464 171.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.547 ' HD3' ' HG2' ' B' ' 22' ' ' PRO . 11.8 Cg_endo -89.52 136.37 2.72 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 121.406 1.404 . . . . 60.31 109.161 169.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -100.69 139.2 20.4 Favored Pre-proline 0 C--N 1.288 -2.073 0 C-N-CA 119.403 -0.919 . . . . 73.4 109.93 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -29.55 124.07 0.06 OUTLIER 'Trans proline' 0 C--N 1.361 1.216 1 C-N-CA 125.674 4.249 . . . . 52.35 114.069 -175.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.775 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -56.09 169.34 0.4 Allowed 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.384 -0.826 . . . . 53.22 113.053 178.542 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' B' ' 31' ' ' LYS . 8.4 t -74.57 165.03 25.89 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.38 0.61 . . . . 44.33 111.925 -172.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.401 ' HA ' ' HD2' ' B' ' 31' ' ' LYS . . . -52.15 -46.41 65.43 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 114.685 -1.143 . . . . 62.44 113.873 -175.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -65.02 -39.39 93.31 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 112.001 0.371 . . . . 60.24 112.001 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.482 ' O ' HG12 ' B' ' 34' ' ' ILE . 4.0 mp0 -60.02 -34.82 73.88 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 116.064 -0.516 . . . . 75.11 110.301 174.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' B' ' 27' ' ' SER . 97.5 mttt -65.37 -41.39 93.82 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.521 -0.548 . . . . 75.41 109.521 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.605 ' N ' ' HE2' ' B' ' 32' ' ' LYS . 0.5 OUTLIER -63.46 -46.73 84.89 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 120.796 -0.362 . . . . 62.41 111.138 176.188 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -71.75 -37.86 70.49 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 113.915 1.08 . . . . 74.41 113.915 -174.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.482 HG12 ' O ' ' B' ' 30' ' ' GLU . 17.9 pt -67.3 -34.04 66.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 C-N-CA 120.136 -0.626 . . . . 64.44 110.649 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -68.73 -44.82 73.02 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.892 -1.151 . . . . 62.51 107.892 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -63.01 -36.16 82.64 Favored 'General case' 0 CA--C 1.558 1.254 0 CA-C-N 114.235 -1.348 . . . . 71.42 111.864 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -102.0 14.05 33.03 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.33 0.863 . . . . 75.43 113.33 -174.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.589 ' OG ' ' HE2' ' B' ' 112' ' ' LYS . 39.1 t -103.03 163.81 11.99 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 113.238 0.829 . . . . 74.22 113.238 -177.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.446 ' CG1' HG23 ' B' ' 91' ' ' VAL . 11.8 m -137.25 163.49 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 124.502 1.121 . . . . 71.4 111.475 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 40' ' ' TYR . . . . . 0.703 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 29.1 t80 -111.6 125.6 54.11 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 125.248 1.419 . . . . 70.34 108.433 177.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 58.1 t -112.78 110.59 32.77 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 106.953 -1.499 . . . . 73.25 106.953 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.95 171.36 13.86 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 119.551 -1.309 . . . . 73.22 113.61 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 65.4 t30 65.79 9.21 5.84 Favored 'General case' 0 C--O 1.213 -0.852 0 C-N-CA 126.321 1.848 . . . . 75.01 111.459 -177.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.14 118.6 6.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.386 -0.968 . . . . 62.1 108.386 174.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -68.38 145.47 54.11 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.328 -0.851 . . . . 74.14 111.405 -173.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 46' ' ' TYR . . . . . 0.415 ' CD1' ' HB2' ' B' ' 77' ' ' PRO . 72.4 t80 -61.45 90.2 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 114.626 -1.17 . . . . 72.15 108.016 177.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.39 -16.77 0.35 Allowed Glycine 0 N--CA 1.426 -2.005 0 CA-C-N 115.334 -0.848 . . . . 61.32 112.521 -175.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 68.0 m -72.29 148.62 45.25 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 118.026 0.913 . . . . 64.31 109.244 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 49' ' ' THR . . . . . 0.549 HG22 HG22 ' A' ' 49' ' ' THR . 59.3 p -99.63 162.5 12.98 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.735 -0.386 . . . . 74.2 111.327 -177.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.485 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -65.1 -45.35 85.53 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 122.712 0.405 . . . . 74.54 109.981 178.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.9 -49.94 74.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.667 -0.697 . . . . 72.4 110.129 178.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -61.31 -40.64 94.93 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 121.038 0.447 . . . . 73.51 110.742 -177.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 45.5 mt -65.44 -47.56 75.75 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.574 -0.739 . . . . 62.12 111.895 177.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.22 -48.6 77.6 Favored 'General case' 0 C--O 1.2 -1.55 0 C-N-CA 122.612 0.365 . . . . 74.03 110.781 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.35 -41.23 75.77 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 120.87 0.367 . . . . 71.3 110.842 178.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -67.96 -37.59 81.75 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.881 -0.6 . . . . 75.43 110.156 -176.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -82.25 -21.97 36.04 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 113.386 0.884 . . . . 63.51 113.386 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 25.7 t -71.92 -24.45 61.64 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.813 -0.63 . . . . 75.44 109.532 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 28.1 m -62.46 -26.29 68.44 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.255 0.55 . . . . 64.21 109.803 172.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 63.5 m -110.08 15.33 22.55 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.242 -0.436 . . . . 72.4 111.383 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 61' ' ' GLY . . . . . 0.412 ' HA3' ' HB3' ' B' ' 90' ' ' SER . . . 172.98 173.77 39.64 Favored Glycine 0 C--O 1.216 -1.026 0 C-N-CA 118.29 -1.909 . . . . 53.11 115.197 -177.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 10.2 p -73.23 -69.39 0.42 Allowed 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.015 0.436 . . . . 60.03 111.718 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . 0.358 57.5 mt 102.71 112.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 C-N-CA 127.302 2.241 . . . . 64.43 111.839 177.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 64' ' ' ASN . . . . . 0.596 ' OD1' ' HB3' ' A' ' 73' ' ' PHE . 32.5 t30 -90.66 -49.9 6.22 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 113.604 -1.634 . . . . 72.35 109.548 -177.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.557 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 65.1 mtp180 -154.58 162.88 40.93 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 106.841 -1.541 . . . . 74.23 106.841 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.486 HG22 HG23 ' B' ' 83' ' ' ILE . 24.4 pt -144.0 142.14 24.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 106.676 -1.601 . . . . 74.43 106.676 172.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 34.2 m -125.17 125.01 43.01 Favored 'General case' 0 C--N 1.27 -2.869 0 N-CA-C 107.86 -1.163 . . . . 74.43 107.86 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.4 mp -122.72 116.18 48.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.18 -1.785 . . . . 70.42 106.18 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.515 ' HG ' ' CE1' ' B' ' 80' ' ' TYR 0.272 0.9 OUTLIER -121.19 128.86 52.87 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-O 121.031 0.444 . . . . 64.45 112.006 179.584 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 75.2 m -117.21 133.6 55.8 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.653 -0.869 . . . . 73.22 108.653 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 4.1 p30 -117.58 134.53 54.77 Favored 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 119.281 -0.968 . . . . 71.24 110.433 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 72' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' B' ' 77' ' ' PRO . 41.2 ttmt -124.26 5.94 8.45 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.1 0.476 . . . . 64.15 109.95 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.439 ' HB3' ' OD1' ' A' ' 64' ' ' ASN . 53.8 p90 -60.47 -25.96 66.43 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.16 0.8 . . . . 75.31 113.16 -177.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 41.9 m -87.92 6.57 35.06 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 120.865 -0.334 . . . . 63.5 111.095 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.04 -58.17 0.42 Allowed Glycine 0 N--CA 1.437 -1.274 0 N-CA-C 111.445 -0.662 . . . . 52.12 111.445 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -95.41 127.6 41.44 Favored Pre-proline 0 C--N 1.307 -1.257 0 N-CA-C 109.574 -0.528 . . . . 71.21 109.574 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 96.8 Cg_endo -76.56 122.78 6.63 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.759 2.306 . . . . 75.2 112.805 -177.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 78' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' B' ' 78' ' ' LYS . 33.9 mtpt -106.15 159.27 16.21 Favored 'General case' 0 CA--C 1.484 -1.579 0 CA-C-N 115.263 -0.881 . . . . 75.44 111.477 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -132.56 136.43 8.73 Favored Glycine 0 N--CA 1.422 -2.266 0 C-N-CA 120.571 -0.823 . . . . 22.32 113.252 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 80' ' ' TYR . . . . . 0.515 ' CE1' ' HG ' ' B' ' 69' ' ' LEU . 11.7 p90 -152.68 143.55 22.93 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 124.24 1.016 . . . . 63.41 110.198 174.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.49 150.34 52.17 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 116.168 -0.469 . . . . 44.1 109.971 -173.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 82' ' ' TYR . . . . . 0.791 ' CD1' ' HD3' ' B' ' 112' ' ' LYS . 96.1 m-85 -126.53 129.9 49.52 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.995 -0.743 . . . . 65.45 108.995 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.486 HG23 HG22 ' B' ' 66' ' ' ILE . 34.2 mm -108.75 115.47 49.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 109.358 -0.608 . . . . 75.45 109.358 -177.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -91.51 119.19 31.24 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.546 -0.538 . . . . 62.15 109.546 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -98.78 156.67 16.74 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.956 -0.465 . . . . 72.14 109.761 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.35 -17.9 44.02 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.277 0.561 . . . . 65.41 110.379 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 87' ' ' GLU . . . . . 0.429 ' HB3' ' OD1' ' B' ' 89' ' ' ASN . 28.6 mt-10 -124.47 140.96 52.46 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.579 -0.737 . . . . 75.25 111.111 -177.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -63.71 -33.72 76.27 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.34 0.59 . . . . 75.01 110.454 172.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 89' ' ' ASN . . . . . 0.429 ' OD1' ' HB3' ' B' ' 87' ' ' GLU . 2.8 p-10 -61.94 -32.22 72.62 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.564 -0.744 . . . . 73.23 112.278 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 90' ' ' SER . . . . . 0.42 ' OG ' ' HB2' ' B' ' 87' ' ' GLU . 15.2 m -67.85 -41.24 83.21 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 120.834 0.35 . . . . 54.41 110.655 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.447 ' O ' HG13 ' B' ' 95' ' ' VAL 0.325 0.4 OUTLIER -65.87 -44.7 92.63 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 112.722 0.638 . . . . 74.43 112.722 178.667 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -59.51 -33.03 70.84 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.942 0.401 . . . . 64.11 112.006 174.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.79 -37.22 65.01 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 120.819 0.343 . . . . 65.23 110.521 177.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.12 -44.38 54.03 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.075 0.398 . . . . 63.3 112.075 -176.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 95' ' ' VAL . . . . . 0.447 HG13 ' O ' ' B' ' 91' ' ' VAL . 29.7 m -51.65 -22.42 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 113.632 0.975 . . . . 61.0 113.632 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.2 -17.56 63.66 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.988 0.423 . . . . 65.32 111.439 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 60.2 mtm -95.47 6.86 47.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.33 -0.395 . . . . 73.21 110.932 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 98' ' ' ASP . . . . . 0.599 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 5.2 p-10 -39.27 -47.62 1.71 Allowed 'General case' 0 C--O 1.204 -1.324 0 N-CA-C 114.925 1.454 . . . . 70.42 114.925 -176.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -113.37 92.62 4.06 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 119.267 0.94 . . . . 73.3 109.718 176.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 100' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' B' ' 106' ' ' THR . 31.6 p -142.16 173.59 11.38 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.671 -1.15 . . . . 62.24 110.989 -178.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.16 129.33 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.761 0 CA-C-O 121.559 0.695 . . . . 72.15 110.036 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -135.57 121.59 20.02 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.897 -1.149 . . . . 71.13 107.897 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 48.1 ttt-85 60.01 33.42 21.36 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 122.155 0.979 . . . . 70.43 111.23 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.38 -5.23 80.71 Favored Glycine 0 C--N 1.317 -0.491 0 CA-C-N 114.847 -1.069 . . . . 72.13 114.507 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -129.47 156.9 43.37 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 117.827 0.814 . . . . 73.23 111.458 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 106' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' B' ' 100' ' ' THR . 62.9 m -80.76 120.49 24.71 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 116.352 -0.385 . . . . 75.14 110.282 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 44.5 pt -102.06 171.99 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.983 -0.377 . . . . 71.51 109.983 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 108' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 55.6 tptt -134.06 127.47 32.27 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.803 -0.814 . . . . 61.23 108.803 -178.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 109' ' ' VAL . . . . . 0.703 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 8.3 p -129.25 122.66 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-O 121.07 0.462 . . . . 64.32 111.684 177.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.37 159.59 41.52 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 107.026 -1.472 . . . . 74.14 107.026 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.96 131.03 35.1 Favored 'Trans proline' 0 N--CA 1.48 0.719 0 C-N-CA 122.476 2.117 . . . . 71.01 113.039 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.791 ' HD3' ' CD1' ' B' ' 82' ' ' TYR . 37.1 ttpt . . . . . 0 CA--C 1.501 -0.907 0 N-CA-C 108.93 -0.767 . . . . 60.23 108.93 178.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 112.416 0.525 . . . . 70.35 112.416 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.461 HG21 ' CZ ' ' B' ' 73' ' ' PHE . 20.2 pt -70.32 -34.36 58.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.425 -0.807 . . . . 63.13 112.697 -174.043 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -67.5 -31.57 71.78 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.227 0.537 . . . . 75.04 110.689 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -70.03 -24.19 63.23 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.688 -0.687 . . . . 74.15 111.072 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -109.3 16.96 22.01 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.598 -0.728 . . . . 74.22 109.806 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.41 ' OG ' ' HG2' ' A' ' 84' ' ' GLU . 36.4 t -107.88 159.72 16.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 121.699 0.761 . . . . 63.12 112.204 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.554 HG13 ' CG2' ' A' ' 91' ' ' VAL . 0.2 OUTLIER -140.42 163.7 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 C-N-CA 124.678 1.191 . . . . 53.52 112.195 -179.445 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.608 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 23.1 t80 -105.75 128.27 53.59 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 126.216 1.806 . . . . 74.31 107.195 176.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 65.5 t -118.87 116.08 50.0 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 107.539 -1.282 . . . . 61.12 107.539 177.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.82 167.46 13.05 Favored Glycine 0 C--N 1.297 -1.626 0 C-N-CA 120.033 -1.08 . . . . 74.11 114.247 -177.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 59.87 62.24 1.72 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.431 1.892 . . . . 64.44 114.751 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.4 p -114.44 131.19 67.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.926 -1.034 . . . . 64.32 110.363 173.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.33 163.39 15.36 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.231 -1.396 . . . . 63.24 107.231 178.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -55.84 123.78 15.38 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.871 0.843 . . . . 75.24 112.311 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.12 -42.37 0.73 Allowed Glycine 0 N--CA 1.412 -2.948 0 N-CA-C 107.46 -2.256 . . . . 63.52 107.46 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.3 m -92.64 136.02 33.59 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 108.179 -1.045 . . . . 65.24 108.179 174.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.1 p -112.17 179.04 4.11 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.373 -0.603 . . . . 72.22 109.373 -178.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.556 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -61.73 -39.25 90.9 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.291 -0.633 . . . . 61.34 109.291 176.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -58.08 -46.5 85.38 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.401 -0.818 . . . . 55.24 111.489 174.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -58.53 -40.35 82.71 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.505 0.669 . . . . 54.51 110.071 178.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.2 mt -69.94 -48.27 59.08 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.704 -1.135 . . . . 72.21 111.265 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.5 -50.26 74.28 Favored 'General case' 0 C--O 1.193 -1.893 0 O-C-N 123.119 0.262 . . . . 61.44 111.704 -178.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.27 -42.57 91.53 Favored 'General case' 0 C--O 1.248 1.025 0 CA-C-O 121.083 0.468 . . . . 74.31 110.78 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -67.22 -39.78 86.29 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.748 -0.66 . . . . 72.2 110.39 -175.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -82.03 -21.44 36.98 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 112.928 0.714 . . . . 73.44 112.928 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.9 t -70.35 -24.37 62.97 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.181 -0.674 . . . . 75.15 109.181 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.7 m -60.15 -30.34 69.24 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-O 120.977 0.418 . . . . 52.25 110.104 173.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 63.8 m -90.65 1.67 56.6 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 112.782 0.66 . . . . 64.23 112.782 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 147.38 -162.48 28.65 Favored Glycine 0 N--CA 1.462 0.427 0 C-N-CA 119.282 -1.437 . . . . 71.42 114.164 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.3 t -104.63 132.41 50.9 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.857 -0.423 . . . . 75.13 109.857 -177.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 72.0 mt -97.84 135.66 31.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.354 0.597 . . . . 52.14 112.581 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.55 ' HB3' ' CE2' ' B' ' 73' ' ' PHE . 12.0 m120 -96.42 -42.05 8.3 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.236 -0.893 . . . . 73.53 111.909 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 43.8 mtt180 -153.57 161.83 41.84 Favored 'General case' 0 CA--C 1.486 -1.494 0 CA-C-N 115.71 -0.677 . . . . 74.22 109.699 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.556 HD11 ' HB1' ' A' ' 50' ' ' ALA . 29.3 pt -148.35 142.73 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 107.665 -1.235 . . . . 62.14 107.665 173.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.3 m -125.15 127.34 46.68 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 106.886 -1.524 . . . . 24.31 106.886 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 68' ' ' ILE . 2.1 mp -125.71 122.7 62.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 106.269 -1.752 . . . . 74.3 106.269 -177.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.433 ' HA ' ' O ' ' B' ' 66' ' ' ILE 0.253 1.3 pt? -121.24 126.36 49.41 Favored 'General case' 0 C--N 1.28 -2.421 0 C-N-CA 120.277 -0.569 . . . . 73.21 111.545 176.299 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 66.2 m -116.44 134.59 54.69 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.124 -0.695 . . . . 73.23 109.124 -177.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' B' ' 65' ' ' ARG . 2.0 p30 -126.65 152.91 46.08 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 119.773 -0.771 . . . . 70.44 113.034 -177.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.563 ' HE2' ' HB3' ' A' ' 77' ' ' PRO . 0.5 OUTLIER -121.93 18.81 10.95 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.817 -0.629 . . . . 70.11 109.722 169.256 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -67.78 -21.89 65.23 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 118.942 -1.103 . . . . 75.11 109.421 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.8 m -84.44 2.26 41.65 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.405 -0.816 . . . . 60.02 110.382 174.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.61 -44.13 2.27 Favored Glycine 0 CA--C 1.507 -0.423 0 N-CA-C 110.997 -0.841 . . . . 33.25 110.997 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -97.18 144.21 27.49 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 108.234 -1.024 . . . . 74.42 108.234 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.563 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 55.8 Cg_endo -65.43 116.85 4.13 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 123.168 2.579 . . . . 72.42 110.464 175.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -122.86 -162.56 1.03 Allowed 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.571 -1.27 . . . . 73.1 107.571 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 172.39 159.16 18.28 Favored Glycine 1 N--CA 1.396 -4.011 0 C-N-CA 119.631 -1.271 . . . . 44.43 113.516 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -151.41 147.78 27.31 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 125.12 1.368 . . . . 73.21 109.319 176.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.12 150.6 49.16 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.046 0.451 . . . . 73.43 110.327 -171.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.42 ' CZ ' ' HD1' ' A' ' 40' ' ' TYR . 39.9 m-85 -118.77 121.81 40.96 Favored 'General case' 0 C--N 1.28 -2.43 0 C-N-CA 123.596 0.758 . . . . 75.23 110.326 176.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.424 ' HA ' HG22 ' A' ' 66' ' ' ILE . 26.4 mm -105.65 127.86 60.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 107.712 -1.218 . . . . 60.2 107.712 -178.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.41 ' HG2' ' OG ' ' A' ' 38' ' ' SER . 32.8 mt-10 -110.39 119.28 38.68 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.544 -0.539 . . . . 64.31 109.544 178.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -95.22 162.67 13.6 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.562 0.696 . . . . 62.35 112.079 -177.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.22 -28.47 38.57 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.915 -1.038 . . . . 70.21 111.942 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.8 150.1 43.28 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.583 -0.847 . . . . 74.24 112.022 -178.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.567 ' O ' HG12 ' A' ' 91' ' ' VAL . 8.9 mmm180 -69.04 -32.71 72.41 Favored 'General case' 0 C--O 1.215 -0.719 0 C-N-CA 123.264 0.626 . . . . 70.44 109.791 177.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -66.9 -28.83 68.63 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.463 -0.895 . . . . 75.11 110.807 177.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.7 m -70.22 -39.41 75.14 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 109.818 -0.438 . . . . 74.23 109.818 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 88' ' ' ARG . 8.3 p -66.19 -38.84 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.652 -0.499 . . . . 71.43 109.652 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -66.98 -30.04 70.05 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-O 120.93 0.395 . . . . 72.45 111.697 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.75 -33.02 64.12 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.541 -0.54 . . . . 64.41 109.541 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.93 -45.07 52.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.735 -0.666 . . . . 73.41 111.089 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 91' ' ' VAL . 19.0 m -57.21 -22.07 16.2 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 N-CA-C 112.762 0.653 . . . . 63.14 112.762 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.04 -20.06 66.05 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.607 0.718 . . . . 73.42 110.887 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 69.0 mtm -94.92 7.91 44.47 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.174 -0.921 . . . . 74.53 110.24 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.662 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 5.1 p-10 -40.23 -45.66 2.11 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 113.814 1.042 . . . . 74.42 113.814 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -118.94 116.6 26.81 Favored 'General case' 0 N--CA 1.405 -2.679 0 N-CA-C 108.158 -1.053 . . . . 70.35 108.158 172.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 106' ' ' THR . 8.2 t -168.9 -179.77 3.82 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.103 -0.953 . . . . 54.45 108.621 -177.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.48 125.73 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-O 121.533 0.683 . . . . 72.25 110.364 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -130.51 128.96 42.24 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.297 -1.001 . . . . 73.44 108.297 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 54.45 33.03 17.85 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.763 1.225 . . . . 73.43 110.487 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.01 -1.81 88.66 Favored Glycine 0 C--N 1.311 -0.831 0 CA-C-N 114.765 -1.107 . . . . 74.53 114.25 177.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -122.31 152.46 40.08 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 117.589 0.694 . . . . 64.22 111.318 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 100' ' ' THR . 30.8 m -81.98 120.72 25.6 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 110.263 -0.273 . . . . 71.03 110.263 -178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 40.0 pt -103.1 172.09 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 116.329 -0.396 . . . . 43.02 110.48 176.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.662 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 57.6 tptt -129.49 133.55 47.34 Favored 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 109.233 -0.655 . . . . 64.42 109.233 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 23.6 t -127.23 114.52 37.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.002 -0.74 . . . . 75.22 109.002 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.424 HD11 ' CG ' ' B' ' 22' ' ' PRO 0.258 0.0 OUTLIER -143.35 146.24 35.32 Favored Pre-proline 0 C--O 1.211 -0.953 0 C-N-CA 119.277 -0.969 . . . . 74.52 109.432 179.168 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -52.08 137.53 53.79 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 123.386 2.724 . . . . 73.52 113.692 -173.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt . . . . . 0 C--O 1.248 0.981 0 CA-C-O 121.2 0.524 . . . . 74.34 111.886 -176.459 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.277 0 CA-C-O 120.177 -0.235 . . . . 70.13 113.615 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.424 ' CG ' HD11 ' A' ' 110' ' ' LEU . 53.8 Cg_exo -53.17 -40.3 77.61 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 124.568 3.512 . . . . 72.43 116.88 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.8 136.05 74.12 Favored 'Trans proline' 0 C--N 1.391 2.768 0 CA-C-N 121.365 1.523 . . . . 71.35 110.377 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' GLN . . . . . 0.417 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 83.9 mm-40 -60.47 134.3 91.38 Favored Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 123.56 0.538 . . . . 64.22 111.59 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' B' ' 24' ' ' GLN . 26.8 Cg_exo -57.88 179.6 0.15 Allowed 'Trans proline' 0 C--O 1.244 0.817 0 C-N-CA 123.484 2.789 . . . . 74.51 114.069 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.599 HD23 ' HB2' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -148.8 159.65 43.96 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 113.598 -1.637 . . . . 62.22 107.397 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.459 ' HB3' ' HG2' ' B' ' 30' ' ' GLU . 39.1 t -57.26 145.47 31.74 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 113.768 1.025 . . . . 70.11 113.768 -171.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.78 -38.89 67.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.451 -1.25 . . . . 32.44 111.142 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -64.79 -34.9 79.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.442 -0.345 . . . . 71.1 110.279 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.599 ' HB2' HD23 ' B' ' 26' ' ' LEU . 17.9 mm-40 -65.43 -35.31 80.55 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 116.207 -0.451 . . . . 75.03 110.008 177.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -72.66 -47.02 50.92 Favored 'General case' 0 CA--C 1.483 -1.611 0 CA-C-N 115.427 -0.806 . . . . 73.14 110.862 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.455 ' O ' ' HE3' ' B' ' 36' ' ' LYS . 50.3 mtpt -54.87 -43.06 72.8 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 115.861 -0.609 . . . . 74.41 111.767 176.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.508 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 0.3 OUTLIER -65.89 -41.13 91.93 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.819 0.847 . . . . 71.1 111.439 -178.517 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . 0.277 11.7 pt -71.27 -34.66 54.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 113.131 0.789 . . . . 75.32 113.131 -175.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.555 ' OD1' ' HE2' ' B' ' 112' ' ' LYS . 62.7 m-20 -64.01 -41.62 97.4 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-O 121.312 0.577 . . . . 74.05 109.851 -179.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.455 ' HE3' ' O ' ' B' ' 32' ' ' LYS . 84.0 mttt -60.27 -27.28 67.14 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.377 0.671 . . . . 75.3 111.63 -177.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' B' ' 33' ' ' GLU . 20.4 mtm180 -104.46 15.41 28.21 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 115.901 -0.591 . . . . 75.1 110.336 -174.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.717 ' OG ' ' HD3' ' B' ' 112' ' ' LYS . 77.7 p -114.89 169.26 9.22 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 113.915 1.08 . . . . 73.44 113.915 -177.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.592 HG13 ' CG2' ' B' ' 91' ' ' VAL . 0.2 OUTLIER -145.46 164.64 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 124.93 1.292 . . . . 73.13 113.24 -174.717 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 40' ' ' TYR . . . . . 0.543 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 30.4 t80 -105.59 125.98 51.61 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 127.125 2.17 . . . . 74.34 106.719 178.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 59.9 t -117.12 115.48 48.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 108.184 -1.043 . . . . 63.5 108.184 176.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.25 166.18 13.31 Favored Glycine 0 C--N 1.3 -1.471 0 C-N-CA 120.166 -1.016 . . . . 63.42 113.125 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 56.1 t30 62.6 65.75 0.82 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.4 1.48 . . . . 70.24 113.454 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.2 118.15 7.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.319 -0.855 . . . . 64.3 111.864 175.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -80.8 167.18 20.23 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 106.498 -1.668 . . . . 74.34 106.498 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 46' ' ' TYR . . . . . 0.604 ' HB3' ' SG ' ' B' ' 70' ' ' CYS . 48.3 p90 -75.33 5.24 5.88 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.145 0.498 . . . . 75.24 112.04 -178.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.34 -24.84 74.4 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.417 -1.073 . . . . 75.33 110.417 174.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 28.2 m -91.84 145.75 24.31 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 106.275 -1.75 . . . . 62.43 106.275 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 43.6 p -103.79 174.5 5.84 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 118.988 -1.085 . . . . 73.41 111.665 -173.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.602 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -64.7 -38.4 90.86 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 108.593 -0.892 . . . . 30.21 108.593 175.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -58.56 -42.46 87.95 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.379 -0.828 . . . . 74.34 111.06 176.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -59.05 -46.38 88.39 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.32 0.581 . . . . 74.4 110.027 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 55.6 mt -65.26 -48.6 72.65 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.898 -1.047 . . . . 73.24 111.969 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.512 ' HG2' HD12 ' B' ' 63' ' ' ILE . 0.8 OUTLIER -62.24 -49.09 77.11 Favored 'General case' 0 C--O 1.195 -1.801 0 N-CA-C 111.983 0.364 . . . . 70.41 111.983 -177.825 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.84 -41.51 87.11 Favored 'General case' 0 C--O 1.26 1.635 0 CA-C-O 121.531 0.681 . . . . 71.3 112.309 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -67.93 -41.22 82.93 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.918 -1.037 . . . . 74.33 109.967 -175.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -82.19 -22.07 36.17 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.395 0.517 . . . . 74.43 112.395 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 29.1 t -71.36 -23.86 61.98 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 109.163 -0.68 . . . . 65.43 109.163 -178.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 38.7 m -64.26 -18.93 65.03 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 115.821 -0.627 . . . . 74.41 109.808 175.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 56.0 m -107.38 10.03 29.69 Favored 'General case' 0 CA--C 1.556 1.211 0 N-CA-C 112.013 0.375 . . . . 74.44 112.013 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 147.89 -168.45 28.76 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 119.577 -1.297 . . . . 72.34 114.511 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 57.6 p -107.19 126.64 52.66 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 121.519 0.676 . . . . 55.31 110.502 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.512 HD12 ' HG2' ' B' ' 54' ' ' GLU . 78.9 mt -90.93 135.27 27.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.305 -0.862 . . . . 72.51 113.112 -175.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -93.03 -40.3 10.61 Favored 'General case' 0 CA--C 1.49 -1.344 0 CA-C-N 116.27 -0.423 . . . . 72.4 110.49 177.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 47.9 mtt180 -154.84 161.0 41.62 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 116.27 -0.423 . . . . 70.31 110.026 -177.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.602 HD11 ' HB1' ' B' ' 50' ' ' ALA . 26.7 pt -147.31 143.2 20.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 107.319 -1.363 . . . . 74.1 107.319 172.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 66.0 m -125.81 124.88 41.94 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 106.76 -1.57 . . . . 65.31 106.76 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.4 mp -124.33 120.2 58.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 106.926 -1.509 . . . . 71.11 106.926 -177.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.251 1.3 pt? -120.74 127.82 52.35 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.999 -0.68 . . . . 54.23 111.426 177.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 70' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' B' ' 46' ' ' TYR . 69.3 m -116.59 133.79 55.6 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.081 -0.711 . . . . 73.4 109.081 -177.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.642 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 4.1 p-10 -119.65 137.72 53.71 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 118.704 -1.198 . . . . 71.43 113.519 -176.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -104.81 10.38 34.53 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.78 0.8 . . . . 73.45 109.714 171.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.55 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 19.7 m-85 -73.42 -2.38 22.13 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.263 -0.88 . . . . 73.53 112.221 175.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 25.2 m -110.92 13.06 22.18 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 114.633 -1.167 . . . . 64.13 108.779 176.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.51 -55.76 5.03 Favored Glycine 0 C--N 1.343 0.958 0 N-CA-C 110.735 -0.946 . . . . 73.55 110.735 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -97.22 136.46 21.43 Favored Pre-proline 0 C--N 1.288 -2.09 0 CA-C-N 114.272 -0.964 . . . . 72.3 108.655 175.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 51.5 Cg_endo -69.55 118.31 5.6 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 121.603 1.535 . . . . 61.2 111.752 -178.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm -112.22 -157.56 0.62 Allowed 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 106.998 -1.482 . . . . 72.32 106.998 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 171.59 158.6 15.95 Favored Glycine 0 N--CA 1.409 -3.165 0 C-N-CA 119.071 -1.538 . . . . 62.02 114.232 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -149.5 144.3 26.2 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 125.468 1.507 . . . . 72.22 109.134 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.43 150.17 51.78 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 112.082 0.401 . . . . 64.33 112.082 -172.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 82' ' ' TYR . . . . . 0.51 ' HH ' ' HD1' ' B' ' 40' ' ' TYR . 26.4 m-85 -117.72 120.44 37.97 Favored 'General case' 0 C--N 1.286 -2.164 0 C-N-CA 123.398 0.679 . . . . 64.43 111.092 177.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.433 HG23 HG22 ' B' ' 66' ' ' ILE . 24.9 mm -106.5 124.36 61.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 108.337 -0.986 . . . . 74.33 108.337 -178.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 84' ' ' GLU . . . . . 0.435 ' HG2' ' CB ' ' B' ' 38' ' ' SER . 30.8 mt-10 -109.14 119.29 39.09 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 110.172 -0.307 . . . . 52.33 110.172 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -97.61 166.58 11.43 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.529 0.566 . . . . 74.43 112.529 -176.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.09 -34.39 26.15 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.321 -0.854 . . . . 61.43 112.265 175.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -114.26 149.84 35.27 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 120.95 0.405 . . . . 74.25 111.295 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.558 ' O ' HG12 ' B' ' 91' ' ' VAL . 19.4 mtp180 -74.87 -28.68 60.75 Favored 'General case' 0 CA--C 1.463 -2.372 0 CA-C-O 122.301 1.048 . . . . 72.12 111.796 176.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -61.31 -32.27 72.13 Favored 'General case' 1 C--N 1.234 -4.419 0 CA-C-N 114.178 -1.373 . . . . 71.42 110.503 172.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 16.5 m -71.24 -37.88 71.97 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 110.267 -0.272 . . . . 73.15 110.267 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.592 ' CG2' HG13 ' B' ' 39' ' ' VAL . 7.5 p -66.85 -38.78 82.14 Favored 'Isoleucine or valine' 0 C--N 1.348 0.527 0 C-N-CA 120.313 -0.555 . . . . 60.52 109.505 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -67.35 -30.43 70.23 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-O 121.101 0.477 . . . . 73.31 111.677 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.1 -32.23 64.83 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.185 0.517 . . . . 75.11 109.83 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.9 -44.87 46.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.761 -0.654 . . . . 61.42 111.28 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 95' ' ' VAL . . . . . 0.494 HG11 ' HG3' ' B' ' 111' ' ' PRO . 30.2 m -57.53 -23.26 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 112.553 0.575 . . . . 55.2 112.553 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.37 -17.28 64.68 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.23 0.538 . . . . 74.53 110.078 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 69.1 mtm -95.46 7.63 45.65 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.122 -0.49 . . . . 72.32 111.719 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 98' ' ' ASP . . . . . 0.408 ' HA ' ' H ' ' B' ' 109' ' ' VAL . 0.8 OUTLIER -49.1 -36.54 18.98 Favored 'General case' 0 C--O 1.201 -1.449 0 N-CA-C 114.312 1.227 . . . . 75.21 114.312 -177.573 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -105.08 17.83 23.41 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-N 119.349 0.977 . . . . 71.44 112.053 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 76.4 p -81.28 172.11 14.01 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 119.276 -0.97 . . . . 52.32 112.561 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.96 122.88 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 CA-C-O 121.746 0.784 . . . . 64.12 111.248 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -117.77 122.96 44.83 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.317 -0.994 . . . . 70.42 108.317 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 53.32 32.74 14.19 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.033 0.753 . . . . 73.22 113.033 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.22 4.6 83.77 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.93 -0.652 . . . . 63.01 114.115 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -125.86 151.39 46.92 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 117.533 0.666 . . . . 74.53 110.065 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 55.2 m -83.34 121.33 27.0 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 109.672 -0.492 . . . . 73.43 109.672 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 39.6 pt -102.05 172.54 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.175 -0.676 . . . . 71.13 109.175 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 108' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 56.3 tptt -128.48 132.59 48.38 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.681 -0.859 . . . . 73.54 108.681 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 109' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 20.9 t -126.5 120.21 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 107.999 -1.111 . . . . 72.03 107.999 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.322 0.3 OUTLIER -145.28 133.28 10.56 Favored Pre-proline 0 C--O 1.192 -1.97 0 N-CA-C 107.841 -1.17 . . . . 72.2 107.841 -167.449 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 111' ' ' PRO . . . . . 0.494 ' HG3' HG11 ' B' ' 95' ' ' VAL . 51.4 Cg_exo -57.16 151.95 48.02 Favored 'Trans proline' 0 N--CA 1.507 2.299 0 C-N-CA 123.504 2.803 . . . . 75.45 116.303 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.717 ' HD3' ' OG ' ' B' ' 38' ' ' SER . 76.2 tttt . . . . . 0 CA--C 1.557 1.24 0 C-N-CA 125.326 1.45 . . . . 62.43 109.84 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 N--CA 1.439 -0.98 0 N-CA-C 113.291 0.848 . . . . 70.23 113.291 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.7 pt -70.31 -35.77 64.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 C-N-CA 119.722 -0.791 . . . . 42.14 111.863 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.46 -29.32 69.42 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.232 0.539 . . . . 72.2 111.263 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -77.76 -10.75 59.7 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.895 -0.593 . . . . 73.23 111.649 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -118.09 18.74 13.8 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.163 -0.471 . . . . 74.23 110.711 -174.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -94.83 139.09 31.77 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.928 -0.767 . . . . 72.24 108.928 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 83' ' ' ILE . 32.1 m -126.18 160.76 33.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 109.616 -0.512 . . . . 64.42 109.616 178.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.531 ' CD2' ' HG2' ' B' ' 22' ' ' PRO . 38.4 t80 -114.56 123.08 48.47 Favored 'General case' 0 C--N 1.274 -2.693 0 C-N-CA 125.159 1.384 . . . . 75.23 108.343 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 97.1 t -112.45 108.28 25.12 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.877 0 N-CA-C 107.087 -1.449 . . . . 71.21 107.087 177.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.07 163.07 20.15 Favored Glycine 0 C--N 1.284 -2.359 0 C-N-CA 119.62 -1.276 . . . . 72.45 112.231 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.408 ' ND2' ' HB3' ' A' ' 105' ' ' ARG . 66.5 t30 57.7 21.12 7.0 Favored 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 125.779 1.632 . . . . 72.43 113.562 178.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 p -54.39 135.44 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-O 121.38 0.61 . . . . 62.42 109.849 175.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.36 148.92 40.84 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 108.081 -1.081 . . . . 73.51 108.081 -176.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -70.24 -15.88 62.97 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.076 0.941 . . . . 64.0 109.189 -176.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.44 -11.62 83.01 Favored Glycine 0 N--CA 1.427 -1.955 0 CA-C-N 115.383 -0.826 . . . . 34.32 112.323 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.6 m -74.5 122.28 22.81 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-O 121.56 0.695 . . . . 63.43 110.069 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.1 p -100.86 171.73 7.49 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.309 -0.86 . . . . 74.24 108.903 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.02 -50.13 75.27 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 118.142 0.428 . . . . 71.32 111.194 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -57.49 -42.03 81.9 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.725 0.639 . . . . 73.23 112.725 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -67.09 -41.2 86.71 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.227 0.537 . . . . 70.2 110.315 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.2 mt -71.37 -48.37 50.46 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.707 -0.679 . . . . 75.12 111.815 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.453 ' HG3' ' OH ' ' B' ' 46' ' ' TYR . 14.2 tm-20 -59.73 -49.07 79.15 Favored 'General case' 0 C--O 1.208 -1.1 0 C-N-CA 123.547 0.739 . . . . 71.41 111.317 -178.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.35 -42.82 87.72 Favored 'General case' 0 C--O 1.27 2.165 0 CA-C-O 121.51 0.672 . . . . 65.02 111.214 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -63.63 -43.51 96.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.741 -1.118 . . . . 72.03 110.517 -175.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -81.36 -21.4 39.11 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 113.73 1.011 . . . . 74.45 113.73 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 69.4 m -66.59 -24.58 66.36 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 120.969 0.414 . . . . 55.43 110.885 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.1 m -58.62 -26.3 63.56 Favored 'General case' 0 CA--C 1.562 1.413 0 CA-C-O 121.144 0.497 . . . . 72.22 110.562 173.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 59.7 m -91.0 -2.78 57.65 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 112.945 0.72 . . . . 74.0 112.945 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.42 -161.86 27.95 Favored Glycine 0 C--N 1.317 -0.48 0 C-N-CA 119.456 -1.354 . . . . 52.41 113.913 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.1 m -97.26 120.26 37.3 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.562 0.696 . . . . 44.52 111.382 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.2 mt -82.01 129.53 37.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 115.001 -0.999 . . . . 71.52 111.168 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.434 ' OD1' ' HA ' ' B' ' 73' ' ' PHE . 48.4 t30 -93.54 -36.95 12.16 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.029 -0.987 . . . . 72.44 109.777 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.544 ' HD2' ' OE1' ' A' ' 84' ' ' GLU . 99.4 mtt180 -157.34 162.43 39.1 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.391 -0.822 . . . . 72.25 109.51 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.596 HG22 HG23 ' A' ' 83' ' ' ILE . 34.7 pt -142.68 137.81 28.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 107.259 -1.385 . . . . 73.34 107.259 171.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' B' ' 68' ' ' ILE . 49.9 m -126.54 130.96 51.58 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 107.55 -1.278 . . . . 61.55 107.55 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.2 mt -125.87 118.11 50.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.315 -1.365 . . . . 51.35 107.315 -177.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.55 ' HA ' ' O ' ' B' ' 66' ' ' ILE 0.342 0.9 OUTLIER -121.59 125.5 46.89 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 119.944 -0.702 . . . . 44.52 112.795 176.798 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 66.1 m -116.38 130.63 56.87 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.923 -1.14 . . . . 64.03 107.923 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.608 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 3.8 p-10 -115.78 137.14 52.37 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 119.196 -1.002 . . . . 72.45 112.377 -176.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -110.61 12.54 22.7 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.679 -0.691 . . . . 63.54 110.13 173.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.514 ' CD2' ' HB2' ' A' ' 71' ' ' ASP . 13.7 p90 -72.66 -9.97 59.24 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.789 0.804 . . . . 75.32 109.447 176.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.7 m -94.22 8.87 40.17 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 114.357 -1.292 . . . . 63.4 109.47 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.28 -54.42 4.53 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 110.492 -1.043 . . . . 55.13 110.492 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -95.61 131.26 29.81 Favored Pre-proline 0 C--N 1.299 -1.587 0 N-CA-C 106.772 -1.566 . . . . 70.22 106.772 176.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.608 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 33.3 Cg_endo -66.7 118.36 5.48 Favored 'Trans proline' 0 C--O 1.243 0.748 0 C-N-CA 121.536 1.491 . . . . 75.21 112.557 -177.098 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.407 ' HB2' ' OD1' ' A' ' 71' ' ' ASP . 25.0 mtmm -100.09 -169.39 1.73 Allowed 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.959 -1.126 . . . . 53.41 107.959 174.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.05 139.8 6.11 Favored Glycine 0 N--CA 1.41 -3.1 0 C-N-CA 119.727 -1.225 . . . . 75.22 112.763 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -151.12 143.31 24.07 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.797 -0.816 . . . . 72.23 108.797 172.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.08 152.01 50.0 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 116.747 -0.206 . . . . 71.43 111.23 -173.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 95.6 m-85 -120.4 115.63 23.89 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 109.044 -0.724 . . . . 75.31 109.044 174.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.596 HG23 HG22 ' A' ' 66' ' ' ILE . 38.6 mm -101.65 121.27 52.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.515 -1.291 . . . . 71.11 107.515 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.544 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 33.7 mt-10 -106.07 123.09 47.45 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 120.242 -0.583 . . . . 64.53 109.5 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -94.45 156.64 16.38 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 112.525 0.565 . . . . 74.33 112.525 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.06 -36.32 55.99 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.515 -0.766 . . . . 61.52 110.404 176.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -103.01 146.23 28.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.771 0.319 . . . . 71.43 110.185 175.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.45 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.77 -32.34 62.03 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.103 -1.443 . . . . 74.15 107.103 178.606 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -60.46 -31.48 70.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.283 -1.326 . . . . 75.11 110.338 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 31.5 m -64.41 -36.64 84.83 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 116.235 -0.439 . . . . 64.45 110.503 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 95' ' ' VAL . 2.3 m -67.68 -38.3 80.13 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.533 0 C-N-CA 119.61 -0.836 . . . . 70.42 109.241 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -58.3 -36.1 72.81 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.064 0.459 . . . . 74.21 111.59 176.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.34 -32.8 64.77 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.929 0.395 . . . . 73.1 110.658 177.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.36 -40.63 50.61 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 116.174 -0.466 . . . . 71.41 111.627 -177.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 91' ' ' VAL . 31.7 m -55.76 -21.85 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 113.117 0.784 . . . . 61.43 113.117 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.08 -14.44 61.74 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 121.586 0.708 . . . . 74.53 110.535 176.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 28.3 mtp -98.17 8.1 45.29 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 124.471 1.108 . . . . 62.34 110.771 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 4.5 p-10 -36.57 -53.47 0.88 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.904 1.076 . . . . 72.3 113.904 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -118.87 106.14 12.2 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-O 121.704 0.764 . . . . 65.12 109.451 175.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.0 t -150.1 173.02 14.35 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 114.811 -1.086 . . . . 74.02 109.275 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.87 131.99 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.221 0 N-CA-C 108.754 -0.832 . . . . 63.32 108.754 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -138.32 113.64 9.47 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 107.289 -1.374 . . . . 72.15 107.289 -177.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 37.5 mtp85 56.1 33.31 21.72 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.906 0.882 . . . . 74.32 112.127 -175.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.06 -10.18 71.77 Favored Glycine 0 C--N 1.312 -0.795 0 CA-C-N 115.215 -0.902 . . . . 24.01 113.191 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.408 ' HB3' ' ND2' ' A' ' 43' ' ' ASN . 93.7 mtt180 -99.31 143.81 29.15 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.839 -0.801 . . . . 73.5 108.839 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.0 m -86.41 119.72 26.98 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.934 -1.506 . . . . 54.53 106.934 174.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 47.8 pt -102.01 171.35 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 120.15 -0.62 . . . . 70.44 110.976 -177.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 57.6 tptt -127.87 125.98 40.71 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.138 -0.937 . . . . 64.34 108.731 -177.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.9 t -114.32 115.53 49.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 106.275 -1.75 . . . . 75.02 106.275 177.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . 0.272 2.5 tt -138.87 128.56 14.52 Favored Pre-proline 0 C--O 1.196 -1.72 0 N-CA-C 106.972 -1.492 . . . . 74.24 106.972 -170.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.66 127.71 15.07 Favored 'Trans proline' 0 C--N 1.355 0.884 0 CA-C-N 121.485 1.566 . . . . 62.2 109.771 175.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.312 -1.058 0 CA-C-O 121.584 0.707 . . . . 75.23 110.744 -170.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.738 0 N-CA-C 109.717 -1.353 . . . . 75.11 109.717 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.531 ' HG2' ' CD2' ' A' ' 40' ' ' TYR . 76.3 Cg_exo -52.9 -37.98 78.33 Favored 'Trans proline' 0 CA--C 1.566 2.103 0 C-N-CA 122.742 2.295 . . . . 62.52 114.225 172.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -55.1 129.67 36.57 Favored 'Trans proline' 0 C--N 1.397 3.081 0 C-N-CA 121.499 1.466 . . . . 71.32 110.99 172.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -54.16 141.5 50.51 Favored Pre-proline 0 C--N 1.302 -1.487 0 CA-C-N 114.257 -1.338 . . . . 75.11 111.277 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.86 114.15 2.3 Favored 'Trans proline' 0 N--CA 1.443 -1.467 0 C-N-CA 122.098 1.866 . . . . 72.23 111.045 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 6.1 mp -61.83 165.83 4.97 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.821 -1.081 . . . . 74.54 109.882 176.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.42 ' O ' ' HG2' ' B' ' 31' ' ' LYS . 25.2 m -58.93 144.94 43.2 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.278 -0.638 . . . . 64.1 109.278 176.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' B' ' 31' ' ' LYS . . . -52.49 -44.18 65.48 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 123.569 0.543 . . . . 71.44 111.775 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -71.31 -30.98 66.88 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.828 0.677 . . . . 71.42 112.828 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.529 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.5 OUTLIER -60.57 -34.58 74.4 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 109.653 -0.499 . . . . 74.2 109.653 170.013 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' B' ' 28' ' ' ALA . 25.2 mmmt -65.84 -46.89 76.83 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 115.58 -0.736 . . . . 70.41 109.956 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.518 ' N ' ' HE2' ' B' ' 32' ' ' LYS . 0.5 OUTLIER -53.7 -46.36 70.71 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.8 -0.36 . . . . 72.44 110.734 176.734 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.77 -45.76 70.54 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.314 0.857 . . . . 63.42 113.314 -174.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.529 HG12 ' O ' ' B' ' 30' ' ' GLU . 26.3 pt -69.58 -35.37 65.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 C-N-CA 120.751 -0.38 . . . . 73.42 111.828 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.9 -35.09 79.23 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.915 0.388 . . . . 75.31 110.781 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 55.1 mtmt -75.12 -11.08 60.01 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.393 0.516 . . . . 42.33 112.393 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -118.23 18.37 13.76 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.328 0.585 . . . . 71.44 110.918 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' B' ' 84' ' ' GLU . 82.8 p -98.9 156.5 16.86 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 115.897 -0.592 . . . . 53.55 111.444 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.428 HG22 ' O ' ' B' ' 83' ' ' ILE . 31.2 m -137.08 163.89 31.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.931 0.396 . . . . 70.25 110.562 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 40' ' ' TYR . . . . . 0.503 ' HD1' ' CE1' ' B' ' 82' ' ' TYR . 38.7 t80 -115.57 123.03 47.44 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 126.118 1.767 . . . . 72.41 107.936 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 85.8 t -112.45 108.02 24.46 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.939 0 N-CA-C 107.461 -1.311 . . . . 72.52 107.461 176.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 42' ' ' GLY . . . . . 0.467 ' O ' ' HB ' ' B' ' 107' ' ' ILE . . . -98.83 164.97 20.87 Favored Glycine 0 C--N 1.289 -2.037 0 C-N-CA 119.697 -1.24 . . . . 75.54 112.201 -177.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 64.0 t30 60.29 18.45 7.99 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.639 1.176 . . . . 75.4 112.875 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 8.0 p -61.49 132.19 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 109.162 -0.681 . . . . 65.24 109.162 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.38 143.95 56.83 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.61 -0.723 . . . . 41.13 109.879 -176.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 46' ' ' TYR . . . . . 0.481 ' CD1' ' HB2' ' B' ' 77' ' ' PRO . 71.7 t80 -55.07 -21.98 14.51 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 124.878 1.271 . . . . 74.43 111.999 -177.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.26 10.84 54.76 Favored Glycine 0 N--CA 1.422 -2.267 0 C-N-CA 120.562 -0.828 . . . . 54.13 113.761 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 12.8 m -75.0 122.32 23.33 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 118.492 1.146 . . . . 70.0 108.687 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 61.8 p -96.57 167.62 11.03 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 111.663 0.245 . . . . 72.3 111.663 -175.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.96 -51.15 70.92 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 112.853 0.686 . . . . 71.01 112.853 -175.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -57.53 -38.4 74.63 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 112.473 0.545 . . . . 75.4 112.473 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -69.49 -42.21 75.1 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.082 0.468 . . . . 74.35 109.973 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.41 -48.56 55.53 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.646 -0.706 . . . . 70.24 112.036 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 tm-20 -59.91 -49.74 76.51 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.198 0.599 . . . . 72.54 111.289 -177.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.41 -42.07 81.57 Favored 'General case' 0 C--O 1.27 2.154 0 CA-C-O 121.602 0.715 . . . . 70.41 111.355 177.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -64.59 -42.79 95.35 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 114.879 -1.055 . . . . 53.42 110.761 -175.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -81.68 -21.43 38.1 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 113.571 0.952 . . . . 71.5 113.571 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 75.4 m -64.74 -26.09 68.21 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 116.36 -0.382 . . . . 51.0 110.946 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.4 m -58.17 -26.85 63.24 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-O 121.038 0.447 . . . . 61.54 110.524 174.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 60' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' B' ' 94' ' ' ALA . 61.7 m -92.05 -0.61 57.46 Favored 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 112.885 0.698 . . . . 55.33 112.885 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.35 -154.83 26.21 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 119.054 -1.546 . . . . 65.31 114.681 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 44.1 m -105.27 117.97 35.37 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.033 0.444 . . . . 74.21 111.229 -176.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 67.3 mt -79.46 130.72 35.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.743 -0.662 . . . . 74.43 112.655 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 64' ' ' ASN . . . . . 0.556 ' OD1' ' HG3' ' B' ' 65' ' ' ARG . 23.6 t-20 -91.16 -41.91 10.75 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.186 0.995 . . . . 75.24 108.356 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.556 ' HG3' ' OD1' ' B' ' 64' ' ' ASN . 99.2 mtt180 -158.05 163.52 37.62 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.842 0.857 . . . . 64.45 109.125 -177.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.628 HG22 HG23 ' B' ' 83' ' ' ILE . 34.8 pt -142.43 137.67 28.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 107.099 -1.445 . . . . 74.21 107.099 170.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 33.4 m -126.74 131.18 51.4 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 107.069 -1.456 . . . . 73.21 107.069 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 68' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 67' ' ' THR . 17.1 mt -125.91 117.47 49.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 107.128 -1.434 . . . . 73.02 107.128 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.308 0.9 OUTLIER -121.49 125.88 47.91 Favored 'General case' 0 C--N 1.283 -2.313 0 C-N-CA 120.21 -0.596 . . . . 70.21 112.241 177.296 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 77.1 m -116.27 129.15 56.13 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 108.302 -0.999 . . . . 44.32 108.302 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 71' ' ' ASP . . . . . 0.715 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 4.8 p-10 -110.63 126.78 54.84 Favored 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 119.48 -0.888 . . . . 60.11 111.021 -177.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -113.49 15.2 19.1 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.039 -1.467 . . . . 74.01 107.039 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.434 ' HA ' ' OD1' ' A' ' 64' ' ' ASN . 30.8 t80 -44.72 -44.3 9.09 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.511 2.324 . . . . 63.14 112.096 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 24.1 m -100.82 18.99 18.04 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 116.208 -0.451 . . . . 71.43 111.558 -175.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.1 -53.17 2.52 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.095 -1.05 . . . . 75.34 111.388 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -91.55 119.89 68.4 Favored Pre-proline 0 CA--C 1.497 -1.085 0 N-CA-C 109.367 -0.605 . . . . 52.42 109.367 177.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 77' ' ' PRO . . . . . 0.715 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 75.3 Cg_endo -77.81 121.1 5.33 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 122.522 2.148 . . . . 64.13 113.682 -174.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 25.8 mtmm -99.98 -167.16 1.42 Allowed 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.397 -0.964 . . . . 55.1 108.397 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.93 140.71 6.67 Favored Glycine 0 N--CA 1.408 -3.2 0 C-N-CA 120.252 -0.975 . . . . 73.13 112.663 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -151.73 143.44 23.65 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.509 -0.923 . . . . 75.54 108.509 171.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.33 152.19 50.81 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-O 121.023 0.44 . . . . 75.34 110.022 -173.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 82' ' ' TYR . . . . . 0.653 ' CD1' ' HD3' ' B' ' 112' ' ' LYS . 96.4 m-85 -121.31 115.21 22.54 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.411 -0.588 . . . . 72.55 109.411 175.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.628 HG23 HG22 ' B' ' 66' ' ' ILE . 40.5 mm -100.12 122.8 52.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 106.904 -1.517 . . . . 72.33 106.904 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 84' ' ' GLU . . . . . 0.555 ' OE1' ' HD2' ' B' ' 65' ' ' ARG . 31.1 mt-10 -107.73 124.15 49.59 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.165 -0.68 . . . . 70.41 109.165 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -96.83 154.1 17.49 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 112.893 0.701 . . . . 71.42 112.893 -177.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.69 -40.47 72.89 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.147 -0.933 . . . . 71.42 110.251 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -105.76 147.94 28.04 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 116.005 -0.543 . . . . 74.21 111.471 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.488 ' O ' HG22 ' B' ' 91' ' ' VAL . 0.0 OUTLIER -74.26 -33.56 63.34 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.398 -1.334 . . . . 73.04 107.398 -179.762 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -63.03 -25.42 68.37 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 115.494 -0.775 . . . . 63.03 111.425 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 42.9 m -66.11 -36.89 84.37 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 110.243 -0.28 . . . . 73.02 110.243 177.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 91' ' ' VAL . . . . . 0.488 HG22 ' O ' ' B' ' 88' ' ' ARG . 3.2 m -67.83 -38.67 80.54 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 N-CA-C 109.003 -0.74 . . . . 61.25 109.003 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -56.87 -38.08 72.25 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.169 0.509 . . . . 73.45 111.576 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.69 -31.58 63.5 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.061 0.457 . . . . 65.43 111.083 177.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 94' ' ' ALA . . . . . 0.454 ' HA ' ' SG ' ' B' ' 60' ' ' CYS . . . -76.32 -40.8 50.49 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.192 -0.458 . . . . 75.45 111.454 -178.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 95' ' ' VAL . . . . . 0.439 HG13 ' O ' ' B' ' 91' ' ' VAL . 22.0 m -56.58 -21.77 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 113.0 0.741 . . . . 62.41 113.0 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.75 -18.85 65.42 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.292 0.567 . . . . 63.02 110.189 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 48.1 mtm -95.06 13.54 24.85 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.699 -0.682 . . . . 64.24 110.872 177.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 98' ' ' ASP . . . . . 0.473 ' HA ' ' HB ' ' B' ' 109' ' ' VAL . 11.1 t70 -33.8 -55.09 0.47 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.471 1.508 . . . . 64.23 113.683 -178.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 99' ' ' GLU . . . . . 0.419 ' HG3' ' OD1' ' B' ' 98' ' ' ASP . 45.6 mt-10 -124.83 62.33 1.15 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.166 -1.013 . . . . 74.3 112.775 171.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 35.0 p -91.69 174.75 7.19 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.297 -0.865 . . . . 62.54 111.72 174.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.4 p -101.67 137.81 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 109.122 -0.695 . . . . 72.51 109.122 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 102' ' ' PHE . . . . . 0.419 ' HB2' HD12 ' B' ' 107' ' ' ILE . 85.5 t80 -142.72 118.61 10.58 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.532 -0.914 . . . . 75.0 108.532 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 45.3 mtp180 55.68 33.22 20.87 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.509 1.123 . . . . 75.13 113.539 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.53 -0.87 65.88 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.038 -0.983 . . . . 71.31 114.191 174.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -130.81 160.62 33.84 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.176 -0.676 . . . . 72.42 109.176 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 85.7 m -92.52 126.98 37.84 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.188 -0.671 . . . . 63.32 109.188 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 107' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' B' ' 42' ' ' GLY . 0.2 OUTLIER -102.8 172.3 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 118.198 -1.401 . . . . 63.2 110.334 177.485 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 108' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 56.8 tptt -119.21 124.72 47.46 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.641 -1.244 . . . . 55.53 107.641 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 109' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' B' ' 98' ' ' ASP . 47.1 t -113.91 113.97 45.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 107.065 -1.458 . . . . 62.21 107.065 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.273 3.0 tt -139.66 128.53 13.61 Favored Pre-proline 0 C--O 1.187 -2.195 0 N-CA-C 106.454 -1.684 . . . . 70.2 106.454 -170.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.35 129.54 28.66 Favored 'Trans proline' 0 CA--C 1.551 1.37 0 CA-C-N 121.499 1.571 . . . . 74.02 112.056 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.653 ' HD3' ' CD1' ' B' ' 82' ' ' TYR . 36.0 ttpt . . . . . 0 C--O 1.218 -0.59 0 CA-C-N 116.199 -0.455 . . . . 75.21 111.039 -174.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.295 0 N-CA-C 109.947 -0.39 . . . . 73.33 109.947 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.8 tt -101.17 130.23 50.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 109.786 -0.45 . . . . 71.31 109.786 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . . . -131.38 121.78 18.63 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 109.999 -0.371 . . . . 51.04 109.999 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 3' ' ' ALA . 20.4 Cg_exo -66.23 108.17 1.3 Allowed 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 122.591 2.194 . . . . 61.43 111.808 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.8 p -107.93 94.01 4.84 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.173 0.511 . . . . 53.34 110.086 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 85.3 mtp 62.9 -170.91 0.17 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.258 -0.883 . . . . 73.24 109.843 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 60.93 -168.26 0.18 Allowed 'General case' 0 C--O 1.241 0.644 0 C-N-CA 122.785 0.434 . . . . 71.34 111.84 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.7 m 70.4 5.03 5.18 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-O 122.085 0.945 . . . . 75.34 111.198 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -90.99 107.87 19.48 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.541 0.686 . . . . 72.23 110.473 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -153.04 96.02 2.03 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.793 0.806 . . . . 35.35 111.51 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.415 ' HB2' ' HB2' ' B' ' 45' ' ' ASP . 23.9 m -120.97 24.12 10.34 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.702 -1.135 . . . . 72.25 110.02 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.509 ' HD2' ' H ' ' A' ' 12' ' ' LYS 0.263 0.0 OUTLIER -78.38 69.59 4.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.937 0.875 . . . . 74.1 113.025 -178.274 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 27.3 ttt -148.27 102.99 3.4 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 107.641 -1.244 . . . . 62.43 107.641 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.1 m -109.29 -19.55 13.26 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 116.207 -0.451 . . . . 74.33 111.588 -175.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 76.08 -46.01 0.53 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.203 1.001 . . . . 72.24 110.137 -173.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.93 69.46 1.32 Allowed Glycine 0 CA--C 1.5 -0.87 0 CA-C-N 116.343 -0.389 . . . . 54.12 113.442 173.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -118.31 -30.29 5.29 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 120.607 0.242 . . . . 61.03 110.545 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.462 ' O ' ' HE2' ' B' ' 108' ' ' LYS . 98.3 m-85 65.13 18.32 11.4 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 122.096 0.95 . . . . 75.25 109.579 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -161.0 30.84 0.14 Allowed 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 126.48 1.912 . . . . 61.13 109.184 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -43.78 -61.56 1.38 Allowed 'General case' 0 C--N 1.348 0.535 0 O-C-N 124.653 1.221 . . . . 74.3 110.649 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.95 -177.44 50.1 Favored Glycine 0 N--CA 1.401 -3.665 0 C-N-CA 120.772 -0.727 . . . . 50.11 111.765 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -48.32 -33.96 23.68 Favored 'Trans proline' 0 CA--C 1.586 3.098 0 C-N-CA 123.56 2.84 . . . . 73.05 117.814 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -90.45 167.66 4.2 Favored 'Trans proline' 0 N--CA 1.413 -3.253 0 N-CA-C 118.313 2.39 . . . . 54.5 118.313 -172.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.562 ' HG2' ' OH ' ' B' ' 80' ' ' TYR . 76.9 mt-30 -134.87 146.93 60.77 Favored Pre-proline 0 N--CA 1.411 -2.386 0 CA-C-N 110.842 -2.89 . . . . 75.21 104.27 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.65 99.69 0.97 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 CA-C-N 120.158 1.092 . . . . 73.41 113.148 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.1 mp -139.38 136.99 35.32 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.622 -0.881 . . . . 75.12 108.622 176.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.3 t -75.85 160.06 30.33 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.782 -1.192 . . . . 60.02 107.782 173.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.2 -40.26 23.69 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 123.198 0.599 . . . . 33.41 112.23 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.293 49.4 mt-10 -75.33 -30.39 60.28 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 114.731 1.382 . . . . 73.42 114.731 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -58.19 -34.95 70.92 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 108.742 -0.836 . . . . 63.25 108.742 169.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -73.22 -37.98 66.23 Favored 'General case' 0 N--CA 1.416 -2.16 0 CA-C-N 114.711 -1.132 . . . . 63.1 111.256 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.559 ' HA ' ' NZ ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -69.2 -43.97 73.05 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 120.045 -0.662 . . . . 62.32 110.139 -178.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.493 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 7.8 mm-40 -62.74 -37.88 88.3 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 116.27 -0.423 . . . . 71.44 111.163 -177.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.4 pt -70.89 -35.91 61.89 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 C-N-CA 120.763 -0.375 . . . . 54.23 111.863 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.316 2.1 p30 -76.53 -27.84 56.11 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 118.929 -1.108 . . . . 64.51 112.208 178.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -65.6 -19.3 65.86 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-O 121.364 0.602 . . . . 74.43 111.318 174.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 12.6 ptp180 -125.06 25.87 7.13 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-O 122.07 0.938 . . . . 71.34 109.624 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.57 ' OG ' ' HG2' ' A' ' 84' ' ' GLU . 39.6 t -104.2 157.23 17.27 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.332 -1.304 . . . . 54.33 110.331 177.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.616 HG22 HG23 ' A' ' 91' ' ' VAL . 17.0 t -131.07 157.04 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 N-CA-C 107.963 -1.125 . . . . 73.22 107.963 -177.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.692 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 25.6 t80 -107.19 125.63 51.36 Favored 'General case' 0 C--N 1.279 -2.5 0 N-CA-C 106.398 -1.705 . . . . 74.41 106.398 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.517 ' HA ' HG12 ' A' ' 109' ' ' VAL . 62.6 t -116.7 107.8 23.38 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.137 0 N-CA-C 106.656 -1.609 . . . . 75.3 106.656 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.467 ' HA3' ' CZ ' ' A' ' 40' ' ' TYR . . . -117.04 172.56 14.3 Favored Glycine 0 C--N 1.275 -2.812 0 C-N-CA 117.734 -2.174 . . . . 75.45 113.652 -176.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 57.73 11.67 1.4 Allowed 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 125.003 1.321 . . . . 74.1 112.92 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.7 p -55.45 142.79 9.38 Favored 'Isoleucine or valine' 0 C--O 1.246 0.906 0 CA-C-O 121.376 0.608 . . . . 74.35 109.858 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -77.6 150.05 34.71 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 107.737 -1.209 . . . . 60.43 107.737 -177.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.416 ' CD2' ' HB2' ' A' ' 77' ' ' PRO . 32.3 t80 -62.12 -20.85 64.5 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 123.886 0.741 . . . . 74.25 110.075 -176.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.16 -23.61 71.51 Favored Glycine 0 N--CA 1.424 -2.163 0 CA-C-N 115.52 -0.763 . . . . 20.43 112.82 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 72.9 m -100.97 75.6 1.69 Allowed 'General case' 0 N--CA 1.427 -1.594 0 C-N-CA 118.667 -1.213 . . . . 61.32 113.264 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.9 p -71.71 -178.0 2.1 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 116.199 -0.455 . . . . 53.42 111.93 170.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.02 -51.09 32.95 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.469 1.285 . . . . 71.24 114.469 -165.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.533 ' HG2' ' CE2' ' B' ' 46' ' ' TYR . 50.5 mt-30 -56.77 -51.88 67.19 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.441 0.534 . . . . 73.45 112.441 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -68.48 -39.19 81.44 Favored 'General case' 0 C--O 1.256 1.407 0 CA-C-O 121.591 0.71 . . . . 73.3 110.657 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.21 -46.69 73.09 Favored 'General case' 0 C--O 1.259 1.583 0 CA-C-N 114.673 -1.148 . . . . 74.24 109.061 -175.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -58.9 -40.94 86.0 Favored 'General case' 0 C--O 1.187 -2.191 0 N-CA-C 112.331 0.493 . . . . 64.11 112.331 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.56 -44.04 72.56 Favored 'General case' 0 C--O 1.266 1.926 0 CA-C-O 121.285 0.564 . . . . 64.3 111.717 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -64.82 -40.65 95.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.197 -0.911 . . . . 73.44 110.386 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.412 ' HZ ' HG11 ' A' ' 109' ' ' VAL . 66.7 m-85 -82.34 -22.76 35.42 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.028 1.122 . . . . 70.01 114.028 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.0 t -68.64 -24.69 64.58 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.01 -0.737 . . . . 72.15 109.01 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.0 m -66.31 -22.68 66.29 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 120.605 -0.438 . . . . 73.13 111.099 173.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 67.6 m -97.19 7.74 45.96 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.42 0.526 . . . . 71.33 112.42 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.21 -163.41 27.78 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 119.055 -1.545 . . . . 52.33 114.286 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.7 p -106.12 127.44 53.2 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.219 0.533 . . . . 73.11 111.236 -177.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.3 mt -86.87 133.93 28.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.683 -0.69 . . . . 53.35 112.14 -177.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.534 ' OD1' ' HG3' ' A' ' 65' ' ' ARG . 24.0 t-20 -96.99 -47.99 5.58 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.389 -0.823 . . . . 71.41 109.695 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.534 ' HG3' ' OD1' ' A' ' 64' ' ' ASN . 54.1 mtp180 -151.58 159.44 44.09 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.359 -0.978 . . . . 74.45 108.359 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.444 HG22 HG23 ' A' ' 83' ' ' ILE . 30.5 pt -146.36 141.87 21.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 107.921 -1.14 . . . . 72.33 107.921 174.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.0 m -127.37 125.4 40.63 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 107.38 -1.341 . . . . 74.34 107.38 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' B' ' 67' ' ' THR . 2.9 mp -122.37 125.45 72.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.272 -1.381 . . . . 55.32 107.272 -176.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.499 HD12 ' NH2' ' B' ' 65' ' ' ARG . 1.6 pt? -119.68 130.35 55.0 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 120.309 -0.556 . . . . 74.04 110.925 176.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.693 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 62.7 m -116.69 127.61 54.58 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.934 -0.576 . . . . 71.13 109.459 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -109.86 128.86 55.6 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.986 -0.686 . . . . 64.14 111.057 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' B' ' 64' ' ' ASN . 52.0 mttm -99.84 8.9 43.82 Favored 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 123.438 0.695 . . . . 75.45 110.213 173.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.622 ' CE2' ' HD2' ' B' ' 65' ' ' ARG . 7.6 m-85 -57.7 -25.87 60.93 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 121.58 0.705 . . . . 74.14 109.361 170.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.4 m -89.49 6.48 40.71 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 114.913 -1.04 . . . . 62.0 111.229 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.84 -52.94 4.67 Favored Glycine 0 N--CA 1.475 1.3 0 N-CA-C 110.488 -1.045 . . . . 65.02 110.488 -177.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -96.7 130.88 29.26 Favored Pre-proline 0 C--N 1.289 -2.043 0 N-CA-C 106.867 -1.531 . . . . 75.3 106.867 174.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.416 ' HB2' ' CD2' ' A' ' 46' ' ' TYR . 55.7 Cg_endo -68.69 120.32 7.25 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 122.007 1.805 . . . . 75.2 111.252 -177.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.693 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 15.1 mtmm -102.97 152.93 20.74 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.324 -1.361 . . . . 62.41 107.324 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.436 ' C ' ' HD1' ' A' ' 80' ' ' TYR . . . -120.48 137.28 12.02 Favored Glycine 0 N--CA 1.417 -2.632 0 C-N-CA 119.027 -1.558 . . . . 62.3 112.979 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.436 ' HD1' ' C ' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -129.06 142.23 50.97 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 102.743 -3.058 . . . . 72.22 102.743 172.373 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -140.47 141.89 35.37 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-N 119.042 0.837 . . . . 63.21 110.63 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.442 ' CD1' ' HD3' ' A' ' 112' ' ' LYS . 44.0 m-85 -110.07 117.2 33.1 Favored 'General case' 0 C--N 1.275 -2.632 0 N-CA-C 107.241 -1.392 . . . . 75.11 107.241 175.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.444 HG23 HG22 ' A' ' 66' ' ' ILE . 25.1 mm -102.98 121.17 53.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 107.347 -1.353 . . . . 74.31 107.347 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.57 ' HG2' ' OG ' ' A' ' 38' ' ' SER . 28.7 mt-10 -108.16 119.53 39.76 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.512 -0.922 . . . . 73.33 108.512 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -93.38 165.47 12.76 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.529 0.681 . . . . 75.41 112.819 -175.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.76 -37.81 64.9 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.065 -0.97 . . . . 74.3 111.011 174.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -118.63 158.61 25.15 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.126 1.158 . . . . 71.52 114.126 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -71.93 -26.47 62.31 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 114.701 -1.136 . . . . 54.45 110.778 175.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -60.21 -41.98 94.2 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.859 -0.61 . . . . 73.23 110.034 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.0 m -69.73 -39.7 76.65 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 115.603 -0.726 . . . . 40.1 111.765 -173.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.616 HG23 HG22 ' A' ' 39' ' ' VAL . 8.3 p -64.86 -39.22 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 120.33 -0.548 . . . . 75.34 109.807 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.68 -34.66 74.27 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.715 0.769 . . . . 73.02 109.928 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.75 -31.8 63.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.261 -0.881 . . . . 63.33 110.581 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.33 -45.05 33.96 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.088 -0.506 . . . . 51.23 110.57 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.1 m -59.44 -21.72 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 113.277 0.843 . . . . 73.02 113.277 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.97 -17.43 64.67 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.446 0.641 . . . . 74.54 110.61 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 71.8 mtm -94.98 9.96 37.4 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.562 -0.745 . . . . 70.3 110.129 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.602 ' HA ' HG22 ' A' ' 109' ' ' VAL . 2.2 p-10 -37.45 -47.53 0.89 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 116.418 2.007 . . . . 74.24 116.418 -174.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -115.47 30.68 7.2 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 118.95 0.795 . . . . 72.24 110.622 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.7 t -69.36 164.94 21.79 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-O 121.38 0.61 . . . . 72.23 110.056 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -109.13 132.13 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.936 0 N-CA-C 107.968 -1.123 . . . . 74.34 107.968 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -138.04 126.27 23.04 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 116.153 -0.476 . . . . 75.4 110.23 -174.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 103' ' ' ARG . 20.0 ttt180 55.54 32.44 19.09 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.845 1.258 . . . . 64.12 111.256 178.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.25 -10.58 72.59 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 114.237 -1.347 . . . . 61.02 113.202 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -113.16 150.65 31.93 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.828 -0.434 . . . . 74.21 109.828 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.4 m -86.6 123.16 31.48 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.252 -1.018 . . . . 72.45 108.252 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 44.4 pt -101.6 171.61 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.782 -0.767 . . . . 72.31 109.541 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 55.6 tptt -132.36 124.76 29.37 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.674 -0.491 . . . . 75.34 109.674 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.692 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 30.2 m -127.78 123.88 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 121.337 0.589 . . . . 73.14 111.317 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.405 HD11 ' HG2' ' B' ' 22' ' ' PRO . 0.0 OUTLIER -147.57 163.69 26.45 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 106.65 -1.611 . . . . 71.52 106.65 179.375 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.83 149.2 86.84 Favored 'Trans proline' 0 N--CA 1.478 0.6 0 C-N-CA 121.839 1.692 . . . . 54.42 112.046 -174.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.509 ' HE3' ' OG ' ' A' ' 38' ' ' SER . 25.5 ttpp -73.11 84.25 1.32 Allowed 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 122.518 1.151 . . . . 74.04 112.109 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.51 ' HA ' ' HD3' ' A' ' 113' ' ' ARG 0.564 24.0 mmt180 43.42 79.25 0.04 OUTLIER 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 119.717 3.229 . . . . 72.4 119.717 -178.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 23.5 m -116.79 84.82 2.21 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 105.5 -2.037 . . . . 63.22 105.5 169.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -141.16 176.37 8.89 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.799 -1.186 . . . . 75.03 107.799 -174.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -114.0 103.35 55.21 Favored Pre-proline 0 C--N 1.307 -1.254 0 CA-C-O 121.558 0.694 . . . . 64.12 110.763 177.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -87.93 16.54 1.88 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.711 2.274 . . . . 51.43 110.578 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 150.78 -142.84 9.93 Favored Glycine 0 N--CA 1.423 -2.2 0 N-CA-C 107.386 -2.286 . . . . 44.14 107.386 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.461 ' O ' HD12 ' A' ' 119' ' ' ILE . 2.5 pp -82.71 135.77 24.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 117.844 0.822 . . . . 75.04 110.992 176.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 52.4 m -145.8 114.2 6.7 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.343 0.592 . . . . 73.13 110.382 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 48.2 m -149.01 135.66 19.58 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.308 -0.997 . . . . 42.02 108.308 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 43.4 m -66.81 -42.88 85.19 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 123.523 0.514 . . . . 63.41 110.275 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -123.23 132.26 53.97 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.07 -1.085 . . . . 73.14 108.07 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.168 0 C-N-CA 120.401 -0.52 . . . . 70.34 111.021 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.795 0 N-CA-C 109.414 -0.587 . . . . 64.52 109.414 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 63.7 mt -107.49 110.38 31.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 109.195 -0.668 . . . . 73.1 109.195 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.09 101.33 49.94 Favored Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 116.283 -0.417 . . . . 73.23 109.917 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -80.99 -16.1 10.15 Favored 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 122.286 1.991 . . . . 61.45 112.709 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 23.2 p -157.44 135.58 11.01 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 116.344 -0.389 . . . . 64.23 110.194 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 26.2 mmt -92.54 103.88 16.24 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.804 -0.813 . . . . 72.0 108.804 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -108.6 116.63 32.35 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.202 -0.453 . . . . 73.12 111.118 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 67.2 m -143.02 95.8 2.83 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.484 0.659 . . . . 71.03 109.595 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 10.6 t -134.38 178.23 7.14 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 115.596 -0.729 . . . . 72.02 109.107 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -99.95 146.66 26.43 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.859 -0.423 . . . . 73.45 109.859 -177.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 20.4 m -81.03 108.62 14.86 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 110.095 -0.335 . . . . 75.34 110.095 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -101.66 145.23 29.37 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.181 -0.674 . . . . 63.24 109.181 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 15.0 tpt -67.13 143.32 56.69 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 123.461 0.475 . . . . 72.11 110.745 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.439 ' O ' ' HB3' ' B' ' 18' ' ' TYR . 15.5 m -99.44 -57.64 2.11 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-O 120.842 0.353 . . . . 63.33 111.425 -177.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.9 131.52 43.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.928 0.394 . . . . 75.41 111.923 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.1 -69.34 0.23 Allowed Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 121.022 -0.609 . . . . 65.33 112.412 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.26 -30.43 18.49 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.082 -0.647 . . . . 73.41 112.714 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.443 ' HB2' ' CD ' ' B' ' 117' ' ' PRO . 93.3 t80 -90.41 -79.57 0.35 Allowed 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 120.443 -0.503 . . . . 73.5 110.106 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 5.2 t -69.86 99.6 1.41 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 113.936 1.087 . . . . 73.53 113.936 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -98.07 3.52 49.27 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 105.48 -2.044 . . . . 71.44 105.48 171.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.41 -149.61 19.53 Favored Glycine 0 N--CA 1.42 -2.375 0 CA-C-N 113.226 -1.806 . . . . 73.01 109.655 -176.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.479 ' N ' ' HD2' ' B' ' 23' ' ' PRO . 33.1 Cg_exo -58.36 -43.09 49.35 Favored 'Trans proline' 0 CA--C 1.574 2.505 0 C-N-CA 123.055 2.503 . . . . 71.11 114.169 174.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' B' ' 22' ' ' PRO . 7.1 Cg_endo -53.43 154.98 13.73 Favored 'Trans proline' 0 C--N 1.397 3.099 0 C-N-CA 122.525 2.15 . . . . 73.23 112.008 175.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.448 ' H ' ' CD ' ' B' ' 24' ' ' GLN . 0.1 OUTLIER -84.26 133.02 45.86 Favored Pre-proline 0 N--CA 1.41 -2.467 0 N-CA-C 107.697 -1.223 . . . . 71.21 107.697 177.44 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' B' ' 24' ' ' GLN . 25.2 Cg_exo -61.39 138.6 77.58 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.351 2.034 . . . . 72.25 112.128 -175.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.758 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -68.79 176.19 3.18 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.71 -0.677 . . . . 63.31 110.555 175.393 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 15.7 m -53.68 143.02 21.48 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.097 0.777 . . . . 45.12 113.097 -170.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.56 -43.21 75.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.758 -1.11 . . . . 72.14 112.13 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . 0.319 49.2 mt-10 -76.8 -29.66 56.09 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.966 1.099 . . . . 74.42 113.966 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.458 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.4 OUTLIER -57.02 -35.62 69.47 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.847 -0.797 . . . . 74.01 108.847 169.174 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -72.33 -39.64 68.04 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.097 -0.956 . . . . 61.13 110.715 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.617 ' N ' ' HE2' ' B' ' 32' ' ' LYS . 0.0 OUTLIER -65.38 -45.92 82.18 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 112.109 0.411 . . . . 75.15 112.109 178.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -64.5 -35.48 81.07 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 123.279 0.362 . . . . 74.24 111.773 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.458 HG12 ' O ' ' B' ' 30' ' ' GLU 0.301 20.0 pt -70.78 -34.04 54.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 112.401 0.519 . . . . 55.23 112.401 179.484 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.519 ' HB3' ' HA ' ' B' ' 113' ' ' ARG . 44.4 m-20 -67.51 -43.34 81.1 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 121.941 0.877 . . . . 73.23 109.055 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -60.88 -19.8 60.85 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.957 -1.019 . . . . 72.53 111.141 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -112.21 11.64 20.28 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.353 -0.61 . . . . 72.45 109.353 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.507 ' OG ' ' HE3' ' B' ' 112' ' ' LYS . 31.4 t -99.08 151.17 21.25 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.679 0.752 . . . . 75.31 111.876 -177.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.579 HG22 HG23 ' B' ' 91' ' ' VAL . 10.5 t -129.09 158.9 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.079 0 N-CA-C 106.718 -1.586 . . . . 61.32 106.718 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' TYR . . . . . 0.696 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 36.7 t80 -110.0 125.44 52.9 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 106.353 -1.721 . . . . 73.32 106.353 174.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.523 ' HA ' HG12 ' B' ' 109' ' ' VAL . 59.9 t -117.22 106.91 21.01 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.098 0 N-CA-C 106.97 -1.493 . . . . 55.2 106.97 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.27 173.72 15.07 Favored Glycine 0 C--N 1.275 -2.842 0 C-N-CA 118.164 -1.97 . . . . 74.12 112.415 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.0 t30 62.25 6.0 1.72 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 124.842 1.257 . . . . 44.31 112.948 -177.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.9 p -61.57 131.24 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 107.274 -1.38 . . . . 51.23 107.274 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.519 ' OD1' ' HD2' ' B' ' 103' ' ' ARG . 3.6 p-10 -87.53 167.38 14.0 Favored 'General case' 0 N--CA 1.419 -1.977 0 C-N-CA 118.596 -1.242 . . . . 54.12 111.194 -172.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' TYR . . . . . 0.533 ' CE2' ' HG2' ' A' ' 51' ' ' GLN . 49.2 t80 -63.81 -12.19 33.58 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 113.981 -1.463 . . . . 72.42 111.189 -174.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.37 -23.6 67.69 Favored Glycine 0 N--CA 1.42 -2.431 0 CA-C-N 115.937 -0.574 . . . . 72.55 112.555 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.7 t -90.04 152.04 21.36 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 119.381 -0.927 . . . . 71.12 108.537 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' THR . . . . . 0.537 ' O ' ' HB2' ' B' ' 53' ' ' LEU . 32.8 p -133.21 178.33 6.98 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.883 -0.784 . . . . 74.12 108.883 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.15 -46.61 82.57 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.576 0.954 . . . . 61.31 113.576 -172.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -57.59 -52.2 66.39 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.088 0.47 . . . . 71.51 111.442 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -64.82 -40.04 94.56 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-N 115.518 -0.765 . . . . 54.02 110.767 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.537 ' HB2' ' O ' ' B' ' 49' ' ' THR . 1.0 OUTLIER -67.3 -47.05 71.74 Favored 'General case' 0 C--O 1.255 1.386 0 CA-C-N 114.875 -1.057 . . . . 60.44 109.135 -177.3 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -58.93 -42.63 90.21 Favored 'General case' 0 C--O 1.188 -2.17 0 C-N-CA 120.671 -0.412 . . . . 73.24 111.932 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.1 -43.5 70.45 Favored 'General case' 0 C--O 1.266 1.955 0 O-C-N 123.196 0.31 . . . . 30.42 110.842 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -65.13 -41.51 94.76 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.073 -0.651 . . . . 71.32 110.534 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -82.32 -23.65 35.03 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 113.891 1.071 . . . . 72.2 113.891 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 34.5 t -71.26 -24.08 62.1 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 123.658 0.783 . . . . 74.03 108.947 -177.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 38.7 m -67.26 -24.71 65.82 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 115.56 -0.746 . . . . 73.5 109.899 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 61.5 m -106.59 14.37 27.11 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.554 0.576 . . . . 54.42 112.554 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' GLY . . . . . 0.444 ' HA3' ' OG ' ' B' ' 90' ' ' SER . . . 151.17 -174.96 30.29 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 118.953 -1.594 . . . . 75.34 115.158 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 46.7 m -105.35 120.0 40.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.422 0.629 . . . . 71.04 110.947 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 67.7 mt -83.23 131.28 34.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.609 -0.723 . . . . 71.51 112.553 -176.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 72' ' ' LYS . 43.3 t-20 -99.47 -42.32 7.0 Favored 'General case' 0 C--O 1.208 -1.1 0 CA-C-N 115.615 -0.72 . . . . 70.52 110.478 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.622 ' HD2' ' CE2' ' A' ' 73' ' ' PHE . 55.6 mtp180 -151.57 160.34 43.71 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.318 -0.993 . . . . 71.42 108.318 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 18.0 pt -148.23 141.47 18.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 107.869 -1.16 . . . . 50.12 107.869 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 47.9 m -127.73 126.44 41.83 Favored 'General case' 0 C--N 1.268 -2.942 0 N-CA-C 107.96 -1.126 . . . . 74.43 107.96 177.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.468 ' O ' HD12 ' A' ' 68' ' ' ILE . 2.3 mp -121.83 127.42 75.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 106.567 -1.642 . . . . 64.14 106.567 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -120.99 132.0 54.64 Favored 'General case' 0 C--N 1.286 -2.19 0 C-N-CA 119.801 -0.76 . . . . 74.44 110.52 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' CYS . . . . . 0.6 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 63.1 m -116.6 127.5 54.53 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 109.35 -0.611 . . . . 73.31 109.35 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -107.29 131.5 54.14 Favored 'General case' 0 CA--C 1.474 -1.956 0 C-N-CA 119.09 -1.044 . . . . 63.14 108.857 177.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.579 ' HE2' ' HB3' ' B' ' 77' ' ' PRO . 40.1 ttmt -125.16 7.42 7.87 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 109.158 -0.682 . . . . 74.34 109.158 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -69.64 -18.32 63.58 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.418 0.627 . . . . 72.1 110.247 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 22.5 p -84.26 1.98 42.2 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 114.85 -1.068 . . . . 71.55 109.955 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.46 -44.05 2.46 Favored Glycine 0 N--CA 1.439 -1.135 0 N-CA-C 110.733 -0.947 . . . . 60.42 110.733 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -95.85 128.1 38.74 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 108.096 -1.076 . . . . 70.21 108.096 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.579 ' HB3' ' HE2' ' B' ' 72' ' ' LYS . 94.2 Cg_endo -78.32 119.0 4.43 Favored 'Trans proline' 0 N--CA 1.434 -1.99 0 C-N-CA 121.298 1.332 . . . . 52.24 110.535 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' LYS . . . . . 0.6 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 1.2 mtpt -116.57 163.52 15.96 Favored 'General case' 0 CA--C 1.471 -2.095 0 CA-C-N 114.798 -1.092 . . . . 71.01 110.324 -174.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' GLY . . . . . 0.415 ' C ' ' HD1' ' B' ' 80' ' ' TYR . . . -134.2 137.84 9.61 Favored Glycine 0 N--CA 1.428 -1.838 0 C-N-CA 119.585 -1.293 . . . . 61.1 113.853 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' TYR . . . . . 0.562 ' OH ' ' HG2' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -130.77 142.6 50.41 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 102.794 -3.039 . . . . 74.32 102.794 172.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.81 141.79 36.7 Favored 'General case' 0 C--N 1.279 -2.467 0 CA-C-N 118.939 0.79 . . . . 63.42 110.486 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' TYR . . . . . 0.516 ' CD1' ' HG3' ' B' ' 112' ' ' LYS . 27.9 m-85 -109.51 117.18 33.31 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 106.793 -1.558 . . . . 71.34 106.793 175.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 33.0 mm -102.7 121.43 53.81 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 107.674 -1.232 . . . . 64.32 107.674 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' B' ' 38' ' ' SER . 31.1 mt-10 -108.07 119.3 39.09 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.704 -0.85 . . . . 72.42 108.704 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -95.31 164.58 12.77 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.408 0.623 . . . . 72.41 112.3 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.91 -30.33 31.93 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.194 -0.912 . . . . 53.0 111.864 176.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.02 147.62 42.18 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 114.79 1.404 . . . . 75.0 114.79 177.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.438 ' O ' HG12 ' B' ' 91' ' ' VAL . 20.4 mmm180 -64.25 -27.44 69.05 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.428 1.091 . . . . 73.23 110.279 175.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -58.44 -42.16 86.7 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.765 -0.652 . . . . 73.53 109.771 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' SER . . . . . 0.444 ' OG ' ' HA3' ' B' ' 61' ' ' GLY . 50.1 m -71.58 -37.32 71.04 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 113.082 0.771 . . . . 62.41 113.082 -173.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.579 HG23 HG22 ' B' ' 39' ' ' VAL . 12.3 p -65.48 -38.58 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 109.15 -0.685 . . . . 62.5 109.15 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -69.37 -35.81 76.2 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.612 0.72 . . . . 71.0 109.847 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.25 -31.85 64.36 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.374 -0.83 . . . . 63.31 110.554 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.31 -45.45 32.28 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.297 -0.41 . . . . 71.02 111.103 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 33.7 m -58.77 -22.23 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 112.874 0.694 . . . . 61.42 112.874 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.63 -13.0 61.7 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.371 0.605 . . . . 73.54 110.796 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 69.6 mtm -99.83 12.81 35.76 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.428 -0.805 . . . . 74.13 110.75 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' ASP . . . . . 0.551 ' HA ' HG22 ' B' ' 109' ' ' VAL . 3.9 p-10 -47.72 -40.47 20.46 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.054 0.761 . . . . 74.31 113.054 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -104.48 108.22 19.53 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 108.2 -1.037 . . . . 72.22 108.2 170.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 11.5 t -163.38 169.34 19.12 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.49 -0.93 . . . . 74.12 108.49 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.77 125.21 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 CA-C-O 121.606 0.717 . . . . 73.32 109.572 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' PHE . . . . . 0.428 ' O ' ' HG2' ' B' ' 105' ' ' ARG . 83.5 t80 -129.64 129.03 43.81 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.628 -0.879 . . . . 74.43 108.628 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' ARG . . . . . 0.519 ' HD2' ' OD1' ' B' ' 45' ' ' ASP . 24.2 ttm-85 55.57 31.91 18.09 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.541 1.136 . . . . 75.23 110.514 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.29 5.62 87.04 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 114.497 -1.229 . . . . 61.43 114.083 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' B' ' 102' ' ' PHE . 12.8 ptm180 -129.11 148.31 51.04 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 117.558 0.679 . . . . 73.45 110.262 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 37.2 m -80.76 120.98 25.34 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.725 -0.472 . . . . 74.31 109.725 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 34.7 pt -102.43 171.1 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 C-N-CA 120.352 -0.539 . . . . 73.44 110.393 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' LYS . . . . . 0.462 ' HE2' ' O ' ' A' ' 18' ' ' TYR . 53.7 tptt -128.61 125.16 37.6 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 109.267 -0.642 . . . . 75.15 109.267 -178.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 33.2 m -127.66 124.4 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-O 121.203 0.525 . . . . 73.3 111.727 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.02 164.05 24.11 Favored Pre-proline 0 C--O 1.197 -1.71 0 N-CA-C 106.916 -1.513 . . . . 70.31 106.916 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -66.45 143.82 70.96 Favored 'Trans proline' 0 CA--C 1.568 2.195 0 C-N-CA 122.182 1.921 . . . . 73.44 114.328 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.535 ' HD2' ' N ' ' B' ' 113' ' ' ARG . 0.9 OUTLIER -114.02 144.68 42.7 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 123.125 0.57 . . . . 72.32 109.83 -177.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.535 ' N ' ' HD2' ' B' ' 112' ' ' LYS . 56.4 ttp180 -149.7 129.04 12.9 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.701 0.63 . . . . 73.41 112.701 177.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.494 HG22 ' OD1' ' B' ' 35' ' ' ASP . 12.8 t -108.83 177.19 4.85 Favored 'General case' 0 CA--C 1.558 1.282 0 N-CA-C 108.667 -0.864 . . . . 75.24 108.667 174.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -156.26 163.02 40.05 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.654 -1.239 . . . . 72.33 107.654 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' MET . . . . . 0.419 ' HA ' ' HD3' ' B' ' 117' ' ' PRO . 1.6 pmm? -109.6 145.07 31.16 Favored Pre-proline 0 N--CA 1.47 0.544 0 CA-C-N 118.674 0.67 . . . . 72.33 112.256 -176.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 117' ' ' PRO . . . . . 0.443 ' CD ' ' HB2' ' B' ' 18' ' ' TYR . 2.3 Cg_endo -87.71 -16.6 2.94 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 122.905 2.403 . . . . 62.04 111.625 173.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . 131.68 130.95 3.2 Favored Glycine 0 N--CA 1.439 -1.135 0 N-CA-C 110.897 -0.881 . . . . 70.11 110.897 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 21.0 pt -121.94 120.76 62.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 120.862 0.363 . . . . 74.41 111.181 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 61.0 m -153.83 142.8 21.18 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.308 -0.245 . . . . 64.32 110.781 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 49.8 m -121.57 121.44 37.43 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.22 -0.659 . . . . 74.32 109.22 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 33.4 m -88.95 124.73 34.52 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.398 -0.593 . . . . 74.44 109.398 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -75.86 -78.65 0.11 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.72 0.295 . . . . 74.3 111.062 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.437 -1.106 0 CA-C-O 118.042 -0.98 . . . . 53.31 111.069 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.75 0 N-CA-C 109.411 -0.589 . . . . 74.25 109.411 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.531 ' O ' HD12 ' A' ' 2' ' ' ILE . 2.4 pp -81.4 137.61 20.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 112.275 0.472 . . . . 74.54 112.275 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.416 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . . . -82.7 119.9 75.43 Favored Pre-proline 0 C--N 1.297 -1.715 0 N-CA-C 107.271 -1.381 . . . . 62.4 107.271 173.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 3' ' ' ALA . 8.0 Cg_endo -49.39 118.11 3.41 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.426 2.751 . . . . 64.25 112.889 -176.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 50.0 t -154.49 148.41 25.62 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.717 -0.674 . . . . 71.2 109.268 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 27.6 ttt -145.65 140.26 27.18 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.253 -1.017 . . . . 51.33 108.253 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -98.01 138.11 35.81 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.028 0.442 . . . . 73.33 110.408 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.3 p -88.99 96.42 10.72 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 115.554 -0.748 . . . . 72.14 112.04 -177.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.2 m -95.32 101.89 13.65 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.274 -1.009 . . . . 64.33 108.274 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -111.2 91.73 3.77 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 113.61 0.967 . . . . 74.45 113.61 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.8 p -100.73 134.18 44.09 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.606 -1.627 . . . . 54.15 106.606 173.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.478 ' HE2' ' CG ' ' B' ' 25' ' ' PRO . 3.4 tmtm? -143.4 132.7 23.27 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.109 -1.036 . . . . 75.14 109.877 -171.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.8 mtt -62.21 113.19 2.73 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.075 -0.713 . . . . 74.23 109.075 174.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.434 ' HB ' ' HA ' ' A' ' 115' ' ' ASN . 39.8 m -71.64 -79.04 0.07 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 114.566 1.321 . . . . 74.04 114.566 -171.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 51.81 92.26 0.02 OUTLIER 'General case' 0 C--O 1.256 1.412 0 C-N-CA 123.902 0.881 . . . . 71.23 112.085 -173.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.04 164.73 29.25 Favored Glycine 1 N--CA 1.385 -4.704 0 C-N-CA 120.018 -1.087 . . . . 73.12 110.989 -176.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 76.98 86.28 0.08 Allowed 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 125.234 1.414 . . . . 72.02 112.813 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -124.79 -58.84 1.47 Allowed 'General case' 0 C--O 1.216 -0.695 0 CA-C-N 114.759 -1.109 . . . . 72.43 109.277 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.2 m -64.95 106.4 1.23 Allowed 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.863 -0.608 . . . . 74.45 109.84 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.435 ' OE2' ' HA ' ' A' ' 25' ' ' PRO . 46.2 mt-10 -113.97 13.38 18.24 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-O 121.368 0.604 . . . . 74.53 109.821 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.613 ' HA3' ' OH ' ' B' ' 82' ' ' TYR . . . 76.7 -125.66 7.66 Favored Glycine 0 N--CA 1.496 2.671 0 CA-C-N 114.864 -1.062 . . . . 53.4 112.663 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -52.5 -53.95 6.01 Favored 'Trans proline' 0 CA--C 1.564 2.008 0 C-N-CA 122.529 2.153 . . . . 73.53 112.592 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.94 140.96 47.2 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 121.194 1.262 . . . . 72.1 110.116 173.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.05 154.54 63.97 Favored Pre-proline 0 C--N 1.292 -1.918 0 N-CA-C 107.524 -1.287 . . . . 74.43 107.524 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.435 ' HA ' ' OE2' ' A' ' 20' ' ' GLU . 11.5 Cg_endo -57.85 128.45 29.05 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 122.119 1.879 . . . . 62.0 110.353 178.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.65 HD13 ' H ' ' A' ' 26' ' ' LEU 0.289 0.0 OUTLIER -71.28 178.17 3.5 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 120.275 -0.57 . . . . 74.35 111.31 179.006 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.536 ' HB2' ' OE1' ' A' ' 30' ' ' GLU . 58.5 m -64.4 144.47 57.15 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 113.888 1.069 . . . . 73.53 113.888 -171.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' A' ' 32' ' ' LYS . . . -53.51 -46.54 70.13 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 114.505 -1.225 . . . . 63.11 112.82 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -67.24 -31.2 71.39 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 112.974 0.731 . . . . 74.53 112.974 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.536 ' OE1' ' HB2' ' A' ' 27' ' ' SER . 0.8 OUTLIER -65.52 -38.45 89.69 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.568 -0.287 . . . . 70.1 110.299 174.601 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.411 ' HG3' HD22 ' A' ' 26' ' ' LEU . 68.5 mttm -69.59 -35.26 75.17 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.886 -0.597 . . . . 72.21 110.163 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.468 ' HE3' ' SD ' ' A' ' 116' ' ' MET . 59.1 mtpt -67.74 -39.72 84.19 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 113.662 0.986 . . . . 63.32 113.662 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -70.59 -38.51 74.02 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 120.54 -0.464 . . . . 71.4 111.06 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 30' ' ' GLU . 13.8 pt -70.77 -33.42 52.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.705 -0.68 . . . . 64.04 110.566 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.444 ' OD1' ' HB2' ' A' ' 115' ' ' ASN . 4.7 t70 -56.13 -44.57 79.28 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.46 1.104 . . . . 74.0 109.654 175.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 99.6 mttt -55.56 -29.67 59.41 Favored 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 115.19 -0.914 . . . . 74.54 112.888 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.49 ' HA ' HG11 ' A' ' 91' ' ' VAL . 17.4 ptp180 -119.53 18.03 12.83 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 121.45 0.643 . . . . 53.33 111.566 -172.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.447 ' OG ' ' HG2' ' A' ' 84' ' ' GLU . 47.2 t -107.57 169.15 8.76 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.788 -0.642 . . . . 72.02 111.249 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 111' ' ' PRO . 11.2 m -140.33 163.72 23.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 124.496 1.118 . . . . 55.22 111.488 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.423 ' HB3' ' HB2' ' A' ' 110' ' ' LEU . 21.4 t80 -116.26 129.7 56.41 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 125.227 1.411 . . . . 65.5 109.608 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 63.0 t -109.12 117.49 54.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.744 -1.206 . . . . 62.34 107.744 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.04 163.75 12.13 Favored Glycine 0 N--CA 1.426 -2.01 0 C-N-CA 119.522 -1.323 . . . . 60.21 113.055 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 63.38 13.06 6.76 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.895 1.678 . . . . 63.45 112.883 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.9 p -64.49 137.62 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.452 0.644 . . . . 71.42 109.533 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -91.09 159.02 16.32 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.394 -0.821 . . . . 53.22 111.435 -174.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.463 ' CE2' ' HB2' ' A' ' 77' ' ' PRO . 4.5 m-85 -61.09 -19.16 61.12 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 114.951 -1.022 . . . . 70.4 112.013 178.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.86 -24.11 77.34 Favored Glycine 0 N--CA 1.428 -1.856 0 CA-C-N 115.88 -0.6 . . . . 73.5 111.727 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.5 m -86.32 140.01 30.46 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 120.581 -0.447 . . . . 74.52 109.844 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.465 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 76.0 p -109.15 173.25 6.4 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.119 -0.492 . . . . 63.13 110.778 -176.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.424 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -67.19 -45.27 77.42 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 110.062 -0.348 . . . . 72.51 110.062 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -58.49 -42.28 87.22 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.472 -0.331 . . . . 73.1 111.229 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.465 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 1.4 t70 -64.35 -37.9 89.13 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.689 0.757 . . . . 72.34 109.02 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 33.7 mt -68.51 -47.93 65.71 Favored 'General case' 0 C--O 1.249 1.038 0 CA-C-N 114.965 -1.016 . . . . 75.4 111.096 177.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -60.81 -49.8 76.03 Favored 'General case' 0 C--O 1.198 -1.654 0 CA-C-N 116.355 -0.384 . . . . 63.22 111.144 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.49 -40.08 77.84 Favored 'General case' 0 C--O 1.258 1.53 0 CA-C-O 121.367 0.603 . . . . 75.25 111.184 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -69.02 -41.09 78.2 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.154 -0.93 . . . . 61.14 110.715 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -82.66 -22.85 34.46 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 113.055 0.761 . . . . 75.32 113.055 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.7 m -72.11 -21.23 61.51 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-N 115.19 -0.914 . . . . 75.35 110.979 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.1 m -57.68 -17.78 16.92 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.388 -0.369 . . . . 53.2 111.161 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.872 ' SG ' ' HA ' ' A' ' 90' ' ' SER . 44.1 t -94.4 -76.56 0.48 Allowed 'General case' 0 N--CA 1.417 -2.08 0 CA-C-O 120.789 0.328 . . . . 54.11 110.638 175.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -130.06 -143.33 5.38 Favored Glycine 0 CA--C 1.508 -0.351 0 C-N-CA 120.257 -0.973 . . . . 54.45 115.217 -176.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.0 m -105.13 121.51 43.96 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 122.437 0.295 . . . . 71.34 110.991 -173.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 61.2 mt -85.22 129.27 38.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 116.028 -0.533 . . . . 64.31 112.014 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -93.4 -44.75 8.12 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.51 0.724 . . . . 75.44 111.504 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -149.12 159.55 44.14 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.216 -0.902 . . . . 75.14 110.27 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.442 HD13 HG21 ' A' ' 66' ' ' ILE . 39.4 pt -145.34 135.0 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.994 0 N-CA-C 106.753 -1.573 . . . . 73.32 106.753 170.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.0 m -124.78 123.8 40.75 Favored 'General case' 0 C--N 1.272 -2.799 0 N-CA-C 106.112 -1.81 . . . . 75.11 106.112 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.6 mp -121.24 117.39 52.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 106.562 -1.644 . . . . 72.3 106.562 -175.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.35 0.9 OUTLIER -121.32 129.83 53.31 Favored 'General case' 0 C--N 1.274 -2.676 0 C-N-CA 120.127 -0.629 . . . . 74.33 112.558 177.763 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.576 ' HB2' HG12 ' B' ' 66' ' ' ILE . 81.0 m -116.55 121.21 41.1 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 115.647 -0.706 . . . . 74.35 109.256 -177.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.608 ' HA ' ' HA ' ' B' ' 65' ' ' ARG . 1.1 t70 -117.48 125.45 50.92 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 123.757 0.823 . . . . 70.14 110.586 -173.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.55 ' HE2' ' HB3' ' A' ' 77' ' ' PRO . 39.6 ttmt -115.9 16.73 16.17 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.224 -0.658 . . . . 73.5 109.224 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.423 ' HD1' ' N ' ' A' ' 74' ' ' SER . 0.0 OUTLIER -63.61 -23.15 67.26 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 119.934 -0.706 . . . . 74.5 112.817 -175.913 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.423 ' N ' ' HD1' ' A' ' 73' ' ' PHE . 14.9 m -81.79 -0.9 45.32 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.154 -0.475 . . . . 62.32 111.134 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.9 -40.57 2.38 Favored Glycine 0 CA--C 1.5 -0.881 0 N-CA-C 110.095 -1.202 . . . . 75.33 110.095 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -95.14 130.28 33.0 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 107.923 -1.14 . . . . 61.41 107.923 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.55 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 36.8 Cg_endo -70.74 118.07 5.49 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.387 1.392 . . . . 72.32 110.505 177.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 37.2 mtmm -108.61 151.45 26.11 Favored 'General case' 0 CA--C 1.476 -1.898 0 CA-C-N 116.242 -0.436 . . . . 72.2 109.943 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.42 140.07 11.5 Favored Glycine 0 N--CA 1.409 -3.159 0 C-N-CA 120.517 -0.849 . . . . 72.21 111.025 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -151.41 144.13 24.37 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.788 -0.449 . . . . 73.51 109.788 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.42 154.81 49.89 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.968 -0.382 . . . . 74.42 109.968 -173.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -122.39 120.57 34.37 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 108.544 -0.91 . . . . 73.2 108.544 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.5 mm -101.73 119.22 49.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 107.17 -1.418 . . . . 74.14 107.17 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.447 ' HG2' ' OG ' ' A' ' 38' ' ' SER . 32.9 mt-10 -104.97 120.47 41.53 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.157 -0.682 . . . . 55.11 109.157 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -100.38 165.44 11.45 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 121.378 0.609 . . . . 65.14 112.055 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.48 ' O ' ' HD3' ' A' ' 37' ' ' ARG . . . -81.16 -32.37 33.67 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.728 -1.124 . . . . 42.32 110.965 175.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -123.5 160.67 26.46 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 113.246 0.832 . . . . 74.03 113.246 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -69.54 -32.48 71.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.359 -1.291 . . . . 75.24 112.279 174.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -60.74 -36.56 79.19 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.948 -0.301 . . . . 73.51 110.702 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.872 ' HA ' ' SG ' ' A' ' 60' ' ' CYS . 14.8 m -63.33 -45.2 92.34 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 116.574 -0.284 . . . . 61.35 111.403 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.49 HG11 ' HA ' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -65.7 -43.2 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 119.317 -0.373 . . . . 73.34 111.71 177.54 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.2 -35.28 75.04 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.687 0.625 . . . . 72.03 112.687 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.579 ' HB3' ' SG ' ' A' ' 60' ' ' CYS . . . -75.34 -37.89 60.46 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.122 0.486 . . . . 64.21 110.954 177.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.51 -40.64 76.83 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 116.086 -0.507 . . . . 73.22 111.861 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 91' ' ' VAL . 24.5 m -56.64 -22.16 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 112.282 0.475 . . . . 62.31 112.282 177.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.89 -19.38 62.62 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-O 120.894 0.378 . . . . 64.51 110.043 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 32.4 mtm -88.46 7.68 31.67 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.202 0.601 . . . . 75.4 111.935 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.564 ' HA ' ' HB ' ' A' ' 109' ' ' VAL . 7.3 t70 -33.39 -54.11 0.41 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 116.938 2.199 . . . . 55.33 116.938 -178.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -124.42 45.37 2.53 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 120.495 1.498 . . . . 74.33 110.125 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 42.9 m -84.95 162.37 19.44 Favored 'General case' 0 CA--C 1.571 1.759 0 CA-C-N 114.3 -1.318 . . . . 63.2 109.752 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.0 p -99.71 137.86 25.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 O-C-N 121.465 -0.772 . . . . 72.2 110.646 -174.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -151.2 117.87 5.77 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.467 -0.938 . . . . 65.22 108.467 -177.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.381 83.2 mtt85 59.99 55.09 3.92 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 116.078 1.881 . . . . 71.23 116.078 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.99 -13.05 1.45 Allowed Glycine 0 N--CA 1.469 0.856 0 CA-C-N 114.806 -1.088 . . . . 44.2 114.893 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -119.39 161.08 21.09 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-O 121.012 0.434 . . . . 71.45 110.383 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.9 m -94.59 127.81 40.78 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 108.366 -0.975 . . . . 64.2 108.366 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 48.2 pt -101.37 171.27 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.334 0 C-N-CA 119.782 -0.767 . . . . 75.25 109.949 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 55.1 tptt -125.88 129.35 49.17 Favored 'General case' 0 N--CA 1.409 -2.522 0 CA-C-N 114.791 -1.095 . . . . 64.11 108.809 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.564 ' HB ' ' HA ' ' A' ' 98' ' ' ASP . 47.3 t -119.95 112.25 36.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 107.658 -1.238 . . . . 72.41 107.658 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 40' ' ' TYR . 72.8 mt -112.4 152.59 44.67 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 109.017 -0.734 . . . . 75.2 109.017 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.452 ' HA ' HG12 ' A' ' 39' ' ' VAL . 3.3 Cg_exo -75.44 129.9 12.36 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 N-CA-C 107.892 -1.618 . . . . 52.41 107.892 171.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.418 ' H ' ' HA ' ' A' ' 39' ' ' VAL . 87.1 tttt -76.35 112.66 13.09 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 107.584 -1.265 . . . . 71.24 107.584 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -149.72 156.91 42.66 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 115.671 -0.695 . . . . 74.44 110.774 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 13.8 m 70.37 17.52 6.94 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-O 122.031 0.92 . . . . 75.52 109.607 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.444 ' HB2' ' OD1' ' A' ' 35' ' ' ASP . 0.8 OUTLIER -91.49 16.23 10.75 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.733 -0.604 . . . . 73.21 109.923 178.444 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.468 ' SD ' ' HE3' ' A' ' 32' ' ' LYS . 54.6 mtm -60.35 122.2 65.46 Favored Pre-proline 0 C--O 1.24 0.579 0 CA-C-N 115.195 -0.911 . . . . 75.23 109.754 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -55.68 141.17 84.49 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 123.075 2.517 . . . . 63.21 112.508 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -93.4 -155.49 31.95 Favored Glycine 0 N--CA 1.434 -1.457 0 CA-C-N 115.608 -0.723 . . . . 45.24 111.355 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . 0.316 2.1 pp -76.74 94.5 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 114.025 1.12 . . . . 73.13 114.025 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.428 ' HA ' ' HD2' ' B' ' 12' ' ' LYS . 32.4 t -152.57 100.07 2.52 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.897 -1.047 . . . . 75.22 108.279 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.3 t -155.83 96.79 1.77 Allowed 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.219 0.533 . . . . 61.32 110.647 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.0 t -131.58 16.27 4.88 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.198 -1.038 . . . . 70.14 108.198 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -143.82 131.15 20.87 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 114.564 -1.198 . . . . 65.35 108.62 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 . . . . . 0 C--N 1.303 -1.44 0 N-CA-C 109.652 -0.499 . . . . 74.22 109.652 -178.056 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.967 0 N-CA-C 109.295 -0.632 . . . . 61.22 109.295 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 50.4 mm -90.57 110.75 22.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 109.156 -0.683 . . . . 72.51 109.156 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -135.91 106.05 9.7 Favored Pre-proline 0 C--N 1.301 -1.537 0 CA-C-N 115.821 -0.627 . . . . 45.43 109.681 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.71 130.66 22.47 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.349 2.033 . . . . 74.32 112.179 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 19.2 p -98.68 6.99 46.62 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.324 0.583 . . . . 73.14 110.616 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -80.51 156.48 26.5 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.486 -0.779 . . . . 72.12 110.853 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' GLN . . . . . 0.476 ' HB3' ' O ' ' B' ' 113' ' ' ARG . 0.0 OUTLIER -142.37 171.52 13.95 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.573 -0.74 . . . . 73.13 110.001 177.602 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 57.1 m -77.2 116.97 18.28 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 120.988 0.423 . . . . 54.13 110.943 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 88.2 m -57.5 133.79 55.53 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.608 0.763 . . . . 75.31 110.143 176.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -75.71 132.77 40.74 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.728 0.64 . . . . 64.44 112.728 -175.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 18.7 m -66.22 -28.86 69.06 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 109.249 -0.648 . . . . 43.24 109.249 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' LYS . . . . . 0.428 ' HD2' ' HA ' ' A' ' 120' ' ' SER . 61.6 tttp 177.43 -64.81 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 125.613 1.565 . . . . 63.33 107.516 174.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 25.9 mmt 63.54 86.22 0.12 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.656 -1.156 . . . . 74.32 113.772 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 11.2 t 171.05 -29.79 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 125.106 1.363 . . . . 74.44 107.781 173.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.95 178.75 10.0 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.954 -1.499 . . . . 63.42 106.954 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.23 -56.09 3.96 Favored Glycine 0 C--N 1.312 -0.781 0 C-N-CA 120.693 -0.765 . . . . 64.22 112.534 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.48 119.48 34.05 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.894 -0.41 . . . . 23.41 109.894 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -121.9 -66.41 1.04 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.28 -0.568 . . . . 72.44 110.804 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.482 ' HB ' ' CB ' ' B' ' 25' ' ' PRO . 10.1 t -140.32 155.85 46.65 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.201 -0.6 . . . . 73.52 111.129 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -76.0 -23.36 55.23 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.027 -0.988 . . . . 74.54 110.665 176.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.97 -140.62 5.89 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 120.848 -0.692 . . . . 51.23 112.141 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.439 ' N ' ' HD2' ' B' ' 23' ' ' PRO . 72.1 Cg_exo -49.74 -44.9 34.19 Favored 'Trans proline' 0 CA--C 1.567 2.125 0 C-N-CA 123.871 3.048 . . . . 73.02 116.031 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' B' ' 22' ' ' PRO . 10.3 Cg_endo -53.84 142.2 63.82 Favored 'Trans proline' 0 C--N 1.395 2.975 0 C-N-CA 121.96 1.774 . . . . 75.05 111.36 176.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -54.16 129.16 58.84 Favored Pre-proline 0 C--O 1.241 0.63 0 N-CA-C 113.454 0.909 . . . . 71.42 113.454 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.482 ' CB ' ' HB ' ' B' ' 19' ' ' THR . 5.7 Cg_exo -59.99 135.51 63.38 Favored 'Trans proline' 0 CA--C 1.501 -1.155 0 C-N-CA 123.641 2.894 . . . . 55.02 114.139 -177.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.512 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -113.92 125.89 54.54 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 107.037 -1.468 . . . . 73.11 107.037 173.346 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 32.8 t -71.84 173.94 7.58 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 113.479 0.918 . . . . 54.14 113.479 -168.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.511 ' O ' ' HG3' ' B' ' 32' ' ' LYS . . . -49.0 -46.17 43.54 Favored 'General case' 0 C--O 1.21 -0.982 0 CA-C-N 114.491 -1.231 . . . . 72.3 112.288 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -68.0 -33.01 73.8 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 112.054 0.39 . . . . 72.33 112.054 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.44 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.9 OUTLIER -65.71 -39.42 91.2 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.446 -0.576 . . . . 60.02 109.446 172.795 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -67.06 -36.87 82.98 Favored 'General case' 0 C--O 1.207 -1.149 0 CA-C-N 115.573 -0.739 . . . . 74.01 110.087 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' B' ' 28' ' ' ALA . 59.9 mtpt -66.35 -40.24 89.69 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 113.497 0.925 . . . . 75.53 113.497 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -70.08 -39.77 75.39 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 120.299 -0.56 . . . . 71.2 111.281 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.44 HG12 ' O ' ' B' ' 30' ' ' GLU . 11.1 pt -70.57 -32.99 51.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.785 -0.643 . . . . 63.21 110.328 178.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.53 ' OD2' ' HB2' ' B' ' 113' ' ' ARG . 10.4 t70 -56.35 -42.96 78.6 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.827 1.251 . . . . 72.4 109.699 176.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.54 ' HA ' ' HB3' ' B' ' 113' ' ' ARG . 97.7 mttt -57.64 -33.28 68.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.05 -0.977 . . . . 64.22 112.015 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -102.89 2.55 35.42 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 123.713 0.805 . . . . 73.11 111.23 -172.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 71.1 p -104.33 162.94 12.79 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 114.51 1.3 . . . . 62.23 114.51 -175.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 13.9 m -133.4 163.61 37.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.674 -1.148 . . . . 40.2 111.08 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' TYR . . . . . 0.486 ' CD2' HD12 ' B' ' 110' ' ' LEU . 23.1 t80 -116.17 130.53 56.84 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 125.281 1.432 . . . . 74.11 109.346 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 71.7 t -109.89 120.49 61.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 124.766 1.226 . . . . 41.11 109.06 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -118.59 169.38 13.44 Favored Glycine 0 N--CA 1.427 -1.95 0 C-N-CA 120.139 -1.029 . . . . 41.12 112.453 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 60.6 t30 65.97 12.54 8.5 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 126.451 1.901 . . . . 75.23 112.834 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -72.09 117.43 15.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 108.218 -1.03 . . . . 63.2 108.218 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -77.04 162.0 27.86 Favored 'General case' 0 C--O 1.253 1.288 0 C-N-CA 119.941 -0.703 . . . . 73.13 111.611 -173.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -69.01 98.52 0.97 Allowed 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 107.21 -1.404 . . . . 74.35 107.21 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 159.15 -26.08 0.36 Allowed Glycine 0 N--CA 1.417 -2.574 0 C-N-CA 120.539 -0.838 . . . . 61.21 112.051 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.7 t -77.18 149.46 35.57 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.7 -1.222 . . . . 72.23 107.7 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 25.2 p -99.55 167.54 10.53 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.444 -0.502 . . . . 74.12 110.883 -173.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.44 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -71.04 -41.78 70.34 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 109.102 -0.703 . . . . 74.15 109.102 177.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -57.39 -44.16 84.25 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.136 -0.484 . . . . 72.43 111.094 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.88 -45.95 78.45 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.133 0.492 . . . . 64.22 110.381 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 74.6 mt -64.26 -47.68 78.69 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.094 -0.957 . . . . 73.43 111.862 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.445 ' HG3' HD12 ' B' ' 63' ' ' ILE . 34.1 tt0 -62.92 -50.85 69.22 Favored 'General case' 0 C--O 1.199 -1.59 0 C-N-CA 120.498 -0.481 . . . . 73.43 111.372 -178.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.97 -40.08 72.73 Favored 'General case' 0 C--O 1.257 1.467 0 CA-C-O 121.594 0.711 . . . . 73.24 111.454 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -69.35 -41.56 76.45 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.78 -1.1 . . . . 73.45 110.542 -176.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -83.06 -23.19 33.27 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.903 0.705 . . . . 73.34 112.903 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 67.1 m -71.32 -22.72 61.89 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 115.472 -0.785 . . . . 62.21 109.534 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 58.3 m -65.84 -18.12 65.12 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.739 -0.664 . . . . 62.3 109.96 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' CYS . . . . . 0.565 ' O ' ' HA ' ' B' ' 90' ' ' SER . 70.3 m -115.29 19.18 15.74 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 116.245 -0.434 . . . . 54.25 111.669 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' GLY . . . . . 0.43 ' HA3' ' OG ' ' B' ' 90' ' ' SER . . . 149.03 -162.64 28.99 Favored Glycine 0 N--CA 1.46 0.284 0 C-N-CA 118.282 -1.913 . . . . 72.04 116.034 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 15.1 m -111.1 115.1 28.86 Favored 'General case' 0 C--O 1.25 1.092 0 C-N-CA 123.018 0.527 . . . . 71.14 110.399 -175.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.445 HD12 ' HG3' ' B' ' 54' ' ' GLU . 65.5 mt -80.73 130.85 35.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.668 0.747 . . . . 71.45 112.995 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -100.31 -43.81 6.14 Favored 'General case' 0 C--O 1.21 -1.001 0 N-CA-C 107.09 -1.448 . . . . 61.25 107.09 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.608 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 86.4 mtt180 -153.64 161.88 41.76 Favored 'General case' 0 C--O 1.21 -1.014 0 C-N-CA 123.732 0.813 . . . . 75.41 110.384 176.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.576 HG12 ' HB2' ' A' ' 70' ' ' CYS . 31.9 pt -144.79 137.81 22.15 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.495 0 N-CA-C 106.656 -1.609 . . . . 73.32 106.656 169.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' B' ' 81' ' ' ALA . 53.3 m -125.75 120.82 31.64 Favored 'General case' 0 C--N 1.273 -2.745 0 N-CA-C 106.912 -1.514 . . . . 63.03 106.912 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mp -117.08 116.72 52.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 106.278 -1.749 . . . . 72.31 106.278 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.306 1.5 pt? -122.12 132.69 54.61 Favored 'General case' 0 C--N 1.275 -2.669 0 C-N-CA 119.666 -0.814 . . . . 73.04 111.531 176.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 73.5 m -116.68 120.5 38.82 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 115.108 -0.951 . . . . 54.43 108.592 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.426 ' HB2' ' CE2' ' B' ' 73' ' ' PHE . 2.4 p-10 -106.14 121.66 44.62 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 116.513 -2.075 . . . . 71.43 111.061 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.468 ' HE3' ' HG3' ' B' ' 77' ' ' PRO . 43.8 mtpt -118.05 -6.79 10.91 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.446 -1.252 . . . . 74.1 111.157 -176.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.426 ' CE2' ' HB2' ' B' ' 71' ' ' ASP . 52.6 p90 -69.93 -17.2 63.31 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.556 0.693 . . . . 63.25 109.837 -177.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 20.1 m -81.21 -1.78 46.12 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.283 -0.871 . . . . 71.31 109.692 176.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.26 -59.66 0.37 Allowed Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 110.979 -0.849 . . . . 65.24 110.979 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' HIS . . . . . 0.478 ' HA ' ' HD3' ' B' ' 77' ' ' PRO . 72.5 m80 -96.5 131.15 28.9 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 110.167 -0.308 . . . . 72.41 110.167 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' B' ' 76' ' ' HIS . 13.6 Cg_exo -72.87 119.28 5.98 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.589 2.193 . . . . 51.45 112.616 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 78' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 37.1 mtmm -112.31 154.83 25.08 Favored 'General case' 0 CA--C 1.48 -1.732 0 N-CA-C 108.069 -1.086 . . . . 71.0 108.069 174.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.56 141.13 12.29 Favored Glycine 0 N--CA 1.411 -3.027 0 C-N-CA 119.612 -1.28 . . . . 74.31 112.325 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -154.61 145.33 22.4 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.001 -0.599 . . . . 74.52 109.634 175.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' B' ' 67' ' ' THR . . . -137.69 154.98 49.59 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 116.216 -0.447 . . . . 53.3 110.381 -172.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' TYR . . . . . 0.613 ' OH ' ' HA3' ' A' ' 21' ' ' GLY . 49.1 m-85 -123.61 119.08 28.82 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.624 -0.88 . . . . 70.31 108.624 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.53 HG23 HG22 ' B' ' 66' ' ' ILE . 19.5 mm -101.66 119.94 50.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 107.07 -1.456 . . . . 75.42 107.07 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -107.19 125.55 51.25 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 108.579 -0.897 . . . . 64.53 108.579 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -106.7 164.52 12.02 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 120.994 0.426 . . . . 72.22 110.471 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.95 -18.72 23.31 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.743 -0.662 . . . . 72.32 111.097 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -127.24 142.06 51.57 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.297 -0.411 . . . . 74.41 111.118 -176.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -61.29 -34.4 75.15 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.116 0.784 . . . . 63.33 113.116 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -56.84 -37.16 70.89 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.537 -0.301 . . . . 74.11 111.103 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' B' ' 60' ' ' CYS . 15.0 m -62.92 -43.91 97.5 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 111.766 0.284 . . . . 74.33 111.766 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.494 ' O ' HG13 ' B' ' 95' ' ' VAL 0.3 0.7 OUTLIER -67.31 -42.9 88.18 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 C-N-CA 120.426 -0.51 . . . . 65.51 111.924 177.515 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -59.55 -36.29 75.88 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.491 -0.484 . . . . 74.14 112.291 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.19 -35.68 63.97 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.802 0.334 . . . . 74.23 111.402 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.57 -38.42 62.68 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.254 -0.43 . . . . 75.04 111.958 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' VAL . . . . . 0.494 HG13 ' O ' ' B' ' 91' ' ' VAL . 28.0 m -58.94 -23.3 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 112.175 0.435 . . . . 72.43 112.175 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.24 -9.89 58.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.419 0.628 . . . . 52.14 111.142 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 8.0 ttp -103.23 7.05 38.52 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.383 -0.969 . . . . 61.23 108.383 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' ASP . . . . . 0.515 ' HA ' ' HB ' ' B' ' 109' ' ' VAL . 4.1 p-10 -41.24 -56.79 2.3 Favored 'General case' 0 C--O 1.209 -1.062 0 N-CA-C 113.463 0.912 . . . . 61.04 113.463 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -101.7 97.12 7.57 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 118.474 0.579 . . . . 71.45 109.735 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 26.0 p -145.83 165.04 30.05 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.212 -0.904 . . . . 74.21 110.537 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 p -107.63 119.46 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-O 121.359 0.599 . . . . 73.3 109.968 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -131.91 127.77 37.13 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.688 -0.687 . . . . 72.13 109.255 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 48.6 ttt-85 62.17 33.2 17.02 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 122.547 1.165 . . . . 74.43 110.229 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.41 5.98 86.45 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 114.073 -1.421 . . . . 70.14 114.899 175.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -136.92 155.72 49.39 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 117.76 0.78 . . . . 71.11 111.077 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 46.8 m -78.49 123.92 27.57 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.921 -0.77 . . . . 63.14 108.921 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 41.4 pt -101.38 171.35 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 C-N-CA 119.969 -0.692 . . . . 74.51 109.643 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -124.43 137.48 54.44 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 106.858 -1.534 . . . . 55.0 106.858 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.515 ' HB ' ' HA ' ' B' ' 98' ' ' ASP . 24.9 t -127.33 122.72 60.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.636 -1.246 . . . . 65.43 107.636 174.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.486 HD12 ' CD2' ' B' ' 40' ' ' TYR . 73.9 mt -121.08 150.1 52.75 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 109.308 -0.627 . . . . 74.0 109.308 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.531 ' HG2' ' HB2' ' B' ' 115' ' ' ASN . 1.1 Cg_endo -81.63 135.28 9.05 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 C-N-CA 121.778 1.652 . . . . 75.01 108.16 170.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -73.87 -28.62 61.66 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.484 -0.887 . . . . 74.24 109.477 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.54 ' HB3' ' HA ' ' B' ' 36' ' ' LYS . 4.3 tpp180 -119.9 -79.06 0.6 Allowed 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 113.254 0.835 . . . . 72.15 113.254 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.465 HG23 ' HG3' ' B' ' 113' ' ' ARG . 4.3 p -122.67 139.41 53.97 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 113.14 0.792 . . . . 72.33 113.14 -172.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 115' ' ' ASN . . . . . 0.531 ' HB2' ' HG2' ' B' ' 111' ' ' PRO . 7.2 t30 -107.44 -18.65 13.8 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.987 -1.006 . . . . 70.54 108.353 174.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 50.2 ttm -84.45 118.0 70.07 Favored Pre-proline 0 N--CA 1.443 -0.777 0 CA-C-N 115.085 -0.961 . . . . 73.31 108.478 177.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 117' ' ' PRO . . . . . 0.454 ' HB2' HG13 ' B' ' 119' ' ' ILE . 1.8 Cg_endo -81.37 -69.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.136 1.89 . . . . 74.31 113.588 -177.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . 80.93 29.91 40.48 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 110.976 -0.85 . . . . 73.41 110.976 -177.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.454 HG13 ' HB2' ' B' ' 117' ' ' PRO . 67.0 mt -57.46 -44.54 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 122.748 0.419 . . . . 75.43 110.304 -178.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 15.8 m 67.54 7.66 5.77 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.392 1.077 . . . . 73.22 111.574 177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 26.3 t -133.17 -177.64 4.61 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 107.777 -1.194 . . . . 71.31 107.777 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 9.8 t -136.29 150.23 48.81 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.067 -0.716 . . . . 63.4 109.067 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -101.22 140.27 35.75 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.497 -1.298 . . . . 73.42 107.497 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.294 -1.82 0 N-CA-C 108.622 -0.881 . . . . 52.51 108.622 -175.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.569 0 N-CA-C 109.994 -0.373 . . . . 60.43 109.994 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.7 tt -89.9 110.55 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 108.67 -0.863 . . . . 72.21 108.67 176.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -95.98 114.33 63.93 Favored Pre-proline 0 C--N 1.311 -1.1 0 CA-C-N 115.48 -0.782 . . . . 74.25 111.035 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.66 147.92 46.17 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.202 1.935 . . . . 73.24 110.035 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 20.0 p -101.39 87.91 3.33 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.801 -0.759 . . . . 73.21 113.023 -176.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -76.61 145.7 38.72 Favored 'General case' 0 C--O 1.249 1.046 0 N-CA-C 107.005 -1.479 . . . . 73.01 107.005 174.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -165.3 110.42 0.9 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.285 0.564 . . . . 72.43 110.811 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.9 t -87.78 87.38 7.35 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-O 122.554 1.168 . . . . 70.42 109.846 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.6 p -102.66 101.16 11.27 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 114.939 -1.028 . . . . 72.0 109.783 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 55.5 m80 -142.57 140.67 31.82 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.501 -0.926 . . . . 73.33 108.501 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.597 ' HA ' ' HD2' ' A' ' 78' ' ' LYS . 24.1 m -79.36 100.91 7.83 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-O 121.137 0.494 . . . . 43.31 110.369 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -74.45 113.45 11.7 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.257 -0.883 . . . . 71.22 112.15 -177.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.4 mpt? 30.77 91.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 126.53 1.932 . . . . 73.51 114.614 174.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.44 ' O ' ' HB3' ' B' ' 23' ' ' PRO . 12.2 t -152.72 140.48 19.99 Favored 'General case' 0 N--CA 1.417 -2.115 0 C-N-CA 120.253 -0.579 . . . . 71.04 110.39 -177.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.46 ' HB3' HD12 ' B' ' 26' ' ' LEU . . . -156.34 159.44 38.79 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 116.649 -0.25 . . . . 75.1 110.357 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.425 ' HA3' ' NH1' ' B' ' 65' ' ' ARG . . . -172.28 -141.67 3.5 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 109.663 -1.375 . . . . 45.11 109.663 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -173.69 148.58 1.51 Allowed 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 123.007 0.523 . . . . 75.52 110.69 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -118.64 151.5 37.81 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.554 -0.535 . . . . 63.22 109.554 176.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.9 m -144.53 142.67 30.38 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.1 -0.704 . . . . 74.43 109.1 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.554 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 41.9 mt-10 -63.16 -31.31 72.42 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 114.951 1.463 . . . . 72.54 114.951 -175.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.21 -118.13 5.24 Favored Glycine 0 N--CA 1.474 1.22 0 C-N-CA 120.959 -0.639 . . . . 42.44 112.829 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -56.32 -47.47 24.09 Favored 'Trans proline' 0 CA--C 1.57 2.277 0 C-N-CA 123.528 2.818 . . . . 52.42 115.504 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.554 ' HD2' ' O ' ' A' ' 20' ' ' GLU . 75.2 Cg_exo -54.0 133.8 56.71 Favored 'Trans proline' 0 C--N 1.396 3.041 0 C-N-CA 121.652 1.568 . . . . 61.14 111.087 176.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -73.31 142.33 81.63 Favored Pre-proline 0 C--N 1.303 -1.445 0 CA-C-N 116.042 -0.526 . . . . 74.23 111.336 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.73 117.57 5.16 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.561 2.174 . . . . 72.52 112.5 -177.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.741 HD13 ' H ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -72.96 176.2 5.94 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.348 -0.842 . . . . 73.41 111.189 178.32 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.6 t -58.76 144.75 42.81 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 113.02 0.748 . . . . 60.42 113.02 -174.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 31' ' ' LYS . . . -54.2 -34.08 59.74 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.633 -1.167 . . . . 60.14 111.311 173.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -72.27 -34.83 68.5 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 119.399 -0.92 . . . . 74.31 109.648 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.493 ' O ' HG12 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -63.54 -36.02 82.4 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.565 -0.531 . . . . 73.41 109.565 174.639 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 28' ' ' ALA . 74.7 mmtt -59.13 -47.82 83.89 Favored 'General case' 0 C--O 1.208 -1.12 0 N-CA-C 108.819 -0.808 . . . . 70.22 108.819 177.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -60.2 -46.11 90.84 Favored 'General case' 0 C--O 1.209 -1.056 0 N-CA-C 113.46 0.911 . . . . 74.3 113.46 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -69.58 -41.01 76.39 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.102 -0.639 . . . . 72.54 112.259 -176.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 30' ' ' GLU . 27.9 pt -70.12 -35.87 65.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 120.513 -0.475 . . . . 72.45 111.059 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.667 ' OD1' ' HE3' ' A' ' 112' ' ' LYS . 30.0 t70 -68.44 -39.27 81.57 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.397 0.679 . . . . 64.24 110.563 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -66.61 -14.5 62.48 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.709 -0.678 . . . . 72.41 112.295 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -112.73 12.69 19.7 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 110.003 -0.369 . . . . 61.41 110.003 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.515 ' OG ' ' HB3' ' A' ' 112' ' ' LYS . 97.5 p -97.02 157.32 15.96 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.639 0.733 . . . . 75.14 112.392 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.59 HG22 HG23 ' A' ' 91' ' ' VAL . 49.0 t -127.82 151.53 34.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 114.912 -1.04 . . . . 70.44 108.401 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.668 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 24.4 t80 -104.4 127.66 52.12 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 125.055 1.342 . . . . 72.43 107.847 174.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.408 ' HA ' HG12 ' A' ' 109' ' ' VAL . 60.6 t -115.44 116.43 52.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 107.927 -1.138 . . . . 75.43 107.927 177.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.26 164.34 12.09 Favored Glycine 0 C--N 1.29 -1.987 0 C-N-CA 119.669 -1.253 . . . . 75.21 112.946 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 t30 68.75 25.02 6.46 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 125.677 1.591 . . . . 74.3 113.163 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.7 p -78.56 119.82 28.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 118.457 -1.297 . . . . 72.42 108.489 174.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -110.87 149.66 30.29 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.995 -1.113 . . . . 70.14 107.995 -173.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -51.45 115.58 1.67 Allowed 'General case' 0 CA--C 1.496 -1.102 0 CA-C-O 122.287 1.041 . . . . 71.43 112.128 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.19 -33.47 0.93 Allowed Glycine 0 N--CA 1.406 -3.318 0 N-CA-C 107.116 -2.393 . . . . 63.1 107.116 -174.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.5 m -102.61 141.85 34.75 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 108.327 -0.99 . . . . 74.33 108.327 173.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.6 p -115.88 178.73 4.2 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 120.4 0.143 . . . . 75.2 111.148 -176.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.528 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -64.64 -40.39 95.37 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 122.88 0.472 . . . . 75.32 110.542 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.54 -43.19 84.19 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 116.039 -0.528 . . . . 75.32 109.792 176.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -60.57 -38.8 85.78 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.382 0.61 . . . . 45.54 109.924 176.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.25 -46.94 75.38 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.187 -0.915 . . . . 35.42 111.066 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -58.75 -50.71 72.92 Favored 'General case' 0 C--O 1.19 -2.047 0 C-N-CA 120.434 -0.507 . . . . 64.43 111.762 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.8 -48.27 78.32 Favored 'General case' 0 C--O 1.271 2.187 0 CA-C-O 121.595 0.712 . . . . 71.34 111.795 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -67.31 -40.47 86.0 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.848 -1.069 . . . . 72.44 110.609 -175.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.467 ' HZ ' HG11 ' A' ' 109' ' ' VAL . 43.8 m-85 -81.57 -22.9 37.5 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 114.365 1.246 . . . . 54.22 114.365 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.1 m -69.85 -24.41 63.43 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.391 -0.368 . . . . 72.35 110.144 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.4 m -59.18 -31.22 68.8 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 119.908 -0.717 . . . . 74.34 109.674 172.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 60.9 m -85.92 3.05 43.64 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 112.909 0.707 . . . . 55.21 112.909 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.94 -158.09 26.15 Favored Glycine 0 N--CA 1.463 0.479 0 C-N-CA 119.528 -1.32 . . . . 65.52 114.138 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.1 m -105.46 126.03 51.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.925 0.393 . . . . 72.15 110.981 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 63.3 mt -91.74 127.28 44.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 115.633 -0.712 . . . . 65.51 111.885 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.554 ' ND2' ' HA ' ' A' ' 86' ' ' ALA . 90.3 m-20 -89.23 -42.1 11.82 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 121.325 0.583 . . . . 72.24 111.276 175.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.432 ' HG2' ' HA ' ' B' ' 71' ' ' ASP . 77.1 mtt180 -153.32 161.23 42.57 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.716 -0.675 . . . . 73.14 110.03 -176.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.528 HD11 ' HB1' ' A' ' 50' ' ' ALA . 35.0 pt -146.0 139.69 21.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 107.562 -1.273 . . . . 74.51 107.562 172.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.4 m -124.74 125.98 44.93 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 106.295 -1.743 . . . . 72.11 106.295 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mp -123.27 117.69 52.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 105.883 -1.895 . . . . 51.23 105.883 -177.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.288 1.0 OUTLIER -120.38 128.46 53.25 Favored 'General case' 0 C--N 1.284 -2.28 0 C-N-CA 120.443 -0.503 . . . . 74.13 112.175 179.031 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 78.3 m -115.31 129.31 56.57 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 115.759 -0.655 . . . . 61.03 110.1 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.454 ' HA ' ' HG2' ' B' ' 65' ' ' ARG . 17.0 t70 -114.69 125.33 53.61 Favored 'General case' 0 CA--C 1.492 -1.285 0 N-CA-C 112.174 0.435 . . . . 64.02 112.174 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -122.12 9.56 9.91 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 109.078 -0.712 . . . . 73.15 109.078 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.498 ' HB3' ' HB3' ' B' ' 64' ' ' ASN . 0.1 OUTLIER -64.79 -16.76 63.48 Favored 'General case' 0 C--N 1.361 1.095 0 N-CA-C 113.438 0.903 . . . . 62.53 113.438 -175.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.3 t -100.14 16.57 23.72 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-O 121.542 0.687 . . . . 70.13 109.847 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.64 -53.1 1.01 Allowed Glycine 0 CA--C 1.497 -1.066 0 C-N-CA 120.324 -0.941 . . . . 53.13 111.909 176.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -88.19 132.33 39.92 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 109.061 -0.718 . . . . 72.11 109.061 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -80.17 117.74 3.55 Favored 'Trans proline' 0 N--CA 1.431 -2.164 0 C-N-CA 121.329 1.353 . . . . 70.44 110.001 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.597 ' HD2' ' HA ' ' A' ' 11' ' ' SER . 34.2 mtmm -115.19 162.7 16.69 Favored 'General case' 0 CA--C 1.466 -2.268 0 C-N-CA 123.9 0.88 . . . . 74.05 108.692 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -144.13 149.99 22.03 Favored Glycine 0 N--CA 1.411 -3.027 0 C-N-CA 118.914 -1.612 . . . . 22.42 113.481 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -146.99 144.32 29.09 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 114.199 -1.0 . . . . 61.35 108.451 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.17 152.49 50.85 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 110.302 -0.258 . . . . 64.44 110.302 -172.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.448 ' CZ ' ' HD1' ' A' ' 40' ' ' TYR . 69.1 m-85 -121.5 123.51 42.19 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 109.679 -0.489 . . . . 63.42 109.679 176.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.451 HG23 HG22 ' A' ' 66' ' ' ILE . 22.9 mm -102.35 121.05 52.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 107.433 -1.321 . . . . 72.42 107.433 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -103.0 119.3 38.6 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.516 -0.55 . . . . 75.32 109.516 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -96.38 158.94 15.2 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.458 0.647 . . . . 74.32 112.637 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.554 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . . . -67.0 -46.98 72.9 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.671 -1.149 . . . . 71.41 112.054 177.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -119.74 156.93 29.61 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 113.316 0.858 . . . . 73.04 113.316 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -61.98 -28.36 69.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.606 -1.179 . . . . 72.13 112.22 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.351 2.0 p-10 -71.26 -24.48 62.18 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 113.605 0.965 . . . . 50.4 113.605 177.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -72.35 -41.58 66.3 Favored 'General case' 0 N--CA 1.433 -1.294 0 O-C-N 122.204 -0.31 . . . . 74.43 111.344 177.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.59 HG23 HG22 ' A' ' 39' ' ' VAL . 7.6 p -63.42 -39.88 86.96 Favored 'Isoleucine or valine' 0 C--N 1.354 0.79 0 N-CA-C 109.646 -0.501 . . . . 72.41 109.646 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -62.98 -34.84 78.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.583 -0.735 . . . . 72.43 110.155 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.15 -38.68 63.65 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.878 -0.601 . . . . 64.33 112.252 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.88 -40.18 65.81 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 116.049 -0.523 . . . . 74.33 110.923 -176.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.463 HG11 ' HB3' ' A' ' 111' ' ' PRO . 30.0 m -59.43 -22.13 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 113.071 0.767 . . . . 70.41 113.071 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.15 -9.87 58.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 122.192 0.996 . . . . 71.41 110.709 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 8.5 ttp -104.51 7.77 35.37 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.416 -1.266 . . . . 60.23 108.406 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.691 ' HA ' HG22 ' A' ' 109' ' ' VAL . 2.8 p-10 -36.53 -50.92 0.82 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 116.645 2.091 . . . . 63.1 116.645 -175.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -123.69 55.58 1.25 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 119.999 1.272 . . . . 73.51 112.942 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.5 p -92.97 -175.71 3.97 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.119 -1.401 . . . . 71.2 110.837 174.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.95 126.07 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 121.322 0.582 . . . . 61.5 110.58 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -111.12 118.76 36.87 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.079 -0.712 . . . . 72.02 109.079 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 43.42 31.67 0.43 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.562 1.545 . . . . 75.42 113.7 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.59 -8.84 37.65 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.837 -0.697 . . . . 34.31 114.395 175.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -123.41 146.08 48.27 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 118.112 0.956 . . . . 74.3 110.033 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.7 m -78.41 118.87 20.99 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 120.551 -0.46 . . . . 75.05 110.014 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 pp -104.51 169.98 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 116.305 -0.407 . . . . 73.41 110.938 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 57.8 tptt -130.49 131.16 44.99 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.708 -0.849 . . . . 74.21 108.708 -176.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.691 HG22 ' HA ' ' A' ' 98' ' ' ASP . 36.0 m -126.47 135.33 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 120.975 0.417 . . . . 63.44 110.511 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.8 mt -131.03 148.53 70.64 Favored Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 108.981 -0.748 . . . . 60.23 108.981 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.463 ' HB3' HG11 ' A' ' 95' ' ' VAL . 55.5 Cg_endo -79.5 135.29 11.66 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 121.126 1.217 . . . . 32.42 109.341 175.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.667 ' HE3' ' OD1' ' A' ' 35' ' ' ASP . 37.3 ttpt -84.28 68.46 10.19 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 118.03 -1.468 . . . . 73.44 109.731 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -176.53 26.99 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.253 -1.794 . . . . 70.4 112.134 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.8 m -80.66 23.5 0.52 Allowed 'General case' 0 CA--C 1.559 1.297 0 CA-C-O 121.637 0.732 . . . . 64.35 110.157 -175.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 41.6 t30 72.92 -62.19 0.48 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.8 1.24 . . . . 73.54 113.757 173.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.432 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 25.2 mmt -63.22 -50.22 76.18 Favored Pre-proline 0 C--N 1.316 -0.886 0 C-N-CA 120.897 -0.321 . . . . 73.15 111.536 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.432 ' HD3' ' HB2' ' A' ' 116' ' ' MET . 3.1 Cg_exo -81.31 97.67 0.98 Allowed 'Trans proline' 0 N--CA 1.441 -1.587 0 N-CA-C 108.951 -1.211 . . . . 61.14 108.951 170.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 158.77 -165.73 34.18 Favored Glycine 0 N--CA 1.435 -1.368 0 N-CA-C 110.237 -1.145 . . . . 72.34 110.237 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 51.0 mm -109.53 -63.48 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 117.267 0.533 . . . . 64.42 109.772 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.7 t 65.94 -87.15 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.429 1.092 . . . . 70.44 111.243 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.6 t 174.22 -173.36 0.06 Allowed 'General case' 0 C--O 1.248 0.984 0 N-CA-C 106.912 -1.514 . . . . 64.32 106.912 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.9 t -159.03 133.09 7.64 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-O 120.648 0.261 . . . . 73.53 110.734 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.2 t70 68.83 -40.04 0.43 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.911 1.684 . . . . 72.44 114.285 176.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.554 ' NE ' ' HA ' ' A' ' 124' ' ' ARG . 1.8 tpm_? . . . . . 0 C--N 1.3 -1.575 0 N-CA-C 109.858 -0.423 . . . . 72.3 109.858 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.685 0 N-CA-C 109.858 -0.423 . . . . 61.25 109.858 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 48.8 mm -108.07 130.06 61.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.509 -0.923 . . . . 72.43 108.509 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.2 140.54 34.57 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 109.181 -0.674 . . . . 72.11 109.181 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.65 115.81 2.34 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.799 2.333 . . . . 73.21 110.976 177.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 45.6 t -82.1 96.8 7.9 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.852 -0.613 . . . . 73.34 110.54 -175.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 25.3 mmt -97.51 103.33 15.26 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.876 -0.602 . . . . 71.33 110.143 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -102.57 -20.97 14.26 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.208 -0.905 . . . . 52.45 109.068 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 11.4 p -73.85 107.77 6.28 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 115.376 -0.829 . . . . 61.42 111.873 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -154.89 -177.25 6.38 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 107.68 -1.23 . . . . 71.32 107.68 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -146.62 138.67 24.78 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 122.588 0.355 . . . . 74.43 110.104 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 39.5 p -106.63 156.59 18.45 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 116.143 -0.48 . . . . 73.42 110.419 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -138.42 88.4 2.3 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.535 0.683 . . . . 65.05 111.686 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -176.59 151.51 0.94 Allowed 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 114.754 -1.112 . . . . 64.02 109.6 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 33.5 p -112.24 -70.46 0.81 Allowed 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.198 0.523 . . . . 70.23 110.231 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.77 -42.26 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.09 -1.448 . . . . 75.22 107.09 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.86 109.49 0.44 Allowed Glycine 0 N--CA 1.426 -1.993 0 CA-C-N 114.416 -1.265 . . . . 74.11 110.066 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -102.16 108.04 19.3 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.23 -0.655 . . . . 64.14 109.23 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.429 ' HB3' ' HB3' ' B' ' 25' ' ' PRO . 36.8 p90 -133.28 -16.31 2.44 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.389 0.885 . . . . 75.43 113.389 -176.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 36.4 p -88.08 70.98 9.36 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 114.305 1.224 . . . . 74.13 114.305 -178.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -94.49 -47.48 6.54 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 103.468 -2.79 . . . . 65.23 103.468 170.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 162.64 -131.02 2.39 Favored Glycine 0 N--CA 1.411 -2.98 0 N-CA-C 107.606 -2.197 . . . . 60.13 107.606 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.53 ' HG2' ' CE2' ' A' ' 40' ' ' TYR . 57.9 Cg_exo -55.75 -36.31 94.9 Favored 'Trans proline' 0 CA--C 1.58 2.817 0 C-N-CA 123.08 2.52 . . . . 73.34 115.258 174.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.44 ' HB3' ' O ' ' A' ' 14' ' ' THR . 78.1 Cg_exo -53.73 158.74 7.83 Favored 'Trans proline' 0 C--N 1.405 3.518 0 C-N-CA 121.952 1.768 . . . . 74.3 114.033 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -89.6 167.24 18.0 Favored Pre-proline 0 C--N 1.309 -1.178 0 CA-C-N 115.021 -0.99 . . . . 72.42 109.712 -177.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.429 ' HB3' ' HB3' ' B' ' 18' ' ' TYR . 19.5 Cg_endo -77.35 159.75 32.7 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 121.208 1.272 . . . . 52.51 112.596 176.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -146.73 162.23 38.97 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.322 -0.854 . . . . 73.24 109.131 176.419 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.657 ' HB2' ' HG2' ' B' ' 30' ' ' GLU . 71.2 m -65.44 143.74 57.51 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 115.088 1.514 . . . . 55.24 115.088 -171.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' B' ' 31' ' ' LYS . . . -55.72 -34.65 65.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.043 -1.435 . . . . 71.43 112.699 174.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . 0.274 6.0 mt-10 -72.89 -29.22 63.0 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 113.327 0.862 . . . . 71.5 113.327 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.657 ' HG2' ' HB2' ' B' ' 27' ' ' SER . 2.3 mm-40 -67.87 -35.39 78.46 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.085 -1.08 . . . . 72.34 108.085 172.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' B' ' 28' ' ' ALA . 74.7 mmtt -60.81 -48.41 81.93 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.151 -0.932 . . . . 64.23 108.955 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -54.24 -49.39 69.59 Favored 'General case' 0 C--N 1.363 1.156 0 N-CA-C 112.752 0.649 . . . . 62.25 112.752 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -70.63 -42.51 70.78 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 112.825 0.676 . . . . 65.31 112.825 -170.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.491 HG12 ' O ' ' B' ' 30' ' ' GLU . 24.2 pt -68.9 -35.6 70.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.018 0.437 . . . . 74.33 110.31 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -67.53 -43.22 81.32 Favored 'General case' 0 C--O 1.201 -1.476 0 CA-C-N 115.533 -0.758 . . . . 73.0 110.418 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' B' ' 113' ' ' ARG . 53.3 mtpt -63.24 -14.32 48.0 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.226 1.011 . . . . 72.41 113.388 -178.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -118.57 20.86 12.83 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 121.598 0.713 . . . . 72.15 110.644 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.523 ' HB2' ' HB3' ' B' ' 112' ' ' LYS . 40.1 m -97.91 160.42 14.31 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.288 -0.869 . . . . 73.31 111.719 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.558 HG22 HG23 ' B' ' 91' ' ' VAL . 46.2 t -129.9 154.64 40.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.772 -0.825 . . . . 74.52 108.772 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' TYR . . . . . 0.66 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 30.0 t80 -108.49 125.58 51.95 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 125.214 1.405 . . . . 71.51 107.953 175.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.403 ' HA ' HG12 ' B' ' 109' ' ' VAL . 59.6 t -113.33 117.45 55.45 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.442 0 N-CA-C 108.431 -0.952 . . . . 64.34 108.431 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.93 173.8 15.33 Favored Glycine 0 N--CA 1.433 -1.555 0 C-N-CA 119.963 -1.113 . . . . 74.13 112.671 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 t30 67.97 22.53 8.53 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.697 1.599 . . . . 72.12 112.139 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 13.2 p -95.09 128.44 46.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 O-C-N 121.628 -0.67 . . . . 75.43 110.106 175.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -116.08 167.17 11.22 Favored 'General case' 0 CA--C 1.483 -1.596 0 N-CA-C 108.456 -0.942 . . . . 74.11 108.456 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -51.33 128.14 21.59 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.817 0.818 . . . . 73.13 110.694 173.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.96 -41.78 1.1 Allowed Glycine 0 N--CA 1.415 -2.748 0 N-CA-C 107.41 -2.276 . . . . 61.41 107.41 -172.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.2 m -95.76 140.23 30.85 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.046 -1.094 . . . . 72.31 108.046 174.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 74.0 p -111.3 177.62 4.6 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.693 -0.403 . . . . 72.04 110.499 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.505 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -66.88 -39.05 87.38 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.996 -0.372 . . . . 70.03 109.996 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.73 -44.05 85.73 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.848 -0.615 . . . . 73.15 109.997 175.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -56.99 -44.67 82.96 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.577 0.703 . . . . 73.02 109.525 175.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' B' ' 50' ' ' ALA . 78.3 mt -60.9 -47.76 84.92 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 114.597 -1.183 . . . . 75.13 112.16 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -58.89 -50.84 72.52 Favored 'General case' 0 C--O 1.198 -1.614 0 C-N-CA 120.412 -0.515 . . . . 63.13 112.126 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.67 -48.38 77.72 Favored 'General case' 0 C--O 1.265 1.9 0 CA-C-O 121.629 0.728 . . . . 65.14 111.783 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -66.73 -41.05 88.51 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.707 -1.133 . . . . 74.52 110.662 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -81.59 -23.09 37.31 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 114.229 1.196 . . . . 65.34 114.229 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 66.7 m -70.61 -24.16 62.69 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.307 -0.406 . . . . 52.04 109.964 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.3 m -58.79 -29.01 66.5 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-O 121.096 0.475 . . . . 65.13 109.94 172.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 60.0 m -92.27 6.37 47.03 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 113.07 0.767 . . . . 52.23 113.07 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 142.84 -158.38 27.1 Favored Glycine 0 C--O 1.226 -0.397 0 C-N-CA 119.143 -1.503 . . . . 61.13 114.371 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 49.9 m -106.21 125.79 51.43 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 122.444 -0.445 . . . . 72.21 111.241 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 71.3 mt -91.42 127.15 43.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 116.029 -0.532 . . . . 73.24 112.401 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' ASN . . . . . 0.642 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 87.3 m-20 -89.06 -43.54 11.02 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-N 116.029 -0.532 . . . . 73.43 110.792 175.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.454 ' HG2' ' HA ' ' A' ' 71' ' ' ASP . 40.0 mtt180 -150.96 161.25 43.08 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.869 -0.605 . . . . 75.13 110.524 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.505 HD11 ' HB1' ' B' ' 50' ' ' ALA . 38.2 pt -146.17 140.15 20.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 107.65 -1.241 . . . . 65.42 107.65 172.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 85.3 m -124.91 126.41 45.48 Favored 'General case' 0 C--N 1.273 -2.73 0 N-CA-C 106.786 -1.561 . . . . 50.22 106.786 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.6 mp -124.28 116.71 48.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 105.817 -1.92 . . . . 74.45 105.817 -177.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -120.56 129.37 53.75 Favored 'General case' 0 C--N 1.283 -2.287 0 C-N-CA 120.216 -0.594 . . . . 65.32 110.996 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' CYS . . . . . 0.425 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 79.4 m -116.22 129.57 56.36 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.383 -0.599 . . . . 73.33 109.383 -177.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.432 ' HA ' ' HG2' ' A' ' 65' ' ' ARG . 8.0 t70 -109.43 124.71 51.47 Favored 'General case' 0 CA--C 1.482 -1.665 0 N-CA-C 112.595 0.591 . . . . 64.32 112.595 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -119.76 3.01 11.14 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 114.973 -1.012 . . . . 70.54 111.358 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.432 ' HB3' ' HB3' ' A' ' 64' ' ' ASN . 0.8 OUTLIER -69.42 -22.44 63.67 Favored 'General case' 0 C--N 1.364 1.216 0 C-N-CA 119.084 -1.046 . . . . 73.02 110.67 -176.75 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 35.2 t -88.97 15.01 9.23 Favored 'General case' 0 CA--C 1.56 1.345 0 CA-C-N 115.242 -0.89 . . . . 62.12 109.599 177.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.75 -61.2 2.74 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.91 -0.586 . . . . 63.23 112.046 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' HIS . . . . . 0.419 ' HA ' ' HD3' ' B' ' 77' ' ' PRO . 37.0 m80 -85.87 129.32 54.87 Favored Pre-proline 0 C--O 1.252 1.216 0 C-N-CA 120.836 -0.346 . . . . 74.13 110.19 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' B' ' 76' ' ' HIS . 9.2 Cg_exo -72.01 117.47 5.16 Favored 'Trans proline' 0 CA--C 1.504 -1.019 0 C-N-CA 121.975 1.783 . . . . 44.33 110.699 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 35.0 mtmm -118.34 159.36 23.54 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 107.666 -1.235 . . . . 65.12 107.666 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -138.94 152.13 22.06 Favored Glycine 0 N--CA 1.411 -3.023 0 C-N-CA 119.055 -1.545 . . . . 73.51 113.312 177.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -149.64 144.99 26.51 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.273 -1.01 . . . . 70.32 108.273 173.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.22 152.83 51.17 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 116.56 -0.291 . . . . 70.22 110.604 -171.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' TYR . . . . . 0.422 ' CZ ' ' HD1' ' B' ' 40' ' ' TYR . 78.2 m-85 -122.45 124.17 42.99 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 109.517 -0.549 . . . . 74.0 109.517 175.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.487 HG23 HG22 ' B' ' 66' ' ' ILE . 23.2 mm -102.97 120.07 52.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.488 -1.301 . . . . 63.15 107.488 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -102.31 119.15 38.34 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.549 -0.908 . . . . 73.32 108.549 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -93.84 160.04 14.92 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 112.734 0.642 . . . . 75.33 112.734 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.642 ' HA ' ' ND2' ' B' ' 64' ' ' ASN . . . -66.61 -43.56 84.47 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.067 -0.969 . . . . 72.15 112.224 176.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -127.0 160.04 32.3 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.381 0.882 . . . . 73.31 113.381 -176.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -63.89 -24.98 67.95 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.517 1.127 . . . . 64.25 112.787 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -63.48 -39.3 94.09 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.457 -0.942 . . . . 72.51 108.457 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 18.6 m -68.97 -38.68 79.5 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.314 -0.857 . . . . 60.23 112.074 -172.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.558 HG23 HG22 ' B' ' 39' ' ' VAL . 7.5 p -65.01 -40.6 89.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 109.201 -0.666 . . . . 74.43 109.201 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.0 -34.33 77.76 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.549 0.69 . . . . 60.3 110.271 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.86 -37.68 64.68 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.73 -0.668 . . . . 74.52 111.111 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.1 -38.78 61.05 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 120.635 -0.426 . . . . 61.24 111.176 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 95' ' ' VAL . . . . . 0.491 HG11 ' HB3' ' B' ' 111' ' ' PRO . 30.1 m -59.66 -22.47 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 112.787 0.662 . . . . 71.05 112.787 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.87 -9.17 50.07 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.145 0.497 . . . . 60.05 110.177 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 22.7 mtm -97.51 4.0 50.54 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 112.843 0.683 . . . . 75.33 112.843 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 98' ' ' ASP . . . . . 0.582 ' HA ' HG22 ' B' ' 109' ' ' VAL . 2.3 p30 -43.86 -38.18 3.2 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 116.77 2.137 . . . . 71.43 116.77 -174.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -117.09 28.03 8.76 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 119.629 1.104 . . . . 74.34 111.405 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 73.6 p -84.41 177.46 8.13 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 121.245 -0.909 . . . . 61.52 111.55 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 13.0 p -101.27 145.73 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 N-CA-C 109.387 -0.598 . . . . 65.01 109.387 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -143.85 121.75 12.01 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.381 -0.97 . . . . 70.23 108.381 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 56.9 ttt-85 52.01 33.59 12.19 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 124.529 1.132 . . . . 72.34 111.868 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.65 1.57 70.95 Favored Glycine 0 C--N 1.313 -0.725 0 CA-C-N 115.188 -0.914 . . . . 71.11 114.33 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -126.94 157.9 38.24 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 117.544 0.672 . . . . 53.11 109.806 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 41.8 m -88.43 120.21 29.59 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.086 -1.079 . . . . 62.05 108.086 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 43.4 pt -101.83 172.0 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 C-N-CA 119.737 -0.785 . . . . 70.15 110.484 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -128.65 127.16 41.65 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.957 -0.757 . . . . 61.3 108.957 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 27.0 m -126.6 134.52 66.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 O-C-N 123.441 0.463 . . . . 62.41 111.018 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 96.4 mt -128.31 148.28 67.19 Favored Pre-proline 0 C--N 1.298 -1.642 0 N-CA-C 109.206 -0.665 . . . . 63.53 109.206 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.491 ' HB3' HG11 ' B' ' 95' ' ' VAL . 53.2 Cg_endo -79.28 133.82 11.05 Favored 'Trans proline' 0 N--CA 1.439 -1.711 0 C-N-CA 121.493 1.462 . . . . 74.15 111.22 175.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.523 ' HB3' ' HB2' ' B' ' 38' ' ' SER . 27.9 ttpp -100.17 131.48 46.09 Favored 'General case' 0 N--CA 1.41 -2.446 0 N-CA-C 105.75 -1.945 . . . . 51.32 105.75 173.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.477 ' HA ' ' HA ' ' B' ' 36' ' ' LYS . 5.1 ppt_? -168.92 172.21 7.82 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.755 0.312 . . . . 70.15 111.613 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 24.8 p -119.95 154.43 34.49 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.177 -1.045 . . . . 74.41 108.177 175.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -121.08 122.14 39.41 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.39 -0.524 . . . . 73.12 109.809 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -149.74 115.19 3.51 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 115.344 -0.844 . . . . 64.54 109.037 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.09 91.23 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.99 1.793 . . . . 71.42 111.294 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . 124.32 156.72 9.53 Favored Glycine 0 N--CA 1.431 -1.645 0 N-CA-C 110.952 -0.859 . . . . 72.5 110.952 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.409 ' N ' HD12 ' B' ' 119' ' ' ILE . 2.5 mp -98.51 -35.96 5.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.842 -0.799 . . . . 71.41 108.842 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 29.8 m 72.35 14.76 5.37 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.643 1.177 . . . . 63.12 112.22 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 25.9 t -92.97 98.99 11.71 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.149 -0.685 . . . . 74.44 109.149 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 24.6 p -83.42 89.95 7.12 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-O 121.712 0.768 . . . . 73.3 112.026 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -99.39 -169.48 1.76 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.686 -1.143 . . . . 71.42 109.622 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.487 ' O ' ' HD2' ' B' ' 124' ' ' ARG 0.271 6.1 ppt_? . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 112.024 0.379 . . . . 72.13 112.024 177.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.244 0 CA-C-O 120.906 0.384 . . . . 62.33 110.259 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.8 mm -87.48 132.55 32.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.942 -0.762 . . . . 74.24 108.942 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.73 118.43 54.5 Favored Pre-proline 0 N--CA 1.44 -0.965 0 N-CA-C 108.87 -0.789 . . . . 61.42 108.87 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -49.56 108.46 0.2 Allowed 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 123.274 2.649 . . . . 74.24 112.603 -177.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 65.4 m -94.39 116.54 28.92 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 108.072 -1.085 . . . . 71.52 108.072 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 15.4 tpt -76.58 84.9 3.26 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 121.595 0.712 . . . . 74.0 109.408 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.6 96.23 0.75 Allowed 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 106.462 -1.681 . . . . 75.33 106.462 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.6 m -129.29 101.26 5.91 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.647 -1.612 . . . . 75.14 106.647 178.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.3 m -55.06 107.62 0.32 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 113.977 1.103 . . . . 74.43 113.977 -171.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -109.06 101.52 10.58 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 107.253 -1.388 . . . . 72.02 107.253 172.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.2 p -90.81 119.64 31.19 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 120.868 0.366 . . . . 62.11 110.977 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -78.77 75.38 5.28 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 108.998 -0.742 . . . . 72.35 108.998 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 52.0 ttm -119.25 83.67 2.07 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-O 121.666 0.746 . . . . 73.43 109.617 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.1 m -120.07 113.14 20.04 Favored 'General case' 0 N--CA 1.41 -2.459 0 CA-C-N 114.214 -1.357 . . . . 51.03 107.694 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.75 -24.83 56.12 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.968 -1.123 . . . . 71.02 107.968 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' B' ' 43' ' ' ASN . . . 130.12 -107.16 0.76 Allowed Glycine 0 N--CA 1.41 -3.056 0 CA-C-N 114.489 -1.232 . . . . 50.15 110.272 177.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 166.6 75.03 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 105.935 -1.876 . . . . 62.21 105.935 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -59.05 -69.35 0.2 Allowed 'General case' 0 C--N 1.318 -0.764 0 O-C-N 123.865 0.728 . . . . 72.53 110.594 -171.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 t -130.85 80.21 1.93 Allowed 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 122.514 1.149 . . . . 52.02 112.084 176.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -93.24 -29.46 15.68 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 106.984 -1.487 . . . . 70.5 106.984 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.25 178.46 49.47 Favored Glycine 1 N--CA 1.389 -4.493 0 N-CA-C 109.075 -1.61 . . . . 55.41 109.075 -173.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.599 ' HA ' ' OH ' ' B' ' 82' ' ' TYR . 71.7 Cg_exo -47.07 -38.59 24.7 Favored 'Trans proline' 0 CA--C 1.587 3.135 0 C-N-CA 122.896 2.398 . . . . 54.21 116.287 174.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -93.41 168.27 2.25 Favored 'Trans proline' 0 N--CA 1.417 -3.003 0 N-CA-C 117.478 2.068 . . . . 71.41 117.478 -173.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.569 ' HG2' ' OH ' ' B' ' 80' ' ' TYR . 29.7 mt-30 -128.8 146.2 59.43 Favored Pre-proline 0 N--CA 1.417 -2.111 0 N-CA-C 103.961 -2.607 . . . . 55.24 103.961 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.47 102.04 1.46 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 121.633 1.556 . . . . 64.22 114.205 -176.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 30' ' ' GLU . 3.9 mp -146.08 145.52 30.58 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.858 -0.793 . . . . 75.54 108.858 177.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.3 t -79.45 160.69 26.5 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 109.046 -0.724 . . . . 52.2 109.046 173.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.7 -42.0 33.56 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 123.53 0.732 . . . . 72.14 112.009 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -67.2 -36.04 80.9 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.64 0.607 . . . . 71.31 112.64 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.458 ' O ' HG12 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -57.38 -36.1 70.82 Favored 'General case' 0 CA--C 1.496 -1.1 0 C-N-CA 120.318 -0.553 . . . . 53.21 109.881 171.517 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.71 -40.41 88.45 Favored 'General case' 0 C--O 1.192 -1.958 0 C-N-CA 119.821 -0.751 . . . . 71.33 111.584 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.703 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -66.08 -38.04 87.27 Favored 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 119.716 -0.794 . . . . 74.33 111.824 178.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.416 ' HB3' HH21 ' A' ' 37' ' ' ARG . 60.0 mm-40 -65.66 -46.33 79.53 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.138 0.494 . . . . 55.42 111.62 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.57 HD12 ' NH2' ' A' ' 65' ' ' ARG . 12.7 pt -70.82 -33.77 53.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.656 -0.702 . . . . 70.04 110.679 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.406 ' OD2' ' NZ ' ' A' ' 112' ' ' LYS . 13.9 t70 -66.0 -38.83 89.48 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.837 0.855 . . . . 74.44 108.887 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -57.4 -30.72 65.15 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.278 -0.874 . . . . 75.34 110.859 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.416 HH21 ' HB3' ' A' ' 33' ' ' GLU . 54.2 mtm180 -104.09 18.82 21.27 Favored 'General case' 0 N--CA 1.419 -2.013 0 CA-C-N 114.842 -1.072 . . . . 71.14 111.856 -175.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.0 m -95.87 146.44 24.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.605 0.717 . . . . 64.01 111.152 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.434 HG22 ' HB ' ' A' ' 83' ' ' ILE . 33.7 m -127.95 160.69 37.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.932 -0.766 . . . . 62.33 108.932 176.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.576 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 28.1 t80 -109.14 126.06 52.83 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.497 -0.927 . . . . 74.11 108.497 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.52 ' HA ' HG12 ' A' ' 109' ' ' VAL . 61.3 t -114.49 111.82 37.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.841 -1.17 . . . . 65.42 107.841 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.2 171.62 13.87 Favored Glycine 0 C--N 1.304 -1.243 0 C-N-CA 120.267 -0.968 . . . . 52.42 113.215 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.436 ' HA ' ' OD1' ' A' ' 45' ' ' ASP . 9.7 t-20 58.65 24.89 12.61 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 125.391 1.477 . . . . 40.2 110.037 -178.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 p -92.63 9.17 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.418 0 CA-C-N 114.524 -1.216 . . . . 61.44 110.069 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.54 ' OD2' ' HA ' ' A' ' 78' ' ' LYS . 6.0 m-20 -37.07 106.84 0.05 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 128.235 2.614 . . . . 72.03 113.617 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.415 ' C ' ' H ' ' A' ' 48' ' ' SER 0.4 41.3 m-85 50.11 162.81 0.0 OUTLIER 'General case' 0 C--N 1.351 0.643 0 N-CA-C 118.116 2.636 . . . . 75.54 118.116 179.436 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.438 ' HA3' ' NH1' ' A' ' 103' ' ' ARG . . . 80.94 -36.97 2.33 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.284 -0.871 . . . . 70.14 111.462 -177.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 46' ' ' TYR . 19.4 m -76.84 118.27 19.28 Favored 'General case' 0 N--CA 1.415 -2.218 0 C-N-CA 124.733 1.213 . . . . 70.33 109.866 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.7 p -100.59 162.99 12.56 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.6 -0.519 . . . . 71.35 109.6 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.487 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -65.81 -50.25 65.31 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.171 0.434 . . . . 63.24 112.171 -175.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -57.79 -38.74 76.04 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 116.824 -0.171 . . . . 60.32 111.091 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.72 -37.67 76.61 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.018 0.437 . . . . 73.2 110.347 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 44.1 mt -68.22 -47.58 67.45 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.362 -0.835 . . . . 51.32 110.803 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -61.9 -48.24 81.34 Favored 'General case' 0 C--O 1.2 -1.538 0 CA-C-N 115.738 -0.665 . . . . 72.23 110.069 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.48 -41.18 84.71 Favored 'General case' 0 C--O 1.248 1.0 0 CA-C-O 121.036 0.446 . . . . 40.44 110.663 177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -65.82 -39.68 91.1 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.852 -0.613 . . . . 73.35 110.307 -175.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -82.33 -21.53 35.97 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 112.967 0.729 . . . . 72.55 112.967 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.9 t -70.11 -24.11 63.15 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.651 -0.704 . . . . 72.24 109.324 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.4 m -62.25 -30.24 70.97 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 109.197 -0.668 . . . . 62.33 109.197 173.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 57.5 m -96.1 11.83 32.83 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.772 -0.649 . . . . 70.31 112.378 -178.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.96 -167.58 30.58 Favored Glycine 0 N--CA 1.464 0.526 0 C-N-CA 118.609 -1.758 . . . . 61.32 115.386 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 86' ' ' ALA . 7.4 m -104.32 115.06 29.72 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.212 -0.662 . . . . 70.33 109.212 -176.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.3 mt -91.11 131.8 37.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 112.537 0.569 . . . . 75.14 112.537 -176.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -95.64 -40.47 9.39 Favored 'General case' 0 C--O 1.204 -1.296 0 CA-C-N 115.26 -0.882 . . . . 54.23 111.915 176.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.57 ' NH2' HD12 ' A' ' 34' ' ' ILE . 73.2 mtm180 -155.86 161.16 40.64 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.763 -0.458 . . . . 75.11 109.763 -177.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.487 HD11 ' HB1' ' A' ' 50' ' ' ALA . 23.0 pt -146.51 141.42 20.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.1 -1.074 . . . . 71.41 108.1 174.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.9 m -126.23 129.24 48.56 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 106.478 -1.675 . . . . 72.12 106.478 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.6 mp -125.06 121.4 60.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 106.878 -1.527 . . . . 73.33 106.878 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -120.62 134.61 55.26 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 120.528 -0.469 . . . . 72.1 112.123 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 83.6 m -117.5 122.66 44.31 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.892 -0.781 . . . . 60.22 108.892 176.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.563 ' HA ' ' HG2' ' B' ' 65' ' ' ARG . 2.5 p30 -113.55 128.87 56.6 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 119.734 -0.786 . . . . 72.01 112.287 -178.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' B' ' 64' ' ' ASN . 38.4 mttm -95.8 4.05 53.22 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.73 -0.668 . . . . 73.12 111.516 175.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' B' ' 64' ' ' ASN . 45.5 m-85 -64.34 -6.25 6.68 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.38 0.881 . . . . 74.45 113.38 172.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.7 t -95.91 0.56 52.12 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.947 -0.76 . . . . 72.42 108.947 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.37 -48.78 3.63 Favored Glycine 0 CA--C 1.506 -0.521 0 N-CA-C 109.187 -1.565 . . . . 64.12 109.187 -175.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -96.96 147.94 33.66 Favored Pre-proline 0 C--N 1.291 -1.961 0 N-CA-C 105.916 -1.883 . . . . 73.24 105.916 173.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.83 118.32 5.02 Favored 'Trans proline' 0 N--CA 1.443 -1.474 0 C-N-CA 120.679 0.919 . . . . 64.24 110.448 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 30.1 mtmm -96.59 149.22 22.02 Favored 'General case' 0 CA--C 1.483 -1.597 0 C-N-CA 119.873 -0.731 . . . . 70.33 109.262 175.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 45' ' ' ASP . . . -128.9 135.13 8.32 Favored Glycine 0 N--CA 1.409 -3.105 0 C-N-CA 120.327 -0.94 . . . . 52.11 112.636 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . 0.349 1.3 p90 -150.8 144.77 25.28 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 124.382 1.073 . . . . 74.25 111.092 175.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.49 154.36 49.9 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.893 -0.594 . . . . 60.33 110.659 -171.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -120.36 124.49 45.66 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.325 -0.991 . . . . 74.24 108.325 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.434 ' HB ' HG22 ' A' ' 39' ' ' VAL . 27.2 mm -108.48 127.59 64.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.823 -1.177 . . . . 74.44 107.823 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -108.94 120.84 43.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.582 0.23 . . . . 63.44 111.039 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -98.89 162.88 12.85 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.98 0.419 . . . . 74.0 111.875 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' A' ' 62' ' ' SER . . . -76.79 -37.88 55.01 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.264 0.626 . . . . 64.21 111.747 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.434 ' HG2' ' OG ' ' A' ' 90' ' ' SER . 0.2 OUTLIER -113.47 138.5 50.02 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 112.509 0.559 . . . . 73.43 112.509 179.422 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.429 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -57.79 -34.31 69.49 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 123.623 0.769 . . . . 73.04 111.26 179.051 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -66.65 -21.14 66.11 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 116.019 -0.537 . . . . 70.03 112.239 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.434 ' OG ' ' HG2' ' A' ' 87' ' ' GLU . 71.4 m -69.15 -36.13 77.09 Favored 'General case' 0 N--CA 1.414 -2.241 0 C-N-CA 120.635 -0.426 . . . . 64.04 111.263 176.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 95' ' ' VAL . 3.0 m -64.69 -41.22 91.62 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.85 0 C-N-CA 119.239 -0.984 . . . . 72.13 108.56 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -61.99 -31.13 71.46 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 116.299 -0.41 . . . . 74.35 111.292 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.31 -39.81 62.64 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.172 -0.467 . . . . 71.32 111.225 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.83 -41.85 59.13 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-N 116.222 -0.445 . . . . 70.31 111.338 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 91' ' ' VAL . 22.6 m -56.21 -22.18 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 111.98 0.363 . . . . 62.55 111.98 177.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.78 -13.86 62.47 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.367 0.603 . . . . 55.3 111.067 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 47.4 mtm -99.36 9.76 42.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.568 -0.742 . . . . 51.25 109.79 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.588 ' HA ' HG22 ' A' ' 109' ' ' VAL . 2.9 p-10 -37.67 -45.59 0.8 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 114.456 1.28 . . . . 70.12 114.456 -177.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -114.67 97.4 6.25 Favored 'General case' 0 N--CA 1.424 -1.741 0 C-N-CA 120.033 -0.667 . . . . 62.34 110.033 174.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.8 p -142.64 165.71 26.65 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.02 -0.991 . . . . 63.51 110.775 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.3 p -104.53 119.68 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-O 121.636 0.731 . . . . 60.12 110.171 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -113.47 116.64 29.91 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.858 -1.164 . . . . 74.52 107.858 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.438 ' NH1' ' HA3' ' A' ' 47' ' ' GLY . 7.1 ptm180 43.09 32.08 0.41 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 126.548 1.939 . . . . 72.45 114.147 -177.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.19 -12.02 33.91 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.007 -0.997 . . . . 70.22 113.87 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.407 ' NH1' ' HB2' ' A' ' 45' ' ' ASP . 65.1 mtt180 -112.42 138.74 48.72 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 117.37 0.585 . . . . 62.43 109.933 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 39.2 m -79.18 120.19 23.33 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.766 -1.198 . . . . 74.14 107.766 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.41 ' HA ' ' HB3' ' A' ' 43' ' ' ASN . 42.2 pt -101.57 171.44 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 C-N-CA 120.464 -0.495 . . . . 74.53 110.723 -177.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 54.7 tptt -133.91 125.75 28.94 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 115.123 -0.944 . . . . 73.51 108.772 -177.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.588 HG22 ' HA ' ' A' ' 98' ' ' ASP . 27.7 m -128.82 132.49 67.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 O-C-N 123.238 0.336 . . . . 54.5 110.948 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.459 HD13 ' HB3' ' A' ' 40' ' ' TYR 0.25 0.0 OUTLIER -148.24 158.79 40.81 Favored Pre-proline 0 C--N 1.292 -1.929 0 N-CA-C 108.561 -0.903 . . . . 42.03 108.561 176.26 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 110' ' ' LEU . 91.8 Cg_endo -76.09 130.28 12.07 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 CA-C-N 120.45 1.196 . . . . 53.35 110.641 -176.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.406 ' NZ ' ' OD2' ' A' ' 35' ' ' ASP . 1.0 OUTLIER -84.5 110.36 18.62 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 104.874 -2.269 . . . . 74.24 104.874 179.27 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -93.97 135.92 34.8 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.373 -0.831 . . . . 72.21 112.5 -162.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.0 m -69.76 147.98 49.76 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.782 -1.099 . . . . 73.54 110.252 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.445 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 7.1 t30 -147.72 129.12 14.86 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.568 -0.901 . . . . 75.23 108.568 177.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 50.9 ttm -99.44 102.71 17.26 Favored Pre-proline 0 C--N 1.307 -1.266 0 N-CA-C 109.038 -0.726 . . . . 71.22 109.038 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 115' ' ' ASN . 2.7 Cg_exo -77.73 -16.38 14.72 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.524 2.149 . . . . 75.1 111.63 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.36 -117.13 3.44 Favored Glycine 0 N--CA 1.426 -1.991 0 N-CA-C 110.038 -1.225 . . . . 51.44 110.038 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 24.8 pt -101.34 106.0 18.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 121.69 0.757 . . . . 73.41 110.382 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.2 m -122.27 5.66 9.69 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.495 -0.775 . . . . 75.34 110.605 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 60.4 m 63.55 109.66 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.818 0.847 . . . . 64.21 111.346 -174.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 60.1 p -64.3 -47.84 77.95 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.7 0.762 . . . . 74.23 110.204 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -162.53 146.86 11.89 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.099 -1.815 . . . . 74.41 106.099 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 . . . . . 0 C--N 1.299 -1.61 0 C-N-CA 119.333 -0.947 . . . . 74.22 109.727 -179.16 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.671 0 N-CA-C 109.087 -0.708 . . . . 33.41 109.087 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.571 HD13 ' H ' ' B' ' 2' ' ' ILE . 0.2 OUTLIER -74.81 136.21 25.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 O-C-N 123.338 0.399 . . . . 61.24 110.816 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' B' ' 4' ' ' PRO . . . -113.08 144.32 30.9 Favored Pre-proline 0 C--N 1.306 -1.313 0 CA-C-N 115.962 -0.563 . . . . 44.14 109.55 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' B' ' 3' ' ' ALA . 24.4 Cg_exo -64.14 104.9 0.53 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.46 2.107 . . . . 71.03 111.32 177.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 79.3 m -148.38 177.44 9.44 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.788 -0.819 . . . . 75.44 108.788 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 66.2 mtt -92.58 152.38 19.63 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.98 -0.378 . . . . 62.31 109.98 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -83.74 136.31 34.22 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.961 -0.563 . . . . 72.43 109.68 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 9.2 t -95.43 142.27 27.99 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.779 -0.823 . . . . 71.25 108.779 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 27.9 m -69.5 100.54 1.43 Allowed 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 123.047 0.539 . . . . 71.43 110.169 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -135.91 -40.84 0.68 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.241 -0.436 . . . . 73.43 110.847 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 50.3 m 65.87 142.3 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.295 1.038 . . . . 70.5 112.6 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -76.08 108.07 8.74 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.603 -0.888 . . . . 73.42 108.603 177.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 13.0 tmm? -83.04 107.02 15.33 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.405 -0.961 . . . . 71.44 108.405 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 12.6 t -140.8 -173.28 3.66 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.702 -0.851 . . . . 75.43 108.702 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -128.89 169.47 14.57 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.54 0.21 . . . . 62.12 111.159 -176.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.87 -25.53 52.84 Favored Glycine 0 C--N 1.336 0.539 0 O-C-N 124.054 0.846 . . . . 60.12 114.093 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.62 -40.97 69.44 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.591 0.756 . . . . 52.44 112.572 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -80.11 -35.5 36.71 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.096 0.474 . . . . 73.01 111.219 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 22.0 p -77.03 -172.49 2.37 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 114.54 1.311 . . . . 73.53 114.54 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' GLU . . . . . 0.411 ' OE2' ' HA ' ' B' ' 25' ' ' PRO . 30.9 mt-10 -59.89 16.35 0.01 OUTLIER 'General case' 0 CA--C 1.594 2.655 0 C-N-CA 127.779 2.432 . . . . 72.31 116.94 -171.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.04 -126.81 20.98 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 114.363 0.505 . . . . 74.44 114.363 177.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -53.36 -52.66 8.15 Favored 'Trans proline' 0 CA--C 1.559 1.73 0 C-N-CA 123.609 2.873 . . . . 74.12 114.181 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.12 141.65 48.43 Favored 'Trans proline' 0 C--N 1.376 1.979 0 CA-C-N 120.813 1.326 . . . . 75.34 108.83 172.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -84.21 146.35 47.91 Favored Pre-proline 0 C--N 1.284 -2.276 0 C-N-CA 119.818 -0.753 . . . . 74.15 109.102 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.411 ' HA ' ' OE2' ' B' ' 20' ' ' GLU . 18.3 Cg_endo -60.69 131.08 35.93 Favored 'Trans proline' 0 N--CA 1.438 -1.777 0 C-N-CA 122.275 1.983 . . . . 72.21 111.71 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.747 HD13 ' H ' ' B' ' 26' ' ' LEU 0.25 0.0 OUTLIER -70.09 178.7 2.64 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.598 -0.728 . . . . 73.21 110.764 176.815 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 13.8 m -57.47 144.6 36.06 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 113.441 0.904 . . . . 74.21 113.441 -171.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.453 ' O ' ' HE2' ' B' ' 32' ' ' LYS . . . -56.5 -44.68 80.91 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.919 -1.037 . . . . 72.2 110.733 174.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -60.51 -45.91 92.05 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.638 -0.256 . . . . 72.01 111.082 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.464 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.5 OUTLIER -55.83 -35.32 66.26 Favored 'General case' 0 C--O 1.22 -0.485 0 O-C-N 123.276 0.36 . . . . 61.35 110.583 174.101 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' B' ' 26' ' ' LEU . 43.2 mttm -70.83 -35.47 72.48 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.757 -0.656 . . . . 74.21 112.399 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.59 ' O ' ' HB2' ' B' ' 36' ' ' LYS . 0.4 OUTLIER -69.76 -38.99 76.94 Favored 'General case' 0 C--O 1.211 -0.953 0 C-N-CA 119.651 -0.82 . . . . 74.13 111.35 174.791 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.539 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 5.9 mm-40 -64.8 -46.26 82.77 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.869 0.366 . . . . 72.12 111.06 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.464 HG12 ' O ' ' B' ' 30' ' ' GLU . 16.2 pt -70.72 -34.67 57.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.87 -0.605 . . . . 74.12 111.401 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -70.95 -35.12 72.05 Favored 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 108.69 -0.855 . . . . 75.1 108.69 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' B' ' 32' ' ' LYS . 31.8 ttmt -62.71 -31.34 72.24 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 124.987 1.315 . . . . 74.21 110.234 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' B' ' 33' ' ' GLU . 10.5 ptt180 -115.35 31.78 6.48 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.567 0.699 . . . . 74.35 112.004 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.446 ' OG ' ' HE3' ' B' ' 112' ' ' LYS . 25.4 t -100.9 163.07 12.47 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.307 -0.861 . . . . 74.22 109.945 174.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.524 ' HA ' ' H ' ' B' ' 112' ' ' LYS . 35.0 m -134.69 164.05 35.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 122.984 0.514 . . . . 42.52 110.732 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' TYR . . . . . 0.537 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 34.7 t80 -109.63 125.2 52.34 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.309 -0.997 . . . . 74.41 108.309 177.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.506 ' HA ' HG12 ' B' ' 109' ' ' VAL . 61.8 t -116.03 112.88 41.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 108.836 -0.801 . . . . 72.22 108.836 175.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.21 173.54 18.15 Favored Glycine 0 N--CA 1.426 -2.024 0 N-CA-C 110.822 -0.911 . . . . 63.54 110.822 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.465 ' HB3' ' HA ' ' B' ' 107' ' ' ILE . 25.7 t-20 80.96 -19.28 0.44 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.102 1.361 . . . . 54.52 113.022 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.403 HG21 HD11 ' B' ' 53' ' ' LEU . 7.5 p -55.39 117.8 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.833 0.825 . . . . 63.2 111.074 -177.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -69.98 153.57 43.06 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.874 -1.057 . . . . 75.22 113.104 -174.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' TYR . . . . . 0.401 ' CD2' ' HB2' ' B' ' 77' ' ' PRO . 60.6 t80 -49.46 -32.33 11.71 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 127.859 2.464 . . . . 74.12 110.817 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.31 0.26 71.39 Favored Glycine 0 N--CA 1.429 -1.796 0 CA-C-O 119.292 -0.727 . . . . 51.11 114.067 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 29.1 t -75.61 147.0 39.92 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 118.703 1.252 . . . . 72.34 109.877 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 36.8 p -98.52 157.56 16.15 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 116.002 -0.545 . . . . 74.32 112.228 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.52 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -72.6 -47.64 46.24 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.865 0.866 . . . . 71.13 112.274 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -34.49 72.31 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 119.523 -0.871 . . . . 73.01 112.533 -178.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -68.8 -39.12 80.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.109 -0.496 . . . . 75.21 110.343 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.403 HD11 HG21 ' B' ' 44' ' ' VAL . 55.7 mt -65.46 -47.7 75.24 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.657 -0.701 . . . . 73.32 111.29 176.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -49.11 78.29 Favored 'General case' 0 C--O 1.207 -1.168 0 CA-C-N 116.213 -0.448 . . . . 70.12 110.001 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.75 -40.71 80.32 Favored 'General case' 0 C--O 1.263 1.783 0 CA-C-O 122.015 0.912 . . . . 63.43 112.059 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -66.09 -40.61 90.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.608 -1.178 . . . . 73.55 109.854 -175.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -82.41 -21.84 35.61 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 112.833 0.679 . . . . 71.02 112.833 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 47.1 t -68.58 -24.59 64.62 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.4 -0.818 . . . . 70.4 110.226 -176.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 32.7 m -63.63 -20.44 65.68 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 120.06 -0.656 . . . . 71.25 110.963 174.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 58.6 m -106.02 17.23 23.91 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 111.852 0.316 . . . . 65.05 111.852 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.54 177.06 20.0 Favored Glycine 0 C--O 1.226 -0.353 0 C-N-CA 119.904 -1.141 . . . . 71.51 113.603 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 23.9 t -93.34 121.09 34.37 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.265 -1.013 . . . . 73.5 108.265 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 76.8 mt -87.53 133.84 29.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-O 121.413 0.625 . . . . 74.22 112.139 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 72' ' ' LYS . 9.4 m120 -97.4 -38.71 9.51 Favored 'General case' 0 C--O 1.206 -1.202 0 CA-C-N 115.173 -0.922 . . . . 55.04 112.676 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.563 ' HG2' ' HA ' ' A' ' 71' ' ' ASP . 71.7 mtm180 -157.39 161.74 39.01 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.12 -0.696 . . . . 72.5 109.12 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.52 HD11 ' HB1' ' B' ' 50' ' ' ALA . 24.1 pt -146.68 140.91 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 N-CA-C 107.875 -1.157 . . . . 65.34 107.875 175.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 68.8 m -126.32 127.97 46.39 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.922 -1.14 . . . . 75.43 107.922 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.421 HD12 ' N ' ' B' ' 68' ' ' ILE . 1.9 mp -124.5 121.43 61.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 106.599 -1.63 . . . . 72.05 106.599 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.36 135.33 55.1 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 120.458 -0.497 . . . . 71.34 111.289 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 73.1 m -116.9 121.76 42.38 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.192 -1.04 . . . . 74.4 108.192 176.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.687 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 3.4 p30 -111.7 128.38 56.06 Favored 'General case' 0 C--O 1.212 -0.88 0 C-N-CA 119.261 -0.976 . . . . 71.33 111.873 -177.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -121.97 5.11 9.88 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.81 -0.632 . . . . 73.5 109.646 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.446 ' CD1' ' HD3' ' A' ' 65' ' ' ARG . 28.3 p90 -59.28 -16.92 24.52 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 114.191 1.182 . . . . 71.03 114.191 -175.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 38.4 p -96.96 4.19 51.67 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 120.855 0.36 . . . . 71.24 111.407 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.25 -60.1 0.35 Allowed Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 111.581 -0.608 . . . . 75.33 111.581 -177.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -96.73 129.17 33.53 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 112.009 0.374 . . . . 72.1 112.009 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.687 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 91.9 Cg_endo -78.41 126.42 7.57 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.546 2.164 . . . . 71.43 113.933 -177.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' LYS . . . . . 0.528 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 32.9 mtmm -109.86 165.23 11.87 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 123.683 0.793 . . . . 73.43 109.753 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -134.11 135.68 8.15 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 119.925 -1.131 . . . . 71.02 113.808 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' TYR . . . . . 0.569 ' OH ' ' HG2' ' A' ' 24' ' ' GLN 0.436 0.4 OUTLIER -150.02 143.96 25.5 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 124.755 1.222 . . . . 72.44 112.083 173.853 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.94 154.89 50.32 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.086 -0.506 . . . . 50.03 110.504 -172.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' TYR . . . . . 0.599 ' OH ' ' HA ' ' A' ' 22' ' ' PRO . 29.5 m-85 -122.43 126.83 48.77 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.978 -1.119 . . . . 71.13 107.978 177.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.423 HG23 HG22 ' B' ' 66' ' ' ILE . 28.5 mm -109.66 127.41 66.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 107.594 -1.261 . . . . 73.12 107.594 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 84' ' ' GLU . . . . . 0.539 ' OE1' ' HB2' ' B' ' 65' ' ' ARG . 45.2 mt-10 -107.82 121.33 44.53 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 110.331 -0.248 . . . . 73.11 110.331 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -98.47 162.14 13.31 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.201 0.524 . . . . 74.42 112.018 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.18 -36.7 77.6 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.253 -0.885 . . . . 70.2 112.075 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.94 157.75 30.54 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.485 0.659 . . . . 75.41 111.341 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.69 -35.3 78.57 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 114.76 -1.109 . . . . 75.2 111.5 175.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -60.38 -32.15 71.03 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 123.525 0.516 . . . . 75.11 110.15 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 14.7 m -63.48 -37.06 85.87 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 116.4 -0.364 . . . . 74.21 111.212 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.596 ' O ' HG13 ' B' ' 95' ' ' VAL . 3.0 m -67.47 -40.21 84.04 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 C-N-CA 119.582 -0.847 . . . . 64.12 108.984 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -63.0 -30.89 71.95 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.961 0.41 . . . . 75.14 110.933 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.73 -40.25 63.69 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.22 -0.445 . . . . 74.01 110.546 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.97 -40.41 63.02 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-N 116.409 -0.359 . . . . 54.13 111.401 -177.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' VAL . . . . . 0.596 HG13 ' O ' ' B' ' 91' ' ' VAL . 16.6 m -58.24 -21.66 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 112.873 0.694 . . . . 63.1 112.873 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.91 -15.94 63.84 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.44 0.638 . . . . 45.13 109.759 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 34.0 mtp -94.68 6.26 49.43 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 123.954 0.902 . . . . 72.14 110.021 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 98' ' ' ASP . . . . . 0.548 ' HA ' HG22 ' B' ' 109' ' ' VAL . 2.0 p-10 -38.87 -46.65 1.32 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.455 1.28 . . . . 73.43 114.455 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -113.19 99.05 7.52 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 118.998 0.817 . . . . 71.44 109.931 171.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' B' ' 106' ' ' THR . 19.0 p -139.65 167.44 22.1 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.064 -0.971 . . . . 73.4 111.462 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 101' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' B' ' 105' ' ' ARG . 7.4 p -102.64 125.27 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 CA-C-O 121.671 0.748 . . . . 73.1 109.907 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 102' ' ' PHE . . . . . 0.4 ' HB3' HG23 ' B' ' 107' ' ' ILE . 74.2 t80 -135.44 120.4 18.65 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.941 -1.133 . . . . 73.34 107.941 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 56.41 32.61 20.94 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.554 1.142 . . . . 74.11 112.31 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.71 4.5 82.62 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 114.661 -1.154 . . . . 63.12 113.488 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' B' ' 101' ' ' VAL . 99.2 mtt180 -120.89 162.85 19.14 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 117.224 0.512 . . . . 71.01 109.929 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' B' ' 100' ' ' THR . 62.9 m -94.12 120.52 34.48 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.067 -1.086 . . . . 45.15 108.067 175.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 107' ' ' ILE . . . . . 0.465 ' HA ' ' HB3' ' B' ' 43' ' ' ASN . 40.8 pt -100.68 170.45 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.116 -1.034 . . . . 73.14 110.164 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 108' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 55.5 tptt -133.1 126.07 30.97 Favored 'General case' 0 N--CA 1.434 -1.227 0 O-C-N 123.728 0.643 . . . . 72.4 109.629 -177.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.548 HG22 ' HA ' ' B' ' 98' ' ' ASP . 27.3 m -128.85 138.36 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-N 116.429 -0.351 . . . . 72.43 111.423 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.72 ' HB3' ' HD2' ' B' ' 111' ' ' PRO 0.255 0.1 OUTLIER -140.01 169.68 11.46 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 105.61 -1.996 . . . . 74.5 105.61 174.636 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.72 ' HD2' ' HB3' ' B' ' 110' ' ' LEU . 89.6 Cg_endo -80.3 130.47 8.14 Favored 'Trans proline' 0 N--CA 1.425 -2.515 0 C-N-CA 121.412 1.408 . . . . 74.54 109.718 172.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.524 ' H ' ' HA ' ' B' ' 39' ' ' VAL . 15.0 ttpp -98.31 108.61 21.34 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 104.723 -2.325 . . . . 60.15 104.723 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -148.94 134.46 18.61 Favored 'General case' 0 CA--C 1.496 -1.097 0 C-N-CA 118.542 -1.263 . . . . 74.21 112.861 -166.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 36.6 p -111.17 85.13 2.06 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 106.954 -1.499 . . . . 73.34 106.954 164.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -73.15 95.53 2.09 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 114.896 -1.047 . . . . 61.01 110.914 -173.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 116' ' ' MET . . . . . 0.422 ' HA ' ' HD3' ' B' ' 117' ' ' PRO . 85.9 mtp -132.72 143.09 47.24 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 107.585 -1.265 . . . . 63.54 107.585 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 117' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' B' ' 116' ' ' MET . 12.8 Cg_exo -70.11 157.56 59.32 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 122.421 2.08 . . . . 60.24 112.369 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -103.21 161.34 16.36 Favored Glycine 0 N--CA 1.432 -1.616 0 N-CA-C 109.77 -1.332 . . . . 41.14 109.77 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 14.1 tt -88.2 83.91 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 CA-C-O 122.711 1.243 . . . . 71.13 111.348 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 37.7 m -135.91 128.48 30.64 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.921 -1.511 . . . . 53.21 106.921 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 61.1 p -68.73 107.27 2.95 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.976 0.417 . . . . 74.2 112.011 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 26.2 m -80.25 86.36 5.65 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.691 -1.226 . . . . 63.42 107.691 176.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -151.45 154.62 36.94 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.253 -1.017 . . . . 55.55 108.253 -174.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.301 -1.542 0 CA-C-O 119.451 -0.309 . . . . 73.05 111.592 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.462 0 CA-C-O 120.702 0.287 . . . . 63.11 110.996 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.503 ' O ' HD12 ' A' ' 2' ' ' ILE . 2.4 pp -102.05 136.71 32.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 120.852 0.358 . . . . 74.52 110.674 175.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . . . -119.82 124.77 27.75 Favored Pre-proline 0 C--N 1.297 -1.697 0 CA-C-N 116.525 -0.307 . . . . 61.23 110.338 -177.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 3' ' ' ALA . 11.4 Cg_exo -71.29 100.84 1.05 Allowed 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 122.077 1.851 . . . . 53.14 109.825 174.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 72.1 m -125.42 79.54 1.82 Allowed 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.702 -0.681 . . . . 74.54 110.223 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -91.42 -46.12 8.18 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.726 -1.213 . . . . 55.12 107.726 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 48.81 76.52 0.12 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.305 1.442 . . . . 54.3 113.426 176.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.1 m -128.36 85.23 2.31 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.738 0.78 . . . . 41.12 109.475 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.5 p -145.7 137.25 25.07 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.674 -1.148 . . . . 43.43 109.598 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -140.54 148.16 40.59 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.712 -0.477 . . . . 62.42 109.712 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.2 p -97.16 -49.11 5.1 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.027 0.442 . . . . 60.23 110.254 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt 65.51 -160.39 0.27 Allowed 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.232 -0.895 . . . . 64.05 110.847 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.505 ' HB2' ' HA ' ' B' ' 23' ' ' PRO . 0.0 OUTLIER -110.23 128.87 55.73 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 113.855 1.057 . . . . 75.15 113.855 -172.873 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 p -151.6 123.9 8.28 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.613 1.565 . . . . 62.14 109.337 173.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.404 ' N ' ' HB3' ' B' ' 23' ' ' PRO . . . -97.94 166.7 11.32 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 112.424 0.527 . . . . 73.12 112.424 -175.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.519 ' HA3' ' NH1' ' B' ' 65' ' ' ARG . . . -166.6 -44.26 0.02 OUTLIER Glycine 0 CA--C 1.532 1.111 0 C-N-CA 120.747 -0.74 . . . . 61.24 113.955 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.14 120.18 41.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 117.738 0.769 . . . . 71.25 112.401 -175.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -92.14 -31.23 15.57 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 116.109 -0.496 . . . . 74.14 112.056 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 t -109.12 -177.5 3.32 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 121.967 -0.458 . . . . 72.21 110.5 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -111.36 -13.19 13.95 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.485 -1.302 . . . . 52.5 107.485 174.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.615 ' HA3' ' OH ' ' B' ' 82' ' ' TYR . . . 86.33 -136.31 14.04 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.561 -1.199 . . . . 64.4 114.751 175.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.446 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 52.4 Cg_exo -55.75 -39.4 91.32 Favored 'Trans proline' 0 CA--C 1.564 1.976 0 C-N-CA 124.368 3.378 . . . . 73.33 116.481 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 22' ' ' PRO . 9.5 Cg_endo -53.82 130.89 41.4 Favored 'Trans proline' 0 C--N 1.394 2.957 0 CA-C-N 121.194 1.462 . . . . 72.32 111.1 176.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -62.81 129.84 93.38 Favored Pre-proline 0 C--N 1.316 -0.891 0 CA-C-N 116.001 -0.545 . . . . 63.35 111.884 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -72.14 120.64 6.93 Favored 'Trans proline' 0 N--CA 1.438 -1.749 0 C-N-CA 122.27 1.98 . . . . 63.45 111.365 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.733 HD13 ' H ' ' A' ' 26' ' ' LEU 0.28 0.0 OUTLIER -74.12 172.25 12.06 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.399 -0.819 . . . . 72.14 112.18 176.913 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.503 ' HB3' ' OE1' ' A' ' 30' ' ' GLU . 37.7 t -67.2 158.29 31.69 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.71 1.004 . . . . 72.23 113.71 -171.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.477 ' O ' ' HE2' ' A' ' 32' ' ' LYS . . . -54.14 -47.14 72.23 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 115.038 -0.983 . . . . 64.2 111.371 176.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -69.56 -30.25 68.0 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.338 0.496 . . . . 75.12 112.338 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.503 ' OE1' ' HB3' ' A' ' 27' ' ' SER . 1.4 mp0 -66.03 -38.9 89.59 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 120.326 -0.55 . . . . 74.43 109.883 170.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.479 ' HA ' HG12 ' A' ' 34' ' ' ILE . 58.3 mttm -68.98 -49.61 56.35 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 112.908 0.707 . . . . 75.41 112.908 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.587 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -58.95 -35.13 72.62 Favored 'General case' 0 C--O 1.215 -0.737 0 C-N-CA 120.092 -0.643 . . . . 75.25 112.132 -178.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.657 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 7.1 mm-40 -70.27 -49.86 45.52 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.93 -0.308 . . . . 75.34 111.067 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.479 HG12 ' HA ' ' A' ' 31' ' ' LYS . 34.0 pt -67.44 -34.99 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 112.413 0.523 . . . . 64.54 112.413 -176.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.575 ' HB2' ' HB ' ' A' ' 114' ' ' THR . 46.3 m-20 -59.52 -39.88 85.31 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.043 0.449 . . . . 64.14 110.014 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 97.1 mttt -76.18 -11.02 59.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.134 -0.939 . . . . 75.42 110.592 -177.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.657 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 61.1 mmt-85 -98.16 5.44 48.52 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 109.052 -0.721 . . . . 72.33 109.052 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.478 ' HB3' ' HE2' ' A' ' 112' ' ' LYS . 46.9 t -109.93 164.61 12.43 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 113.677 0.992 . . . . 71.11 113.677 -174.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.98 162.18 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 114.937 -1.029 . . . . 61.23 110.017 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.536 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 28.5 t80 -110.34 124.64 52.06 Favored 'General case' 0 C--N 1.29 -2.01 0 C-N-CA 124.826 1.25 . . . . 64.44 107.722 177.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.8 t -111.07 116.43 52.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 N-CA-C 108.08 -1.081 . . . . 64.51 108.08 178.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.86 166.61 12.78 Favored Glycine 0 N--CA 1.417 -2.582 0 C-N-CA 119.909 -1.139 . . . . 71.24 112.092 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.8 t30 67.99 18.11 9.52 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 125.732 1.613 . . . . 74.42 113.449 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.522 ' O ' ' HA3' ' A' ' 79' ' ' GLY . 7.1 p -73.95 116.67 16.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.941 -0.762 . . . . 75.01 108.941 175.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -94.98 168.18 10.94 Favored 'General case' 0 C--O 1.255 1.373 0 CA-C-O 121.226 0.536 . . . . 74.01 111.851 -172.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.661 ' CE1' ' HB2' ' A' ' 77' ' ' PRO . 4.5 m-85 -64.77 96.44 0.18 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.405 -1.27 . . . . 61.43 110.935 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.42 -26.32 0.3 Allowed Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 109.949 -1.261 . . . . 45.33 109.949 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.5 m -84.14 135.06 34.53 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.222 -1.029 . . . . 53.15 108.222 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.1 p -105.84 170.8 7.69 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 119.755 -0.164 . . . . 75.33 111.095 -176.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.481 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -64.2 -50.55 67.65 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 117.828 0.286 . . . . 71.52 111.105 -177.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.406 ' HG2' ' CE2' ' B' ' 46' ' ' TYR . 78.8 mt-30 -59.03 -38.87 80.28 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.465 0.543 . . . . 74.32 112.465 176.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -64.53 -37.62 88.2 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.779 0.799 . . . . 74.05 109.43 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.5 mt -72.68 -47.35 48.04 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.996 -1.002 . . . . 65.33 110.955 177.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -61.39 -49.39 77.08 Favored 'General case' 0 C--O 1.204 -1.308 0 C-N-CA 123.295 0.638 . . . . 34.3 110.855 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.07 -44.09 78.59 Favored 'General case' 0 C--O 1.256 1.443 0 CA-C-O 121.269 0.557 . . . . 71.24 111.042 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -64.58 -39.98 94.7 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.268 -0.878 . . . . 74.13 110.858 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -82.1 -22.43 36.24 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 113.266 0.839 . . . . 70.41 113.266 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.2 t -70.31 -23.88 62.93 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.781 -0.645 . . . . 73.11 109.3 -177.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.9 m -58.96 -27.76 65.66 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-O 121.266 0.555 . . . . 65.21 109.861 172.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 58.9 m -94.12 5.39 51.87 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.023 0.529 . . . . 55.23 112.161 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.33 -166.81 27.58 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.306 -1.426 . . . . 73.32 114.259 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.2 t -98.83 123.0 42.8 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 120.896 0.379 . . . . 52.44 110.548 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.8 mt -83.41 134.28 27.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-O 121.606 0.717 . . . . 50.53 112.58 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.652 ' OD1' ' HB3' ' B' ' 73' ' ' PHE . 34.2 t30 -98.07 -45.08 6.37 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.443 -1.253 . . . . 72.04 110.254 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' B' ' 71' ' ' ASP . 49.4 mtp180 -155.57 165.03 37.83 Favored 'General case' 0 C--O 1.213 -0.86 0 N-CA-C 107.873 -1.158 . . . . 71.13 107.873 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.481 HD11 ' HB1' ' A' ' 50' ' ' ALA . 19.2 pt -146.08 144.38 20.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.237 -1.024 . . . . 71.0 108.237 171.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.573 ' OG1' ' HB2' ' A' ' 82' ' ' TYR . 39.7 p -122.43 137.2 54.95 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 105.414 -2.069 . . . . 64.22 105.414 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.1 mp -129.26 112.54 25.46 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 105.705 -1.961 . . . . 73.43 105.705 173.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.457 ' HG ' ' CE2' ' A' ' 80' ' ' TYR 0.255 1.6 pt? -120.38 123.59 43.44 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 119.772 -0.771 . . . . 75.11 111.2 -179.228 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 73.4 m -117.83 136.47 53.4 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.204 -0.907 . . . . 44.41 109.592 -177.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.65 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 4.0 p30 -120.24 143.43 48.3 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 119.928 -0.709 . . . . 75.51 110.011 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -124.85 5.31 8.07 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.336 -0.616 . . . . 62.31 109.336 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.621 ' HB3' ' OD1' ' B' ' 64' ' ' ASN . 36.9 p90 -64.52 -25.68 68.09 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 112.198 0.444 . . . . 61.55 112.198 -176.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.9 t -80.97 -8.47 59.77 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.151 0.5 . . . . 74.1 110.67 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.98 -55.19 0.57 Allowed Glycine 0 CA--C 1.494 -1.225 0 N-CA-C 110.427 -1.069 . . . . 60.41 110.427 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -96.63 133.81 24.09 Favored Pre-proline 0 C--N 1.295 -1.795 0 N-CA-C 107.482 -1.303 . . . . 71.41 107.482 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.661 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 74.2 Cg_endo -76.78 117.27 4.46 Favored 'Trans proline' 0 N--CA 1.426 -2.492 0 C-N-CA 120.613 0.875 . . . . 63.42 111.134 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 29.5 mtmm -100.77 147.11 26.43 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 115.552 -0.749 . . . . 73.21 109.283 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 44' ' ' VAL . . . -122.38 137.01 11.11 Favored Glycine 0 N--CA 1.418 -2.558 0 C-N-CA 120.05 -1.071 . . . . 23.1 112.494 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.457 ' CE2' ' HG ' ' A' ' 69' ' ' LEU . 5.2 p90 -149.87 143.09 25.08 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 124.407 1.083 . . . . 71.23 109.338 176.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.32 153.95 45.43 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 116.509 -0.314 . . . . 72.15 111.825 -171.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.702 ' OH ' ' HA3' ' B' ' 21' ' ' GLY . 20.0 m-85 -116.78 125.1 51.11 Favored 'General case' 0 CA--C 1.461 -2.449 0 C-N-CA 122.864 0.466 . . . . 70.32 110.729 173.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.3 mm -103.69 110.7 30.83 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.536 0 N-CA-C 106.375 -1.713 . . . . 72.13 106.375 175.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.46 ' HG2' ' OG ' ' A' ' 38' ' ' SER . 29.2 mt-10 -96.88 121.08 38.36 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.325 -0.991 . . . . 63.42 108.325 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -99.43 170.98 8.24 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.218 0.533 . . . . 73.32 111.239 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.62 -41.01 22.09 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.474 -0.784 . . . . 73.34 110.637 173.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.405 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 40.7 mm-40 -101.81 146.99 27.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.06 0.457 . . . . 75.3 111.355 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.559 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.8 OUTLIER -74.71 -34.05 62.51 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.077 -1.453 . . . . 71.24 107.077 -179.304 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.286 0.9 OUTLIER -65.98 -20.06 66.07 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.156 -0.929 . . . . 72.13 113.212 177.425 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.405 ' OG ' ' HB2' ' A' ' 87' ' ' GLU . 22.6 m -66.27 -36.6 83.41 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 109.824 -0.436 . . . . 71.04 109.824 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 88' ' ' ARG . 3.6 m -66.26 -40.42 86.81 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 N-CA-C 108.629 -0.878 . . . . 65.34 108.629 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -55.54 -38.52 69.39 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.435 0.694 . . . . 65.03 110.529 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.71 -37.92 65.0 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.838 -0.619 . . . . 61.23 111.421 177.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.85 -39.91 55.7 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.188 0.44 . . . . 53.03 112.188 -176.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 91' ' ' VAL . 33.0 m -55.41 -22.06 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 113.068 0.766 . . . . 53.14 113.068 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.31 -9.63 42.89 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 120.991 0.424 . . . . 41.41 110.37 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.5 ' C ' ' H ' ' A' ' 99' ' ' GLU . 68.3 mtm -99.17 5.98 46.58 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.153 0.797 . . . . 75.35 113.153 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 109' ' ' VAL . 1.4 p-10 -67.57 24.07 0.02 OUTLIER 'General case' 0 N--CA 1.528 3.43 0 C-N-CA 123.641 0.776 . . . . 74.23 112.578 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.5 ' H ' ' C ' ' A' ' 97' ' ' MET . 39.6 tt0 -156.21 -7.81 0.11 Allowed 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.805 -1.089 . . . . 71.42 109.171 -168.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.4 p -88.03 169.2 12.17 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.517 -0.765 . . . . 73.01 111.625 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.7 p -106.46 132.44 53.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-N 115.401 -0.818 . . . . 61.23 109.814 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -127.14 123.68 37.33 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.561 -0.903 . . . . 75.41 108.561 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.3 ttt-85 54.52 33.01 17.98 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-O 122.975 1.369 . . . . 65.22 111.003 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.0 14.62 69.08 Favored Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 114.224 -1.353 . . . . 74.32 114.449 176.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -136.12 148.82 48.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 118.043 0.922 . . . . 61.31 110.64 174.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.5 m -79.15 121.64 25.26 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.768 -0.827 . . . . 33.32 108.768 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 37.4 pt -102.32 172.13 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.18 0.514 . . . . 72.31 111.287 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.409 ' HE3' ' HB3' ' A' ' 110' ' ' LEU . 55.1 tptt -124.89 127.28 46.87 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.228 -1.027 . . . . 63.51 108.228 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 23.8 t -126.79 115.95 43.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 107.746 -1.205 . . . . 75.34 107.746 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.477 HD13 ' HB3' ' A' ' 40' ' ' TYR 0.283 0.0 OUTLIER -138.38 141.39 31.38 Favored Pre-proline 0 C--N 1.311 -1.073 0 C-N-CA 119.536 -0.865 . . . . 72.32 109.112 -179.533 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.01 140.0 44.32 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 122.326 2.017 . . . . 63.1 114.153 -171.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.581 ' HD2' ' HB ' ' B' ' 19' ' ' THR . 32.8 ttpt -84.81 136.94 33.46 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 109.109 -0.7 . . . . 72.25 109.109 177.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -113.38 164.54 13.45 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.411 -0.959 . . . . 63.24 108.411 175.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.575 ' HB ' ' HB2' ' A' ' 35' ' ' ASP . 13.2 t -104.2 110.95 23.35 Favored 'General case' 0 N--CA 1.404 -2.727 0 N-CA-C 106.871 -1.529 . . . . 75.43 106.871 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -77.55 87.02 3.88 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.993 0.902 . . . . 62.45 111.193 -173.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.478 ' H ' ' CD ' ' A' ' 117' ' ' PRO . 0.2 OUTLIER -123.01 -49.61 0.04 OUTLIER Pre-proline 0 C--N 1.303 -1.423 0 CA-C-N 113.773 -1.558 . . . . 73.03 110.002 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.478 ' CD ' ' H ' ' A' ' 116' ' ' MET . 2.9 Cg_endo -89.77 31.27 0.38 Allowed 'Trans proline' 0 C--N 1.388 2.637 0 C-N-CA 122.361 2.041 . . . . 64.13 110.954 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -92.55 38.21 3.22 Favored Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 115.815 -0.63 . . . . 73.35 112.172 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 mp 63.42 99.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 124.379 1.072 . . . . 60.33 112.314 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.9 m -88.66 -25.8 22.19 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.656 -0.702 . . . . 64.1 109.956 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 53.1 m 65.94 -178.23 0.19 Allowed 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.184 0.994 . . . . 65.55 111.89 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.5 p -95.49 103.7 15.58 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 121.091 0.472 . . . . 72.22 110.504 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -80.01 107.84 13.11 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 108.884 -0.784 . . . . 74.14 108.884 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 . . . . . 0 C--N 1.302 -1.479 0 N-CA-C 109.448 -0.575 . . . . 73.13 109.448 -178.101 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.454 0 CA-C-O 120.978 0.418 . . . . 74.34 110.367 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 50.3 mm -117.5 110.97 32.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 108.678 -0.86 . . . . 74.44 108.678 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -126.92 94.53 39.36 Favored Pre-proline 0 C--N 1.312 -1.042 0 CA-C-O 120.959 0.409 . . . . 22.34 111.161 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -94.83 -163.8 0.1 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 123.061 2.507 . . . . 74.2 110.111 176.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 42.0 t -76.51 108.43 9.48 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.225 -1.028 . . . . 62.32 108.225 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 66.3 mtt -81.34 93.06 6.49 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.791 -0.641 . . . . 74.13 111.722 -174.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -111.19 -6.51 14.56 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.49 -0.777 . . . . 63.43 109.459 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 26.3 m -87.86 94.13 9.67 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.298 -0.865 . . . . 72.13 109.301 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 51.6 m -151.7 139.28 19.64 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.035 -0.728 . . . . 63.33 109.035 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -105.85 101.76 11.25 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.592 0.71 . . . . 73.3 110.244 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 21.8 p -80.94 162.56 23.83 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.753 -1.112 . . . . 64.15 110.94 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' LYS . . . . . 0.465 ' N ' ' HD2' ' B' ' 12' ' ' LYS . 11.0 mptt -104.17 88.66 3.05 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.139 -0.482 . . . . 74.13 110.012 -177.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 65.7 mtt -90.56 140.37 29.82 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.801 -0.636 . . . . 72.2 109.785 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 84.9 m 75.51 -29.02 0.18 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.643 0.777 . . . . 73.3 111.379 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -78.71 -61.45 2.01 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 109.104 -0.702 . . . . 72.32 109.104 175.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.43 -173.11 23.68 Favored Glycine 0 N--CA 1.433 -1.552 0 C-N-CA 120.838 -0.696 . . . . 62.5 112.705 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.65 -154.65 0.48 Allowed 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.583 -0.895 . . . . 63.53 108.583 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -91.81 -3.16 56.44 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.758 -0.83 . . . . 70.31 108.758 174.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.581 ' HB ' ' HD2' ' A' ' 112' ' ' LYS . 28.8 m 60.54 101.56 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.788 1.235 . . . . 75.32 113.994 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -69.74 -13.44 62.29 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 121.135 -0.226 . . . . 64.3 110.648 174.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.702 ' HA3' ' OH ' ' A' ' 82' ' ' TYR . . . 94.08 -124.6 7.94 Favored Glycine 0 C--N 1.344 1.009 0 N-CA-C 115.093 0.797 . . . . 54.42 115.093 170.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.65 -35.98 97.8 Favored 'Trans proline' 0 CA--C 1.558 1.724 0 C-N-CA 123.492 2.795 . . . . 71.25 114.762 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.505 ' HA ' ' HB2' ' A' ' 13' ' ' MET . 58.6 Cg_exo -47.52 123.57 8.26 Favored 'Trans proline' 0 C--N 1.4 3.27 0 C-N-CA 122.073 1.849 . . . . 75.41 113.041 174.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -91.03 141.52 26.56 Favored Pre-proline 0 C--N 1.294 -1.841 0 CA-C-N 114.56 -1.2 . . . . 63.14 108.874 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -49.3 117.73 3.1 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.998 2.465 . . . . 63.41 113.515 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 7.2 mp -58.04 -176.04 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.191 0 CA-C-N 113.98 -1.464 . . . . 70.32 110.453 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 20.3 m -66.58 142.93 57.32 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 107.254 -1.387 . . . . 63.01 107.254 171.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.501 ' O ' ' HE2' ' B' ' 32' ' ' LYS . . . -56.02 -42.84 77.07 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.577 -0.738 . . . . 65.11 110.68 176.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -68.4 -30.84 69.85 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 112.812 0.671 . . . . 74.41 112.812 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.75 -39.74 91.38 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.636 -0.505 . . . . 62.3 109.636 171.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.483 ' HA ' HG12 ' B' ' 34' ' ' ILE . 57.3 mttm -70.19 -49.98 44.83 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 113.162 0.801 . . . . 53.23 113.162 -178.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.559 ' N ' ' HE2' ' B' ' 32' ' ' LYS . 0.3 OUTLIER -56.09 -39.15 71.7 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 120.146 -0.622 . . . . 75.21 112.639 -178.648 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 17.9 mt-10 -71.85 -41.61 67.91 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 118.945 -1.102 . . . . 74.23 112.629 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.483 HG12 ' HA ' ' B' ' 31' ' ' LYS . 35.1 pt -68.88 -35.46 69.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 C-N-CA 120.213 -0.595 . . . . 73.34 111.351 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -59.85 -44.08 94.31 Favored 'General case' 0 C--O 1.217 -0.625 0 N-CA-C 109.674 -0.491 . . . . 72.14 109.674 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 98.4 mttt -70.33 -18.22 63.08 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.269 -0.878 . . . . 65.24 112.298 -175.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' B' ' 33' ' ' GLU . 18.8 ptp180 -109.8 24.93 12.38 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-O 121.443 0.64 . . . . 71.04 111.383 -178.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.511 ' HB2' ' HD3' ' B' ' 112' ' ' LYS . 19.5 m -115.51 172.69 6.95 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.656 -0.702 . . . . 53.54 110.997 174.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.4 163.66 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 123.19 0.596 . . . . 74.25 110.573 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 36.0 t80 -111.97 125.61 54.25 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 125.596 1.559 . . . . 61.4 107.94 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 57.9 t -114.66 116.31 52.2 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 C-N-CA 123.651 0.78 . . . . 74.22 109.191 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.98 165.39 12.52 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 120.716 -0.754 . . . . 61.12 112.406 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 t30 57.81 20.43 6.53 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 126.241 1.816 . . . . 72.34 113.26 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.72 129.0 19.08 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 CA-C-O 121.396 0.617 . . . . 71.24 109.389 173.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.487 ' HA ' ' CZ ' ' B' ' 105' ' ' ARG . 20.8 t70 -61.35 139.23 58.22 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 114.674 -1.148 . . . . 52.43 109.274 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' TYR . . . . . 0.406 ' CE2' ' HG2' ' A' ' 51' ' ' GLN . 32.6 t80 -70.32 0.15 7.01 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.714 -0.676 . . . . 74.23 111.072 -174.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -107.6 -0.23 34.61 Favored Glycine 0 N--CA 1.421 -2.304 0 CA-C-N 115.799 -0.637 . . . . 71.23 112.148 175.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.9 t -80.51 146.27 31.42 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.599 -1.26 . . . . 63.1 107.599 176.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 71.7 p -105.52 172.58 6.72 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.982 -0.377 . . . . 73.03 109.982 -177.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.48 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -63.72 -50.4 69.29 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 120.57 0.224 . . . . 71.21 110.539 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -61.03 -35.99 78.36 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 111.838 0.311 . . . . 75.21 111.838 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -64.17 -43.65 94.49 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 109.61 -0.515 . . . . 65.21 109.61 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 52.0 mt -67.67 -48.14 67.48 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.208 -0.905 . . . . 73.14 112.042 176.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.32 -49.16 78.71 Favored 'General case' 0 C--O 1.207 -1.132 0 C-N-CA 123.387 0.675 . . . . 63.02 110.809 -177.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.28 -43.25 78.62 Favored 'General case' 0 C--O 1.262 1.718 0 CA-C-O 121.215 0.531 . . . . 55.31 111.123 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -65.77 -39.25 90.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.479 -0.782 . . . . 74.22 110.718 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -82.45 -22.55 35.19 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 113.432 0.901 . . . . 75.15 113.432 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 36.1 t -69.23 -25.16 64.17 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.958 -0.565 . . . . 72.24 109.766 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.9 m -62.9 -24.97 68.09 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 120.387 -0.525 . . . . 74.31 110.511 173.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 58.4 m -96.55 3.73 52.46 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 122.744 0.418 . . . . 51.32 112.061 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.13 -171.72 32.73 Favored Glycine 0 C--O 1.222 -0.634 0 C-N-CA 119.281 -1.438 . . . . 65.41 114.456 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 21.7 m -98.86 119.38 37.52 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.707 -0.479 . . . . 51.41 109.707 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 50.8 mt -82.52 132.74 30.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 112.997 0.74 . . . . 70.35 112.997 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' ASN . . . . . 0.621 ' OD1' ' HB3' ' A' ' 73' ' ' PHE . 46.1 t-20 -93.79 -51.29 4.97 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 125.315 1.446 . . . . 73.04 109.225 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.519 ' NH1' ' HA3' ' A' ' 16' ' ' GLY . 46.5 mtp180 -153.14 166.75 31.53 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.547 -1.279 . . . . 43.33 107.547 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.48 HD11 ' HB1' ' B' ' 50' ' ' ALA . 19.9 pt -147.13 144.28 19.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 108.059 -1.089 . . . . 75.32 108.059 171.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' THR . . . . . 0.577 ' OG1' ' HB2' ' B' ' 82' ' ' TYR . 36.9 p -121.71 136.88 54.93 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 105.387 -2.079 . . . . 55.1 105.387 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.2 mp -129.25 113.08 26.93 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 N-CA-C 105.561 -2.014 . . . . 74.4 105.561 173.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.498 ' HG ' ' CE2' ' B' ' 80' ' ' TYR 0.274 1.5 pt? -120.72 123.03 41.72 Favored 'General case' 0 C--N 1.281 -2.387 0 C-N-CA 119.987 -0.685 . . . . 72.31 111.486 -179.497 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 70' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 67.0 m -117.6 134.82 54.47 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.621 -0.718 . . . . 75.01 109.631 -177.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 3.5 p30 -115.11 140.38 49.11 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.878 -0.729 . . . . 74.44 109.871 177.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.451 ' HG2' ' HB3' ' B' ' 77' ' ' PRO . 7.6 mtpm? -112.5 7.67 19.06 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 116.126 -0.488 . . . . 73.35 110.365 -178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.652 ' HB3' ' OD1' ' A' ' 64' ' ' ASN . 12.5 p90 -73.08 -11.2 60.46 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 121.524 0.678 . . . . 73.43 110.585 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 20.7 m -88.13 9.48 22.59 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.117 -0.947 . . . . 61.25 110.09 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.95 -51.0 4.39 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 109.607 -1.397 . . . . 72.44 109.607 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -96.43 145.53 29.74 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 105.806 -1.924 . . . . 72.32 105.806 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.451 ' HB3' ' HG2' ' B' ' 72' ' ' LYS . 58.2 Cg_endo -77.43 118.1 4.52 Favored 'Trans proline' 0 N--CA 1.437 -1.81 0 C-N-CA 120.767 0.978 . . . . 65.42 110.623 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 78' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 28.8 mtmm -93.71 137.49 32.91 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 108.13 -1.063 . . . . 50.44 108.13 177.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -116.17 133.33 10.73 Favored Glycine 0 N--CA 1.413 -2.887 0 C-N-CA 119.974 -1.108 . . . . 62.0 111.773 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' TYR . . . . . 0.498 ' CE2' ' HG ' ' B' ' 69' ' ' LEU . 6.8 p90 -147.74 142.73 26.97 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 124.04 0.936 . . . . 75.13 109.42 175.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.08 154.37 45.91 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 116.397 -0.365 . . . . 74.23 111.728 -172.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' TYR . . . . . 0.615 ' OH ' ' HA3' ' A' ' 21' ' ' GLY . 19.4 m-85 -117.25 124.96 50.31 Favored 'General case' 0 CA--C 1.467 -2.23 0 C-N-CA 122.78 0.432 . . . . 72.2 110.442 173.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 34.5 mm -102.75 110.11 28.5 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 106.635 -1.617 . . . . 74.04 106.635 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' GLU . . . . . 0.444 ' OE1' ' HD3' ' B' ' 65' ' ' ARG . 31.2 mt-10 -95.3 120.61 35.83 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.417 -0.957 . . . . 54.43 108.417 -178.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.418 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 98.0 m-85 -99.09 162.2 13.2 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.413 0.625 . . . . 65.43 111.111 -177.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.32 -11.37 56.48 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.509 -0.769 . . . . 65.2 109.983 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' GLU . . . . . 0.605 ' HB3' ' OG ' ' B' ' 90' ' ' SER . 43.2 tt0 -124.23 140.6 52.8 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.309 -0.405 . . . . 54.11 111.094 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.507 ' O ' HG22 ' B' ' 91' ' ' VAL . 0.6 OUTLIER -74.99 -34.91 62.02 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.64 -1.244 . . . . 74.03 107.64 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 89' ' ' ASN . . . . . 0.42 ' H ' ' HG2' ' B' ' 87' ' ' GLU . 0.6 OUTLIER -62.13 -28.38 69.6 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.512 -0.921 . . . . 75.42 108.512 -179.742 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 90' ' ' SER . . . . . 0.605 ' OG ' ' HB3' ' B' ' 87' ' ' GLU . 70.2 m -63.46 -36.34 83.43 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 116.19 -0.459 . . . . 71.24 111.025 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.507 HG22 ' O ' ' B' ' 88' ' ' ARG . 3.6 m -67.18 -40.13 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.519 0 N-CA-C 108.551 -0.907 . . . . 61.13 108.551 179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -56.96 -37.68 71.9 Favored 'General case' 0 N--CA 1.455 -0.225 0 O-C-N 123.828 0.705 . . . . 75.05 110.9 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.9 -37.18 64.76 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.753 -0.658 . . . . 61.33 111.48 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.83 -41.15 53.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.506 . . . . 73.51 111.87 -176.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 95' ' ' VAL . . . . . 0.493 HG13 ' O ' ' B' ' 91' ' ' VAL . 32.8 m -55.23 -21.46 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 112.905 0.705 . . . . 72.3 112.905 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.07 -13.77 62.25 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.805 0.812 . . . . 72.24 111.14 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 68.2 mtm -97.2 9.69 41.5 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.418 -0.81 . . . . 72.43 110.011 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' ASP . . . . . 0.709 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 6.1 p-10 -36.27 -46.81 0.55 Allowed 'General case' 0 C--O 1.204 -1.31 0 N-CA-C 115.694 1.739 . . . . 63.21 115.694 -176.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -128.47 41.89 3.41 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 118.585 -1.246 . . . . 73.3 110.792 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 40.8 p -79.62 176.87 9.32 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.88 -0.6 . . . . 74.4 110.794 175.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.04 132.96 55.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.139 0.495 . . . . 74.12 109.876 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -140.49 125.82 18.78 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.482 -0.781 . . . . 74.41 109.004 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . 0.263 20.7 ttt180 50.49 54.78 10.56 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 122.295 1.045 . . . . 74.35 113.747 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.89 -7.5 42.38 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 114.341 -1.3 . . . . 12.14 115.568 176.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.487 ' CZ ' ' HA ' ' B' ' 45' ' ' ASP . 10.2 ptt180 -136.7 159.89 40.48 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 114.35 1.241 . . . . 74.4 114.35 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 34.5 m -87.12 120.93 28.91 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.169 -0.923 . . . . 61.54 109.931 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 39.5 pt -101.78 172.01 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 116.204 -0.453 . . . . 73.32 110.413 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' LYS . . . . . 0.709 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 56.1 tptt -125.84 129.39 49.29 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.828 -0.804 . . . . 71.02 108.828 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 18.0 t -124.54 121.58 61.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 107.653 -1.24 . . . . 64.44 107.653 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.295 0.4 OUTLIER -140.09 135.05 16.02 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 106.25 -1.759 . . . . 73.21 106.25 -170.597 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.33 143.53 53.2 Favored 'Trans proline' 0 CA--C 1.551 1.363 0 C-N-CA 121.885 1.723 . . . . 71.31 113.93 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.511 ' HD3' ' HB2' ' B' ' 38' ' ' SER . 66.0 tttt -91.08 148.53 22.32 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 123.54 0.736 . . . . 70.22 110.436 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -158.4 135.83 10.18 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 105.061 -2.2 . . . . 54.32 105.061 168.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 62.1 m -147.29 110.2 4.73 Favored 'General case' 0 N--CA 1.421 -1.902 0 C-N-CA 119.085 -1.046 . . . . 54.12 113.177 -172.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 115' ' ' ASN . . . . . 0.441 ' O ' ' HD3' ' B' ' 117' ' ' PRO . 2.7 t-20 60.05 111.96 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 115.669 1.729 . . . . 74.2 115.669 168.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -107.34 96.14 15.19 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 108.188 -1.042 . . . . 70.21 108.188 171.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 117' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' B' ' 115' ' ' ASN . 13.4 Cg_exo -69.95 -174.8 1.02 Allowed 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 122.853 2.368 . . . . 62.31 112.205 -177.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.63 105.5 1.74 Allowed Glycine 0 N--CA 1.427 -1.958 0 C-N-CA 120.94 -0.647 . . . . 63.12 111.505 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 66.0 mt -64.11 -43.35 97.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.481 -0.933 . . . . 63.25 108.481 177.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 32.4 t -149.93 115.37 5.5 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 115.11 -0.95 . . . . 71.1 109.233 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 32.4 t -83.94 -43.04 15.65 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.406 -1.331 . . . . 70.33 107.406 177.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 10.2 t -156.72 132.04 9.24 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 107.87 -1.159 . . . . 72.45 107.87 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -78.65 -37.11 42.83 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 108.485 -0.931 . . . . 75.51 108.485 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 . . . . . 0 N--CA 1.423 -1.803 0 CA-C-N 114.637 -1.165 . . . . 62.44 109.061 175.001 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.55 0 N-CA-C 109.82 -0.437 . . . . 64.22 109.82 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.5 mm -99.59 118.96 46.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.516 -0.55 . . . . 74.43 109.516 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.08 89.2 6.09 Favored Pre-proline 0 C--N 1.308 -1.237 0 CA-C-N 116.188 -0.46 . . . . 73.24 110.037 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -85.4 12.47 3.05 Favored 'Trans proline' 0 C--O 1.242 0.679 0 C-N-CA 123.354 2.702 . . . . 74.44 112.114 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.2 t 68.75 90.57 0.09 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.277 1.431 . . . . 63.44 113.255 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -124.33 129.52 50.87 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.094 -1.076 . . . . 72.34 108.094 173.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -79.27 93.82 5.34 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.998 -1.112 . . . . 74.24 107.998 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.9 p -78.56 4.34 13.67 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 113.735 1.013 . . . . 61.25 113.735 -173.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.5 t -76.51 126.77 31.58 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 106.857 -1.535 . . . . 55.54 106.857 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -135.28 116.82 14.8 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 116.216 -0.447 . . . . 72.31 110.891 -171.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.7 t -95.62 -90.89 0.23 Allowed 'General case' 0 N--CA 1.403 -2.797 0 N-CA-C 107.026 -1.472 . . . . 72.11 107.026 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.519 ' HD2' ' SD ' ' A' ' 13' ' ' MET . 0.3 OUTLIER 43.74 89.68 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 124.759 1.223 . . . . 74.11 109.073 177.502 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.519 ' SD ' ' HD2' ' A' ' 12' ' ' LYS . 1.2 mpt? 82.05 75.61 0.03 OUTLIER 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 124.907 1.283 . . . . 74.44 108.211 -163.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.4 m -71.9 -30.67 65.62 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 113.921 -1.491 . . . . 70.32 110.739 -176.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 69.23 129.16 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 124.713 1.205 . . . . 60.43 112.304 -178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 169.51 153.4 8.47 Favored Glycine 0 N--CA 1.41 -3.048 0 N-CA-C 109.346 -1.502 . . . . 72.33 109.346 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.17 -74.79 0.08 Allowed 'General case' 0 C--N 1.308 -1.213 0 O-C-N 123.845 0.38 . . . . 43.11 110.716 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.563 ' OH ' ' HA ' ' B' ' 114' ' ' THR . 78.9 t80 -170.6 110.18 0.36 Allowed 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 113.313 0.857 . . . . 72.34 113.313 177.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.426 ' OG1' ' HA ' ' A' ' 25' ' ' PRO . 53.9 m -170.16 120.03 0.61 Allowed 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 106.079 -1.823 . . . . 72.13 106.079 170.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 59.76 26.71 15.89 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 122.367 1.08 . . . . 74.2 109.711 -176.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.39 -118.34 4.77 Favored Glycine 0 N--CA 1.432 -1.613 0 CA-C-N 113.449 -1.705 . . . . 60.13 111.357 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.98 -26.95 50.8 Favored 'Trans proline' 0 CA--C 1.597 3.626 0 C-N-CA 124.178 3.252 . . . . 65.45 118.752 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.56 167.64 7.88 Favored 'Trans proline' 0 C--N 1.389 2.7 0 C-N-CA 122.516 2.144 . . . . 71.21 114.48 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -62.5 139.99 96.7 Favored Pre-proline 0 C--O 1.238 0.461 0 CA-C-N 115.731 -0.668 . . . . 74.21 110.914 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.426 ' HA ' ' OG1' ' A' ' 19' ' ' THR . 94.3 Cg_endo -80.02 132.33 9.42 Favored 'Trans proline' 0 N--CA 1.437 -1.845 0 C-N-CA 122.158 1.905 . . . . 65.44 112.973 -179.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.46 HD23 ' HB2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -137.31 142.72 41.89 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 114.766 -1.107 . . . . 74.52 108.178 174.275 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.3 t -67.86 155.26 39.77 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 123.317 0.386 . . . . 65.11 111.502 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.674 ' O ' ' HG2' ' A' ' 32' ' ' LYS . . . -49.34 -33.08 12.53 Favored 'General case' 0 C--O 1.188 -2.166 0 CA-C-N 115.641 -0.709 . . . . 44.52 110.748 172.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -66.57 -33.77 76.41 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.819 0.674 . . . . 74.12 112.819 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.506 ' O ' HG12 ' A' ' 34' ' ' ILE . 1.5 mp0 -67.27 -35.9 80.47 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 108.782 -0.822 . . . . 62.31 108.782 171.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 28' ' ' ALA . 55.8 mmtt -63.67 -45.23 91.05 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-N 114.766 -1.106 . . . . 61.51 108.543 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.725 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 30.5 mmmt -56.42 -47.16 79.63 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 116.204 -0.453 . . . . 74.5 110.628 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -67.18 -46.32 74.31 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.306 -0.406 . . . . 72.32 111.513 -174.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 30' ' ' GLU . 15.3 pt -71.09 -36.74 64.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.966 -0.561 . . . . 63.42 111.904 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.5 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 29.9 m-20 -76.17 -19.14 58.73 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.712 0.634 . . . . 75.04 112.712 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.725 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 97.3 mttt -66.96 -26.42 66.81 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.361 0.6 . . . . 70.34 110.339 174.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -96.89 16.03 20.51 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.153 -0.684 . . . . 72.01 109.153 -177.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.522 ' OG ' ' HG3' ' A' ' 84' ' ' GLU . 14.9 m -103.5 163.01 12.56 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 115.542 -0.754 . . . . 62.44 110.48 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 111' ' ' PRO . 27.2 m -131.64 164.16 35.29 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 115.469 -0.787 . . . . 73.34 109.883 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 23.7 t80 -110.87 126.03 54.25 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 107.44 -1.318 . . . . 73.11 107.44 175.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.0 t -115.89 111.99 37.8 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 N-CA-C 107.753 -1.203 . . . . 53.1 107.753 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.6 172.03 18.89 Favored Glycine 0 CA--C 1.478 -2.256 0 N-CA-C 109.706 -1.358 . . . . 32.44 109.706 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.687 ' OD1' ' HG3' ' A' ' 105' ' ' ARG . 26.2 t-20 69.42 -11.05 0.51 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.356 0.662 . . . . 64.15 112.395 -178.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.7 p -70.19 91.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 107.372 -1.344 . . . . 71.31 107.372 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.38 10.5 m-20 -74.43 168.02 20.53 Favored 'General case' 0 CA--C 1.457 -2.618 0 N-CA-C 116.341 1.978 . . . . 61.15 116.341 -166.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -39.33 -34.49 0.2 Allowed 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 128.231 2.612 . . . . 73.3 114.791 -173.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.66 -1.53 85.37 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.435 -0.888 . . . . 74.32 114.075 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.454 ' HA ' ' CZ ' ' A' ' 103' ' ' ARG . 19.7 m -75.26 133.33 41.37 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 117.677 0.738 . . . . 63.34 111.041 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.612 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 12.6 p -92.22 155.89 17.68 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 115.583 -0.735 . . . . 74.13 111.046 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.581 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -65.54 -47.82 74.58 Favored 'General case' 0 C--O 1.212 -0.904 0 C-N-CA 122.641 0.376 . . . . 71.42 110.831 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -56.81 -53.43 57.89 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.519 0.728 . . . . 63.01 112.529 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.61 -36.75 83.75 Favored 'General case' 0 C--O 1.25 1.128 0 CA-C-O 121.397 0.617 . . . . 55.51 111.348 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' A' ' 49' ' ' THR . 2.9 tt -72.17 -46.56 55.86 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.78 -1.1 . . . . 74.32 108.493 -176.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -58.26 -48.3 80.86 Favored 'General case' 0 C--O 1.207 -1.158 0 C-N-CA 123.482 0.713 . . . . 74.12 111.039 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.92 -38.23 69.99 Favored 'General case' 0 C--O 1.258 1.551 0 CA-C-O 121.268 0.556 . . . . 45.54 110.752 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -65.39 -40.3 93.27 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.117 -0.947 . . . . 75.04 110.189 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -83.04 -21.33 33.83 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 113.751 1.019 . . . . 74.21 113.751 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.8 t -60.47 -33.69 72.94 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.988 -0.745 . . . . 72.55 108.988 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.9 m -59.04 -27.8 65.82 Favored 'General case' 0 CA--C 1.565 1.536 0 CA-C-N 115.789 -0.641 . . . . 63.01 111.807 174.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 67.5 m -92.0 -0.85 57.48 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.36 0.874 . . . . 73.03 113.36 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.69 -169.96 30.53 Favored Glycine 0 C--N 1.319 -0.399 0 C-N-CA 118.951 -1.595 . . . . 74.1 114.562 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.4 m -94.56 116.78 29.19 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 123.205 0.602 . . . . 71.01 110.479 -175.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 85.1 mt -89.23 130.1 39.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 C-N-CA 123.015 0.526 . . . . 74.15 112.368 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.47 HD21 ' HB2' ' A' ' 86' ' ' ALA . 11.7 m120 -99.34 -40.41 7.92 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.686 -0.688 . . . . 71.43 111.106 177.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' B' ' 71' ' ' ASP . 55.6 mtp180 -150.55 160.9 43.47 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 107.91 -1.145 . . . . 73.31 107.91 -177.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.581 HD11 ' HB1' ' A' ' 50' ' ' ALA . 26.4 pt -145.14 137.97 21.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.382 -1.34 . . . . 74.32 107.382 173.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.9 m -125.61 120.89 32.03 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 107.604 -1.258 . . . . 64.05 107.604 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.402 ' O ' HD12 ' B' ' 68' ' ' ILE . 2.8 mp -118.18 118.45 58.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 106.218 -1.771 . . . . 74.23 106.218 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.45 ' HG ' ' CE2' ' A' ' 80' ' ' TYR 0.26 1.2 pt? -121.9 125.59 46.76 Favored 'General case' 0 C--N 1.285 -2.22 0 C-N-CA 120.257 -0.577 . . . . 60.21 111.967 179.156 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 73.1 m -117.37 136.0 53.47 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.734 -0.839 . . . . 71.42 108.734 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.502 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 2.5 p30 -131.07 153.52 49.22 Favored 'General case' 0 CA--C 1.495 -1.141 0 C-N-CA 119.146 -1.022 . . . . 61.13 112.033 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.411 ' HE3' ' OE1' ' B' ' 54' ' ' GLU . 97.9 mttt -121.54 18.33 11.26 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 124.048 0.843 . . . . 72.1 110.883 176.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -69.03 -21.18 64.13 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 119.049 -1.06 . . . . 51.44 112.98 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.7 p -91.8 10.61 27.82 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.405 0.621 . . . . 73.34 110.471 174.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.63 -47.87 1.4 Allowed Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.552 -0.619 . . . . 62.35 111.552 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -97.27 136.83 21.24 Favored Pre-proline 0 C--N 1.301 -1.543 0 CA-C-N 115.512 -0.344 . . . . 72.33 110.23 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 31.7 Cg_endo -69.0 118.61 5.78 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.616 1.544 . . . . 71.14 110.364 175.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 34.6 mtmm -113.33 149.74 33.55 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.337 -0.616 . . . . 70.21 109.337 -178.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -120.38 134.8 10.56 Favored Glycine 0 N--CA 1.423 -2.195 0 C-N-CA 119.847 -1.168 . . . . 73.23 112.791 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.45 ' CE2' ' HG ' ' A' ' 69' ' ' LEU . 17.6 p90 -152.85 144.42 23.42 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 124.326 1.05 . . . . 74.11 109.644 175.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.23 155.89 45.97 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.035 0.445 . . . . 64.01 111.811 -173.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -115.14 130.09 56.84 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.183 -1.414 . . . . 74.04 107.183 174.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.48 HG23 HG22 ' A' ' 66' ' ' ILE . 40.9 mm -112.39 112.88 42.38 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 108.454 -0.943 . . . . 73.23 108.454 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.522 ' HG3' ' OG ' ' A' ' 38' ' ' SER . 1.9 mp0 -88.08 118.96 28.01 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 122.61 0.364 . . . . 73.42 110.801 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -103.82 163.69 12.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.486 0.66 . . . . 73.22 111.602 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.47 ' HB2' HD21 ' A' ' 64' ' ' ASN . . . -78.27 -23.91 47.07 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.135 -0.938 . . . . 73.4 112.098 176.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -125.67 150.37 47.67 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 113.541 0.941 . . . . 74.12 113.541 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.555 ' O ' HG22 ' A' ' 91' ' ' VAL . 21.7 mmm180 -70.52 -29.3 65.77 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.248 -0.887 . . . . 73.31 108.986 173.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.95 -35.38 73.04 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.03 -0.532 . . . . 71.51 110.188 176.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.8 m -64.64 -36.91 85.8 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 116.745 -0.207 . . . . 73.21 111.077 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 88' ' ' ARG . 3.7 m -64.79 -39.26 85.05 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.885 0 C-N-CA 119.509 -0.876 . . . . 74.3 109.001 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.437 ' HA ' HG22 ' A' ' 95' ' ' VAL . 38.5 m-20 -60.07 -34.96 74.16 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.069 0.461 . . . . 74.3 111.783 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.74 -37.54 65.05 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.905 -0.589 . . . . 73.53 110.351 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.14 -44.76 59.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.138 -0.483 . . . . 65.15 110.741 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 91' ' ' VAL . 14.8 m -61.09 -23.33 29.6 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.019 0 CA-C-N 116.456 -0.338 . . . . 75.11 111.8 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.01 -16.0 63.11 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.664 0.745 . . . . 75.43 110.431 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 25.2 ttp -104.89 9.22 34.78 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.835 -1.075 . . . . 72.02 109.134 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 4.5 p-10 -37.4 -49.52 1.01 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 113.812 1.041 . . . . 73.23 113.812 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -115.44 104.17 11.5 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-O 121.744 0.783 . . . . 70.24 110.268 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 106' ' ' THR . 14.5 t -145.15 173.62 11.77 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 114.712 -1.131 . . . . 70.32 108.644 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.14 115.76 48.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.827 0.822 . . . . 71.15 110.301 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -122.58 117.71 26.48 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.034 -1.099 . . . . 75.41 108.034 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.454 ' CZ ' ' HA ' ' A' ' 48' ' ' SER . 54.3 mtt180 62.26 33.6 16.52 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.79 0.836 . . . . 74.01 112.841 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.37 -2.64 81.19 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 114.7 -1.136 . . . . 72.42 114.137 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.687 ' HG3' ' OD1' ' A' ' 43' ' ' ASN . 18.0 ptp180 -130.21 154.84 47.15 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 117.479 0.64 . . . . 74.1 111.293 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 100' ' ' THR . 88.6 m -83.65 120.96 26.63 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 116.063 -0.517 . . . . 71.44 111.277 -174.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.656 ' HA ' ' HB3' ' A' ' 43' ' ' ASN . 40.3 pt -99.83 172.13 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 C-N-CA 120.595 -0.442 . . . . 62.31 111.968 -174.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 54.1 tptt -131.4 126.65 35.7 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.094 -0.957 . . . . 72.42 109.572 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 35.9 t -127.93 128.69 69.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.368 -0.605 . . . . 74.31 109.368 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.542 ' HB2' ' HD2' ' A' ' 111' ' ' PRO 0.295 0.0 OUTLIER -148.45 161.94 31.91 Favored Pre-proline 0 C--N 1.303 -1.433 0 CA-C-O 117.604 -1.189 . . . . 75.04 108.301 174.15 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.542 ' HD2' ' HB2' ' A' ' 110' ' ' LEU . 50.4 Cg_endo -67.73 149.47 78.76 Favored 'Trans proline' 0 C--N 1.357 1.02 0 CA-C-N 121.833 1.69 . . . . 54.22 109.122 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.473 ' HE2' ' HB2' ' A' ' 38' ' ' SER . 35.8 ttpt -70.04 93.19 0.78 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.332 -1.359 . . . . 71.45 107.332 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.492 ' HD3' ' OD1' ' A' ' 115' ' ' ASN 0.262 0.9 OUTLIER -75.26 137.92 41.53 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 118.581 2.808 . . . . 64.13 118.581 -163.813 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 32.5 p -103.0 -11.92 17.82 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 113.373 -1.739 . . . . 54.13 107.991 172.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.492 ' OD1' ' HD3' ' A' ' 113' ' ' ARG . 19.3 m120 70.74 -68.21 0.22 Allowed 'General case' 0 C--N 1.351 0.666 0 C-N-CA 125.936 1.695 . . . . 72.01 113.513 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 25.2 mmt -109.38 107.81 59.74 Favored Pre-proline 0 C--N 1.308 -1.204 0 CA-C-N 116.218 -0.446 . . . . 65.55 111.501 -176.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -88.08 -1.72 7.09 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.565 2.176 . . . . 72.42 111.194 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -108.03 -54.48 0.63 Allowed Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 110.86 -0.896 . . . . 64.34 110.86 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.9 mm -72.42 97.42 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.022 0.439 . . . . 72.43 110.879 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.9 t -177.19 155.65 1.17 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.143 -1.799 . . . . 64.23 106.143 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 49.4 m -130.38 98.13 4.61 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.295 0.569 . . . . 73.11 110.738 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.4 m -77.17 85.05 3.64 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 121.71 0.767 . . . . 74.21 110.399 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 170.72 -25.95 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 125.722 1.609 . . . . 73.45 107.028 -177.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 . . . . . 0 C--O 1.248 1.005 0 CA-C-N 114.912 -1.04 . . . . 74.13 109.739 -178.59 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.381 0 CA-C-O 121.375 0.607 . . . . 45.52 109.886 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.405 HD12 ' N ' ' B' ' 2' ' ' ILE . 2.5 mp -91.04 133.31 33.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 107.858 -1.164 . . . . 71.14 107.858 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -130.77 125.2 21.27 Favored Pre-proline 0 C--N 1.303 -1.451 0 CA-C-N 116.775 -0.193 . . . . 74.12 110.938 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -61.3 -51.01 4.84 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.387 2.058 . . . . 65.52 109.354 175.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' B' ' 118' ' ' GLY . 76.9 m -161.33 123.07 2.93 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 105.01 -2.219 . . . . 45.25 105.01 175.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.26 97.79 6.87 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 119.407 -0.917 . . . . 74.55 113.26 -178.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 56.53 -86.81 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.924 1.69 . . . . 62.12 113.658 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 41.6 p -94.79 97.12 9.82 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 120.895 0.379 . . . . 64.11 110.807 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 98.4 m -78.44 96.93 5.5 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.179 0.514 . . . . 75.52 109.907 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -85.76 83.27 7.9 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 108.415 -0.957 . . . . 73.31 108.415 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 41.6 m -151.41 157.53 42.52 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.827 -1.175 . . . . 75.32 107.827 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -89.2 -17.69 28.59 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.446 -0.576 . . . . 64.21 109.446 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 64.9 mtt 70.54 -59.27 0.53 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.862 1.265 . . . . 65.53 112.315 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 39.1 m -68.45 -40.6 81.05 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 108.874 -0.787 . . . . 63.5 108.874 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.85 94.21 4.95 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 109.195 -0.668 . . . . 72.32 109.195 174.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.7 -60.12 0.29 Allowed Glycine 0 CA--C 1.484 -1.867 0 N-CA-C 109.429 -1.468 . . . . 74.51 109.429 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 88.24 4.56 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 106.997 -1.483 . . . . 74.11 106.997 172.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -64.16 128.23 34.88 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.4 -0.818 . . . . 74.43 111.482 -175.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 40.8 m -89.0 112.21 23.09 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 109.073 -0.714 . . . . 75.35 109.073 177.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' GLU . . . . . 0.403 ' HB2' ' HG2' ' B' ' 23' ' ' PRO . 36.8 mt-10 -84.3 1.86 42.93 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 122.099 0.952 . . . . 71.43 110.396 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.65 -100.98 2.31 Favored Glycine 0 C--N 1.3 -1.419 0 CA-C-N 114.015 -1.448 . . . . 71.02 110.325 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.534 ' HG2' ' HD3' ' B' ' 23' ' ' PRO . 2.2 Cg_endo -40.84 -51.21 3.76 Favored 'Trans proline' 0 CA--C 1.561 1.87 0 C-N-CA 124.158 3.239 . . . . 71.23 113.791 172.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.534 ' HD3' ' HG2' ' B' ' 22' ' ' PRO . 1.5 Cg_endo -82.96 123.59 3.64 Favored 'Trans proline' 0 C--N 1.375 1.97 0 CA-C-N 120.825 1.33 . . . . 34.32 109.763 173.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -62.29 150.39 84.85 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 115.613 -0.721 . . . . 61.14 111.447 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.38 109.86 0.44 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.476 2.784 . . . . 73.24 112.914 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.557 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -107.67 148.63 29.13 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.986 -1.116 . . . . 65.14 107.986 175.421 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.477 ' HB3' ' OE2' ' B' ' 30' ' ' GLU . 40.1 t -61.04 145.86 49.26 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.206 0.817 . . . . 75.34 113.206 -170.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.653 ' O ' ' HG2' ' B' ' 32' ' ' LYS . . . -49.5 -35.25 19.31 Favored 'General case' 0 C--O 1.196 -1.732 0 CA-C-N 114.638 -1.165 . . . . 74.32 110.95 172.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.401 ' HA ' ' HG2' ' B' ' 32' ' ' LYS . 45.8 mt-10 -66.26 -34.95 79.17 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.104 0.409 . . . . 75.54 112.104 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.477 ' OE2' ' HB3' ' B' ' 27' ' ' SER . 0.7 OUTLIER -66.76 -35.23 79.61 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 109.096 -0.705 . . . . 60.43 109.096 172.409 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -69.82 -37.23 76.15 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.512 -0.767 . . . . 62.41 110.947 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.68 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 30.6 mmmt -57.63 -46.87 83.59 Favored 'General case' 0 C--O 1.204 -1.333 0 N-CA-C 109.85 -0.426 . . . . 74.32 109.85 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -66.23 -47.94 72.16 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.102 -0.499 . . . . 64.02 111.516 -175.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.473 HG12 ' O ' ' B' ' 30' ' ' GLU . 16.1 pt -70.97 -36.11 62.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.766 -0.652 . . . . 71.24 112.143 -178.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.434 ' HB3' ' HD2' ' B' ' 112' ' ' LYS . 29.0 m-20 -76.48 -20.14 57.29 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.093 0.775 . . . . 75.52 113.093 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.68 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 95.9 mttt -67.09 -25.04 66.03 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.783 0.802 . . . . 73.43 109.64 174.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.629 ' HD3' ' O ' ' B' ' 86' ' ' ALA . 97.3 mtt180 -97.93 13.9 29.11 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.59 -1.186 . . . . 64.03 109.284 -174.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.515 ' OG ' ' HE3' ' B' ' 112' ' ' LYS . 43.6 t -107.15 169.41 8.58 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 115.029 -0.987 . . . . 65.43 110.533 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.49 164.25 33.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 123.651 0.781 . . . . 65.23 110.244 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' TYR . . . . . 0.572 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 18.6 t80 -110.17 125.83 53.45 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 107.741 -1.207 . . . . 75.14 107.741 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.07 112.42 39.51 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 N-CA-C 107.636 -1.246 . . . . 75.25 107.636 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.29 163.2 13.68 Favored Glycine 0 N--CA 1.421 -2.305 0 C-N-CA 120.041 -1.076 . . . . 74.21 113.46 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 7.9 t30 56.56 22.79 6.97 Favored 'General case' 0 CA--C 1.564 1.507 0 C-N-CA 125.983 1.713 . . . . 52.53 112.802 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 10.6 p -57.5 134.67 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 109.116 -0.698 . . . . 73.21 109.116 174.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -66.25 141.5 58.01 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.061 -0.718 . . . . 64.14 109.061 -177.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -64.51 -10.77 27.98 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-O 121.558 0.694 . . . . 70.32 109.892 -176.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.47 -10.09 58.4 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-N 115.677 -0.692 . . . . 54.12 113.026 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.5 m -98.21 79.7 2.59 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-N 118.685 1.242 . . . . 53.23 110.994 176.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' THR . . . . . 0.443 ' OG1' HG22 ' A' ' 49' ' ' THR . 22.6 p -71.06 -177.48 1.68 Allowed 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 113.632 0.975 . . . . 75.11 113.632 175.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.581 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -51.13 -51.5 52.93 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 115.01 1.485 . . . . 65.11 115.01 -164.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -58.21 -53.52 57.29 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 112.825 0.676 . . . . 64.33 112.825 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -63.5 -40.59 97.48 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-O 121.568 0.699 . . . . 54.32 111.02 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 2.7 tt -67.73 -46.76 71.24 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.901 -1.045 . . . . 74.13 109.298 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.411 ' OE1' ' HE3' ' A' ' 72' ' ' LYS . 29.5 tt0 -58.84 -48.28 81.9 Favored 'General case' 0 C--O 1.206 -1.206 0 C-N-CA 122.474 0.31 . . . . 62.21 111.422 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.64 -37.63 68.48 Favored 'General case' 0 C--O 1.262 1.726 0 CA-C-O 121.389 0.614 . . . . 74.42 110.757 -178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -64.92 -40.73 95.51 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.133 -0.94 . . . . 74.43 110.23 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -83.33 -21.94 33.03 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.715 1.006 . . . . 75.41 113.715 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 40.5 t -62.93 -32.66 74.01 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 123.812 0.845 . . . . 73.12 110.06 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 18.2 m -62.42 -24.88 67.65 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-N 116.15 -0.477 . . . . 54.34 111.197 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 58.8 m -96.04 5.93 50.01 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 112.903 0.705 . . . . 62.24 112.903 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.24 -177.29 30.12 Favored Glycine 0 C--N 1.32 -0.345 0 C-N-CA 118.823 -1.656 . . . . 62.34 114.433 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 20.1 m -96.0 114.95 26.71 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.384 0.611 . . . . 71.21 110.287 -177.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 62.4 mt -85.55 131.44 34.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.789 -0.641 . . . . 53.32 111.866 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -99.04 -41.65 7.46 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.406 -0.816 . . . . 62.04 111.514 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -151.32 160.9 43.55 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 107.886 -1.153 . . . . 63.01 107.886 -177.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.581 HD11 ' HB1' ' B' ' 50' ' ' ALA . 23.6 pt -145.32 138.23 21.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.379 -1.341 . . . . 64.24 107.379 172.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 54.0 m -125.64 120.77 31.64 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 107.577 -1.268 . . . . 71.45 107.577 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 68' ' ' ILE . 3.2 mp -117.83 116.82 52.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 106.612 -1.625 . . . . 62.21 106.612 -177.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.275 1.1 pt? -120.9 124.5 45.11 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 120.211 -0.595 . . . . 73.33 112.33 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 66.4 m -117.51 134.56 54.72 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 108.859 -0.793 . . . . 73.41 108.859 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 2.8 p30 -125.54 143.2 51.12 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.575 -0.85 . . . . 61.41 108.822 177.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -118.72 15.53 13.57 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.124 -0.695 . . . . 64.54 109.124 -177.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -70.4 -11.28 60.81 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.317 0.579 . . . . 75.14 111.954 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 50.5 m -89.87 3.48 52.85 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.63 -0.713 . . . . 72.31 110.135 174.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.76 -47.89 2.05 Favored Glycine 0 CA--C 1.498 -1.018 0 N-CA-C 110.28 -1.128 . . . . 74.32 110.28 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -96.09 135.09 22.92 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 106.648 -1.612 . . . . 72.24 106.648 175.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.62 118.36 5.29 Favored 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 120.716 0.944 . . . . 62.32 110.609 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 32.9 mtmm -96.76 144.12 27.04 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 109.287 -0.635 . . . . 63.23 109.287 -178.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -119.42 132.01 9.31 Favored Glycine 0 N--CA 1.415 -2.728 0 C-N-CA 120.123 -1.037 . . . . 65.45 112.063 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -150.79 143.91 24.76 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 123.959 0.904 . . . . 72.53 109.641 175.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.36 156.48 45.82 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.078 0.466 . . . . 75.02 111.613 -173.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' TYR . . . . . 0.444 ' CG ' ' HE2' ' B' ' 112' ' ' LYS . 27.2 m-85 -115.99 130.83 56.99 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.526 -1.287 . . . . 73.3 107.526 174.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.483 HG23 HG22 ' B' ' 66' ' ' ILE . 35.8 mm -114.51 110.74 33.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.621 -0.881 . . . . 74.35 108.621 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -86.24 119.34 26.41 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.48 -0.327 . . . . 75.45 110.988 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.25 165.21 11.2 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.909 0.385 . . . . 73.33 109.997 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.629 ' O ' ' HD3' ' B' ' 37' ' ' ARG . . . -79.46 -34.56 41.39 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.34 -0.391 . . . . 55.44 112.018 176.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -111.18 150.46 29.47 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.137 0.494 . . . . 73.41 112.282 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.597 ' O ' HG22 ' B' ' 91' ' ' VAL . 21.2 mmm180 -68.95 -28.8 66.97 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.411 -0.813 . . . . 74.54 109.533 172.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -63.7 -29.33 70.57 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.633 -0.712 . . . . 73.05 111.143 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 19.5 m -67.74 -36.36 80.42 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 116.664 -0.244 . . . . 71.13 110.491 177.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.597 HG22 ' O ' ' B' ' 88' ' ' ARG . 3.6 m -64.24 -39.53 85.84 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.775 0 N-CA-C 108.802 -0.814 . . . . 75.11 108.802 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.402 ' HA ' HG22 ' B' ' 95' ' ' VAL . 6.0 m-20 -57.08 -37.22 71.57 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.513 0.561 . . . . 65.31 112.513 175.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.55 -35.93 65.57 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.947 -0.569 . . . . 70.42 110.526 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.46 -42.72 52.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.869 -0.605 . . . . 64.44 110.942 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' VAL . . . . . 0.505 HG13 ' O ' ' B' ' 91' ' ' VAL . 19.2 m -62.11 -23.36 31.5 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.962 0 N-CA-C 111.896 0.332 . . . . 73.42 111.896 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.7 -16.19 63.3 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.28 0.562 . . . . 44.02 110.442 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 16.5 ttm -101.3 3.03 40.35 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 123.994 0.918 . . . . 73.24 109.013 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' ASP . . . . . 0.586 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 4.2 p-10 -35.85 -50.36 0.65 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 116.291 1.96 . . . . 71.5 116.291 -172.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -115.77 93.49 4.29 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 118.204 -1.398 . . . . 75.03 110.945 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 13.1 t -135.2 172.8 12.49 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.145 -1.389 . . . . 62.14 109.925 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.0 p -101.58 128.63 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 108.876 -0.787 . . . . 74.21 108.876 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -130.51 119.63 22.88 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.941 -0.763 . . . . 73.12 108.941 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 31.0 ttm-85 50.71 33.42 8.29 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.612 1.565 . . . . 73.45 112.151 -175.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 99.57 -2.93 57.51 Favored Glycine 0 C--N 1.296 -1.64 0 CA-C-N 114.439 -1.255 . . . . 63.12 114.345 172.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -131.77 149.18 52.55 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 118.171 0.986 . . . . 75.32 112.162 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 25.7 m -75.5 124.86 27.91 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.994 -0.548 . . . . 62.04 110.929 -174.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 43.1 pt -102.83 171.56 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.016 0.436 . . . . 73.31 110.832 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' LYS . . . . . 0.586 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 55.0 tptt -135.41 131.93 36.87 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.0 -1.111 . . . . 71.54 108.0 178.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 28.0 t -127.28 134.35 66.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.608 -0.515 . . . . 75.42 109.608 -177.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.686 ' HB3' ' HD2' ' B' ' 111' ' ' PRO 0.262 0.1 OUTLIER -144.13 170.0 9.2 Favored Pre-proline 0 C--O 1.215 -0.76 0 N-CA-C 105.292 -2.114 . . . . 75.4 105.292 174.167 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.686 ' HD2' ' HB3' ' B' ' 110' ' ' LEU . 73.6 Cg_endo -73.53 151.51 47.44 Favored 'Trans proline' 0 CA--C 1.552 1.422 0 C-N-CA 122.015 1.81 . . . . 65.51 110.114 171.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.515 ' HE3' ' OG ' ' B' ' 38' ' ' SER . 35.1 ttmt -86.77 140.77 29.4 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.007 0.432 . . . . 63.51 110.742 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -143.88 125.34 14.82 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.337 -1.357 . . . . 74.31 107.337 172.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.563 ' HA ' ' OH ' ' A' ' 18' ' ' TYR . 85.5 m -146.85 115.25 6.69 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 112.795 0.665 . . . . 43.33 112.795 -175.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 45.42 106.94 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 117.064 2.246 . . . . 72.41 117.064 169.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.65 117.75 68.65 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 106.75 -1.574 . . . . 73.22 106.75 175.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -79.65 102.92 1.53 Allowed 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.038 1.825 . . . . 64.34 111.167 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 118' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' B' ' 5' ' ' CYS . . . -80.8 57.72 4.78 Favored Glycine 0 N--CA 1.439 -1.122 0 CA-C-N 115.797 -0.638 . . . . 34.01 112.217 -177.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 10.2 tt -152.26 130.78 2.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.773 -0.825 . . . . 73.5 108.773 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 56.3 m -152.54 158.52 42.65 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.425 -0.954 . . . . 61.51 108.425 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 35.1 m -79.81 103.98 10.09 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.97 -0.752 . . . . 60.43 108.97 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 62.3 m -105.49 119.04 38.11 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 116.274 -0.421 . . . . 70.4 110.169 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -150.73 -56.0 0.16 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.185 -0.672 . . . . 74.04 109.185 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 . . . . . 0 N--CA 1.43 -1.441 0 CA-C-N 115.644 -0.707 . . . . 74.2 111.667 -176.348 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.56 0 N-CA-C 109.387 -0.597 . . . . 71.51 109.387 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 66.7 mt -81.51 112.86 20.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 121.167 0.508 . . . . 65.44 110.516 -177.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.07 117.0 15.77 Favored Pre-proline 0 C--N 1.298 -1.641 0 N-CA-C 107.932 -1.136 . . . . 72.42 107.932 177.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -65.82 99.53 0.39 Allowed 'Trans proline' 0 C--O 1.241 0.646 0 C-N-CA 122.286 1.991 . . . . 70.03 112.637 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 66.9 m -116.79 94.63 4.68 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 108.782 -0.822 . . . . 61.45 108.782 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.419 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 81.8 mtp -127.83 131.38 49.53 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.699 -0.852 . . . . 74.12 108.699 -177.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -122.52 119.57 31.29 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.019 0.438 . . . . 61.24 110.849 -177.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 59.7 m -152.86 150.14 29.01 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.215 -0.448 . . . . 54.24 109.869 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.0 m 74.91 -73.03 0.1 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.586 1.154 . . . . 50.02 112.658 175.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.589 ' HA ' ' HD3' ' A' ' 108' ' ' LYS 0.342 16.3 p80 44.81 81.04 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.244 1.572 . . . . 75.03 115.244 -176.131 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.4 m -82.58 161.42 22.27 Favored 'General case' 0 C--O 1.247 0.954 0 CA-C-N 115.462 -0.79 . . . . 65.04 109.799 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.433 ' HB2' ' SD ' ' A' ' 13' ' ' MET . 63.6 pttt -168.59 157.58 8.77 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 111.748 0.277 . . . . 74.44 111.748 -176.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.433 ' SD ' ' HB2' ' A' ' 12' ' ' LYS . 1.5 mpt? 54.01 113.77 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.703 1.742 . . . . 73.13 115.703 173.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 t -163.32 162.73 25.25 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-N 116.39 -0.368 . . . . 75.14 111.42 178.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.61 ' HA ' ' HB ' ' A' ' 114' ' ' THR . . . -150.37 128.66 12.05 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.262 0.625 . . . . 53.1 110.798 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 158.27 129.0 1.05 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 121.02 -0.61 . . . . 73.14 112.967 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' B' ' 19' ' ' THR . . . -170.49 103.82 0.27 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.908 0.883 . . . . 74.14 109.735 177.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -146.2 -26.88 0.43 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 117.341 2.349 . . . . 73.31 117.341 -174.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.522 ' HB ' ' O ' ' B' ' 17' ' ' ALA . 24.9 m -133.48 138.0 45.94 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 120.822 1.646 . . . . 72.21 112.556 -169.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -126.07 -78.43 0.59 Allowed 'General case' 0 CA--C 1.557 1.244 0 N-CA-C 110.313 -0.254 . . . . 74.23 110.313 174.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.74 -139.73 3.48 Favored Glycine 0 N--CA 1.473 1.162 0 N-CA-C 111.275 -0.73 . . . . 54.52 111.275 176.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -51.0 -49.93 15.49 Favored 'Trans proline' 0 CA--C 1.556 1.612 0 C-N-CA 122.672 2.248 . . . . 52.32 112.212 174.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.11 135.86 65.2 Favored 'Trans proline' 0 C--N 1.388 2.609 0 N-CA-C 108.584 -1.352 . . . . 74.31 108.584 170.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.42 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 29.4 mm-40 -78.88 159.06 74.43 Favored Pre-proline 0 C--N 1.296 -1.726 0 C-N-CA 120.78 -0.368 . . . . 71.21 111.744 -173.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 24' ' ' GLN . 27.3 Cg_endo -70.23 58.13 1.75 Allowed 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 123.217 2.611 . . . . 64.11 113.463 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.405 ' HB3' ' H ' ' A' ' 27' ' ' SER . 5.5 mp 36.3 -166.04 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 117.068 2.247 . . . . 73.11 117.068 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.405 ' H ' ' HB3' ' A' ' 26' ' ' LEU . 10.9 m -90.44 150.76 21.69 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 114.191 -1.368 . . . . 61.14 107.484 174.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.507 ' HA ' ' HE3' ' A' ' 31' ' ' LYS . . . -51.92 -47.0 64.87 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.663 0.616 . . . . 73.41 112.663 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -76.26 -30.37 57.83 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 113.941 1.089 . . . . 71.31 113.941 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.33 -35.22 73.44 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 120.381 -0.528 . . . . 74.42 110.04 172.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.507 ' HE3' ' HA ' ' A' ' 28' ' ' ALA . 48.5 mtmt -66.22 -45.83 79.34 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 115.187 -0.915 . . . . 73.42 111.841 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.719 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -64.94 -30.99 72.02 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 119.644 -0.822 . . . . 63.23 112.576 177.864 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -64.4 -47.05 80.65 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.2 0.524 . . . . 61.03 110.971 174.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . 0.26 15.5 pt -70.94 -35.65 60.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 113.204 0.816 . . . . 74.33 113.204 -178.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -61.43 -41.4 97.12 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.207 1.003 . . . . 73.03 109.416 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.497 ' HG2' ' HG2' ' A' ' 88' ' ' ARG . 28.3 ttmt -58.51 -25.51 62.47 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 125.18 1.392 . . . . 73.42 112.767 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.437 ' HA ' HG11 ' A' ' 91' ' ' VAL . 88.5 mtm180 -119.52 10.38 11.8 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 112.389 0.514 . . . . 64.51 112.389 -175.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.0 t -98.32 154.7 17.63 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.253 0.549 . . . . 52.35 111.778 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.604 HG13 ' CG2' ' A' ' 91' ' ' VAL . 0.2 OUTLIER -140.64 161.9 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 C-N-CA 124.062 0.945 . . . . 31.31 111.719 176.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 25.7 t80 -112.49 126.5 55.38 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 107.642 -1.244 . . . . 72.44 107.642 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 59.7 t -113.32 110.35 31.87 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 N-CA-C 107.082 -1.451 . . . . 65.13 107.082 176.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.36 165.92 12.84 Favored Glycine 0 C--N 1.291 -1.958 0 C-N-CA 119.512 -1.328 . . . . 52.04 114.272 -175.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.464 ' O ' ' HD3' ' A' ' 105' ' ' ARG . 19.1 t-20 64.58 24.72 13.08 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.121 1.368 . . . . 72.14 112.193 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.431 HG21 HD21 ' A' ' 53' ' ' LEU . 8.0 p -106.07 95.38 3.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-O 122.058 0.932 . . . . 71.41 110.451 176.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.526 ' HA ' ' HA3' ' A' ' 79' ' ' GLY . 4.9 m-20 -106.3 137.9 43.43 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 118.563 -0.732 . . . . 73.11 109.903 -169.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.566 ' CE1' ' HB2' ' A' ' 77' ' ' PRO 0.394 50.2 m-85 42.02 -60.52 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 121.247 3.795 . . . . 74.53 121.247 169.824 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.8 -20.46 62.03 Favored Glycine 0 N--CA 1.466 0.635 0 N-CA-C 115.073 0.789 . . . . 62.31 115.073 -173.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.9 m -95.69 134.7 38.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 117.477 0.638 . . . . 63.23 109.893 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 47.9 p -98.85 176.34 5.64 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 109.173 -0.677 . . . . 74.01 109.173 -177.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.484 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -60.2 -44.35 95.2 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 110.061 -0.348 . . . . 65.41 110.061 176.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -57.18 -46.29 82.95 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 116.547 -0.297 . . . . 75.53 110.621 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -56.44 -42.72 78.57 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.239 0.542 . . . . 62.12 111.446 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.431 HD21 HG21 ' A' ' 44' ' ' VAL . 62.4 mt -73.38 -49.3 27.93 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.267 -0.879 . . . . 64.52 111.696 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.18 -49.47 71.91 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.953 -0.567 . . . . 62.44 110.965 -176.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.31 -42.35 91.17 Favored 'General case' 0 C--O 1.267 2.001 0 CA-C-O 121.442 0.639 . . . . 44.31 111.752 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -66.42 -34.75 78.66 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.877 -0.602 . . . . 73.23 109.61 -176.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . 0.25 49.3 m-85 -82.31 -20.95 36.39 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 113.499 0.926 . . . . 70.12 113.499 175.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.0 m -61.05 -32.62 72.25 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.257 -0.646 . . . . 73.45 109.257 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 m -58.65 -30.74 67.56 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.945 -0.57 . . . . 52.52 110.618 174.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 61.0 m -97.71 -1.27 43.86 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 112.536 0.569 . . . . 73.43 112.536 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' A' ' 90' ' ' SER . . . 168.16 -174.18 43.01 Favored Glycine 0 C--O 1.223 -0.546 0 C-N-CA 118.379 -1.867 . . . . 74.05 116.0 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.4 p -70.55 -71.7 0.24 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.938 0.895 . . . . 62.2 112.428 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.3 73.7 mt 99.77 113.12 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 C-N-CA 126.71 2.004 . . . . 54.53 112.669 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.516 ' OD1' ' HB2' ' A' ' 86' ' ' ALA . 3.7 m-20 -106.81 -28.24 10.25 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-N 114.354 -1.293 . . . . 74.45 112.57 -177.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.478 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 75.3 mtt180 -151.61 155.45 38.44 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.788 -0.819 . . . . 61.54 108.788 174.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.498 HG22 HG23 ' A' ' 83' ' ' ILE . 20.5 pt -144.02 137.25 23.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 105.428 -2.064 . . . . 72.53 105.428 169.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 58.5 m -125.09 125.21 43.41 Favored 'General case' 0 C--N 1.262 -3.224 0 N-CA-C 107.708 -1.219 . . . . 73.4 107.708 -177.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mp -122.0 118.32 55.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 106.188 -1.782 . . . . 72.33 106.188 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.41 HD23 ' N ' ' A' ' 69' ' ' LEU 0.298 0.9 OUTLIER -121.53 133.19 55.02 Favored 'General case' 0 C--N 1.278 -2.525 0 C-N-CA 120.047 -0.661 . . . . 74.2 111.942 177.058 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 79.3 m -116.67 124.99 51.08 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.211 -1.033 . . . . 74.42 108.211 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.517 ' HB2' ' CD2' ' A' ' 73' ' ' PHE . 2.9 p-10 -112.12 138.43 48.8 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 119.047 -1.061 . . . . 64.2 112.131 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -117.13 7.48 13.04 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 114.763 -1.108 . . . . 72.32 110.239 173.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.517 ' CD2' ' HB2' ' A' ' 71' ' ' ASP . 37.3 p90 -69.58 -15.93 63.31 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.93 0.871 . . . . 75.05 109.637 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.2 m -86.92 6.98 29.31 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 114.727 -1.124 . . . . 73.34 109.515 175.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.34 -53.99 4.44 Favored Glycine 0 CA--C 1.503 -0.661 0 N-CA-C 110.596 -1.001 . . . . 64.23 110.596 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -96.24 138.15 21.59 Favored Pre-proline 0 C--N 1.298 -1.646 0 CA-C-N 114.27 -0.965 . . . . 71.13 108.774 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.566 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 46.9 Cg_endo -71.62 118.43 5.65 Favored 'Trans proline' 0 C--O 1.247 0.951 0 C-N-CA 122.203 1.936 . . . . 73.23 112.719 -177.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 29.1 mtmm -113.21 165.54 12.31 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 109.07 -0.715 . . . . 72.21 109.07 175.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 45' ' ' ASP . . . -138.2 146.0 17.66 Favored Glycine 0 N--CA 1.42 -2.403 0 C-N-CA 120.235 -0.983 . . . . 63.41 113.405 175.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -154.08 145.22 22.83 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.569 -0.816 . . . . 71.04 109.674 175.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 67' ' ' THR . . . -132.74 152.72 51.68 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.482 -0.326 . . . . 74.52 110.882 -172.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.408 ' CZ ' ' HD1' ' A' ' 40' ' ' TYR . 77.3 m-85 -123.9 131.56 53.6 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.556 -0.905 . . . . 75.43 108.556 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.498 HG23 HG22 ' A' ' 66' ' ' ILE . 23.4 mm -115.38 120.6 65.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 109.227 -0.657 . . . . 61.3 109.227 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 65' ' ' ARG . 1.9 mp0 -100.14 121.59 41.67 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.882 -0.414 . . . . 74.51 109.882 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -98.81 161.83 13.43 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.699 -0.228 . . . . 73.0 110.796 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.516 ' HB2' ' OD1' ' A' ' 64' ' ' ASN . . . -85.16 -29.89 24.4 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.802 -0.359 . . . . 70.44 111.231 175.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.467 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 5.6 mp0 -97.81 142.94 28.96 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.639 -0.504 . . . . 73.21 109.639 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.497 ' HG2' ' HG2' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -71.17 -30.79 66.88 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 105.882 -1.896 . . . . 61.21 105.882 176.08 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -67.57 -35.55 79.22 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.583 -1.189 . . . . 74.25 110.605 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.467 ' OG ' ' HB2' ' A' ' 87' ' ' GLU . 50.1 m -70.93 -36.81 72.79 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 120.696 0.284 . . . . 72.01 111.742 -177.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.604 ' CG2' HG13 ' A' ' 39' ' ' VAL . 14.5 p -65.99 -37.22 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 109.257 -0.645 . . . . 60.43 109.257 177.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -65.29 -31.58 72.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.518 -0.764 . . . . 63.1 110.035 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.5 -31.57 63.8 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.854 -0.612 . . . . 75.23 110.845 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.61 -43.94 53.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.039 -0.528 . . . . 65.52 110.451 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 20.5 m -58.25 -22.41 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 112.942 0.719 . . . . 54.33 112.942 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.46 -13.15 61.73 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.372 0.606 . . . . 71.0 110.415 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 47.7 ttp -103.4 9.46 37.8 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.007 -0.738 . . . . 73.21 109.007 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.592 ' HA ' ' HB ' ' A' ' 109' ' ' VAL . 5.5 p-10 -37.37 -57.09 0.93 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 115.016 1.487 . . . . 62.44 115.016 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 6' ' ' MET . 35.8 tt0 -110.09 85.12 2.05 Favored 'General case' 0 N--CA 1.397 -3.117 0 CA-C-O 122.167 0.984 . . . . 74.41 109.419 -174.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.2 p -129.6 167.47 17.9 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 113.849 -1.523 . . . . 70.04 111.904 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.2 p -110.73 106.18 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.163 0 CA-C-O 121.855 0.836 . . . . 74.21 109.017 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -105.69 126.23 51.91 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.115 -0.948 . . . . 73.44 108.543 -176.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 41.4 ttt-85 52.29 32.91 11.68 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 124.731 1.212 . . . . 72.14 111.348 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.72 -4.88 76.34 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 115.107 -0.951 . . . . 60.4 114.288 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.464 ' HD3' ' O ' ' A' ' 43' ' ' ASN . 4.6 ptp180 -121.88 138.41 54.41 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 117.593 0.696 . . . . 64.43 111.218 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 45.6 m -76.12 122.13 23.84 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-O 120.803 0.335 . . . . 53.44 110.761 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 44.6 pt -101.78 171.87 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.909 -0.587 . . . . 73.52 111.119 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.589 ' HD3' ' HA ' ' A' ' 10' ' ' HIS . 15.0 mmmt -125.1 131.13 53.35 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-N 114.952 -1.022 . . . . 72.51 109.245 176.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.609 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 24.7 t -127.47 116.19 42.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 108.361 -0.978 . . . . 70.02 108.361 174.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.426 ' CD1' ' HD2' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -146.99 156.4 47.29 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 106.912 -1.514 . . . . 60.24 106.912 177.808 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -62.61 129.3 25.97 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 121.841 1.694 . . . . 63.1 113.373 -175.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.03 100.48 13.29 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 103.155 -2.905 . . . . 72.12 103.155 173.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.432 ' HE ' ' HB2' ' A' ' 116' ' ' MET . 2.7 tmt_? -160.73 93.91 1.02 Allowed 'General case' 0 C--N 1.272 -2.787 0 N-CA-C 106.638 -1.615 . . . . 75.12 106.638 -164.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.61 ' HB ' ' HA ' ' A' ' 15' ' ' ALA . 40.6 p -106.27 -76.7 0.6 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.528 -1.669 . . . . 64.53 111.42 -170.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -79.71 110.9 15.49 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 102.842 -3.022 . . . . 73.34 102.842 170.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.432 ' HB2' ' HE ' ' A' ' 113' ' ' ARG . 24.7 ptt? -137.72 162.3 55.33 Favored Pre-proline 0 C--N 1.272 -2.776 0 N-CA-C 114.812 1.412 . . . . 73.14 114.812 -159.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -61.18 137.29 70.19 Favored 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 122.83 2.353 . . . . 54.41 109.386 169.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 108.47 35.47 2.45 Favored Glycine 0 C--N 1.299 -1.517 0 N-CA-C 110.298 -1.121 . . . . 53.02 110.298 -175.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . 0.29 9.7 tt 42.06 79.49 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 125.953 1.701 . . . . 75.13 115.118 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 55.6 p -95.24 -22.35 17.86 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.77 -0.65 . . . . 73.01 109.343 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.1 m 63.72 -163.36 0.27 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.331 -0.849 . . . . 75.55 110.742 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.2 m 75.23 88.53 0.09 Allowed 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.097 0.959 . . . . 73.34 112.452 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -161.41 -46.23 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 114.142 -1.39 . . . . 64.24 108.472 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 . . . . . 0 C--N 1.313 -1.01 0 CA-C-N 115.169 -0.923 . . . . 73.03 110.212 176.788 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 110.469 -0.197 . . . . 74.14 110.469 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 2.3 mp -97.71 134.61 35.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.918 -0.771 . . . . 65.43 108.918 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.99 101.4 9.43 Favored Pre-proline 0 C--N 1.312 -1.03 0 N-CA-C 110.276 -0.268 . . . . 73.23 110.276 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -75.94 121.46 6.23 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 122.327 2.018 . . . . 72.13 111.491 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 54.1 t -146.15 103.38 3.72 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.849 -0.614 . . . . 72.43 109.784 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 22.5 ptp -146.77 144.12 29.15 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.788 0.328 . . . . 74.01 110.887 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' GLN . . . . . 0.435 ' HB2' ' NH1' ' B' ' 113' ' ' ARG . 27.1 mt-30 -118.58 116.18 26.09 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.974 -1.491 . . . . 70.41 106.974 174.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 8.8 t -79.82 144.94 33.07 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.356 0.598 . . . . 75.4 110.855 -174.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 11.4 t -168.82 173.55 7.06 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 107.019 -1.475 . . . . 75.04 107.019 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -128.21 100.41 5.83 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.945 -0.391 . . . . 62.51 109.945 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t -143.67 -167.59 2.62 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.906 -1.146 . . . . 62.12 107.906 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -84.98 164.63 18.18 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.626 -0.509 . . . . 72.33 109.626 -177.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 25.8 ptm -95.01 3.31 55.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.131 0.491 . . . . 73.13 110.023 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 29.6 p -74.77 84.61 2.15 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 121.611 0.719 . . . . 73.12 110.757 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.446 ' HA ' ' OG1' ' A' ' 19' ' ' THR . . . -113.51 117.71 32.42 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.257 -0.883 . . . . 63.41 109.87 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.64 34.92 0.75 Allowed Glycine 0 C--N 1.294 -1.757 0 N-CA-C 110.944 -0.863 . . . . 40.4 110.944 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.522 ' O ' ' HB ' ' A' ' 19' ' ' THR . . . 67.11 -83.71 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 124.401 1.08 . . . . 63.34 109.783 -175.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 19' ' ' THR . 96.8 m-85 -139.64 -75.56 0.35 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.511 0.196 . . . . 73.34 111.244 175.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 10.2 t 166.85 30.45 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.775 -1.194 . . . . 73.23 107.775 -171.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -59.95 -82.97 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 114.704 1.372 . . . . 73.24 114.704 -166.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.09 -91.25 0.23 Allowed Glycine 0 C--N 1.28 -2.575 0 C-N-CA 119.016 -1.564 . . . . 55.32 110.828 -171.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.584 ' HG3' ' CZ ' ' A' ' 40' ' ' TYR . 2.3 Cg_endo -43.64 -51.82 5.82 Favored 'Trans proline' 0 CA--C 1.556 1.588 0 C-N-CA 123.418 2.745 . . . . 75.54 113.268 176.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.432 ' HD3' ' HG2' ' B' ' 22' ' ' PRO . 11.2 Cg_exo -71.92 123.62 9.47 Favored 'Trans proline' 0 C--N 1.38 2.196 0 N-CA-C 108.132 -1.526 . . . . 75.44 108.132 171.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.422 ' CD ' ' H ' ' B' ' 24' ' ' GLN . 0.5 OUTLIER -73.5 160.12 83.08 Favored Pre-proline 0 C--N 1.288 -2.093 0 CA-C-N 115.287 -0.87 . . . . 73.12 109.784 -177.598 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.94 101.27 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 122.381 2.054 . . . . 75.01 111.457 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.747 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -72.49 171.98 11.35 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 114.21 -1.359 . . . . 75.13 111.42 178.924 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.522 ' HB3' ' OE1' ' B' ' 30' ' ' GLU . 34.3 t -65.08 145.99 55.59 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.704 0.764 . . . . 60.23 112.276 -173.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.23 -40.87 25.89 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.85 -1.523 . . . . 53.03 111.673 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -75.93 -30.25 58.64 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 113.746 1.017 . . . . 73.4 113.746 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.522 ' OE1' ' HB3' ' B' ' 27' ' ' SER . 1.1 mp0 -60.73 -34.61 74.67 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 120.32 -0.552 . . . . 74.33 109.814 171.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -66.18 -50.71 62.95 Favored 'General case' 0 C--O 1.199 -1.553 0 CA-C-N 115.81 -0.632 . . . . 65.44 109.756 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.687 ' N ' ' HE2' ' B' ' 32' ' ' LYS . 0.4 OUTLIER -61.43 -29.71 70.11 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 119.839 -0.744 . . . . 75.35 112.123 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' B' ' 36' ' ' LYS . 9.4 tp10 -69.23 -44.72 71.43 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 108.558 -0.905 . . . . 71.33 108.558 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . 0.25 11.8 pt -71.95 -35.21 53.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 112.608 0.596 . . . . 71.52 112.608 177.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' B' ' 113' ' ' ARG . 9.6 m-20 -58.41 -43.63 88.73 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.323 0.582 . . . . 73.15 110.616 177.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' B' ' 33' ' ' GLU . 15.0 ptpt -68.88 -18.34 64.12 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.457 0.54 . . . . 73.3 112.457 -173.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.63 ' HD2' ' O ' ' B' ' 85' ' ' PHE . 21.7 ptt180 -118.83 15.91 13.48 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.596 0.591 . . . . 71.02 112.596 -178.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 47.3 t -102.35 154.87 18.65 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.274 0.559 . . . . 44.3 111.738 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.618 HG13 ' CG2' ' B' ' 91' ' ' VAL . 0.3 OUTLIER -140.31 164.01 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 C-N-CA 124.287 1.035 . . . . 75.2 112.072 178.554 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 40' ' ' TYR . . . . . 0.619 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 30.7 t80 -115.71 127.39 55.1 Favored 'General case' 0 CA--C 1.48 -1.726 0 CA-C-N 114.557 -1.201 . . . . 74.4 107.76 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.36 109.65 29.31 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 N-CA-C 107.256 -1.387 . . . . 43.12 107.256 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -109.41 170.13 14.23 Favored Glycine 0 N--CA 1.435 -1.415 0 C-N-CA 120.257 -0.973 . . . . 51.55 112.602 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.2 t30 63.96 -0.66 0.77 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 126.213 1.805 . . . . 73.32 112.54 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.548 HG21 HD21 ' B' ' 53' ' ' LEU . 3.6 p -58.39 130.89 22.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 108.913 -0.773 . . . . 74.44 108.913 175.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -76.09 153.26 36.46 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 115.694 -0.685 . . . . 75.52 111.624 -173.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -50.55 -34.1 24.26 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 126.172 1.789 . . . . 75.44 111.214 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.7 3.99 78.73 Favored Glycine 0 CA--C 1.501 -0.842 0 C-N-CA 119.897 -1.144 . . . . 72.02 113.72 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 36.8 t -73.06 118.84 16.5 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 105.137 -2.172 . . . . 63.01 105.137 172.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.49 166.92 12.29 Favored 'General case' 0 N--CA 1.405 -2.701 0 N-CA-C 109.201 -0.666 . . . . 61.53 109.201 -169.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.448 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -56.08 -45.5 79.35 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 117.911 0.323 . . . . 72.3 111.439 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' GLN . . . . . 0.4 ' H ' ' CD ' ' B' ' 51' ' ' GLN . 22.1 mp0 -57.18 -44.84 83.94 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.525 0.516 . . . . 53.42 111.042 178.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -57.17 -45.1 83.95 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 121.167 0.508 . . . . 71.24 111.348 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.548 HD21 HG21 ' B' ' 44' ' ' VAL . 80.5 mt -72.2 -49.2 37.32 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.399 -0.818 . . . . 70.03 111.585 -177.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -63.2 -49.4 74.39 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 116.105 -0.498 . . . . 63.33 111.151 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.46 97.77 Favored 'General case' 0 C--O 1.267 2.014 0 CA-C-O 121.522 0.677 . . . . 70.54 111.812 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -66.39 -34.43 77.95 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.821 -0.627 . . . . 75.42 109.697 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -82.48 -21.36 35.59 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 113.678 0.992 . . . . 71.12 113.678 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 71.8 m -61.88 -30.69 71.04 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 116.379 -0.373 . . . . 62.44 110.295 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 17.4 m -58.69 -31.14 67.94 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 115.895 -0.593 . . . . 74.43 110.265 175.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 63.0 m -91.44 6.47 45.35 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 113.474 0.916 . . . . 35.45 113.474 -177.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.23 -159.93 26.25 Favored Glycine 0 N--CA 1.469 0.856 0 C-N-CA 118.914 -1.613 . . . . 70.32 115.108 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 12.9 m -101.48 123.26 45.24 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.021 0.439 . . . . 75.5 110.406 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 57.6 mt -92.04 134.91 28.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 123.583 0.753 . . . . 53.51 112.073 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -103.98 -33.15 8.92 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.711 0.805 . . . . 64.24 112.021 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.452 ' HB2' ' HB2' ' B' ' 84' ' ' GLU . 82.8 mtt180 -151.86 156.87 41.02 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.218 -0.66 . . . . 64.24 109.218 178.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.514 HG22 HG23 ' B' ' 83' ' ' ILE . 17.7 pt -143.61 138.15 25.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 105.824 -1.917 . . . . 64.41 105.824 168.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 53.8 m -125.29 125.73 44.0 Favored 'General case' 0 C--N 1.269 -2.926 0 N-CA-C 107.668 -1.234 . . . . 70.22 107.668 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.8 mp -122.78 117.54 52.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 106.337 -1.727 . . . . 73.31 106.337 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.402 HD23 ' N ' ' B' ' 69' ' ' LEU 0.288 0.9 OUTLIER -121.03 132.52 54.95 Favored 'General case' 0 C--N 1.283 -2.288 0 C-N-CA 120.028 -0.669 . . . . 62.14 111.8 177.774 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' B' B ' 70' ' ' CYS . . . . . 0.493 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 70.6 m -116.98 123.01 45.88 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 108.73 -0.841 . . . . 72.14 108.73 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.606 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 2.8 p30 -110.2 132.09 54.48 Favored 'General case' 0 C--O 1.208 -1.11 0 C-N-CA 119.913 -0.715 . . . . 73.24 110.115 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -118.9 10.8 12.38 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.937 -1.134 . . . . 72.0 107.937 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.494 ' CD2' ' HB2' ' B' ' 71' ' ' ASP . 4.1 p90 -56.86 -17.41 9.3 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 115.902 1.816 . . . . 64.12 115.902 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 30.6 m -110.32 9.73 23.58 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 118.242 0.473 . . . . 72.21 111.61 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.39 -55.63 0.52 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.257 -0.973 . . . . 75.32 112.368 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -96.16 129.72 33.03 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 109.956 -0.387 . . . . 72.44 109.956 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.606 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 92.0 Cg_endo -77.04 119.61 5.12 Favored 'Trans proline' 0 N--CA 1.441 -1.617 0 C-N-CA 121.8 1.667 . . . . 74.33 111.932 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 30.1 mtmm -102.32 164.45 11.67 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 108.199 -1.037 . . . . 65.42 108.199 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -134.28 141.16 12.43 Favored Glycine 0 N--CA 1.423 -2.226 0 C-N-CA 119.658 -1.258 . . . . 73.44 113.027 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' TYR . . . . . 0.452 ' HA ' ' CG1' ' B' ' 44' ' ' VAL . 19.5 p90 -150.71 143.34 24.47 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.183 -0.509 . . . . 75.03 110.117 173.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.45 152.33 51.55 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.419 -0.355 . . . . 74.3 110.872 -172.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' TYR . . . . . 0.574 ' CD2' ' HG3' ' B' ' 112' ' ' LYS . 88.1 m-85 -124.15 130.05 51.88 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 108.944 -0.762 . . . . 71.11 108.944 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.514 HG23 HG22 ' B' ' 66' ' ' ILE . 23.5 mm -113.27 121.6 65.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 109.004 -0.739 . . . . 73.2 109.004 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 84' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' B' ' 65' ' ' ARG . 1.2 mp0 -100.14 119.68 38.71 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.463 -0.569 . . . . 44.35 109.463 176.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.63 ' O ' ' HD2' ' B' ' 37' ' ' ARG . 96.5 m-85 -94.48 162.32 13.86 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 110.274 -0.269 . . . . 73.31 110.274 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.41 -34.58 31.5 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.305 -0.407 . . . . 42.23 110.608 174.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' GLU . . . . . 0.409 ' HB2' ' OG ' ' B' ' 90' ' ' SER . 9.7 mp0 -99.96 147.95 25.02 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.199 -0.6 . . . . 73.12 111.472 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.522 ' O ' HG12 ' B' ' 91' ' ' VAL . 0.0 OUTLIER -74.16 -31.64 62.79 Favored 'General case' 0 C--O 1.212 -0.891 0 N-CA-C 106.215 -1.772 . . . . 73.52 106.215 177.438 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -71.69 -29.18 64.3 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 120.479 -0.488 . . . . 74.35 111.885 177.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 90' ' ' SER . . . . . 0.409 ' OG ' ' HB2' ' B' ' 87' ' ' GLU . 49.4 m -71.49 -36.98 71.31 Favored 'General case' 0 N--CA 1.439 -0.99 0 O-C-N 122.224 -0.297 . . . . 73.53 111.349 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.618 ' CG2' HG13 ' B' ' 39' ' ' VAL . 14.5 p -65.87 -37.69 80.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 108.64 -0.874 . . . . 73.34 108.64 177.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -63.77 -33.56 75.94 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.394 -0.821 . . . . 60.34 109.816 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.12 -31.3 64.21 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.829 -0.623 . . . . 75.14 110.539 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.67 -44.71 48.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.979 -0.555 . . . . 74.54 110.396 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 21.1 m -58.61 -22.46 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 112.41 0.522 . . . . 74.04 112.41 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.76 -18.49 63.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.897 0.855 . . . . 64.13 111.034 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 43.8 ttp -98.87 11.94 37.26 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 114.34 -1.3 . . . . 73.35 109.213 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 98' ' ' ASP . . . . . 0.56 ' HA ' ' HB ' ' B' ' 109' ' ' VAL . 9.8 t70 -35.11 -61.23 0.44 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 117.037 2.236 . . . . 63.12 117.037 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 99' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' B' ' 107' ' ' ILE . 35.7 tt0 -115.74 34.98 4.65 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 119.542 1.065 . . . . 73.11 110.631 -174.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 76.4 p -77.72 -175.22 3.8 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.735 -0.666 . . . . 74.13 111.106 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -103.0 135.42 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 N-CA-C 109.334 -0.617 . . . . 71.23 109.334 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -142.23 128.19 19.53 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.596 -0.89 . . . . 74.45 108.596 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 57.2 ttt-85 56.3 32.99 21.46 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.277 1.031 . . . . 72.31 110.377 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.57 5.5 89.87 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.127 -0.942 . . . . 74.25 114.462 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -129.27 166.11 20.07 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 117.867 0.834 . . . . 61.42 109.976 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 32.4 m -90.99 122.74 33.91 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.785 -0.45 . . . . 63.32 109.785 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' B' ' 99' ' ' GLU . 39.7 pt -101.21 173.38 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 120.739 0.304 . . . . 74.03 111.763 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -130.86 120.76 24.14 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.241 -1.022 . . . . 70.33 108.241 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.619 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 42.3 t -127.0 116.04 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 123.361 0.413 . . . . 73.42 109.922 -177.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.472 HD13 ' HB3' ' B' ' 40' ' ' TYR . 0.0 OUTLIER -146.45 155.88 49.48 Favored Pre-proline 0 C--N 1.314 -0.963 0 N-CA-C 107.263 -1.384 . . . . 72.12 107.263 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.73 134.38 46.85 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.67 2.247 . . . . 72.35 113.151 -175.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.574 ' HG3' ' CD2' ' B' ' 82' ' ' TYR . 3.2 tmmm? -105.54 123.73 48.38 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 106.831 -1.544 . . . . 74.14 106.831 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.519 ' HB2' ' HB3' ' B' ' 35' ' ' ASP . 13.7 ptm180 -166.55 162.2 16.53 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-O 121.331 0.586 . . . . 64.35 112.149 -177.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 30.8 p -104.81 -172.53 2.12 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 114.09 -1.414 . . . . 61.34 108.508 173.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 115' ' ' ASN . . . . . 0.489 ' O ' ' HD3' ' B' ' 117' ' ' PRO . 27.8 t-20 -150.56 150.89 31.8 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.778 -0.453 . . . . 71.4 109.778 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 26.7 ttt -107.48 93.24 9.59 Favored Pre-proline 0 C--N 1.314 -0.959 0 N-CA-C 109.396 -0.594 . . . . 74.42 109.396 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 117' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' B' ' 115' ' ' ASN . 51.6 Cg_endo -94.7 15.61 1.14 Allowed 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.798 2.332 . . . . 55.25 111.85 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.16 66.84 3.55 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.936 -0.575 . . . . 65.34 112.021 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 23.1 pt -131.53 128.29 60.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 109.298 -0.631 . . . . 64.12 109.298 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 25.0 t -117.55 88.67 2.96 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 120.399 -0.52 . . . . 74.04 110.363 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 39.2 m 52.26 25.25 3.26 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.355 1.062 . . . . 54.35 112.947 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 22.4 m -89.1 84.41 6.56 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 120.996 0.426 . . . . 52.35 110.501 -175.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -168.36 142.14 3.21 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.624 -0.716 . . . . 74.43 109.455 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 . . . . . 0 C--N 1.311 -1.089 0 O-C-N 123.246 0.341 . . . . 75.12 110.67 178.853 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.556 0 N-CA-C 109.578 -0.527 . . . . 73.33 109.578 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 mp -83.97 110.19 18.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 109.3 -0.63 . . . . 71.21 109.3 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -117.34 98.95 52.43 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 108.942 -0.762 . . . . 52.43 108.942 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -88.12 96.62 0.4 Allowed 'Trans proline' 0 N--CA 1.427 -2.434 0 C-N-CA 122.308 2.005 . . . . 73.05 111.312 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 58.8 m -95.37 102.81 14.64 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.04 -0.726 . . . . 72.32 109.04 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.554 ' HG3' ' O ' ' B' ' 74' ' ' SER . 26.8 ttt -121.39 93.33 3.98 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.893 -0.78 . . . . 41.41 108.893 -177.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -128.83 116.09 18.92 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.691 -0.686 . . . . 64.41 111.785 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 t -90.46 -7.71 52.36 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.933 -0.766 . . . . 75.21 108.933 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.467 HG21 ' HA ' ' A' ' 23' ' ' PRO . 88.6 m 70.96 89.06 0.1 Allowed 'General case' 0 C--O 1.244 0.794 0 CA-C-N 114.626 -1.17 . . . . 75.2 111.458 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -100.71 77.3 1.87 Allowed 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.969 0.89 . . . . 73.33 110.395 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.8 p -177.29 -177.45 0.71 Allowed 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 113.686 -1.597 . . . . 73.21 107.066 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -159.79 138.44 10.61 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.701 -0.481 . . . . 63.52 109.701 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -128.92 -67.9 0.77 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.651 -1.611 . . . . 64.04 106.651 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.3 m 50.9 30.91 5.59 Favored 'General case' 0 CA--C 1.583 2.221 0 C-N-CA 124.407 1.083 . . . . 74.52 113.749 168.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.48 -25.41 57.34 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.374 -0.829 . . . . 53.44 110.731 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.75 50.08 0.98 Allowed Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.276 -0.964 . . . . 72.23 113.385 176.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.0 86.47 2.28 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 109.699 -0.482 . . . . 61.1 109.699 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.511 ' H ' HG23 ' B' ' 14' ' ' THR . 96.0 m-85 62.39 25.08 14.96 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.96 0.904 . . . . 72.54 109.388 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.9 m -91.26 149.27 21.83 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 114.138 -1.392 . . . . 74.0 110.122 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.478 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 4.5 mm-40 -94.26 27.48 2.88 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 107.032 -1.47 . . . . 71.41 107.032 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.88 -109.5 2.86 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 109.718 -1.353 . . . . 42.21 109.718 -170.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.611 ' HG3' ' CZ ' ' B' ' 40' ' ' TYR . 2.1 Cg_endo -51.67 -53.54 6.86 Favored 'Trans proline' 0 CA--C 1.574 2.513 0 C-N-CA 123.418 2.746 . . . . 60.41 114.387 174.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.517 ' HD3' ' HG2' ' A' ' 22' ' ' PRO . 11.7 Cg_exo -70.36 133.83 25.34 Favored 'Trans proline' 0 C--N 1.386 2.526 0 CA-C-N 120.96 1.379 . . . . 62.54 110.753 173.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.8 pm0 -73.04 161.76 77.82 Favored Pre-proline 0 C--N 1.297 -1.688 0 CA-C-N 115.023 -0.989 . . . . 75.02 109.107 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.79 100.26 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.537 1.491 . . . . 53.04 109.236 173.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.548 ' HG ' ' H ' ' A' ' 27' ' ' SER . 0.5 OUTLIER -65.52 -84.83 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.457 -0.792 . . . . 61.44 111.999 -176.419 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.548 ' H ' ' HG ' ' A' ' 26' ' ' LEU . 29.3 t -140.43 143.71 35.75 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 120.409 -0.516 . . . . 72.0 110.381 172.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.81 -40.37 75.85 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 124.006 0.816 . . . . 72.42 109.51 171.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.28 39.7 mt-10 -76.65 -29.24 56.33 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 113.992 1.108 . . . . 73.01 113.992 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.511 ' HB2' ' HB3' ' A' ' 27' ' ' SER . 14.7 tp10 -64.12 -38.91 92.77 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 106.385 -1.709 . . . . 70.4 106.385 175.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -64.82 -45.16 87.36 Favored 'General case' 0 C--O 1.199 -1.591 0 CA-C-N 114.713 -1.131 . . . . 75.23 108.813 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.558 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -56.79 -46.99 81.18 Favored 'General case' 0 N--CA 1.42 -1.936 0 C-N-CA 123.514 0.726 . . . . 74.1 111.686 178.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -68.41 -44.45 75.0 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 121.028 -0.269 . . . . 75.33 111.389 -177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 30' ' ' GLU . 12.9 pt -66.64 -34.22 68.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.08 0.467 . . . . 75.04 110.742 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.24 -40.01 89.91 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.65 1.18 . . . . 55.51 110.985 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.558 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 98.6 mttt -64.2 -21.0 66.41 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.596 0.712 . . . . 73.44 110.492 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.522 ' HD3' ' O ' ' A' ' 86' ' ' ALA . 90.9 mtt180 -109.64 16.48 22.12 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.35 -0.841 . . . . 71.41 109.657 -174.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 46.9 m -101.05 158.4 16.04 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 121.471 0.653 . . . . 40.12 111.762 178.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.5 m -134.58 163.56 36.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.583 -0.735 . . . . 73.2 109.684 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.691 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 23.3 t80 -109.49 128.13 54.94 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.545 -1.28 . . . . 73.32 107.545 174.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.9 t -120.94 109.28 24.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 107.843 -1.169 . . . . 72.24 107.843 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.65 170.99 15.87 Favored Glycine 0 C--N 1.293 -1.842 0 C-N-CA 119.785 -1.198 . . . . 40.35 113.783 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t30 67.55 17.31 9.98 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 125.297 1.439 . . . . 63.24 112.163 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.439 ' O ' ' HA3' ' A' ' 79' ' ' GLY . 14.5 p -72.16 141.58 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 109.257 -0.646 . . . . 71.12 109.257 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -107.24 165.27 11.5 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 112.077 0.399 . . . . 53.34 112.077 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.408 ' CE1' ' HB3' ' A' ' 70' ' ' CYS . 21.7 m-85 -59.31 -26.51 65.06 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.316 0.646 . . . . 74.51 111.948 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.94 -16.57 80.58 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.36 -0.696 . . . . 53.45 111.36 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 24.7 m -95.8 125.96 40.73 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 107.342 -1.355 . . . . 72.34 107.342 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.48 HG21 ' HB ' ' B' ' 49' ' ' THR 0.253 3.6 p -126.31 179.31 5.34 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 114.527 1.306 . . . . 75.35 114.527 -172.023 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.463 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -56.86 -52.65 64.28 Favored 'General case' 0 C--O 1.213 -0.818 0 N-CA-C 114.459 1.281 . . . . 54.34 114.459 -168.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.25 28.1 pt20 -64.37 -32.14 73.63 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 119.103 -1.039 . . . . 72.12 112.941 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -59.9 -44.93 93.97 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.101 -0.703 . . . . 51.14 109.101 176.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 69.8 mt -73.04 -48.54 35.17 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.562 -1.199 . . . . 71.5 111.214 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.34 -49.62 74.86 Favored 'General case' 0 C--O 1.198 -1.625 0 CA-C-N 116.197 -0.456 . . . . 73.11 111.429 -177.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.6 -41.73 86.48 Favored 'General case' 0 C--O 1.257 1.482 0 CA-C-O 121.434 0.635 . . . . 64.13 111.98 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -68.02 -39.2 83.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.995 -1.002 . . . . 73.14 110.023 -176.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -82.23 -21.52 36.29 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.213 0.82 . . . . 65.15 113.213 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.3 t -68.83 -24.29 64.36 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.988 -0.745 . . . . 72.43 108.988 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.2 m -60.28 -33.92 73.02 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.521 0.677 . . . . 71.44 109.526 172.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 63.4 m -90.33 5.05 48.91 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.515 -0.766 . . . . 73.33 112.373 -177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.83 -168.62 29.96 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 118.688 -1.72 . . . . 73.34 115.08 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.436 ' HB2' ' HB3' ' A' ' 86' ' ' ALA . 9.9 m -97.96 122.73 41.43 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.315 -0.624 . . . . 74.01 109.315 -176.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.5 mt -91.46 131.23 39.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 113.018 0.747 . . . . 74.31 113.018 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -100.05 -40.95 7.37 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.162 -0.926 . . . . 71.12 110.905 176.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.431 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 88.6 mtt180 -149.91 158.91 44.64 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 108.837 -0.801 . . . . 75.12 108.837 -177.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.463 HD11 ' HB1' ' A' ' 50' ' ' ALA . 27.3 pt -144.95 140.82 23.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 106.941 -1.503 . . . . 61.33 106.941 169.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.0 m -125.25 125.35 43.44 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 106.498 -1.667 . . . . 74.33 106.498 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.458 HD12 ' O ' ' B' ' 68' ' ' ILE . 3.4 mp -122.12 118.57 55.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.812 -1.551 . . . . 72.32 106.812 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.263 1.2 pt? -120.09 122.81 41.9 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 120.206 -0.597 . . . . 63.35 111.111 178.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.445 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 64.2 m -116.85 132.63 56.65 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.271 -1.011 . . . . 74.14 108.271 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 3.6 p-10 -118.74 138.18 52.84 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 119.559 -0.856 . . . . 62.04 112.005 -176.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -117.59 13.25 14.28 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.297 -0.865 . . . . 63.1 109.631 173.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.46 ' CD2' ' HB2' ' A' ' 71' ' ' ASP . 13.9 p90 -65.8 -23.53 66.72 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.428 0.632 . . . . 64.13 110.395 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.1 t -83.49 0.55 45.91 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.781 -0.645 . . . . 65.4 110.151 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.92 -58.72 1.05 Allowed Glycine 0 N--CA 1.438 -1.213 0 N-CA-C 110.533 -1.027 . . . . 44.32 110.533 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -95.13 130.35 32.81 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 108.703 -0.851 . . . . 71.04 108.703 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 24.3 Cg_endo -62.32 119.28 6.31 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 123.028 2.486 . . . . 72.13 114.183 -175.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -104.43 -168.92 1.55 Allowed 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.582 -1.266 . . . . 75.35 107.582 171.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 70' ' ' CYS . . . -172.33 141.79 6.47 Favored Glycine 0 N--CA 1.407 -3.299 0 C-N-CA 119.792 -1.194 . . . . 71.23 112.726 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -151.57 145.47 25.15 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 123.813 0.845 . . . . 63.14 109.033 175.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.91 159.46 42.14 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-O 120.925 0.393 . . . . 50.1 111.178 -172.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -123.06 123.34 40.62 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.988 -0.745 . . . . 61.33 108.988 175.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.431 HG23 HG22 ' A' ' 66' ' ' ILE . 33.4 mm -103.06 119.93 52.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 106.624 -1.621 . . . . 73.03 106.624 177.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 38' ' ' SER . 35.0 mt-10 -107.12 119.31 39.03 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.068 0.461 . . . . 53.11 110.049 -176.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -100.58 167.48 10.33 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.389 0.614 . . . . 72.04 112.468 -174.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.522 ' O ' ' HD3' ' A' ' 37' ' ' ARG . . . -83.85 -33.26 24.89 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.184 -0.916 . . . . 72.4 111.665 174.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.421 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 4.5 mp0 -104.55 143.66 32.74 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 110.119 -0.326 . . . . 62.32 110.119 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.479 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -73.04 -29.66 63.15 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 106.005 -1.85 . . . . 75.42 106.005 177.174 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' A' ' 92' ' ' ASP . 13.9 m120 -60.48 -28.07 68.06 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.989 -1.459 . . . . 71.15 110.425 177.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 87' ' ' GLU . 26.8 m -67.35 -36.38 81.28 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 116.553 -0.294 . . . . 62.03 110.922 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 88' ' ' ARG . 3.2 m -64.06 -39.05 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 N-CA-C 108.429 -0.952 . . . . 74.14 108.429 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 89' ' ' ASN . 21.2 t70 -55.89 -39.6 71.8 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.929 0.768 . . . . 75.34 110.585 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.23 -37.43 63.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.891 -0.595 . . . . 62.33 111.452 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.56 -45.24 62.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.945 0.402 . . . . 54.24 111.357 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.485 HG11 ' HD3' ' A' ' 111' ' ' PRO . 28.6 m -56.97 -22.15 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 113.16 0.8 . . . . 73.4 113.16 178.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.69 -17.73 64.81 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.277 0.561 . . . . 72.43 110.806 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.51 ' O ' HG22 ' A' ' 100' ' ' THR . 66.2 mtm -99.58 8.11 44.71 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.754 -0.657 . . . . 73.03 110.676 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -41.75 -42.33 2.57 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 115.476 1.658 . . . . 61.31 115.476 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 41.9 tt0 -107.36 16.33 24.05 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 118.737 0.699 . . . . 64.34 112.439 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 97' ' ' MET . 7.3 t -81.79 175.38 10.49 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 118.809 -1.156 . . . . 73.44 109.865 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.3 m -108.8 118.91 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 CA-C-O 121.652 0.739 . . . . 64.34 110.884 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.479 ' HB2' HD13 ' A' ' 107' ' ' ILE . 61.0 t80 -92.06 117.79 30.18 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 107.494 -1.298 . . . . 74.34 107.494 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 50.03 32.85 6.12 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.801 1.241 . . . . 73.21 112.135 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 99.5 -4.97 58.45 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 114.855 0.702 . . . . 61.23 114.855 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -118.67 137.02 53.6 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 118.209 1.004 . . . . 72.51 110.68 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.6 m -70.26 119.09 13.93 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.131 0.491 . . . . 64.22 110.38 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 102' ' ' PHE . 45.7 pt -103.51 172.65 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 CA-C-N 116.054 -0.521 . . . . 70.43 110.223 177.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.427 ' HD2' ' HA ' ' A' ' 108' ' ' LYS . 19.8 mmmt -123.94 129.41 50.91 Favored 'General case' 0 CA--C 1.472 -2.03 0 CA-C-N 115.739 -0.664 . . . . 75.42 109.621 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.691 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 22.7 t -127.77 122.81 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 108.651 -0.87 . . . . 75.1 108.651 176.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.52 HD13 ' HB3' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -146.73 155.35 48.48 Favored Pre-proline 0 C--N 1.292 -1.913 0 N-CA-C 107.464 -1.31 . . . . 74.12 107.464 175.808 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.485 ' HD3' HG11 ' A' ' 95' ' ' VAL . 49.7 Cg_endo -66.29 140.92 60.42 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.134 1.223 . . . . 62.13 110.061 -175.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -61.06 106.33 0.58 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.249 0.547 . . . . 75.01 111.038 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -123.15 -171.16 2.24 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.345 -0.843 . . . . 74.4 109.797 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.0 m 78.76 69.68 0.04 OUTLIER 'General case' 0 C--O 1.246 0.901 0 CA-C-O 122.911 1.339 . . . . 63.3 109.99 -176.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -168.6 103.6 0.42 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 112.714 -2.039 . . . . 75.52 106.979 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 27.4 ttt -102.46 119.19 56.91 Favored Pre-proline 0 C--N 1.3 -1.547 0 CA-C-N 116.205 -0.452 . . . . 73.43 111.498 -176.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -71.94 100.12 1.05 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.001 1.801 . . . . 63.25 109.599 174.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.56 87.71 1.55 Allowed Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 115.745 -0.661 . . . . 61.15 113.311 -175.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 21.6 pt -128.22 87.58 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-O 121.962 0.887 . . . . 63.42 109.484 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.1 m -84.26 144.82 28.65 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.344 -0.844 . . . . 70.44 112.571 -172.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 50.5 m -148.33 103.08 3.4 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.604 -0.726 . . . . 71.32 109.356 175.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 43.0 m -107.48 -30.9 8.38 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.979 -0.555 . . . . 65.14 110.584 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.3 t70 73.21 -47.31 0.66 Allowed 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 124.141 0.976 . . . . 72.4 113.469 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 . . . . . 0 C--N 1.308 -1.223 0 N-CA-C 110.006 -0.368 . . . . 74.52 110.006 -179.432 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.496 0 N-CA-C 110.007 -0.368 . . . . 55.2 110.007 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 47.1 mm -123.14 110.19 25.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 108.978 -0.749 . . . . 71.24 108.978 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -144.82 85.4 8.37 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 109.867 -0.419 . . . . 71.43 109.867 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -80.63 -10.28 13.19 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 122.945 2.43 . . . . 61.01 112.092 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 70.9 m 59.47 90.18 0.06 Allowed 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.973 0.909 . . . . 64.34 111.674 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 24.1 mmt -82.32 101.13 10.36 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.023 -0.732 . . . . 74.15 109.023 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -125.9 100.28 6.31 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.502 -0.555 . . . . 53.23 109.502 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 50.2 m -73.45 97.27 2.52 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 115.764 -0.653 . . . . 75.15 110.693 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 23.5 p -137.18 -67.91 0.49 Allowed 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.045 -0.724 . . . . 70.32 109.045 175.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 62.75 19.73 11.63 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 121.879 0.847 . . . . 74.42 110.369 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 32.4 t -172.89 174.62 3.51 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.198 -1.408 . . . . 54.44 107.198 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -108.13 98.5 8.05 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.67 -1.233 . . . . 73.3 107.67 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 64.1 mtt -106.85 110.76 23.0 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.317 -0.401 . . . . 65.45 110.243 -175.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.511 HG23 ' H ' ' A' ' 18' ' ' TYR . 8.9 t -133.26 136.19 45.38 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.388 0.613 . . . . 74.22 111.706 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.69 178.33 8.25 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.538 -0.755 . . . . 63.42 109.966 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.06 -75.11 0.79 Allowed Glycine 0 N--CA 1.443 -0.842 0 O-C-N 123.596 0.56 . . . . 64.3 113.298 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.41 104.73 4.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.061 0.457 . . . . 71.32 111.344 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -150.74 91.71 1.76 Allowed 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.104 -0.702 . . . . 74.12 109.104 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 48.9 m -135.59 139.77 44.11 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.211 -0.663 . . . . 75.41 109.211 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' GLU . . . . . 0.46 ' O ' ' HD2' ' B' ' 23' ' ' PRO . 2.4 mp0 -51.89 -28.35 15.9 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 114.201 1.186 . . . . 74.53 114.201 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.11 -130.72 10.08 Favored Glycine 0 CA--C 1.502 -0.762 0 N-CA-C 111.045 -0.822 . . . . 73.44 111.045 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -51.13 -45.04 39.09 Favored 'Trans proline' 0 CA--C 1.566 2.105 0 C-N-CA 123.542 2.828 . . . . 74.55 114.884 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.46 ' HD2' ' O ' ' B' ' 20' ' ' GLU . 62.1 Cg_exo -54.51 150.53 34.29 Favored 'Trans proline' 0 C--N 1.394 2.952 0 C-N-CA 121.839 1.692 . . . . 73.41 111.937 176.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -73.16 139.25 79.06 Favored Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 116.368 -0.378 . . . . 70.24 110.806 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -69.79 140.95 43.81 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.744 2.296 . . . . 74.2 113.517 -176.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.585 HD23 ' HB3' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -90.13 177.86 6.33 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.911 -1.041 . . . . 71.32 111.033 173.797 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 46.2 t -59.7 144.67 47.42 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 112.712 0.634 . . . . 51.34 112.712 -175.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.03 -37.74 54.56 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.994 -1.003 . . . . 64.23 111.024 171.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -76.43 -28.49 56.63 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 113.116 0.784 . . . . 70.14 113.116 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.585 ' HB3' HD23 ' B' ' 26' ' ' LEU . 3.7 tp10 -64.5 -39.3 93.53 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 106.276 -1.75 . . . . 73.51 106.276 175.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -64.87 -44.32 90.08 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 114.424 -1.262 . . . . 73.44 108.697 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.61 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 0.1 OUTLIER -57.2 -47.57 80.95 Favored 'General case' 0 N--CA 1.413 -2.309 0 C-N-CA 123.597 0.759 . . . . 71.33 111.745 179.095 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.409 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 80.4 mm-40 -68.42 -44.57 74.7 Favored 'General case' 0 CA--C 1.505 -0.751 0 O-C-N 123.068 0.23 . . . . 72.12 111.363 -177.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.502 HG12 ' O ' ' B' ' 30' ' ' GLU . 11.3 pt -66.35 -34.93 73.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 O-C-N 123.376 0.422 . . . . 72.12 110.428 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -65.6 -42.07 92.04 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.49 0.716 . . . . 75.4 109.91 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.61 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 99.1 mttt -61.07 -24.19 66.03 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.613 -0.721 . . . . 70.51 110.777 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.55 ' HD3' ' O ' ' B' ' 86' ' ' ALA . 67.6 mtt180 -106.89 17.05 23.62 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.561 -0.745 . . . . 71.33 110.12 -174.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.433 ' HB2' ' HB3' ' B' ' 112' ' ' LYS . 26.2 m -106.43 169.08 8.73 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.176 0.512 . . . . 55.13 111.976 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 28.1 m -139.91 164.74 22.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 124.129 0.972 . . . . 74.23 110.211 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' TYR . . . . . 0.69 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 28.6 t80 -109.73 129.03 55.65 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.669 -1.234 . . . . 75.04 107.669 174.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 97.5 t -122.18 111.93 32.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 108.451 -0.944 . . . . 73.11 108.451 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.93 171.22 16.66 Favored Glycine 0 C--N 1.289 -2.044 0 C-N-CA 120.022 -1.085 . . . . 64.12 113.558 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 61.4 t30 65.95 23.67 11.22 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.144 1.778 . . . . 73.25 112.754 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 14.1 p -65.83 130.95 31.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.838 -0.801 . . . . 72.43 108.838 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -99.95 161.37 13.65 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.39 -0.823 . . . . 63.35 111.393 -175.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' TYR . . . . . 0.764 ' CE1' ' HB2' ' B' ' 77' ' ' PRO . 17.7 m-85 -71.47 92.06 1.08 Allowed 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.489 -0.778 . . . . 71.01 109.793 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 164.75 -23.2 0.16 Allowed Glycine 0 N--CA 1.419 -2.446 0 CA-C-N 114.353 -1.294 . . . . 60.04 110.03 -177.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 40.3 m -79.47 128.54 33.48 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 109.097 -0.705 . . . . 70.12 109.097 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' THR . . . . . 0.48 ' HB ' HG21 ' A' ' 49' ' ' THR . 82.7 p -92.45 170.2 9.95 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 108.575 -0.898 . . . . 71.41 108.575 177.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.59 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -61.27 -44.07 97.83 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 110.274 -0.269 . . . . 74.21 110.274 175.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -62.36 -36.35 81.97 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.444 0.535 . . . . 65.23 112.444 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -56.64 -45.72 81.43 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.622 0.725 . . . . 71.04 109.727 176.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 57.0 mt -69.97 -48.24 59.05 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.664 -1.153 . . . . 54.54 111.642 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -62.1 -49.41 76.03 Favored 'General case' 0 C--O 1.199 -1.603 0 C-N-CA 122.831 0.452 . . . . 61.13 111.503 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.43 96.34 Favored 'General case' 0 C--O 1.252 1.23 0 CA-C-O 120.936 0.398 . . . . 43.54 110.651 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -66.37 -39.59 89.21 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.145 -0.48 . . . . 62.3 110.172 -176.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -82.18 -21.6 36.43 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 113.556 0.947 . . . . 71.32 113.556 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 23.2 t -70.09 -23.56 63.08 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.452 -0.944 . . . . 74.0 108.452 -178.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.3 m -58.66 -31.18 67.93 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-O 121.234 0.54 . . . . 54.53 109.773 172.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 69.5 m -95.3 10.72 35.15 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.809 -0.632 . . . . 73.34 112.567 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 143.42 -172.4 24.81 Favored Glycine 0 N--CA 1.462 0.388 0 C-N-CA 119.67 -1.252 . . . . 12.15 113.992 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 36.0 t -97.03 127.26 42.83 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 109.787 -0.449 . . . . 71.24 109.787 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 71.1 mt -90.62 133.62 31.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 115.789 -0.642 . . . . 73.24 112.661 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' ASN . . . . . 0.487 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 95.8 m-20 -101.39 -35.46 9.2 Favored 'General case' 0 C--O 1.206 -1.203 0 CA-C-N 115.488 -0.778 . . . . 71.23 111.68 176.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.437 ' HB2' ' HB2' ' B' ' 84' ' ' GLU . 94.0 mtt180 -153.19 159.72 42.72 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.885 -0.783 . . . . 75.23 108.885 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.59 HD11 ' HB1' ' B' ' 50' ' ' ALA . 24.6 pt -145.37 139.39 21.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.112 -1.44 . . . . 72.31 107.112 170.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 90.7 m -125.43 123.71 39.87 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 107.638 -1.245 . . . . 74.24 107.638 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.458 ' O ' HD12 ' A' ' 68' ' ' ILE . 2.3 mp -119.63 121.23 65.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 106.078 -1.823 . . . . 73.32 106.078 -177.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 66' ' ' ILE 0.298 1.2 pt? -121.06 122.85 40.97 Favored 'General case' 0 C--N 1.28 -2.434 0 C-N-CA 120.21 -0.596 . . . . 70.44 111.881 176.508 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 70' ' ' CYS . . . . . 0.437 ' HA ' ' HA2' ' B' ' 79' ' ' GLY . 64.6 m -116.74 130.99 57.06 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.939 -1.134 . . . . 73.11 107.939 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.537 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 3.5 p-10 -121.15 144.16 48.72 Favored 'General case' 0 C--O 1.201 -1.475 0 C-N-CA 119.756 -0.778 . . . . 61.31 110.627 -176.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -121.69 5.16 10.03 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.199 -0.667 . . . . 64.02 109.199 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.441 ' CD2' ' HB2' ' B' ' 71' ' ' ASP . 34.5 p90 -67.31 -26.52 66.56 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-O 121.132 0.492 . . . . 63.33 109.836 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.554 ' O ' ' HG3' ' A' ' 6' ' ' MET . 41.0 m -66.15 -18.8 65.58 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.555 -0.748 . . . . 75.24 111.758 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.34 -51.76 0.76 Allowed Glycine 0 CA--C 1.482 -2.028 0 N-CA-C 108.308 -1.917 . . . . 74.14 108.308 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 53.9 m170 -97.14 148.92 35.11 Favored Pre-proline 0 CA--C 1.479 -1.77 0 N-CA-C 105.851 -1.907 . . . . 73.35 105.851 173.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.764 ' HB2' ' CE1' ' B' ' 46' ' ' TYR . 74.5 Cg_endo -80.49 116.51 3.27 Favored 'Trans proline' 0 N--CA 1.417 -3.016 0 N-CA-C 108.955 -1.209 . . . . 75.43 108.955 173.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 78' ' ' LYS . . . . . 0.44 ' HZ3' ' CG ' ' B' ' 71' ' ' ASP . 23.9 mtmm -104.83 -168.52 1.49 Allowed 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 108.643 -0.873 . . . . 62.14 108.643 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' B' ' 70' ' ' CYS . . . -168.38 139.77 5.85 Favored Glycine 0 N--CA 1.403 -3.559 0 C-N-CA 119.7 -1.238 . . . . 54.12 113.17 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -150.12 144.67 25.86 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 114.662 -0.769 . . . . 61.13 109.344 174.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.44 159.91 41.07 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-O 120.716 0.293 . . . . 64.25 110.763 -172.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 82' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -123.0 125.55 45.45 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.427 -0.953 . . . . 74.15 108.427 174.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.433 HG23 HG22 ' B' ' 66' ' ' ILE . 44.6 mm -103.87 120.46 54.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 106.752 -1.573 . . . . 72.5 106.752 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 84' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' B' ' 65' ' ' ARG . 34.3 mt-10 -107.4 118.73 37.5 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.079 0.466 . . . . 73.54 110.025 -175.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -99.93 166.73 10.92 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.998 0.74 . . . . 63.32 112.998 -173.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.55 ' O ' ' HD3' ' B' ' 37' ' ' ARG . . . -77.57 -36.84 51.64 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.641 -1.163 . . . . 52.33 111.378 174.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -109.08 146.82 33.37 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.15 0.5 . . . . 61.14 112.029 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.486 ' O ' HG22 ' B' ' 91' ' ' VAL . 0.6 OUTLIER -73.93 -29.77 62.21 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 106.407 -1.701 . . . . 72.53 106.407 178.759 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -64.15 -24.08 67.55 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 114.773 -1.103 . . . . 71.14 110.667 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 19.8 m -68.33 -36.28 79.04 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 116.394 -0.366 . . . . 62.34 110.314 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.486 HG22 ' O ' ' B' ' 88' ' ' ARG . 3.1 m -64.49 -38.99 84.03 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.071 0 N-CA-C 108.373 -0.973 . . . . 74.35 108.373 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.3 -38.56 74.19 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 123.769 0.668 . . . . 33.34 110.601 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.27 -35.4 63.76 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.054 -0.521 . . . . 74.33 111.3 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.77 -45.24 59.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.911 0.386 . . . . 54.15 111.056 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 95' ' ' VAL . . . . . 0.43 HG13 ' O ' ' B' ' 91' ' ' VAL . 26.0 m -57.79 -21.58 16.74 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 N-CA-C 112.935 0.717 . . . . 70.33 112.935 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.25 -15.4 63.16 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 121.581 0.705 . . . . 71.11 110.62 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 67.3 mtm -103.35 12.27 35.61 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.536 -0.756 . . . . 74.24 109.662 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 98' ' ' ASP . . . . . 0.614 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 2.1 p-10 -36.21 -43.45 0.35 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.249 1.574 . . . . 65.04 115.249 -176.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -130.09 61.76 1.58 Allowed 'General case' 0 N--CA 1.421 -1.918 0 C-N-CA 118.665 -1.214 . . . . 73.43 111.129 174.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 15.0 t -89.84 173.84 8.03 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 113.914 -1.493 . . . . 74.4 109.995 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.35 128.77 63.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.261 0.553 . . . . 45.42 109.841 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -140.68 126.11 18.84 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.647 -1.242 . . . . 74.52 107.647 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . 0.366 12.6 ptm85 50.37 55.03 10.11 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.114 1.524 . . . . 73.34 115.114 -176.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.72 -4.4 9.73 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 114.616 -1.175 . . . . 74.43 115.484 177.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -127.76 161.89 27.91 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 117.897 0.849 . . . . 72.55 110.666 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 37.1 m -95.64 128.37 42.45 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 109.53 -0.544 . . . . 62.12 109.53 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 35.8 pt -102.49 171.69 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 120.922 -0.311 . . . . 54.12 111.075 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' LYS . . . . . 0.614 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 41.7 tptt -131.04 126.8 36.83 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 109.394 -0.595 . . . . 73.33 109.394 -176.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.69 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 18.1 t -126.88 131.58 70.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.112 -0.699 . . . . 72.14 109.112 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.659 ' HB3' ' HD2' ' B' ' 111' ' ' PRO 0.266 0.2 OUTLIER -136.26 168.42 17.26 Favored Pre-proline 0 CA--C 1.502 -0.894 0 N-CA-C 105.493 -2.04 . . . . 71.13 105.493 172.387 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.659 ' HD2' ' HB3' ' B' ' 110' ' ' LEU . 95.3 Cg_endo -76.55 148.75 29.82 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.363 1.375 . . . . 62.31 109.887 171.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' B' ' 38' ' ' SER . 72.3 tttt -89.72 124.25 34.45 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.217 -1.771 . . . . 63.53 106.217 178.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.7 78.09 1.78 Allowed 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.958 -1.497 . . . . 53.24 106.958 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.587 HG22 ' H ' ' B' ' 115' ' ' ASN . 4.4 m -154.08 -142.24 0.11 Allowed 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 107.428 -1.323 . . . . 70.15 107.428 -175.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 115' ' ' ASN . . . . . 0.587 ' H ' HG22 ' B' ' 114' ' ' THR . 7.4 t30 165.31 179.13 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 103.873 -2.639 . . . . 64.03 103.873 174.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 28.0 ttt -126.85 71.22 74.41 Favored Pre-proline 0 C--N 1.297 -1.706 0 C-N-CA 118.995 -1.082 . . . . 71.54 110.713 172.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 117' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' B' ' 14' ' ' THR . 74.0 Cg_endo -107.65 24.56 0.07 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.837 0 C-N-CA 123.644 2.896 . . . . 75.23 109.566 175.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.04 -9.38 63.22 Favored Glycine 0 CA--C 1.493 -1.308 0 CA-C-N 115.501 -0.772 . . . . 53.11 112.02 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 60.4 mt -79.2 86.87 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.017 0 N-CA-C 107.289 -1.375 . . . . 64.04 107.289 175.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 42.6 m -148.06 111.97 5.12 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.735 -0.839 . . . . 75.44 108.735 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 53.4 m -152.38 127.15 9.54 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.721 -0.474 . . . . 72.03 109.721 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 38.7 m -85.78 93.24 8.83 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-O 121.554 0.692 . . . . 73.11 109.546 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -87.54 78.1 8.64 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.938 0.875 . . . . 74.32 109.404 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.456 ' C ' ' HE ' ' B' ' 124' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.494 -1.195 0 N-CA-C 106.883 -1.525 . . . . 74.35 106.883 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.572 0 N-CA-C 110.025 -0.361 . . . . 72.45 110.025 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.3 pt -80.96 135.56 24.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 120.857 0.361 . . . . 74.41 110.051 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.83 112.11 9.65 Favored Pre-proline 0 C--N 1.305 -1.354 0 CA-C-N 116.477 -0.329 . . . . 43.21 110.857 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.82 104.05 1.84 Allowed 'Trans proline' 0 N--CA 1.44 -1.658 0 C-N-CA 121.81 1.673 . . . . 62.35 110.173 176.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 58.0 m -106.76 115.72 30.69 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.481 -0.781 . . . . 62.14 109.198 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.541 ' HG2' ' OE1' ' A' ' 99' ' ' GLU . 1.6 mpt? -84.69 88.05 7.33 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.181 0.515 . . . . 61.42 111.927 -176.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -97.35 102.79 14.63 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.703 -1.592 . . . . 75.52 106.703 177.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.3 t -163.49 172.21 14.78 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.341 -0.985 . . . . 63.54 108.341 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -168.49 -178.82 3.65 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 107.923 -1.14 . . . . 75.42 107.923 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.425 ' CB ' ' HG ' ' A' ' 110' ' ' LEU . 8.2 p80 -124.66 153.33 42.44 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.045 -0.724 . . . . 65.15 109.045 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.7 m -76.26 94.61 3.58 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 109.877 -0.416 . . . . 73.24 109.877 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -75.03 91.27 2.52 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 122.242 1.02 . . . . 72.12 111.871 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.6 ttp -165.66 151.44 9.27 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.739 -1.573 . . . . 64.2 106.944 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.8 m -57.53 116.9 3.65 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.559 -0.534 . . . . 72.24 109.559 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.79 -33.64 76.07 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 115.99 -0.55 . . . . 53.12 112.143 -176.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.7 -179.47 16.24 Favored Glycine 0 N--CA 1.429 -1.802 0 C-N-CA 120.407 -0.901 . . . . 74.14 111.721 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -108.64 158.67 17.38 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 109.977 -0.379 . . . . 74.35 109.977 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -108.21 136.32 48.06 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.092 -0.706 . . . . 75.35 109.092 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.0 m -74.84 97.17 3.24 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.943 -0.571 . . . . 64.32 109.861 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -70.83 159.1 35.2 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.536 -0.913 . . . . 71.3 108.536 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.429 ' HA3' ' HD3' ' A' ' 22' ' ' PRO . . . -87.91 -108.06 0.97 Allowed Glycine 0 C--N 1.306 -1.101 0 C-N-CA 120.491 -0.862 . . . . 61.42 113.861 -174.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.476 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 8.6 Cg_endo -75.82 -20.78 14.97 Favored 'Trans proline' 0 CA--C 1.589 3.26 0 N-CA-C 119.179 2.723 . . . . 70.22 119.179 -177.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 22' ' ' PRO . 11.7 Cg_endo -52.74 124.48 15.45 Favored 'Trans proline' 0 C--N 1.403 3.429 0 CA-C-N 122.85 2.053 . . . . 71.41 113.575 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -59.71 150.55 66.82 Favored Pre-proline 0 C--O 1.245 0.849 0 CA-C-N 115.256 -0.884 . . . . 63.23 112.591 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -55.37 121.62 10.25 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.675 2.917 . . . . 62.41 116.097 -176.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.641 HD13 ' H ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -102.93 164.1 11.82 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.272 -1.751 . . . . 71.51 106.272 165.738 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.469 ' HB3' ' OE2' ' A' ' 30' ' ' GLU . 46.1 t -59.99 143.79 50.87 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 113.234 0.827 . . . . 73.21 113.234 -172.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.401 ' O ' ' HE2' ' A' ' 32' ' ' LYS . . . -53.39 -33.18 52.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.1 -1.409 . . . . 71.12 110.801 174.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -66.75 -38.58 86.91 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 116.672 -0.24 . . . . 73.52 111.253 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.469 ' OE2' ' HB3' ' A' ' 27' ' ' SER . 0.6 OUTLIER -65.08 -34.82 79.33 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 116.449 -0.341 . . . . 73.02 110.909 174.775 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -67.13 -45.47 77.04 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.022 0.439 . . . . 53.3 110.36 -176.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.401 ' HE2' ' O ' ' A' ' 28' ' ' ALA . 46.6 mtmt -61.2 -42.64 98.94 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.936 -0.575 . . . . 70.43 112.07 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.48 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 11.3 mm-40 -71.27 -40.66 70.8 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-N 116.045 -0.525 . . . . 72.35 112.3 -176.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.9 pt -65.37 -35.59 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 112.934 0.716 . . . . 72.2 112.934 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -71.15 -29.5 65.29 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 119.878 -0.729 . . . . 71.1 110.778 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -73.69 -15.91 61.21 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.525 0.73 . . . . 74.54 110.067 176.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 98.3 mtt180 -104.9 12.02 32.95 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.303 -0.862 . . . . 71.23 109.019 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.453 ' HB3' ' HE2' ' A' ' 112' ' ' LYS . 33.0 t -107.21 156.65 18.61 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 121.58 0.705 . . . . 74.05 110.853 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.514 ' CG1' ' HB ' ' A' ' 91' ' ' VAL . 34.3 m -136.23 164.58 31.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.359 -0.837 . . . . 70.53 109.66 -177.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.585 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 22.4 t80 -110.18 127.0 54.69 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 107.847 -1.168 . . . . 72.54 107.847 176.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 58.0 t -121.31 112.73 36.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 107.518 -1.29 . . . . 75.42 107.518 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -117.81 172.71 14.48 Favored Glycine 0 C--N 1.294 -1.789 0 C-N-CA 118.978 -1.582 . . . . 73.4 114.036 -176.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.7 t30 60.41 20.86 10.49 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 125.749 1.62 . . . . 71.55 112.198 -176.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.87 139.92 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 121.093 0.473 . . . . 62.53 110.039 176.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -82.83 156.03 23.85 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.672 -0.862 . . . . 74.11 108.672 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -68.63 -18.62 64.33 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.741 0.781 . . . . 72.14 109.235 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.4 -15.7 81.18 Favored Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 115.055 -0.975 . . . . 74.1 112.296 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.4 m -87.1 127.34 35.13 Favored 'General case' 0 N--CA 1.411 -2.388 0 N-CA-C 108.011 -1.107 . . . . 34.14 108.011 176.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.3 p -105.49 178.67 4.49 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.613 -0.514 . . . . 74.15 109.613 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.585 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -60.7 -46.07 91.79 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.753 -0.462 . . . . 45.23 109.753 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -58.41 -36.25 73.29 Favored 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 115.596 -0.729 . . . . 73.14 111.305 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -67.45 -40.61 85.43 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.206 0.526 . . . . 62.14 110.463 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.6 mt -66.49 -47.94 71.43 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 115.165 -0.925 . . . . 60.24 111.744 -177.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -60.62 -46.39 90.46 Favored 'General case' 0 C--O 1.181 -2.528 0 N-CA-C 113.645 0.98 . . . . 55.31 113.645 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.38 -47.83 75.23 Favored 'General case' 0 C--O 1.271 2.189 0 CA-C-O 121.662 0.744 . . . . 52.25 111.455 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -63.86 -43.01 97.38 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.851 -1.068 . . . . 74.01 110.568 -178.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -82.13 -22.21 36.27 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 114.843 1.423 . . . . 63.01 114.843 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.4 t -67.07 -26.97 67.0 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.284 -0.636 . . . . 53.42 109.284 -177.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.2 m -59.1 -24.94 63.38 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 120.534 -0.466 . . . . 71.4 111.004 173.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 76.7 m -95.72 7.2 46.96 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.876 1.065 . . . . 63.44 113.876 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.38 -147.25 18.4 Favored Glycine 0 C--O 1.238 0.35 0 C-N-CA 118.51 -1.805 . . . . 60.0 115.067 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 52.8 p -112.95 122.97 49.23 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.021 0.438 . . . . 62.5 111.541 -175.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.3 mt -89.39 130.52 38.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-O 121.21 0.528 . . . . 71.34 112.03 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -92.68 -48.95 6.33 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.043 -0.981 . . . . 70.53 109.055 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.42 ' HG2' ' HB2' ' B' ' 71' ' ' ASP . 79.2 mtm180 -155.83 163.78 39.37 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.613 -0.884 . . . . 74.41 108.613 -176.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.585 HD11 ' HB1' ' A' ' 50' ' ' ALA . 31.3 pt -145.87 144.51 20.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 109.185 -0.672 . . . . 64.11 109.185 176.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.4 m -125.71 126.03 43.96 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 107.334 -1.358 . . . . 75.12 107.334 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.8 mp -122.48 122.89 67.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.113 -1.44 . . . . 71.32 107.113 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.286 1.0 OUTLIER -121.0 128.37 52.64 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 120.207 -0.597 . . . . 71.03 111.918 176.143 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 62.6 m -114.36 125.38 53.8 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.543 -1.28 . . . . 72.45 107.543 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' A' ' 78' ' ' LYS . 2.2 p-10 -110.64 130.43 55.57 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 118.462 -1.295 . . . . 55.24 112.013 -177.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -107.49 13.03 27.26 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.368 -1.345 . . . . 72.41 107.368 170.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -61.47 -36.63 80.98 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 113.921 -1.491 . . . . 75.34 108.508 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.5 t -81.68 7.78 11.57 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-N 115.495 -0.775 . . . . 55.53 111.154 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.74 -47.95 3.25 Favored Glycine 0 N--CA 1.462 0.418 0 O-C-N 121.615 -0.678 . . . . 74.14 111.429 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -95.77 137.28 21.89 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 106.737 -1.579 . . . . 74.44 106.737 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.34 117.01 4.66 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 CA-C-N 119.313 0.79 . . . . 72.41 110.706 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.447 ' HB2' ' OD1' ' A' ' 71' ' ' ASP . 13.0 mmmm -104.96 -176.47 3.09 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 115.0 -1.0 . . . . 75.22 108.663 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.54 137.59 4.91 Favored Glycine 0 N--CA 1.41 -3.061 0 C-N-CA 119.596 -1.288 . . . . 52.33 112.785 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -154.43 143.29 20.96 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 123.931 0.892 . . . . 71.33 109.27 173.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.26 151.8 50.04 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-O 120.9 0.381 . . . . 62.22 110.574 -172.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 28.1 m-85 -118.82 115.68 24.93 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 108.386 -0.968 . . . . 72.1 108.386 176.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.479 HG23 HG22 ' A' ' 66' ' ' ILE . 40.0 mm -97.57 122.03 48.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.223 -1.029 . . . . 74.53 108.223 -176.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -102.38 119.79 39.41 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.195 -0.669 . . . . 55.42 109.195 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.26 156.47 16.41 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-O 121.062 0.458 . . . . 73.34 110.533 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.22 -27.84 56.95 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.156 -0.475 . . . . 51.54 110.051 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -112.48 136.86 51.49 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.826 -0.625 . . . . 54.02 110.848 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.464 ' O ' HG22 ' A' ' 91' ' ' VAL . 1.4 tmm_? -69.72 -32.12 70.51 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.815 -1.18 . . . . 70.31 107.815 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -67.68 -21.67 65.33 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 115.807 -0.633 . . . . 71.32 111.498 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.3 m -67.85 -36.04 79.61 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.739 -0.467 . . . . 62.53 109.739 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.514 ' HB ' ' CG1' ' A' ' 39' ' ' VAL . 2.2 m -67.15 -38.57 81.37 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 N-CA-C 108.354 -0.98 . . . . 73.21 108.354 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -61.36 -35.55 77.76 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.439 -0.801 . . . . 70.23 110.735 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.31 -31.65 62.56 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.079 -0.509 . . . . 64.12 110.826 175.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 97' ' ' MET . . . -76.46 -42.93 42.08 Favored 'General case' 0 C--O 1.205 -1.269 0 CA-C-N 115.999 -0.546 . . . . 75.44 111.094 -177.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 91' ' ' VAL . 19.9 m -56.09 -21.37 11.37 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.957 0 N-CA-C 113.458 0.91 . . . . 75.02 113.458 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.07 -10.54 58.12 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-O 121.933 0.873 . . . . 65.35 110.235 176.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.515 ' HA ' ' OG1' ' A' ' 100' ' ' THR . 18.7 mtp -101.62 9.65 40.93 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 125.111 1.364 . . . . 71.2 109.866 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 12.4 t70 -35.73 -57.95 0.63 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 115.703 1.742 . . . . 74.24 115.703 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.541 ' OE1' ' HG2' ' A' ' 6' ' ' MET . 42.0 tt0 -116.99 30.39 7.36 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 122.327 1.06 . . . . 64.51 109.329 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.515 ' OG1' ' HA ' ' A' ' 97' ' ' MET . 89.8 m -74.71 167.39 21.89 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.915 -1.039 . . . . 74.22 110.195 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.25 133.12 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 CA-C-O 121.356 0.598 . . . . 50.31 110.143 -173.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -133.23 127.79 34.49 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.476 -0.784 . . . . 70.42 109.059 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 103' ' ' ARG . 21.0 ttt180 57.05 32.64 22.02 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 122.303 1.049 . . . . 73.21 110.484 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.19 5.85 87.45 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.012 -0.995 . . . . 75.55 113.444 177.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -124.88 145.75 49.66 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 117.086 0.443 . . . . 71.43 110.137 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.5 m -79.31 119.74 22.79 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 110.018 -0.364 . . . . 61.25 110.018 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 45.9 pt -102.72 171.11 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 109.758 -0.46 . . . . 62.03 109.758 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 22.5 mmmt -118.02 130.15 56.0 Favored 'General case' 0 CA--C 1.472 -2.05 0 N-CA-C 108.883 -0.784 . . . . 75.4 108.883 176.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 41.1 t -125.59 111.79 28.53 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 107.304 -1.369 . . . . 70.33 107.304 172.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.43 HD13 ' CD2' ' A' ' 40' ' ' TYR 0.266 0.0 OUTLIER -138.9 146.75 51.27 Favored Pre-proline 0 N--CA 1.432 -1.345 0 C-N-CA 119.215 -0.994 . . . . 73.23 108.363 178.103 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.411 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 62.0 Cg_endo -76.53 137.29 18.29 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.614 1.543 . . . . 63.01 112.217 -173.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.453 ' HE2' ' HB3' ' A' ' 38' ' ' SER . 37.6 ttpt -83.39 86.56 7.05 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 108.498 -0.927 . . . . 71.21 108.498 -177.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.411 ' HG2' ' HB2' ' A' ' 111' ' ' PRO . 6.6 ptm180 -178.74 179.89 0.68 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.158 -0.928 . . . . 75.04 111.831 -172.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.5 t -100.89 157.26 16.86 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 115.405 -0.816 . . . . 64.53 109.118 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -139.9 156.42 46.7 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.628 -1.249 . . . . 71.1 107.628 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 27.3 ttt -57.01 112.41 4.56 Favored Pre-proline 0 CA--C 1.536 0.408 0 O-C-N 123.616 0.572 . . . . 63.53 111.36 -177.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.89 -29.9 14.68 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.52 2.147 . . . . 61.21 112.241 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.38 -64.44 3.23 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.742 -0.742 . . . . 42.31 111.707 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.5 pt -86.15 7.0 2.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.35 0.595 . . . . 71.51 111.068 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.1 t -149.39 162.69 39.59 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 107.264 -1.384 . . . . 75.15 107.264 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 62.4 p -148.24 -161.18 1.28 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.87 -0.789 . . . . 74.04 108.87 -176.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.6 p -74.71 0.26 15.8 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 112.447 0.536 . . . . 54.51 112.447 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -78.56 104.32 9.08 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 109.15 -0.685 . . . . 64.51 109.15 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.489 0 CA-C-N 115.927 -0.579 . . . . 73.22 112.294 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.558 0 CA-C-O 120.621 0.248 . . . . 55.13 110.522 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 51.0 mm -97.94 129.39 48.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.42 -0.955 . . . . 73.24 108.42 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.78 91.8 32.39 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 111.967 0.358 . . . . 42.31 111.967 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -98.62 178.73 0.35 Allowed 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 123.058 2.505 . . . . 71.43 110.857 176.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 21.8 p -101.61 -2.96 29.22 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.178 0.514 . . . . 54.34 110.718 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 20.9 ptp -90.28 107.5 19.18 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.424 0.63 . . . . 61.43 111.545 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -138.02 97.4 3.4 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.511 -0.768 . . . . 63.14 110.758 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 42.5 m -72.68 -28.82 62.93 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.113 -0.494 . . . . 75.32 111.058 -178.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 19.6 m -73.98 81.0 1.69 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 116.493 -0.321 . . . . 64.01 111.491 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 13.5 m170 176.38 -32.7 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 127.8 2.44 . . . . 74.21 110.192 177.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 54.1 p -64.68 134.7 54.78 Favored 'General case' 0 C--O 1.244 0.779 0 O-C-N 123.283 0.364 . . . . 74.35 111.185 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -72.36 95.64 1.77 Allowed 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.122 -0.695 . . . . 74.22 109.122 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -48.12 -44.49 32.0 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.798 1.036 . . . . 55.12 113.798 -174.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 70.1 m 68.76 95.34 0.07 Allowed 'General case' 0 CA--C 1.55 0.973 0 CA-C-O 122.286 1.041 . . . . 54.22 113.342 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.4 -159.44 0.99 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 105.394 -2.076 . . . . 75.12 105.394 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.6 -38.18 70.47 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 109.951 -1.26 . . . . 74.14 109.951 174.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.59 94.41 8.07 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 107.042 -1.466 . . . . 72.54 107.042 171.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.461 ' CE2' ' HB3' ' B' ' 20' ' ' GLU . 66.1 t80 -101.0 -19.58 15.77 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.54 -0.755 . . . . 72.13 111.555 -174.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 30.7 m 57.92 -59.6 0.03 OUTLIER 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 114.451 1.278 . . . . 62.43 114.451 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' GLU . . . . . 0.461 ' HB3' ' CE2' ' B' ' 18' ' ' TYR . 41.6 tt0 -54.9 -26.96 39.34 Favored 'General case' 0 CA--C 1.572 1.815 0 C-N-CA 126.168 1.787 . . . . 55.32 111.869 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.412 ' HA3' ' HD2' ' B' ' 22' ' ' PRO . . . 79.33 -120.86 5.37 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 116.021 1.168 . . . . 73.41 116.021 171.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.577 ' HG3' ' CE1' ' A' ' 40' ' ' TYR . 2.8 Cg_endo -41.69 -52.91 3.59 Favored 'Trans proline' 0 C--N 1.366 1.451 1 C-N-CA 125.475 4.117 . . . . 64.21 118.287 -173.658 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -58.63 123.7 14.16 Favored 'Trans proline' 0 C--N 1.379 2.179 0 CA-C-N 120.802 1.322 . . . . 73.32 111.557 -174.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -59.79 136.47 90.07 Favored Pre-proline 0 N--CA 1.435 -1.216 0 CA-C-N 115.573 -0.74 . . . . 75.32 110.356 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.52 103.08 0.09 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 123.237 2.625 . . . . 75.32 114.149 -172.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.69 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -70.56 170.84 11.32 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 114.973 -1.012 . . . . 74.2 109.876 174.376 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 47.6 t -59.42 143.47 49.7 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.53 0.681 . . . . 71.24 112.707 -173.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.5 ' O ' ' HE2' ' B' ' 32' ' ' LYS . . . -52.73 -36.25 57.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.328 -1.306 . . . . 74.41 111.703 176.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -60.98 -49.2 78.42 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.555 -0.535 . . . . 63.32 109.555 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.457 ' HB2' HD23 ' B' ' 26' ' ' LEU . 0.8 OUTLIER -61.52 -36.51 80.75 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-N 115.997 -0.547 . . . . 72.41 112.09 178.595 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.533 ' HA ' HG12 ' B' ' 34' ' ' ILE 0.516 5.3 ptpt -71.48 -35.43 70.82 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 115.049 1.5 . . . . 73.43 115.049 -179.146 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.5 ' HE2' ' O ' ' B' ' 28' ' ' ALA . 45.6 mtmt -64.41 -40.94 96.74 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.04 0.447 . . . . 54.01 111.066 174.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.548 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 38.6 mm-40 -71.07 -42.98 68.68 Favored 'General case' 0 C--O 1.211 -0.929 0 CA-C-N 115.622 -0.717 . . . . 73.41 112.768 -177.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.533 HG12 ' HA ' ' B' ' 31' ' ' LYS . 13.6 pt -64.79 -35.53 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 112.843 0.682 . . . . 73.54 112.843 -176.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -72.91 -23.69 60.73 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 119.994 -0.682 . . . . 70.01 111.329 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.446 ' HG3' ' HB ' ' B' ' 114' ' ' THR . 55.5 mtpt -77.1 -14.99 59.72 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.709 0.804 . . . . 74.44 109.741 174.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' B' ' 33' ' ' GLU . 89.7 mtt180 -109.22 14.1 24.01 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 115.218 -0.901 . . . . 74.52 108.883 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 49.6 m -101.31 153.71 19.41 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.191 -0.913 . . . . 71.21 110.937 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.495 ' CG1' ' HB ' ' B' ' 91' ' ' VAL . 35.7 m -133.3 163.85 36.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.321 -0.854 . . . . 61.24 109.273 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 35.0 t80 -110.9 124.47 52.16 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 107.623 -1.251 . . . . 73.42 107.623 177.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 59.1 t -122.91 110.1 25.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 107.923 -1.14 . . . . 73.31 107.923 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' B' ' 43' ' ' ASN . . . -133.88 109.02 0.77 Allowed Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 115.547 -3.216 . . . . 63.44 116.42 -177.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' B' ' 42' ' ' GLY . 62.0 t30 166.41 26.35 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 125.868 1.667 . . . . 75.21 108.011 157.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 12.0 p -69.67 136.22 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 115.208 -0.905 . . . . 75.03 109.921 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -111.9 167.09 10.65 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.666 -0.697 . . . . 63.52 110.788 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' TYR . . . . . 0.537 ' CE1' ' HB2' ' B' ' 77' ' ' PRO . 5.5 m-85 -69.25 101.55 1.52 Allowed 'General case' 0 CA--C 1.496 -1.13 0 CA-C-O 121.629 0.728 . . . . 73.4 109.796 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' GLY . . . . . 0.467 ' HA3' ' NH1' ' B' ' 103' ' ' ARG . . . 159.7 -33.58 0.45 Allowed Glycine 0 N--CA 1.413 -2.879 0 N-CA-C 109.218 -1.553 . . . . 43.34 109.218 -175.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.46 ' OG ' ' HE2' ' B' ' 102' ' ' PHE . 18.3 m -90.78 135.14 33.92 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 108.361 -0.977 . . . . 73.04 108.361 176.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 82.0 p -105.45 178.83 4.45 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 116.219 -0.446 . . . . 52.35 109.972 -177.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.623 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -61.98 -41.98 98.63 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.265 -1.013 . . . . 61.02 108.265 175.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -58.29 -35.41 71.77 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 114.949 -1.023 . . . . 74.32 111.392 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -69.55 -41.3 76.1 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 121.087 0.47 . . . . 75.4 110.472 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 61.2 mt -63.94 -47.82 78.98 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.348 -0.842 . . . . 73.22 112.244 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -60.14 -47.31 86.43 Favored 'General case' 0 C--O 1.182 -2.467 0 N-CA-C 113.796 1.036 . . . . 43.42 113.796 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.54 -48.02 75.38 Favored 'General case' 0 C--O 1.266 1.952 0 CA-C-N 118.413 0.551 . . . . 71.23 110.408 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -64.08 -41.57 97.27 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.549 -0.751 . . . . 74.13 110.719 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -82.51 -21.78 35.33 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 114.95 1.463 . . . . 71.3 114.95 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 48.5 t -66.89 -27.96 67.93 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.6 -0.518 . . . . 71.03 109.6 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.8 m -58.61 -31.55 68.17 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-O 121.003 0.43 . . . . 73.13 110.19 173.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 85.9 m -91.79 1.76 56.95 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.32 0.859 . . . . 64.24 113.32 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.65 -159.11 28.11 Favored Glycine 0 C--O 1.243 0.663 0 C-N-CA 118.033 -2.032 . . . . 35.35 116.383 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 17.5 m -106.05 116.21 31.54 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.053 -0.574 . . . . 75.51 110.592 -175.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 77.4 mt -84.18 132.16 32.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 121.594 0.712 . . . . 73.04 112.617 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -94.82 -49.07 5.75 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.635 -1.166 . . . . 65.22 109.281 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -155.93 164.32 38.64 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.659 -0.867 . . . . 74.4 108.659 -176.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.623 HD11 ' HB1' ' B' ' 50' ' ' ALA . 31.3 pt -145.98 144.59 20.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 109.002 -0.74 . . . . 71.11 109.002 176.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 58.5 m -125.47 125.71 43.74 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.263 -1.384 . . . . 74.33 107.263 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.7 mp -122.43 122.63 66.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 106.881 -1.526 . . . . 74.21 106.881 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.262 1.4 pt? -121.09 128.32 52.47 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.98 -0.688 . . . . 65.31 111.611 176.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 64.3 m -113.92 125.62 54.25 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.734 -1.21 . . . . 74.2 107.734 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.42 ' HB2' ' HG2' ' A' ' 65' ' ' ARG . 3.3 p-10 -112.01 130.04 56.0 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 118.895 -1.122 . . . . 71.24 112.284 -177.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.413 ' HE3' ' OH ' ' B' ' 46' ' ' TYR . 97.9 mttt -106.85 10.98 30.52 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.086 -1.079 . . . . 71.34 108.086 172.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -59.82 -33.69 72.09 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 113.733 -1.576 . . . . 73.24 107.892 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 24.8 m -82.35 8.31 11.68 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 115.087 -0.961 . . . . 53.2 111.799 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.2 -49.1 3.93 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-O 121.872 0.706 . . . . 72.21 111.388 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -95.01 131.63 29.81 Favored Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 105.37 -2.085 . . . . 53.25 105.37 176.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.537 ' HB2' ' CE1' ' B' ' 46' ' ' TYR . 19.7 Cg_endo -63.42 116.67 3.77 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.212 1.275 . . . . 63.35 111.691 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' LYS . . . . . 0.408 ' HB2' ' OD1' ' B' ' 71' ' ' ASP . 13.4 mmmm -103.8 -178.61 3.71 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.239 -0.891 . . . . 64.23 109.303 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.55 136.44 4.22 Favored Glycine 0 N--CA 1.412 -2.945 0 C-N-CA 119.66 -1.257 . . . . 75.42 113.1 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -152.24 144.8 24.17 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 123.976 0.91 . . . . 75.13 109.756 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.98 151.48 49.05 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-O 121.001 0.429 . . . . 73.24 110.41 -172.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' B' ' 39' ' ' VAL . 28.1 m-85 -118.83 115.93 25.46 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 108.129 -1.063 . . . . 74.25 108.129 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.497 HG23 HG22 ' B' ' 66' ' ' ILE . 40.7 mm -97.2 122.18 48.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 108.151 -1.055 . . . . 73.01 108.151 -177.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -101.97 119.46 38.83 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.067 -0.716 . . . . 71.31 109.067 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -98.02 155.66 17.0 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 116.279 -0.419 . . . . 64.32 109.972 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.97 -30.28 55.92 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.277 0.56 . . . . 74.24 109.644 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' GLU . . . . . 0.513 ' HB2' ' OG ' ' B' ' 90' ' ' SER . 35.6 mt-10 -105.14 136.71 44.14 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.862 -0.608 . . . . 74.1 109.627 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.403 ' O ' HG22 ' B' ' 91' ' ' VAL . 1.5 tmm_? -72.52 -32.32 66.05 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.349 -1.352 . . . . 70.2 107.349 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -66.54 -22.42 66.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.429 -0.805 . . . . 72.34 111.357 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' SER . . . . . 0.513 ' OG ' ' HB2' ' B' ' 87' ' ' GLU . 49.6 m -67.48 -36.01 80.29 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.976 -0.379 . . . . 75.55 109.976 176.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.498 ' O ' HG13 ' B' ' 95' ' ' VAL . 2.0 m -67.01 -38.4 81.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 N-CA-C 108.121 -1.066 . . . . 73.32 108.121 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.34 -37.48 83.46 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.405 -0.816 . . . . 55.44 110.219 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.34 -30.92 63.66 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.195 0.521 . . . . 73.15 110.835 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.13 -44.79 36.75 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-N 116.086 -0.506 . . . . 73.51 111.352 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' VAL . . . . . 0.498 HG13 ' O ' ' B' ' 91' ' ' VAL . 25.7 m -55.46 -21.63 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.924 0.89 . . . . 74.24 112.819 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.62 -8.96 52.04 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.306 0.574 . . . . 62.25 110.481 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 32.9 mtm -105.02 12.97 31.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.495 -0.775 . . . . 75.34 110.583 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' ASP . . . . . 0.42 ' HA ' ' H ' ' B' ' 109' ' ' VAL . 3.7 p30 -39.55 -44.32 1.42 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.195 1.183 . . . . 74.4 114.195 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -110.05 95.14 5.4 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 121.545 0.688 . . . . 72.12 110.274 172.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' B' ' 106' ' ' THR . 6.7 p -132.11 156.08 46.99 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.119 -0.946 . . . . 64.34 111.934 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.68 127.14 65.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 121.095 0.474 . . . . 71.23 109.904 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' PHE . . . . . 0.46 ' HE2' ' OG ' ' B' ' 48' ' ' SER . 43.1 t80 -143.18 126.22 16.35 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.708 -1.59 . . . . 71.54 106.708 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' ARG . . . . . 0.467 ' NH1' ' HA3' ' B' ' 47' ' ' GLY . 72.9 mtp85 62.59 33.36 15.88 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.208 0.603 . . . . 72.21 111.101 -175.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.08 14.56 66.17 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 115.524 -0.762 . . . . 73.24 113.141 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -130.81 143.93 51.09 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 122.404 -0.468 . . . . 70.13 110.126 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 106' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' B' ' 100' ' ' THR . 53.5 m -83.0 126.68 32.8 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 120.777 0.322 . . . . 75.42 110.356 -177.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 107' ' ' ILE . . . . . 0.429 HG22 ' HB3' ' B' ' 43' ' ' ASN . 38.7 pt -100.87 167.26 2.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 109.227 -0.657 . . . . 60.24 109.227 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 108' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 44.9 tptt -121.26 124.99 45.98 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.577 -0.898 . . . . 73.0 108.577 -175.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 35.6 t -122.01 119.19 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 108.413 -0.958 . . . . 75.15 108.413 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.327 0.3 OUTLIER -143.53 137.37 14.45 Favored Pre-proline 0 C--N 1.285 -2.197 0 N-CA-C 106.454 -1.684 . . . . 72.01 106.454 -169.837 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -77.18 130.11 10.9 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 120.771 1.311 . . . . 71.3 110.446 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -69.4 -42.06 75.61 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.08 -0.648 . . . . 74.14 110.597 -174.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.482 ' HG2' ' H ' ' B' ' 114' ' ' THR . 30.0 ttm-85 68.6 171.33 0.29 Allowed 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.044 0.938 . . . . 71.3 111.765 174.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.482 ' H ' ' HG2' ' B' ' 113' ' ' ARG . 28.8 m -160.75 169.68 22.28 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 104.326 -2.472 . . . . 74.02 104.326 -177.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -72.56 141.12 48.43 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-O 121.015 0.436 . . . . 63.35 111.122 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 94.7 mmm -77.38 116.3 56.62 Favored Pre-proline 0 C--N 1.31 -1.124 0 CA-C-N 115.272 -0.876 . . . . 70.14 109.219 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.35 14.9 0.86 Allowed 'Trans proline' 0 N--CA 1.478 0.581 0 C-N-CA 123.165 2.576 . . . . 35.23 113.584 -177.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.04 -135.32 32.09 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 121.311 -0.471 . . . . 61.14 112.2 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 34.9 pt -130.72 -175.51 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 109.678 -0.49 . . . . 72.24 109.678 -178.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 33.8 m 69.14 79.87 0.2 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 114.209 1.189 . . . . 61.41 114.209 175.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 18.9 p -92.31 -69.14 0.76 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.663 -1.236 . . . . 64.11 107.663 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 24.1 p -144.01 -52.39 0.33 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.765 -1.198 . . . . 70.45 107.765 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 33.4 t70 64.3 107.78 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.861 1.264 . . . . 62.54 111.664 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 . . . . . 0 C--N 1.301 -1.533 0 CA-C-O 118.636 -0.697 . . . . 55.32 110.106 -176.954 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.299 0 CA-C-O 121.099 0.476 . . . . 71.12 110.204 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.9 mm -106.95 135.85 44.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 109.042 -0.725 . . . . 73.31 109.042 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.85 99.74 49.04 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 110.172 -0.307 . . . . 72.02 110.172 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.99 101.8 1.55 Allowed 'Trans proline' 0 N--CA 1.442 -1.508 0 C-N-CA 122.103 1.868 . . . . 62.34 110.54 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 23.8 p -91.33 -42.37 10.4 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.536 -0.756 . . . . 55.54 109.667 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 63.0 mtm 61.05 22.62 12.87 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.047 0.939 . . . . 55.0 111.051 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -90.5 94.61 9.79 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.252 0.549 . . . . 73.52 109.772 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 99.0 m -145.87 132.19 19.56 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.77 -0.65 . . . . 40.1 110.951 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.2 p -106.56 153.51 22.23 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.227 -1.027 . . . . 73.43 108.227 175.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 -137.14 137.28 39.05 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.846 -0.742 . . . . 74.3 112.677 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' A' ' 12' ' ' LYS . 28.9 t 59.5 91.08 0.05 OUTLIER 'General case' 0 C--O 1.246 0.912 0 C-N-CA 125.306 1.442 . . . . 74.12 113.524 175.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 11' ' ' SER . 20.3 mtmm 171.59 126.2 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.092 0 C-N-CA 126.953 2.101 . . . . 65.2 110.305 175.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -120.4 23.43 10.88 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.926 -1.139 . . . . 72.13 107.926 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.3 p -68.79 97.71 0.85 Allowed 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 114.991 -1.004 . . . . 55.44 113.366 -176.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.413 ' HB2' ' HB ' ' A' ' 114' ' ' THR . . . -146.38 127.81 14.98 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.1 -0.955 . . . . 72.41 109.151 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.93 86.16 0.08 OUTLIER Glycine 0 C--N 1.3 -1.47 0 C-N-CA 120.486 -0.864 . . . . 54.13 111.4 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -119.42 27.45 8.78 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 120.695 0.283 . . . . 62.03 110.902 -177.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.585 ' CE1' ' HA ' ' B' ' 15' ' ' ALA . 47.1 t80 -106.5 115.22 29.84 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.499 0.666 . . . . 65.44 111.162 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.4 m -148.38 -84.84 0.1 Allowed 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 106.721 -1.585 . . . . 61.4 106.721 170.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 60.75 -77.88 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 125.0 1.32 . . . . 74.24 114.125 173.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.28 -124.65 7.68 Favored Glycine 0 N--CA 1.429 -1.826 0 N-CA-C 109.449 -1.46 . . . . 70.1 109.449 -175.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.58 ' HG2' ' CE2' ' B' ' 40' ' ' TYR . 52.1 Cg_exo -56.88 -41.66 72.94 Favored 'Trans proline' 0 CA--C 1.576 2.625 0 C-N-CA 123.407 2.738 . . . . 73.23 114.963 176.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 22' ' ' PRO . 7.4 Cg_endo -56.49 144.92 82.51 Favored 'Trans proline' 0 C--N 1.395 2.979 0 C-N-CA 121.473 1.449 . . . . 51.52 110.569 171.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -70.05 124.34 90.52 Favored Pre-proline 0 C--N 1.316 -0.887 0 C-N-CA 120.327 -0.549 . . . . 61.04 111.458 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -68.59 121.97 8.92 Favored 'Trans proline' 0 N--CA 1.435 -1.927 0 C-N-CA 122.243 1.962 . . . . 64.13 110.343 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.735 HD13 ' H ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -73.94 169.94 16.42 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.601 -0.727 . . . . 72.0 110.876 -179.482 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.7 t -63.27 143.84 57.46 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.462 0.648 . . . . 72.14 112.412 -170.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.17 -41.05 64.81 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 114.686 -1.143 . . . . 70.21 113.157 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.265 27.3 mt-10 -66.25 -37.79 86.35 Favored 'General case' 0 CA--C 1.494 -1.188 0 C-N-CA 118.683 -1.207 . . . . 75.25 112.52 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.48 ' O ' HG12 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -58.07 -37.78 75.12 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 123.597 0.561 . . . . 74.03 109.532 172.102 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -67.65 -42.46 82.2 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.487 -0.779 . . . . 64.23 111.76 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.73 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -71.21 -36.06 71.75 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 118.772 -1.171 . . . . 73.14 111.412 177.26 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -63.6 -40.8 97.85 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.728 0.299 . . . . 75.43 110.431 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 30' ' ' GLU . 13.2 pt -71.63 -35.97 57.88 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 CA-C-N 115.578 -0.737 . . . . 71.13 110.747 176.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -58.98 -42.61 90.38 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 120.831 0.348 . . . . 74.34 110.169 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.73 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 88.9 mttt -60.26 -26.8 66.73 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.889 0.876 . . . . 71.5 111.804 -176.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.459 ' HD3' ' O ' ' A' ' 86' ' ' ALA . 15.8 ptp180 -112.55 21.91 15.15 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.672 0.748 . . . . 74.3 109.93 -176.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 56.9 m -113.83 170.83 7.97 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.372 -0.831 . . . . 62.21 110.78 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.88 162.14 31.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.421 0.629 . . . . 74.11 111.567 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.557 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -96.33 125.58 40.93 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 105.996 -1.853 . . . . 44.13 105.996 169.548 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.44 ' N ' ' HD1' ' A' ' 40' ' ' TYR . 94.4 t -128.37 106.54 14.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 107.247 -1.39 . . . . 72.4 107.247 173.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -151.89 113.06 0.56 Allowed Glycine 0 N--CA 1.423 -2.216 0 C-N-CA 116.174 -2.917 . . . . 74.45 117.783 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.579 ' HB3' ' HA ' ' A' ' 107' ' ' ILE . 9.3 t30 176.18 23.85 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 103.346 -2.835 . . . . 73.43 103.346 161.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.435 ' CG2' ' HB2' ' A' ' 48' ' ' SER . 7.1 p -107.76 100.82 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-N 113.03 -1.895 . . . . 72.54 110.816 -173.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.408 ' HA ' ' HA3' ' A' ' 79' ' ' GLY . 7.9 m-20 -92.16 170.44 9.82 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.861 -1.063 . . . . 71.14 108.165 -175.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -28.08 -32.97 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 117.465 2.395 . . . . 52.14 117.465 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.94 -32.7 42.24 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.743 -0.265 . . . . 61.14 113.152 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.435 ' HB2' ' CG2' ' A' ' 44' ' ' VAL . 41.4 m -109.93 154.08 23.61 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 109.641 -0.503 . . . . 61.2 109.641 176.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 63.7 p -121.83 178.6 4.8 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 112.046 0.387 . . . . 64.12 112.046 -171.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.497 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -63.15 -44.27 95.97 Favored 'General case' 0 C--O 1.215 -0.76 0 C-N-CA 123.636 0.775 . . . . 71.53 111.636 -177.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -58.13 -38.36 76.38 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.871 0.367 . . . . 72.33 111.517 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -64.17 -32.69 74.35 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.525 0.678 . . . . 64.22 109.608 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 62.8 mt -69.87 -46.08 66.3 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 114.185 -1.37 . . . . 72.41 110.595 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -57.89 -50.12 74.4 Favored 'General case' 0 C--O 1.191 -1.988 0 C-N-CA 120.944 -0.302 . . . . 75.52 111.211 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.33 -48.3 79.33 Favored 'General case' 0 C--O 1.263 1.809 0 CA-C-O 121.653 0.74 . . . . 63.53 112.458 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -69.56 -40.78 76.59 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.775 -1.102 . . . . 73.23 111.119 -175.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -82.63 -22.66 34.62 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 114.592 1.33 . . . . 74.13 114.592 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.5 t -71.26 -23.53 62.0 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.655 -0.498 . . . . 74.44 109.655 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.0 t -57.98 -31.63 67.1 Favored 'General case' 0 CA--C 1.558 1.255 0 N-CA-C 108.944 -0.762 . . . . 64.32 108.944 172.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 60.7 m -90.51 -0.35 57.63 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 112.751 0.649 . . . . 70.3 112.751 -177.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.64 -169.86 29.15 Favored Glycine 0 C--O 1.229 -0.18 0 C-N-CA 119.505 -1.331 . . . . 53.12 114.436 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.0 m -95.68 123.21 39.14 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 121.15 0.5 . . . . 55.51 110.453 -177.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 72.7 mt -91.56 124.84 44.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.777 -0.647 . . . . 61.34 110.875 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -91.47 -35.54 14.28 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-O 121.077 0.465 . . . . 74.33 111.835 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.481 ' HD2' ' OE2' ' A' ' 84' ' ' GLU 0.266 0.0 OUTLIER -157.21 152.97 26.86 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.708 -1.219 . . . . 73.2 107.708 -167.489 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.527 HG22 ' HA ' ' A' ' 83' ' ' ILE . 34.5 pt -148.21 143.86 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 CA-C-N 118.451 0.569 . . . . 73.22 109.908 174.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.3 m -126.26 123.87 39.08 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.747 -1.205 . . . . 72.44 107.747 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.598 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.2 mp -120.95 121.26 64.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 106.041 -1.837 . . . . 71.21 106.041 -176.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.41 ' N ' HD23 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -120.55 130.15 54.1 Favored 'General case' 0 C--N 1.275 -2.642 0 C-N-CA 120.199 -0.6 . . . . 75.43 112.032 179.067 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 69.1 m -112.07 111.79 22.96 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.998 -1.112 . . . . 63.12 107.998 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -102.16 120.22 40.09 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 108.408 -0.96 . . . . 65.33 108.408 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.545 ' HE2' ' HB3' ' A' ' 77' ' ' PRO . 38.9 ttmt -111.0 15.65 21.6 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.059 -0.719 . . . . 74.42 109.059 -178.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -67.75 -18.0 64.74 Favored 'General case' 0 C--N 1.35 0.607 0 CA-C-O 121.341 0.591 . . . . 70.54 111.187 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.8 m -78.29 -7.28 57.02 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.913 -0.585 . . . . 63.21 110.654 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.26 -51.05 1.28 Allowed Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 109.308 -1.517 . . . . 70.54 109.308 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -96.38 134.42 23.51 Favored Pre-proline 0 C--N 1.287 -2.111 0 N-CA-C 105.677 -1.972 . . . . 74.13 105.677 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.545 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 41.5 Cg_endo -66.3 118.05 5.2 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.274 1.316 . . . . 73.35 112.232 -175.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -100.66 141.53 33.4 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.368 -0.833 . . . . 74.42 108.865 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 44' ' ' VAL . . . -127.76 140.51 11.88 Favored Glycine 0 N--CA 1.41 -3.045 0 C-N-CA 119.738 -1.22 . . . . 51.12 112.73 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . 0.25 3.1 p90 -156.65 146.92 21.29 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 123.745 0.818 . . . . 74.03 110.07 175.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.598 ' HB2' HG23 ' A' ' 68' ' ' ILE . . . -139.48 155.06 47.8 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-O 121.489 0.661 . . . . 74.44 109.233 -172.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.603 ' CD2' ' HD3' ' A' ' 112' ' ' LYS . 84.8 m-85 -121.27 115.89 23.84 Favored 'General case' 0 C--N 1.263 -3.172 0 N-CA-C 108.231 -1.026 . . . . 63.13 108.231 175.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.527 ' HA ' HG22 ' A' ' 66' ' ' ILE . 35.9 mm -95.9 119.04 43.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.318 -1.364 . . . . 64.41 107.318 -176.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.481 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 31.7 mt-10 -101.95 117.94 35.87 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.527 -0.546 . . . . 64.3 109.527 -174.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -102.23 169.56 8.64 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 121.986 0.898 . . . . 75.5 113.326 -173.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.459 ' O ' ' HD3' ' A' ' 37' ' ' ARG . . . -74.41 -38.82 62.97 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.36 -1.291 . . . . 62.1 112.45 174.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -126.03 159.07 33.71 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.552 -0.859 . . . . 62.11 113.145 -175.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.453 ' O ' HG22 ' A' ' 91' ' ' VAL . 11.4 mmm180 -66.44 -31.32 72.0 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 114.487 -1.233 . . . . 75.12 108.687 173.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -57.66 -39.35 76.85 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 114.133 -1.394 . . . . 71.13 109.951 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.0 m -67.71 -38.38 83.54 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.978 -0.555 . . . . 73.54 111.148 -177.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 88' ' ' ARG . 3.2 m -68.22 -39.15 80.7 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.224 0 C-N-CA 119.733 -0.787 . . . . 75.21 108.978 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -58.43 -38.62 77.84 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.614 0.766 . . . . 73.13 110.202 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.47 -38.07 63.02 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.667 -0.697 . . . . 71.43 111.187 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.17 -45.24 57.64 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 116.243 -0.435 . . . . 60.25 111.706 -176.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 91' ' ' VAL . 25.8 m -57.32 -22.16 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.286 0.634 . . . . 74.1 112.669 177.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.41 -14.03 62.68 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.444 0.64 . . . . 72.24 110.256 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 60.1 mtm -100.38 11.49 39.3 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.718 -0.673 . . . . 53.24 110.231 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.452 ' HA ' ' HB ' ' A' ' 109' ' ' VAL . 6.4 p-10 -36.71 -49.54 0.78 Allowed 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 115.356 1.613 . . . . 62.21 115.356 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -107.25 25.5 11.33 Favored 'General case' 0 CA--C 1.556 1.186 0 CA-C-O 120.908 0.385 . . . . 74.11 111.627 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 67.7 p -84.0 172.41 12.06 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 119.417 -0.913 . . . . 71.11 111.571 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 106' ' ' THR . 8.3 p -102.95 135.91 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.912 0 N-CA-C 109.019 -0.734 . . . . 54.54 109.019 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -123.78 118.18 26.58 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.626 -0.509 . . . . 73.53 109.626 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 103' ' ' ARG . 43.4 mtp180 45.3 32.34 0.98 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.834 1.653 . . . . 64.54 113.568 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.27 -10.55 33.59 Favored Glycine 0 CA--C 1.522 0.49 0 CA-C-N 115.264 -0.88 . . . . 72.41 113.896 174.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.434 ' HD3' ' O ' ' A' ' 43' ' ' ASN . 3.8 ptp180 -124.25 132.53 53.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 117.059 0.429 . . . . 54.04 111.779 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 101' ' ' VAL . 87.6 m -71.35 121.56 18.75 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.101 -0.499 . . . . 75.33 110.478 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.579 ' HA ' ' HB3' ' A' ' 43' ' ' ASN . 33.2 pt -103.02 172.13 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 115.787 -0.642 . . . . 73.11 111.593 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.506 ' HE2' HD12 ' A' ' 110' ' ' LEU . 19.0 tptm -118.71 126.67 52.42 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.582 -0.896 . . . . 60.54 108.582 177.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 23.4 t -125.62 121.52 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 108.045 -1.095 . . . . 73.13 108.045 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.506 HD12 ' HE2' ' A' ' 108' ' ' LYS 0.253 0.0 OUTLIER -142.59 153.47 61.93 Favored Pre-proline 0 C--O 1.208 -1.125 0 N-CA-C 107.693 -1.225 . . . . 65.31 107.693 174.627 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.33 149.67 28.01 Favored 'Trans proline' 0 CA--C 1.507 -0.861 0 CA-C-N 120.721 1.293 . . . . 61.4 112.634 -175.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.603 ' HD3' ' CD2' ' A' ' 82' ' ' TYR . 47.3 mtmt -84.07 125.57 32.24 Favored 'General case' 0 N--CA 1.409 -2.519 0 N-CA-C 105.765 -1.939 . . . . 62.41 105.765 172.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -130.06 131.15 45.68 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 120.217 -0.593 . . . . 71.54 111.131 -170.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' A' ' 15' ' ' ALA . 9.9 t -141.32 -156.09 0.65 Allowed 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 107.279 -1.378 . . . . 71.41 107.279 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.618 ' O ' ' HE2' ' A' ' 36' ' ' LYS . 18.2 m120 -43.37 156.26 0.05 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 126.224 1.81 . . . . 62.51 113.684 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.05 164.52 58.48 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.829 -0.623 . . . . 71.4 111.086 -177.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -66.79 123.72 11.39 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.866 1.711 . . . . 54.41 107.936 169.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 101.3 93.22 2.17 Favored Glycine 0 C--N 1.298 -1.547 0 N-CA-C 107.974 -2.05 . . . . 71.43 107.974 -171.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 66.2 mt 74.7 86.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 124.479 1.112 . . . . 75.3 108.142 -171.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 11.5 t -100.8 53.5 0.86 Allowed 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 114.85 -1.068 . . . . 72.12 108.374 -173.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.6 t 78.81 178.88 0.12 Allowed 'General case' 0 C--N 1.35 0.629 0 C-N-CA 125.219 1.407 . . . . 73.32 109.01 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.1 p -82.14 -65.98 0.95 Allowed 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.159 0.504 . . . . 60.14 109.761 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.0 t70 169.36 -60.13 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 126.664 1.986 . . . . 72.44 105.829 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.2 ptt85 . . . . . 0 C--N 1.297 -1.717 0 CA-C-N 113.837 -1.529 . . . . 72.01 110.148 177.758 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 109.651 -0.5 . . . . 73.14 109.651 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 51.1 mm -93.89 110.72 23.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 109.296 -0.631 . . . . 62.5 109.296 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.06 107.11 59.05 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 116.056 -0.52 . . . . 35.21 110.066 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.29 130.32 13.94 Favored 'Trans proline' 0 C--O 1.247 0.967 0 C-N-CA 122.399 2.066 . . . . 62.01 111.551 178.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 28.1 p -133.19 141.2 47.97 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.265 -0.643 . . . . 62.55 109.265 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 25.2 ptm -99.0 106.56 18.83 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.734 0.778 . . . . 42.31 110.489 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -91.28 111.34 22.78 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 115.681 -0.69 . . . . 74.33 110.685 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 35.4 p -104.33 -178.13 3.57 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 107.772 -1.196 . . . . 73.0 107.772 175.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 40.7 p -77.36 98.73 5.32 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 119.732 -0.787 . . . . 43.53 109.579 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -126.6 97.23 4.94 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-O 122.098 0.951 . . . . 73.31 110.875 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 40.5 t -157.49 110.59 2.49 Favored 'General case' 0 C--N 1.278 -2.5 0 N-CA-C 105.711 -1.959 . . . . 70.53 105.711 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -168.0 175.19 6.85 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.454 -0.339 . . . . 74.41 110.245 -172.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 86.5 mtp 66.99 102.45 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.651 1.181 . . . . 73.53 113.654 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 25.3 m -116.44 34.84 4.82 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 106.41 -1.7 . . . . 72.33 106.41 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.585 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . -76.51 127.82 33.58 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.124 -1.398 . . . . 75.13 111.291 -176.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.63 11.71 30.16 Favored Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 120.555 -0.831 . . . . 41.34 111.754 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.96 83.64 5.22 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.409 0.623 . . . . 64.34 110.472 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -118.82 171.25 8.35 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.253 -0.885 . . . . 74.41 109.205 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 19.6 m -87.34 136.11 33.06 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 120.225 -0.59 . . . . 65.25 110.954 -176.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -131.28 -48.09 0.99 Allowed 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 104.671 -2.344 . . . . 63.52 104.671 173.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.461 ' HA3' ' HD3' ' B' ' 22' ' ' PRO . . . 72.4 -124.36 9.77 Favored Glycine 0 N--CA 1.422 -2.29 0 CA-C-N 114.63 -1.168 . . . . 42.54 114.329 172.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.53 ' HG2' ' CE2' ' A' ' 40' ' ' TYR . 43.4 Cg_exo -55.04 -49.6 16.01 Favored 'Trans proline' 0 CA--C 1.578 2.702 0 C-N-CA 123.896 3.064 . . . . 75.24 115.564 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -54.29 138.25 72.32 Favored 'Trans proline' 0 C--N 1.398 3.144 0 CA-C-N 121.302 1.501 . . . . 63.13 109.635 173.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -64.08 122.23 76.27 Favored Pre-proline 0 N--CA 1.434 -1.249 0 C-N-CA 120.572 -0.451 . . . . 72.32 111.589 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -67.89 125.9 13.81 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.938 2.425 . . . . 70.51 110.664 -175.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.71 HD13 ' H ' ' B' ' 26' ' ' LEU 0.348 0.0 OUTLIER -77.73 171.43 14.97 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.812 -0.755 . . . . 71.12 112.014 -179.66 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.587 ' HB2' ' OE1' ' B' ' 30' ' ' GLU . 68.4 m -70.23 145.5 51.34 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 115.033 1.494 . . . . 70.52 115.033 -171.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.71 -45.7 70.52 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 114.864 -1.062 . . . . 71.33 113.428 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' B' ' 33' ' ' GLU . 8.6 mm-40 -63.15 -41.96 99.36 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 122.078 -0.389 . . . . 61.4 110.635 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.587 ' OE1' ' HB2' ' B' ' 27' ' ' SER . 3.6 mp0 -56.26 -39.21 72.25 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 109.86 -0.422 . . . . 73.4 109.86 172.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.539 ' HE3' ' O ' ' B' ' 26' ' ' LEU . 98.7 mttt -69.39 -41.7 76.11 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.616 -0.72 . . . . 70.22 111.776 -177.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.687 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 0.4 OUTLIER -70.42 -35.61 73.51 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 118.977 -1.089 . . . . 72.14 111.349 176.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' B' ' 29' ' ' GLU . 17.6 mt-10 -68.31 -37.7 80.87 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 120.126 -0.63 . . . . 55.52 111.569 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 15.4 pt -70.78 -34.63 57.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 C-N-CA 120.545 -0.462 . . . . 63.43 110.368 176.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' B' ' 31' ' ' LYS . 0.9 OUTLIER -64.82 -37.09 86.44 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.732 -0.84 . . . . 70.23 108.732 -177.805 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.687 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 95.8 mttt -62.02 -28.82 69.85 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.932 -1.031 . . . . 74.4 110.679 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.504 ' HD2' ' O ' ' B' ' 86' ' ' ALA . 71.7 mtm180 -106.29 18.13 22.44 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.601 -0.727 . . . . 64.33 111.221 -176.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 44.3 m -110.23 170.56 8.0 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 116.237 -0.438 . . . . 71.12 110.544 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.442 ' HA ' ' H ' ' B' ' 112' ' ' LYS . 30.5 m -137.41 164.66 28.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.171 0.51 . . . . 72.34 111.47 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' TYR . . . . . 0.58 ' CE2' ' HG2' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -106.46 120.78 42.81 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 126.41 1.884 . . . . 72.41 106.273 175.608 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 100.0 t -124.79 106.68 16.95 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 N-CA-C 107.742 -1.207 . . . . 64.14 107.742 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.66 113.2 0.58 Allowed Glycine 0 N--CA 1.423 -2.228 0 C-N-CA 116.318 -2.849 . . . . 64.11 117.724 -175.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.635 ' HB3' ' HA ' ' B' ' 107' ' ' ILE . 9.2 t30 176.22 23.76 0.0 OUTLIER 'General case' 0 C--O 1.209 -1.042 0 N-CA-C 105.41 -2.07 . . . . 73.22 105.41 160.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.473 ' O ' ' HA3' ' B' ' 79' ' ' GLY . 5.7 p -103.53 96.18 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-N 113.746 -1.57 . . . . 64.14 108.903 -178.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' B' ' 77' ' ' PRO . 6.0 m-20 -106.98 102.67 12.01 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.558 -1.645 . . . . 70.52 106.558 -170.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 51.21 -177.96 0.02 OUTLIER 'General case' 0 C--O 1.248 1.018 0 N-CA-C 114.935 1.457 . . . . 55.53 114.935 -173.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.22 -59.55 4.97 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 111.176 -0.77 . . . . 62.44 111.176 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.2 m -88.83 155.28 19.64 Favored 'General case' 0 N--CA 1.421 -1.875 0 N-CA-C 109.358 -0.608 . . . . 73.04 109.358 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 44.6 p -119.64 178.91 4.39 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 120.713 -0.395 . . . . 75.11 111.391 -174.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.548 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -64.53 -40.68 96.05 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 123.21 0.604 . . . . 74.32 109.904 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -58.39 -41.21 84.38 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 116.167 -0.47 . . . . 63.25 111.989 174.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -59.9 -35.88 75.8 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.637 0.732 . . . . 72.35 109.656 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' B' ' 50' ' ' ALA . 86.6 mt -67.65 -45.68 74.62 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.838 -1.074 . . . . 74.32 111.354 178.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -58.17 -50.82 72.19 Favored 'General case' 0 C--O 1.189 -2.13 0 C-N-CA 120.751 -0.38 . . . . 72.42 111.856 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.8 -48.25 80.25 Favored 'General case' 0 C--O 1.257 1.463 0 CA-C-O 120.937 0.398 . . . . 71.33 111.537 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -68.82 -40.22 79.6 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.675 -0.693 . . . . 74.25 111.192 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -83.36 -22.68 32.75 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 114.976 1.472 . . . . 73.33 114.976 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 35.7 t -72.24 -26.63 62.09 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 110.06 -0.348 . . . . 53.25 110.06 -177.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 20.4 m -64.49 -27.18 68.8 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 119.498 -0.881 . . . . 34.32 109.428 174.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 57.3 m -95.58 9.21 40.99 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.681 -0.69 . . . . 64.24 112.04 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.92 -167.37 32.71 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 118.619 -1.753 . . . . 74.33 115.815 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 20.4 m -108.17 116.29 31.69 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.302 -0.629 . . . . 51.44 109.302 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 64.9 mt -91.11 123.4 43.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.063 0.458 . . . . 73.42 111.579 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -95.79 -34.43 11.89 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.596 -0.729 . . . . 71.02 111.944 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.526 ' HD2' ' OE1' ' B' ' 84' ' ' GLU 0.253 0.0 OUTLIER -157.87 153.41 26.29 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.593 -1.262 . . . . 70.22 107.593 -169.922 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.548 HD11 ' HB1' ' B' ' 50' ' ' ALA . 35.0 pt -148.33 144.0 18.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 109.115 -0.698 . . . . 70.13 109.115 174.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 36.3 m -125.45 124.41 41.35 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.58 -1.637 . . . . 72.24 106.58 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.617 HG23 ' HB2' ' B' ' 81' ' ' ALA . 1.1 mp -121.85 121.55 64.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 106.11 -1.811 . . . . 61.22 106.11 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.71 130.59 54.13 Favored 'General case' 0 C--N 1.277 -2.566 0 C-N-CA 120.337 -0.545 . . . . 72.12 112.27 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 85.5 m -112.52 111.86 23.0 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.243 -1.021 . . . . 50.4 108.243 178.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -101.18 116.39 32.72 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.211 -1.033 . . . . 51.01 108.211 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.422 ' HE3' ' HB3' ' B' ' 77' ' ' PRO . 46.7 mtpt -112.37 4.77 17.81 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.324 -0.551 . . . . 42.43 110.6 -177.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -80.49 -6.64 58.47 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 119.308 -0.957 . . . . 74.34 110.727 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 33.7 t -80.93 7.82 9.76 Favored 'General case' 0 CA--C 1.557 1.249 0 CA-C-N 114.89 -1.05 . . . . 70.04 108.716 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.57 -58.87 2.59 Favored Glycine 0 CA--C 1.492 -1.392 0 N-CA-C 110.371 -1.092 . . . . 72.23 110.371 178.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -97.11 137.38 21.24 Favored Pre-proline 0 C--N 1.284 -2.253 0 N-CA-C 108.687 -0.857 . . . . 74.24 108.687 175.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.422 ' HB3' ' HE3' ' B' ' 72' ' ' LYS . 15.7 Cg_endo -61.21 117.89 4.72 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.662 1.575 . . . . 63.51 111.54 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -108.7 140.66 41.78 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 108.67 -0.863 . . . . 64.32 108.67 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' B' ' 44' ' ' VAL . . . -128.37 138.16 10.18 Favored Glycine 0 N--CA 1.411 -3.025 0 C-N-CA 120.495 -0.86 . . . . 55.31 112.469 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -154.51 147.01 24.05 Favored 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 123.695 0.798 . . . . 73.35 109.74 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.617 ' HB2' HG23 ' B' ' 68' ' ' ILE . . . -138.57 152.83 48.51 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-N 115.969 -0.559 . . . . 64.41 110.78 -172.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 82' ' ' TYR . . . . . 0.462 ' CE2' ' HB2' ' B' ' 40' ' ' TYR . 59.8 m-85 -118.47 115.3 24.34 Favored 'General case' 0 C--N 1.266 -3.062 0 N-CA-C 108.515 -0.92 . . . . 74.44 108.515 175.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.535 ' HA ' HG22 ' B' ' 66' ' ' ILE . 37.7 mm -95.3 118.72 42.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.668 -1.604 . . . . 74.2 106.668 -176.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' GLU . . . . . 0.526 ' OE1' ' HD2' ' B' ' 65' ' ' ARG . 32.3 mt-10 -102.78 117.79 35.42 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.308 -0.627 . . . . 63.43 109.308 -174.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -103.88 168.62 9.01 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.738 0.78 . . . . 73.51 112.261 -174.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.504 ' O ' ' HD2' ' B' ' 37' ' ' ARG . . . -81.01 -34.56 32.83 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.635 -1.166 . . . . 70.44 111.793 174.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -112.75 149.94 32.27 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 113.186 0.81 . . . . 74.42 113.186 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.426 ' O ' HG22 ' B' ' 91' ' ' VAL . 10.5 mmm180 -67.71 -31.16 70.91 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 107.542 -1.281 . . . . 64.54 107.542 168.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -56.79 -41.45 77.74 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 113.838 -1.528 . . . . 75.03 109.713 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 18.2 m -65.69 -39.5 91.35 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 116.06 -0.518 . . . . 72.15 111.356 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.446 ' O ' HG13 ' B' ' 95' ' ' VAL . 3.1 m -67.91 -38.73 80.53 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.354 0 C-N-CA 119.493 -0.883 . . . . 71.42 108.803 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.71 -38.76 79.01 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.678 0.791 . . . . 71.2 110.296 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.37 -36.96 63.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.624 -0.716 . . . . 63.24 111.223 177.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.4 -45.1 48.92 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 116.285 -0.416 . . . . 63.31 111.447 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' VAL . . . . . 0.446 HG13 ' O ' ' B' ' 91' ' ' VAL . 25.6 m -58.56 -21.98 19.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 C-N-CA 123.778 0.831 . . . . 52.11 112.358 177.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.31 -14.49 62.96 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.106 0.479 . . . . 73.44 110.229 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 72.0 mtm -99.26 13.65 32.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.542 -0.754 . . . . 72.31 110.152 178.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -36.27 -56.28 0.77 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 114.294 1.22 . . . . 74.41 114.294 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -107.1 91.6 3.73 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.541 0.686 . . . . 74.23 110.224 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 33.4 p -135.13 169.19 17.82 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.959 -1.019 . . . . 74.53 111.64 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 11.7 p -102.58 138.76 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 N-CA-C 108.866 -0.79 . . . . 74.41 108.866 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' PHE . . . . . 0.483 ' O ' ' HG2' ' B' ' 105' ' ' ARG . 57.3 t80 -141.15 116.44 10.03 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 107.632 -1.248 . . . . 75.34 107.632 177.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 103' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' B' ' 103' ' ' ARG . 20.4 ttt180 56.31 33.62 22.6 Favored 'General case' 0 CA--C 1.559 1.324 0 CA-C-O 122.684 1.231 . . . . 71.41 111.039 -176.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.18 2.54 87.9 Favored Glycine 0 C--N 1.314 -0.666 0 CA-C-N 114.754 -1.112 . . . . 75.13 114.259 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' B' ' 102' ' ' PHE . 4.1 ptp180 -120.02 137.28 54.19 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.419 -0.586 . . . . 53.52 109.419 177.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 28.0 m -78.39 120.92 23.82 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.529 -0.545 . . . . 74.45 109.529 -176.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' ILE . . . . . 0.635 ' HA ' ' HB3' ' B' ' 43' ' ' ASN . 41.2 pt -102.3 167.22 2.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 120.403 -0.519 . . . . 74.33 111.618 -177.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -118.76 126.13 51.18 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.014 -0.994 . . . . 71.43 109.185 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 21.5 t -124.17 122.37 64.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 N-CA-C 107.969 -1.123 . . . . 73.0 107.969 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.553 HD13 ' HD2' ' B' ' 40' ' ' TYR 0.306 0.1 OUTLIER -146.76 144.03 19.63 Favored Pre-proline 0 C--N 1.284 -2.251 0 N-CA-C 105.729 -1.952 . . . . 75.21 105.729 -172.38 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.465 ' O ' HG23 ' B' ' 114' ' ' THR . 17.4 Cg_endo -66.0 136.19 43.75 Favored 'Trans proline' 0 C--N 1.357 1.019 0 CA-C-N 121.657 1.627 . . . . 71.41 111.832 -177.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.442 ' H ' ' HA ' ' B' ' 39' ' ' VAL . 86.3 tttt -55.67 -50.65 69.68 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.244 0.617 . . . . 62.55 111.21 -171.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -83.81 75.63 10.07 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.827 -0.624 . . . . 71.43 110.141 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.465 HG23 ' O ' ' B' ' 111' ' ' PRO . 1.1 p -95.98 90.0 5.41 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.891 0.853 . . . . 61.14 112.109 176.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -164.42 140.76 6.2 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.739 -1.578 . . . . 65.25 106.739 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 26.7 ttt -64.16 109.46 2.75 Favored Pre-proline 0 C--N 1.321 -0.643 0 O-C-N 123.935 0.772 . . . . 73.41 110.425 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -88.25 -175.14 1.27 Allowed 'Trans proline' 0 N--CA 1.442 -1.501 0 C-N-CA 122.275 1.983 . . . . 73.33 112.441 -177.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -98.43 91.58 1.14 Allowed Glycine 0 N--CA 1.429 -1.8 0 N-CA-C 110.067 -1.213 . . . . 64.24 110.067 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 13.1 tt -150.81 150.05 13.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.573 -0.899 . . . . 54.53 108.573 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 31.6 t -77.72 -54.87 5.85 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.812 -1.181 . . . . 72.12 107.812 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 31.5 t 66.8 166.46 0.22 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.308 1.043 . . . . 70.01 112.173 176.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 9.4 t -171.05 155.22 4.36 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.287 -1.005 . . . . 73.23 108.287 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -156.11 148.65 23.76 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 109.353 -0.61 . . . . 54.22 109.353 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? . . . . . 0 C--N 1.287 -2.117 0 N-CA-C 107.272 -1.381 . . . . 73.21 107.272 177.684 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.585 0 N-CA-C 109.643 -0.502 . . . . 43.03 109.643 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.3 mp -85.11 110.64 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 107.497 -1.297 . . . . 71.21 107.497 177.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . . . -115.0 123.25 32.14 Favored Pre-proline 0 N--CA 1.426 -1.652 0 CA-C-N 116.442 -0.344 . . . . 74.13 111.389 -176.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 3' ' ' ALA . 7.4 Cg_exo -75.03 141.41 26.52 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.476 2.117 . . . . 61.01 110.147 174.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 45.9 t -84.4 93.51 8.29 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.602 -0.888 . . . . 70.33 108.602 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 84.8 mtp -82.59 107.87 15.56 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.677 -0.692 . . . . 72.43 109.716 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -138.52 117.35 12.35 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.66 0.743 . . . . 72.33 111.359 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.9 t -163.1 144.81 9.91 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 106.197 -1.779 . . . . 75.2 106.197 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.418 ' HA ' ' OD2' ' B' ' 92' ' ' ASP . 57.5 m -68.8 91.62 0.46 Allowed 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 121.584 0.706 . . . . 61.14 111.238 -177.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -104.42 -5.32 21.78 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.599 0.714 . . . . 72.31 109.305 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.2 t -85.52 96.22 9.55 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 107.632 -1.247 . . . . 70.44 107.632 176.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -78.79 -75.26 0.24 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.728 -0.669 . . . . 72.33 111.001 -176.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 16.2 tpt -174.92 131.69 0.32 Allowed 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 106.646 -1.613 . . . . 63.34 106.646 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -161.92 175.23 12.08 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.029 0.442 . . . . 74.12 110.135 -177.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.07 -18.35 21.08 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.948 -1.13 . . . . 51.24 107.948 175.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.84 156.31 28.29 Favored Glycine 0 N--CA 1.42 -2.368 0 CA-C-N 114.627 -1.169 . . . . 52.43 111.401 -178.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.12 99.86 12.07 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.521 -0.918 . . . . 61.23 108.521 176.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -134.49 169.9 16.58 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 112.884 0.698 . . . . 74.52 112.884 -176.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 31.1 m 70.17 70.05 0.22 Allowed 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.445 -1.252 . . . . 53.11 109.96 -177.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.502 ' HB3' ' HG2' ' A' ' 23' ' ' PRO . 1.0 OUTLIER 72.98 -39.15 0.44 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 113.971 -1.468 . . . . 73.14 112.654 179.49 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.431 ' HA3' ' HD2' ' A' ' 22' ' ' PRO . . . 76.74 -109.95 2.91 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 119.275 -0.736 . . . . 63.42 113.039 177.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.431 ' HD2' ' HA3' ' A' ' 21' ' ' GLY . 1.7 Cg_endo -37.6 -53.78 1.36 Allowed 'Trans proline' 0 CA--C 1.561 1.846 1 C-N-CA 125.52 4.147 . . . . 43.02 117.11 179.404 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.502 ' HG2' ' HB3' ' A' ' 20' ' ' GLU . 37.7 Cg_endo -61.67 147.26 95.74 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 121.475 1.45 . . . . 72.32 111.281 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -68.35 142.17 94.31 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 109.24 -0.652 . . . . 62.45 109.24 -175.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.56 102.83 0.1 OUTLIER 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.913 2.408 . . . . 51.12 112.374 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.709 HD13 ' H ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.17 168.53 17.6 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 114.997 -1.001 . . . . 72.55 112.026 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.1 t -79.22 153.59 29.86 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-O 121.211 0.529 . . . . 71.35 110.839 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.89 -33.99 8.3 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.66 -1.154 . . . . 75.12 111.609 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -70.71 -36.29 73.17 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 113.078 0.77 . . . . 73.55 113.078 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.541 ' O ' HG12 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -59.5 -36.37 75.95 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 109.023 -0.732 . . . . 65.24 109.023 173.109 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.585 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 66.1 mttm -63.32 -42.63 99.0 Favored 'General case' 0 C--O 1.196 -1.721 0 O-C-N 123.823 0.702 . . . . 74.54 111.08 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.717 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -64.44 -44.62 90.59 Favored 'General case' 0 C--O 1.202 -1.403 0 C-N-CA 119.677 -0.809 . . . . 63.04 111.679 177.254 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.406 ' HA ' ' OE1' ' A' ' 33' ' ' GLU . 5.3 mm-40 -65.81 -42.83 90.17 Favored 'General case' 0 C--O 1.211 -0.934 0 C-N-CA 120.645 -0.422 . . . . 65.24 111.652 -174.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 30' ' ' GLU . 12.8 pt -70.33 -35.32 62.09 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.182 0 C-N-CA 120.981 -0.288 . . . . 65.33 110.945 178.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.585 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 7.0 t70 -73.06 -32.02 64.76 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.731 0.777 . . . . 73.25 109.717 -176.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.565 ' HA ' ' HG2' ' A' ' 113' ' ' ARG . 52.9 mtpt -71.51 -19.17 62.22 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 115.042 -0.981 . . . . 72.21 110.298 176.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -107.56 9.2 29.51 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.784 -0.644 . . . . 74.2 110.4 -177.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 69.2 m -95.36 149.81 20.95 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.587 0.708 . . . . 75.45 109.96 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 32.4 m -128.33 160.93 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 CA-C-N 115.028 -0.987 . . . . 75.43 109.779 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.605 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 18.5 t80 -105.63 121.07 43.23 Favored 'General case' 0 C--N 1.269 -2.898 0 C-N-CA 124.896 1.278 . . . . 74.51 108.072 176.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.6 t -113.9 108.92 26.73 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 107.809 -1.182 . . . . 61.15 107.809 176.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.31 165.36 12.76 Favored Glycine 0 C--N 1.296 -1.67 0 C-N-CA 119.596 -1.288 . . . . 63.14 113.711 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.6 t30 57.75 20.57 6.57 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.976 1.711 . . . . 61.12 113.374 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.3 p -62.41 133.26 28.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 CA-C-O 121.497 0.665 . . . . 61.33 109.301 174.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.448 ' HB3' ' HD2' ' A' ' 103' ' ' ARG . 15.0 t70 -80.73 153.93 27.56 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.235 -1.024 . . . . 75.52 108.235 -177.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -65.55 -17.08 64.3 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.386 0.612 . . . . 75.32 109.523 -174.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.54 -22.17 71.27 Favored Glycine 0 N--CA 1.439 -1.117 0 CA-C-N 115.905 -0.589 . . . . 64.43 112.944 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.5 m -92.29 145.0 24.83 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 119.296 -0.962 . . . . 72.31 111.483 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.2 p -124.28 179.83 4.74 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.831 -1.077 . . . . 72.54 109.197 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.88 -50.28 72.98 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 112.634 0.605 . . . . 73.42 112.634 -174.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -58.55 -43.03 89.18 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.452 0.538 . . . . 72.53 112.452 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.49 -44.36 97.22 Favored 'General case' 0 C--O 1.254 1.328 0 CA-C-O 121.762 0.791 . . . . 73.22 109.414 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 76.2 mt -68.31 -46.06 71.32 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-N 114.733 -1.121 . . . . 75.44 112.037 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -58.6 -47.89 82.81 Favored 'General case' 0 C--O 1.203 -1.366 0 N-CA-C 113.09 0.774 . . . . 61.13 113.09 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.7 -47.66 76.44 Favored 'General case' 0 C--O 1.276 2.496 0 CA-C-O 120.89 0.376 . . . . 43.33 110.779 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -64.29 -34.89 79.16 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 120.103 -0.639 . . . . 73.14 110.928 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -81.45 -21.63 38.67 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.812 1.042 . . . . 75.23 113.812 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.2 m -64.55 -26.62 68.5 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 121.067 0.46 . . . . 42.01 110.006 -178.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.0 m -57.7 -32.58 67.52 Favored 'General case' 0 CA--C 1.567 1.62 0 CA-C-N 116.065 -0.516 . . . . 61.03 110.455 172.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.1 m -91.21 4.5 52.12 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 113.599 0.963 . . . . 62.11 113.599 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.21 -164.97 27.52 Favored Glycine 0 CA--C 1.511 -0.191 0 C-N-CA 118.944 -1.598 . . . . 74.33 113.978 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.7 m -101.72 121.94 42.98 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.228 -0.286 . . . . 73.2 110.228 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.5 mt -78.97 127.98 38.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 121.715 0.769 . . . . 62.23 112.262 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -87.03 -47.12 9.19 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.371 -1.286 . . . . 51.11 108.766 177.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.536 ' HB2' ' OE1' ' A' ' 84' ' ' GLU . 50.1 mtm180 -155.39 165.02 37.91 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.168 -0.679 . . . . 74.04 109.168 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.423 HG13 HG12 ' A' ' 83' ' ' ILE . 1.1 tt -149.18 133.35 8.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 122.966 0.506 . . . . 75.22 111.557 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.0 m -125.65 131.77 52.57 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.674 -1.232 . . . . 71.31 107.674 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mp -128.66 124.16 60.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 107.335 -1.357 . . . . 75.4 107.335 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.437 ' HB3' HG23 ' B' ' 67' ' ' THR . 1.6 pt? -120.67 131.95 54.85 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.959 -0.696 . . . . 75.52 111.643 176.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 66.7 m -117.36 127.43 54.04 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 108.867 -0.79 . . . . 64.35 108.867 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.535 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 3.1 p30 -104.73 119.31 38.69 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 119.298 -0.961 . . . . 71.55 109.09 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -110.06 -4.11 16.04 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 120.072 -0.651 . . . . 71.15 112.084 -175.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.585 ' HB3' ' OD1' ' B' ' 64' ' ' ASN . 50.7 p90 -58.1 -20.29 38.86 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 119.447 -0.901 . . . . 54.43 111.188 176.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 28.5 t -79.22 -3.66 46.86 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.165 0.586 . . . . 61.45 111.42 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.0 -61.16 0.8 Allowed Glycine 0 CA--C 1.496 -1.126 0 N-CA-C 109.748 -1.341 . . . . 64.33 109.748 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -95.23 120.49 63.96 Favored Pre-proline 0 CA--C 1.484 -1.575 0 N-CA-C 106.689 -1.597 . . . . 70.53 106.689 173.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 65.6 Cg_endo -68.9 119.34 6.34 Favored 'Trans proline' 0 N--CA 1.442 -1.553 0 C-N-CA 121.841 1.694 . . . . 74.21 111.5 -176.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 32.6 mtmm -95.9 151.92 18.98 Favored 'General case' 0 CA--C 1.472 -2.021 0 N-CA-C 107.619 -1.252 . . . . 75.24 107.619 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.05 144.24 15.47 Favored Glycine 0 N--CA 1.405 -3.432 0 C-N-CA 118.743 -1.694 . . . . 12.12 113.492 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -152.14 146.32 25.4 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.479 -0.86 . . . . 60.35 109.018 172.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.11 154.08 50.91 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 120.691 0.282 . . . . 71.2 111.416 -171.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.45 ' OH ' ' HA3' ' B' ' 21' ' ' GLY . 92.6 m-85 -126.74 122.67 35.51 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.613 -0.884 . . . . 64.14 108.613 175.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.423 HG12 HG13 ' A' ' 66' ' ' ILE . 76.1 mt -122.71 134.17 66.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 116.139 -0.482 . . . . 70.12 110.886 -174.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.536 ' OE1' ' HB2' ' A' ' 65' ' ' ARG . 2.9 mp0 -102.02 134.48 45.18 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.921 -0.77 . . . . 63.14 108.921 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -102.44 160.26 14.71 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.841 -0.429 . . . . 71.2 109.841 173.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.87 -37.69 87.88 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.944 0.402 . . . . 73.2 111.395 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -110.58 149.77 29.91 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.144 -0.48 . . . . 70.23 111.403 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.42 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.9 OUTLIER -74.77 -30.02 61.32 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.242 -1.392 . . . . 70.34 107.242 178.716 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -67.46 -21.18 65.55 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.395 -0.82 . . . . 73.24 111.28 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.7 m -70.49 -35.22 73.12 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 109.451 -0.574 . . . . 72.54 109.451 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 88' ' ' ARG . 2.2 m -65.63 -37.99 81.28 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 N-CA-C 108.209 -1.034 . . . . 65.12 108.209 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -56.49 -38.58 71.94 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.923 -0.58 . . . . 73.41 110.435 177.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.85 -31.49 63.2 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.598 0.713 . . . . 62.1 111.347 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.39 -44.88 34.2 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.715 -0.675 . . . . 71.12 110.795 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.7 m -62.36 -21.65 27.47 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.772 0 C-N-CA 122.656 0.383 . . . . 72.33 111.991 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.91 -10.33 52.31 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.639 0.733 . . . . 44.34 110.047 174.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 35.4 mtm -102.73 11.23 37.92 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.586 -0.734 . . . . 73.55 110.302 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -46.52 -46.85 19.46 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.525 0.565 . . . . 63.11 112.525 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -95.44 93.28 7.12 Favored 'General case' 0 N--CA 1.437 -1.1 0 O-C-N 121.708 -0.62 . . . . 74.55 109.496 174.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 21.9 p -148.88 160.01 43.65 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 122.594 0.357 . . . . 72.15 110.817 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.2 p -107.78 126.01 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 109.03 -0.73 . . . . 75.03 109.03 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -133.49 119.58 19.74 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 108.441 -0.948 . . . . 75.11 108.441 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.448 ' HD2' ' HB3' ' A' ' 45' ' ' ASP . 48.6 ttm-85 55.26 54.27 8.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.957 0.884 . . . . 75.43 112.411 -177.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.24 -8.44 17.64 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 114.54 -1.209 . . . . 65.53 115.888 176.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -130.88 156.58 44.8 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 118.044 0.922 . . . . 72.15 110.997 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.4 m -84.3 125.25 32.09 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 120.985 0.421 . . . . 64.54 110.483 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 47.6 pt -101.76 172.07 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 116.079 -0.509 . . . . 70.12 110.011 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.42 134.43 47.11 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.191 -0.913 . . . . 74.54 109.874 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 28.0 t -124.74 126.0 70.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.992 -1.114 . . . . 53.21 107.992 177.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.487 ' HB2' ' HB3' ' A' ' 40' ' ' TYR . 97.0 mt -134.89 161.63 62.51 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 108.616 -0.883 . . . . 64.44 108.616 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.53 140.5 24.11 Favored 'Trans proline' 0 N--CA 1.44 -1.658 0 N-CA-C 107.977 -1.586 . . . . 60.05 107.977 171.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 64.7 tttm -69.02 -29.65 67.87 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 119.891 -0.723 . . . . 72.23 110.835 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.565 ' HG2' ' HA ' ' A' ' 36' ' ' LYS 0.32 0.0 OUTLIER -87.92 112.78 22.91 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 119.408 -0.917 . . . . 71.14 111.504 171.58 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.6 p -145.45 164.46 31.51 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.41 -0.814 . . . . 70.02 109.21 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -156.78 99.06 1.83 Allowed 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.741 -0.466 . . . . 71.52 109.741 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 28.1 ttt -114.73 103.46 54.82 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 109.428 -0.582 . . . . 64.41 109.428 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.83 124.34 10.56 Favored 'Trans proline' 0 C--O 1.242 0.712 0 C-N-CA 122.538 2.159 . . . . 63.52 111.562 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -92.05 -120.81 2.69 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.866 -0.894 . . . . 64.53 110.866 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.9 tt -154.3 103.97 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 121.588 0.709 . . . . 74.54 111.611 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.8 m -144.08 106.3 4.37 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.02 -0.733 . . . . 73.1 109.02 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 50.6 m -85.8 106.84 17.33 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 121.321 0.582 . . . . 74.31 110.45 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 57.7 m -151.3 94.77 2.07 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.555 -0.906 . . . . 70.23 108.555 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -149.45 153.18 36.89 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.941 -0.572 . . . . 71.02 109.743 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 . . . . . 0 C--N 1.296 -1.734 0 CA-C-N 115.437 -0.801 . . . . 75.43 110.162 -177.817 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.505 0 CA-C-O 121.539 0.685 . . . . 50.14 109.906 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 48.0 mm -96.22 136.47 26.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 115.226 -0.897 . . . . 74.32 109.291 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.61 129.24 24.6 Favored Pre-proline 0 C--N 1.308 -1.198 0 N-CA-C 109.547 -0.538 . . . . 62.31 109.547 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -74.64 96.18 0.98 Allowed 'Trans proline' 0 C--O 1.249 1.037 0 C-N-CA 122.105 1.87 . . . . 75.23 110.973 177.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 62.7 m -148.41 95.55 2.47 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.298 -1.001 . . . . 65.34 108.298 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.68 113.66 21.45 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.933 -0.576 . . . . 63.15 111.038 -176.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -136.61 78.28 1.69 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.385 1.088 . . . . 62.03 111.872 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 3.5 p -139.22 112.22 7.97 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 113.886 -1.507 . . . . 54.31 108.731 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 71.9 p 65.67 107.0 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.042 1.737 . . . . 70.1 110.987 -173.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -67.79 154.55 41.29 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 116.112 -0.494 . . . . 75.41 111.343 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 13.4 p -68.76 -43.43 75.83 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 116.166 -0.47 . . . . 34.14 110.571 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -89.3 132.22 35.02 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 107.885 -1.154 . . . . 75.24 107.885 175.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 18.0 ptm -159.55 139.74 11.92 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.57 -0.452 . . . . 63.4 111.903 -174.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 54.9 p -88.37 30.98 0.84 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.871 0.868 . . . . 73.44 110.749 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.34 147.3 21.6 Favored 'General case' 0 CA--C 1.504 -0.819 0 C-N-CA 124.592 1.157 . . . . 53.42 113.544 -176.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.406 ' O ' ' HG ' ' B' ' 26' ' ' LEU . . . 148.25 -169.16 28.94 Favored Glycine 0 N--CA 1.412 -2.959 0 CA-C-N 115.322 -0.853 . . . . 64.53 111.995 175.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.97 92.24 8.27 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.667 -0.864 . . . . 54.52 108.667 177.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.472 ' C ' ' H ' ' B' ' 20' ' ' GLU . 92.7 m-85 -134.97 -162.77 1.29 Allowed 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 115.062 -0.972 . . . . 75.33 109.615 -178.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.443 HG23 ' HA ' ' B' ' 25' ' ' PRO . 42.4 p 50.94 -23.19 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.701 0 N-CA-C 116.712 2.115 . . . . 72.53 116.712 -170.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' GLU . . . . . 0.472 ' H ' ' C ' ' B' ' 18' ' ' TYR . 39.5 mt-10 -74.45 82.63 1.96 Allowed 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 108.179 -1.045 . . . . 71.43 108.179 178.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.45 ' HA3' ' OH ' ' A' ' 82' ' ' TYR . . . 99.81 -150.6 19.08 Favored Glycine 0 C--N 1.33 0.237 0 CA-C-N 114.176 -1.375 . . . . 41.33 110.002 -175.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.569 ' N ' ' HD2' ' B' ' 23' ' ' PRO . 52.7 Cg_exo -54.36 -40.24 83.75 Favored 'Trans proline' 0 CA--C 1.586 3.092 0 C-N-CA 123.409 2.739 . . . . 73.23 115.855 177.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' B' ' 22' ' ' PRO . 16.8 Cg_exo -30.21 126.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.411 3.866 0 C-N-CA 124.822 3.681 . . . . 74.05 115.85 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' B' ' 18' ' ' TYR . 90.7 mm-40 -61.3 140.84 94.48 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 124.157 0.983 . . . . 74.05 112.888 -177.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.443 ' HA ' HG23 ' B' ' 19' ' ' THR . 41.8 Cg_exo -40.94 149.54 0.17 Allowed 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 125.039 3.826 . . . . 62.22 117.595 -177.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.61 HD23 ' HB2' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -134.39 164.64 26.98 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 105.542 -2.022 . . . . 73.44 105.542 177.603 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.45 ' HB3' ' OE1' ' B' ' 30' ' ' GLU . 45.8 t -76.01 144.79 40.69 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 118.264 -1.375 . . . . 53.04 112.576 -172.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.43 -32.9 8.38 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.034 -1.439 . . . . 53.52 111.62 173.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -71.45 -35.04 70.77 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 112.982 0.734 . . . . 64.52 112.982 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.61 ' HB2' HD23 ' B' ' 26' ' ' LEU . 0.9 OUTLIER -59.17 -37.85 78.36 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 109.03 -0.73 . . . . 71.12 109.03 172.6 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' B' ' 35' ' ' ASP . 65.1 mttm -63.29 -42.22 99.06 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 115.403 -0.817 . . . . 74.43 111.232 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.647 ' N ' ' HE2' ' B' ' 32' ' ' LYS . 0.5 OUTLIER -64.54 -44.47 90.71 Favored 'General case' 0 C--O 1.204 -1.3 0 C-N-CA 119.817 -0.753 . . . . 72.32 111.553 176.228 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -65.07 -42.27 94.33 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.782 -0.367 . . . . 52.11 111.346 -175.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.503 HG12 ' O ' ' B' ' 30' ' ' GLU . 11.7 pt -70.96 -34.68 56.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 116.254 -0.43 . . . . 75.43 111.482 178.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.48 ' HB3' ' HB2' ' B' ' 113' ' ' ARG . 3.8 m-20 -68.03 -41.32 82.29 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.971 0.509 . . . . 74.31 111.786 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -68.44 -23.53 64.62 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.14 -0.936 . . . . 74.12 110.519 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -101.89 10.54 39.7 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.641 -0.708 . . . . 64.55 110.947 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' B' ' 84' ' ' GLU . 16.3 t -105.24 155.1 19.38 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-O 121.317 0.58 . . . . 74.23 110.622 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.458 HG22 ' O ' ' B' ' 83' ' ' ILE . 32.5 m -131.05 164.13 35.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.423 -0.808 . . . . 74.24 110.777 -176.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 40' ' ' TYR . . . . . 0.615 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 22.5 t80 -109.54 122.81 48.25 Favored 'General case' 0 C--N 1.281 -2.394 0 C-N-CA 125.712 1.605 . . . . 73.35 108.031 176.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 46.6 t -115.95 112.92 41.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 107.759 -1.2 . . . . 73.13 107.759 176.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.3 175.81 16.51 Favored Glycine 0 C--N 1.306 -1.102 0 C-N-CA 119.806 -1.188 . . . . 53.32 113.732 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 62.68 1.75 0.84 Allowed 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 126.462 1.905 . . . . 64.21 115.001 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.01 105.64 16.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.042 -1.036 . . . . 72.54 110.561 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -114.92 130.67 56.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 118.694 -0.669 . . . . 73.41 109.526 -171.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 46' ' ' TYR . . . . . 0.74 ' CE1' ' HB2' ' B' ' 77' ' ' PRO 0.344 13.6 m-85 52.11 -52.76 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 121.213 3.783 . . . . 72.12 121.213 170.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.74 -36.32 89.37 Favored Glycine 0 C--N 1.312 -0.777 0 N-CA-C 114.25 0.46 . . . . 72.14 114.25 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -91.44 147.84 22.74 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.095 0.474 . . . . 71.23 109.977 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 66.6 p -119.31 178.56 4.49 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.703 -0.68 . . . . 73.01 109.518 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.32 -50.29 74.22 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.021 0.378 . . . . 51.44 112.021 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -58.53 -40.81 83.97 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 120.972 0.415 . . . . 71.11 111.122 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -63.06 -47.74 81.64 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-N 115.665 -0.698 . . . . 74.33 109.766 -178.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 81.3 mt -62.36 -46.21 89.7 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-N 115.384 -0.826 . . . . 75.43 112.248 177.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -58.38 -47.69 83.03 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 112.636 0.606 . . . . 74.54 112.636 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.74 -45.44 78.01 Favored 'General case' 0 C--O 1.264 1.818 0 CA-C-O 121.463 0.649 . . . . 73.12 112.595 -176.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -67.35 -35.7 79.9 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.499 -0.773 . . . . 73.21 110.455 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -81.11 -22.94 38.74 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.052 0.76 . . . . 74.03 113.052 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' SER . . . . . 0.61 ' HA ' ' O ' ' B' ' 61' ' ' GLY . 68.6 m -67.09 -28.73 68.42 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 116.428 -0.351 . . . . 62.01 110.829 -177.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 16.0 m -59.33 -30.56 68.46 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.059 0.457 . . . . 72.12 110.845 175.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 71.4 m -106.73 -0.16 23.75 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 113.449 0.907 . . . . 74.32 113.449 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' B' ' 58' ' ' SER . . . 178.07 164.83 31.93 Favored Glycine 0 C--O 1.215 -1.075 0 C-N-CA 118.844 -1.646 . . . . 60.15 114.144 -177.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 40.1 m -98.92 120.92 40.17 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.829 -0.804 . . . . 34.45 108.829 177.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 84.7 mt -82.16 129.44 37.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 114.717 1.377 . . . . 52.43 114.717 -173.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 64' ' ' ASN . . . . . 0.585 ' OD1' ' HB3' ' A' ' 73' ' ' PHE . 31.1 t-20 -88.22 -46.21 9.43 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.598 1.559 . . . . 72.4 109.265 177.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.485 ' HG2' ' HA ' ' A' ' 71' ' ' ASP . 52.5 mtm180 -156.05 166.04 34.65 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.556 -0.535 . . . . 71.35 109.556 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.402 HG13 HG12 ' B' ' 83' ' ' ILE . 1.3 tt -149.76 134.51 9.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 115.869 -0.605 . . . . 74.31 111.478 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 67' ' ' THR . . . . . 0.437 HG23 ' HB3' ' A' ' 69' ' ' LEU . 28.2 m -125.76 133.16 52.15 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.527 -1.286 . . . . 71.3 107.527 -178.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.426 HD12 ' N ' ' B' ' 68' ' ' ILE . 1.5 mp -130.25 125.04 59.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 107.052 -1.462 . . . . 71.13 107.052 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.255 1.3 pt? -121.11 132.21 54.73 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.169 -0.612 . . . . 75.45 111.657 175.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 70' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 86.1 m -117.3 126.71 53.17 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.326 -0.99 . . . . 51.1 108.326 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.611 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 3.1 p-10 -113.13 134.46 54.54 Favored 'General case' 0 CA--C 1.489 -1.394 0 C-N-CA 119.328 -0.949 . . . . 61.41 110.759 -177.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.499 ' HE2' ' HB3' ' B' ' 77' ' ' PRO . 35.8 ttmt -119.49 14.26 12.75 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 105.698 -1.964 . . . . 61.1 105.698 176.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -43.75 -37.93 2.95 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 127.418 2.287 . . . . 73.5 113.27 177.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 49.8 m -110.37 22.24 15.73 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 120.891 0.377 . . . . 75.12 111.865 -177.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.83 -51.96 1.31 Allowed Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.366 -0.921 . . . . 74.35 112.857 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -95.4 119.16 65.84 Favored Pre-proline 0 C--N 1.311 -1.083 0 C-N-CA 120.586 -0.446 . . . . 72.43 110.385 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.74 ' HB2' ' CE1' ' B' ' 46' ' ' TYR . 57.3 Cg_endo -70.18 118.64 5.8 Favored 'Trans proline' 0 C--N 1.32 -0.97 0 C-N-CA 122.727 2.285 . . . . 53.32 113.335 -175.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 78' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 32.4 mtmm -113.83 166.25 11.75 Favored 'General case' 0 C--O 1.211 -0.963 0 CA-C-N 115.616 -0.72 . . . . 70.14 109.426 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -138.89 146.98 18.87 Favored Glycine 0 N--CA 1.421 -2.319 0 C-N-CA 120.042 -1.075 . . . . 45.43 114.177 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -153.16 146.3 24.66 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.467 -0.867 . . . . 74.14 108.891 172.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.38 154.12 48.95 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 120.946 0.403 . . . . 55.55 111.46 -172.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 82' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -127.64 121.07 29.5 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.863 -0.792 . . . . 74.03 108.863 175.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.458 ' O ' HG22 ' B' ' 39' ' ' VAL . 71.2 mt -121.2 136.02 59.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 116.344 -0.389 . . . . 53.4 110.101 -174.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 84' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' B' ' 38' ' ' SER 0.387 1.3 pm0 -110.82 132.63 54.03 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.81 1.041 . . . . 65.21 113.81 174.635 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -97.99 162.02 13.44 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.473 -0.785 . . . . 73.14 111.755 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.69 -38.26 81.08 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.24 -0.891 . . . . 74.11 112.119 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 87' ' ' GLU . . . . . 0.493 ' CD ' ' H ' ' B' ' 88' ' ' ARG . 0.3 OUTLIER -120.67 156.42 31.77 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 120.045 -0.662 . . . . 73.23 111.122 178.623 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.493 ' H ' ' CD ' ' B' ' 87' ' ' GLU . 0.8 OUTLIER -75.22 -32.32 61.11 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 107.157 -1.423 . . . . 74.3 107.157 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -63.82 -22.77 67.07 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.527 -0.76 . . . . 61.02 110.857 176.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 16.0 m -71.07 -35.66 71.96 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 109.315 -0.624 . . . . 72.4 109.315 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.417 HG22 ' O ' ' B' ' 88' ' ' ARG . 2.1 m -66.53 -37.12 78.92 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.157 0 N-CA-C 108.601 -0.888 . . . . 65.23 108.601 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.418 ' OD2' ' HA ' ' A' ' 9' ' ' THR . 23.1 t70 -57.38 -38.46 74.27 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.353 0.597 . . . . 74.23 110.367 177.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.73 -33.0 64.15 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.458 -0.792 . . . . 73.42 110.043 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 94' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' B' ' 97' ' ' MET . . . -75.45 -43.67 48.31 Favored 'General case' 0 C--O 1.209 -1.049 0 CA-C-O 121.082 0.468 . . . . 63.42 110.562 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 24.7 m -63.24 -20.61 26.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 112.325 0.491 . . . . 74.14 112.325 176.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.95 -12.17 61.42 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 121.873 0.844 . . . . 53.13 109.882 174.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 97' ' ' MET . . . . . 0.494 ' HB2' ' O ' ' B' ' 94' ' ' ALA . 40.0 mtp -99.66 10.18 41.8 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.583 -1.19 . . . . 62.41 109.51 178.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 98' ' ' ASP . . . . . 0.684 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 6.9 p-10 -36.57 -45.41 0.51 Allowed 'General case' 0 C--O 1.206 -1.218 0 N-CA-C 115.564 1.691 . . . . 74.14 115.564 -176.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -124.52 49.41 1.82 Allowed 'General case' 0 C--O 1.241 0.614 0 CA-C-N 119.98 1.264 . . . . 75.35 112.258 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 31.7 p -81.54 177.26 9.04 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.761 -0.654 . . . . 72.14 112.363 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 8.7 p -108.06 136.37 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-O 121.156 0.503 . . . . 63.21 110.174 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -139.17 120.92 15.35 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.77 -1.567 . . . . 73.24 106.77 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 53.71 33.27 16.35 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.315 0.857 . . . . 61.22 113.315 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.59 1.49 87.57 Favored Glycine 0 C--N 1.314 -0.647 0 CA-C-N 115.828 -0.624 . . . . 62.44 113.7 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -120.81 157.19 30.29 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.073 -0.714 . . . . 71.44 109.073 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 52.1 m -91.61 120.3 32.27 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 109.166 -0.679 . . . . 72.4 109.166 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 pp -102.14 164.67 3.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 119.668 -0.813 . . . . 74.42 111.089 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 108' ' ' LYS . . . . . 0.684 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 16.4 tptm -125.69 125.13 42.55 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.985 -0.746 . . . . 63.44 108.985 -169.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.615 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 22.9 t -121.16 131.37 73.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 110.046 -0.353 . . . . 74.04 110.046 -175.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.44 ' HB2' ' HB3' ' B' ' 40' ' ' TYR . 96.9 mt -138.77 163.71 44.72 Favored Pre-proline 0 C--O 1.211 -0.924 0 C-N-CA 123.533 0.733 . . . . 65.04 109.34 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.31 142.38 26.87 Favored 'Trans proline' 0 CA--C 1.554 1.513 0 C-N-CA 122.506 2.137 . . . . 52.12 108.924 171.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.615 ' HG2' ' HD2' ' B' ' 113' ' ' ARG . 35.6 ttpt -85.27 -57.57 3.02 Favored 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 114.04 1.126 . . . . 74.15 114.04 -171.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.615 ' HD2' ' HG2' ' B' ' 112' ' ' LYS . 4.2 mpt_? -133.52 148.86 51.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.743 -1.223 . . . . 74.41 112.235 175.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 20.9 m -151.72 26.75 0.65 Allowed 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 107.212 -1.403 . . . . 71.32 107.212 174.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -149.99 173.76 13.47 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 107.172 -1.418 . . . . 54.12 107.172 -178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 65.1 mtt 74.02 103.64 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 125.397 1.479 . . . . 72.55 113.588 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 117' ' ' PRO . . . . . 0.471 ' HA ' ' HD3' ' B' ' 32' ' ' LYS . 63.7 Cg_endo -94.26 -172.29 0.28 Allowed 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 123.213 2.609 . . . . 73.54 112.234 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -153.04 167.53 31.74 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.883 -0.887 . . . . 62.24 110.883 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 12.8 tt -156.13 128.72 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.394 0.616 . . . . 65.0 112.046 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 35.7 t -136.25 94.35 3.02 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.304 -1.739 . . . . 52.54 106.304 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 23.2 t -94.43 -55.82 3.03 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.021 -0.536 . . . . 61.41 110.867 -174.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 48.8 m 64.29 95.35 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.621 0.769 . . . . 73.31 111.709 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -135.94 140.97 44.42 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 115.829 -0.623 . . . . 64.22 110.117 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 . . . . . 0 C--N 1.304 -1.391 0 N-CA-C 108.907 -0.775 . . . . 74.43 108.907 179.182 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.53 0 N-CA-C 109.659 -0.497 . . . . 54.3 109.659 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 27.9 pt -120.72 128.03 76.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.118 0.485 . . . . 74.42 110.366 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -102.27 121.44 50.21 Favored Pre-proline 0 C--N 1.286 -2.168 0 N-CA-C 108.053 -1.091 . . . . 73.53 108.053 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.02 120.24 7.94 Favored 'Trans proline' 0 C--O 1.245 0.846 0 C-N-CA 122.349 2.032 . . . . 60.25 110.767 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 63.3 m -101.96 116.8 33.47 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.742 -0.663 . . . . 61.43 110.362 -177.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -96.97 122.34 39.85 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.415 -0.587 . . . . 72.34 109.415 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -82.91 101.71 11.2 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.917 -0.713 . . . . 74.45 109.78 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.6 p -59.23 124.47 20.1 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.85 -1.068 . . . . 54.44 112.081 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -88.27 130.41 35.11 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-O 121.496 0.665 . . . . 71.21 109.602 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -131.65 92.64 3.19 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.461 -0.79 . . . . 63.22 110.719 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.1 t -78.57 146.83 34.0 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.606 -1.179 . . . . 60.24 110.323 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -85.8 97.36 10.13 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 109.177 -0.675 . . . . 72.11 109.177 177.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.4 ptm -72.46 109.22 6.0 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.615 -1.254 . . . . 72.3 107.615 174.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -81.51 137.6 35.57 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.838 -1.074 . . . . 73.2 113.43 -168.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.424 ' H ' ' HG3' ' B' ' 78' ' ' LYS . . . -85.65 91.63 8.34 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 114.863 -1.062 . . . . 55.1 108.198 171.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.46 75.44 2.0 Favored Glycine 0 CA--C 1.495 -1.194 0 N-CA-C 110.035 -1.226 . . . . 65.12 110.035 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -100.89 133.55 45.21 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 122.699 0.4 . . . . 73.34 111.235 -176.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.583 ' HB3' ' O ' ' A' ' 24' ' ' GLN . 90.7 m-85 -79.62 77.63 6.21 Favored 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 108.213 -1.032 . . . . 74.32 108.213 175.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.493 HG21 ' NH2' ' A' ' 65' ' ' ARG . 26.5 m -105.35 -71.89 0.73 Allowed 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 115.664 1.727 . . . . 52.14 115.664 -177.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -149.99 149.38 30.28 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.982 -1.118 . . . . 62.2 107.982 -167.351 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.63 -133.01 11.49 Favored Glycine 0 C--N 1.317 -0.523 0 N-CA-C 110.527 -1.029 . . . . 73.13 110.527 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -51.18 -50.37 14.12 Favored 'Trans proline' 0 CA--C 1.566 2.123 0 C-N-CA 122.465 2.11 . . . . 62.15 113.116 174.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.521 ' HG2' ' O ' ' A' ' 20' ' ' GLU . 3.9 Cg_endo -54.58 134.97 64.78 Favored 'Trans proline' 0 C--N 1.397 3.121 0 C-N-CA 121.697 1.598 . . . . 71.03 110.913 171.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.583 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 16.2 mm100 -84.37 163.01 49.35 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-N 116.19 -0.459 . . . . 72.41 110.571 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.87 125.16 18.2 Favored 'Trans proline' 0 C--O 1.247 0.968 0 C-N-CA 122.681 2.254 . . . . 74.33 113.816 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.708 HD13 ' H ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.24 166.14 16.99 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.607 -1.178 . . . . 75.24 112.498 177.258 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.4 t -73.48 157.37 36.93 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 113.624 0.972 . . . . 74.55 113.624 -172.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.71 -45.7 74.07 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.338 -1.301 . . . . 74.22 112.39 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -58.67 -44.08 90.08 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.175 0.19 . . . . 72.43 110.686 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.467 ' O ' HG12 ' A' ' 34' ' ' ILE . 0.5 OUTLIER -59.33 -36.24 75.31 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 116.401 -0.363 . . . . 75.33 111.905 177.713 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -65.62 -51.79 56.93 Favored 'General case' 0 CA--C 1.5 -0.966 0 O-C-N 123.324 0.39 . . . . 63.55 110.056 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.557 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 47.7 mtmt -53.6 -34.87 59.94 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 113.925 1.083 . . . . 75.34 113.925 177.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -70.96 -49.18 48.28 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.262 0.468 . . . . 72.43 112.262 174.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 30' ' ' GLU . 16.0 pt -70.37 -36.1 65.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 112.926 0.714 . . . . 55.01 112.926 -175.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.95 -39.16 74.03 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-O 120.985 0.422 . . . . 73.01 111.422 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.557 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 99.0 mttt -57.35 -37.27 72.33 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 112.711 0.634 . . . . 73.23 112.711 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.566 ' HA ' HG11 ' A' ' 91' ' ' VAL . 4.9 ptp180 -114.44 14.74 17.91 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 114.492 1.293 . . . . 64.25 114.492 -165.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 62.7 p -104.21 158.19 16.61 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.219 1.192 . . . . 54.44 114.219 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.5 ' CG1' HG23 ' A' ' 91' ' ' VAL . 16.2 m -140.36 164.92 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 113.118 0.785 . . . . 64.55 113.118 -177.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.606 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 16.0 t80 -113.04 127.84 56.33 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 126.576 1.951 . . . . 75.23 108.448 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.28 114.41 43.8 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 N-CA-C 107.591 -1.263 . . . . 71.12 107.591 176.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.26 168.0 12.89 Favored Glycine 0 N--CA 1.425 -2.075 0 C-N-CA 119.729 -1.224 . . . . 72.41 113.909 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . 0.255 10.0 t30 60.63 67.07 0.86 Allowed 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 126.025 1.73 . . . . 72.35 114.988 -178.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 p -120.65 135.21 61.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 114.597 -1.183 . . . . 55.4 109.743 171.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -112.81 167.02 10.83 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.902 -1.518 . . . . 74.24 106.902 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -59.93 103.65 0.23 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 122.083 0.944 . . . . 75.14 113.029 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -179.51 -44.32 0.08 OUTLIER Glycine 0 N--CA 1.42 -2.428 0 N-CA-C 107.163 -2.375 . . . . 75.25 107.163 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 73.3 m -94.16 150.44 20.32 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.06 -0.57 . . . . 55.33 109.609 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.9 p -124.67 179.18 5.08 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.497 -0.774 . . . . 50.15 109.027 -178.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.669 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -61.25 -45.38 94.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.072 0.463 . . . . 61.24 109.837 -178.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -58.66 -39.18 79.89 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.61 -0.723 . . . . 72.03 111.431 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -67.48 -37.95 83.66 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-O 121.692 0.758 . . . . 64.11 109.09 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.4 mt -66.33 -46.22 77.6 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 114.569 -1.196 . . . . 63.52 111.454 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.426 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 35.3 mt-10 -58.38 -47.32 84.23 Favored 'General case' 0 C--O 1.187 -2.185 0 N-CA-C 113.002 0.741 . . . . 73.14 113.002 178.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.03 -47.42 74.77 Favored 'General case' 0 C--O 1.267 2.016 0 CA-C-O 121.006 0.431 . . . . 75.2 111.857 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -66.2 -39.17 89.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.987 -0.552 . . . . 65.41 110.666 -176.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -82.28 -22.63 35.64 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.883 1.068 . . . . 74.52 113.883 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.7 t -67.38 -30.89 70.79 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 123.377 0.671 . . . . 74.14 109.692 -176.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.0 m -62.06 -21.07 64.64 Favored 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 120.332 -0.547 . . . . 73.21 111.035 175.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 90' ' ' SER . 77.3 m -96.59 4.89 51.7 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 112.687 0.625 . . . . 71.34 112.687 178.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.28 -172.02 26.19 Favored Glycine 0 CA--C 1.503 -0.676 0 C-N-CA 119.215 -1.469 . . . . 53.23 114.325 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.2 m -94.67 118.54 31.87 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.273 0.559 . . . . 65.51 110.618 -177.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.426 ' CD1' ' HA ' ' A' ' 54' ' ' GLU . 51.2 mt -76.34 132.67 32.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.313 -0.858 . . . . 71.03 111.314 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -97.33 -46.47 6.08 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.948 -1.023 . . . . 73.42 110.172 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.493 ' NH2' HG21 ' A' ' 19' ' ' THR . 38.8 mtp180 -155.85 162.62 40.42 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.191 -1.411 . . . . 61.04 107.191 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.669 HD11 ' HB1' ' A' ' 50' ' ' ALA . 29.0 pt -147.93 144.24 19.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 108.775 -0.824 . . . . 74.33 108.775 173.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.4 m -125.44 130.24 51.44 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.426 -1.324 . . . . 72.35 107.426 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.441 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.8 mp -129.32 120.43 51.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 106.527 -1.657 . . . . 65.21 106.527 -178.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.286 1.3 pt? -122.09 134.24 54.77 Favored 'General case' 0 C--N 1.283 -2.324 0 C-N-CA 119.635 -0.826 . . . . 61.43 112.629 177.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 60.9 m -117.03 126.84 53.48 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.777 -0.823 . . . . 74.11 108.777 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -112.44 130.07 56.11 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 107.404 -1.332 . . . . 65.21 107.404 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -128.94 13.38 6.28 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 120.111 -0.636 . . . . 73.12 110.294 -176.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -63.08 -20.51 65.42 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.22 1.192 . . . . 64.52 114.22 -171.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 52.1 m -96.16 9.62 40.35 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.211 0.449 . . . . 74.42 112.211 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.42 -56.08 0.48 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.012 -1.089 . . . . 42.12 113.09 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 42.2 m-70 -95.11 133.35 26.34 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 108.834 -0.802 . . . . 61.31 108.834 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 76' ' ' HIS . 2.0 Cg_endo -76.82 117.57 4.54 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 C-N-CA 121.302 1.335 . . . . 51.02 110.503 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -100.28 140.51 34.43 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 108.253 -1.017 . . . . 52.05 108.253 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -129.63 147.85 18.1 Favored Glycine 0 N--CA 1.397 -3.904 0 C-N-CA 119.313 -1.423 . . . . 64.35 112.417 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -149.8 143.47 25.39 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 114.109 -1.046 . . . . 74.33 109.087 174.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.81 150.19 52.19 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 116.255 -0.43 . . . . 72.33 110.611 -171.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -120.87 117.53 27.6 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 109.141 -0.688 . . . . 72.24 109.141 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.454 HG23 HG22 ' A' ' 66' ' ' ILE . 34.3 mm -99.72 127.49 52.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.281 -1.377 . . . . 65.23 107.281 -178.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -113.15 124.25 52.12 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.762 -0.829 . . . . 72.34 108.762 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -98.24 165.67 11.76 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 111.602 0.223 . . . . 74.0 111.602 -177.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.05 -33.47 57.25 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.265 -0.425 . . . . 74.52 111.99 176.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -121.05 162.11 20.54 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 113.393 0.886 . . . . 54.43 113.393 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.408 ' HD3' ' HB3' ' A' ' 36' ' ' LYS . 16.5 mmm180 -66.39 -33.71 76.32 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 114.45 -1.25 . . . . 74.05 111.692 174.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -66.91 -29.28 69.11 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.61 -0.436 . . . . 71.12 111.47 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 60' ' ' CYS . 9.6 m -71.01 -42.08 70.04 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-O 120.723 0.296 . . . . 32.34 110.533 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.566 HG11 ' HA ' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -67.64 -39.49 82.31 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 N-CA-C 110.313 -0.254 . . . . 73.44 110.313 176.649 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -61.69 -37.21 83.27 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.354 0.597 . . . . 65.02 110.267 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.37 -31.29 62.33 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.804 -0.635 . . . . 73.34 110.829 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.88 -44.77 38.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.652 0.263 . . . . 54.05 111.161 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.404 HG11 ' HG3' ' A' ' 111' ' ' PRO . 32.5 m -57.74 -22.48 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 112.508 0.558 . . . . 73.52 112.508 177.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.2 -11.59 61.01 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 120.988 0.423 . . . . 75.43 110.05 176.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 64.9 mtm -102.75 10.78 38.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.224 -0.444 . . . . 75.41 110.293 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.619 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 4.7 p-10 -37.71 -48.71 1.09 Allowed 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.848 1.055 . . . . 73.45 113.848 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -114.72 99.92 7.87 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-O 121.975 0.893 . . . . 73.2 109.803 175.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 106' ' ' THR . 17.5 p -138.91 167.02 22.94 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.146 -1.388 . . . . 73.55 110.829 -178.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.0 p -113.85 105.55 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 CA-C-O 122.191 0.996 . . . . 62.0 109.494 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.568 ' O ' ' HG2' ' A' ' 105' ' ' ARG . 89.9 t80 -113.95 124.9 53.3 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.822 -1.081 . . . . 74.42 108.396 -176.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 20.6 ttt85 54.41 47.89 21.86 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 122.255 1.026 . . . . 73.55 110.131 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.57 8.0 55.14 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 113.769 -1.56 . . . . 73.1 115.146 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 102' ' ' PHE . 15.1 ptp180 -131.92 145.88 51.77 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 118.101 0.951 . . . . 55.11 111.135 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 100' ' ' THR . 27.8 m -77.76 120.18 22.31 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 120.903 0.382 . . . . 72.14 110.049 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 39.7 pt -102.55 171.25 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 109.596 -0.52 . . . . 73.35 109.596 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.619 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 42.0 tptt -134.73 130.8 36.8 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.894 -0.78 . . . . 71.14 108.894 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 17.7 t -121.13 127.81 75.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.043 -0.725 . . . . 73.3 109.043 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 89.7 mt -132.08 160.94 65.71 Favored Pre-proline 0 C--O 1.199 -1.605 0 N-CA-C 108.749 -0.834 . . . . 63.13 108.749 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.404 ' HG3' HG11 ' A' ' 95' ' ' VAL . 8.1 Cg_exo -77.65 140.74 19.03 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.031 1.821 . . . . 75.41 110.869 173.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -107.02 109.22 21.05 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 104.928 -2.249 . . . . 51.23 104.928 173.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.577 ' HD2' ' O ' ' A' ' 113' ' ' ARG . 5.7 ppt_? -161.87 137.45 7.55 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 113.946 1.091 . . . . 74.35 113.946 -170.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 39.1 m -91.79 84.17 5.37 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 122.249 1.023 . . . . 74.11 108.82 171.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.46 ' HB3' ' HD3' ' A' ' 113' ' ' ARG . 26.8 t-20 -125.58 142.96 51.23 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.16 -1.793 . . . . 71.42 106.16 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 47.3 ttm 71.06 135.82 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.809 0 O-C-N 124.544 1.153 . . . . 73.24 110.095 -176.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -58.41 106.4 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.001 1.801 . . . . 74.15 111.12 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.36 17.93 0.3 Allowed Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.872 -0.68 . . . . 71.5 112.311 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.407 HG13 ' HA ' ' B' ' 17' ' ' ALA . 12.3 tt -91.72 134.19 30.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 108.103 -1.073 . . . . 52.32 108.103 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.7 t -94.05 90.08 6.28 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.643 -0.823 . . . . 54.24 110.995 -177.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.2 m -160.91 -84.29 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.725 -0.67 . . . . 73.31 109.852 177.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.1 t 174.35 32.31 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 106.871 -1.529 . . . . 73.44 106.871 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.9 t70 75.07 142.64 0.07 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 114.489 -1.232 . . . . 64.14 111.816 -174.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 . . . . . 0 C--O 1.25 1.114 0 CA-C-O 121.977 0.894 . . . . 64.42 110.211 -177.428 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.585 0 N-CA-C 110.041 -0.355 . . . . 74.41 110.041 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 49.5 mm -85.49 119.32 33.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 109.115 -0.698 . . . . 72.34 109.115 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -117.19 94.63 45.47 Favored Pre-proline 0 C--N 1.309 -1.195 0 CA-C-N 116.621 -0.263 . . . . 52.44 110.56 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -85.65 142.49 8.07 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 122.192 1.928 . . . . 61.15 112.415 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 10.1 p -75.53 106.78 7.26 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.881 -0.6 . . . . 63.24 110.307 177.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 85.1 mtp -122.82 103.1 8.42 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.547 -0.752 . . . . 64.23 109.204 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 62.52 34.58 15.17 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.598 0.759 . . . . 63.31 110.574 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 61.6 m -69.84 102.71 2.01 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.305 -0.862 . . . . 64.04 110.473 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -95.64 147.94 23.06 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 115.711 -0.677 . . . . 63.21 109.186 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 65.2 t-80 -113.61 -29.34 7.18 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.516 -0.473 . . . . 55.04 110.384 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 31.5 t -97.57 144.09 27.61 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.215 -0.661 . . . . 73.13 109.215 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 65.51 78.47 0.27 Allowed 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.975 0.91 . . . . 74.34 111.766 -178.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 63.9 mtt -111.04 -159.68 0.69 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.444 -1.253 . . . . 75.13 107.968 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 24.8 p -57.29 -34.63 68.89 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 120.996 0.427 . . . . 73.02 110.253 175.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.45 102.38 6.84 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.697 -0.853 . . . . 54.21 108.697 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.9 -33.39 2.73 Favored Glycine 0 C--N 1.299 -1.497 0 N-CA-C 108.979 -1.648 . . . . 60.41 108.979 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.407 ' HA ' HG13 ' A' ' 119' ' ' ILE . . . -85.23 -47.31 10.21 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.874 -1.158 . . . . 74.34 107.874 173.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -132.18 151.61 51.71 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.792 -1.095 . . . . 75.11 110.695 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 9.8 t -152.27 -168.83 3.18 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 105.839 -1.912 . . . . 71.32 105.839 176.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -74.64 -49.86 19.87 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.029 -1.1 . . . . 72.11 108.029 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 160.0 -113.01 0.55 Allowed Glycine 0 CA--C 1.495 -1.159 0 N-CA-C 107.872 -2.091 . . . . 71.24 107.872 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -53.95 -40.29 81.49 Favored 'Trans proline' 0 CA--C 1.574 2.501 0 C-N-CA 122.744 2.296 . . . . 72.35 113.887 172.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.69 136.12 60.55 Favored 'Trans proline' 0 C--N 1.394 2.964 0 C-N-CA 121.301 1.334 . . . . 72.11 111.379 173.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -66.54 141.11 96.86 Favored Pre-proline 0 C--N 1.31 -1.14 0 CA-C-N 115.289 -0.868 . . . . 74.24 110.892 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -59.06 116.45 3.27 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 122.7 2.267 . . . . 63.3 111.112 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.661 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -67.14 160.75 26.15 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.751 -1.113 . . . . 51.21 112.068 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.524 ' HB3' ' OE1' ' B' ' 30' ' ' GLU . 29.6 t -82.04 164.68 21.25 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.507 0.67 . . . . 74.1 112.332 -173.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.4 -38.68 63.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.5 -1.227 . . . . 52.53 112.617 -178.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -69.47 -36.38 76.51 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 120.706 -0.398 . . . . 72.24 111.551 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.524 ' OE1' ' HB3' ' B' ' 27' ' ' SER . 3.6 mp0 -62.37 -35.23 78.51 Favored 'General case' 0 CA--C 1.503 -0.832 0 O-C-N 123.481 0.488 . . . . 73.34 110.645 175.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -66.03 -51.35 59.04 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 123.302 0.377 . . . . 75.24 110.466 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.485 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 47.9 mtmt -53.93 -35.52 61.78 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 114.141 1.163 . . . . 53.44 114.141 176.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.538 ' O ' ' HD3' ' B' ' 37' ' ' ARG . 24.5 mm-40 -70.25 -47.55 60.84 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.198 0.444 . . . . 74.34 112.198 174.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.53 HD12 ' HA ' ' B' ' 115' ' ' ASN . 10.3 pt -70.92 -35.7 60.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 112.934 0.716 . . . . 71.42 112.934 -176.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.32 -35.49 65.2 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.229 0.537 . . . . 72.4 111.21 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 97.9 mttt -63.3 -35.07 79.14 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.126 -0.943 . . . . 74.01 112.685 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.538 ' HD3' ' O ' ' B' ' 33' ' ' GLU . 11.3 mtp180 -111.3 5.41 19.81 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 114.727 1.38 . . . . 73.14 114.727 -164.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.583 ' HB2' ' O ' ' B' ' 112' ' ' LYS . 15.5 m -96.97 154.98 16.98 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 112.906 0.706 . . . . 75.1 112.906 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.5 ' CG1' HG23 ' B' ' 91' ' ' VAL . 11.4 m -139.54 164.99 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.609 1.163 . . . . 41.43 112.522 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 40' ' ' TYR . . . . . 0.65 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 18.4 t80 -113.51 126.88 55.8 Favored 'General case' 0 CA--C 1.489 -1.372 0 C-N-CA 126.624 1.97 . . . . 73.42 108.592 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 66.2 t -121.03 114.25 42.72 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 N-CA-C 108.303 -0.999 . . . . 62.23 108.303 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.27 174.05 15.28 Favored Glycine 0 N--CA 1.421 -2.311 0 C-N-CA 119.514 -1.327 . . . . 54.33 113.176 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.5 t30 64.65 21.28 12.38 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.95 1.7 . . . . 63.54 112.877 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 8.7 p -69.81 123.68 24.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.092 -0.707 . . . . 74.32 109.092 173.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -82.39 159.71 22.95 Favored 'General case' 0 C--O 1.253 1.281 0 CA-C-N 115.48 -0.782 . . . . 75.0 109.675 -174.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -76.24 91.07 3.17 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-O 121.743 0.782 . . . . 74.03 108.945 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 168.2 -18.92 0.08 OUTLIER Glycine 0 N--CA 1.41 -3.048 0 CA-C-N 114.694 -1.139 . . . . 53.31 110.543 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -84.19 143.3 29.71 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 107.799 -1.185 . . . . 74.3 107.799 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 77.8 p -99.89 170.19 8.7 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 110.296 -0.261 . . . . 72.24 110.296 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.677 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -67.05 -39.85 87.01 Favored 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 108.87 -0.789 . . . . 73.04 108.87 175.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -57.43 -44.55 84.75 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.553 -1.203 . . . . 72.12 110.961 174.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.05 -47.89 77.05 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.384 0.611 . . . . 64.44 110.86 174.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 41.2 mt -58.76 -47.04 86.05 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 114.493 -1.23 . . . . 63.42 112.52 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.45 ' HA ' ' CD1' ' B' ' 63' ' ' ILE . 93.9 mt-10 -58.85 -47.87 83.37 Favored 'General case' 0 C--O 1.183 -2.431 0 N-CA-C 112.57 0.582 . . . . 72.11 112.57 177.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.13 -47.73 74.63 Favored 'General case' 0 C--O 1.27 2.142 0 N-CA-C 112.334 0.494 . . . . 60.4 112.334 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -67.16 -38.39 85.4 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.02 -0.536 . . . . 61.32 110.598 -176.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -82.61 -22.0 34.93 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.686 0.995 . . . . 71.33 113.686 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 37.8 t -64.55 -32.22 73.78 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 123.693 0.797 . . . . 75.2 109.454 -178.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.8 m -59.6 -24.34 63.71 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-N 116.271 -0.422 . . . . 71.15 110.978 174.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 60' ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' B' ' 90' ' ' SER . 68.8 m -88.1 -4.0 58.82 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.435 0.531 . . . . 74.33 112.435 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.94 -159.67 26.57 Favored Glycine 0 C--N 1.318 -0.425 0 C-N-CA 119.394 -1.384 . . . . 61.52 114.08 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 50.7 m -94.6 119.09 32.71 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 121.091 0.472 . . . . 73.12 112.102 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.45 ' CD1' ' HA ' ' B' ' 54' ' ' GLU . 68.0 mt -78.67 128.24 38.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.692 -0.686 . . . . 70.15 111.625 177.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 64' ' ' ASN . . . . . 0.489 ' OD1' ' HG3' ' B' ' 65' ' ' ARG . 19.0 t-20 -90.66 -50.23 6.03 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.797 -1.092 . . . . 71.23 108.529 -177.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.489 ' HG3' ' OD1' ' B' ' 64' ' ' ASN . 41.2 mtp180 -155.31 164.79 38.28 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 107.41 -1.33 . . . . 75.02 107.41 -177.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.677 HD11 ' HB1' ' B' ' 50' ' ' ALA . 28.9 pt -148.34 144.29 18.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.407 -0.96 . . . . 74.15 108.407 173.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 61.5 m -125.65 130.58 51.9 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 107.055 -1.461 . . . . 73.04 107.055 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.415 HD12 ' N ' ' B' ' 68' ' ' ILE . 1.9 mp -129.32 119.9 49.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 106.657 -1.609 . . . . 70.33 106.657 -178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.479 HD12 HH22 ' A' ' 65' ' ' ARG 0.264 1.5 pt? -121.77 134.14 54.92 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 119.701 -0.799 . . . . 74.01 112.272 177.749 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 61.9 m -117.11 125.72 51.7 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.52 -0.918 . . . . 63.15 108.52 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.532 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 10.3 t70 -105.74 127.18 52.93 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.624 -1.25 . . . . 72.23 107.624 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' B' ' 77' ' ' PRO . 40.2 ttmt -127.01 17.56 7.24 Favored 'General case' 0 N--CA 1.423 -1.799 0 C-N-CA 120.719 -0.393 . . . . 73.13 110.138 -177.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . 0.255 1.4 p90 -70.25 -16.25 63.01 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 118.367 -1.333 . . . . 65.12 112.672 -177.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 46.0 m -94.42 17.89 12.21 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.203 -0.453 . . . . 71.32 110.393 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.42 -63.76 1.95 Allowed Glycine 0 CA--C 1.492 -1.354 0 C-N-CA 120.75 -0.738 . . . . 51.51 111.569 176.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . 0.255 78.2 m80 -96.4 125.07 48.91 Favored Pre-proline 0 C--N 1.291 -1.975 0 C-N-CA 120.414 -0.514 . . . . 63.35 110.852 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 98.6 Cg_endo -73.6 135.72 22.39 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.944 2.429 . . . . 54.35 115.051 -171.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 78' ' ' LYS . . . . . 0.424 ' HG3' ' H ' ' A' ' 15' ' ' ALA . 12.8 mmmm -112.12 146.13 38.56 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 124.883 1.273 . . . . 73.34 107.842 176.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.8 148.03 17.86 Favored Glycine 0 N--CA 1.412 -2.961 0 C-N-CA 119.142 -1.504 . . . . 73.32 112.968 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 80' ' ' TYR . . . . . 0.437 ' OH ' ' HB ' ' A' ' 19' ' ' THR . 31.0 p90 -151.48 143.37 23.82 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 114.362 -0.919 . . . . 74.5 109.736 172.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.13 151.61 51.69 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 116.169 -0.468 . . . . 61.5 110.657 -172.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 82' ' ' TYR . . . . . 0.735 ' CD1' ' HE2' ' B' ' 112' ' ' LYS . 89.9 m-85 -122.32 116.52 24.21 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 109.253 -0.647 . . . . 63.25 109.253 177.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.491 HG23 HG22 ' B' ' 66' ' ' ILE . 34.3 mm -98.86 127.21 51.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 107.31 -1.367 . . . . 63.3 107.31 -178.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 84' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' B' ' 38' ' ' SER . 29.3 mt-10 -112.36 125.62 54.4 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 108.836 -0.801 . . . . 72.53 108.836 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -100.07 162.38 13.01 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.432 0.634 . . . . 64.1 112.245 -177.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.45 -29.77 53.0 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.328 -0.851 . . . . 71.32 111.387 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -122.67 150.0 43.28 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 112.9 0.704 . . . . 54.15 112.9 -175.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.469 ' HD3' ' HB3' ' B' ' 36' ' ' LYS . 14.4 mmm180 -63.08 -34.89 78.56 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.116 0.566 . . . . 75.54 110.676 175.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -62.73 -32.15 73.22 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.577 -0.738 . . . . 71.35 110.913 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 90' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' B' ' 60' ' ' CYS . 15.1 m -71.15 -41.4 70.47 Favored 'General case' 0 N--CA 1.433 -1.313 0 O-C-N 122.335 -0.228 . . . . 75.55 110.949 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.5 HG23 ' CG1' ' B' ' 39' ' ' VAL . 0.2 OUTLIER -68.05 -38.98 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 C-N-CA 120.727 -0.389 . . . . 74.02 111.016 176.832 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -63.01 -36.68 84.36 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.476 0.655 . . . . 72.11 109.579 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.49 -31.03 63.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.797 -0.638 . . . . 71.24 111.789 178.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.05 -44.95 36.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.584 -0.734 . . . . 73.33 110.763 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 33.1 m -58.75 -22.29 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 112.334 0.494 . . . . 75.4 112.334 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.91 -14.91 63.28 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 121.51 0.671 . . . . 53.31 111.331 176.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 65.6 mtm -100.54 12.74 36.66 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.334 -0.848 . . . . 73.23 109.951 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 98' ' ' ASP . . . . . 0.694 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 3.0 p-10 -35.6 -51.98 0.66 Allowed 'General case' 0 C--O 1.178 -2.659 0 N-CA-C 115.51 1.67 . . . . 61.43 115.51 -174.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 99' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' B' ' 107' ' ' ILE . 19.0 tt0 -129.36 40.52 3.59 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 117.794 -1.562 . . . . 55.1 110.323 -178.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 47.6 p -75.63 -173.54 2.21 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.573 -1.194 . . . . 63.44 111.445 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.58 136.14 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 O-C-N 122.098 -0.376 . . . . 73.5 110.4 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -138.23 128.5 25.99 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 122.992 0.517 . . . . 64.44 109.924 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 50.17 32.45 6.02 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 124.998 1.319 . . . . 64.23 112.689 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.11 2.74 60.65 Favored Glycine 0 C--N 1.315 -0.617 0 CA-C-N 114.771 -1.104 . . . . 60.22 114.756 173.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -134.16 158.64 43.14 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 118.002 0.901 . . . . 72.34 111.169 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 68.4 m -85.47 119.85 26.27 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.338 -0.616 . . . . 54.34 109.338 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 107' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' B' ' 99' ' ' GLU . 42.1 pt -102.86 172.2 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 109.648 -0.501 . . . . 73.1 109.648 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 108' ' ' LYS . . . . . 0.694 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 0.1 OUTLIER -131.18 132.06 44.46 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.618 -1.253 . . . . 65.11 107.618 -179.654 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 21.2 t -121.67 130.82 74.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 108.099 -1.074 . . . . 74.14 108.099 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 90.1 mt -136.49 162.68 54.82 Favored Pre-proline 0 C--O 1.19 -2.046 0 N-CA-C 108.871 -0.789 . . . . 70.22 108.871 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -73.77 147.53 39.86 Favored 'Trans proline' 0 CA--C 1.564 1.98 0 C-N-CA 122.733 2.289 . . . . 70.32 110.564 173.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.735 ' HE2' ' CD1' ' B' ' 82' ' ' TYR . 0.0 OUTLIER -157.61 -173.21 4.28 Favored 'General case' 0 CA--C 1.56 1.331 0 N-CA-C 109.633 -0.506 . . . . 70.31 109.633 -172.372 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.574 ' H ' ' HD2' ' B' ' 112' ' ' LYS . 0.3 OUTLIER -153.24 127.96 9.46 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.541 0.736 . . . . 64.0 110.653 175.575 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 47.8 m -111.04 -83.28 0.57 Allowed 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 118.532 -1.267 . . . . 73.12 111.361 176.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 115' ' ' ASN . . . . . 0.53 ' HA ' HD12 ' B' ' 34' ' ' ILE . 34.0 m-20 179.68 -164.84 0.06 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.704 1.202 . . . . 71.43 110.456 -176.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 116' ' ' MET . . . . . 0.495 ' HG2' ' HG ' ' B' ' 26' ' ' LEU . 23.1 ptm -153.44 157.26 32.81 Favored Pre-proline 0 N--CA 1.441 -0.891 0 N-CA-C 106.099 -1.815 . . . . 71.22 106.099 174.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -92.77 -162.62 0.1 Allowed 'Trans proline' 0 N--CA 1.439 -1.689 0 C-N-CA 122.178 1.919 . . . . 54.12 114.099 -173.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -162.4 -164.87 18.35 Favored Glycine 0 N--CA 1.423 -2.227 0 N-CA-C 107.515 -2.234 . . . . 74.31 107.515 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 11.1 tt -64.1 107.56 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.87 0 CA-C-O 122.168 0.985 . . . . 60.51 112.363 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 36.1 p -93.27 118.53 31.38 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.694 -1.139 . . . . 63.33 108.493 176.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 5.4 p -69.76 106.44 3.11 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 113.231 0.826 . . . . 74.1 113.231 -177.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 9.7 t -142.46 28.14 1.67 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 106.276 -1.75 . . . . 53.22 106.276 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -69.45 156.36 38.98 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 113.647 -1.615 . . . . 74.11 111.531 -176.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 . . . . . 0 C--N 1.304 -1.371 0 N-CA-C 108.268 -1.012 . . . . 73.33 108.268 179.409 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.835 0 N-CA-C 109.286 -0.635 . . . . 65.42 109.286 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.465 ' O ' HD12 ' A' ' 2' ' ' ILE . 2.3 pp -120.05 129.33 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 112.919 0.711 . . . . 64.13 112.919 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.71 92.23 31.4 Favored Pre-proline 0 C--N 1.302 -1.478 0 CA-C-N 115.476 -0.784 . . . . 53.42 109.64 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.85 113.82 3.51 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.671 2.247 . . . . 62.53 110.953 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.6 p -90.72 103.09 15.83 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 110.275 -0.269 . . . . 54.23 110.275 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.2 ttt -168.79 144.64 3.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.001 0.429 . . . . 72.35 110.779 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -144.9 152.31 40.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.754 -1.572 . . . . 70.31 106.754 176.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.491 ' HA ' ' OE1' ' A' ' 99' ' ' GLU . 15.1 t -146.71 142.85 28.26 Favored 'General case' 0 N--CA 1.422 -1.841 0 C-N-CA 118.399 -1.321 . . . . 70.22 113.858 -177.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.1 p -140.49 -176.62 4.7 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 126.799 2.04 . . . . 62.2 106.642 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -149.26 112.64 4.98 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 118.479 0.581 . . . . 74.12 110.875 175.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.6 p -89.57 -89.93 0.15 Allowed 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 116.0 -0.545 . . . . 71.45 112.201 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -164.16 155.14 15.57 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.771 -0.455 . . . . 70.4 109.771 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -132.8 95.14 3.52 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.956 -0.757 . . . . 60.12 108.956 177.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.2 m -154.38 140.43 18.36 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.327 -0.397 . . . . 73.23 112.053 -173.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 72.4 -175.57 0.17 Allowed 'General case' 0 C--O 1.262 1.736 0 N-CA-C 115.798 1.777 . . . . 34.32 115.798 167.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.62 115.62 3.11 Favored Glycine 0 N--CA 1.422 -2.252 0 CA-C-N 113.883 -1.508 . . . . 62.12 111.753 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' B' ' 19' ' ' THR . . . -87.81 -174.71 4.86 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.013 -0.736 . . . . 73.4 109.013 175.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.445 ' HE2' ' NH1' ' A' ' 65' ' ' ARG . 69.7 t80 -148.89 126.69 11.82 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 120.643 -0.423 . . . . 74.33 110.74 -175.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.6 m -102.82 154.42 19.21 Favored 'General case' 0 CA--C 1.56 1.356 0 CA-C-N 115.99 -0.55 . . . . 70.11 110.087 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -130.69 -72.27 0.57 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 120.85 0.357 . . . . 74.41 110.041 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.514 ' HA3' ' OH ' ' B' ' 82' ' ' TYR . . . 118.62 -141.69 16.27 Favored Glycine 0 N--CA 1.469 0.891 0 CA-C-N 116.379 -0.373 . . . . 54.24 112.528 177.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.524 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 62.3 Cg_exo -51.9 -43.08 54.36 Favored 'Trans proline' 0 CA--C 1.567 2.149 0 C-N-CA 124.306 3.337 . . . . 51.55 116.579 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 22' ' ' PRO . 2.4 Cg_endo -43.13 142.36 2.49 Favored 'Trans proline' 0 C--N 1.404 3.458 0 C-N-CA 123.689 2.926 . . . . 73.41 113.607 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -53.77 134.52 56.07 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 115.831 -0.622 . . . . 74.24 111.107 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.87 -176.04 2.8 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 122.722 2.281 . . . . 75.15 113.322 -175.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.03 166.12 26.25 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 114.568 -1.196 . . . . 71.02 109.732 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.446 ' HB3' ' OE1' ' A' ' 30' ' ' GLU . 23.3 t -82.56 164.22 20.99 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 120.681 0.277 . . . . 73.5 111.584 -172.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.711 ' O ' ' HG2' ' A' ' 32' ' ' LYS . . . -48.75 -46.71 41.57 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 115.56 -0.745 . . . . 73.33 112.226 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.434 ' HA ' ' HG2' ' A' ' 32' ' ' LYS . 17.0 mm-40 -63.62 -32.88 74.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.793 0.664 . . . . 72.34 112.793 -178.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.535 ' O ' HG12 ' A' ' 34' ' ' ILE . 1.9 mp0 -63.88 -37.74 88.5 Favored 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 120.683 -0.407 . . . . 53.22 110.202 173.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -68.12 -44.76 75.41 Favored 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 124.003 0.814 . . . . 74.21 109.403 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.711 ' HG2' ' O ' ' A' ' 28' ' ' ALA . 29.3 mmmt -53.69 -48.27 69.68 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 123.197 0.599 . . . . 63.32 109.97 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -72.29 -42.1 65.89 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 113.786 1.032 . . . . 74.23 113.786 -175.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 30' ' ' GLU . 23.1 pt -69.33 -33.99 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.771 0.319 . . . . 75.34 111.457 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -62.32 -38.54 89.85 Favored 'General case' 0 C--O 1.203 -1.387 0 CA-C-N 115.611 -0.722 . . . . 72.22 111.521 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 62.8 mttt -70.35 -16.1 62.94 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 120.521 0.201 . . . . 63.33 111.17 -175.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.483 ' HA ' ' CG1' ' A' ' 91' ' ' VAL . 3.9 ptp180 -113.39 16.65 18.87 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 112.384 0.513 . . . . 74.03 112.384 -173.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.547 ' HB2' ' HG3' ' A' ' 84' ' ' GLU . 43.9 t -99.9 159.67 14.9 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-O 121.535 0.683 . . . . 65.3 111.607 177.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.484 ' CG1' HG23 ' A' ' 91' ' ' VAL . 5.5 m -139.7 164.12 24.16 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.942 0 C-N-CA 124.492 1.117 . . . . 73.34 110.686 176.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.644 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 16.4 t80 -118.9 128.39 54.38 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 125.236 1.415 . . . . 74.41 108.009 178.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 60.8 t -116.58 116.7 53.06 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 107.929 -1.137 . . . . 71.21 107.929 178.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.08 176.47 17.09 Favored Glycine 0 C--N 1.294 -1.771 0 C-N-CA 119.831 -1.176 . . . . 72.33 113.567 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 68.51 8.52 6.73 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.759 1.624 . . . . 72.02 113.405 177.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.4 p -91.15 104.45 15.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.634 0.731 . . . . 73.33 109.766 176.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.407 ' CG ' ' HA ' ' A' ' 78' ' ' LYS . 28.6 m-20 -116.79 102.98 9.87 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 106.985 -1.487 . . . . 75.12 106.985 -172.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 49.26 -175.78 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.594 1.331 . . . . 54.03 114.594 -172.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.69 -56.78 5.04 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.868 -0.682 . . . . 45.52 111.96 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.6 m -86.14 143.56 27.96 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 121.107 0.479 . . . . 61.1 110.071 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 61.7 p -114.79 178.82 4.14 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.199 -0.667 . . . . 73.55 109.199 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.52 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -58.91 -43.24 91.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.163 0.506 . . . . 64.23 109.777 178.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -56.96 -44.93 83.09 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 115.304 -0.862 . . . . 65.3 111.814 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -61.12 -42.49 98.64 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.513 0.673 . . . . 72.11 110.57 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.4 mt -69.89 -47.36 62.83 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 114.755 -1.111 . . . . 74.5 111.623 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.501 ' HB2' ' OH ' ' B' ' 46' ' ' TYR . 21.5 tt0 -59.15 -50.6 73.42 Favored 'General case' 0 C--O 1.194 -1.836 0 C-N-CA 121.108 -0.237 . . . . 72.24 111.486 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.32 79.67 Favored 'General case' 0 C--O 1.265 1.878 0 CA-C-O 121.763 0.792 . . . . 74.3 110.999 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -67.31 -38.45 84.99 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.209 -1.36 . . . . 71.13 110.107 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . 0.278 46.5 m-85 -82.48 -21.14 35.67 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 114.516 1.302 . . . . 64.24 114.516 177.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 71.4 m -64.81 -28.81 69.82 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 109.523 -0.547 . . . . 62.41 109.523 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.8 m -58.48 -25.23 62.09 Favored 'General case' 0 CA--C 1.56 1.351 0 CA-C-N 115.815 -0.63 . . . . 74.24 110.09 173.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 61.1 m -107.63 3.24 24.58 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 112.859 0.689 . . . . 71.33 112.859 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 58' ' ' SER . . . 173.51 177.54 42.81 Favored Glycine 0 N--CA 1.466 0.683 0 C-N-CA 118.551 -1.785 . . . . 31.44 115.159 -177.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.8 m -78.25 -61.09 2.11 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 122.389 0.276 . . . . 74.0 111.159 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 85' ' ' PHE 0.264 56.2 mt 99.85 117.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 126.11 1.764 . . . . 61.32 113.261 175.729 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.46 ' ND2' ' HA ' ' A' ' 86' ' ' ALA . 80.2 m-20 -98.59 -39.18 8.83 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 115.275 -0.875 . . . . 73.12 111.692 177.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.445 ' NH1' ' HE2' ' A' ' 18' ' ' TYR . 96.6 mtt180 -151.45 159.52 44.16 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.816 -0.809 . . . . 75.53 108.816 -177.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.52 HD11 ' HB1' ' A' ' 50' ' ' ALA . 17.1 pt -148.32 144.48 18.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.073 -1.455 . . . . 75.54 107.073 171.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.534 ' OG1' ' HB2' ' A' ' 82' ' ' TYR . 43.0 p -123.49 138.74 54.51 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 106.018 -1.845 . . . . 63.43 106.018 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.465 HD12 ' O ' ' B' ' 68' ' ' ILE . 2.9 mp -129.89 116.4 37.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 106.371 -1.714 . . . . 74.31 106.371 175.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -120.55 125.66 48.38 Favored 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 120.078 -0.649 . . . . 53.44 111.037 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.435 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 82.9 m -115.61 133.55 55.93 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.19 -0.67 . . . . 75.4 109.19 -177.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -119.07 127.97 53.89 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 118.63 -1.228 . . . . 74.11 110.513 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 77' ' ' PRO . 36.7 ttmt -121.32 12.14 10.88 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.549 -0.908 . . . . 75.44 108.549 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -62.64 -22.04 66.13 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.273 0.471 . . . . 71.44 112.273 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.5 t -90.72 5.11 49.51 Favored 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 115.98 -0.554 . . . . 73.43 110.668 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.48 -56.25 0.48 Allowed Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.702 -0.761 . . . . 54.42 111.977 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -96.26 136.48 21.98 Favored Pre-proline 0 C--N 1.304 -1.394 0 N-CA-C 110.149 -0.315 . . . . 74.4 110.149 176.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.433 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 80.3 Cg_endo -79.54 119.0 3.98 Favored 'Trans proline' 0 N--CA 1.441 -1.593 0 C-N-CA 121.774 1.649 . . . . 71.21 113.051 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.407 ' HA ' ' CG ' ' A' ' 45' ' ' ASP . 37.1 mtmm -105.34 -163.82 0.98 Allowed 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.785 -1.098 . . . . 64.35 108.742 175.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 70' ' ' CYS . . . 173.64 162.56 25.72 Favored Glycine 0 N--CA 1.412 -2.936 0 C-N-CA 119.591 -1.29 . . . . 73.24 114.453 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -158.53 153.91 25.84 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 113.641 -1.279 . . . . 75.05 108.988 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.92 152.95 50.79 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 120.386 0.136 . . . . 41.11 111.106 -173.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.534 ' HB2' ' OG1' ' A' ' 67' ' ' THR . 27.0 m-85 -118.22 130.05 55.85 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.572 -0.529 . . . . 74.45 109.572 174.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.449 HG23 HG22 ' A' ' 66' ' ' ILE . 32.8 mm -111.4 112.49 40.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 109.086 -0.709 . . . . 75.24 109.086 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.547 ' HG3' ' HB2' ' A' ' 38' ' ' SER . 4.1 mp0 -94.84 120.24 34.74 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.147 0.499 . . . . 65.23 110.943 176.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 99.1 m-85 -92.78 164.12 13.47 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.791 -0.448 . . . . 74.24 109.791 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.46 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . . . -85.02 -17.97 35.86 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.111 0.482 . . . . 63.1 109.969 174.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.426 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 0.7 OUTLIER -117.24 141.85 47.78 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 115.407 -0.815 . . . . 72.0 111.171 -178.313 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -75.57 -29.39 59.33 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 108.362 -0.977 . . . . 71.11 108.362 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -67.71 -24.79 65.43 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.76 -0.587 . . . . 74.32 110.713 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.426 ' OG ' ' HB2' ' A' ' 87' ' ' GLU . 20.1 m -71.69 -37.1 70.74 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 112.092 0.404 . . . . 74.14 112.092 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.484 HG23 ' CG1' ' A' ' 39' ' ' VAL . 0.2 OUTLIER -65.87 -38.46 82.21 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 C-N-CA 120.095 -0.642 . . . . 64.55 109.507 173.871 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.08 -37.59 77.46 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.291 0.567 . . . . 65.1 110.239 175.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.52 -31.76 63.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.101 -0.499 . . . . 72.52 111.429 177.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.34 -41.17 49.22 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.117 -0.492 . . . . 71.11 111.161 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.409 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 30.9 m -60.95 -21.99 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 112.716 0.636 . . . . 64.15 112.716 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.13 -10.92 60.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.525 0.678 . . . . 40.33 110.455 176.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 8.8 ttp -111.37 8.2 21.22 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.978 -1.119 . . . . 75.51 107.978 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.698 ' HA ' ' HB ' ' A' ' 109' ' ' VAL . 0.5 OUTLIER -44.31 -44.15 7.91 Favored 'General case' 0 CA--C 1.473 -1.982 0 N-CA-C 114.431 1.271 . . . . 60.41 114.431 -176.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.491 ' OE1' ' HA ' ' A' ' 8' ' ' THR . 34.6 tt0 -122.89 98.66 6.01 Favored 'General case' 0 N--CA 1.389 -3.481 0 CA-C-O 122.511 1.148 . . . . 70.22 110.061 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 106' ' ' THR . 19.7 p -140.02 173.25 11.71 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 113.187 -1.824 . . . . 73.4 111.122 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.0 p -111.51 112.58 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.804 0 CA-C-O 122.316 1.055 . . . . 73.15 110.036 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -121.48 126.55 49.52 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.355 -1.293 . . . . 73.42 107.643 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.7 ttt-85 58.81 33.15 22.87 Favored 'General case' 0 CA--C 1.558 1.259 0 CA-C-O 122.054 0.93 . . . . 75.23 109.759 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.47 1.56 86.5 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.3 -0.864 . . . . 72.44 113.898 178.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -126.13 153.7 44.19 Favored 'General case' 0 C--N 1.314 -0.974 0 O-C-N 122.25 -0.559 . . . . 74.32 110.289 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 100' ' ' THR . 27.2 m -79.75 119.74 23.07 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.447 -0.575 . . . . 62.24 109.447 -178.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 pp -102.82 159.0 4.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 C-N-CA 119.601 -0.839 . . . . 64.42 109.815 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 57.7 tptt -123.56 129.89 51.86 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.321 -0.622 . . . . 65.24 109.321 -170.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.698 ' HB ' ' HA ' ' A' ' 98' ' ' ASP . 21.7 t -118.53 128.13 75.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 108.728 -0.842 . . . . 62.13 108.728 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 40' ' ' TYR . 93.5 mt -125.51 141.36 38.77 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 108.999 -0.741 . . . . 74.32 108.999 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.07 136.96 18.88 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.546 1.497 . . . . 72.34 111.811 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 38' ' ' SER . 0.3 OUTLIER -97.72 120.19 37.66 Favored 'General case' 0 C--N 1.276 -2.59 0 N-CA-C 104.075 -2.565 . . . . 73.34 104.075 170.564 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 76.4 ttt180 166.69 -37.86 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.279 -1.748 . . . . 73.21 106.279 -174.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 23.3 p -91.54 99.79 12.66 Favored 'General case' 0 N--CA 1.405 -2.677 0 CA-C-N 114.225 -1.352 . . . . 63.22 110.567 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -81.52 -24.42 36.66 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.18 -1.415 . . . . 65.24 107.18 176.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 66.6 mtt -142.01 147.15 43.35 Favored Pre-proline 0 N--CA 1.441 -0.886 0 N-CA-C 106.114 -1.81 . . . . 62.33 106.114 174.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.52 139.17 52.64 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 122.154 1.903 . . . . 74.42 112.418 -177.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 85.57 -68.74 3.37 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.042 -0.599 . . . . 42.25 111.932 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 11.2 tt -137.91 143.32 33.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.361 -0.977 . . . . 63.54 108.361 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 54.0 m -120.07 103.02 8.94 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 121.272 0.558 . . . . 73.25 111.864 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.9 m -107.2 108.52 19.99 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 106.761 -1.57 . . . . 72.31 106.761 173.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 44.9 m -64.19 143.8 57.61 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 123.243 0.617 . . . . 73.52 111.28 -175.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -62.82 129.15 39.2 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.79 0.805 . . . . 74.52 112.58 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 . . . . . 0 C--N 1.298 -1.653 0 CA-C-N 114.27 -1.332 . . . . 74.33 110.854 -178.833 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.801 0 CA-C-O 121.35 0.595 . . . . 61.01 110.272 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 49.0 mm -107.5 121.95 61.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 115.599 -0.728 . . . . 73.51 109.484 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.88 114.7 55.73 Favored Pre-proline 0 C--N 1.31 -1.145 0 N-CA-C 109.295 -0.631 . . . . 63.5 109.295 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.19 109.42 1.54 Allowed 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.804 2.336 . . . . 72.34 112.593 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 26.3 p -154.13 134.9 13.68 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.347 -0.983 . . . . 54.1 108.347 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -95.68 96.19 8.84 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.873 -0.331 . . . . 71.02 110.287 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -81.3 76.09 8.24 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 122.136 0.969 . . . . 74.54 110.238 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 6.9 t -168.7 83.74 0.16 Allowed 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 113.579 -1.646 . . . . 61.11 107.388 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 24.0 p -100.51 169.03 9.35 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.81 -1.086 . . . . 75.42 111.263 -176.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 175.93 -176.6 0.12 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 105.606 -1.998 . . . . 72.55 105.606 -177.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 32.8 m -61.23 160.48 10.39 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 108.949 -0.76 . . . . 63.44 108.949 172.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -60.23 104.13 0.29 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 113.745 1.017 . . . . 74.22 113.745 -176.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -110.33 75.84 0.95 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.812 0.815 . . . . 64.14 109.939 169.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 91.5 m -107.1 112.21 25.01 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.82 -1.082 . . . . 61.55 109.667 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.79 159.74 33.03 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.294 -1.002 . . . . 50.31 108.294 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.15 -44.95 6.43 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 110.851 -0.9 . . . . 34.14 110.851 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.85 97.96 7.72 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.693 -0.854 . . . . 73.12 108.693 177.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -52.51 -24.67 8.51 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 115.267 1.58 . . . . 74.41 115.267 -177.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 12.3 t -172.83 -13.29 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.067 0.46 . . . . 64.23 110.243 178.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 20' ' ' GLU . . . . . 0.433 ' HB3' ' HG2' ' B' ' 23' ' ' PRO . 39.3 mt-10 -56.67 -52.54 64.51 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.06 0.944 . . . . 73.32 112.098 -178.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.473 ' HA3' ' OH ' ' A' ' 82' ' ' TYR . . . 104.29 -119.8 6.41 Favored Glycine 0 CA--C 1.504 -0.628 0 C-N-CA 120.214 -0.993 . . . . 63.2 113.291 175.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.439 ' N ' ' HD2' ' B' ' 23' ' ' PRO . 54.1 Cg_exo -52.35 -44.44 46.65 Favored 'Trans proline' 0 CA--C 1.565 2.027 0 C-N-CA 123.792 2.995 . . . . 50.32 115.508 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' B' ' 22' ' ' PRO . 11.3 Cg_endo -53.78 146.72 44.01 Favored 'Trans proline' 0 C--N 1.389 2.696 0 C-N-CA 121.757 1.638 . . . . 70.03 112.349 177.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 15.3 pm0 -70.37 150.36 95.79 Favored Pre-proline 0 C--N 1.303 -1.436 0 CA-C-N 115.172 -0.922 . . . . 75.02 111.012 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.23 119.31 6.31 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.569 2.179 . . . . 71.03 112.144 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.625 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -77.03 168.5 19.98 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.168 -0.924 . . . . 64.4 110.69 176.271 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.62 ' HB3' ' OE1' ' B' ' 30' ' ' GLU . 47.4 t -68.12 147.06 52.84 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.612 0.967 . . . . 63.23 113.612 -173.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.718 ' O ' ' HG2' ' B' ' 32' ' ' LYS . . . -48.22 -46.22 35.01 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-N 114.001 -1.454 . . . . 64.14 111.949 177.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.403 ' HA ' ' CG ' ' B' ' 32' ' ' LYS . 69.9 mm-40 -63.65 -36.2 83.05 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.996 0.739 . . . . 74.22 112.996 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.62 ' OE1' ' HB3' ' B' ' 27' ' ' SER . 2.0 mp0 -63.12 -35.84 81.62 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.467 -0.493 . . . . 72.33 110.127 173.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' B' ' 26' ' ' LEU . 97.5 mttt -68.03 -43.59 78.39 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.032 -0.531 . . . . 75.15 109.581 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.718 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 28.9 mmmt -55.03 -47.36 74.84 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.628 0.771 . . . . 64.44 110.329 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -70.33 -46.28 64.49 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.341 -0.845 . . . . 54.22 111.745 -175.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 17.1 pt -69.72 -35.02 63.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.927 0.394 . . . . 74.42 111.569 -175.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.87 -44.36 96.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.768 -0.651 . . . . 74.54 111.825 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.586 ' HG2' ' O ' ' B' ' 32' ' ' LYS . 12.3 ptpt -68.47 -10.64 56.78 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 112.48 0.548 . . . . 62.2 112.48 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.432 ' HD3' ' O ' ' B' ' 86' ' ' ALA . 92.3 mtt180 -107.3 9.51 29.97 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.966 0.412 . . . . 73.2 110.871 -176.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.514 ' HB2' ' HB3' ' B' ' 112' ' ' LYS . 24.3 m -103.01 162.39 12.97 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 114.226 1.195 . . . . 74.43 114.226 -175.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.462 ' CG1' HG23 ' B' ' 91' ' ' VAL . 12.1 m -141.22 164.45 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.551 1.14 . . . . 75.24 111.907 176.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 40' ' ' TYR . . . . . 0.562 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 17.6 t80 -119.11 130.96 55.85 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 126.109 1.764 . . . . 71.34 107.999 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 58.1 t -119.42 117.58 54.48 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 C-N-CA 123.945 0.898 . . . . 64.43 108.81 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.77 166.13 14.78 Favored Glycine 0 C--N 1.293 -1.806 0 C-N-CA 120.205 -0.998 . . . . 63.54 111.961 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 60.3 t30 66.29 20.36 11.03 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.738 1.615 . . . . 73.24 113.152 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 11.3 p -64.32 133.33 29.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 O-C-N 121.544 -0.723 . . . . 75.0 109.651 177.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.483 ' HB2' ' HD3' ' B' ' 105' ' ' ARG . 21.7 t70 -72.43 141.34 48.65 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 108.294 -1.002 . . . . 74.52 108.294 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' TYR . . . . . 0.501 ' OH ' ' HB2' ' A' ' 54' ' ' GLU . 4.6 t80 -56.92 -28.15 61.73 Favored 'General case' 0 CA--C 1.551 0.996 0 O-C-N 124.187 0.929 . . . . 71.4 109.754 -178.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.33 0.77 81.51 Favored Glycine 0 N--CA 1.427 -1.924 0 CA-C-N 115.787 -0.642 . . . . 65.11 113.366 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 18.6 m -78.99 135.33 36.88 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 107.781 -1.192 . . . . 71.55 107.781 176.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 63.6 p -94.38 169.97 9.83 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 119.115 -1.034 . . . . 71.54 110.457 -176.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.628 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -60.47 -38.61 84.79 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.506 -0.924 . . . . 44.31 108.506 174.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -57.26 -46.68 82.82 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.191 -0.913 . . . . 51.53 111.242 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -58.55 -47.49 84.06 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.669 0.747 . . . . 43.4 110.183 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 66.2 mt -64.88 -48.03 75.69 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.645 -1.162 . . . . 71.33 112.344 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -59.7 -50.71 72.79 Favored 'General case' 0 C--O 1.206 -1.231 0 N-CA-C 111.656 0.243 . . . . 73.22 111.656 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.53 -45.42 81.15 Favored 'General case' 0 C--O 1.269 2.106 0 CA-C-O 121.631 0.729 . . . . 70.24 111.127 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -66.78 -39.21 87.73 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.457 -1.247 . . . . 62.31 109.942 -174.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . 0.259 46.4 m-85 -82.09 -21.47 36.77 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 114.617 1.339 . . . . 70.51 114.617 177.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 68.2 m -64.57 -28.03 69.36 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.166 0.508 . . . . 72.33 109.784 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 18.8 m -58.42 -28.94 65.7 Favored 'General case' 0 CA--C 1.557 1.248 0 CA-C-N 115.892 -0.595 . . . . 74.24 110.837 173.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 82.2 m -95.89 3.17 53.83 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 113.616 0.969 . . . . 61.33 113.616 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.9 -169.67 27.27 Favored Glycine 0 N--CA 1.464 0.515 0 C-N-CA 118.662 -1.733 . . . . 52.15 115.244 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 27.1 m -93.73 127.88 39.67 Favored 'General case' 0 C--O 1.216 -0.68 0 C-N-CA 123.391 0.677 . . . . 71.32 110.372 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 85.5 mt -97.88 132.04 43.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 124.023 0.929 . . . . 72.04 113.284 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 64' ' ' ASN . . . . . 0.468 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 75.5 m-20 -100.03 -38.69 8.47 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.84 0.856 . . . . 72.24 112.304 176.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.433 ' HB2' ' HB2' ' B' ' 84' ' ' GLU . 95.3 mtt180 -151.76 160.36 43.61 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.096 -0.705 . . . . 71.31 109.096 -177.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.628 HD11 ' HB1' ' B' ' 50' ' ' ALA . 20.1 pt -148.52 144.52 18.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.094 -1.447 . . . . 75.0 107.094 172.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 67' ' ' THR . . . . . 0.546 ' OG1' ' HB2' ' B' ' 82' ' ' TYR . 43.4 p -123.98 139.7 53.7 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 105.936 -1.876 . . . . 63.01 105.936 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.465 ' O ' HD12 ' A' ' 68' ' ' ILE . 2.4 mp -130.61 118.41 42.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 106.009 -1.848 . . . . 64.02 106.009 175.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.293 1.0 OUTLIER -121.39 125.56 47.24 Favored 'General case' 0 C--N 1.28 -2.44 0 C-N-CA 120.348 -0.541 . . . . 74.13 111.977 177.77 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 70' ' ' CYS . . . . . 0.467 ' HA ' ' HA2' ' B' ' 79' ' ' GLY . 68.7 m -116.53 133.5 55.94 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.198 -0.667 . . . . 63.22 109.198 -176.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 5.4 p-10 -122.52 133.82 54.57 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 118.701 -1.2 . . . . 74.04 111.426 -179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.4 ' HE3' ' HG3' ' B' ' 77' ' ' PRO . 39.9 mtpt -116.74 17.36 15.2 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.551 -1.648 . . . . 75.2 106.551 178.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -44.64 -35.03 2.41 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.811 2.044 . . . . 74.32 112.847 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 39.9 m -115.24 26.29 10.21 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 111.773 0.286 . . . . 74.41 111.773 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.27 -60.22 0.49 Allowed Glycine 0 C--O 1.236 0.276 0 C-N-CA 120.617 -0.802 . . . . 64.21 114.054 175.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 76' ' ' HIS . . . . . 0.408 ' HA ' ' HD3' ' B' ' 77' ' ' PRO . 12.0 m170 -84.78 141.91 38.81 Favored Pre-proline 0 C--N 1.31 -1.147 0 N-CA-C 110.176 -0.305 . . . . 73.04 110.176 -177.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' B' ' 76' ' ' HIS . 3.0 Cg_exo -78.88 118.04 4.03 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 121.177 1.251 . . . . 74.04 111.854 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -112.43 -166.47 1.08 Allowed 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 109.207 -0.664 . . . . 75.44 109.207 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 79' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' B' ' 70' ' ' CYS . . . 171.58 159.41 17.74 Favored Glycine 0 N--CA 1.414 -2.768 0 C-N-CA 119.652 -1.261 . . . . 63.25 114.16 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -154.64 152.14 29.62 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 125.06 1.344 . . . . 70.53 109.091 176.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.08 153.93 51.17 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 122.001 0.121 . . . . 65.22 110.982 -173.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 82' ' ' TYR . . . . . 0.546 ' HB2' ' OG1' ' B' ' 67' ' ' THR . 30.8 m-85 -119.95 127.0 52.26 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 110.047 -0.353 . . . . 75.45 110.047 174.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.484 HG23 HG22 ' B' ' 66' ' ' ILE . 23.8 mm -107.97 118.74 56.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 107.497 -1.297 . . . . 64.11 107.497 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 84' ' ' GLU . . . . . 0.433 ' HB2' ' HB2' ' B' ' 65' ' ' ARG . 61.6 mt-10 -105.73 119.63 39.64 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.249 0.547 . . . . 71.15 110.235 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -95.81 162.0 13.78 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.671 -0.695 . . . . 71.5 112.285 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.468 ' HA ' ' ND2' ' B' ' 64' ' ' ASN . . . -79.03 -32.04 44.86 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.771 -1.104 . . . . 64.24 111.168 175.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.39 146.4 34.5 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 120.06 -0.656 . . . . 65.55 110.26 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -74.69 -26.67 59.99 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 108.015 -1.105 . . . . 73.43 108.015 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -72.51 -20.28 61.39 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 119.723 -0.791 . . . . 71.2 111.625 177.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 21.9 m -69.46 -37.35 77.28 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 110.505 -0.183 . . . . 62.4 110.505 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.462 HG23 ' CG1' ' B' ' 39' ' ' VAL . 0.2 OUTLIER -67.08 -39.05 82.43 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 C-N-CA 120.427 -0.509 . . . . 61.2 109.905 175.173 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.93 -37.08 75.88 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.213 0.53 . . . . 74.14 110.716 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.42 -31.41 62.3 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.033 -0.53 . . . . 62.15 111.173 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.73 -43.02 48.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.197 -0.456 . . . . 63.54 111.167 -178.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 33.6 m -57.11 -22.24 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 112.724 0.638 . . . . 73.34 112.724 177.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.4 -15.74 63.85 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.219 0.533 . . . . 71.2 110.515 176.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 11.2 mtm -98.71 15.64 24.63 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.654 0.782 . . . . 75.21 111.436 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 98' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 6.0 t70 -33.85 -52.25 0.42 Allowed 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 114.807 1.41 . . . . 75.55 114.807 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -123.91 64.42 1.05 Allowed 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 118.778 -1.169 . . . . 71.43 111.182 174.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 10.8 t -97.72 -177.63 3.85 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.772 -1.104 . . . . 65.43 110.087 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 9.7 p -108.6 134.5 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 CA-C-O 121.254 0.55 . . . . 51.03 109.652 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -130.31 115.83 17.48 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.073 -0.714 . . . . 61.43 109.073 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 40.0 mtp-105 49.98 32.24 5.49 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.471 1.508 . . . . 75.23 112.23 -178.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.66 -6.32 62.7 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.502 -0.772 . . . . 73.31 112.879 175.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.483 ' HD3' ' HB2' ' B' ' 45' ' ' ASP . 30.2 mtp180 -110.14 133.56 53.09 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.808 -0.442 . . . . 71.3 109.808 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 14.4 m -75.57 120.51 21.08 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.044 -1.095 . . . . 72.24 108.044 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 41.6 pt -103.13 172.08 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-O 121.475 0.655 . . . . 74.22 112.262 -178.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 108' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 57.6 tptt -125.93 126.44 44.37 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.667 -1.151 . . . . 74.43 107.97 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 48.5 t -117.71 122.06 68.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.904 -0.776 . . . . 74.03 108.904 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.46 ' HB2' ' HB3' ' B' ' 40' ' ' TYR . 95.8 mt -121.53 145.19 42.12 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 108.918 -0.771 . . . . 70.12 108.918 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.55 130.84 13.07 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.857 1.705 . . . . 75.22 109.66 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.514 ' HB3' ' HB2' ' B' ' 38' ' ' SER . 25.7 ttpp -86.11 135.93 33.42 Favored 'General case' 0 CA--C 1.5 -0.981 0 C-N-CA 119.981 -0.688 . . . . 64.12 112.368 -178.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -139.18 136.28 34.89 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 106.635 -1.617 . . . . 73.34 106.635 171.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 14.9 t -73.95 -175.66 2.23 Favored 'General case' 0 N--CA 1.413 -2.299 0 CA-C-O 122.192 0.996 . . . . 74.21 110.607 -176.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -143.28 135.63 27.2 Favored 'General case' 0 N--CA 1.394 -3.275 0 N-CA-C 108.132 -1.062 . . . . 62.22 108.132 -174.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 46.3 ttm -156.17 105.12 2.06 Favored Pre-proline 0 N--CA 1.428 -1.548 0 N-CA-C 109.318 -0.623 . . . . 75.3 109.318 -176.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.7 164.21 16.61 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.434 2.089 . . . . 61.32 110.46 175.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.14 57.03 4.63 Favored Glycine 0 C--N 1.313 -0.742 0 C-N-CA 120.777 -0.725 . . . . 61.3 113.01 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . 0.301 2.0 pp 49.39 178.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 126.876 2.071 . . . . 75.12 115.839 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 49.4 m -134.22 119.84 19.28 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.186 -1.042 . . . . 71.22 108.186 175.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 36.5 t -163.45 128.92 3.08 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 108.713 -0.847 . . . . 74.5 108.713 -177.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 86.7 m -143.3 101.02 3.73 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.622 -0.881 . . . . 53.3 108.622 175.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -81.39 144.46 31.42 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.927 -1.138 . . . . 52.14 107.927 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.545 ' C ' ' HE ' ' B' ' 124' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.374 0 N-CA-C 107.66 -1.237 . . . . 73.02 107.66 -174.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.497 0 CA-C-O 121.131 0.491 . . . . 71.35 110.838 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.7 mm -83.26 112.69 21.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 115.852 -0.613 . . . . 44.13 109.738 178.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.87 125.82 6.39 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 108.365 -0.976 . . . . 72.32 108.365 178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -66.95 103.96 0.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 121.828 1.685 . . . . 51.21 111.236 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 46.0 t -90.97 105.99 18.21 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.469 -0.567 . . . . 73.54 109.469 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 65.2 mtt -136.13 146.45 46.95 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.94 -0.573 . . . . 72.12 109.61 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -77.45 101.18 6.29 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.47 -0.567 . . . . 75.13 109.47 176.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.9 p -78.83 98.27 6.26 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 115.315 -0.857 . . . . 62.34 111.265 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -164.15 94.85 0.75 Allowed 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 115.195 -0.911 . . . . 62.44 109.191 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -93.23 131.84 37.96 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.94 -0.573 . . . . 73.41 110.137 -177.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.0 t -60.97 109.03 0.96 Allowed 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 108.497 -0.927 . . . . 71.32 108.497 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -127.18 112.72 15.46 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.472 -1.307 . . . . 63.34 107.472 -177.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.8 ptp -126.71 142.43 51.54 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.782 -0.644 . . . . 73.43 111.558 -175.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.2 m -148.0 151.62 36.07 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.003 -1.48 . . . . 73.2 107.003 -178.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.21 86.76 6.16 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 119.991 -0.683 . . . . 63.31 109.566 175.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.43 68.89 3.38 Favored Glycine 0 CA--C 1.497 -1.038 0 N-CA-C 111.039 -0.825 . . . . 63.32 111.039 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.74 -162.73 1.33 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.913 -0.773 . . . . 60.34 108.913 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 65.39 84.81 0.15 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.946 0.899 . . . . 71.15 111.7 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.0 m 149.22 -72.82 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 129.851 3.26 . . . . 64.13 105.464 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 44.4 -175.66 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.699 1.6 . . . . 75.4 114.469 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.571 ' HA2' ' CE1' ' B' ' 40' ' ' TYR . . . 116.49 -149.91 18.68 Favored Glycine 0 N--CA 1.402 -3.577 0 N-CA-C 106.846 -2.502 . . . . 61.42 106.846 177.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.719 ' HA ' ' OH ' ' B' ' 82' ' ' TYR . 56.7 Cg_exo -50.26 -34.36 39.86 Favored 'Trans proline' 0 CA--C 1.601 3.849 0 C-N-CA 122.479 2.119 . . . . 71.41 115.264 171.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -106.8 170.01 0.12 Allowed 'Trans proline' 0 C--N 1.375 1.93 0 N-CA-C 117.35 2.019 . . . . 71.45 117.35 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.517 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 21.8 mm-40 -109.44 120.78 44.37 Favored Pre-proline 0 N--CA 1.418 -2.028 0 CA-C-N 112.26 -2.245 . . . . 74.24 106.781 177.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.14 123.07 8.55 Favored 'Trans proline' 0 C--O 1.244 0.821 0 C-N-CA 122.622 2.215 . . . . 73.24 112.229 -177.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 24' ' ' GLN . 0.4 OUTLIER -160.5 175.31 12.88 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 114.515 -1.22 . . . . 72.41 112.708 -174.361 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.3 t -89.73 156.35 18.59 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.36 -0.836 . . . . 65.35 110.167 178.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.76 -44.32 63.29 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 112.609 0.596 . . . . 74.32 112.609 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -64.65 -30.19 71.21 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 112.104 0.409 . . . . 74.21 112.104 178.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -64.81 -34.22 77.85 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.498 -1.297 . . . . 73.5 107.498 176.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.481 ' HA ' HG12 ' A' ' 34' ' ' ILE . 95.7 mttt -69.83 -50.55 41.7 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.05 -0.977 . . . . 62.32 110.766 -174.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.564 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -57.2 -39.5 75.54 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 119.889 -0.725 . . . . 73.22 111.75 -178.49 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -72.58 -40.42 66.61 Favored 'General case' 0 N--CA 1.415 -2.196 0 C-N-CA 119.203 -0.999 . . . . 72.14 112.74 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.481 HG12 ' HA ' ' A' ' 31' ' ' LYS . 15.8 pt -65.94 -34.33 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 120.46 -0.496 . . . . 71.32 110.827 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -61.16 -42.6 98.85 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.779 -0.823 . . . . 72.13 108.779 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -78.64 -26.79 45.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.363 -0.835 . . . . 72.25 112.386 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.438 HH21 HG23 ' A' ' 34' ' ' ILE . 89.3 mtm180 -89.71 12.96 15.46 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 123.068 0.547 . . . . 64.35 111.943 -177.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.3 t -96.64 145.21 25.96 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.277 0.561 . . . . 75.14 111.403 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.48 ' CG1' ' HB ' ' A' ' 91' ' ' VAL . 28.3 m -128.17 160.02 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.764 0 CA-C-N 115.839 -0.619 . . . . 72.21 110.487 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.572 ' CZ ' ' HG3' ' B' ' 22' ' ' PRO . 15.1 t80 -110.4 121.21 44.75 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 107.692 -1.225 . . . . 72.41 107.692 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.716 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 66.6 t -121.55 108.8 23.1 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 N-CA-C 107.404 -1.332 . . . . 70.5 107.404 173.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.18 172.03 17.42 Favored Glycine 0 C--N 1.284 -2.359 0 C-N-CA 118.813 -1.661 . . . . 64.44 112.825 -176.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.3 t30 61.64 34.1 17.79 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 124.269 1.028 . . . . 71.45 110.421 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.499 ' HA ' ' NH1' ' A' ' 105' ' ' ARG . 7.4 p -90.89 14.11 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.706 0 CA-C-N 115.03 -0.986 . . . . 64.42 111.231 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -36.62 112.27 0.18 Allowed 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 127.929 2.492 . . . . 64.45 114.69 -177.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . 0.524 32.1 m-85 50.11 -43.91 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.846 1 N-CA-C 122.467 4.247 . . . . 74.33 122.467 173.418 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.84 0.18 46.49 Favored Glycine 0 C--N 1.306 -1.108 0 CA-C-N 119.145 0.884 . . . . 30.0 113.32 -175.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.489 ' HB2' HG22 ' A' ' 44' ' ' VAL . 49.6 m -129.48 137.31 50.76 Favored 'General case' 0 N--CA 1.409 -2.497 0 O-C-N 122.45 -0.441 . . . . 64.14 110.046 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 47.1 p -125.25 179.34 5.12 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.238 -1.023 . . . . 64.31 108.238 -176.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.96 -49.77 76.38 Favored 'General case' 0 C--O 1.207 -1.159 0 CA-C-N 118.349 0.522 . . . . 63.2 111.134 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -58.26 -41.12 83.54 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.888 0.699 . . . . 63.3 112.888 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -62.93 -44.64 95.52 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.941 0.877 . . . . 63.31 110.1 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.45 ' HB3' ' HE2' ' A' ' 57' ' ' PHE . 63.4 mt -73.0 -46.72 50.59 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.497 -1.229 . . . . 73.24 112.482 -175.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.5 ' HG3' ' OH ' ' B' ' 46' ' ' TYR . 6.1 tm-20 -57.48 -48.68 78.57 Favored 'General case' 0 C--O 1.196 -1.711 0 C-N-CA 122.804 0.442 . . . . 74.35 110.441 -176.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.22 -42.73 77.74 Favored 'General case' 0 C--O 1.267 2.008 0 CA-C-O 121.724 0.773 . . . . 43.02 110.747 176.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -68.08 -43.59 78.22 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.248 -0.887 . . . . 71.2 111.335 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.609 ' CD2' HG12 ' A' ' 83' ' ' ILE . 65.9 m-85 -80.15 -22.98 41.44 Favored 'General case' 0 C--O 1.225 -0.218 0 O-C-N 121.91 -0.494 . . . . 71.25 111.435 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.9 t -69.46 -24.14 63.76 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.9 -0.778 . . . . 41.23 108.9 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.8 m -63.27 -22.57 66.96 Favored 'General case' 0 CA--C 1.568 1.641 0 CA-C-N 116.121 -0.49 . . . . 55.11 110.78 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 78.7 m -97.03 7.43 46.67 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.821 0.674 . . . . 74.25 112.821 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 142.97 -161.79 27.52 Favored Glycine 0 C--O 1.221 -0.682 0 C-N-CA 119.45 -1.357 . . . . 65.24 113.838 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.3 m -99.26 129.81 45.51 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.404 -0.591 . . . . 63.54 109.404 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.44 HD11 ' HB2' ' A' ' 57' ' ' PHE . 72.0 mt -85.23 133.3 29.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 113.084 0.772 . . . . 65.24 113.084 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.496 ' OD1' ' HG3' ' A' ' 65' ' ' ARG . 24.1 t-20 -94.7 -48.19 6.17 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.865 1.266 . . . . 64.44 108.234 178.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.496 ' HG3' ' OD1' ' A' ' 64' ' ' ASN . 98.9 mtt180 -148.57 158.84 44.4 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.506 -0.77 . . . . 72.21 109.003 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.417 ' HB ' HG13 ' A' ' 83' ' ' ILE . 1.5 tt -149.31 127.6 2.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 C-N-CA 123.198 0.599 . . . . 54.15 110.138 173.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 30.2 m -125.08 133.65 52.81 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.627 -1.249 . . . . 62.53 107.627 -173.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.0 mp -131.03 120.6 47.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 106.646 -1.613 . . . . 63.44 106.646 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.469 ' H ' HD23 ' A' ' 69' ' ' LEU . 1.6 pt? -120.63 134.33 55.29 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.871 -0.332 . . . . 72.01 110.14 178.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 80.8 m -116.58 126.51 53.38 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.642 -0.873 . . . . 73.24 108.642 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.603 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 4.3 p30 -105.29 126.6 52.29 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.403 -0.519 . . . . 73.54 111.108 -177.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.451 ' HG2' ' HB3' ' A' ' 77' ' ' PRO . 96.3 mttt -119.47 2.53 11.25 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 112.62 0.6 . . . . 61.23 112.62 177.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.664 ' HB3' ' OD1' ' B' ' 64' ' ' ASN . 41.8 p90 -56.96 -27.67 61.49 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 113.924 1.083 . . . . 74.14 113.924 -176.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.0 t -97.24 10.87 38.31 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.259 0.552 . . . . 64.4 110.191 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.35 -55.78 0.55 Allowed Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 121.072 -0.585 . . . . 42.41 112.677 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.3 m80 -95.5 125.56 49.12 Favored Pre-proline 0 C--N 1.308 -1.237 0 C-N-CA 120.964 -0.294 . . . . 75.22 110.946 -177.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.603 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 26.5 Cg_endo -67.88 119.59 6.59 Favored 'Trans proline' 0 C--O 1.247 0.94 0 C-N-CA 122.829 2.353 . . . . 63.4 112.744 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.453 ' HB2' ' OD2' ' A' ' 71' ' ' ASP . 28.1 mtmm -113.21 -160.37 0.72 Allowed 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.796 -1.187 . . . . 72.14 107.796 172.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 69' ' ' LEU . . . 179.04 153.15 11.23 Favored Glycine 0 N--CA 1.423 -2.225 0 C-N-CA 119.145 -1.502 . . . . 63.22 114.786 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.414 ' O ' HD23 ' A' ' 69' ' ' LEU . 24.9 m-85 -136.22 153.31 51.26 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.628 -1.99 . . . . 71.51 105.628 174.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.486 ' HB2' HG11 ' A' ' 44' ' ' VAL . . . -131.64 131.19 42.99 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.588 -0.893 . . . . 72.15 108.588 176.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -115.39 120.45 39.63 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.594 -1.261 . . . . 71.41 107.594 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.609 HG12 ' CD2' ' A' ' 57' ' ' PHE . 1.1 mp -113.76 129.05 70.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 108.894 -0.78 . . . . 71.33 108.894 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 65' ' ' ARG . 2.1 mp0 -99.6 124.43 44.79 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.2 -1.408 . . . . 74.24 107.2 174.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -94.03 155.93 16.86 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 121.248 -0.181 . . . . 74.23 110.628 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.29 -32.05 72.78 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.427 -0.352 . . . . 14.31 111.427 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.86 148.34 44.17 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.777 -0.769 . . . . 74.11 110.163 175.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -70.76 -27.09 63.67 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.319 -0.855 . . . . 75.24 109.608 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -62.49 -33.91 75.81 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.921 -0.582 . . . . 71.23 110.521 174.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.5 m -66.75 -35.94 81.28 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 116.048 -0.524 . . . . 53.5 110.902 -177.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.504 ' O ' HG13 ' A' ' 95' ' ' VAL . 1.5 m -68.95 -37.69 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 108.435 -0.95 . . . . 72.34 108.435 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.639 ' O ' HG22 ' A' ' 95' ' ' VAL . 9.9 t70 -68.02 -30.52 69.77 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.722 0.772 . . . . 64.33 109.499 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.01 -31.24 64.36 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.667 -0.697 . . . . 73.11 110.088 175.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.85 -36.17 59.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.889 -0.596 . . . . 53.21 111.453 -177.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 92' ' ' ASP . 11.2 m -53.86 -21.63 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 112.597 0.592 . . . . 74.14 112.597 178.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.75 -12.2 44.6 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.304 0.573 . . . . 54.23 110.991 177.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.565 ' HA ' ' OG1' ' A' ' 100' ' ' THR . 68.0 mtm -100.43 5.43 44.25 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 116.1 -0.5 . . . . 64.32 111.092 178.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.541 ' HA ' ' H ' ' A' ' 109' ' ' VAL . 0.4 OUTLIER -48.4 -49.02 36.53 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.569 1.322 . . . . 74.35 114.569 -177.171 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -101.97 12.82 36.29 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-O 121.887 0.851 . . . . 72.23 110.539 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.565 ' OG1' ' HA ' ' A' ' 97' ' ' MET . 62.9 m -72.24 151.93 42.53 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.917 -0.583 . . . . 73.14 109.984 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -101.56 134.34 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 N-CA-C 108.559 -0.904 . . . . 73.52 108.559 -177.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.48 ' HE2' ' OG ' ' A' ' 48' ' ' SER . 82.6 t80 -130.12 118.81 22.05 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 115.654 -0.703 . . . . 74.35 109.17 -173.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 54.55 32.06 16.18 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.717 1.006 . . . . 64.02 113.717 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.71 -5.47 73.33 Favored Glycine 0 N--CA 1.461 0.352 0 CA-C-N 115.227 -0.897 . . . . 64.15 113.406 174.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.499 ' NH1' ' HA ' ' A' ' 44' ' ' VAL . 21.9 ptt85 -121.52 145.49 47.9 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 122.846 0.458 . . . . 74.43 110.301 178.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.2 m -82.61 122.24 27.86 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.545 -0.909 . . . . 64.44 108.545 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 41.3 pt -101.44 171.52 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 N-CA-C 108.44 -0.948 . . . . 63.13 108.44 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.716 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 22.9 mmmt -121.91 128.23 51.32 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 109.685 -0.487 . . . . 71.15 109.685 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.541 ' H ' ' HA ' ' A' ' 98' ' ' ASP . 60.5 t -117.48 112.16 37.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 105.127 -2.175 . . . . 62.52 105.127 173.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 tt -140.41 129.97 13.38 Favored Pre-proline 0 C--N 1.274 -2.681 0 N-CA-C 105.146 -2.168 . . . . 75.31 105.146 -172.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -55.12 136.81 74.81 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 121.584 1.523 . . . . 72.41 109.736 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.25 24.2 ttpp -79.33 65.68 4.57 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 122.615 1.197 . . . . 71.43 112.204 -178.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 35.51 -99.31 0.02 OUTLIER 'General case' 0 C--O 1.246 0.887 0 CA-C-N 111.543 -2.571 . . . . 62.13 115.512 -178.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 62.2 m 71.01 -47.4 0.66 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.943 1.697 . . . . 73.02 109.272 -175.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -75.72 104.4 6.26 Favored 'General case' 0 N--CA 1.418 -2.03 0 C-N-CA 125.651 1.58 . . . . 61.05 109.299 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 1.5 mmt -115.65 161.38 30.63 Favored Pre-proline 0 C--N 1.291 -1.968 0 N-CA-C 108.629 -0.878 . . . . 62.52 108.629 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.18 -15.85 46.92 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.755 2.303 . . . . 71.53 111.88 177.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -133.32 177.77 18.72 Favored Glycine 0 N--CA 1.437 -1.25 0 N-CA-C 109.442 -1.463 . . . . 62.23 109.442 176.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 27.3 pt -91.99 106.78 18.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 117.646 0.723 . . . . 74.21 110.533 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.2 t -89.76 127.2 35.92 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.6 -0.727 . . . . 63.55 109.681 -177.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.401 ' OG ' ' HD3' ' A' ' 124' ' ' ARG . 39.6 p -101.11 98.16 8.62 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.496 -0.32 . . . . 73.12 110.222 178.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.6 m -81.76 120.71 25.49 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.536 -0.542 . . . . 71.41 109.536 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.4 t70 64.57 92.7 0.07 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.851 0.861 . . . . 73.41 112.345 -178.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.401 ' HD3' ' OG ' ' A' ' 121' ' ' SER . 32.6 ptt180 . . . . . 0 C--N 1.306 -1.29 0 CA-C-N 115.262 -0.881 . . . . 62.34 109.659 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.726 0 CA-C-O 120.618 0.247 . . . . 75.52 110.342 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 64.3 mt -92.97 110.74 23.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 107.895 -1.15 . . . . 72.21 107.895 177.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.37 134.9 33.54 Favored Pre-proline 0 C--N 1.298 -1.662 0 CA-C-N 115.88 -0.6 . . . . 60.14 110.515 -176.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.37 101.68 0.44 Allowed 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 122.156 1.904 . . . . 74.14 110.419 176.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 61.0 m -85.01 172.89 10.95 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.447 -0.797 . . . . 75.41 109.606 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -76.36 -178.24 4.49 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.719 -0.474 . . . . 71.41 109.719 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -80.09 85.76 5.62 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 119.883 -0.727 . . . . 73.21 111.927 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 95.4 m -97.54 102.06 13.74 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 107.503 -1.295 . . . . 73.1 107.503 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.537 ' HA ' ' NH2' ' B' ' 113' ' ' ARG . 12.6 t -143.04 164.77 29.2 Favored 'General case' 0 N--CA 1.407 -2.594 0 C-N-CA 119.946 -0.702 . . . . 63.32 111.312 -176.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -136.2 22.09 3.23 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.978 -1.49 . . . . 71.5 106.978 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 79.1 p -80.2 171.59 14.88 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.317 -0.856 . . . . 74.34 112.723 -176.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 58.5 tttm 175.38 168.83 0.33 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 102.648 -3.093 . . . . 73.41 102.648 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 64.3 mtt -67.97 93.04 0.4 Allowed 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 120.029 1.286 . . . . 64.31 108.484 172.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 14.5 p -112.15 171.5 7.47 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 114.492 -1.231 . . . . 60.13 109.425 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.436 ' HB1' ' HA ' ' B' ' 18' ' ' TYR . . . -126.91 100.38 6.13 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 113.449 0.907 . . . . 65.05 113.449 -175.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.465 ' HA3' ' OD1' ' B' ' 35' ' ' ASP . . . -76.42 -42.23 23.25 Favored Glycine 0 CA--C 1.491 -1.431 0 N-CA-C 106.53 -2.628 . . . . 61.31 106.53 169.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.6 85.28 5.65 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 106.749 -1.574 . . . . 65.13 106.749 169.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.436 ' HA ' ' HB1' ' B' ' 15' ' ' ALA . 56.1 t80 -69.58 170.18 11.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.827 -1.079 . . . . 72.31 108.975 -175.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 49.2 p -68.73 81.83 0.28 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.589 0.709 . . . . 75.13 109.439 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' GLU . . . . . 0.539 ' O ' ' HD2' ' B' ' 22' ' ' PRO . 27.7 tt0 -70.29 -24.87 63.11 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 113.925 -1.489 . . . . 72.31 110.782 -177.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.52 -106.03 2.98 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.768 -0.651 . . . . 71.2 113.417 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.572 ' HG3' ' CZ ' ' A' ' 40' ' ' TYR . 0.9 OUTLIER -40.54 -57.27 1.3 Allowed 'Trans proline' 0 CA--C 1.573 2.47 0 C-N-CA 124.797 3.665 . . . . 54.15 116.192 -178.794 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.525 ' HG2' ' OE2' ' B' ' 20' ' ' GLU . 4.8 Cg_exo -83.95 165.61 13.31 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 121.95 1.767 . . . . 64.4 110.734 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -103.91 145.38 30.53 Favored Pre-proline 0 C--N 1.283 -2.31 0 N-CA-C 109.382 -0.599 . . . . 65.01 109.382 176.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -46.78 127.6 12.23 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.266 2.644 . . . . 43.54 113.841 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.802 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -61.61 -167.97 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 114.47 -1.241 . . . . 65.54 113.837 178.754 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.572 ' O ' ' HG3' ' B' ' 31' ' ' LYS . 47.0 t -54.19 143.51 22.56 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.765 0.793 . . . . 52.44 112.583 -176.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.423 ' O ' ' HE2' ' B' ' 32' ' ' LYS . . . -60.89 -43.74 98.06 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.16 -1.382 . . . . 72.43 111.709 178.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -66.92 -33.02 74.68 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 111.715 0.265 . . . . 52.33 111.715 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.64 ' HB3' HD23 ' B' ' 26' ' ' LEU . 10.8 tp10 -62.64 -34.89 77.97 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 107.631 -1.248 . . . . 52.04 107.631 177.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.572 ' HG3' ' O ' ' B' ' 27' ' ' SER . 92.6 mttt -70.07 -50.43 41.11 Favored 'General case' 0 C--O 1.203 -1.359 0 CA-C-N 115.341 -0.845 . . . . 72.32 111.101 -174.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.532 ' N ' ' HE2' ' B' ' 32' ' ' LYS . 0.2 OUTLIER -57.66 -37.42 73.36 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 120.106 -0.637 . . . . 72.15 112.062 -177.455 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.659 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 7.1 mm-40 -71.14 -47.41 58.04 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.074 -0.512 . . . . 72.03 110.635 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.509 HG12 ' HA ' ' B' ' 31' ' ' LYS . 21.4 pt -64.83 -34.65 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 122.975 0.172 . . . . 63.15 111.211 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.588 ' HB3' ' O ' ' B' ' 114' ' ' THR . 67.8 m-20 -60.63 -42.66 97.33 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-O 121.183 0.516 . . . . 74.35 109.807 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.436 ' O ' ' HD3' ' B' ' 88' ' ' ARG . 98.4 mttt -78.38 -25.87 46.38 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.153 0.798 . . . . 75.31 113.153 -176.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.659 ' HG2' ' O ' ' B' ' 33' ' ' GLU . 14.7 ptp180 -108.29 31.96 5.17 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.704 0.764 . . . . 74.54 112.2 -174.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' B' ' 84' ' ' GLU . 35.2 t -95.55 155.78 16.6 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.092 -1.447 . . . . 63.21 107.092 172.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.495 ' CG1' ' HB ' ' B' ' 91' ' ' VAL . 26.8 m -135.49 158.39 40.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.931 -0.48 . . . . 75.32 110.11 176.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 40' ' ' TYR . . . . . 0.571 ' CE1' ' HA2' ' A' ' 21' ' ' GLY . 22.1 t80 -107.73 119.82 40.51 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 107.354 -1.35 . . . . 63.41 107.354 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 67.3 t -122.0 107.57 20.14 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 N-CA-C 106.806 -1.553 . . . . 51.05 106.806 173.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.86 171.49 19.99 Favored Glycine 0 C--N 1.276 -2.802 0 C-N-CA 118.29 -1.909 . . . . 75.42 112.712 -176.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.6 t30 66.57 28.66 9.26 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.289 1.436 . . . . 72.33 112.208 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 14.7 p -58.49 134.5 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-O 121.412 0.625 . . . . 71.25 109.862 175.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -73.69 146.32 44.57 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.479 -0.782 . . . . 73.22 109.547 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 46' ' ' TYR . . . . . 0.5 ' OH ' ' HG3' ' A' ' 54' ' ' GLU . 45.8 t80 -61.71 -19.24 62.17 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.794 0.838 . . . . 72.42 110.93 -176.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.32 -0.53 55.75 Favored Glycine 0 N--CA 1.427 -1.924 0 CA-C-N 116.01 -0.541 . . . . 73.01 112.551 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 34.0 m -84.64 133.36 34.41 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.895 -0.78 . . . . 74.42 108.895 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 62.0 p -113.02 178.73 4.18 Favored 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 119.74 -0.784 . . . . 64.22 111.132 -177.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.8 -43.36 99.01 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.741 -0.663 . . . . 53.41 110.984 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -58.62 -43.13 89.58 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 111.724 0.268 . . . . 74.35 111.724 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -60.34 -47.93 83.93 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.912 0.863 . . . . 71.32 109.614 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.462 ' HB3' ' HE2' ' B' ' 57' ' ' PHE . 69.4 mt -68.73 -47.32 66.61 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-N 114.271 -1.331 . . . . 74.44 112.816 -177.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -57.34 -48.85 77.92 Favored 'General case' 0 C--O 1.205 -1.284 0 C-N-CA 122.872 0.469 . . . . 64.2 110.569 -176.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.34 -42.72 78.2 Favored 'General case' 0 C--O 1.258 1.522 0 CA-C-O 121.286 0.565 . . . . 70.24 110.631 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -69.1 -42.03 76.67 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.363 -0.835 . . . . 72.14 111.201 -176.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.572 ' CD2' HG13 ' B' ' 83' ' ' ILE . 66.2 m-85 -80.52 -23.17 40.23 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.454 -0.499 . . . . 70.24 111.114 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 32.9 t -71.37 -24.54 62.1 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.435 -0.58 . . . . 75.45 109.435 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 23.8 m -63.95 -27.01 68.85 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.1 0.476 . . . . 71.1 110.005 176.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 63.5 m -97.43 7.51 46.38 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.574 0.583 . . . . 74.33 112.574 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.09 -165.18 29.78 Favored Glycine 0 CA--C 1.507 -0.461 0 C-N-CA 118.169 -1.967 . . . . 74.32 115.783 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 14.7 m -98.18 123.99 42.53 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.862 -0.669 . . . . 72.31 109.442 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.45 HD11 ' HB2' ' B' ' 57' ' ' PHE . 61.9 mt -88.72 131.83 35.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 113.223 0.823 . . . . 73.54 113.223 -178.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 64' ' ' ASN . . . . . 0.664 ' OD1' ' HB3' ' A' ' 73' ' ' PHE . 18.8 t-20 -99.73 -45.25 5.82 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 124.5 1.12 . . . . 54.52 109.955 177.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.483 ' HB2' ' HB2' ' B' ' 84' ' ' GLU . 98.3 mtt180 -147.46 158.47 43.99 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.181 -0.674 . . . . 70.22 109.181 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -148.93 127.49 3.19 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 C-N-CA 123.658 0.783 . . . . 65.22 109.972 174.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 38.6 m -125.93 133.21 51.92 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.065 -0.971 . . . . 72.52 108.61 -175.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.418 HD12 ' N ' ' B' ' 68' ' ' ILE . 1.2 mp -129.9 122.34 54.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 106.353 -1.721 . . . . 75.33 106.353 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.479 HD23 ' H ' ' B' ' 69' ' ' LEU . 1.7 pt? -121.71 135.25 54.95 Favored 'General case' 0 C--N 1.287 -2.151 0 C-N-CA 120.6 -0.44 . . . . 62.3 110.468 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 64.5 m -115.87 127.08 54.74 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.03 -1.1 . . . . 72.14 108.03 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.484 ' HB3' ' NE2' ' A' ' 24' ' ' GLN . 3.7 p30 -107.8 127.52 53.78 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.258 -0.645 . . . . 72.45 109.258 -177.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.487 ' HE3' ' HB3' ' B' ' 77' ' ' PRO . 44.9 mtpt -124.1 10.88 8.81 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 120.732 -0.387 . . . . 63.21 110.015 -178.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -61.51 -22.7 65.34 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 113.893 1.072 . . . . 74.41 113.893 -177.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 19.8 m -97.81 14.08 28.25 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.025 0.44 . . . . 62.22 109.99 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.22 -44.37 3.09 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 111.275 -0.73 . . . . 75.3 111.275 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -91.37 125.62 57.44 Favored Pre-proline 0 CA--C 1.505 -0.762 0 N-CA-C 110.011 -0.366 . . . . 70.11 110.011 178.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.487 ' HB3' ' HE3' ' B' ' 72' ' ' LYS . 69.3 Cg_endo -76.57 119.55 5.24 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.905 2.404 . . . . 70.44 112.843 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 78' ' ' LYS . . . . . 0.43 ' HB2' ' OD2' ' B' ' 71' ' ' ASP . 24.6 mtmm -118.77 -160.82 0.81 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.094 -1.076 . . . . 70.33 108.094 175.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 178.79 158.26 20.95 Favored Glycine 0 N--CA 1.416 -2.698 0 C-N-CA 119.193 -1.48 . . . . 62.31 114.226 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 80' ' ' TYR . . . . . 0.405 ' O ' HD23 ' B' ' 69' ' ' LEU . 30.2 m-85 -136.17 153.95 51.1 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 105.784 -1.932 . . . . 73.01 105.784 173.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.37 130.33 40.57 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 109.935 -0.394 . . . . 73.01 109.935 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 82' ' ' TYR . . . . . 0.719 ' OH ' ' HA ' ' A' ' 22' ' ' PRO . 64.0 m-85 -114.03 122.39 46.77 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.912 -1.144 . . . . 54.33 107.912 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.572 HG13 ' CD2' ' B' ' 57' ' ' PHE . 4.6 mm -114.03 129.38 70.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.106 -1.072 . . . . 74.02 108.106 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 84' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' B' ' 65' ' ' ARG . 1.3 mp0 -99.48 120.74 40.11 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.54 -1.281 . . . . 74.32 107.54 173.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -88.9 152.8 21.52 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 108.515 -0.92 . . . . 71.34 108.515 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.63 -24.23 64.53 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 110.239 -0.282 . . . . 71.43 110.239 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -120.91 147.09 45.9 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.924 -0.58 . . . . 73.11 110.675 -178.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.436 ' HD3' ' O ' ' B' ' 36' ' ' LYS . 0.0 OUTLIER -72.59 -34.14 67.21 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.0 -0.741 . . . . 73.43 109.0 177.658 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -59.46 -35.26 73.71 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.204 -0.907 . . . . 74.43 110.465 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 30.8 m -65.78 -36.26 83.02 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.931 -0.577 . . . . 71.54 110.555 -178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.517 ' O ' HG13 ' B' ' 95' ' ' VAL . 1.4 m -69.12 -37.46 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 108.906 -0.775 . . . . 73.52 108.906 -178.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.662 ' O ' HG22 ' B' ' 95' ' ' VAL . 7.2 t70 -68.49 -31.05 70.04 Favored 'General case' 0 C--O 1.215 -0.763 0 CA-C-O 121.67 0.748 . . . . 65.33 109.066 -178.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.99 -31.15 64.32 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.842 -0.617 . . . . 73.21 109.868 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.32 -35.55 61.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.796 -0.638 . . . . 73.51 111.481 -178.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 95' ' ' VAL . . . . . 0.662 HG22 ' O ' ' B' ' 92' ' ' ASP . 10.4 m -54.31 -21.18 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 112.582 0.586 . . . . 70.31 112.582 178.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.57 -13.97 61.73 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.213 0.53 . . . . 43.41 110.835 177.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 67.1 mtm -96.9 12.98 30.37 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 116.263 -0.426 . . . . 44.03 110.627 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -35.41 -58.36 0.58 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.283 1.033 . . . . 63.41 113.082 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -112.02 98.95 7.7 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 118.553 -1.259 . . . . 63.04 109.14 170.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 75.4 m -139.44 150.85 45.71 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.526 -1.215 . . . . 74.44 109.941 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.05 122.59 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-O 121.481 0.657 . . . . 74.32 110.302 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -120.36 124.89 46.64 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.736 -0.839 . . . . 74.22 108.736 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 61.0 ttt-85 47.9 31.5 2.36 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 125.566 1.546 . . . . 71.03 112.044 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 100.4 -6.36 57.67 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 115.666 -0.697 . . . . 32.42 114.35 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -121.91 150.97 41.23 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 117.838 0.819 . . . . 73.1 111.304 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 30.0 m -82.07 121.58 26.74 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 116.431 -0.35 . . . . 74.33 110.232 -176.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 45.8 pt -101.2 170.66 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 120.577 -0.449 . . . . 60.25 110.151 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 108' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 46.7 tptt -128.81 121.61 28.69 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.955 -1.128 . . . . 72.11 107.955 -176.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 95.6 t -115.19 114.42 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 N-CA-C 107.374 -1.343 . . . . 72.31 107.374 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.411 HD23 ' HD2' ' B' ' 111' ' ' PRO . 3.6 tt -138.83 131.12 15.67 Favored Pre-proline 0 C--N 1.292 -1.925 0 N-CA-C 105.938 -1.875 . . . . 71.04 105.938 -173.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.411 ' HD2' HD23 ' B' ' 110' ' ' LEU . 73.6 Cg_exo -53.57 133.51 53.95 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.871 1.714 . . . . 74.03 112.888 178.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' B' ' 38' ' ' SER . 45.1 tttm -109.94 103.6 12.39 Favored 'General case' 0 N--CA 1.389 -3.485 0 N-CA-C 106.495 -1.668 . . . . 65.33 106.495 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.537 ' NH2' ' HA ' ' B' ' 9' ' ' THR 0.358 3.4 ppt_? -115.57 98.68 6.85 Favored 'General case' 0 N--CA 1.409 -2.498 0 C-N-CA 117.57 -1.652 . . . . 72.42 108.825 -177.223 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.588 ' O ' ' HB3' ' B' ' 35' ' ' ASP . 23.4 m -80.29 161.72 24.95 Favored 'General case' 0 C--N 1.27 -2.853 0 CA-C-N 112.275 -2.238 . . . . 74.13 108.378 -173.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -161.11 107.67 1.43 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.63 -0.428 . . . . 72.11 109.95 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 47.4 ttm -104.11 104.21 42.46 Favored Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 109.214 -0.662 . . . . 53.12 109.214 176.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -81.63 103.71 1.4 Allowed 'Trans proline' 0 N--CA 1.442 -1.556 0 C-N-CA 121.792 1.661 . . . . 70.41 109.556 175.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -151.32 60.62 0.41 Allowed Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 119.768 -1.205 . . . . 63.34 113.24 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 32.8 pt -88.6 150.26 3.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 109.12 -0.696 . . . . 71.24 109.12 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 47.7 m -76.63 107.41 8.91 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.195 0.521 . . . . 73.42 109.878 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 23.7 p -106.09 150.82 25.42 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 108.603 -0.888 . . . . 74.21 108.603 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 9.0 t -66.15 140.24 58.19 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.11 0.481 . . . . 63.25 109.888 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -85.38 116.86 23.95 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.215 -0.661 . . . . 54.31 109.215 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 . . . . . 0 C--N 1.301 -1.508 0 N-CA-C 108.484 -0.932 . . . . 75.33 108.484 -179.59 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.104 0 CA-C-O 120.65 0.262 . . . . 70.33 110.949 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.9 pt -94.58 110.75 24.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.589 0.709 . . . . 75.44 111.27 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.81 136.18 15.1 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 108.395 -0.965 . . . . 75.42 108.395 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -61.98 109.21 0.76 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.359 2.039 . . . . 70.4 111.126 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.2 p -119.3 10.59 12.01 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.637 0.732 . . . . 73.53 109.737 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.14 153.74 18.24 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 115.374 -0.83 . . . . 72.01 110.396 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -133.47 106.29 7.38 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 105.058 -2.201 . . . . 65.33 105.058 174.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 79.9 p 71.53 111.95 0.06 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.155 1.782 . . . . 63.41 110.796 -171.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.4 m -58.89 133.5 56.09 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.055 -0.521 . . . . 70.1 111.299 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -80.58 128.44 33.61 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.618 -0.882 . . . . 74.42 108.618 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.4 t -74.3 166.85 22.76 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-O 120.877 0.37 . . . . 73.54 111.7 -176.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp 67.74 -70.97 0.11 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.499 1.52 . . . . 74.14 111.238 -175.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 27.4 ttt -125.44 120.75 31.88 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.43 -1.322 . . . . 74.15 107.43 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.0 p -78.93 -29.36 44.1 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 112.772 0.656 . . . . 62.44 112.772 -173.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -126.94 -167.24 1.7 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.204 0.526 . . . . 52.44 111.166 -176.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 165.37 -143.65 8.63 Favored Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 107.546 -2.222 . . . . 74.42 107.546 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.488 ' HA ' ' CZ ' ' A' ' 65' ' ' ARG . . . 72.88 151.36 0.11 Allowed 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.528 0.936 . . . . 33.31 113.528 174.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.647 ' CD1' ' HG2' ' A' ' 117' ' ' PRO . 55.7 m-85 -94.27 -163.85 1.1 Allowed 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 105.878 -1.897 . . . . 74.3 105.878 175.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.621 ' OG1' ' HA ' ' A' ' 25' ' ' PRO . 34.6 m -111.15 75.3 0.91 Allowed 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 107.717 -1.216 . . . . 71.52 107.717 171.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.51 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -100.64 102.27 13.36 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 115.357 -0.838 . . . . 71.53 111.603 178.28 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.45 -132.6 14.75 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 115.526 -0.761 . . . . 63.31 113.37 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.34 -41.83 69.87 Favored 'Trans proline' 0 CA--C 1.572 2.376 0 C-N-CA 124.267 3.311 . . . . 64.4 117.36 -178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.51 ' HD2' ' O ' ' A' ' 20' ' ' GLU . 43.2 Cg_exo -43.06 151.06 0.29 Allowed 'Trans proline' 0 C--N 1.403 3.421 0 C-N-CA 123.204 2.603 . . . . 75.11 113.819 177.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -76.88 136.77 66.41 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 116.182 -0.463 . . . . 74.14 112.077 -174.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.621 ' HA ' ' OG1' ' A' ' 19' ' ' THR . 27.8 Cg_endo -63.04 132.18 35.67 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.121 2.547 . . . . 61.25 113.605 -177.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.401 ' H ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -116.4 172.26 7.31 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.18 -0.918 . . . . 54.31 111.602 177.139 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.1 t -73.34 146.78 44.99 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.845 -0.616 . . . . 73.53 112.412 -176.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.97 -34.08 8.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.638 -1.164 . . . . 61.43 111.2 172.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -59.87 -47.1 87.13 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.394 0.678 . . . . 52.1 109.201 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.559 ' O ' HG12 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -64.05 -41.75 97.27 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 116.673 -0.24 . . . . 75.41 111.179 177.287 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.18 -42.24 98.23 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.699 0.761 . . . . 75.31 109.356 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.518 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -70.97 -37.68 72.77 Favored 'General case' 0 N--CA 1.379 -3.98 0 CA-C-N 114.771 -1.104 . . . . 74.12 112.589 -178.54 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 41.3 mm-40 -71.17 -44.13 66.11 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.236 0.458 . . . . 74.34 112.236 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.559 HG12 ' O ' ' A' ' 30' ' ' GLU . 21.2 pt -67.42 -35.17 72.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.177 0.513 . . . . 63.0 111.541 -177.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.411 ' OD1' ' HB3' ' A' ' 115' ' ' ASN . 34.7 t70 -68.9 -24.02 64.26 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.881 -0.6 . . . . 74.03 110.471 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 99.7 mttt -77.92 -32.03 51.42 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.2 0.524 . . . . 75.31 110.746 176.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 96.5 mtt180 -94.49 10.8 33.14 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.605 0.717 . . . . 71.35 110.56 -171.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.574 ' HB3' ' HG2' ' A' ' 84' ' ' GLU . 13.6 p -112.16 169.4 8.89 Favored 'General case' 0 N--CA 1.401 -2.887 0 CA-C-N 115.424 -0.807 . . . . 61.01 111.771 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 27.3 m -135.32 158.62 40.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 116.155 -0.475 . . . . 75.55 110.912 -175.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.673 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 46.7 t80 -99.0 121.78 41.4 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 124.572 1.149 . . . . 74.5 108.665 175.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 58.2 t -115.07 113.53 43.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 107.639 -1.245 . . . . 71.35 107.639 174.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.23 170.23 14.0 Favored Glycine 0 C--N 1.305 -1.182 0 C-N-CA 120.052 -1.07 . . . . 41.53 113.769 -177.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.471 ' O ' ' HD3' ' A' ' 105' ' ' ARG . 65.4 t30 68.71 21.49 7.81 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 126.425 1.89 . . . . 61.54 112.505 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.496 ' O ' ' HA3' ' A' ' 79' ' ' GLY . 7.4 p -91.63 103.65 14.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 O-C-N 121.203 -0.936 . . . . 71.11 110.99 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.404 ' HB2' ' NH2' ' A' ' 105' ' ' ARG . 2.3 m-20 -86.71 166.74 15.06 Favored 'General case' 0 C--O 1.261 1.686 0 N-CA-C 108.391 -0.966 . . . . 63.44 108.391 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -50.81 131.77 26.28 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 123.41 0.444 . . . . 73.13 109.825 174.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 137.89 -38.49 1.7 Allowed Glycine 0 N--CA 1.427 -1.945 0 N-CA-C 110.1 -1.2 . . . . 75.32 110.1 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.4 m -84.08 131.97 34.75 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 108.131 -1.063 . . . . 74.33 108.131 176.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.0 p -94.1 162.86 13.7 Favored 'General case' 0 N--CA 1.418 -2.066 0 N-CA-C 109.678 -0.49 . . . . 72.25 109.678 -179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.666 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -65.9 -41.64 91.2 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 109.902 -0.407 . . . . 71.33 109.902 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -37.31 82.22 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 120.21 -0.596 . . . . 63.11 112.254 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.279 1.9 p30 -73.57 -28.21 61.73 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 119.368 -0.933 . . . . 63.43 110.87 178.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.3 mt -62.61 -46.37 88.59 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 115.431 -0.804 . . . . 71.13 110.076 172.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -58.45 -47.43 84.03 Favored 'General case' 0 C--O 1.189 -2.124 0 N-CA-C 112.957 0.725 . . . . 72.44 112.957 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.59 -47.37 73.43 Favored 'General case' 0 C--O 1.27 2.136 0 CA-C-O 120.957 0.408 . . . . 75.41 111.054 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -64.04 -43.04 96.77 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.147 -0.933 . . . . 74.53 110.825 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -82.65 -25.6 32.94 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 116.081 1.882 . . . . 71.33 116.081 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.5 m -69.89 -28.07 65.32 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-O 120.761 0.315 . . . . 61.4 110.932 -176.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.1 m -59.34 -26.53 65.11 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 120.412 -0.515 . . . . 75.41 110.886 173.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 79.0 m -105.99 9.24 32.63 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.013 0.746 . . . . 71.5 113.013 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' A' ' 90' ' ' SER . . . 163.46 176.5 35.49 Favored Glycine 0 CA--C 1.502 -0.74 0 C-N-CA 118.176 -1.964 . . . . 71.35 115.484 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.5 m -100.66 116.47 32.64 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.107 -0.546 . . . . 75.21 110.109 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.4 mt -83.78 128.29 38.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 115.352 -0.84 . . . . 24.25 112.862 -176.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.536 HD21 ' HA ' ' A' ' 86' ' ' ALA . 89.2 m-20 -87.25 -45.55 10.52 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 115.424 -0.807 . . . . 74.03 109.621 175.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.519 ' HD3' ' OE1' ' A' ' 84' ' ' GLU . 53.8 mtp180 -159.27 165.96 32.35 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.242 -1.392 . . . . 75.15 107.242 -173.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.666 HD11 ' HB1' ' A' ' 50' ' ' ALA . 22.4 pt -146.19 141.94 21.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.193 -1.04 . . . . 75.03 108.193 174.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.6 m -125.32 125.41 43.45 Favored 'General case' 0 C--N 1.269 -2.933 0 N-CA-C 107.217 -1.401 . . . . 62.15 107.217 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.9 mp -120.46 115.88 48.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 105.541 -2.022 . . . . 74.24 105.541 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.574 HD12 ' NH2' ' B' ' 65' ' ' ARG . 1.0 OUTLIER -121.09 128.87 53.0 Favored 'General case' 0 C--N 1.283 -2.292 0 C-N-CA 120.348 -0.541 . . . . 53.32 112.096 -178.477 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 66.1 m -117.37 133.6 55.79 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.805 -0.634 . . . . 64.43 109.795 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -118.41 144.48 45.9 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 120.343 -0.543 . . . . 64.51 110.743 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -111.64 12.04 21.17 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.25 0.548 . . . . 64.32 111.208 174.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.614 ' CE2' ' HB3' ' B' ' 64' ' ' ASN . 30.5 m-85 -66.75 -20.73 66.02 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.633 -0.712 . . . . 75.31 111.275 175.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.6 t -86.13 3.87 40.84 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.71 -0.677 . . . . 65.13 109.658 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.1 -44.26 3.29 Favored Glycine 0 CA--C 1.502 -0.776 0 N-CA-C 110.149 -1.181 . . . . 63.35 110.149 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -96.81 147.16 32.51 Favored Pre-proline 0 C--N 1.292 -1.909 0 N-CA-C 105.915 -1.883 . . . . 73.44 105.915 177.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -75.44 116.57 4.54 Favored 'Trans proline' 0 N--CA 1.432 -2.125 0 N-CA-C 108.792 -1.272 . . . . 64.4 108.792 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 24.7 mtmm -108.05 156.93 18.71 Favored 'General case' 0 CA--C 1.461 -2.449 0 N-CA-C 107.73 -1.211 . . . . 73.33 107.73 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 44' ' ' VAL . . . -136.34 145.25 17.16 Favored Glycine 1 N--CA 1.395 -4.035 0 C-N-CA 119.167 -1.492 . . . . 61.21 112.226 176.724 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -146.2 143.55 29.32 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 108.31 -0.996 . . . . 74.31 108.31 174.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.09 144.37 51.31 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-O 120.777 0.322 . . . . 63.44 110.577 -173.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.741 ' CD1' ' HD2' ' A' ' 112' ' ' LYS . 68.7 m-85 -115.83 115.54 26.43 Favored 'General case' 0 N--CA 1.409 -2.482 0 CA-C-N 115.908 -0.587 . . . . 74.41 109.599 177.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.448 HG23 HG22 ' A' ' 66' ' ' ILE . 33.0 mm -99.85 119.51 48.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 107.632 -1.248 . . . . 73.14 107.632 -177.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.574 ' HG2' ' HB3' ' A' ' 38' ' ' SER . 43.5 mt-10 -96.18 119.96 35.61 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.793 -0.363 . . . . 75.03 110.583 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -99.66 153.14 19.32 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.09 0.472 . . . . 53.44 110.136 177.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.536 ' HA ' HD21 ' A' ' 64' ' ' ASN . . . -64.13 -37.18 86.53 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.667 -0.697 . . . . 70.11 111.515 177.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -116.94 145.38 43.65 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.502 -0.772 . . . . 63.14 112.905 -176.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.544 ' O ' HG22 ' A' ' 91' ' ' VAL . 17.5 mmm180 -62.34 -33.16 74.18 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.381 -0.827 . . . . 75.44 109.549 171.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -62.81 -32.41 73.6 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.217 -0.901 . . . . 72.41 110.449 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.467 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . 47.3 m -67.75 -36.86 81.31 Favored 'General case' 0 N--CA 1.426 -1.67 0 O-C-N 122.383 -0.198 . . . . 61.33 110.546 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 88' ' ' ARG . 2.9 m -64.92 -39.18 84.81 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.886 0 C-N-CA 119.656 -0.818 . . . . 73.23 109.877 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -60.22 -36.3 77.4 Favored 'General case' 0 CA--C 1.502 -0.902 0 O-C-N 123.361 0.413 . . . . 75.51 111.935 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.73 -36.67 65.21 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.055 0.455 . . . . 54.23 110.298 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.07 -45.32 57.95 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.887 -0.597 . . . . 52.34 111.574 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 91' ' ' VAL . 22.1 m -55.39 -21.58 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 113.101 0.778 . . . . 74.52 113.101 177.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.97 -19.04 65.73 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.293 0.568 . . . . 75.32 110.461 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 56.9 mtm -96.19 9.43 41.0 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.653 -0.703 . . . . 63.1 110.173 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.597 ' HA ' HG12 ' A' ' 109' ' ' VAL . 2.7 p-10 -41.97 -41.71 2.59 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.825 0.676 . . . . 73.33 112.825 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -102.22 101.49 11.79 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 119.668 -0.813 . . . . 63.55 109.539 170.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.7 p -140.61 148.27 40.65 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.276 -0.874 . . . . 61.34 110.309 174.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.1 p -113.57 93.14 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 CA-C-O 122.764 1.269 . . . . 62.31 108.981 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -112.36 128.81 56.4 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 114.058 -1.428 . . . . 74.42 107.553 -173.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 61.1 33.18 19.59 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.27 1.028 . . . . 71.53 109.566 -175.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.59 -2.4 63.32 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 114.768 -1.105 . . . . 75.15 114.5 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.471 ' HD3' ' O ' ' A' ' 43' ' ' ASN . 5.5 ptp180 -113.0 141.14 47.18 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 122.058 -0.672 . . . . 73.31 109.523 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.0 m -83.68 119.72 25.12 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 108.322 -0.992 . . . . 74.34 108.322 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 33.3 pt -101.7 172.16 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 109.619 -0.512 . . . . 75.55 109.619 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 55.3 tptt -132.89 132.32 41.93 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.644 -0.873 . . . . 62.22 108.644 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.673 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 5.0 p -128.18 123.17 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 O-C-N 123.355 0.41 . . . . 71.41 110.498 175.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . 0.289 0.0 OUTLIER -141.95 146.79 42.05 Favored Pre-proline 0 N--CA 1.431 -1.383 0 N-CA-C 108.99 -0.744 . . . . 74.3 108.99 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.46 ' HD3' HG11 ' A' ' 95' ' ' VAL . 37.2 Cg_endo -68.95 131.01 21.43 Favored 'Trans proline' 0 C--O 1.244 0.818 0 C-N-CA 122.099 1.866 . . . . 72.24 114.017 -171.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.741 ' HD2' ' CD1' ' A' ' 82' ' ' TYR . 48.3 mtpt -76.15 152.89 36.58 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.484 -1.235 . . . . 75.53 112.735 -177.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -167.96 160.86 12.49 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 115.584 -0.735 . . . . 71.34 112.348 173.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 114' ' ' THR . 25.3 m 68.76 18.48 8.65 Favored 'General case' 0 CA--C 1.568 1.638 0 C-N-CA 125.096 1.358 . . . . 70.14 114.514 169.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.411 ' HB3' ' OD1' ' A' ' 35' ' ' ASP . 48.0 t30 -97.95 122.58 41.24 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.571 -1.331 . . . . 75.43 108.607 173.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 27.1 ttt -122.95 95.37 46.3 Favored Pre-proline 0 C--N 1.29 -1.982 0 N-CA-C 109.027 -0.731 . . . . 75.23 109.027 177.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.647 ' HG2' ' CD1' ' A' ' 18' ' ' TYR . 50.8 Cg_exo -58.79 111.42 0.88 Allowed 'Trans proline' 0 C--O 1.247 0.939 0 C-N-CA 122.722 2.282 . . . . 55.35 111.677 178.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.41 -20.52 0.02 OUTLIER Glycine 0 N--CA 1.432 -1.615 0 CA-C-N 114.769 -1.105 . . . . 75.34 110.91 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 mp 74.55 -11.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.385 0 C-N-CA 123.254 0.622 . . . . 74.53 112.311 175.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 47.3 m 57.57 69.25 0.76 Allowed 'General case' 0 C--O 1.245 0.822 0 CA-C-O 122.283 1.04 . . . . 60.22 108.284 -171.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 50.1 m -93.26 103.36 15.62 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 114.668 -1.151 . . . . 74.15 113.503 -171.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.7 m -92.2 -16.72 25.85 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 105.588 -2.004 . . . . 74.45 105.588 169.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -59.67 128.52 37.37 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 112.335 -2.211 . . . . 75.1 112.677 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 . . . . . 0 C--O 1.248 1.019 0 N-CA-C 109.485 -0.561 . . . . 64.13 109.485 175.403 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.698 0 N-CA-C 109.775 -0.454 . . . . 52.13 109.775 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 32.3 pt -94.03 120.55 43.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 121.305 0.574 . . . . 74.22 111.45 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.79 142.45 10.05 Favored Pre-proline 0 C--N 1.308 -1.229 0 N-CA-C 109.068 -0.715 . . . . 73.14 109.068 178.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -82.08 11.56 3.1 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.604 2.203 . . . . 73.25 112.261 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 52.4 t -95.35 100.44 12.22 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.363 0.602 . . . . 74.02 112.28 -177.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -132.43 101.38 5.32 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 105.293 -2.114 . . . . 64.12 105.293 172.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -137.65 100.88 4.32 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.654 -0.418 . . . . 63.34 111.148 -175.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 55.8 m -125.16 81.41 1.96 Allowed 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.966 -1.124 . . . . 64.24 107.966 174.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 12.9 p -87.63 92.1 8.98 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 114.211 1.189 . . . . 71.32 114.211 -173.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 17.8 p80 175.96 151.49 0.14 Allowed 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 125.877 1.671 . . . . 75.4 107.257 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 20.3 p -72.2 148.15 45.84 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.03 0.443 . . . . 65.32 111.287 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -107.5 170.12 8.17 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.952 -0.567 . . . . 72.2 110.177 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -79.15 79.03 5.6 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.616 0.722 . . . . 73.34 112.281 -176.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 86.0 m -157.7 100.86 1.79 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.141 -0.936 . . . . 73.2 108.495 176.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.5 148.08 9.2 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 108.43 -0.952 . . . . 71.03 108.43 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.456 ' HA3' ' HB2' ' B' ' 24' ' ' GLN . . . -143.63 -158.9 7.75 Favored Glycine 0 N--CA 1.415 -2.704 0 N-CA-C 111.058 -0.817 . . . . 74.2 111.058 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.97 68.45 10.02 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 113.035 0.754 . . . . 31.52 113.035 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . 0.251 94.3 m-85 74.19 -161.24 0.08 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 114.442 1.275 . . . . 74.3 114.442 173.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 5.2 t -92.7 170.57 9.61 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 113.803 1.038 . . . . 62.13 113.803 -165.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . 0.293 31.1 tt0 48.03 140.69 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 129.662 3.185 . . . . 74.3 117.96 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.14 -145.96 30.13 Favored Glycine 0 CA--C 1.501 -0.798 0 CA-C-N 113.874 -1.512 . . . . 50.53 114.056 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -50.52 -44.3 40.56 Favored 'Trans proline' 0 CA--C 1.553 1.444 0 C-N-CA 124.326 3.351 . . . . 74.41 115.339 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -46.47 133.03 16.24 Favored 'Trans proline' 0 C--N 1.396 3.029 0 C-N-CA 122.301 2.001 . . . . 72.53 112.94 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.456 ' HB2' ' HA3' ' B' ' 16' ' ' GLY . 16.0 mm100 -65.87 140.4 97.21 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 115.835 -0.62 . . . . 63.3 110.957 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.16 119.46 6.53 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 122.746 2.297 . . . . 74.11 113.283 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.69 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -79.91 176.0 10.12 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.034 -0.985 . . . . 62.11 110.394 177.462 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.583 ' HB3' ' OE1' ' B' ' 30' ' ' GLU . 41.2 t -67.71 144.54 55.4 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.927 0.714 . . . . 54.35 112.927 -173.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.99 -35.53 34.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.371 -1.286 . . . . 71.14 111.349 173.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -65.43 -45.33 84.28 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 116.392 -0.367 . . . . 60.23 110.923 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.583 ' OE1' ' HB3' ' B' ' 27' ' ' SER . 2.8 mp0 -64.19 -38.68 91.91 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 120.776 -0.37 . . . . 72.43 110.974 176.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.1 -41.95 98.73 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.493 0.663 . . . . 75.14 109.294 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.532 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 0.0 OUTLIER -72.27 -38.0 68.93 Favored 'General case' 0 N--CA 1.384 -3.739 0 CA-C-N 115.225 -0.898 . . . . 72.04 112.59 -178.438 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -71.24 -41.36 70.21 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.311 0.486 . . . . 73.11 112.311 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.432 HG12 ' O ' ' B' ' 30' ' ' GLU . 15.7 pt -70.01 -35.42 64.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.367 -0.379 . . . . 74.42 110.983 -177.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.65 ' OD2' ' HB2' ' B' ' 113' ' ' ARG . 12.5 t70 -69.38 -27.37 65.25 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.686 -0.688 . . . . 75.0 109.378 -177.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 99.3 mttt -71.18 -34.26 70.76 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.631 -0.713 . . . . 51.01 111.133 176.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -99.77 19.65 15.6 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.051 0.929 . . . . 73.23 110.33 -175.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 68.6 m -96.55 158.33 15.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.192 -1.367 . . . . 75.31 108.554 173.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' B' ' 82' ' ' TYR . 28.2 m -131.74 157.64 43.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.458 -0.571 . . . . 74.3 109.458 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 40' ' ' TYR . . . . . 0.649 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 40.7 t80 -103.93 119.07 38.16 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.041 -1.096 . . . . 71.05 108.041 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 58.5 t -112.02 109.79 29.84 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 107.414 -1.328 . . . . 74.3 107.414 175.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -113.44 173.96 15.42 Favored Glycine 0 N--CA 1.438 -1.197 0 C-N-CA 120.621 -0.799 . . . . 62.24 112.788 -176.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 7.4 t30 61.01 9.01 2.13 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 126.002 1.721 . . . . 45.03 111.542 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 5.6 p -84.33 90.84 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 106.394 -1.706 . . . . 72.45 106.394 173.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -82.14 84.93 6.88 Favored 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 115.474 1.657 . . . . 53.32 115.474 -165.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 46' ' ' TYR . . . . . 0.565 ' HA ' ' SG ' ' B' ' 70' ' ' CYS . 7.6 t80 70.68 -69.54 0.18 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 113.658 -1.61 . . . . 73.34 113.986 163.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.08 -4.53 22.35 Favored Glycine 0 N--CA 1.468 0.786 0 N-CA-C 116.432 1.333 . . . . 75.5 116.432 -170.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 71.2 m -71.22 130.34 41.18 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 117.989 0.894 . . . . 70.42 110.515 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 36.1 p -79.83 151.71 30.11 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.185 -0.462 . . . . 54.4 111.556 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.63 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -69.29 -41.56 76.66 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.437 0.695 . . . . 72.23 111.573 -175.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -41.8 81.7 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.868 -0.605 . . . . 75.43 111.587 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -69.04 -34.64 75.52 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.837 -0.62 . . . . 64.12 110.994 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 21.3 mt -61.51 -46.45 89.93 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-N 115.485 -0.779 . . . . 74.25 111.638 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -58.64 -47.05 85.72 Favored 'General case' 0 C--O 1.194 -1.827 0 N-CA-C 113.501 0.926 . . . . 75.53 113.501 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.64 -47.66 73.22 Favored 'General case' 0 C--O 1.268 2.029 0 CA-C-N 118.041 0.382 . . . . 70.1 111.185 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -64.26 -42.14 96.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.373 -0.831 . . . . 70.41 111.007 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -82.8 -25.63 32.53 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 115.903 1.816 . . . . 53.14 115.903 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 69.5 m -69.78 -25.0 63.59 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 120.651 0.262 . . . . 71.51 110.673 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 21.4 m -58.44 -27.25 64.18 Favored 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 120.432 -0.507 . . . . 72.12 110.764 172.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 68.2 m -99.94 7.36 44.88 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.741 1.015 . . . . 70.42 113.741 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.41 -167.96 32.54 Favored Glycine 0 CA--C 1.5 -0.856 0 C-N-CA 118.24 -1.933 . . . . 71.51 115.242 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 14.6 m -101.54 120.72 40.75 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 123.127 0.571 . . . . 63.0 110.087 -176.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 64.3 mt -87.52 125.82 41.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.07 0.462 . . . . 53.03 112.178 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 64' ' ' ASN . . . . . 0.614 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 90.5 m-20 -85.65 -46.85 10.37 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.959 0.885 . . . . 75.13 110.084 177.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.574 ' NH2' HD12 ' A' ' 69' ' ' LEU . 49.6 mtp180 -158.7 165.73 33.67 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.613 -1.625 . . . . 65.41 106.613 -172.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.63 HD11 ' HB1' ' B' ' 50' ' ' ALA . 23.2 pt -146.08 142.09 21.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.142 -1.059 . . . . 74.52 108.142 175.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 91.5 m -125.31 125.73 43.96 Favored 'General case' 0 C--N 1.272 -2.784 0 N-CA-C 107.351 -1.351 . . . . 72.11 107.351 -178.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mp -120.4 116.69 50.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 105.162 -2.162 . . . . 74.34 105.162 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.444 HD12 ' NH2' ' A' ' 65' ' ' ARG 0.256 1.0 OUTLIER -121.36 129.86 53.29 Favored 'General case' 0 C--N 1.277 -2.577 0 C-N-CA 120.308 -0.557 . . . . 73.13 112.106 -178.935 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' B' B ' 70' ' ' CYS . . . . . 0.565 ' SG ' ' HA ' ' B' ' 46' ' ' TYR . 63.1 m -118.02 131.7 56.45 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 115.484 -0.78 . . . . 55.42 109.446 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.539 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 4.5 p-10 -113.5 137.83 51.0 Favored 'General case' 0 CA--C 1.492 -1.282 0 C-N-CA 119.681 -0.808 . . . . 72.32 109.696 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -120.16 12.44 11.85 Favored 'General case' 0 N--CA 1.423 -1.81 0 C-N-CA 119.69 -0.804 . . . . 73.52 108.97 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.408 ' CD2' ' HB2' ' B' ' 71' ' ' ASP . 38.3 p90 -69.79 -22.33 63.33 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 108.48 -0.933 . . . . 73.11 108.48 176.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 40.3 m -75.71 4.27 8.15 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 114.809 -1.087 . . . . 55.21 110.367 175.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.12 -52.99 4.8 Favored Glycine 0 CA--C 1.496 -1.116 0 N-CA-C 110.5 -1.04 . . . . 65.34 110.5 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -95.38 122.74 58.71 Favored Pre-proline 0 C--N 1.287 -2.148 0 N-CA-C 106.952 -1.499 . . . . 72.0 106.952 174.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 59.4 Cg_endo -68.37 119.79 6.78 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 122.068 1.846 . . . . 55.31 111.903 -175.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 78' ' ' LYS . . . . . 0.445 ' HZ3' ' CG ' ' B' ' 71' ' ' ASP . 27.7 mtmm -106.22 162.92 13.23 Favored 'General case' 0 CA--C 1.476 -1.888 0 N-CA-C 108.285 -1.006 . . . . 74.31 108.285 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -133.97 144.55 16.53 Favored Glycine 0 N--CA 1.407 -3.257 0 C-N-CA 119.498 -1.334 . . . . 64.31 112.14 175.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -148.68 143.28 26.37 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.622 -0.881 . . . . 75.03 108.622 172.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.79 144.55 51.53 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 120.851 0.358 . . . . 44.13 110.734 -172.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 82' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' B' ' 39' ' ' VAL . 72.6 m-85 -115.31 115.65 26.99 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 115.852 -0.613 . . . . 70.5 109.455 176.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.45 HG23 HG22 ' B' ' 66' ' ' ILE . 33.1 mm -100.37 118.52 47.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 107.425 -1.324 . . . . 70.23 107.425 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 84' ' ' GLU . . . . . 0.427 ' OE1' ' HD3' ' B' ' 65' ' ' ARG . 46.5 mt-10 -95.6 119.21 33.7 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.667 -0.413 . . . . 72.35 110.331 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -97.4 153.71 17.93 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.005 0.431 . . . . 65.53 110.855 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.456 ' HA ' HD21 ' B' ' 64' ' ' ASN . . . -61.14 -30.31 70.31 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.492 -0.776 . . . . 73.02 112.046 177.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -131.27 157.82 42.27 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.477 0.656 . . . . 74.21 112.3 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.59 ' O ' HG22 ' B' ' 91' ' ' VAL . 19.8 mmm180 -68.29 -33.36 74.2 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.535 -1.212 . . . . 74.31 109.941 172.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -65.26 -28.6 69.46 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.312 -0.404 . . . . 73.12 111.461 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 39.9 m -68.77 -37.23 79.18 Favored 'General case' 0 N--CA 1.433 -1.298 0 O-C-N 122.273 -0.267 . . . . 45.33 110.36 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.59 HG22 ' O ' ' B' ' 88' ' ' ARG . 3.6 m -65.89 -38.48 82.25 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 N-CA-C 108.894 -0.78 . . . . 72.41 108.894 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -62.76 -35.83 81.1 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.549 0.74 . . . . 73.34 109.424 -177.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.38 -37.8 63.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.762 -0.654 . . . . 65.31 110.858 177.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.0 -45.23 61.72 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.951 -0.568 . . . . 51.32 111.659 -176.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 95' ' ' VAL . . . . . 0.509 HG13 ' O ' ' B' ' 91' ' ' VAL . 25.5 m -54.53 -21.86 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 113.191 0.812 . . . . 52.01 113.191 178.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.97 -12.42 61.64 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.107 0.48 . . . . 63.13 110.862 177.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 60.6 mtm -100.03 9.72 42.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.171 -0.468 . . . . 54.2 110.707 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 98' ' ' ASP . . . . . 0.553 ' HA ' HG12 ' B' ' 109' ' ' VAL . 2.5 p-10 -46.91 -34.5 5.52 Favored 'General case' 0 C--O 1.201 -1.483 0 N-CA-C 115.549 1.685 . . . . 70.32 115.549 -177.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -100.52 29.62 4.34 Favored 'General case' 0 CA--C 1.58 2.104 0 CA-C-N 119.81 1.187 . . . . 74.32 111.941 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 43.4 p -88.95 160.17 17.28 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.259 -0.9 . . . . 73.12 111.815 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 101' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' B' ' 106' ' ' THR . 14.9 p -97.16 139.61 19.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.465 -0.569 . . . . 74.21 109.465 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -138.92 122.84 17.76 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 109.185 -0.672 . . . . 73.21 109.185 -176.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 62.5 ttp85 54.44 32.51 16.8 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 125.279 1.431 . . . . 74.32 111.292 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.81 -7.6 63.1 Favored Glycine 0 C--N 1.305 -1.166 0 CA-C-N 115.035 -0.984 . . . . 41.21 114.741 175.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -132.8 153.58 51.12 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 117.862 0.831 . . . . 74.23 110.218 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 106' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' B' ' 101' ' ' VAL . 56.8 m -77.89 126.46 30.88 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 120.595 0.236 . . . . 52.4 111.015 -174.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 2.4 pp -102.83 172.58 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 120.456 -0.497 . . . . 71.04 111.202 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 108' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 56.7 tptt -129.58 132.71 46.86 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.67 -0.863 . . . . 65.14 108.67 -178.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.649 ' HA ' ' O ' ' B' ' 40' ' ' TYR 0.276 6.2 p -127.4 126.94 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-O 121.638 0.732 . . . . 72.44 110.277 175.333 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.321 0.3 OUTLIER -143.1 137.08 14.51 Favored Pre-proline 0 C--N 1.285 -2.202 0 N-CA-C 105.916 -1.883 . . . . 72.45 105.916 -168.638 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.576 ' HB2' ' OG1' ' B' ' 114' ' ' THR . 58.2 Cg_endo -74.2 136.75 22.65 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 121.775 1.65 . . . . 72.15 112.862 -177.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -92.81 146.45 23.64 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 115.641 -0.709 . . . . 73.43 110.28 -176.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.65 ' HB2' ' OD2' ' B' ' 35' ' ' ASP . 9.2 tpt180 54.82 32.41 17.59 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.371 1.081 . . . . 73.11 110.138 175.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.576 ' OG1' ' HB2' ' B' ' 111' ' ' PRO . 95.5 m -80.08 84.57 5.78 Favored 'General case' 0 N--CA 1.399 -3.0 0 CA-C-O 122.352 1.072 . . . . 71.44 112.9 -175.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -108.47 92.78 4.2 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 103.705 -2.702 . . . . 74.45 103.705 169.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 24.1 ttt -120.28 139.54 28.72 Favored Pre-proline 0 C--N 1.284 -2.279 0 CA-C-N 115.053 -0.976 . . . . 74.31 110.715 -169.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -67.85 99.58 0.56 Allowed 'Trans proline' 0 N--CA 1.445 -1.362 0 N-CA-C 108.117 -1.532 . . . . 72.53 108.117 170.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.65 -176.81 33.9 Favored Glycine 0 N--CA 1.431 -1.68 0 CA-C-N 115.391 -0.822 . . . . 73.34 113.612 -174.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 2.0 mp 70.44 108.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.772 0 C-N-CA 124.174 0.99 . . . . 70.11 110.966 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 39.5 p -62.05 133.99 56.03 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 114.954 -1.021 . . . . 63.42 109.958 178.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 20.3 p -72.05 95.02 1.56 Allowed 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 120.914 0.388 . . . . 71.3 111.159 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 40.8 p -128.82 102.12 6.41 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.315 0.579 . . . . 55.55 110.912 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -111.47 123.82 51.0 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.423 -0.584 . . . . 75.34 109.423 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 . . . . . 0 C--N 1.307 -1.249 0 CA-C-O 118.663 -0.684 . . . . 72.2 110.544 -178.349 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.845 0 N-CA-C 109.67 -0.493 . . . . 75.5 109.67 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.413 ' N ' HD12 ' A' ' 2' ' ' ILE . 2.4 mp -86.05 117.66 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 107.7 -1.222 . . . . 64.14 107.7 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -123.99 135.69 26.62 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 116.21 -0.45 . . . . 70.51 110.128 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.8 103.58 0.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.26 1.974 . . . . 74.25 111.033 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.1 p -155.69 147.42 23.09 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.365 -0.834 . . . . 61.2 109.162 -177.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 27.5 ttt -139.68 104.48 4.92 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.43 -0.582 . . . . 71.22 109.43 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -138.86 101.86 4.41 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.888 0.852 . . . . 74.44 110.485 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.5 m -145.2 83.64 1.68 Allowed 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.785 -0.82 . . . . 70.23 108.785 178.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.6 p -143.43 81.81 1.72 Allowed 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.419 -0.81 . . . . 63.45 112.611 -178.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -138.52 88.03 2.27 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.499 -1.297 . . . . 75.05 107.499 174.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.1 p -139.46 2.62 2.05 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 112.682 0.623 . . . . 60.41 112.682 -176.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.459 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 11.2 mptt -107.13 94.63 5.2 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.37 0.605 . . . . 62.23 109.796 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.486 ' O ' ' HB2' ' B' ' 22' ' ' PRO . 12.2 tpt -126.99 -55.72 1.37 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.161 -1.051 . . . . 61.01 108.161 -177.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.7 m -72.07 131.89 43.47 Favored 'General case' 0 C--O 1.252 1.215 0 N-CA-C 108.803 -0.814 . . . . 72.24 108.803 177.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.585 ' HA ' ' NZ ' ' A' ' 78' ' ' LYS . . . -132.55 -82.97 0.49 Allowed 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 115.601 1.704 . . . . 63.3 115.601 -171.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.89 -155.72 16.08 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.851 -1.166 . . . . 72.41 112.75 -176.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.52 -170.37 1.71 Allowed 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.621 0.724 . . . . 44.51 112.679 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -126.33 122.97 36.95 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 124.28 1.032 . . . . 65.52 108.223 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.8 m -142.55 141.34 32.02 Favored 'General case' 0 CA--C 1.553 1.085 0 O-C-N 123.403 0.439 . . . . 73.43 110.859 -171.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -156.49 -172.25 4.0 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 105.252 -2.129 . . . . 64.42 105.252 175.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.402 ' H ' ' HD2' ' A' ' 23' ' ' PRO . . . -126.65 -99.62 1.11 Allowed Glycine 0 C--N 1.312 -0.771 0 N-CA-C 110.294 -1.123 . . . . 64.03 110.294 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.457 ' HD2' ' OH ' ' B' ' 82' ' ' TYR . 10.3 Cg_endo -53.68 -39.17 84.33 Favored 'Trans proline' 0 CA--C 1.577 2.672 0 C-N-CA 122.793 2.328 . . . . 74.54 116.273 176.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.402 ' HD2' ' H ' ' A' ' 21' ' ' GLY . 84.7 Cg_endo -76.5 138.61 19.72 Favored 'Trans proline' 0 C--N 1.392 2.861 0 CA-C-N 121.64 1.621 . . . . 73.31 113.034 -176.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -135.34 165.69 34.5 Favored Pre-proline 0 C--N 1.297 -1.688 0 N-CA-C 106.816 -1.549 . . . . 72.43 106.816 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -50.26 112.27 0.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.461 2.107 . . . . 73.24 112.373 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.819 HD13 ' H ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -61.72 -160.98 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 126.759 2.023 . . . . 72.31 114.203 178.467 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.533 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 42.7 m -60.5 145.67 47.63 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 121.969 -0.457 . . . . 60.23 111.157 -178.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.722 ' O ' ' HG2' ' A' ' 32' ' ' LYS . . . -54.94 -49.16 72.05 Favored 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 114.688 1.366 . . . . 50.25 114.688 -172.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.531 ' OE2' ' HG3' ' A' ' 32' ' ' LYS . 32.7 mm-40 -73.34 -29.93 63.0 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 113.295 0.85 . . . . 70.52 113.295 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.435 ' CB ' HD23 ' A' ' 26' ' ' LEU . 4.3 mp0 -60.87 -37.63 82.8 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.104 -0.332 . . . . 73.22 110.104 171.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 27' ' ' SER . 94.5 mttt -62.1 -50.86 70.25 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 108.312 -0.995 . . . . 72.31 108.312 179.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.722 ' HG2' ' O ' ' A' ' 28' ' ' ALA . 10.4 mmmm -53.05 -47.04 68.72 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-N 114.677 -1.147 . . . . 72.54 110.114 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -71.09 -45.88 62.89 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.864 -1.062 . . . . 73.45 111.072 -172.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 20.4 pt -71.35 -37.95 67.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 112.386 0.513 . . . . 72.45 112.386 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.506 ' OD2' ' HA ' ' A' ' 114' ' ' THR . 31.8 t70 -65.23 -32.2 73.75 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.931 0.492 . . . . 75.42 111.489 -177.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.691 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 98.2 mttt -56.73 -26.2 56.51 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.461 0.648 . . . . 73.12 111.206 177.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 -115.9 15.79 16.24 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-N 115.871 -0.604 . . . . 73.43 111.258 -172.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.563 ' OG ' ' HE2' ' A' ' 112' ' ' LYS . 10.3 t -95.66 143.95 26.5 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 121.569 0.7 . . . . 74.44 110.168 -177.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.723 HG22 HG23 ' A' ' 91' ' ' VAL . 13.7 t -127.36 148.42 32.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 115.663 -0.698 . . . . 51.52 109.459 -175.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.63 ' CZ ' ' HG3' ' B' ' 22' ' ' PRO . 35.7 t80 -96.32 124.86 40.47 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.907 -1.145 . . . . 62.31 107.907 169.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.1 t -118.51 112.18 37.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.438 -1.319 . . . . 54.54 107.438 174.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.66 164.04 12.65 Favored Glycine 0 C--N 1.289 -2.066 0 C-N-CA 119.637 -1.268 . . . . 75.54 113.836 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.554 HD21 ' HB2' ' A' ' 105' ' ' ARG . 12.3 t30 55.79 32.28 19.22 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.487 1.515 . . . . 71.31 112.905 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.0 p -55.92 132.48 19.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 121.479 0.657 . . . . 64.41 109.564 172.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -69.33 140.96 54.36 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 114.994 -1.003 . . . . 72.32 108.852 -174.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.541 ' CD2' ' HB2' ' A' ' 77' ' ' PRO . 0.7 OUTLIER -74.95 93.82 2.74 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 108.33 -0.989 . . . . 54.33 108.33 -179.52 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.76 -20.73 1.15 Allowed Glycine 0 N--CA 1.414 -2.821 0 N-CA-C 109.037 -1.625 . . . . 74.21 109.037 -174.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.528 ' OG ' ' HD3' ' A' ' 103' ' ' ARG . 73.1 m -91.89 78.52 5.36 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-O 121.951 0.881 . . . . 73.32 109.614 177.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.582 HG21 ' HB ' ' B' ' 49' ' ' THR . 51.5 p -65.39 -178.03 0.47 Allowed 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 114.429 -1.259 . . . . 64.24 113.15 177.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.501 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -51.22 -48.5 62.04 Favored 'General case' 0 C--O 1.202 -1.404 0 CA-C-N 115.12 -0.946 . . . . 61.55 112.152 -173.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -60.45 -38.81 85.36 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.711 0.634 . . . . 75.32 112.711 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -39.89 95.1 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 107.657 -1.238 . . . . 65.42 107.657 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.5 mt -71.97 -43.31 65.35 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 113.934 -1.484 . . . . 74.31 111.43 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 51.0 mt-10 -57.62 -48.93 78.08 Favored 'General case' 0 C--O 1.181 -2.509 0 CA-C-O 119.396 -0.335 . . . . 73.42 110.848 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.93 -48.28 80.37 Favored 'General case' 0 C--O 1.264 1.862 0 CA-C-O 121.341 0.591 . . . . 64.51 111.356 -177.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -66.33 -38.88 88.7 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.324 -0.853 . . . . 74.45 110.95 -176.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -81.37 -22.39 38.4 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 113.793 1.035 . . . . 72.52 113.793 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.8 t -68.74 -25.42 64.73 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.679 -0.86 . . . . 64.34 108.679 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.6 m -62.01 -28.51 69.63 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 116.026 -0.534 . . . . 73.23 110.004 174.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 61.1 m -95.68 0.27 52.43 Favored 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 112.917 0.71 . . . . 54.44 112.917 178.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.37 -159.32 28.07 Favored Glycine 0 C--O 1.22 -0.745 0 C-N-CA 118.865 -1.636 . . . . 62.04 115.424 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.9 m -112.85 127.95 56.32 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 122.523 0.329 . . . . 53.43 110.899 -175.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.466 ' CD1' ' HA ' ' A' ' 54' ' ' GLU . 75.3 mt -89.14 134.15 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 N-CA-C 113.186 0.81 . . . . 74.21 113.186 -177.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -101.54 -44.41 5.6 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.537 1.135 . . . . 54.24 111.869 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.435 ' HD3' ' OE2' ' A' ' 84' ' ' GLU . 26.7 mtp180 -145.15 152.82 40.63 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 108.266 -1.012 . . . . 63.43 108.266 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.1 tt -149.03 132.47 7.64 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-N 115.782 -0.644 . . . . 71.3 109.895 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.3 m -124.73 129.17 49.97 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.136 -1.431 . . . . 53.44 107.136 -176.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 mp -128.18 119.93 52.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 106.384 -1.71 . . . . 73.2 106.384 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.58 ' HG ' ' CE1' ' A' ' 80' ' ' TYR 0.352 1.0 OUTLIER -120.75 130.99 54.26 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 119.672 -0.811 . . . . 74.4 112.13 176.344 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.553 ' HB2' HG23 ' B' ' 66' ' ' ILE . 66.4 m -113.43 118.64 35.09 Favored 'General case' 0 N--CA 1.411 -2.402 0 C-N-CA 124.461 1.105 . . . . 72.43 108.754 -176.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.517 ' HA ' ' HA ' ' B' ' 65' ' ' ARG . 9.5 t0 -116.23 118.23 32.22 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 122.77 0.428 . . . . 73.5 109.968 -176.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 39.0 ttmt -114.65 16.48 17.51 Favored 'General case' 0 C--N 1.274 -2.686 0 C-N-CA 123.646 0.778 . . . . 61.21 110.632 -174.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.4 ' HB3' ' HB3' ' B' ' 64' ' ' ASN . 0.7 OUTLIER -63.07 -23.7 67.57 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 119.481 -0.888 . . . . 73.13 112.773 -176.154 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.0 t -92.39 11.5 25.87 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.396 0.617 . . . . 75.34 110.831 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.18 -52.66 1.62 Allowed Glycine 0 CA--C 1.5 -0.888 0 C-N-CA 120.474 -0.87 . . . . 65.15 111.319 178.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -89.98 126.88 55.84 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 107.748 -1.205 . . . . 61.13 107.748 175.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.541 ' HB2' ' CD2' ' A' ' 46' ' ' TYR . 73.4 Cg_endo -72.58 118.71 5.71 Favored 'Trans proline' 0 N--CA 1.436 -1.878 0 C-N-CA 121.586 1.524 . . . . 72.55 112.225 -176.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.585 ' NZ ' ' HA ' ' A' ' 15' ' ' ALA . 23.7 mtmt -89.78 173.15 8.42 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 114.842 -1.072 . . . . 73.35 109.175 178.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.15 137.52 4.83 Favored Glycine 1 N--CA 1.386 -4.667 0 C-N-CA 120.361 -0.923 . . . . 25.22 111.106 -178.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.58 ' CE1' ' HG ' ' A' ' 69' ' ' LEU 0.263 0.0 OUTLIER -150.49 143.53 24.79 Favored 'General case' 0 C--N 1.273 -2.74 0 CA-C-N 114.906 -0.647 . . . . 74.22 110.032 173.642 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.45 147.56 52.56 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.68 -0.691 . . . . 65.13 109.568 -173.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 80.7 m-85 -122.66 119.15 29.9 Favored 'General case' 0 C--N 1.273 -2.733 0 N-CA-C 108.198 -1.038 . . . . 73.01 108.198 176.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.6 mm -108.93 136.0 46.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 107.775 -1.194 . . . . 70.35 107.775 -175.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.435 ' OE2' ' HD3' ' A' ' 65' ' ' ARG . 41.7 mt-10 -113.82 124.88 53.31 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.098 -0.704 . . . . 74.12 109.098 176.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -97.11 164.25 12.58 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 111.806 0.298 . . . . 74.04 111.806 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.69 -41.98 59.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.234 0.54 . . . . 61.51 110.659 174.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -101.6 144.56 30.19 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.298 0.57 . . . . 54.4 112.134 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.77 -25.4 59.05 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.178 -1.416 . . . . 75.43 107.178 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -72.43 -20.96 61.32 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.266 -0.574 . . . . 72.43 111.085 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 m -71.58 -39.89 70.29 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 122.208 -0.307 . . . . 54.12 110.561 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.723 HG23 HG22 ' A' ' 39' ' ' VAL . 2.8 p -67.52 -39.38 82.32 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 C-N-CA 120.295 -0.562 . . . . 52.42 109.88 178.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -61.84 -32.5 72.83 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.766 -0.652 . . . . 74.43 110.149 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.89 -35.23 64.67 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.209 -0.451 . . . . 60.42 111.255 176.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.29 -38.09 56.62 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 116.216 -0.447 . . . . 73.14 111.239 -175.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 91' ' ' VAL . 14.4 m -56.84 -21.76 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 114.043 1.127 . . . . 73.1 114.043 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.49 -11.57 60.94 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.934 0.873 . . . . 62.13 110.385 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 7.1 ttp -101.25 5.36 42.47 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.855 -1.066 . . . . 70.21 108.546 -176.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 1.3 p-10 -37.7 -42.11 0.54 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.799 1.407 . . . . 72.1 114.799 -177.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -117.42 104.53 11.19 Favored 'General case' 0 N--CA 1.408 -2.539 0 CA-C-O 121.841 0.829 . . . . 72.13 109.777 174.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.5 t -147.49 165.2 31.0 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 114.01 -1.45 . . . . 65.14 108.451 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 106' ' ' THR . 7.1 p -112.7 110.58 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-O 122.244 1.021 . . . . 73.03 109.551 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -107.31 123.58 48.54 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.792 -1.094 . . . . 62.5 109.416 -173.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.528 ' HD3' ' OG ' ' A' ' 48' ' ' SER . 42.8 mtp-105 44.5 31.34 0.59 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.287 1.435 . . . . 75.43 114.632 -176.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 104.23 -4.34 44.5 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 114.984 -1.007 . . . . 74.13 113.342 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.554 ' HB2' HD21 ' A' ' 43' ' ' ASN . 1.3 ptp180 -130.02 139.97 50.94 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 113.182 0.808 . . . . 70.24 113.182 176.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 101' ' ' VAL . 31.9 m -72.05 122.61 21.21 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.439 -0.801 . . . . 60.5 111.088 -177.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 43.6 pt -102.53 170.74 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 120.844 0.354 . . . . 70.01 110.765 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 27.0 mmmt -127.01 122.86 35.67 Favored 'General case' 0 CA--C 1.486 -1.487 0 C-N-CA 124.159 0.984 . . . . 74.53 109.632 176.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 32.9 m -128.31 115.95 40.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-O 121.048 0.451 . . . . 60.43 109.89 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.486 HD23 ' NH1' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -146.15 160.13 43.79 Favored Pre-proline 0 C--N 1.289 -2.064 0 N-CA-C 108.758 -0.83 . . . . 64.02 108.758 -177.186 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.43 139.94 13.23 Favored 'Trans proline' 0 N--CA 1.436 -1.884 0 C-N-CA 121.118 1.212 . . . . 64.21 111.335 -173.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.563 ' HE2' ' OG ' ' A' ' 38' ' ' SER . 33.3 mtmt -77.92 135.91 37.93 Favored 'General case' 0 N--CA 1.406 -2.651 0 N-CA-C 106.533 -1.655 . . . . 65.33 106.533 175.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.486 ' NH1' HD23 ' A' ' 110' ' ' LEU . 10.2 mpt_? -78.45 -64.73 1.1 Allowed 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 113.336 0.865 . . . . 74.13 113.336 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.506 ' HA ' ' OD2' ' A' ' 35' ' ' ASP . 20.4 p -148.85 98.07 2.8 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.863 0.319 . . . . 71.21 111.863 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.597 ' HB2' ' HB ' ' B' ' 19' ' ' THR . 39.1 t30 -157.89 107.3 2.09 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 121.669 0.747 . . . . 73.31 112.418 173.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 23.9 ptp -67.36 125.19 90.75 Favored Pre-proline 0 C--N 1.304 -1.386 0 CA-C-N 114.302 -1.317 . . . . 73.11 111.331 -178.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -94.32 174.95 1.33 Allowed 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.615 2.21 . . . . 70.22 111.942 176.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -102.3 148.2 17.49 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 111.788 -0.525 . . . . 40.15 111.788 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.499 HG22 HD12 ' A' ' 26' ' ' LEU . 10.8 tt -148.71 171.04 2.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 107.844 -1.169 . . . . 75.23 107.844 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.2 m -70.51 99.66 1.66 Allowed 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.573 -0.529 . . . . 64.44 109.573 175.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.5 m -79.52 96.66 6.17 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 115.803 -0.635 . . . . 65.03 110.132 -178.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.7 t -137.97 137.85 38.35 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 109.611 -0.515 . . . . 74.12 109.611 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -172.36 -72.24 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.801 -0.636 . . . . 71.25 109.342 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 . . . . . 0 C--N 1.31 -1.127 0 CA-C-N 115.618 -0.719 . . . . 74.32 109.28 -179.456 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.421 0 CA-C-O 121.563 0.697 . . . . 71.13 109.791 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 22.6 pt -99.73 110.35 26.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 115.115 -0.948 . . . . 55.15 111.41 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' ALA . . . . . 0.508 ' HB1' ' HD2' ' B' ' 4' ' ' PRO . . . -151.36 173.75 4.14 Favored Pre-proline 0 C--N 1.302 -1.472 0 N-CA-C 107.445 -1.317 . . . . 54.11 107.445 -178.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.508 ' HD2' ' HB1' ' B' ' 3' ' ' ALA . 52.9 Cg_exo -26.58 120.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.393 2.885 0 C-N-CA 124.982 3.788 . . . . 75.15 114.337 175.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 12.2 p -57.02 98.33 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 114.775 1.398 . . . . 70.31 114.775 -175.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -169.44 156.33 6.7 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.488 -1.301 . . . . 52.02 107.488 176.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -91.48 148.8 22.04 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.622 -0.431 . . . . 54.34 109.925 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 28.2 p -75.15 85.48 2.38 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 121.613 0.721 . . . . 72.53 111.364 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 5.2 t -144.16 135.92 26.06 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.095 -1.076 . . . . 54.11 108.095 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -89.43 76.63 7.46 Favored 'General case' 0 CA--C 1.494 -1.211 0 CA-C-O 121.713 0.768 . . . . 70.4 109.846 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 22.0 p -146.44 93.86 2.36 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 114.51 -1.223 . . . . 65.01 109.969 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -108.15 -41.51 4.89 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.203 -0.908 . . . . 74.31 109.256 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 27.9 ttt -143.15 82.22 1.74 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.705 -0.68 . . . . 74.24 109.753 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 5.3 t -158.84 95.92 1.32 Allowed 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 114.869 -1.06 . . . . 71.43 109.425 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.07 134.12 35.54 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.754 -0.657 . . . . 52.31 109.682 -178.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.52 -48.17 4.0 Favored Glycine 0 C--N 1.306 -1.093 0 CA-C-N 116.518 -0.31 . . . . 74.03 112.679 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.02 99.76 7.82 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.101 0.477 . . . . 70.24 111.829 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -135.89 -57.11 0.77 Allowed 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 106.55 -1.648 . . . . 74.43 106.55 176.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.597 ' HB ' ' HB2' ' A' ' 115' ' ' ASN 0.524 49.3 m 88.83 66.44 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 118.521 2.785 . . . . 64.01 118.521 169.548 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 20' ' ' GLU . . . . . 0.421 ' H ' ' CD ' ' B' ' 20' ' ' GLU . 0.1 OUTLIER -108.13 -30.72 8.25 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 102.445 -3.168 . . . . 75.2 102.445 163.896 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.417 ' HA3' ' HD2' ' B' ' 22' ' ' PRO . . . 101.16 -100.73 2.14 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 112.483 -2.144 . . . . 35.41 113.162 170.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.63 ' HG3' ' CZ ' ' A' ' 40' ' ' TYR . 6.6 Cg_endo -43.1 -55.55 2.75 Favored 'Trans proline' 0 CA--C 1.6 3.801 0 C-N-CA 124.657 3.571 . . . . 71.32 115.607 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.558 ' HG3' ' HB3' ' A' ' 15' ' ' ALA . 19.8 Cg_endo -91.4 167.5 3.45 Favored 'Trans proline' 0 C--N 1.364 1.358 0 C-N-CA 122.498 2.132 . . . . 72.23 111.729 177.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -124.96 155.52 70.43 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-O 118.991 -0.528 . . . . 74.35 110.372 176.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -27.82 115.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.167 1 C-N-CA 125.967 4.445 . . . . 45.43 116.623 -176.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.692 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -78.12 172.04 14.14 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.302 -1.317 . . . . 63.02 112.174 175.728 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 19.6 m -69.19 147.81 50.78 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 113.798 1.036 . . . . 73.03 113.798 -175.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.716 ' O ' ' HG2' ' B' ' 32' ' ' LYS . . . -53.74 -46.68 70.93 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 114.992 -1.004 . . . . 72.35 110.458 174.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.542 ' HA ' ' CG ' ' B' ' 32' ' ' LYS . 68.5 mm-40 -68.95 -29.41 67.64 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 112.988 0.736 . . . . 72.11 112.988 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.514 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.4 OUTLIER -61.39 -37.61 84.04 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.502 -0.479 . . . . 64.11 110.608 172.116 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -63.12 -50.26 71.15 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 107.651 -1.241 . . . . 73.42 107.651 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.716 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 10.4 mmmm -52.06 -47.05 65.33 Favored 'General case' 0 C--O 1.214 -0.771 0 C-N-CA 124.459 1.103 . . . . 73.13 110.764 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -66.3 -49.87 65.57 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 114.005 1.113 . . . . 74.4 114.005 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.514 HG12 ' O ' ' B' ' 30' ' ' GLU . 28.6 pt -70.52 -36.17 64.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 111.969 0.359 . . . . 63.34 111.969 -174.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.61 ' OD2' ' HD2' ' B' ' 113' ' ' ARG . 7.6 t70 -63.04 -36.37 83.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.809 -0.632 . . . . 64.01 111.449 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.655 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 98.5 mttt -56.69 -25.26 53.59 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.474 0.654 . . . . 74.13 110.795 177.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.574 ' HD3' ' O ' ' B' ' 85' ' ' PHE . 70.1 mtt85 -112.37 14.11 20.35 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 115.515 -0.766 . . . . 74.12 111.857 -172.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 42.4 m -93.89 143.45 26.33 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.474 0.654 . . . . 71.14 110.946 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.655 HG22 HG23 ' B' ' 91' ' ' VAL . 14.7 t -129.85 152.71 37.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.714 -0.847 . . . . 60.54 108.714 -178.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 40' ' ' TYR . . . . . 0.612 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 18.9 t80 -105.33 123.42 47.83 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 107.117 -1.438 . . . . 73.23 107.117 173.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 48.9 t -116.76 111.58 35.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 107.364 -1.347 . . . . 71.32 107.364 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 42' ' ' GLY . . . . . 0.431 ' O ' ' HB ' ' B' ' 107' ' ' ILE . . . -112.9 169.7 13.08 Favored Glycine 0 C--N 1.291 -1.941 0 C-N-CA 119.463 -1.351 . . . . 74.32 114.127 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 64.7 t30 62.98 17.32 9.99 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 126.059 1.743 . . . . 73.23 113.267 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.423 HG22 ' HB2' ' B' ' 48' ' ' SER . 11.9 p -62.08 131.59 27.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.264 0.554 . . . . 71.4 109.943 176.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -75.43 156.72 35.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.52 -0.764 . . . . 70.05 109.067 -176.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -68.92 -18.16 64.07 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-O 121.808 0.813 . . . . 72.13 109.839 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.18 -12.73 80.37 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 115.559 -0.746 . . . . 32.12 111.808 178.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.423 ' HB2' HG22 ' B' ' 44' ' ' VAL . 25.1 m -87.23 133.07 33.71 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 108.45 -0.945 . . . . 71.44 108.45 178.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 49' ' ' THR . . . . . 0.582 ' HB ' HG21 ' A' ' 49' ' ' THR . 63.2 p -111.9 178.87 4.18 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 116.178 -0.464 . . . . 74.11 111.565 -172.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.439 ' O ' ' HG3' ' B' ' 54' ' ' GLU . . . -63.11 -48.12 79.9 Favored 'General case' 0 C--O 1.2 -1.549 0 N-CA-C 109.954 -0.387 . . . . 71.03 109.954 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -59.12 -39.59 82.77 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 111.946 0.35 . . . . 75.32 111.946 176.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.526 ' HB2' ' H ' ' B' ' 49' ' ' THR . 0.8 OUTLIER -55.94 -46.28 78.58 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.818 0.818 . . . . 74.04 109.765 173.715 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 99.2 mt -68.35 -43.88 76.51 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.369 -1.287 . . . . 72.3 112.149 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.46 ' HA ' ' CD1' ' B' ' 63' ' ' ILE . 48.3 mt-10 -57.97 -50.11 74.51 Favored 'General case' 0 C--O 1.183 -2.432 0 C-N-CA 120.645 -0.422 . . . . 75.03 111.061 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.44 -48.1 77.73 Favored 'General case' 0 C--O 1.25 1.081 0 O-C-N 123.554 0.534 . . . . 62.22 111.643 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -67.3 -37.66 83.72 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.486 -0.779 . . . . 72.11 110.868 -175.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -82.58 -22.88 34.68 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.647 0.98 . . . . 75.03 113.647 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 38.9 t -67.78 -27.96 67.19 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.891 -0.781 . . . . 23.53 108.891 -177.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 21.8 m -60.06 -25.4 65.34 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 115.806 -0.633 . . . . 74.02 110.673 174.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 77.1 m -102.1 2.97 38.14 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.092 0.775 . . . . 52.4 113.092 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.66 -167.6 29.82 Favored Glycine 0 N--CA 1.461 0.321 0 C-N-CA 119.058 -1.544 . . . . 72.31 114.977 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 19.4 t -105.86 127.92 53.43 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-O 120.857 0.36 . . . . 40.45 110.548 -176.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.46 ' CD1' ' HA ' ' B' ' 54' ' ' GLU . 74.2 mt -87.04 133.51 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 113.519 0.933 . . . . 74.1 113.519 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 64' ' ' ASN . . . . . 0.419 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 94.2 m-20 -103.88 -35.94 7.98 Favored 'General case' 0 C--O 1.172 -3.022 0 CA-C-N 115.823 -0.626 . . . . 71.3 111.757 174.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 43.3 mtp180 -149.02 152.29 36.01 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.622 -0.881 . . . . 72.2 108.622 178.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.553 HG23 ' HB2' ' A' ' 70' ' ' CYS . 0.3 OUTLIER -149.51 131.39 5.65 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.698 0 C-N-CA 124.024 0.93 . . . . 72.13 109.886 177.231 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 67' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' B' ' 81' ' ' ALA . 74.1 m -124.79 128.68 49.11 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 106.964 -1.495 . . . . 75.21 106.964 -176.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.16 121.76 60.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 106.098 -1.816 . . . . 64.12 106.098 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.389 1.2 pt? -120.7 132.35 55.03 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 119.311 -0.956 . . . . 73.0 112.64 175.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 70' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 63.7 m -114.43 118.19 33.13 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 107.527 -1.286 . . . . 70.12 107.527 -178.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 8.8 t70 -110.75 115.33 29.37 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 118.788 -1.165 . . . . 64.42 109.276 -176.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -112.63 3.74 16.82 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.191 -1.411 . . . . 64.44 107.191 -178.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -56.96 -21.72 32.47 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 126.551 1.94 . . . . 72.24 113.755 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 43.4 m -109.84 13.81 23.42 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.014 0.435 . . . . 74.23 111.005 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.27 -64.85 0.29 Allowed Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.779 -0.724 . . . . 71.3 112.128 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -96.4 129.63 32.89 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 109.83 -0.433 . . . . 70.02 109.83 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 84.1 Cg_endo -75.4 118.58 5.22 Favored 'Trans proline' 0 N--CA 1.435 -1.957 0 C-N-CA 121.39 1.393 . . . . 74.22 112.714 -178.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 78' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 39.6 mtpt -94.16 -179.59 4.99 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 125.278 1.431 . . . . 75.44 109.578 175.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.35 135.58 3.94 Favored Glycine 0 N--CA 1.403 -3.503 0 C-N-CA 119.177 -1.487 . . . . 63.25 113.407 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . 0.266 0.2 OUTLIER -151.23 145.49 25.42 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 114.616 -0.792 . . . . 75.53 109.97 172.307 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' B' ' 67' ' ' THR . . . -130.75 148.2 52.5 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.553 -0.748 . . . . 71.34 110.265 -174.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 82' ' ' TYR . . . . . 0.457 ' OH ' ' HD2' ' A' ' 22' ' ' PRO . 81.6 m-85 -123.16 116.63 23.75 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.816 -0.809 . . . . 63.33 108.816 177.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 11.4 mm -107.47 133.9 50.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 107.791 -1.188 . . . . 73.11 107.791 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 84' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' B' ' 37' ' ' ARG . 53.4 mt-10 -112.2 125.31 54.0 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.171 -1.048 . . . . 75.34 108.171 175.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.574 ' O ' ' HD3' ' B' ' 37' ' ' ARG . 89.4 m-85 -96.54 167.23 11.27 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 112.032 0.382 . . . . 64.4 112.032 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.419 ' HA ' ' ND2' ' B' ' 64' ' ' ASN . . . -81.92 -37.17 27.2 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.923 -0.58 . . . . 75.31 110.811 174.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 87' ' ' GLU . . . . . 0.541 ' HB2' ' OG ' ' B' ' 90' ' ' SER . 6.9 mp0 -98.73 141.84 31.03 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.462 -0.57 . . . . 61.22 109.462 178.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.25 -26.86 59.17 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 106.762 -1.57 . . . . 72.54 106.762 177.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -70.97 -21.79 62.28 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.641 -0.709 . . . . 63.12 111.278 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 90' ' ' SER . . . . . 0.541 ' OG ' ' HB2' ' B' ' 87' ' ' GLU . 51.4 m -71.95 -37.19 70.02 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 111.957 0.354 . . . . 73.42 111.957 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.655 HG23 HG22 ' B' ' 39' ' ' VAL . 2.2 p -67.83 -41.24 84.85 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 C-N-CA 119.407 -0.917 . . . . 61.22 109.489 175.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -59.16 -33.68 71.19 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.994 -0.548 . . . . 72.21 110.502 178.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.53 -34.24 65.12 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.209 -0.45 . . . . 45.13 111.848 176.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.86 -39.55 50.71 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-O 120.701 0.286 . . . . 74.51 111.163 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 95' ' ' VAL . . . . . 0.527 HG13 ' O ' ' B' ' 91' ' ' VAL . 19.9 m -56.25 -21.81 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 113.1 0.778 . . . . 44.0 113.1 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.99 -11.24 60.73 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.567 0.699 . . . . 73.14 110.819 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 19.9 mtm -93.88 -0.49 55.68 Favored 'General case' 0 C--O 1.175 -2.83 0 CA-C-O 117.872 -1.061 . . . . 75.15 110.994 175.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 98' ' ' ASP . . . . . 0.575 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 2.2 p-10 -35.82 -46.27 0.44 Allowed 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 115.372 1.619 . . . . 62.33 115.372 -168.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -93.63 85.33 4.84 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.052 -1.462 . . . . 70.24 107.052 169.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 100' ' ' THR . . . . . 0.627 ' HB ' HG12 ' B' ' 107' ' ' ILE . 1.3 m -95.7 137.72 34.37 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 119.979 -0.688 . . . . 63.53 109.404 -175.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 3.7 p -99.91 103.81 15.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 107.664 -1.236 . . . . 54.14 107.664 173.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -134.08 123.68 24.89 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.79 -1.095 . . . . 72.25 109.48 -173.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 58.29 33.48 23.18 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 122.405 1.098 . . . . 55.34 111.356 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.54 2.4 84.77 Favored Glycine 0 C--N 1.317 -0.475 0 CA-C-N 114.827 -1.079 . . . . 75.22 112.522 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -109.7 163.57 13.36 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 109.551 -0.537 . . . . 75.33 109.551 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 106' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' B' ' 100' ' ' THR . 62.0 m -108.36 118.73 37.54 Favored 'General case' 0 N--CA 1.404 -2.755 0 N-CA-C 106.985 -1.487 . . . . 61.42 106.985 172.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 107' ' ' ILE . . . . . 0.627 HG12 ' HB ' ' B' ' 100' ' ' THR . 46.3 pt -103.45 171.61 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 C-N-CA 119.792 -0.763 . . . . 74.43 109.293 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 108' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 26.7 mmmt -125.2 125.62 43.92 Favored 'General case' 0 CA--C 1.479 -1.782 0 O-C-N 123.652 0.595 . . . . 74.42 110.019 -177.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 33.9 m -128.12 115.78 39.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 123.786 0.679 . . . . 74.22 109.739 176.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.2 158.56 47.74 Favored Pre-proline 0 C--N 1.294 -1.819 0 N-CA-C 108.762 -0.829 . . . . 73.05 108.762 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.23 146.43 25.14 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 121.498 1.465 . . . . 74.15 114.001 -172.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.479 ' NZ ' ' HA ' ' B' ' 112' ' ' LYS . 0.2 OUTLIER -108.15 138.12 44.97 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.19 -1.411 . . . . 55.2 107.19 176.15 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.61 ' HD2' ' OD2' ' B' ' 35' ' ' ASP . 18.7 tpt180 -167.03 133.22 2.24 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.845 -0.342 . . . . 70.22 110.91 -175.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.439 HG23 HD22 ' B' ' 115' ' ' ASN . 10.0 t -156.63 161.52 39.9 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.064 0.946 . . . . 74.14 109.544 175.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 115' ' ' ASN . . . . . 0.439 HD22 HG23 ' B' ' 114' ' ' THR . 43.3 m-80 68.14 111.86 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.424 0 C-N-CA 124.445 1.098 . . . . 74.53 113.406 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 49.4 ttm -152.64 114.37 2.81 Favored Pre-proline 0 N--CA 1.477 0.917 0 O-C-N 121.716 -0.615 . . . . 65.11 111.417 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -91.91 -38.12 0.04 OUTLIER 'Trans proline' 0 CA--C 1.562 1.899 0 C-N-CA 122.405 2.07 . . . . 62.24 113.196 175.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . 94.19 26.06 15.12 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.849 -0.691 . . . . 60.03 112.531 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 2.3 pp -140.64 179.67 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 122.963 0.505 . . . . 75.43 111.059 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 76.0 p 61.06 89.96 0.07 Allowed 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.941 1.296 . . . . 72.32 113.162 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 27.8 p -140.54 155.66 46.54 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.127 -0.942 . . . . 33.13 110.011 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 34.7 p -64.67 117.41 7.4 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 122.52 0.328 . . . . 75.2 110.639 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -66.85 -54.87 18.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.909 0.385 . . . . 75.43 110.319 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 . . . . . 0 C--N 1.307 -1.251 0 N-CA-C 108.838 -0.801 . . . . 52.21 108.838 176.715 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.637 0 N-CA-C 109.757 -0.46 . . . . 64.3 109.757 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.1 pt -110.09 136.26 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 121.605 0.717 . . . . 74.21 112.029 -177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -150.15 153.65 35.53 Favored Pre-proline 0 C--N 1.291 -1.973 0 N-CA-C 106.066 -1.828 . . . . 64.31 106.066 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.472 ' HB2' ' HG2' ' A' ' 7' ' ' GLN . 34.2 Cg_exo -56.55 127.88 27.77 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.61 1.54 . . . . 74.44 109.952 177.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 65.0 m -72.24 116.25 12.45 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.905 -0.589 . . . . 74.5 109.916 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 65.1 mtt 64.58 79.07 0.26 Allowed 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.618 0.767 . . . . 72.01 111.398 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.472 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 49.7 mt-30 -81.43 124.06 29.11 Favored 'General case' 0 CA--C 1.486 -1.514 0 CA-C-N 115.37 -0.832 . . . . 75.13 109.779 178.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.9 p -81.9 95.93 7.5 Favored 'General case' 0 N--CA 1.41 -2.452 0 N-CA-C 108.953 -0.758 . . . . 42.53 108.953 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.444 HG22 ' OD2' ' A' ' 92' ' ' ASP . 40.9 p -105.61 -70.13 0.79 Allowed 'General case' 0 N--CA 1.416 -2.175 0 N-CA-C 108.858 -0.794 . . . . 72.25 108.858 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 57.3 22.83 8.15 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.397 1.079 . . . . 63.43 110.085 177.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.3 t -86.16 79.41 9.12 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-O 121.911 0.862 . . . . 74.44 110.74 -175.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -126.59 83.64 2.19 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.268 -1.382 . . . . 64.33 107.268 174.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 14.9 tpt -159.85 156.69 27.83 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.725 -1.213 . . . . 63.44 107.725 -175.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.0 m -132.97 89.69 2.65 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-O 121.739 0.78 . . . . 72.14 110.14 175.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.54 ' HB3' ' HG2' ' A' ' 112' ' ' LYS . . . -115.03 115.02 26.15 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 115.071 -0.968 . . . . 74.1 108.52 178.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.75 -121.39 0.48 Allowed Glycine 0 N--CA 1.427 -1.937 0 CA-C-N 115.602 -0.726 . . . . 74.33 114.139 -175.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.74 -173.75 3.79 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.321 0.581 . . . . 72.51 112.339 -170.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -133.86 -166.19 1.75 Allowed 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 105.153 -2.166 . . . . 73.42 105.153 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.6 t -137.85 139.05 39.71 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 120.028 1.285 . . . . 62.42 111.026 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.421 ' HG2' ' ND2' ' A' ' 115' ' ' ASN . 17.5 mm-40 -75.4 -177.16 3.44 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 115.028 1.492 . . . . 75.32 115.028 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.0 -113.97 2.9 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 113.587 -1.642 . . . . 65.43 110.85 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.64 -42.84 60.93 Favored 'Trans proline' 0 CA--C 1.575 2.527 0 C-N-CA 123.744 2.963 . . . . 72.21 116.835 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.58 143.39 74.97 Favored 'Trans proline' 0 C--N 1.39 2.715 0 CA-C-N 121.443 1.551 . . . . 42.24 113.594 -178.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -101.42 170.8 6.04 Favored Pre-proline 0 C--N 1.295 -1.77 0 CA-C-N 114.255 -1.339 . . . . 72.22 109.037 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.415 ' C ' HD13 ' A' ' 26' ' ' LEU . 59.5 Cg_exo -57.5 -156.17 0.01 OUTLIER 'Trans proline' 0 CA--C 1.561 1.846 0 C-N-CA 122.577 2.184 . . . . 65.14 113.926 174.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.415 HD13 ' C ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -134.68 -167.53 2.0 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 104.321 -2.474 . . . . 74.43 104.321 -173.338 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.569 ' HB3' ' OE1' ' A' ' 30' ' ' GLU . 20.9 t -73.57 155.12 39.46 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 108.085 -1.08 . . . . 73.42 108.085 173.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.48 -47.55 57.09 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 113.716 1.006 . . . . 74.44 113.716 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -64.86 -39.24 93.24 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.906 0.384 . . . . 63.52 111.472 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.569 ' OE1' ' HB3' ' A' ' 27' ' ' SER . 4.5 mp0 -59.91 -35.27 74.51 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 115.749 -0.66 . . . . 74.31 111.396 177.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -67.6 -50.67 57.09 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.551 0.691 . . . . 74.02 109.367 -178.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 37.0 mtpt -61.48 -38.79 88.56 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 114.687 1.366 . . . . 63.44 114.687 -177.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -69.47 -43.45 73.18 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 111.841 0.312 . . . . 72.42 111.841 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 30' ' ' GLU . 29.4 pt -71.07 -33.91 53.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.01 0.433 . . . . 70.41 111.556 -178.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.85 -34.67 69.97 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.572 1.149 . . . . 73.53 110.372 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 91.6 mttt -77.96 -16.46 58.14 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.591 -1.186 . . . . 71.2 111.035 -177.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.423 ' HG2' ' HA ' ' A' ' 88' ' ' ARG . 89.7 mtt180 -123.89 18.21 9.36 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 114.209 1.189 . . . . 73.01 114.209 -164.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.543 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 33.0 m -96.2 150.72 20.22 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 120.092 -0.643 . . . . 45.2 110.365 176.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 83' ' ' ILE . 33.2 m -140.02 164.11 23.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.125 0.488 . . . . 74.32 110.271 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.72 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 13.3 t80 -110.48 134.86 51.95 Favored 'General case' 0 C--N 1.284 -2.244 0 C-N-CA 124.974 1.31 . . . . 60.21 108.736 177.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.516 HG22 HG12 ' A' ' 109' ' ' VAL . 61.4 t -121.94 118.18 54.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.499 -1.297 . . . . 74.21 107.499 174.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -111.16 166.33 12.26 Favored Glycine 0 C--N 1.286 -2.232 0 C-N-CA 119.276 -1.44 . . . . 73.2 113.688 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.46 ' ND2' ' HB3' ' A' ' 105' ' ' ARG . 66.3 t30 56.3 27.42 11.83 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 126.137 1.775 . . . . 70.14 113.558 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.448 HG22 ' HB2' ' A' ' 48' ' ' SER . 14.6 p -61.55 138.64 21.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 N-CA-C 108.94 -0.763 . . . . 64.2 108.94 173.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.62 150.39 39.65 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.419 -0.586 . . . . 75.5 109.419 -173.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.494 ' CD1' ' HB2' ' A' ' 77' ' ' PRO . 78.3 t80 -65.36 -14.2 60.3 Favored 'General case' 0 CA--C 1.558 1.285 0 CA-C-O 121.586 0.708 . . . . 63.24 110.232 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.53 -7.39 59.15 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 116.003 -0.544 . . . . 73.12 112.921 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.448 ' HB2' HG22 ' A' ' 44' ' ' VAL . 26.4 m -80.03 133.97 36.18 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 117.424 0.612 . . . . 75.44 110.087 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.0 p -97.62 170.71 8.83 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 120.944 -0.303 . . . . 73.23 111.069 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.526 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -62.28 -45.22 94.23 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.594 -0.521 . . . . 75.21 109.594 175.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.82 -44.9 86.72 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.084 0.554 . . . . 41.31 109.885 176.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -55.91 -43.69 77.54 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.119 0.485 . . . . 54.32 111.55 176.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.3 mt -70.86 -47.55 58.71 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.522 -0.763 . . . . 74.11 111.71 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.35 -48.0 83.31 Favored 'General case' 0 C--O 1.204 -1.326 0 C-N-CA 123.424 0.69 . . . . 63.55 110.85 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.35 -42.57 96.01 Favored 'General case' 0 C--O 1.259 1.601 0 CA-C-O 121.523 0.678 . . . . 54.24 111.151 176.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -64.26 -41.89 96.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.41 -0.813 . . . . 61.35 110.428 -175.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -81.21 -20.51 40.95 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 113.289 0.848 . . . . 70.42 113.289 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.0 t -65.85 -26.63 67.74 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.712 -0.676 . . . . 71.34 109.481 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.4 m -60.19 -33.73 72.63 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-O 121.362 0.601 . . . . 75.32 110.023 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.427 ' SG ' ' SD ' ' A' ' 97' ' ' MET . 72.6 m -92.97 4.32 54.19 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 113.699 1.0 . . . . 70.14 113.699 -177.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.44 -169.92 33.39 Favored Glycine 0 CA--C 1.497 -1.053 0 C-N-CA 118.627 -1.749 . . . . 74.1 114.623 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.9 m -102.64 127.63 49.67 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.295 -0.631 . . . . 74.0 109.295 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.6 mt -95.6 130.05 44.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 113.788 1.033 . . . . 74.01 113.788 -175.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -91.53 -44.76 8.89 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-N 115.355 -0.839 . . . . 74.21 110.908 176.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.409 ' HD2' ' OE1' ' A' ' 84' ' ' GLU . 66.2 mtt180 -151.46 159.51 44.16 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 115.324 -0.853 . . . . 74.53 109.669 -173.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.526 HD11 ' HB1' ' A' ' 50' ' ' ALA . 28.2 pt -148.34 143.52 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 107.766 -1.198 . . . . 61.0 107.766 173.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.3 m -126.2 132.21 51.82 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 106.969 -1.493 . . . . 75.22 106.969 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 68' ' ' ILE . 2.4 mp -127.78 123.34 60.84 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 N-CA-C 106.085 -1.82 . . . . 33.15 106.085 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.46 ' HB3' ' HA ' ' B' ' 67' ' ' THR 0.345 1.0 OUTLIER -121.17 125.39 47.06 Favored 'General case' 0 C--N 1.273 -2.76 0 C-N-CA 120.073 -0.651 . . . . 72.45 112.588 175.861 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.406 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 81.8 m -116.73 128.61 55.49 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.784 -0.821 . . . . 71.11 108.784 -177.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.623 ' HA ' ' HA ' ' B' ' 65' ' ' ARG . 2.8 p-10 -121.35 152.14 39.32 Favored 'General case' 0 C--O 1.19 -2.056 0 C-N-CA 119.647 -0.821 . . . . 70.22 110.554 -177.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -127.06 15.81 7.32 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 108.63 -0.878 . . . . 62.31 108.63 175.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.468 ' HB3' ' HB3' ' B' ' 64' ' ' ASN . 37.7 p90 -66.84 -20.57 65.96 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 119.864 -0.734 . . . . 65.22 111.453 -177.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.6 m -86.82 9.16 19.97 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 116.162 -0.472 . . . . 74.55 110.833 176.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.33 -46.15 3.19 Favored Glycine 0 CA--C 1.501 -0.811 0 N-CA-C 111.084 -0.806 . . . . 52.13 111.084 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -95.5 129.2 35.52 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 106.779 -1.563 . . . . 50.14 106.779 176.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 72.2 Cg_endo -72.61 119.27 6.01 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 121.55 1.5 . . . . 61.45 111.404 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -110.71 -165.61 1.01 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.4 -0.818 . . . . 74.01 109.589 -176.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 70' ' ' CYS . . . -171.18 148.58 11.31 Favored Glycine 0 N--CA 1.407 -3.267 0 C-N-CA 120.367 -0.92 . . . . 72.23 113.166 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -149.61 143.53 25.6 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 124.512 1.125 . . . . 75.24 109.236 172.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.37 156.1 47.25 Favored 'General case' 0 C--O 1.192 -1.959 0 CA-C-O 120.664 0.269 . . . . 64.12 110.927 -172.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.467 ' HE2' ' HZ3' ' A' ' 112' ' ' LYS . 44.3 m-85 -124.24 124.63 42.85 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.482 -0.562 . . . . 62.31 109.482 176.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.48 HG23 HG22 ' A' ' 66' ' ' ILE . 29.1 mm -108.94 124.88 65.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 109.224 -0.658 . . . . 74.04 109.224 -177.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.409 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 32.0 tt0 -102.35 119.57 39.03 Favored 'General case' 0 C--O 1.25 1.112 0 N-CA-C 108.605 -0.887 . . . . 72.33 108.605 177.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -98.1 157.29 16.23 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.431 0.634 . . . . 73.21 112.708 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.19 -43.09 83.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.217 -0.902 . . . . 65.25 112.339 176.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -112.89 155.92 23.85 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 121.222 0.534 . . . . 74.21 111.836 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.494 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -69.91 -35.0 74.23 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.271 -1.011 . . . . 72.34 108.271 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -21.42 66.84 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 115.759 -0.655 . . . . 50.24 112.109 -177.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.9 m -68.21 -36.28 79.29 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 109.82 -0.437 . . . . 42.21 109.82 176.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 95' ' ' VAL . 3.1 m -69.31 -40.03 79.68 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.054 0 N-CA-C 108.97 -0.752 . . . . 74.44 108.97 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.444 ' OD2' HG22 ' A' ' 9' ' ' THR . 3.6 m-20 -56.87 -35.95 69.49 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.765 0.793 . . . . 73.12 110.032 176.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.34 -36.2 63.64 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.62 -0.718 . . . . 63.31 111.472 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.45 -42.49 43.71 Favored 'General case' 0 C--O 1.204 -1.309 0 CA-C-N 115.733 -0.667 . . . . 61.55 111.319 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 91' ' ' VAL . 23.8 m -56.69 -22.45 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 112.756 0.65 . . . . 72.02 112.756 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.34 -9.27 52.61 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.523 0.678 . . . . 35.11 110.469 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.427 ' SD ' ' SG ' ' A' ' 60' ' ' CYS . 37.8 mtp -105.67 4.52 30.22 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.176 -0.92 . . . . 73.53 110.405 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.515 ' HA ' HG22 ' A' ' 109' ' ' VAL . 1.6 p-10 -44.54 -36.89 3.21 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 114.884 1.439 . . . . 72.25 114.884 -176.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -115.33 92.29 3.88 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.341 -0.944 . . . . 72.44 109.537 171.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.9 p -138.45 172.31 13.08 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.263 -1.335 . . . . 45.12 110.649 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.4 p -119.75 126.28 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-O 121.412 0.625 . . . . 74.11 110.527 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -128.16 124.03 35.82 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 108.358 -0.978 . . . . 74.21 108.358 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 49.37 33.15 5.1 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.543 1.537 . . . . 73.45 111.204 -174.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.78 0.74 87.56 Favored Glycine 0 C--N 1.308 -1.016 0 CA-C-N 115.153 -0.93 . . . . 62.51 113.39 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.46 ' HB3' ' ND2' ' A' ' 43' ' ' ASN . 58.3 mtt180 -106.6 140.46 39.44 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.395 -0.594 . . . . 71.23 109.395 175.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.1 m -80.5 119.2 22.86 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.705 -1.22 . . . . 64.42 107.705 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 38.3 pt -101.49 169.46 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 C-N-CA 120.451 -0.5 . . . . 64.1 110.527 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 53.9 tptt -134.99 134.2 40.25 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.462 -0.79 . . . . 73.14 109.67 -177.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.72 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 16.0 m -127.17 126.84 68.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 O-C-N 123.044 0.215 . . . . 74.23 111.055 174.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . 0.255 0.0 OUTLIER -145.83 144.61 22.63 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 109.2 -0.667 . . . . 53.35 109.2 176.92 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -62.82 139.87 76.89 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 123.191 2.594 . . . . 74.24 113.782 -175.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 38' ' ' SER . 39.7 mtpt -145.73 173.96 11.63 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.981 -0.554 . . . . 73.05 111.761 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -99.44 -32.37 11.17 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.783 -1.192 . . . . 65.13 107.783 175.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.1 m 75.41 -69.83 0.16 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.259 -1.337 . . . . 64.55 113.328 171.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.421 ' ND2' ' HG2' ' A' ' 20' ' ' GLU . 7.5 t30 176.49 -30.72 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 112.009 0.374 . . . . 75.34 112.009 -174.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.4 ' HB3' HD21 ' A' ' 26' ' ' LEU . 57.4 mtt 74.13 57.47 0.3 Allowed Pre-proline 0 N--CA 1.484 1.265 0 O-C-N 124.455 1.097 . . . . 73.11 108.26 -172.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.5 ' HB3' HD12 ' B' ' 69' ' ' LEU . 0.2 OUTLIER -19.44 -80.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.384 2.439 1 C-N-CA 126.181 4.587 . . . . 75.33 118.762 -168.519 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 171.3 -177.57 44.12 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 119.042 -1.551 . . . . 74.42 113.052 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.46 HG12 ' N ' ' A' ' 120' ' ' SER . 11.2 tt -173.02 177.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 105.332 -2.099 . . . . 74.31 105.332 -175.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.46 ' N ' HG12 ' A' ' 119' ' ' ILE . 29.5 m -77.13 92.48 3.79 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 105.48 -2.044 . . . . 75.52 105.48 168.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 49.6 m -53.78 130.54 37.21 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 114.314 1.228 . . . . 63.1 114.314 -172.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.7 t -164.3 155.04 15.14 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 105.802 -1.925 . . . . 61.35 105.802 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -148.78 -72.36 0.19 Allowed 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 120.588 -0.445 . . . . 54.34 111.888 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 . . . . . 0 C--N 1.309 -1.19 0 N-CA-C 109.506 -0.553 . . . . 74.02 109.506 -177.709 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.514 0 CA-C-O 121.713 0.768 . . . . 52.13 109.978 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 67.7 mt -83.79 121.39 36.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 115.075 -0.966 . . . . 54.53 109.192 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -161.0 129.09 2.85 Favored Pre-proline 0 C--N 1.316 -0.888 0 N-CA-C 110.158 -0.312 . . . . 62.42 110.158 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.57 104.44 1.81 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.596 2.197 . . . . 71.31 111.592 178.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 50.1 t -80.05 147.46 31.47 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.258 -0.645 . . . . 63.44 109.258 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' MET . . . . . 0.629 ' SD ' ' HB ' ' B' ' 9' ' ' THR . 24.7 ptt? -149.7 135.72 18.79 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.145 -0.687 . . . . 65.24 109.145 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -64.57 -60.05 3.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.576 0.703 . . . . 54.02 109.109 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 8.4 t -149.0 122.47 9.09 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 115.36 -0.836 . . . . 73.23 109.405 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.629 ' HB ' ' SD ' ' B' ' 6' ' ' MET . 62.2 m -150.06 87.96 1.5 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.583 0.706 . . . . 73.15 110.711 176.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -150.16 90.52 1.68 Allowed 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.024 -0.989 . . . . 65.23 108.994 174.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 34.2 t -133.76 152.83 51.98 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 108.096 -1.076 . . . . 75.01 108.096 -176.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -71.07 163.93 26.6 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.282 -1.007 . . . . 75.21 108.282 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 27.9 ttt -69.45 86.65 0.44 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.984 0.897 . . . . 62.21 111.878 -174.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 46.2 m -148.4 -75.57 0.17 Allowed 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.894 -1.048 . . . . 74.23 109.023 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . 67.59 -31.05 0.17 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.562 1.319 . . . . 55.14 114.562 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.43 -93.86 0.16 Allowed Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 110.506 -1.038 . . . . 31.14 110.506 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.02 101.79 12.01 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.318 -0.623 . . . . 73.42 109.318 177.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.454 ' O ' ' HG3' ' B' ' 25' ' ' PRO . 25.7 p90 -137.71 -5.2 1.75 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.033 -0.531 . . . . 65.31 110.098 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.436 HG22 ' NZ ' ' A' ' 112' ' ' LYS . 61.4 m -75.63 82.38 2.63 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 114.571 1.323 . . . . 70.42 114.571 -175.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 20' ' ' GLU . . . . . 0.483 ' OE2' ' HG2' ' B' ' 23' ' ' PRO . 30.8 tt0 -133.85 126.85 31.35 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 102.938 -2.986 . . . . 74.01 102.938 176.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.78 -79.56 1.21 Allowed Glycine 0 CA--C 1.531 1.042 0 N-CA-C 115.695 1.038 . . . . 63.14 115.695 -169.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.576 ' HD3' ' CZ ' ' A' ' 40' ' ' TYR . 1.6 Cg_endo -40.12 -53.79 2.38 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 125.079 3.852 . . . . 74.11 114.505 -177.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.495 ' HD3' ' HG2' ' B' ' 22' ' ' PRO . 22.1 Cg_endo -93.17 122.81 0.48 Allowed 'Trans proline' 0 N--CA 1.416 -3.074 0 N-CA-C 108.442 -1.407 . . . . 64.3 108.442 170.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -69.02 135.8 89.55 Favored Pre-proline 0 C--N 1.313 -1.012 0 C-N-CA 120.145 -0.622 . . . . 72.14 109.884 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.454 ' HG3' ' O ' ' B' ' 18' ' ' TYR . 73.3 Cg_exo -28.73 104.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.385 2.485 1 C-N-CA 125.354 4.036 . . . . 75.13 113.57 -174.587 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.539 HD13 ' H ' ' B' ' 26' ' ' LEU 0.283 0.0 OUTLIER -52.64 153.16 3.28 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 113.333 -1.758 . . . . 64.34 115.079 -176.954 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.513 ' O ' ' HG3' ' B' ' 31' ' ' LYS . 14.8 m -60.46 163.83 4.94 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 125.687 1.595 . . . . 44.34 113.35 -177.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.5 75.74 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.021 -0.536 . . . . 73.44 112.393 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -73.21 -31.07 63.94 Favored 'General case' 0 CA--C 1.49 -1.352 0 CA-C-O 120.974 0.416 . . . . 72.35 111.851 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.405 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.4 OUTLIER -60.4 -33.92 73.18 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.228 -0.896 . . . . 75.43 110.457 173.313 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' B' ' 27' ' ' SER . 95.7 mttt -69.58 -51.56 34.18 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.397 -0.594 . . . . 61.34 109.397 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 0.7 OUTLIER -53.97 -47.32 71.49 Favored 'General case' 0 C--N 1.359 1.014 0 N-CA-C 113.516 0.932 . . . . 70.34 113.516 179.474 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 11.2 mm-40 -64.81 -44.39 90.06 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.471 0.545 . . . . 75.33 112.471 -174.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.405 HG12 ' O ' ' B' ' 30' ' ' GLU . 24.3 pt -70.47 -33.33 53.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.196 0.522 . . . . 73.14 110.793 -178.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -56.92 -38.41 72.83 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.182 1.393 . . . . 50.34 111.311 -177.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 90.0 mttt -75.86 -25.26 56.03 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.639 -1.164 . . . . 72.12 112.327 -176.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' B' ' 33' ' ' GLU . 20.5 ptt180 -118.72 25.69 10.07 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 114.047 1.129 . . . . 73.52 114.047 -168.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 37.1 m -96.69 148.44 22.87 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 116.642 -0.254 . . . . 72.24 111.268 175.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.409 HG22 ' O ' ' B' ' 83' ' ' ILE . 29.3 m -139.97 165.29 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-O 121.09 0.471 . . . . 72.01 111.541 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 40' ' ' TYR . . . . . 0.697 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 9.7 t80 -114.29 132.18 56.26 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 125.68 1.592 . . . . 72.0 108.721 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 59.1 t -119.51 118.4 57.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 124.568 1.147 . . . . 75.11 108.124 174.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.38 172.51 14.33 Favored Glycine 0 C--N 1.293 -1.849 0 C-N-CA 119.339 -1.41 . . . . 72.43 113.387 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 65.7 t30 63.99 8.52 3.99 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 126.211 1.804 . . . . 72.15 114.597 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.64 126.49 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-O 121.577 0.704 . . . . 74.4 109.747 175.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.99 156.72 25.78 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.475 -0.784 . . . . 43.44 111.399 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 46' ' ' TYR . . . . . 0.592 ' CD2' ' HB2' ' B' ' 77' ' ' PRO . 9.4 t80 -75.36 86.3 2.53 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 106.314 -1.735 . . . . 75.05 106.314 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.83 -27.62 0.07 OUTLIER Glycine 0 N--CA 1.419 -2.481 0 N-CA-C 109.728 -1.349 . . . . 65.0 109.728 -174.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 26.6 t -84.44 148.15 26.72 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 106.749 -1.574 . . . . 65.21 106.749 173.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 50.5 p -111.74 178.07 4.44 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 110.242 -0.281 . . . . 71.32 110.242 -177.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.505 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -62.31 -47.74 82.94 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 110.19 -0.3 . . . . 73.33 110.19 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -57.48 -44.02 84.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.208 -0.451 . . . . 72.34 110.534 177.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -60.36 -40.01 89.26 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-O 121.68 0.753 . . . . 63.45 109.789 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 56.0 mt -72.64 -47.31 48.6 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.086 -0.961 . . . . 73.32 112.288 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.54 -48.68 80.7 Favored 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 123.269 0.628 . . . . 72.35 110.727 -178.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.32 -42.77 87.51 Favored 'General case' 0 C--O 1.255 1.347 0 CA-C-O 121.252 0.548 . . . . 62.2 110.925 176.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -64.14 -41.58 97.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.556 -0.747 . . . . 70.12 110.496 -176.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.421 ' CZ ' HG11 ' B' ' 109' ' ' VAL 0.268 51.7 m-85 -81.83 -20.77 38.31 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 113.747 1.017 . . . . 73.21 113.747 178.451 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 33.4 t -66.67 -24.18 66.24 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.537 -0.912 . . . . 72.25 108.537 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 15.6 m -58.94 -31.91 69.12 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 115.934 -0.575 . . . . 61.42 110.155 172.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 74.7 m -93.89 7.33 45.4 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.973 0.731 . . . . 71.4 112.973 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.72 -148.51 20.22 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 118.242 -1.933 . . . . 64.21 115.698 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 62' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' B' ' 86' ' ' ALA . 15.6 m -110.94 124.48 52.2 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.73 -0.47 . . . . 70.34 109.73 -176.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 63.8 mt -94.69 130.55 43.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 113.642 0.978 . . . . 65.02 113.642 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 64' ' ' ASN . . . . . 0.482 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 93.0 m-20 -94.82 -43.55 8.17 Favored 'General case' 0 C--O 1.197 -1.658 0 CA-C-N 115.208 -0.906 . . . . 73.0 110.827 175.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.623 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 67.4 mtt180 -152.45 157.44 41.19 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 109.399 -0.593 . . . . 71.44 109.399 -175.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.523 HG22 HG23 ' B' ' 83' ' ' ILE . 23.2 pt -147.3 142.87 20.11 Favored 'Isoleucine or valine' 0 C--O 1.191 -2.002 0 N-CA-C 106.77 -1.567 . . . . 73.33 106.77 173.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 67' ' ' THR . . . . . 0.46 ' HA ' ' HB3' ' A' ' 69' ' ' LEU . 61.8 m -126.4 131.64 51.69 Favored 'General case' 0 C--N 1.272 -2.769 0 N-CA-C 106.914 -1.513 . . . . 74.02 106.914 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 3.0 mp -127.25 120.54 55.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 106.697 -1.594 . . . . 65.1 106.697 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.5 HD12 ' HB3' ' A' ' 117' ' ' PRO 0.282 1.1 pt? -120.49 127.75 52.5 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 120.065 -0.654 . . . . 50.55 111.62 177.131 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 80.1 m -116.91 130.23 56.57 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.217 -0.902 . . . . 63.21 109.342 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.702 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 4.0 p30 -111.57 127.76 55.83 Favored 'General case' 0 C--O 1.216 -0.682 0 C-N-CA 119.497 -0.881 . . . . 72.35 110.488 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.442 ' O ' ' HG2' ' B' ' 72' ' ' LYS . 33.2 ttmt -123.45 4.4 9.04 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.193 0.52 . . . . 71.23 109.931 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' B' ' 71' ' ' ASP . 53.3 p90 -64.04 -6.97 7.22 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 113.831 1.049 . . . . 70.3 113.831 -174.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 42.8 m -106.56 6.38 29.99 Favored 'General case' 0 C--N 1.313 -1.009 0 O-C-N 121.782 -0.574 . . . . 73.22 111.24 175.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.6 -61.86 0.3 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.835 -0.698 . . . . 70.21 111.745 -178.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -96.26 129.65 33.06 Favored Pre-proline 0 C--N 1.305 -1.337 0 N-CA-C 109.757 -0.46 . . . . 75.13 109.757 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.702 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 96.2 Cg_endo -79.32 126.69 7.03 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.639 2.226 . . . . 63.45 113.561 -177.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -107.35 -167.7 1.3 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.897 -1.149 . . . . 73.03 107.897 176.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.54 147.74 11.7 Favored Glycine 0 N--CA 1.415 -2.758 0 C-N-CA 119.791 -1.195 . . . . 44.25 113.576 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -151.64 144.79 24.62 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 124.502 1.121 . . . . 71.13 108.81 172.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -134.05 155.21 50.42 Favored 'General case' 0 C--O 1.194 -1.863 0 CA-C-O 120.681 0.277 . . . . 63.02 111.199 -172.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 82' ' ' TYR . . . . . 0.425 ' CD2' ' HD3' ' B' ' 112' ' ' LYS . 51.7 m-85 -124.32 124.09 41.63 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.279 -0.637 . . . . 61.34 109.279 176.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.523 HG23 HG22 ' B' ' 66' ' ' ILE . 30.4 mm -107.9 124.79 64.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 109.038 -0.727 . . . . 71.24 109.038 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 84' ' ' GLU . . . . . 0.424 ' HB3' ' HB2' ' B' ' 65' ' ' ARG . 36.6 tt0 -103.57 119.4 38.82 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.739 -1.208 . . . . 72.41 107.739 176.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -94.89 162.73 13.63 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 110.331 -0.248 . . . . 75.31 110.331 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.482 ' HA ' ' ND2' ' B' ' 64' ' ' ASN . . . -83.63 -21.24 32.57 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.101 0.477 . . . . 35.42 111.343 175.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 87' ' ' GLU . . . . . 0.457 ' HB2' ' OG ' ' B' ' 90' ' ' SER . 27.9 mt-10 -119.39 145.23 46.39 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 116.187 -0.46 . . . . 73.41 109.763 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.463 ' O ' HG22 ' B' ' 91' ' ' VAL . 0.5 OUTLIER -72.03 -34.29 68.68 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 107.203 -1.406 . . . . 71.31 107.203 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -59.31 -32.17 69.82 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.719 -1.128 . . . . 75.52 108.996 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 90' ' ' SER . . . . . 0.457 ' OG ' ' HB2' ' B' ' 87' ' ' GLU . 23.3 m -63.46 -35.94 82.11 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.757 -0.656 . . . . 75.41 110.955 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.534 ' O ' HG13 ' B' ' 95' ' ' VAL . 3.1 m -69.35 -39.41 78.87 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.192 0 C-N-CA 119.302 -0.959 . . . . 73.11 108.678 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -57.72 -37.75 74.07 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.082 0.468 . . . . 73.3 110.811 176.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.46 -34.06 65.18 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.936 -0.575 . . . . 71.43 110.437 178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.6 -44.65 33.48 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 116.785 -0.189 . . . . 60.03 111.154 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 95' ' ' VAL . . . . . 0.534 HG13 ' O ' ' B' ' 91' ' ' VAL . 22.0 m -56.65 -22.85 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 112.68 0.622 . . . . 73.43 112.68 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.1 -9.33 45.5 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.349 0.595 . . . . 75.24 110.651 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 56.5 mtm -104.69 10.2 34.83 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.757 -0.656 . . . . 74.15 110.984 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . 0.264 4.1 p-10 -44.46 -44.95 8.88 Favored 'General case' 0 C--O 1.204 -1.298 0 N-CA-C 114.91 1.448 . . . . 72.14 114.91 -176.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -110.84 71.38 0.74 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-N 119.822 1.192 . . . . 74.42 112.146 167.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 47.4 p -115.84 168.43 10.06 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.115 -0.493 . . . . 53.23 111.771 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 9.6 p -100.64 136.42 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-O 121.41 0.624 . . . . 74.24 109.52 -177.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -132.39 109.91 10.18 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 107.961 -1.126 . . . . 61.15 107.961 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 49.53 32.21 4.68 Favored 'General case' 0 CA--C 1.563 1.46 0 C-N-CA 125.4 1.48 . . . . 65.22 112.628 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.22 -9.58 39.2 Favored Glycine 0 C--N 1.318 -0.428 0 C-N-CA 120.674 -0.774 . . . . 23.44 113.741 174.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -116.4 151.85 35.14 Favored 'General case' 0 C--O 1.206 -1.215 0 CA-C-N 117.135 0.467 . . . . 53.34 109.883 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 92.9 m -86.87 120.14 27.84 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.835 -1.172 . . . . 75.12 107.835 174.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 2.6 pp -102.13 166.74 2.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 119.691 -0.804 . . . . 62.44 110.267 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 108' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 54.3 tptt -125.37 132.99 52.7 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.734 -0.469 . . . . 72.51 109.734 -172.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.697 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 15.7 m -127.0 128.79 70.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.277 0.56 . . . . 65.15 111.301 176.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.333 0.4 OUTLIER -147.01 133.43 9.71 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 106.279 -1.749 . . . . 63.31 106.279 -169.802 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.5 141.78 87.81 Favored 'Trans proline' 0 N--CA 1.486 1.038 0 C-N-CA 122.504 2.136 . . . . 62.44 113.068 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.425 ' HD3' ' CD2' ' B' ' 82' ' ' TYR . 22.6 ttpp -120.42 144.87 47.71 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 109.138 -0.69 . . . . 65.44 109.138 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -106.25 162.68 13.45 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 107.227 -1.398 . . . . 72.21 107.227 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 54.3 m -134.33 -41.85 0.79 Allowed 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 112.49 0.552 . . . . 72.45 112.49 -176.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -89.07 134.99 33.8 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 123.592 0.757 . . . . 72.3 110.202 -173.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -144.19 167.96 13.8 Favored Pre-proline 0 C--N 1.304 -1.387 0 N-CA-C 105.952 -1.87 . . . . 74.44 105.952 174.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -48.03 -40.74 33.7 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 122.6 2.2 . . . . 73.13 112.361 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.71 -144.49 29.07 Favored Glycine 0 N--CA 1.436 -1.33 0 CA-C-N 115.94 -0.573 . . . . 65.13 112.054 176.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 55.4 mt 69.29 3.9 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 C-N-CA 124.175 0.99 . . . . 75.15 110.205 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 37.8 m 63.67 96.87 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.233 1.013 . . . . 64.32 111.009 -177.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 4.8 p -70.19 85.91 0.56 Allowed 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 113.913 1.079 . . . . 72.34 113.913 -176.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 24.7 m -126.16 16.07 7.84 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.047 -1.464 . . . . 74.4 107.047 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -118.49 127.47 53.67 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 113.824 -1.534 . . . . 71.13 110.132 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? . . . . . 0 C--N 1.305 -1.356 0 N-CA-C 107.243 -1.392 . . . . 64.34 107.243 178.35 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.932 0 N-CA-C 109.05 -0.722 . . . . 73.42 109.05 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.485 ' O ' HD12 ' A' ' 2' ' ' ILE . 2.5 pp -89.2 137.63 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 110.205 -0.294 . . . . 74.54 110.205 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.26 113.51 11.69 Favored Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 108.048 -1.093 . . . . 75.12 108.048 176.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.77 109.9 1.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.806 2.337 . . . . 71.34 113.295 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 63.1 m -80.51 -56.4 4.2 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 106.332 -1.729 . . . . 43.24 106.332 172.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.408 ' HB3' ' H ' ' A' ' 7' ' ' GLN . 64.9 mtt 50.47 -159.22 0.08 Allowed 'General case' 0 C--N 1.353 0.738 0 CA-C-N 115.144 -0.934 . . . . 74.33 112.391 175.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.408 ' H ' ' HB3' ' A' ' 6' ' ' MET . 77.2 mt-30 76.52 -19.44 0.42 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.403 1.081 . . . . 72.42 112.618 176.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.4 p -76.67 90.58 3.39 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 108.806 -0.813 . . . . 74.25 108.806 174.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.404 ' HA ' ' CB ' ' B' ' 24' ' ' GLN . 10.7 t -115.39 3.11 14.08 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 115.815 -0.63 . . . . 71.34 111.482 -174.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.617 ' HB2' ' O ' ' B' ' 25' ' ' PRO . 38.6 m80 65.16 -68.35 0.11 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.052 1.341 . . . . 65.35 112.341 178.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.4 t -166.11 114.95 0.95 Allowed 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 122.792 0.437 . . . . 70.33 110.804 -177.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -151.02 159.12 44.76 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 110.028 -0.36 . . . . 52.1 110.028 173.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.459 ' H ' ' HB2' ' B' ' 17' ' ' ALA . 25.5 ptt? -160.31 94.64 1.09 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.834 -0.802 . . . . 72.44 108.834 177.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.3 m 62.3 87.28 0.1 Allowed 'General case' 0 C--O 1.246 0.881 0 CA-C-O 121.925 0.869 . . . . 64.0 111.053 -175.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.07 153.06 29.01 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.393 -0.821 . . . . 54.32 111.568 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 177.08 -104.38 0.19 Allowed Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 110.337 -1.105 . . . . 64.53 110.337 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -155.98 146.5 21.82 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.685 -0.487 . . . . 65.15 109.685 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -118.08 -159.95 0.77 Allowed 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.84 -0.8 . . . . 74.01 108.84 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.2 t -80.58 152.13 28.73 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 108.973 -0.751 . . . . 62.5 108.973 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.74 -39.95 6.46 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 116.593 -0.276 . . . . 71.42 110.365 177.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 160.83 -129.81 2.22 Favored Glycine 0 N--CA 1.453 -0.223 0 N-CA-C 110.485 -1.046 . . . . 33.22 110.485 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.66 -38.56 55.91 Favored 'Trans proline' 0 CA--C 1.58 2.817 0 C-N-CA 123.938 3.092 . . . . 71.03 116.247 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -49.94 167.66 0.2 Allowed 'Trans proline' 0 C--N 1.395 2.997 0 C-N-CA 123.054 2.502 . . . . 73.42 114.064 175.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -70.8 138.49 85.52 Favored Pre-proline 0 C--N 1.309 -1.154 0 CA-C-N 115.906 -0.588 . . . . 62.05 112.476 -176.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -79.15 106.16 2.02 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 122.645 2.23 . . . . 73.24 110.647 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.665 HD13 ' H ' ' A' ' 26' ' ' LEU 0.304 0.0 OUTLIER -73.07 153.5 40.81 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 112.498 0.555 . . . . 74.42 112.498 -179.953 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -71.97 160.68 32.1 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.56 -0.745 . . . . 44.23 112.155 -173.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.48 -43.74 35.15 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 114.825 -1.08 . . . . 73.1 112.953 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -67.2 -34.19 76.98 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 119.674 -0.81 . . . . 72.12 113.036 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.514 ' O ' HG12 ' A' ' 34' ' ' ILE . 0.5 OUTLIER -60.04 -34.9 74.03 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 109.854 -0.424 . . . . 64.52 109.854 173.337 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -66.1 -40.18 90.57 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 123.639 0.587 . . . . 73.43 109.708 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.625 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -64.92 -45.81 84.3 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 120.799 -0.361 . . . . 74.2 111.01 175.949 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -71.46 -41.08 69.86 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 113.759 1.022 . . . . 73.21 113.759 -174.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 30' ' ' GLU . 15.4 pt -63.06 -33.69 62.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.641 -0.424 . . . . 74.2 110.511 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.44 -38.45 81.15 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 108.949 -0.76 . . . . 61.22 108.949 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -66.01 -42.0 90.28 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 114.468 1.284 . . . . 55.42 114.468 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.673 ' HG3' ' O ' ' A' ' 85' ' ' PHE . 3.4 ptm180 -102.85 19.18 19.82 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 111.797 0.295 . . . . 75.4 111.797 -169.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.9 p -110.52 167.12 10.45 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.658 0.985 . . . . 34.05 113.658 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.404 ' CG1' HG23 ' A' ' 91' ' ' VAL . 9.7 m -140.3 164.95 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.277 1.031 . . . . 73.44 112.023 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.659 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 27.9 t80 -109.89 127.03 54.47 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 124.882 1.273 . . . . 72.25 108.469 176.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.7 t -115.58 112.01 38.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 107.812 -1.181 . . . . 75.41 107.812 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.427 ' HA3' ' CZ ' ' A' ' 40' ' ' TYR . . . -121.62 -177.34 15.48 Favored Glycine 0 N--CA 1.435 -1.385 0 C-N-CA 119.556 -1.307 . . . . 73.32 114.738 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.3 t30 72.7 -7.35 1.45 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.062 2.145 . . . . 61.33 112.475 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.78 103.55 4.13 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.929 0 CA-C-O 121.488 0.661 . . . . 63.11 109.866 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -81.06 83.57 6.71 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 114.162 1.171 . . . . 72.21 114.162 -168.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.55 ' H ' ' HA3' ' A' ' 79' ' ' GLY . 63.6 t80 68.22 -20.52 0.14 Allowed 'General case' 0 CA--C 1.577 1.989 0 N-CA-C 115.526 1.676 . . . . 73.12 115.526 163.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.27 5.35 45.15 Favored Glycine 0 C--O 1.241 0.577 0 N-CA-C 116.912 1.525 . . . . 51.02 116.912 -169.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.2 t -87.65 147.74 25.12 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 119.318 1.559 . . . . 70.32 109.885 176.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.549 HG22 HG22 ' B' ' 49' ' ' THR . 82.6 p -97.37 158.92 15.22 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.007 -0.542 . . . . 71.33 111.207 -176.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.484 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -65.16 -48.25 74.19 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 122.557 0.343 . . . . 54.31 110.835 -177.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.01 -40.3 80.46 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.333 0.494 . . . . 72.33 112.333 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.9 -38.06 76.18 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.216 0.531 . . . . 72.12 110.515 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.2 mt -68.77 -47.2 66.82 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.381 -0.827 . . . . 64.25 111.209 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -61.92 -48.19 81.54 Favored 'General case' 0 C--O 1.202 -1.433 0 CA-C-N 115.755 -0.657 . . . . 65.14 110.875 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.65 -43.99 80.86 Favored 'General case' 0 C--O 1.26 1.609 0 CA-C-O 121.789 0.804 . . . . 52.44 111.256 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -64.77 -38.51 91.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.667 -1.152 . . . . 74.44 110.355 -176.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -82.33 -21.64 35.94 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.496 0.925 . . . . 64.23 113.496 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.7 t -70.63 -23.88 62.61 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.845 -0.616 . . . . 74.41 109.78 -176.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.8 m -59.97 -27.27 66.69 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-O 121.055 0.455 . . . . 62.55 110.36 173.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 62.7 m -92.66 7.93 41.32 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 112.568 0.581 . . . . 73.02 112.568 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.67 -169.82 25.04 Favored Glycine 0 CA--C 1.505 -0.538 0 C-N-CA 119.559 -1.305 . . . . 74.34 113.28 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.1 m -96.08 126.44 41.32 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 121.614 0.721 . . . . 71.14 110.156 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.5 mt -85.02 134.38 27.16 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.398 0 CA-C-N 114.938 -1.028 . . . . 75.31 112.462 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.462 ' OD1' ' HG3' ' A' ' 65' ' ' ARG . 50.9 t-20 -89.72 -54.24 4.15 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.633 -1.167 . . . . 73.44 108.51 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.462 ' HG3' ' OD1' ' A' ' 64' ' ' ASN . 66.0 mtp180 -154.34 164.17 39.02 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 106.624 -1.621 . . . . 74.24 106.624 -176.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.484 HD11 ' HB1' ' A' ' 50' ' ' ALA . 31.4 pt -143.59 142.59 24.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 107.166 -1.42 . . . . 73.31 107.166 172.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.7 m -124.81 125.14 43.54 Favored 'General case' 0 C--N 1.273 -2.726 0 N-CA-C 107.912 -1.144 . . . . 63.14 107.912 -177.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.0 mp -123.57 116.39 48.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 106.139 -1.8 . . . . 74.22 106.139 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.461 ' HG ' ' CE1' ' A' ' 80' ' ' TYR 0.286 0.8 OUTLIER -121.43 128.79 52.53 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 120.376 -0.53 . . . . 62.44 112.372 179.525 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 74.3 m -117.48 130.61 56.56 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 109.031 -0.729 . . . . 72.45 109.031 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.557 ' HA ' ' HA ' ' B' ' 65' ' ' ARG . 3.1 p30 -118.63 146.49 44.61 Favored 'General case' 0 CA--C 1.484 -1.588 0 C-N-CA 120.024 -0.67 . . . . 73.32 110.691 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -120.1 11.1 11.58 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.681 -0.859 . . . . 74.41 108.681 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.596 ' HB3' ' OD1' ' B' ' 64' ' ' ASN . 10.8 p90 -66.82 -19.95 65.84 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 120.325 -0.55 . . . . 75.44 110.958 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 31.2 t -79.59 -1.21 36.95 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 115.111 -0.95 . . . . 55.01 110.045 178.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.47 -51.39 1.58 Allowed Glycine 0 CA--C 1.491 -1.458 0 N-CA-C 110.093 -1.203 . . . . 73.2 110.093 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -96.08 133.48 25.1 Favored Pre-proline 0 C--N 1.29 -2.004 0 N-CA-C 106.683 -1.599 . . . . 75.52 106.683 175.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.478 ' HB2' ' CD1' ' A' ' 46' ' ' TYR . 63.3 Cg_endo -71.06 118.76 5.86 Favored 'Trans proline' 0 N--CA 1.44 -1.652 0 C-N-CA 121.081 1.188 . . . . 44.42 111.001 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm -101.07 158.35 16.08 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.594 -1.184 . . . . 74.4 109.607 -175.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.55 ' HA3' ' H ' ' A' ' 46' ' ' TYR . . . -136.25 138.69 10.07 Favored Glycine 0 N--CA 1.418 -2.531 0 C-N-CA 120.497 -0.859 . . . . 62.5 112.581 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.461 ' CE1' ' HG ' ' A' ' 69' ' ' LEU . 12.6 p90 -154.79 144.18 21.27 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 123.905 0.882 . . . . 70.35 110.32 174.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.75 150.03 52.21 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 116.026 -0.533 . . . . 74.25 109.658 -172.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.656 ' CD2' ' HD3' ' A' ' 112' ' ' LYS . 90.2 m-85 -126.74 130.85 51.14 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.738 -0.838 . . . . 72.34 108.738 177.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.446 HG23 HG22 ' A' ' 66' ' ' ILE . 34.1 mm -108.78 117.08 53.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 109.301 -0.629 . . . . 63.23 109.301 -177.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -93.17 119.24 32.14 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.716 -0.846 . . . . 65.33 108.716 176.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.673 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 95.6 m-85 -96.02 161.95 13.76 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 112.753 0.649 . . . . 71.21 112.753 -178.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.0 -15.55 60.65 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 115.264 -0.88 . . . . 74.32 111.424 174.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.5 161.33 42.33 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 118.504 -1.279 . . . . 73.14 111.857 177.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -64.21 -34.95 79.27 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 114.338 -1.301 . . . . 74.53 110.843 173.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -61.24 -33.52 73.65 Favored 'General case' 0 CA--C 1.509 -0.61 0 C-N-CA 120.13 -0.628 . . . . 72.11 111.036 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.0 m -69.67 -40.28 76.49 Favored 'General case' 0 N--CA 1.42 -1.952 0 O-C-N 122.299 -0.251 . . . . 73.15 111.213 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.452 HG11 ' HA ' ' A' ' 37' ' ' ARG 0.266 0.2 OUTLIER -65.63 -47.31 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 120.586 -0.446 . . . . 52.11 111.954 176.626 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.13 -32.41 68.12 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.192 0.52 . . . . 63.31 111.727 176.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.08 -36.51 64.29 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.204 0.526 . . . . 52.34 111.884 177.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.68 -43.76 45.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.688 -0.687 . . . . 71.33 111.943 -176.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 91' ' ' VAL . 34.2 m -50.92 -22.42 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 113.025 0.75 . . . . 74.23 113.025 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.24 -11.45 50.18 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.919 0.39 . . . . 63.41 111.438 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 68.5 mtm -99.48 7.41 45.42 Favored 'General case' 0 C--O 1.216 -0.695 0 CA-C-N 116.29 -0.414 . . . . 72.41 110.929 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 3.6 p-10 -42.86 -41.33 3.24 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.707 1.373 . . . . 71.35 114.707 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -111.83 100.34 8.84 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.792 -0.818 . . . . 73.33 108.792 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 106' ' ' THR . 11.2 t -151.08 166.3 31.19 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.899 -0.591 . . . . 74.42 109.451 -177.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.89 118.61 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-O 121.825 0.821 . . . . 61.12 109.647 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -134.28 121.58 21.48 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.002 -0.999 . . . . 74.42 108.762 -177.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 54.0 54.84 9.1 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 114.538 1.31 . . . . 74.32 114.538 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.53 3.16 53.2 Favored Glycine 0 N--CA 1.468 0.829 0 CA-C-N 114.901 -1.045 . . . . 70.54 115.642 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -135.29 157.0 48.01 Favored 'General case' 0 C--N 1.298 -1.63 0 CA-C-N 117.399 0.6 . . . . 75.13 111.349 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 100' ' ' THR . 33.9 m -88.31 120.01 29.27 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.834 -1.543 . . . . 65.44 106.834 175.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 44.8 pt -101.69 171.14 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 119.31 -0.956 . . . . 73.52 110.709 -176.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 55.4 tptt -129.33 125.75 37.4 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.163 -0.68 . . . . 71.01 109.163 -176.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 12.1 p -129.78 121.85 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-O 121.158 0.504 . . . . 62.14 111.61 178.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.89 159.91 42.01 Favored Pre-proline 0 C--N 1.294 -1.827 0 N-CA-C 107.085 -1.45 . . . . 75.22 107.085 -178.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.71 134.12 52.24 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.279 1.986 . . . . 75.42 113.508 -175.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.656 ' HD3' ' CD2' ' A' ' 82' ' ' TYR . 35.5 ttpt -80.94 101.78 9.7 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 105.46 -2.052 . . . . 65.22 105.46 173.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -132.13 123.97 28.2 Favored 'General case' 0 C--N 1.288 -2.076 0 C-N-CA 119.895 -0.722 . . . . 72.5 112.174 -168.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 91.5 m -82.37 106.3 14.14 Favored 'General case' 0 N--CA 1.4 -2.966 0 N-CA-C 105.45 -2.056 . . . . 75.35 105.45 172.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -76.99 104.28 7.4 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.863 0.84 . . . . 71.33 112.063 -172.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 21.2 ptp -140.25 156.01 70.1 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 106.638 -1.615 . . . . 74.15 106.638 177.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -51.16 -46.95 28.17 Favored 'Trans proline' 0 C--O 1.24 0.582 0 C-N-CA 122.869 2.38 . . . . 65.05 112.183 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 169.48 -179.53 41.95 Favored Glycine 0 N--CA 1.425 -2.086 0 N-CA-C 110.106 -1.197 . . . . 62.14 110.106 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.436 HG12 ' HG2' ' A' ' 32' ' ' LYS . 1.9 mp -82.12 82.32 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 108.962 -0.755 . . . . 62.11 108.962 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.8 t -174.47 -36.94 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.095 -1.446 . . . . 73.12 107.095 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 39.4 p -72.92 108.73 6.01 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 106.834 -1.543 . . . . 62.2 106.834 173.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.6 m 67.68 76.31 0.27 Allowed 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.0 -1.481 . . . . 70.41 107.0 -168.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -85.43 107.39 17.38 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-N 115.055 -0.975 . . . . 70.52 110.813 -174.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 . . . . . 0 C--N 1.296 -1.744 0 CA-C-N 115.0 -1.0 . . . . 72.15 108.83 177.191 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.595 0 N-CA-C 109.651 -0.5 . . . . 45.13 109.651 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.464 ' O ' HD12 ' B' ' 2' ' ' ILE . 2.4 pp -123.31 136.8 58.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 112.744 0.646 . . . . 73.44 112.744 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.34 152.09 18.03 Favored Pre-proline 0 C--N 1.293 -1.889 0 N-CA-C 106.28 -1.748 . . . . 31.12 106.28 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -52.56 117.25 3.48 Favored 'Trans proline' 0 C--O 1.246 0.903 0 C-N-CA 122.627 2.218 . . . . 63.01 111.835 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 13.3 p -77.99 -27.03 48.95 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.109 -0.496 . . . . 64.11 110.671 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -81.11 150.16 28.86 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.66 -0.7 . . . . 61.31 110.006 176.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -152.05 134.69 15.43 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 107.644 -1.243 . . . . 74.21 107.644 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 15.0 m -111.4 94.08 4.79 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.267 0.556 . . . . 72.45 110.177 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 23.0 p -137.48 147.64 45.42 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.776 -1.194 . . . . 74.1 107.776 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . 0.262 11.1 p80 -78.04 69.35 4.25 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.582 0.956 . . . . 72.44 113.582 -177.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 71.8 m -178.81 112.22 0.06 Allowed 'General case' 0 C--O 1.24 0.566 0 C-N-CA 128.255 2.622 . . . . 73.14 107.448 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -109.25 16.74 22.21 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.723 -0.843 . . . . 65.33 108.723 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.04 121.71 6.4 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.99 -1.004 . . . . 74.34 110.621 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 29.5 m -82.71 -28.48 30.48 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.874 0.845 . . . . 60.32 108.764 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.46 116.07 7.17 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 114.99 -1.005 . . . . 74.14 108.427 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.425 ' HA2' ' HD3' ' B' ' 31' ' ' LYS . . . -143.96 -80.82 0.05 OUTLIER Glycine 0 N--CA 1.427 -1.926 0 C-N-CA 120.423 -0.894 . . . . 53.32 111.429 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.459 ' HB2' ' H ' ' A' ' 13' ' ' MET . . . -101.61 103.83 14.66 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.257 0.551 . . . . 72.43 110.429 178.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -145.92 127.25 14.89 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.354 -1.35 . . . . 61.14 107.354 177.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 48.5 m -80.58 94.18 6.24 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 120.977 0.418 . . . . 70.04 111.819 -174.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 20' ' ' GLU . . . . . 0.672 ' HB2' ' O ' ' B' ' 23' ' ' PRO . 33.6 mt-10 -69.46 -33.28 72.69 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.923 -0.769 . . . . 51.13 108.923 175.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.31 -95.19 1.34 Allowed Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.749 -0.659 . . . . 71.53 111.787 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.547 ' HG2' ' HD3' ' B' ' 23' ' ' PRO . 2.0 Cg_endo -47.51 -56.91 2.66 Favored 'Trans proline' 0 CA--C 1.582 2.895 0 C-N-CA 122.478 2.119 . . . . 73.33 111.464 171.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.672 ' O ' ' HB2' ' B' ' 20' ' ' GLU . 11.8 Cg_endo -89.52 136.37 2.72 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 121.406 1.404 . . . . 60.31 109.161 169.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.404 ' CB ' ' HA ' ' A' ' 9' ' ' THR . 15.2 mm100 -100.69 139.2 20.4 Favored Pre-proline 0 C--N 1.288 -2.073 0 C-N-CA 119.403 -0.919 . . . . 73.4 109.93 175.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.617 ' O ' ' HB2' ' A' ' 10' ' ' HIS . 39.1 Cg_exo -29.55 124.07 0.06 OUTLIER 'Trans proline' 0 C--N 1.361 1.216 1 C-N-CA 125.674 4.249 . . . . 52.35 114.069 -175.34 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.775 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -56.09 169.34 0.4 Allowed 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.384 -0.826 . . . . 53.22 113.053 178.542 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' B' ' 31' ' ' LYS . 8.4 t -74.57 165.03 25.89 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.38 0.61 . . . . 44.33 111.925 -172.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.401 ' HA ' ' HD2' ' B' ' 31' ' ' LYS . . . -52.15 -46.41 65.43 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 114.685 -1.143 . . . . 62.44 113.873 -175.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -65.02 -39.39 93.31 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 112.001 0.371 . . . . 60.24 112.001 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.482 ' O ' HG12 ' B' ' 34' ' ' ILE . 4.0 mp0 -60.02 -34.82 73.88 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 116.064 -0.516 . . . . 75.11 110.301 174.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' B' ' 27' ' ' SER . 97.5 mttt -65.37 -41.39 93.82 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.521 -0.548 . . . . 75.41 109.521 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.605 ' N ' ' HE2' ' B' ' 32' ' ' LYS . 0.5 OUTLIER -63.46 -46.73 84.89 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 120.796 -0.362 . . . . 62.41 111.138 176.188 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -71.75 -37.86 70.49 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 113.915 1.08 . . . . 74.41 113.915 -174.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.482 HG12 ' O ' ' B' ' 30' ' ' GLU . 17.9 pt -67.3 -34.04 66.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 C-N-CA 120.136 -0.626 . . . . 64.44 110.649 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -68.73 -44.82 73.02 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.892 -1.151 . . . . 62.51 107.892 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.481 ' HG3' ' HB2' ' B' ' 116' ' ' MET . 33.6 ttmt -63.01 -36.16 82.64 Favored 'General case' 0 CA--C 1.558 1.254 0 CA-C-N 114.235 -1.348 . . . . 71.42 111.864 -177.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -102.0 14.05 33.03 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.33 0.863 . . . . 75.43 113.33 -174.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.589 ' OG ' ' HE2' ' B' ' 112' ' ' LYS . 39.1 t -103.03 163.81 11.99 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 113.238 0.829 . . . . 74.22 113.238 -177.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.446 ' CG1' HG23 ' B' ' 91' ' ' VAL . 11.8 m -137.25 163.49 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 124.502 1.121 . . . . 71.4 111.475 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 40' ' ' TYR . . . . . 0.703 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 29.1 t80 -111.6 125.6 54.11 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 125.248 1.419 . . . . 70.34 108.433 177.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 58.1 t -112.78 110.59 32.77 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 106.953 -1.499 . . . . 73.25 106.953 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.95 171.36 13.86 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 119.551 -1.309 . . . . 73.22 113.61 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 65.4 t30 65.79 9.21 5.84 Favored 'General case' 0 C--O 1.213 -0.852 0 C-N-CA 126.321 1.848 . . . . 75.01 111.459 -177.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.14 118.6 6.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.386 -0.968 . . . . 62.1 108.386 174.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -68.38 145.47 54.11 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.328 -0.851 . . . . 74.14 111.405 -173.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 46' ' ' TYR . . . . . 0.415 ' CD1' ' HB2' ' B' ' 77' ' ' PRO . 72.4 t80 -61.45 90.2 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 114.626 -1.17 . . . . 72.15 108.016 177.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.39 -16.77 0.35 Allowed Glycine 0 N--CA 1.426 -2.005 0 CA-C-N 115.334 -0.848 . . . . 61.32 112.521 -175.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 68.0 m -72.29 148.62 45.25 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 118.026 0.913 . . . . 64.31 109.244 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 49' ' ' THR . . . . . 0.549 HG22 HG22 ' A' ' 49' ' ' THR . 59.3 p -99.63 162.5 12.98 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.735 -0.386 . . . . 74.2 111.327 -177.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.485 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -65.1 -45.35 85.53 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 122.712 0.405 . . . . 74.54 109.981 178.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.9 -49.94 74.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.667 -0.697 . . . . 72.4 110.129 178.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -61.31 -40.64 94.93 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 121.038 0.447 . . . . 73.51 110.742 -177.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 45.5 mt -65.44 -47.56 75.75 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.574 -0.739 . . . . 62.12 111.895 177.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.22 -48.6 77.6 Favored 'General case' 0 C--O 1.2 -1.55 0 C-N-CA 122.612 0.365 . . . . 74.03 110.781 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.35 -41.23 75.77 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 120.87 0.367 . . . . 71.3 110.842 178.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -67.96 -37.59 81.75 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.881 -0.6 . . . . 75.43 110.156 -176.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -82.25 -21.97 36.04 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 113.386 0.884 . . . . 63.51 113.386 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 25.7 t -71.92 -24.45 61.64 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.813 -0.63 . . . . 75.44 109.532 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 28.1 m -62.46 -26.29 68.44 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.255 0.55 . . . . 64.21 109.803 172.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 63.5 m -110.08 15.33 22.55 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.242 -0.436 . . . . 72.4 111.383 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 61' ' ' GLY . . . . . 0.412 ' HA3' ' HB3' ' B' ' 90' ' ' SER . . . 172.98 173.77 39.64 Favored Glycine 0 C--O 1.216 -1.026 0 C-N-CA 118.29 -1.909 . . . . 53.11 115.197 -177.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 10.2 p -73.23 -69.39 0.42 Allowed 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.015 0.436 . . . . 60.03 111.718 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . 0.358 57.5 mt 102.71 112.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 C-N-CA 127.302 2.241 . . . . 64.43 111.839 177.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 64' ' ' ASN . . . . . 0.596 ' OD1' ' HB3' ' A' ' 73' ' ' PHE . 32.5 t30 -90.66 -49.9 6.22 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 113.604 -1.634 . . . . 72.35 109.548 -177.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.557 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 65.1 mtp180 -154.58 162.88 40.93 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 106.841 -1.541 . . . . 74.23 106.841 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.486 HG22 HG23 ' B' ' 83' ' ' ILE . 24.4 pt -144.0 142.14 24.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 106.676 -1.601 . . . . 74.43 106.676 172.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 34.2 m -125.17 125.01 43.01 Favored 'General case' 0 C--N 1.27 -2.869 0 N-CA-C 107.86 -1.163 . . . . 74.43 107.86 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.4 mp -122.72 116.18 48.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.18 -1.785 . . . . 70.42 106.18 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.515 ' HG ' ' CE1' ' B' ' 80' ' ' TYR 0.272 0.9 OUTLIER -121.19 128.86 52.87 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-O 121.031 0.444 . . . . 64.45 112.006 179.584 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 75.2 m -117.21 133.6 55.8 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.653 -0.869 . . . . 73.22 108.653 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 4.1 p30 -117.58 134.53 54.77 Favored 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 119.281 -0.968 . . . . 71.24 110.433 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' B' ' 77' ' ' PRO . 41.2 ttmt -124.26 5.94 8.45 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.1 0.476 . . . . 64.15 109.95 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.439 ' HB3' ' OD1' ' A' ' 64' ' ' ASN . 53.8 p90 -60.47 -25.96 66.43 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.16 0.8 . . . . 75.31 113.16 -177.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 41.9 m -87.92 6.57 35.06 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 120.865 -0.334 . . . . 63.5 111.095 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.04 -58.17 0.42 Allowed Glycine 0 N--CA 1.437 -1.274 0 N-CA-C 111.445 -0.662 . . . . 52.12 111.445 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -95.41 127.6 41.44 Favored Pre-proline 0 C--N 1.307 -1.257 0 N-CA-C 109.574 -0.528 . . . . 71.21 109.574 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 96.8 Cg_endo -76.56 122.78 6.63 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.759 2.306 . . . . 75.2 112.805 -177.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 78' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' B' ' 78' ' ' LYS . 33.9 mtpt -106.15 159.27 16.21 Favored 'General case' 0 CA--C 1.484 -1.579 0 CA-C-N 115.263 -0.881 . . . . 75.44 111.477 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -132.56 136.43 8.73 Favored Glycine 0 N--CA 1.422 -2.266 0 C-N-CA 120.571 -0.823 . . . . 22.32 113.252 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 80' ' ' TYR . . . . . 0.515 ' CE1' ' HG ' ' B' ' 69' ' ' LEU . 11.7 p90 -152.68 143.55 22.93 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 124.24 1.016 . . . . 63.41 110.198 174.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.49 150.34 52.17 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 116.168 -0.469 . . . . 44.1 109.971 -173.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 82' ' ' TYR . . . . . 0.791 ' CD1' ' HD3' ' B' ' 112' ' ' LYS . 96.1 m-85 -126.53 129.9 49.52 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.995 -0.743 . . . . 65.45 108.995 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.486 HG23 HG22 ' B' ' 66' ' ' ILE . 34.2 mm -108.75 115.47 49.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 109.358 -0.608 . . . . 75.45 109.358 -177.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -91.51 119.19 31.24 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.546 -0.538 . . . . 62.15 109.546 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -98.78 156.67 16.74 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.956 -0.465 . . . . 72.14 109.761 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.35 -17.9 44.02 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.277 0.561 . . . . 65.41 110.379 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 87' ' ' GLU . . . . . 0.429 ' HB3' ' OD1' ' B' ' 89' ' ' ASN . 28.6 mt-10 -124.47 140.96 52.46 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.579 -0.737 . . . . 75.25 111.111 -177.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -63.71 -33.72 76.27 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.34 0.59 . . . . 75.01 110.454 172.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 89' ' ' ASN . . . . . 0.429 ' OD1' ' HB3' ' B' ' 87' ' ' GLU . 2.8 p-10 -61.94 -32.22 72.62 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.564 -0.744 . . . . 73.23 112.278 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 90' ' ' SER . . . . . 0.42 ' OG ' ' HB2' ' B' ' 87' ' ' GLU . 15.2 m -67.85 -41.24 83.21 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 120.834 0.35 . . . . 54.41 110.655 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.447 ' O ' HG13 ' B' ' 95' ' ' VAL 0.325 0.4 OUTLIER -65.87 -44.7 92.63 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 112.722 0.638 . . . . 74.43 112.722 178.667 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -59.51 -33.03 70.84 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.942 0.401 . . . . 64.11 112.006 174.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.79 -37.22 65.01 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 120.819 0.343 . . . . 65.23 110.521 177.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.12 -44.38 54.03 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.075 0.398 . . . . 63.3 112.075 -176.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 95' ' ' VAL . . . . . 0.447 HG13 ' O ' ' B' ' 91' ' ' VAL . 29.7 m -51.65 -22.42 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 113.632 0.975 . . . . 61.0 113.632 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.2 -17.56 63.66 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.988 0.423 . . . . 65.32 111.439 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 60.2 mtm -95.47 6.86 47.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.33 -0.395 . . . . 73.21 110.932 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 98' ' ' ASP . . . . . 0.599 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 5.2 p-10 -39.27 -47.62 1.71 Allowed 'General case' 0 C--O 1.204 -1.324 0 N-CA-C 114.925 1.454 . . . . 70.42 114.925 -176.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -113.37 92.62 4.06 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 119.267 0.94 . . . . 73.3 109.718 176.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 100' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' B' ' 106' ' ' THR . 31.6 p -142.16 173.59 11.38 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.671 -1.15 . . . . 62.24 110.989 -178.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.16 129.33 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.761 0 CA-C-O 121.559 0.695 . . . . 72.15 110.036 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -135.57 121.59 20.02 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.897 -1.149 . . . . 71.13 107.897 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 48.1 ttt-85 60.01 33.42 21.36 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 122.155 0.979 . . . . 70.43 111.23 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.38 -5.23 80.71 Favored Glycine 0 C--N 1.317 -0.491 0 CA-C-N 114.847 -1.069 . . . . 72.13 114.507 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -129.47 156.9 43.37 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 117.827 0.814 . . . . 73.23 111.458 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 106' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' B' ' 100' ' ' THR . 62.9 m -80.76 120.49 24.71 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 116.352 -0.385 . . . . 75.14 110.282 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 44.5 pt -102.06 171.99 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.983 -0.377 . . . . 71.51 109.983 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 108' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 55.6 tptt -134.06 127.47 32.27 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.803 -0.814 . . . . 61.23 108.803 -178.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.703 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 8.3 p -129.25 122.66 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-O 121.07 0.462 . . . . 64.32 111.684 177.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.37 159.59 41.52 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 107.026 -1.472 . . . . 74.14 107.026 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.96 131.03 35.1 Favored 'Trans proline' 0 N--CA 1.48 0.719 0 C-N-CA 122.476 2.117 . . . . 71.01 113.039 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.791 ' HD3' ' CD1' ' B' ' 82' ' ' TYR . 37.1 ttpt -78.41 93.24 4.69 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 108.93 -0.767 . . . . 60.23 108.93 178.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 58.63 120.35 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.676 0 O-C-N 125.141 1.526 . . . . 75.23 111.78 -173.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 15.9 m -97.67 82.46 3.06 Favored 'General case' 0 N--CA 1.407 -2.591 0 C-N-CA 118.147 -1.421 . . . . 75.14 110.318 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -91.93 91.48 7.9 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.02 -1.104 . . . . 72.24 108.02 176.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 116' ' ' MET . . . . . 0.481 ' HB2' ' HG3' ' B' ' 36' ' ' LYS . 26.6 ttt -162.65 137.23 5.04 Favored Pre-proline 0 C--N 1.293 -1.88 0 N-CA-C 107.832 -1.174 . . . . 63.04 107.832 -174.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -65.78 109.61 1.5 Allowed 'Trans proline' 0 N--CA 1.441 -1.58 0 C-N-CA 121.235 1.29 . . . . 61.11 109.947 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.98 -45.55 95.89 Favored Glycine 0 CA--C 1.493 -1.312 0 N-CA-C 110.429 -1.069 . . . . 74.05 110.429 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 10.0 tt -79.25 127.37 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.062 0 N-CA-C 108.347 -0.983 . . . . 64.24 108.347 174.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 38.7 m -69.52 117.0 10.59 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 108.74 -0.837 . . . . 74.13 108.74 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 32.8 m -62.66 98.4 0.12 Allowed 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.838 0.828 . . . . 72.43 111.01 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 25.4 p -138.61 -165.46 1.82 Allowed 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 114.12 -1.4 . . . . 63.01 107.423 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -77.99 -25.77 48.26 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.063 0.459 . . . . 63.55 110.461 177.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? . . . . . 0 C--N 1.308 -1.214 0 N-CA-C 107.653 -1.24 . . . . 64.25 107.653 179.569 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.28 0 CA-C-O 120.744 0.307 . . . . 34.41 110.278 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.2 pt -116.02 137.47 49.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-O 120.931 0.396 . . . . 73.12 110.719 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.19 144.11 62.04 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 108.835 -0.802 . . . . 62.05 108.835 175.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -61.36 144.63 98.51 Favored 'Trans proline' 0 C--O 1.243 0.727 0 C-N-CA 122.537 2.158 . . . . 74.15 111.918 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 68.4 m -73.28 108.68 6.29 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 116.299 -0.409 . . . . 61.33 109.924 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 66.3 mtt -86.09 153.4 22.13 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.894 -0.594 . . . . 74.42 109.445 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -122.27 137.29 54.89 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.002 0.429 . . . . 75.34 111.342 -176.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 t -150.92 102.39 2.97 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.478 -0.934 . . . . 70.04 108.478 176.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p -88.27 132.9 34.21 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 116.017 -0.538 . . . . 74.41 111.67 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -90.73 165.18 13.81 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.003 -1.11 . . . . 63.33 108.003 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.4 t -82.19 152.97 26.2 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.056 -0.72 . . . . 71.24 109.056 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -87.6 168.7 12.8 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.07 -0.715 . . . . 74.3 109.07 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.3 mtt -71.79 94.31 1.39 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.399 0.619 . . . . 75.31 111.384 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.0 p -82.17 134.07 35.29 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.169 -0.923 . . . . 70.44 111.326 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -98.28 170.89 8.56 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.802 -0.636 . . . . 70.24 110.437 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.98 39.38 6.15 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 116.233 -0.439 . . . . 74.32 112.146 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -108.56 105.56 15.24 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 110.028 -0.36 . . . . 72.03 110.028 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -136.37 -53.29 0.73 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.49 -0.323 . . . . 72.34 111.539 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.9 t -134.6 145.73 48.92 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-O 121.277 0.561 . . . . 52.44 112.175 -177.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -137.11 -20.08 1.26 Allowed 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 125.208 1.403 . . . . 74.2 109.232 176.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.43 -167.06 54.79 Favored Glycine 0 N--CA 1.429 -1.77 0 CA-C-N 114.919 -1.037 . . . . 51.34 111.598 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -57.74 -39.86 84.01 Favored 'Trans proline' 0 CA--C 1.564 1.998 0 C-N-CA 122.715 2.277 . . . . 75.23 117.384 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -90.64 167.49 4.03 Favored 'Trans proline' 0 N--CA 1.416 -3.046 0 N-CA-C 115.93 1.473 . . . . 73.25 115.93 -169.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.484 ' HG2' ' NH1' ' A' ' 65' ' ' ARG . 19.3 mt-30 -93.93 117.26 67.18 Favored Pre-proline 0 N--CA 1.379 -3.976 0 N-CA-C 103.912 -2.625 . . . . 71.14 103.912 175.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.538 ' C ' HD12 ' A' ' 26' ' ' LEU . 74.2 Cg_endo -84.95 96.5 0.66 Allowed 'Trans proline' 0 C--O 1.249 1.047 0 C-N-CA 121.941 1.761 . . . . 73.23 112.636 -177.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.538 HD12 ' C ' ' A' ' 25' ' ' PRO . 4.7 mp -142.09 169.54 17.4 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.52 -1.218 . . . . 72.31 109.425 -178.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 68.6 m -74.43 148.79 40.8 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 108.337 -0.986 . . . . 64.43 108.337 170.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.29 -45.53 62.2 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 111.944 0.35 . . . . 61.11 111.944 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -61.47 -37.24 82.87 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.951 0.405 . . . . 75.14 111.449 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.533 ' HB3' HD23 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -61.75 -40.09 93.88 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.749 -0.66 . . . . 71.51 111.222 175.955 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -73.97 -38.96 64.01 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.723 -0.473 . . . . 72.41 109.723 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 51.6 mtpt -59.2 -41.9 89.64 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.586 0.587 . . . . 71.5 112.586 176.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -67.57 -40.84 84.86 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.416 0.525 . . . . 70.35 112.416 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.461 HG21 ' CZ ' ' B' ' 73' ' ' PHE . 20.2 pt -70.32 -34.36 58.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.425 -0.807 . . . . 63.13 112.697 -174.043 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -67.5 -31.57 71.78 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.227 0.537 . . . . 75.04 110.689 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 93.5 mttt -70.03 -24.19 63.23 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.688 -0.687 . . . . 74.15 111.072 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -109.3 16.96 22.01 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.598 -0.728 . . . . 74.22 109.806 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.41 ' OG ' ' HG2' ' A' ' 84' ' ' GLU . 36.4 t -107.88 159.72 16.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 121.699 0.761 . . . . 63.12 112.204 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.554 HG13 ' CG2' ' A' ' 91' ' ' VAL . 0.2 OUTLIER -140.42 163.7 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 C-N-CA 124.678 1.191 . . . . 53.52 112.195 -179.445 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.608 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 23.1 t80 -105.75 128.27 53.59 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 126.216 1.806 . . . . 74.31 107.195 176.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 65.5 t -118.87 116.08 50.0 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 107.539 -1.282 . . . . 61.12 107.539 177.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.82 167.46 13.05 Favored Glycine 0 C--N 1.297 -1.626 0 C-N-CA 120.033 -1.08 . . . . 74.11 114.247 -177.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 59.87 62.24 1.72 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.431 1.892 . . . . 64.44 114.751 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.4 p -114.44 131.19 67.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.926 -1.034 . . . . 64.32 110.363 173.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.33 163.39 15.36 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.231 -1.396 . . . . 63.24 107.231 178.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -55.84 123.78 15.38 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.871 0.843 . . . . 75.24 112.311 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.12 -42.37 0.73 Allowed Glycine 0 N--CA 1.412 -2.948 0 N-CA-C 107.46 -2.256 . . . . 63.52 107.46 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.3 m -92.64 136.02 33.59 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 108.179 -1.045 . . . . 65.24 108.179 174.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.1 p -112.17 179.04 4.11 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.373 -0.603 . . . . 72.22 109.373 -178.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.556 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -61.73 -39.25 90.9 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.291 -0.633 . . . . 61.34 109.291 176.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -58.08 -46.5 85.38 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.401 -0.818 . . . . 55.24 111.489 174.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -58.53 -40.35 82.71 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.505 0.669 . . . . 54.51 110.071 178.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.2 mt -69.94 -48.27 59.08 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.704 -1.135 . . . . 72.21 111.265 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.5 -50.26 74.28 Favored 'General case' 0 C--O 1.193 -1.893 0 O-C-N 123.119 0.262 . . . . 61.44 111.704 -178.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.27 -42.57 91.53 Favored 'General case' 0 C--O 1.248 1.025 0 CA-C-O 121.083 0.468 . . . . 74.31 110.78 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -67.22 -39.78 86.29 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.748 -0.66 . . . . 72.2 110.39 -175.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -82.03 -21.44 36.98 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 112.928 0.714 . . . . 73.44 112.928 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.9 t -70.35 -24.37 62.97 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.181 -0.674 . . . . 75.15 109.181 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.7 m -60.15 -30.34 69.24 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-O 120.977 0.418 . . . . 52.25 110.104 173.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 63.8 m -90.65 1.67 56.6 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 112.782 0.66 . . . . 64.23 112.782 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 147.38 -162.48 28.65 Favored Glycine 0 N--CA 1.462 0.427 0 C-N-CA 119.282 -1.437 . . . . 71.42 114.164 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.3 t -104.63 132.41 50.9 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.857 -0.423 . . . . 75.13 109.857 -177.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 72.0 mt -97.84 135.66 31.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.354 0.597 . . . . 52.14 112.581 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.55 ' HB3' ' CE2' ' B' ' 73' ' ' PHE . 12.0 m120 -96.42 -42.05 8.3 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.236 -0.893 . . . . 73.53 111.909 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.484 ' NH1' ' HG2' ' A' ' 24' ' ' GLN . 43.8 mtt180 -153.57 161.83 41.84 Favored 'General case' 0 CA--C 1.486 -1.494 0 CA-C-N 115.71 -0.677 . . . . 74.22 109.699 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.556 HD11 ' HB1' ' A' ' 50' ' ' ALA . 29.3 pt -148.35 142.73 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 107.665 -1.235 . . . . 62.14 107.665 173.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.3 m -125.15 127.34 46.68 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 106.886 -1.524 . . . . 24.31 106.886 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 68' ' ' ILE . 2.1 mp -125.71 122.7 62.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 106.269 -1.752 . . . . 74.3 106.269 -177.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.433 ' HA ' ' O ' ' B' ' 66' ' ' ILE 0.253 1.3 pt? -121.24 126.36 49.41 Favored 'General case' 0 C--N 1.28 -2.421 0 C-N-CA 120.277 -0.569 . . . . 73.21 111.545 176.299 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 66.2 m -116.44 134.59 54.69 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.124 -0.695 . . . . 73.23 109.124 -177.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' B' ' 65' ' ' ARG . 2.0 p30 -126.65 152.91 46.08 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 119.773 -0.771 . . . . 70.44 113.034 -177.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.563 ' HE2' ' HB3' ' A' ' 77' ' ' PRO . 0.5 OUTLIER -121.93 18.81 10.95 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.817 -0.629 . . . . 70.11 109.722 169.256 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -67.78 -21.89 65.23 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 118.942 -1.103 . . . . 75.11 109.421 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.8 m -84.44 2.26 41.65 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.405 -0.816 . . . . 60.02 110.382 174.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.61 -44.13 2.27 Favored Glycine 0 CA--C 1.507 -0.423 0 N-CA-C 110.997 -0.841 . . . . 33.25 110.997 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -97.18 144.21 27.49 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 108.234 -1.024 . . . . 74.42 108.234 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.563 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 55.8 Cg_endo -65.43 116.85 4.13 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 123.168 2.579 . . . . 72.42 110.464 175.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -122.86 -162.56 1.03 Allowed 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.571 -1.27 . . . . 73.1 107.571 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 172.39 159.16 18.28 Favored Glycine 1 N--CA 1.396 -4.011 0 C-N-CA 119.631 -1.271 . . . . 44.43 113.516 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -151.41 147.78 27.31 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 125.12 1.368 . . . . 73.21 109.319 176.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.12 150.6 49.16 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.046 0.451 . . . . 73.43 110.327 -171.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.42 ' CZ ' ' HD1' ' A' ' 40' ' ' TYR . 39.9 m-85 -118.77 121.81 40.96 Favored 'General case' 0 C--N 1.28 -2.43 0 C-N-CA 123.596 0.758 . . . . 75.23 110.326 176.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.424 ' HA ' HG22 ' A' ' 66' ' ' ILE . 26.4 mm -105.65 127.86 60.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 107.712 -1.218 . . . . 60.2 107.712 -178.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.41 ' HG2' ' OG ' ' A' ' 38' ' ' SER . 32.8 mt-10 -110.39 119.28 38.68 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.544 -0.539 . . . . 64.31 109.544 178.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -95.22 162.67 13.6 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.562 0.696 . . . . 62.35 112.079 -177.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.22 -28.47 38.57 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.915 -1.038 . . . . 70.21 111.942 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.8 150.1 43.28 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.583 -0.847 . . . . 74.24 112.022 -178.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.567 ' O ' HG12 ' A' ' 91' ' ' VAL . 8.9 mmm180 -69.04 -32.71 72.41 Favored 'General case' 0 C--O 1.215 -0.719 0 C-N-CA 123.264 0.626 . . . . 70.44 109.791 177.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -66.9 -28.83 68.63 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.463 -0.895 . . . . 75.11 110.807 177.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.7 m -70.22 -39.41 75.14 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 109.818 -0.438 . . . . 74.23 109.818 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 88' ' ' ARG . 8.3 p -66.19 -38.84 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.652 -0.499 . . . . 71.43 109.652 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -66.98 -30.04 70.05 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-O 120.93 0.395 . . . . 72.45 111.697 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.75 -33.02 64.12 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.541 -0.54 . . . . 64.41 109.541 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.93 -45.07 52.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.735 -0.666 . . . . 73.41 111.089 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 91' ' ' VAL . 19.0 m -57.21 -22.07 16.2 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 N-CA-C 112.762 0.653 . . . . 63.14 112.762 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.04 -20.06 66.05 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.607 0.718 . . . . 73.42 110.887 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 69.0 mtm -94.92 7.91 44.47 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.174 -0.921 . . . . 74.53 110.24 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.662 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 5.1 p-10 -40.23 -45.66 2.11 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 113.814 1.042 . . . . 74.42 113.814 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -118.94 116.6 26.81 Favored 'General case' 0 N--CA 1.405 -2.679 0 N-CA-C 108.158 -1.053 . . . . 70.35 108.158 172.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 106' ' ' THR . 8.2 t -168.9 -179.77 3.82 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.103 -0.953 . . . . 54.45 108.621 -177.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.48 125.73 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-O 121.533 0.683 . . . . 72.25 110.364 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -130.51 128.96 42.24 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.297 -1.001 . . . . 73.44 108.297 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 54.45 33.03 17.85 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.763 1.225 . . . . 73.43 110.487 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.01 -1.81 88.66 Favored Glycine 0 C--N 1.311 -0.831 0 CA-C-N 114.765 -1.107 . . . . 74.53 114.25 177.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -122.31 152.46 40.08 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 117.589 0.694 . . . . 64.22 111.318 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 100' ' ' THR . 30.8 m -81.98 120.72 25.6 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 110.263 -0.273 . . . . 71.03 110.263 -178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 40.0 pt -103.1 172.09 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 116.329 -0.396 . . . . 43.02 110.48 176.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.662 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 57.6 tptt -129.49 133.55 47.34 Favored 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 109.233 -0.655 . . . . 64.42 109.233 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 23.6 t -127.23 114.52 37.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.002 -0.74 . . . . 75.22 109.002 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.424 HD11 ' CG ' ' B' ' 22' ' ' PRO 0.258 0.0 OUTLIER -143.35 146.24 35.32 Favored Pre-proline 0 C--O 1.211 -0.953 0 C-N-CA 119.277 -0.969 . . . . 74.52 109.432 179.168 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -52.08 137.53 53.79 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 123.386 2.724 . . . . 73.52 113.692 -173.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -67.93 97.93 0.71 Allowed 'General case' 0 C--O 1.248 0.981 0 CA-C-O 121.2 0.524 . . . . 74.34 111.886 -176.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.44 ' O ' ' HB ' ' A' ' 114' ' ' THR . 40.2 ptt180 173.81 -164.13 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 126.145 1.778 . . . . 64.32 106.993 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 113' ' ' ARG . 86.3 m 80.53 143.87 0.08 Allowed 'General case' 0 CA--C 1.543 0.69 0 O-C-N 123.865 0.728 . . . . 70.41 110.968 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 78.2 14.61 1.46 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.414 1.086 . . . . 75.32 110.504 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 25.9 ttt -88.13 128.24 54.36 Favored Pre-proline 0 C--N 1.311 -1.092 0 CA-C-N 115.246 -0.888 . . . . 44.24 109.106 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -59.63 150.56 75.69 Favored 'Trans proline' 0 C--O 1.249 1.027 0 C-N-CA 122.415 2.077 . . . . 55.54 111.281 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -156.15 -152.84 6.38 Favored Glycine 0 N--CA 1.427 -1.925 0 C-N-CA 120.584 -0.817 . . . . 72.43 111.791 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.443 ' O ' HD12 ' A' ' 119' ' ' ILE 0.264 2.3 pp -57.77 114.1 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 114.134 1.161 . . . . 65.2 114.134 -178.88 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.2 t -173.69 122.25 0.34 Allowed 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.216 -1.401 . . . . 73.41 107.216 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.7 p -83.27 84.75 7.38 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 121.683 0.754 . . . . 71.13 111.065 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.1 p -81.68 149.3 28.57 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.274 -0.875 . . . . 52.44 112.247 -177.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -121.12 109.08 14.58 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.394 -0.965 . . . . 74.12 108.394 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? . . . . . 0 C--N 1.305 -1.334 0 N-CA-C 108.742 -0.836 . . . . 72.01 108.742 -177.667 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.651 0 N-CA-C 109.185 -0.672 . . . . 73.32 109.185 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 66.1 mt -123.17 112.52 34.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 109.085 -0.709 . . . . 63.22 109.085 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.91 156.62 54.1 Favored Pre-proline 0 C--N 1.308 -1.216 0 N-CA-C 109.398 -0.593 . . . . 73.43 109.398 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -63.46 118.28 5.21 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.437 2.091 . . . . 62.31 111.198 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 26.2 p 52.79 83.44 0.06 Allowed 'General case' 0 C--O 1.246 0.886 0 C-N-CA 124.749 1.22 . . . . 63.32 112.434 -177.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 65.5 mtm -83.57 82.82 8.13 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.255 -0.884 . . . . 73.32 110.953 -178.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -158.96 -71.09 0.08 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.867 -1.06 . . . . 53.14 109.188 176.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 56.6 m -157.5 151.46 24.41 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.62 -0.511 . . . . 74.11 109.62 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 34.7 m 74.89 108.16 0.07 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.59 1.33 . . . . 65.44 114.59 173.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -129.21 119.72 24.52 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.924 -0.769 . . . . 74.01 108.924 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 49.5 m 53.26 86.74 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.522 1.304 . . . . 64.02 114.522 176.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -178.29 166.16 1.87 Allowed 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 124.514 1.125 . . . . 64.43 109.629 176.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 27.5 ttt -68.5 88.67 0.34 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.707 1.003 . . . . 65.54 113.707 -175.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 16.7 p -162.38 150.96 14.82 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 126.147 1.779 . . . . 74.13 106.685 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.6 95.39 2.33 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 118.045 0.384 . . . . 63.54 110.476 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.95 -117.36 11.13 Favored Glycine 0 C--O 1.245 0.832 0 N-CA-C 110.575 -1.01 . . . . 75.3 110.575 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.63 -0.73 57.6 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.104 0.478 . . . . 71.04 110.746 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -81.31 128.81 34.22 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 121.371 0.605 . . . . 72.23 110.158 177.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 59.6 m -164.31 171.49 14.77 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 103.752 -2.685 . . . . 74.13 103.752 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.89 -46.31 78.36 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 119.493 1.042 . . . . 64.23 109.398 177.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.79 -123.57 6.45 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 115.687 -0.688 . . . . 70.13 113.615 173.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.424 ' CG ' HD11 ' A' ' 110' ' ' LEU . 53.8 Cg_exo -53.17 -40.3 77.61 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 124.568 3.512 . . . . 72.43 116.88 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.8 136.05 74.12 Favored 'Trans proline' 0 C--N 1.391 2.768 0 CA-C-N 121.365 1.523 . . . . 71.35 110.377 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.417 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 83.9 mm-40 -60.47 134.3 91.38 Favored Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 123.56 0.538 . . . . 64.22 111.59 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' B' ' 24' ' ' GLN . 26.8 Cg_exo -57.88 179.6 0.15 Allowed 'Trans proline' 0 C--O 1.244 0.817 0 C-N-CA 123.484 2.789 . . . . 74.51 114.069 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.599 HD23 ' HB2' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -148.8 159.65 43.96 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 113.598 -1.637 . . . . 62.22 107.397 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.459 ' HB3' ' HG2' ' B' ' 30' ' ' GLU . 39.1 t -57.26 145.47 31.74 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 113.768 1.025 . . . . 70.11 113.768 -171.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.78 -38.89 67.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.451 -1.25 . . . . 32.44 111.142 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -64.79 -34.9 79.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.442 -0.345 . . . . 71.1 110.279 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.599 ' HB2' HD23 ' B' ' 26' ' ' LEU . 17.9 mm-40 -65.43 -35.31 80.55 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 116.207 -0.451 . . . . 75.03 110.008 177.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -72.66 -47.02 50.92 Favored 'General case' 0 CA--C 1.483 -1.611 0 CA-C-N 115.427 -0.806 . . . . 73.14 110.862 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.455 ' O ' ' HE3' ' B' ' 36' ' ' LYS . 50.3 mtpt -54.87 -43.06 72.8 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 115.861 -0.609 . . . . 74.41 111.767 176.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.508 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 0.3 OUTLIER -65.89 -41.13 91.93 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.819 0.847 . . . . 71.1 111.439 -178.517 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . 0.277 11.7 pt -71.27 -34.66 54.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 113.131 0.789 . . . . 75.32 113.131 -175.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.555 ' OD1' ' HE2' ' B' ' 112' ' ' LYS . 62.7 m-20 -64.01 -41.62 97.4 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-O 121.312 0.577 . . . . 74.05 109.851 -179.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.608 ' HZ2' ' HA ' ' B' ' 117' ' ' PRO . 84.0 mttt -60.27 -27.28 67.14 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.377 0.671 . . . . 75.3 111.63 -177.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' B' ' 33' ' ' GLU . 20.4 mtm180 -104.46 15.41 28.21 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 115.901 -0.591 . . . . 75.1 110.336 -174.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.717 ' OG ' ' HD3' ' B' ' 112' ' ' LYS . 77.7 p -114.89 169.26 9.22 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 113.915 1.08 . . . . 73.44 113.915 -177.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.592 HG13 ' CG2' ' B' ' 91' ' ' VAL . 0.2 OUTLIER -145.46 164.64 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 124.93 1.292 . . . . 73.13 113.24 -174.717 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 40' ' ' TYR . . . . . 0.543 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 30.4 t80 -105.59 125.98 51.61 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 127.125 2.17 . . . . 74.34 106.719 178.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 59.9 t -117.12 115.48 48.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 108.184 -1.043 . . . . 63.5 108.184 176.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.25 166.18 13.31 Favored Glycine 0 C--N 1.3 -1.471 0 C-N-CA 120.166 -1.016 . . . . 63.42 113.125 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 56.1 t30 62.6 65.75 0.82 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.4 1.48 . . . . 70.24 113.454 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.2 118.15 7.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.319 -0.855 . . . . 64.3 111.864 175.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -80.8 167.18 20.23 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 106.498 -1.668 . . . . 74.34 106.498 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 46' ' ' TYR . . . . . 0.604 ' HB3' ' SG ' ' B' ' 70' ' ' CYS . 48.3 p90 -75.33 5.24 5.88 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.145 0.498 . . . . 75.24 112.04 -178.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.34 -24.84 74.4 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.417 -1.073 . . . . 75.33 110.417 174.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 28.2 m -91.84 145.75 24.31 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 106.275 -1.75 . . . . 62.43 106.275 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 43.6 p -103.79 174.5 5.84 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 118.988 -1.085 . . . . 73.41 111.665 -173.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.602 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -64.7 -38.4 90.86 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 108.593 -0.892 . . . . 30.21 108.593 175.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -58.56 -42.46 87.95 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.379 -0.828 . . . . 74.34 111.06 176.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -59.05 -46.38 88.39 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.32 0.581 . . . . 74.4 110.027 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 55.6 mt -65.26 -48.6 72.65 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.898 -1.047 . . . . 73.24 111.969 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.512 ' HG2' HD12 ' B' ' 63' ' ' ILE . 0.8 OUTLIER -62.24 -49.09 77.11 Favored 'General case' 0 C--O 1.195 -1.801 0 N-CA-C 111.983 0.364 . . . . 70.41 111.983 -177.825 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.84 -41.51 87.11 Favored 'General case' 0 C--O 1.26 1.635 0 CA-C-O 121.531 0.681 . . . . 71.3 112.309 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -67.93 -41.22 82.93 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.918 -1.037 . . . . 74.33 109.967 -175.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -82.19 -22.07 36.17 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.395 0.517 . . . . 74.43 112.395 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 29.1 t -71.36 -23.86 61.98 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 109.163 -0.68 . . . . 65.43 109.163 -178.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 38.7 m -64.26 -18.93 65.03 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 115.821 -0.627 . . . . 74.41 109.808 175.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 56.0 m -107.38 10.03 29.69 Favored 'General case' 0 CA--C 1.556 1.211 0 N-CA-C 112.013 0.375 . . . . 74.44 112.013 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 147.89 -168.45 28.76 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 119.577 -1.297 . . . . 72.34 114.511 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 57.6 p -107.19 126.64 52.66 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 121.519 0.676 . . . . 55.31 110.502 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.512 HD12 ' HG2' ' B' ' 54' ' ' GLU . 78.9 mt -90.93 135.27 27.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.305 -0.862 . . . . 72.51 113.112 -175.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -93.03 -40.3 10.61 Favored 'General case' 0 CA--C 1.49 -1.344 0 CA-C-N 116.27 -0.423 . . . . 72.4 110.49 177.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 47.9 mtt180 -154.84 161.0 41.62 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 116.27 -0.423 . . . . 70.31 110.026 -177.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.602 HD11 ' HB1' ' B' ' 50' ' ' ALA . 26.7 pt -147.31 143.2 20.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 107.319 -1.363 . . . . 74.1 107.319 172.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 66.0 m -125.81 124.88 41.94 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 106.76 -1.57 . . . . 65.31 106.76 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.4 mp -124.33 120.2 58.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 106.926 -1.509 . . . . 71.11 106.926 -177.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.251 1.3 pt? -120.74 127.82 52.35 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.999 -0.68 . . . . 54.23 111.426 177.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 70' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' B' ' 46' ' ' TYR . 69.3 m -116.59 133.79 55.6 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.081 -0.711 . . . . 73.4 109.081 -177.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.642 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 4.1 p-10 -119.65 137.72 53.71 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 118.704 -1.198 . . . . 71.43 113.519 -176.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -104.81 10.38 34.53 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.78 0.8 . . . . 73.45 109.714 171.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.55 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 19.7 m-85 -73.42 -2.38 22.13 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.263 -0.88 . . . . 73.53 112.221 175.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 25.2 m -110.92 13.06 22.18 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 114.633 -1.167 . . . . 64.13 108.779 176.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.51 -55.76 5.03 Favored Glycine 0 C--N 1.343 0.958 0 N-CA-C 110.735 -0.946 . . . . 73.55 110.735 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -97.22 136.46 21.43 Favored Pre-proline 0 C--N 1.288 -2.09 0 CA-C-N 114.272 -0.964 . . . . 72.3 108.655 175.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 51.5 Cg_endo -69.55 118.31 5.6 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 121.603 1.535 . . . . 61.2 111.752 -178.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm -112.22 -157.56 0.62 Allowed 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 106.998 -1.482 . . . . 72.32 106.998 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 171.59 158.6 15.95 Favored Glycine 0 N--CA 1.409 -3.165 0 C-N-CA 119.071 -1.538 . . . . 62.02 114.232 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -149.5 144.3 26.2 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 125.468 1.507 . . . . 72.22 109.134 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.43 150.17 51.78 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 112.082 0.401 . . . . 64.33 112.082 -172.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 82' ' ' TYR . . . . . 0.51 ' HH ' ' HD1' ' B' ' 40' ' ' TYR . 26.4 m-85 -117.72 120.44 37.97 Favored 'General case' 0 C--N 1.286 -2.164 0 C-N-CA 123.398 0.679 . . . . 64.43 111.092 177.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.433 HG23 HG22 ' B' ' 66' ' ' ILE . 24.9 mm -106.5 124.36 61.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 108.337 -0.986 . . . . 74.33 108.337 -178.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 84' ' ' GLU . . . . . 0.435 ' HG2' ' CB ' ' B' ' 38' ' ' SER . 30.8 mt-10 -109.14 119.29 39.09 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 110.172 -0.307 . . . . 52.33 110.172 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -97.61 166.58 11.43 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.529 0.566 . . . . 74.43 112.529 -176.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.09 -34.39 26.15 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.321 -0.854 . . . . 61.43 112.265 175.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -114.26 149.84 35.27 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 120.95 0.405 . . . . 74.25 111.295 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.558 ' O ' HG12 ' B' ' 91' ' ' VAL . 19.4 mtp180 -74.87 -28.68 60.75 Favored 'General case' 0 CA--C 1.463 -2.372 0 CA-C-O 122.301 1.048 . . . . 72.12 111.796 176.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -61.31 -32.27 72.13 Favored 'General case' 1 C--N 1.234 -4.419 0 CA-C-N 114.178 -1.373 . . . . 71.42 110.503 172.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 16.5 m -71.24 -37.88 71.97 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 110.267 -0.272 . . . . 73.15 110.267 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.592 ' CG2' HG13 ' B' ' 39' ' ' VAL . 7.5 p -66.85 -38.78 82.14 Favored 'Isoleucine or valine' 0 C--N 1.348 0.527 0 C-N-CA 120.313 -0.555 . . . . 60.52 109.505 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -67.35 -30.43 70.23 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-O 121.101 0.477 . . . . 73.31 111.677 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.1 -32.23 64.83 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.185 0.517 . . . . 75.11 109.83 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.9 -44.87 46.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.761 -0.654 . . . . 61.42 111.28 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 95' ' ' VAL . . . . . 0.494 HG11 ' HG3' ' B' ' 111' ' ' PRO . 30.2 m -57.53 -23.26 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 112.553 0.575 . . . . 55.2 112.553 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.37 -17.28 64.68 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.23 0.538 . . . . 74.53 110.078 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 69.1 mtm -95.46 7.63 45.65 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.122 -0.49 . . . . 72.32 111.719 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 98' ' ' ASP . . . . . 0.408 ' HA ' ' H ' ' B' ' 109' ' ' VAL . 0.8 OUTLIER -49.1 -36.54 18.98 Favored 'General case' 0 C--O 1.201 -1.449 0 N-CA-C 114.312 1.227 . . . . 75.21 114.312 -177.573 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -105.08 17.83 23.41 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-N 119.349 0.977 . . . . 71.44 112.053 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 76.4 p -81.28 172.11 14.01 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 119.276 -0.97 . . . . 52.32 112.561 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.96 122.88 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 CA-C-O 121.746 0.784 . . . . 64.12 111.248 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -117.77 122.96 44.83 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.317 -0.994 . . . . 70.42 108.317 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 53.32 32.74 14.19 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.033 0.753 . . . . 73.22 113.033 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.22 4.6 83.77 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.93 -0.652 . . . . 63.01 114.115 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -125.86 151.39 46.92 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 117.533 0.666 . . . . 74.53 110.065 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 55.2 m -83.34 121.33 27.0 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 109.672 -0.492 . . . . 73.43 109.672 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 39.6 pt -102.05 172.54 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.175 -0.676 . . . . 71.13 109.175 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 108' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 56.3 tptt -128.48 132.59 48.38 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.681 -0.859 . . . . 73.54 108.681 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 20.9 t -126.5 120.21 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 107.999 -1.111 . . . . 72.03 107.999 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.322 0.3 OUTLIER -145.28 133.28 10.56 Favored Pre-proline 0 C--O 1.192 -1.97 0 N-CA-C 107.841 -1.17 . . . . 72.2 107.841 -167.449 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.494 ' HG3' HG11 ' B' ' 95' ' ' VAL . 51.4 Cg_exo -57.16 151.95 48.02 Favored 'Trans proline' 0 N--CA 1.507 2.299 0 C-N-CA 123.504 2.803 . . . . 75.45 116.303 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.717 ' HD3' ' OG ' ' B' ' 38' ' ' SER . 76.2 tttt -109.69 117.4 33.81 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 125.326 1.45 . . . . 62.43 109.84 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 61.7 168.99 0.11 Allowed 'General case' 0 N--CA 1.51 2.562 0 C-N-CA 124.308 1.043 . . . . 73.23 113.549 175.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 20.6 p -142.01 139.64 32.43 Favored 'General case' 0 CA--C 1.566 1.577 0 C-N-CA 124.117 0.967 . . . . 53.45 111.262 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 115' ' ' ASN . . . . . 0.581 ' HB3' ' HE2' ' B' ' 36' ' ' LYS . 3.7 t-20 177.78 151.52 0.23 Allowed 'General case' 0 N--CA 1.505 2.291 0 C-N-CA 123.656 0.782 . . . . 71.33 110.038 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 116' ' ' MET . . . . . 0.433 ' HA ' ' HD3' ' B' ' 117' ' ' PRO . 0.0 OUTLIER -81.11 144.34 54.39 Favored Pre-proline 0 N--CA 1.481 1.102 0 C-N-CA 122.777 0.431 . . . . 62.44 110.588 179.127 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 117' ' ' PRO . . . . . 0.608 ' HA ' ' HZ2' ' B' ' 36' ' ' LYS . 3.8 Cg_exo -76.27 161.75 34.67 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 123.97 3.113 . . . . 72.23 115.987 -174.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -145.13 -176.14 18.86 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 115.283 -0.871 . . . . 72.41 110.946 176.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 68.0 mt -137.45 141.93 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 117.654 0.727 . . . . 73.05 110.051 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 67.5 m -156.57 141.39 17.03 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.782 0.433 . . . . 72.54 110.354 178.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 31.7 m -142.79 168.4 19.8 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 110.247 -0.279 . . . . 62.24 110.247 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 78.0 m -144.68 124.34 13.3 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.884 0.373 . . . . 72.24 110.383 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -133.16 -170.18 2.42 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.503 -0.925 . . . . 64.21 108.503 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 . . . . . 0 N--CA 1.433 -1.324 0 N-CA-C 106.723 -1.584 . . . . 74.41 106.723 173.275 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.337 0 N-CA-C 109.126 -0.694 . . . . 52.45 109.126 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.2 mt -106.91 113.38 43.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 108.603 -0.888 . . . . 74.5 108.603 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -150.69 145.58 18.52 Favored Pre-proline 0 C--N 1.305 -1.34 0 N-CA-C 108.92 -0.771 . . . . 70.44 108.92 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.3 162.94 25.0 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 122.356 2.037 . . . . 75.23 111.763 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 72.6 m -77.28 158.05 30.44 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.991 -0.55 . . . . 74.32 109.963 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.4 127.74 32.48 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.904 -0.318 . . . . 75.12 110.467 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -151.74 6.12 0.45 Allowed 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.303 0.573 . . . . 60.33 111.976 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.8 t -117.43 135.42 53.91 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 106.279 -1.748 . . . . 73.25 106.279 174.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.0 p -141.85 172.88 12.08 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 111.897 0.332 . . . . 75.34 111.897 -172.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 76.7 t60 69.36 -55.07 0.58 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.264 1.426 . . . . 63.22 113.285 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.457 ' HB3' ' OG1' ' B' ' 14' ' ' THR . 49.8 m -89.48 138.84 31.11 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 116.24 -0.437 . . . . 71.42 110.289 -177.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.487 ' HD3' ' N ' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -161.52 -2.85 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.839 -0.619 . . . . 74.33 111.875 -173.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.7 mtt -70.99 102.91 2.53 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.659 0.742 . . . . 74.41 112.633 -176.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.8 m -154.45 -55.77 0.1 Allowed 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.526 -1.215 . . . . 54.34 108.629 175.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.522 ' HA ' ' OE2' ' A' ' 20' ' ' GLU . . . -158.83 167.57 29.1 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-N 116.453 -0.34 . . . . 62.11 110.649 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.29 -107.74 0.5 Allowed Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 110.44 -1.064 . . . . 74.41 110.44 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.41 26.95 0.93 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 122.182 0.991 . . . . 64.01 108.505 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -136.23 -15.95 1.67 Allowed 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 114.512 1.301 . . . . 74.11 114.512 -171.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.3 m -126.26 29.51 5.8 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.51 -1.663 . . . . 71.11 106.51 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.522 ' OE2' ' HA ' ' A' ' 15' ' ' ALA . 2.3 mp0 -100.85 97.03 7.68 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 116.396 1.999 . . . . 71.41 116.396 -169.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 50.05 -149.35 5.91 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 119.314 2.485 . . . . 55.45 119.314 167.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.445 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 78.8 Cg_exo -48.11 -45.56 25.14 Favored 'Trans proline' 0 C--N 1.365 1.415 1 C-N-CA 125.925 4.417 . . . . 64.22 118.388 -173.505 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.481 ' HG3' ' CE2' ' B' ' 80' ' ' TYR . 2.6 Cg_endo -42.35 129.49 4.75 Favored 'Trans proline' 0 C--N 1.391 2.781 0 C-N-CA 122.659 2.239 . . . . 64.41 112.388 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -58.79 139.31 86.54 Favored Pre-proline 0 C--O 1.247 0.968 0 CA-C-N 115.316 -0.856 . . . . 73.03 111.991 -177.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -72.1 103.28 1.47 Allowed 'Trans proline' 0 N--CA 1.432 -2.113 0 C-N-CA 122.112 1.874 . . . . 71.12 110.413 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.659 HD13 ' H ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -63.85 175.54 1.14 Allowed 'General case' 0 C--O 1.247 0.929 0 CA-C-N 115.158 -0.928 . . . . 72.32 111.671 177.812 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.9 m -53.35 143.43 18.9 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.879 0.696 . . . . 63.33 112.879 -172.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 31' ' ' LYS . . . -55.7 -46.13 77.72 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.721 -1.127 . . . . 73.4 112.189 -178.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -69.38 -31.76 70.35 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.467 -0.893 . . . . 65.32 112.923 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.416 ' CB ' HD23 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -61.63 -34.1 75.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.485 -0.325 . . . . 55.22 110.256 170.701 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.45 ' HE2' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -65.45 -47.41 76.25 Favored 'General case' 0 C--O 1.211 -0.964 0 N-CA-C 108.334 -0.987 . . . . 43.44 108.334 178.719 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.549 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -53.4 -47.0 69.92 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-O 120.401 0.143 . . . . 74.3 110.798 177.746 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -70.45 -43.44 69.85 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 113.291 0.848 . . . . 70.23 113.291 -174.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.45 HD11 ' HE2' ' A' ' 31' ' ' LYS . 18.7 pt -70.31 -35.77 64.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 C-N-CA 119.722 -0.791 . . . . 42.14 111.863 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.46 -29.32 69.42 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.232 0.539 . . . . 72.2 111.263 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 54.0 mtmt -77.76 -10.75 59.7 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.895 -0.593 . . . . 73.23 111.649 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -118.09 18.74 13.8 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.163 -0.471 . . . . 74.23 110.711 -174.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -94.83 139.09 31.77 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.928 -0.767 . . . . 72.24 108.928 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 83' ' ' ILE . 32.1 m -126.18 160.76 33.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 109.616 -0.512 . . . . 64.42 109.616 178.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.531 ' CD2' ' HG2' ' B' ' 22' ' ' PRO . 38.4 t80 -114.56 123.08 48.47 Favored 'General case' 0 C--N 1.274 -2.693 0 C-N-CA 125.159 1.384 . . . . 75.23 108.343 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 97.1 t -112.45 108.28 25.12 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.877 0 N-CA-C 107.087 -1.449 . . . . 71.21 107.087 177.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.07 163.07 20.15 Favored Glycine 0 C--N 1.284 -2.359 0 C-N-CA 119.62 -1.276 . . . . 72.45 112.231 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.408 ' ND2' ' HB3' ' A' ' 105' ' ' ARG . 66.5 t30 57.7 21.12 7.0 Favored 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 125.779 1.632 . . . . 72.43 113.562 178.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 p -54.39 135.44 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-O 121.38 0.61 . . . . 62.42 109.849 175.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.36 148.92 40.84 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 108.081 -1.081 . . . . 73.51 108.081 -176.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -70.24 -15.88 62.97 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.076 0.941 . . . . 64.0 109.189 -176.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.44 -11.62 83.01 Favored Glycine 0 N--CA 1.427 -1.955 0 CA-C-N 115.383 -0.826 . . . . 34.32 112.323 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.6 m -74.5 122.28 22.81 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-O 121.56 0.695 . . . . 63.43 110.069 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.1 p -100.86 171.73 7.49 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.309 -0.86 . . . . 74.24 108.903 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.02 -50.13 75.27 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 118.142 0.428 . . . . 71.32 111.194 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -57.49 -42.03 81.9 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.725 0.639 . . . . 73.23 112.725 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -67.09 -41.2 86.71 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.227 0.537 . . . . 70.2 110.315 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.2 mt -71.37 -48.37 50.46 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.707 -0.679 . . . . 75.12 111.815 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.453 ' HG3' ' OH ' ' B' ' 46' ' ' TYR . 14.2 tm-20 -59.73 -49.07 79.15 Favored 'General case' 0 C--O 1.208 -1.1 0 C-N-CA 123.547 0.739 . . . . 71.41 111.317 -178.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.35 -42.82 87.72 Favored 'General case' 0 C--O 1.27 2.165 0 CA-C-O 121.51 0.672 . . . . 65.02 111.214 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -63.63 -43.51 96.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.741 -1.118 . . . . 72.03 110.517 -175.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -81.36 -21.4 39.11 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 113.73 1.011 . . . . 74.45 113.73 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 69.4 m -66.59 -24.58 66.36 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 120.969 0.414 . . . . 55.43 110.885 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.1 m -58.62 -26.3 63.56 Favored 'General case' 0 CA--C 1.562 1.413 0 CA-C-O 121.144 0.497 . . . . 72.22 110.562 173.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 59.7 m -91.0 -2.78 57.65 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 112.945 0.72 . . . . 74.0 112.945 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.42 -161.86 27.95 Favored Glycine 0 C--N 1.317 -0.48 0 C-N-CA 119.456 -1.354 . . . . 52.41 113.913 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.1 m -97.26 120.26 37.3 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.562 0.696 . . . . 44.52 111.382 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.2 mt -82.01 129.53 37.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 115.001 -0.999 . . . . 71.52 111.168 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.434 ' OD1' ' HA ' ' B' ' 73' ' ' PHE . 48.4 t30 -93.54 -36.95 12.16 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.029 -0.987 . . . . 72.44 109.777 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.544 ' HD2' ' OE1' ' A' ' 84' ' ' GLU . 99.4 mtt180 -157.34 162.43 39.1 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.391 -0.822 . . . . 72.25 109.51 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.596 HG22 HG23 ' A' ' 83' ' ' ILE . 34.7 pt -142.68 137.81 28.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 107.259 -1.385 . . . . 73.34 107.259 171.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' B' ' 68' ' ' ILE . 49.9 m -126.54 130.96 51.58 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 107.55 -1.278 . . . . 61.55 107.55 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.2 mt -125.87 118.11 50.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.315 -1.365 . . . . 51.35 107.315 -177.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.55 ' HA ' ' O ' ' B' ' 66' ' ' ILE 0.342 0.9 OUTLIER -121.59 125.5 46.89 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 119.944 -0.702 . . . . 44.52 112.795 176.798 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 66.1 m -116.38 130.63 56.87 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.923 -1.14 . . . . 64.03 107.923 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.608 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 3.8 p-10 -115.78 137.14 52.37 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 119.196 -1.002 . . . . 72.45 112.377 -176.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -110.61 12.54 22.7 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.679 -0.691 . . . . 63.54 110.13 173.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.514 ' CD2' ' HB2' ' A' ' 71' ' ' ASP . 13.7 p90 -72.66 -9.97 59.24 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.789 0.804 . . . . 75.32 109.447 176.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.7 m -94.22 8.87 40.17 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 114.357 -1.292 . . . . 63.4 109.47 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.28 -54.42 4.53 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 110.492 -1.043 . . . . 55.13 110.492 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -95.61 131.26 29.81 Favored Pre-proline 0 C--N 1.299 -1.587 0 N-CA-C 106.772 -1.566 . . . . 70.22 106.772 176.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.608 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 33.3 Cg_endo -66.7 118.36 5.48 Favored 'Trans proline' 0 C--O 1.243 0.748 0 C-N-CA 121.536 1.491 . . . . 75.21 112.557 -177.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.407 ' HB2' ' OD1' ' A' ' 71' ' ' ASP . 25.0 mtmm -100.09 -169.39 1.73 Allowed 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.959 -1.126 . . . . 53.41 107.959 174.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.05 139.8 6.11 Favored Glycine 0 N--CA 1.41 -3.1 0 C-N-CA 119.727 -1.225 . . . . 75.22 112.763 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -151.12 143.31 24.07 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.797 -0.816 . . . . 72.23 108.797 172.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.08 152.01 50.0 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 116.747 -0.206 . . . . 71.43 111.23 -173.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 95.6 m-85 -120.4 115.63 23.89 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 109.044 -0.724 . . . . 75.31 109.044 174.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.596 HG23 HG22 ' A' ' 66' ' ' ILE . 38.6 mm -101.65 121.27 52.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.515 -1.291 . . . . 71.11 107.515 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.544 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 33.7 mt-10 -106.07 123.09 47.45 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 120.242 -0.583 . . . . 64.53 109.5 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -94.45 156.64 16.38 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 112.525 0.565 . . . . 74.33 112.525 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.06 -36.32 55.99 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.515 -0.766 . . . . 61.52 110.404 176.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -103.01 146.23 28.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.771 0.319 . . . . 71.43 110.185 175.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.45 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.77 -32.34 62.03 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.103 -1.443 . . . . 74.15 107.103 178.606 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -60.46 -31.48 70.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.283 -1.326 . . . . 75.11 110.338 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 31.5 m -64.41 -36.64 84.83 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 116.235 -0.439 . . . . 64.45 110.503 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 95' ' ' VAL . 2.3 m -67.68 -38.3 80.13 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.533 0 C-N-CA 119.61 -0.836 . . . . 70.42 109.241 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -58.3 -36.1 72.81 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.064 0.459 . . . . 74.21 111.59 176.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.34 -32.8 64.77 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.929 0.395 . . . . 73.1 110.658 177.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.36 -40.63 50.61 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 116.174 -0.466 . . . . 71.41 111.627 -177.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 91' ' ' VAL . 31.7 m -55.76 -21.85 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 113.117 0.784 . . . . 61.43 113.117 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.08 -14.44 61.74 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 121.586 0.708 . . . . 74.53 110.535 176.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 28.3 mtp -98.17 8.1 45.29 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 124.471 1.108 . . . . 62.34 110.771 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 4.5 p-10 -36.57 -53.47 0.88 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.904 1.076 . . . . 72.3 113.904 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -118.87 106.14 12.2 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-O 121.704 0.764 . . . . 65.12 109.451 175.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.0 t -150.1 173.02 14.35 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 114.811 -1.086 . . . . 74.02 109.275 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.87 131.99 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.221 0 N-CA-C 108.754 -0.832 . . . . 63.32 108.754 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -138.32 113.64 9.47 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 107.289 -1.374 . . . . 72.15 107.289 -177.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 37.5 mtp85 56.1 33.31 21.72 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.906 0.882 . . . . 74.32 112.127 -175.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.06 -10.18 71.77 Favored Glycine 0 C--N 1.312 -0.795 0 CA-C-N 115.215 -0.902 . . . . 24.01 113.191 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.408 ' HB3' ' ND2' ' A' ' 43' ' ' ASN . 93.7 mtt180 -99.31 143.81 29.15 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.839 -0.801 . . . . 73.5 108.839 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.0 m -86.41 119.72 26.98 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.934 -1.506 . . . . 54.53 106.934 174.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 47.8 pt -102.01 171.35 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 120.15 -0.62 . . . . 70.44 110.976 -177.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 57.6 tptt -127.87 125.98 40.71 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.138 -0.937 . . . . 64.34 108.731 -177.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.9 t -114.32 115.53 49.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 106.275 -1.75 . . . . 75.02 106.275 177.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.637 HD21 ' HB3' ' A' ' 115' ' ' ASN 0.272 2.5 tt -138.87 128.56 14.52 Favored Pre-proline 0 C--O 1.196 -1.72 0 N-CA-C 106.972 -1.492 . . . . 74.24 106.972 -170.511 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.66 127.71 15.07 Favored 'Trans proline' 0 C--N 1.355 0.884 0 CA-C-N 121.485 1.566 . . . . 62.2 109.771 175.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 -7.01 58.24 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.584 0.707 . . . . 75.23 110.744 -170.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.496 ' HD2' ' O ' ' A' ' 113' ' ' ARG . 3.4 tmm_? -90.02 -33.98 16.14 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.861 -0.792 . . . . 74.11 108.861 175.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.7 m -84.24 -47.73 10.5 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.624 -0.716 . . . . 62.02 112.351 -172.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.637 ' HB3' HD21 ' A' ' 110' ' ' LEU . 38.1 t-20 -121.12 110.08 15.78 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.845 0.831 . . . . 55.23 112.236 -174.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 66.9 mtm -127.43 108.92 21.07 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 107.854 -1.165 . . . . 33.4 107.854 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.11 163.88 25.07 Favored 'Trans proline' 0 C--O 1.242 0.704 0 C-N-CA 122.953 2.435 . . . . 54.21 113.539 -176.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 139.27 -141.79 12.16 Favored Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 115.47 -0.786 . . . . 73.12 111.513 177.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.7 mm -107.32 146.87 13.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 106.893 -1.521 . . . . 63.22 106.893 178.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.8 m -65.92 96.9 0.32 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.115 0.483 . . . . 73.43 110.263 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.4 m -121.14 76.78 1.25 Allowed 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 121.966 0.889 . . . . 52.11 108.969 177.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.2 m -150.49 83.32 1.36 Allowed 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 107.169 -1.419 . . . . 73.52 107.169 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -161.13 148.01 14.96 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.895 -0.593 . . . . 71.3 109.627 -178.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 . . . . . 0 C--N 1.295 -1.789 0 CA-C-N 115.658 -0.701 . . . . 73.21 109.642 -178.793 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.271 0 CA-C-O 121.149 0.499 . . . . 62.32 110.213 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.442 ' O ' HD12 ' B' ' 2' ' ' ILE 0.303 2.3 pp -82.06 111.65 18.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 122.255 1.026 . . . . 65.32 113.347 179.736 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.42 165.38 18.31 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 107.928 -1.138 . . . . 54.33 107.928 -177.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -59.73 94.11 0.09 OUTLIER 'Trans proline' 0 C--N 1.364 1.354 0 C-N-CA 122.103 1.869 . . . . 54.15 110.793 175.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 45.8 t -162.56 161.68 26.94 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 107.097 -1.446 . . . . 51.02 107.097 -176.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 65.3 mtt 70.37 167.85 0.3 Allowed 'General case' 0 C--O 1.247 0.945 0 C-N-CA 124.301 1.04 . . . . 72.12 111.42 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -112.94 119.62 38.57 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.99 -0.55 . . . . 73.32 109.745 -178.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 34.6 p -81.21 105.79 12.69 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.745 0.783 . . . . 73.02 110.575 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 34.6 p -88.71 131.18 35.13 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 115.881 -0.599 . . . . 75.33 111.663 -177.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -97.51 -11.28 23.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.997 -0.547 . . . . 75.23 110.297 177.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.42 ' CB ' ' HA ' ' B' ' 115' ' ' ASN . 10.2 p -132.8 -176.12 4.0 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.87 -0.605 . . . . 74.12 111.126 -177.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -106.57 104.86 14.65 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.099 -1.074 . . . . 73.32 108.099 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 24.6 ttt -110.97 140.7 45.27 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.857 -0.61 . . . . 65.33 112.464 -173.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.457 ' OG1' ' HB3' ' A' ' 11' ' ' SER . 5.9 t -89.83 140.91 29.13 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.775 -1.194 . . . . 62.44 107.775 171.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.98 115.25 18.54 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.046 0.45 . . . . 60.3 110.161 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.05 -87.29 0.22 Allowed Glycine 0 N--CA 1.428 -1.891 0 N-CA-C 110.704 -0.959 . . . . 32.01 110.704 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.77 150.23 32.73 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.369 -0.604 . . . . 71.31 109.369 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.432 ' HB3' ' HE2' ' B' ' 31' ' ' LYS . 71.1 m-85 -85.76 124.92 32.81 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.559 -0.904 . . . . 63.32 108.559 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 9.5 t -146.25 142.61 28.53 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.397 0.617 . . . . 61.33 111.295 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 20' ' ' GLU . . . . . 0.505 ' HG3' ' HB3' ' A' ' 15' ' ' ALA . 1.1 mp0 -80.2 -26.89 38.98 Favored 'General case' 0 CA--C 1.566 1.561 0 CA-C-N 115.117 -0.947 . . . . 70.13 109.897 178.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.69 -125.24 1.45 Allowed Glycine 0 CA--C 1.502 -0.738 0 N-CA-C 109.717 -1.353 . . . . 75.11 109.717 178.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.531 ' HG2' ' CD2' ' A' ' 40' ' ' TYR . 76.3 Cg_exo -52.9 -37.98 78.33 Favored 'Trans proline' 0 CA--C 1.566 2.103 0 C-N-CA 122.742 2.295 . . . . 62.52 114.225 172.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -55.1 129.67 36.57 Favored 'Trans proline' 0 C--N 1.397 3.081 0 C-N-CA 121.499 1.466 . . . . 71.32 110.99 172.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -54.16 141.5 50.51 Favored Pre-proline 0 C--N 1.302 -1.487 0 CA-C-N 114.257 -1.338 . . . . 75.11 111.277 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.86 114.15 2.3 Favored 'Trans proline' 0 N--CA 1.443 -1.467 0 C-N-CA 122.098 1.866 . . . . 72.23 111.045 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 6.1 mp -61.83 165.83 4.97 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.821 -1.081 . . . . 74.54 109.882 176.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.42 ' O ' ' HG2' ' B' ' 31' ' ' LYS . 25.2 m -58.93 144.94 43.2 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.278 -0.638 . . . . 64.1 109.278 176.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' B' ' 31' ' ' LYS . . . -52.49 -44.18 65.48 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 123.569 0.543 . . . . 71.44 111.775 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -71.31 -30.98 66.88 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.828 0.677 . . . . 71.42 112.828 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.529 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.5 OUTLIER -60.57 -34.58 74.4 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 109.653 -0.499 . . . . 74.2 109.653 170.013 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' B' ' 28' ' ' ALA . 25.2 mmmt -65.84 -46.89 76.83 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 115.58 -0.736 . . . . 70.41 109.956 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.518 ' N ' ' HE2' ' B' ' 32' ' ' LYS . 0.5 OUTLIER -53.7 -46.36 70.71 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.8 -0.36 . . . . 72.44 110.734 176.734 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.77 -45.76 70.54 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.314 0.857 . . . . 63.42 113.314 -174.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.529 HG12 ' O ' ' B' ' 30' ' ' GLU . 26.3 pt -69.58 -35.37 65.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 C-N-CA 120.751 -0.38 . . . . 73.42 111.828 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.9 -35.09 79.23 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.915 0.388 . . . . 75.31 110.781 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 55.1 mtmt -75.12 -11.08 60.01 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.393 0.516 . . . . 42.33 112.393 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -118.23 18.37 13.76 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.328 0.585 . . . . 71.44 110.918 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' B' ' 84' ' ' GLU . 82.8 p -98.9 156.5 16.86 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 115.897 -0.592 . . . . 53.55 111.444 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.428 HG22 ' O ' ' B' ' 83' ' ' ILE . 31.2 m -137.08 163.89 31.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.931 0.396 . . . . 70.25 110.562 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 40' ' ' TYR . . . . . 0.503 ' HD1' ' CE1' ' B' ' 82' ' ' TYR . 38.7 t80 -115.57 123.03 47.44 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 126.118 1.767 . . . . 72.41 107.936 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 85.8 t -112.45 108.02 24.46 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.939 0 N-CA-C 107.461 -1.311 . . . . 72.52 107.461 176.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 42' ' ' GLY . . . . . 0.467 ' O ' ' HB ' ' B' ' 107' ' ' ILE . . . -98.83 164.97 20.87 Favored Glycine 0 C--N 1.289 -2.037 0 C-N-CA 119.697 -1.24 . . . . 75.54 112.201 -177.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 64.0 t30 60.29 18.45 7.99 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.639 1.176 . . . . 75.4 112.875 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 8.0 p -61.49 132.19 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 109.162 -0.681 . . . . 65.24 109.162 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.38 143.95 56.83 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.61 -0.723 . . . . 41.13 109.879 -176.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 46' ' ' TYR . . . . . 0.481 ' CD1' ' HB2' ' B' ' 77' ' ' PRO . 71.7 t80 -55.07 -21.98 14.51 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 124.878 1.271 . . . . 74.43 111.999 -177.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.26 10.84 54.76 Favored Glycine 0 N--CA 1.422 -2.267 0 C-N-CA 120.562 -0.828 . . . . 54.13 113.761 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 12.8 m -75.0 122.32 23.33 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 118.492 1.146 . . . . 70.0 108.687 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 61.8 p -96.57 167.62 11.03 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 111.663 0.245 . . . . 72.3 111.663 -175.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.96 -51.15 70.92 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 112.853 0.686 . . . . 71.01 112.853 -175.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -57.53 -38.4 74.63 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 112.473 0.545 . . . . 75.4 112.473 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -69.49 -42.21 75.1 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.082 0.468 . . . . 74.35 109.973 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.41 -48.56 55.53 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.646 -0.706 . . . . 70.24 112.036 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 tm-20 -59.91 -49.74 76.51 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.198 0.599 . . . . 72.54 111.289 -177.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.41 -42.07 81.57 Favored 'General case' 0 C--O 1.27 2.154 0 CA-C-O 121.602 0.715 . . . . 70.41 111.355 177.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -64.59 -42.79 95.35 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 114.879 -1.055 . . . . 53.42 110.761 -175.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -81.68 -21.43 38.1 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 113.571 0.952 . . . . 71.5 113.571 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 75.4 m -64.74 -26.09 68.21 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 116.36 -0.382 . . . . 51.0 110.946 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.4 m -58.17 -26.85 63.24 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-O 121.038 0.447 . . . . 61.54 110.524 174.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 60' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' B' ' 94' ' ' ALA . 61.7 m -92.05 -0.61 57.46 Favored 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 112.885 0.698 . . . . 55.33 112.885 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.35 -154.83 26.21 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 119.054 -1.546 . . . . 65.31 114.681 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 44.1 m -105.27 117.97 35.37 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.033 0.444 . . . . 74.21 111.229 -176.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 67.3 mt -79.46 130.72 35.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.743 -0.662 . . . . 74.43 112.655 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 64' ' ' ASN . . . . . 0.556 ' OD1' ' HG3' ' B' ' 65' ' ' ARG . 23.6 t-20 -91.16 -41.91 10.75 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.186 0.995 . . . . 75.24 108.356 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.556 ' HG3' ' OD1' ' B' ' 64' ' ' ASN . 99.2 mtt180 -158.05 163.52 37.62 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.842 0.857 . . . . 64.45 109.125 -177.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.628 HG22 HG23 ' B' ' 83' ' ' ILE . 34.8 pt -142.43 137.67 28.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 107.099 -1.445 . . . . 74.21 107.099 170.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 33.4 m -126.74 131.18 51.4 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 107.069 -1.456 . . . . 73.21 107.069 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 67' ' ' THR . 17.1 mt -125.91 117.47 49.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 107.128 -1.434 . . . . 73.02 107.128 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.308 0.9 OUTLIER -121.49 125.88 47.91 Favored 'General case' 0 C--N 1.283 -2.313 0 C-N-CA 120.21 -0.596 . . . . 70.21 112.241 177.296 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 77.1 m -116.27 129.15 56.13 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 108.302 -0.999 . . . . 44.32 108.302 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 71' ' ' ASP . . . . . 0.715 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 4.8 p-10 -110.63 126.78 54.84 Favored 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 119.48 -0.888 . . . . 60.11 111.021 -177.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -113.49 15.2 19.1 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.039 -1.467 . . . . 74.01 107.039 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.434 ' HA ' ' OD1' ' A' ' 64' ' ' ASN . 30.8 t80 -44.72 -44.3 9.09 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.511 2.324 . . . . 63.14 112.096 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 24.1 m -100.82 18.99 18.04 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 116.208 -0.451 . . . . 71.43 111.558 -175.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.1 -53.17 2.52 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.095 -1.05 . . . . 75.34 111.388 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -91.55 119.89 68.4 Favored Pre-proline 0 CA--C 1.497 -1.085 0 N-CA-C 109.367 -0.605 . . . . 52.42 109.367 177.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 77' ' ' PRO . . . . . 0.715 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 75.3 Cg_endo -77.81 121.1 5.33 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 122.522 2.148 . . . . 64.13 113.682 -174.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 25.8 mtmm -99.98 -167.16 1.42 Allowed 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.397 -0.964 . . . . 55.1 108.397 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.93 140.71 6.67 Favored Glycine 0 N--CA 1.408 -3.2 0 C-N-CA 120.252 -0.975 . . . . 73.13 112.663 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 80' ' ' TYR . . . . . 0.481 ' CE2' ' HG3' ' A' ' 23' ' ' PRO . 16.3 p90 -151.73 143.44 23.65 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.509 -0.923 . . . . 75.54 108.509 171.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.33 152.19 50.81 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-O 121.023 0.44 . . . . 75.34 110.022 -173.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 82' ' ' TYR . . . . . 0.653 ' CD1' ' HD3' ' B' ' 112' ' ' LYS . 96.4 m-85 -121.31 115.21 22.54 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.411 -0.588 . . . . 72.55 109.411 175.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.628 HG23 HG22 ' B' ' 66' ' ' ILE . 40.5 mm -100.12 122.8 52.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 106.904 -1.517 . . . . 72.33 106.904 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 84' ' ' GLU . . . . . 0.555 ' OE1' ' HD2' ' B' ' 65' ' ' ARG . 31.1 mt-10 -107.73 124.15 49.59 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.165 -0.68 . . . . 70.41 109.165 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -96.83 154.1 17.49 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 112.893 0.701 . . . . 71.42 112.893 -177.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.69 -40.47 72.89 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.147 -0.933 . . . . 71.42 110.251 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -105.76 147.94 28.04 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 116.005 -0.543 . . . . 74.21 111.471 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.488 ' O ' HG22 ' B' ' 91' ' ' VAL . 0.0 OUTLIER -74.26 -33.56 63.34 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.398 -1.334 . . . . 73.04 107.398 -179.762 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -63.03 -25.42 68.37 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 115.494 -0.775 . . . . 63.03 111.425 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 42.9 m -66.11 -36.89 84.37 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 110.243 -0.28 . . . . 73.02 110.243 177.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.488 HG22 ' O ' ' B' ' 88' ' ' ARG . 3.2 m -67.83 -38.67 80.54 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 N-CA-C 109.003 -0.74 . . . . 61.25 109.003 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -56.87 -38.08 72.25 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.169 0.509 . . . . 73.45 111.576 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.69 -31.58 63.5 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.061 0.457 . . . . 65.43 111.083 177.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 94' ' ' ALA . . . . . 0.454 ' HA ' ' SG ' ' B' ' 60' ' ' CYS . . . -76.32 -40.8 50.49 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.192 -0.458 . . . . 75.45 111.454 -178.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 95' ' ' VAL . . . . . 0.439 HG13 ' O ' ' B' ' 91' ' ' VAL . 22.0 m -56.58 -21.77 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 113.0 0.741 . . . . 62.41 113.0 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.75 -18.85 65.42 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.292 0.567 . . . . 63.02 110.189 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 48.1 mtm -95.06 13.54 24.85 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.699 -0.682 . . . . 64.24 110.872 177.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 98' ' ' ASP . . . . . 0.473 ' HA ' ' HB ' ' B' ' 109' ' ' VAL . 11.1 t70 -33.8 -55.09 0.47 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.471 1.508 . . . . 64.23 113.683 -178.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 99' ' ' GLU . . . . . 0.419 ' HG3' ' OD1' ' B' ' 98' ' ' ASP . 45.6 mt-10 -124.83 62.33 1.15 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.166 -1.013 . . . . 74.3 112.775 171.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 35.0 p -91.69 174.75 7.19 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.297 -0.865 . . . . 62.54 111.72 174.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.4 p -101.67 137.81 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 109.122 -0.695 . . . . 72.51 109.122 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 102' ' ' PHE . . . . . 0.419 ' HB2' HD12 ' B' ' 107' ' ' ILE . 85.5 t80 -142.72 118.61 10.58 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.532 -0.914 . . . . 75.0 108.532 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 45.3 mtp180 55.68 33.22 20.87 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.509 1.123 . . . . 75.13 113.539 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.53 -0.87 65.88 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.038 -0.983 . . . . 71.31 114.191 174.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -130.81 160.62 33.84 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.176 -0.676 . . . . 72.42 109.176 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 85.7 m -92.52 126.98 37.84 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.188 -0.671 . . . . 63.32 109.188 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 107' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' B' ' 42' ' ' GLY . 0.2 OUTLIER -102.8 172.3 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 118.198 -1.401 . . . . 63.2 110.334 177.485 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 108' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 56.8 tptt -119.21 124.72 47.46 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.641 -1.244 . . . . 55.53 107.641 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' B' ' 98' ' ' ASP . 47.1 t -113.91 113.97 45.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 107.065 -1.458 . . . . 62.21 107.065 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.273 3.0 tt -139.66 128.53 13.61 Favored Pre-proline 0 C--O 1.187 -2.195 0 N-CA-C 106.454 -1.684 . . . . 70.2 106.454 -170.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.35 129.54 28.66 Favored 'Trans proline' 0 CA--C 1.551 1.37 0 CA-C-N 121.499 1.571 . . . . 74.02 112.056 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.653 ' HD3' ' CD1' ' B' ' 82' ' ' TYR . 36.0 ttpt -88.29 131.56 34.74 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 116.199 -0.455 . . . . 75.21 111.039 -174.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 45.28 -175.32 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 116.94 2.2 . . . . 74.35 116.94 173.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 88.5 m -162.71 95.07 0.88 Allowed 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 125.824 1.649 . . . . 73.14 106.84 173.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 115' ' ' ASN . . . . . 0.42 ' HA ' ' CB ' ' B' ' 11' ' ' SER . 16.4 t30 -78.19 99.63 6.3 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.776 0.798 . . . . 64.52 111.785 -177.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 50.1 ttm -156.07 95.22 2.38 Favored Pre-proline 0 C--N 1.312 -1.043 0 CA-C-N 114.723 -1.126 . . . . 51.13 111.034 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -94.89 -1.34 2.6 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 122.829 2.353 . . . . 55.52 110.712 172.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.34 -72.27 2.78 Favored Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 111.343 -0.703 . . . . 62.21 111.343 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 55.6 mt 59.68 89.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.247 0.929 0 C-N-CA 124.25 1.02 . . . . 71.0 110.444 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 16.4 m -105.23 111.4 24.13 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 115.4 -0.818 . . . . 60.11 109.438 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 25.5 p -132.76 85.09 2.19 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 121.319 0.58 . . . . 70.32 109.893 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 23.7 p -129.51 6.31 5.22 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.217 -0.901 . . . . 74.23 110.52 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 70.39 -47.0 0.63 Allowed 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 125.237 1.415 . . . . 75.25 111.629 -175.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 . . . . . 0 N--CA 1.416 -2.17 0 N-CA-C 106.692 -1.596 . . . . 71.22 106.692 174.294 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.493 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 7.8 mm-40 . . . . . 0 C--O 1.221 -0.401 0 CA-C-O 120.341 0.115 . . . . 71.44 111.163 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.4 pt -70.89 -35.91 61.89 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 C-N-CA 120.763 -0.375 . . . . 54.23 111.863 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.316 2.1 p30 -76.53 -27.84 56.11 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 118.929 -1.108 . . . . 64.51 112.208 178.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -65.6 -19.3 65.86 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-O 121.364 0.602 . . . . 74.43 111.318 174.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 12.6 ptp180 -125.06 25.87 7.13 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-O 122.07 0.938 . . . . 71.34 109.624 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.57 ' OG ' ' HG2' ' A' ' 84' ' ' GLU . 39.6 t -104.2 157.23 17.27 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.332 -1.304 . . . . 54.33 110.331 177.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.616 HG22 HG23 ' A' ' 91' ' ' VAL . 17.0 t -131.07 157.04 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 N-CA-C 107.963 -1.125 . . . . 73.22 107.963 -177.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.692 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 25.6 t80 -107.19 125.63 51.36 Favored 'General case' 0 C--N 1.279 -2.5 0 N-CA-C 106.398 -1.705 . . . . 74.41 106.398 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.517 ' HA ' HG12 ' A' ' 109' ' ' VAL . 62.6 t -116.7 107.8 23.38 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.137 0 N-CA-C 106.656 -1.609 . . . . 75.3 106.656 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.467 ' HA3' ' CZ ' ' A' ' 40' ' ' TYR . . . -117.04 172.56 14.3 Favored Glycine 0 C--N 1.275 -2.812 0 C-N-CA 117.734 -2.174 . . . . 75.45 113.652 -176.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.1 t30 57.73 11.67 1.4 Allowed 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 125.003 1.321 . . . . 74.1 112.92 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.7 p -55.45 142.79 9.38 Favored 'Isoleucine or valine' 0 C--O 1.246 0.906 0 CA-C-O 121.376 0.608 . . . . 74.35 109.858 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -77.6 150.05 34.71 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 107.737 -1.209 . . . . 60.43 107.737 -177.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.416 ' CD2' ' HB2' ' A' ' 77' ' ' PRO . 32.3 t80 -62.12 -20.85 64.5 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 123.886 0.741 . . . . 74.25 110.075 -176.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.16 -23.61 71.51 Favored Glycine 0 N--CA 1.424 -2.163 0 CA-C-N 115.52 -0.763 . . . . 20.43 112.82 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 72.9 m -100.97 75.6 1.69 Allowed 'General case' 0 N--CA 1.427 -1.594 0 C-N-CA 118.667 -1.213 . . . . 61.32 113.264 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.9 p -71.71 -178.0 2.1 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 116.199 -0.455 . . . . 53.42 111.93 170.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.02 -51.09 32.95 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.469 1.285 . . . . 71.24 114.469 -165.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.533 ' HG2' ' CE2' ' B' ' 46' ' ' TYR . 50.5 mt-30 -56.77 -51.88 67.19 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.441 0.534 . . . . 73.45 112.441 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -68.48 -39.19 81.44 Favored 'General case' 0 C--O 1.256 1.407 0 CA-C-O 121.591 0.71 . . . . 73.3 110.657 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.21 -46.69 73.09 Favored 'General case' 0 C--O 1.259 1.583 0 CA-C-N 114.673 -1.148 . . . . 74.24 109.061 -175.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -58.9 -40.94 86.0 Favored 'General case' 0 C--O 1.187 -2.191 0 N-CA-C 112.331 0.493 . . . . 64.11 112.331 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.56 -44.04 72.56 Favored 'General case' 0 C--O 1.266 1.926 0 CA-C-O 121.285 0.564 . . . . 64.3 111.717 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -64.82 -40.65 95.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.197 -0.911 . . . . 73.44 110.386 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.412 ' HZ ' HG11 ' A' ' 109' ' ' VAL . 66.7 m-85 -82.34 -22.76 35.42 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.028 1.122 . . . . 70.01 114.028 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.0 t -68.64 -24.69 64.58 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.01 -0.737 . . . . 72.15 109.01 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.0 m -66.31 -22.68 66.29 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 120.605 -0.438 . . . . 73.13 111.099 173.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 67.6 m -97.19 7.74 45.96 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.42 0.526 . . . . 71.33 112.42 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.21 -163.41 27.78 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 119.055 -1.545 . . . . 52.33 114.286 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.7 p -106.12 127.44 53.2 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.219 0.533 . . . . 73.11 111.236 -177.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.3 mt -86.87 133.93 28.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.683 -0.69 . . . . 53.35 112.14 -177.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.534 ' OD1' ' HG3' ' A' ' 65' ' ' ARG . 24.0 t-20 -96.99 -47.99 5.58 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.389 -0.823 . . . . 71.41 109.695 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.534 ' HG3' ' OD1' ' A' ' 64' ' ' ASN . 54.1 mtp180 -151.58 159.44 44.09 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.359 -0.978 . . . . 74.45 108.359 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.444 HG22 HG23 ' A' ' 83' ' ' ILE . 30.5 pt -146.36 141.87 21.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 107.921 -1.14 . . . . 72.33 107.921 174.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.0 m -127.37 125.4 40.63 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 107.38 -1.341 . . . . 74.34 107.38 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' B' ' 67' ' ' THR . 2.9 mp -122.37 125.45 72.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.272 -1.381 . . . . 55.32 107.272 -176.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.499 HD12 ' NH2' ' B' ' 65' ' ' ARG . 1.6 pt? -119.68 130.35 55.0 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 120.309 -0.556 . . . . 74.04 110.925 176.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.693 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 62.7 m -116.69 127.61 54.58 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.934 -0.576 . . . . 71.13 109.459 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -109.86 128.86 55.6 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.986 -0.686 . . . . 64.14 111.057 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' B' ' 64' ' ' ASN . 52.0 mttm -99.84 8.9 43.82 Favored 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 123.438 0.695 . . . . 75.45 110.213 173.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.622 ' CE2' ' HD2' ' B' ' 65' ' ' ARG . 7.6 m-85 -57.7 -25.87 60.93 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 121.58 0.705 . . . . 74.14 109.361 170.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.4 m -89.49 6.48 40.71 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 114.913 -1.04 . . . . 62.0 111.229 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.84 -52.94 4.67 Favored Glycine 0 N--CA 1.475 1.3 0 N-CA-C 110.488 -1.045 . . . . 65.02 110.488 -177.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -96.7 130.88 29.26 Favored Pre-proline 0 C--N 1.289 -2.043 0 N-CA-C 106.867 -1.531 . . . . 75.3 106.867 174.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.416 ' HB2' ' CD2' ' A' ' 46' ' ' TYR . 55.7 Cg_endo -68.69 120.32 7.25 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 122.007 1.805 . . . . 75.2 111.252 -177.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.693 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 15.1 mtmm -102.97 152.93 20.74 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.324 -1.361 . . . . 62.41 107.324 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.436 ' C ' ' HD1' ' A' ' 80' ' ' TYR . . . -120.48 137.28 12.02 Favored Glycine 0 N--CA 1.417 -2.632 0 C-N-CA 119.027 -1.558 . . . . 62.3 112.979 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.436 ' HD1' ' C ' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -129.06 142.23 50.97 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 102.743 -3.058 . . . . 72.22 102.743 172.373 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -140.47 141.89 35.37 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-N 119.042 0.837 . . . . 63.21 110.63 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.442 ' CD1' ' HD3' ' A' ' 112' ' ' LYS . 44.0 m-85 -110.07 117.2 33.1 Favored 'General case' 0 C--N 1.275 -2.632 0 N-CA-C 107.241 -1.392 . . . . 75.11 107.241 175.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.444 HG23 HG22 ' A' ' 66' ' ' ILE . 25.1 mm -102.98 121.17 53.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 107.347 -1.353 . . . . 74.31 107.347 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.57 ' HG2' ' OG ' ' A' ' 38' ' ' SER . 28.7 mt-10 -108.16 119.53 39.76 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.512 -0.922 . . . . 73.33 108.512 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -93.38 165.47 12.76 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.529 0.681 . . . . 75.41 112.819 -175.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.76 -37.81 64.9 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.065 -0.97 . . . . 74.3 111.011 174.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -118.63 158.61 25.15 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.126 1.158 . . . . 71.52 114.126 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -71.93 -26.47 62.31 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 114.701 -1.136 . . . . 54.45 110.778 175.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -60.21 -41.98 94.2 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.859 -0.61 . . . . 73.23 110.034 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.0 m -69.73 -39.7 76.65 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 115.603 -0.726 . . . . 40.1 111.765 -173.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.616 HG23 HG22 ' A' ' 39' ' ' VAL . 8.3 p -64.86 -39.22 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 120.33 -0.548 . . . . 75.34 109.807 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.68 -34.66 74.27 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.715 0.769 . . . . 73.02 109.928 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.75 -31.8 63.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.261 -0.881 . . . . 63.33 110.581 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.33 -45.05 33.96 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.088 -0.506 . . . . 51.23 110.57 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.1 m -59.44 -21.72 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 113.277 0.843 . . . . 73.02 113.277 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.97 -17.43 64.67 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.446 0.641 . . . . 74.54 110.61 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 71.8 mtm -94.98 9.96 37.4 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.562 -0.745 . . . . 70.3 110.129 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.602 ' HA ' HG22 ' A' ' 109' ' ' VAL . 2.2 p-10 -37.45 -47.53 0.89 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 116.418 2.007 . . . . 74.24 116.418 -174.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -115.47 30.68 7.2 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 118.95 0.795 . . . . 72.24 110.622 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.7 t -69.36 164.94 21.79 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-O 121.38 0.61 . . . . 72.23 110.056 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -109.13 132.13 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.936 0 N-CA-C 107.968 -1.123 . . . . 74.34 107.968 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -138.04 126.27 23.04 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 116.153 -0.476 . . . . 75.4 110.23 -174.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 103' ' ' ARG . 20.0 ttt180 55.54 32.44 19.09 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.845 1.258 . . . . 64.12 111.256 178.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.25 -10.58 72.59 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 114.237 -1.347 . . . . 61.02 113.202 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -113.16 150.65 31.93 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.828 -0.434 . . . . 74.21 109.828 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.4 m -86.6 123.16 31.48 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.252 -1.018 . . . . 72.45 108.252 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 44.4 pt -101.6 171.61 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.782 -0.767 . . . . 72.31 109.541 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 55.6 tptt -132.36 124.76 29.37 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.674 -0.491 . . . . 75.34 109.674 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.692 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 30.2 m -127.78 123.88 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 121.337 0.589 . . . . 73.14 111.317 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.405 HD11 ' HG2' ' B' ' 22' ' ' PRO . 0.0 OUTLIER -147.57 163.69 26.45 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 106.65 -1.611 . . . . 71.52 106.65 179.375 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.83 149.2 86.84 Favored 'Trans proline' 0 N--CA 1.478 0.6 0 C-N-CA 121.839 1.692 . . . . 54.42 112.046 -174.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.509 ' HE3' ' OG ' ' A' ' 38' ' ' SER . 25.5 ttpp . . . . . 0 N--CA 1.437 -1.108 0 CA-C-O 122.518 1.151 . . . . 74.04 112.109 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.375 0 N-CA-C 109.655 -1.378 . . . . 73.01 109.655 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.479 ' N ' ' HD2' ' B' ' 23' ' ' PRO . 33.1 Cg_exo -58.36 -43.09 49.35 Favored 'Trans proline' 0 CA--C 1.574 2.505 0 C-N-CA 123.055 2.503 . . . . 71.11 114.169 174.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' B' ' 22' ' ' PRO . 7.1 Cg_endo -53.43 154.98 13.73 Favored 'Trans proline' 0 C--N 1.397 3.099 0 C-N-CA 122.525 2.15 . . . . 73.23 112.008 175.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.448 ' H ' ' CD ' ' B' ' 24' ' ' GLN . 0.1 OUTLIER -84.26 133.02 45.86 Favored Pre-proline 0 N--CA 1.41 -2.467 0 N-CA-C 107.697 -1.223 . . . . 71.21 107.697 177.44 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' B' ' 24' ' ' GLN . 25.2 Cg_exo -61.39 138.6 77.58 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.351 2.034 . . . . 72.25 112.128 -175.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.758 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -68.79 176.19 3.18 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.71 -0.677 . . . . 63.31 110.555 175.393 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 15.7 m -53.68 143.02 21.48 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.097 0.777 . . . . 45.12 113.097 -170.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.56 -43.21 75.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.758 -1.11 . . . . 72.14 112.13 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . 0.319 49.2 mt-10 -76.8 -29.66 56.09 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.966 1.099 . . . . 74.42 113.966 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.458 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.4 OUTLIER -57.02 -35.62 69.47 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.847 -0.797 . . . . 74.01 108.847 169.174 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -72.33 -39.64 68.04 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.097 -0.956 . . . . 61.13 110.715 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.617 ' N ' ' HE2' ' B' ' 32' ' ' LYS . 0.0 OUTLIER -65.38 -45.92 82.18 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 112.109 0.411 . . . . 75.15 112.109 178.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -64.5 -35.48 81.07 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 123.279 0.362 . . . . 74.24 111.773 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.458 HG12 ' O ' ' B' ' 30' ' ' GLU 0.301 20.0 pt -70.78 -34.04 54.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 112.401 0.519 . . . . 55.23 112.401 179.484 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -67.51 -43.34 81.1 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 121.941 0.877 . . . . 73.23 109.055 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -60.88 -19.8 60.85 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.957 -1.019 . . . . 72.53 111.141 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -112.21 11.64 20.28 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.353 -0.61 . . . . 72.45 109.353 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.507 ' OG ' ' HE3' ' B' ' 112' ' ' LYS . 31.4 t -99.08 151.17 21.25 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.679 0.752 . . . . 75.31 111.876 -177.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.579 HG22 HG23 ' B' ' 91' ' ' VAL . 10.5 t -129.09 158.9 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.079 0 N-CA-C 106.718 -1.586 . . . . 61.32 106.718 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . 0.696 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 36.7 t80 -110.0 125.44 52.9 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 106.353 -1.721 . . . . 73.32 106.353 174.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.523 ' HA ' HG12 ' B' ' 109' ' ' VAL . 59.9 t -117.22 106.91 21.01 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.098 0 N-CA-C 106.97 -1.493 . . . . 55.2 106.97 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.27 173.72 15.07 Favored Glycine 0 C--N 1.275 -2.842 0 C-N-CA 118.164 -1.97 . . . . 74.12 112.415 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.0 t30 62.25 6.0 1.72 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 124.842 1.257 . . . . 44.31 112.948 -177.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.9 p -61.57 131.24 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 107.274 -1.38 . . . . 51.23 107.274 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.519 ' OD1' ' HD2' ' B' ' 103' ' ' ARG . 3.6 p-10 -87.53 167.38 14.0 Favored 'General case' 0 N--CA 1.419 -1.977 0 C-N-CA 118.596 -1.242 . . . . 54.12 111.194 -172.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' TYR . . . . . 0.533 ' CE2' ' HG2' ' A' ' 51' ' ' GLN . 49.2 t80 -63.81 -12.19 33.58 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 113.981 -1.463 . . . . 72.42 111.189 -174.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.37 -23.6 67.69 Favored Glycine 0 N--CA 1.42 -2.431 0 CA-C-N 115.937 -0.574 . . . . 72.55 112.555 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.7 t -90.04 152.04 21.36 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 119.381 -0.927 . . . . 71.12 108.537 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' THR . . . . . 0.537 ' O ' ' HB2' ' B' ' 53' ' ' LEU . 32.8 p -133.21 178.33 6.98 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.883 -0.784 . . . . 74.12 108.883 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.15 -46.61 82.57 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.576 0.954 . . . . 61.31 113.576 -172.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -57.59 -52.2 66.39 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.088 0.47 . . . . 71.51 111.442 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -64.82 -40.04 94.56 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-N 115.518 -0.765 . . . . 54.02 110.767 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.537 ' HB2' ' O ' ' B' ' 49' ' ' THR . 1.0 OUTLIER -67.3 -47.05 71.74 Favored 'General case' 0 C--O 1.255 1.386 0 CA-C-N 114.875 -1.057 . . . . 60.44 109.135 -177.3 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -58.93 -42.63 90.21 Favored 'General case' 0 C--O 1.188 -2.17 0 C-N-CA 120.671 -0.412 . . . . 73.24 111.932 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.1 -43.5 70.45 Favored 'General case' 0 C--O 1.266 1.955 0 O-C-N 123.196 0.31 . . . . 30.42 110.842 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -65.13 -41.51 94.76 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.073 -0.651 . . . . 71.32 110.534 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -82.32 -23.65 35.03 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 113.891 1.071 . . . . 72.2 113.891 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 34.5 t -71.26 -24.08 62.1 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 123.658 0.783 . . . . 74.03 108.947 -177.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 38.7 m -67.26 -24.71 65.82 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 115.56 -0.746 . . . . 73.5 109.899 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 61.5 m -106.59 14.37 27.11 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.554 0.576 . . . . 54.42 112.554 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . 0.444 ' HA3' ' OG ' ' B' ' 90' ' ' SER . . . 151.17 -174.96 30.29 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 118.953 -1.594 . . . . 75.34 115.158 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 46.7 m -105.35 120.0 40.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.422 0.629 . . . . 71.04 110.947 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 67.7 mt -83.23 131.28 34.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.609 -0.723 . . . . 71.51 112.553 -176.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 72' ' ' LYS . 43.3 t-20 -99.47 -42.32 7.0 Favored 'General case' 0 C--O 1.208 -1.1 0 CA-C-N 115.615 -0.72 . . . . 70.52 110.478 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.622 ' HD2' ' CE2' ' A' ' 73' ' ' PHE . 55.6 mtp180 -151.57 160.34 43.71 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.318 -0.993 . . . . 71.42 108.318 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 18.0 pt -148.23 141.47 18.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 107.869 -1.16 . . . . 50.12 107.869 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 47.9 m -127.73 126.44 41.83 Favored 'General case' 0 C--N 1.268 -2.942 0 N-CA-C 107.96 -1.126 . . . . 74.43 107.96 177.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . 0.468 ' O ' HD12 ' A' ' 68' ' ' ILE . 2.3 mp -121.83 127.42 75.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 106.567 -1.642 . . . . 64.14 106.567 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -120.99 132.0 54.64 Favored 'General case' 0 C--N 1.286 -2.19 0 C-N-CA 119.801 -0.76 . . . . 74.44 110.52 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' CYS . . . . . 0.6 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 63.1 m -116.6 127.5 54.53 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 109.35 -0.611 . . . . 73.31 109.35 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -107.29 131.5 54.14 Favored 'General case' 0 CA--C 1.474 -1.956 0 C-N-CA 119.09 -1.044 . . . . 63.14 108.857 177.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . 0.579 ' HE2' ' HB3' ' B' ' 77' ' ' PRO . 40.1 ttmt -125.16 7.42 7.87 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 109.158 -0.682 . . . . 74.34 109.158 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -69.64 -18.32 63.58 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.418 0.627 . . . . 72.1 110.247 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 22.5 p -84.26 1.98 42.2 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 114.85 -1.068 . . . . 71.55 109.955 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.46 -44.05 2.46 Favored Glycine 0 N--CA 1.439 -1.135 0 N-CA-C 110.733 -0.947 . . . . 60.42 110.733 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -95.85 128.1 38.74 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 108.096 -1.076 . . . . 70.21 108.096 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.579 ' HB3' ' HE2' ' B' ' 72' ' ' LYS . 94.2 Cg_endo -78.32 119.0 4.43 Favored 'Trans proline' 0 N--CA 1.434 -1.99 0 C-N-CA 121.298 1.332 . . . . 52.24 110.535 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' LYS . . . . . 0.6 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 1.2 mtpt -116.57 163.52 15.96 Favored 'General case' 0 CA--C 1.471 -2.095 0 CA-C-N 114.798 -1.092 . . . . 71.01 110.324 -174.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . 0.415 ' C ' ' HD1' ' B' ' 80' ' ' TYR . . . -134.2 137.84 9.61 Favored Glycine 0 N--CA 1.428 -1.838 0 C-N-CA 119.585 -1.293 . . . . 61.1 113.853 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . 0.415 ' HD1' ' C ' ' B' ' 79' ' ' GLY . 0.1 OUTLIER -130.77 142.6 50.41 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 102.794 -3.039 . . . . 74.32 102.794 172.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.81 141.79 36.7 Favored 'General case' 0 C--N 1.279 -2.467 0 CA-C-N 118.939 0.79 . . . . 63.42 110.486 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' TYR . . . . . 0.516 ' CD1' ' HG3' ' B' ' 112' ' ' LYS . 27.9 m-85 -109.51 117.18 33.31 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 106.793 -1.558 . . . . 71.34 106.793 175.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 33.0 mm -102.7 121.43 53.81 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 107.674 -1.232 . . . . 64.32 107.674 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' B' ' 38' ' ' SER . 31.1 mt-10 -108.07 119.3 39.09 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.704 -0.85 . . . . 72.42 108.704 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -95.31 164.58 12.77 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.408 0.623 . . . . 72.41 112.3 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.91 -30.33 31.93 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.194 -0.912 . . . . 53.0 111.864 176.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.02 147.62 42.18 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 114.79 1.404 . . . . 75.0 114.79 177.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.438 ' O ' HG12 ' B' ' 91' ' ' VAL . 20.4 mmm180 -64.25 -27.44 69.05 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.428 1.091 . . . . 73.23 110.279 175.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -58.44 -42.16 86.7 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.765 -0.652 . . . . 73.53 109.771 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' SER . . . . . 0.444 ' OG ' ' HA3' ' B' ' 61' ' ' GLY . 50.1 m -71.58 -37.32 71.04 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 113.082 0.771 . . . . 62.41 113.082 -173.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.579 HG23 HG22 ' B' ' 39' ' ' VAL . 12.3 p -65.48 -38.58 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 109.15 -0.685 . . . . 62.5 109.15 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -69.37 -35.81 76.2 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.612 0.72 . . . . 71.0 109.847 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.25 -31.85 64.36 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.374 -0.83 . . . . 63.31 110.554 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.31 -45.45 32.28 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.297 -0.41 . . . . 71.02 111.103 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 33.7 m -58.77 -22.23 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 112.874 0.694 . . . . 61.42 112.874 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.63 -13.0 61.7 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.371 0.605 . . . . 73.54 110.796 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 69.6 mtm -99.83 12.81 35.76 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.428 -0.805 . . . . 74.13 110.75 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . 0.551 ' HA ' HG22 ' B' ' 109' ' ' VAL . 3.9 p-10 -47.72 -40.47 20.46 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.054 0.761 . . . . 74.31 113.054 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -104.48 108.22 19.53 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 108.2 -1.037 . . . . 72.22 108.2 170.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 11.5 t -163.38 169.34 19.12 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.49 -0.93 . . . . 74.12 108.49 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.77 125.21 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 CA-C-O 121.606 0.717 . . . . 73.32 109.572 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' PHE . . . . . 0.428 ' O ' ' HG2' ' B' ' 105' ' ' ARG . 83.5 t80 -129.64 129.03 43.81 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.628 -0.879 . . . . 74.43 108.628 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' ARG . . . . . 0.519 ' HD2' ' OD1' ' B' ' 45' ' ' ASP . 24.2 ttm-85 55.57 31.91 18.09 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.541 1.136 . . . . 75.23 110.514 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.29 5.62 87.04 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 114.497 -1.229 . . . . 61.43 114.083 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' B' ' 102' ' ' PHE . 12.8 ptm180 -129.11 148.31 51.04 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 117.558 0.679 . . . . 73.45 110.262 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 37.2 m -80.76 120.98 25.34 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.725 -0.472 . . . . 74.31 109.725 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 34.7 pt -102.43 171.1 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 C-N-CA 120.352 -0.539 . . . . 73.44 110.393 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -128.61 125.16 37.6 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 109.267 -0.642 . . . . 75.15 109.267 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 33.2 m -127.66 124.4 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-O 121.203 0.525 . . . . 73.3 111.727 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.02 164.05 24.11 Favored Pre-proline 0 C--O 1.197 -1.71 0 N-CA-C 106.916 -1.513 . . . . 70.31 106.916 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -66.45 143.82 70.96 Favored 'Trans proline' 0 CA--C 1.568 2.195 0 C-N-CA 122.182 1.921 . . . . 73.44 114.328 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.516 ' HG3' ' CD1' ' B' ' 82' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.83 0 C-N-CA 123.125 0.57 . . . . 72.32 109.83 -177.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 120.964 0.411 . . . . 71.4 111.06 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.8 pt -70.77 -33.42 52.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.705 -0.68 . . . . 64.04 110.566 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -56.13 -44.57 79.28 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.46 1.104 . . . . 74.0 109.654 175.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -55.56 -29.67 59.41 Favored 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 115.19 -0.914 . . . . 74.54 112.888 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.49 ' HA ' HG11 ' A' ' 91' ' ' VAL . 17.4 ptp180 -119.53 18.03 12.83 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 121.45 0.643 . . . . 53.33 111.566 -172.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.447 ' OG ' ' HG2' ' A' ' 84' ' ' GLU . 47.2 t -107.57 169.15 8.76 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.788 -0.642 . . . . 72.02 111.249 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 111' ' ' PRO . 11.2 m -140.33 163.72 23.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 124.496 1.118 . . . . 55.22 111.488 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.423 ' HB3' ' HB2' ' A' ' 110' ' ' LEU . 21.4 t80 -116.26 129.7 56.41 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 125.227 1.411 . . . . 65.5 109.608 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 63.0 t -109.12 117.49 54.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.744 -1.206 . . . . 62.34 107.744 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.04 163.75 12.13 Favored Glycine 0 N--CA 1.426 -2.01 0 C-N-CA 119.522 -1.323 . . . . 60.21 113.055 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.9 t30 63.38 13.06 6.76 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.895 1.678 . . . . 63.45 112.883 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.9 p -64.49 137.62 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.452 0.644 . . . . 71.42 109.533 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -91.09 159.02 16.32 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.394 -0.821 . . . . 53.22 111.435 -174.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.463 ' CE2' ' HB2' ' A' ' 77' ' ' PRO . 4.5 m-85 -61.09 -19.16 61.12 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 114.951 -1.022 . . . . 70.4 112.013 178.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.86 -24.11 77.34 Favored Glycine 0 N--CA 1.428 -1.856 0 CA-C-N 115.88 -0.6 . . . . 73.5 111.727 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.5 m -86.32 140.01 30.46 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 120.581 -0.447 . . . . 74.52 109.844 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.465 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 76.0 p -109.15 173.25 6.4 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.119 -0.492 . . . . 63.13 110.778 -176.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.424 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -67.19 -45.27 77.42 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 110.062 -0.348 . . . . 72.51 110.062 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -58.49 -42.28 87.22 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.472 -0.331 . . . . 73.1 111.229 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.465 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 1.4 t70 -64.35 -37.9 89.13 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.689 0.757 . . . . 72.34 109.02 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 33.7 mt -68.51 -47.93 65.71 Favored 'General case' 0 C--O 1.249 1.038 0 CA-C-N 114.965 -1.016 . . . . 75.4 111.096 177.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -60.81 -49.8 76.03 Favored 'General case' 0 C--O 1.198 -1.654 0 CA-C-N 116.355 -0.384 . . . . 63.22 111.144 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.49 -40.08 77.84 Favored 'General case' 0 C--O 1.258 1.53 0 CA-C-O 121.367 0.603 . . . . 75.25 111.184 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -69.02 -41.09 78.2 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.154 -0.93 . . . . 61.14 110.715 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -82.66 -22.85 34.46 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 113.055 0.761 . . . . 75.32 113.055 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.7 m -72.11 -21.23 61.51 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-N 115.19 -0.914 . . . . 75.35 110.979 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.1 m -57.68 -17.78 16.92 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.388 -0.369 . . . . 53.2 111.161 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.872 ' SG ' ' HA ' ' A' ' 90' ' ' SER . 44.1 t -94.4 -76.56 0.48 Allowed 'General case' 0 N--CA 1.417 -2.08 0 CA-C-O 120.789 0.328 . . . . 54.11 110.638 175.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -130.06 -143.33 5.38 Favored Glycine 0 CA--C 1.508 -0.351 0 C-N-CA 120.257 -0.973 . . . . 54.45 115.217 -176.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.0 m -105.13 121.51 43.96 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 122.437 0.295 . . . . 71.34 110.991 -173.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 61.2 mt -85.22 129.27 38.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 116.028 -0.533 . . . . 64.31 112.014 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -93.4 -44.75 8.12 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.51 0.724 . . . . 75.44 111.504 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -149.12 159.55 44.14 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.216 -0.902 . . . . 75.14 110.27 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.442 HD13 HG21 ' A' ' 66' ' ' ILE . 39.4 pt -145.34 135.0 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.994 0 N-CA-C 106.753 -1.573 . . . . 73.32 106.753 170.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.0 m -124.78 123.8 40.75 Favored 'General case' 0 C--N 1.272 -2.799 0 N-CA-C 106.112 -1.81 . . . . 75.11 106.112 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.6 mp -121.24 117.39 52.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 106.562 -1.644 . . . . 72.3 106.562 -175.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.35 0.9 OUTLIER -121.32 129.83 53.31 Favored 'General case' 0 C--N 1.274 -2.676 0 C-N-CA 120.127 -0.629 . . . . 74.33 112.558 177.763 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.576 ' HB2' HG12 ' B' ' 66' ' ' ILE . 81.0 m -116.55 121.21 41.1 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 115.647 -0.706 . . . . 74.35 109.256 -177.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.608 ' HA ' ' HA ' ' B' ' 65' ' ' ARG . 1.1 t70 -117.48 125.45 50.92 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 123.757 0.823 . . . . 70.14 110.586 -173.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.55 ' HE2' ' HB3' ' A' ' 77' ' ' PRO . 39.6 ttmt -115.9 16.73 16.17 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.224 -0.658 . . . . 73.5 109.224 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.423 ' HD1' ' N ' ' A' ' 74' ' ' SER . 0.0 OUTLIER -63.61 -23.15 67.26 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 119.934 -0.706 . . . . 74.5 112.817 -175.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.423 ' N ' ' HD1' ' A' ' 73' ' ' PHE . 14.9 m -81.79 -0.9 45.32 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.154 -0.475 . . . . 62.32 111.134 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.9 -40.57 2.38 Favored Glycine 0 CA--C 1.5 -0.881 0 N-CA-C 110.095 -1.202 . . . . 75.33 110.095 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -95.14 130.28 33.0 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 107.923 -1.14 . . . . 61.41 107.923 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.55 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 36.8 Cg_endo -70.74 118.07 5.49 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.387 1.392 . . . . 72.32 110.505 177.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 37.2 mtmm -108.61 151.45 26.11 Favored 'General case' 0 CA--C 1.476 -1.898 0 CA-C-N 116.242 -0.436 . . . . 72.2 109.943 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.42 140.07 11.5 Favored Glycine 0 N--CA 1.409 -3.159 0 C-N-CA 120.517 -0.849 . . . . 72.21 111.025 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -151.41 144.13 24.37 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.788 -0.449 . . . . 73.51 109.788 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.42 154.81 49.89 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.968 -0.382 . . . . 74.42 109.968 -173.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -122.39 120.57 34.37 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 108.544 -0.91 . . . . 73.2 108.544 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.5 mm -101.73 119.22 49.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 107.17 -1.418 . . . . 74.14 107.17 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.447 ' HG2' ' OG ' ' A' ' 38' ' ' SER . 32.9 mt-10 -104.97 120.47 41.53 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.157 -0.682 . . . . 55.11 109.157 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -100.38 165.44 11.45 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 121.378 0.609 . . . . 65.14 112.055 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.48 ' O ' ' HD3' ' A' ' 37' ' ' ARG . . . -81.16 -32.37 33.67 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.728 -1.124 . . . . 42.32 110.965 175.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -123.5 160.67 26.46 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 113.246 0.832 . . . . 74.03 113.246 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -69.54 -32.48 71.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.359 -1.291 . . . . 75.24 112.279 174.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -60.74 -36.56 79.19 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.948 -0.301 . . . . 73.51 110.702 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.872 ' HA ' ' SG ' ' A' ' 60' ' ' CYS . 14.8 m -63.33 -45.2 92.34 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 116.574 -0.284 . . . . 61.35 111.403 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.49 HG11 ' HA ' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -65.7 -43.2 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 119.317 -0.373 . . . . 73.34 111.71 177.54 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.2 -35.28 75.04 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.687 0.625 . . . . 72.03 112.687 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.579 ' HB3' ' SG ' ' A' ' 60' ' ' CYS . . . -75.34 -37.89 60.46 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.122 0.486 . . . . 64.21 110.954 177.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.51 -40.64 76.83 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 116.086 -0.507 . . . . 73.22 111.861 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 91' ' ' VAL . 24.5 m -56.64 -22.16 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 112.282 0.475 . . . . 62.31 112.282 177.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.89 -19.38 62.62 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-O 120.894 0.378 . . . . 64.51 110.043 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 32.4 mtm -88.46 7.68 31.67 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.202 0.601 . . . . 75.4 111.935 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.564 ' HA ' ' HB ' ' A' ' 109' ' ' VAL . 7.3 t70 -33.39 -54.11 0.41 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 116.938 2.199 . . . . 55.33 116.938 -178.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -124.42 45.37 2.53 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 120.495 1.498 . . . . 74.33 110.125 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 42.9 m -84.95 162.37 19.44 Favored 'General case' 0 CA--C 1.571 1.759 0 CA-C-N 114.3 -1.318 . . . . 63.2 109.752 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.0 p -99.71 137.86 25.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 O-C-N 121.465 -0.772 . . . . 72.2 110.646 -174.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -151.2 117.87 5.77 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.467 -0.938 . . . . 65.22 108.467 -177.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.381 83.2 mtt85 59.99 55.09 3.92 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 116.078 1.881 . . . . 71.23 116.078 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.99 -13.05 1.45 Allowed Glycine 0 N--CA 1.469 0.856 0 CA-C-N 114.806 -1.088 . . . . 44.2 114.893 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -119.39 161.08 21.09 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-O 121.012 0.434 . . . . 71.45 110.383 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.9 m -94.59 127.81 40.78 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 108.366 -0.975 . . . . 64.2 108.366 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 48.2 pt -101.37 171.27 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.334 0 C-N-CA 119.782 -0.767 . . . . 75.25 109.949 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 55.1 tptt -125.88 129.35 49.17 Favored 'General case' 0 N--CA 1.409 -2.522 0 CA-C-N 114.791 -1.095 . . . . 64.11 108.809 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.564 ' HB ' ' HA ' ' A' ' 98' ' ' ASP . 47.3 t -119.95 112.25 36.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 107.658 -1.238 . . . . 72.41 107.658 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 40' ' ' TYR . 72.8 mt -112.4 152.59 44.67 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 109.017 -0.734 . . . . 75.2 109.017 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.452 ' HA ' HG12 ' A' ' 39' ' ' VAL . 3.3 Cg_exo -75.44 129.9 12.36 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 N-CA-C 107.892 -1.618 . . . . 52.41 107.892 171.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.418 ' H ' ' HA ' ' A' ' 39' ' ' VAL . 87.1 tttt . . . . . 0 CA--C 1.487 -1.446 0 N-CA-C 107.584 -1.265 . . . . 71.24 107.584 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.411 0 N-CA-C 112.141 -0.384 . . . . 51.23 112.141 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.439 ' N ' ' HD2' ' B' ' 23' ' ' PRO . 72.1 Cg_exo -49.74 -44.9 34.19 Favored 'Trans proline' 0 CA--C 1.567 2.125 0 C-N-CA 123.871 3.048 . . . . 73.02 116.031 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' B' ' 22' ' ' PRO . 10.3 Cg_endo -53.84 142.2 63.82 Favored 'Trans proline' 0 C--N 1.395 2.975 0 C-N-CA 121.96 1.774 . . . . 75.05 111.36 176.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -54.16 129.16 58.84 Favored Pre-proline 0 C--O 1.241 0.63 0 N-CA-C 113.454 0.909 . . . . 71.42 113.454 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -59.99 135.51 63.38 Favored 'Trans proline' 0 CA--C 1.501 -1.155 0 C-N-CA 123.641 2.894 . . . . 55.02 114.139 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.512 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -113.92 125.89 54.54 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 107.037 -1.468 . . . . 73.11 107.037 173.346 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 32.8 t -71.84 173.94 7.58 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 113.479 0.918 . . . . 54.14 113.479 -168.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.511 ' O ' ' HG3' ' B' ' 32' ' ' LYS . . . -49.0 -46.17 43.54 Favored 'General case' 0 C--O 1.21 -0.982 0 CA-C-N 114.491 -1.231 . . . . 72.3 112.288 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -68.0 -33.01 73.8 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 112.054 0.39 . . . . 72.33 112.054 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.44 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.9 OUTLIER -65.71 -39.42 91.2 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.446 -0.576 . . . . 60.02 109.446 172.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -67.06 -36.87 82.98 Favored 'General case' 0 C--O 1.207 -1.149 0 CA-C-N 115.573 -0.739 . . . . 74.01 110.087 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' B' ' 28' ' ' ALA . 59.9 mtpt -66.35 -40.24 89.69 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 113.497 0.925 . . . . 75.53 113.497 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -70.08 -39.77 75.39 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 120.299 -0.56 . . . . 71.2 111.281 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.44 HG12 ' O ' ' B' ' 30' ' ' GLU . 11.1 pt -70.57 -32.99 51.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.785 -0.643 . . . . 63.21 110.328 178.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' B' ' 32' ' ' LYS . 10.4 t70 -56.35 -42.96 78.6 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.827 1.251 . . . . 72.4 109.699 176.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 97.7 mttt -57.64 -33.28 68.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.05 -0.977 . . . . 64.22 112.015 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -102.89 2.55 35.42 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 123.713 0.805 . . . . 73.11 111.23 -172.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 71.1 p -104.33 162.94 12.79 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 114.51 1.3 . . . . 62.23 114.51 -175.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 13.9 m -133.4 163.61 37.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.674 -1.148 . . . . 40.2 111.08 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . 0.486 ' CD2' HD12 ' B' ' 110' ' ' LEU . 23.1 t80 -116.17 130.53 56.84 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 125.281 1.432 . . . . 74.11 109.346 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 71.7 t -109.89 120.49 61.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 124.766 1.226 . . . . 41.11 109.06 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -118.59 169.38 13.44 Favored Glycine 0 N--CA 1.427 -1.95 0 C-N-CA 120.139 -1.029 . . . . 41.12 112.453 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 60.6 t30 65.97 12.54 8.5 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 126.451 1.901 . . . . 75.23 112.834 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -72.09 117.43 15.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 108.218 -1.03 . . . . 63.2 108.218 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -77.04 162.0 27.86 Favored 'General case' 0 C--O 1.253 1.288 0 C-N-CA 119.941 -0.703 . . . . 73.13 111.611 -173.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -69.01 98.52 0.97 Allowed 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 107.21 -1.404 . . . . 74.35 107.21 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 159.15 -26.08 0.36 Allowed Glycine 0 N--CA 1.417 -2.574 0 C-N-CA 120.539 -0.838 . . . . 61.21 112.051 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.7 t -77.18 149.46 35.57 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.7 -1.222 . . . . 72.23 107.7 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 25.2 p -99.55 167.54 10.53 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.444 -0.502 . . . . 74.12 110.883 -173.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.44 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -71.04 -41.78 70.34 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 109.102 -0.703 . . . . 74.15 109.102 177.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -57.39 -44.16 84.25 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.136 -0.484 . . . . 72.43 111.094 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.88 -45.95 78.45 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.133 0.492 . . . . 64.22 110.381 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 74.6 mt -64.26 -47.68 78.69 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.094 -0.957 . . . . 73.43 111.862 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.445 ' HG3' HD12 ' B' ' 63' ' ' ILE . 34.1 tt0 -62.92 -50.85 69.22 Favored 'General case' 0 C--O 1.199 -1.59 0 C-N-CA 120.498 -0.481 . . . . 73.43 111.372 -178.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.97 -40.08 72.73 Favored 'General case' 0 C--O 1.257 1.467 0 CA-C-O 121.594 0.711 . . . . 73.24 111.454 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -69.35 -41.56 76.45 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.78 -1.1 . . . . 73.45 110.542 -176.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -83.06 -23.19 33.27 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.903 0.705 . . . . 73.34 112.903 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 67.1 m -71.32 -22.72 61.89 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 115.472 -0.785 . . . . 62.21 109.534 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 58.3 m -65.84 -18.12 65.12 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.739 -0.664 . . . . 62.3 109.96 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . 0.565 ' O ' ' HA ' ' B' ' 90' ' ' SER . 70.3 m -115.29 19.18 15.74 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 116.245 -0.434 . . . . 54.25 111.669 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . 0.43 ' HA3' ' OG ' ' B' ' 90' ' ' SER . . . 149.03 -162.64 28.99 Favored Glycine 0 N--CA 1.46 0.284 0 C-N-CA 118.282 -1.913 . . . . 72.04 116.034 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 15.1 m -111.1 115.1 28.86 Favored 'General case' 0 C--O 1.25 1.092 0 C-N-CA 123.018 0.527 . . . . 71.14 110.399 -175.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.445 HD12 ' HG3' ' B' ' 54' ' ' GLU . 65.5 mt -80.73 130.85 35.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.668 0.747 . . . . 71.45 112.995 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -100.31 -43.81 6.14 Favored 'General case' 0 C--O 1.21 -1.001 0 N-CA-C 107.09 -1.448 . . . . 61.25 107.09 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.608 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 86.4 mtt180 -153.64 161.88 41.76 Favored 'General case' 0 C--O 1.21 -1.014 0 C-N-CA 123.732 0.813 . . . . 75.41 110.384 176.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.576 HG12 ' HB2' ' A' ' 70' ' ' CYS . 31.9 pt -144.79 137.81 22.15 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.495 0 N-CA-C 106.656 -1.609 . . . . 73.32 106.656 169.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' B' ' 81' ' ' ALA . 53.3 m -125.75 120.82 31.64 Favored 'General case' 0 C--N 1.273 -2.745 0 N-CA-C 106.912 -1.514 . . . . 63.03 106.912 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mp -117.08 116.72 52.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 106.278 -1.749 . . . . 72.31 106.278 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.306 1.5 pt? -122.12 132.69 54.61 Favored 'General case' 0 C--N 1.275 -2.669 0 C-N-CA 119.666 -0.814 . . . . 73.04 111.531 176.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 73.5 m -116.68 120.5 38.82 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 115.108 -0.951 . . . . 54.43 108.592 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.426 ' HB2' ' CE2' ' B' ' 73' ' ' PHE . 2.4 p-10 -106.14 121.66 44.62 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 116.513 -2.075 . . . . 71.43 111.061 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . 0.468 ' HE3' ' HG3' ' B' ' 77' ' ' PRO . 43.8 mtpt -118.05 -6.79 10.91 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.446 -1.252 . . . . 74.1 111.157 -176.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.426 ' CE2' ' HB2' ' B' ' 71' ' ' ASP . 52.6 p90 -69.93 -17.2 63.31 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.556 0.693 . . . . 63.25 109.837 -177.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 20.1 m -81.21 -1.78 46.12 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.283 -0.871 . . . . 71.31 109.692 176.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.26 -59.66 0.37 Allowed Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 110.979 -0.849 . . . . 65.24 110.979 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . 0.478 ' HA ' ' HD3' ' B' ' 77' ' ' PRO . 72.5 m80 -96.5 131.15 28.9 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 110.167 -0.308 . . . . 72.41 110.167 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' B' ' 76' ' ' HIS . 13.6 Cg_exo -72.87 119.28 5.98 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.589 2.193 . . . . 51.45 112.616 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 37.1 mtmm -112.31 154.83 25.08 Favored 'General case' 0 CA--C 1.48 -1.732 0 N-CA-C 108.069 -1.086 . . . . 71.0 108.069 174.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.56 141.13 12.29 Favored Glycine 0 N--CA 1.411 -3.027 0 C-N-CA 119.612 -1.28 . . . . 74.31 112.325 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -154.61 145.33 22.4 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.001 -0.599 . . . . 74.52 109.634 175.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' B' ' 67' ' ' THR . . . -137.69 154.98 49.59 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 116.216 -0.447 . . . . 53.3 110.381 -172.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' B' ' 66' ' ' ILE . 49.1 m-85 -123.61 119.08 28.82 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.624 -0.88 . . . . 70.31 108.624 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.53 HG23 HG22 ' B' ' 66' ' ' ILE . 19.5 mm -101.66 119.94 50.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 107.07 -1.456 . . . . 75.42 107.07 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -107.19 125.55 51.25 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 108.579 -0.897 . . . . 64.53 108.579 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -106.7 164.52 12.02 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 120.994 0.426 . . . . 72.22 110.471 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.95 -18.72 23.31 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.743 -0.662 . . . . 72.32 111.097 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -127.24 142.06 51.57 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.297 -0.411 . . . . 74.41 111.118 -176.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -61.29 -34.4 75.15 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.116 0.784 . . . . 63.33 113.116 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -56.84 -37.16 70.89 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.537 -0.301 . . . . 74.11 111.103 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' B' ' 60' ' ' CYS . 15.0 m -62.92 -43.91 97.5 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 111.766 0.284 . . . . 74.33 111.766 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.494 ' O ' HG13 ' B' ' 95' ' ' VAL 0.3 0.7 OUTLIER -67.31 -42.9 88.18 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 C-N-CA 120.426 -0.51 . . . . 65.51 111.924 177.515 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -59.55 -36.29 75.88 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.491 -0.484 . . . . 74.14 112.291 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.19 -35.68 63.97 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.802 0.334 . . . . 74.23 111.402 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.57 -38.42 62.68 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.254 -0.43 . . . . 75.04 111.958 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . 0.494 HG13 ' O ' ' B' ' 91' ' ' VAL . 28.0 m -58.94 -23.3 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 112.175 0.435 . . . . 72.43 112.175 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.24 -9.89 58.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.419 0.628 . . . . 52.14 111.142 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 8.0 ttp -103.23 7.05 38.52 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.383 -0.969 . . . . 61.23 108.383 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . 0.515 ' HA ' ' HB ' ' B' ' 109' ' ' VAL . 4.1 p-10 -41.24 -56.79 2.3 Favored 'General case' 0 C--O 1.209 -1.062 0 N-CA-C 113.463 0.912 . . . . 61.04 113.463 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -101.7 97.12 7.57 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 118.474 0.579 . . . . 71.45 109.735 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 26.0 p -145.83 165.04 30.05 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.212 -0.904 . . . . 74.21 110.537 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 p -107.63 119.46 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-O 121.359 0.599 . . . . 73.3 109.968 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -131.91 127.77 37.13 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.688 -0.687 . . . . 72.13 109.255 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 48.6 ttt-85 62.17 33.2 17.02 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 122.547 1.165 . . . . 74.43 110.229 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.41 5.98 86.45 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 114.073 -1.421 . . . . 70.14 114.899 175.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -136.92 155.72 49.39 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 117.76 0.78 . . . . 71.11 111.077 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 46.8 m -78.49 123.92 27.57 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.921 -0.77 . . . . 63.14 108.921 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 41.4 pt -101.38 171.35 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 C-N-CA 119.969 -0.692 . . . . 74.51 109.643 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -124.43 137.48 54.44 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 106.858 -1.534 . . . . 55.0 106.858 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . 0.515 ' HB ' ' HA ' ' B' ' 98' ' ' ASP . 24.9 t -127.33 122.72 60.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.636 -1.246 . . . . 65.43 107.636 174.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.486 HD12 ' CD2' ' B' ' 40' ' ' TYR . 73.9 mt -121.08 150.1 52.75 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 109.308 -0.627 . . . . 74.0 109.308 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -81.63 135.28 9.05 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 C-N-CA 121.778 1.652 . . . . 75.01 108.16 170.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt . . . . . 0 C--N 1.304 -1.374 0 C-N-CA 119.484 -0.887 . . . . 74.24 109.477 -179.107 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 . . . . . 0 C--O 1.22 -0.482 0 N-CA-C 112.259 0.466 . . . . 72.54 112.259 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.9 pt -70.12 -35.87 65.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 120.513 -0.475 . . . . 72.45 111.059 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.667 ' OD1' ' HE3' ' A' ' 112' ' ' LYS . 30.0 t70 -68.44 -39.27 81.57 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.397 0.679 . . . . 64.24 110.563 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -66.61 -14.5 62.48 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.709 -0.678 . . . . 72.41 112.295 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -112.73 12.69 19.7 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 110.003 -0.369 . . . . 61.41 110.003 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.515 ' OG ' ' HB3' ' A' ' 112' ' ' LYS . 97.5 p -97.02 157.32 15.96 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.639 0.733 . . . . 75.14 112.392 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.59 HG22 HG23 ' A' ' 91' ' ' VAL . 49.0 t -127.82 151.53 34.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 114.912 -1.04 . . . . 70.44 108.401 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.668 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 24.4 t80 -104.4 127.66 52.12 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 125.055 1.342 . . . . 72.43 107.847 174.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.408 ' HA ' HG12 ' A' ' 109' ' ' VAL . 60.6 t -115.44 116.43 52.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 107.927 -1.138 . . . . 75.43 107.927 177.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.26 164.34 12.09 Favored Glycine 0 C--N 1.29 -1.987 0 C-N-CA 119.669 -1.253 . . . . 75.21 112.946 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 t30 68.75 25.02 6.46 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 125.677 1.591 . . . . 74.3 113.163 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.7 p -78.56 119.82 28.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 118.457 -1.297 . . . . 72.42 108.489 174.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -110.87 149.66 30.29 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.995 -1.113 . . . . 70.14 107.995 -173.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -51.45 115.58 1.67 Allowed 'General case' 0 CA--C 1.496 -1.102 0 CA-C-O 122.287 1.041 . . . . 71.43 112.128 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.19 -33.47 0.93 Allowed Glycine 0 N--CA 1.406 -3.318 0 N-CA-C 107.116 -2.393 . . . . 63.1 107.116 -174.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.5 m -102.61 141.85 34.75 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 108.327 -0.99 . . . . 74.33 108.327 173.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.6 p -115.88 178.73 4.2 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 120.4 0.143 . . . . 75.2 111.148 -176.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.528 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -64.64 -40.39 95.37 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 122.88 0.472 . . . . 75.32 110.542 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.54 -43.19 84.19 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 116.039 -0.528 . . . . 75.32 109.792 176.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -60.57 -38.8 85.78 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.382 0.61 . . . . 45.54 109.924 176.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.25 -46.94 75.38 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.187 -0.915 . . . . 35.42 111.066 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -58.75 -50.71 72.92 Favored 'General case' 0 C--O 1.19 -2.047 0 C-N-CA 120.434 -0.507 . . . . 64.43 111.762 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.8 -48.27 78.32 Favored 'General case' 0 C--O 1.271 2.187 0 CA-C-O 121.595 0.712 . . . . 71.34 111.795 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -67.31 -40.47 86.0 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.848 -1.069 . . . . 72.44 110.609 -175.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.467 ' HZ ' HG11 ' A' ' 109' ' ' VAL . 43.8 m-85 -81.57 -22.9 37.5 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 114.365 1.246 . . . . 54.22 114.365 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.1 m -69.85 -24.41 63.43 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.391 -0.368 . . . . 72.35 110.144 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.4 m -59.18 -31.22 68.8 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 119.908 -0.717 . . . . 74.34 109.674 172.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 60.9 m -85.92 3.05 43.64 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 112.909 0.707 . . . . 55.21 112.909 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.94 -158.09 26.15 Favored Glycine 0 N--CA 1.463 0.479 0 C-N-CA 119.528 -1.32 . . . . 65.52 114.138 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.1 m -105.46 126.03 51.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.925 0.393 . . . . 72.15 110.981 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 63.3 mt -91.74 127.28 44.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 115.633 -0.712 . . . . 65.51 111.885 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.554 ' ND2' ' HA ' ' A' ' 86' ' ' ALA . 90.3 m-20 -89.23 -42.1 11.82 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 121.325 0.583 . . . . 72.24 111.276 175.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.432 ' HG2' ' HA ' ' B' ' 71' ' ' ASP . 77.1 mtt180 -153.32 161.23 42.57 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.716 -0.675 . . . . 73.14 110.03 -176.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.528 HD11 ' HB1' ' A' ' 50' ' ' ALA . 35.0 pt -146.0 139.69 21.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 107.562 -1.273 . . . . 74.51 107.562 172.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.4 m -124.74 125.98 44.93 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 106.295 -1.743 . . . . 72.11 106.295 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mp -123.27 117.69 52.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 105.883 -1.895 . . . . 51.23 105.883 -177.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.288 1.0 OUTLIER -120.38 128.46 53.25 Favored 'General case' 0 C--N 1.284 -2.28 0 C-N-CA 120.443 -0.503 . . . . 74.13 112.175 179.031 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 78.3 m -115.31 129.31 56.57 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 115.759 -0.655 . . . . 61.03 110.1 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.454 ' HA ' ' HG2' ' B' ' 65' ' ' ARG . 17.0 t70 -114.69 125.33 53.61 Favored 'General case' 0 CA--C 1.492 -1.285 0 N-CA-C 112.174 0.435 . . . . 64.02 112.174 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -122.12 9.56 9.91 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 109.078 -0.712 . . . . 73.15 109.078 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.498 ' HB3' ' HB3' ' B' ' 64' ' ' ASN . 0.1 OUTLIER -64.79 -16.76 63.48 Favored 'General case' 0 C--N 1.361 1.095 0 N-CA-C 113.438 0.903 . . . . 62.53 113.438 -175.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.3 t -100.14 16.57 23.72 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-O 121.542 0.687 . . . . 70.13 109.847 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.64 -53.1 1.01 Allowed Glycine 0 CA--C 1.497 -1.066 0 C-N-CA 120.324 -0.941 . . . . 53.13 111.909 176.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -88.19 132.33 39.92 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 109.061 -0.718 . . . . 72.11 109.061 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -80.17 117.74 3.55 Favored 'Trans proline' 0 N--CA 1.431 -2.164 0 C-N-CA 121.329 1.353 . . . . 70.44 110.001 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 34.2 mtmm -115.19 162.7 16.69 Favored 'General case' 0 CA--C 1.466 -2.268 0 C-N-CA 123.9 0.88 . . . . 74.05 108.692 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -144.13 149.99 22.03 Favored Glycine 0 N--CA 1.411 -3.027 0 C-N-CA 118.914 -1.612 . . . . 22.42 113.481 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -146.99 144.32 29.09 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 114.199 -1.0 . . . . 61.35 108.451 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.17 152.49 50.85 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 110.302 -0.258 . . . . 64.44 110.302 -172.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.448 ' CZ ' ' HD1' ' A' ' 40' ' ' TYR . 69.1 m-85 -121.5 123.51 42.19 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 109.679 -0.489 . . . . 63.42 109.679 176.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.451 HG23 HG22 ' A' ' 66' ' ' ILE . 22.9 mm -102.35 121.05 52.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 107.433 -1.321 . . . . 72.42 107.433 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -103.0 119.3 38.6 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.516 -0.55 . . . . 75.32 109.516 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -96.38 158.94 15.2 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.458 0.647 . . . . 74.32 112.637 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.554 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . . . -67.0 -46.98 72.9 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.671 -1.149 . . . . 71.41 112.054 177.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -119.74 156.93 29.61 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 113.316 0.858 . . . . 73.04 113.316 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -61.98 -28.36 69.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.606 -1.179 . . . . 72.13 112.22 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.351 2.0 p-10 -71.26 -24.48 62.18 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 113.605 0.965 . . . . 50.4 113.605 177.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -72.35 -41.58 66.3 Favored 'General case' 0 N--CA 1.433 -1.294 0 O-C-N 122.204 -0.31 . . . . 74.43 111.344 177.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.59 HG23 HG22 ' A' ' 39' ' ' VAL . 7.6 p -63.42 -39.88 86.96 Favored 'Isoleucine or valine' 0 C--N 1.354 0.79 0 N-CA-C 109.646 -0.501 . . . . 72.41 109.646 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -62.98 -34.84 78.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.583 -0.735 . . . . 72.43 110.155 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.15 -38.68 63.65 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.878 -0.601 . . . . 64.33 112.252 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.88 -40.18 65.81 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 116.049 -0.523 . . . . 74.33 110.923 -176.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.463 HG11 ' HB3' ' A' ' 111' ' ' PRO . 30.0 m -59.43 -22.13 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 113.071 0.767 . . . . 70.41 113.071 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.15 -9.87 58.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 122.192 0.996 . . . . 71.41 110.709 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 8.5 ttp -104.51 7.77 35.37 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.416 -1.266 . . . . 60.23 108.406 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.691 ' HA ' HG22 ' A' ' 109' ' ' VAL . 2.8 p-10 -36.53 -50.92 0.82 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 116.645 2.091 . . . . 63.1 116.645 -175.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -123.69 55.58 1.25 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 119.999 1.272 . . . . 73.51 112.942 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.5 p -92.97 -175.71 3.97 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.119 -1.401 . . . . 71.2 110.837 174.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.95 126.07 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 121.322 0.582 . . . . 61.5 110.58 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -111.12 118.76 36.87 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.079 -0.712 . . . . 72.02 109.079 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 43.42 31.67 0.43 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.562 1.545 . . . . 75.42 113.7 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.59 -8.84 37.65 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.837 -0.697 . . . . 34.31 114.395 175.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -123.41 146.08 48.27 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 118.112 0.956 . . . . 74.3 110.033 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.7 m -78.41 118.87 20.99 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 120.551 -0.46 . . . . 75.05 110.014 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 pp -104.51 169.98 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 116.305 -0.407 . . . . 73.41 110.938 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 57.8 tptt -130.49 131.16 44.99 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.708 -0.849 . . . . 74.21 108.708 -176.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.691 HG22 ' HA ' ' A' ' 98' ' ' ASP . 36.0 m -126.47 135.33 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 120.975 0.417 . . . . 63.44 110.511 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.8 mt -131.03 148.53 70.64 Favored Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 108.981 -0.748 . . . . 60.23 108.981 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.463 ' HB3' HG11 ' A' ' 95' ' ' VAL . 55.5 Cg_endo -79.5 135.29 11.66 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 121.126 1.217 . . . . 32.42 109.341 175.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.667 ' HE3' ' OD1' ' A' ' 35' ' ' ASP . 37.3 ttpt . . . . . 0 C--N 1.294 -1.811 0 C-N-CA 118.03 -1.468 . . . . 73.44 109.731 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.411 -2.98 0 N-CA-C 107.606 -2.197 . . . . 60.13 107.606 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.53 ' HG2' ' CE2' ' A' ' 40' ' ' TYR . 57.9 Cg_exo -55.75 -36.31 94.9 Favored 'Trans proline' 0 CA--C 1.58 2.817 0 C-N-CA 123.08 2.52 . . . . 73.34 115.258 174.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -53.73 158.74 7.83 Favored 'Trans proline' 0 C--N 1.405 3.518 0 C-N-CA 121.952 1.768 . . . . 74.3 114.033 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -89.6 167.24 18.0 Favored Pre-proline 0 C--N 1.309 -1.178 0 CA-C-N 115.021 -0.99 . . . . 72.42 109.712 -177.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -77.35 159.75 32.7 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 121.208 1.272 . . . . 52.51 112.596 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -146.73 162.23 38.97 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.322 -0.854 . . . . 73.24 109.131 176.419 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.657 ' HB2' ' HG2' ' B' ' 30' ' ' GLU . 71.2 m -65.44 143.74 57.51 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 115.088 1.514 . . . . 55.24 115.088 -171.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' B' ' 31' ' ' LYS . . . -55.72 -34.65 65.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.043 -1.435 . . . . 71.43 112.699 174.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . 0.274 6.0 mt-10 -72.89 -29.22 63.0 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 113.327 0.862 . . . . 71.5 113.327 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.657 ' HG2' ' HB2' ' B' ' 27' ' ' SER . 2.3 mm-40 -67.87 -35.39 78.46 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.085 -1.08 . . . . 72.34 108.085 172.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' B' ' 28' ' ' ALA . 74.7 mmtt -60.81 -48.41 81.93 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.151 -0.932 . . . . 64.23 108.955 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -54.24 -49.39 69.59 Favored 'General case' 0 C--N 1.363 1.156 0 N-CA-C 112.752 0.649 . . . . 62.25 112.752 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -70.63 -42.51 70.78 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 112.825 0.676 . . . . 65.31 112.825 -170.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.491 HG12 ' O ' ' B' ' 30' ' ' GLU . 24.2 pt -68.9 -35.6 70.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.018 0.437 . . . . 74.33 110.31 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -67.53 -43.22 81.32 Favored 'General case' 0 C--O 1.201 -1.476 0 CA-C-N 115.533 -0.758 . . . . 73.0 110.418 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -63.24 -14.32 48.0 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.226 1.011 . . . . 72.41 113.388 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -118.57 20.86 12.83 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 121.598 0.713 . . . . 72.15 110.644 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.523 ' HB2' ' HB3' ' B' ' 112' ' ' LYS . 40.1 m -97.91 160.42 14.31 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.288 -0.869 . . . . 73.31 111.719 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.558 HG22 HG23 ' B' ' 91' ' ' VAL . 46.2 t -129.9 154.64 40.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.772 -0.825 . . . . 74.52 108.772 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . 0.66 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 30.0 t80 -108.49 125.58 51.95 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 125.214 1.405 . . . . 71.51 107.953 175.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.403 ' HA ' HG12 ' B' ' 109' ' ' VAL . 59.6 t -113.33 117.45 55.45 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.442 0 N-CA-C 108.431 -0.952 . . . . 64.34 108.431 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.93 173.8 15.33 Favored Glycine 0 N--CA 1.433 -1.555 0 C-N-CA 119.963 -1.113 . . . . 74.13 112.671 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 t30 67.97 22.53 8.53 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.697 1.599 . . . . 72.12 112.139 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 13.2 p -95.09 128.44 46.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 O-C-N 121.628 -0.67 . . . . 75.43 110.106 175.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -116.08 167.17 11.22 Favored 'General case' 0 CA--C 1.483 -1.596 0 N-CA-C 108.456 -0.942 . . . . 74.11 108.456 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -51.33 128.14 21.59 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.817 0.818 . . . . 73.13 110.694 173.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.96 -41.78 1.1 Allowed Glycine 0 N--CA 1.415 -2.748 0 N-CA-C 107.41 -2.276 . . . . 61.41 107.41 -172.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.2 m -95.76 140.23 30.85 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.046 -1.094 . . . . 72.31 108.046 174.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 74.0 p -111.3 177.62 4.6 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.693 -0.403 . . . . 72.04 110.499 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.505 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -66.88 -39.05 87.38 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.996 -0.372 . . . . 70.03 109.996 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.73 -44.05 85.73 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.848 -0.615 . . . . 73.15 109.997 175.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -56.99 -44.67 82.96 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.577 0.703 . . . . 73.02 109.525 175.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' B' ' 50' ' ' ALA . 78.3 mt -60.9 -47.76 84.92 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 114.597 -1.183 . . . . 75.13 112.16 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -58.89 -50.84 72.52 Favored 'General case' 0 C--O 1.198 -1.614 0 C-N-CA 120.412 -0.515 . . . . 63.13 112.126 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.67 -48.38 77.72 Favored 'General case' 0 C--O 1.265 1.9 0 CA-C-O 121.629 0.728 . . . . 65.14 111.783 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -66.73 -41.05 88.51 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.707 -1.133 . . . . 74.52 110.662 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -81.59 -23.09 37.31 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 114.229 1.196 . . . . 65.34 114.229 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 66.7 m -70.61 -24.16 62.69 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.307 -0.406 . . . . 52.04 109.964 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.3 m -58.79 -29.01 66.5 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-O 121.096 0.475 . . . . 65.13 109.94 172.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 60.0 m -92.27 6.37 47.03 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 113.07 0.767 . . . . 52.23 113.07 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 142.84 -158.38 27.1 Favored Glycine 0 C--O 1.226 -0.397 0 C-N-CA 119.143 -1.503 . . . . 61.13 114.371 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 49.9 m -106.21 125.79 51.43 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 122.444 -0.445 . . . . 72.21 111.241 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 71.3 mt -91.42 127.15 43.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 116.029 -0.532 . . . . 73.24 112.401 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . 0.642 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 87.3 m-20 -89.06 -43.54 11.02 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-N 116.029 -0.532 . . . . 73.43 110.792 175.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.454 ' HG2' ' HA ' ' A' ' 71' ' ' ASP . 40.0 mtt180 -150.96 161.25 43.08 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.869 -0.605 . . . . 75.13 110.524 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.505 HD11 ' HB1' ' B' ' 50' ' ' ALA . 38.2 pt -146.17 140.15 20.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 107.65 -1.241 . . . . 65.42 107.65 172.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 85.3 m -124.91 126.41 45.48 Favored 'General case' 0 C--N 1.273 -2.73 0 N-CA-C 106.786 -1.561 . . . . 50.22 106.786 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.6 mp -124.28 116.71 48.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 105.817 -1.92 . . . . 74.45 105.817 -177.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -120.56 129.37 53.75 Favored 'General case' 0 C--N 1.283 -2.287 0 C-N-CA 120.216 -0.594 . . . . 65.32 110.996 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' CYS . . . . . 0.425 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 79.4 m -116.22 129.57 56.36 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.383 -0.599 . . . . 73.33 109.383 -177.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.432 ' HA ' ' HG2' ' A' ' 65' ' ' ARG . 8.0 t70 -109.43 124.71 51.47 Favored 'General case' 0 CA--C 1.482 -1.665 0 N-CA-C 112.595 0.591 . . . . 64.32 112.595 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -119.76 3.01 11.14 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 114.973 -1.012 . . . . 70.54 111.358 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.432 ' HB3' ' HB3' ' A' ' 64' ' ' ASN . 0.8 OUTLIER -69.42 -22.44 63.67 Favored 'General case' 0 C--N 1.364 1.216 0 C-N-CA 119.084 -1.046 . . . . 73.02 110.67 -176.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 35.2 t -88.97 15.01 9.23 Favored 'General case' 0 CA--C 1.56 1.345 0 CA-C-N 115.242 -0.89 . . . . 62.12 109.599 177.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.75 -61.2 2.74 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.91 -0.586 . . . . 63.23 112.046 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . 0.419 ' HA ' ' HD3' ' B' ' 77' ' ' PRO . 37.0 m80 -85.87 129.32 54.87 Favored Pre-proline 0 C--O 1.252 1.216 0 C-N-CA 120.836 -0.346 . . . . 74.13 110.19 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' B' ' 76' ' ' HIS . 9.2 Cg_exo -72.01 117.47 5.16 Favored 'Trans proline' 0 CA--C 1.504 -1.019 0 C-N-CA 121.975 1.783 . . . . 44.33 110.699 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 35.0 mtmm -118.34 159.36 23.54 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 107.666 -1.235 . . . . 65.12 107.666 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -138.94 152.13 22.06 Favored Glycine 0 N--CA 1.411 -3.023 0 C-N-CA 119.055 -1.545 . . . . 73.51 113.312 177.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -149.64 144.99 26.51 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.273 -1.01 . . . . 70.32 108.273 173.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.22 152.83 51.17 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 116.56 -0.291 . . . . 70.22 110.604 -171.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' TYR . . . . . 0.422 ' CZ ' ' HD1' ' B' ' 40' ' ' TYR . 78.2 m-85 -122.45 124.17 42.99 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 109.517 -0.549 . . . . 74.0 109.517 175.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.487 HG23 HG22 ' B' ' 66' ' ' ILE . 23.2 mm -102.97 120.07 52.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.488 -1.301 . . . . 63.15 107.488 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -102.31 119.15 38.34 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.549 -0.908 . . . . 73.32 108.549 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -93.84 160.04 14.92 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 112.734 0.642 . . . . 75.33 112.734 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.642 ' HA ' ' ND2' ' B' ' 64' ' ' ASN . . . -66.61 -43.56 84.47 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.067 -0.969 . . . . 72.15 112.224 176.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -127.0 160.04 32.3 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.381 0.882 . . . . 73.31 113.381 -176.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -63.89 -24.98 67.95 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.517 1.127 . . . . 64.25 112.787 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -63.48 -39.3 94.09 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.457 -0.942 . . . . 72.51 108.457 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 18.6 m -68.97 -38.68 79.5 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.314 -0.857 . . . . 60.23 112.074 -172.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.558 HG23 HG22 ' B' ' 39' ' ' VAL . 7.5 p -65.01 -40.6 89.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 109.201 -0.666 . . . . 74.43 109.201 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.0 -34.33 77.76 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.549 0.69 . . . . 60.3 110.271 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.86 -37.68 64.68 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.73 -0.668 . . . . 74.52 111.111 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.1 -38.78 61.05 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 120.635 -0.426 . . . . 61.24 111.176 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . 0.491 HG11 ' HB3' ' B' ' 111' ' ' PRO . 30.1 m -59.66 -22.47 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 112.787 0.662 . . . . 71.05 112.787 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.87 -9.17 50.07 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.145 0.497 . . . . 60.05 110.177 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 22.7 mtm -97.51 4.0 50.54 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 112.843 0.683 . . . . 75.33 112.843 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . 0.582 ' HA ' HG22 ' B' ' 109' ' ' VAL . 2.3 p30 -43.86 -38.18 3.2 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 116.77 2.137 . . . . 71.43 116.77 -174.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -117.09 28.03 8.76 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 119.629 1.104 . . . . 74.34 111.405 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 73.6 p -84.41 177.46 8.13 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 121.245 -0.909 . . . . 61.52 111.55 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 13.0 p -101.27 145.73 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 N-CA-C 109.387 -0.598 . . . . 65.01 109.387 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -143.85 121.75 12.01 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.381 -0.97 . . . . 70.23 108.381 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 56.9 ttt-85 52.01 33.59 12.19 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 124.529 1.132 . . . . 72.34 111.868 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.65 1.57 70.95 Favored Glycine 0 C--N 1.313 -0.725 0 CA-C-N 115.188 -0.914 . . . . 71.11 114.33 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -126.94 157.9 38.24 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 117.544 0.672 . . . . 53.11 109.806 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 41.8 m -88.43 120.21 29.59 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.086 -1.079 . . . . 62.05 108.086 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 43.4 pt -101.83 172.0 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 C-N-CA 119.737 -0.785 . . . . 70.15 110.484 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -128.65 127.16 41.65 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.957 -0.757 . . . . 61.3 108.957 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 27.0 m -126.6 134.52 66.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 O-C-N 123.441 0.463 . . . . 62.41 111.018 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 96.4 mt -128.31 148.28 67.19 Favored Pre-proline 0 C--N 1.298 -1.642 0 N-CA-C 109.206 -0.665 . . . . 63.53 109.206 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.491 ' HB3' HG11 ' B' ' 95' ' ' VAL . 53.2 Cg_endo -79.28 133.82 11.05 Favored 'Trans proline' 0 N--CA 1.439 -1.711 0 C-N-CA 121.493 1.462 . . . . 74.15 111.22 175.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.523 ' HB3' ' HB2' ' B' ' 38' ' ' SER . 27.9 ttpp . . . . . 0 N--CA 1.41 -2.446 0 N-CA-C 105.75 -1.945 . . . . 51.32 105.75 173.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.416 ' HB3' HH21 ' A' ' 37' ' ' ARG . 60.0 mm-40 . . . . . 0 C--O 1.224 -0.26 0 CA-C-O 121.138 0.494 . . . . 55.42 111.62 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.57 HD12 ' NH2' ' A' ' 65' ' ' ARG . 12.7 pt -70.82 -33.77 53.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.656 -0.702 . . . . 70.04 110.679 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.406 ' OD2' ' NZ ' ' A' ' 112' ' ' LYS . 13.9 t70 -66.0 -38.83 89.48 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.837 0.855 . . . . 74.44 108.887 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -57.4 -30.72 65.15 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.278 -0.874 . . . . 75.34 110.859 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.416 HH21 ' HB3' ' A' ' 33' ' ' GLU . 54.2 mtm180 -104.09 18.82 21.27 Favored 'General case' 0 N--CA 1.419 -2.013 0 CA-C-N 114.842 -1.072 . . . . 71.14 111.856 -175.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.0 m -95.87 146.44 24.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.605 0.717 . . . . 64.01 111.152 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.434 HG22 ' HB ' ' A' ' 83' ' ' ILE . 33.7 m -127.95 160.69 37.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.932 -0.766 . . . . 62.33 108.932 176.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.576 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 28.1 t80 -109.14 126.06 52.83 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.497 -0.927 . . . . 74.11 108.497 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.52 ' HA ' HG12 ' A' ' 109' ' ' VAL . 61.3 t -114.49 111.82 37.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.841 -1.17 . . . . 65.42 107.841 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.2 171.62 13.87 Favored Glycine 0 C--N 1.304 -1.243 0 C-N-CA 120.267 -0.968 . . . . 52.42 113.215 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.479 ' ND2' ' HB3' ' A' ' 105' ' ' ARG . 4.8 t30 58.65 24.89 12.61 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 125.391 1.477 . . . . 40.2 110.037 -178.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 p -92.63 9.17 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.418 0 CA-C-N 114.524 -1.216 . . . . 61.44 110.069 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.54 ' OD2' ' HA ' ' A' ' 78' ' ' LYS . 6.0 m-20 -37.07 106.84 0.05 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 128.235 2.614 . . . . 72.03 113.617 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.415 ' C ' ' H ' ' A' ' 48' ' ' SER 0.4 41.3 m-85 50.11 162.81 0.0 OUTLIER 'General case' 0 C--N 1.351 0.643 0 N-CA-C 118.116 2.636 . . . . 75.54 118.116 179.436 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.438 ' HA3' ' NH1' ' A' ' 103' ' ' ARG . . . 80.94 -36.97 2.33 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.284 -0.871 . . . . 70.14 111.462 -177.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 46' ' ' TYR . 19.4 m -76.84 118.27 19.28 Favored 'General case' 0 N--CA 1.415 -2.218 0 C-N-CA 124.733 1.213 . . . . 70.33 109.866 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.7 p -100.59 162.99 12.56 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.6 -0.519 . . . . 71.35 109.6 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.487 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -65.81 -50.25 65.31 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.171 0.434 . . . . 63.24 112.171 -175.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -57.79 -38.74 76.04 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 116.824 -0.171 . . . . 60.32 111.091 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.72 -37.67 76.61 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.018 0.437 . . . . 73.2 110.347 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 44.1 mt -68.22 -47.58 67.45 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.362 -0.835 . . . . 51.32 110.803 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -61.9 -48.24 81.34 Favored 'General case' 0 C--O 1.2 -1.538 0 CA-C-N 115.738 -0.665 . . . . 72.23 110.069 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.48 -41.18 84.71 Favored 'General case' 0 C--O 1.248 1.0 0 CA-C-O 121.036 0.446 . . . . 40.44 110.663 177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -65.82 -39.68 91.1 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.852 -0.613 . . . . 73.35 110.307 -175.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -82.33 -21.53 35.97 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 112.967 0.729 . . . . 72.55 112.967 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.9 t -70.11 -24.11 63.15 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.651 -0.704 . . . . 72.24 109.324 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.4 m -62.25 -30.24 70.97 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 109.197 -0.668 . . . . 62.33 109.197 173.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 57.5 m -96.1 11.83 32.83 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.772 -0.649 . . . . 70.31 112.378 -178.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.96 -167.58 30.58 Favored Glycine 0 N--CA 1.464 0.526 0 C-N-CA 118.609 -1.758 . . . . 61.32 115.386 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 86' ' ' ALA . 7.4 m -104.32 115.06 29.72 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.212 -0.662 . . . . 70.33 109.212 -176.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.3 mt -91.11 131.8 37.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 112.537 0.569 . . . . 75.14 112.537 -176.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.589 HD21 ' HB2' ' A' ' 86' ' ' ALA . 1.0 OUTLIER -95.64 -40.47 9.39 Favored 'General case' 0 C--O 1.204 -1.296 0 CA-C-N 115.26 -0.882 . . . . 54.23 111.915 176.515 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.57 ' NH2' HD12 ' A' ' 34' ' ' ILE . 73.2 mtm180 -155.86 161.16 40.64 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.763 -0.458 . . . . 75.11 109.763 -177.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.487 HD11 ' HB1' ' A' ' 50' ' ' ALA . 23.0 pt -146.51 141.42 20.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.1 -1.074 . . . . 71.41 108.1 174.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.9 m -126.23 129.24 48.56 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 106.478 -1.675 . . . . 72.12 106.478 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.6 mp -125.06 121.4 60.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 106.878 -1.527 . . . . 73.33 106.878 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -120.62 134.61 55.26 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 120.528 -0.469 . . . . 72.1 112.123 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 83.6 m -117.5 122.66 44.31 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.892 -0.781 . . . . 60.22 108.892 176.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.563 ' HA ' ' HG2' ' B' ' 65' ' ' ARG . 2.5 p30 -113.55 128.87 56.6 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 119.734 -0.786 . . . . 72.01 112.287 -178.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' B' ' 64' ' ' ASN . 38.4 mttm -95.8 4.05 53.22 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.73 -0.668 . . . . 73.12 111.516 175.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' B' ' 64' ' ' ASN . 45.5 m-85 -64.34 -6.25 6.68 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.38 0.881 . . . . 74.45 113.38 172.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.7 t -95.91 0.56 52.12 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.947 -0.76 . . . . 72.42 108.947 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.37 -48.78 3.63 Favored Glycine 0 CA--C 1.506 -0.521 0 N-CA-C 109.187 -1.565 . . . . 64.12 109.187 -175.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -96.96 147.94 33.66 Favored Pre-proline 0 C--N 1.291 -1.961 0 N-CA-C 105.916 -1.883 . . . . 73.24 105.916 173.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.83 118.32 5.02 Favored 'Trans proline' 0 N--CA 1.443 -1.474 0 C-N-CA 120.679 0.919 . . . . 64.24 110.448 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 30.1 mtmm -96.59 149.22 22.02 Favored 'General case' 0 CA--C 1.483 -1.597 0 C-N-CA 119.873 -0.731 . . . . 70.33 109.262 175.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 45' ' ' ASP . . . -128.9 135.13 8.32 Favored Glycine 0 N--CA 1.409 -3.105 0 C-N-CA 120.327 -0.94 . . . . 52.11 112.636 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . 0.349 1.3 p90 -150.8 144.77 25.28 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 124.382 1.073 . . . . 74.25 111.092 175.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.49 154.36 49.9 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.893 -0.594 . . . . 60.33 110.659 -171.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -120.36 124.49 45.66 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.325 -0.991 . . . . 74.24 108.325 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.434 ' HB ' HG22 ' A' ' 39' ' ' VAL . 27.2 mm -108.48 127.59 64.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.823 -1.177 . . . . 74.44 107.823 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -108.94 120.84 43.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.582 0.23 . . . . 63.44 111.039 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -98.89 162.88 12.85 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.98 0.419 . . . . 74.0 111.875 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.589 ' HB2' HD21 ' A' ' 64' ' ' ASN . . . -76.79 -37.88 55.01 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.264 0.626 . . . . 64.21 111.747 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.434 ' HG2' ' OG ' ' A' ' 90' ' ' SER . 0.2 OUTLIER -113.47 138.5 50.02 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 112.509 0.559 . . . . 73.43 112.509 179.422 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.429 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -57.79 -34.31 69.49 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 123.623 0.769 . . . . 73.04 111.26 179.051 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -66.65 -21.14 66.11 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 116.019 -0.537 . . . . 70.03 112.239 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.434 ' OG ' ' HG2' ' A' ' 87' ' ' GLU . 71.4 m -69.15 -36.13 77.09 Favored 'General case' 0 N--CA 1.414 -2.241 0 C-N-CA 120.635 -0.426 . . . . 64.04 111.263 176.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 95' ' ' VAL . 3.0 m -64.69 -41.22 91.62 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.85 0 C-N-CA 119.239 -0.984 . . . . 72.13 108.56 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -61.99 -31.13 71.46 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 116.299 -0.41 . . . . 74.35 111.292 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.31 -39.81 62.64 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.172 -0.467 . . . . 71.32 111.225 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.83 -41.85 59.13 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-N 116.222 -0.445 . . . . 70.31 111.338 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 91' ' ' VAL . 22.6 m -56.21 -22.18 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 111.98 0.363 . . . . 62.55 111.98 177.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.78 -13.86 62.47 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.367 0.603 . . . . 55.3 111.067 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 47.4 mtm -99.36 9.76 42.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.568 -0.742 . . . . 51.25 109.79 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.588 ' HA ' HG22 ' A' ' 109' ' ' VAL . 2.9 p-10 -37.67 -45.59 0.8 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 114.456 1.28 . . . . 70.12 114.456 -177.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -114.67 97.4 6.25 Favored 'General case' 0 N--CA 1.424 -1.741 0 C-N-CA 120.033 -0.667 . . . . 62.34 110.033 174.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.8 p -142.64 165.71 26.65 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.02 -0.991 . . . . 63.51 110.775 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.3 p -104.53 119.68 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-O 121.636 0.731 . . . . 60.12 110.171 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -113.47 116.64 29.91 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.858 -1.164 . . . . 74.52 107.858 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.438 ' NH1' ' HA3' ' A' ' 47' ' ' GLY . 7.1 ptm180 43.09 32.08 0.41 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 126.548 1.939 . . . . 72.45 114.147 -177.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.19 -12.02 33.91 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.007 -0.997 . . . . 70.22 113.87 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.479 ' HB3' ' ND2' ' A' ' 43' ' ' ASN . 65.1 mtt180 -112.42 138.74 48.72 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 117.37 0.585 . . . . 62.43 109.933 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 39.2 m -79.18 120.19 23.33 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.766 -1.198 . . . . 74.14 107.766 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.41 ' HA ' ' HB3' ' A' ' 43' ' ' ASN . 42.2 pt -101.57 171.44 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 C-N-CA 120.464 -0.495 . . . . 74.53 110.723 -177.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 54.7 tptt -133.91 125.75 28.94 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 115.123 -0.944 . . . . 73.51 108.772 -177.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.588 HG22 ' HA ' ' A' ' 98' ' ' ASP . 27.7 m -128.82 132.49 67.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 O-C-N 123.238 0.336 . . . . 54.5 110.948 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.459 HD13 ' HB3' ' A' ' 40' ' ' TYR 0.25 0.0 OUTLIER -148.24 158.79 40.81 Favored Pre-proline 0 C--N 1.292 -1.929 0 N-CA-C 108.561 -0.903 . . . . 42.03 108.561 176.26 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 110' ' ' LEU . 91.8 Cg_endo -76.09 130.28 12.07 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 CA-C-N 120.45 1.196 . . . . 53.35 110.641 -176.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.406 ' NZ ' ' OD2' ' A' ' 35' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.423 -1.783 0 N-CA-C 104.874 -2.269 . . . . 74.24 104.874 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.19 0 N-CA-C 114.363 0.505 . . . . 74.44 114.363 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -53.36 -52.66 8.15 Favored 'Trans proline' 0 CA--C 1.559 1.73 0 C-N-CA 123.609 2.873 . . . . 74.12 114.181 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.12 141.65 48.43 Favored 'Trans proline' 0 C--N 1.376 1.979 0 CA-C-N 120.813 1.326 . . . . 75.34 108.83 172.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -84.21 146.35 47.91 Favored Pre-proline 0 C--N 1.284 -2.276 0 C-N-CA 119.818 -0.753 . . . . 74.15 109.102 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.69 131.08 35.93 Favored 'Trans proline' 0 N--CA 1.438 -1.777 0 C-N-CA 122.275 1.983 . . . . 72.21 111.71 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.747 HD13 ' H ' ' B' ' 26' ' ' LEU 0.25 0.0 OUTLIER -70.09 178.7 2.64 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.598 -0.728 . . . . 73.21 110.764 176.815 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 13.8 m -57.47 144.6 36.06 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 113.441 0.904 . . . . 74.21 113.441 -171.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.453 ' O ' ' HE2' ' B' ' 32' ' ' LYS . . . -56.5 -44.68 80.91 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.919 -1.037 . . . . 72.2 110.733 174.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -60.51 -45.91 92.05 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.638 -0.256 . . . . 72.01 111.082 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.464 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.5 OUTLIER -55.83 -35.32 66.26 Favored 'General case' 0 C--O 1.22 -0.485 0 O-C-N 123.276 0.36 . . . . 61.35 110.583 174.101 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' B' ' 26' ' ' LEU . 43.2 mttm -70.83 -35.47 72.48 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.757 -0.656 . . . . 74.21 112.399 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.59 ' O ' ' HB2' ' B' ' 36' ' ' LYS . 0.4 OUTLIER -69.76 -38.99 76.94 Favored 'General case' 0 C--O 1.211 -0.953 0 C-N-CA 119.651 -0.82 . . . . 74.13 111.35 174.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.539 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 5.9 mm-40 -64.8 -46.26 82.77 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.869 0.366 . . . . 72.12 111.06 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.464 HG12 ' O ' ' B' ' 30' ' ' GLU . 16.2 pt -70.72 -34.67 57.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.87 -0.605 . . . . 74.12 111.401 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -70.95 -35.12 72.05 Favored 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 108.69 -0.855 . . . . 75.1 108.69 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' B' ' 32' ' ' LYS . 31.8 ttmt -62.71 -31.34 72.24 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 124.987 1.315 . . . . 74.21 110.234 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' B' ' 33' ' ' GLU . 10.5 ptt180 -115.35 31.78 6.48 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.567 0.699 . . . . 74.35 112.004 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.446 ' OG ' ' HE3' ' B' ' 112' ' ' LYS . 25.4 t -100.9 163.07 12.47 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.307 -0.861 . . . . 74.22 109.945 174.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.524 ' HA ' ' H ' ' B' ' 112' ' ' LYS . 35.0 m -134.69 164.05 35.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 122.984 0.514 . . . . 42.52 110.732 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . 0.537 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 34.7 t80 -109.63 125.2 52.34 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.309 -0.997 . . . . 74.41 108.309 177.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.506 ' HA ' HG12 ' B' ' 109' ' ' VAL . 61.8 t -116.03 112.88 41.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 108.836 -0.801 . . . . 72.22 108.836 175.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.21 173.54 18.15 Favored Glycine 0 N--CA 1.426 -2.024 0 N-CA-C 110.822 -0.911 . . . . 63.54 110.822 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.465 ' HB3' ' HA ' ' B' ' 107' ' ' ILE . 25.7 t-20 80.96 -19.28 0.44 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.102 1.361 . . . . 54.52 113.022 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.403 HG21 HD11 ' B' ' 53' ' ' LEU . 7.5 p -55.39 117.8 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.833 0.825 . . . . 63.2 111.074 -177.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -69.98 153.57 43.06 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.874 -1.057 . . . . 75.22 113.104 -174.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' TYR . . . . . 0.401 ' CD2' ' HB2' ' B' ' 77' ' ' PRO . 60.6 t80 -49.46 -32.33 11.71 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 127.859 2.464 . . . . 74.12 110.817 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.31 0.26 71.39 Favored Glycine 0 N--CA 1.429 -1.796 0 CA-C-O 119.292 -0.727 . . . . 51.11 114.067 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 29.1 t -75.61 147.0 39.92 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 118.703 1.252 . . . . 72.34 109.877 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 36.8 p -98.52 157.56 16.15 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 116.002 -0.545 . . . . 74.32 112.228 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.52 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -72.6 -47.64 46.24 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.865 0.866 . . . . 71.13 112.274 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -34.49 72.31 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 119.523 -0.871 . . . . 73.01 112.533 -178.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -68.8 -39.12 80.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.109 -0.496 . . . . 75.21 110.343 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.403 HD11 HG21 ' B' ' 44' ' ' VAL . 55.7 mt -65.46 -47.7 75.24 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.657 -0.701 . . . . 73.32 111.29 176.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -49.11 78.29 Favored 'General case' 0 C--O 1.207 -1.168 0 CA-C-N 116.213 -0.448 . . . . 70.12 110.001 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.75 -40.71 80.32 Favored 'General case' 0 C--O 1.263 1.783 0 CA-C-O 122.015 0.912 . . . . 63.43 112.059 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -66.09 -40.61 90.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.608 -1.178 . . . . 73.55 109.854 -175.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -82.41 -21.84 35.61 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 112.833 0.679 . . . . 71.02 112.833 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 47.1 t -68.58 -24.59 64.62 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.4 -0.818 . . . . 70.4 110.226 -176.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 32.7 m -63.63 -20.44 65.68 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 120.06 -0.656 . . . . 71.25 110.963 174.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 58.6 m -106.02 17.23 23.91 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 111.852 0.316 . . . . 65.05 111.852 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.54 177.06 20.0 Favored Glycine 0 C--O 1.226 -0.353 0 C-N-CA 119.904 -1.141 . . . . 71.51 113.603 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 23.9 t -93.34 121.09 34.37 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.265 -1.013 . . . . 73.5 108.265 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 76.8 mt -87.53 133.84 29.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-O 121.413 0.625 . . . . 74.22 112.139 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . 0.475 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 68.6 m-20 -97.4 -38.71 9.51 Favored 'General case' 0 C--O 1.206 -1.202 0 CA-C-N 115.173 -0.922 . . . . 55.04 112.676 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.563 ' HG2' ' HA ' ' A' ' 71' ' ' ASP . 71.7 mtm180 -157.39 161.74 39.01 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.12 -0.696 . . . . 72.5 109.12 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.52 HD11 ' HB1' ' B' ' 50' ' ' ALA . 24.1 pt -146.68 140.91 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 N-CA-C 107.875 -1.157 . . . . 65.34 107.875 175.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 68.8 m -126.32 127.97 46.39 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.922 -1.14 . . . . 75.43 107.922 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . 0.421 HD12 ' N ' ' B' ' 68' ' ' ILE . 1.9 mp -124.5 121.43 61.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 106.599 -1.63 . . . . 72.05 106.599 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.36 135.33 55.1 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 120.458 -0.497 . . . . 71.34 111.289 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 73.1 m -116.9 121.76 42.38 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.192 -1.04 . . . . 74.4 108.192 176.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.687 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 3.4 p30 -111.7 128.38 56.06 Favored 'General case' 0 C--O 1.212 -0.88 0 C-N-CA 119.261 -0.976 . . . . 71.33 111.873 -177.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -121.97 5.11 9.88 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.81 -0.632 . . . . 73.5 109.646 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.446 ' CD1' ' HD3' ' A' ' 65' ' ' ARG . 28.3 p90 -59.28 -16.92 24.52 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 114.191 1.182 . . . . 71.03 114.191 -175.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 38.4 p -96.96 4.19 51.67 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 120.855 0.36 . . . . 71.24 111.407 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.25 -60.1 0.35 Allowed Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 111.581 -0.608 . . . . 75.33 111.581 -177.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -96.73 129.17 33.53 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 112.009 0.374 . . . . 72.1 112.009 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.687 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 91.9 Cg_endo -78.41 126.42 7.57 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.546 2.164 . . . . 71.43 113.933 -177.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' LYS . . . . . 0.528 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 32.9 mtmm -109.86 165.23 11.87 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 123.683 0.793 . . . . 73.43 109.753 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -134.11 135.68 8.15 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 119.925 -1.131 . . . . 71.02 113.808 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . 0.436 0.4 OUTLIER -150.02 143.96 25.5 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 124.755 1.222 . . . . 72.44 112.083 173.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.94 154.89 50.32 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.086 -0.506 . . . . 50.03 110.504 -172.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -122.43 126.83 48.77 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.978 -1.119 . . . . 71.13 107.978 177.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.423 HG23 HG22 ' B' ' 66' ' ' ILE . 28.5 mm -109.66 127.41 66.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 107.594 -1.261 . . . . 73.12 107.594 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' GLU . . . . . 0.539 ' OE1' ' HB2' ' B' ' 65' ' ' ARG . 45.2 mt-10 -107.82 121.33 44.53 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 110.331 -0.248 . . . . 73.11 110.331 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -98.47 162.14 13.31 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.201 0.524 . . . . 74.42 112.018 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.475 ' HA ' ' ND2' ' B' ' 64' ' ' ASN . . . -69.18 -36.7 77.6 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.253 -0.885 . . . . 70.2 112.075 176.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.94 157.75 30.54 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.485 0.659 . . . . 75.41 111.341 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.69 -35.3 78.57 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 114.76 -1.109 . . . . 75.2 111.5 175.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -60.38 -32.15 71.03 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 123.525 0.516 . . . . 75.11 110.15 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 14.7 m -63.48 -37.06 85.87 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 116.4 -0.364 . . . . 74.21 111.212 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.596 ' O ' HG13 ' B' ' 95' ' ' VAL . 3.0 m -67.47 -40.21 84.04 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 C-N-CA 119.582 -0.847 . . . . 64.12 108.984 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -63.0 -30.89 71.95 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.961 0.41 . . . . 75.14 110.933 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.73 -40.25 63.69 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.22 -0.445 . . . . 74.01 110.546 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.97 -40.41 63.02 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-N 116.409 -0.359 . . . . 54.13 111.401 -177.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . 0.596 HG13 ' O ' ' B' ' 91' ' ' VAL . 16.6 m -58.24 -21.66 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 112.873 0.694 . . . . 63.1 112.873 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.91 -15.94 63.84 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.44 0.638 . . . . 45.13 109.759 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 34.0 mtp -94.68 6.26 49.43 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 123.954 0.902 . . . . 72.14 110.021 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . 0.548 ' HA ' HG22 ' B' ' 109' ' ' VAL . 2.0 p-10 -38.87 -46.65 1.32 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.455 1.28 . . . . 73.43 114.455 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -113.19 99.05 7.52 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 118.998 0.817 . . . . 71.44 109.931 171.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' B' ' 106' ' ' THR . 19.0 p -139.65 167.44 22.1 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.064 -0.971 . . . . 73.4 111.462 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' B' ' 105' ' ' ARG . 7.4 p -102.64 125.27 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 CA-C-O 121.671 0.748 . . . . 73.1 109.907 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' PHE . . . . . 0.4 ' HB3' HG23 ' B' ' 107' ' ' ILE . 74.2 t80 -135.44 120.4 18.65 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.941 -1.133 . . . . 73.34 107.941 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 56.41 32.61 20.94 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.554 1.142 . . . . 74.11 112.31 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.71 4.5 82.62 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 114.661 -1.154 . . . . 63.12 113.488 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' B' ' 101' ' ' VAL . 99.2 mtt180 -120.89 162.85 19.14 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 117.224 0.512 . . . . 71.01 109.929 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' B' ' 100' ' ' THR . 62.9 m -94.12 120.52 34.48 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.067 -1.086 . . . . 45.15 108.067 175.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . 0.465 ' HA ' ' HB3' ' B' ' 43' ' ' ASN . 40.8 pt -100.68 170.45 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.116 -1.034 . . . . 73.14 110.164 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 55.5 tptt -133.1 126.07 30.97 Favored 'General case' 0 N--CA 1.434 -1.227 0 O-C-N 123.728 0.643 . . . . 72.4 109.629 -177.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . 0.548 HG22 ' HA ' ' B' ' 98' ' ' ASP . 27.3 m -128.85 138.36 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-N 116.429 -0.351 . . . . 72.43 111.423 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.72 ' HB3' ' HD2' ' B' ' 111' ' ' PRO 0.255 0.1 OUTLIER -140.01 169.68 11.46 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 105.61 -1.996 . . . . 74.5 105.61 174.636 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.72 ' HD2' ' HB3' ' B' ' 110' ' ' LEU . 89.6 Cg_endo -80.3 130.47 8.14 Favored 'Trans proline' 0 N--CA 1.425 -2.515 0 C-N-CA 121.412 1.408 . . . . 74.54 109.718 172.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.524 ' H ' ' HA ' ' B' ' 39' ' ' VAL . 15.0 ttpp . . . . . 0 C--N 1.29 -1.997 0 N-CA-C 104.723 -2.325 . . . . 60.15 104.723 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.657 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 7.1 mm-40 . . . . . 0 N--CA 1.444 -0.768 0 CA-C-O 119.976 -0.059 . . . . 75.34 111.067 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.0 pt -67.44 -34.99 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 112.413 0.523 . . . . 64.54 112.413 -176.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.53 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . 46.3 m-20 -59.52 -39.88 85.31 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.043 0.449 . . . . 64.14 110.014 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -76.18 -11.02 59.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.134 -0.939 . . . . 75.42 110.592 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.657 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 61.1 mmt-85 -98.16 5.44 48.52 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 109.052 -0.721 . . . . 72.33 109.052 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.478 ' HB3' ' HE2' ' A' ' 112' ' ' LYS . 46.9 t -109.93 164.61 12.43 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 113.677 0.992 . . . . 71.11 113.677 -174.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.98 162.18 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 114.937 -1.029 . . . . 61.23 110.017 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.536 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 28.5 t80 -110.34 124.64 52.06 Favored 'General case' 0 C--N 1.29 -2.01 0 C-N-CA 124.826 1.25 . . . . 64.44 107.722 177.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.8 t -111.07 116.43 52.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 N-CA-C 108.08 -1.081 . . . . 64.51 108.08 178.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.86 166.61 12.78 Favored Glycine 0 N--CA 1.417 -2.582 0 C-N-CA 119.909 -1.139 . . . . 71.24 112.092 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.8 t30 67.99 18.11 9.52 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 125.732 1.613 . . . . 74.42 113.449 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.522 ' O ' ' HA3' ' A' ' 79' ' ' GLY . 7.1 p -73.95 116.67 16.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.941 -0.762 . . . . 75.01 108.941 175.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -94.98 168.18 10.94 Favored 'General case' 0 C--O 1.255 1.373 0 CA-C-O 121.226 0.536 . . . . 74.01 111.851 -172.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.661 ' CE1' ' HB2' ' A' ' 77' ' ' PRO . 4.5 m-85 -64.77 96.44 0.18 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.405 -1.27 . . . . 61.43 110.935 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.42 -26.32 0.3 Allowed Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 109.949 -1.261 . . . . 45.33 109.949 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.5 m -84.14 135.06 34.53 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.222 -1.029 . . . . 53.15 108.222 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.1 p -105.84 170.8 7.69 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 119.755 -0.164 . . . . 75.33 111.095 -176.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.481 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -64.2 -50.55 67.65 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 117.828 0.286 . . . . 71.52 111.105 -177.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.406 ' HG2' ' CE2' ' B' ' 46' ' ' TYR . 78.8 mt-30 -59.03 -38.87 80.28 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.465 0.543 . . . . 74.32 112.465 176.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -64.53 -37.62 88.2 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.779 0.799 . . . . 74.05 109.43 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.5 mt -72.68 -47.35 48.04 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.996 -1.002 . . . . 65.33 110.955 177.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -61.39 -49.39 77.08 Favored 'General case' 0 C--O 1.204 -1.308 0 C-N-CA 123.295 0.638 . . . . 34.3 110.855 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.07 -44.09 78.59 Favored 'General case' 0 C--O 1.256 1.443 0 CA-C-O 121.269 0.557 . . . . 71.24 111.042 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -64.58 -39.98 94.7 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.268 -0.878 . . . . 74.13 110.858 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -82.1 -22.43 36.24 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 113.266 0.839 . . . . 70.41 113.266 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.2 t -70.31 -23.88 62.93 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.781 -0.645 . . . . 73.11 109.3 -177.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.9 m -58.96 -27.76 65.66 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-O 121.266 0.555 . . . . 65.21 109.861 172.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 58.9 m -94.12 5.39 51.87 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.023 0.529 . . . . 55.23 112.161 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.33 -166.81 27.58 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.306 -1.426 . . . . 73.32 114.259 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.2 t -98.83 123.0 42.8 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 120.896 0.379 . . . . 52.44 110.548 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.8 mt -83.41 134.28 27.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-O 121.606 0.717 . . . . 50.53 112.58 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.652 ' OD1' ' HB3' ' B' ' 73' ' ' PHE . 34.2 t30 -98.07 -45.08 6.37 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.443 -1.253 . . . . 72.04 110.254 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' B' ' 71' ' ' ASP . 49.4 mtp180 -155.57 165.03 37.83 Favored 'General case' 0 C--O 1.213 -0.86 0 N-CA-C 107.873 -1.158 . . . . 71.13 107.873 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.481 HD11 ' HB1' ' A' ' 50' ' ' ALA . 19.2 pt -146.08 144.38 20.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.237 -1.024 . . . . 71.0 108.237 171.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.573 ' OG1' ' HB2' ' A' ' 82' ' ' TYR . 39.7 p -122.43 137.2 54.95 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 105.414 -2.069 . . . . 64.22 105.414 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.1 mp -129.26 112.54 25.46 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 105.705 -1.961 . . . . 73.43 105.705 173.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.457 ' HG ' ' CE2' ' A' ' 80' ' ' TYR 0.255 1.6 pt? -120.38 123.59 43.44 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 119.772 -0.771 . . . . 75.11 111.2 -179.228 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 73.4 m -117.83 136.47 53.4 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.204 -0.907 . . . . 44.41 109.592 -177.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.65 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 4.0 p30 -120.24 143.43 48.3 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 119.928 -0.709 . . . . 75.51 110.011 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -124.85 5.31 8.07 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.336 -0.616 . . . . 62.31 109.336 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.621 ' HB3' ' OD1' ' B' ' 64' ' ' ASN . 36.9 p90 -64.52 -25.68 68.09 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 112.198 0.444 . . . . 61.55 112.198 -176.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.9 t -80.97 -8.47 59.77 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.151 0.5 . . . . 74.1 110.67 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.98 -55.19 0.57 Allowed Glycine 0 CA--C 1.494 -1.225 0 N-CA-C 110.427 -1.069 . . . . 60.41 110.427 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -96.63 133.81 24.09 Favored Pre-proline 0 C--N 1.295 -1.795 0 N-CA-C 107.482 -1.303 . . . . 71.41 107.482 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.661 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 74.2 Cg_endo -76.78 117.27 4.46 Favored 'Trans proline' 0 N--CA 1.426 -2.492 0 C-N-CA 120.613 0.875 . . . . 63.42 111.134 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 29.5 mtmm -100.77 147.11 26.43 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 115.552 -0.749 . . . . 73.21 109.283 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 44' ' ' VAL . . . -122.38 137.01 11.11 Favored Glycine 0 N--CA 1.418 -2.558 0 C-N-CA 120.05 -1.071 . . . . 23.1 112.494 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.457 ' CE2' ' HG ' ' A' ' 69' ' ' LEU . 5.2 p90 -149.87 143.09 25.08 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 124.407 1.083 . . . . 71.23 109.338 176.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.32 153.95 45.43 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 116.509 -0.314 . . . . 72.15 111.825 -171.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.702 ' OH ' ' HA3' ' B' ' 21' ' ' GLY . 20.0 m-85 -116.78 125.1 51.11 Favored 'General case' 0 CA--C 1.461 -2.449 0 C-N-CA 122.864 0.466 . . . . 70.32 110.729 173.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.3 mm -103.69 110.7 30.83 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.536 0 N-CA-C 106.375 -1.713 . . . . 72.13 106.375 175.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.46 ' HG2' ' OG ' ' A' ' 38' ' ' SER . 29.2 mt-10 -96.88 121.08 38.36 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.325 -0.991 . . . . 63.42 108.325 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -99.43 170.98 8.24 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.218 0.533 . . . . 73.32 111.239 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.62 -41.01 22.09 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.474 -0.784 . . . . 73.34 110.637 173.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.405 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 40.7 mm-40 -101.81 146.99 27.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.06 0.457 . . . . 75.3 111.355 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.559 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.8 OUTLIER -74.71 -34.05 62.51 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.077 -1.453 . . . . 71.24 107.077 -179.304 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.286 0.9 OUTLIER -65.98 -20.06 66.07 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.156 -0.929 . . . . 72.13 113.212 177.425 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.405 ' OG ' ' HB2' ' A' ' 87' ' ' GLU . 22.6 m -66.27 -36.6 83.41 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 109.824 -0.436 . . . . 71.04 109.824 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 88' ' ' ARG . 3.6 m -66.26 -40.42 86.81 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 N-CA-C 108.629 -0.878 . . . . 65.34 108.629 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -55.54 -38.52 69.39 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.435 0.694 . . . . 65.03 110.529 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.71 -37.92 65.0 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.838 -0.619 . . . . 61.23 111.421 177.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.85 -39.91 55.7 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.188 0.44 . . . . 53.03 112.188 -176.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 91' ' ' VAL . 33.0 m -55.41 -22.06 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 113.068 0.766 . . . . 53.14 113.068 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.31 -9.63 42.89 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 120.991 0.424 . . . . 41.41 110.37 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.5 ' C ' ' H ' ' A' ' 99' ' ' GLU . 68.3 mtm -99.17 5.98 46.58 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.153 0.797 . . . . 75.35 113.153 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 109' ' ' VAL . 1.4 p-10 -67.57 24.07 0.02 OUTLIER 'General case' 0 N--CA 1.528 3.43 0 C-N-CA 123.641 0.776 . . . . 74.23 112.578 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.5 ' H ' ' C ' ' A' ' 97' ' ' MET . 39.6 tt0 -156.21 -7.81 0.11 Allowed 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.805 -1.089 . . . . 71.42 109.171 -168.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.4 p -88.03 169.2 12.17 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.517 -0.765 . . . . 73.01 111.625 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.7 p -106.46 132.44 53.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-N 115.401 -0.818 . . . . 61.23 109.814 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -127.14 123.68 37.33 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.561 -0.903 . . . . 75.41 108.561 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.3 ttt-85 54.52 33.01 17.98 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-O 122.975 1.369 . . . . 65.22 111.003 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.0 14.62 69.08 Favored Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 114.224 -1.353 . . . . 74.32 114.449 176.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -136.12 148.82 48.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 118.043 0.922 . . . . 61.31 110.64 174.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.5 m -79.15 121.64 25.26 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.768 -0.827 . . . . 33.32 108.768 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 37.4 pt -102.32 172.13 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.18 0.514 . . . . 72.31 111.287 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.409 ' HE3' ' HB3' ' A' ' 110' ' ' LEU . 55.1 tptt -124.89 127.28 46.87 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.228 -1.027 . . . . 63.51 108.228 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 23.8 t -126.79 115.95 43.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 107.746 -1.205 . . . . 75.34 107.746 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.477 HD13 ' HB3' ' A' ' 40' ' ' TYR 0.283 0.0 OUTLIER -138.38 141.39 31.38 Favored Pre-proline 0 C--N 1.311 -1.073 0 C-N-CA 119.536 -0.865 . . . . 72.32 109.112 -179.533 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.01 140.0 44.32 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 122.326 2.017 . . . . 63.1 114.153 -171.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.53 ' HE3' ' HA ' ' A' ' 35' ' ' ASP . 32.8 ttpt . . . . . 0 N--CA 1.429 -1.5 0 N-CA-C 109.109 -0.7 . . . . 72.25 109.109 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.702 ' HA3' ' OH ' ' A' ' 82' ' ' TYR . . . . . . . . 0 C--O 1.239 0.436 0 N-CA-C 115.093 0.797 . . . . 54.42 115.093 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.65 -35.98 97.8 Favored 'Trans proline' 0 CA--C 1.558 1.724 0 C-N-CA 123.492 2.795 . . . . 71.25 114.762 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -47.52 123.57 8.26 Favored 'Trans proline' 0 C--N 1.4 3.27 0 C-N-CA 122.073 1.849 . . . . 75.41 113.041 174.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -91.03 141.52 26.56 Favored Pre-proline 0 C--N 1.294 -1.841 0 CA-C-N 114.56 -1.2 . . . . 63.14 108.874 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -49.3 117.73 3.1 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.998 2.465 . . . . 63.41 113.515 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 7.2 mp -58.04 -176.04 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.191 0 CA-C-N 113.98 -1.464 . . . . 70.32 110.453 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 20.3 m -66.58 142.93 57.32 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 107.254 -1.387 . . . . 63.01 107.254 171.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.501 ' O ' ' HE2' ' B' ' 32' ' ' LYS . . . -56.02 -42.84 77.07 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.577 -0.738 . . . . 65.11 110.68 176.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -68.4 -30.84 69.85 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 112.812 0.671 . . . . 74.41 112.812 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.75 -39.74 91.38 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.636 -0.505 . . . . 62.3 109.636 171.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.483 ' HA ' HG12 ' B' ' 34' ' ' ILE . 57.3 mttm -70.19 -49.98 44.83 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 113.162 0.801 . . . . 53.23 113.162 -178.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.559 ' N ' ' HE2' ' B' ' 32' ' ' LYS . 0.3 OUTLIER -56.09 -39.15 71.7 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 120.146 -0.622 . . . . 75.21 112.639 -178.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 17.9 mt-10 -71.85 -41.61 67.91 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 118.945 -1.102 . . . . 74.23 112.629 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.483 HG12 ' HA ' ' B' ' 31' ' ' LYS . 35.1 pt -68.88 -35.46 69.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 C-N-CA 120.213 -0.595 . . . . 73.34 111.351 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -59.85 -44.08 94.31 Favored 'General case' 0 C--O 1.217 -0.625 0 N-CA-C 109.674 -0.491 . . . . 72.14 109.674 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 98.4 mttt -70.33 -18.22 63.08 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.269 -0.878 . . . . 65.24 112.298 -175.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' B' ' 33' ' ' GLU . 18.8 ptp180 -109.8 24.93 12.38 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-O 121.443 0.64 . . . . 71.04 111.383 -178.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.511 ' HB2' ' HD3' ' B' ' 112' ' ' LYS . 19.5 m -115.51 172.69 6.95 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.656 -0.702 . . . . 53.54 110.997 174.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.4 163.66 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 123.19 0.596 . . . . 74.25 110.573 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 36.0 t80 -111.97 125.61 54.25 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 125.596 1.559 . . . . 61.4 107.94 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 57.9 t -114.66 116.31 52.2 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 C-N-CA 123.651 0.78 . . . . 74.22 109.191 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.98 165.39 12.52 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 120.716 -0.754 . . . . 61.12 112.406 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 t30 57.81 20.43 6.53 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 126.241 1.816 . . . . 72.34 113.26 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.72 129.0 19.08 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 CA-C-O 121.396 0.617 . . . . 71.24 109.389 173.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.487 ' HA ' ' CZ ' ' B' ' 105' ' ' ARG . 20.8 t70 -61.35 139.23 58.22 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 114.674 -1.148 . . . . 52.43 109.274 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' TYR . . . . . 0.406 ' CE2' ' HG2' ' A' ' 51' ' ' GLN . 32.6 t80 -70.32 0.15 7.01 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.714 -0.676 . . . . 74.23 111.072 -174.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -107.6 -0.23 34.61 Favored Glycine 0 N--CA 1.421 -2.304 0 CA-C-N 115.799 -0.637 . . . . 71.23 112.148 175.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.9 t -80.51 146.27 31.42 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.599 -1.26 . . . . 63.1 107.599 176.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 71.7 p -105.52 172.58 6.72 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.982 -0.377 . . . . 73.03 109.982 -177.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.48 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -63.72 -50.4 69.29 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 120.57 0.224 . . . . 71.21 110.539 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -61.03 -35.99 78.36 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 111.838 0.311 . . . . 75.21 111.838 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -64.17 -43.65 94.49 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 109.61 -0.515 . . . . 65.21 109.61 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 52.0 mt -67.67 -48.14 67.48 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.208 -0.905 . . . . 73.14 112.042 176.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.32 -49.16 78.71 Favored 'General case' 0 C--O 1.207 -1.132 0 C-N-CA 123.387 0.675 . . . . 63.02 110.809 -177.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.28 -43.25 78.62 Favored 'General case' 0 C--O 1.262 1.718 0 CA-C-O 121.215 0.531 . . . . 55.31 111.123 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -65.77 -39.25 90.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.479 -0.782 . . . . 74.22 110.718 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -82.45 -22.55 35.19 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 113.432 0.901 . . . . 75.15 113.432 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 36.1 t -69.23 -25.16 64.17 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.958 -0.565 . . . . 72.24 109.766 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.9 m -62.9 -24.97 68.09 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 120.387 -0.525 . . . . 74.31 110.511 173.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 58.4 m -96.55 3.73 52.46 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 122.744 0.418 . . . . 51.32 112.061 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.13 -171.72 32.73 Favored Glycine 0 C--O 1.222 -0.634 0 C-N-CA 119.281 -1.438 . . . . 65.41 114.456 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 21.7 m -98.86 119.38 37.52 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.707 -0.479 . . . . 51.41 109.707 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 50.8 mt -82.52 132.74 30.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 112.997 0.74 . . . . 70.35 112.997 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . 0.621 ' OD1' ' HB3' ' A' ' 73' ' ' PHE . 46.1 t-20 -93.79 -51.29 4.97 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 125.315 1.446 . . . . 73.04 109.225 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.444 ' HD3' ' OE1' ' B' ' 84' ' ' GLU . 46.5 mtp180 -153.14 166.75 31.53 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.547 -1.279 . . . . 43.33 107.547 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.48 HD11 ' HB1' ' B' ' 50' ' ' ALA . 19.9 pt -147.13 144.28 19.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 108.059 -1.089 . . . . 75.32 108.059 171.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . 0.577 ' OG1' ' HB2' ' B' ' 82' ' ' TYR . 36.9 p -121.71 136.88 54.93 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 105.387 -2.079 . . . . 55.1 105.387 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.2 mp -129.25 113.08 26.93 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 N-CA-C 105.561 -2.014 . . . . 74.4 105.561 173.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.498 ' HG ' ' CE2' ' B' ' 80' ' ' TYR 0.274 1.5 pt? -120.72 123.03 41.72 Favored 'General case' 0 C--N 1.281 -2.387 0 C-N-CA 119.987 -0.685 . . . . 72.31 111.486 -179.497 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 67.0 m -117.6 134.82 54.47 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.621 -0.718 . . . . 75.01 109.631 -177.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 3.5 p30 -115.11 140.38 49.11 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.878 -0.729 . . . . 74.44 109.871 177.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . 0.451 ' HG2' ' HB3' ' B' ' 77' ' ' PRO . 7.6 mtpm? -112.5 7.67 19.06 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 116.126 -0.488 . . . . 73.35 110.365 -178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.652 ' HB3' ' OD1' ' A' ' 64' ' ' ASN . 12.5 p90 -73.08 -11.2 60.46 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 121.524 0.678 . . . . 73.43 110.585 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 20.7 m -88.13 9.48 22.59 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.117 -0.947 . . . . 61.25 110.09 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.95 -51.0 4.39 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 109.607 -1.397 . . . . 72.44 109.607 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -96.43 145.53 29.74 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 105.806 -1.924 . . . . 72.32 105.806 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.451 ' HB3' ' HG2' ' B' ' 72' ' ' LYS . 58.2 Cg_endo -77.43 118.1 4.52 Favored 'Trans proline' 0 N--CA 1.437 -1.81 0 C-N-CA 120.767 0.978 . . . . 65.42 110.623 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 28.8 mtmm -93.71 137.49 32.91 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 108.13 -1.063 . . . . 50.44 108.13 177.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -116.17 133.33 10.73 Favored Glycine 0 N--CA 1.413 -2.887 0 C-N-CA 119.974 -1.108 . . . . 62.0 111.773 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . 0.498 ' CE2' ' HG ' ' B' ' 69' ' ' LEU . 6.8 p90 -147.74 142.73 26.97 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 124.04 0.936 . . . . 75.13 109.42 175.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.08 154.37 45.91 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 116.397 -0.365 . . . . 74.23 111.728 -172.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' TYR . . . . . 0.577 ' HB2' ' OG1' ' B' ' 67' ' ' THR . 19.4 m-85 -117.25 124.96 50.31 Favored 'General case' 0 CA--C 1.467 -2.23 0 C-N-CA 122.78 0.432 . . . . 72.2 110.442 173.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 34.5 mm -102.75 110.11 28.5 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 106.635 -1.617 . . . . 74.04 106.635 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' GLU . . . . . 0.444 ' OE1' ' HD3' ' B' ' 65' ' ' ARG . 31.2 mt-10 -95.3 120.61 35.83 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.417 -0.957 . . . . 54.43 108.417 -178.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.418 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 98.0 m-85 -99.09 162.2 13.2 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.413 0.625 . . . . 65.43 111.111 -177.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.32 -11.37 56.48 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.509 -0.769 . . . . 65.2 109.983 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . 0.605 ' HB3' ' OG ' ' B' ' 90' ' ' SER . 43.2 tt0 -124.23 140.6 52.8 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.309 -0.405 . . . . 54.11 111.094 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.507 ' O ' HG22 ' B' ' 91' ' ' VAL . 0.6 OUTLIER -74.99 -34.91 62.02 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.64 -1.244 . . . . 74.03 107.64 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . 0.42 ' H ' ' HG2' ' B' ' 87' ' ' GLU . 0.6 OUTLIER -62.13 -28.38 69.6 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.512 -0.921 . . . . 75.42 108.512 -179.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' SER . . . . . 0.605 ' OG ' ' HB3' ' B' ' 87' ' ' GLU . 70.2 m -63.46 -36.34 83.43 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 116.19 -0.459 . . . . 71.24 111.025 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.507 HG22 ' O ' ' B' ' 88' ' ' ARG . 3.6 m -67.18 -40.13 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.519 0 N-CA-C 108.551 -0.907 . . . . 61.13 108.551 179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -56.96 -37.68 71.9 Favored 'General case' 0 N--CA 1.455 -0.225 0 O-C-N 123.828 0.705 . . . . 75.05 110.9 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.9 -37.18 64.76 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.753 -0.658 . . . . 61.33 111.48 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.83 -41.15 53.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.506 . . . . 73.51 111.87 -176.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . 0.493 HG13 ' O ' ' B' ' 91' ' ' VAL . 32.8 m -55.23 -21.46 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 112.905 0.705 . . . . 72.3 112.905 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.07 -13.77 62.25 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.805 0.812 . . . . 72.24 111.14 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 68.2 mtm -97.2 9.69 41.5 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.418 -0.81 . . . . 72.43 110.011 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . 0.709 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 6.1 p-10 -36.27 -46.81 0.55 Allowed 'General case' 0 C--O 1.204 -1.31 0 N-CA-C 115.694 1.739 . . . . 63.21 115.694 -176.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -128.47 41.89 3.41 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 118.585 -1.246 . . . . 73.3 110.792 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 40.8 p -79.62 176.87 9.32 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.88 -0.6 . . . . 74.4 110.794 175.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.04 132.96 55.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.139 0.495 . . . . 74.12 109.876 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -140.49 125.82 18.78 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.482 -0.781 . . . . 74.41 109.004 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . 0.263 20.7 ttt180 50.49 54.78 10.56 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 122.295 1.045 . . . . 74.35 113.747 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.89 -7.5 42.38 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 114.341 -1.3 . . . . 12.14 115.568 176.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.487 ' CZ ' ' HA ' ' B' ' 45' ' ' ASP . 10.2 ptt180 -136.7 159.89 40.48 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 114.35 1.241 . . . . 74.4 114.35 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 34.5 m -87.12 120.93 28.91 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.169 -0.923 . . . . 61.54 109.931 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 39.5 pt -101.78 172.01 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 116.204 -0.453 . . . . 73.32 110.413 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' LYS . . . . . 0.709 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 56.1 tptt -125.84 129.39 49.29 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.828 -0.804 . . . . 71.02 108.828 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 18.0 t -124.54 121.58 61.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 107.653 -1.24 . . . . 64.44 107.653 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.295 0.4 OUTLIER -140.09 135.05 16.02 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 106.25 -1.759 . . . . 73.21 106.25 -170.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.33 143.53 53.2 Favored 'Trans proline' 0 CA--C 1.551 1.363 0 C-N-CA 121.885 1.723 . . . . 71.31 113.93 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.511 ' HD3' ' HB2' ' B' ' 38' ' ' SER . 66.0 tttt . . . . . 0 C--N 1.323 -0.57 0 C-N-CA 123.54 0.736 . . . . 70.22 110.436 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 120.546 0.212 . . . . 72.32 111.513 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.3 pt -71.09 -36.74 64.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.966 -0.561 . . . . 63.42 111.904 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.5 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 29.9 m-20 -76.17 -19.14 58.73 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.712 0.634 . . . . 75.04 112.712 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -66.96 -26.42 66.81 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.361 0.6 . . . . 70.34 110.339 174.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -96.89 16.03 20.51 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.153 -0.684 . . . . 72.01 109.153 -177.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.522 ' OG ' ' HG3' ' A' ' 84' ' ' GLU . 14.9 m -103.5 163.01 12.56 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 115.542 -0.754 . . . . 62.44 110.48 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 111' ' ' PRO . 27.2 m -131.64 164.16 35.29 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 115.469 -0.787 . . . . 73.34 109.883 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 23.7 t80 -110.87 126.03 54.25 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 107.44 -1.318 . . . . 73.11 107.44 175.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.0 t -115.89 111.99 37.8 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 N-CA-C 107.753 -1.203 . . . . 53.1 107.753 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.6 172.03 18.89 Favored Glycine 0 CA--C 1.478 -2.256 0 N-CA-C 109.706 -1.358 . . . . 32.44 109.706 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.687 ' OD1' ' HG3' ' A' ' 105' ' ' ARG . 26.2 t-20 69.42 -11.05 0.51 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.356 0.662 . . . . 64.15 112.395 -178.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.7 p -70.19 91.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 107.372 -1.344 . . . . 71.31 107.372 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.38 10.5 m-20 -74.43 168.02 20.53 Favored 'General case' 0 CA--C 1.457 -2.618 0 N-CA-C 116.341 1.978 . . . . 61.15 116.341 -166.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -39.33 -34.49 0.2 Allowed 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 128.231 2.612 . . . . 73.3 114.791 -173.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.66 -1.53 85.37 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.435 -0.888 . . . . 74.32 114.075 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.454 ' HA ' ' CZ ' ' A' ' 103' ' ' ARG . 19.7 m -75.26 133.33 41.37 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 117.677 0.738 . . . . 63.34 111.041 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.612 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 12.6 p -92.22 155.89 17.68 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 115.583 -0.735 . . . . 74.13 111.046 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.581 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -65.54 -47.82 74.58 Favored 'General case' 0 C--O 1.212 -0.904 0 C-N-CA 122.641 0.376 . . . . 71.42 110.831 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -56.81 -53.43 57.89 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.519 0.728 . . . . 63.01 112.529 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.61 -36.75 83.75 Favored 'General case' 0 C--O 1.25 1.128 0 CA-C-O 121.397 0.617 . . . . 55.51 111.348 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' A' ' 49' ' ' THR . 2.9 tt -72.17 -46.56 55.86 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.78 -1.1 . . . . 74.32 108.493 -176.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -58.26 -48.3 80.86 Favored 'General case' 0 C--O 1.207 -1.158 0 C-N-CA 123.482 0.713 . . . . 74.12 111.039 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.92 -38.23 69.99 Favored 'General case' 0 C--O 1.258 1.551 0 CA-C-O 121.268 0.556 . . . . 45.54 110.752 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -65.39 -40.3 93.27 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.117 -0.947 . . . . 75.04 110.189 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -83.04 -21.33 33.83 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 113.751 1.019 . . . . 74.21 113.751 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.8 t -60.47 -33.69 72.94 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.988 -0.745 . . . . 72.55 108.988 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.9 m -59.04 -27.8 65.82 Favored 'General case' 0 CA--C 1.565 1.536 0 CA-C-N 115.789 -0.641 . . . . 63.01 111.807 174.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 67.5 m -92.0 -0.85 57.48 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.36 0.874 . . . . 73.03 113.36 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.69 -169.96 30.53 Favored Glycine 0 C--N 1.319 -0.399 0 C-N-CA 118.951 -1.595 . . . . 74.1 114.562 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.4 m -94.56 116.78 29.19 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 123.205 0.602 . . . . 71.01 110.479 -175.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 85.1 mt -89.23 130.1 39.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 C-N-CA 123.015 0.526 . . . . 74.15 112.368 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.47 HD21 ' HB2' ' A' ' 86' ' ' ALA . 11.7 m120 -99.34 -40.41 7.92 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.686 -0.688 . . . . 71.43 111.106 177.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' B' ' 71' ' ' ASP . 55.6 mtp180 -150.55 160.9 43.47 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 107.91 -1.145 . . . . 73.31 107.91 -177.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.581 HD11 ' HB1' ' A' ' 50' ' ' ALA . 26.4 pt -145.14 137.97 21.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.382 -1.34 . . . . 74.32 107.382 173.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.9 m -125.61 120.89 32.03 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 107.604 -1.258 . . . . 64.05 107.604 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.402 ' O ' HD12 ' B' ' 68' ' ' ILE . 2.8 mp -118.18 118.45 58.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 106.218 -1.771 . . . . 74.23 106.218 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.45 ' HG ' ' CE2' ' A' ' 80' ' ' TYR 0.26 1.2 pt? -121.9 125.59 46.76 Favored 'General case' 0 C--N 1.285 -2.22 0 C-N-CA 120.257 -0.577 . . . . 60.21 111.967 179.156 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 73.1 m -117.37 136.0 53.47 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.734 -0.839 . . . . 71.42 108.734 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.502 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 2.5 p30 -131.07 153.52 49.22 Favored 'General case' 0 CA--C 1.495 -1.141 0 C-N-CA 119.146 -1.022 . . . . 61.13 112.033 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.411 ' HE3' ' OE1' ' B' ' 54' ' ' GLU . 97.9 mttt -121.54 18.33 11.26 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 124.048 0.843 . . . . 72.1 110.883 176.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -69.03 -21.18 64.13 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 119.049 -1.06 . . . . 51.44 112.98 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.7 p -91.8 10.61 27.82 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.405 0.621 . . . . 73.34 110.471 174.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.63 -47.87 1.4 Allowed Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.552 -0.619 . . . . 62.35 111.552 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -97.27 136.83 21.24 Favored Pre-proline 0 C--N 1.301 -1.543 0 CA-C-N 115.512 -0.344 . . . . 72.33 110.23 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 31.7 Cg_endo -69.0 118.61 5.78 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.616 1.544 . . . . 71.14 110.364 175.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 34.6 mtmm -113.33 149.74 33.55 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.337 -0.616 . . . . 70.21 109.337 -178.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -120.38 134.8 10.56 Favored Glycine 0 N--CA 1.423 -2.195 0 C-N-CA 119.847 -1.168 . . . . 73.23 112.791 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.45 ' CE2' ' HG ' ' A' ' 69' ' ' LEU . 17.6 p90 -152.85 144.42 23.42 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 124.326 1.05 . . . . 74.11 109.644 175.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.23 155.89 45.97 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.035 0.445 . . . . 64.01 111.811 -173.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -115.14 130.09 56.84 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.183 -1.414 . . . . 74.04 107.183 174.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.48 HG23 HG22 ' A' ' 66' ' ' ILE . 40.9 mm -112.39 112.88 42.38 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 108.454 -0.943 . . . . 73.23 108.454 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.522 ' HG3' ' OG ' ' A' ' 38' ' ' SER . 1.9 mp0 -88.08 118.96 28.01 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 122.61 0.364 . . . . 73.42 110.801 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -103.82 163.69 12.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.486 0.66 . . . . 73.22 111.602 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.47 ' HB2' HD21 ' A' ' 64' ' ' ASN . . . -78.27 -23.91 47.07 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.135 -0.938 . . . . 73.4 112.098 176.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -125.67 150.37 47.67 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 113.541 0.941 . . . . 74.12 113.541 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.555 ' O ' HG22 ' A' ' 91' ' ' VAL . 21.7 mmm180 -70.52 -29.3 65.77 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.248 -0.887 . . . . 73.31 108.986 173.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.95 -35.38 73.04 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.03 -0.532 . . . . 71.51 110.188 176.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.8 m -64.64 -36.91 85.8 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 116.745 -0.207 . . . . 73.21 111.077 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 88' ' ' ARG . 3.7 m -64.79 -39.26 85.05 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.885 0 C-N-CA 119.509 -0.876 . . . . 74.3 109.001 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.437 ' HA ' HG22 ' A' ' 95' ' ' VAL . 38.5 m-20 -60.07 -34.96 74.16 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.069 0.461 . . . . 74.3 111.783 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.74 -37.54 65.05 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.905 -0.589 . . . . 73.53 110.351 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.14 -44.76 59.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.138 -0.483 . . . . 65.15 110.741 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 91' ' ' VAL . 14.8 m -61.09 -23.33 29.6 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.019 0 CA-C-N 116.456 -0.338 . . . . 75.11 111.8 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.01 -16.0 63.11 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.664 0.745 . . . . 75.43 110.431 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 25.2 ttp -104.89 9.22 34.78 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.835 -1.075 . . . . 72.02 109.134 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 4.5 p-10 -37.4 -49.52 1.01 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 113.812 1.041 . . . . 73.23 113.812 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -115.44 104.17 11.5 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-O 121.744 0.783 . . . . 70.24 110.268 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 106' ' ' THR . 14.5 t -145.15 173.62 11.77 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 114.712 -1.131 . . . . 70.32 108.644 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.14 115.76 48.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.827 0.822 . . . . 71.15 110.301 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -122.58 117.71 26.48 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.034 -1.099 . . . . 75.41 108.034 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.454 ' CZ ' ' HA ' ' A' ' 48' ' ' SER . 54.3 mtt180 62.26 33.6 16.52 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.79 0.836 . . . . 74.01 112.841 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.37 -2.64 81.19 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 114.7 -1.136 . . . . 72.42 114.137 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.687 ' HG3' ' OD1' ' A' ' 43' ' ' ASN . 18.0 ptp180 -130.21 154.84 47.15 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 117.479 0.64 . . . . 74.1 111.293 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 100' ' ' THR . 88.6 m -83.65 120.96 26.63 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 116.063 -0.517 . . . . 71.44 111.277 -174.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.656 ' HA ' ' HB3' ' A' ' 43' ' ' ASN . 40.3 pt -99.83 172.13 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 C-N-CA 120.595 -0.442 . . . . 62.31 111.968 -174.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 54.1 tptt -131.4 126.65 35.7 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.094 -0.957 . . . . 72.42 109.572 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 35.9 t -127.93 128.69 69.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.368 -0.605 . . . . 74.31 109.368 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.542 ' HB2' ' HD2' ' A' ' 111' ' ' PRO 0.295 0.0 OUTLIER -148.45 161.94 31.91 Favored Pre-proline 0 C--N 1.303 -1.433 0 CA-C-O 117.604 -1.189 . . . . 75.04 108.301 174.15 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.542 ' HD2' ' HB2' ' A' ' 110' ' ' LEU . 50.4 Cg_endo -67.73 149.47 78.76 Favored 'Trans proline' 0 C--N 1.357 1.02 0 CA-C-N 121.833 1.69 . . . . 54.22 109.122 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.473 ' HE2' ' HB2' ' A' ' 38' ' ' SER . 35.8 ttpt . . . . . 0 C--N 1.319 -0.725 0 N-CA-C 107.332 -1.359 . . . . 71.45 107.332 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.643 0 N-CA-C 110.325 -1.11 . . . . 71.02 110.325 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.534 ' HG2' ' HD3' ' B' ' 23' ' ' PRO . 2.2 Cg_endo -40.84 -51.21 3.76 Favored 'Trans proline' 0 CA--C 1.561 1.87 0 C-N-CA 124.158 3.239 . . . . 71.23 113.791 172.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.534 ' HD3' ' HG2' ' B' ' 22' ' ' PRO . 1.5 Cg_endo -82.96 123.59 3.64 Favored 'Trans proline' 0 C--N 1.375 1.97 0 CA-C-N 120.825 1.33 . . . . 34.32 109.763 173.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -62.29 150.39 84.85 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 115.613 -0.721 . . . . 61.14 111.447 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.38 109.86 0.44 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.476 2.784 . . . . 73.24 112.914 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.557 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -107.67 148.63 29.13 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.986 -1.116 . . . . 65.14 107.986 175.421 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.477 ' HB3' ' OE2' ' B' ' 30' ' ' GLU . 40.1 t -61.04 145.86 49.26 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.206 0.817 . . . . 75.34 113.206 -170.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.653 ' O ' ' HG2' ' B' ' 32' ' ' LYS . . . -49.5 -35.25 19.31 Favored 'General case' 0 C--O 1.196 -1.732 0 CA-C-N 114.638 -1.165 . . . . 74.32 110.95 172.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.401 ' HA ' ' HG2' ' B' ' 32' ' ' LYS . 45.8 mt-10 -66.26 -34.95 79.17 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.104 0.409 . . . . 75.54 112.104 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.477 ' OE2' ' HB3' ' B' ' 27' ' ' SER . 0.7 OUTLIER -66.76 -35.23 79.61 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 109.096 -0.705 . . . . 60.43 109.096 172.409 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -69.82 -37.23 76.15 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.512 -0.767 . . . . 62.41 110.947 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.68 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 30.6 mmmt -57.63 -46.87 83.59 Favored 'General case' 0 C--O 1.204 -1.333 0 N-CA-C 109.85 -0.426 . . . . 74.32 109.85 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -66.23 -47.94 72.16 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.102 -0.499 . . . . 64.02 111.516 -175.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.473 HG12 ' O ' ' B' ' 30' ' ' GLU . 16.1 pt -70.97 -36.11 62.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.766 -0.652 . . . . 71.24 112.143 -178.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.434 ' HB3' ' HD2' ' B' ' 112' ' ' LYS . 29.0 m-20 -76.48 -20.14 57.29 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.093 0.775 . . . . 75.52 113.093 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.68 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 95.9 mttt -67.09 -25.04 66.03 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.783 0.802 . . . . 73.43 109.64 174.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.629 ' HD3' ' O ' ' B' ' 86' ' ' ALA . 97.3 mtt180 -97.93 13.9 29.11 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.59 -1.186 . . . . 64.03 109.284 -174.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.515 ' OG ' ' HE3' ' B' ' 112' ' ' LYS . 43.6 t -107.15 169.41 8.58 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 115.029 -0.987 . . . . 65.43 110.533 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.49 164.25 33.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 123.651 0.781 . . . . 65.23 110.244 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . 0.572 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 18.6 t80 -110.17 125.83 53.45 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 107.741 -1.207 . . . . 75.14 107.741 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.07 112.42 39.51 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 N-CA-C 107.636 -1.246 . . . . 75.25 107.636 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.29 163.2 13.68 Favored Glycine 0 N--CA 1.421 -2.305 0 C-N-CA 120.041 -1.076 . . . . 74.21 113.46 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 7.9 t30 56.56 22.79 6.97 Favored 'General case' 0 CA--C 1.564 1.507 0 C-N-CA 125.983 1.713 . . . . 52.53 112.802 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 10.6 p -57.5 134.67 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 109.116 -0.698 . . . . 73.21 109.116 174.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -66.25 141.5 58.01 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.061 -0.718 . . . . 64.14 109.061 -177.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -64.51 -10.77 27.98 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-O 121.558 0.694 . . . . 70.32 109.892 -176.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.47 -10.09 58.4 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-N 115.677 -0.692 . . . . 54.12 113.026 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.5 m -98.21 79.7 2.59 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-N 118.685 1.242 . . . . 53.23 110.994 176.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' THR . . . . . 0.443 ' OG1' HG22 ' A' ' 49' ' ' THR . 22.6 p -71.06 -177.48 1.68 Allowed 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 113.632 0.975 . . . . 75.11 113.632 175.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.581 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -51.13 -51.5 52.93 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 115.01 1.485 . . . . 65.11 115.01 -164.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -58.21 -53.52 57.29 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 112.825 0.676 . . . . 64.33 112.825 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -63.5 -40.59 97.48 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-O 121.568 0.699 . . . . 54.32 111.02 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 2.7 tt -67.73 -46.76 71.24 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.901 -1.045 . . . . 74.13 109.298 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.411 ' OE1' ' HE3' ' A' ' 72' ' ' LYS . 29.5 tt0 -58.84 -48.28 81.9 Favored 'General case' 0 C--O 1.206 -1.206 0 C-N-CA 122.474 0.31 . . . . 62.21 111.422 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.64 -37.63 68.48 Favored 'General case' 0 C--O 1.262 1.726 0 CA-C-O 121.389 0.614 . . . . 74.42 110.757 -178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -64.92 -40.73 95.51 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.133 -0.94 . . . . 74.43 110.23 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -83.33 -21.94 33.03 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.715 1.006 . . . . 75.41 113.715 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 40.5 t -62.93 -32.66 74.01 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 123.812 0.845 . . . . 73.12 110.06 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 18.2 m -62.42 -24.88 67.65 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-N 116.15 -0.477 . . . . 54.34 111.197 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 58.8 m -96.04 5.93 50.01 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 112.903 0.705 . . . . 62.24 112.903 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.24 -177.29 30.12 Favored Glycine 0 C--N 1.32 -0.345 0 C-N-CA 118.823 -1.656 . . . . 62.34 114.433 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 20.1 m -96.0 114.95 26.71 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.384 0.611 . . . . 71.21 110.287 -177.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 62.4 mt -85.55 131.44 34.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.789 -0.641 . . . . 53.32 111.866 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . 0.434 HD21 ' HB2' ' B' ' 86' ' ' ALA . 1.0 OUTLIER -99.04 -41.65 7.46 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.406 -0.816 . . . . 62.04 111.514 177.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -151.32 160.9 43.55 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 107.886 -1.153 . . . . 63.01 107.886 -177.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.581 HD11 ' HB1' ' B' ' 50' ' ' ALA . 23.6 pt -145.32 138.23 21.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.379 -1.341 . . . . 64.24 107.379 172.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 54.0 m -125.64 120.77 31.64 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 107.577 -1.268 . . . . 71.45 107.577 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 68' ' ' ILE . 3.2 mp -117.83 116.82 52.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 106.612 -1.625 . . . . 62.21 106.612 -177.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.275 1.1 pt? -120.9 124.5 45.11 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 120.211 -0.595 . . . . 73.33 112.33 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 66.4 m -117.51 134.56 54.72 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 108.859 -0.793 . . . . 73.41 108.859 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 2.8 p30 -125.54 143.2 51.12 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.575 -0.85 . . . . 61.41 108.822 177.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -118.72 15.53 13.57 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.124 -0.695 . . . . 64.54 109.124 -177.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -70.4 -11.28 60.81 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.317 0.579 . . . . 75.14 111.954 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 50.5 m -89.87 3.48 52.85 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.63 -0.713 . . . . 72.31 110.135 174.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.76 -47.89 2.05 Favored Glycine 0 CA--C 1.498 -1.018 0 N-CA-C 110.28 -1.128 . . . . 74.32 110.28 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -96.09 135.09 22.92 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 106.648 -1.612 . . . . 72.24 106.648 175.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.62 118.36 5.29 Favored 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 120.716 0.944 . . . . 62.32 110.609 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 32.9 mtmm -96.76 144.12 27.04 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 109.287 -0.635 . . . . 63.23 109.287 -178.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -119.42 132.01 9.31 Favored Glycine 0 N--CA 1.415 -2.728 0 C-N-CA 120.123 -1.037 . . . . 65.45 112.063 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -150.79 143.91 24.76 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 123.959 0.904 . . . . 72.53 109.641 175.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.36 156.48 45.82 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.078 0.466 . . . . 75.02 111.613 -173.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' TYR . . . . . 0.444 ' CG ' ' HE2' ' B' ' 112' ' ' LYS . 27.2 m-85 -115.99 130.83 56.99 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.526 -1.287 . . . . 73.3 107.526 174.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.483 HG23 HG22 ' B' ' 66' ' ' ILE . 35.8 mm -114.51 110.74 33.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.621 -0.881 . . . . 74.35 108.621 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -86.24 119.34 26.41 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.48 -0.327 . . . . 75.45 110.988 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.25 165.21 11.2 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.909 0.385 . . . . 73.33 109.997 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.629 ' O ' ' HD3' ' B' ' 37' ' ' ARG . . . -79.46 -34.56 41.39 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.34 -0.391 . . . . 55.44 112.018 176.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -111.18 150.46 29.47 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.137 0.494 . . . . 73.41 112.282 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.597 ' O ' HG22 ' B' ' 91' ' ' VAL . 21.2 mmm180 -68.95 -28.8 66.97 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.411 -0.813 . . . . 74.54 109.533 172.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -63.7 -29.33 70.57 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.633 -0.712 . . . . 73.05 111.143 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 19.5 m -67.74 -36.36 80.42 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 116.664 -0.244 . . . . 71.13 110.491 177.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.597 HG22 ' O ' ' B' ' 88' ' ' ARG . 3.6 m -64.24 -39.53 85.84 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.775 0 N-CA-C 108.802 -0.814 . . . . 75.11 108.802 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.402 ' HA ' HG22 ' B' ' 95' ' ' VAL . 6.0 m-20 -57.08 -37.22 71.57 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.513 0.561 . . . . 65.31 112.513 175.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.55 -35.93 65.57 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.947 -0.569 . . . . 70.42 110.526 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.46 -42.72 52.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.869 -0.605 . . . . 64.44 110.942 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . 0.505 HG13 ' O ' ' B' ' 91' ' ' VAL . 19.2 m -62.11 -23.36 31.5 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.962 0 N-CA-C 111.896 0.332 . . . . 73.42 111.896 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.7 -16.19 63.3 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.28 0.562 . . . . 44.02 110.442 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 16.5 ttm -101.3 3.03 40.35 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 123.994 0.918 . . . . 73.24 109.013 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . 0.586 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 4.2 p-10 -35.85 -50.36 0.65 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 116.291 1.96 . . . . 71.5 116.291 -172.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -115.77 93.49 4.29 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 118.204 -1.398 . . . . 75.03 110.945 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 13.1 t -135.2 172.8 12.49 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.145 -1.389 . . . . 62.14 109.925 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.0 p -101.58 128.63 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 108.876 -0.787 . . . . 74.21 108.876 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -130.51 119.63 22.88 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.941 -0.763 . . . . 73.12 108.941 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 31.0 ttm-85 50.71 33.42 8.29 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.612 1.565 . . . . 73.45 112.151 -175.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 99.57 -2.93 57.51 Favored Glycine 0 C--N 1.296 -1.64 0 CA-C-N 114.439 -1.255 . . . . 63.12 114.345 172.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -131.77 149.18 52.55 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 118.171 0.986 . . . . 75.32 112.162 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 25.7 m -75.5 124.86 27.91 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.994 -0.548 . . . . 62.04 110.929 -174.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 43.1 pt -102.83 171.56 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.016 0.436 . . . . 73.31 110.832 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' LYS . . . . . 0.586 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 55.0 tptt -135.41 131.93 36.87 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.0 -1.111 . . . . 71.54 108.0 178.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 28.0 t -127.28 134.35 66.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.608 -0.515 . . . . 75.42 109.608 -177.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.686 ' HB3' ' HD2' ' B' ' 111' ' ' PRO 0.262 0.1 OUTLIER -144.13 170.0 9.2 Favored Pre-proline 0 C--O 1.215 -0.76 0 N-CA-C 105.292 -2.114 . . . . 75.4 105.292 174.167 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.686 ' HD2' ' HB3' ' B' ' 110' ' ' LEU . 73.6 Cg_endo -73.53 151.51 47.44 Favored 'Trans proline' 0 CA--C 1.552 1.422 0 C-N-CA 122.015 1.81 . . . . 65.51 110.114 171.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.515 ' HE3' ' OG ' ' B' ' 38' ' ' SER . 35.1 ttmt . . . . . 0 C--N 1.317 -0.808 0 CA-C-O 121.007 0.432 . . . . 63.51 110.742 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 . . . . . 0 CA--C 1.511 -0.528 0 CA-C-O 121.2 0.524 . . . . 61.03 110.971 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . 0.26 15.5 pt -70.94 -35.65 60.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 113.204 0.816 . . . . 74.33 113.204 -178.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -61.43 -41.4 97.12 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.207 1.003 . . . . 73.03 109.416 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.497 ' HG2' ' HG2' ' A' ' 88' ' ' ARG . 28.3 ttmt -58.51 -25.51 62.47 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 125.18 1.392 . . . . 73.42 112.767 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.437 ' HA ' HG11 ' A' ' 91' ' ' VAL . 88.5 mtm180 -119.52 10.38 11.8 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 112.389 0.514 . . . . 64.51 112.389 -175.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.0 t -98.32 154.7 17.63 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.253 0.549 . . . . 52.35 111.778 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.604 HG13 ' CG2' ' A' ' 91' ' ' VAL . 0.2 OUTLIER -140.64 161.9 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 C-N-CA 124.062 0.945 . . . . 31.31 111.719 176.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 25.7 t80 -112.49 126.5 55.38 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 107.642 -1.244 . . . . 72.44 107.642 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 59.7 t -113.32 110.35 31.87 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 N-CA-C 107.082 -1.451 . . . . 65.13 107.082 176.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.36 165.92 12.84 Favored Glycine 0 C--N 1.291 -1.958 0 C-N-CA 119.512 -1.328 . . . . 52.04 114.272 -175.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.464 ' O ' ' HD3' ' A' ' 105' ' ' ARG . 9.8 t30 64.58 24.72 13.08 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.121 1.368 . . . . 72.14 112.193 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.431 HG21 HD21 ' A' ' 53' ' ' LEU . 8.0 p -106.07 95.38 3.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-O 122.058 0.932 . . . . 71.41 110.451 176.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.526 ' HA ' ' HA3' ' A' ' 79' ' ' GLY . 4.9 m-20 -106.3 137.9 43.43 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 118.563 -0.732 . . . . 73.11 109.903 -169.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.566 ' CE1' ' HB2' ' A' ' 77' ' ' PRO 0.394 50.2 m-85 42.02 -60.52 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 121.247 3.795 . . . . 74.53 121.247 169.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.8 -20.46 62.03 Favored Glycine 0 N--CA 1.466 0.635 0 N-CA-C 115.073 0.789 . . . . 62.31 115.073 -173.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.9 m -95.69 134.7 38.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 117.477 0.638 . . . . 63.23 109.893 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 47.9 p -98.85 176.34 5.64 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 109.173 -0.677 . . . . 74.01 109.173 -177.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.484 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -60.2 -44.35 95.2 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 110.061 -0.348 . . . . 65.41 110.061 176.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -57.18 -46.29 82.95 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 116.547 -0.297 . . . . 75.53 110.621 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -56.44 -42.72 78.57 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.239 0.542 . . . . 62.12 111.446 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.431 HD21 HG21 ' A' ' 44' ' ' VAL . 62.4 mt -73.38 -49.3 27.93 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.267 -0.879 . . . . 64.52 111.696 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.18 -49.47 71.91 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.953 -0.567 . . . . 62.44 110.965 -176.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.31 -42.35 91.17 Favored 'General case' 0 C--O 1.267 2.001 0 CA-C-O 121.442 0.639 . . . . 44.31 111.752 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -66.42 -34.75 78.66 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.877 -0.602 . . . . 73.23 109.61 -176.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . 0.25 49.3 m-85 -82.31 -20.95 36.39 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 113.499 0.926 . . . . 70.12 113.499 175.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.0 m -61.05 -32.62 72.25 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.257 -0.646 . . . . 73.45 109.257 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 m -58.65 -30.74 67.56 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.945 -0.57 . . . . 52.52 110.618 174.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 61.0 m -97.71 -1.27 43.86 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 112.536 0.569 . . . . 73.43 112.536 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' A' ' 90' ' ' SER . . . 168.16 -174.18 43.01 Favored Glycine 0 C--O 1.223 -0.546 0 C-N-CA 118.379 -1.867 . . . . 74.05 116.0 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.4 p -70.55 -71.7 0.24 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.938 0.895 . . . . 62.2 112.428 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.3 73.7 mt 99.77 113.12 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 C-N-CA 126.71 2.004 . . . . 54.53 112.669 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.516 ' OD1' ' HB2' ' A' ' 86' ' ' ALA . 3.7 m-20 -106.81 -28.24 10.25 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-N 114.354 -1.293 . . . . 74.45 112.57 -177.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.478 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 75.3 mtt180 -151.61 155.45 38.44 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.788 -0.819 . . . . 61.54 108.788 174.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.498 HG22 HG23 ' A' ' 83' ' ' ILE . 20.5 pt -144.02 137.25 23.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 105.428 -2.064 . . . . 72.53 105.428 169.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 58.5 m -125.09 125.21 43.41 Favored 'General case' 0 C--N 1.262 -3.224 0 N-CA-C 107.708 -1.219 . . . . 73.4 107.708 -177.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mp -122.0 118.32 55.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 106.188 -1.782 . . . . 72.33 106.188 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.41 HD23 ' N ' ' A' ' 69' ' ' LEU 0.298 0.9 OUTLIER -121.53 133.19 55.02 Favored 'General case' 0 C--N 1.278 -2.525 0 C-N-CA 120.047 -0.661 . . . . 74.2 111.942 177.058 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 79.3 m -116.67 124.99 51.08 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.211 -1.033 . . . . 74.42 108.211 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.517 ' HB2' ' CD2' ' A' ' 73' ' ' PHE . 2.9 p-10 -112.12 138.43 48.8 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 119.047 -1.061 . . . . 64.2 112.131 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -117.13 7.48 13.04 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 114.763 -1.108 . . . . 72.32 110.239 173.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.517 ' CD2' ' HB2' ' A' ' 71' ' ' ASP . 37.3 p90 -69.58 -15.93 63.31 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.93 0.871 . . . . 75.05 109.637 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.2 m -86.92 6.98 29.31 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 114.727 -1.124 . . . . 73.34 109.515 175.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.34 -53.99 4.44 Favored Glycine 0 CA--C 1.503 -0.661 0 N-CA-C 110.596 -1.001 . . . . 64.23 110.596 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -96.24 138.15 21.59 Favored Pre-proline 0 C--N 1.298 -1.646 0 CA-C-N 114.27 -0.965 . . . . 71.13 108.774 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.566 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 46.9 Cg_endo -71.62 118.43 5.65 Favored 'Trans proline' 0 C--O 1.247 0.951 0 C-N-CA 122.203 1.936 . . . . 73.23 112.719 -177.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 29.1 mtmm -113.21 165.54 12.31 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 109.07 -0.715 . . . . 72.21 109.07 175.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 45' ' ' ASP . . . -138.2 146.0 17.66 Favored Glycine 0 N--CA 1.42 -2.403 0 C-N-CA 120.235 -0.983 . . . . 63.41 113.405 175.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -154.08 145.22 22.83 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.569 -0.816 . . . . 71.04 109.674 175.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 67' ' ' THR . . . -132.74 152.72 51.68 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.482 -0.326 . . . . 74.52 110.882 -172.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.408 ' CZ ' ' HD1' ' A' ' 40' ' ' TYR . 77.3 m-85 -123.9 131.56 53.6 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.556 -0.905 . . . . 75.43 108.556 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.498 HG23 HG22 ' A' ' 66' ' ' ILE . 23.4 mm -115.38 120.6 65.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 109.227 -0.657 . . . . 61.3 109.227 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 65' ' ' ARG . 1.9 mp0 -100.14 121.59 41.67 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.882 -0.414 . . . . 74.51 109.882 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -98.81 161.83 13.43 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.699 -0.228 . . . . 73.0 110.796 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.516 ' HB2' ' OD1' ' A' ' 64' ' ' ASN . . . -85.16 -29.89 24.4 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.802 -0.359 . . . . 70.44 111.231 175.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.467 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 5.6 mp0 -97.81 142.94 28.96 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.639 -0.504 . . . . 73.21 109.639 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.497 ' HG2' ' HG2' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -71.17 -30.79 66.88 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 105.882 -1.896 . . . . 61.21 105.882 176.08 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -67.57 -35.55 79.22 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.583 -1.189 . . . . 74.25 110.605 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.467 ' OG ' ' HB2' ' A' ' 87' ' ' GLU . 50.1 m -70.93 -36.81 72.79 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 120.696 0.284 . . . . 72.01 111.742 -177.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.604 ' CG2' HG13 ' A' ' 39' ' ' VAL . 14.5 p -65.99 -37.22 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 109.257 -0.645 . . . . 60.43 109.257 177.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -65.29 -31.58 72.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.518 -0.764 . . . . 63.1 110.035 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.5 -31.57 63.8 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.854 -0.612 . . . . 75.23 110.845 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.61 -43.94 53.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.039 -0.528 . . . . 65.52 110.451 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 20.5 m -58.25 -22.41 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 112.942 0.719 . . . . 54.33 112.942 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.46 -13.15 61.73 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.372 0.606 . . . . 71.0 110.415 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 47.7 ttp -103.4 9.46 37.8 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.007 -0.738 . . . . 73.21 109.007 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.592 ' HA ' ' HB ' ' A' ' 109' ' ' VAL . 5.5 p-10 -37.37 -57.09 0.93 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 115.016 1.487 . . . . 62.44 115.016 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -110.09 85.12 2.05 Favored 'General case' 0 N--CA 1.397 -3.117 0 CA-C-O 122.167 0.984 . . . . 74.41 109.419 -174.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.2 p -129.6 167.47 17.9 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 113.849 -1.523 . . . . 70.04 111.904 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.2 p -110.73 106.18 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.163 0 CA-C-O 121.855 0.836 . . . . 74.21 109.017 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -105.69 126.23 51.91 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.115 -0.948 . . . . 73.44 108.543 -176.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 41.4 ttt-85 52.29 32.91 11.68 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 124.731 1.212 . . . . 72.14 111.348 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.72 -4.88 76.34 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 115.107 -0.951 . . . . 60.4 114.288 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.464 ' HD3' ' O ' ' A' ' 43' ' ' ASN . 4.6 ptp180 -121.88 138.41 54.41 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 117.593 0.696 . . . . 64.43 111.218 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 45.6 m -76.12 122.13 23.84 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-O 120.803 0.335 . . . . 53.44 110.761 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 44.6 pt -101.78 171.87 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.909 -0.587 . . . . 73.52 111.119 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 15.0 mmmt -125.1 131.13 53.35 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-N 114.952 -1.022 . . . . 72.51 109.245 176.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.609 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 24.7 t -127.47 116.19 42.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 108.361 -0.978 . . . . 70.02 108.361 174.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.426 ' CD1' ' HD2' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -146.99 156.4 47.29 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 106.912 -1.514 . . . . 60.24 106.912 177.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -62.61 129.3 25.97 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 121.841 1.694 . . . . 63.1 113.373 -175.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.423 -1.808 0 N-CA-C 103.155 -2.905 . . . . 72.12 103.155 173.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.461 0 N-CA-C 110.828 -0.909 . . . . 55.32 110.828 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.584 ' HG3' ' CZ ' ' A' ' 40' ' ' TYR . 2.3 Cg_endo -43.64 -51.82 5.82 Favored 'Trans proline' 0 CA--C 1.556 1.588 0 C-N-CA 123.418 2.745 . . . . 75.54 113.268 176.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.432 ' HD3' ' HG2' ' B' ' 22' ' ' PRO . 11.2 Cg_exo -71.92 123.62 9.47 Favored 'Trans proline' 0 C--N 1.38 2.196 0 N-CA-C 108.132 -1.526 . . . . 75.44 108.132 171.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.422 ' CD ' ' H ' ' B' ' 24' ' ' GLN . 0.5 OUTLIER -73.5 160.12 83.08 Favored Pre-proline 0 C--N 1.288 -2.093 0 CA-C-N 115.287 -0.87 . . . . 73.12 109.784 -177.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.94 101.27 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 122.381 2.054 . . . . 75.01 111.457 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.747 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -72.49 171.98 11.35 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 114.21 -1.359 . . . . 75.13 111.42 178.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.522 ' HB3' ' OE1' ' B' ' 30' ' ' GLU . 34.3 t -65.08 145.99 55.59 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.704 0.764 . . . . 60.23 112.276 -173.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.23 -40.87 25.89 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.85 -1.523 . . . . 53.03 111.673 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -75.93 -30.25 58.64 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 113.746 1.017 . . . . 73.4 113.746 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.522 ' OE1' ' HB3' ' B' ' 27' ' ' SER . 1.1 mp0 -60.73 -34.61 74.67 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 120.32 -0.552 . . . . 74.33 109.814 171.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -66.18 -50.71 62.95 Favored 'General case' 0 C--O 1.199 -1.553 0 CA-C-N 115.81 -0.632 . . . . 65.44 109.756 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.687 ' N ' ' HE2' ' B' ' 32' ' ' LYS . 0.4 OUTLIER -61.43 -29.71 70.11 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 119.839 -0.744 . . . . 75.35 112.123 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' B' ' 36' ' ' LYS . 9.4 tp10 -69.23 -44.72 71.43 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 108.558 -0.905 . . . . 71.33 108.558 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . 0.25 11.8 pt -71.95 -35.21 53.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 112.608 0.596 . . . . 71.52 112.608 177.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -58.41 -43.63 88.73 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.323 0.582 . . . . 73.15 110.616 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' B' ' 33' ' ' GLU . 15.0 ptpt -68.88 -18.34 64.12 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.457 0.54 . . . . 73.3 112.457 -173.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.63 ' HD2' ' O ' ' B' ' 85' ' ' PHE . 21.7 ptt180 -118.83 15.91 13.48 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.596 0.591 . . . . 71.02 112.596 -178.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 47.3 t -102.35 154.87 18.65 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.274 0.559 . . . . 44.3 111.738 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.618 HG13 ' CG2' ' B' ' 91' ' ' VAL . 0.3 OUTLIER -140.31 164.01 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 C-N-CA 124.287 1.035 . . . . 75.2 112.072 178.554 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . 0.619 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 30.7 t80 -115.71 127.39 55.1 Favored 'General case' 0 CA--C 1.48 -1.726 0 CA-C-N 114.557 -1.201 . . . . 74.4 107.76 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.36 109.65 29.31 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 N-CA-C 107.256 -1.387 . . . . 43.12 107.256 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -109.41 170.13 14.23 Favored Glycine 0 N--CA 1.435 -1.415 0 C-N-CA 120.257 -0.973 . . . . 51.55 112.602 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.2 t30 63.96 -0.66 0.77 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 126.213 1.805 . . . . 73.32 112.54 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.548 HG21 HD21 ' B' ' 53' ' ' LEU . 3.6 p -58.39 130.89 22.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 108.913 -0.773 . . . . 74.44 108.913 175.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -76.09 153.26 36.46 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 115.694 -0.685 . . . . 75.52 111.624 -173.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -50.55 -34.1 24.26 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 126.172 1.789 . . . . 75.44 111.214 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.7 3.99 78.73 Favored Glycine 0 CA--C 1.501 -0.842 0 C-N-CA 119.897 -1.144 . . . . 72.02 113.72 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 36.8 t -73.06 118.84 16.5 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 105.137 -2.172 . . . . 63.01 105.137 172.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.49 166.92 12.29 Favored 'General case' 0 N--CA 1.405 -2.701 0 N-CA-C 109.201 -0.666 . . . . 61.53 109.201 -169.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.448 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -56.08 -45.5 79.35 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 117.911 0.323 . . . . 72.3 111.439 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' GLN . . . . . 0.4 ' H ' ' CD ' ' B' ' 51' ' ' GLN . 22.1 mp0 -57.18 -44.84 83.94 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.525 0.516 . . . . 53.42 111.042 178.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -57.17 -45.1 83.95 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 121.167 0.508 . . . . 71.24 111.348 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.548 HD21 HG21 ' B' ' 44' ' ' VAL . 80.5 mt -72.2 -49.2 37.32 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.399 -0.818 . . . . 70.03 111.585 -177.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -63.2 -49.4 74.39 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 116.105 -0.498 . . . . 63.33 111.151 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.46 97.77 Favored 'General case' 0 C--O 1.267 2.014 0 CA-C-O 121.522 0.677 . . . . 70.54 111.812 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -66.39 -34.43 77.95 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.821 -0.627 . . . . 75.42 109.697 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -82.48 -21.36 35.59 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 113.678 0.992 . . . . 71.12 113.678 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 71.8 m -61.88 -30.69 71.04 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 116.379 -0.373 . . . . 62.44 110.295 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 17.4 m -58.69 -31.14 67.94 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 115.895 -0.593 . . . . 74.43 110.265 175.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 63.0 m -91.44 6.47 45.35 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 113.474 0.916 . . . . 35.45 113.474 -177.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.23 -159.93 26.25 Favored Glycine 0 N--CA 1.469 0.856 0 C-N-CA 118.914 -1.613 . . . . 70.32 115.108 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 12.9 m -101.48 123.26 45.24 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.021 0.439 . . . . 75.5 110.406 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 57.6 mt -92.04 134.91 28.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 123.583 0.753 . . . . 53.51 112.073 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . 0.525 ' ND2' ' HB2' ' B' ' 86' ' ' ALA . 0.8 OUTLIER -103.98 -33.15 8.92 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.711 0.805 . . . . 64.24 112.021 176.462 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.452 ' HB2' ' HB2' ' B' ' 84' ' ' GLU . 82.8 mtt180 -151.86 156.87 41.02 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.218 -0.66 . . . . 64.24 109.218 178.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.514 HG22 HG23 ' B' ' 83' ' ' ILE . 17.7 pt -143.61 138.15 25.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 105.824 -1.917 . . . . 64.41 105.824 168.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 53.8 m -125.29 125.73 44.0 Favored 'General case' 0 C--N 1.269 -2.926 0 N-CA-C 107.668 -1.234 . . . . 70.22 107.668 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.8 mp -122.78 117.54 52.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 106.337 -1.727 . . . . 73.31 106.337 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.402 HD23 ' N ' ' B' ' 69' ' ' LEU 0.288 0.9 OUTLIER -121.03 132.52 54.95 Favored 'General case' 0 C--N 1.283 -2.288 0 C-N-CA 120.028 -0.669 . . . . 62.14 111.8 177.774 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' CYS . . . . . 0.493 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 70.6 m -116.98 123.01 45.88 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 108.73 -0.841 . . . . 72.14 108.73 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.606 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 2.8 p30 -110.2 132.09 54.48 Favored 'General case' 0 C--O 1.208 -1.11 0 C-N-CA 119.913 -0.715 . . . . 73.24 110.115 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -118.9 10.8 12.38 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.937 -1.134 . . . . 72.0 107.937 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.494 ' CD2' ' HB2' ' B' ' 71' ' ' ASP . 4.1 p90 -56.86 -17.41 9.3 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 115.902 1.816 . . . . 64.12 115.902 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 30.6 m -110.32 9.73 23.58 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 118.242 0.473 . . . . 72.21 111.61 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.39 -55.63 0.52 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.257 -0.973 . . . . 75.32 112.368 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -96.16 129.72 33.03 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 109.956 -0.387 . . . . 72.44 109.956 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.606 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 92.0 Cg_endo -77.04 119.61 5.12 Favored 'Trans proline' 0 N--CA 1.441 -1.617 0 C-N-CA 121.8 1.667 . . . . 74.33 111.932 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 30.1 mtmm -102.32 164.45 11.67 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 108.199 -1.037 . . . . 65.42 108.199 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -134.28 141.16 12.43 Favored Glycine 0 N--CA 1.423 -2.226 0 C-N-CA 119.658 -1.258 . . . . 73.44 113.027 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . 0.452 ' HA ' ' CG1' ' B' ' 44' ' ' VAL . 19.5 p90 -150.71 143.34 24.47 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.183 -0.509 . . . . 75.03 110.117 173.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.45 152.33 51.55 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.419 -0.355 . . . . 74.3 110.872 -172.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' TYR . . . . . 0.574 ' CD2' ' HG3' ' B' ' 112' ' ' LYS . 88.1 m-85 -124.15 130.05 51.88 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 108.944 -0.762 . . . . 71.11 108.944 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.514 HG23 HG22 ' B' ' 66' ' ' ILE . 23.5 mm -113.27 121.6 65.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 109.004 -0.739 . . . . 73.2 109.004 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' B' ' 65' ' ' ARG . 1.2 mp0 -100.14 119.68 38.71 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.463 -0.569 . . . . 44.35 109.463 176.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.63 ' O ' ' HD2' ' B' ' 37' ' ' ARG . 96.5 m-85 -94.48 162.32 13.86 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 110.274 -0.269 . . . . 73.31 110.274 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.525 ' HB2' ' ND2' ' B' ' 64' ' ' ASN . . . -81.41 -34.58 31.5 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.305 -0.407 . . . . 42.23 110.608 174.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . 0.409 ' HB2' ' OG ' ' B' ' 90' ' ' SER . 9.7 mp0 -99.96 147.95 25.02 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.199 -0.6 . . . . 73.12 111.472 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.522 ' O ' HG12 ' B' ' 91' ' ' VAL . 0.0 OUTLIER -74.16 -31.64 62.79 Favored 'General case' 0 C--O 1.212 -0.891 0 N-CA-C 106.215 -1.772 . . . . 73.52 106.215 177.438 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -71.69 -29.18 64.3 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 120.479 -0.488 . . . . 74.35 111.885 177.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' SER . . . . . 0.409 ' OG ' ' HB2' ' B' ' 87' ' ' GLU . 49.4 m -71.49 -36.98 71.31 Favored 'General case' 0 N--CA 1.439 -0.99 0 O-C-N 122.224 -0.297 . . . . 73.53 111.349 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.618 ' CG2' HG13 ' B' ' 39' ' ' VAL . 14.5 p -65.87 -37.69 80.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 108.64 -0.874 . . . . 73.34 108.64 177.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -63.77 -33.56 75.94 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.394 -0.821 . . . . 60.34 109.816 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.12 -31.3 64.21 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.829 -0.623 . . . . 75.14 110.539 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.67 -44.71 48.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.979 -0.555 . . . . 74.54 110.396 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 21.1 m -58.61 -22.46 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 112.41 0.522 . . . . 74.04 112.41 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.76 -18.49 63.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.897 0.855 . . . . 64.13 111.034 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 43.8 ttp -98.87 11.94 37.26 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 114.34 -1.3 . . . . 73.35 109.213 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . 0.56 ' HA ' ' HB ' ' B' ' 109' ' ' VAL . 9.8 t70 -35.11 -61.23 0.44 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 117.037 2.236 . . . . 63.12 117.037 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' B' ' 107' ' ' ILE . 35.7 tt0 -115.74 34.98 4.65 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 119.542 1.065 . . . . 73.11 110.631 -174.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 76.4 p -77.72 -175.22 3.8 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.735 -0.666 . . . . 74.13 111.106 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -103.0 135.42 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 N-CA-C 109.334 -0.617 . . . . 71.23 109.334 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -142.23 128.19 19.53 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.596 -0.89 . . . . 74.45 108.596 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 57.2 ttt-85 56.3 32.99 21.46 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.277 1.031 . . . . 72.31 110.377 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.57 5.5 89.87 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.127 -0.942 . . . . 74.25 114.462 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -129.27 166.11 20.07 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 117.867 0.834 . . . . 61.42 109.976 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 32.4 m -90.99 122.74 33.91 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.785 -0.45 . . . . 63.32 109.785 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' B' ' 99' ' ' GLU . 39.7 pt -101.21 173.38 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 120.739 0.304 . . . . 74.03 111.763 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -130.86 120.76 24.14 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.241 -1.022 . . . . 70.33 108.241 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . 0.619 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 42.3 t -127.0 116.04 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 123.361 0.413 . . . . 73.42 109.922 -177.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.472 HD13 ' HB3' ' B' ' 40' ' ' TYR . 0.0 OUTLIER -146.45 155.88 49.48 Favored Pre-proline 0 C--N 1.314 -0.963 0 N-CA-C 107.263 -1.384 . . . . 72.12 107.263 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.73 134.38 46.85 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.67 2.247 . . . . 72.35 113.151 -175.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.574 ' HG3' ' CD2' ' B' ' 82' ' ' TYR . 3.2 tmmm? . . . . . 0 C--N 1.29 -1.984 0 N-CA-C 106.831 -1.544 . . . . 74.14 106.831 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 . . . . . 0 C--O 1.214 -0.764 0 N-CA-C 111.389 0.144 . . . . 75.33 111.389 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.9 pt -66.64 -34.22 68.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.08 0.467 . . . . 75.04 110.742 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.24 -40.01 89.91 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.65 1.18 . . . . 55.51 110.985 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -64.2 -21.0 66.41 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.596 0.712 . . . . 73.44 110.492 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.522 ' HD3' ' O ' ' A' ' 86' ' ' ALA . 90.9 mtt180 -109.64 16.48 22.12 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.35 -0.841 . . . . 71.41 109.657 -174.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 46.9 m -101.05 158.4 16.04 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 121.471 0.653 . . . . 40.12 111.762 178.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.5 m -134.58 163.56 36.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.583 -0.735 . . . . 73.2 109.684 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.691 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 23.3 t80 -109.49 128.13 54.94 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.545 -1.28 . . . . 73.32 107.545 174.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.9 t -120.94 109.28 24.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 107.843 -1.169 . . . . 72.24 107.843 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.65 170.99 15.87 Favored Glycine 0 C--N 1.293 -1.842 0 C-N-CA 119.785 -1.198 . . . . 40.35 113.783 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t30 67.55 17.31 9.98 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 125.297 1.439 . . . . 63.24 112.163 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.439 ' O ' ' HA3' ' A' ' 79' ' ' GLY . 14.5 p -72.16 141.58 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 109.257 -0.646 . . . . 71.12 109.257 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -107.24 165.27 11.5 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 112.077 0.399 . . . . 53.34 112.077 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.408 ' CE1' ' HB3' ' A' ' 70' ' ' CYS . 21.7 m-85 -59.31 -26.51 65.06 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.316 0.646 . . . . 74.51 111.948 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.94 -16.57 80.58 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.36 -0.696 . . . . 53.45 111.36 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 24.7 m -95.8 125.96 40.73 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 107.342 -1.355 . . . . 72.34 107.342 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.48 HG21 ' HB ' ' B' ' 49' ' ' THR 0.253 3.6 p -126.31 179.31 5.34 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 114.527 1.306 . . . . 75.35 114.527 -172.023 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.463 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -56.86 -52.65 64.28 Favored 'General case' 0 C--O 1.213 -0.818 0 N-CA-C 114.459 1.281 . . . . 54.34 114.459 -168.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.25 28.1 pt20 -64.37 -32.14 73.63 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 119.103 -1.039 . . . . 72.12 112.941 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -59.9 -44.93 93.97 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.101 -0.703 . . . . 51.14 109.101 176.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 69.8 mt -73.04 -48.54 35.17 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.562 -1.199 . . . . 71.5 111.214 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.34 -49.62 74.86 Favored 'General case' 0 C--O 1.198 -1.625 0 CA-C-N 116.197 -0.456 . . . . 73.11 111.429 -177.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.6 -41.73 86.48 Favored 'General case' 0 C--O 1.257 1.482 0 CA-C-O 121.434 0.635 . . . . 64.13 111.98 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -68.02 -39.2 83.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.995 -1.002 . . . . 73.14 110.023 -176.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -82.23 -21.52 36.29 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.213 0.82 . . . . 65.15 113.213 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.3 t -68.83 -24.29 64.36 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.988 -0.745 . . . . 72.43 108.988 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.2 m -60.28 -33.92 73.02 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.521 0.677 . . . . 71.44 109.526 172.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 63.4 m -90.33 5.05 48.91 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.515 -0.766 . . . . 73.33 112.373 -177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.83 -168.62 29.96 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 118.688 -1.72 . . . . 73.34 115.08 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.436 ' HB2' ' HB3' ' A' ' 86' ' ' ALA . 9.9 m -97.96 122.73 41.43 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.315 -0.624 . . . . 74.01 109.315 -176.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.5 mt -91.46 131.23 39.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 113.018 0.747 . . . . 74.31 113.018 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -100.05 -40.95 7.37 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.162 -0.926 . . . . 71.12 110.905 176.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.431 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 88.6 mtt180 -149.91 158.91 44.64 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 108.837 -0.801 . . . . 75.12 108.837 -177.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.463 HD11 ' HB1' ' A' ' 50' ' ' ALA . 27.3 pt -144.95 140.82 23.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 106.941 -1.503 . . . . 61.33 106.941 169.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.0 m -125.25 125.35 43.44 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 106.498 -1.667 . . . . 74.33 106.498 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.458 HD12 ' O ' ' B' ' 68' ' ' ILE . 3.4 mp -122.12 118.57 55.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.812 -1.551 . . . . 72.32 106.812 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.263 1.2 pt? -120.09 122.81 41.9 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 120.206 -0.597 . . . . 63.35 111.111 178.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.445 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 64.2 m -116.85 132.63 56.65 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.271 -1.011 . . . . 74.14 108.271 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 3.6 p-10 -118.74 138.18 52.84 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 119.559 -0.856 . . . . 62.04 112.005 -176.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -117.59 13.25 14.28 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.297 -0.865 . . . . 63.1 109.631 173.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.46 ' CD2' ' HB2' ' A' ' 71' ' ' ASP . 13.9 p90 -65.8 -23.53 66.72 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.428 0.632 . . . . 64.13 110.395 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.1 t -83.49 0.55 45.91 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.781 -0.645 . . . . 65.4 110.151 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.92 -58.72 1.05 Allowed Glycine 0 N--CA 1.438 -1.213 0 N-CA-C 110.533 -1.027 . . . . 44.32 110.533 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -95.13 130.35 32.81 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 108.703 -0.851 . . . . 71.04 108.703 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 24.3 Cg_endo -62.32 119.28 6.31 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 123.028 2.486 . . . . 72.13 114.183 -175.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -104.43 -168.92 1.55 Allowed 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.582 -1.266 . . . . 75.35 107.582 171.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 70' ' ' CYS . . . -172.33 141.79 6.47 Favored Glycine 0 N--CA 1.407 -3.299 0 C-N-CA 119.792 -1.194 . . . . 71.23 112.726 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -151.57 145.47 25.15 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 123.813 0.845 . . . . 63.14 109.033 175.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.91 159.46 42.14 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-O 120.925 0.393 . . . . 50.1 111.178 -172.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -123.06 123.34 40.62 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.988 -0.745 . . . . 61.33 108.988 175.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.431 HG23 HG22 ' A' ' 66' ' ' ILE . 33.4 mm -103.06 119.93 52.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 106.624 -1.621 . . . . 73.03 106.624 177.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 38' ' ' SER . 35.0 mt-10 -107.12 119.31 39.03 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.068 0.461 . . . . 53.11 110.049 -176.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -100.58 167.48 10.33 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.389 0.614 . . . . 72.04 112.468 -174.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.522 ' O ' ' HD3' ' A' ' 37' ' ' ARG . . . -83.85 -33.26 24.89 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.184 -0.916 . . . . 72.4 111.665 174.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.421 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 4.5 mp0 -104.55 143.66 32.74 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 110.119 -0.326 . . . . 62.32 110.119 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.479 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -73.04 -29.66 63.15 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 106.005 -1.85 . . . . 75.42 106.005 177.174 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' A' ' 92' ' ' ASP . 13.9 m120 -60.48 -28.07 68.06 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.989 -1.459 . . . . 71.15 110.425 177.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 87' ' ' GLU . 26.8 m -67.35 -36.38 81.28 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 116.553 -0.294 . . . . 62.03 110.922 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 88' ' ' ARG . 3.2 m -64.06 -39.05 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 N-CA-C 108.429 -0.952 . . . . 74.14 108.429 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 89' ' ' ASN . 21.2 t70 -55.89 -39.6 71.8 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.929 0.768 . . . . 75.34 110.585 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.23 -37.43 63.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.891 -0.595 . . . . 62.33 111.452 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.56 -45.24 62.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.945 0.402 . . . . 54.24 111.357 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.485 HG11 ' HD3' ' A' ' 111' ' ' PRO . 28.6 m -56.97 -22.15 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 113.16 0.8 . . . . 73.4 113.16 178.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.69 -17.73 64.81 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.277 0.561 . . . . 72.43 110.806 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.51 ' O ' HG22 ' A' ' 100' ' ' THR . 66.2 mtm -99.58 8.11 44.71 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.754 -0.657 . . . . 73.03 110.676 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -41.75 -42.33 2.57 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 115.476 1.658 . . . . 61.31 115.476 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 41.9 tt0 -107.36 16.33 24.05 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 118.737 0.699 . . . . 64.34 112.439 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 97' ' ' MET . 7.3 t -81.79 175.38 10.49 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 118.809 -1.156 . . . . 73.44 109.865 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.3 m -108.8 118.91 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 CA-C-O 121.652 0.739 . . . . 64.34 110.884 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.479 ' HB2' HD13 ' A' ' 107' ' ' ILE . 61.0 t80 -92.06 117.79 30.18 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 107.494 -1.298 . . . . 74.34 107.494 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 50.03 32.85 6.12 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.801 1.241 . . . . 73.21 112.135 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 99.5 -4.97 58.45 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 114.855 0.702 . . . . 61.23 114.855 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -118.67 137.02 53.6 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 118.209 1.004 . . . . 72.51 110.68 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.6 m -70.26 119.09 13.93 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.131 0.491 . . . . 64.22 110.38 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 102' ' ' PHE . 45.7 pt -103.51 172.65 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 CA-C-N 116.054 -0.521 . . . . 70.43 110.223 177.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.427 ' HD2' ' HA ' ' A' ' 108' ' ' LYS . 19.8 mmmt -123.94 129.41 50.91 Favored 'General case' 0 CA--C 1.472 -2.03 0 CA-C-N 115.739 -0.664 . . . . 75.42 109.621 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.691 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 22.7 t -127.77 122.81 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 108.651 -0.87 . . . . 75.1 108.651 176.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.52 HD13 ' HB3' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -146.73 155.35 48.48 Favored Pre-proline 0 C--N 1.292 -1.913 0 N-CA-C 107.464 -1.31 . . . . 74.12 107.464 175.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.485 ' HD3' HG11 ' A' ' 95' ' ' VAL . 49.7 Cg_endo -66.29 140.92 60.42 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.134 1.223 . . . . 62.13 110.061 -175.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt . . . . . 0 C--N 1.326 -0.417 0 CA-C-O 121.249 0.547 . . . . 75.01 111.038 -175.768 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.762 0 N-CA-C 111.045 -0.822 . . . . 73.44 111.045 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -51.13 -45.04 39.09 Favored 'Trans proline' 0 CA--C 1.566 2.105 0 C-N-CA 123.542 2.828 . . . . 74.55 114.884 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -54.51 150.53 34.29 Favored 'Trans proline' 0 C--N 1.394 2.952 0 C-N-CA 121.839 1.692 . . . . 73.41 111.937 176.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -73.16 139.25 79.06 Favored Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 116.368 -0.378 . . . . 70.24 110.806 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -69.79 140.95 43.81 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.744 2.296 . . . . 74.2 113.517 -176.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.585 HD23 ' HB3' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -90.13 177.86 6.33 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.911 -1.041 . . . . 71.32 111.033 173.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 46.2 t -59.7 144.67 47.42 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 112.712 0.634 . . . . 51.34 112.712 -175.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.03 -37.74 54.56 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.994 -1.003 . . . . 64.23 111.024 171.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -76.43 -28.49 56.63 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 113.116 0.784 . . . . 70.14 113.116 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.585 ' HB3' HD23 ' B' ' 26' ' ' LEU . 3.7 tp10 -64.5 -39.3 93.53 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 106.276 -1.75 . . . . 73.51 106.276 175.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -64.87 -44.32 90.08 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 114.424 -1.262 . . . . 73.44 108.697 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.61 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 0.1 OUTLIER -57.2 -47.57 80.95 Favored 'General case' 0 N--CA 1.413 -2.309 0 C-N-CA 123.597 0.759 . . . . 71.33 111.745 179.095 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.409 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 80.4 mm-40 -68.42 -44.57 74.7 Favored 'General case' 0 CA--C 1.505 -0.751 0 O-C-N 123.068 0.23 . . . . 72.12 111.363 -177.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.502 HG12 ' O ' ' B' ' 30' ' ' GLU . 11.3 pt -66.35 -34.93 73.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 O-C-N 123.376 0.422 . . . . 72.12 110.428 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -65.6 -42.07 92.04 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.49 0.716 . . . . 75.4 109.91 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.61 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 99.1 mttt -61.07 -24.19 66.03 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.613 -0.721 . . . . 70.51 110.777 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.55 ' HD3' ' O ' ' B' ' 86' ' ' ALA . 67.6 mtt180 -106.89 17.05 23.62 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.561 -0.745 . . . . 71.33 110.12 -174.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.433 ' HB2' ' HB3' ' B' ' 112' ' ' LYS . 26.2 m -106.43 169.08 8.73 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.176 0.512 . . . . 55.13 111.976 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 28.1 m -139.91 164.74 22.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 124.129 0.972 . . . . 74.23 110.211 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . 0.69 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 28.6 t80 -109.73 129.03 55.65 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.669 -1.234 . . . . 75.04 107.669 174.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 97.5 t -122.18 111.93 32.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 108.451 -0.944 . . . . 73.11 108.451 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.93 171.22 16.66 Favored Glycine 0 C--N 1.289 -2.044 0 C-N-CA 120.022 -1.085 . . . . 64.12 113.558 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 61.4 t30 65.95 23.67 11.22 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.144 1.778 . . . . 73.25 112.754 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 14.1 p -65.83 130.95 31.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.838 -0.801 . . . . 72.43 108.838 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -99.95 161.37 13.65 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.39 -0.823 . . . . 63.35 111.393 -175.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' TYR . . . . . 0.764 ' CE1' ' HB2' ' B' ' 77' ' ' PRO . 17.7 m-85 -71.47 92.06 1.08 Allowed 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.489 -0.778 . . . . 71.01 109.793 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 164.75 -23.2 0.16 Allowed Glycine 0 N--CA 1.419 -2.446 0 CA-C-N 114.353 -1.294 . . . . 60.04 110.03 -177.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 40.3 m -79.47 128.54 33.48 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 109.097 -0.705 . . . . 70.12 109.097 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' THR . . . . . 0.48 ' HB ' HG21 ' A' ' 49' ' ' THR . 82.7 p -92.45 170.2 9.95 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 108.575 -0.898 . . . . 71.41 108.575 177.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.59 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -61.27 -44.07 97.83 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 110.274 -0.269 . . . . 74.21 110.274 175.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -62.36 -36.35 81.97 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.444 0.535 . . . . 65.23 112.444 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -56.64 -45.72 81.43 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.622 0.725 . . . . 71.04 109.727 176.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 57.0 mt -69.97 -48.24 59.05 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.664 -1.153 . . . . 54.54 111.642 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -62.1 -49.41 76.03 Favored 'General case' 0 C--O 1.199 -1.603 0 C-N-CA 122.831 0.452 . . . . 61.13 111.503 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.43 96.34 Favored 'General case' 0 C--O 1.252 1.23 0 CA-C-O 120.936 0.398 . . . . 43.54 110.651 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -66.37 -39.59 89.21 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.145 -0.48 . . . . 62.3 110.172 -176.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -82.18 -21.6 36.43 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 113.556 0.947 . . . . 71.32 113.556 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 23.2 t -70.09 -23.56 63.08 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.452 -0.944 . . . . 74.0 108.452 -178.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.3 m -58.66 -31.18 67.93 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-O 121.234 0.54 . . . . 54.53 109.773 172.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 69.5 m -95.3 10.72 35.15 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.809 -0.632 . . . . 73.34 112.567 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 143.42 -172.4 24.81 Favored Glycine 0 N--CA 1.462 0.388 0 C-N-CA 119.67 -1.252 . . . . 12.15 113.992 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 36.0 t -97.03 127.26 42.83 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 109.787 -0.449 . . . . 71.24 109.787 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 71.1 mt -90.62 133.62 31.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 115.789 -0.642 . . . . 73.24 112.661 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . 0.487 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 95.8 m-20 -101.39 -35.46 9.2 Favored 'General case' 0 C--O 1.206 -1.203 0 CA-C-N 115.488 -0.778 . . . . 71.23 111.68 176.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.437 ' HB2' ' HB2' ' B' ' 84' ' ' GLU . 94.0 mtt180 -153.19 159.72 42.72 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.885 -0.783 . . . . 75.23 108.885 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.59 HD11 ' HB1' ' B' ' 50' ' ' ALA . 24.6 pt -145.37 139.39 21.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.112 -1.44 . . . . 72.31 107.112 170.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 90.7 m -125.43 123.71 39.87 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 107.638 -1.245 . . . . 74.24 107.638 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . 0.458 ' O ' HD12 ' A' ' 68' ' ' ILE . 2.3 mp -119.63 121.23 65.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 106.078 -1.823 . . . . 73.32 106.078 -177.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 66' ' ' ILE 0.298 1.2 pt? -121.06 122.85 40.97 Favored 'General case' 0 C--N 1.28 -2.434 0 C-N-CA 120.21 -0.596 . . . . 70.44 111.881 176.508 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' CYS . . . . . 0.437 ' HA ' ' HA2' ' B' ' 79' ' ' GLY . 64.6 m -116.74 130.99 57.06 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.939 -1.134 . . . . 73.11 107.939 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.537 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 3.5 p-10 -121.15 144.16 48.72 Favored 'General case' 0 C--O 1.201 -1.475 0 C-N-CA 119.756 -0.778 . . . . 61.31 110.627 -176.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -121.69 5.16 10.03 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.199 -0.667 . . . . 64.02 109.199 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.441 ' CD2' ' HB2' ' B' ' 71' ' ' ASP . 34.5 p90 -67.31 -26.52 66.56 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-O 121.132 0.492 . . . . 63.33 109.836 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 41.0 m -66.15 -18.8 65.58 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.555 -0.748 . . . . 75.24 111.758 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.34 -51.76 0.76 Allowed Glycine 0 CA--C 1.482 -2.028 0 N-CA-C 108.308 -1.917 . . . . 74.14 108.308 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 53.9 m170 -97.14 148.92 35.11 Favored Pre-proline 0 CA--C 1.479 -1.77 0 N-CA-C 105.851 -1.907 . . . . 73.35 105.851 173.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.764 ' HB2' ' CE1' ' B' ' 46' ' ' TYR . 74.5 Cg_endo -80.49 116.51 3.27 Favored 'Trans proline' 0 N--CA 1.417 -3.016 0 N-CA-C 108.955 -1.209 . . . . 75.43 108.955 173.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' LYS . . . . . 0.44 ' HZ3' ' CG ' ' B' ' 71' ' ' ASP . 23.9 mtmm -104.83 -168.52 1.49 Allowed 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 108.643 -0.873 . . . . 62.14 108.643 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' B' ' 70' ' ' CYS . . . -168.38 139.77 5.85 Favored Glycine 0 N--CA 1.403 -3.559 0 C-N-CA 119.7 -1.238 . . . . 54.12 113.17 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -150.12 144.67 25.86 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 114.662 -0.769 . . . . 61.13 109.344 174.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.44 159.91 41.07 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-O 120.716 0.293 . . . . 64.25 110.763 -172.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -123.0 125.55 45.45 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.427 -0.953 . . . . 74.15 108.427 174.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.433 HG23 HG22 ' B' ' 66' ' ' ILE . 44.6 mm -103.87 120.46 54.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 106.752 -1.573 . . . . 72.5 106.752 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' B' ' 65' ' ' ARG . 34.3 mt-10 -107.4 118.73 37.5 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.079 0.466 . . . . 73.54 110.025 -175.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -99.93 166.73 10.92 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.998 0.74 . . . . 63.32 112.998 -173.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.55 ' O ' ' HD3' ' B' ' 37' ' ' ARG . . . -77.57 -36.84 51.64 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.641 -1.163 . . . . 52.33 111.378 174.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -109.08 146.82 33.37 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.15 0.5 . . . . 61.14 112.029 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.486 ' O ' HG22 ' B' ' 91' ' ' VAL . 0.6 OUTLIER -73.93 -29.77 62.21 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 106.407 -1.701 . . . . 72.53 106.407 178.759 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -64.15 -24.08 67.55 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 114.773 -1.103 . . . . 71.14 110.667 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 19.8 m -68.33 -36.28 79.04 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 116.394 -0.366 . . . . 62.34 110.314 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.486 HG22 ' O ' ' B' ' 88' ' ' ARG . 3.1 m -64.49 -38.99 84.03 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.071 0 N-CA-C 108.373 -0.973 . . . . 74.35 108.373 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.3 -38.56 74.19 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 123.769 0.668 . . . . 33.34 110.601 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.27 -35.4 63.76 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.054 -0.521 . . . . 74.33 111.3 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.77 -45.24 59.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.911 0.386 . . . . 54.15 111.056 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . 0.43 HG13 ' O ' ' B' ' 91' ' ' VAL . 26.0 m -57.79 -21.58 16.74 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 N-CA-C 112.935 0.717 . . . . 70.33 112.935 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.25 -15.4 63.16 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 121.581 0.705 . . . . 71.11 110.62 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 67.3 mtm -103.35 12.27 35.61 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.536 -0.756 . . . . 74.24 109.662 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . 0.614 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 2.1 p-10 -36.21 -43.45 0.35 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.249 1.574 . . . . 65.04 115.249 -176.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -130.09 61.76 1.58 Allowed 'General case' 0 N--CA 1.421 -1.918 0 C-N-CA 118.665 -1.214 . . . . 73.43 111.129 174.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 15.0 t -89.84 173.84 8.03 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 113.914 -1.493 . . . . 74.4 109.995 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.35 128.77 63.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.261 0.553 . . . . 45.42 109.841 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -140.68 126.11 18.84 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.647 -1.242 . . . . 74.52 107.647 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . 0.366 12.6 ptm85 50.37 55.03 10.11 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.114 1.524 . . . . 73.34 115.114 -176.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.72 -4.4 9.73 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 114.616 -1.175 . . . . 74.43 115.484 177.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -127.76 161.89 27.91 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 117.897 0.849 . . . . 72.55 110.666 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 37.1 m -95.64 128.37 42.45 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 109.53 -0.544 . . . . 62.12 109.53 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 35.8 pt -102.49 171.69 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 120.922 -0.311 . . . . 54.12 111.075 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' LYS . . . . . 0.614 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 41.7 tptt -131.04 126.8 36.83 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 109.394 -0.595 . . . . 73.33 109.394 -176.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . 0.69 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 18.1 t -126.88 131.58 70.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.112 -0.699 . . . . 72.14 109.112 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.659 ' HB3' ' HD2' ' B' ' 111' ' ' PRO 0.266 0.2 OUTLIER -136.26 168.42 17.26 Favored Pre-proline 0 CA--C 1.502 -0.894 0 N-CA-C 105.493 -2.04 . . . . 71.13 105.493 172.387 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.659 ' HD2' ' HB3' ' B' ' 110' ' ' LEU . 95.3 Cg_endo -76.55 148.75 29.82 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.363 1.375 . . . . 62.31 109.887 171.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' B' ' 38' ' ' SER . 72.3 tttt . . . . . 0 C--N 1.292 -1.92 0 N-CA-C 106.217 -1.771 . . . . 63.53 106.217 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.48 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 11.3 mm-40 . . . . . 0 C--O 1.209 -1.053 0 N-CA-C 112.3 0.482 . . . . 72.35 112.3 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.9 pt -65.37 -35.59 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 112.934 0.716 . . . . 72.2 112.934 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -71.15 -29.5 65.29 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 119.878 -0.729 . . . . 71.1 110.778 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -73.69 -15.91 61.21 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.525 0.73 . . . . 74.54 110.067 176.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 98.3 mtt180 -104.9 12.02 32.95 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.303 -0.862 . . . . 71.23 109.019 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.453 ' HB3' ' HE2' ' A' ' 112' ' ' LYS . 33.0 t -107.21 156.65 18.61 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 121.58 0.705 . . . . 74.05 110.853 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.514 ' CG1' ' HB ' ' A' ' 91' ' ' VAL . 34.3 m -136.23 164.58 31.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.359 -0.837 . . . . 70.53 109.66 -177.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.585 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 22.4 t80 -110.18 127.0 54.69 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 107.847 -1.168 . . . . 72.54 107.847 176.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 58.0 t -121.31 112.73 36.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 107.518 -1.29 . . . . 75.42 107.518 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -117.81 172.71 14.48 Favored Glycine 0 C--N 1.294 -1.789 0 C-N-CA 118.978 -1.582 . . . . 73.4 114.036 -176.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.7 t30 60.41 20.86 10.49 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 125.749 1.62 . . . . 71.55 112.198 -176.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.87 139.92 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 121.093 0.473 . . . . 62.53 110.039 176.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -82.83 156.03 23.85 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.672 -0.862 . . . . 74.11 108.672 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -68.63 -18.62 64.33 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.741 0.781 . . . . 72.14 109.235 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.4 -15.7 81.18 Favored Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 115.055 -0.975 . . . . 74.1 112.296 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.4 m -87.1 127.34 35.13 Favored 'General case' 0 N--CA 1.411 -2.388 0 N-CA-C 108.011 -1.107 . . . . 34.14 108.011 176.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.3 p -105.49 178.67 4.49 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.613 -0.514 . . . . 74.15 109.613 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.585 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -60.7 -46.07 91.79 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.753 -0.462 . . . . 45.23 109.753 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -58.41 -36.25 73.29 Favored 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 115.596 -0.729 . . . . 73.14 111.305 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -67.45 -40.61 85.43 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.206 0.526 . . . . 62.14 110.463 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.6 mt -66.49 -47.94 71.43 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 115.165 -0.925 . . . . 60.24 111.744 -177.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -60.62 -46.39 90.46 Favored 'General case' 0 C--O 1.181 -2.528 0 N-CA-C 113.645 0.98 . . . . 55.31 113.645 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.38 -47.83 75.23 Favored 'General case' 0 C--O 1.271 2.189 0 CA-C-O 121.662 0.744 . . . . 52.25 111.455 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -63.86 -43.01 97.38 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.851 -1.068 . . . . 74.01 110.568 -178.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -82.13 -22.21 36.27 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 114.843 1.423 . . . . 63.01 114.843 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.4 t -67.07 -26.97 67.0 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.284 -0.636 . . . . 53.42 109.284 -177.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.2 m -59.1 -24.94 63.38 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 120.534 -0.466 . . . . 71.4 111.004 173.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 76.7 m -95.72 7.2 46.96 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.876 1.065 . . . . 63.44 113.876 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.38 -147.25 18.4 Favored Glycine 0 C--O 1.238 0.35 0 C-N-CA 118.51 -1.805 . . . . 60.0 115.067 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 52.8 p -112.95 122.97 49.23 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.021 0.438 . . . . 62.5 111.541 -175.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.3 mt -89.39 130.52 38.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-O 121.21 0.528 . . . . 71.34 112.03 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -92.68 -48.95 6.33 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.043 -0.981 . . . . 70.53 109.055 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.42 ' HG2' ' HB2' ' B' ' 71' ' ' ASP . 79.2 mtm180 -155.83 163.78 39.37 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.613 -0.884 . . . . 74.41 108.613 -176.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.585 HD11 ' HB1' ' A' ' 50' ' ' ALA . 31.3 pt -145.87 144.51 20.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 109.185 -0.672 . . . . 64.11 109.185 176.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.4 m -125.71 126.03 43.96 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 107.334 -1.358 . . . . 75.12 107.334 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.8 mp -122.48 122.89 67.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.113 -1.44 . . . . 71.32 107.113 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.286 1.0 OUTLIER -121.0 128.37 52.64 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 120.207 -0.597 . . . . 71.03 111.918 176.143 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 62.6 m -114.36 125.38 53.8 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.543 -1.28 . . . . 72.45 107.543 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' A' ' 78' ' ' LYS . 2.2 p-10 -110.64 130.43 55.57 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 118.462 -1.295 . . . . 55.24 112.013 -177.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -107.49 13.03 27.26 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.368 -1.345 . . . . 72.41 107.368 170.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -61.47 -36.63 80.98 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 113.921 -1.491 . . . . 75.34 108.508 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.5 t -81.68 7.78 11.57 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-N 115.495 -0.775 . . . . 55.53 111.154 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.74 -47.95 3.25 Favored Glycine 0 N--CA 1.462 0.418 0 O-C-N 121.615 -0.678 . . . . 74.14 111.429 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -95.77 137.28 21.89 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 106.737 -1.579 . . . . 74.44 106.737 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.34 117.01 4.66 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 CA-C-N 119.313 0.79 . . . . 72.41 110.706 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.447 ' HB2' ' OD1' ' A' ' 71' ' ' ASP . 13.0 mmmm -104.96 -176.47 3.09 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 115.0 -1.0 . . . . 75.22 108.663 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.54 137.59 4.91 Favored Glycine 0 N--CA 1.41 -3.061 0 C-N-CA 119.596 -1.288 . . . . 52.33 112.785 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -154.43 143.29 20.96 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 123.931 0.892 . . . . 71.33 109.27 173.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.26 151.8 50.04 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-O 120.9 0.381 . . . . 62.22 110.574 -172.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 28.1 m-85 -118.82 115.68 24.93 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 108.386 -0.968 . . . . 72.1 108.386 176.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.479 HG23 HG22 ' A' ' 66' ' ' ILE . 40.0 mm -97.57 122.03 48.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.223 -1.029 . . . . 74.53 108.223 -176.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -102.38 119.79 39.41 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.195 -0.669 . . . . 55.42 109.195 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.26 156.47 16.41 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-O 121.062 0.458 . . . . 73.34 110.533 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.22 -27.84 56.95 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.156 -0.475 . . . . 51.54 110.051 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -112.48 136.86 51.49 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.826 -0.625 . . . . 54.02 110.848 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.464 ' O ' HG22 ' A' ' 91' ' ' VAL . 1.4 tmm_? -69.72 -32.12 70.51 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.815 -1.18 . . . . 70.31 107.815 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -67.68 -21.67 65.33 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 115.807 -0.633 . . . . 71.32 111.498 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.3 m -67.85 -36.04 79.61 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.739 -0.467 . . . . 62.53 109.739 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.514 ' HB ' ' CG1' ' A' ' 39' ' ' VAL . 2.2 m -67.15 -38.57 81.37 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 N-CA-C 108.354 -0.98 . . . . 73.21 108.354 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -61.36 -35.55 77.76 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.439 -0.801 . . . . 70.23 110.735 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.31 -31.65 62.56 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.079 -0.509 . . . . 64.12 110.826 175.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 97' ' ' MET . . . -76.46 -42.93 42.08 Favored 'General case' 0 C--O 1.205 -1.269 0 CA-C-N 115.999 -0.546 . . . . 75.44 111.094 -177.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 91' ' ' VAL . 19.9 m -56.09 -21.37 11.37 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.957 0 N-CA-C 113.458 0.91 . . . . 75.02 113.458 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.07 -10.54 58.12 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-O 121.933 0.873 . . . . 65.35 110.235 176.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.515 ' HA ' ' OG1' ' A' ' 100' ' ' THR . 18.7 mtp -101.62 9.65 40.93 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 125.111 1.364 . . . . 71.2 109.866 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 12.4 t70 -35.73 -57.95 0.63 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 115.703 1.742 . . . . 74.24 115.703 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -116.99 30.39 7.36 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 122.327 1.06 . . . . 64.51 109.329 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.515 ' OG1' ' HA ' ' A' ' 97' ' ' MET . 89.8 m -74.71 167.39 21.89 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.915 -1.039 . . . . 74.22 110.195 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.25 133.12 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 CA-C-O 121.356 0.598 . . . . 50.31 110.143 -173.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -133.23 127.79 34.49 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.476 -0.784 . . . . 70.42 109.059 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 103' ' ' ARG . 21.0 ttt180 57.05 32.64 22.02 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 122.303 1.049 . . . . 73.21 110.484 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.19 5.85 87.45 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.012 -0.995 . . . . 75.55 113.444 177.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -124.88 145.75 49.66 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 117.086 0.443 . . . . 71.43 110.137 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.5 m -79.31 119.74 22.79 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 110.018 -0.364 . . . . 61.25 110.018 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 45.9 pt -102.72 171.11 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 109.758 -0.46 . . . . 62.03 109.758 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 22.5 mmmt -118.02 130.15 56.0 Favored 'General case' 0 CA--C 1.472 -2.05 0 N-CA-C 108.883 -0.784 . . . . 75.4 108.883 176.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 41.1 t -125.59 111.79 28.53 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 107.304 -1.369 . . . . 70.33 107.304 172.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.43 HD13 ' CD2' ' A' ' 40' ' ' TYR 0.266 0.0 OUTLIER -138.9 146.75 51.27 Favored Pre-proline 0 N--CA 1.432 -1.345 0 C-N-CA 119.215 -0.994 . . . . 73.23 108.363 178.103 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -76.53 137.29 18.29 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.614 1.543 . . . . 63.01 112.217 -173.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.453 ' HE2' ' HB3' ' A' ' 38' ' ' SER . 37.6 ttpt . . . . . 0 N--CA 1.426 -1.657 0 N-CA-C 108.498 -0.927 . . . . 71.21 108.498 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.412 ' HA3' ' HD2' ' B' ' 22' ' ' PRO . . . . . . . . 0 CA--C 1.534 1.221 0 N-CA-C 116.021 1.168 . . . . 73.41 116.021 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.577 ' HG3' ' CE1' ' A' ' 40' ' ' TYR . 2.8 Cg_endo -41.69 -52.91 3.59 Favored 'Trans proline' 0 C--N 1.366 1.451 1 C-N-CA 125.475 4.117 . . . . 64.21 118.287 -173.658 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -58.63 123.7 14.16 Favored 'Trans proline' 0 C--N 1.379 2.179 0 CA-C-N 120.802 1.322 . . . . 73.32 111.557 -174.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -59.79 136.47 90.07 Favored Pre-proline 0 N--CA 1.435 -1.216 0 CA-C-N 115.573 -0.74 . . . . 75.32 110.356 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.52 103.08 0.09 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 123.237 2.625 . . . . 75.32 114.149 -172.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.69 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -70.56 170.84 11.32 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 114.973 -1.012 . . . . 74.2 109.876 174.376 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 47.6 t -59.42 143.47 49.7 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.53 0.681 . . . . 71.24 112.707 -173.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.5 ' O ' ' HE2' ' B' ' 32' ' ' LYS . . . -52.73 -36.25 57.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.328 -1.306 . . . . 74.41 111.703 176.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -60.98 -49.2 78.42 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.555 -0.535 . . . . 63.32 109.555 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.457 ' HB2' HD23 ' B' ' 26' ' ' LEU . 0.8 OUTLIER -61.52 -36.51 80.75 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-N 115.997 -0.547 . . . . 72.41 112.09 178.595 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.533 ' HA ' HG12 ' B' ' 34' ' ' ILE 0.516 5.3 ptpt -71.48 -35.43 70.82 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 115.049 1.5 . . . . 73.43 115.049 -179.146 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.5 ' HE2' ' O ' ' B' ' 28' ' ' ALA . 45.6 mtmt -64.41 -40.94 96.74 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.04 0.447 . . . . 54.01 111.066 174.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.548 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 38.6 mm-40 -71.07 -42.98 68.68 Favored 'General case' 0 C--O 1.211 -0.929 0 CA-C-N 115.622 -0.717 . . . . 73.41 112.768 -177.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.533 HG12 ' HA ' ' B' ' 31' ' ' LYS . 13.6 pt -64.79 -35.53 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 112.843 0.682 . . . . 73.54 112.843 -176.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -72.91 -23.69 60.73 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 119.994 -0.682 . . . . 70.01 111.329 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -77.1 -14.99 59.72 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.709 0.804 . . . . 74.44 109.741 174.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' B' ' 33' ' ' GLU . 89.7 mtt180 -109.22 14.1 24.01 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 115.218 -0.901 . . . . 74.52 108.883 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 49.6 m -101.31 153.71 19.41 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.191 -0.913 . . . . 71.21 110.937 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.495 ' CG1' ' HB ' ' B' ' 91' ' ' VAL . 35.7 m -133.3 163.85 36.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.321 -0.854 . . . . 61.24 109.273 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 35.0 t80 -110.9 124.47 52.16 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 107.623 -1.251 . . . . 73.42 107.623 177.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 59.1 t -122.91 110.1 25.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 107.923 -1.14 . . . . 73.31 107.923 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' B' ' 43' ' ' ASN . . . -133.88 109.02 0.77 Allowed Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 115.547 -3.216 . . . . 63.44 116.42 -177.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' B' ' 42' ' ' GLY . 62.0 t30 166.41 26.35 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 125.868 1.667 . . . . 75.21 108.011 157.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 12.0 p -69.67 136.22 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 115.208 -0.905 . . . . 75.03 109.921 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -111.9 167.09 10.65 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.666 -0.697 . . . . 63.52 110.788 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' TYR . . . . . 0.537 ' CE1' ' HB2' ' B' ' 77' ' ' PRO . 5.5 m-85 -69.25 101.55 1.52 Allowed 'General case' 0 CA--C 1.496 -1.13 0 CA-C-O 121.629 0.728 . . . . 73.4 109.796 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . 0.467 ' HA3' ' NH1' ' B' ' 103' ' ' ARG . . . 159.7 -33.58 0.45 Allowed Glycine 0 N--CA 1.413 -2.879 0 N-CA-C 109.218 -1.553 . . . . 43.34 109.218 -175.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.46 ' OG ' ' HE2' ' B' ' 102' ' ' PHE . 18.3 m -90.78 135.14 33.92 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 108.361 -0.977 . . . . 73.04 108.361 176.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 82.0 p -105.45 178.83 4.45 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 116.219 -0.446 . . . . 52.35 109.972 -177.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.623 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -61.98 -41.98 98.63 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.265 -1.013 . . . . 61.02 108.265 175.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -58.29 -35.41 71.77 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 114.949 -1.023 . . . . 74.32 111.392 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -69.55 -41.3 76.1 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 121.087 0.47 . . . . 75.4 110.472 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 61.2 mt -63.94 -47.82 78.98 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.348 -0.842 . . . . 73.22 112.244 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -60.14 -47.31 86.43 Favored 'General case' 0 C--O 1.182 -2.467 0 N-CA-C 113.796 1.036 . . . . 43.42 113.796 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.54 -48.02 75.38 Favored 'General case' 0 C--O 1.266 1.952 0 CA-C-N 118.413 0.551 . . . . 71.23 110.408 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -64.08 -41.57 97.27 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.549 -0.751 . . . . 74.13 110.719 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -82.51 -21.78 35.33 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 114.95 1.463 . . . . 71.3 114.95 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 48.5 t -66.89 -27.96 67.93 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.6 -0.518 . . . . 71.03 109.6 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.8 m -58.61 -31.55 68.17 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-O 121.003 0.43 . . . . 73.13 110.19 173.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 85.9 m -91.79 1.76 56.95 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.32 0.859 . . . . 64.24 113.32 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.65 -159.11 28.11 Favored Glycine 0 C--O 1.243 0.663 0 C-N-CA 118.033 -2.032 . . . . 35.35 116.383 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 17.5 m -106.05 116.21 31.54 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.053 -0.574 . . . . 75.51 110.592 -175.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 77.4 mt -84.18 132.16 32.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 121.594 0.712 . . . . 73.04 112.617 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -94.82 -49.07 5.75 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.635 -1.166 . . . . 65.22 109.281 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -155.93 164.32 38.64 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.659 -0.867 . . . . 74.4 108.659 -176.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.623 HD11 ' HB1' ' B' ' 50' ' ' ALA . 31.3 pt -145.98 144.59 20.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 109.002 -0.74 . . . . 71.11 109.002 176.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 58.5 m -125.47 125.71 43.74 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.263 -1.384 . . . . 74.33 107.263 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.7 mp -122.43 122.63 66.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 106.881 -1.526 . . . . 74.21 106.881 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.262 1.4 pt? -121.09 128.32 52.47 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.98 -0.688 . . . . 65.31 111.611 176.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 64.3 m -113.92 125.62 54.25 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.734 -1.21 . . . . 74.2 107.734 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.42 ' HB2' ' HG2' ' A' ' 65' ' ' ARG . 3.3 p-10 -112.01 130.04 56.0 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 118.895 -1.122 . . . . 71.24 112.284 -177.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . 0.413 ' HE3' ' OH ' ' B' ' 46' ' ' TYR . 97.9 mttt -106.85 10.98 30.52 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.086 -1.079 . . . . 71.34 108.086 172.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -59.82 -33.69 72.09 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 113.733 -1.576 . . . . 73.24 107.892 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 24.8 m -82.35 8.31 11.68 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 115.087 -0.961 . . . . 53.2 111.799 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.2 -49.1 3.93 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-O 121.872 0.706 . . . . 72.21 111.388 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -95.01 131.63 29.81 Favored Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 105.37 -2.085 . . . . 53.25 105.37 176.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.537 ' HB2' ' CE1' ' B' ' 46' ' ' TYR . 19.7 Cg_endo -63.42 116.67 3.77 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.212 1.275 . . . . 63.35 111.691 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' LYS . . . . . 0.408 ' HB2' ' OD1' ' B' ' 71' ' ' ASP . 13.4 mmmm -103.8 -178.61 3.71 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.239 -0.891 . . . . 64.23 109.303 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.55 136.44 4.22 Favored Glycine 0 N--CA 1.412 -2.945 0 C-N-CA 119.66 -1.257 . . . . 75.42 113.1 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -152.24 144.8 24.17 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 123.976 0.91 . . . . 75.13 109.756 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.98 151.48 49.05 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-O 121.001 0.429 . . . . 73.24 110.41 -172.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' B' ' 39' ' ' VAL . 28.1 m-85 -118.83 115.93 25.46 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 108.129 -1.063 . . . . 74.25 108.129 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.497 HG23 HG22 ' B' ' 66' ' ' ILE . 40.7 mm -97.2 122.18 48.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 108.151 -1.055 . . . . 73.01 108.151 -177.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -101.97 119.46 38.83 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.067 -0.716 . . . . 71.31 109.067 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -98.02 155.66 17.0 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 116.279 -0.419 . . . . 64.32 109.972 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.97 -30.28 55.92 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.277 0.56 . . . . 74.24 109.644 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . 0.513 ' HB2' ' OG ' ' B' ' 90' ' ' SER . 35.6 mt-10 -105.14 136.71 44.14 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.862 -0.608 . . . . 74.1 109.627 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.403 ' O ' HG22 ' B' ' 91' ' ' VAL . 1.5 tmm_? -72.52 -32.32 66.05 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.349 -1.352 . . . . 70.2 107.349 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -66.54 -22.42 66.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.429 -0.805 . . . . 72.34 111.357 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' SER . . . . . 0.513 ' OG ' ' HB2' ' B' ' 87' ' ' GLU . 49.6 m -67.48 -36.01 80.29 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.976 -0.379 . . . . 75.55 109.976 176.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.498 ' O ' HG13 ' B' ' 95' ' ' VAL . 2.0 m -67.01 -38.4 81.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 N-CA-C 108.121 -1.066 . . . . 73.32 108.121 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.34 -37.48 83.46 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.405 -0.816 . . . . 55.44 110.219 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.34 -30.92 63.66 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.195 0.521 . . . . 73.15 110.835 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.13 -44.79 36.75 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-N 116.086 -0.506 . . . . 73.51 111.352 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . 0.498 HG13 ' O ' ' B' ' 91' ' ' VAL . 25.7 m -55.46 -21.63 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.924 0.89 . . . . 74.24 112.819 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.62 -8.96 52.04 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.306 0.574 . . . . 62.25 110.481 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 32.9 mtm -105.02 12.97 31.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.495 -0.775 . . . . 75.34 110.583 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . 0.42 ' HA ' ' H ' ' B' ' 109' ' ' VAL . 3.7 p30 -39.55 -44.32 1.42 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.195 1.183 . . . . 74.4 114.195 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -110.05 95.14 5.4 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 121.545 0.688 . . . . 72.12 110.274 172.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' B' ' 106' ' ' THR . 6.7 p -132.11 156.08 46.99 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.119 -0.946 . . . . 64.34 111.934 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.68 127.14 65.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 121.095 0.474 . . . . 71.23 109.904 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' PHE . . . . . 0.46 ' HE2' ' OG ' ' B' ' 48' ' ' SER . 43.1 t80 -143.18 126.22 16.35 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.708 -1.59 . . . . 71.54 106.708 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' ARG . . . . . 0.467 ' NH1' ' HA3' ' B' ' 47' ' ' GLY . 72.9 mtp85 62.59 33.36 15.88 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.208 0.603 . . . . 72.21 111.101 -175.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.08 14.56 66.17 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 115.524 -0.762 . . . . 73.24 113.141 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -130.81 143.93 51.09 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 122.404 -0.468 . . . . 70.13 110.126 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' B' ' 100' ' ' THR . 53.5 m -83.0 126.68 32.8 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 120.777 0.322 . . . . 75.42 110.356 -177.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . 0.429 HG22 ' HB3' ' B' ' 43' ' ' ASN . 38.7 pt -100.87 167.26 2.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 109.227 -0.657 . . . . 60.24 109.227 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 44.9 tptt -121.26 124.99 45.98 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.577 -0.898 . . . . 73.0 108.577 -175.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 35.6 t -122.01 119.19 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 108.413 -0.958 . . . . 75.15 108.413 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.327 0.3 OUTLIER -143.53 137.37 14.45 Favored Pre-proline 0 C--N 1.285 -2.197 0 N-CA-C 106.454 -1.684 . . . . 72.01 106.454 -169.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -77.18 130.11 10.9 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 120.771 1.311 . . . . 71.3 110.446 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt . . . . . 0 C--N 1.317 -0.821 0 C-N-CA 120.08 -0.648 . . . . 74.14 110.597 -174.124 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 120.728 0.299 . . . . 75.43 110.431 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.2 pt -71.63 -35.97 57.88 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 CA-C-N 115.578 -0.737 . . . . 71.13 110.747 176.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -58.98 -42.61 90.38 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 120.831 0.348 . . . . 74.34 110.169 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -60.26 -26.8 66.73 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.889 0.876 . . . . 71.5 111.804 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.459 ' HD3' ' O ' ' A' ' 86' ' ' ALA . 15.8 ptp180 -112.55 21.91 15.15 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.672 0.748 . . . . 74.3 109.93 -176.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 56.9 m -113.83 170.83 7.97 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.372 -0.831 . . . . 62.21 110.78 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.88 162.14 31.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.421 0.629 . . . . 74.11 111.567 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.557 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -96.33 125.58 40.93 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 105.996 -1.853 . . . . 44.13 105.996 169.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.44 ' N ' ' HD1' ' A' ' 40' ' ' TYR . 94.4 t -128.37 106.54 14.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 107.247 -1.39 . . . . 72.4 107.247 173.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -151.89 113.06 0.56 Allowed Glycine 0 N--CA 1.423 -2.216 0 C-N-CA 116.174 -2.917 . . . . 74.45 117.783 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.579 ' HB3' ' HA ' ' A' ' 107' ' ' ILE . 9.3 t30 176.18 23.85 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 103.346 -2.835 . . . . 73.43 103.346 161.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.435 ' CG2' ' HB2' ' A' ' 48' ' ' SER . 7.1 p -107.76 100.82 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-N 113.03 -1.895 . . . . 72.54 110.816 -173.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.408 ' HA ' ' HA3' ' A' ' 79' ' ' GLY . 7.9 m-20 -92.16 170.44 9.82 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.861 -1.063 . . . . 71.14 108.165 -175.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -28.08 -32.97 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 117.465 2.395 . . . . 52.14 117.465 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.94 -32.7 42.24 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.743 -0.265 . . . . 61.14 113.152 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.435 ' HB2' ' CG2' ' A' ' 44' ' ' VAL . 41.4 m -109.93 154.08 23.61 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 109.641 -0.503 . . . . 61.2 109.641 176.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 63.7 p -121.83 178.6 4.8 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 112.046 0.387 . . . . 64.12 112.046 -171.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.497 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -63.15 -44.27 95.97 Favored 'General case' 0 C--O 1.215 -0.76 0 C-N-CA 123.636 0.775 . . . . 71.53 111.636 -177.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -58.13 -38.36 76.38 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.871 0.367 . . . . 72.33 111.517 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -64.17 -32.69 74.35 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.525 0.678 . . . . 64.22 109.608 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 62.8 mt -69.87 -46.08 66.3 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 114.185 -1.37 . . . . 72.41 110.595 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -57.89 -50.12 74.4 Favored 'General case' 0 C--O 1.191 -1.988 0 C-N-CA 120.944 -0.302 . . . . 75.52 111.211 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.33 -48.3 79.33 Favored 'General case' 0 C--O 1.263 1.809 0 CA-C-O 121.653 0.74 . . . . 63.53 112.458 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -69.56 -40.78 76.59 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.775 -1.102 . . . . 73.23 111.119 -175.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -82.63 -22.66 34.62 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 114.592 1.33 . . . . 74.13 114.592 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.5 t -71.26 -23.53 62.0 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.655 -0.498 . . . . 74.44 109.655 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.0 t -57.98 -31.63 67.1 Favored 'General case' 0 CA--C 1.558 1.255 0 N-CA-C 108.944 -0.762 . . . . 64.32 108.944 172.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 60.7 m -90.51 -0.35 57.63 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 112.751 0.649 . . . . 70.3 112.751 -177.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.64 -169.86 29.15 Favored Glycine 0 C--O 1.229 -0.18 0 C-N-CA 119.505 -1.331 . . . . 53.12 114.436 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.0 m -95.68 123.21 39.14 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 121.15 0.5 . . . . 55.51 110.453 -177.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 72.7 mt -91.56 124.84 44.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.777 -0.647 . . . . 61.34 110.875 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.488 ' ND2' ' HA ' ' A' ' 86' ' ' ALA . 65.8 m-80 -91.47 -35.54 14.28 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-O 121.077 0.465 . . . . 74.33 111.835 177.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.481 ' HD2' ' OE2' ' A' ' 84' ' ' GLU 0.266 0.0 OUTLIER -157.21 152.97 26.86 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.708 -1.219 . . . . 73.2 107.708 -167.489 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.527 HG22 ' HA ' ' A' ' 83' ' ' ILE . 34.5 pt -148.21 143.86 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 CA-C-N 118.451 0.569 . . . . 73.22 109.908 174.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.3 m -126.26 123.87 39.08 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.747 -1.205 . . . . 72.44 107.747 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.598 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.2 mp -120.95 121.26 64.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 106.041 -1.837 . . . . 71.21 106.041 -176.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.41 ' N ' HD23 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -120.55 130.15 54.1 Favored 'General case' 0 C--N 1.275 -2.642 0 C-N-CA 120.199 -0.6 . . . . 75.43 112.032 179.067 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 69.1 m -112.07 111.79 22.96 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.998 -1.112 . . . . 63.12 107.998 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -102.16 120.22 40.09 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 108.408 -0.96 . . . . 65.33 108.408 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.545 ' HE2' ' HB3' ' A' ' 77' ' ' PRO . 38.9 ttmt -111.0 15.65 21.6 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.059 -0.719 . . . . 74.42 109.059 -178.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -67.75 -18.0 64.74 Favored 'General case' 0 C--N 1.35 0.607 0 CA-C-O 121.341 0.591 . . . . 70.54 111.187 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.8 m -78.29 -7.28 57.02 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.913 -0.585 . . . . 63.21 110.654 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.26 -51.05 1.28 Allowed Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 109.308 -1.517 . . . . 70.54 109.308 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -96.38 134.42 23.51 Favored Pre-proline 0 C--N 1.287 -2.111 0 N-CA-C 105.677 -1.972 . . . . 74.13 105.677 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.545 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 41.5 Cg_endo -66.3 118.05 5.2 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.274 1.316 . . . . 73.35 112.232 -175.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -100.66 141.53 33.4 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.368 -0.833 . . . . 74.42 108.865 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 44' ' ' VAL . . . -127.76 140.51 11.88 Favored Glycine 0 N--CA 1.41 -3.045 0 C-N-CA 119.738 -1.22 . . . . 51.12 112.73 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . 0.25 3.1 p90 -156.65 146.92 21.29 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 123.745 0.818 . . . . 74.03 110.07 175.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.598 ' HB2' HG23 ' A' ' 68' ' ' ILE . . . -139.48 155.06 47.8 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-O 121.489 0.661 . . . . 74.44 109.233 -172.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.603 ' CD2' ' HD3' ' A' ' 112' ' ' LYS . 84.8 m-85 -121.27 115.89 23.84 Favored 'General case' 0 C--N 1.263 -3.172 0 N-CA-C 108.231 -1.026 . . . . 63.13 108.231 175.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.527 ' HA ' HG22 ' A' ' 66' ' ' ILE . 35.9 mm -95.9 119.04 43.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.318 -1.364 . . . . 64.41 107.318 -176.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.481 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 31.7 mt-10 -101.95 117.94 35.87 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.527 -0.546 . . . . 64.3 109.527 -174.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -102.23 169.56 8.64 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 121.986 0.898 . . . . 75.5 113.326 -173.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.488 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . . . -74.41 -38.82 62.97 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.36 -1.291 . . . . 62.1 112.45 174.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -126.03 159.07 33.71 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.552 -0.859 . . . . 62.11 113.145 -175.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.453 ' O ' HG22 ' A' ' 91' ' ' VAL . 11.4 mmm180 -66.44 -31.32 72.0 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 114.487 -1.233 . . . . 75.12 108.687 173.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -57.66 -39.35 76.85 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 114.133 -1.394 . . . . 71.13 109.951 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.0 m -67.71 -38.38 83.54 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.978 -0.555 . . . . 73.54 111.148 -177.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 88' ' ' ARG . 3.2 m -68.22 -39.15 80.7 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.224 0 C-N-CA 119.733 -0.787 . . . . 75.21 108.978 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -58.43 -38.62 77.84 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.614 0.766 . . . . 73.13 110.202 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.47 -38.07 63.02 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.667 -0.697 . . . . 71.43 111.187 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.17 -45.24 57.64 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 116.243 -0.435 . . . . 60.25 111.706 -176.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 91' ' ' VAL . 25.8 m -57.32 -22.16 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.286 0.634 . . . . 74.1 112.669 177.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.41 -14.03 62.68 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.444 0.64 . . . . 72.24 110.256 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 60.1 mtm -100.38 11.49 39.3 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.718 -0.673 . . . . 53.24 110.231 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.452 ' HA ' ' HB ' ' A' ' 109' ' ' VAL . 6.4 p-10 -36.71 -49.54 0.78 Allowed 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 115.356 1.613 . . . . 62.21 115.356 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -107.25 25.5 11.33 Favored 'General case' 0 CA--C 1.556 1.186 0 CA-C-O 120.908 0.385 . . . . 74.11 111.627 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 67.7 p -84.0 172.41 12.06 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 119.417 -0.913 . . . . 71.11 111.571 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 106' ' ' THR . 8.3 p -102.95 135.91 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.912 0 N-CA-C 109.019 -0.734 . . . . 54.54 109.019 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -123.78 118.18 26.58 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.626 -0.509 . . . . 73.53 109.626 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 103' ' ' ARG . 43.4 mtp180 45.3 32.34 0.98 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.834 1.653 . . . . 64.54 113.568 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.27 -10.55 33.59 Favored Glycine 0 CA--C 1.522 0.49 0 CA-C-N 115.264 -0.88 . . . . 72.41 113.896 174.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.434 ' HD3' ' O ' ' A' ' 43' ' ' ASN . 3.8 ptp180 -124.25 132.53 53.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 117.059 0.429 . . . . 54.04 111.779 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 101' ' ' VAL . 87.6 m -71.35 121.56 18.75 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.101 -0.499 . . . . 75.33 110.478 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.579 ' HA ' ' HB3' ' A' ' 43' ' ' ASN . 33.2 pt -103.02 172.13 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 115.787 -0.642 . . . . 73.11 111.593 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.506 ' HE2' HD12 ' A' ' 110' ' ' LEU . 19.0 tptm -118.71 126.67 52.42 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.582 -0.896 . . . . 60.54 108.582 177.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 23.4 t -125.62 121.52 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 108.045 -1.095 . . . . 73.13 108.045 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.506 HD12 ' HE2' ' A' ' 108' ' ' LYS 0.253 0.0 OUTLIER -142.59 153.47 61.93 Favored Pre-proline 0 C--O 1.208 -1.125 0 N-CA-C 107.693 -1.225 . . . . 65.31 107.693 174.627 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.33 149.67 28.01 Favored 'Trans proline' 0 CA--C 1.507 -0.861 0 CA-C-N 120.721 1.293 . . . . 61.4 112.634 -175.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.603 ' HD3' ' CD2' ' A' ' 82' ' ' TYR . 47.3 mtmt . . . . . 0 N--CA 1.409 -2.519 0 N-CA-C 105.765 -1.939 . . . . 62.41 105.765 172.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.461 ' HA3' ' HD3' ' B' ' 22' ' ' PRO . . . . . . . . 0 N--CA 1.422 -2.29 0 N-CA-C 114.329 0.492 . . . . 42.54 114.329 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.53 ' HG2' ' CE2' ' A' ' 40' ' ' TYR . 43.4 Cg_exo -55.04 -49.6 16.01 Favored 'Trans proline' 0 CA--C 1.578 2.702 0 C-N-CA 123.896 3.064 . . . . 75.24 115.564 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -54.29 138.25 72.32 Favored 'Trans proline' 0 C--N 1.398 3.144 0 CA-C-N 121.302 1.501 . . . . 63.13 109.635 173.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -64.08 122.23 76.27 Favored Pre-proline 0 N--CA 1.434 -1.249 0 C-N-CA 120.572 -0.451 . . . . 72.32 111.589 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -67.89 125.9 13.81 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.938 2.425 . . . . 70.51 110.664 -175.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.71 HD13 ' H ' ' B' ' 26' ' ' LEU 0.348 0.0 OUTLIER -77.73 171.43 14.97 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.812 -0.755 . . . . 71.12 112.014 -179.66 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.587 ' HB2' ' OE1' ' B' ' 30' ' ' GLU . 68.4 m -70.23 145.5 51.34 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 115.033 1.494 . . . . 70.52 115.033 -171.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.71 -45.7 70.52 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 114.864 -1.062 . . . . 71.33 113.428 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' B' ' 33' ' ' GLU . 8.6 mm-40 -63.15 -41.96 99.36 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 122.078 -0.389 . . . . 61.4 110.635 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.587 ' OE1' ' HB2' ' B' ' 27' ' ' SER . 3.6 mp0 -56.26 -39.21 72.25 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 109.86 -0.422 . . . . 73.4 109.86 172.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.539 ' HE3' ' O ' ' B' ' 26' ' ' LEU . 98.7 mttt -69.39 -41.7 76.11 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.616 -0.72 . . . . 70.22 111.776 -177.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.687 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 0.4 OUTLIER -70.42 -35.61 73.51 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 118.977 -1.089 . . . . 72.14 111.349 176.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' B' ' 29' ' ' GLU . 17.6 mt-10 -68.31 -37.7 80.87 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 120.126 -0.63 . . . . 55.52 111.569 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 15.4 pt -70.78 -34.63 57.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 C-N-CA 120.545 -0.462 . . . . 63.43 110.368 176.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' B' ' 31' ' ' LYS . 0.9 OUTLIER -64.82 -37.09 86.44 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.732 -0.84 . . . . 70.23 108.732 -177.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.687 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 95.8 mttt -62.02 -28.82 69.85 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.932 -1.031 . . . . 74.4 110.679 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.504 ' HD2' ' O ' ' B' ' 86' ' ' ALA . 71.7 mtm180 -106.29 18.13 22.44 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.601 -0.727 . . . . 64.33 111.221 -176.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 44.3 m -110.23 170.56 8.0 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 116.237 -0.438 . . . . 71.12 110.544 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.442 ' HA ' ' H ' ' B' ' 112' ' ' LYS . 30.5 m -137.41 164.66 28.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.171 0.51 . . . . 72.34 111.47 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 0.8 OUTLIER -106.46 120.78 42.81 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 126.41 1.884 . . . . 72.41 106.273 175.608 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 100.0 t -124.79 106.68 16.95 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 N-CA-C 107.742 -1.207 . . . . 64.14 107.742 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.66 113.2 0.58 Allowed Glycine 0 N--CA 1.423 -2.228 0 C-N-CA 116.318 -2.849 . . . . 64.11 117.724 -175.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.635 ' HB3' ' HA ' ' B' ' 107' ' ' ILE . 9.2 t30 176.22 23.76 0.0 OUTLIER 'General case' 0 C--O 1.209 -1.042 0 N-CA-C 105.41 -2.07 . . . . 73.22 105.41 160.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.473 ' O ' ' HA3' ' B' ' 79' ' ' GLY . 5.7 p -103.53 96.18 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-N 113.746 -1.57 . . . . 64.14 108.903 -178.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' B' ' 77' ' ' PRO . 6.0 m-20 -106.98 102.67 12.01 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.558 -1.645 . . . . 70.52 106.558 -170.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 51.21 -177.96 0.02 OUTLIER 'General case' 0 C--O 1.248 1.018 0 N-CA-C 114.935 1.457 . . . . 55.53 114.935 -173.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.22 -59.55 4.97 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 111.176 -0.77 . . . . 62.44 111.176 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.2 m -88.83 155.28 19.64 Favored 'General case' 0 N--CA 1.421 -1.875 0 N-CA-C 109.358 -0.608 . . . . 73.04 109.358 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 44.6 p -119.64 178.91 4.39 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 120.713 -0.395 . . . . 75.11 111.391 -174.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.548 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -64.53 -40.68 96.05 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 123.21 0.604 . . . . 74.32 109.904 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -58.39 -41.21 84.38 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 116.167 -0.47 . . . . 63.25 111.989 174.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -59.9 -35.88 75.8 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.637 0.732 . . . . 72.35 109.656 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' B' ' 50' ' ' ALA . 86.6 mt -67.65 -45.68 74.62 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.838 -1.074 . . . . 74.32 111.354 178.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -58.17 -50.82 72.19 Favored 'General case' 0 C--O 1.189 -2.13 0 C-N-CA 120.751 -0.38 . . . . 72.42 111.856 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.8 -48.25 80.25 Favored 'General case' 0 C--O 1.257 1.463 0 CA-C-O 120.937 0.398 . . . . 71.33 111.537 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -68.82 -40.22 79.6 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.675 -0.693 . . . . 74.25 111.192 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -83.36 -22.68 32.75 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 114.976 1.472 . . . . 73.33 114.976 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 35.7 t -72.24 -26.63 62.09 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 110.06 -0.348 . . . . 53.25 110.06 -177.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 20.4 m -64.49 -27.18 68.8 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 119.498 -0.881 . . . . 34.32 109.428 174.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 57.3 m -95.58 9.21 40.99 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.681 -0.69 . . . . 64.24 112.04 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.92 -167.37 32.71 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 118.619 -1.753 . . . . 74.33 115.815 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 20.4 m -108.17 116.29 31.69 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.302 -0.629 . . . . 51.44 109.302 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 64.9 mt -91.11 123.4 43.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.063 0.458 . . . . 73.42 111.579 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -95.79 -34.43 11.89 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.596 -0.729 . . . . 71.02 111.944 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.526 ' HD2' ' OE1' ' B' ' 84' ' ' GLU 0.253 0.0 OUTLIER -157.87 153.41 26.29 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.593 -1.262 . . . . 70.22 107.593 -169.922 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.548 HD11 ' HB1' ' B' ' 50' ' ' ALA . 35.0 pt -148.33 144.0 18.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 109.115 -0.698 . . . . 70.13 109.115 174.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 36.3 m -125.45 124.41 41.35 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.58 -1.637 . . . . 72.24 106.58 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . 0.617 HG23 ' HB2' ' B' ' 81' ' ' ALA . 1.1 mp -121.85 121.55 64.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 106.11 -1.811 . . . . 61.22 106.11 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.71 130.59 54.13 Favored 'General case' 0 C--N 1.277 -2.566 0 C-N-CA 120.337 -0.545 . . . . 72.12 112.27 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 85.5 m -112.52 111.86 23.0 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.243 -1.021 . . . . 50.4 108.243 178.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -101.18 116.39 32.72 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.211 -1.033 . . . . 51.01 108.211 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . 0.422 ' HE3' ' HB3' ' B' ' 77' ' ' PRO . 46.7 mtpt -112.37 4.77 17.81 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.324 -0.551 . . . . 42.43 110.6 -177.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -80.49 -6.64 58.47 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 119.308 -0.957 . . . . 74.34 110.727 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 33.7 t -80.93 7.82 9.76 Favored 'General case' 0 CA--C 1.557 1.249 0 CA-C-N 114.89 -1.05 . . . . 70.04 108.716 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.57 -58.87 2.59 Favored Glycine 0 CA--C 1.492 -1.392 0 N-CA-C 110.371 -1.092 . . . . 72.23 110.371 178.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -97.11 137.38 21.24 Favored Pre-proline 0 C--N 1.284 -2.253 0 N-CA-C 108.687 -0.857 . . . . 74.24 108.687 175.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.422 ' HB3' ' HE3' ' B' ' 72' ' ' LYS . 15.7 Cg_endo -61.21 117.89 4.72 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.662 1.575 . . . . 63.51 111.54 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -108.7 140.66 41.78 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 108.67 -0.863 . . . . 64.32 108.67 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' B' ' 44' ' ' VAL . . . -128.37 138.16 10.18 Favored Glycine 0 N--CA 1.411 -3.025 0 C-N-CA 120.495 -0.86 . . . . 55.31 112.469 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -154.51 147.01 24.05 Favored 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 123.695 0.798 . . . . 73.35 109.74 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.617 ' HB2' HG23 ' B' ' 68' ' ' ILE . . . -138.57 152.83 48.51 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-N 115.969 -0.559 . . . . 64.41 110.78 -172.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' TYR . . . . . 0.462 ' CE2' ' HB2' ' B' ' 40' ' ' TYR . 59.8 m-85 -118.47 115.3 24.34 Favored 'General case' 0 C--N 1.266 -3.062 0 N-CA-C 108.515 -0.92 . . . . 74.44 108.515 175.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.535 ' HA ' HG22 ' B' ' 66' ' ' ILE . 37.7 mm -95.3 118.72 42.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.668 -1.604 . . . . 74.2 106.668 -176.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' GLU . . . . . 0.526 ' OE1' ' HD2' ' B' ' 65' ' ' ARG . 32.3 mt-10 -102.78 117.79 35.42 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.308 -0.627 . . . . 63.43 109.308 -174.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -103.88 168.62 9.01 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.738 0.78 . . . . 73.51 112.261 -174.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.504 ' O ' ' HD2' ' B' ' 37' ' ' ARG . . . -81.01 -34.56 32.83 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.635 -1.166 . . . . 70.44 111.793 174.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -112.75 149.94 32.27 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 113.186 0.81 . . . . 74.42 113.186 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.426 ' O ' HG22 ' B' ' 91' ' ' VAL . 10.5 mmm180 -67.71 -31.16 70.91 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 107.542 -1.281 . . . . 64.54 107.542 168.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -56.79 -41.45 77.74 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 113.838 -1.528 . . . . 75.03 109.713 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 18.2 m -65.69 -39.5 91.35 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 116.06 -0.518 . . . . 72.15 111.356 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.446 ' O ' HG13 ' B' ' 95' ' ' VAL . 3.1 m -67.91 -38.73 80.53 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.354 0 C-N-CA 119.493 -0.883 . . . . 71.42 108.803 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.71 -38.76 79.01 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.678 0.791 . . . . 71.2 110.296 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.37 -36.96 63.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.624 -0.716 . . . . 63.24 111.223 177.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.4 -45.1 48.92 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 116.285 -0.416 . . . . 63.31 111.447 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . 0.446 HG13 ' O ' ' B' ' 91' ' ' VAL . 25.6 m -58.56 -21.98 19.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 C-N-CA 123.778 0.831 . . . . 52.11 112.358 177.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.31 -14.49 62.96 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.106 0.479 . . . . 73.44 110.229 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 72.0 mtm -99.26 13.65 32.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.542 -0.754 . . . . 72.31 110.152 178.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -36.27 -56.28 0.77 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 114.294 1.22 . . . . 74.41 114.294 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -107.1 91.6 3.73 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.541 0.686 . . . . 74.23 110.224 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 33.4 p -135.13 169.19 17.82 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.959 -1.019 . . . . 74.53 111.64 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 11.7 p -102.58 138.76 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 N-CA-C 108.866 -0.79 . . . . 74.41 108.866 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' PHE . . . . . 0.483 ' O ' ' HG2' ' B' ' 105' ' ' ARG . 57.3 t80 -141.15 116.44 10.03 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 107.632 -1.248 . . . . 75.34 107.632 177.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' B' ' 103' ' ' ARG . 20.4 ttt180 56.31 33.62 22.6 Favored 'General case' 0 CA--C 1.559 1.324 0 CA-C-O 122.684 1.231 . . . . 71.41 111.039 -176.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.18 2.54 87.9 Favored Glycine 0 C--N 1.314 -0.666 0 CA-C-N 114.754 -1.112 . . . . 75.13 114.259 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' B' ' 102' ' ' PHE . 4.1 ptp180 -120.02 137.28 54.19 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.419 -0.586 . . . . 53.52 109.419 177.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 28.0 m -78.39 120.92 23.82 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.529 -0.545 . . . . 74.45 109.529 -176.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . 0.635 ' HA ' ' HB3' ' B' ' 43' ' ' ASN . 41.2 pt -102.3 167.22 2.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 120.403 -0.519 . . . . 74.33 111.618 -177.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -118.76 126.13 51.18 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.014 -0.994 . . . . 71.43 109.185 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 21.5 t -124.17 122.37 64.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 N-CA-C 107.969 -1.123 . . . . 73.0 107.969 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.553 HD13 ' HD2' ' B' ' 40' ' ' TYR 0.306 0.1 OUTLIER -146.76 144.03 19.63 Favored Pre-proline 0 C--N 1.284 -2.251 0 N-CA-C 105.729 -1.952 . . . . 75.21 105.729 -172.38 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -66.0 136.19 43.75 Favored 'Trans proline' 0 C--N 1.357 1.019 0 CA-C-N 121.657 1.627 . . . . 71.41 111.832 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.442 ' H ' ' HA ' ' B' ' 39' ' ' VAL . 86.3 tttt . . . . . 0 N--CA 1.48 1.072 0 C-N-CA 123.244 0.617 . . . . 62.55 111.21 -171.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.406 ' HA ' ' OE1' ' A' ' 33' ' ' GLU . 5.3 mm-40 . . . . . 0 C--O 1.211 -0.934 0 N-CA-C 111.652 0.241 . . . . 65.24 111.652 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.8 pt -70.33 -35.32 62.09 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.182 0 C-N-CA 120.981 -0.288 . . . . 65.33 110.945 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -73.06 -32.02 64.76 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.731 0.777 . . . . 73.25 109.717 -176.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -71.51 -19.17 62.22 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 115.042 -0.981 . . . . 72.21 110.298 176.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -107.56 9.2 29.51 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.784 -0.644 . . . . 74.2 110.4 -177.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 69.2 m -95.36 149.81 20.95 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.587 0.708 . . . . 75.45 109.96 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 32.4 m -128.33 160.93 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 CA-C-N 115.028 -0.987 . . . . 75.43 109.779 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.605 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 18.5 t80 -105.63 121.07 43.23 Favored 'General case' 0 C--N 1.269 -2.898 0 C-N-CA 124.896 1.278 . . . . 74.51 108.072 176.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.6 t -113.9 108.92 26.73 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 107.809 -1.182 . . . . 61.15 107.809 176.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.31 165.36 12.76 Favored Glycine 0 C--N 1.296 -1.67 0 C-N-CA 119.596 -1.288 . . . . 63.14 113.711 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.6 t30 57.75 20.57 6.57 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.976 1.711 . . . . 61.12 113.374 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.3 p -62.41 133.26 28.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 CA-C-O 121.497 0.665 . . . . 61.33 109.301 174.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.448 ' HB3' ' HD2' ' A' ' 103' ' ' ARG . 15.0 t70 -80.73 153.93 27.56 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.235 -1.024 . . . . 75.52 108.235 -177.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -65.55 -17.08 64.3 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.386 0.612 . . . . 75.32 109.523 -174.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.54 -22.17 71.27 Favored Glycine 0 N--CA 1.439 -1.117 0 CA-C-N 115.905 -0.589 . . . . 64.43 112.944 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.5 m -92.29 145.0 24.83 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 119.296 -0.962 . . . . 72.31 111.483 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.2 p -124.28 179.83 4.74 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.831 -1.077 . . . . 72.54 109.197 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.88 -50.28 72.98 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 112.634 0.605 . . . . 73.42 112.634 -174.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -58.55 -43.03 89.18 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.452 0.538 . . . . 72.53 112.452 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.49 -44.36 97.22 Favored 'General case' 0 C--O 1.254 1.328 0 CA-C-O 121.762 0.791 . . . . 73.22 109.414 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 76.2 mt -68.31 -46.06 71.32 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-N 114.733 -1.121 . . . . 75.44 112.037 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -58.6 -47.89 82.81 Favored 'General case' 0 C--O 1.203 -1.366 0 N-CA-C 113.09 0.774 . . . . 61.13 113.09 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.7 -47.66 76.44 Favored 'General case' 0 C--O 1.276 2.496 0 CA-C-O 120.89 0.376 . . . . 43.33 110.779 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -64.29 -34.89 79.16 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 120.103 -0.639 . . . . 73.14 110.928 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -81.45 -21.63 38.67 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.812 1.042 . . . . 75.23 113.812 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.2 m -64.55 -26.62 68.5 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 121.067 0.46 . . . . 42.01 110.006 -178.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.0 m -57.7 -32.58 67.52 Favored 'General case' 0 CA--C 1.567 1.62 0 CA-C-N 116.065 -0.516 . . . . 61.03 110.455 172.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.1 m -91.21 4.5 52.12 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 113.599 0.963 . . . . 62.11 113.599 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.21 -164.97 27.52 Favored Glycine 0 CA--C 1.511 -0.191 0 C-N-CA 118.944 -1.598 . . . . 74.33 113.978 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.7 m -101.72 121.94 42.98 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.228 -0.286 . . . . 73.2 110.228 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.5 mt -78.97 127.98 38.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 121.715 0.769 . . . . 62.23 112.262 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -87.03 -47.12 9.19 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.371 -1.286 . . . . 51.11 108.766 177.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.536 ' HB2' ' OE1' ' A' ' 84' ' ' GLU . 50.1 mtm180 -155.39 165.02 37.91 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.168 -0.679 . . . . 74.04 109.168 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.423 HG13 HG12 ' A' ' 83' ' ' ILE . 1.1 tt -149.18 133.35 8.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 122.966 0.506 . . . . 75.22 111.557 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.0 m -125.65 131.77 52.57 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.674 -1.232 . . . . 71.31 107.674 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mp -128.66 124.16 60.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 107.335 -1.357 . . . . 75.4 107.335 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.437 ' HB3' HG23 ' B' ' 67' ' ' THR . 1.6 pt? -120.67 131.95 54.85 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.959 -0.696 . . . . 75.52 111.643 176.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 66.7 m -117.36 127.43 54.04 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 108.867 -0.79 . . . . 64.35 108.867 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.535 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 3.1 p30 -104.73 119.31 38.69 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 119.298 -0.961 . . . . 71.55 109.09 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -110.06 -4.11 16.04 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 120.072 -0.651 . . . . 71.15 112.084 -175.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.585 ' HB3' ' OD1' ' B' ' 64' ' ' ASN . 50.7 p90 -58.1 -20.29 38.86 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 119.447 -0.901 . . . . 54.43 111.188 176.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 28.5 t -79.22 -3.66 46.86 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.165 0.586 . . . . 61.45 111.42 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.0 -61.16 0.8 Allowed Glycine 0 CA--C 1.496 -1.126 0 N-CA-C 109.748 -1.341 . . . . 64.33 109.748 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -95.23 120.49 63.96 Favored Pre-proline 0 CA--C 1.484 -1.575 0 N-CA-C 106.689 -1.597 . . . . 70.53 106.689 173.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 65.6 Cg_endo -68.9 119.34 6.34 Favored 'Trans proline' 0 N--CA 1.442 -1.553 0 C-N-CA 121.841 1.694 . . . . 74.21 111.5 -176.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 32.6 mtmm -95.9 151.92 18.98 Favored 'General case' 0 CA--C 1.472 -2.021 0 N-CA-C 107.619 -1.252 . . . . 75.24 107.619 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.05 144.24 15.47 Favored Glycine 0 N--CA 1.405 -3.432 0 C-N-CA 118.743 -1.694 . . . . 12.12 113.492 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -152.14 146.32 25.4 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.479 -0.86 . . . . 60.35 109.018 172.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.11 154.08 50.91 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 120.691 0.282 . . . . 71.2 111.416 -171.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.45 ' OH ' ' HA3' ' B' ' 21' ' ' GLY . 92.6 m-85 -126.74 122.67 35.51 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.613 -0.884 . . . . 64.14 108.613 175.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.423 HG12 HG13 ' A' ' 66' ' ' ILE . 76.1 mt -122.71 134.17 66.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 116.139 -0.482 . . . . 70.12 110.886 -174.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.536 ' OE1' ' HB2' ' A' ' 65' ' ' ARG . 2.9 mp0 -102.02 134.48 45.18 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.921 -0.77 . . . . 63.14 108.921 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -102.44 160.26 14.71 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.841 -0.429 . . . . 71.2 109.841 173.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.87 -37.69 87.88 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.944 0.402 . . . . 73.2 111.395 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -110.58 149.77 29.91 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.144 -0.48 . . . . 70.23 111.403 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.42 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.9 OUTLIER -74.77 -30.02 61.32 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.242 -1.392 . . . . 70.34 107.242 178.716 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -67.46 -21.18 65.55 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.395 -0.82 . . . . 73.24 111.28 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.7 m -70.49 -35.22 73.12 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 109.451 -0.574 . . . . 72.54 109.451 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 88' ' ' ARG . 2.2 m -65.63 -37.99 81.28 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 N-CA-C 108.209 -1.034 . . . . 65.12 108.209 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -56.49 -38.58 71.94 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.923 -0.58 . . . . 73.41 110.435 177.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.85 -31.49 63.2 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.598 0.713 . . . . 62.1 111.347 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.39 -44.88 34.2 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.715 -0.675 . . . . 71.12 110.795 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.7 m -62.36 -21.65 27.47 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.772 0 C-N-CA 122.656 0.383 . . . . 72.33 111.991 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.91 -10.33 52.31 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.639 0.733 . . . . 44.34 110.047 174.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 35.4 mtm -102.73 11.23 37.92 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.586 -0.734 . . . . 73.55 110.302 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -46.52 -46.85 19.46 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.525 0.565 . . . . 63.11 112.525 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -95.44 93.28 7.12 Favored 'General case' 0 N--CA 1.437 -1.1 0 O-C-N 121.708 -0.62 . . . . 74.55 109.496 174.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 21.9 p -148.88 160.01 43.65 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 122.594 0.357 . . . . 72.15 110.817 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.2 p -107.78 126.01 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 109.03 -0.73 . . . . 75.03 109.03 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -133.49 119.58 19.74 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 108.441 -0.948 . . . . 75.11 108.441 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.448 ' HD2' ' HB3' ' A' ' 45' ' ' ASP . 48.6 ttm-85 55.26 54.27 8.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.957 0.884 . . . . 75.43 112.411 -177.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.24 -8.44 17.64 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 114.54 -1.209 . . . . 65.53 115.888 176.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -130.88 156.58 44.8 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 118.044 0.922 . . . . 72.15 110.997 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.4 m -84.3 125.25 32.09 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 120.985 0.421 . . . . 64.54 110.483 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 47.6 pt -101.76 172.07 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 116.079 -0.509 . . . . 70.12 110.011 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.42 134.43 47.11 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.191 -0.913 . . . . 74.54 109.874 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 28.0 t -124.74 126.0 70.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.992 -1.114 . . . . 53.21 107.992 177.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.487 ' HB2' ' HB3' ' A' ' 40' ' ' TYR . 97.0 mt -134.89 161.63 62.51 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 108.616 -0.883 . . . . 64.44 108.616 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.53 140.5 24.11 Favored 'Trans proline' 0 N--CA 1.44 -1.658 0 N-CA-C 107.977 -1.586 . . . . 60.05 107.977 171.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 64.7 tttm . . . . . 0 N--CA 1.428 -1.538 0 C-N-CA 119.891 -0.723 . . . . 72.23 110.835 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.45 ' HA3' ' OH ' ' A' ' 82' ' ' TYR . . . . . . . . 0 C--O 1.235 0.2 0 N-CA-C 110.002 -1.239 . . . . 41.33 110.002 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.569 ' N ' ' HD2' ' B' ' 23' ' ' PRO . 52.7 Cg_exo -54.36 -40.24 83.75 Favored 'Trans proline' 0 CA--C 1.586 3.092 0 C-N-CA 123.409 2.739 . . . . 73.23 115.855 177.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' B' ' 22' ' ' PRO . 16.8 Cg_exo -30.21 126.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.411 3.866 0 C-N-CA 124.822 3.681 . . . . 74.05 115.85 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -61.3 140.84 94.48 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 124.157 0.983 . . . . 74.05 112.888 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -40.94 149.54 0.17 Allowed 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 125.039 3.826 . . . . 62.22 117.595 -177.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.61 HD23 ' HB2' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -134.39 164.64 26.98 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 105.542 -2.022 . . . . 73.44 105.542 177.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.45 ' HB3' ' OE1' ' B' ' 30' ' ' GLU . 45.8 t -76.01 144.79 40.69 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 118.264 -1.375 . . . . 53.04 112.576 -172.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.43 -32.9 8.38 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.034 -1.439 . . . . 53.52 111.62 173.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -71.45 -35.04 70.77 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 112.982 0.734 . . . . 64.52 112.982 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.61 ' HB2' HD23 ' B' ' 26' ' ' LEU . 0.9 OUTLIER -59.17 -37.85 78.36 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 109.03 -0.73 . . . . 71.12 109.03 172.6 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' B' ' 35' ' ' ASP . 65.1 mttm -63.29 -42.22 99.06 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 115.403 -0.817 . . . . 74.43 111.232 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.647 ' N ' ' HE2' ' B' ' 32' ' ' LYS . 0.5 OUTLIER -64.54 -44.47 90.71 Favored 'General case' 0 C--O 1.204 -1.3 0 C-N-CA 119.817 -0.753 . . . . 72.32 111.553 176.228 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -65.07 -42.27 94.33 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.782 -0.367 . . . . 52.11 111.346 -175.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.503 HG12 ' O ' ' B' ' 30' ' ' GLU . 11.7 pt -70.96 -34.68 56.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 116.254 -0.43 . . . . 75.43 111.482 178.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' B' ' 31' ' ' LYS . 3.8 m-20 -68.03 -41.32 82.29 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.971 0.509 . . . . 74.31 111.786 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -68.44 -23.53 64.62 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.14 -0.936 . . . . 74.12 110.519 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -101.89 10.54 39.7 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.641 -0.708 . . . . 64.55 110.947 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' B' ' 84' ' ' GLU . 16.3 t -105.24 155.1 19.38 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-O 121.317 0.58 . . . . 74.23 110.622 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.458 HG22 ' O ' ' B' ' 83' ' ' ILE . 32.5 m -131.05 164.13 35.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.423 -0.808 . . . . 74.24 110.777 -176.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . 0.615 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 22.5 t80 -109.54 122.81 48.25 Favored 'General case' 0 C--N 1.281 -2.394 0 C-N-CA 125.712 1.605 . . . . 73.35 108.031 176.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 46.6 t -115.95 112.92 41.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 107.759 -1.2 . . . . 73.13 107.759 176.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.3 175.81 16.51 Favored Glycine 0 C--N 1.306 -1.102 0 C-N-CA 119.806 -1.188 . . . . 53.32 113.732 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 10.7 t30 62.68 1.75 0.84 Allowed 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 126.462 1.905 . . . . 64.21 115.001 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.01 105.64 16.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.042 -1.036 . . . . 72.54 110.561 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -114.92 130.67 56.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 118.694 -0.669 . . . . 73.41 109.526 -171.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' TYR . . . . . 0.74 ' CE1' ' HB2' ' B' ' 77' ' ' PRO 0.344 13.6 m-85 52.11 -52.76 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 121.213 3.783 . . . . 72.12 121.213 170.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.74 -36.32 89.37 Favored Glycine 0 C--N 1.312 -0.777 0 N-CA-C 114.25 0.46 . . . . 72.14 114.25 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -91.44 147.84 22.74 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.095 0.474 . . . . 71.23 109.977 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 66.6 p -119.31 178.56 4.49 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.703 -0.68 . . . . 73.01 109.518 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.32 -50.29 74.22 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.021 0.378 . . . . 51.44 112.021 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -58.53 -40.81 83.97 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 120.972 0.415 . . . . 71.11 111.122 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -63.06 -47.74 81.64 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-N 115.665 -0.698 . . . . 74.33 109.766 -178.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 81.3 mt -62.36 -46.21 89.7 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-N 115.384 -0.826 . . . . 75.43 112.248 177.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -58.38 -47.69 83.03 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 112.636 0.606 . . . . 74.54 112.636 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.74 -45.44 78.01 Favored 'General case' 0 C--O 1.264 1.818 0 CA-C-O 121.463 0.649 . . . . 73.12 112.595 -176.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -67.35 -35.7 79.9 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.499 -0.773 . . . . 73.21 110.455 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -81.11 -22.94 38.74 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.052 0.76 . . . . 74.03 113.052 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . 0.61 ' HA ' ' O ' ' B' ' 61' ' ' GLY . 68.6 m -67.09 -28.73 68.42 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 116.428 -0.351 . . . . 62.01 110.829 -177.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 16.0 m -59.33 -30.56 68.46 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.059 0.457 . . . . 72.12 110.845 175.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 71.4 m -106.73 -0.16 23.75 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 113.449 0.907 . . . . 74.32 113.449 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' B' ' 58' ' ' SER . . . 178.07 164.83 31.93 Favored Glycine 0 C--O 1.215 -1.075 0 C-N-CA 118.844 -1.646 . . . . 60.15 114.144 -177.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 40.1 m -98.92 120.92 40.17 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.829 -0.804 . . . . 34.45 108.829 177.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 84.7 mt -82.16 129.44 37.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 114.717 1.377 . . . . 52.43 114.717 -173.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . 0.585 ' OD1' ' HB3' ' A' ' 73' ' ' PHE . 31.1 t-20 -88.22 -46.21 9.43 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.598 1.559 . . . . 72.4 109.265 177.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.485 ' HG2' ' HA ' ' A' ' 71' ' ' ASP . 52.5 mtm180 -156.05 166.04 34.65 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.556 -0.535 . . . . 71.35 109.556 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.402 HG13 HG12 ' B' ' 83' ' ' ILE . 1.3 tt -149.76 134.51 9.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 115.869 -0.605 . . . . 74.31 111.478 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . 0.437 HG23 ' HB3' ' A' ' 69' ' ' LEU . 28.2 m -125.76 133.16 52.15 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.527 -1.286 . . . . 71.3 107.527 -178.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . 0.426 HD12 ' N ' ' B' ' 68' ' ' ILE . 1.5 mp -130.25 125.04 59.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 107.052 -1.462 . . . . 71.13 107.052 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.255 1.3 pt? -121.11 132.21 54.73 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.169 -0.612 . . . . 75.45 111.657 175.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 86.1 m -117.3 126.71 53.17 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.326 -0.99 . . . . 51.1 108.326 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.611 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 3.1 p-10 -113.13 134.46 54.54 Favored 'General case' 0 CA--C 1.489 -1.394 0 C-N-CA 119.328 -0.949 . . . . 61.41 110.759 -177.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . 0.499 ' HE2' ' HB3' ' B' ' 77' ' ' PRO . 35.8 ttmt -119.49 14.26 12.75 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 105.698 -1.964 . . . . 61.1 105.698 176.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -43.75 -37.93 2.95 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 127.418 2.287 . . . . 73.5 113.27 177.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 49.8 m -110.37 22.24 15.73 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 120.891 0.377 . . . . 75.12 111.865 -177.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.83 -51.96 1.31 Allowed Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.366 -0.921 . . . . 74.35 112.857 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -95.4 119.16 65.84 Favored Pre-proline 0 C--N 1.311 -1.083 0 C-N-CA 120.586 -0.446 . . . . 72.43 110.385 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.74 ' HB2' ' CE1' ' B' ' 46' ' ' TYR . 57.3 Cg_endo -70.18 118.64 5.8 Favored 'Trans proline' 0 C--N 1.32 -0.97 0 C-N-CA 122.727 2.285 . . . . 53.32 113.335 -175.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 32.4 mtmm -113.83 166.25 11.75 Favored 'General case' 0 C--O 1.211 -0.963 0 CA-C-N 115.616 -0.72 . . . . 70.14 109.426 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -138.89 146.98 18.87 Favored Glycine 0 N--CA 1.421 -2.319 0 C-N-CA 120.042 -1.075 . . . . 45.43 114.177 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -153.16 146.3 24.66 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.467 -0.867 . . . . 74.14 108.891 172.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.38 154.12 48.95 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 120.946 0.403 . . . . 55.55 111.46 -172.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -127.64 121.07 29.5 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.863 -0.792 . . . . 74.03 108.863 175.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.458 ' O ' HG22 ' B' ' 39' ' ' VAL . 71.2 mt -121.2 136.02 59.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 116.344 -0.389 . . . . 53.4 110.101 -174.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' B' ' 38' ' ' SER 0.387 1.3 pm0 -110.82 132.63 54.03 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.81 1.041 . . . . 65.21 113.81 174.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -97.99 162.02 13.44 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.473 -0.785 . . . . 73.14 111.755 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.69 -38.26 81.08 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.24 -0.891 . . . . 74.11 112.119 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . 0.493 ' CD ' ' H ' ' B' ' 88' ' ' ARG . 0.3 OUTLIER -120.67 156.42 31.77 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 120.045 -0.662 . . . . 73.23 111.122 178.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.493 ' H ' ' CD ' ' B' ' 87' ' ' GLU . 0.8 OUTLIER -75.22 -32.32 61.11 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 107.157 -1.423 . . . . 74.3 107.157 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -63.82 -22.77 67.07 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.527 -0.76 . . . . 61.02 110.857 176.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 16.0 m -71.07 -35.66 71.96 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 109.315 -0.624 . . . . 72.4 109.315 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.417 HG22 ' O ' ' B' ' 88' ' ' ARG . 2.1 m -66.53 -37.12 78.92 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.157 0 N-CA-C 108.601 -0.888 . . . . 65.23 108.601 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -57.38 -38.46 74.27 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.353 0.597 . . . . 74.23 110.367 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.73 -33.0 64.15 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.458 -0.792 . . . . 73.42 110.043 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' B' ' 97' ' ' MET . . . -75.45 -43.67 48.31 Favored 'General case' 0 C--O 1.209 -1.049 0 CA-C-O 121.082 0.468 . . . . 63.42 110.562 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 24.7 m -63.24 -20.61 26.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 112.325 0.491 . . . . 74.14 112.325 176.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.95 -12.17 61.42 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 121.873 0.844 . . . . 53.13 109.882 174.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' MET . . . . . 0.494 ' HB2' ' O ' ' B' ' 94' ' ' ALA . 40.0 mtp -99.66 10.18 41.8 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.583 -1.19 . . . . 62.41 109.51 178.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . 0.684 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 6.9 p-10 -36.57 -45.41 0.51 Allowed 'General case' 0 C--O 1.206 -1.218 0 N-CA-C 115.564 1.691 . . . . 74.14 115.564 -176.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -124.52 49.41 1.82 Allowed 'General case' 0 C--O 1.241 0.614 0 CA-C-N 119.98 1.264 . . . . 75.35 112.258 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 31.7 p -81.54 177.26 9.04 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.761 -0.654 . . . . 72.14 112.363 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 8.7 p -108.06 136.37 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-O 121.156 0.503 . . . . 63.21 110.174 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -139.17 120.92 15.35 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.77 -1.567 . . . . 73.24 106.77 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 53.71 33.27 16.35 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.315 0.857 . . . . 61.22 113.315 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.59 1.49 87.57 Favored Glycine 0 C--N 1.314 -0.647 0 CA-C-N 115.828 -0.624 . . . . 62.44 113.7 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -120.81 157.19 30.29 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.073 -0.714 . . . . 71.44 109.073 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 52.1 m -91.61 120.3 32.27 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 109.166 -0.679 . . . . 72.4 109.166 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 pp -102.14 164.67 3.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 119.668 -0.813 . . . . 74.42 111.089 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 108' ' ' LYS . . . . . 0.684 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 16.4 tptm -125.69 125.13 42.55 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.985 -0.746 . . . . 63.44 108.985 -169.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . 0.615 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 22.9 t -121.16 131.37 73.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 110.046 -0.353 . . . . 74.04 110.046 -175.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.44 ' HB2' ' HB3' ' B' ' 40' ' ' TYR . 96.9 mt -138.77 163.71 44.72 Favored Pre-proline 0 C--O 1.211 -0.924 0 C-N-CA 123.533 0.733 . . . . 65.04 109.34 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.31 142.38 26.87 Favored 'Trans proline' 0 CA--C 1.554 1.513 0 C-N-CA 122.506 2.137 . . . . 52.12 108.924 171.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt . . . . . 0 CA--C 1.564 1.508 0 N-CA-C 114.04 1.126 . . . . 74.15 114.04 -171.875 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 . . . . . 0 CA--C 1.532 0.255 0 N-CA-C 112.262 0.468 . . . . 72.43 112.262 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.0 pt -70.37 -36.1 65.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 112.926 0.714 . . . . 55.01 112.926 -175.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.95 -39.16 74.03 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-O 120.985 0.422 . . . . 73.01 111.422 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.408 ' HB3' ' HD3' ' A' ' 88' ' ' ARG . 99.0 mttt -57.35 -37.27 72.33 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 112.711 0.634 . . . . 73.23 112.711 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.566 ' HA ' HG11 ' A' ' 91' ' ' VAL . 4.9 ptp180 -114.44 14.74 17.91 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 114.492 1.293 . . . . 64.25 114.492 -165.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 62.7 p -104.21 158.19 16.61 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.219 1.192 . . . . 54.44 114.219 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.5 ' CG1' HG23 ' A' ' 91' ' ' VAL . 16.2 m -140.36 164.92 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 113.118 0.785 . . . . 64.55 113.118 -177.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.606 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 16.0 t80 -113.04 127.84 56.33 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 126.576 1.951 . . . . 75.23 108.448 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.28 114.41 43.8 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 N-CA-C 107.591 -1.263 . . . . 71.12 107.591 176.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.26 168.0 12.89 Favored Glycine 0 N--CA 1.425 -2.075 0 C-N-CA 119.729 -1.224 . . . . 72.41 113.909 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . 0.255 10.0 t30 60.63 67.07 0.86 Allowed 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 126.025 1.73 . . . . 72.35 114.988 -178.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 p -120.65 135.21 61.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 114.597 -1.183 . . . . 55.4 109.743 171.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -112.81 167.02 10.83 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.902 -1.518 . . . . 74.24 106.902 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -59.93 103.65 0.23 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 122.083 0.944 . . . . 75.14 113.029 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -179.51 -44.32 0.08 OUTLIER Glycine 0 N--CA 1.42 -2.428 0 N-CA-C 107.163 -2.375 . . . . 75.25 107.163 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 73.3 m -94.16 150.44 20.32 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.06 -0.57 . . . . 55.33 109.609 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.9 p -124.67 179.18 5.08 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.497 -0.774 . . . . 50.15 109.027 -178.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.669 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -61.25 -45.38 94.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.072 0.463 . . . . 61.24 109.837 -178.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -58.66 -39.18 79.89 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.61 -0.723 . . . . 72.03 111.431 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -67.48 -37.95 83.66 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-O 121.692 0.758 . . . . 64.11 109.09 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.4 mt -66.33 -46.22 77.6 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 114.569 -1.196 . . . . 63.52 111.454 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.426 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 35.3 mt-10 -58.38 -47.32 84.23 Favored 'General case' 0 C--O 1.187 -2.185 0 N-CA-C 113.002 0.741 . . . . 73.14 113.002 178.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.03 -47.42 74.77 Favored 'General case' 0 C--O 1.267 2.016 0 CA-C-O 121.006 0.431 . . . . 75.2 111.857 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -66.2 -39.17 89.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.987 -0.552 . . . . 65.41 110.666 -176.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -82.28 -22.63 35.64 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.883 1.068 . . . . 74.52 113.883 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.7 t -67.38 -30.89 70.79 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 123.377 0.671 . . . . 74.14 109.692 -176.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.0 m -62.06 -21.07 64.64 Favored 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 120.332 -0.547 . . . . 73.21 111.035 175.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 90' ' ' SER . 77.3 m -96.59 4.89 51.7 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 112.687 0.625 . . . . 71.34 112.687 178.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.28 -172.02 26.19 Favored Glycine 0 CA--C 1.503 -0.676 0 C-N-CA 119.215 -1.469 . . . . 53.23 114.325 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.2 m -94.67 118.54 31.87 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.273 0.559 . . . . 65.51 110.618 -177.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.426 ' CD1' ' HA ' ' A' ' 54' ' ' GLU . 51.2 mt -76.34 132.67 32.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.313 -0.858 . . . . 71.03 111.314 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -97.33 -46.47 6.08 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.948 -1.023 . . . . 73.42 110.172 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.479 HH22 HD12 ' B' ' 69' ' ' LEU . 38.8 mtp180 -155.85 162.62 40.42 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.191 -1.411 . . . . 61.04 107.191 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.669 HD11 ' HB1' ' A' ' 50' ' ' ALA . 29.0 pt -147.93 144.24 19.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 108.775 -0.824 . . . . 74.33 108.775 173.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.4 m -125.44 130.24 51.44 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.426 -1.324 . . . . 72.35 107.426 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.441 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.8 mp -129.32 120.43 51.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 106.527 -1.657 . . . . 65.21 106.527 -178.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.286 1.3 pt? -122.09 134.24 54.77 Favored 'General case' 0 C--N 1.283 -2.324 0 C-N-CA 119.635 -0.826 . . . . 61.43 112.629 177.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 60.9 m -117.03 126.84 53.48 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.777 -0.823 . . . . 74.11 108.777 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -112.44 130.07 56.11 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 107.404 -1.332 . . . . 65.21 107.404 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -128.94 13.38 6.28 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 120.111 -0.636 . . . . 73.12 110.294 -176.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -63.08 -20.51 65.42 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.22 1.192 . . . . 64.52 114.22 -171.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 52.1 m -96.16 9.62 40.35 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.211 0.449 . . . . 74.42 112.211 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.42 -56.08 0.48 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.012 -1.089 . . . . 42.12 113.09 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 42.2 m-70 -95.11 133.35 26.34 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 108.834 -0.802 . . . . 61.31 108.834 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 76' ' ' HIS . 2.0 Cg_endo -76.82 117.57 4.54 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 C-N-CA 121.302 1.335 . . . . 51.02 110.503 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -100.28 140.51 34.43 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 108.253 -1.017 . . . . 52.05 108.253 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -129.63 147.85 18.1 Favored Glycine 0 N--CA 1.397 -3.904 0 C-N-CA 119.313 -1.423 . . . . 64.35 112.417 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -149.8 143.47 25.39 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 114.109 -1.046 . . . . 74.33 109.087 174.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.81 150.19 52.19 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 116.255 -0.43 . . . . 72.33 110.611 -171.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -120.87 117.53 27.6 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 109.141 -0.688 . . . . 72.24 109.141 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.454 HG23 HG22 ' A' ' 66' ' ' ILE . 34.3 mm -99.72 127.49 52.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.281 -1.377 . . . . 65.23 107.281 -178.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -113.15 124.25 52.12 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.762 -0.829 . . . . 72.34 108.762 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -98.24 165.67 11.76 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 111.602 0.223 . . . . 74.0 111.602 -177.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.05 -33.47 57.25 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.265 -0.425 . . . . 74.52 111.99 176.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -121.05 162.11 20.54 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 113.393 0.886 . . . . 54.43 113.393 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.408 ' HD3' ' HB3' ' A' ' 36' ' ' LYS . 16.5 mmm180 -66.39 -33.71 76.32 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 114.45 -1.25 . . . . 74.05 111.692 174.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -66.91 -29.28 69.11 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.61 -0.436 . . . . 71.12 111.47 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 60' ' ' CYS . 9.6 m -71.01 -42.08 70.04 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-O 120.723 0.296 . . . . 32.34 110.533 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.566 HG11 ' HA ' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -67.64 -39.49 82.31 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 N-CA-C 110.313 -0.254 . . . . 73.44 110.313 176.649 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -61.69 -37.21 83.27 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.354 0.597 . . . . 65.02 110.267 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.37 -31.29 62.33 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.804 -0.635 . . . . 73.34 110.829 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.88 -44.77 38.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.652 0.263 . . . . 54.05 111.161 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.404 HG11 ' HG3' ' A' ' 111' ' ' PRO . 32.5 m -57.74 -22.48 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 112.508 0.558 . . . . 73.52 112.508 177.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.2 -11.59 61.01 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 120.988 0.423 . . . . 75.43 110.05 176.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 64.9 mtm -102.75 10.78 38.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.224 -0.444 . . . . 75.41 110.293 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.619 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 4.7 p-10 -37.71 -48.71 1.09 Allowed 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.848 1.055 . . . . 73.45 113.848 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -114.72 99.92 7.87 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-O 121.975 0.893 . . . . 73.2 109.803 175.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 106' ' ' THR . 17.5 p -138.91 167.02 22.94 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.146 -1.388 . . . . 73.55 110.829 -178.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.0 p -113.85 105.55 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 CA-C-O 122.191 0.996 . . . . 62.0 109.494 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.568 ' O ' ' HG2' ' A' ' 105' ' ' ARG . 89.9 t80 -113.95 124.9 53.3 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.822 -1.081 . . . . 74.42 108.396 -176.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 20.6 ttt85 54.41 47.89 21.86 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 122.255 1.026 . . . . 73.55 110.131 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.57 8.0 55.14 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 113.769 -1.56 . . . . 73.1 115.146 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 102' ' ' PHE . 15.1 ptp180 -131.92 145.88 51.77 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 118.101 0.951 . . . . 55.11 111.135 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 100' ' ' THR . 27.8 m -77.76 120.18 22.31 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 120.903 0.382 . . . . 72.14 110.049 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 39.7 pt -102.55 171.25 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 109.596 -0.52 . . . . 73.35 109.596 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.619 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 42.0 tptt -134.73 130.8 36.8 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.894 -0.78 . . . . 71.14 108.894 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 17.7 t -121.13 127.81 75.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.043 -0.725 . . . . 73.3 109.043 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 89.7 mt -132.08 160.94 65.71 Favored Pre-proline 0 C--O 1.199 -1.605 0 N-CA-C 108.749 -0.834 . . . . 63.13 108.749 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.404 ' HG3' HG11 ' A' ' 95' ' ' VAL . 8.1 Cg_exo -77.65 140.74 19.03 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.031 1.821 . . . . 75.41 110.869 173.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp . . . . . 0 N--CA 1.423 -1.776 0 N-CA-C 104.928 -2.249 . . . . 51.23 104.928 173.684 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.159 0 N-CA-C 107.872 -2.091 . . . . 71.24 107.872 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -53.95 -40.29 81.49 Favored 'Trans proline' 0 CA--C 1.574 2.501 0 C-N-CA 122.744 2.296 . . . . 72.35 113.887 172.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.69 136.12 60.55 Favored 'Trans proline' 0 C--N 1.394 2.964 0 C-N-CA 121.301 1.334 . . . . 72.11 111.379 173.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -66.54 141.11 96.86 Favored Pre-proline 0 C--N 1.31 -1.14 0 CA-C-N 115.289 -0.868 . . . . 74.24 110.892 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -59.06 116.45 3.27 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 122.7 2.267 . . . . 63.3 111.112 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.661 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -67.14 160.75 26.15 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.751 -1.113 . . . . 51.21 112.068 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.524 ' HB3' ' OE1' ' B' ' 30' ' ' GLU . 29.6 t -82.04 164.68 21.25 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.507 0.67 . . . . 74.1 112.332 -173.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.4 -38.68 63.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.5 -1.227 . . . . 52.53 112.617 -178.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -69.47 -36.38 76.51 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 120.706 -0.398 . . . . 72.24 111.551 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.524 ' OE1' ' HB3' ' B' ' 27' ' ' SER . 3.6 mp0 -62.37 -35.23 78.51 Favored 'General case' 0 CA--C 1.503 -0.832 0 O-C-N 123.481 0.488 . . . . 73.34 110.645 175.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -66.03 -51.35 59.04 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 123.302 0.377 . . . . 75.24 110.466 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.485 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 47.9 mtmt -53.93 -35.52 61.78 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 114.141 1.163 . . . . 53.44 114.141 176.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.538 ' O ' ' HD3' ' B' ' 37' ' ' ARG . 24.5 mm-40 -70.25 -47.55 60.84 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.198 0.444 . . . . 74.34 112.198 174.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.444 HG12 ' O ' ' B' ' 30' ' ' GLU . 10.3 pt -70.92 -35.7 60.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 112.934 0.716 . . . . 71.42 112.934 -176.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.32 -35.49 65.2 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.229 0.537 . . . . 72.4 111.21 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 97.9 mttt -63.3 -35.07 79.14 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.126 -0.943 . . . . 74.01 112.685 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.538 ' HD3' ' O ' ' B' ' 33' ' ' GLU . 11.3 mtp180 -111.3 5.41 19.81 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 114.727 1.38 . . . . 73.14 114.727 -164.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.583 ' HB2' ' O ' ' B' ' 112' ' ' LYS . 15.5 m -96.97 154.98 16.98 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 112.906 0.706 . . . . 75.1 112.906 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.5 ' CG1' HG23 ' B' ' 91' ' ' VAL . 11.4 m -139.54 164.99 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.609 1.163 . . . . 41.43 112.522 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . 0.65 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 18.4 t80 -113.51 126.88 55.8 Favored 'General case' 0 CA--C 1.489 -1.372 0 C-N-CA 126.624 1.97 . . . . 73.42 108.592 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 66.2 t -121.03 114.25 42.72 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 N-CA-C 108.303 -0.999 . . . . 62.23 108.303 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.27 174.05 15.28 Favored Glycine 0 N--CA 1.421 -2.311 0 C-N-CA 119.514 -1.327 . . . . 54.33 113.176 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.5 t30 64.65 21.28 12.38 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.95 1.7 . . . . 63.54 112.877 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 8.7 p -69.81 123.68 24.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.092 -0.707 . . . . 74.32 109.092 173.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -82.39 159.71 22.95 Favored 'General case' 0 C--O 1.253 1.281 0 CA-C-N 115.48 -0.782 . . . . 75.0 109.675 -174.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -76.24 91.07 3.17 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-O 121.743 0.782 . . . . 74.03 108.945 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 168.2 -18.92 0.08 OUTLIER Glycine 0 N--CA 1.41 -3.048 0 CA-C-N 114.694 -1.139 . . . . 53.31 110.543 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -84.19 143.3 29.71 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 107.799 -1.185 . . . . 74.3 107.799 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 77.8 p -99.89 170.19 8.7 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 110.296 -0.261 . . . . 72.24 110.296 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.677 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -67.05 -39.85 87.01 Favored 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 108.87 -0.789 . . . . 73.04 108.87 175.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -57.43 -44.55 84.75 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.553 -1.203 . . . . 72.12 110.961 174.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.05 -47.89 77.05 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.384 0.611 . . . . 64.44 110.86 174.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 41.2 mt -58.76 -47.04 86.05 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 114.493 -1.23 . . . . 63.42 112.52 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.45 ' HA ' ' CD1' ' B' ' 63' ' ' ILE . 93.9 mt-10 -58.85 -47.87 83.37 Favored 'General case' 0 C--O 1.183 -2.431 0 N-CA-C 112.57 0.582 . . . . 72.11 112.57 177.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.13 -47.73 74.63 Favored 'General case' 0 C--O 1.27 2.142 0 N-CA-C 112.334 0.494 . . . . 60.4 112.334 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -67.16 -38.39 85.4 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.02 -0.536 . . . . 61.32 110.598 -176.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -82.61 -22.0 34.93 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.686 0.995 . . . . 71.33 113.686 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 37.8 t -64.55 -32.22 73.78 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 123.693 0.797 . . . . 75.2 109.454 -178.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.8 m -59.6 -24.34 63.71 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-N 116.271 -0.422 . . . . 71.15 110.978 174.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' B' ' 90' ' ' SER . 68.8 m -88.1 -4.0 58.82 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.435 0.531 . . . . 74.33 112.435 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.94 -159.67 26.57 Favored Glycine 0 C--N 1.318 -0.425 0 C-N-CA 119.394 -1.384 . . . . 61.52 114.08 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 50.7 m -94.6 119.09 32.71 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 121.091 0.472 . . . . 73.12 112.102 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.45 ' CD1' ' HA ' ' B' ' 54' ' ' GLU . 68.0 mt -78.67 128.24 38.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.692 -0.686 . . . . 70.15 111.625 177.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . 0.489 ' OD1' ' HG3' ' B' ' 65' ' ' ARG . 19.0 t-20 -90.66 -50.23 6.03 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.797 -1.092 . . . . 71.23 108.529 -177.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.489 ' HG3' ' OD1' ' B' ' 64' ' ' ASN . 41.2 mtp180 -155.31 164.79 38.28 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 107.41 -1.33 . . . . 75.02 107.41 -177.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.677 HD11 ' HB1' ' B' ' 50' ' ' ALA . 28.9 pt -148.34 144.29 18.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.407 -0.96 . . . . 74.15 108.407 173.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 61.5 m -125.65 130.58 51.9 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 107.055 -1.461 . . . . 73.04 107.055 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . 0.415 HD12 ' N ' ' B' ' 68' ' ' ILE . 1.9 mp -129.32 119.9 49.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 106.657 -1.609 . . . . 70.33 106.657 -178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.479 HD12 HH22 ' A' ' 65' ' ' ARG 0.264 1.5 pt? -121.77 134.14 54.92 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 119.701 -0.799 . . . . 74.01 112.272 177.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 61.9 m -117.11 125.72 51.7 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.52 -0.918 . . . . 63.15 108.52 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.532 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 10.3 t70 -105.74 127.18 52.93 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.624 -1.25 . . . . 72.23 107.624 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' B' ' 77' ' ' PRO . 40.2 ttmt -127.01 17.56 7.24 Favored 'General case' 0 N--CA 1.423 -1.799 0 C-N-CA 120.719 -0.393 . . . . 73.13 110.138 -177.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . 0.255 1.4 p90 -70.25 -16.25 63.01 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 118.367 -1.333 . . . . 65.12 112.672 -177.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 46.0 m -94.42 17.89 12.21 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.203 -0.453 . . . . 71.32 110.393 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.42 -63.76 1.95 Allowed Glycine 0 CA--C 1.492 -1.354 0 C-N-CA 120.75 -0.738 . . . . 51.51 111.569 176.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . 0.255 89.6 m-70 -96.4 125.07 48.91 Favored Pre-proline 0 C--N 1.291 -1.975 0 C-N-CA 120.414 -0.514 . . . . 63.35 110.852 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 98.6 Cg_endo -73.6 135.72 22.39 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.944 2.429 . . . . 54.35 115.051 -171.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -112.12 146.13 38.56 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 124.883 1.273 . . . . 73.34 107.842 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.8 148.03 17.86 Favored Glycine 0 N--CA 1.412 -2.961 0 C-N-CA 119.142 -1.504 . . . . 73.32 112.968 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -151.48 143.37 23.82 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 114.362 -0.919 . . . . 74.5 109.736 172.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.13 151.61 51.69 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 116.169 -0.468 . . . . 61.5 110.657 -172.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' TYR . . . . . 0.735 ' CD1' ' HE2' ' B' ' 112' ' ' LYS . 89.9 m-85 -122.32 116.52 24.21 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 109.253 -0.647 . . . . 63.25 109.253 177.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.491 HG23 HG22 ' B' ' 66' ' ' ILE . 34.3 mm -98.86 127.21 51.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 107.31 -1.367 . . . . 63.3 107.31 -178.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' B' ' 38' ' ' SER . 29.3 mt-10 -112.36 125.62 54.4 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 108.836 -0.801 . . . . 72.53 108.836 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -100.07 162.38 13.01 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.432 0.634 . . . . 64.1 112.245 -177.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.45 -29.77 53.0 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.328 -0.851 . . . . 71.32 111.387 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -122.67 150.0 43.28 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 112.9 0.704 . . . . 54.15 112.9 -175.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.469 ' HD3' ' HB3' ' B' ' 36' ' ' LYS . 14.4 mmm180 -63.08 -34.89 78.56 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.116 0.566 . . . . 75.54 110.676 175.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -62.73 -32.15 73.22 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.577 -0.738 . . . . 71.35 110.913 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' B' ' 60' ' ' CYS . 15.1 m -71.15 -41.4 70.47 Favored 'General case' 0 N--CA 1.433 -1.313 0 O-C-N 122.335 -0.228 . . . . 75.55 110.949 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.5 HG23 ' CG1' ' B' ' 39' ' ' VAL . 0.2 OUTLIER -68.05 -38.98 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 C-N-CA 120.727 -0.389 . . . . 74.02 111.016 176.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -63.01 -36.68 84.36 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.476 0.655 . . . . 72.11 109.579 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.49 -31.03 63.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.797 -0.638 . . . . 71.24 111.789 178.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.05 -44.95 36.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.584 -0.734 . . . . 73.33 110.763 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 33.1 m -58.75 -22.29 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 112.334 0.494 . . . . 75.4 112.334 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.91 -14.91 63.28 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 121.51 0.671 . . . . 53.31 111.331 176.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 65.6 mtm -100.54 12.74 36.66 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.334 -0.848 . . . . 73.23 109.951 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . 0.694 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 3.0 p-10 -35.6 -51.98 0.66 Allowed 'General case' 0 C--O 1.178 -2.659 0 N-CA-C 115.51 1.67 . . . . 61.43 115.51 -174.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' B' ' 107' ' ' ILE . 19.0 tt0 -129.36 40.52 3.59 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 117.794 -1.562 . . . . 55.1 110.323 -178.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 47.6 p -75.63 -173.54 2.21 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.573 -1.194 . . . . 63.44 111.445 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.58 136.14 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 O-C-N 122.098 -0.376 . . . . 73.5 110.4 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -138.23 128.5 25.99 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 122.992 0.517 . . . . 64.44 109.924 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 50.17 32.45 6.02 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 124.998 1.319 . . . . 64.23 112.689 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.11 2.74 60.65 Favored Glycine 0 C--N 1.315 -0.617 0 CA-C-N 114.771 -1.104 . . . . 60.22 114.756 173.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -134.16 158.64 43.14 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 118.002 0.901 . . . . 72.34 111.169 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 68.4 m -85.47 119.85 26.27 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.338 -0.616 . . . . 54.34 109.338 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' B' ' 99' ' ' GLU . 42.1 pt -102.86 172.2 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 109.648 -0.501 . . . . 73.1 109.648 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 108' ' ' LYS . . . . . 0.694 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 0.1 OUTLIER -131.18 132.06 44.46 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.618 -1.253 . . . . 65.11 107.618 -179.654 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 21.2 t -121.67 130.82 74.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 108.099 -1.074 . . . . 74.14 108.099 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 90.1 mt -136.49 162.68 54.82 Favored Pre-proline 0 C--O 1.19 -2.046 0 N-CA-C 108.871 -0.789 . . . . 70.22 108.871 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -73.77 147.53 39.86 Favored 'Trans proline' 0 CA--C 1.564 1.98 0 C-N-CA 122.733 2.289 . . . . 70.32 110.564 173.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.735 ' HE2' ' CD1' ' B' ' 82' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.56 1.331 0 N-CA-C 109.633 -0.506 . . . . 70.31 109.633 -172.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 . . . . . 0 N--CA 1.445 -0.693 0 N-CA-C 113.786 1.032 . . . . 74.23 113.786 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.1 pt -69.33 -33.99 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.771 0.319 . . . . 75.34 111.457 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -62.32 -38.54 89.85 Favored 'General case' 0 C--O 1.203 -1.387 0 CA-C-N 115.611 -0.722 . . . . 72.22 111.521 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -70.35 -16.1 62.94 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 120.521 0.201 . . . . 63.33 111.17 -175.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.483 ' HA ' ' CG1' ' A' ' 91' ' ' VAL . 3.9 ptp180 -113.39 16.65 18.87 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 112.384 0.513 . . . . 74.03 112.384 -173.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.547 ' HB2' ' HG3' ' A' ' 84' ' ' GLU . 43.9 t -99.9 159.67 14.9 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-O 121.535 0.683 . . . . 65.3 111.607 177.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.484 ' CG1' HG23 ' A' ' 91' ' ' VAL . 5.5 m -139.7 164.12 24.16 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.942 0 C-N-CA 124.492 1.117 . . . . 73.34 110.686 176.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.644 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 16.4 t80 -118.9 128.39 54.38 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 125.236 1.415 . . . . 74.41 108.009 178.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 60.8 t -116.58 116.7 53.06 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 107.929 -1.137 . . . . 71.21 107.929 178.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.08 176.47 17.09 Favored Glycine 0 C--N 1.294 -1.771 0 C-N-CA 119.831 -1.176 . . . . 72.33 113.567 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.433 ' ND2' ' HD3' ' A' ' 105' ' ' ARG . 7.1 t30 68.51 8.52 6.73 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.759 1.624 . . . . 72.02 113.405 177.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.4 p -91.15 104.45 15.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.634 0.731 . . . . 73.33 109.766 176.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.407 ' CG ' ' HA ' ' A' ' 78' ' ' LYS . 28.6 m-20 -116.79 102.98 9.87 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 106.985 -1.487 . . . . 75.12 106.985 -172.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 49.26 -175.78 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.594 1.331 . . . . 54.03 114.594 -172.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.69 -56.78 5.04 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.868 -0.682 . . . . 45.52 111.96 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.6 m -86.14 143.56 27.96 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 121.107 0.479 . . . . 61.1 110.071 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 61.7 p -114.79 178.82 4.14 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.199 -0.667 . . . . 73.55 109.199 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.52 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -58.91 -43.24 91.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.163 0.506 . . . . 64.23 109.777 178.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -56.96 -44.93 83.09 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 115.304 -0.862 . . . . 65.3 111.814 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -61.12 -42.49 98.64 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.513 0.673 . . . . 72.11 110.57 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.4 mt -69.89 -47.36 62.83 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 114.755 -1.111 . . . . 74.5 111.623 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.501 ' HB2' ' OH ' ' B' ' 46' ' ' TYR . 21.5 tt0 -59.15 -50.6 73.42 Favored 'General case' 0 C--O 1.194 -1.836 0 C-N-CA 121.108 -0.237 . . . . 72.24 111.486 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.32 79.67 Favored 'General case' 0 C--O 1.265 1.878 0 CA-C-O 121.763 0.792 . . . . 74.3 110.999 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -67.31 -38.45 84.99 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.209 -1.36 . . . . 71.13 110.107 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . 0.278 46.5 m-85 -82.48 -21.14 35.67 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 114.516 1.302 . . . . 64.24 114.516 177.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 71.4 m -64.81 -28.81 69.82 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 109.523 -0.547 . . . . 62.41 109.523 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.8 m -58.48 -25.23 62.09 Favored 'General case' 0 CA--C 1.56 1.351 0 CA-C-N 115.815 -0.63 . . . . 74.24 110.09 173.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 61.1 m -107.63 3.24 24.58 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 112.859 0.689 . . . . 71.33 112.859 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 58' ' ' SER . . . 173.51 177.54 42.81 Favored Glycine 0 N--CA 1.466 0.683 0 C-N-CA 118.551 -1.785 . . . . 31.44 115.159 -177.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.8 m -78.25 -61.09 2.11 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 122.389 0.276 . . . . 74.0 111.159 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 85' ' ' PHE 0.264 56.2 mt 99.85 117.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 126.11 1.764 . . . . 61.32 113.261 175.729 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.46 ' ND2' ' HA ' ' A' ' 86' ' ' ALA . 80.2 m-20 -98.59 -39.18 8.83 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 115.275 -0.875 . . . . 73.12 111.692 177.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.425 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 96.6 mtt180 -151.45 159.52 44.16 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.816 -0.809 . . . . 75.53 108.816 -177.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.52 HD11 ' HB1' ' A' ' 50' ' ' ALA . 17.1 pt -148.32 144.48 18.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.073 -1.455 . . . . 75.54 107.073 171.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.534 ' OG1' ' HB2' ' A' ' 82' ' ' TYR . 43.0 p -123.49 138.74 54.51 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 106.018 -1.845 . . . . 63.43 106.018 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.465 HD12 ' O ' ' B' ' 68' ' ' ILE . 2.9 mp -129.89 116.4 37.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 106.371 -1.714 . . . . 74.31 106.371 175.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -120.55 125.66 48.38 Favored 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 120.078 -0.649 . . . . 53.44 111.037 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.435 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 82.9 m -115.61 133.55 55.93 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.19 -0.67 . . . . 75.4 109.19 -177.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -119.07 127.97 53.89 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 118.63 -1.228 . . . . 74.11 110.513 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 77' ' ' PRO . 36.7 ttmt -121.32 12.14 10.88 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.549 -0.908 . . . . 75.44 108.549 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -62.64 -22.04 66.13 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.273 0.471 . . . . 71.44 112.273 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.5 t -90.72 5.11 49.51 Favored 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 115.98 -0.554 . . . . 73.43 110.668 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.48 -56.25 0.48 Allowed Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.702 -0.761 . . . . 54.42 111.977 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -96.26 136.48 21.98 Favored Pre-proline 0 C--N 1.304 -1.394 0 N-CA-C 110.149 -0.315 . . . . 74.4 110.149 176.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.433 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 80.3 Cg_endo -79.54 119.0 3.98 Favored 'Trans proline' 0 N--CA 1.441 -1.593 0 C-N-CA 121.774 1.649 . . . . 71.21 113.051 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.407 ' HA ' ' CG ' ' A' ' 45' ' ' ASP . 37.1 mtmm -105.34 -163.82 0.98 Allowed 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.785 -1.098 . . . . 64.35 108.742 175.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 70' ' ' CYS . . . 173.64 162.56 25.72 Favored Glycine 0 N--CA 1.412 -2.936 0 C-N-CA 119.591 -1.29 . . . . 73.24 114.453 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -158.53 153.91 25.84 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 113.641 -1.279 . . . . 75.05 108.988 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.92 152.95 50.79 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 120.386 0.136 . . . . 41.11 111.106 -173.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.534 ' HB2' ' OG1' ' A' ' 67' ' ' THR . 27.0 m-85 -118.22 130.05 55.85 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.572 -0.529 . . . . 74.45 109.572 174.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.449 HG23 HG22 ' A' ' 66' ' ' ILE . 32.8 mm -111.4 112.49 40.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 109.086 -0.709 . . . . 75.24 109.086 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.547 ' HG3' ' HB2' ' A' ' 38' ' ' SER . 4.1 mp0 -94.84 120.24 34.74 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.147 0.499 . . . . 65.23 110.943 176.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 99.1 m-85 -92.78 164.12 13.47 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.791 -0.448 . . . . 74.24 109.791 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.46 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . . . -85.02 -17.97 35.86 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.111 0.482 . . . . 63.1 109.969 174.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.426 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 0.7 OUTLIER -117.24 141.85 47.78 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 115.407 -0.815 . . . . 72.0 111.171 -178.313 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -75.57 -29.39 59.33 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 108.362 -0.977 . . . . 71.11 108.362 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -67.71 -24.79 65.43 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.76 -0.587 . . . . 74.32 110.713 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.426 ' OG ' ' HB2' ' A' ' 87' ' ' GLU . 20.1 m -71.69 -37.1 70.74 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 112.092 0.404 . . . . 74.14 112.092 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.484 HG23 ' CG1' ' A' ' 39' ' ' VAL . 0.2 OUTLIER -65.87 -38.46 82.21 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 C-N-CA 120.095 -0.642 . . . . 64.55 109.507 173.871 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.08 -37.59 77.46 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.291 0.567 . . . . 65.1 110.239 175.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.52 -31.76 63.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.101 -0.499 . . . . 72.52 111.429 177.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.34 -41.17 49.22 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.117 -0.492 . . . . 71.11 111.161 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.409 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 30.9 m -60.95 -21.99 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 112.716 0.636 . . . . 64.15 112.716 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.13 -10.92 60.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.525 0.678 . . . . 40.33 110.455 176.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 8.8 ttp -111.37 8.2 21.22 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.978 -1.119 . . . . 75.51 107.978 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.698 ' HA ' ' HB ' ' A' ' 109' ' ' VAL . 0.5 OUTLIER -44.31 -44.15 7.91 Favored 'General case' 0 CA--C 1.473 -1.982 0 N-CA-C 114.431 1.271 . . . . 60.41 114.431 -176.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -122.89 98.66 6.01 Favored 'General case' 0 N--CA 1.389 -3.481 0 CA-C-O 122.511 1.148 . . . . 70.22 110.061 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 106' ' ' THR . 19.7 p -140.02 173.25 11.71 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 113.187 -1.824 . . . . 73.4 111.122 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.0 p -111.51 112.58 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.804 0 CA-C-O 122.316 1.055 . . . . 73.15 110.036 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -121.48 126.55 49.52 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.355 -1.293 . . . . 73.42 107.643 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.7 ttt-85 58.81 33.15 22.87 Favored 'General case' 0 CA--C 1.558 1.259 0 CA-C-O 122.054 0.93 . . . . 75.23 109.759 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.47 1.56 86.5 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.3 -0.864 . . . . 72.44 113.898 178.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.433 ' HD3' ' ND2' ' A' ' 43' ' ' ASN . 13.1 ptp180 -126.13 153.7 44.19 Favored 'General case' 0 C--N 1.314 -0.974 0 O-C-N 122.25 -0.559 . . . . 74.32 110.289 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 100' ' ' THR . 27.2 m -79.75 119.74 23.07 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.447 -0.575 . . . . 62.24 109.447 -178.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 pp -102.82 159.0 4.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 C-N-CA 119.601 -0.839 . . . . 64.42 109.815 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 57.7 tptt -123.56 129.89 51.86 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.321 -0.622 . . . . 65.24 109.321 -170.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.698 ' HB ' ' HA ' ' A' ' 98' ' ' ASP . 21.7 t -118.53 128.13 75.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 108.728 -0.842 . . . . 62.13 108.728 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 40' ' ' TYR . 93.5 mt -125.51 141.36 38.77 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 108.999 -0.741 . . . . 74.32 108.999 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.07 136.96 18.88 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.546 1.497 . . . . 72.34 111.811 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 38' ' ' SER . 0.3 OUTLIER . . . . . 0 C--N 1.276 -2.59 0 N-CA-C 104.075 -2.565 . . . . 73.34 104.075 170.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.473 ' HA3' ' OH ' ' A' ' 82' ' ' TYR . . . . . . . . 0 CA--C 1.504 -0.628 0 CA-C-O 120.032 -0.315 . . . . 63.2 113.291 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.439 ' N ' ' HD2' ' B' ' 23' ' ' PRO . 54.1 Cg_exo -52.35 -44.44 46.65 Favored 'Trans proline' 0 CA--C 1.565 2.027 0 C-N-CA 123.792 2.995 . . . . 50.32 115.508 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' B' ' 22' ' ' PRO . 11.3 Cg_endo -53.78 146.72 44.01 Favored 'Trans proline' 0 C--N 1.389 2.696 0 C-N-CA 121.757 1.638 . . . . 70.03 112.349 177.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 15.3 pm0 -70.37 150.36 95.79 Favored Pre-proline 0 C--N 1.303 -1.436 0 CA-C-N 115.172 -0.922 . . . . 75.02 111.012 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.23 119.31 6.31 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.569 2.179 . . . . 71.03 112.144 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.625 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -77.03 168.5 19.98 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.168 -0.924 . . . . 64.4 110.69 176.271 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.62 ' HB3' ' OE1' ' B' ' 30' ' ' GLU . 47.4 t -68.12 147.06 52.84 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.612 0.967 . . . . 63.23 113.612 -173.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.718 ' O ' ' HG2' ' B' ' 32' ' ' LYS . . . -48.22 -46.22 35.01 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-N 114.001 -1.454 . . . . 64.14 111.949 177.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.403 ' HA ' ' CG ' ' B' ' 32' ' ' LYS . 69.9 mm-40 -63.65 -36.2 83.05 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.996 0.739 . . . . 74.22 112.996 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.62 ' OE1' ' HB3' ' B' ' 27' ' ' SER . 2.0 mp0 -63.12 -35.84 81.62 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.467 -0.493 . . . . 72.33 110.127 173.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' B' ' 26' ' ' LEU . 97.5 mttt -68.03 -43.59 78.39 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.032 -0.531 . . . . 75.15 109.581 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.718 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 28.9 mmmt -55.03 -47.36 74.84 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.628 0.771 . . . . 64.44 110.329 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -70.33 -46.28 64.49 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.341 -0.845 . . . . 54.22 111.745 -175.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 17.1 pt -69.72 -35.02 63.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.927 0.394 . . . . 74.42 111.569 -175.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.87 -44.36 96.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.768 -0.651 . . . . 74.54 111.825 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.586 ' HG2' ' O ' ' B' ' 32' ' ' LYS . 12.3 ptpt -68.47 -10.64 56.78 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 112.48 0.548 . . . . 62.2 112.48 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.432 ' HD3' ' O ' ' B' ' 86' ' ' ALA . 92.3 mtt180 -107.3 9.51 29.97 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.966 0.412 . . . . 73.2 110.871 -176.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.514 ' HB2' ' HB3' ' B' ' 112' ' ' LYS . 24.3 m -103.01 162.39 12.97 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 114.226 1.195 . . . . 74.43 114.226 -175.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.462 ' CG1' HG23 ' B' ' 91' ' ' VAL . 12.1 m -141.22 164.45 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.551 1.14 . . . . 75.24 111.907 176.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . 0.562 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 17.6 t80 -119.11 130.96 55.85 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 126.109 1.764 . . . . 71.34 107.999 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 58.1 t -119.42 117.58 54.48 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 C-N-CA 123.945 0.898 . . . . 64.43 108.81 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.77 166.13 14.78 Favored Glycine 0 C--N 1.293 -1.806 0 C-N-CA 120.205 -0.998 . . . . 63.54 111.961 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 60.3 t30 66.29 20.36 11.03 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.738 1.615 . . . . 73.24 113.152 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 11.3 p -64.32 133.33 29.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 O-C-N 121.544 -0.723 . . . . 75.0 109.651 177.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.483 ' HB2' ' HD3' ' B' ' 105' ' ' ARG . 21.7 t70 -72.43 141.34 48.65 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 108.294 -1.002 . . . . 74.52 108.294 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' TYR . . . . . 0.501 ' OH ' ' HB2' ' A' ' 54' ' ' GLU . 4.6 t80 -56.92 -28.15 61.73 Favored 'General case' 0 CA--C 1.551 0.996 0 O-C-N 124.187 0.929 . . . . 71.4 109.754 -178.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.33 0.77 81.51 Favored Glycine 0 N--CA 1.427 -1.924 0 CA-C-N 115.787 -0.642 . . . . 65.11 113.366 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 18.6 m -78.99 135.33 36.88 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 107.781 -1.192 . . . . 71.55 107.781 176.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 63.6 p -94.38 169.97 9.83 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 119.115 -1.034 . . . . 71.54 110.457 -176.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.628 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -60.47 -38.61 84.79 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.506 -0.924 . . . . 44.31 108.506 174.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -57.26 -46.68 82.82 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.191 -0.913 . . . . 51.53 111.242 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -58.55 -47.49 84.06 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.669 0.747 . . . . 43.4 110.183 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 66.2 mt -64.88 -48.03 75.69 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.645 -1.162 . . . . 71.33 112.344 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -59.7 -50.71 72.79 Favored 'General case' 0 C--O 1.206 -1.231 0 N-CA-C 111.656 0.243 . . . . 73.22 111.656 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.53 -45.42 81.15 Favored 'General case' 0 C--O 1.269 2.106 0 CA-C-O 121.631 0.729 . . . . 70.24 111.127 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -66.78 -39.21 87.73 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.457 -1.247 . . . . 62.31 109.942 -174.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . 0.259 46.4 m-85 -82.09 -21.47 36.77 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 114.617 1.339 . . . . 70.51 114.617 177.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 68.2 m -64.57 -28.03 69.36 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.166 0.508 . . . . 72.33 109.784 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 18.8 m -58.42 -28.94 65.7 Favored 'General case' 0 CA--C 1.557 1.248 0 CA-C-N 115.892 -0.595 . . . . 74.24 110.837 173.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 82.2 m -95.89 3.17 53.83 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 113.616 0.969 . . . . 61.33 113.616 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.9 -169.67 27.27 Favored Glycine 0 N--CA 1.464 0.515 0 C-N-CA 118.662 -1.733 . . . . 52.15 115.244 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 27.1 m -93.73 127.88 39.67 Favored 'General case' 0 C--O 1.216 -0.68 0 C-N-CA 123.391 0.677 . . . . 71.32 110.372 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 85.5 mt -97.88 132.04 43.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 124.023 0.929 . . . . 72.04 113.284 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . 0.468 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 75.5 m-20 -100.03 -38.69 8.47 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.84 0.856 . . . . 72.24 112.304 176.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.433 ' HB2' ' HB2' ' B' ' 84' ' ' GLU . 95.3 mtt180 -151.76 160.36 43.61 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.096 -0.705 . . . . 71.31 109.096 -177.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.628 HD11 ' HB1' ' B' ' 50' ' ' ALA . 20.1 pt -148.52 144.52 18.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.094 -1.447 . . . . 75.0 107.094 172.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . 0.546 ' OG1' ' HB2' ' B' ' 82' ' ' TYR . 43.4 p -123.98 139.7 53.7 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 105.936 -1.876 . . . . 63.01 105.936 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . 0.465 ' O ' HD12 ' A' ' 68' ' ' ILE . 2.4 mp -130.61 118.41 42.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 106.009 -1.848 . . . . 64.02 106.009 175.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.293 1.0 OUTLIER -121.39 125.56 47.24 Favored 'General case' 0 C--N 1.28 -2.44 0 C-N-CA 120.348 -0.541 . . . . 74.13 111.977 177.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' CYS . . . . . 0.467 ' HA ' ' HA2' ' B' ' 79' ' ' GLY . 68.7 m -116.53 133.5 55.94 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.198 -0.667 . . . . 63.22 109.198 -176.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 5.4 p-10 -122.52 133.82 54.57 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 118.701 -1.2 . . . . 74.04 111.426 -179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . 0.4 ' HE3' ' HG3' ' B' ' 77' ' ' PRO . 39.9 mtpt -116.74 17.36 15.2 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.551 -1.648 . . . . 75.2 106.551 178.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -44.64 -35.03 2.41 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.811 2.044 . . . . 74.32 112.847 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 39.9 m -115.24 26.29 10.21 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 111.773 0.286 . . . . 74.41 111.773 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.27 -60.22 0.49 Allowed Glycine 0 C--O 1.236 0.276 0 C-N-CA 120.617 -0.802 . . . . 64.21 114.054 175.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . 0.408 ' HA ' ' HD3' ' B' ' 77' ' ' PRO . 12.0 m170 -84.78 141.91 38.81 Favored Pre-proline 0 C--N 1.31 -1.147 0 N-CA-C 110.176 -0.305 . . . . 73.04 110.176 -177.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' B' ' 76' ' ' HIS . 3.0 Cg_exo -78.88 118.04 4.03 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 121.177 1.251 . . . . 74.04 111.854 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -112.43 -166.47 1.08 Allowed 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 109.207 -0.664 . . . . 75.44 109.207 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' B' ' 70' ' ' CYS . . . 171.58 159.41 17.74 Favored Glycine 0 N--CA 1.414 -2.768 0 C-N-CA 119.652 -1.261 . . . . 63.25 114.16 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -154.64 152.14 29.62 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 125.06 1.344 . . . . 70.53 109.091 176.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.08 153.93 51.17 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 122.001 0.121 . . . . 65.22 110.982 -173.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' TYR . . . . . 0.546 ' HB2' ' OG1' ' B' ' 67' ' ' THR . 30.8 m-85 -119.95 127.0 52.26 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 110.047 -0.353 . . . . 75.45 110.047 174.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.484 HG23 HG22 ' B' ' 66' ' ' ILE . 23.8 mm -107.97 118.74 56.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 107.497 -1.297 . . . . 64.11 107.497 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' GLU . . . . . 0.433 ' HB2' ' HB2' ' B' ' 65' ' ' ARG . 61.6 mt-10 -105.73 119.63 39.64 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.249 0.547 . . . . 71.15 110.235 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -95.81 162.0 13.78 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.671 -0.695 . . . . 71.5 112.285 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.468 ' HA ' ' ND2' ' B' ' 64' ' ' ASN . . . -79.03 -32.04 44.86 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.771 -1.104 . . . . 64.24 111.168 175.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.39 146.4 34.5 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 120.06 -0.656 . . . . 65.55 110.26 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -74.69 -26.67 59.99 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 108.015 -1.105 . . . . 73.43 108.015 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -72.51 -20.28 61.39 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 119.723 -0.791 . . . . 71.2 111.625 177.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 21.9 m -69.46 -37.35 77.28 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 110.505 -0.183 . . . . 62.4 110.505 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.462 HG23 ' CG1' ' B' ' 39' ' ' VAL . 0.2 OUTLIER -67.08 -39.05 82.43 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 C-N-CA 120.427 -0.509 . . . . 61.2 109.905 175.173 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.93 -37.08 75.88 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.213 0.53 . . . . 74.14 110.716 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.42 -31.41 62.3 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.033 -0.53 . . . . 62.15 111.173 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.73 -43.02 48.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.197 -0.456 . . . . 63.54 111.167 -178.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 33.6 m -57.11 -22.24 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 112.724 0.638 . . . . 73.34 112.724 177.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.4 -15.74 63.85 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.219 0.533 . . . . 71.2 110.515 176.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 11.2 mtm -98.71 15.64 24.63 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.654 0.782 . . . . 75.21 111.436 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 6.0 t70 -33.85 -52.25 0.42 Allowed 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 114.807 1.41 . . . . 75.55 114.807 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -123.91 64.42 1.05 Allowed 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 118.778 -1.169 . . . . 71.43 111.182 174.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 10.8 t -97.72 -177.63 3.85 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.772 -1.104 . . . . 65.43 110.087 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 9.7 p -108.6 134.5 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 CA-C-O 121.254 0.55 . . . . 51.03 109.652 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -130.31 115.83 17.48 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.073 -0.714 . . . . 61.43 109.073 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 40.0 mtp-105 49.98 32.24 5.49 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.471 1.508 . . . . 75.23 112.23 -178.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.66 -6.32 62.7 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.502 -0.772 . . . . 73.31 112.879 175.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.483 ' HD3' ' HB2' ' B' ' 45' ' ' ASP . 30.2 mtp180 -110.14 133.56 53.09 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.808 -0.442 . . . . 71.3 109.808 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 14.4 m -75.57 120.51 21.08 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.044 -1.095 . . . . 72.24 108.044 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 41.6 pt -103.13 172.08 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-O 121.475 0.655 . . . . 74.22 112.262 -178.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 108' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 57.6 tptt -125.93 126.44 44.37 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.667 -1.151 . . . . 74.43 107.97 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 48.5 t -117.71 122.06 68.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.904 -0.776 . . . . 74.03 108.904 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.46 ' HB2' ' HB3' ' B' ' 40' ' ' TYR . 95.8 mt -121.53 145.19 42.12 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 108.918 -0.771 . . . . 70.12 108.918 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.55 130.84 13.07 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.857 1.705 . . . . 75.22 109.66 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.514 ' HB3' ' HB2' ' B' ' 38' ' ' SER . 25.7 ttpp . . . . . 0 CA--C 1.5 -0.981 0 C-N-CA 119.981 -0.688 . . . . 64.12 112.368 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 . . . . . 0 N--CA 1.415 -2.196 0 N-CA-C 112.74 0.644 . . . . 72.14 112.74 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.438 HG23 HH21 ' A' ' 37' ' ' ARG . 15.8 pt -65.94 -34.33 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 120.46 -0.496 . . . . 71.32 110.827 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -61.16 -42.6 98.85 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.779 -0.823 . . . . 72.13 108.779 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -78.64 -26.79 45.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.363 -0.835 . . . . 72.25 112.386 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.438 HH21 HG23 ' A' ' 34' ' ' ILE . 89.3 mtm180 -89.71 12.96 15.46 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 123.068 0.547 . . . . 64.35 111.943 -177.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.3 t -96.64 145.21 25.96 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.277 0.561 . . . . 75.14 111.403 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.48 ' CG1' ' HB ' ' A' ' 91' ' ' VAL . 28.3 m -128.17 160.02 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.764 0 CA-C-N 115.839 -0.619 . . . . 72.21 110.487 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.572 ' CZ ' ' HG3' ' B' ' 22' ' ' PRO . 15.1 t80 -110.4 121.21 44.75 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 107.692 -1.225 . . . . 72.41 107.692 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.716 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 66.6 t -121.55 108.8 23.1 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 N-CA-C 107.404 -1.332 . . . . 70.5 107.404 173.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.18 172.03 17.42 Favored Glycine 0 C--N 1.284 -2.359 0 C-N-CA 118.813 -1.661 . . . . 64.44 112.825 -176.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.3 t30 61.64 34.1 17.79 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 124.269 1.028 . . . . 71.45 110.421 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.499 ' HA ' ' NH1' ' A' ' 105' ' ' ARG . 7.4 p -90.89 14.11 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.706 0 CA-C-N 115.03 -0.986 . . . . 64.42 111.231 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -36.62 112.27 0.18 Allowed 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 127.929 2.492 . . . . 64.45 114.69 -177.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . 0.524 32.1 m-85 50.11 -43.91 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.846 1 N-CA-C 122.467 4.247 . . . . 74.33 122.467 173.418 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.84 0.18 46.49 Favored Glycine 0 C--N 1.306 -1.108 0 CA-C-N 119.145 0.884 . . . . 30.0 113.32 -175.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.489 ' HB2' HG22 ' A' ' 44' ' ' VAL . 49.6 m -129.48 137.31 50.76 Favored 'General case' 0 N--CA 1.409 -2.497 0 O-C-N 122.45 -0.441 . . . . 64.14 110.046 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 47.1 p -125.25 179.34 5.12 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.238 -1.023 . . . . 64.31 108.238 -176.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.96 -49.77 76.38 Favored 'General case' 0 C--O 1.207 -1.159 0 CA-C-N 118.349 0.522 . . . . 63.2 111.134 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -58.26 -41.12 83.54 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.888 0.699 . . . . 63.3 112.888 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -62.93 -44.64 95.52 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.941 0.877 . . . . 63.31 110.1 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.45 ' HB3' ' HE2' ' A' ' 57' ' ' PHE . 63.4 mt -73.0 -46.72 50.59 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.497 -1.229 . . . . 73.24 112.482 -175.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.5 ' HG3' ' OH ' ' B' ' 46' ' ' TYR . 6.1 tm-20 -57.48 -48.68 78.57 Favored 'General case' 0 C--O 1.196 -1.711 0 C-N-CA 122.804 0.442 . . . . 74.35 110.441 -176.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.22 -42.73 77.74 Favored 'General case' 0 C--O 1.267 2.008 0 CA-C-O 121.724 0.773 . . . . 43.02 110.747 176.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -68.08 -43.59 78.22 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.248 -0.887 . . . . 71.2 111.335 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.609 ' CD2' HG12 ' A' ' 83' ' ' ILE . 65.9 m-85 -80.15 -22.98 41.44 Favored 'General case' 0 C--O 1.225 -0.218 0 O-C-N 121.91 -0.494 . . . . 71.25 111.435 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.9 t -69.46 -24.14 63.76 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.9 -0.778 . . . . 41.23 108.9 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.8 m -63.27 -22.57 66.96 Favored 'General case' 0 CA--C 1.568 1.641 0 CA-C-N 116.121 -0.49 . . . . 55.11 110.78 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 78.7 m -97.03 7.43 46.67 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.821 0.674 . . . . 74.25 112.821 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 142.97 -161.79 27.52 Favored Glycine 0 C--O 1.221 -0.682 0 C-N-CA 119.45 -1.357 . . . . 65.24 113.838 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.3 m -99.26 129.81 45.51 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.404 -0.591 . . . . 63.54 109.404 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.44 HD11 ' HB2' ' A' ' 57' ' ' PHE . 72.0 mt -85.23 133.3 29.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 113.084 0.772 . . . . 65.24 113.084 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.496 ' OD1' ' HG3' ' A' ' 65' ' ' ARG . 24.1 t-20 -94.7 -48.19 6.17 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.865 1.266 . . . . 64.44 108.234 178.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.496 ' HG3' ' OD1' ' A' ' 64' ' ' ASN . 98.9 mtt180 -148.57 158.84 44.4 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.506 -0.77 . . . . 72.21 109.003 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.417 ' HB ' HG13 ' A' ' 83' ' ' ILE . 1.5 tt -149.31 127.6 2.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 C-N-CA 123.198 0.599 . . . . 54.15 110.138 173.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 30.2 m -125.08 133.65 52.81 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.627 -1.249 . . . . 62.53 107.627 -173.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.0 mp -131.03 120.6 47.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 106.646 -1.613 . . . . 63.44 106.646 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.469 ' H ' HD23 ' A' ' 69' ' ' LEU . 1.6 pt? -120.63 134.33 55.29 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.871 -0.332 . . . . 72.01 110.14 178.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 80.8 m -116.58 126.51 53.38 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.642 -0.873 . . . . 73.24 108.642 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.603 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 4.3 p30 -105.29 126.6 52.29 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.403 -0.519 . . . . 73.54 111.108 -177.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.451 ' HG2' ' HB3' ' A' ' 77' ' ' PRO . 96.3 mttt -119.47 2.53 11.25 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 112.62 0.6 . . . . 61.23 112.62 177.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.664 ' HB3' ' OD1' ' B' ' 64' ' ' ASN . 41.8 p90 -56.96 -27.67 61.49 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 113.924 1.083 . . . . 74.14 113.924 -176.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.0 t -97.24 10.87 38.31 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.259 0.552 . . . . 64.4 110.191 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.35 -55.78 0.55 Allowed Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 121.072 -0.585 . . . . 42.41 112.677 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.3 m80 -95.5 125.56 49.12 Favored Pre-proline 0 C--N 1.308 -1.237 0 C-N-CA 120.964 -0.294 . . . . 75.22 110.946 -177.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.603 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 26.5 Cg_endo -67.88 119.59 6.59 Favored 'Trans proline' 0 C--O 1.247 0.94 0 C-N-CA 122.829 2.353 . . . . 63.4 112.744 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.453 ' HB2' ' OD2' ' A' ' 71' ' ' ASP . 28.1 mtmm -113.21 -160.37 0.72 Allowed 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.796 -1.187 . . . . 72.14 107.796 172.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 69' ' ' LEU . . . 179.04 153.15 11.23 Favored Glycine 0 N--CA 1.423 -2.225 0 C-N-CA 119.145 -1.502 . . . . 63.22 114.786 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.414 ' O ' HD23 ' A' ' 69' ' ' LEU . 24.9 m-85 -136.22 153.31 51.26 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.628 -1.99 . . . . 71.51 105.628 174.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.486 ' HB2' HG11 ' A' ' 44' ' ' VAL . . . -131.64 131.19 42.99 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.588 -0.893 . . . . 72.15 108.588 176.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -115.39 120.45 39.63 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.594 -1.261 . . . . 71.41 107.594 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.609 HG12 ' CD2' ' A' ' 57' ' ' PHE . 1.1 mp -113.76 129.05 70.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 108.894 -0.78 . . . . 71.33 108.894 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 65' ' ' ARG . 2.1 mp0 -99.6 124.43 44.79 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.2 -1.408 . . . . 74.24 107.2 174.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -94.03 155.93 16.86 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 121.248 -0.181 . . . . 74.23 110.628 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.29 -32.05 72.78 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.427 -0.352 . . . . 14.31 111.427 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.86 148.34 44.17 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.777 -0.769 . . . . 74.11 110.163 175.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -70.76 -27.09 63.67 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.319 -0.855 . . . . 75.24 109.608 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -62.49 -33.91 75.81 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.921 -0.582 . . . . 71.23 110.521 174.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.5 m -66.75 -35.94 81.28 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 116.048 -0.524 . . . . 53.5 110.902 -177.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.504 ' O ' HG13 ' A' ' 95' ' ' VAL . 1.5 m -68.95 -37.69 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 108.435 -0.95 . . . . 72.34 108.435 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.639 ' O ' HG22 ' A' ' 95' ' ' VAL . 9.9 t70 -68.02 -30.52 69.77 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.722 0.772 . . . . 64.33 109.499 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.01 -31.24 64.36 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.667 -0.697 . . . . 73.11 110.088 175.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.85 -36.17 59.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.889 -0.596 . . . . 53.21 111.453 -177.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 92' ' ' ASP . 11.2 m -53.86 -21.63 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 112.597 0.592 . . . . 74.14 112.597 178.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.75 -12.2 44.6 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.304 0.573 . . . . 54.23 110.991 177.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.565 ' HA ' ' OG1' ' A' ' 100' ' ' THR . 68.0 mtm -100.43 5.43 44.25 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 116.1 -0.5 . . . . 64.32 111.092 178.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.541 ' HA ' ' H ' ' A' ' 109' ' ' VAL . 0.4 OUTLIER -48.4 -49.02 36.53 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.569 1.322 . . . . 74.35 114.569 -177.171 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -101.97 12.82 36.29 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-O 121.887 0.851 . . . . 72.23 110.539 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.565 ' OG1' ' HA ' ' A' ' 97' ' ' MET . 62.9 m -72.24 151.93 42.53 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.917 -0.583 . . . . 73.14 109.984 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -101.56 134.34 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 N-CA-C 108.559 -0.904 . . . . 73.52 108.559 -177.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.48 ' HE2' ' OG ' ' A' ' 48' ' ' SER . 82.6 t80 -130.12 118.81 22.05 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 115.654 -0.703 . . . . 74.35 109.17 -173.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 54.55 32.06 16.18 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.717 1.006 . . . . 64.02 113.717 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.71 -5.47 73.33 Favored Glycine 0 N--CA 1.461 0.352 0 CA-C-N 115.227 -0.897 . . . . 64.15 113.406 174.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.499 ' NH1' ' HA ' ' A' ' 44' ' ' VAL . 21.9 ptt85 -121.52 145.49 47.9 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 122.846 0.458 . . . . 74.43 110.301 178.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.2 m -82.61 122.24 27.86 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.545 -0.909 . . . . 64.44 108.545 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 41.3 pt -101.44 171.52 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 N-CA-C 108.44 -0.948 . . . . 63.13 108.44 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.716 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 22.9 mmmt -121.91 128.23 51.32 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 109.685 -0.487 . . . . 71.15 109.685 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.541 ' H ' ' HA ' ' A' ' 98' ' ' ASP . 60.5 t -117.48 112.16 37.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 105.127 -2.175 . . . . 62.52 105.127 173.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 tt -140.41 129.97 13.38 Favored Pre-proline 0 C--N 1.274 -2.681 0 N-CA-C 105.146 -2.168 . . . . 75.31 105.146 -172.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -55.12 136.81 74.81 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 121.584 1.523 . . . . 72.41 109.736 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.25 24.2 ttpp . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 122.615 1.197 . . . . 71.43 112.204 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.776 0 CA-C-O 119.879 -0.4 . . . . 71.2 113.417 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.572 ' HG3' ' CZ ' ' A' ' 40' ' ' TYR . 0.9 OUTLIER -40.54 -57.27 1.3 Allowed 'Trans proline' 0 CA--C 1.573 2.47 0 C-N-CA 124.797 3.665 . . . . 54.15 116.192 -178.794 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.512 ' HD3' ' HG2' ' B' ' 22' ' ' PRO . 4.8 Cg_exo -83.95 165.61 13.31 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 121.95 1.767 . . . . 64.4 110.734 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -103.91 145.38 30.53 Favored Pre-proline 0 C--N 1.283 -2.31 0 N-CA-C 109.382 -0.599 . . . . 65.01 109.382 176.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -46.78 127.6 12.23 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.266 2.644 . . . . 43.54 113.841 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.802 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -61.61 -167.97 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 114.47 -1.241 . . . . 65.54 113.837 178.754 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.572 ' O ' ' HG3' ' B' ' 31' ' ' LYS . 47.0 t -54.19 143.51 22.56 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.765 0.793 . . . . 52.44 112.583 -176.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.423 ' O ' ' HE2' ' B' ' 32' ' ' LYS . . . -60.89 -43.74 98.06 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.16 -1.382 . . . . 72.43 111.709 178.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -66.92 -33.02 74.68 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 111.715 0.265 . . . . 52.33 111.715 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.64 ' HB3' HD23 ' B' ' 26' ' ' LEU . 10.8 tp10 -62.64 -34.89 77.97 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 107.631 -1.248 . . . . 52.04 107.631 177.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.572 ' HG3' ' O ' ' B' ' 27' ' ' SER . 92.6 mttt -70.07 -50.43 41.11 Favored 'General case' 0 C--O 1.203 -1.359 0 CA-C-N 115.341 -0.845 . . . . 72.32 111.101 -174.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.532 ' N ' ' HE2' ' B' ' 32' ' ' LYS . 0.2 OUTLIER -57.66 -37.42 73.36 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 120.106 -0.637 . . . . 72.15 112.062 -177.455 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.659 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 7.1 mm-40 -71.14 -47.41 58.04 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.074 -0.512 . . . . 72.03 110.635 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.509 HG12 ' HA ' ' B' ' 31' ' ' LYS . 21.4 pt -64.83 -34.65 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 122.975 0.172 . . . . 63.15 111.211 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -60.63 -42.66 97.33 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-O 121.183 0.516 . . . . 74.35 109.807 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.436 ' O ' ' HD3' ' B' ' 88' ' ' ARG . 98.4 mttt -78.38 -25.87 46.38 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.153 0.798 . . . . 75.31 113.153 -176.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.659 ' HG2' ' O ' ' B' ' 33' ' ' GLU . 14.7 ptp180 -108.29 31.96 5.17 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.704 0.764 . . . . 74.54 112.2 -174.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' B' ' 84' ' ' GLU . 35.2 t -95.55 155.78 16.6 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.092 -1.447 . . . . 63.21 107.092 172.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.495 ' CG1' ' HB ' ' B' ' 91' ' ' VAL . 26.8 m -135.49 158.39 40.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.931 -0.48 . . . . 75.32 110.11 176.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -107.73 119.82 40.51 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 107.354 -1.35 . . . . 63.41 107.354 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 67.3 t -122.0 107.57 20.14 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 N-CA-C 106.806 -1.553 . . . . 51.05 106.806 173.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.86 171.49 19.99 Favored Glycine 0 C--N 1.276 -2.802 0 C-N-CA 118.29 -1.909 . . . . 75.42 112.712 -176.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.6 t30 66.57 28.66 9.26 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.289 1.436 . . . . 72.33 112.208 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 14.7 p -58.49 134.5 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-O 121.412 0.625 . . . . 71.25 109.862 175.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -73.69 146.32 44.57 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.479 -0.782 . . . . 73.22 109.547 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' TYR . . . . . 0.5 ' OH ' ' HG3' ' A' ' 54' ' ' GLU . 45.8 t80 -61.71 -19.24 62.17 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.794 0.838 . . . . 72.42 110.93 -176.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.32 -0.53 55.75 Favored Glycine 0 N--CA 1.427 -1.924 0 CA-C-N 116.01 -0.541 . . . . 73.01 112.551 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 34.0 m -84.64 133.36 34.41 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.895 -0.78 . . . . 74.42 108.895 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 62.0 p -113.02 178.73 4.18 Favored 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 119.74 -0.784 . . . . 64.22 111.132 -177.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.8 -43.36 99.01 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.741 -0.663 . . . . 53.41 110.984 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -58.62 -43.13 89.58 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 111.724 0.268 . . . . 74.35 111.724 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -60.34 -47.93 83.93 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.912 0.863 . . . . 71.32 109.614 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.462 ' HB3' ' HE2' ' B' ' 57' ' ' PHE . 69.4 mt -68.73 -47.32 66.61 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-N 114.271 -1.331 . . . . 74.44 112.816 -177.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -57.34 -48.85 77.92 Favored 'General case' 0 C--O 1.205 -1.284 0 C-N-CA 122.872 0.469 . . . . 64.2 110.569 -176.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.34 -42.72 78.2 Favored 'General case' 0 C--O 1.258 1.522 0 CA-C-O 121.286 0.565 . . . . 70.24 110.631 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -69.1 -42.03 76.67 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.363 -0.835 . . . . 72.14 111.201 -176.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.572 ' CD2' HG13 ' B' ' 83' ' ' ILE . 66.2 m-85 -80.52 -23.17 40.23 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.454 -0.499 . . . . 70.24 111.114 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 32.9 t -71.37 -24.54 62.1 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.435 -0.58 . . . . 75.45 109.435 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 23.8 m -63.95 -27.01 68.85 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.1 0.476 . . . . 71.1 110.005 176.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 63.5 m -97.43 7.51 46.38 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.574 0.583 . . . . 74.33 112.574 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.09 -165.18 29.78 Favored Glycine 0 CA--C 1.507 -0.461 0 C-N-CA 118.169 -1.967 . . . . 74.32 115.783 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 14.7 m -98.18 123.99 42.53 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.862 -0.669 . . . . 72.31 109.442 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.45 HD11 ' HB2' ' B' ' 57' ' ' PHE . 61.9 mt -88.72 131.83 35.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 113.223 0.823 . . . . 73.54 113.223 -178.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . 0.664 ' OD1' ' HB3' ' A' ' 73' ' ' PHE . 18.8 t-20 -99.73 -45.25 5.82 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 124.5 1.12 . . . . 54.52 109.955 177.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.483 ' HB2' ' HB2' ' B' ' 84' ' ' GLU . 98.3 mtt180 -147.46 158.47 43.99 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.181 -0.674 . . . . 70.22 109.181 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -148.93 127.49 3.19 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 C-N-CA 123.658 0.783 . . . . 65.22 109.972 174.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 38.6 m -125.93 133.21 51.92 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.065 -0.971 . . . . 72.52 108.61 -175.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . 0.418 HD12 ' N ' ' B' ' 68' ' ' ILE . 1.2 mp -129.9 122.34 54.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 106.353 -1.721 . . . . 75.33 106.353 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.479 HD23 ' H ' ' B' ' 69' ' ' LEU . 1.7 pt? -121.71 135.25 54.95 Favored 'General case' 0 C--N 1.287 -2.151 0 C-N-CA 120.6 -0.44 . . . . 62.3 110.468 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 64.5 m -115.87 127.08 54.74 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.03 -1.1 . . . . 72.14 108.03 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 3.7 p30 -107.8 127.52 53.78 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.258 -0.645 . . . . 72.45 109.258 -177.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . 0.487 ' HE3' ' HB3' ' B' ' 77' ' ' PRO . 44.9 mtpt -124.1 10.88 8.81 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 120.732 -0.387 . . . . 63.21 110.015 -178.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -61.51 -22.7 65.34 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 113.893 1.072 . . . . 74.41 113.893 -177.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 19.8 m -97.81 14.08 28.25 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.025 0.44 . . . . 62.22 109.99 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.22 -44.37 3.09 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 111.275 -0.73 . . . . 75.3 111.275 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -91.37 125.62 57.44 Favored Pre-proline 0 CA--C 1.505 -0.762 0 N-CA-C 110.011 -0.366 . . . . 70.11 110.011 178.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.487 ' HB3' ' HE3' ' B' ' 72' ' ' LYS . 69.3 Cg_endo -76.57 119.55 5.24 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.905 2.404 . . . . 70.44 112.843 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' LYS . . . . . 0.43 ' HB2' ' OD2' ' B' ' 71' ' ' ASP . 24.6 mtmm -118.77 -160.82 0.81 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.094 -1.076 . . . . 70.33 108.094 175.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 178.79 158.26 20.95 Favored Glycine 0 N--CA 1.416 -2.698 0 C-N-CA 119.193 -1.48 . . . . 62.31 114.226 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . 0.405 ' O ' HD23 ' B' ' 69' ' ' LEU . 30.2 m-85 -136.17 153.95 51.1 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 105.784 -1.932 . . . . 73.01 105.784 173.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.37 130.33 40.57 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 109.935 -0.394 . . . . 73.01 109.935 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -114.03 122.39 46.77 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.912 -1.144 . . . . 54.33 107.912 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.572 HG13 ' CD2' ' B' ' 57' ' ' PHE . 4.6 mm -114.03 129.38 70.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.106 -1.072 . . . . 74.02 108.106 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' B' ' 65' ' ' ARG . 1.3 mp0 -99.48 120.74 40.11 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.54 -1.281 . . . . 74.32 107.54 173.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -88.9 152.8 21.52 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 108.515 -0.92 . . . . 71.34 108.515 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.63 -24.23 64.53 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 110.239 -0.282 . . . . 71.43 110.239 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -120.91 147.09 45.9 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.924 -0.58 . . . . 73.11 110.675 -178.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.436 ' HD3' ' O ' ' B' ' 36' ' ' LYS . 0.0 OUTLIER -72.59 -34.14 67.21 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.0 -0.741 . . . . 73.43 109.0 177.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -59.46 -35.26 73.71 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.204 -0.907 . . . . 74.43 110.465 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 30.8 m -65.78 -36.26 83.02 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.931 -0.577 . . . . 71.54 110.555 -178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.517 ' O ' HG13 ' B' ' 95' ' ' VAL . 1.4 m -69.12 -37.46 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 108.906 -0.775 . . . . 73.52 108.906 -178.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.662 ' O ' HG22 ' B' ' 95' ' ' VAL . 7.2 t70 -68.49 -31.05 70.04 Favored 'General case' 0 C--O 1.215 -0.763 0 CA-C-O 121.67 0.748 . . . . 65.33 109.066 -178.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.99 -31.15 64.32 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.842 -0.617 . . . . 73.21 109.868 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.32 -35.55 61.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.796 -0.638 . . . . 73.51 111.481 -178.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . 0.662 HG22 ' O ' ' B' ' 92' ' ' ASP . 10.4 m -54.31 -21.18 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 112.582 0.586 . . . . 70.31 112.582 178.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.57 -13.97 61.73 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.213 0.53 . . . . 43.41 110.835 177.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 67.1 mtm -96.9 12.98 30.37 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 116.263 -0.426 . . . . 44.03 110.627 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -35.41 -58.36 0.58 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.283 1.033 . . . . 63.41 113.082 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -112.02 98.95 7.7 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 118.553 -1.259 . . . . 63.04 109.14 170.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 75.4 m -139.44 150.85 45.71 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.526 -1.215 . . . . 74.44 109.941 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.05 122.59 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-O 121.481 0.657 . . . . 74.32 110.302 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -120.36 124.89 46.64 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.736 -0.839 . . . . 74.22 108.736 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 61.0 ttt-85 47.9 31.5 2.36 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 125.566 1.546 . . . . 71.03 112.044 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 100.4 -6.36 57.67 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 115.666 -0.697 . . . . 32.42 114.35 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -121.91 150.97 41.23 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 117.838 0.819 . . . . 73.1 111.304 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 30.0 m -82.07 121.58 26.74 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 116.431 -0.35 . . . . 74.33 110.232 -176.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 45.8 pt -101.2 170.66 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 120.577 -0.449 . . . . 60.25 110.151 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 108' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 46.7 tptt -128.81 121.61 28.69 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.955 -1.128 . . . . 72.11 107.955 -176.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 95.6 t -115.19 114.42 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 N-CA-C 107.374 -1.343 . . . . 72.31 107.374 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.411 HD23 ' HD2' ' B' ' 111' ' ' PRO . 3.6 tt -138.83 131.12 15.67 Favored Pre-proline 0 C--N 1.292 -1.925 0 N-CA-C 105.938 -1.875 . . . . 71.04 105.938 -173.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.411 ' HD2' HD23 ' B' ' 110' ' ' LEU . 73.6 Cg_exo -53.57 133.51 53.95 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.871 1.714 . . . . 74.03 112.888 178.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' B' ' 38' ' ' SER . 45.1 tttm . . . . . 0 N--CA 1.389 -3.485 0 N-CA-C 106.495 -1.668 . . . . 65.33 106.495 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 41.3 mm-40 . . . . . 0 N--CA 1.469 0.475 0 N-CA-C 112.236 0.458 . . . . 74.34 112.236 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 21.2 pt -67.42 -35.17 72.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.177 0.513 . . . . 63.0 111.541 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -68.9 -24.02 64.26 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.881 -0.6 . . . . 74.03 110.471 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -77.92 -32.03 51.42 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.2 0.524 . . . . 75.31 110.746 176.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 96.5 mtt180 -94.49 10.8 33.14 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.605 0.717 . . . . 71.35 110.56 -171.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.574 ' HB3' ' HG2' ' A' ' 84' ' ' GLU . 13.6 p -112.16 169.4 8.89 Favored 'General case' 0 N--CA 1.401 -2.887 0 CA-C-N 115.424 -0.807 . . . . 61.01 111.771 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 27.3 m -135.32 158.62 40.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 116.155 -0.475 . . . . 75.55 110.912 -175.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.673 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 46.7 t80 -99.0 121.78 41.4 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 124.572 1.149 . . . . 74.5 108.665 175.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 58.2 t -115.07 113.53 43.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 107.639 -1.245 . . . . 71.35 107.639 174.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.23 170.23 14.0 Favored Glycine 0 C--N 1.305 -1.182 0 C-N-CA 120.052 -1.07 . . . . 41.53 113.769 -177.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.471 ' O ' ' HD3' ' A' ' 105' ' ' ARG . 65.4 t30 68.71 21.49 7.81 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 126.425 1.89 . . . . 61.54 112.505 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.496 ' O ' ' HA3' ' A' ' 79' ' ' GLY . 7.4 p -91.63 103.65 14.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 O-C-N 121.203 -0.936 . . . . 71.11 110.99 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.404 ' HB2' ' NH2' ' A' ' 105' ' ' ARG . 2.3 m-20 -86.71 166.74 15.06 Favored 'General case' 0 C--O 1.261 1.686 0 N-CA-C 108.391 -0.966 . . . . 63.44 108.391 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -50.81 131.77 26.28 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 123.41 0.444 . . . . 73.13 109.825 174.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 137.89 -38.49 1.7 Allowed Glycine 0 N--CA 1.427 -1.945 0 N-CA-C 110.1 -1.2 . . . . 75.32 110.1 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.4 m -84.08 131.97 34.75 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 108.131 -1.063 . . . . 74.33 108.131 176.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.0 p -94.1 162.86 13.7 Favored 'General case' 0 N--CA 1.418 -2.066 0 N-CA-C 109.678 -0.49 . . . . 72.25 109.678 -179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.666 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -65.9 -41.64 91.2 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 109.902 -0.407 . . . . 71.33 109.902 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.535 HE21 ' N ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -61.06 -37.31 82.22 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 120.21 -0.596 . . . . 63.11 112.254 178.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.535 ' N ' HE21 ' A' ' 51' ' ' GLN 0.279 1.9 p30 -73.57 -28.21 61.73 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 119.368 -0.933 . . . . 63.43 110.87 178.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.3 mt -62.61 -46.37 88.59 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 115.431 -0.804 . . . . 71.13 110.076 172.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -58.45 -47.43 84.03 Favored 'General case' 0 C--O 1.189 -2.124 0 N-CA-C 112.957 0.725 . . . . 72.44 112.957 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.59 -47.37 73.43 Favored 'General case' 0 C--O 1.27 2.136 0 CA-C-O 120.957 0.408 . . . . 75.41 111.054 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -64.04 -43.04 96.77 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.147 -0.933 . . . . 74.53 110.825 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -82.65 -25.6 32.94 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 116.081 1.882 . . . . 71.33 116.081 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.5 m -69.89 -28.07 65.32 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-O 120.761 0.315 . . . . 61.4 110.932 -176.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.1 m -59.34 -26.53 65.11 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 120.412 -0.515 . . . . 75.41 110.886 173.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 79.0 m -105.99 9.24 32.63 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.013 0.746 . . . . 71.5 113.013 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' A' ' 90' ' ' SER . . . 163.46 176.5 35.49 Favored Glycine 0 CA--C 1.502 -0.74 0 C-N-CA 118.176 -1.964 . . . . 71.35 115.484 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.5 m -100.66 116.47 32.64 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.107 -0.546 . . . . 75.21 110.109 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.4 mt -83.78 128.29 38.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 115.352 -0.84 . . . . 24.25 112.862 -176.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.536 HD21 ' HA ' ' A' ' 86' ' ' ALA . 89.2 m-20 -87.25 -45.55 10.52 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 115.424 -0.807 . . . . 74.03 109.621 175.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.519 ' HD3' ' OE1' ' A' ' 84' ' ' GLU . 53.8 mtp180 -159.27 165.96 32.35 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.242 -1.392 . . . . 75.15 107.242 -173.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.666 HD11 ' HB1' ' A' ' 50' ' ' ALA . 22.4 pt -146.19 141.94 21.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.193 -1.04 . . . . 75.03 108.193 174.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.6 m -125.32 125.41 43.45 Favored 'General case' 0 C--N 1.269 -2.933 0 N-CA-C 107.217 -1.401 . . . . 62.15 107.217 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.9 mp -120.46 115.88 48.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 105.541 -2.022 . . . . 74.24 105.541 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.574 HD12 ' NH2' ' B' ' 65' ' ' ARG . 1.0 OUTLIER -121.09 128.87 53.0 Favored 'General case' 0 C--N 1.283 -2.292 0 C-N-CA 120.348 -0.541 . . . . 53.32 112.096 -178.477 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 66.1 m -117.37 133.6 55.79 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.805 -0.634 . . . . 64.43 109.795 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -118.41 144.48 45.9 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 120.343 -0.543 . . . . 64.51 110.743 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -111.64 12.04 21.17 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.25 0.548 . . . . 64.32 111.208 174.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.614 ' CE2' ' HB3' ' B' ' 64' ' ' ASN . 30.5 m-85 -66.75 -20.73 66.02 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.633 -0.712 . . . . 75.31 111.275 175.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.6 t -86.13 3.87 40.84 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.71 -0.677 . . . . 65.13 109.658 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.1 -44.26 3.29 Favored Glycine 0 CA--C 1.502 -0.776 0 N-CA-C 110.149 -1.181 . . . . 63.35 110.149 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -96.81 147.16 32.51 Favored Pre-proline 0 C--N 1.292 -1.909 0 N-CA-C 105.915 -1.883 . . . . 73.44 105.915 177.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -75.44 116.57 4.54 Favored 'Trans proline' 0 N--CA 1.432 -2.125 0 N-CA-C 108.792 -1.272 . . . . 64.4 108.792 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 24.7 mtmm -108.05 156.93 18.71 Favored 'General case' 0 CA--C 1.461 -2.449 0 N-CA-C 107.73 -1.211 . . . . 73.33 107.73 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 44' ' ' VAL . . . -136.34 145.25 17.16 Favored Glycine 1 N--CA 1.395 -4.035 0 C-N-CA 119.167 -1.492 . . . . 61.21 112.226 176.724 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -146.2 143.55 29.32 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 108.31 -0.996 . . . . 74.31 108.31 174.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.09 144.37 51.31 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-O 120.777 0.322 . . . . 63.44 110.577 -173.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.741 ' CD1' ' HD2' ' A' ' 112' ' ' LYS . 68.7 m-85 -115.83 115.54 26.43 Favored 'General case' 0 N--CA 1.409 -2.482 0 CA-C-N 115.908 -0.587 . . . . 74.41 109.599 177.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.448 HG23 HG22 ' A' ' 66' ' ' ILE . 33.0 mm -99.85 119.51 48.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 107.632 -1.248 . . . . 73.14 107.632 -177.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.574 ' HG2' ' HB3' ' A' ' 38' ' ' SER . 43.5 mt-10 -96.18 119.96 35.61 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.793 -0.363 . . . . 75.03 110.583 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -99.66 153.14 19.32 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.09 0.472 . . . . 53.44 110.136 177.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.536 ' HA ' HD21 ' A' ' 64' ' ' ASN . . . -64.13 -37.18 86.53 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.667 -0.697 . . . . 70.11 111.515 177.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -116.94 145.38 43.65 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.502 -0.772 . . . . 63.14 112.905 -176.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.544 ' O ' HG22 ' A' ' 91' ' ' VAL . 17.5 mmm180 -62.34 -33.16 74.18 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.381 -0.827 . . . . 75.44 109.549 171.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -62.81 -32.41 73.6 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.217 -0.901 . . . . 72.41 110.449 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.467 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . 47.3 m -67.75 -36.86 81.31 Favored 'General case' 0 N--CA 1.426 -1.67 0 O-C-N 122.383 -0.198 . . . . 61.33 110.546 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 88' ' ' ARG . 2.9 m -64.92 -39.18 84.81 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.886 0 C-N-CA 119.656 -0.818 . . . . 73.23 109.877 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -60.22 -36.3 77.4 Favored 'General case' 0 CA--C 1.502 -0.902 0 O-C-N 123.361 0.413 . . . . 75.51 111.935 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.73 -36.67 65.21 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.055 0.455 . . . . 54.23 110.298 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.07 -45.32 57.95 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.887 -0.597 . . . . 52.34 111.574 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 91' ' ' VAL . 22.1 m -55.39 -21.58 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 113.101 0.778 . . . . 74.52 113.101 177.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.97 -19.04 65.73 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.293 0.568 . . . . 75.32 110.461 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 56.9 mtm -96.19 9.43 41.0 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.653 -0.703 . . . . 63.1 110.173 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.597 ' HA ' HG12 ' A' ' 109' ' ' VAL . 2.7 p-10 -41.97 -41.71 2.59 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.825 0.676 . . . . 73.33 112.825 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -102.22 101.49 11.79 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 119.668 -0.813 . . . . 63.55 109.539 170.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.7 p -140.61 148.27 40.65 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.276 -0.874 . . . . 61.34 110.309 174.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.1 p -113.57 93.14 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 CA-C-O 122.764 1.269 . . . . 62.31 108.981 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -112.36 128.81 56.4 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 114.058 -1.428 . . . . 74.42 107.553 -173.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 61.1 33.18 19.59 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.27 1.028 . . . . 71.53 109.566 -175.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.59 -2.4 63.32 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 114.768 -1.105 . . . . 75.15 114.5 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.471 ' HD3' ' O ' ' A' ' 43' ' ' ASN . 5.5 ptp180 -113.0 141.14 47.18 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 122.058 -0.672 . . . . 73.31 109.523 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.0 m -83.68 119.72 25.12 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 108.322 -0.992 . . . . 74.34 108.322 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 33.3 pt -101.7 172.16 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 109.619 -0.512 . . . . 75.55 109.619 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 55.3 tptt -132.89 132.32 41.93 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.644 -0.873 . . . . 62.22 108.644 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.673 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 5.0 p -128.18 123.17 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 O-C-N 123.355 0.41 . . . . 71.41 110.498 175.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . 0.289 0.0 OUTLIER -141.95 146.79 42.05 Favored Pre-proline 0 N--CA 1.431 -1.383 0 N-CA-C 108.99 -0.744 . . . . 74.3 108.99 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.46 ' HD3' HG11 ' A' ' 95' ' ' VAL . 37.2 Cg_endo -68.95 131.01 21.43 Favored 'Trans proline' 0 C--O 1.244 0.818 0 C-N-CA 122.099 1.866 . . . . 72.24 114.017 -171.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.741 ' HD2' ' CD1' ' A' ' 82' ' ' TYR . 48.3 mtpt . . . . . 0 C--N 1.313 -0.997 0 CA-C-N 114.484 -1.235 . . . . 75.53 112.735 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.798 0 N-CA-C 114.056 0.382 . . . . 50.53 114.056 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -50.52 -44.3 40.56 Favored 'Trans proline' 0 CA--C 1.553 1.444 0 C-N-CA 124.326 3.351 . . . . 74.41 115.339 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -46.47 133.03 16.24 Favored 'Trans proline' 0 C--N 1.396 3.029 0 C-N-CA 122.301 2.001 . . . . 72.53 112.94 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -65.87 140.4 97.21 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 115.835 -0.62 . . . . 63.3 110.957 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.16 119.46 6.53 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 122.746 2.297 . . . . 74.11 113.283 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.69 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -79.91 176.0 10.12 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.034 -0.985 . . . . 62.11 110.394 177.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.583 ' HB3' ' OE1' ' B' ' 30' ' ' GLU . 41.2 t -67.71 144.54 55.4 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.927 0.714 . . . . 54.35 112.927 -173.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.99 -35.53 34.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.371 -1.286 . . . . 71.14 111.349 173.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -65.43 -45.33 84.28 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 116.392 -0.367 . . . . 60.23 110.923 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.583 ' OE1' ' HB3' ' B' ' 27' ' ' SER . 2.8 mp0 -64.19 -38.68 91.91 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 120.776 -0.37 . . . . 72.43 110.974 176.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.1 -41.95 98.73 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.493 0.663 . . . . 75.14 109.294 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.532 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 0.0 OUTLIER -72.27 -38.0 68.93 Favored 'General case' 0 N--CA 1.384 -3.739 0 CA-C-N 115.225 -0.898 . . . . 72.04 112.59 -178.438 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -71.24 -41.36 70.21 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.311 0.486 . . . . 73.11 112.311 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.432 HG12 ' O ' ' B' ' 30' ' ' GLU . 15.7 pt -70.01 -35.42 64.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.367 -0.379 . . . . 74.42 110.983 -177.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -69.38 -27.37 65.25 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.686 -0.688 . . . . 75.0 109.378 -177.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 99.3 mttt -71.18 -34.26 70.76 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.631 -0.713 . . . . 51.01 111.133 176.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -99.77 19.65 15.6 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.051 0.929 . . . . 73.23 110.33 -175.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 68.6 m -96.55 158.33 15.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.192 -1.367 . . . . 75.31 108.554 173.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' B' ' 82' ' ' TYR . 28.2 m -131.74 157.64 43.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.458 -0.571 . . . . 74.3 109.458 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . 0.649 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 40.7 t80 -103.93 119.07 38.16 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.041 -1.096 . . . . 71.05 108.041 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 58.5 t -112.02 109.79 29.84 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 107.414 -1.328 . . . . 74.3 107.414 175.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -113.44 173.96 15.42 Favored Glycine 0 N--CA 1.438 -1.197 0 C-N-CA 120.621 -0.799 . . . . 62.24 112.788 -176.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 7.4 t30 61.01 9.01 2.13 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 126.002 1.721 . . . . 45.03 111.542 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 5.6 p -84.33 90.84 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 106.394 -1.706 . . . . 72.45 106.394 173.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -82.14 84.93 6.88 Favored 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 115.474 1.657 . . . . 53.32 115.474 -165.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' TYR . . . . . 0.565 ' HA ' ' SG ' ' B' ' 70' ' ' CYS . 7.6 t80 70.68 -69.54 0.18 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 113.658 -1.61 . . . . 73.34 113.986 163.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.08 -4.53 22.35 Favored Glycine 0 N--CA 1.468 0.786 0 N-CA-C 116.432 1.333 . . . . 75.5 116.432 -170.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 71.2 m -71.22 130.34 41.18 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 117.989 0.894 . . . . 70.42 110.515 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 36.1 p -79.83 151.71 30.11 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.185 -0.462 . . . . 54.4 111.556 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.63 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -69.29 -41.56 76.66 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.437 0.695 . . . . 72.23 111.573 -175.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -41.8 81.7 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.868 -0.605 . . . . 75.43 111.587 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -69.04 -34.64 75.52 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.837 -0.62 . . . . 64.12 110.994 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 21.3 mt -61.51 -46.45 89.93 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-N 115.485 -0.779 . . . . 74.25 111.638 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -58.64 -47.05 85.72 Favored 'General case' 0 C--O 1.194 -1.827 0 N-CA-C 113.501 0.926 . . . . 75.53 113.501 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.64 -47.66 73.22 Favored 'General case' 0 C--O 1.268 2.029 0 CA-C-N 118.041 0.382 . . . . 70.1 111.185 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -64.26 -42.14 96.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.373 -0.831 . . . . 70.41 111.007 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -82.8 -25.63 32.53 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 115.903 1.816 . . . . 53.14 115.903 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 69.5 m -69.78 -25.0 63.59 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 120.651 0.262 . . . . 71.51 110.673 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 21.4 m -58.44 -27.25 64.18 Favored 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 120.432 -0.507 . . . . 72.12 110.764 172.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 68.2 m -99.94 7.36 44.88 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.741 1.015 . . . . 70.42 113.741 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.41 -167.96 32.54 Favored Glycine 0 CA--C 1.5 -0.856 0 C-N-CA 118.24 -1.933 . . . . 71.51 115.242 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 14.6 m -101.54 120.72 40.75 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 123.127 0.571 . . . . 63.0 110.087 -176.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 64.3 mt -87.52 125.82 41.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.07 0.462 . . . . 53.03 112.178 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . 0.614 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 90.5 m-20 -85.65 -46.85 10.37 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.959 0.885 . . . . 75.13 110.084 177.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.574 ' NH2' HD12 ' A' ' 69' ' ' LEU . 49.6 mtp180 -158.7 165.73 33.67 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.613 -1.625 . . . . 65.41 106.613 -172.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.63 HD11 ' HB1' ' B' ' 50' ' ' ALA . 23.2 pt -146.08 142.09 21.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.142 -1.059 . . . . 74.52 108.142 175.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 91.5 m -125.31 125.73 43.96 Favored 'General case' 0 C--N 1.272 -2.784 0 N-CA-C 107.351 -1.351 . . . . 72.11 107.351 -178.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mp -120.4 116.69 50.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 105.162 -2.162 . . . . 74.34 105.162 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.444 HD12 ' NH2' ' A' ' 65' ' ' ARG 0.256 1.0 OUTLIER -121.36 129.86 53.29 Favored 'General case' 0 C--N 1.277 -2.577 0 C-N-CA 120.308 -0.557 . . . . 73.13 112.106 -178.935 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' CYS . . . . . 0.565 ' SG ' ' HA ' ' B' ' 46' ' ' TYR . 63.1 m -118.02 131.7 56.45 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 115.484 -0.78 . . . . 55.42 109.446 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.539 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 4.5 p-10 -113.5 137.83 51.0 Favored 'General case' 0 CA--C 1.492 -1.282 0 C-N-CA 119.681 -0.808 . . . . 72.32 109.696 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -120.16 12.44 11.85 Favored 'General case' 0 N--CA 1.423 -1.81 0 C-N-CA 119.69 -0.804 . . . . 73.52 108.97 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.408 ' CD2' ' HB2' ' B' ' 71' ' ' ASP . 38.3 p90 -69.79 -22.33 63.33 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 108.48 -0.933 . . . . 73.11 108.48 176.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 40.3 m -75.71 4.27 8.15 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 114.809 -1.087 . . . . 55.21 110.367 175.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.12 -52.99 4.8 Favored Glycine 0 CA--C 1.496 -1.116 0 N-CA-C 110.5 -1.04 . . . . 65.34 110.5 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -95.38 122.74 58.71 Favored Pre-proline 0 C--N 1.287 -2.148 0 N-CA-C 106.952 -1.499 . . . . 72.0 106.952 174.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 59.4 Cg_endo -68.37 119.79 6.78 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 122.068 1.846 . . . . 55.31 111.903 -175.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' LYS . . . . . 0.445 ' HZ3' ' CG ' ' B' ' 71' ' ' ASP . 27.7 mtmm -106.22 162.92 13.23 Favored 'General case' 0 CA--C 1.476 -1.888 0 N-CA-C 108.285 -1.006 . . . . 74.31 108.285 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -133.97 144.55 16.53 Favored Glycine 0 N--CA 1.407 -3.257 0 C-N-CA 119.498 -1.334 . . . . 64.31 112.14 175.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -148.68 143.28 26.37 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.622 -0.881 . . . . 75.03 108.622 172.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.79 144.55 51.53 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 120.851 0.358 . . . . 44.13 110.734 -172.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' B' ' 39' ' ' VAL . 72.6 m-85 -115.31 115.65 26.99 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 115.852 -0.613 . . . . 70.5 109.455 176.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.45 HG23 HG22 ' B' ' 66' ' ' ILE . 33.1 mm -100.37 118.52 47.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 107.425 -1.324 . . . . 70.23 107.425 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' GLU . . . . . 0.427 ' OE1' ' HD3' ' B' ' 65' ' ' ARG . 46.5 mt-10 -95.6 119.21 33.7 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.667 -0.413 . . . . 72.35 110.331 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -97.4 153.71 17.93 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.005 0.431 . . . . 65.53 110.855 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.456 ' HA ' HD21 ' B' ' 64' ' ' ASN . . . -61.14 -30.31 70.31 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.492 -0.776 . . . . 73.02 112.046 177.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -131.27 157.82 42.27 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.477 0.656 . . . . 74.21 112.3 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.59 ' O ' HG22 ' B' ' 91' ' ' VAL . 19.8 mmm180 -68.29 -33.36 74.2 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.535 -1.212 . . . . 74.31 109.941 172.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -65.26 -28.6 69.46 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.312 -0.404 . . . . 73.12 111.461 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 39.9 m -68.77 -37.23 79.18 Favored 'General case' 0 N--CA 1.433 -1.298 0 O-C-N 122.273 -0.267 . . . . 45.33 110.36 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.59 HG22 ' O ' ' B' ' 88' ' ' ARG . 3.6 m -65.89 -38.48 82.25 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 N-CA-C 108.894 -0.78 . . . . 72.41 108.894 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -62.76 -35.83 81.1 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.549 0.74 . . . . 73.34 109.424 -177.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.38 -37.8 63.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.762 -0.654 . . . . 65.31 110.858 177.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.0 -45.23 61.72 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.951 -0.568 . . . . 51.32 111.659 -176.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . 0.509 HG13 ' O ' ' B' ' 91' ' ' VAL . 25.5 m -54.53 -21.86 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 113.191 0.812 . . . . 52.01 113.191 178.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.97 -12.42 61.64 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.107 0.48 . . . . 63.13 110.862 177.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 60.6 mtm -100.03 9.72 42.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.171 -0.468 . . . . 54.2 110.707 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . 0.553 ' HA ' HG12 ' B' ' 109' ' ' VAL . 2.5 p-10 -46.91 -34.5 5.52 Favored 'General case' 0 C--O 1.201 -1.483 0 N-CA-C 115.549 1.685 . . . . 70.32 115.549 -177.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -100.52 29.62 4.34 Favored 'General case' 0 CA--C 1.58 2.104 0 CA-C-N 119.81 1.187 . . . . 74.32 111.941 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 43.4 p -88.95 160.17 17.28 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.259 -0.9 . . . . 73.12 111.815 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' B' ' 106' ' ' THR . 14.9 p -97.16 139.61 19.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.465 -0.569 . . . . 74.21 109.465 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -138.92 122.84 17.76 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 109.185 -0.672 . . . . 73.21 109.185 -176.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 62.5 ttp85 54.44 32.51 16.8 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 125.279 1.431 . . . . 74.32 111.292 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.81 -7.6 63.1 Favored Glycine 0 C--N 1.305 -1.166 0 CA-C-N 115.035 -0.984 . . . . 41.21 114.741 175.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -132.8 153.58 51.12 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 117.862 0.831 . . . . 74.23 110.218 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' B' ' 101' ' ' VAL . 56.8 m -77.89 126.46 30.88 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 120.595 0.236 . . . . 52.4 111.015 -174.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 2.4 pp -102.83 172.58 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 120.456 -0.497 . . . . 71.04 111.202 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 108' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 56.7 tptt -129.58 132.71 46.86 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.67 -0.863 . . . . 65.14 108.67 -178.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . 0.649 ' HA ' ' O ' ' B' ' 40' ' ' TYR 0.276 6.2 p -127.4 126.94 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-O 121.638 0.732 . . . . 72.44 110.277 175.333 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.321 0.3 OUTLIER -143.1 137.08 14.51 Favored Pre-proline 0 C--N 1.285 -2.202 0 N-CA-C 105.916 -1.883 . . . . 72.45 105.916 -168.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.433 ' HD3' HG11 ' B' ' 95' ' ' VAL . 58.2 Cg_endo -74.2 136.75 22.65 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 121.775 1.65 . . . . 72.15 112.862 -177.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 59.3 tttm . . . . . 0 N--CA 1.432 -1.366 0 CA-C-N 115.641 -0.709 . . . . 73.43 110.28 -176.325 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 N--CA 1.437 -1.109 0 CA-C-O 120.46 0.172 . . . . 73.45 111.072 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 20.4 pt -71.35 -37.95 67.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 112.386 0.513 . . . . 72.45 112.386 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.23 -32.2 73.75 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.931 0.492 . . . . 75.42 111.489 -177.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -56.73 -26.2 56.51 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.461 0.648 . . . . 73.12 111.206 177.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 -115.9 15.79 16.24 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-N 115.871 -0.604 . . . . 73.43 111.258 -172.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.563 ' OG ' ' HE2' ' A' ' 112' ' ' LYS . 10.3 t -95.66 143.95 26.5 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 121.569 0.7 . . . . 74.44 110.168 -177.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.723 HG22 HG23 ' A' ' 91' ' ' VAL . 13.7 t -127.36 148.42 32.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 115.663 -0.698 . . . . 51.52 109.459 -175.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.63 ' CZ ' ' HG3' ' B' ' 22' ' ' PRO . 35.7 t80 -96.32 124.86 40.47 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.907 -1.145 . . . . 62.31 107.907 169.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.1 t -118.51 112.18 37.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.438 -1.319 . . . . 54.54 107.438 174.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.66 164.04 12.65 Favored Glycine 0 C--N 1.289 -2.066 0 C-N-CA 119.637 -1.268 . . . . 75.54 113.836 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.554 HD21 ' HB2' ' A' ' 105' ' ' ARG . 12.3 t30 55.79 32.28 19.22 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.487 1.515 . . . . 71.31 112.905 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.0 p -55.92 132.48 19.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 121.479 0.657 . . . . 64.41 109.564 172.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -69.33 140.96 54.36 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 114.994 -1.003 . . . . 72.32 108.852 -174.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.541 ' CD2' ' HB2' ' A' ' 77' ' ' PRO . 0.7 OUTLIER -74.95 93.82 2.74 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 108.33 -0.989 . . . . 54.33 108.33 -179.52 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.76 -20.73 1.15 Allowed Glycine 0 N--CA 1.414 -2.821 0 N-CA-C 109.037 -1.625 . . . . 74.21 109.037 -174.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.528 ' OG ' ' HD3' ' A' ' 103' ' ' ARG . 73.1 m -91.89 78.52 5.36 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-O 121.951 0.881 . . . . 73.32 109.614 177.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.582 HG21 ' HB ' ' B' ' 49' ' ' THR . 51.5 p -65.39 -178.03 0.47 Allowed 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 114.429 -1.259 . . . . 64.24 113.15 177.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.501 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -51.22 -48.5 62.04 Favored 'General case' 0 C--O 1.202 -1.404 0 CA-C-N 115.12 -0.946 . . . . 61.55 112.152 -173.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -60.45 -38.81 85.36 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.711 0.634 . . . . 75.32 112.711 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -39.89 95.1 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 107.657 -1.238 . . . . 65.42 107.657 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.5 mt -71.97 -43.31 65.35 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 113.934 -1.484 . . . . 74.31 111.43 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 51.0 mt-10 -57.62 -48.93 78.08 Favored 'General case' 0 C--O 1.181 -2.509 0 CA-C-O 119.396 -0.335 . . . . 73.42 110.848 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.93 -48.28 80.37 Favored 'General case' 0 C--O 1.264 1.862 0 CA-C-O 121.341 0.591 . . . . 64.51 111.356 -177.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -66.33 -38.88 88.7 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.324 -0.853 . . . . 74.45 110.95 -176.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -81.37 -22.39 38.4 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 113.793 1.035 . . . . 72.52 113.793 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.8 t -68.74 -25.42 64.73 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.679 -0.86 . . . . 64.34 108.679 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.6 m -62.01 -28.51 69.63 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 116.026 -0.534 . . . . 73.23 110.004 174.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 61.1 m -95.68 0.27 52.43 Favored 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 112.917 0.71 . . . . 54.44 112.917 178.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.37 -159.32 28.07 Favored Glycine 0 C--O 1.22 -0.745 0 C-N-CA 118.865 -1.636 . . . . 62.04 115.424 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.9 m -112.85 127.95 56.32 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 122.523 0.329 . . . . 53.43 110.899 -175.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.466 ' CD1' ' HA ' ' A' ' 54' ' ' GLU . 75.3 mt -89.14 134.15 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 N-CA-C 113.186 0.81 . . . . 74.21 113.186 -177.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -101.54 -44.41 5.6 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.537 1.135 . . . . 54.24 111.869 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.435 ' HD3' ' OE2' ' A' ' 84' ' ' GLU . 26.7 mtp180 -145.15 152.82 40.63 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 108.266 -1.012 . . . . 63.43 108.266 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.1 tt -149.03 132.47 7.64 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-N 115.782 -0.644 . . . . 71.3 109.895 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.3 m -124.73 129.17 49.97 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.136 -1.431 . . . . 53.44 107.136 -176.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 mp -128.18 119.93 52.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 106.384 -1.71 . . . . 73.2 106.384 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.58 ' HG ' ' CE1' ' A' ' 80' ' ' TYR 0.352 1.0 OUTLIER -120.75 130.99 54.26 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 119.672 -0.811 . . . . 74.4 112.13 176.344 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.553 ' HB2' HG23 ' B' ' 66' ' ' ILE . 66.4 m -113.43 118.64 35.09 Favored 'General case' 0 N--CA 1.411 -2.402 0 C-N-CA 124.461 1.105 . . . . 72.43 108.754 -176.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.517 ' HA ' ' HA ' ' B' ' 65' ' ' ARG . 9.5 t0 -116.23 118.23 32.22 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 122.77 0.428 . . . . 73.5 109.968 -176.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 39.0 ttmt -114.65 16.48 17.51 Favored 'General case' 0 C--N 1.274 -2.686 0 C-N-CA 123.646 0.778 . . . . 61.21 110.632 -174.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.4 ' HB3' ' HB3' ' B' ' 64' ' ' ASN . 0.7 OUTLIER -63.07 -23.7 67.57 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 119.481 -0.888 . . . . 73.13 112.773 -176.154 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.0 t -92.39 11.5 25.87 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.396 0.617 . . . . 75.34 110.831 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.18 -52.66 1.62 Allowed Glycine 0 CA--C 1.5 -0.888 0 C-N-CA 120.474 -0.87 . . . . 65.15 111.319 178.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -89.98 126.88 55.84 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 107.748 -1.205 . . . . 61.13 107.748 175.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.541 ' HB2' ' CD2' ' A' ' 46' ' ' TYR . 73.4 Cg_endo -72.58 118.71 5.71 Favored 'Trans proline' 0 N--CA 1.436 -1.878 0 C-N-CA 121.586 1.524 . . . . 72.55 112.225 -176.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -89.78 173.15 8.42 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 114.842 -1.072 . . . . 73.35 109.175 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.15 137.52 4.83 Favored Glycine 1 N--CA 1.386 -4.667 0 C-N-CA 120.361 -0.923 . . . . 25.22 111.106 -178.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.58 ' CE1' ' HG ' ' A' ' 69' ' ' LEU 0.263 0.0 OUTLIER -150.49 143.53 24.79 Favored 'General case' 0 C--N 1.273 -2.74 0 CA-C-N 114.906 -0.647 . . . . 74.22 110.032 173.642 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.45 147.56 52.56 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.68 -0.691 . . . . 65.13 109.568 -173.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 80.7 m-85 -122.66 119.15 29.9 Favored 'General case' 0 C--N 1.273 -2.733 0 N-CA-C 108.198 -1.038 . . . . 73.01 108.198 176.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.6 mm -108.93 136.0 46.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 107.775 -1.194 . . . . 70.35 107.775 -175.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.435 ' OE2' ' HD3' ' A' ' 65' ' ' ARG . 41.7 mt-10 -113.82 124.88 53.31 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.098 -0.704 . . . . 74.12 109.098 176.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -97.11 164.25 12.58 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 111.806 0.298 . . . . 74.04 111.806 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.69 -41.98 59.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.234 0.54 . . . . 61.51 110.659 174.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.441 ' HB3' ' ND2' ' A' ' 89' ' ' ASN . 27.9 mm-40 -101.6 144.56 30.19 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.298 0.57 . . . . 54.4 112.134 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.77 -25.4 59.05 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.178 -1.416 . . . . 75.43 107.178 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.441 ' ND2' ' HB3' ' A' ' 87' ' ' GLU . 9.0 p30 -72.43 -20.96 61.32 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.266 -0.574 . . . . 72.43 111.085 178.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 m -71.58 -39.89 70.29 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 122.208 -0.307 . . . . 54.12 110.561 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.723 HG23 HG22 ' A' ' 39' ' ' VAL . 2.8 p -67.52 -39.38 82.32 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 C-N-CA 120.295 -0.562 . . . . 52.42 109.88 178.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -61.84 -32.5 72.83 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.766 -0.652 . . . . 74.43 110.149 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.89 -35.23 64.67 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.209 -0.451 . . . . 60.42 111.255 176.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.29 -38.09 56.62 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 116.216 -0.447 . . . . 73.14 111.239 -175.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 91' ' ' VAL . 14.4 m -56.84 -21.76 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 114.043 1.127 . . . . 73.1 114.043 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.49 -11.57 60.94 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.934 0.873 . . . . 62.13 110.385 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 7.1 ttp -101.25 5.36 42.47 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.855 -1.066 . . . . 70.21 108.546 -176.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 1.3 p-10 -37.7 -42.11 0.54 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.799 1.407 . . . . 72.1 114.799 -177.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -117.42 104.53 11.19 Favored 'General case' 0 N--CA 1.408 -2.539 0 CA-C-O 121.841 0.829 . . . . 72.13 109.777 174.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.5 t -147.49 165.2 31.0 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 114.01 -1.45 . . . . 65.14 108.451 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 106' ' ' THR . 7.1 p -112.7 110.58 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-O 122.244 1.021 . . . . 73.03 109.551 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -107.31 123.58 48.54 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.792 -1.094 . . . . 62.5 109.416 -173.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.528 ' HD3' ' OG ' ' A' ' 48' ' ' SER . 42.8 mtp-105 44.5 31.34 0.59 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.287 1.435 . . . . 75.43 114.632 -176.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 104.23 -4.34 44.5 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 114.984 -1.007 . . . . 74.13 113.342 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.554 ' HB2' HD21 ' A' ' 43' ' ' ASN . 1.3 ptp180 -130.02 139.97 50.94 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 113.182 0.808 . . . . 70.24 113.182 176.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 101' ' ' VAL . 31.9 m -72.05 122.61 21.21 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.439 -0.801 . . . . 60.5 111.088 -177.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 43.6 pt -102.53 170.74 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 120.844 0.354 . . . . 70.01 110.765 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 27.0 mmmt -127.01 122.86 35.67 Favored 'General case' 0 CA--C 1.486 -1.487 0 C-N-CA 124.159 0.984 . . . . 74.53 109.632 176.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 32.9 m -128.31 115.95 40.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-O 121.048 0.451 . . . . 60.43 109.89 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.402 ' CD1' ' HD2' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -146.15 160.13 43.79 Favored Pre-proline 0 C--N 1.289 -2.064 0 N-CA-C 108.758 -0.83 . . . . 64.02 108.758 -177.186 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.43 139.94 13.23 Favored 'Trans proline' 0 N--CA 1.436 -1.884 0 C-N-CA 121.118 1.212 . . . . 64.21 111.335 -173.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.563 ' HE2' ' OG ' ' A' ' 38' ' ' SER . 33.3 mtmt . . . . . 0 N--CA 1.406 -2.651 0 N-CA-C 106.533 -1.655 . . . . 65.33 106.533 175.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.417 ' HA3' ' HD2' ' B' ' 22' ' ' PRO . . . . . . . . 0 N--CA 1.436 -1.365 0 CA-C-O 120.196 -0.224 . . . . 35.41 113.162 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.63 ' HG3' ' CZ ' ' A' ' 40' ' ' TYR . 6.6 Cg_endo -43.1 -55.55 2.75 Favored 'Trans proline' 0 CA--C 1.6 3.801 0 C-N-CA 124.657 3.571 . . . . 71.32 115.607 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.495 ' HD3' ' HG2' ' B' ' 22' ' ' PRO . 19.8 Cg_endo -91.4 167.5 3.45 Favored 'Trans proline' 0 C--N 1.364 1.358 0 C-N-CA 122.498 2.132 . . . . 72.23 111.729 177.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -124.96 155.52 70.43 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-O 118.991 -0.528 . . . . 74.35 110.372 176.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -27.82 115.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.167 1 C-N-CA 125.967 4.445 . . . . 45.43 116.623 -176.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.692 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -78.12 172.04 14.14 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.302 -1.317 . . . . 63.02 112.174 175.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 19.6 m -69.19 147.81 50.78 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 113.798 1.036 . . . . 73.03 113.798 -175.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.716 ' O ' ' HG2' ' B' ' 32' ' ' LYS . . . -53.74 -46.68 70.93 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 114.992 -1.004 . . . . 72.35 110.458 174.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.542 ' HA ' ' CG ' ' B' ' 32' ' ' LYS . 68.5 mm-40 -68.95 -29.41 67.64 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 112.988 0.736 . . . . 72.11 112.988 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.514 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.4 OUTLIER -61.39 -37.61 84.04 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.502 -0.479 . . . . 64.11 110.608 172.116 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -63.12 -50.26 71.15 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 107.651 -1.241 . . . . 73.42 107.651 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.716 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 10.4 mmmm -52.06 -47.05 65.33 Favored 'General case' 0 C--O 1.214 -0.771 0 C-N-CA 124.459 1.103 . . . . 73.13 110.764 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -66.3 -49.87 65.57 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 114.005 1.113 . . . . 74.4 114.005 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.514 HG12 ' O ' ' B' ' 30' ' ' GLU . 28.6 pt -70.52 -36.17 64.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 111.969 0.359 . . . . 63.34 111.969 -174.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -63.04 -36.37 83.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.809 -0.632 . . . . 64.01 111.449 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.655 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 98.5 mttt -56.69 -25.26 53.59 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.474 0.654 . . . . 74.13 110.795 177.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.574 ' HD3' ' O ' ' B' ' 85' ' ' PHE . 70.1 mtt85 -112.37 14.11 20.35 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 115.515 -0.766 . . . . 74.12 111.857 -172.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 42.4 m -93.89 143.45 26.33 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.474 0.654 . . . . 71.14 110.946 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.655 HG22 HG23 ' B' ' 91' ' ' VAL . 14.7 t -129.85 152.71 37.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.714 -0.847 . . . . 60.54 108.714 -178.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . 0.612 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 18.9 t80 -105.33 123.42 47.83 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 107.117 -1.438 . . . . 73.23 107.117 173.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 48.9 t -116.76 111.58 35.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 107.364 -1.347 . . . . 71.32 107.364 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . 0.431 ' O ' ' HB ' ' B' ' 107' ' ' ILE . . . -112.9 169.7 13.08 Favored Glycine 0 C--N 1.291 -1.941 0 C-N-CA 119.463 -1.351 . . . . 74.32 114.127 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 64.7 t30 62.98 17.32 9.99 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 126.059 1.743 . . . . 73.23 113.267 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.423 HG22 ' HB2' ' B' ' 48' ' ' SER . 11.9 p -62.08 131.59 27.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.264 0.554 . . . . 71.4 109.943 176.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -75.43 156.72 35.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.52 -0.764 . . . . 70.05 109.067 -176.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -68.92 -18.16 64.07 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-O 121.808 0.813 . . . . 72.13 109.839 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.18 -12.73 80.37 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 115.559 -0.746 . . . . 32.12 111.808 178.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.423 ' HB2' HG22 ' B' ' 44' ' ' VAL . 25.1 m -87.23 133.07 33.71 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 108.45 -0.945 . . . . 71.44 108.45 178.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' THR . . . . . 0.582 ' HB ' HG21 ' A' ' 49' ' ' THR . 63.2 p -111.9 178.87 4.18 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 116.178 -0.464 . . . . 74.11 111.565 -172.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.439 ' O ' ' HG3' ' B' ' 54' ' ' GLU . . . -63.11 -48.12 79.9 Favored 'General case' 0 C--O 1.2 -1.549 0 N-CA-C 109.954 -0.387 . . . . 71.03 109.954 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -59.12 -39.59 82.77 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 111.946 0.35 . . . . 75.32 111.946 176.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.526 ' HB2' ' H ' ' B' ' 49' ' ' THR . 0.8 OUTLIER -55.94 -46.28 78.58 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.818 0.818 . . . . 74.04 109.765 173.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 99.2 mt -68.35 -43.88 76.51 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.369 -1.287 . . . . 72.3 112.149 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.46 ' HA ' ' CD1' ' B' ' 63' ' ' ILE . 48.3 mt-10 -57.97 -50.11 74.51 Favored 'General case' 0 C--O 1.183 -2.432 0 C-N-CA 120.645 -0.422 . . . . 75.03 111.061 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.44 -48.1 77.73 Favored 'General case' 0 C--O 1.25 1.081 0 O-C-N 123.554 0.534 . . . . 62.22 111.643 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -67.3 -37.66 83.72 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.486 -0.779 . . . . 72.11 110.868 -175.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -82.58 -22.88 34.68 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.647 0.98 . . . . 75.03 113.647 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 38.9 t -67.78 -27.96 67.19 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.891 -0.781 . . . . 23.53 108.891 -177.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 21.8 m -60.06 -25.4 65.34 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 115.806 -0.633 . . . . 74.02 110.673 174.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 77.1 m -102.1 2.97 38.14 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.092 0.775 . . . . 52.4 113.092 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.66 -167.6 29.82 Favored Glycine 0 N--CA 1.461 0.321 0 C-N-CA 119.058 -1.544 . . . . 72.31 114.977 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 19.4 t -105.86 127.92 53.43 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-O 120.857 0.36 . . . . 40.45 110.548 -176.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.46 ' CD1' ' HA ' ' B' ' 54' ' ' GLU . 74.2 mt -87.04 133.51 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 113.519 0.933 . . . . 74.1 113.519 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . 0.419 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 94.2 m-20 -103.88 -35.94 7.98 Favored 'General case' 0 C--O 1.172 -3.022 0 CA-C-N 115.823 -0.626 . . . . 71.3 111.757 174.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 43.3 mtp180 -149.02 152.29 36.01 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.622 -0.881 . . . . 72.2 108.622 178.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.553 HG23 ' HB2' ' A' ' 70' ' ' CYS . 0.3 OUTLIER -149.51 131.39 5.65 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.698 0 C-N-CA 124.024 0.93 . . . . 72.13 109.886 177.231 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' B' ' 81' ' ' ALA . 74.1 m -124.79 128.68 49.11 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 106.964 -1.495 . . . . 75.21 106.964 -176.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.16 121.76 60.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 106.098 -1.816 . . . . 64.12 106.098 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.389 1.2 pt? -120.7 132.35 55.03 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 119.311 -0.956 . . . . 73.0 112.64 175.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 63.7 m -114.43 118.19 33.13 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 107.527 -1.286 . . . . 70.12 107.527 -178.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 8.8 t70 -110.75 115.33 29.37 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 118.788 -1.165 . . . . 64.42 109.276 -176.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -112.63 3.74 16.82 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.191 -1.411 . . . . 64.44 107.191 -178.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -56.96 -21.72 32.47 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 126.551 1.94 . . . . 72.24 113.755 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 43.4 m -109.84 13.81 23.42 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.014 0.435 . . . . 74.23 111.005 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.27 -64.85 0.29 Allowed Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.779 -0.724 . . . . 71.3 112.128 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -96.4 129.63 32.89 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 109.83 -0.433 . . . . 70.02 109.83 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 84.1 Cg_endo -75.4 118.58 5.22 Favored 'Trans proline' 0 N--CA 1.435 -1.957 0 C-N-CA 121.39 1.393 . . . . 74.22 112.714 -178.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 39.6 mtpt -94.16 -179.59 4.99 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 125.278 1.431 . . . . 75.44 109.578 175.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.35 135.58 3.94 Favored Glycine 0 N--CA 1.403 -3.503 0 C-N-CA 119.177 -1.487 . . . . 63.25 113.407 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . 0.266 0.2 OUTLIER -151.23 145.49 25.42 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 114.616 -0.792 . . . . 75.53 109.97 172.307 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' B' ' 67' ' ' THR . . . -130.75 148.2 52.5 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.553 -0.748 . . . . 71.34 110.265 -174.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' TYR . . . . . 0.429 ' CZ ' ' HD1' ' B' ' 40' ' ' TYR . 81.6 m-85 -123.16 116.63 23.75 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.816 -0.809 . . . . 63.33 108.816 177.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 11.4 mm -107.47 133.9 50.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 107.791 -1.188 . . . . 73.11 107.791 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' B' ' 37' ' ' ARG . 53.4 mt-10 -112.2 125.31 54.0 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.171 -1.048 . . . . 75.34 108.171 175.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.574 ' O ' ' HD3' ' B' ' 37' ' ' ARG . 89.4 m-85 -96.54 167.23 11.27 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 112.032 0.382 . . . . 64.4 112.032 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.419 ' HA ' ' ND2' ' B' ' 64' ' ' ASN . . . -81.92 -37.17 27.2 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.923 -0.58 . . . . 75.31 110.811 174.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . 0.541 ' HB2' ' OG ' ' B' ' 90' ' ' SER . 6.9 mp0 -98.73 141.84 31.03 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.462 -0.57 . . . . 61.22 109.462 178.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.25 -26.86 59.17 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 106.762 -1.57 . . . . 72.54 106.762 177.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . 0.442 ' ND2' ' HB3' ' B' ' 87' ' ' GLU . 9.1 p30 -70.97 -21.79 62.28 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.641 -0.709 . . . . 63.12 111.278 177.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' SER . . . . . 0.541 ' OG ' ' HB2' ' B' ' 87' ' ' GLU . 51.4 m -71.95 -37.19 70.02 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 111.957 0.354 . . . . 73.42 111.957 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.655 HG23 HG22 ' B' ' 39' ' ' VAL . 2.2 p -67.83 -41.24 84.85 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 C-N-CA 119.407 -0.917 . . . . 61.22 109.489 175.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -59.16 -33.68 71.19 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.994 -0.548 . . . . 72.21 110.502 178.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.53 -34.24 65.12 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.209 -0.45 . . . . 45.13 111.848 176.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.86 -39.55 50.71 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-O 120.701 0.286 . . . . 74.51 111.163 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . 0.527 HG13 ' O ' ' B' ' 91' ' ' VAL . 19.9 m -56.25 -21.81 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 113.1 0.778 . . . . 44.0 113.1 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.99 -11.24 60.73 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.567 0.699 . . . . 73.14 110.819 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 19.9 mtm -93.88 -0.49 55.68 Favored 'General case' 0 C--O 1.175 -2.83 0 CA-C-O 117.872 -1.061 . . . . 75.15 110.994 175.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . 0.575 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 2.2 p-10 -35.82 -46.27 0.44 Allowed 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 115.372 1.619 . . . . 62.33 115.372 -168.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -93.63 85.33 4.84 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.052 -1.462 . . . . 70.24 107.052 169.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . 0.627 ' HB ' HG12 ' B' ' 107' ' ' ILE . 1.3 m -95.7 137.72 34.37 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 119.979 -0.688 . . . . 63.53 109.404 -175.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 3.7 p -99.91 103.81 15.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 107.664 -1.236 . . . . 54.14 107.664 173.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -134.08 123.68 24.89 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.79 -1.095 . . . . 72.25 109.48 -173.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 58.29 33.48 23.18 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 122.405 1.098 . . . . 55.34 111.356 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.54 2.4 84.77 Favored Glycine 0 C--N 1.317 -0.475 0 CA-C-N 114.827 -1.079 . . . . 75.22 112.522 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -109.7 163.57 13.36 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 109.551 -0.537 . . . . 75.33 109.551 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' B' ' 100' ' ' THR . 62.0 m -108.36 118.73 37.54 Favored 'General case' 0 N--CA 1.404 -2.755 0 N-CA-C 106.985 -1.487 . . . . 61.42 106.985 172.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . 0.627 HG12 ' HB ' ' B' ' 100' ' ' THR . 46.3 pt -103.45 171.61 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 C-N-CA 119.792 -0.763 . . . . 74.43 109.293 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 108' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 26.7 mmmt -125.2 125.62 43.92 Favored 'General case' 0 CA--C 1.479 -1.782 0 O-C-N 123.652 0.595 . . . . 74.42 110.019 -177.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 33.9 m -128.12 115.78 39.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 123.786 0.679 . . . . 74.22 109.739 176.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.2 158.56 47.74 Favored Pre-proline 0 C--N 1.294 -1.819 0 N-CA-C 108.762 -0.829 . . . . 73.05 108.762 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.23 146.43 25.14 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 121.498 1.465 . . . . 74.15 114.001 -172.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.479 ' NZ ' ' HA ' ' B' ' 112' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.286 -2.162 0 N-CA-C 107.19 -1.411 . . . . 55.2 107.19 176.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 111.841 0.312 . . . . 72.42 111.841 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.4 pt -71.07 -33.91 53.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.01 0.433 . . . . 70.41 111.556 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.85 -34.67 69.97 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.572 1.149 . . . . 73.53 110.372 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -77.96 -16.46 58.14 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.591 -1.186 . . . . 71.2 111.035 -177.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.423 ' HG2' ' HA ' ' A' ' 88' ' ' ARG . 89.7 mtt180 -123.89 18.21 9.36 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 114.209 1.189 . . . . 73.01 114.209 -164.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.543 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 33.0 m -96.2 150.72 20.22 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 120.092 -0.643 . . . . 45.2 110.365 176.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 83' ' ' ILE . 33.2 m -140.02 164.11 23.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.125 0.488 . . . . 74.32 110.271 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.72 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 13.3 t80 -110.48 134.86 51.95 Favored 'General case' 0 C--N 1.284 -2.244 0 C-N-CA 124.974 1.31 . . . . 60.21 108.736 177.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.516 HG22 HG12 ' A' ' 109' ' ' VAL . 61.4 t -121.94 118.18 54.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.499 -1.297 . . . . 74.21 107.499 174.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -111.16 166.33 12.26 Favored Glycine 0 C--N 1.286 -2.232 0 C-N-CA 119.276 -1.44 . . . . 73.2 113.688 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.46 ' ND2' ' HB3' ' A' ' 105' ' ' ARG . 66.3 t30 56.3 27.42 11.83 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 126.137 1.775 . . . . 70.14 113.558 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.448 HG22 ' HB2' ' A' ' 48' ' ' SER . 14.6 p -61.55 138.64 21.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 N-CA-C 108.94 -0.763 . . . . 64.2 108.94 173.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.62 150.39 39.65 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.419 -0.586 . . . . 75.5 109.419 -173.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.494 ' CD1' ' HB2' ' A' ' 77' ' ' PRO . 78.3 t80 -65.36 -14.2 60.3 Favored 'General case' 0 CA--C 1.558 1.285 0 CA-C-O 121.586 0.708 . . . . 63.24 110.232 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.53 -7.39 59.15 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 116.003 -0.544 . . . . 73.12 112.921 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.448 ' HB2' HG22 ' A' ' 44' ' ' VAL . 26.4 m -80.03 133.97 36.18 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 117.424 0.612 . . . . 75.44 110.087 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.0 p -97.62 170.71 8.83 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 120.944 -0.303 . . . . 73.23 111.069 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.526 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -62.28 -45.22 94.23 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.594 -0.521 . . . . 75.21 109.594 175.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.82 -44.9 86.72 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.084 0.554 . . . . 41.31 109.885 176.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -55.91 -43.69 77.54 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.119 0.485 . . . . 54.32 111.55 176.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.3 mt -70.86 -47.55 58.71 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.522 -0.763 . . . . 74.11 111.71 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.35 -48.0 83.31 Favored 'General case' 0 C--O 1.204 -1.326 0 C-N-CA 123.424 0.69 . . . . 63.55 110.85 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.35 -42.57 96.01 Favored 'General case' 0 C--O 1.259 1.601 0 CA-C-O 121.523 0.678 . . . . 54.24 111.151 176.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -64.26 -41.89 96.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.41 -0.813 . . . . 61.35 110.428 -175.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -81.21 -20.51 40.95 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 113.289 0.848 . . . . 70.42 113.289 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.0 t -65.85 -26.63 67.74 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.712 -0.676 . . . . 71.34 109.481 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.4 m -60.19 -33.73 72.63 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-O 121.362 0.601 . . . . 75.32 110.023 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.427 ' SG ' ' SD ' ' A' ' 97' ' ' MET . 72.6 m -92.97 4.32 54.19 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 113.699 1.0 . . . . 70.14 113.699 -177.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.44 -169.92 33.39 Favored Glycine 0 CA--C 1.497 -1.053 0 C-N-CA 118.627 -1.749 . . . . 74.1 114.623 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.9 m -102.64 127.63 49.67 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.295 -0.631 . . . . 74.0 109.295 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.6 mt -95.6 130.05 44.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 113.788 1.033 . . . . 74.01 113.788 -175.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -91.53 -44.76 8.89 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-N 115.355 -0.839 . . . . 74.21 110.908 176.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.409 ' HD2' ' OE1' ' A' ' 84' ' ' GLU . 66.2 mtt180 -151.46 159.51 44.16 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 115.324 -0.853 . . . . 74.53 109.669 -173.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.526 HD11 ' HB1' ' A' ' 50' ' ' ALA . 28.2 pt -148.34 143.52 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 107.766 -1.198 . . . . 61.0 107.766 173.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.3 m -126.2 132.21 51.82 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 106.969 -1.493 . . . . 75.22 106.969 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 68' ' ' ILE . 2.4 mp -127.78 123.34 60.84 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 N-CA-C 106.085 -1.82 . . . . 33.15 106.085 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.46 ' HB3' ' HA ' ' B' ' 67' ' ' THR 0.345 1.0 OUTLIER -121.17 125.39 47.06 Favored 'General case' 0 C--N 1.273 -2.76 0 C-N-CA 120.073 -0.651 . . . . 72.45 112.588 175.861 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.406 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 81.8 m -116.73 128.61 55.49 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.784 -0.821 . . . . 71.11 108.784 -177.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.623 ' HA ' ' HA ' ' B' ' 65' ' ' ARG . 2.8 p-10 -121.35 152.14 39.32 Favored 'General case' 0 C--O 1.19 -2.056 0 C-N-CA 119.647 -0.821 . . . . 70.22 110.554 -177.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -127.06 15.81 7.32 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 108.63 -0.878 . . . . 62.31 108.63 175.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.468 ' HB3' ' HB3' ' B' ' 64' ' ' ASN . 37.7 p90 -66.84 -20.57 65.96 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 119.864 -0.734 . . . . 65.22 111.453 -177.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.6 m -86.82 9.16 19.97 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 116.162 -0.472 . . . . 74.55 110.833 176.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.33 -46.15 3.19 Favored Glycine 0 CA--C 1.501 -0.811 0 N-CA-C 111.084 -0.806 . . . . 52.13 111.084 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -95.5 129.2 35.52 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 106.779 -1.563 . . . . 50.14 106.779 176.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 72.2 Cg_endo -72.61 119.27 6.01 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 121.55 1.5 . . . . 61.45 111.404 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -110.71 -165.61 1.01 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.4 -0.818 . . . . 74.01 109.589 -176.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 70' ' ' CYS . . . -171.18 148.58 11.31 Favored Glycine 0 N--CA 1.407 -3.267 0 C-N-CA 120.367 -0.92 . . . . 72.23 113.166 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -149.61 143.53 25.6 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 124.512 1.125 . . . . 75.24 109.236 172.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.37 156.1 47.25 Favored 'General case' 0 C--O 1.192 -1.959 0 CA-C-O 120.664 0.269 . . . . 64.12 110.927 -172.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.441 ' HE2' ' HZ3' ' A' ' 112' ' ' LYS . 44.3 m-85 -124.24 124.63 42.85 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.482 -0.562 . . . . 62.31 109.482 176.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.48 HG23 HG22 ' A' ' 66' ' ' ILE . 29.1 mm -108.94 124.88 65.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 109.224 -0.658 . . . . 74.04 109.224 -177.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.409 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 32.0 tt0 -102.35 119.57 39.03 Favored 'General case' 0 C--O 1.25 1.112 0 N-CA-C 108.605 -0.887 . . . . 72.33 108.605 177.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -98.1 157.29 16.23 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.431 0.634 . . . . 73.21 112.708 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.19 -43.09 83.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.217 -0.902 . . . . 65.25 112.339 176.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -112.89 155.92 23.85 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 121.222 0.534 . . . . 74.21 111.836 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.494 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -69.91 -35.0 74.23 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.271 -1.011 . . . . 72.34 108.271 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -21.42 66.84 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 115.759 -0.655 . . . . 50.24 112.109 -177.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.9 m -68.21 -36.28 79.29 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 109.82 -0.437 . . . . 42.21 109.82 176.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 95' ' ' VAL . 3.1 m -69.31 -40.03 79.68 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.054 0 N-CA-C 108.97 -0.752 . . . . 74.44 108.97 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -56.87 -35.95 69.49 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.765 0.793 . . . . 73.12 110.032 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.34 -36.2 63.64 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.62 -0.718 . . . . 63.31 111.472 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.45 -42.49 43.71 Favored 'General case' 0 C--O 1.204 -1.309 0 CA-C-N 115.733 -0.667 . . . . 61.55 111.319 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 91' ' ' VAL . 23.8 m -56.69 -22.45 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 112.756 0.65 . . . . 72.02 112.756 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.34 -9.27 52.61 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.523 0.678 . . . . 35.11 110.469 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.427 ' SD ' ' SG ' ' A' ' 60' ' ' CYS . 37.8 mtp -105.67 4.52 30.22 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.176 -0.92 . . . . 73.53 110.405 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.515 ' HA ' HG22 ' A' ' 109' ' ' VAL . 1.6 p-10 -44.54 -36.89 3.21 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 114.884 1.439 . . . . 72.25 114.884 -176.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -115.33 92.29 3.88 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.341 -0.944 . . . . 72.44 109.537 171.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.9 p -138.45 172.31 13.08 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.263 -1.335 . . . . 45.12 110.649 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.4 p -119.75 126.28 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-O 121.412 0.625 . . . . 74.11 110.527 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -128.16 124.03 35.82 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 108.358 -0.978 . . . . 74.21 108.358 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 49.37 33.15 5.1 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.543 1.537 . . . . 73.45 111.204 -174.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.78 0.74 87.56 Favored Glycine 0 C--N 1.308 -1.016 0 CA-C-N 115.153 -0.93 . . . . 62.51 113.39 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.46 ' HB3' ' ND2' ' A' ' 43' ' ' ASN . 58.3 mtt180 -106.6 140.46 39.44 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.395 -0.594 . . . . 71.23 109.395 175.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.1 m -80.5 119.2 22.86 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.705 -1.22 . . . . 64.42 107.705 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 38.3 pt -101.49 169.46 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 C-N-CA 120.451 -0.5 . . . . 64.1 110.527 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 53.9 tptt -134.99 134.2 40.25 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.462 -0.79 . . . . 73.14 109.67 -177.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.72 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 16.0 m -127.17 126.84 68.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 O-C-N 123.044 0.215 . . . . 74.23 111.055 174.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . 0.255 0.0 OUTLIER -145.83 144.61 22.63 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 109.2 -0.667 . . . . 53.35 109.2 176.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -62.82 139.87 76.89 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 123.191 2.594 . . . . 74.24 113.782 -175.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 38' ' ' SER . 39.7 mtpt . . . . . 0 C--N 1.314 -0.935 0 CA-C-N 115.981 -0.554 . . . . 73.05 111.761 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.042 0 N-CA-C 115.695 1.038 . . . . 63.14 115.695 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.576 ' HD3' ' CZ ' ' A' ' 40' ' ' TYR . 1.6 Cg_endo -40.12 -53.79 2.38 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 125.079 3.852 . . . . 74.11 114.505 -177.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.495 ' HD3' ' HG2' ' B' ' 22' ' ' PRO . 22.1 Cg_endo -93.17 122.81 0.48 Allowed 'Trans proline' 0 N--CA 1.416 -3.074 0 N-CA-C 108.442 -1.407 . . . . 64.3 108.442 170.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -69.02 135.8 89.55 Favored Pre-proline 0 C--N 1.313 -1.012 0 C-N-CA 120.145 -0.622 . . . . 72.14 109.884 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -28.73 104.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.385 2.485 1 C-N-CA 125.354 4.036 . . . . 75.13 113.57 -174.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.539 HD13 ' H ' ' B' ' 26' ' ' LEU 0.283 0.0 OUTLIER -52.64 153.16 3.28 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 113.333 -1.758 . . . . 64.34 115.079 -176.954 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.513 ' O ' ' HG3' ' B' ' 31' ' ' LYS . 14.8 m -60.46 163.83 4.94 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 125.687 1.595 . . . . 44.34 113.35 -177.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.5 75.74 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.021 -0.536 . . . . 73.44 112.393 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -73.21 -31.07 63.94 Favored 'General case' 0 CA--C 1.49 -1.352 0 CA-C-O 120.974 0.416 . . . . 72.35 111.851 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.405 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.4 OUTLIER -60.4 -33.92 73.18 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.228 -0.896 . . . . 75.43 110.457 173.313 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' B' ' 27' ' ' SER . 95.7 mttt -69.58 -51.56 34.18 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.397 -0.594 . . . . 61.34 109.397 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 0.7 OUTLIER -53.97 -47.32 71.49 Favored 'General case' 0 C--N 1.359 1.014 0 N-CA-C 113.516 0.932 . . . . 70.34 113.516 179.474 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 11.2 mm-40 -64.81 -44.39 90.06 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.471 0.545 . . . . 75.33 112.471 -174.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.405 HG12 ' O ' ' B' ' 30' ' ' GLU . 24.3 pt -70.47 -33.33 53.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.196 0.522 . . . . 73.14 110.793 -178.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -56.92 -38.41 72.83 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.182 1.393 . . . . 50.34 111.311 -177.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 90.0 mttt -75.86 -25.26 56.03 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.639 -1.164 . . . . 72.12 112.327 -176.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' B' ' 33' ' ' GLU . 20.5 ptt180 -118.72 25.69 10.07 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 114.047 1.129 . . . . 73.52 114.047 -168.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 37.1 m -96.69 148.44 22.87 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 116.642 -0.254 . . . . 72.24 111.268 175.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.409 HG22 ' O ' ' B' ' 83' ' ' ILE . 29.3 m -139.97 165.29 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-O 121.09 0.471 . . . . 72.01 111.541 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . 0.697 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 9.7 t80 -114.29 132.18 56.26 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 125.68 1.592 . . . . 72.0 108.721 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 59.1 t -119.51 118.4 57.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 124.568 1.147 . . . . 75.11 108.124 174.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.38 172.51 14.33 Favored Glycine 0 C--N 1.293 -1.849 0 C-N-CA 119.339 -1.41 . . . . 72.43 113.387 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 65.7 t30 63.99 8.52 3.99 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 126.211 1.804 . . . . 72.15 114.597 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.64 126.49 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-O 121.577 0.704 . . . . 74.4 109.747 175.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.99 156.72 25.78 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.475 -0.784 . . . . 43.44 111.399 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' TYR . . . . . 0.592 ' CD2' ' HB2' ' B' ' 77' ' ' PRO . 9.4 t80 -75.36 86.3 2.53 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 106.314 -1.735 . . . . 75.05 106.314 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.83 -27.62 0.07 OUTLIER Glycine 0 N--CA 1.419 -2.481 0 N-CA-C 109.728 -1.349 . . . . 65.0 109.728 -174.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 26.6 t -84.44 148.15 26.72 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 106.749 -1.574 . . . . 65.21 106.749 173.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 50.5 p -111.74 178.07 4.44 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 110.242 -0.281 . . . . 71.32 110.242 -177.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.505 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -62.31 -47.74 82.94 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 110.19 -0.3 . . . . 73.33 110.19 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -57.48 -44.02 84.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.208 -0.451 . . . . 72.34 110.534 177.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -60.36 -40.01 89.26 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-O 121.68 0.753 . . . . 63.45 109.789 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 56.0 mt -72.64 -47.31 48.6 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.086 -0.961 . . . . 73.32 112.288 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.54 -48.68 80.7 Favored 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 123.269 0.628 . . . . 72.35 110.727 -178.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.32 -42.77 87.51 Favored 'General case' 0 C--O 1.255 1.347 0 CA-C-O 121.252 0.548 . . . . 62.2 110.925 176.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -64.14 -41.58 97.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.556 -0.747 . . . . 70.12 110.496 -176.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.421 ' CZ ' HG11 ' B' ' 109' ' ' VAL 0.268 51.7 m-85 -81.83 -20.77 38.31 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 113.747 1.017 . . . . 73.21 113.747 178.451 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 33.4 t -66.67 -24.18 66.24 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.537 -0.912 . . . . 72.25 108.537 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 15.6 m -58.94 -31.91 69.12 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 115.934 -0.575 . . . . 61.42 110.155 172.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 74.7 m -93.89 7.33 45.4 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.973 0.731 . . . . 71.4 112.973 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.72 -148.51 20.22 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 118.242 -1.933 . . . . 64.21 115.698 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' B' ' 86' ' ' ALA . 15.6 m -110.94 124.48 52.2 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.73 -0.47 . . . . 70.34 109.73 -176.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 63.8 mt -94.69 130.55 43.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 113.642 0.978 . . . . 65.02 113.642 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . 0.482 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 93.0 m-20 -94.82 -43.55 8.17 Favored 'General case' 0 C--O 1.197 -1.658 0 CA-C-N 115.208 -0.906 . . . . 73.0 110.827 175.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.623 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 67.4 mtt180 -152.45 157.44 41.19 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 109.399 -0.593 . . . . 71.44 109.399 -175.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.523 HG22 HG23 ' B' ' 83' ' ' ILE . 23.2 pt -147.3 142.87 20.11 Favored 'Isoleucine or valine' 0 C--O 1.191 -2.002 0 N-CA-C 106.77 -1.567 . . . . 73.33 106.77 173.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . 0.46 ' HA ' ' HB3' ' A' ' 69' ' ' LEU . 61.8 m -126.4 131.64 51.69 Favored 'General case' 0 C--N 1.272 -2.769 0 N-CA-C 106.914 -1.513 . . . . 74.02 106.914 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 3.0 mp -127.25 120.54 55.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 106.697 -1.594 . . . . 65.1 106.697 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.282 1.1 pt? -120.49 127.75 52.5 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 120.065 -0.654 . . . . 50.55 111.62 177.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 80.1 m -116.91 130.23 56.57 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.217 -0.902 . . . . 63.21 109.342 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.702 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 4.0 p30 -111.57 127.76 55.83 Favored 'General case' 0 C--O 1.216 -0.682 0 C-N-CA 119.497 -0.881 . . . . 72.35 110.488 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . 0.442 ' O ' ' HG2' ' B' ' 72' ' ' LYS . 33.2 ttmt -123.45 4.4 9.04 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.193 0.52 . . . . 71.23 109.931 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' B' ' 71' ' ' ASP . 53.3 p90 -64.04 -6.97 7.22 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 113.831 1.049 . . . . 70.3 113.831 -174.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 42.8 m -106.56 6.38 29.99 Favored 'General case' 0 C--N 1.313 -1.009 0 O-C-N 121.782 -0.574 . . . . 73.22 111.24 175.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.6 -61.86 0.3 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.835 -0.698 . . . . 70.21 111.745 -178.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -96.26 129.65 33.06 Favored Pre-proline 0 C--N 1.305 -1.337 0 N-CA-C 109.757 -0.46 . . . . 75.13 109.757 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.702 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 96.2 Cg_endo -79.32 126.69 7.03 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.639 2.226 . . . . 63.45 113.561 -177.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -107.35 -167.7 1.3 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.897 -1.149 . . . . 73.03 107.897 176.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.54 147.74 11.7 Favored Glycine 0 N--CA 1.415 -2.758 0 C-N-CA 119.791 -1.195 . . . . 44.25 113.576 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -151.64 144.79 24.62 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 124.502 1.121 . . . . 71.13 108.81 172.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -134.05 155.21 50.42 Favored 'General case' 0 C--O 1.194 -1.863 0 CA-C-O 120.681 0.277 . . . . 63.02 111.199 -172.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' TYR . . . . . 0.425 ' CD2' ' HD3' ' B' ' 112' ' ' LYS . 51.7 m-85 -124.32 124.09 41.63 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.279 -0.637 . . . . 61.34 109.279 176.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.523 HG23 HG22 ' B' ' 66' ' ' ILE . 30.4 mm -107.9 124.79 64.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 109.038 -0.727 . . . . 71.24 109.038 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' GLU . . . . . 0.424 ' HB3' ' HB2' ' B' ' 65' ' ' ARG . 36.6 tt0 -103.57 119.4 38.82 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.739 -1.208 . . . . 72.41 107.739 176.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -94.89 162.73 13.63 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 110.331 -0.248 . . . . 75.31 110.331 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.482 ' HA ' ' ND2' ' B' ' 64' ' ' ASN . . . -83.63 -21.24 32.57 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.101 0.477 . . . . 35.42 111.343 175.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . 0.457 ' HB2' ' OG ' ' B' ' 90' ' ' SER . 27.9 mt-10 -119.39 145.23 46.39 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 116.187 -0.46 . . . . 73.41 109.763 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.463 ' O ' HG22 ' B' ' 91' ' ' VAL . 0.5 OUTLIER -72.03 -34.29 68.68 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 107.203 -1.406 . . . . 71.31 107.203 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -59.31 -32.17 69.82 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.719 -1.128 . . . . 75.52 108.996 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' SER . . . . . 0.457 ' OG ' ' HB2' ' B' ' 87' ' ' GLU . 23.3 m -63.46 -35.94 82.11 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.757 -0.656 . . . . 75.41 110.955 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.534 ' O ' HG13 ' B' ' 95' ' ' VAL . 3.1 m -69.35 -39.41 78.87 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.192 0 C-N-CA 119.302 -0.959 . . . . 73.11 108.678 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -57.72 -37.75 74.07 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.082 0.468 . . . . 73.3 110.811 176.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.46 -34.06 65.18 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.936 -0.575 . . . . 71.43 110.437 178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.6 -44.65 33.48 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 116.785 -0.189 . . . . 60.03 111.154 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . 0.534 HG13 ' O ' ' B' ' 91' ' ' VAL . 22.0 m -56.65 -22.85 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 112.68 0.622 . . . . 73.43 112.68 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.1 -9.33 45.5 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.349 0.595 . . . . 75.24 110.651 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 56.5 mtm -104.69 10.2 34.83 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.757 -0.656 . . . . 74.15 110.984 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . 0.264 4.1 p-10 -44.46 -44.95 8.88 Favored 'General case' 0 C--O 1.204 -1.298 0 N-CA-C 114.91 1.448 . . . . 72.14 114.91 -176.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -110.84 71.38 0.74 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-N 119.822 1.192 . . . . 74.42 112.146 167.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 47.4 p -115.84 168.43 10.06 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.115 -0.493 . . . . 53.23 111.771 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 9.6 p -100.64 136.42 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-O 121.41 0.624 . . . . 74.24 109.52 -177.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -132.39 109.91 10.18 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 107.961 -1.126 . . . . 61.15 107.961 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 49.53 32.21 4.68 Favored 'General case' 0 CA--C 1.563 1.46 0 C-N-CA 125.4 1.48 . . . . 65.22 112.628 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.22 -9.58 39.2 Favored Glycine 0 C--N 1.318 -0.428 0 C-N-CA 120.674 -0.774 . . . . 23.44 113.741 174.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -116.4 151.85 35.14 Favored 'General case' 0 C--O 1.206 -1.215 0 CA-C-N 117.135 0.467 . . . . 53.34 109.883 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 92.9 m -86.87 120.14 27.84 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.835 -1.172 . . . . 75.12 107.835 174.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 2.6 pp -102.13 166.74 2.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 119.691 -0.804 . . . . 62.44 110.267 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 108' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 54.3 tptt -125.37 132.99 52.7 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.734 -0.469 . . . . 72.51 109.734 -172.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . 0.697 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 15.7 m -127.0 128.79 70.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.277 0.56 . . . . 65.15 111.301 176.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.333 0.4 OUTLIER -147.01 133.43 9.71 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 106.279 -1.749 . . . . 63.31 106.279 -169.802 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.5 141.78 87.81 Favored 'Trans proline' 0 N--CA 1.486 1.038 0 C-N-CA 122.504 2.136 . . . . 62.44 113.068 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.425 ' HD3' ' CD2' ' B' ' 82' ' ' TYR . 22.6 ttpp . . . . . 0 N--CA 1.431 -1.407 0 N-CA-C 109.138 -0.69 . . . . 65.44 109.138 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 N--CA 1.44 -0.972 0 N-CA-C 113.759 1.022 . . . . 73.21 113.759 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.4 pt -63.06 -33.69 62.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.641 -0.424 . . . . 74.2 110.511 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.44 -38.45 81.15 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 108.949 -0.76 . . . . 61.22 108.949 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -66.01 -42.0 90.28 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 114.468 1.284 . . . . 55.42 114.468 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.673 ' HG3' ' O ' ' A' ' 85' ' ' PHE . 3.4 ptm180 -102.85 19.18 19.82 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 111.797 0.295 . . . . 75.4 111.797 -169.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.9 p -110.52 167.12 10.45 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.658 0.985 . . . . 34.05 113.658 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.404 ' CG1' HG23 ' A' ' 91' ' ' VAL . 9.7 m -140.3 164.95 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.277 1.031 . . . . 73.44 112.023 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.659 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 27.9 t80 -109.89 127.03 54.47 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 124.882 1.273 . . . . 72.25 108.469 176.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.7 t -115.58 112.01 38.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 107.812 -1.181 . . . . 75.41 107.812 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.427 ' HA3' ' CZ ' ' A' ' 40' ' ' TYR . . . -121.62 -177.34 15.48 Favored Glycine 0 N--CA 1.435 -1.385 0 C-N-CA 119.556 -1.307 . . . . 73.32 114.738 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.3 t30 72.7 -7.35 1.45 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.062 2.145 . . . . 61.33 112.475 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.78 103.55 4.13 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.929 0 CA-C-O 121.488 0.661 . . . . 63.11 109.866 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -81.06 83.57 6.71 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 114.162 1.171 . . . . 72.21 114.162 -168.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.55 ' H ' ' HA3' ' A' ' 79' ' ' GLY . 63.6 t80 68.22 -20.52 0.14 Allowed 'General case' 0 CA--C 1.577 1.989 0 N-CA-C 115.526 1.676 . . . . 73.12 115.526 163.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.27 5.35 45.15 Favored Glycine 0 C--O 1.241 0.577 0 N-CA-C 116.912 1.525 . . . . 51.02 116.912 -169.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.2 t -87.65 147.74 25.12 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 119.318 1.559 . . . . 70.32 109.885 176.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.549 HG22 HG22 ' B' ' 49' ' ' THR . 82.6 p -97.37 158.92 15.22 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.007 -0.542 . . . . 71.33 111.207 -176.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.484 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -65.16 -48.25 74.19 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 122.557 0.343 . . . . 54.31 110.835 -177.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.01 -40.3 80.46 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.333 0.494 . . . . 72.33 112.333 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.9 -38.06 76.18 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.216 0.531 . . . . 72.12 110.515 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.2 mt -68.77 -47.2 66.82 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.381 -0.827 . . . . 64.25 111.209 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -61.92 -48.19 81.54 Favored 'General case' 0 C--O 1.202 -1.433 0 CA-C-N 115.755 -0.657 . . . . 65.14 110.875 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.65 -43.99 80.86 Favored 'General case' 0 C--O 1.26 1.609 0 CA-C-O 121.789 0.804 . . . . 52.44 111.256 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -64.77 -38.51 91.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.667 -1.152 . . . . 74.44 110.355 -176.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -82.33 -21.64 35.94 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.496 0.925 . . . . 64.23 113.496 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.7 t -70.63 -23.88 62.61 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.845 -0.616 . . . . 74.41 109.78 -176.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.8 m -59.97 -27.27 66.69 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-O 121.055 0.455 . . . . 62.55 110.36 173.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 62.7 m -92.66 7.93 41.32 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 112.568 0.581 . . . . 73.02 112.568 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.67 -169.82 25.04 Favored Glycine 0 CA--C 1.505 -0.538 0 C-N-CA 119.559 -1.305 . . . . 74.34 113.28 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.1 m -96.08 126.44 41.32 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 121.614 0.721 . . . . 71.14 110.156 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.5 mt -85.02 134.38 27.16 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.398 0 CA-C-N 114.938 -1.028 . . . . 75.31 112.462 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.462 ' OD1' ' HG3' ' A' ' 65' ' ' ARG . 50.9 t-20 -89.72 -54.24 4.15 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.633 -1.167 . . . . 73.44 108.51 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.462 ' HG3' ' OD1' ' A' ' 64' ' ' ASN . 66.0 mtp180 -154.34 164.17 39.02 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 106.624 -1.621 . . . . 74.24 106.624 -176.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.484 HD11 ' HB1' ' A' ' 50' ' ' ALA . 31.4 pt -143.59 142.59 24.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 107.166 -1.42 . . . . 73.31 107.166 172.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.7 m -124.81 125.14 43.54 Favored 'General case' 0 C--N 1.273 -2.726 0 N-CA-C 107.912 -1.144 . . . . 63.14 107.912 -177.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.0 mp -123.57 116.39 48.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 106.139 -1.8 . . . . 74.22 106.139 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.461 ' HG ' ' CE1' ' A' ' 80' ' ' TYR 0.286 0.8 OUTLIER -121.43 128.79 52.53 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 120.376 -0.53 . . . . 62.44 112.372 179.525 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 74.3 m -117.48 130.61 56.56 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 109.031 -0.729 . . . . 72.45 109.031 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.557 ' HA ' ' HA ' ' B' ' 65' ' ' ARG . 3.1 p30 -118.63 146.49 44.61 Favored 'General case' 0 CA--C 1.484 -1.588 0 C-N-CA 120.024 -0.67 . . . . 73.32 110.691 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -120.1 11.1 11.58 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.681 -0.859 . . . . 74.41 108.681 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.596 ' HB3' ' OD1' ' B' ' 64' ' ' ASN . 10.8 p90 -66.82 -19.95 65.84 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 120.325 -0.55 . . . . 75.44 110.958 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 31.2 t -79.59 -1.21 36.95 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 115.111 -0.95 . . . . 55.01 110.045 178.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.47 -51.39 1.58 Allowed Glycine 0 CA--C 1.491 -1.458 0 N-CA-C 110.093 -1.203 . . . . 73.2 110.093 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -96.08 133.48 25.1 Favored Pre-proline 0 C--N 1.29 -2.004 0 N-CA-C 106.683 -1.599 . . . . 75.52 106.683 175.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.478 ' HB2' ' CD1' ' A' ' 46' ' ' TYR . 63.3 Cg_endo -71.06 118.76 5.86 Favored 'Trans proline' 0 N--CA 1.44 -1.652 0 C-N-CA 121.081 1.188 . . . . 44.42 111.001 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm -101.07 158.35 16.08 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.594 -1.184 . . . . 74.4 109.607 -175.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.55 ' HA3' ' H ' ' A' ' 46' ' ' TYR . . . -136.25 138.69 10.07 Favored Glycine 0 N--CA 1.418 -2.531 0 C-N-CA 120.497 -0.859 . . . . 62.5 112.581 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.461 ' CE1' ' HG ' ' A' ' 69' ' ' LEU . 12.6 p90 -154.79 144.18 21.27 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 123.905 0.882 . . . . 70.35 110.32 174.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.75 150.03 52.21 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 116.026 -0.533 . . . . 74.25 109.658 -172.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.656 ' CD2' ' HD3' ' A' ' 112' ' ' LYS . 90.2 m-85 -126.74 130.85 51.14 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.738 -0.838 . . . . 72.34 108.738 177.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.446 HG23 HG22 ' A' ' 66' ' ' ILE . 34.1 mm -108.78 117.08 53.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 109.301 -0.629 . . . . 63.23 109.301 -177.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -93.17 119.24 32.14 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.716 -0.846 . . . . 65.33 108.716 176.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.673 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 95.6 m-85 -96.02 161.95 13.76 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 112.753 0.649 . . . . 71.21 112.753 -178.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.0 -15.55 60.65 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 115.264 -0.88 . . . . 74.32 111.424 174.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.5 161.33 42.33 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 118.504 -1.279 . . . . 73.14 111.857 177.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -64.21 -34.95 79.27 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 114.338 -1.301 . . . . 74.53 110.843 173.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -61.24 -33.52 73.65 Favored 'General case' 0 CA--C 1.509 -0.61 0 C-N-CA 120.13 -0.628 . . . . 72.11 111.036 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.0 m -69.67 -40.28 76.49 Favored 'General case' 0 N--CA 1.42 -1.952 0 O-C-N 122.299 -0.251 . . . . 73.15 111.213 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.452 HG11 ' HA ' ' A' ' 37' ' ' ARG 0.266 0.2 OUTLIER -65.63 -47.31 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 120.586 -0.446 . . . . 52.11 111.954 176.626 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.13 -32.41 68.12 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.192 0.52 . . . . 63.31 111.727 176.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.08 -36.51 64.29 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.204 0.526 . . . . 52.34 111.884 177.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.68 -43.76 45.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.688 -0.687 . . . . 71.33 111.943 -176.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 91' ' ' VAL . 34.2 m -50.92 -22.42 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 113.025 0.75 . . . . 74.23 113.025 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.24 -11.45 50.18 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.919 0.39 . . . . 63.41 111.438 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 68.5 mtm -99.48 7.41 45.42 Favored 'General case' 0 C--O 1.216 -0.695 0 CA-C-N 116.29 -0.414 . . . . 72.41 110.929 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 3.6 p-10 -42.86 -41.33 3.24 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.707 1.373 . . . . 71.35 114.707 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -111.83 100.34 8.84 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.792 -0.818 . . . . 73.33 108.792 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 106' ' ' THR . 11.2 t -151.08 166.3 31.19 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.899 -0.591 . . . . 74.42 109.451 -177.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.89 118.61 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-O 121.825 0.821 . . . . 61.12 109.647 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -134.28 121.58 21.48 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.002 -0.999 . . . . 74.42 108.762 -177.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 54.0 54.84 9.1 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 114.538 1.31 . . . . 74.32 114.538 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.53 3.16 53.2 Favored Glycine 0 N--CA 1.468 0.829 0 CA-C-N 114.901 -1.045 . . . . 70.54 115.642 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -135.29 157.0 48.01 Favored 'General case' 0 C--N 1.298 -1.63 0 CA-C-N 117.399 0.6 . . . . 75.13 111.349 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 100' ' ' THR . 33.9 m -88.31 120.01 29.27 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.834 -1.543 . . . . 65.44 106.834 175.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 44.8 pt -101.69 171.14 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 119.31 -0.956 . . . . 73.52 110.709 -176.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 55.4 tptt -129.33 125.75 37.4 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.163 -0.68 . . . . 71.01 109.163 -176.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 12.1 p -129.78 121.85 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-O 121.158 0.504 . . . . 62.14 111.61 178.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.89 159.91 42.01 Favored Pre-proline 0 C--N 1.294 -1.827 0 N-CA-C 107.085 -1.45 . . . . 75.22 107.085 -178.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.71 134.12 52.24 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.279 1.986 . . . . 75.42 113.508 -175.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.656 ' HD3' ' CD2' ' A' ' 82' ' ' TYR . 35.5 ttpt . . . . . 0 N--CA 1.428 -1.535 0 N-CA-C 105.46 -2.052 . . . . 65.22 105.46 173.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.827 0 N-CA-C 111.787 -0.525 . . . . 71.53 111.787 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.547 ' HG2' ' HD3' ' B' ' 23' ' ' PRO . 2.0 Cg_endo -47.51 -56.91 2.66 Favored 'Trans proline' 0 CA--C 1.582 2.895 0 C-N-CA 122.478 2.119 . . . . 73.33 111.464 171.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.547 ' HD3' ' HG2' ' B' ' 22' ' ' PRO . 11.8 Cg_endo -89.52 136.37 2.72 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 121.406 1.404 . . . . 60.31 109.161 169.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -100.69 139.2 20.4 Favored Pre-proline 0 C--N 1.288 -2.073 0 C-N-CA 119.403 -0.919 . . . . 73.4 109.93 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -29.55 124.07 0.06 OUTLIER 'Trans proline' 0 C--N 1.361 1.216 1 C-N-CA 125.674 4.249 . . . . 52.35 114.069 -175.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.775 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -56.09 169.34 0.4 Allowed 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.384 -0.826 . . . . 53.22 113.053 178.542 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' B' ' 31' ' ' LYS . 8.4 t -74.57 165.03 25.89 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.38 0.61 . . . . 44.33 111.925 -172.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.401 ' HA ' ' HD2' ' B' ' 31' ' ' LYS . . . -52.15 -46.41 65.43 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 114.685 -1.143 . . . . 62.44 113.873 -175.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -65.02 -39.39 93.31 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 112.001 0.371 . . . . 60.24 112.001 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.482 ' O ' HG12 ' B' ' 34' ' ' ILE . 4.0 mp0 -60.02 -34.82 73.88 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 116.064 -0.516 . . . . 75.11 110.301 174.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' B' ' 27' ' ' SER . 97.5 mttt -65.37 -41.39 93.82 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.521 -0.548 . . . . 75.41 109.521 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.605 ' N ' ' HE2' ' B' ' 32' ' ' LYS . 0.5 OUTLIER -63.46 -46.73 84.89 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 120.796 -0.362 . . . . 62.41 111.138 176.188 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -71.75 -37.86 70.49 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 113.915 1.08 . . . . 74.41 113.915 -174.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.482 HG12 ' O ' ' B' ' 30' ' ' GLU . 17.9 pt -67.3 -34.04 66.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 C-N-CA 120.136 -0.626 . . . . 64.44 110.649 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -68.73 -44.82 73.02 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.892 -1.151 . . . . 62.51 107.892 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -63.01 -36.16 82.64 Favored 'General case' 0 CA--C 1.558 1.254 0 CA-C-N 114.235 -1.348 . . . . 71.42 111.864 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -102.0 14.05 33.03 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.33 0.863 . . . . 75.43 113.33 -174.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.589 ' OG ' ' HE2' ' B' ' 112' ' ' LYS . 39.1 t -103.03 163.81 11.99 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 113.238 0.829 . . . . 74.22 113.238 -177.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.446 ' CG1' HG23 ' B' ' 91' ' ' VAL . 11.8 m -137.25 163.49 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 124.502 1.121 . . . . 71.4 111.475 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . 0.703 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 29.1 t80 -111.6 125.6 54.11 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 125.248 1.419 . . . . 70.34 108.433 177.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 58.1 t -112.78 110.59 32.77 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 106.953 -1.499 . . . . 73.25 106.953 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.95 171.36 13.86 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 119.551 -1.309 . . . . 73.22 113.61 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 65.4 t30 65.79 9.21 5.84 Favored 'General case' 0 C--O 1.213 -0.852 0 C-N-CA 126.321 1.848 . . . . 75.01 111.459 -177.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.14 118.6 6.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.386 -0.968 . . . . 62.1 108.386 174.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -68.38 145.47 54.11 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.328 -0.851 . . . . 74.14 111.405 -173.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' TYR . . . . . 0.415 ' CD1' ' HB2' ' B' ' 77' ' ' PRO . 72.4 t80 -61.45 90.2 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 114.626 -1.17 . . . . 72.15 108.016 177.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.39 -16.77 0.35 Allowed Glycine 0 N--CA 1.426 -2.005 0 CA-C-N 115.334 -0.848 . . . . 61.32 112.521 -175.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 68.0 m -72.29 148.62 45.25 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 118.026 0.913 . . . . 64.31 109.244 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' THR . . . . . 0.549 HG22 HG22 ' A' ' 49' ' ' THR . 59.3 p -99.63 162.5 12.98 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.735 -0.386 . . . . 74.2 111.327 -177.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.485 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -65.1 -45.35 85.53 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 122.712 0.405 . . . . 74.54 109.981 178.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.9 -49.94 74.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.667 -0.697 . . . . 72.4 110.129 178.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -61.31 -40.64 94.93 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 121.038 0.447 . . . . 73.51 110.742 -177.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 45.5 mt -65.44 -47.56 75.75 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.574 -0.739 . . . . 62.12 111.895 177.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.22 -48.6 77.6 Favored 'General case' 0 C--O 1.2 -1.55 0 C-N-CA 122.612 0.365 . . . . 74.03 110.781 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.35 -41.23 75.77 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 120.87 0.367 . . . . 71.3 110.842 178.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -67.96 -37.59 81.75 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.881 -0.6 . . . . 75.43 110.156 -176.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -82.25 -21.97 36.04 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 113.386 0.884 . . . . 63.51 113.386 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 25.7 t -71.92 -24.45 61.64 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.813 -0.63 . . . . 75.44 109.532 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 28.1 m -62.46 -26.29 68.44 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.255 0.55 . . . . 64.21 109.803 172.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 63.5 m -110.08 15.33 22.55 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.242 -0.436 . . . . 72.4 111.383 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . 0.412 ' HA3' ' HB3' ' B' ' 90' ' ' SER . . . 172.98 173.77 39.64 Favored Glycine 0 C--O 1.216 -1.026 0 C-N-CA 118.29 -1.909 . . . . 53.11 115.197 -177.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 10.2 p -73.23 -69.39 0.42 Allowed 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.015 0.436 . . . . 60.03 111.718 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . 0.358 57.5 mt 102.71 112.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 C-N-CA 127.302 2.241 . . . . 64.43 111.839 177.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . 0.596 ' OD1' ' HB3' ' A' ' 73' ' ' PHE . 32.5 t30 -90.66 -49.9 6.22 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 113.604 -1.634 . . . . 72.35 109.548 -177.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.557 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 65.1 mtp180 -154.58 162.88 40.93 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 106.841 -1.541 . . . . 74.23 106.841 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.486 HG22 HG23 ' B' ' 83' ' ' ILE . 24.4 pt -144.0 142.14 24.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 106.676 -1.601 . . . . 74.43 106.676 172.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 34.2 m -125.17 125.01 43.01 Favored 'General case' 0 C--N 1.27 -2.869 0 N-CA-C 107.86 -1.163 . . . . 74.43 107.86 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.4 mp -122.72 116.18 48.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.18 -1.785 . . . . 70.42 106.18 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.515 ' HG ' ' CE1' ' B' ' 80' ' ' TYR 0.272 0.9 OUTLIER -121.19 128.86 52.87 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-O 121.031 0.444 . . . . 64.45 112.006 179.584 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 75.2 m -117.21 133.6 55.8 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.653 -0.869 . . . . 73.22 108.653 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 4.1 p30 -117.58 134.53 54.77 Favored 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 119.281 -0.968 . . . . 71.24 110.433 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' B' ' 77' ' ' PRO . 41.2 ttmt -124.26 5.94 8.45 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.1 0.476 . . . . 64.15 109.95 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.439 ' HB3' ' OD1' ' A' ' 64' ' ' ASN . 53.8 p90 -60.47 -25.96 66.43 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.16 0.8 . . . . 75.31 113.16 -177.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 41.9 m -87.92 6.57 35.06 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 120.865 -0.334 . . . . 63.5 111.095 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.04 -58.17 0.42 Allowed Glycine 0 N--CA 1.437 -1.274 0 N-CA-C 111.445 -0.662 . . . . 52.12 111.445 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -95.41 127.6 41.44 Favored Pre-proline 0 C--N 1.307 -1.257 0 N-CA-C 109.574 -0.528 . . . . 71.21 109.574 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 96.8 Cg_endo -76.56 122.78 6.63 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.759 2.306 . . . . 75.2 112.805 -177.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' B' ' 78' ' ' LYS . 33.9 mtpt -106.15 159.27 16.21 Favored 'General case' 0 CA--C 1.484 -1.579 0 CA-C-N 115.263 -0.881 . . . . 75.44 111.477 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -132.56 136.43 8.73 Favored Glycine 0 N--CA 1.422 -2.266 0 C-N-CA 120.571 -0.823 . . . . 22.32 113.252 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . 0.515 ' CE1' ' HG ' ' B' ' 69' ' ' LEU . 11.7 p90 -152.68 143.55 22.93 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 124.24 1.016 . . . . 63.41 110.198 174.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.49 150.34 52.17 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 116.168 -0.469 . . . . 44.1 109.971 -173.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' TYR . . . . . 0.791 ' CD1' ' HD3' ' B' ' 112' ' ' LYS . 96.1 m-85 -126.53 129.9 49.52 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.995 -0.743 . . . . 65.45 108.995 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.486 HG23 HG22 ' B' ' 66' ' ' ILE . 34.2 mm -108.75 115.47 49.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 109.358 -0.608 . . . . 75.45 109.358 -177.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -91.51 119.19 31.24 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.546 -0.538 . . . . 62.15 109.546 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -98.78 156.67 16.74 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.956 -0.465 . . . . 72.14 109.761 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.35 -17.9 44.02 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.277 0.561 . . . . 65.41 110.379 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . 0.429 ' HB3' ' OD1' ' B' ' 89' ' ' ASN . 28.6 mt-10 -124.47 140.96 52.46 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.579 -0.737 . . . . 75.25 111.111 -177.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -63.71 -33.72 76.27 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.34 0.59 . . . . 75.01 110.454 172.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . 0.429 ' OD1' ' HB3' ' B' ' 87' ' ' GLU . 2.8 p-10 -61.94 -32.22 72.62 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.564 -0.744 . . . . 73.23 112.278 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' SER . . . . . 0.42 ' OG ' ' HB2' ' B' ' 87' ' ' GLU . 15.2 m -67.85 -41.24 83.21 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 120.834 0.35 . . . . 54.41 110.655 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.447 ' O ' HG13 ' B' ' 95' ' ' VAL 0.325 0.4 OUTLIER -65.87 -44.7 92.63 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 112.722 0.638 . . . . 74.43 112.722 178.667 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -59.51 -33.03 70.84 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.942 0.401 . . . . 64.11 112.006 174.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.79 -37.22 65.01 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 120.819 0.343 . . . . 65.23 110.521 177.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.12 -44.38 54.03 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.075 0.398 . . . . 63.3 112.075 -176.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . 0.447 HG13 ' O ' ' B' ' 91' ' ' VAL . 29.7 m -51.65 -22.42 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 113.632 0.975 . . . . 61.0 113.632 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.2 -17.56 63.66 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.988 0.423 . . . . 65.32 111.439 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 60.2 mtm -95.47 6.86 47.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.33 -0.395 . . . . 73.21 110.932 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . 0.599 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 5.2 p-10 -39.27 -47.62 1.71 Allowed 'General case' 0 C--O 1.204 -1.324 0 N-CA-C 114.925 1.454 . . . . 70.42 114.925 -176.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -113.37 92.62 4.06 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 119.267 0.94 . . . . 73.3 109.718 176.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' B' ' 106' ' ' THR . 31.6 p -142.16 173.59 11.38 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.671 -1.15 . . . . 62.24 110.989 -178.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.16 129.33 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.761 0 CA-C-O 121.559 0.695 . . . . 72.15 110.036 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -135.57 121.59 20.02 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.897 -1.149 . . . . 71.13 107.897 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 48.1 ttt-85 60.01 33.42 21.36 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 122.155 0.979 . . . . 70.43 111.23 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.38 -5.23 80.71 Favored Glycine 0 C--N 1.317 -0.491 0 CA-C-N 114.847 -1.069 . . . . 72.13 114.507 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -129.47 156.9 43.37 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 117.827 0.814 . . . . 73.23 111.458 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' B' ' 100' ' ' THR . 62.9 m -80.76 120.49 24.71 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 116.352 -0.385 . . . . 75.14 110.282 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 44.5 pt -102.06 171.99 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.983 -0.377 . . . . 71.51 109.983 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 108' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 55.6 tptt -134.06 127.47 32.27 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.803 -0.814 . . . . 61.23 108.803 -178.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . 0.703 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 8.3 p -129.25 122.66 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-O 121.07 0.462 . . . . 64.32 111.684 177.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.37 159.59 41.52 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 107.026 -1.472 . . . . 74.14 107.026 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.96 131.03 35.1 Favored 'Trans proline' 0 N--CA 1.48 0.719 0 C-N-CA 122.476 2.117 . . . . 71.01 113.039 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.791 ' HD3' ' CD1' ' B' ' 82' ' ' TYR . 37.1 ttpt . . . . . 0 CA--C 1.501 -0.907 0 N-CA-C 108.93 -0.767 . . . . 60.23 108.93 178.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 112.416 0.525 . . . . 70.35 112.416 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.461 HG21 ' CZ ' ' B' ' 73' ' ' PHE . 20.2 pt -70.32 -34.36 58.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.425 -0.807 . . . . 63.13 112.697 -174.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -67.5 -31.57 71.78 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.227 0.537 . . . . 75.04 110.689 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -70.03 -24.19 63.23 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.688 -0.687 . . . . 74.15 111.072 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -109.3 16.96 22.01 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.598 -0.728 . . . . 74.22 109.806 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.41 ' OG ' ' HG2' ' A' ' 84' ' ' GLU . 36.4 t -107.88 159.72 16.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 121.699 0.761 . . . . 63.12 112.204 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.554 HG13 ' CG2' ' A' ' 91' ' ' VAL . 0.2 OUTLIER -140.42 163.7 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 C-N-CA 124.678 1.191 . . . . 53.52 112.195 -179.445 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.608 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 23.1 t80 -105.75 128.27 53.59 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 126.216 1.806 . . . . 74.31 107.195 176.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 65.5 t -118.87 116.08 50.0 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 107.539 -1.282 . . . . 61.12 107.539 177.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.82 167.46 13.05 Favored Glycine 0 C--N 1.297 -1.626 0 C-N-CA 120.033 -1.08 . . . . 74.11 114.247 -177.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.7 t30 59.87 62.24 1.72 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.431 1.892 . . . . 64.44 114.751 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.4 p -114.44 131.19 67.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.926 -1.034 . . . . 64.32 110.363 173.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.33 163.39 15.36 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.231 -1.396 . . . . 63.24 107.231 178.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -55.84 123.78 15.38 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.871 0.843 . . . . 75.24 112.311 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.12 -42.37 0.73 Allowed Glycine 0 N--CA 1.412 -2.948 0 N-CA-C 107.46 -2.256 . . . . 63.52 107.46 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.3 m -92.64 136.02 33.59 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 108.179 -1.045 . . . . 65.24 108.179 174.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.1 p -112.17 179.04 4.11 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.373 -0.603 . . . . 72.22 109.373 -178.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.556 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -61.73 -39.25 90.9 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.291 -0.633 . . . . 61.34 109.291 176.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -58.08 -46.5 85.38 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.401 -0.818 . . . . 55.24 111.489 174.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -58.53 -40.35 82.71 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.505 0.669 . . . . 54.51 110.071 178.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.2 mt -69.94 -48.27 59.08 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.704 -1.135 . . . . 72.21 111.265 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.5 -50.26 74.28 Favored 'General case' 0 C--O 1.193 -1.893 0 O-C-N 123.119 0.262 . . . . 61.44 111.704 -178.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.27 -42.57 91.53 Favored 'General case' 0 C--O 1.248 1.025 0 CA-C-O 121.083 0.468 . . . . 74.31 110.78 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -67.22 -39.78 86.29 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.748 -0.66 . . . . 72.2 110.39 -175.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -82.03 -21.44 36.98 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 112.928 0.714 . . . . 73.44 112.928 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.9 t -70.35 -24.37 62.97 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.181 -0.674 . . . . 75.15 109.181 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.7 m -60.15 -30.34 69.24 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-O 120.977 0.418 . . . . 52.25 110.104 173.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 63.8 m -90.65 1.67 56.6 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 112.782 0.66 . . . . 64.23 112.782 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 147.38 -162.48 28.65 Favored Glycine 0 N--CA 1.462 0.427 0 C-N-CA 119.282 -1.437 . . . . 71.42 114.164 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.3 t -104.63 132.41 50.9 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.857 -0.423 . . . . 75.13 109.857 -177.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 72.0 mt -97.84 135.66 31.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.354 0.597 . . . . 52.14 112.581 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.55 ' HB3' ' CE2' ' B' ' 73' ' ' PHE . 79.5 m-20 -96.42 -42.05 8.3 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.236 -0.893 . . . . 73.53 111.909 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 43.8 mtt180 -153.57 161.83 41.84 Favored 'General case' 0 CA--C 1.486 -1.494 0 CA-C-N 115.71 -0.677 . . . . 74.22 109.699 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.556 HD11 ' HB1' ' A' ' 50' ' ' ALA . 29.3 pt -148.35 142.73 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 107.665 -1.235 . . . . 62.14 107.665 173.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.3 m -125.15 127.34 46.68 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 106.886 -1.524 . . . . 24.31 106.886 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 68' ' ' ILE . 2.1 mp -125.71 122.7 62.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 106.269 -1.752 . . . . 74.3 106.269 -177.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.433 ' HA ' ' O ' ' B' ' 66' ' ' ILE 0.253 1.3 pt? -121.24 126.36 49.41 Favored 'General case' 0 C--N 1.28 -2.421 0 C-N-CA 120.277 -0.569 . . . . 73.21 111.545 176.299 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 66.2 m -116.44 134.59 54.69 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.124 -0.695 . . . . 73.23 109.124 -177.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' B' ' 65' ' ' ARG . 2.0 p30 -126.65 152.91 46.08 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 119.773 -0.771 . . . . 70.44 113.034 -177.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.563 ' HE2' ' HB3' ' A' ' 77' ' ' PRO . 0.5 OUTLIER -121.93 18.81 10.95 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.817 -0.629 . . . . 70.11 109.722 169.256 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -67.78 -21.89 65.23 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 118.942 -1.103 . . . . 75.11 109.421 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.8 m -84.44 2.26 41.65 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.405 -0.816 . . . . 60.02 110.382 174.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.61 -44.13 2.27 Favored Glycine 0 CA--C 1.507 -0.423 0 N-CA-C 110.997 -0.841 . . . . 33.25 110.997 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -97.18 144.21 27.49 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 108.234 -1.024 . . . . 74.42 108.234 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.563 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 55.8 Cg_endo -65.43 116.85 4.13 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 123.168 2.579 . . . . 72.42 110.464 175.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -122.86 -162.56 1.03 Allowed 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.571 -1.27 . . . . 73.1 107.571 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 172.39 159.16 18.28 Favored Glycine 1 N--CA 1.396 -4.011 0 C-N-CA 119.631 -1.271 . . . . 44.43 113.516 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -151.41 147.78 27.31 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 125.12 1.368 . . . . 73.21 109.319 176.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.12 150.6 49.16 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.046 0.451 . . . . 73.43 110.327 -171.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.42 ' CZ ' ' HD1' ' A' ' 40' ' ' TYR . 39.9 m-85 -118.77 121.81 40.96 Favored 'General case' 0 C--N 1.28 -2.43 0 C-N-CA 123.596 0.758 . . . . 75.23 110.326 176.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.424 ' HA ' HG22 ' A' ' 66' ' ' ILE . 26.4 mm -105.65 127.86 60.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 107.712 -1.218 . . . . 60.2 107.712 -178.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.41 ' HG2' ' OG ' ' A' ' 38' ' ' SER . 32.8 mt-10 -110.39 119.28 38.68 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.544 -0.539 . . . . 64.31 109.544 178.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -95.22 162.67 13.6 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.562 0.696 . . . . 62.35 112.079 -177.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.543 ' HA ' HD21 ' A' ' 64' ' ' ASN . . . -80.22 -28.47 38.57 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.915 -1.038 . . . . 70.21 111.942 176.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.8 150.1 43.28 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.583 -0.847 . . . . 74.24 112.022 -178.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.567 ' O ' HG12 ' A' ' 91' ' ' VAL . 8.9 mmm180 -69.04 -32.71 72.41 Favored 'General case' 0 C--O 1.215 -0.719 0 C-N-CA 123.264 0.626 . . . . 70.44 109.791 177.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -66.9 -28.83 68.63 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.463 -0.895 . . . . 75.11 110.807 177.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.7 m -70.22 -39.41 75.14 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 109.818 -0.438 . . . . 74.23 109.818 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 88' ' ' ARG . 8.3 p -66.19 -38.84 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.652 -0.499 . . . . 71.43 109.652 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -66.98 -30.04 70.05 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-O 120.93 0.395 . . . . 72.45 111.697 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.75 -33.02 64.12 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.541 -0.54 . . . . 64.41 109.541 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.93 -45.07 52.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.735 -0.666 . . . . 73.41 111.089 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 91' ' ' VAL . 19.0 m -57.21 -22.07 16.2 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 N-CA-C 112.762 0.653 . . . . 63.14 112.762 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.04 -20.06 66.05 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.607 0.718 . . . . 73.42 110.887 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 69.0 mtm -94.92 7.91 44.47 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.174 -0.921 . . . . 74.53 110.24 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.662 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 5.1 p-10 -40.23 -45.66 2.11 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 113.814 1.042 . . . . 74.42 113.814 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -118.94 116.6 26.81 Favored 'General case' 0 N--CA 1.405 -2.679 0 N-CA-C 108.158 -1.053 . . . . 70.35 108.158 172.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 106' ' ' THR . 8.2 t -168.9 -179.77 3.82 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.103 -0.953 . . . . 54.45 108.621 -177.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.48 125.73 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-O 121.533 0.683 . . . . 72.25 110.364 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -130.51 128.96 42.24 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.297 -1.001 . . . . 73.44 108.297 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 54.45 33.03 17.85 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.763 1.225 . . . . 73.43 110.487 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.01 -1.81 88.66 Favored Glycine 0 C--N 1.311 -0.831 0 CA-C-N 114.765 -1.107 . . . . 74.53 114.25 177.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -122.31 152.46 40.08 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 117.589 0.694 . . . . 64.22 111.318 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 100' ' ' THR . 30.8 m -81.98 120.72 25.6 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 110.263 -0.273 . . . . 71.03 110.263 -178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 40.0 pt -103.1 172.09 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 116.329 -0.396 . . . . 43.02 110.48 176.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.662 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 57.6 tptt -129.49 133.55 47.34 Favored 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 109.233 -0.655 . . . . 64.42 109.233 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 23.6 t -127.23 114.52 37.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.002 -0.74 . . . . 75.22 109.002 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.424 HD11 ' CG ' ' B' ' 22' ' ' PRO 0.258 0.0 OUTLIER -143.35 146.24 35.32 Favored Pre-proline 0 C--O 1.211 -0.953 0 C-N-CA 119.277 -0.969 . . . . 74.52 109.432 179.168 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -52.08 137.53 53.79 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 123.386 2.724 . . . . 73.52 113.692 -173.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt . . . . . 0 C--O 1.248 0.981 0 CA-C-O 121.2 0.524 . . . . 74.34 111.886 -176.459 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.277 0 CA-C-O 120.177 -0.235 . . . . 70.13 113.615 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.424 ' CG ' HD11 ' A' ' 110' ' ' LEU . 53.8 Cg_exo -53.17 -40.3 77.61 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 124.568 3.512 . . . . 72.43 116.88 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.8 136.05 74.12 Favored 'Trans proline' 0 C--N 1.391 2.768 0 CA-C-N 121.365 1.523 . . . . 71.35 110.377 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.417 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 83.9 mm-40 -60.47 134.3 91.38 Favored Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 123.56 0.538 . . . . 64.22 111.59 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' B' ' 24' ' ' GLN . 26.8 Cg_exo -57.88 179.6 0.15 Allowed 'Trans proline' 0 C--O 1.244 0.817 0 C-N-CA 123.484 2.789 . . . . 74.51 114.069 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.599 HD23 ' HB2' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -148.8 159.65 43.96 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 113.598 -1.637 . . . . 62.22 107.397 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.459 ' HB3' ' HG2' ' B' ' 30' ' ' GLU . 39.1 t -57.26 145.47 31.74 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 113.768 1.025 . . . . 70.11 113.768 -171.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.78 -38.89 67.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.451 -1.25 . . . . 32.44 111.142 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -64.79 -34.9 79.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.442 -0.345 . . . . 71.1 110.279 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.599 ' HB2' HD23 ' B' ' 26' ' ' LEU . 17.9 mm-40 -65.43 -35.31 80.55 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 116.207 -0.451 . . . . 75.03 110.008 177.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -72.66 -47.02 50.92 Favored 'General case' 0 CA--C 1.483 -1.611 0 CA-C-N 115.427 -0.806 . . . . 73.14 110.862 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.455 ' O ' ' HE3' ' B' ' 36' ' ' LYS . 50.3 mtpt -54.87 -43.06 72.8 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 115.861 -0.609 . . . . 74.41 111.767 176.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.508 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 0.3 OUTLIER -65.89 -41.13 91.93 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.819 0.847 . . . . 71.1 111.439 -178.517 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . 0.277 11.7 pt -71.27 -34.66 54.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 113.131 0.789 . . . . 75.32 113.131 -175.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.555 ' OD1' ' HE2' ' B' ' 112' ' ' LYS . 62.7 m-20 -64.01 -41.62 97.4 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-O 121.312 0.577 . . . . 74.05 109.851 -179.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.455 ' HE3' ' O ' ' B' ' 32' ' ' LYS . 84.0 mttt -60.27 -27.28 67.14 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.377 0.671 . . . . 75.3 111.63 -177.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' B' ' 33' ' ' GLU . 20.4 mtm180 -104.46 15.41 28.21 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 115.901 -0.591 . . . . 75.1 110.336 -174.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.717 ' OG ' ' HD3' ' B' ' 112' ' ' LYS . 77.7 p -114.89 169.26 9.22 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 113.915 1.08 . . . . 73.44 113.915 -177.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.592 HG13 ' CG2' ' B' ' 91' ' ' VAL . 0.2 OUTLIER -145.46 164.64 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 124.93 1.292 . . . . 73.13 113.24 -174.717 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . 0.543 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 30.4 t80 -105.59 125.98 51.61 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 127.125 2.17 . . . . 74.34 106.719 178.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 59.9 t -117.12 115.48 48.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 108.184 -1.043 . . . . 63.5 108.184 176.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.25 166.18 13.31 Favored Glycine 0 C--N 1.3 -1.471 0 C-N-CA 120.166 -1.016 . . . . 63.42 113.125 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 56.1 t30 62.6 65.75 0.82 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.4 1.48 . . . . 70.24 113.454 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.2 118.15 7.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.319 -0.855 . . . . 64.3 111.864 175.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -80.8 167.18 20.23 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 106.498 -1.668 . . . . 74.34 106.498 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' TYR . . . . . 0.604 ' HB3' ' SG ' ' B' ' 70' ' ' CYS . 48.3 p90 -75.33 5.24 5.88 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.145 0.498 . . . . 75.24 112.04 -178.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.34 -24.84 74.4 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.417 -1.073 . . . . 75.33 110.417 174.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 28.2 m -91.84 145.75 24.31 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 106.275 -1.75 . . . . 62.43 106.275 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 43.6 p -103.79 174.5 5.84 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 118.988 -1.085 . . . . 73.41 111.665 -173.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.602 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -64.7 -38.4 90.86 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 108.593 -0.892 . . . . 30.21 108.593 175.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -58.56 -42.46 87.95 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.379 -0.828 . . . . 74.34 111.06 176.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -59.05 -46.38 88.39 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.32 0.581 . . . . 74.4 110.027 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 55.6 mt -65.26 -48.6 72.65 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.898 -1.047 . . . . 73.24 111.969 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.512 ' HG2' HD12 ' B' ' 63' ' ' ILE . 0.8 OUTLIER -62.24 -49.09 77.11 Favored 'General case' 0 C--O 1.195 -1.801 0 N-CA-C 111.983 0.364 . . . . 70.41 111.983 -177.825 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.84 -41.51 87.11 Favored 'General case' 0 C--O 1.26 1.635 0 CA-C-O 121.531 0.681 . . . . 71.3 112.309 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -67.93 -41.22 82.93 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.918 -1.037 . . . . 74.33 109.967 -175.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -82.19 -22.07 36.17 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.395 0.517 . . . . 74.43 112.395 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 29.1 t -71.36 -23.86 61.98 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 109.163 -0.68 . . . . 65.43 109.163 -178.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 38.7 m -64.26 -18.93 65.03 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 115.821 -0.627 . . . . 74.41 109.808 175.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 56.0 m -107.38 10.03 29.69 Favored 'General case' 0 CA--C 1.556 1.211 0 N-CA-C 112.013 0.375 . . . . 74.44 112.013 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 147.89 -168.45 28.76 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 119.577 -1.297 . . . . 72.34 114.511 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 57.6 p -107.19 126.64 52.66 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 121.519 0.676 . . . . 55.31 110.502 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.512 HD12 ' HG2' ' B' ' 54' ' ' GLU . 78.9 mt -90.93 135.27 27.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.305 -0.862 . . . . 72.51 113.112 -175.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -93.03 -40.3 10.61 Favored 'General case' 0 CA--C 1.49 -1.344 0 CA-C-N 116.27 -0.423 . . . . 72.4 110.49 177.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 47.9 mtt180 -154.84 161.0 41.62 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 116.27 -0.423 . . . . 70.31 110.026 -177.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.602 HD11 ' HB1' ' B' ' 50' ' ' ALA . 26.7 pt -147.31 143.2 20.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 107.319 -1.363 . . . . 74.1 107.319 172.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 66.0 m -125.81 124.88 41.94 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 106.76 -1.57 . . . . 65.31 106.76 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.4 mp -124.33 120.2 58.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 106.926 -1.509 . . . . 71.11 106.926 -177.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.251 1.3 pt? -120.74 127.82 52.35 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.999 -0.68 . . . . 54.23 111.426 177.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' B' ' 46' ' ' TYR . 69.3 m -116.59 133.79 55.6 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.081 -0.711 . . . . 73.4 109.081 -177.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.642 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 4.1 p-10 -119.65 137.72 53.71 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 118.704 -1.198 . . . . 71.43 113.519 -176.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -104.81 10.38 34.53 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.78 0.8 . . . . 73.45 109.714 171.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.55 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 19.7 m-85 -73.42 -2.38 22.13 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.263 -0.88 . . . . 73.53 112.221 175.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 25.2 m -110.92 13.06 22.18 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 114.633 -1.167 . . . . 64.13 108.779 176.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.51 -55.76 5.03 Favored Glycine 0 C--N 1.343 0.958 0 N-CA-C 110.735 -0.946 . . . . 73.55 110.735 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -97.22 136.46 21.43 Favored Pre-proline 0 C--N 1.288 -2.09 0 CA-C-N 114.272 -0.964 . . . . 72.3 108.655 175.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 51.5 Cg_endo -69.55 118.31 5.6 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 121.603 1.535 . . . . 61.2 111.752 -178.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm -112.22 -157.56 0.62 Allowed 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 106.998 -1.482 . . . . 72.32 106.998 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 171.59 158.6 15.95 Favored Glycine 0 N--CA 1.409 -3.165 0 C-N-CA 119.071 -1.538 . . . . 62.02 114.232 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -149.5 144.3 26.2 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 125.468 1.507 . . . . 72.22 109.134 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.43 150.17 51.78 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 112.082 0.401 . . . . 64.33 112.082 -172.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' TYR . . . . . 0.51 ' HH ' ' HD1' ' B' ' 40' ' ' TYR . 26.4 m-85 -117.72 120.44 37.97 Favored 'General case' 0 C--N 1.286 -2.164 0 C-N-CA 123.398 0.679 . . . . 64.43 111.092 177.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.433 HG23 HG22 ' B' ' 66' ' ' ILE . 24.9 mm -106.5 124.36 61.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 108.337 -0.986 . . . . 74.33 108.337 -178.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' GLU . . . . . 0.435 ' HG2' ' CB ' ' B' ' 38' ' ' SER . 30.8 mt-10 -109.14 119.29 39.09 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 110.172 -0.307 . . . . 52.33 110.172 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -97.61 166.58 11.43 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.529 0.566 . . . . 74.43 112.529 -176.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.09 -34.39 26.15 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.321 -0.854 . . . . 61.43 112.265 175.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -114.26 149.84 35.27 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 120.95 0.405 . . . . 74.25 111.295 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.558 ' O ' HG12 ' B' ' 91' ' ' VAL . 19.4 mtp180 -74.87 -28.68 60.75 Favored 'General case' 0 CA--C 1.463 -2.372 0 CA-C-O 122.301 1.048 . . . . 72.12 111.796 176.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -61.31 -32.27 72.13 Favored 'General case' 1 C--N 1.234 -4.419 0 CA-C-N 114.178 -1.373 . . . . 71.42 110.503 172.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 16.5 m -71.24 -37.88 71.97 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 110.267 -0.272 . . . . 73.15 110.267 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.592 ' CG2' HG13 ' B' ' 39' ' ' VAL . 7.5 p -66.85 -38.78 82.14 Favored 'Isoleucine or valine' 0 C--N 1.348 0.527 0 C-N-CA 120.313 -0.555 . . . . 60.52 109.505 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -67.35 -30.43 70.23 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-O 121.101 0.477 . . . . 73.31 111.677 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.1 -32.23 64.83 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.185 0.517 . . . . 75.11 109.83 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.9 -44.87 46.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.761 -0.654 . . . . 61.42 111.28 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . 0.494 HG11 ' HG3' ' B' ' 111' ' ' PRO . 30.2 m -57.53 -23.26 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 112.553 0.575 . . . . 55.2 112.553 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.37 -17.28 64.68 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.23 0.538 . . . . 74.53 110.078 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 69.1 mtm -95.46 7.63 45.65 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.122 -0.49 . . . . 72.32 111.719 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . 0.408 ' HA ' ' H ' ' B' ' 109' ' ' VAL . 0.8 OUTLIER -49.1 -36.54 18.98 Favored 'General case' 0 C--O 1.201 -1.449 0 N-CA-C 114.312 1.227 . . . . 75.21 114.312 -177.573 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -105.08 17.83 23.41 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-N 119.349 0.977 . . . . 71.44 112.053 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 76.4 p -81.28 172.11 14.01 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 119.276 -0.97 . . . . 52.32 112.561 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.96 122.88 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 CA-C-O 121.746 0.784 . . . . 64.12 111.248 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -117.77 122.96 44.83 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.317 -0.994 . . . . 70.42 108.317 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 53.32 32.74 14.19 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.033 0.753 . . . . 73.22 113.033 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.22 4.6 83.77 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.93 -0.652 . . . . 63.01 114.115 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -125.86 151.39 46.92 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 117.533 0.666 . . . . 74.53 110.065 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 55.2 m -83.34 121.33 27.0 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 109.672 -0.492 . . . . 73.43 109.672 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 39.6 pt -102.05 172.54 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.175 -0.676 . . . . 71.13 109.175 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 108' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 56.3 tptt -128.48 132.59 48.38 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.681 -0.859 . . . . 73.54 108.681 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 20.9 t -126.5 120.21 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 107.999 -1.111 . . . . 72.03 107.999 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.322 0.3 OUTLIER -145.28 133.28 10.56 Favored Pre-proline 0 C--O 1.192 -1.97 0 N-CA-C 107.841 -1.17 . . . . 72.2 107.841 -167.449 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . 0.494 ' HG3' HG11 ' B' ' 95' ' ' VAL . 51.4 Cg_exo -57.16 151.95 48.02 Favored 'Trans proline' 0 N--CA 1.507 2.299 0 C-N-CA 123.504 2.803 . . . . 75.45 116.303 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.717 ' HD3' ' OG ' ' B' ' 38' ' ' SER . 76.2 tttt . . . . . 0 CA--C 1.557 1.24 0 C-N-CA 125.326 1.45 . . . . 62.43 109.84 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 N--CA 1.439 -0.98 0 N-CA-C 113.291 0.848 . . . . 70.23 113.291 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.7 pt -70.31 -35.77 64.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 C-N-CA 119.722 -0.791 . . . . 42.14 111.863 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.46 -29.32 69.42 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.232 0.539 . . . . 72.2 111.263 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -77.76 -10.75 59.7 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.895 -0.593 . . . . 73.23 111.649 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -118.09 18.74 13.8 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.163 -0.471 . . . . 74.23 110.711 -174.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -94.83 139.09 31.77 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.928 -0.767 . . . . 72.24 108.928 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 83' ' ' ILE . 32.1 m -126.18 160.76 33.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 109.616 -0.512 . . . . 64.42 109.616 178.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.531 ' CD2' ' HG2' ' B' ' 22' ' ' PRO . 38.4 t80 -114.56 123.08 48.47 Favored 'General case' 0 C--N 1.274 -2.693 0 C-N-CA 125.159 1.384 . . . . 75.23 108.343 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 97.1 t -112.45 108.28 25.12 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.877 0 N-CA-C 107.087 -1.449 . . . . 71.21 107.087 177.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.07 163.07 20.15 Favored Glycine 0 C--N 1.284 -2.359 0 C-N-CA 119.62 -1.276 . . . . 72.45 112.231 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.408 ' ND2' ' HB3' ' A' ' 105' ' ' ARG . 66.5 t30 57.7 21.12 7.0 Favored 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 125.779 1.632 . . . . 72.43 113.562 178.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 p -54.39 135.44 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-O 121.38 0.61 . . . . 62.42 109.849 175.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.36 148.92 40.84 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 108.081 -1.081 . . . . 73.51 108.081 -176.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -70.24 -15.88 62.97 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.076 0.941 . . . . 64.0 109.189 -176.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.44 -11.62 83.01 Favored Glycine 0 N--CA 1.427 -1.955 0 CA-C-N 115.383 -0.826 . . . . 34.32 112.323 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.6 m -74.5 122.28 22.81 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-O 121.56 0.695 . . . . 63.43 110.069 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.1 p -100.86 171.73 7.49 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.309 -0.86 . . . . 74.24 108.903 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.02 -50.13 75.27 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 118.142 0.428 . . . . 71.32 111.194 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -57.49 -42.03 81.9 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.725 0.639 . . . . 73.23 112.725 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -67.09 -41.2 86.71 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.227 0.537 . . . . 70.2 110.315 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.2 mt -71.37 -48.37 50.46 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.707 -0.679 . . . . 75.12 111.815 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.453 ' HG3' ' OH ' ' B' ' 46' ' ' TYR . 14.2 tm-20 -59.73 -49.07 79.15 Favored 'General case' 0 C--O 1.208 -1.1 0 C-N-CA 123.547 0.739 . . . . 71.41 111.317 -178.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.35 -42.82 87.72 Favored 'General case' 0 C--O 1.27 2.165 0 CA-C-O 121.51 0.672 . . . . 65.02 111.214 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -63.63 -43.51 96.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.741 -1.118 . . . . 72.03 110.517 -175.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -81.36 -21.4 39.11 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 113.73 1.011 . . . . 74.45 113.73 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 69.4 m -66.59 -24.58 66.36 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 120.969 0.414 . . . . 55.43 110.885 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.1 m -58.62 -26.3 63.56 Favored 'General case' 0 CA--C 1.562 1.413 0 CA-C-O 121.144 0.497 . . . . 72.22 110.562 173.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 59.7 m -91.0 -2.78 57.65 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 112.945 0.72 . . . . 74.0 112.945 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.42 -161.86 27.95 Favored Glycine 0 C--N 1.317 -0.48 0 C-N-CA 119.456 -1.354 . . . . 52.41 113.913 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.1 m -97.26 120.26 37.3 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.562 0.696 . . . . 44.52 111.382 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.2 mt -82.01 129.53 37.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 115.001 -0.999 . . . . 71.52 111.168 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.434 ' OD1' ' HA ' ' B' ' 73' ' ' PHE . 48.4 t30 -93.54 -36.95 12.16 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.029 -0.987 . . . . 72.44 109.777 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.544 ' HD2' ' OE1' ' A' ' 84' ' ' GLU . 99.4 mtt180 -157.34 162.43 39.1 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.391 -0.822 . . . . 72.25 109.51 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.596 HG22 HG23 ' A' ' 83' ' ' ILE . 34.7 pt -142.68 137.81 28.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 107.259 -1.385 . . . . 73.34 107.259 171.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' B' ' 68' ' ' ILE . 49.9 m -126.54 130.96 51.58 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 107.55 -1.278 . . . . 61.55 107.55 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.2 mt -125.87 118.11 50.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.315 -1.365 . . . . 51.35 107.315 -177.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.55 ' HA ' ' O ' ' B' ' 66' ' ' ILE 0.342 0.9 OUTLIER -121.59 125.5 46.89 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 119.944 -0.702 . . . . 44.52 112.795 176.798 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 66.1 m -116.38 130.63 56.87 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.923 -1.14 . . . . 64.03 107.923 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.608 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 3.8 p-10 -115.78 137.14 52.37 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 119.196 -1.002 . . . . 72.45 112.377 -176.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -110.61 12.54 22.7 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.679 -0.691 . . . . 63.54 110.13 173.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.514 ' CD2' ' HB2' ' A' ' 71' ' ' ASP . 13.7 p90 -72.66 -9.97 59.24 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.789 0.804 . . . . 75.32 109.447 176.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.7 m -94.22 8.87 40.17 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 114.357 -1.292 . . . . 63.4 109.47 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.28 -54.42 4.53 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 110.492 -1.043 . . . . 55.13 110.492 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -95.61 131.26 29.81 Favored Pre-proline 0 C--N 1.299 -1.587 0 N-CA-C 106.772 -1.566 . . . . 70.22 106.772 176.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.608 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 33.3 Cg_endo -66.7 118.36 5.48 Favored 'Trans proline' 0 C--O 1.243 0.748 0 C-N-CA 121.536 1.491 . . . . 75.21 112.557 -177.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.407 ' HB2' ' OD1' ' A' ' 71' ' ' ASP . 25.0 mtmm -100.09 -169.39 1.73 Allowed 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.959 -1.126 . . . . 53.41 107.959 174.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.05 139.8 6.11 Favored Glycine 0 N--CA 1.41 -3.1 0 C-N-CA 119.727 -1.225 . . . . 75.22 112.763 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -151.12 143.31 24.07 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.797 -0.816 . . . . 72.23 108.797 172.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.08 152.01 50.0 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 116.747 -0.206 . . . . 71.43 111.23 -173.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 95.6 m-85 -120.4 115.63 23.89 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 109.044 -0.724 . . . . 75.31 109.044 174.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.596 HG23 HG22 ' A' ' 66' ' ' ILE . 38.6 mm -101.65 121.27 52.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.515 -1.291 . . . . 71.11 107.515 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.544 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 33.7 mt-10 -106.07 123.09 47.45 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 120.242 -0.583 . . . . 64.53 109.5 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -94.45 156.64 16.38 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 112.525 0.565 . . . . 74.33 112.525 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.06 -36.32 55.99 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.515 -0.766 . . . . 61.52 110.404 176.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -103.01 146.23 28.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.771 0.319 . . . . 71.43 110.185 175.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.45 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.77 -32.34 62.03 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.103 -1.443 . . . . 74.15 107.103 178.606 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -60.46 -31.48 70.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.283 -1.326 . . . . 75.11 110.338 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 31.5 m -64.41 -36.64 84.83 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 116.235 -0.439 . . . . 64.45 110.503 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 95' ' ' VAL . 2.3 m -67.68 -38.3 80.13 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.533 0 C-N-CA 119.61 -0.836 . . . . 70.42 109.241 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -58.3 -36.1 72.81 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.064 0.459 . . . . 74.21 111.59 176.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.34 -32.8 64.77 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.929 0.395 . . . . 73.1 110.658 177.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.36 -40.63 50.61 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 116.174 -0.466 . . . . 71.41 111.627 -177.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 91' ' ' VAL . 31.7 m -55.76 -21.85 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 113.117 0.784 . . . . 61.43 113.117 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.08 -14.44 61.74 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 121.586 0.708 . . . . 74.53 110.535 176.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 28.3 mtp -98.17 8.1 45.29 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 124.471 1.108 . . . . 62.34 110.771 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 4.5 p-10 -36.57 -53.47 0.88 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.904 1.076 . . . . 72.3 113.904 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -118.87 106.14 12.2 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-O 121.704 0.764 . . . . 65.12 109.451 175.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.0 t -150.1 173.02 14.35 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 114.811 -1.086 . . . . 74.02 109.275 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.87 131.99 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.221 0 N-CA-C 108.754 -0.832 . . . . 63.32 108.754 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -138.32 113.64 9.47 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 107.289 -1.374 . . . . 72.15 107.289 -177.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 37.5 mtp85 56.1 33.31 21.72 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.906 0.882 . . . . 74.32 112.127 -175.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.06 -10.18 71.77 Favored Glycine 0 C--N 1.312 -0.795 0 CA-C-N 115.215 -0.902 . . . . 24.01 113.191 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.408 ' HB3' ' ND2' ' A' ' 43' ' ' ASN . 93.7 mtt180 -99.31 143.81 29.15 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.839 -0.801 . . . . 73.5 108.839 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.0 m -86.41 119.72 26.98 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.934 -1.506 . . . . 54.53 106.934 174.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 47.8 pt -102.01 171.35 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 120.15 -0.62 . . . . 70.44 110.976 -177.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 57.6 tptt -127.87 125.98 40.71 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.138 -0.937 . . . . 64.34 108.731 -177.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.9 t -114.32 115.53 49.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 106.275 -1.75 . . . . 75.02 106.275 177.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . 0.272 2.5 tt -138.87 128.56 14.52 Favored Pre-proline 0 C--O 1.196 -1.72 0 N-CA-C 106.972 -1.492 . . . . 74.24 106.972 -170.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.66 127.71 15.07 Favored 'Trans proline' 0 C--N 1.355 0.884 0 CA-C-N 121.485 1.566 . . . . 62.2 109.771 175.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.312 -1.058 0 CA-C-O 121.584 0.707 . . . . 75.23 110.744 -170.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.738 0 N-CA-C 109.717 -1.353 . . . . 75.11 109.717 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.531 ' HG2' ' CD2' ' A' ' 40' ' ' TYR . 76.3 Cg_exo -52.9 -37.98 78.33 Favored 'Trans proline' 0 CA--C 1.566 2.103 0 C-N-CA 122.742 2.295 . . . . 62.52 114.225 172.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -55.1 129.67 36.57 Favored 'Trans proline' 0 C--N 1.397 3.081 0 C-N-CA 121.499 1.466 . . . . 71.32 110.99 172.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -54.16 141.5 50.51 Favored Pre-proline 0 C--N 1.302 -1.487 0 CA-C-N 114.257 -1.338 . . . . 75.11 111.277 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.86 114.15 2.3 Favored 'Trans proline' 0 N--CA 1.443 -1.467 0 C-N-CA 122.098 1.866 . . . . 72.23 111.045 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 6.1 mp -61.83 165.83 4.97 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.821 -1.081 . . . . 74.54 109.882 176.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.42 ' O ' ' HG2' ' B' ' 31' ' ' LYS . 25.2 m -58.93 144.94 43.2 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.278 -0.638 . . . . 64.1 109.278 176.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' B' ' 31' ' ' LYS . . . -52.49 -44.18 65.48 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 123.569 0.543 . . . . 71.44 111.775 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -71.31 -30.98 66.88 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.828 0.677 . . . . 71.42 112.828 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.529 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.5 OUTLIER -60.57 -34.58 74.4 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 109.653 -0.499 . . . . 74.2 109.653 170.013 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' B' ' 28' ' ' ALA . 25.2 mmmt -65.84 -46.89 76.83 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 115.58 -0.736 . . . . 70.41 109.956 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.518 ' N ' ' HE2' ' B' ' 32' ' ' LYS . 0.5 OUTLIER -53.7 -46.36 70.71 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.8 -0.36 . . . . 72.44 110.734 176.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.77 -45.76 70.54 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.314 0.857 . . . . 63.42 113.314 -174.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.529 HG12 ' O ' ' B' ' 30' ' ' GLU . 26.3 pt -69.58 -35.37 65.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 C-N-CA 120.751 -0.38 . . . . 73.42 111.828 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.9 -35.09 79.23 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.915 0.388 . . . . 75.31 110.781 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 55.1 mtmt -75.12 -11.08 60.01 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.393 0.516 . . . . 42.33 112.393 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -118.23 18.37 13.76 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.328 0.585 . . . . 71.44 110.918 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' B' ' 84' ' ' GLU . 82.8 p -98.9 156.5 16.86 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 115.897 -0.592 . . . . 53.55 111.444 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.428 HG22 ' O ' ' B' ' 83' ' ' ILE . 31.2 m -137.08 163.89 31.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.931 0.396 . . . . 70.25 110.562 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . 0.503 ' HD1' ' CE1' ' B' ' 82' ' ' TYR . 38.7 t80 -115.57 123.03 47.44 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 126.118 1.767 . . . . 72.41 107.936 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 85.8 t -112.45 108.02 24.46 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.939 0 N-CA-C 107.461 -1.311 . . . . 72.52 107.461 176.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . 0.467 ' O ' ' HB ' ' B' ' 107' ' ' ILE . . . -98.83 164.97 20.87 Favored Glycine 0 C--N 1.289 -2.037 0 C-N-CA 119.697 -1.24 . . . . 75.54 112.201 -177.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 64.0 t30 60.29 18.45 7.99 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.639 1.176 . . . . 75.4 112.875 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 8.0 p -61.49 132.19 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 109.162 -0.681 . . . . 65.24 109.162 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.38 143.95 56.83 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.61 -0.723 . . . . 41.13 109.879 -176.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' TYR . . . . . 0.481 ' CD1' ' HB2' ' B' ' 77' ' ' PRO . 71.7 t80 -55.07 -21.98 14.51 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 124.878 1.271 . . . . 74.43 111.999 -177.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.26 10.84 54.76 Favored Glycine 0 N--CA 1.422 -2.267 0 C-N-CA 120.562 -0.828 . . . . 54.13 113.761 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 12.8 m -75.0 122.32 23.33 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 118.492 1.146 . . . . 70.0 108.687 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 61.8 p -96.57 167.62 11.03 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 111.663 0.245 . . . . 72.3 111.663 -175.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.96 -51.15 70.92 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 112.853 0.686 . . . . 71.01 112.853 -175.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -57.53 -38.4 74.63 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 112.473 0.545 . . . . 75.4 112.473 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -69.49 -42.21 75.1 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.082 0.468 . . . . 74.35 109.973 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.41 -48.56 55.53 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.646 -0.706 . . . . 70.24 112.036 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 tm-20 -59.91 -49.74 76.51 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.198 0.599 . . . . 72.54 111.289 -177.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.41 -42.07 81.57 Favored 'General case' 0 C--O 1.27 2.154 0 CA-C-O 121.602 0.715 . . . . 70.41 111.355 177.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -64.59 -42.79 95.35 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 114.879 -1.055 . . . . 53.42 110.761 -175.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -81.68 -21.43 38.1 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 113.571 0.952 . . . . 71.5 113.571 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 75.4 m -64.74 -26.09 68.21 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 116.36 -0.382 . . . . 51.0 110.946 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.4 m -58.17 -26.85 63.24 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-O 121.038 0.447 . . . . 61.54 110.524 174.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' B' ' 94' ' ' ALA . 61.7 m -92.05 -0.61 57.46 Favored 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 112.885 0.698 . . . . 55.33 112.885 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.35 -154.83 26.21 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 119.054 -1.546 . . . . 65.31 114.681 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 44.1 m -105.27 117.97 35.37 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.033 0.444 . . . . 74.21 111.229 -176.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 67.3 mt -79.46 130.72 35.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.743 -0.662 . . . . 74.43 112.655 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . 0.556 ' OD1' ' HG3' ' B' ' 65' ' ' ARG . 23.6 t-20 -91.16 -41.91 10.75 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.186 0.995 . . . . 75.24 108.356 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.556 ' HG3' ' OD1' ' B' ' 64' ' ' ASN . 99.2 mtt180 -158.05 163.52 37.62 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.842 0.857 . . . . 64.45 109.125 -177.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.628 HG22 HG23 ' B' ' 83' ' ' ILE . 34.8 pt -142.43 137.67 28.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 107.099 -1.445 . . . . 74.21 107.099 170.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 33.4 m -126.74 131.18 51.4 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 107.069 -1.456 . . . . 73.21 107.069 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 67' ' ' THR . 17.1 mt -125.91 117.47 49.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 107.128 -1.434 . . . . 73.02 107.128 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.308 0.9 OUTLIER -121.49 125.88 47.91 Favored 'General case' 0 C--N 1.283 -2.313 0 C-N-CA 120.21 -0.596 . . . . 70.21 112.241 177.296 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 77.1 m -116.27 129.15 56.13 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 108.302 -0.999 . . . . 44.32 108.302 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . 0.715 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 4.8 p-10 -110.63 126.78 54.84 Favored 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 119.48 -0.888 . . . . 60.11 111.021 -177.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -113.49 15.2 19.1 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.039 -1.467 . . . . 74.01 107.039 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.434 ' HA ' ' OD1' ' A' ' 64' ' ' ASN . 30.8 t80 -44.72 -44.3 9.09 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.511 2.324 . . . . 63.14 112.096 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 24.1 m -100.82 18.99 18.04 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 116.208 -0.451 . . . . 71.43 111.558 -175.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.1 -53.17 2.52 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.095 -1.05 . . . . 75.34 111.388 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -91.55 119.89 68.4 Favored Pre-proline 0 CA--C 1.497 -1.085 0 N-CA-C 109.367 -0.605 . . . . 52.42 109.367 177.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' PRO . . . . . 0.715 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 75.3 Cg_endo -77.81 121.1 5.33 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 122.522 2.148 . . . . 64.13 113.682 -174.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 25.8 mtmm -99.98 -167.16 1.42 Allowed 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.397 -0.964 . . . . 55.1 108.397 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.93 140.71 6.67 Favored Glycine 0 N--CA 1.408 -3.2 0 C-N-CA 120.252 -0.975 . . . . 73.13 112.663 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -151.73 143.44 23.65 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.509 -0.923 . . . . 75.54 108.509 171.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.33 152.19 50.81 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-O 121.023 0.44 . . . . 75.34 110.022 -173.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' TYR . . . . . 0.653 ' CD1' ' HD3' ' B' ' 112' ' ' LYS . 96.4 m-85 -121.31 115.21 22.54 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.411 -0.588 . . . . 72.55 109.411 175.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.628 HG23 HG22 ' B' ' 66' ' ' ILE . 40.5 mm -100.12 122.8 52.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 106.904 -1.517 . . . . 72.33 106.904 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' GLU . . . . . 0.555 ' OE1' ' HD2' ' B' ' 65' ' ' ARG . 31.1 mt-10 -107.73 124.15 49.59 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.165 -0.68 . . . . 70.41 109.165 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -96.83 154.1 17.49 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 112.893 0.701 . . . . 71.42 112.893 -177.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.69 -40.47 72.89 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.147 -0.933 . . . . 71.42 110.251 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -105.76 147.94 28.04 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 116.005 -0.543 . . . . 74.21 111.471 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.488 ' O ' HG22 ' B' ' 91' ' ' VAL . 0.0 OUTLIER -74.26 -33.56 63.34 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.398 -1.334 . . . . 73.04 107.398 -179.762 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -63.03 -25.42 68.37 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 115.494 -0.775 . . . . 63.03 111.425 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 42.9 m -66.11 -36.89 84.37 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 110.243 -0.28 . . . . 73.02 110.243 177.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' VAL . . . . . 0.488 HG22 ' O ' ' B' ' 88' ' ' ARG . 3.2 m -67.83 -38.67 80.54 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 N-CA-C 109.003 -0.74 . . . . 61.25 109.003 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -56.87 -38.08 72.25 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.169 0.509 . . . . 73.45 111.576 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.69 -31.58 63.5 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.061 0.457 . . . . 65.43 111.083 177.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 94' ' ' ALA . . . . . 0.454 ' HA ' ' SG ' ' B' ' 60' ' ' CYS . . . -76.32 -40.8 50.49 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.192 -0.458 . . . . 75.45 111.454 -178.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . 0.439 HG13 ' O ' ' B' ' 91' ' ' VAL . 22.0 m -56.58 -21.77 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 113.0 0.741 . . . . 62.41 113.0 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.75 -18.85 65.42 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.292 0.567 . . . . 63.02 110.189 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 48.1 mtm -95.06 13.54 24.85 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.699 -0.682 . . . . 64.24 110.872 177.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . 0.473 ' HA ' ' HB ' ' B' ' 109' ' ' VAL . 11.1 t70 -33.8 -55.09 0.47 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.471 1.508 . . . . 64.23 113.683 -178.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . 0.419 ' HG3' ' OD1' ' B' ' 98' ' ' ASP . 45.6 mt-10 -124.83 62.33 1.15 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.166 -1.013 . . . . 74.3 112.775 171.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 35.0 p -91.69 174.75 7.19 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.297 -0.865 . . . . 62.54 111.72 174.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.4 p -101.67 137.81 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 109.122 -0.695 . . . . 72.51 109.122 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 102' ' ' PHE . . . . . 0.419 ' HB2' HD12 ' B' ' 107' ' ' ILE . 85.5 t80 -142.72 118.61 10.58 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.532 -0.914 . . . . 75.0 108.532 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 45.3 mtp180 55.68 33.22 20.87 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.509 1.123 . . . . 75.13 113.539 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.53 -0.87 65.88 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.038 -0.983 . . . . 71.31 114.191 174.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -130.81 160.62 33.84 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.176 -0.676 . . . . 72.42 109.176 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 85.7 m -92.52 126.98 37.84 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.188 -0.671 . . . . 63.32 109.188 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' B' ' 42' ' ' GLY . 0.2 OUTLIER -102.8 172.3 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 118.198 -1.401 . . . . 63.2 110.334 177.485 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 108' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 56.8 tptt -119.21 124.72 47.46 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.641 -1.244 . . . . 55.53 107.641 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' B' ' 98' ' ' ASP . 47.1 t -113.91 113.97 45.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 107.065 -1.458 . . . . 62.21 107.065 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.273 3.0 tt -139.66 128.53 13.61 Favored Pre-proline 0 C--O 1.187 -2.195 0 N-CA-C 106.454 -1.684 . . . . 70.2 106.454 -170.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.35 129.54 28.66 Favored 'Trans proline' 0 CA--C 1.551 1.37 0 CA-C-N 121.499 1.571 . . . . 74.02 112.056 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.653 ' HD3' ' CD1' ' B' ' 82' ' ' TYR . 36.0 ttpt . . . . . 0 C--O 1.218 -0.59 0 CA-C-N 116.199 -0.455 . . . . 75.21 111.039 -174.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.295 0 N-CA-C 109.947 -0.39 . . . . 73.33 109.947 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.8 tt -101.17 130.23 50.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 109.786 -0.45 . . . . 71.31 109.786 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . . . -131.38 121.78 18.63 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 109.999 -0.371 . . . . 51.04 109.999 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 3' ' ' ALA . 20.4 Cg_exo -66.23 108.17 1.3 Allowed 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 122.591 2.194 . . . . 61.43 111.808 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.8 p -107.93 94.01 4.84 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.173 0.511 . . . . 53.34 110.086 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 85.3 mtp 62.9 -170.91 0.17 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.258 -0.883 . . . . 73.24 109.843 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 60.93 -168.26 0.18 Allowed 'General case' 0 C--O 1.241 0.644 0 C-N-CA 122.785 0.434 . . . . 71.34 111.84 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.7 m 70.4 5.03 5.18 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-O 122.085 0.945 . . . . 75.34 111.198 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -90.99 107.87 19.48 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.541 0.686 . . . . 72.23 110.473 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -153.04 96.02 2.03 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.793 0.806 . . . . 35.35 111.51 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.415 ' HB2' ' HB2' ' B' ' 45' ' ' ASP . 23.9 m -120.97 24.12 10.34 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.702 -1.135 . . . . 72.25 110.02 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.509 ' HD2' ' H ' ' A' ' 12' ' ' LYS 0.263 0.0 OUTLIER -78.38 69.59 4.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.937 0.875 . . . . 74.1 113.025 -178.274 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 27.3 ttt -148.27 102.99 3.4 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 107.641 -1.244 . . . . 62.43 107.641 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.1 m -109.29 -19.55 13.26 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 116.207 -0.451 . . . . 74.33 111.588 -175.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 76.08 -46.01 0.53 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.203 1.001 . . . . 72.24 110.137 -173.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.93 69.46 1.32 Allowed Glycine 0 CA--C 1.5 -0.87 0 CA-C-N 116.343 -0.389 . . . . 54.12 113.442 173.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -118.31 -30.29 5.29 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 120.607 0.242 . . . . 61.03 110.545 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.462 ' O ' ' HE2' ' B' ' 108' ' ' LYS . 98.3 m-85 65.13 18.32 11.4 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 122.096 0.95 . . . . 75.25 109.579 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -161.0 30.84 0.14 Allowed 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 126.48 1.912 . . . . 61.13 109.184 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -43.78 -61.56 1.38 Allowed 'General case' 0 C--N 1.348 0.535 0 O-C-N 124.653 1.221 . . . . 74.3 110.649 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.95 -177.44 50.1 Favored Glycine 0 N--CA 1.401 -3.665 0 C-N-CA 120.772 -0.727 . . . . 50.11 111.765 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -48.32 -33.96 23.68 Favored 'Trans proline' 0 CA--C 1.586 3.098 0 C-N-CA 123.56 2.84 . . . . 73.05 117.814 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -90.45 167.66 4.2 Favored 'Trans proline' 0 N--CA 1.413 -3.253 0 N-CA-C 118.313 2.39 . . . . 54.5 118.313 -172.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.562 ' HG2' ' OH ' ' B' ' 80' ' ' TYR . 76.9 mt-30 -134.87 146.93 60.77 Favored Pre-proline 0 N--CA 1.411 -2.386 0 CA-C-N 110.842 -2.89 . . . . 75.21 104.27 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.65 99.69 0.97 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 CA-C-N 120.158 1.092 . . . . 73.41 113.148 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.1 mp -139.38 136.99 35.32 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.622 -0.881 . . . . 75.12 108.622 176.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.3 t -75.85 160.06 30.33 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.782 -1.192 . . . . 60.02 107.782 173.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.2 -40.26 23.69 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 123.198 0.599 . . . . 33.41 112.23 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.293 49.4 mt-10 -75.33 -30.39 60.28 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 114.731 1.382 . . . . 73.42 114.731 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -58.19 -34.95 70.92 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 108.742 -0.836 . . . . 63.25 108.742 169.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -73.22 -37.98 66.23 Favored 'General case' 0 N--CA 1.416 -2.16 0 CA-C-N 114.711 -1.132 . . . . 63.1 111.256 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.559 ' HA ' ' NZ ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -69.2 -43.97 73.05 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 120.045 -0.662 . . . . 62.32 110.139 -178.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.493 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 7.8 mm-40 -62.74 -37.88 88.3 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 116.27 -0.423 . . . . 71.44 111.163 -177.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.4 pt -70.89 -35.91 61.89 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 C-N-CA 120.763 -0.375 . . . . 54.23 111.863 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.316 2.1 p30 -76.53 -27.84 56.11 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 118.929 -1.108 . . . . 64.51 112.208 178.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -65.6 -19.3 65.86 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-O 121.364 0.602 . . . . 74.43 111.318 174.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 12.6 ptp180 -125.06 25.87 7.13 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-O 122.07 0.938 . . . . 71.34 109.624 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.57 ' OG ' ' HG2' ' A' ' 84' ' ' GLU . 39.6 t -104.2 157.23 17.27 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.332 -1.304 . . . . 54.33 110.331 177.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.616 HG22 HG23 ' A' ' 91' ' ' VAL . 17.0 t -131.07 157.04 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 N-CA-C 107.963 -1.125 . . . . 73.22 107.963 -177.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.692 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 25.6 t80 -107.19 125.63 51.36 Favored 'General case' 0 C--N 1.279 -2.5 0 N-CA-C 106.398 -1.705 . . . . 74.41 106.398 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.517 ' HA ' HG12 ' A' ' 109' ' ' VAL . 62.6 t -116.7 107.8 23.38 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.137 0 N-CA-C 106.656 -1.609 . . . . 75.3 106.656 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.467 ' HA3' ' CZ ' ' A' ' 40' ' ' TYR . . . -117.04 172.56 14.3 Favored Glycine 0 C--N 1.275 -2.812 0 C-N-CA 117.734 -2.174 . . . . 75.45 113.652 -176.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.1 t30 57.73 11.67 1.4 Allowed 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 125.003 1.321 . . . . 74.1 112.92 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.7 p -55.45 142.79 9.38 Favored 'Isoleucine or valine' 0 C--O 1.246 0.906 0 CA-C-O 121.376 0.608 . . . . 74.35 109.858 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -77.6 150.05 34.71 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 107.737 -1.209 . . . . 60.43 107.737 -177.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.416 ' CD2' ' HB2' ' A' ' 77' ' ' PRO . 32.3 t80 -62.12 -20.85 64.5 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 123.886 0.741 . . . . 74.25 110.075 -176.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.16 -23.61 71.51 Favored Glycine 0 N--CA 1.424 -2.163 0 CA-C-N 115.52 -0.763 . . . . 20.43 112.82 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 72.9 m -100.97 75.6 1.69 Allowed 'General case' 0 N--CA 1.427 -1.594 0 C-N-CA 118.667 -1.213 . . . . 61.32 113.264 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.9 p -71.71 -178.0 2.1 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 116.199 -0.455 . . . . 53.42 111.93 170.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.02 -51.09 32.95 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.469 1.285 . . . . 71.24 114.469 -165.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.533 ' HG2' ' CE2' ' B' ' 46' ' ' TYR . 50.5 mt-30 -56.77 -51.88 67.19 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.441 0.534 . . . . 73.45 112.441 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -68.48 -39.19 81.44 Favored 'General case' 0 C--O 1.256 1.407 0 CA-C-O 121.591 0.71 . . . . 73.3 110.657 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.21 -46.69 73.09 Favored 'General case' 0 C--O 1.259 1.583 0 CA-C-N 114.673 -1.148 . . . . 74.24 109.061 -175.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -58.9 -40.94 86.0 Favored 'General case' 0 C--O 1.187 -2.191 0 N-CA-C 112.331 0.493 . . . . 64.11 112.331 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.56 -44.04 72.56 Favored 'General case' 0 C--O 1.266 1.926 0 CA-C-O 121.285 0.564 . . . . 64.3 111.717 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -64.82 -40.65 95.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.197 -0.911 . . . . 73.44 110.386 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.412 ' HZ ' HG11 ' A' ' 109' ' ' VAL . 66.7 m-85 -82.34 -22.76 35.42 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.028 1.122 . . . . 70.01 114.028 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.0 t -68.64 -24.69 64.58 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.01 -0.737 . . . . 72.15 109.01 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.0 m -66.31 -22.68 66.29 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 120.605 -0.438 . . . . 73.13 111.099 173.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 67.6 m -97.19 7.74 45.96 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.42 0.526 . . . . 71.33 112.42 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.21 -163.41 27.78 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 119.055 -1.545 . . . . 52.33 114.286 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.7 p -106.12 127.44 53.2 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.219 0.533 . . . . 73.11 111.236 -177.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.3 mt -86.87 133.93 28.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.683 -0.69 . . . . 53.35 112.14 -177.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.534 ' OD1' ' HG3' ' A' ' 65' ' ' ARG . 24.0 t-20 -96.99 -47.99 5.58 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.389 -0.823 . . . . 71.41 109.695 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.534 ' HG3' ' OD1' ' A' ' 64' ' ' ASN . 54.1 mtp180 -151.58 159.44 44.09 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.359 -0.978 . . . . 74.45 108.359 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.444 HG22 HG23 ' A' ' 83' ' ' ILE . 30.5 pt -146.36 141.87 21.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 107.921 -1.14 . . . . 72.33 107.921 174.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.0 m -127.37 125.4 40.63 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 107.38 -1.341 . . . . 74.34 107.38 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' B' ' 67' ' ' THR . 2.9 mp -122.37 125.45 72.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.272 -1.381 . . . . 55.32 107.272 -176.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.499 HD12 ' NH2' ' B' ' 65' ' ' ARG . 1.6 pt? -119.68 130.35 55.0 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 120.309 -0.556 . . . . 74.04 110.925 176.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.693 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 62.7 m -116.69 127.61 54.58 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.934 -0.576 . . . . 71.13 109.459 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -109.86 128.86 55.6 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.986 -0.686 . . . . 64.14 111.057 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' B' ' 64' ' ' ASN . 52.0 mttm -99.84 8.9 43.82 Favored 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 123.438 0.695 . . . . 75.45 110.213 173.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.622 ' CE2' ' HD2' ' B' ' 65' ' ' ARG . 7.6 m-85 -57.7 -25.87 60.93 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 121.58 0.705 . . . . 74.14 109.361 170.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.4 m -89.49 6.48 40.71 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 114.913 -1.04 . . . . 62.0 111.229 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.84 -52.94 4.67 Favored Glycine 0 N--CA 1.475 1.3 0 N-CA-C 110.488 -1.045 . . . . 65.02 110.488 -177.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -96.7 130.88 29.26 Favored Pre-proline 0 C--N 1.289 -2.043 0 N-CA-C 106.867 -1.531 . . . . 75.3 106.867 174.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.416 ' HB2' ' CD2' ' A' ' 46' ' ' TYR . 55.7 Cg_endo -68.69 120.32 7.25 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 122.007 1.805 . . . . 75.2 111.252 -177.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.693 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 15.1 mtmm -102.97 152.93 20.74 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.324 -1.361 . . . . 62.41 107.324 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.436 ' C ' ' HD1' ' A' ' 80' ' ' TYR . . . -120.48 137.28 12.02 Favored Glycine 0 N--CA 1.417 -2.632 0 C-N-CA 119.027 -1.558 . . . . 62.3 112.979 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.436 ' HD1' ' C ' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -129.06 142.23 50.97 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 102.743 -3.058 . . . . 72.22 102.743 172.373 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -140.47 141.89 35.37 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-N 119.042 0.837 . . . . 63.21 110.63 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.442 ' CD1' ' HD3' ' A' ' 112' ' ' LYS . 44.0 m-85 -110.07 117.2 33.1 Favored 'General case' 0 C--N 1.275 -2.632 0 N-CA-C 107.241 -1.392 . . . . 75.11 107.241 175.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.444 HG23 HG22 ' A' ' 66' ' ' ILE . 25.1 mm -102.98 121.17 53.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 107.347 -1.353 . . . . 74.31 107.347 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.57 ' HG2' ' OG ' ' A' ' 38' ' ' SER . 28.7 mt-10 -108.16 119.53 39.76 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.512 -0.922 . . . . 73.33 108.512 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -93.38 165.47 12.76 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.529 0.681 . . . . 75.41 112.819 -175.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.76 -37.81 64.9 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.065 -0.97 . . . . 74.3 111.011 174.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -118.63 158.61 25.15 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.126 1.158 . . . . 71.52 114.126 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -71.93 -26.47 62.31 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 114.701 -1.136 . . . . 54.45 110.778 175.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -60.21 -41.98 94.2 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.859 -0.61 . . . . 73.23 110.034 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.0 m -69.73 -39.7 76.65 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 115.603 -0.726 . . . . 40.1 111.765 -173.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.616 HG23 HG22 ' A' ' 39' ' ' VAL . 8.3 p -64.86 -39.22 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 120.33 -0.548 . . . . 75.34 109.807 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.68 -34.66 74.27 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.715 0.769 . . . . 73.02 109.928 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.75 -31.8 63.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.261 -0.881 . . . . 63.33 110.581 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.33 -45.05 33.96 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.088 -0.506 . . . . 51.23 110.57 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.1 m -59.44 -21.72 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 113.277 0.843 . . . . 73.02 113.277 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.97 -17.43 64.67 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.446 0.641 . . . . 74.54 110.61 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 71.8 mtm -94.98 9.96 37.4 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.562 -0.745 . . . . 70.3 110.129 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.602 ' HA ' HG22 ' A' ' 109' ' ' VAL . 2.2 p-10 -37.45 -47.53 0.89 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 116.418 2.007 . . . . 74.24 116.418 -174.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -115.47 30.68 7.2 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 118.95 0.795 . . . . 72.24 110.622 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.7 t -69.36 164.94 21.79 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-O 121.38 0.61 . . . . 72.23 110.056 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -109.13 132.13 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.936 0 N-CA-C 107.968 -1.123 . . . . 74.34 107.968 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -138.04 126.27 23.04 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 116.153 -0.476 . . . . 75.4 110.23 -174.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 103' ' ' ARG . 20.0 ttt180 55.54 32.44 19.09 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.845 1.258 . . . . 64.12 111.256 178.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.25 -10.58 72.59 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 114.237 -1.347 . . . . 61.02 113.202 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -113.16 150.65 31.93 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.828 -0.434 . . . . 74.21 109.828 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.4 m -86.6 123.16 31.48 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.252 -1.018 . . . . 72.45 108.252 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 44.4 pt -101.6 171.61 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.782 -0.767 . . . . 72.31 109.541 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 55.6 tptt -132.36 124.76 29.37 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.674 -0.491 . . . . 75.34 109.674 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.692 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 30.2 m -127.78 123.88 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 121.337 0.589 . . . . 73.14 111.317 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.405 HD11 ' HG2' ' B' ' 22' ' ' PRO . 0.0 OUTLIER -147.57 163.69 26.45 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 106.65 -1.611 . . . . 71.52 106.65 179.375 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.83 149.2 86.84 Favored 'Trans proline' 0 N--CA 1.478 0.6 0 C-N-CA 121.839 1.692 . . . . 54.42 112.046 -174.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.509 ' HE3' ' OG ' ' A' ' 38' ' ' SER . 25.5 ttpp -73.11 84.25 1.32 Allowed 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 122.518 1.151 . . . . 74.04 112.109 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.51 ' HA ' ' HD3' ' A' ' 113' ' ' ARG 0.564 24.0 mmt180 43.42 79.25 0.04 OUTLIER 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 119.717 3.229 . . . . 72.4 119.717 -178.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 23.5 m -116.79 84.82 2.21 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 105.5 -2.037 . . . . 63.22 105.5 169.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -141.16 176.37 8.89 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.799 -1.186 . . . . 75.03 107.799 -174.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -114.0 103.35 55.21 Favored Pre-proline 0 C--N 1.307 -1.254 0 CA-C-O 121.558 0.694 . . . . 64.12 110.763 177.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -87.93 16.54 1.88 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.711 2.274 . . . . 51.43 110.578 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 150.78 -142.84 9.93 Favored Glycine 0 N--CA 1.423 -2.2 0 N-CA-C 107.386 -2.286 . . . . 44.14 107.386 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.461 ' O ' HD12 ' A' ' 119' ' ' ILE . 2.5 pp -82.71 135.77 24.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 117.844 0.822 . . . . 75.04 110.992 176.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 52.4 m -145.8 114.2 6.7 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.343 0.592 . . . . 73.13 110.382 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 48.2 m -149.01 135.66 19.58 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.308 -0.997 . . . . 42.02 108.308 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 43.4 m -66.81 -42.88 85.19 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 123.523 0.514 . . . . 63.41 110.275 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -123.23 132.26 53.97 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.07 -1.085 . . . . 73.14 108.07 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.168 0 C-N-CA 120.401 -0.52 . . . . 70.34 111.021 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.795 0 N-CA-C 109.414 -0.587 . . . . 64.52 109.414 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 63.7 mt -107.49 110.38 31.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 109.195 -0.668 . . . . 73.1 109.195 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.09 101.33 49.94 Favored Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 116.283 -0.417 . . . . 73.23 109.917 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -80.99 -16.1 10.15 Favored 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 122.286 1.991 . . . . 61.45 112.709 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 23.2 p -157.44 135.58 11.01 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 116.344 -0.389 . . . . 64.23 110.194 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 26.2 mmt -92.54 103.88 16.24 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.804 -0.813 . . . . 72.0 108.804 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -108.6 116.63 32.35 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.202 -0.453 . . . . 73.12 111.118 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 67.2 m -143.02 95.8 2.83 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.484 0.659 . . . . 71.03 109.595 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 10.6 t -134.38 178.23 7.14 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 115.596 -0.729 . . . . 72.02 109.107 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -99.95 146.66 26.43 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.859 -0.423 . . . . 73.45 109.859 -177.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 20.4 m -81.03 108.62 14.86 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 110.095 -0.335 . . . . 75.34 110.095 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -101.66 145.23 29.37 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.181 -0.674 . . . . 63.24 109.181 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 15.0 tpt -67.13 143.32 56.69 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 123.461 0.475 . . . . 72.11 110.745 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.439 ' O ' ' HB3' ' B' ' 18' ' ' TYR . 15.5 m -99.44 -57.64 2.11 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-O 120.842 0.353 . . . . 63.33 111.425 -177.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.9 131.52 43.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.928 0.394 . . . . 75.41 111.923 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.1 -69.34 0.23 Allowed Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 121.022 -0.609 . . . . 65.33 112.412 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.26 -30.43 18.49 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.082 -0.647 . . . . 73.41 112.714 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.443 ' HB2' ' CD ' ' B' ' 117' ' ' PRO . 93.3 t80 -90.41 -79.57 0.35 Allowed 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 120.443 -0.503 . . . . 73.5 110.106 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 5.2 t -69.86 99.6 1.41 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 113.936 1.087 . . . . 73.53 113.936 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -98.07 3.52 49.27 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 105.48 -2.044 . . . . 71.44 105.48 171.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.41 -149.61 19.53 Favored Glycine 0 N--CA 1.42 -2.375 0 CA-C-N 113.226 -1.806 . . . . 73.01 109.655 -176.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.479 ' N ' ' HD2' ' B' ' 23' ' ' PRO . 33.1 Cg_exo -58.36 -43.09 49.35 Favored 'Trans proline' 0 CA--C 1.574 2.505 0 C-N-CA 123.055 2.503 . . . . 71.11 114.169 174.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' B' ' 22' ' ' PRO . 7.1 Cg_endo -53.43 154.98 13.73 Favored 'Trans proline' 0 C--N 1.397 3.099 0 C-N-CA 122.525 2.15 . . . . 73.23 112.008 175.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.448 ' H ' ' CD ' ' B' ' 24' ' ' GLN . 0.1 OUTLIER -84.26 133.02 45.86 Favored Pre-proline 0 N--CA 1.41 -2.467 0 N-CA-C 107.697 -1.223 . . . . 71.21 107.697 177.44 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' B' ' 24' ' ' GLN . 25.2 Cg_exo -61.39 138.6 77.58 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.351 2.034 . . . . 72.25 112.128 -175.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.758 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -68.79 176.19 3.18 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.71 -0.677 . . . . 63.31 110.555 175.393 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 15.7 m -53.68 143.02 21.48 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.097 0.777 . . . . 45.12 113.097 -170.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.56 -43.21 75.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.758 -1.11 . . . . 72.14 112.13 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . 0.319 49.2 mt-10 -76.8 -29.66 56.09 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.966 1.099 . . . . 74.42 113.966 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.458 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.4 OUTLIER -57.02 -35.62 69.47 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.847 -0.797 . . . . 74.01 108.847 169.174 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -72.33 -39.64 68.04 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.097 -0.956 . . . . 61.13 110.715 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.617 ' N ' ' HE2' ' B' ' 32' ' ' LYS . 0.0 OUTLIER -65.38 -45.92 82.18 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 112.109 0.411 . . . . 75.15 112.109 178.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -64.5 -35.48 81.07 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 123.279 0.362 . . . . 74.24 111.773 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.458 HG12 ' O ' ' B' ' 30' ' ' GLU 0.301 20.0 pt -70.78 -34.04 54.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 112.401 0.519 . . . . 55.23 112.401 179.484 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.519 ' HB3' ' HA ' ' B' ' 113' ' ' ARG . 44.4 m-20 -67.51 -43.34 81.1 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 121.941 0.877 . . . . 73.23 109.055 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -60.88 -19.8 60.85 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.957 -1.019 . . . . 72.53 111.141 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -112.21 11.64 20.28 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.353 -0.61 . . . . 72.45 109.353 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.507 ' OG ' ' HE3' ' B' ' 112' ' ' LYS . 31.4 t -99.08 151.17 21.25 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.679 0.752 . . . . 75.31 111.876 -177.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.579 HG22 HG23 ' B' ' 91' ' ' VAL . 10.5 t -129.09 158.9 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.079 0 N-CA-C 106.718 -1.586 . . . . 61.32 106.718 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . 0.696 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 36.7 t80 -110.0 125.44 52.9 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 106.353 -1.721 . . . . 73.32 106.353 174.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.523 ' HA ' HG12 ' B' ' 109' ' ' VAL . 59.9 t -117.22 106.91 21.01 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.098 0 N-CA-C 106.97 -1.493 . . . . 55.2 106.97 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.27 173.72 15.07 Favored Glycine 0 C--N 1.275 -2.842 0 C-N-CA 118.164 -1.97 . . . . 74.12 112.415 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.0 t30 62.25 6.0 1.72 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 124.842 1.257 . . . . 44.31 112.948 -177.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.9 p -61.57 131.24 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 107.274 -1.38 . . . . 51.23 107.274 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.519 ' OD1' ' HD2' ' B' ' 103' ' ' ARG . 3.6 p-10 -87.53 167.38 14.0 Favored 'General case' 0 N--CA 1.419 -1.977 0 C-N-CA 118.596 -1.242 . . . . 54.12 111.194 -172.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' TYR . . . . . 0.533 ' CE2' ' HG2' ' A' ' 51' ' ' GLN . 49.2 t80 -63.81 -12.19 33.58 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 113.981 -1.463 . . . . 72.42 111.189 -174.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.37 -23.6 67.69 Favored Glycine 0 N--CA 1.42 -2.431 0 CA-C-N 115.937 -0.574 . . . . 72.55 112.555 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.7 t -90.04 152.04 21.36 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 119.381 -0.927 . . . . 71.12 108.537 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . 0.537 ' O ' ' HB2' ' B' ' 53' ' ' LEU . 32.8 p -133.21 178.33 6.98 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.883 -0.784 . . . . 74.12 108.883 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.15 -46.61 82.57 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.576 0.954 . . . . 61.31 113.576 -172.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -57.59 -52.2 66.39 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.088 0.47 . . . . 71.51 111.442 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -64.82 -40.04 94.56 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-N 115.518 -0.765 . . . . 54.02 110.767 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.537 ' HB2' ' O ' ' B' ' 49' ' ' THR . 1.0 OUTLIER -67.3 -47.05 71.74 Favored 'General case' 0 C--O 1.255 1.386 0 CA-C-N 114.875 -1.057 . . . . 60.44 109.135 -177.3 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -58.93 -42.63 90.21 Favored 'General case' 0 C--O 1.188 -2.17 0 C-N-CA 120.671 -0.412 . . . . 73.24 111.932 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.1 -43.5 70.45 Favored 'General case' 0 C--O 1.266 1.955 0 O-C-N 123.196 0.31 . . . . 30.42 110.842 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -65.13 -41.51 94.76 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.073 -0.651 . . . . 71.32 110.534 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -82.32 -23.65 35.03 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 113.891 1.071 . . . . 72.2 113.891 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 34.5 t -71.26 -24.08 62.1 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 123.658 0.783 . . . . 74.03 108.947 -177.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 38.7 m -67.26 -24.71 65.82 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 115.56 -0.746 . . . . 73.5 109.899 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 61.5 m -106.59 14.37 27.11 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.554 0.576 . . . . 54.42 112.554 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . 0.444 ' HA3' ' OG ' ' B' ' 90' ' ' SER . . . 151.17 -174.96 30.29 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 118.953 -1.594 . . . . 75.34 115.158 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 46.7 m -105.35 120.0 40.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.422 0.629 . . . . 71.04 110.947 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 67.7 mt -83.23 131.28 34.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.609 -0.723 . . . . 71.51 112.553 -176.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 72' ' ' LYS . 43.3 t-20 -99.47 -42.32 7.0 Favored 'General case' 0 C--O 1.208 -1.1 0 CA-C-N 115.615 -0.72 . . . . 70.52 110.478 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.622 ' HD2' ' CE2' ' A' ' 73' ' ' PHE . 55.6 mtp180 -151.57 160.34 43.71 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.318 -0.993 . . . . 71.42 108.318 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 18.0 pt -148.23 141.47 18.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 107.869 -1.16 . . . . 50.12 107.869 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 47.9 m -127.73 126.44 41.83 Favored 'General case' 0 C--N 1.268 -2.942 0 N-CA-C 107.96 -1.126 . . . . 74.43 107.96 177.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.468 ' O ' HD12 ' A' ' 68' ' ' ILE . 2.3 mp -121.83 127.42 75.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 106.567 -1.642 . . . . 64.14 106.567 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -120.99 132.0 54.64 Favored 'General case' 0 C--N 1.286 -2.19 0 C-N-CA 119.801 -0.76 . . . . 74.44 110.52 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' CYS . . . . . 0.6 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 63.1 m -116.6 127.5 54.53 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 109.35 -0.611 . . . . 73.31 109.35 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -107.29 131.5 54.14 Favored 'General case' 0 CA--C 1.474 -1.956 0 C-N-CA 119.09 -1.044 . . . . 63.14 108.857 177.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.579 ' HE2' ' HB3' ' B' ' 77' ' ' PRO . 40.1 ttmt -125.16 7.42 7.87 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 109.158 -0.682 . . . . 74.34 109.158 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -69.64 -18.32 63.58 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.418 0.627 . . . . 72.1 110.247 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 22.5 p -84.26 1.98 42.2 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 114.85 -1.068 . . . . 71.55 109.955 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.46 -44.05 2.46 Favored Glycine 0 N--CA 1.439 -1.135 0 N-CA-C 110.733 -0.947 . . . . 60.42 110.733 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -95.85 128.1 38.74 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 108.096 -1.076 . . . . 70.21 108.096 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.579 ' HB3' ' HE2' ' B' ' 72' ' ' LYS . 94.2 Cg_endo -78.32 119.0 4.43 Favored 'Trans proline' 0 N--CA 1.434 -1.99 0 C-N-CA 121.298 1.332 . . . . 52.24 110.535 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' LYS . . . . . 0.6 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 1.2 mtpt -116.57 163.52 15.96 Favored 'General case' 0 CA--C 1.471 -2.095 0 CA-C-N 114.798 -1.092 . . . . 71.01 110.324 -174.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . 0.415 ' C ' ' HD1' ' B' ' 80' ' ' TYR . . . -134.2 137.84 9.61 Favored Glycine 0 N--CA 1.428 -1.838 0 C-N-CA 119.585 -1.293 . . . . 61.1 113.853 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . 0.562 ' OH ' ' HG2' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -130.77 142.6 50.41 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 102.794 -3.039 . . . . 74.32 102.794 172.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.81 141.79 36.7 Favored 'General case' 0 C--N 1.279 -2.467 0 CA-C-N 118.939 0.79 . . . . 63.42 110.486 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' TYR . . . . . 0.516 ' CD1' ' HG3' ' B' ' 112' ' ' LYS . 27.9 m-85 -109.51 117.18 33.31 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 106.793 -1.558 . . . . 71.34 106.793 175.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 33.0 mm -102.7 121.43 53.81 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 107.674 -1.232 . . . . 64.32 107.674 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' B' ' 38' ' ' SER . 31.1 mt-10 -108.07 119.3 39.09 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.704 -0.85 . . . . 72.42 108.704 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -95.31 164.58 12.77 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.408 0.623 . . . . 72.41 112.3 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.91 -30.33 31.93 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.194 -0.912 . . . . 53.0 111.864 176.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.02 147.62 42.18 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 114.79 1.404 . . . . 75.0 114.79 177.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.438 ' O ' HG12 ' B' ' 91' ' ' VAL . 20.4 mmm180 -64.25 -27.44 69.05 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.428 1.091 . . . . 73.23 110.279 175.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -58.44 -42.16 86.7 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.765 -0.652 . . . . 73.53 109.771 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' SER . . . . . 0.444 ' OG ' ' HA3' ' B' ' 61' ' ' GLY . 50.1 m -71.58 -37.32 71.04 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 113.082 0.771 . . . . 62.41 113.082 -173.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.579 HG23 HG22 ' B' ' 39' ' ' VAL . 12.3 p -65.48 -38.58 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 109.15 -0.685 . . . . 62.5 109.15 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -69.37 -35.81 76.2 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.612 0.72 . . . . 71.0 109.847 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.25 -31.85 64.36 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.374 -0.83 . . . . 63.31 110.554 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.31 -45.45 32.28 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.297 -0.41 . . . . 71.02 111.103 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 33.7 m -58.77 -22.23 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 112.874 0.694 . . . . 61.42 112.874 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.63 -13.0 61.7 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.371 0.605 . . . . 73.54 110.796 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 69.6 mtm -99.83 12.81 35.76 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.428 -0.805 . . . . 74.13 110.75 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . 0.551 ' HA ' HG22 ' B' ' 109' ' ' VAL . 3.9 p-10 -47.72 -40.47 20.46 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.054 0.761 . . . . 74.31 113.054 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -104.48 108.22 19.53 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 108.2 -1.037 . . . . 72.22 108.2 170.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 11.5 t -163.38 169.34 19.12 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.49 -0.93 . . . . 74.12 108.49 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.77 125.21 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 CA-C-O 121.606 0.717 . . . . 73.32 109.572 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' PHE . . . . . 0.428 ' O ' ' HG2' ' B' ' 105' ' ' ARG . 83.5 t80 -129.64 129.03 43.81 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.628 -0.879 . . . . 74.43 108.628 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . 0.519 ' HD2' ' OD1' ' B' ' 45' ' ' ASP . 24.2 ttm-85 55.57 31.91 18.09 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.541 1.136 . . . . 75.23 110.514 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.29 5.62 87.04 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 114.497 -1.229 . . . . 61.43 114.083 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' B' ' 102' ' ' PHE . 12.8 ptm180 -129.11 148.31 51.04 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 117.558 0.679 . . . . 73.45 110.262 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 37.2 m -80.76 120.98 25.34 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.725 -0.472 . . . . 74.31 109.725 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 34.7 pt -102.43 171.1 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 C-N-CA 120.352 -0.539 . . . . 73.44 110.393 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . 0.462 ' HE2' ' O ' ' A' ' 18' ' ' TYR . 53.7 tptt -128.61 125.16 37.6 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 109.267 -0.642 . . . . 75.15 109.267 -178.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 33.2 m -127.66 124.4 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-O 121.203 0.525 . . . . 73.3 111.727 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.02 164.05 24.11 Favored Pre-proline 0 C--O 1.197 -1.71 0 N-CA-C 106.916 -1.513 . . . . 70.31 106.916 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -66.45 143.82 70.96 Favored 'Trans proline' 0 CA--C 1.568 2.195 0 C-N-CA 122.182 1.921 . . . . 73.44 114.328 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.535 ' HD2' ' N ' ' B' ' 113' ' ' ARG . 0.9 OUTLIER -114.02 144.68 42.7 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 123.125 0.57 . . . . 72.32 109.83 -177.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.535 ' N ' ' HD2' ' B' ' 112' ' ' LYS . 56.4 ttp180 -149.7 129.04 12.9 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.701 0.63 . . . . 73.41 112.701 177.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.494 HG22 ' OD1' ' B' ' 35' ' ' ASP . 12.8 t -108.83 177.19 4.85 Favored 'General case' 0 CA--C 1.558 1.282 0 N-CA-C 108.667 -0.864 . . . . 75.24 108.667 174.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -156.26 163.02 40.05 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.654 -1.239 . . . . 72.33 107.654 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' MET . . . . . 0.419 ' HA ' ' HD3' ' B' ' 117' ' ' PRO . 1.6 pmm? -109.6 145.07 31.16 Favored Pre-proline 0 N--CA 1.47 0.544 0 CA-C-N 118.674 0.67 . . . . 72.33 112.256 -176.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' PRO . . . . . 0.443 ' CD ' ' HB2' ' B' ' 18' ' ' TYR . 2.3 Cg_endo -87.71 -16.6 2.94 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 122.905 2.403 . . . . 62.04 111.625 173.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . 131.68 130.95 3.2 Favored Glycine 0 N--CA 1.439 -1.135 0 N-CA-C 110.897 -0.881 . . . . 70.11 110.897 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 21.0 pt -121.94 120.76 62.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 120.862 0.363 . . . . 74.41 111.181 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 61.0 m -153.83 142.8 21.18 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.308 -0.245 . . . . 64.32 110.781 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 49.8 m -121.57 121.44 37.43 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.22 -0.659 . . . . 74.32 109.22 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 33.4 m -88.95 124.73 34.52 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.398 -0.593 . . . . 74.44 109.398 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -75.86 -78.65 0.11 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.72 0.295 . . . . 74.3 111.062 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.437 -1.106 0 CA-C-O 118.042 -0.98 . . . . 53.31 111.069 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.75 0 N-CA-C 109.411 -0.589 . . . . 74.25 109.411 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.531 ' O ' HD12 ' A' ' 2' ' ' ILE . 2.4 pp -81.4 137.61 20.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 112.275 0.472 . . . . 74.54 112.275 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.416 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . . . -82.7 119.9 75.43 Favored Pre-proline 0 C--N 1.297 -1.715 0 N-CA-C 107.271 -1.381 . . . . 62.4 107.271 173.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 3' ' ' ALA . 8.0 Cg_endo -49.39 118.11 3.41 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.426 2.751 . . . . 64.25 112.889 -176.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 50.0 t -154.49 148.41 25.62 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.717 -0.674 . . . . 71.2 109.268 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 27.6 ttt -145.65 140.26 27.18 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.253 -1.017 . . . . 51.33 108.253 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -98.01 138.11 35.81 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.028 0.442 . . . . 73.33 110.408 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.3 p -88.99 96.42 10.72 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 115.554 -0.748 . . . . 72.14 112.04 -177.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.2 m -95.32 101.89 13.65 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.274 -1.009 . . . . 64.33 108.274 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -111.2 91.73 3.77 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 113.61 0.967 . . . . 74.45 113.61 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.8 p -100.73 134.18 44.09 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.606 -1.627 . . . . 54.15 106.606 173.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.478 ' HE2' ' CG ' ' B' ' 25' ' ' PRO . 3.4 tmtm? -143.4 132.7 23.27 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.109 -1.036 . . . . 75.14 109.877 -171.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.8 mtt -62.21 113.19 2.73 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.075 -0.713 . . . . 74.23 109.075 174.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.434 ' HB ' ' HA ' ' A' ' 115' ' ' ASN . 39.8 m -71.64 -79.04 0.07 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 114.566 1.321 . . . . 74.04 114.566 -171.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 51.81 92.26 0.02 OUTLIER 'General case' 0 C--O 1.256 1.412 0 C-N-CA 123.902 0.881 . . . . 71.23 112.085 -173.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.04 164.73 29.25 Favored Glycine 1 N--CA 1.385 -4.704 0 C-N-CA 120.018 -1.087 . . . . 73.12 110.989 -176.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 76.98 86.28 0.08 Allowed 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 125.234 1.414 . . . . 72.02 112.813 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -124.79 -58.84 1.47 Allowed 'General case' 0 C--O 1.216 -0.695 0 CA-C-N 114.759 -1.109 . . . . 72.43 109.277 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.2 m -64.95 106.4 1.23 Allowed 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.863 -0.608 . . . . 74.45 109.84 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.435 ' OE2' ' HA ' ' A' ' 25' ' ' PRO . 46.2 mt-10 -113.97 13.38 18.24 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-O 121.368 0.604 . . . . 74.53 109.821 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.613 ' HA3' ' OH ' ' B' ' 82' ' ' TYR . . . 76.7 -125.66 7.66 Favored Glycine 0 N--CA 1.496 2.671 0 CA-C-N 114.864 -1.062 . . . . 53.4 112.663 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -52.5 -53.95 6.01 Favored 'Trans proline' 0 CA--C 1.564 2.008 0 C-N-CA 122.529 2.153 . . . . 73.53 112.592 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.94 140.96 47.2 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 121.194 1.262 . . . . 72.1 110.116 173.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.05 154.54 63.97 Favored Pre-proline 0 C--N 1.292 -1.918 0 N-CA-C 107.524 -1.287 . . . . 74.43 107.524 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.435 ' HA ' ' OE2' ' A' ' 20' ' ' GLU . 11.5 Cg_endo -57.85 128.45 29.05 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 122.119 1.879 . . . . 62.0 110.353 178.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.65 HD13 ' H ' ' A' ' 26' ' ' LEU 0.289 0.0 OUTLIER -71.28 178.17 3.5 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 120.275 -0.57 . . . . 74.35 111.31 179.006 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.536 ' HB2' ' OE1' ' A' ' 30' ' ' GLU . 58.5 m -64.4 144.47 57.15 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 113.888 1.069 . . . . 73.53 113.888 -171.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' A' ' 32' ' ' LYS . . . -53.51 -46.54 70.13 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 114.505 -1.225 . . . . 63.11 112.82 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -67.24 -31.2 71.39 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 112.974 0.731 . . . . 74.53 112.974 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.536 ' OE1' ' HB2' ' A' ' 27' ' ' SER . 0.8 OUTLIER -65.52 -38.45 89.69 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.568 -0.287 . . . . 70.1 110.299 174.601 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.411 ' HG3' HD22 ' A' ' 26' ' ' LEU . 68.5 mttm -69.59 -35.26 75.17 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.886 -0.597 . . . . 72.21 110.163 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.468 ' HE3' ' SD ' ' A' ' 116' ' ' MET . 59.1 mtpt -67.74 -39.72 84.19 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 113.662 0.986 . . . . 63.32 113.662 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -70.59 -38.51 74.02 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 120.54 -0.464 . . . . 71.4 111.06 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 30' ' ' GLU . 13.8 pt -70.77 -33.42 52.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.705 -0.68 . . . . 64.04 110.566 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.444 ' OD1' ' HB2' ' A' ' 115' ' ' ASN . 4.7 t70 -56.13 -44.57 79.28 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.46 1.104 . . . . 74.0 109.654 175.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 99.6 mttt -55.56 -29.67 59.41 Favored 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 115.19 -0.914 . . . . 74.54 112.888 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.49 ' HA ' HG11 ' A' ' 91' ' ' VAL . 17.4 ptp180 -119.53 18.03 12.83 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 121.45 0.643 . . . . 53.33 111.566 -172.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.447 ' OG ' ' HG2' ' A' ' 84' ' ' GLU . 47.2 t -107.57 169.15 8.76 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.788 -0.642 . . . . 72.02 111.249 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 111' ' ' PRO . 11.2 m -140.33 163.72 23.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 124.496 1.118 . . . . 55.22 111.488 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.423 ' HB3' ' HB2' ' A' ' 110' ' ' LEU . 21.4 t80 -116.26 129.7 56.41 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 125.227 1.411 . . . . 65.5 109.608 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 63.0 t -109.12 117.49 54.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.744 -1.206 . . . . 62.34 107.744 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.04 163.75 12.13 Favored Glycine 0 N--CA 1.426 -2.01 0 C-N-CA 119.522 -1.323 . . . . 60.21 113.055 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.9 t30 63.38 13.06 6.76 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.895 1.678 . . . . 63.45 112.883 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.9 p -64.49 137.62 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.452 0.644 . . . . 71.42 109.533 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -91.09 159.02 16.32 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.394 -0.821 . . . . 53.22 111.435 -174.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.463 ' CE2' ' HB2' ' A' ' 77' ' ' PRO . 4.5 m-85 -61.09 -19.16 61.12 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 114.951 -1.022 . . . . 70.4 112.013 178.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.86 -24.11 77.34 Favored Glycine 0 N--CA 1.428 -1.856 0 CA-C-N 115.88 -0.6 . . . . 73.5 111.727 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.5 m -86.32 140.01 30.46 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 120.581 -0.447 . . . . 74.52 109.844 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.465 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 76.0 p -109.15 173.25 6.4 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.119 -0.492 . . . . 63.13 110.778 -176.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.424 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -67.19 -45.27 77.42 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 110.062 -0.348 . . . . 72.51 110.062 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -58.49 -42.28 87.22 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.472 -0.331 . . . . 73.1 111.229 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.465 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 1.4 t70 -64.35 -37.9 89.13 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.689 0.757 . . . . 72.34 109.02 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 33.7 mt -68.51 -47.93 65.71 Favored 'General case' 0 C--O 1.249 1.038 0 CA-C-N 114.965 -1.016 . . . . 75.4 111.096 177.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -60.81 -49.8 76.03 Favored 'General case' 0 C--O 1.198 -1.654 0 CA-C-N 116.355 -0.384 . . . . 63.22 111.144 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.49 -40.08 77.84 Favored 'General case' 0 C--O 1.258 1.53 0 CA-C-O 121.367 0.603 . . . . 75.25 111.184 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -69.02 -41.09 78.2 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.154 -0.93 . . . . 61.14 110.715 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -82.66 -22.85 34.46 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 113.055 0.761 . . . . 75.32 113.055 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.7 m -72.11 -21.23 61.51 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-N 115.19 -0.914 . . . . 75.35 110.979 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.1 m -57.68 -17.78 16.92 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.388 -0.369 . . . . 53.2 111.161 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.872 ' SG ' ' HA ' ' A' ' 90' ' ' SER . 44.1 t -94.4 -76.56 0.48 Allowed 'General case' 0 N--CA 1.417 -2.08 0 CA-C-O 120.789 0.328 . . . . 54.11 110.638 175.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -130.06 -143.33 5.38 Favored Glycine 0 CA--C 1.508 -0.351 0 C-N-CA 120.257 -0.973 . . . . 54.45 115.217 -176.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.0 m -105.13 121.51 43.96 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 122.437 0.295 . . . . 71.34 110.991 -173.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 61.2 mt -85.22 129.27 38.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 116.028 -0.533 . . . . 64.31 112.014 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -93.4 -44.75 8.12 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.51 0.724 . . . . 75.44 111.504 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -149.12 159.55 44.14 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.216 -0.902 . . . . 75.14 110.27 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.442 HD13 HG21 ' A' ' 66' ' ' ILE . 39.4 pt -145.34 135.0 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.994 0 N-CA-C 106.753 -1.573 . . . . 73.32 106.753 170.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.0 m -124.78 123.8 40.75 Favored 'General case' 0 C--N 1.272 -2.799 0 N-CA-C 106.112 -1.81 . . . . 75.11 106.112 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.6 mp -121.24 117.39 52.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 106.562 -1.644 . . . . 72.3 106.562 -175.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.35 0.9 OUTLIER -121.32 129.83 53.31 Favored 'General case' 0 C--N 1.274 -2.676 0 C-N-CA 120.127 -0.629 . . . . 74.33 112.558 177.763 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.576 ' HB2' HG12 ' B' ' 66' ' ' ILE . 81.0 m -116.55 121.21 41.1 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 115.647 -0.706 . . . . 74.35 109.256 -177.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.608 ' HA ' ' HA ' ' B' ' 65' ' ' ARG . 1.1 t70 -117.48 125.45 50.92 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 123.757 0.823 . . . . 70.14 110.586 -173.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.55 ' HE2' ' HB3' ' A' ' 77' ' ' PRO . 39.6 ttmt -115.9 16.73 16.17 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.224 -0.658 . . . . 73.5 109.224 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.423 ' HD1' ' N ' ' A' ' 74' ' ' SER . 0.0 OUTLIER -63.61 -23.15 67.26 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 119.934 -0.706 . . . . 74.5 112.817 -175.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.423 ' N ' ' HD1' ' A' ' 73' ' ' PHE . 14.9 m -81.79 -0.9 45.32 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.154 -0.475 . . . . 62.32 111.134 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.9 -40.57 2.38 Favored Glycine 0 CA--C 1.5 -0.881 0 N-CA-C 110.095 -1.202 . . . . 75.33 110.095 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -95.14 130.28 33.0 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 107.923 -1.14 . . . . 61.41 107.923 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.55 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 36.8 Cg_endo -70.74 118.07 5.49 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.387 1.392 . . . . 72.32 110.505 177.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 37.2 mtmm -108.61 151.45 26.11 Favored 'General case' 0 CA--C 1.476 -1.898 0 CA-C-N 116.242 -0.436 . . . . 72.2 109.943 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.42 140.07 11.5 Favored Glycine 0 N--CA 1.409 -3.159 0 C-N-CA 120.517 -0.849 . . . . 72.21 111.025 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -151.41 144.13 24.37 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.788 -0.449 . . . . 73.51 109.788 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.42 154.81 49.89 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.968 -0.382 . . . . 74.42 109.968 -173.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -122.39 120.57 34.37 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 108.544 -0.91 . . . . 73.2 108.544 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.5 mm -101.73 119.22 49.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 107.17 -1.418 . . . . 74.14 107.17 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.447 ' HG2' ' OG ' ' A' ' 38' ' ' SER . 32.9 mt-10 -104.97 120.47 41.53 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.157 -0.682 . . . . 55.11 109.157 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -100.38 165.44 11.45 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 121.378 0.609 . . . . 65.14 112.055 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.48 ' O ' ' HD3' ' A' ' 37' ' ' ARG . . . -81.16 -32.37 33.67 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.728 -1.124 . . . . 42.32 110.965 175.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -123.5 160.67 26.46 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 113.246 0.832 . . . . 74.03 113.246 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -69.54 -32.48 71.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.359 -1.291 . . . . 75.24 112.279 174.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -60.74 -36.56 79.19 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.948 -0.301 . . . . 73.51 110.702 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.872 ' HA ' ' SG ' ' A' ' 60' ' ' CYS . 14.8 m -63.33 -45.2 92.34 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 116.574 -0.284 . . . . 61.35 111.403 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.49 HG11 ' HA ' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -65.7 -43.2 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 119.317 -0.373 . . . . 73.34 111.71 177.54 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.2 -35.28 75.04 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.687 0.625 . . . . 72.03 112.687 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.579 ' HB3' ' SG ' ' A' ' 60' ' ' CYS . . . -75.34 -37.89 60.46 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.122 0.486 . . . . 64.21 110.954 177.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.51 -40.64 76.83 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 116.086 -0.507 . . . . 73.22 111.861 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 91' ' ' VAL . 24.5 m -56.64 -22.16 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 112.282 0.475 . . . . 62.31 112.282 177.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.89 -19.38 62.62 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-O 120.894 0.378 . . . . 64.51 110.043 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 32.4 mtm -88.46 7.68 31.67 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.202 0.601 . . . . 75.4 111.935 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.564 ' HA ' ' HB ' ' A' ' 109' ' ' VAL . 7.3 t70 -33.39 -54.11 0.41 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 116.938 2.199 . . . . 55.33 116.938 -178.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -124.42 45.37 2.53 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 120.495 1.498 . . . . 74.33 110.125 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 42.9 m -84.95 162.37 19.44 Favored 'General case' 0 CA--C 1.571 1.759 0 CA-C-N 114.3 -1.318 . . . . 63.2 109.752 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.0 p -99.71 137.86 25.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 O-C-N 121.465 -0.772 . . . . 72.2 110.646 -174.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -151.2 117.87 5.77 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.467 -0.938 . . . . 65.22 108.467 -177.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.381 83.2 mtt85 59.99 55.09 3.92 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 116.078 1.881 . . . . 71.23 116.078 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.99 -13.05 1.45 Allowed Glycine 0 N--CA 1.469 0.856 0 CA-C-N 114.806 -1.088 . . . . 44.2 114.893 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -119.39 161.08 21.09 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-O 121.012 0.434 . . . . 71.45 110.383 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.9 m -94.59 127.81 40.78 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 108.366 -0.975 . . . . 64.2 108.366 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 48.2 pt -101.37 171.27 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.334 0 C-N-CA 119.782 -0.767 . . . . 75.25 109.949 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 55.1 tptt -125.88 129.35 49.17 Favored 'General case' 0 N--CA 1.409 -2.522 0 CA-C-N 114.791 -1.095 . . . . 64.11 108.809 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.564 ' HB ' ' HA ' ' A' ' 98' ' ' ASP . 47.3 t -119.95 112.25 36.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 107.658 -1.238 . . . . 72.41 107.658 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 40' ' ' TYR . 72.8 mt -112.4 152.59 44.67 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 109.017 -0.734 . . . . 75.2 109.017 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.452 ' HA ' HG12 ' A' ' 39' ' ' VAL . 3.3 Cg_exo -75.44 129.9 12.36 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 N-CA-C 107.892 -1.618 . . . . 52.41 107.892 171.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.418 ' H ' ' HA ' ' A' ' 39' ' ' VAL . 87.1 tttt -76.35 112.66 13.09 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 107.584 -1.265 . . . . 71.24 107.584 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -149.72 156.91 42.66 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 115.671 -0.695 . . . . 74.44 110.774 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 13.8 m 70.37 17.52 6.94 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-O 122.031 0.92 . . . . 75.52 109.607 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.444 ' HB2' ' OD1' ' A' ' 35' ' ' ASP . 0.8 OUTLIER -91.49 16.23 10.75 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.733 -0.604 . . . . 73.21 109.923 178.444 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.468 ' SD ' ' HE3' ' A' ' 32' ' ' LYS . 54.6 mtm -60.35 122.2 65.46 Favored Pre-proline 0 C--O 1.24 0.579 0 CA-C-N 115.195 -0.911 . . . . 75.23 109.754 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -55.68 141.17 84.49 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 123.075 2.517 . . . . 63.21 112.508 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -93.4 -155.49 31.95 Favored Glycine 0 N--CA 1.434 -1.457 0 CA-C-N 115.608 -0.723 . . . . 45.24 111.355 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . 0.316 2.1 pp -76.74 94.5 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 114.025 1.12 . . . . 73.13 114.025 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.428 ' HA ' ' HD2' ' B' ' 12' ' ' LYS . 32.4 t -152.57 100.07 2.52 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.897 -1.047 . . . . 75.22 108.279 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.3 t -155.83 96.79 1.77 Allowed 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.219 0.533 . . . . 61.32 110.647 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.0 t -131.58 16.27 4.88 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.198 -1.038 . . . . 70.14 108.198 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -143.82 131.15 20.87 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 114.564 -1.198 . . . . 65.35 108.62 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 . . . . . 0 C--N 1.303 -1.44 0 N-CA-C 109.652 -0.499 . . . . 74.22 109.652 -178.056 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.967 0 N-CA-C 109.295 -0.632 . . . . 61.22 109.295 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 50.4 mm -90.57 110.75 22.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 109.156 -0.683 . . . . 72.51 109.156 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -135.91 106.05 9.7 Favored Pre-proline 0 C--N 1.301 -1.537 0 CA-C-N 115.821 -0.627 . . . . 45.43 109.681 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.71 130.66 22.47 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.349 2.033 . . . . 74.32 112.179 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 19.2 p -98.68 6.99 46.62 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.324 0.583 . . . . 73.14 110.616 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -80.51 156.48 26.5 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.486 -0.779 . . . . 72.12 110.853 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . 0.476 ' HB3' ' O ' ' B' ' 113' ' ' ARG . 0.0 OUTLIER -142.37 171.52 13.95 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.573 -0.74 . . . . 73.13 110.001 177.602 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 57.1 m -77.2 116.97 18.28 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 120.988 0.423 . . . . 54.13 110.943 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 88.2 m -57.5 133.79 55.53 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.608 0.763 . . . . 75.31 110.143 176.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -75.71 132.77 40.74 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.728 0.64 . . . . 64.44 112.728 -175.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 18.7 m -66.22 -28.86 69.06 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 109.249 -0.648 . . . . 43.24 109.249 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . 0.428 ' HD2' ' HA ' ' A' ' 120' ' ' SER . 61.6 tttp 177.43 -64.81 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 125.613 1.565 . . . . 63.33 107.516 174.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 25.9 mmt 63.54 86.22 0.12 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.656 -1.156 . . . . 74.32 113.772 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 11.2 t 171.05 -29.79 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 125.106 1.363 . . . . 74.44 107.781 173.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.95 178.75 10.0 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.954 -1.499 . . . . 63.42 106.954 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.23 -56.09 3.96 Favored Glycine 0 C--N 1.312 -0.781 0 C-N-CA 120.693 -0.765 . . . . 64.22 112.534 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.48 119.48 34.05 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.894 -0.41 . . . . 23.41 109.894 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -121.9 -66.41 1.04 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.28 -0.568 . . . . 72.44 110.804 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.482 ' HB ' ' CB ' ' B' ' 25' ' ' PRO . 10.1 t -140.32 155.85 46.65 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.201 -0.6 . . . . 73.52 111.129 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -76.0 -23.36 55.23 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.027 -0.988 . . . . 74.54 110.665 176.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.97 -140.62 5.89 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 120.848 -0.692 . . . . 51.23 112.141 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.439 ' N ' ' HD2' ' B' ' 23' ' ' PRO . 72.1 Cg_exo -49.74 -44.9 34.19 Favored 'Trans proline' 0 CA--C 1.567 2.125 0 C-N-CA 123.871 3.048 . . . . 73.02 116.031 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' B' ' 22' ' ' PRO . 10.3 Cg_endo -53.84 142.2 63.82 Favored 'Trans proline' 0 C--N 1.395 2.975 0 C-N-CA 121.96 1.774 . . . . 75.05 111.36 176.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -54.16 129.16 58.84 Favored Pre-proline 0 C--O 1.241 0.63 0 N-CA-C 113.454 0.909 . . . . 71.42 113.454 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.482 ' CB ' ' HB ' ' B' ' 19' ' ' THR . 5.7 Cg_exo -59.99 135.51 63.38 Favored 'Trans proline' 0 CA--C 1.501 -1.155 0 C-N-CA 123.641 2.894 . . . . 55.02 114.139 -177.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.512 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -113.92 125.89 54.54 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 107.037 -1.468 . . . . 73.11 107.037 173.346 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 32.8 t -71.84 173.94 7.58 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 113.479 0.918 . . . . 54.14 113.479 -168.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.511 ' O ' ' HG3' ' B' ' 32' ' ' LYS . . . -49.0 -46.17 43.54 Favored 'General case' 0 C--O 1.21 -0.982 0 CA-C-N 114.491 -1.231 . . . . 72.3 112.288 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -68.0 -33.01 73.8 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 112.054 0.39 . . . . 72.33 112.054 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.44 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.9 OUTLIER -65.71 -39.42 91.2 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.446 -0.576 . . . . 60.02 109.446 172.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -67.06 -36.87 82.98 Favored 'General case' 0 C--O 1.207 -1.149 0 CA-C-N 115.573 -0.739 . . . . 74.01 110.087 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' B' ' 28' ' ' ALA . 59.9 mtpt -66.35 -40.24 89.69 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 113.497 0.925 . . . . 75.53 113.497 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -70.08 -39.77 75.39 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 120.299 -0.56 . . . . 71.2 111.281 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.44 HG12 ' O ' ' B' ' 30' ' ' GLU . 11.1 pt -70.57 -32.99 51.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.785 -0.643 . . . . 63.21 110.328 178.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.53 ' OD2' ' HB2' ' B' ' 113' ' ' ARG . 10.4 t70 -56.35 -42.96 78.6 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.827 1.251 . . . . 72.4 109.699 176.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.54 ' HA ' ' HB3' ' B' ' 113' ' ' ARG . 97.7 mttt -57.64 -33.28 68.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.05 -0.977 . . . . 64.22 112.015 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -102.89 2.55 35.42 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 123.713 0.805 . . . . 73.11 111.23 -172.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 71.1 p -104.33 162.94 12.79 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 114.51 1.3 . . . . 62.23 114.51 -175.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 13.9 m -133.4 163.61 37.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.674 -1.148 . . . . 40.2 111.08 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . 0.486 ' CD2' HD12 ' B' ' 110' ' ' LEU . 23.1 t80 -116.17 130.53 56.84 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 125.281 1.432 . . . . 74.11 109.346 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 71.7 t -109.89 120.49 61.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 124.766 1.226 . . . . 41.11 109.06 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -118.59 169.38 13.44 Favored Glycine 0 N--CA 1.427 -1.95 0 C-N-CA 120.139 -1.029 . . . . 41.12 112.453 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 60.6 t30 65.97 12.54 8.5 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 126.451 1.901 . . . . 75.23 112.834 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -72.09 117.43 15.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 108.218 -1.03 . . . . 63.2 108.218 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -77.04 162.0 27.86 Favored 'General case' 0 C--O 1.253 1.288 0 C-N-CA 119.941 -0.703 . . . . 73.13 111.611 -173.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -69.01 98.52 0.97 Allowed 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 107.21 -1.404 . . . . 74.35 107.21 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 159.15 -26.08 0.36 Allowed Glycine 0 N--CA 1.417 -2.574 0 C-N-CA 120.539 -0.838 . . . . 61.21 112.051 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.7 t -77.18 149.46 35.57 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.7 -1.222 . . . . 72.23 107.7 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 25.2 p -99.55 167.54 10.53 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.444 -0.502 . . . . 74.12 110.883 -173.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.44 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -71.04 -41.78 70.34 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 109.102 -0.703 . . . . 74.15 109.102 177.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -57.39 -44.16 84.25 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.136 -0.484 . . . . 72.43 111.094 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.88 -45.95 78.45 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.133 0.492 . . . . 64.22 110.381 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 74.6 mt -64.26 -47.68 78.69 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.094 -0.957 . . . . 73.43 111.862 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.445 ' HG3' HD12 ' B' ' 63' ' ' ILE . 34.1 tt0 -62.92 -50.85 69.22 Favored 'General case' 0 C--O 1.199 -1.59 0 C-N-CA 120.498 -0.481 . . . . 73.43 111.372 -178.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.97 -40.08 72.73 Favored 'General case' 0 C--O 1.257 1.467 0 CA-C-O 121.594 0.711 . . . . 73.24 111.454 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -69.35 -41.56 76.45 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.78 -1.1 . . . . 73.45 110.542 -176.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -83.06 -23.19 33.27 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.903 0.705 . . . . 73.34 112.903 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 67.1 m -71.32 -22.72 61.89 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 115.472 -0.785 . . . . 62.21 109.534 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 58.3 m -65.84 -18.12 65.12 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.739 -0.664 . . . . 62.3 109.96 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . 0.565 ' O ' ' HA ' ' B' ' 90' ' ' SER . 70.3 m -115.29 19.18 15.74 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 116.245 -0.434 . . . . 54.25 111.669 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . 0.43 ' HA3' ' OG ' ' B' ' 90' ' ' SER . . . 149.03 -162.64 28.99 Favored Glycine 0 N--CA 1.46 0.284 0 C-N-CA 118.282 -1.913 . . . . 72.04 116.034 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 15.1 m -111.1 115.1 28.86 Favored 'General case' 0 C--O 1.25 1.092 0 C-N-CA 123.018 0.527 . . . . 71.14 110.399 -175.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.445 HD12 ' HG3' ' B' ' 54' ' ' GLU . 65.5 mt -80.73 130.85 35.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.668 0.747 . . . . 71.45 112.995 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -100.31 -43.81 6.14 Favored 'General case' 0 C--O 1.21 -1.001 0 N-CA-C 107.09 -1.448 . . . . 61.25 107.09 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.608 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 86.4 mtt180 -153.64 161.88 41.76 Favored 'General case' 0 C--O 1.21 -1.014 0 C-N-CA 123.732 0.813 . . . . 75.41 110.384 176.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.576 HG12 ' HB2' ' A' ' 70' ' ' CYS . 31.9 pt -144.79 137.81 22.15 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.495 0 N-CA-C 106.656 -1.609 . . . . 73.32 106.656 169.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' B' ' 81' ' ' ALA . 53.3 m -125.75 120.82 31.64 Favored 'General case' 0 C--N 1.273 -2.745 0 N-CA-C 106.912 -1.514 . . . . 63.03 106.912 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mp -117.08 116.72 52.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 106.278 -1.749 . . . . 72.31 106.278 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.306 1.5 pt? -122.12 132.69 54.61 Favored 'General case' 0 C--N 1.275 -2.669 0 C-N-CA 119.666 -0.814 . . . . 73.04 111.531 176.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 73.5 m -116.68 120.5 38.82 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 115.108 -0.951 . . . . 54.43 108.592 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.426 ' HB2' ' CE2' ' B' ' 73' ' ' PHE . 2.4 p-10 -106.14 121.66 44.62 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 116.513 -2.075 . . . . 71.43 111.061 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.468 ' HE3' ' HG3' ' B' ' 77' ' ' PRO . 43.8 mtpt -118.05 -6.79 10.91 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.446 -1.252 . . . . 74.1 111.157 -176.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.426 ' CE2' ' HB2' ' B' ' 71' ' ' ASP . 52.6 p90 -69.93 -17.2 63.31 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.556 0.693 . . . . 63.25 109.837 -177.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 20.1 m -81.21 -1.78 46.12 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.283 -0.871 . . . . 71.31 109.692 176.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.26 -59.66 0.37 Allowed Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 110.979 -0.849 . . . . 65.24 110.979 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . 0.478 ' HA ' ' HD3' ' B' ' 77' ' ' PRO . 72.5 m80 -96.5 131.15 28.9 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 110.167 -0.308 . . . . 72.41 110.167 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' B' ' 76' ' ' HIS . 13.6 Cg_exo -72.87 119.28 5.98 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.589 2.193 . . . . 51.45 112.616 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 37.1 mtmm -112.31 154.83 25.08 Favored 'General case' 0 CA--C 1.48 -1.732 0 N-CA-C 108.069 -1.086 . . . . 71.0 108.069 174.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.56 141.13 12.29 Favored Glycine 0 N--CA 1.411 -3.027 0 C-N-CA 119.612 -1.28 . . . . 74.31 112.325 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -154.61 145.33 22.4 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.001 -0.599 . . . . 74.52 109.634 175.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' B' ' 67' ' ' THR . . . -137.69 154.98 49.59 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 116.216 -0.447 . . . . 53.3 110.381 -172.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' TYR . . . . . 0.613 ' OH ' ' HA3' ' A' ' 21' ' ' GLY . 49.1 m-85 -123.61 119.08 28.82 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.624 -0.88 . . . . 70.31 108.624 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.53 HG23 HG22 ' B' ' 66' ' ' ILE . 19.5 mm -101.66 119.94 50.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 107.07 -1.456 . . . . 75.42 107.07 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -107.19 125.55 51.25 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 108.579 -0.897 . . . . 64.53 108.579 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -106.7 164.52 12.02 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 120.994 0.426 . . . . 72.22 110.471 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.95 -18.72 23.31 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.743 -0.662 . . . . 72.32 111.097 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -127.24 142.06 51.57 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.297 -0.411 . . . . 74.41 111.118 -176.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -61.29 -34.4 75.15 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.116 0.784 . . . . 63.33 113.116 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -56.84 -37.16 70.89 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.537 -0.301 . . . . 74.11 111.103 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' B' ' 60' ' ' CYS . 15.0 m -62.92 -43.91 97.5 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 111.766 0.284 . . . . 74.33 111.766 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.494 ' O ' HG13 ' B' ' 95' ' ' VAL 0.3 0.7 OUTLIER -67.31 -42.9 88.18 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 C-N-CA 120.426 -0.51 . . . . 65.51 111.924 177.515 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -59.55 -36.29 75.88 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.491 -0.484 . . . . 74.14 112.291 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.19 -35.68 63.97 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.802 0.334 . . . . 74.23 111.402 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.57 -38.42 62.68 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.254 -0.43 . . . . 75.04 111.958 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . 0.494 HG13 ' O ' ' B' ' 91' ' ' VAL . 28.0 m -58.94 -23.3 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 112.175 0.435 . . . . 72.43 112.175 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.24 -9.89 58.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.419 0.628 . . . . 52.14 111.142 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 8.0 ttp -103.23 7.05 38.52 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.383 -0.969 . . . . 61.23 108.383 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . 0.515 ' HA ' ' HB ' ' B' ' 109' ' ' VAL . 4.1 p-10 -41.24 -56.79 2.3 Favored 'General case' 0 C--O 1.209 -1.062 0 N-CA-C 113.463 0.912 . . . . 61.04 113.463 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -101.7 97.12 7.57 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 118.474 0.579 . . . . 71.45 109.735 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 26.0 p -145.83 165.04 30.05 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.212 -0.904 . . . . 74.21 110.537 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 p -107.63 119.46 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-O 121.359 0.599 . . . . 73.3 109.968 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -131.91 127.77 37.13 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.688 -0.687 . . . . 72.13 109.255 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 48.6 ttt-85 62.17 33.2 17.02 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 122.547 1.165 . . . . 74.43 110.229 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.41 5.98 86.45 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 114.073 -1.421 . . . . 70.14 114.899 175.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -136.92 155.72 49.39 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 117.76 0.78 . . . . 71.11 111.077 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 46.8 m -78.49 123.92 27.57 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.921 -0.77 . . . . 63.14 108.921 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 41.4 pt -101.38 171.35 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 C-N-CA 119.969 -0.692 . . . . 74.51 109.643 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -124.43 137.48 54.44 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 106.858 -1.534 . . . . 55.0 106.858 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.515 ' HB ' ' HA ' ' B' ' 98' ' ' ASP . 24.9 t -127.33 122.72 60.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.636 -1.246 . . . . 65.43 107.636 174.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.486 HD12 ' CD2' ' B' ' 40' ' ' TYR . 73.9 mt -121.08 150.1 52.75 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 109.308 -0.627 . . . . 74.0 109.308 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.531 ' HG2' ' HB2' ' B' ' 115' ' ' ASN . 1.1 Cg_endo -81.63 135.28 9.05 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 C-N-CA 121.778 1.652 . . . . 75.01 108.16 170.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -73.87 -28.62 61.66 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.484 -0.887 . . . . 74.24 109.477 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.54 ' HB3' ' HA ' ' B' ' 36' ' ' LYS . 4.3 tpp180 -119.9 -79.06 0.6 Allowed 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 113.254 0.835 . . . . 72.15 113.254 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.465 HG23 ' HG3' ' B' ' 113' ' ' ARG . 4.3 p -122.67 139.41 53.97 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 113.14 0.792 . . . . 72.33 113.14 -172.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' ASN . . . . . 0.531 ' HB2' ' HG2' ' B' ' 111' ' ' PRO . 7.2 t30 -107.44 -18.65 13.8 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.987 -1.006 . . . . 70.54 108.353 174.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 50.2 ttm -84.45 118.0 70.07 Favored Pre-proline 0 N--CA 1.443 -0.777 0 CA-C-N 115.085 -0.961 . . . . 73.31 108.478 177.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' PRO . . . . . 0.454 ' HB2' HG13 ' B' ' 119' ' ' ILE . 1.8 Cg_endo -81.37 -69.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.136 1.89 . . . . 74.31 113.588 -177.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . 80.93 29.91 40.48 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 110.976 -0.85 . . . . 73.41 110.976 -177.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.454 HG13 ' HB2' ' B' ' 117' ' ' PRO . 67.0 mt -57.46 -44.54 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 122.748 0.419 . . . . 75.43 110.304 -178.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 15.8 m 67.54 7.66 5.77 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.392 1.077 . . . . 73.22 111.574 177.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 26.3 t -133.17 -177.64 4.61 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 107.777 -1.194 . . . . 71.31 107.777 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 9.8 t -136.29 150.23 48.81 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.067 -0.716 . . . . 63.4 109.067 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -101.22 140.27 35.75 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.497 -1.298 . . . . 73.42 107.497 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.294 -1.82 0 N-CA-C 108.622 -0.881 . . . . 52.51 108.622 -175.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.569 0 N-CA-C 109.994 -0.373 . . . . 60.43 109.994 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.7 tt -89.9 110.55 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 108.67 -0.863 . . . . 72.21 108.67 176.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -95.98 114.33 63.93 Favored Pre-proline 0 C--N 1.311 -1.1 0 CA-C-N 115.48 -0.782 . . . . 74.25 111.035 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.66 147.92 46.17 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.202 1.935 . . . . 73.24 110.035 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 20.0 p -101.39 87.91 3.33 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.801 -0.759 . . . . 73.21 113.023 -176.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -76.61 145.7 38.72 Favored 'General case' 0 C--O 1.249 1.046 0 N-CA-C 107.005 -1.479 . . . . 73.01 107.005 174.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -165.3 110.42 0.9 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.285 0.564 . . . . 72.43 110.811 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.9 t -87.78 87.38 7.35 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-O 122.554 1.168 . . . . 70.42 109.846 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.6 p -102.66 101.16 11.27 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 114.939 -1.028 . . . . 72.0 109.783 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 55.5 m80 -142.57 140.67 31.82 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.501 -0.926 . . . . 73.33 108.501 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.597 ' HA ' ' HD2' ' A' ' 78' ' ' LYS . 24.1 m -79.36 100.91 7.83 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-O 121.137 0.494 . . . . 43.31 110.369 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -74.45 113.45 11.7 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.257 -0.883 . . . . 71.22 112.15 -177.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.4 mpt? 30.77 91.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 126.53 1.932 . . . . 73.51 114.614 174.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.44 ' O ' ' HB3' ' B' ' 23' ' ' PRO . 12.2 t -152.72 140.48 19.99 Favored 'General case' 0 N--CA 1.417 -2.115 0 C-N-CA 120.253 -0.579 . . . . 71.04 110.39 -177.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.46 ' HB3' HD12 ' B' ' 26' ' ' LEU . . . -156.34 159.44 38.79 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 116.649 -0.25 . . . . 75.1 110.357 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.425 ' HA3' ' NH1' ' B' ' 65' ' ' ARG . . . -172.28 -141.67 3.5 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 109.663 -1.375 . . . . 45.11 109.663 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -173.69 148.58 1.51 Allowed 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 123.007 0.523 . . . . 75.52 110.69 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -118.64 151.5 37.81 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.554 -0.535 . . . . 63.22 109.554 176.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.9 m -144.53 142.67 30.38 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.1 -0.704 . . . . 74.43 109.1 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.554 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 41.9 mt-10 -63.16 -31.31 72.42 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 114.951 1.463 . . . . 72.54 114.951 -175.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.21 -118.13 5.24 Favored Glycine 0 N--CA 1.474 1.22 0 C-N-CA 120.959 -0.639 . . . . 42.44 112.829 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -56.32 -47.47 24.09 Favored 'Trans proline' 0 CA--C 1.57 2.277 0 C-N-CA 123.528 2.818 . . . . 52.42 115.504 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.554 ' HD2' ' O ' ' A' ' 20' ' ' GLU . 75.2 Cg_exo -54.0 133.8 56.71 Favored 'Trans proline' 0 C--N 1.396 3.041 0 C-N-CA 121.652 1.568 . . . . 61.14 111.087 176.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -73.31 142.33 81.63 Favored Pre-proline 0 C--N 1.303 -1.445 0 CA-C-N 116.042 -0.526 . . . . 74.23 111.336 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.73 117.57 5.16 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.561 2.174 . . . . 72.52 112.5 -177.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.741 HD13 ' H ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -72.96 176.2 5.94 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.348 -0.842 . . . . 73.41 111.189 178.32 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.6 t -58.76 144.75 42.81 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 113.02 0.748 . . . . 60.42 113.02 -174.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 31' ' ' LYS . . . -54.2 -34.08 59.74 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.633 -1.167 . . . . 60.14 111.311 173.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -72.27 -34.83 68.5 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 119.399 -0.92 . . . . 74.31 109.648 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.493 ' O ' HG12 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -63.54 -36.02 82.4 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.565 -0.531 . . . . 73.41 109.565 174.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 28' ' ' ALA . 74.7 mmtt -59.13 -47.82 83.89 Favored 'General case' 0 C--O 1.208 -1.12 0 N-CA-C 108.819 -0.808 . . . . 70.22 108.819 177.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -60.2 -46.11 90.84 Favored 'General case' 0 C--O 1.209 -1.056 0 N-CA-C 113.46 0.911 . . . . 74.3 113.46 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -69.58 -41.01 76.39 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.102 -0.639 . . . . 72.54 112.259 -176.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 30' ' ' GLU . 27.9 pt -70.12 -35.87 65.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 120.513 -0.475 . . . . 72.45 111.059 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.667 ' OD1' ' HE3' ' A' ' 112' ' ' LYS . 30.0 t70 -68.44 -39.27 81.57 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.397 0.679 . . . . 64.24 110.563 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -66.61 -14.5 62.48 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.709 -0.678 . . . . 72.41 112.295 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -112.73 12.69 19.7 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 110.003 -0.369 . . . . 61.41 110.003 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.515 ' OG ' ' HB3' ' A' ' 112' ' ' LYS . 97.5 p -97.02 157.32 15.96 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.639 0.733 . . . . 75.14 112.392 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.59 HG22 HG23 ' A' ' 91' ' ' VAL . 49.0 t -127.82 151.53 34.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 114.912 -1.04 . . . . 70.44 108.401 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.668 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 24.4 t80 -104.4 127.66 52.12 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 125.055 1.342 . . . . 72.43 107.847 174.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.408 ' HA ' HG12 ' A' ' 109' ' ' VAL . 60.6 t -115.44 116.43 52.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 107.927 -1.138 . . . . 75.43 107.927 177.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.26 164.34 12.09 Favored Glycine 0 C--N 1.29 -1.987 0 C-N-CA 119.669 -1.253 . . . . 75.21 112.946 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 t30 68.75 25.02 6.46 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 125.677 1.591 . . . . 74.3 113.163 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.7 p -78.56 119.82 28.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 118.457 -1.297 . . . . 72.42 108.489 174.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -110.87 149.66 30.29 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.995 -1.113 . . . . 70.14 107.995 -173.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -51.45 115.58 1.67 Allowed 'General case' 0 CA--C 1.496 -1.102 0 CA-C-O 122.287 1.041 . . . . 71.43 112.128 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.19 -33.47 0.93 Allowed Glycine 0 N--CA 1.406 -3.318 0 N-CA-C 107.116 -2.393 . . . . 63.1 107.116 -174.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.5 m -102.61 141.85 34.75 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 108.327 -0.99 . . . . 74.33 108.327 173.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.6 p -115.88 178.73 4.2 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 120.4 0.143 . . . . 75.2 111.148 -176.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.528 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -64.64 -40.39 95.37 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 122.88 0.472 . . . . 75.32 110.542 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.54 -43.19 84.19 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 116.039 -0.528 . . . . 75.32 109.792 176.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -60.57 -38.8 85.78 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.382 0.61 . . . . 45.54 109.924 176.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.25 -46.94 75.38 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.187 -0.915 . . . . 35.42 111.066 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -58.75 -50.71 72.92 Favored 'General case' 0 C--O 1.19 -2.047 0 C-N-CA 120.434 -0.507 . . . . 64.43 111.762 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.8 -48.27 78.32 Favored 'General case' 0 C--O 1.271 2.187 0 CA-C-O 121.595 0.712 . . . . 71.34 111.795 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -67.31 -40.47 86.0 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.848 -1.069 . . . . 72.44 110.609 -175.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.467 ' HZ ' HG11 ' A' ' 109' ' ' VAL . 43.8 m-85 -81.57 -22.9 37.5 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 114.365 1.246 . . . . 54.22 114.365 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.1 m -69.85 -24.41 63.43 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.391 -0.368 . . . . 72.35 110.144 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.4 m -59.18 -31.22 68.8 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 119.908 -0.717 . . . . 74.34 109.674 172.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 60.9 m -85.92 3.05 43.64 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 112.909 0.707 . . . . 55.21 112.909 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.94 -158.09 26.15 Favored Glycine 0 N--CA 1.463 0.479 0 C-N-CA 119.528 -1.32 . . . . 65.52 114.138 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.1 m -105.46 126.03 51.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.925 0.393 . . . . 72.15 110.981 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 63.3 mt -91.74 127.28 44.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 115.633 -0.712 . . . . 65.51 111.885 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.554 ' ND2' ' HA ' ' A' ' 86' ' ' ALA . 90.3 m-20 -89.23 -42.1 11.82 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 121.325 0.583 . . . . 72.24 111.276 175.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.432 ' HG2' ' HA ' ' B' ' 71' ' ' ASP . 77.1 mtt180 -153.32 161.23 42.57 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.716 -0.675 . . . . 73.14 110.03 -176.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.528 HD11 ' HB1' ' A' ' 50' ' ' ALA . 35.0 pt -146.0 139.69 21.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 107.562 -1.273 . . . . 74.51 107.562 172.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.4 m -124.74 125.98 44.93 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 106.295 -1.743 . . . . 72.11 106.295 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mp -123.27 117.69 52.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 105.883 -1.895 . . . . 51.23 105.883 -177.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.288 1.0 OUTLIER -120.38 128.46 53.25 Favored 'General case' 0 C--N 1.284 -2.28 0 C-N-CA 120.443 -0.503 . . . . 74.13 112.175 179.031 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 78.3 m -115.31 129.31 56.57 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 115.759 -0.655 . . . . 61.03 110.1 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.454 ' HA ' ' HG2' ' B' ' 65' ' ' ARG . 17.0 t70 -114.69 125.33 53.61 Favored 'General case' 0 CA--C 1.492 -1.285 0 N-CA-C 112.174 0.435 . . . . 64.02 112.174 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -122.12 9.56 9.91 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 109.078 -0.712 . . . . 73.15 109.078 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.498 ' HB3' ' HB3' ' B' ' 64' ' ' ASN . 0.1 OUTLIER -64.79 -16.76 63.48 Favored 'General case' 0 C--N 1.361 1.095 0 N-CA-C 113.438 0.903 . . . . 62.53 113.438 -175.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.3 t -100.14 16.57 23.72 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-O 121.542 0.687 . . . . 70.13 109.847 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.64 -53.1 1.01 Allowed Glycine 0 CA--C 1.497 -1.066 0 C-N-CA 120.324 -0.941 . . . . 53.13 111.909 176.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -88.19 132.33 39.92 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 109.061 -0.718 . . . . 72.11 109.061 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -80.17 117.74 3.55 Favored 'Trans proline' 0 N--CA 1.431 -2.164 0 C-N-CA 121.329 1.353 . . . . 70.44 110.001 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.597 ' HD2' ' HA ' ' A' ' 11' ' ' SER . 34.2 mtmm -115.19 162.7 16.69 Favored 'General case' 0 CA--C 1.466 -2.268 0 C-N-CA 123.9 0.88 . . . . 74.05 108.692 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -144.13 149.99 22.03 Favored Glycine 0 N--CA 1.411 -3.027 0 C-N-CA 118.914 -1.612 . . . . 22.42 113.481 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -146.99 144.32 29.09 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 114.199 -1.0 . . . . 61.35 108.451 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.17 152.49 50.85 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 110.302 -0.258 . . . . 64.44 110.302 -172.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.448 ' CZ ' ' HD1' ' A' ' 40' ' ' TYR . 69.1 m-85 -121.5 123.51 42.19 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 109.679 -0.489 . . . . 63.42 109.679 176.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.451 HG23 HG22 ' A' ' 66' ' ' ILE . 22.9 mm -102.35 121.05 52.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 107.433 -1.321 . . . . 72.42 107.433 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -103.0 119.3 38.6 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.516 -0.55 . . . . 75.32 109.516 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -96.38 158.94 15.2 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.458 0.647 . . . . 74.32 112.637 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.554 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . . . -67.0 -46.98 72.9 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.671 -1.149 . . . . 71.41 112.054 177.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -119.74 156.93 29.61 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 113.316 0.858 . . . . 73.04 113.316 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -61.98 -28.36 69.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.606 -1.179 . . . . 72.13 112.22 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.351 2.0 p-10 -71.26 -24.48 62.18 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 113.605 0.965 . . . . 50.4 113.605 177.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -72.35 -41.58 66.3 Favored 'General case' 0 N--CA 1.433 -1.294 0 O-C-N 122.204 -0.31 . . . . 74.43 111.344 177.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.59 HG23 HG22 ' A' ' 39' ' ' VAL . 7.6 p -63.42 -39.88 86.96 Favored 'Isoleucine or valine' 0 C--N 1.354 0.79 0 N-CA-C 109.646 -0.501 . . . . 72.41 109.646 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -62.98 -34.84 78.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.583 -0.735 . . . . 72.43 110.155 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.15 -38.68 63.65 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.878 -0.601 . . . . 64.33 112.252 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.88 -40.18 65.81 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 116.049 -0.523 . . . . 74.33 110.923 -176.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.463 HG11 ' HB3' ' A' ' 111' ' ' PRO . 30.0 m -59.43 -22.13 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 113.071 0.767 . . . . 70.41 113.071 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.15 -9.87 58.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 122.192 0.996 . . . . 71.41 110.709 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 8.5 ttp -104.51 7.77 35.37 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.416 -1.266 . . . . 60.23 108.406 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.691 ' HA ' HG22 ' A' ' 109' ' ' VAL . 2.8 p-10 -36.53 -50.92 0.82 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 116.645 2.091 . . . . 63.1 116.645 -175.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -123.69 55.58 1.25 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 119.999 1.272 . . . . 73.51 112.942 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.5 p -92.97 -175.71 3.97 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.119 -1.401 . . . . 71.2 110.837 174.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.95 126.07 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 121.322 0.582 . . . . 61.5 110.58 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -111.12 118.76 36.87 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.079 -0.712 . . . . 72.02 109.079 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 43.42 31.67 0.43 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.562 1.545 . . . . 75.42 113.7 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.59 -8.84 37.65 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.837 -0.697 . . . . 34.31 114.395 175.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -123.41 146.08 48.27 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 118.112 0.956 . . . . 74.3 110.033 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.7 m -78.41 118.87 20.99 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 120.551 -0.46 . . . . 75.05 110.014 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 pp -104.51 169.98 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 116.305 -0.407 . . . . 73.41 110.938 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 57.8 tptt -130.49 131.16 44.99 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.708 -0.849 . . . . 74.21 108.708 -176.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.691 HG22 ' HA ' ' A' ' 98' ' ' ASP . 36.0 m -126.47 135.33 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 120.975 0.417 . . . . 63.44 110.511 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.8 mt -131.03 148.53 70.64 Favored Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 108.981 -0.748 . . . . 60.23 108.981 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.463 ' HB3' HG11 ' A' ' 95' ' ' VAL . 55.5 Cg_endo -79.5 135.29 11.66 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 121.126 1.217 . . . . 32.42 109.341 175.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.667 ' HE3' ' OD1' ' A' ' 35' ' ' ASP . 37.3 ttpt -84.28 68.46 10.19 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 118.03 -1.468 . . . . 73.44 109.731 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -176.53 26.99 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.253 -1.794 . . . . 70.4 112.134 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.8 m -80.66 23.5 0.52 Allowed 'General case' 0 CA--C 1.559 1.297 0 CA-C-O 121.637 0.732 . . . . 64.35 110.157 -175.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 41.6 t30 72.92 -62.19 0.48 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.8 1.24 . . . . 73.54 113.757 173.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.432 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 25.2 mmt -63.22 -50.22 76.18 Favored Pre-proline 0 C--N 1.316 -0.886 0 C-N-CA 120.897 -0.321 . . . . 73.15 111.536 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.432 ' HD3' ' HB2' ' A' ' 116' ' ' MET . 3.1 Cg_exo -81.31 97.67 0.98 Allowed 'Trans proline' 0 N--CA 1.441 -1.587 0 N-CA-C 108.951 -1.211 . . . . 61.14 108.951 170.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 158.77 -165.73 34.18 Favored Glycine 0 N--CA 1.435 -1.368 0 N-CA-C 110.237 -1.145 . . . . 72.34 110.237 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 51.0 mm -109.53 -63.48 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 117.267 0.533 . . . . 64.42 109.772 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.7 t 65.94 -87.15 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.429 1.092 . . . . 70.44 111.243 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.6 t 174.22 -173.36 0.06 Allowed 'General case' 0 C--O 1.248 0.984 0 N-CA-C 106.912 -1.514 . . . . 64.32 106.912 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.9 t -159.03 133.09 7.64 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-O 120.648 0.261 . . . . 73.53 110.734 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.2 t70 68.83 -40.04 0.43 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.911 1.684 . . . . 72.44 114.285 176.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.554 ' NE ' ' HA ' ' A' ' 124' ' ' ARG . 1.8 tpm_? . . . . . 0 C--N 1.3 -1.575 0 N-CA-C 109.858 -0.423 . . . . 72.3 109.858 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.685 0 N-CA-C 109.858 -0.423 . . . . 61.25 109.858 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 48.8 mm -108.07 130.06 61.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.509 -0.923 . . . . 72.43 108.509 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.2 140.54 34.57 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 109.181 -0.674 . . . . 72.11 109.181 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.65 115.81 2.34 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.799 2.333 . . . . 73.21 110.976 177.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 45.6 t -82.1 96.8 7.9 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.852 -0.613 . . . . 73.34 110.54 -175.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 25.3 mmt -97.51 103.33 15.26 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.876 -0.602 . . . . 71.33 110.143 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -102.57 -20.97 14.26 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.208 -0.905 . . . . 52.45 109.068 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 11.4 p -73.85 107.77 6.28 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 115.376 -0.829 . . . . 61.42 111.873 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -154.89 -177.25 6.38 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 107.68 -1.23 . . . . 71.32 107.68 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -146.62 138.67 24.78 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 122.588 0.355 . . . . 74.43 110.104 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 39.5 p -106.63 156.59 18.45 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 116.143 -0.48 . . . . 73.42 110.419 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -138.42 88.4 2.3 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.535 0.683 . . . . 65.05 111.686 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -176.59 151.51 0.94 Allowed 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 114.754 -1.112 . . . . 64.02 109.6 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 33.5 p -112.24 -70.46 0.81 Allowed 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.198 0.523 . . . . 70.23 110.231 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.77 -42.26 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.09 -1.448 . . . . 75.22 107.09 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.86 109.49 0.44 Allowed Glycine 0 N--CA 1.426 -1.993 0 CA-C-N 114.416 -1.265 . . . . 74.11 110.066 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -102.16 108.04 19.3 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.23 -0.655 . . . . 64.14 109.23 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.429 ' HB3' ' HB3' ' B' ' 25' ' ' PRO . 36.8 p90 -133.28 -16.31 2.44 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.389 0.885 . . . . 75.43 113.389 -176.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 36.4 p -88.08 70.98 9.36 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 114.305 1.224 . . . . 74.13 114.305 -178.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -94.49 -47.48 6.54 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 103.468 -2.79 . . . . 65.23 103.468 170.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 162.64 -131.02 2.39 Favored Glycine 0 N--CA 1.411 -2.98 0 N-CA-C 107.606 -2.197 . . . . 60.13 107.606 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.53 ' HG2' ' CE2' ' A' ' 40' ' ' TYR . 57.9 Cg_exo -55.75 -36.31 94.9 Favored 'Trans proline' 0 CA--C 1.58 2.817 0 C-N-CA 123.08 2.52 . . . . 73.34 115.258 174.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.44 ' HB3' ' O ' ' A' ' 14' ' ' THR . 78.1 Cg_exo -53.73 158.74 7.83 Favored 'Trans proline' 0 C--N 1.405 3.518 0 C-N-CA 121.952 1.768 . . . . 74.3 114.033 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -89.6 167.24 18.0 Favored Pre-proline 0 C--N 1.309 -1.178 0 CA-C-N 115.021 -0.99 . . . . 72.42 109.712 -177.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.429 ' HB3' ' HB3' ' B' ' 18' ' ' TYR . 19.5 Cg_endo -77.35 159.75 32.7 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 121.208 1.272 . . . . 52.51 112.596 176.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -146.73 162.23 38.97 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.322 -0.854 . . . . 73.24 109.131 176.419 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.657 ' HB2' ' HG2' ' B' ' 30' ' ' GLU . 71.2 m -65.44 143.74 57.51 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 115.088 1.514 . . . . 55.24 115.088 -171.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' B' ' 31' ' ' LYS . . . -55.72 -34.65 65.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.043 -1.435 . . . . 71.43 112.699 174.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . 0.274 6.0 mt-10 -72.89 -29.22 63.0 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 113.327 0.862 . . . . 71.5 113.327 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.657 ' HG2' ' HB2' ' B' ' 27' ' ' SER . 2.3 mm-40 -67.87 -35.39 78.46 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.085 -1.08 . . . . 72.34 108.085 172.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' B' ' 28' ' ' ALA . 74.7 mmtt -60.81 -48.41 81.93 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.151 -0.932 . . . . 64.23 108.955 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -54.24 -49.39 69.59 Favored 'General case' 0 C--N 1.363 1.156 0 N-CA-C 112.752 0.649 . . . . 62.25 112.752 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -70.63 -42.51 70.78 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 112.825 0.676 . . . . 65.31 112.825 -170.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.491 HG12 ' O ' ' B' ' 30' ' ' GLU . 24.2 pt -68.9 -35.6 70.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.018 0.437 . . . . 74.33 110.31 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -67.53 -43.22 81.32 Favored 'General case' 0 C--O 1.201 -1.476 0 CA-C-N 115.533 -0.758 . . . . 73.0 110.418 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' B' ' 113' ' ' ARG . 53.3 mtpt -63.24 -14.32 48.0 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.226 1.011 . . . . 72.41 113.388 -178.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -118.57 20.86 12.83 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 121.598 0.713 . . . . 72.15 110.644 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.523 ' HB2' ' HB3' ' B' ' 112' ' ' LYS . 40.1 m -97.91 160.42 14.31 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.288 -0.869 . . . . 73.31 111.719 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.558 HG22 HG23 ' B' ' 91' ' ' VAL . 46.2 t -129.9 154.64 40.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.772 -0.825 . . . . 74.52 108.772 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . 0.66 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 30.0 t80 -108.49 125.58 51.95 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 125.214 1.405 . . . . 71.51 107.953 175.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.403 ' HA ' HG12 ' B' ' 109' ' ' VAL . 59.6 t -113.33 117.45 55.45 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.442 0 N-CA-C 108.431 -0.952 . . . . 64.34 108.431 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.93 173.8 15.33 Favored Glycine 0 N--CA 1.433 -1.555 0 C-N-CA 119.963 -1.113 . . . . 74.13 112.671 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 t30 67.97 22.53 8.53 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.697 1.599 . . . . 72.12 112.139 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 13.2 p -95.09 128.44 46.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 O-C-N 121.628 -0.67 . . . . 75.43 110.106 175.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -116.08 167.17 11.22 Favored 'General case' 0 CA--C 1.483 -1.596 0 N-CA-C 108.456 -0.942 . . . . 74.11 108.456 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -51.33 128.14 21.59 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.817 0.818 . . . . 73.13 110.694 173.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.96 -41.78 1.1 Allowed Glycine 0 N--CA 1.415 -2.748 0 N-CA-C 107.41 -2.276 . . . . 61.41 107.41 -172.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.2 m -95.76 140.23 30.85 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.046 -1.094 . . . . 72.31 108.046 174.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 74.0 p -111.3 177.62 4.6 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.693 -0.403 . . . . 72.04 110.499 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.505 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -66.88 -39.05 87.38 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.996 -0.372 . . . . 70.03 109.996 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.73 -44.05 85.73 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.848 -0.615 . . . . 73.15 109.997 175.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -56.99 -44.67 82.96 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.577 0.703 . . . . 73.02 109.525 175.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' B' ' 50' ' ' ALA . 78.3 mt -60.9 -47.76 84.92 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 114.597 -1.183 . . . . 75.13 112.16 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -58.89 -50.84 72.52 Favored 'General case' 0 C--O 1.198 -1.614 0 C-N-CA 120.412 -0.515 . . . . 63.13 112.126 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.67 -48.38 77.72 Favored 'General case' 0 C--O 1.265 1.9 0 CA-C-O 121.629 0.728 . . . . 65.14 111.783 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -66.73 -41.05 88.51 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.707 -1.133 . . . . 74.52 110.662 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -81.59 -23.09 37.31 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 114.229 1.196 . . . . 65.34 114.229 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 66.7 m -70.61 -24.16 62.69 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.307 -0.406 . . . . 52.04 109.964 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.3 m -58.79 -29.01 66.5 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-O 121.096 0.475 . . . . 65.13 109.94 172.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 60.0 m -92.27 6.37 47.03 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 113.07 0.767 . . . . 52.23 113.07 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 142.84 -158.38 27.1 Favored Glycine 0 C--O 1.226 -0.397 0 C-N-CA 119.143 -1.503 . . . . 61.13 114.371 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 49.9 m -106.21 125.79 51.43 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 122.444 -0.445 . . . . 72.21 111.241 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 71.3 mt -91.42 127.15 43.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 116.029 -0.532 . . . . 73.24 112.401 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . 0.642 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 87.3 m-20 -89.06 -43.54 11.02 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-N 116.029 -0.532 . . . . 73.43 110.792 175.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.454 ' HG2' ' HA ' ' A' ' 71' ' ' ASP . 40.0 mtt180 -150.96 161.25 43.08 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.869 -0.605 . . . . 75.13 110.524 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.505 HD11 ' HB1' ' B' ' 50' ' ' ALA . 38.2 pt -146.17 140.15 20.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 107.65 -1.241 . . . . 65.42 107.65 172.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 85.3 m -124.91 126.41 45.48 Favored 'General case' 0 C--N 1.273 -2.73 0 N-CA-C 106.786 -1.561 . . . . 50.22 106.786 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.6 mp -124.28 116.71 48.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 105.817 -1.92 . . . . 74.45 105.817 -177.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -120.56 129.37 53.75 Favored 'General case' 0 C--N 1.283 -2.287 0 C-N-CA 120.216 -0.594 . . . . 65.32 110.996 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' CYS . . . . . 0.425 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 79.4 m -116.22 129.57 56.36 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.383 -0.599 . . . . 73.33 109.383 -177.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.432 ' HA ' ' HG2' ' A' ' 65' ' ' ARG . 8.0 t70 -109.43 124.71 51.47 Favored 'General case' 0 CA--C 1.482 -1.665 0 N-CA-C 112.595 0.591 . . . . 64.32 112.595 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -119.76 3.01 11.14 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 114.973 -1.012 . . . . 70.54 111.358 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.432 ' HB3' ' HB3' ' A' ' 64' ' ' ASN . 0.8 OUTLIER -69.42 -22.44 63.67 Favored 'General case' 0 C--N 1.364 1.216 0 C-N-CA 119.084 -1.046 . . . . 73.02 110.67 -176.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 35.2 t -88.97 15.01 9.23 Favored 'General case' 0 CA--C 1.56 1.345 0 CA-C-N 115.242 -0.89 . . . . 62.12 109.599 177.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.75 -61.2 2.74 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.91 -0.586 . . . . 63.23 112.046 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . 0.419 ' HA ' ' HD3' ' B' ' 77' ' ' PRO . 37.0 m80 -85.87 129.32 54.87 Favored Pre-proline 0 C--O 1.252 1.216 0 C-N-CA 120.836 -0.346 . . . . 74.13 110.19 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' B' ' 76' ' ' HIS . 9.2 Cg_exo -72.01 117.47 5.16 Favored 'Trans proline' 0 CA--C 1.504 -1.019 0 C-N-CA 121.975 1.783 . . . . 44.33 110.699 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 35.0 mtmm -118.34 159.36 23.54 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 107.666 -1.235 . . . . 65.12 107.666 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -138.94 152.13 22.06 Favored Glycine 0 N--CA 1.411 -3.023 0 C-N-CA 119.055 -1.545 . . . . 73.51 113.312 177.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -149.64 144.99 26.51 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.273 -1.01 . . . . 70.32 108.273 173.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.22 152.83 51.17 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 116.56 -0.291 . . . . 70.22 110.604 -171.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' TYR . . . . . 0.422 ' CZ ' ' HD1' ' B' ' 40' ' ' TYR . 78.2 m-85 -122.45 124.17 42.99 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 109.517 -0.549 . . . . 74.0 109.517 175.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.487 HG23 HG22 ' B' ' 66' ' ' ILE . 23.2 mm -102.97 120.07 52.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.488 -1.301 . . . . 63.15 107.488 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -102.31 119.15 38.34 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.549 -0.908 . . . . 73.32 108.549 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -93.84 160.04 14.92 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 112.734 0.642 . . . . 75.33 112.734 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.642 ' HA ' ' ND2' ' B' ' 64' ' ' ASN . . . -66.61 -43.56 84.47 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.067 -0.969 . . . . 72.15 112.224 176.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -127.0 160.04 32.3 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.381 0.882 . . . . 73.31 113.381 -176.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -63.89 -24.98 67.95 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.517 1.127 . . . . 64.25 112.787 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -63.48 -39.3 94.09 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.457 -0.942 . . . . 72.51 108.457 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 18.6 m -68.97 -38.68 79.5 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.314 -0.857 . . . . 60.23 112.074 -172.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.558 HG23 HG22 ' B' ' 39' ' ' VAL . 7.5 p -65.01 -40.6 89.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 109.201 -0.666 . . . . 74.43 109.201 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.0 -34.33 77.76 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.549 0.69 . . . . 60.3 110.271 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.86 -37.68 64.68 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.73 -0.668 . . . . 74.52 111.111 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.1 -38.78 61.05 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 120.635 -0.426 . . . . 61.24 111.176 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . 0.491 HG11 ' HB3' ' B' ' 111' ' ' PRO . 30.1 m -59.66 -22.47 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 112.787 0.662 . . . . 71.05 112.787 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.87 -9.17 50.07 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.145 0.497 . . . . 60.05 110.177 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 22.7 mtm -97.51 4.0 50.54 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 112.843 0.683 . . . . 75.33 112.843 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . 0.582 ' HA ' HG22 ' B' ' 109' ' ' VAL . 2.3 p30 -43.86 -38.18 3.2 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 116.77 2.137 . . . . 71.43 116.77 -174.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -117.09 28.03 8.76 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 119.629 1.104 . . . . 74.34 111.405 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 73.6 p -84.41 177.46 8.13 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 121.245 -0.909 . . . . 61.52 111.55 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 13.0 p -101.27 145.73 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 N-CA-C 109.387 -0.598 . . . . 65.01 109.387 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -143.85 121.75 12.01 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.381 -0.97 . . . . 70.23 108.381 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 56.9 ttt-85 52.01 33.59 12.19 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 124.529 1.132 . . . . 72.34 111.868 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.65 1.57 70.95 Favored Glycine 0 C--N 1.313 -0.725 0 CA-C-N 115.188 -0.914 . . . . 71.11 114.33 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -126.94 157.9 38.24 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 117.544 0.672 . . . . 53.11 109.806 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 41.8 m -88.43 120.21 29.59 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.086 -1.079 . . . . 62.05 108.086 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 43.4 pt -101.83 172.0 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 C-N-CA 119.737 -0.785 . . . . 70.15 110.484 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -128.65 127.16 41.65 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.957 -0.757 . . . . 61.3 108.957 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 27.0 m -126.6 134.52 66.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 O-C-N 123.441 0.463 . . . . 62.41 111.018 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 96.4 mt -128.31 148.28 67.19 Favored Pre-proline 0 C--N 1.298 -1.642 0 N-CA-C 109.206 -0.665 . . . . 63.53 109.206 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.491 ' HB3' HG11 ' B' ' 95' ' ' VAL . 53.2 Cg_endo -79.28 133.82 11.05 Favored 'Trans proline' 0 N--CA 1.439 -1.711 0 C-N-CA 121.493 1.462 . . . . 74.15 111.22 175.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.523 ' HB3' ' HB2' ' B' ' 38' ' ' SER . 27.9 ttpp -100.17 131.48 46.09 Favored 'General case' 0 N--CA 1.41 -2.446 0 N-CA-C 105.75 -1.945 . . . . 51.32 105.75 173.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.477 ' HA ' ' HA ' ' B' ' 36' ' ' LYS . 5.1 ppt_? -168.92 172.21 7.82 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.755 0.312 . . . . 70.15 111.613 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 24.8 p -119.95 154.43 34.49 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.177 -1.045 . . . . 74.41 108.177 175.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -121.08 122.14 39.41 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.39 -0.524 . . . . 73.12 109.809 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -149.74 115.19 3.51 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 115.344 -0.844 . . . . 64.54 109.037 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.09 91.23 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.99 1.793 . . . . 71.42 111.294 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . 124.32 156.72 9.53 Favored Glycine 0 N--CA 1.431 -1.645 0 N-CA-C 110.952 -0.859 . . . . 72.5 110.952 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.409 ' N ' HD12 ' B' ' 119' ' ' ILE . 2.5 mp -98.51 -35.96 5.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.842 -0.799 . . . . 71.41 108.842 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 29.8 m 72.35 14.76 5.37 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.643 1.177 . . . . 63.12 112.22 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 25.9 t -92.97 98.99 11.71 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.149 -0.685 . . . . 74.44 109.149 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 24.6 p -83.42 89.95 7.12 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-O 121.712 0.768 . . . . 73.3 112.026 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -99.39 -169.48 1.76 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.686 -1.143 . . . . 71.42 109.622 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.487 ' O ' ' HD2' ' B' ' 124' ' ' ARG 0.271 6.1 ppt_? . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 112.024 0.379 . . . . 72.13 112.024 177.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.244 0 CA-C-O 120.906 0.384 . . . . 62.33 110.259 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.8 mm -87.48 132.55 32.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.942 -0.762 . . . . 74.24 108.942 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.73 118.43 54.5 Favored Pre-proline 0 N--CA 1.44 -0.965 0 N-CA-C 108.87 -0.789 . . . . 61.42 108.87 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -49.56 108.46 0.2 Allowed 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 123.274 2.649 . . . . 74.24 112.603 -177.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 65.4 m -94.39 116.54 28.92 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 108.072 -1.085 . . . . 71.52 108.072 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 15.4 tpt -76.58 84.9 3.26 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 121.595 0.712 . . . . 74.0 109.408 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.6 96.23 0.75 Allowed 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 106.462 -1.681 . . . . 75.33 106.462 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.6 m -129.29 101.26 5.91 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.647 -1.612 . . . . 75.14 106.647 178.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.3 m -55.06 107.62 0.32 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 113.977 1.103 . . . . 74.43 113.977 -171.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -109.06 101.52 10.58 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 107.253 -1.388 . . . . 72.02 107.253 172.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.2 p -90.81 119.64 31.19 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 120.868 0.366 . . . . 62.11 110.977 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -78.77 75.38 5.28 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 108.998 -0.742 . . . . 72.35 108.998 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 52.0 ttm -119.25 83.67 2.07 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-O 121.666 0.746 . . . . 73.43 109.617 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.1 m -120.07 113.14 20.04 Favored 'General case' 0 N--CA 1.41 -2.459 0 CA-C-N 114.214 -1.357 . . . . 51.03 107.694 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.75 -24.83 56.12 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.968 -1.123 . . . . 71.02 107.968 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' B' ' 43' ' ' ASN . . . 130.12 -107.16 0.76 Allowed Glycine 0 N--CA 1.41 -3.056 0 CA-C-N 114.489 -1.232 . . . . 50.15 110.272 177.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 166.6 75.03 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 105.935 -1.876 . . . . 62.21 105.935 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -59.05 -69.35 0.2 Allowed 'General case' 0 C--N 1.318 -0.764 0 O-C-N 123.865 0.728 . . . . 72.53 110.594 -171.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 t -130.85 80.21 1.93 Allowed 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 122.514 1.149 . . . . 52.02 112.084 176.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -93.24 -29.46 15.68 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 106.984 -1.487 . . . . 70.5 106.984 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.25 178.46 49.47 Favored Glycine 1 N--CA 1.389 -4.493 0 N-CA-C 109.075 -1.61 . . . . 55.41 109.075 -173.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.599 ' HA ' ' OH ' ' B' ' 82' ' ' TYR . 71.7 Cg_exo -47.07 -38.59 24.7 Favored 'Trans proline' 0 CA--C 1.587 3.135 0 C-N-CA 122.896 2.398 . . . . 54.21 116.287 174.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -93.41 168.27 2.25 Favored 'Trans proline' 0 N--CA 1.417 -3.003 0 N-CA-C 117.478 2.068 . . . . 71.41 117.478 -173.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.569 ' HG2' ' OH ' ' B' ' 80' ' ' TYR . 29.7 mt-30 -128.8 146.2 59.43 Favored Pre-proline 0 N--CA 1.417 -2.111 0 N-CA-C 103.961 -2.607 . . . . 55.24 103.961 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.47 102.04 1.46 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 121.633 1.556 . . . . 64.22 114.205 -176.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 30' ' ' GLU . 3.9 mp -146.08 145.52 30.58 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.858 -0.793 . . . . 75.54 108.858 177.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.3 t -79.45 160.69 26.5 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 109.046 -0.724 . . . . 52.2 109.046 173.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.7 -42.0 33.56 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 123.53 0.732 . . . . 72.14 112.009 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -67.2 -36.04 80.9 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.64 0.607 . . . . 71.31 112.64 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.458 ' O ' HG12 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -57.38 -36.1 70.82 Favored 'General case' 0 CA--C 1.496 -1.1 0 C-N-CA 120.318 -0.553 . . . . 53.21 109.881 171.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.71 -40.41 88.45 Favored 'General case' 0 C--O 1.192 -1.958 0 C-N-CA 119.821 -0.751 . . . . 71.33 111.584 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.703 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -66.08 -38.04 87.27 Favored 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 119.716 -0.794 . . . . 74.33 111.824 178.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.416 ' HB3' HH21 ' A' ' 37' ' ' ARG . 60.0 mm-40 -65.66 -46.33 79.53 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.138 0.494 . . . . 55.42 111.62 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.57 HD12 ' NH2' ' A' ' 65' ' ' ARG . 12.7 pt -70.82 -33.77 53.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.656 -0.702 . . . . 70.04 110.679 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.406 ' OD2' ' NZ ' ' A' ' 112' ' ' LYS . 13.9 t70 -66.0 -38.83 89.48 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.837 0.855 . . . . 74.44 108.887 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -57.4 -30.72 65.15 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.278 -0.874 . . . . 75.34 110.859 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.416 HH21 ' HB3' ' A' ' 33' ' ' GLU . 54.2 mtm180 -104.09 18.82 21.27 Favored 'General case' 0 N--CA 1.419 -2.013 0 CA-C-N 114.842 -1.072 . . . . 71.14 111.856 -175.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.0 m -95.87 146.44 24.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.605 0.717 . . . . 64.01 111.152 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.434 HG22 ' HB ' ' A' ' 83' ' ' ILE . 33.7 m -127.95 160.69 37.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.932 -0.766 . . . . 62.33 108.932 176.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.576 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 28.1 t80 -109.14 126.06 52.83 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.497 -0.927 . . . . 74.11 108.497 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.52 ' HA ' HG12 ' A' ' 109' ' ' VAL . 61.3 t -114.49 111.82 37.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.841 -1.17 . . . . 65.42 107.841 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.2 171.62 13.87 Favored Glycine 0 C--N 1.304 -1.243 0 C-N-CA 120.267 -0.968 . . . . 52.42 113.215 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.479 ' ND2' ' HB3' ' A' ' 105' ' ' ARG . 4.8 t30 58.65 24.89 12.61 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 125.391 1.477 . . . . 40.2 110.037 -178.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 p -92.63 9.17 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.418 0 CA-C-N 114.524 -1.216 . . . . 61.44 110.069 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.54 ' OD2' ' HA ' ' A' ' 78' ' ' LYS . 6.0 m-20 -37.07 106.84 0.05 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 128.235 2.614 . . . . 72.03 113.617 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.415 ' C ' ' H ' ' A' ' 48' ' ' SER 0.4 41.3 m-85 50.11 162.81 0.0 OUTLIER 'General case' 0 C--N 1.351 0.643 0 N-CA-C 118.116 2.636 . . . . 75.54 118.116 179.436 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.438 ' HA3' ' NH1' ' A' ' 103' ' ' ARG . . . 80.94 -36.97 2.33 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.284 -0.871 . . . . 70.14 111.462 -177.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 46' ' ' TYR . 19.4 m -76.84 118.27 19.28 Favored 'General case' 0 N--CA 1.415 -2.218 0 C-N-CA 124.733 1.213 . . . . 70.33 109.866 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.7 p -100.59 162.99 12.56 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.6 -0.519 . . . . 71.35 109.6 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.487 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -65.81 -50.25 65.31 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.171 0.434 . . . . 63.24 112.171 -175.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -57.79 -38.74 76.04 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 116.824 -0.171 . . . . 60.32 111.091 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.72 -37.67 76.61 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.018 0.437 . . . . 73.2 110.347 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 44.1 mt -68.22 -47.58 67.45 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.362 -0.835 . . . . 51.32 110.803 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -61.9 -48.24 81.34 Favored 'General case' 0 C--O 1.2 -1.538 0 CA-C-N 115.738 -0.665 . . . . 72.23 110.069 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.48 -41.18 84.71 Favored 'General case' 0 C--O 1.248 1.0 0 CA-C-O 121.036 0.446 . . . . 40.44 110.663 177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -65.82 -39.68 91.1 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.852 -0.613 . . . . 73.35 110.307 -175.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -82.33 -21.53 35.97 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 112.967 0.729 . . . . 72.55 112.967 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.9 t -70.11 -24.11 63.15 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.651 -0.704 . . . . 72.24 109.324 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.4 m -62.25 -30.24 70.97 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 109.197 -0.668 . . . . 62.33 109.197 173.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 57.5 m -96.1 11.83 32.83 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.772 -0.649 . . . . 70.31 112.378 -178.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.96 -167.58 30.58 Favored Glycine 0 N--CA 1.464 0.526 0 C-N-CA 118.609 -1.758 . . . . 61.32 115.386 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 86' ' ' ALA . 7.4 m -104.32 115.06 29.72 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.212 -0.662 . . . . 70.33 109.212 -176.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.3 mt -91.11 131.8 37.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 112.537 0.569 . . . . 75.14 112.537 -176.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.589 HD21 ' HB2' ' A' ' 86' ' ' ALA . 1.0 OUTLIER -95.64 -40.47 9.39 Favored 'General case' 0 C--O 1.204 -1.296 0 CA-C-N 115.26 -0.882 . . . . 54.23 111.915 176.515 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.57 ' NH2' HD12 ' A' ' 34' ' ' ILE . 73.2 mtm180 -155.86 161.16 40.64 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.763 -0.458 . . . . 75.11 109.763 -177.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.487 HD11 ' HB1' ' A' ' 50' ' ' ALA . 23.0 pt -146.51 141.42 20.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.1 -1.074 . . . . 71.41 108.1 174.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.9 m -126.23 129.24 48.56 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 106.478 -1.675 . . . . 72.12 106.478 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.6 mp -125.06 121.4 60.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 106.878 -1.527 . . . . 73.33 106.878 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -120.62 134.61 55.26 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 120.528 -0.469 . . . . 72.1 112.123 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 83.6 m -117.5 122.66 44.31 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.892 -0.781 . . . . 60.22 108.892 176.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.563 ' HA ' ' HG2' ' B' ' 65' ' ' ARG . 2.5 p30 -113.55 128.87 56.6 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 119.734 -0.786 . . . . 72.01 112.287 -178.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' B' ' 64' ' ' ASN . 38.4 mttm -95.8 4.05 53.22 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.73 -0.668 . . . . 73.12 111.516 175.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' B' ' 64' ' ' ASN . 45.5 m-85 -64.34 -6.25 6.68 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.38 0.881 . . . . 74.45 113.38 172.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.7 t -95.91 0.56 52.12 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.947 -0.76 . . . . 72.42 108.947 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.37 -48.78 3.63 Favored Glycine 0 CA--C 1.506 -0.521 0 N-CA-C 109.187 -1.565 . . . . 64.12 109.187 -175.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -96.96 147.94 33.66 Favored Pre-proline 0 C--N 1.291 -1.961 0 N-CA-C 105.916 -1.883 . . . . 73.24 105.916 173.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.83 118.32 5.02 Favored 'Trans proline' 0 N--CA 1.443 -1.474 0 C-N-CA 120.679 0.919 . . . . 64.24 110.448 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 30.1 mtmm -96.59 149.22 22.02 Favored 'General case' 0 CA--C 1.483 -1.597 0 C-N-CA 119.873 -0.731 . . . . 70.33 109.262 175.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 45' ' ' ASP . . . -128.9 135.13 8.32 Favored Glycine 0 N--CA 1.409 -3.105 0 C-N-CA 120.327 -0.94 . . . . 52.11 112.636 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . 0.349 1.3 p90 -150.8 144.77 25.28 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 124.382 1.073 . . . . 74.25 111.092 175.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.49 154.36 49.9 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.893 -0.594 . . . . 60.33 110.659 -171.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -120.36 124.49 45.66 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.325 -0.991 . . . . 74.24 108.325 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.434 ' HB ' HG22 ' A' ' 39' ' ' VAL . 27.2 mm -108.48 127.59 64.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.823 -1.177 . . . . 74.44 107.823 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -108.94 120.84 43.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.582 0.23 . . . . 63.44 111.039 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -98.89 162.88 12.85 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.98 0.419 . . . . 74.0 111.875 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.589 ' HB2' HD21 ' A' ' 64' ' ' ASN . . . -76.79 -37.88 55.01 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.264 0.626 . . . . 64.21 111.747 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.434 ' HG2' ' OG ' ' A' ' 90' ' ' SER . 0.2 OUTLIER -113.47 138.5 50.02 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 112.509 0.559 . . . . 73.43 112.509 179.422 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.429 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -57.79 -34.31 69.49 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 123.623 0.769 . . . . 73.04 111.26 179.051 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -66.65 -21.14 66.11 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 116.019 -0.537 . . . . 70.03 112.239 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.434 ' OG ' ' HG2' ' A' ' 87' ' ' GLU . 71.4 m -69.15 -36.13 77.09 Favored 'General case' 0 N--CA 1.414 -2.241 0 C-N-CA 120.635 -0.426 . . . . 64.04 111.263 176.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 95' ' ' VAL . 3.0 m -64.69 -41.22 91.62 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.85 0 C-N-CA 119.239 -0.984 . . . . 72.13 108.56 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -61.99 -31.13 71.46 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 116.299 -0.41 . . . . 74.35 111.292 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.31 -39.81 62.64 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.172 -0.467 . . . . 71.32 111.225 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.83 -41.85 59.13 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-N 116.222 -0.445 . . . . 70.31 111.338 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 91' ' ' VAL . 22.6 m -56.21 -22.18 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 111.98 0.363 . . . . 62.55 111.98 177.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.78 -13.86 62.47 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.367 0.603 . . . . 55.3 111.067 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 47.4 mtm -99.36 9.76 42.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.568 -0.742 . . . . 51.25 109.79 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.588 ' HA ' HG22 ' A' ' 109' ' ' VAL . 2.9 p-10 -37.67 -45.59 0.8 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 114.456 1.28 . . . . 70.12 114.456 -177.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -114.67 97.4 6.25 Favored 'General case' 0 N--CA 1.424 -1.741 0 C-N-CA 120.033 -0.667 . . . . 62.34 110.033 174.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.8 p -142.64 165.71 26.65 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.02 -0.991 . . . . 63.51 110.775 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.3 p -104.53 119.68 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-O 121.636 0.731 . . . . 60.12 110.171 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -113.47 116.64 29.91 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.858 -1.164 . . . . 74.52 107.858 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.438 ' NH1' ' HA3' ' A' ' 47' ' ' GLY . 7.1 ptm180 43.09 32.08 0.41 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 126.548 1.939 . . . . 72.45 114.147 -177.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.19 -12.02 33.91 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.007 -0.997 . . . . 70.22 113.87 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.479 ' HB3' ' ND2' ' A' ' 43' ' ' ASN . 65.1 mtt180 -112.42 138.74 48.72 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 117.37 0.585 . . . . 62.43 109.933 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 39.2 m -79.18 120.19 23.33 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.766 -1.198 . . . . 74.14 107.766 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.41 ' HA ' ' HB3' ' A' ' 43' ' ' ASN . 42.2 pt -101.57 171.44 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 C-N-CA 120.464 -0.495 . . . . 74.53 110.723 -177.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 54.7 tptt -133.91 125.75 28.94 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 115.123 -0.944 . . . . 73.51 108.772 -177.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.588 HG22 ' HA ' ' A' ' 98' ' ' ASP . 27.7 m -128.82 132.49 67.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 O-C-N 123.238 0.336 . . . . 54.5 110.948 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.459 HD13 ' HB3' ' A' ' 40' ' ' TYR 0.25 0.0 OUTLIER -148.24 158.79 40.81 Favored Pre-proline 0 C--N 1.292 -1.929 0 N-CA-C 108.561 -0.903 . . . . 42.03 108.561 176.26 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 110' ' ' LEU . 91.8 Cg_endo -76.09 130.28 12.07 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 CA-C-N 120.45 1.196 . . . . 53.35 110.641 -176.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.406 ' NZ ' ' OD2' ' A' ' 35' ' ' ASP . 1.0 OUTLIER -84.5 110.36 18.62 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 104.874 -2.269 . . . . 74.24 104.874 179.27 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -93.97 135.92 34.8 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.373 -0.831 . . . . 72.21 112.5 -162.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.0 m -69.76 147.98 49.76 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.782 -1.099 . . . . 73.54 110.252 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.445 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 7.1 t30 -147.72 129.12 14.86 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.568 -0.901 . . . . 75.23 108.568 177.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 50.9 ttm -99.44 102.71 17.26 Favored Pre-proline 0 C--N 1.307 -1.266 0 N-CA-C 109.038 -0.726 . . . . 71.22 109.038 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 115' ' ' ASN . 2.7 Cg_exo -77.73 -16.38 14.72 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.524 2.149 . . . . 75.1 111.63 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.36 -117.13 3.44 Favored Glycine 0 N--CA 1.426 -1.991 0 N-CA-C 110.038 -1.225 . . . . 51.44 110.038 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 24.8 pt -101.34 106.0 18.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 121.69 0.757 . . . . 73.41 110.382 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.2 m -122.27 5.66 9.69 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.495 -0.775 . . . . 75.34 110.605 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 60.4 m 63.55 109.66 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.818 0.847 . . . . 64.21 111.346 -174.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 60.1 p -64.3 -47.84 77.95 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.7 0.762 . . . . 74.23 110.204 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -162.53 146.86 11.89 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.099 -1.815 . . . . 74.41 106.099 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 . . . . . 0 C--N 1.299 -1.61 0 C-N-CA 119.333 -0.947 . . . . 74.22 109.727 -179.16 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.671 0 N-CA-C 109.087 -0.708 . . . . 33.41 109.087 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.571 HD13 ' H ' ' B' ' 2' ' ' ILE . 0.2 OUTLIER -74.81 136.21 25.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 O-C-N 123.338 0.399 . . . . 61.24 110.816 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' B' ' 4' ' ' PRO . . . -113.08 144.32 30.9 Favored Pre-proline 0 C--N 1.306 -1.313 0 CA-C-N 115.962 -0.563 . . . . 44.14 109.55 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' B' ' 3' ' ' ALA . 24.4 Cg_exo -64.14 104.9 0.53 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.46 2.107 . . . . 71.03 111.32 177.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 79.3 m -148.38 177.44 9.44 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.788 -0.819 . . . . 75.44 108.788 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 66.2 mtt -92.58 152.38 19.63 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.98 -0.378 . . . . 62.31 109.98 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -83.74 136.31 34.22 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.961 -0.563 . . . . 72.43 109.68 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 9.2 t -95.43 142.27 27.99 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.779 -0.823 . . . . 71.25 108.779 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 27.9 m -69.5 100.54 1.43 Allowed 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 123.047 0.539 . . . . 71.43 110.169 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -135.91 -40.84 0.68 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.241 -0.436 . . . . 73.43 110.847 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 50.3 m 65.87 142.3 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.295 1.038 . . . . 70.5 112.6 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -76.08 108.07 8.74 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.603 -0.888 . . . . 73.42 108.603 177.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 13.0 tmm? -83.04 107.02 15.33 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.405 -0.961 . . . . 71.44 108.405 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 12.6 t -140.8 -173.28 3.66 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.702 -0.851 . . . . 75.43 108.702 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -128.89 169.47 14.57 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.54 0.21 . . . . 62.12 111.159 -176.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.87 -25.53 52.84 Favored Glycine 0 C--N 1.336 0.539 0 O-C-N 124.054 0.846 . . . . 60.12 114.093 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.62 -40.97 69.44 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.591 0.756 . . . . 52.44 112.572 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -80.11 -35.5 36.71 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.096 0.474 . . . . 73.01 111.219 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 22.0 p -77.03 -172.49 2.37 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 114.54 1.311 . . . . 73.53 114.54 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . 0.411 ' OE2' ' HA ' ' B' ' 25' ' ' PRO . 30.9 mt-10 -59.89 16.35 0.01 OUTLIER 'General case' 0 CA--C 1.594 2.655 0 C-N-CA 127.779 2.432 . . . . 72.31 116.94 -171.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.04 -126.81 20.98 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 114.363 0.505 . . . . 74.44 114.363 177.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -53.36 -52.66 8.15 Favored 'Trans proline' 0 CA--C 1.559 1.73 0 C-N-CA 123.609 2.873 . . . . 74.12 114.181 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.12 141.65 48.43 Favored 'Trans proline' 0 C--N 1.376 1.979 0 CA-C-N 120.813 1.326 . . . . 75.34 108.83 172.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -84.21 146.35 47.91 Favored Pre-proline 0 C--N 1.284 -2.276 0 C-N-CA 119.818 -0.753 . . . . 74.15 109.102 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.411 ' HA ' ' OE2' ' B' ' 20' ' ' GLU . 18.3 Cg_endo -60.69 131.08 35.93 Favored 'Trans proline' 0 N--CA 1.438 -1.777 0 C-N-CA 122.275 1.983 . . . . 72.21 111.71 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.747 HD13 ' H ' ' B' ' 26' ' ' LEU 0.25 0.0 OUTLIER -70.09 178.7 2.64 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.598 -0.728 . . . . 73.21 110.764 176.815 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 13.8 m -57.47 144.6 36.06 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 113.441 0.904 . . . . 74.21 113.441 -171.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.453 ' O ' ' HE2' ' B' ' 32' ' ' LYS . . . -56.5 -44.68 80.91 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.919 -1.037 . . . . 72.2 110.733 174.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -60.51 -45.91 92.05 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.638 -0.256 . . . . 72.01 111.082 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.464 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.5 OUTLIER -55.83 -35.32 66.26 Favored 'General case' 0 C--O 1.22 -0.485 0 O-C-N 123.276 0.36 . . . . 61.35 110.583 174.101 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' B' ' 26' ' ' LEU . 43.2 mttm -70.83 -35.47 72.48 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.757 -0.656 . . . . 74.21 112.399 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.59 ' O ' ' HB2' ' B' ' 36' ' ' LYS . 0.4 OUTLIER -69.76 -38.99 76.94 Favored 'General case' 0 C--O 1.211 -0.953 0 C-N-CA 119.651 -0.82 . . . . 74.13 111.35 174.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.539 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 5.9 mm-40 -64.8 -46.26 82.77 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.869 0.366 . . . . 72.12 111.06 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.464 HG12 ' O ' ' B' ' 30' ' ' GLU . 16.2 pt -70.72 -34.67 57.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.87 -0.605 . . . . 74.12 111.401 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -70.95 -35.12 72.05 Favored 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 108.69 -0.855 . . . . 75.1 108.69 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' B' ' 32' ' ' LYS . 31.8 ttmt -62.71 -31.34 72.24 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 124.987 1.315 . . . . 74.21 110.234 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' B' ' 33' ' ' GLU . 10.5 ptt180 -115.35 31.78 6.48 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.567 0.699 . . . . 74.35 112.004 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.446 ' OG ' ' HE3' ' B' ' 112' ' ' LYS . 25.4 t -100.9 163.07 12.47 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.307 -0.861 . . . . 74.22 109.945 174.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.524 ' HA ' ' H ' ' B' ' 112' ' ' LYS . 35.0 m -134.69 164.05 35.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 122.984 0.514 . . . . 42.52 110.732 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . 0.537 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 34.7 t80 -109.63 125.2 52.34 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.309 -0.997 . . . . 74.41 108.309 177.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.506 ' HA ' HG12 ' B' ' 109' ' ' VAL . 61.8 t -116.03 112.88 41.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 108.836 -0.801 . . . . 72.22 108.836 175.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.21 173.54 18.15 Favored Glycine 0 N--CA 1.426 -2.024 0 N-CA-C 110.822 -0.911 . . . . 63.54 110.822 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.465 ' HB3' ' HA ' ' B' ' 107' ' ' ILE . 25.7 t-20 80.96 -19.28 0.44 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.102 1.361 . . . . 54.52 113.022 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.403 HG21 HD11 ' B' ' 53' ' ' LEU . 7.5 p -55.39 117.8 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.833 0.825 . . . . 63.2 111.074 -177.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -69.98 153.57 43.06 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.874 -1.057 . . . . 75.22 113.104 -174.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' TYR . . . . . 0.401 ' CD2' ' HB2' ' B' ' 77' ' ' PRO . 60.6 t80 -49.46 -32.33 11.71 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 127.859 2.464 . . . . 74.12 110.817 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.31 0.26 71.39 Favored Glycine 0 N--CA 1.429 -1.796 0 CA-C-O 119.292 -0.727 . . . . 51.11 114.067 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 29.1 t -75.61 147.0 39.92 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 118.703 1.252 . . . . 72.34 109.877 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 36.8 p -98.52 157.56 16.15 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 116.002 -0.545 . . . . 74.32 112.228 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.52 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -72.6 -47.64 46.24 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.865 0.866 . . . . 71.13 112.274 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -34.49 72.31 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 119.523 -0.871 . . . . 73.01 112.533 -178.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -68.8 -39.12 80.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.109 -0.496 . . . . 75.21 110.343 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.403 HD11 HG21 ' B' ' 44' ' ' VAL . 55.7 mt -65.46 -47.7 75.24 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.657 -0.701 . . . . 73.32 111.29 176.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -49.11 78.29 Favored 'General case' 0 C--O 1.207 -1.168 0 CA-C-N 116.213 -0.448 . . . . 70.12 110.001 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.75 -40.71 80.32 Favored 'General case' 0 C--O 1.263 1.783 0 CA-C-O 122.015 0.912 . . . . 63.43 112.059 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -66.09 -40.61 90.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.608 -1.178 . . . . 73.55 109.854 -175.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -82.41 -21.84 35.61 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 112.833 0.679 . . . . 71.02 112.833 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 47.1 t -68.58 -24.59 64.62 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.4 -0.818 . . . . 70.4 110.226 -176.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 32.7 m -63.63 -20.44 65.68 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 120.06 -0.656 . . . . 71.25 110.963 174.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 58.6 m -106.02 17.23 23.91 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 111.852 0.316 . . . . 65.05 111.852 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.54 177.06 20.0 Favored Glycine 0 C--O 1.226 -0.353 0 C-N-CA 119.904 -1.141 . . . . 71.51 113.603 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 23.9 t -93.34 121.09 34.37 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.265 -1.013 . . . . 73.5 108.265 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 76.8 mt -87.53 133.84 29.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-O 121.413 0.625 . . . . 74.22 112.139 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . 0.475 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 68.6 m-20 -97.4 -38.71 9.51 Favored 'General case' 0 C--O 1.206 -1.202 0 CA-C-N 115.173 -0.922 . . . . 55.04 112.676 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.563 ' HG2' ' HA ' ' A' ' 71' ' ' ASP . 71.7 mtm180 -157.39 161.74 39.01 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.12 -0.696 . . . . 72.5 109.12 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.52 HD11 ' HB1' ' B' ' 50' ' ' ALA . 24.1 pt -146.68 140.91 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 N-CA-C 107.875 -1.157 . . . . 65.34 107.875 175.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 68.8 m -126.32 127.97 46.39 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.922 -1.14 . . . . 75.43 107.922 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.421 HD12 ' N ' ' B' ' 68' ' ' ILE . 1.9 mp -124.5 121.43 61.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 106.599 -1.63 . . . . 72.05 106.599 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -121.36 135.33 55.1 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 120.458 -0.497 . . . . 71.34 111.289 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 73.1 m -116.9 121.76 42.38 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.192 -1.04 . . . . 74.4 108.192 176.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.687 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 3.4 p30 -111.7 128.38 56.06 Favored 'General case' 0 C--O 1.212 -0.88 0 C-N-CA 119.261 -0.976 . . . . 71.33 111.873 -177.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -121.97 5.11 9.88 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.81 -0.632 . . . . 73.5 109.646 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.446 ' CD1' ' HD3' ' A' ' 65' ' ' ARG . 28.3 p90 -59.28 -16.92 24.52 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 114.191 1.182 . . . . 71.03 114.191 -175.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 38.4 p -96.96 4.19 51.67 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 120.855 0.36 . . . . 71.24 111.407 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.25 -60.1 0.35 Allowed Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 111.581 -0.608 . . . . 75.33 111.581 -177.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -96.73 129.17 33.53 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 112.009 0.374 . . . . 72.1 112.009 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.687 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 91.9 Cg_endo -78.41 126.42 7.57 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.546 2.164 . . . . 71.43 113.933 -177.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' LYS . . . . . 0.528 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 32.9 mtmm -109.86 165.23 11.87 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 123.683 0.793 . . . . 73.43 109.753 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -134.11 135.68 8.15 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 119.925 -1.131 . . . . 71.02 113.808 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . 0.569 ' OH ' ' HG2' ' A' ' 24' ' ' GLN 0.436 0.4 OUTLIER -150.02 143.96 25.5 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 124.755 1.222 . . . . 72.44 112.083 173.853 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.94 154.89 50.32 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.086 -0.506 . . . . 50.03 110.504 -172.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' TYR . . . . . 0.599 ' OH ' ' HA ' ' A' ' 22' ' ' PRO . 29.5 m-85 -122.43 126.83 48.77 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.978 -1.119 . . . . 71.13 107.978 177.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.423 HG23 HG22 ' B' ' 66' ' ' ILE . 28.5 mm -109.66 127.41 66.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 107.594 -1.261 . . . . 73.12 107.594 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' GLU . . . . . 0.539 ' OE1' ' HB2' ' B' ' 65' ' ' ARG . 45.2 mt-10 -107.82 121.33 44.53 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 110.331 -0.248 . . . . 73.11 110.331 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -98.47 162.14 13.31 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.201 0.524 . . . . 74.42 112.018 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.475 ' HA ' ' ND2' ' B' ' 64' ' ' ASN . . . -69.18 -36.7 77.6 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.253 -0.885 . . . . 70.2 112.075 176.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.94 157.75 30.54 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.485 0.659 . . . . 75.41 111.341 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.69 -35.3 78.57 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 114.76 -1.109 . . . . 75.2 111.5 175.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -60.38 -32.15 71.03 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 123.525 0.516 . . . . 75.11 110.15 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 14.7 m -63.48 -37.06 85.87 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 116.4 -0.364 . . . . 74.21 111.212 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.596 ' O ' HG13 ' B' ' 95' ' ' VAL . 3.0 m -67.47 -40.21 84.04 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 C-N-CA 119.582 -0.847 . . . . 64.12 108.984 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -63.0 -30.89 71.95 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.961 0.41 . . . . 75.14 110.933 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.73 -40.25 63.69 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.22 -0.445 . . . . 74.01 110.546 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.97 -40.41 63.02 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-N 116.409 -0.359 . . . . 54.13 111.401 -177.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . 0.596 HG13 ' O ' ' B' ' 91' ' ' VAL . 16.6 m -58.24 -21.66 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 112.873 0.694 . . . . 63.1 112.873 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.91 -15.94 63.84 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.44 0.638 . . . . 45.13 109.759 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 34.0 mtp -94.68 6.26 49.43 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 123.954 0.902 . . . . 72.14 110.021 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . 0.548 ' HA ' HG22 ' B' ' 109' ' ' VAL . 2.0 p-10 -38.87 -46.65 1.32 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.455 1.28 . . . . 73.43 114.455 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -113.19 99.05 7.52 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 118.998 0.817 . . . . 71.44 109.931 171.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' B' ' 106' ' ' THR . 19.0 p -139.65 167.44 22.1 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.064 -0.971 . . . . 73.4 111.462 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' B' ' 105' ' ' ARG . 7.4 p -102.64 125.27 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 CA-C-O 121.671 0.748 . . . . 73.1 109.907 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' PHE . . . . . 0.4 ' HB3' HG23 ' B' ' 107' ' ' ILE . 74.2 t80 -135.44 120.4 18.65 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.941 -1.133 . . . . 73.34 107.941 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 56.41 32.61 20.94 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.554 1.142 . . . . 74.11 112.31 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.71 4.5 82.62 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 114.661 -1.154 . . . . 63.12 113.488 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' B' ' 101' ' ' VAL . 99.2 mtt180 -120.89 162.85 19.14 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 117.224 0.512 . . . . 71.01 109.929 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' B' ' 100' ' ' THR . 62.9 m -94.12 120.52 34.48 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.067 -1.086 . . . . 45.15 108.067 175.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . 0.465 ' HA ' ' HB3' ' B' ' 43' ' ' ASN . 40.8 pt -100.68 170.45 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.116 -1.034 . . . . 73.14 110.164 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 55.5 tptt -133.1 126.07 30.97 Favored 'General case' 0 N--CA 1.434 -1.227 0 O-C-N 123.728 0.643 . . . . 72.4 109.629 -177.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.548 HG22 ' HA ' ' B' ' 98' ' ' ASP . 27.3 m -128.85 138.36 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-N 116.429 -0.351 . . . . 72.43 111.423 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.72 ' HB3' ' HD2' ' B' ' 111' ' ' PRO 0.255 0.1 OUTLIER -140.01 169.68 11.46 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 105.61 -1.996 . . . . 74.5 105.61 174.636 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.72 ' HD2' ' HB3' ' B' ' 110' ' ' LEU . 89.6 Cg_endo -80.3 130.47 8.14 Favored 'Trans proline' 0 N--CA 1.425 -2.515 0 C-N-CA 121.412 1.408 . . . . 74.54 109.718 172.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.524 ' H ' ' HA ' ' B' ' 39' ' ' VAL . 15.0 ttpp -98.31 108.61 21.34 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 104.723 -2.325 . . . . 60.15 104.723 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -148.94 134.46 18.61 Favored 'General case' 0 CA--C 1.496 -1.097 0 C-N-CA 118.542 -1.263 . . . . 74.21 112.861 -166.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 36.6 p -111.17 85.13 2.06 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 106.954 -1.499 . . . . 73.34 106.954 164.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -73.15 95.53 2.09 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 114.896 -1.047 . . . . 61.01 110.914 -173.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' MET . . . . . 0.422 ' HA ' ' HD3' ' B' ' 117' ' ' PRO . 85.9 mtp -132.72 143.09 47.24 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 107.585 -1.265 . . . . 63.54 107.585 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' B' ' 116' ' ' MET . 12.8 Cg_exo -70.11 157.56 59.32 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 122.421 2.08 . . . . 60.24 112.369 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -103.21 161.34 16.36 Favored Glycine 0 N--CA 1.432 -1.616 0 N-CA-C 109.77 -1.332 . . . . 41.14 109.77 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 14.1 tt -88.2 83.91 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 CA-C-O 122.711 1.243 . . . . 71.13 111.348 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 37.7 m -135.91 128.48 30.64 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.921 -1.511 . . . . 53.21 106.921 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 61.1 p -68.73 107.27 2.95 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.976 0.417 . . . . 74.2 112.011 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 26.2 m -80.25 86.36 5.65 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.691 -1.226 . . . . 63.42 107.691 176.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -151.45 154.62 36.94 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.253 -1.017 . . . . 55.55 108.253 -174.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.301 -1.542 0 CA-C-O 119.451 -0.309 . . . . 73.05 111.592 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.462 0 CA-C-O 120.702 0.287 . . . . 63.11 110.996 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.503 ' O ' HD12 ' A' ' 2' ' ' ILE . 2.4 pp -102.05 136.71 32.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 120.852 0.358 . . . . 74.52 110.674 175.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . . . -119.82 124.77 27.75 Favored Pre-proline 0 C--N 1.297 -1.697 0 CA-C-N 116.525 -0.307 . . . . 61.23 110.338 -177.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 3' ' ' ALA . 11.4 Cg_exo -71.29 100.84 1.05 Allowed 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 122.077 1.851 . . . . 53.14 109.825 174.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 72.1 m -125.42 79.54 1.82 Allowed 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.702 -0.681 . . . . 74.54 110.223 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -91.42 -46.12 8.18 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.726 -1.213 . . . . 55.12 107.726 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 48.81 76.52 0.12 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.305 1.442 . . . . 54.3 113.426 176.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.1 m -128.36 85.23 2.31 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.738 0.78 . . . . 41.12 109.475 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.5 p -145.7 137.25 25.07 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.674 -1.148 . . . . 43.43 109.598 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -140.54 148.16 40.59 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.712 -0.477 . . . . 62.42 109.712 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.2 p -97.16 -49.11 5.1 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.027 0.442 . . . . 60.23 110.254 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt 65.51 -160.39 0.27 Allowed 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.232 -0.895 . . . . 64.05 110.847 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.505 ' HB2' ' HA ' ' B' ' 23' ' ' PRO . 0.0 OUTLIER -110.23 128.87 55.73 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 113.855 1.057 . . . . 75.15 113.855 -172.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 p -151.6 123.9 8.28 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.613 1.565 . . . . 62.14 109.337 173.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.404 ' N ' ' HB3' ' B' ' 23' ' ' PRO . . . -97.94 166.7 11.32 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 112.424 0.527 . . . . 73.12 112.424 -175.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.519 ' HA3' ' NH1' ' B' ' 65' ' ' ARG . . . -166.6 -44.26 0.02 OUTLIER Glycine 0 CA--C 1.532 1.111 0 C-N-CA 120.747 -0.74 . . . . 61.24 113.955 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.14 120.18 41.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 117.738 0.769 . . . . 71.25 112.401 -175.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -92.14 -31.23 15.57 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 116.109 -0.496 . . . . 74.14 112.056 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 t -109.12 -177.5 3.32 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 121.967 -0.458 . . . . 72.21 110.5 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -111.36 -13.19 13.95 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.485 -1.302 . . . . 52.5 107.485 174.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.615 ' HA3' ' OH ' ' B' ' 82' ' ' TYR . . . 86.33 -136.31 14.04 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.561 -1.199 . . . . 64.4 114.751 175.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.446 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 52.4 Cg_exo -55.75 -39.4 91.32 Favored 'Trans proline' 0 CA--C 1.564 1.976 0 C-N-CA 124.368 3.378 . . . . 73.33 116.481 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 22' ' ' PRO . 9.5 Cg_endo -53.82 130.89 41.4 Favored 'Trans proline' 0 C--N 1.394 2.957 0 CA-C-N 121.194 1.462 . . . . 72.32 111.1 176.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -62.81 129.84 93.38 Favored Pre-proline 0 C--N 1.316 -0.891 0 CA-C-N 116.001 -0.545 . . . . 63.35 111.884 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -72.14 120.64 6.93 Favored 'Trans proline' 0 N--CA 1.438 -1.749 0 C-N-CA 122.27 1.98 . . . . 63.45 111.365 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.733 HD13 ' H ' ' A' ' 26' ' ' LEU 0.28 0.0 OUTLIER -74.12 172.25 12.06 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.399 -0.819 . . . . 72.14 112.18 176.913 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.503 ' HB3' ' OE1' ' A' ' 30' ' ' GLU . 37.7 t -67.2 158.29 31.69 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.71 1.004 . . . . 72.23 113.71 -171.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.477 ' O ' ' HE2' ' A' ' 32' ' ' LYS . . . -54.14 -47.14 72.23 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 115.038 -0.983 . . . . 64.2 111.371 176.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -69.56 -30.25 68.0 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.338 0.496 . . . . 75.12 112.338 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.503 ' OE1' ' HB3' ' A' ' 27' ' ' SER . 1.4 mp0 -66.03 -38.9 89.59 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 120.326 -0.55 . . . . 74.43 109.883 170.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.479 ' HA ' HG12 ' A' ' 34' ' ' ILE . 58.3 mttm -68.98 -49.61 56.35 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 112.908 0.707 . . . . 75.41 112.908 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.587 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -58.95 -35.13 72.62 Favored 'General case' 0 C--O 1.215 -0.737 0 C-N-CA 120.092 -0.643 . . . . 75.25 112.132 -178.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.657 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 7.1 mm-40 -70.27 -49.86 45.52 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.93 -0.308 . . . . 75.34 111.067 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.479 HG12 ' HA ' ' A' ' 31' ' ' LYS . 34.0 pt -67.44 -34.99 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 112.413 0.523 . . . . 64.54 112.413 -176.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.575 ' HB2' ' HB ' ' A' ' 114' ' ' THR . 46.3 m-20 -59.52 -39.88 85.31 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.043 0.449 . . . . 64.14 110.014 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 97.1 mttt -76.18 -11.02 59.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.134 -0.939 . . . . 75.42 110.592 -177.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.657 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 61.1 mmt-85 -98.16 5.44 48.52 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 109.052 -0.721 . . . . 72.33 109.052 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.478 ' HB3' ' HE2' ' A' ' 112' ' ' LYS . 46.9 t -109.93 164.61 12.43 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 113.677 0.992 . . . . 71.11 113.677 -174.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.98 162.18 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 114.937 -1.029 . . . . 61.23 110.017 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.536 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 28.5 t80 -110.34 124.64 52.06 Favored 'General case' 0 C--N 1.29 -2.01 0 C-N-CA 124.826 1.25 . . . . 64.44 107.722 177.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.8 t -111.07 116.43 52.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 N-CA-C 108.08 -1.081 . . . . 64.51 108.08 178.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.86 166.61 12.78 Favored Glycine 0 N--CA 1.417 -2.582 0 C-N-CA 119.909 -1.139 . . . . 71.24 112.092 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.8 t30 67.99 18.11 9.52 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 125.732 1.613 . . . . 74.42 113.449 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.522 ' O ' ' HA3' ' A' ' 79' ' ' GLY . 7.1 p -73.95 116.67 16.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.941 -0.762 . . . . 75.01 108.941 175.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -94.98 168.18 10.94 Favored 'General case' 0 C--O 1.255 1.373 0 CA-C-O 121.226 0.536 . . . . 74.01 111.851 -172.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.661 ' CE1' ' HB2' ' A' ' 77' ' ' PRO . 4.5 m-85 -64.77 96.44 0.18 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.405 -1.27 . . . . 61.43 110.935 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.42 -26.32 0.3 Allowed Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 109.949 -1.261 . . . . 45.33 109.949 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.5 m -84.14 135.06 34.53 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.222 -1.029 . . . . 53.15 108.222 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.1 p -105.84 170.8 7.69 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 119.755 -0.164 . . . . 75.33 111.095 -176.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.481 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -64.2 -50.55 67.65 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 117.828 0.286 . . . . 71.52 111.105 -177.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.406 ' HG2' ' CE2' ' B' ' 46' ' ' TYR . 78.8 mt-30 -59.03 -38.87 80.28 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.465 0.543 . . . . 74.32 112.465 176.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -64.53 -37.62 88.2 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.779 0.799 . . . . 74.05 109.43 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.5 mt -72.68 -47.35 48.04 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.996 -1.002 . . . . 65.33 110.955 177.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -61.39 -49.39 77.08 Favored 'General case' 0 C--O 1.204 -1.308 0 C-N-CA 123.295 0.638 . . . . 34.3 110.855 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.07 -44.09 78.59 Favored 'General case' 0 C--O 1.256 1.443 0 CA-C-O 121.269 0.557 . . . . 71.24 111.042 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -64.58 -39.98 94.7 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.268 -0.878 . . . . 74.13 110.858 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -82.1 -22.43 36.24 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 113.266 0.839 . . . . 70.41 113.266 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.2 t -70.31 -23.88 62.93 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.781 -0.645 . . . . 73.11 109.3 -177.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.9 m -58.96 -27.76 65.66 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-O 121.266 0.555 . . . . 65.21 109.861 172.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 58.9 m -94.12 5.39 51.87 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.023 0.529 . . . . 55.23 112.161 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.33 -166.81 27.58 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.306 -1.426 . . . . 73.32 114.259 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.2 t -98.83 123.0 42.8 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 120.896 0.379 . . . . 52.44 110.548 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.8 mt -83.41 134.28 27.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-O 121.606 0.717 . . . . 50.53 112.58 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.652 ' OD1' ' HB3' ' B' ' 73' ' ' PHE . 34.2 t30 -98.07 -45.08 6.37 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.443 -1.253 . . . . 72.04 110.254 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' B' ' 71' ' ' ASP . 49.4 mtp180 -155.57 165.03 37.83 Favored 'General case' 0 C--O 1.213 -0.86 0 N-CA-C 107.873 -1.158 . . . . 71.13 107.873 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.481 HD11 ' HB1' ' A' ' 50' ' ' ALA . 19.2 pt -146.08 144.38 20.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.237 -1.024 . . . . 71.0 108.237 171.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.573 ' OG1' ' HB2' ' A' ' 82' ' ' TYR . 39.7 p -122.43 137.2 54.95 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 105.414 -2.069 . . . . 64.22 105.414 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.1 mp -129.26 112.54 25.46 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 105.705 -1.961 . . . . 73.43 105.705 173.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.457 ' HG ' ' CE2' ' A' ' 80' ' ' TYR 0.255 1.6 pt? -120.38 123.59 43.44 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 119.772 -0.771 . . . . 75.11 111.2 -179.228 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 73.4 m -117.83 136.47 53.4 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.204 -0.907 . . . . 44.41 109.592 -177.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.65 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 4.0 p30 -120.24 143.43 48.3 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 119.928 -0.709 . . . . 75.51 110.011 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -124.85 5.31 8.07 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.336 -0.616 . . . . 62.31 109.336 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.621 ' HB3' ' OD1' ' B' ' 64' ' ' ASN . 36.9 p90 -64.52 -25.68 68.09 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 112.198 0.444 . . . . 61.55 112.198 -176.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.9 t -80.97 -8.47 59.77 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.151 0.5 . . . . 74.1 110.67 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.98 -55.19 0.57 Allowed Glycine 0 CA--C 1.494 -1.225 0 N-CA-C 110.427 -1.069 . . . . 60.41 110.427 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -96.63 133.81 24.09 Favored Pre-proline 0 C--N 1.295 -1.795 0 N-CA-C 107.482 -1.303 . . . . 71.41 107.482 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.661 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 74.2 Cg_endo -76.78 117.27 4.46 Favored 'Trans proline' 0 N--CA 1.426 -2.492 0 C-N-CA 120.613 0.875 . . . . 63.42 111.134 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 29.5 mtmm -100.77 147.11 26.43 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 115.552 -0.749 . . . . 73.21 109.283 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 44' ' ' VAL . . . -122.38 137.01 11.11 Favored Glycine 0 N--CA 1.418 -2.558 0 C-N-CA 120.05 -1.071 . . . . 23.1 112.494 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.457 ' CE2' ' HG ' ' A' ' 69' ' ' LEU . 5.2 p90 -149.87 143.09 25.08 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 124.407 1.083 . . . . 71.23 109.338 176.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.32 153.95 45.43 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 116.509 -0.314 . . . . 72.15 111.825 -171.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.702 ' OH ' ' HA3' ' B' ' 21' ' ' GLY . 20.0 m-85 -116.78 125.1 51.11 Favored 'General case' 0 CA--C 1.461 -2.449 0 C-N-CA 122.864 0.466 . . . . 70.32 110.729 173.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.3 mm -103.69 110.7 30.83 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.536 0 N-CA-C 106.375 -1.713 . . . . 72.13 106.375 175.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.46 ' HG2' ' OG ' ' A' ' 38' ' ' SER . 29.2 mt-10 -96.88 121.08 38.36 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.325 -0.991 . . . . 63.42 108.325 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -99.43 170.98 8.24 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.218 0.533 . . . . 73.32 111.239 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.62 -41.01 22.09 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.474 -0.784 . . . . 73.34 110.637 173.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.405 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 40.7 mm-40 -101.81 146.99 27.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.06 0.457 . . . . 75.3 111.355 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.559 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.8 OUTLIER -74.71 -34.05 62.51 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.077 -1.453 . . . . 71.24 107.077 -179.304 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.286 0.9 OUTLIER -65.98 -20.06 66.07 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.156 -0.929 . . . . 72.13 113.212 177.425 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.405 ' OG ' ' HB2' ' A' ' 87' ' ' GLU . 22.6 m -66.27 -36.6 83.41 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 109.824 -0.436 . . . . 71.04 109.824 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 88' ' ' ARG . 3.6 m -66.26 -40.42 86.81 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 N-CA-C 108.629 -0.878 . . . . 65.34 108.629 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -55.54 -38.52 69.39 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.435 0.694 . . . . 65.03 110.529 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.71 -37.92 65.0 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.838 -0.619 . . . . 61.23 111.421 177.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.85 -39.91 55.7 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.188 0.44 . . . . 53.03 112.188 -176.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 91' ' ' VAL . 33.0 m -55.41 -22.06 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 113.068 0.766 . . . . 53.14 113.068 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.31 -9.63 42.89 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 120.991 0.424 . . . . 41.41 110.37 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.5 ' C ' ' H ' ' A' ' 99' ' ' GLU . 68.3 mtm -99.17 5.98 46.58 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.153 0.797 . . . . 75.35 113.153 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 109' ' ' VAL . 1.4 p-10 -67.57 24.07 0.02 OUTLIER 'General case' 0 N--CA 1.528 3.43 0 C-N-CA 123.641 0.776 . . . . 74.23 112.578 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.5 ' H ' ' C ' ' A' ' 97' ' ' MET . 39.6 tt0 -156.21 -7.81 0.11 Allowed 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.805 -1.089 . . . . 71.42 109.171 -168.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.4 p -88.03 169.2 12.17 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.517 -0.765 . . . . 73.01 111.625 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.7 p -106.46 132.44 53.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-N 115.401 -0.818 . . . . 61.23 109.814 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -127.14 123.68 37.33 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.561 -0.903 . . . . 75.41 108.561 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.3 ttt-85 54.52 33.01 17.98 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-O 122.975 1.369 . . . . 65.22 111.003 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.0 14.62 69.08 Favored Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 114.224 -1.353 . . . . 74.32 114.449 176.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -136.12 148.82 48.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 118.043 0.922 . . . . 61.31 110.64 174.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.5 m -79.15 121.64 25.26 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.768 -0.827 . . . . 33.32 108.768 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 37.4 pt -102.32 172.13 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.18 0.514 . . . . 72.31 111.287 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.409 ' HE3' ' HB3' ' A' ' 110' ' ' LEU . 55.1 tptt -124.89 127.28 46.87 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.228 -1.027 . . . . 63.51 108.228 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 23.8 t -126.79 115.95 43.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 107.746 -1.205 . . . . 75.34 107.746 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.477 HD13 ' HB3' ' A' ' 40' ' ' TYR 0.283 0.0 OUTLIER -138.38 141.39 31.38 Favored Pre-proline 0 C--N 1.311 -1.073 0 C-N-CA 119.536 -0.865 . . . . 72.32 109.112 -179.533 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.01 140.0 44.32 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 122.326 2.017 . . . . 63.1 114.153 -171.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.581 ' HD2' ' HB ' ' B' ' 19' ' ' THR . 32.8 ttpt -84.81 136.94 33.46 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 109.109 -0.7 . . . . 72.25 109.109 177.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -113.38 164.54 13.45 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.411 -0.959 . . . . 63.24 108.411 175.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.575 ' HB ' ' HB2' ' A' ' 35' ' ' ASP . 13.2 t -104.2 110.95 23.35 Favored 'General case' 0 N--CA 1.404 -2.727 0 N-CA-C 106.871 -1.529 . . . . 75.43 106.871 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -77.55 87.02 3.88 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.993 0.902 . . . . 62.45 111.193 -173.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.478 ' H ' ' CD ' ' A' ' 117' ' ' PRO . 0.2 OUTLIER -123.01 -49.61 0.04 OUTLIER Pre-proline 0 C--N 1.303 -1.423 0 CA-C-N 113.773 -1.558 . . . . 73.03 110.002 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.478 ' CD ' ' H ' ' A' ' 116' ' ' MET . 2.9 Cg_endo -89.77 31.27 0.38 Allowed 'Trans proline' 0 C--N 1.388 2.637 0 C-N-CA 122.361 2.041 . . . . 64.13 110.954 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -92.55 38.21 3.22 Favored Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 115.815 -0.63 . . . . 73.35 112.172 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 mp 63.42 99.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 124.379 1.072 . . . . 60.33 112.314 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.9 m -88.66 -25.8 22.19 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.656 -0.702 . . . . 64.1 109.956 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 53.1 m 65.94 -178.23 0.19 Allowed 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.184 0.994 . . . . 65.55 111.89 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.5 p -95.49 103.7 15.58 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 121.091 0.472 . . . . 72.22 110.504 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -80.01 107.84 13.11 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 108.884 -0.784 . . . . 74.14 108.884 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 . . . . . 0 C--N 1.302 -1.479 0 N-CA-C 109.448 -0.575 . . . . 73.13 109.448 -178.101 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.454 0 CA-C-O 120.978 0.418 . . . . 74.34 110.367 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 50.3 mm -117.5 110.97 32.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 108.678 -0.86 . . . . 74.44 108.678 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -126.92 94.53 39.36 Favored Pre-proline 0 C--N 1.312 -1.042 0 CA-C-O 120.959 0.409 . . . . 22.34 111.161 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -94.83 -163.8 0.1 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 123.061 2.507 . . . . 74.2 110.111 176.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 42.0 t -76.51 108.43 9.48 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.225 -1.028 . . . . 62.32 108.225 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 66.3 mtt -81.34 93.06 6.49 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.791 -0.641 . . . . 74.13 111.722 -174.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -111.19 -6.51 14.56 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.49 -0.777 . . . . 63.43 109.459 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 26.3 m -87.86 94.13 9.67 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.298 -0.865 . . . . 72.13 109.301 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 51.6 m -151.7 139.28 19.64 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.035 -0.728 . . . . 63.33 109.035 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -105.85 101.76 11.25 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.592 0.71 . . . . 73.3 110.244 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 21.8 p -80.94 162.56 23.83 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.753 -1.112 . . . . 64.15 110.94 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . 0.465 ' N ' ' HD2' ' B' ' 12' ' ' LYS . 11.0 mptt -104.17 88.66 3.05 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.139 -0.482 . . . . 74.13 110.012 -177.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 65.7 mtt -90.56 140.37 29.82 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.801 -0.636 . . . . 72.2 109.785 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 84.9 m 75.51 -29.02 0.18 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.643 0.777 . . . . 73.3 111.379 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -78.71 -61.45 2.01 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 109.104 -0.702 . . . . 72.32 109.104 175.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.43 -173.11 23.68 Favored Glycine 0 N--CA 1.433 -1.552 0 C-N-CA 120.838 -0.696 . . . . 62.5 112.705 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.65 -154.65 0.48 Allowed 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.583 -0.895 . . . . 63.53 108.583 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -91.81 -3.16 56.44 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.758 -0.83 . . . . 70.31 108.758 174.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.581 ' HB ' ' HD2' ' A' ' 112' ' ' LYS . 28.8 m 60.54 101.56 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.788 1.235 . . . . 75.32 113.994 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -69.74 -13.44 62.29 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 121.135 -0.226 . . . . 64.3 110.648 174.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.702 ' HA3' ' OH ' ' A' ' 82' ' ' TYR . . . 94.08 -124.6 7.94 Favored Glycine 0 C--N 1.344 1.009 0 N-CA-C 115.093 0.797 . . . . 54.42 115.093 170.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.65 -35.98 97.8 Favored 'Trans proline' 0 CA--C 1.558 1.724 0 C-N-CA 123.492 2.795 . . . . 71.25 114.762 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.505 ' HA ' ' HB2' ' A' ' 13' ' ' MET . 58.6 Cg_exo -47.52 123.57 8.26 Favored 'Trans proline' 0 C--N 1.4 3.27 0 C-N-CA 122.073 1.849 . . . . 75.41 113.041 174.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -91.03 141.52 26.56 Favored Pre-proline 0 C--N 1.294 -1.841 0 CA-C-N 114.56 -1.2 . . . . 63.14 108.874 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -49.3 117.73 3.1 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.998 2.465 . . . . 63.41 113.515 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 7.2 mp -58.04 -176.04 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.191 0 CA-C-N 113.98 -1.464 . . . . 70.32 110.453 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 20.3 m -66.58 142.93 57.32 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 107.254 -1.387 . . . . 63.01 107.254 171.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.501 ' O ' ' HE2' ' B' ' 32' ' ' LYS . . . -56.02 -42.84 77.07 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.577 -0.738 . . . . 65.11 110.68 176.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -68.4 -30.84 69.85 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 112.812 0.671 . . . . 74.41 112.812 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.75 -39.74 91.38 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.636 -0.505 . . . . 62.3 109.636 171.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.483 ' HA ' HG12 ' B' ' 34' ' ' ILE . 57.3 mttm -70.19 -49.98 44.83 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 113.162 0.801 . . . . 53.23 113.162 -178.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.559 ' N ' ' HE2' ' B' ' 32' ' ' LYS . 0.3 OUTLIER -56.09 -39.15 71.7 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 120.146 -0.622 . . . . 75.21 112.639 -178.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 17.9 mt-10 -71.85 -41.61 67.91 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 118.945 -1.102 . . . . 74.23 112.629 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.483 HG12 ' HA ' ' B' ' 31' ' ' LYS . 35.1 pt -68.88 -35.46 69.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 C-N-CA 120.213 -0.595 . . . . 73.34 111.351 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -59.85 -44.08 94.31 Favored 'General case' 0 C--O 1.217 -0.625 0 N-CA-C 109.674 -0.491 . . . . 72.14 109.674 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 98.4 mttt -70.33 -18.22 63.08 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.269 -0.878 . . . . 65.24 112.298 -175.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' B' ' 33' ' ' GLU . 18.8 ptp180 -109.8 24.93 12.38 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-O 121.443 0.64 . . . . 71.04 111.383 -178.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.511 ' HB2' ' HD3' ' B' ' 112' ' ' LYS . 19.5 m -115.51 172.69 6.95 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.656 -0.702 . . . . 53.54 110.997 174.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.4 163.66 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 123.19 0.596 . . . . 74.25 110.573 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 36.0 t80 -111.97 125.61 54.25 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 125.596 1.559 . . . . 61.4 107.94 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 57.9 t -114.66 116.31 52.2 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 C-N-CA 123.651 0.78 . . . . 74.22 109.191 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.98 165.39 12.52 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 120.716 -0.754 . . . . 61.12 112.406 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 t30 57.81 20.43 6.53 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 126.241 1.816 . . . . 72.34 113.26 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.72 129.0 19.08 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 CA-C-O 121.396 0.617 . . . . 71.24 109.389 173.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.487 ' HA ' ' CZ ' ' B' ' 105' ' ' ARG . 20.8 t70 -61.35 139.23 58.22 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 114.674 -1.148 . . . . 52.43 109.274 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' TYR . . . . . 0.406 ' CE2' ' HG2' ' A' ' 51' ' ' GLN . 32.6 t80 -70.32 0.15 7.01 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.714 -0.676 . . . . 74.23 111.072 -174.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -107.6 -0.23 34.61 Favored Glycine 0 N--CA 1.421 -2.304 0 CA-C-N 115.799 -0.637 . . . . 71.23 112.148 175.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.9 t -80.51 146.27 31.42 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.599 -1.26 . . . . 63.1 107.599 176.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 71.7 p -105.52 172.58 6.72 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.982 -0.377 . . . . 73.03 109.982 -177.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.48 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -63.72 -50.4 69.29 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 120.57 0.224 . . . . 71.21 110.539 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -61.03 -35.99 78.36 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 111.838 0.311 . . . . 75.21 111.838 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -64.17 -43.65 94.49 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 109.61 -0.515 . . . . 65.21 109.61 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 52.0 mt -67.67 -48.14 67.48 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.208 -0.905 . . . . 73.14 112.042 176.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.32 -49.16 78.71 Favored 'General case' 0 C--O 1.207 -1.132 0 C-N-CA 123.387 0.675 . . . . 63.02 110.809 -177.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.28 -43.25 78.62 Favored 'General case' 0 C--O 1.262 1.718 0 CA-C-O 121.215 0.531 . . . . 55.31 111.123 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -65.77 -39.25 90.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.479 -0.782 . . . . 74.22 110.718 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -82.45 -22.55 35.19 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 113.432 0.901 . . . . 75.15 113.432 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 36.1 t -69.23 -25.16 64.17 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.958 -0.565 . . . . 72.24 109.766 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.9 m -62.9 -24.97 68.09 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 120.387 -0.525 . . . . 74.31 110.511 173.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 58.4 m -96.55 3.73 52.46 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 122.744 0.418 . . . . 51.32 112.061 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.13 -171.72 32.73 Favored Glycine 0 C--O 1.222 -0.634 0 C-N-CA 119.281 -1.438 . . . . 65.41 114.456 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 21.7 m -98.86 119.38 37.52 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.707 -0.479 . . . . 51.41 109.707 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 50.8 mt -82.52 132.74 30.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 112.997 0.74 . . . . 70.35 112.997 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . 0.621 ' OD1' ' HB3' ' A' ' 73' ' ' PHE . 46.1 t-20 -93.79 -51.29 4.97 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 125.315 1.446 . . . . 73.04 109.225 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.519 ' NH1' ' HA3' ' A' ' 16' ' ' GLY . 46.5 mtp180 -153.14 166.75 31.53 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.547 -1.279 . . . . 43.33 107.547 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.48 HD11 ' HB1' ' B' ' 50' ' ' ALA . 19.9 pt -147.13 144.28 19.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 108.059 -1.089 . . . . 75.32 108.059 171.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . 0.577 ' OG1' ' HB2' ' B' ' 82' ' ' TYR . 36.9 p -121.71 136.88 54.93 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 105.387 -2.079 . . . . 55.1 105.387 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.2 mp -129.25 113.08 26.93 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 N-CA-C 105.561 -2.014 . . . . 74.4 105.561 173.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.498 ' HG ' ' CE2' ' B' ' 80' ' ' TYR 0.274 1.5 pt? -120.72 123.03 41.72 Favored 'General case' 0 C--N 1.281 -2.387 0 C-N-CA 119.987 -0.685 . . . . 72.31 111.486 -179.497 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 67.0 m -117.6 134.82 54.47 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.621 -0.718 . . . . 75.01 109.631 -177.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 3.5 p30 -115.11 140.38 49.11 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.878 -0.729 . . . . 74.44 109.871 177.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.451 ' HG2' ' HB3' ' B' ' 77' ' ' PRO . 7.6 mtpm? -112.5 7.67 19.06 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 116.126 -0.488 . . . . 73.35 110.365 -178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.652 ' HB3' ' OD1' ' A' ' 64' ' ' ASN . 12.5 p90 -73.08 -11.2 60.46 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 121.524 0.678 . . . . 73.43 110.585 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 20.7 m -88.13 9.48 22.59 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.117 -0.947 . . . . 61.25 110.09 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.95 -51.0 4.39 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 109.607 -1.397 . . . . 72.44 109.607 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -96.43 145.53 29.74 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 105.806 -1.924 . . . . 72.32 105.806 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.451 ' HB3' ' HG2' ' B' ' 72' ' ' LYS . 58.2 Cg_endo -77.43 118.1 4.52 Favored 'Trans proline' 0 N--CA 1.437 -1.81 0 C-N-CA 120.767 0.978 . . . . 65.42 110.623 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 28.8 mtmm -93.71 137.49 32.91 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 108.13 -1.063 . . . . 50.44 108.13 177.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -116.17 133.33 10.73 Favored Glycine 0 N--CA 1.413 -2.887 0 C-N-CA 119.974 -1.108 . . . . 62.0 111.773 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . 0.498 ' CE2' ' HG ' ' B' ' 69' ' ' LEU . 6.8 p90 -147.74 142.73 26.97 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 124.04 0.936 . . . . 75.13 109.42 175.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.08 154.37 45.91 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 116.397 -0.365 . . . . 74.23 111.728 -172.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' TYR . . . . . 0.615 ' OH ' ' HA3' ' A' ' 21' ' ' GLY . 19.4 m-85 -117.25 124.96 50.31 Favored 'General case' 0 CA--C 1.467 -2.23 0 C-N-CA 122.78 0.432 . . . . 72.2 110.442 173.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 34.5 mm -102.75 110.11 28.5 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 106.635 -1.617 . . . . 74.04 106.635 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' GLU . . . . . 0.444 ' OE1' ' HD3' ' B' ' 65' ' ' ARG . 31.2 mt-10 -95.3 120.61 35.83 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.417 -0.957 . . . . 54.43 108.417 -178.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.418 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 98.0 m-85 -99.09 162.2 13.2 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.413 0.625 . . . . 65.43 111.111 -177.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.32 -11.37 56.48 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.509 -0.769 . . . . 65.2 109.983 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . 0.605 ' HB3' ' OG ' ' B' ' 90' ' ' SER . 43.2 tt0 -124.23 140.6 52.8 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.309 -0.405 . . . . 54.11 111.094 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.507 ' O ' HG22 ' B' ' 91' ' ' VAL . 0.6 OUTLIER -74.99 -34.91 62.02 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.64 -1.244 . . . . 74.03 107.64 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . 0.42 ' H ' ' HG2' ' B' ' 87' ' ' GLU . 0.6 OUTLIER -62.13 -28.38 69.6 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.512 -0.921 . . . . 75.42 108.512 -179.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' SER . . . . . 0.605 ' OG ' ' HB3' ' B' ' 87' ' ' GLU . 70.2 m -63.46 -36.34 83.43 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 116.19 -0.459 . . . . 71.24 111.025 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.507 HG22 ' O ' ' B' ' 88' ' ' ARG . 3.6 m -67.18 -40.13 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.519 0 N-CA-C 108.551 -0.907 . . . . 61.13 108.551 179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -56.96 -37.68 71.9 Favored 'General case' 0 N--CA 1.455 -0.225 0 O-C-N 123.828 0.705 . . . . 75.05 110.9 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.9 -37.18 64.76 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.753 -0.658 . . . . 61.33 111.48 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.83 -41.15 53.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.506 . . . . 73.51 111.87 -176.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . 0.493 HG13 ' O ' ' B' ' 91' ' ' VAL . 32.8 m -55.23 -21.46 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 112.905 0.705 . . . . 72.3 112.905 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.07 -13.77 62.25 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.805 0.812 . . . . 72.24 111.14 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 68.2 mtm -97.2 9.69 41.5 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.418 -0.81 . . . . 72.43 110.011 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . 0.709 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 6.1 p-10 -36.27 -46.81 0.55 Allowed 'General case' 0 C--O 1.204 -1.31 0 N-CA-C 115.694 1.739 . . . . 63.21 115.694 -176.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -128.47 41.89 3.41 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 118.585 -1.246 . . . . 73.3 110.792 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 40.8 p -79.62 176.87 9.32 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.88 -0.6 . . . . 74.4 110.794 175.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.04 132.96 55.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.139 0.495 . . . . 74.12 109.876 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -140.49 125.82 18.78 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.482 -0.781 . . . . 74.41 109.004 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . 0.263 20.7 ttt180 50.49 54.78 10.56 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 122.295 1.045 . . . . 74.35 113.747 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.89 -7.5 42.38 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 114.341 -1.3 . . . . 12.14 115.568 176.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.487 ' CZ ' ' HA ' ' B' ' 45' ' ' ASP . 10.2 ptt180 -136.7 159.89 40.48 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 114.35 1.241 . . . . 74.4 114.35 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 34.5 m -87.12 120.93 28.91 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.169 -0.923 . . . . 61.54 109.931 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 39.5 pt -101.78 172.01 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 116.204 -0.453 . . . . 73.32 110.413 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . 0.709 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 56.1 tptt -125.84 129.39 49.29 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.828 -0.804 . . . . 71.02 108.828 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 18.0 t -124.54 121.58 61.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 107.653 -1.24 . . . . 64.44 107.653 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.295 0.4 OUTLIER -140.09 135.05 16.02 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 106.25 -1.759 . . . . 73.21 106.25 -170.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.33 143.53 53.2 Favored 'Trans proline' 0 CA--C 1.551 1.363 0 C-N-CA 121.885 1.723 . . . . 71.31 113.93 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.511 ' HD3' ' HB2' ' B' ' 38' ' ' SER . 66.0 tttt -91.08 148.53 22.32 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 123.54 0.736 . . . . 70.22 110.436 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -158.4 135.83 10.18 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 105.061 -2.2 . . . . 54.32 105.061 168.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 62.1 m -147.29 110.2 4.73 Favored 'General case' 0 N--CA 1.421 -1.902 0 C-N-CA 119.085 -1.046 . . . . 54.12 113.177 -172.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' ASN . . . . . 0.441 ' O ' ' HD3' ' B' ' 117' ' ' PRO . 2.7 t-20 60.05 111.96 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 115.669 1.729 . . . . 74.2 115.669 168.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -107.34 96.14 15.19 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 108.188 -1.042 . . . . 70.21 108.188 171.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' B' ' 115' ' ' ASN . 13.4 Cg_exo -69.95 -174.8 1.02 Allowed 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 122.853 2.368 . . . . 62.31 112.205 -177.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.63 105.5 1.74 Allowed Glycine 0 N--CA 1.427 -1.958 0 C-N-CA 120.94 -0.647 . . . . 63.12 111.505 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 66.0 mt -64.11 -43.35 97.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.481 -0.933 . . . . 63.25 108.481 177.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 32.4 t -149.93 115.37 5.5 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 115.11 -0.95 . . . . 71.1 109.233 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 32.4 t -83.94 -43.04 15.65 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.406 -1.331 . . . . 70.33 107.406 177.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 10.2 t -156.72 132.04 9.24 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 107.87 -1.159 . . . . 72.45 107.87 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -78.65 -37.11 42.83 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 108.485 -0.931 . . . . 75.51 108.485 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 . . . . . 0 N--CA 1.423 -1.803 0 CA-C-N 114.637 -1.165 . . . . 62.44 109.061 175.001 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.55 0 N-CA-C 109.82 -0.437 . . . . 64.22 109.82 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.5 mm -99.59 118.96 46.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.516 -0.55 . . . . 74.43 109.516 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.08 89.2 6.09 Favored Pre-proline 0 C--N 1.308 -1.237 0 CA-C-N 116.188 -0.46 . . . . 73.24 110.037 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -85.4 12.47 3.05 Favored 'Trans proline' 0 C--O 1.242 0.679 0 C-N-CA 123.354 2.702 . . . . 74.44 112.114 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.2 t 68.75 90.57 0.09 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.277 1.431 . . . . 63.44 113.255 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -124.33 129.52 50.87 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.094 -1.076 . . . . 72.34 108.094 173.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -79.27 93.82 5.34 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.998 -1.112 . . . . 74.24 107.998 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.9 p -78.56 4.34 13.67 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 113.735 1.013 . . . . 61.25 113.735 -173.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.5 t -76.51 126.77 31.58 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 106.857 -1.535 . . . . 55.54 106.857 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -135.28 116.82 14.8 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 116.216 -0.447 . . . . 72.31 110.891 -171.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.7 t -95.62 -90.89 0.23 Allowed 'General case' 0 N--CA 1.403 -2.797 0 N-CA-C 107.026 -1.472 . . . . 72.11 107.026 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.519 ' HD2' ' SD ' ' A' ' 13' ' ' MET . 0.3 OUTLIER 43.74 89.68 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 124.759 1.223 . . . . 74.11 109.073 177.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.519 ' SD ' ' HD2' ' A' ' 12' ' ' LYS . 1.2 mpt? 82.05 75.61 0.03 OUTLIER 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 124.907 1.283 . . . . 74.44 108.211 -163.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.4 m -71.9 -30.67 65.62 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 113.921 -1.491 . . . . 70.32 110.739 -176.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 69.23 129.16 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 124.713 1.205 . . . . 60.43 112.304 -178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 169.51 153.4 8.47 Favored Glycine 0 N--CA 1.41 -3.048 0 N-CA-C 109.346 -1.502 . . . . 72.33 109.346 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.17 -74.79 0.08 Allowed 'General case' 0 C--N 1.308 -1.213 0 O-C-N 123.845 0.38 . . . . 43.11 110.716 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.563 ' OH ' ' HA ' ' B' ' 114' ' ' THR . 78.9 t80 -170.6 110.18 0.36 Allowed 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 113.313 0.857 . . . . 72.34 113.313 177.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.426 ' OG1' ' HA ' ' A' ' 25' ' ' PRO . 53.9 m -170.16 120.03 0.61 Allowed 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 106.079 -1.823 . . . . 72.13 106.079 170.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 59.76 26.71 15.89 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 122.367 1.08 . . . . 74.2 109.711 -176.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.39 -118.34 4.77 Favored Glycine 0 N--CA 1.432 -1.613 0 CA-C-N 113.449 -1.705 . . . . 60.13 111.357 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.98 -26.95 50.8 Favored 'Trans proline' 0 CA--C 1.597 3.626 0 C-N-CA 124.178 3.252 . . . . 65.45 118.752 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.56 167.64 7.88 Favored 'Trans proline' 0 C--N 1.389 2.7 0 C-N-CA 122.516 2.144 . . . . 71.21 114.48 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -62.5 139.99 96.7 Favored Pre-proline 0 C--O 1.238 0.461 0 CA-C-N 115.731 -0.668 . . . . 74.21 110.914 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.426 ' HA ' ' OG1' ' A' ' 19' ' ' THR . 94.3 Cg_endo -80.02 132.33 9.42 Favored 'Trans proline' 0 N--CA 1.437 -1.845 0 C-N-CA 122.158 1.905 . . . . 65.44 112.973 -179.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.46 HD23 ' HB2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -137.31 142.72 41.89 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 114.766 -1.107 . . . . 74.52 108.178 174.275 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.3 t -67.86 155.26 39.77 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 123.317 0.386 . . . . 65.11 111.502 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.674 ' O ' ' HG2' ' A' ' 32' ' ' LYS . . . -49.34 -33.08 12.53 Favored 'General case' 0 C--O 1.188 -2.166 0 CA-C-N 115.641 -0.709 . . . . 44.52 110.748 172.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -66.57 -33.77 76.41 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.819 0.674 . . . . 74.12 112.819 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.506 ' O ' HG12 ' A' ' 34' ' ' ILE . 1.5 mp0 -67.27 -35.9 80.47 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 108.782 -0.822 . . . . 62.31 108.782 171.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 28' ' ' ALA . 55.8 mmtt -63.67 -45.23 91.05 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-N 114.766 -1.106 . . . . 61.51 108.543 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.725 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 30.5 mmmt -56.42 -47.16 79.63 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 116.204 -0.453 . . . . 74.5 110.628 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -67.18 -46.32 74.31 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.306 -0.406 . . . . 72.32 111.513 -174.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 30' ' ' GLU . 15.3 pt -71.09 -36.74 64.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.966 -0.561 . . . . 63.42 111.904 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.5 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 29.9 m-20 -76.17 -19.14 58.73 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.712 0.634 . . . . 75.04 112.712 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.725 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 97.3 mttt -66.96 -26.42 66.81 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.361 0.6 . . . . 70.34 110.339 174.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -96.89 16.03 20.51 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.153 -0.684 . . . . 72.01 109.153 -177.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.522 ' OG ' ' HG3' ' A' ' 84' ' ' GLU . 14.9 m -103.5 163.01 12.56 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 115.542 -0.754 . . . . 62.44 110.48 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 111' ' ' PRO . 27.2 m -131.64 164.16 35.29 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 115.469 -0.787 . . . . 73.34 109.883 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 23.7 t80 -110.87 126.03 54.25 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 107.44 -1.318 . . . . 73.11 107.44 175.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.0 t -115.89 111.99 37.8 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 N-CA-C 107.753 -1.203 . . . . 53.1 107.753 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.6 172.03 18.89 Favored Glycine 0 CA--C 1.478 -2.256 0 N-CA-C 109.706 -1.358 . . . . 32.44 109.706 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.687 ' OD1' ' HG3' ' A' ' 105' ' ' ARG . 26.2 t-20 69.42 -11.05 0.51 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.356 0.662 . . . . 64.15 112.395 -178.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.7 p -70.19 91.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 107.372 -1.344 . . . . 71.31 107.372 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.38 10.5 m-20 -74.43 168.02 20.53 Favored 'General case' 0 CA--C 1.457 -2.618 0 N-CA-C 116.341 1.978 . . . . 61.15 116.341 -166.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -39.33 -34.49 0.2 Allowed 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 128.231 2.612 . . . . 73.3 114.791 -173.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.66 -1.53 85.37 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.435 -0.888 . . . . 74.32 114.075 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.454 ' HA ' ' CZ ' ' A' ' 103' ' ' ARG . 19.7 m -75.26 133.33 41.37 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 117.677 0.738 . . . . 63.34 111.041 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.612 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 12.6 p -92.22 155.89 17.68 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 115.583 -0.735 . . . . 74.13 111.046 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.581 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -65.54 -47.82 74.58 Favored 'General case' 0 C--O 1.212 -0.904 0 C-N-CA 122.641 0.376 . . . . 71.42 110.831 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -56.81 -53.43 57.89 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.519 0.728 . . . . 63.01 112.529 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.61 -36.75 83.75 Favored 'General case' 0 C--O 1.25 1.128 0 CA-C-O 121.397 0.617 . . . . 55.51 111.348 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' A' ' 49' ' ' THR . 2.9 tt -72.17 -46.56 55.86 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.78 -1.1 . . . . 74.32 108.493 -176.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -58.26 -48.3 80.86 Favored 'General case' 0 C--O 1.207 -1.158 0 C-N-CA 123.482 0.713 . . . . 74.12 111.039 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.92 -38.23 69.99 Favored 'General case' 0 C--O 1.258 1.551 0 CA-C-O 121.268 0.556 . . . . 45.54 110.752 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -65.39 -40.3 93.27 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.117 -0.947 . . . . 75.04 110.189 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -83.04 -21.33 33.83 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 113.751 1.019 . . . . 74.21 113.751 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.8 t -60.47 -33.69 72.94 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.988 -0.745 . . . . 72.55 108.988 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.9 m -59.04 -27.8 65.82 Favored 'General case' 0 CA--C 1.565 1.536 0 CA-C-N 115.789 -0.641 . . . . 63.01 111.807 174.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 67.5 m -92.0 -0.85 57.48 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.36 0.874 . . . . 73.03 113.36 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.69 -169.96 30.53 Favored Glycine 0 C--N 1.319 -0.399 0 C-N-CA 118.951 -1.595 . . . . 74.1 114.562 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.4 m -94.56 116.78 29.19 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 123.205 0.602 . . . . 71.01 110.479 -175.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 85.1 mt -89.23 130.1 39.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 C-N-CA 123.015 0.526 . . . . 74.15 112.368 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.47 HD21 ' HB2' ' A' ' 86' ' ' ALA . 11.7 m120 -99.34 -40.41 7.92 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.686 -0.688 . . . . 71.43 111.106 177.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' B' ' 71' ' ' ASP . 55.6 mtp180 -150.55 160.9 43.47 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 107.91 -1.145 . . . . 73.31 107.91 -177.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.581 HD11 ' HB1' ' A' ' 50' ' ' ALA . 26.4 pt -145.14 137.97 21.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.382 -1.34 . . . . 74.32 107.382 173.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.9 m -125.61 120.89 32.03 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 107.604 -1.258 . . . . 64.05 107.604 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.402 ' O ' HD12 ' B' ' 68' ' ' ILE . 2.8 mp -118.18 118.45 58.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 106.218 -1.771 . . . . 74.23 106.218 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.45 ' HG ' ' CE2' ' A' ' 80' ' ' TYR 0.26 1.2 pt? -121.9 125.59 46.76 Favored 'General case' 0 C--N 1.285 -2.22 0 C-N-CA 120.257 -0.577 . . . . 60.21 111.967 179.156 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 73.1 m -117.37 136.0 53.47 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.734 -0.839 . . . . 71.42 108.734 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.502 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 2.5 p30 -131.07 153.52 49.22 Favored 'General case' 0 CA--C 1.495 -1.141 0 C-N-CA 119.146 -1.022 . . . . 61.13 112.033 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.411 ' HE3' ' OE1' ' B' ' 54' ' ' GLU . 97.9 mttt -121.54 18.33 11.26 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 124.048 0.843 . . . . 72.1 110.883 176.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -69.03 -21.18 64.13 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 119.049 -1.06 . . . . 51.44 112.98 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.7 p -91.8 10.61 27.82 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.405 0.621 . . . . 73.34 110.471 174.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.63 -47.87 1.4 Allowed Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.552 -0.619 . . . . 62.35 111.552 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -97.27 136.83 21.24 Favored Pre-proline 0 C--N 1.301 -1.543 0 CA-C-N 115.512 -0.344 . . . . 72.33 110.23 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 31.7 Cg_endo -69.0 118.61 5.78 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.616 1.544 . . . . 71.14 110.364 175.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 34.6 mtmm -113.33 149.74 33.55 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.337 -0.616 . . . . 70.21 109.337 -178.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -120.38 134.8 10.56 Favored Glycine 0 N--CA 1.423 -2.195 0 C-N-CA 119.847 -1.168 . . . . 73.23 112.791 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.45 ' CE2' ' HG ' ' A' ' 69' ' ' LEU . 17.6 p90 -152.85 144.42 23.42 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 124.326 1.05 . . . . 74.11 109.644 175.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.23 155.89 45.97 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.035 0.445 . . . . 64.01 111.811 -173.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -115.14 130.09 56.84 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.183 -1.414 . . . . 74.04 107.183 174.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.48 HG23 HG22 ' A' ' 66' ' ' ILE . 40.9 mm -112.39 112.88 42.38 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 108.454 -0.943 . . . . 73.23 108.454 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.522 ' HG3' ' OG ' ' A' ' 38' ' ' SER . 1.9 mp0 -88.08 118.96 28.01 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 122.61 0.364 . . . . 73.42 110.801 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -103.82 163.69 12.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.486 0.66 . . . . 73.22 111.602 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.47 ' HB2' HD21 ' A' ' 64' ' ' ASN . . . -78.27 -23.91 47.07 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.135 -0.938 . . . . 73.4 112.098 176.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -125.67 150.37 47.67 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 113.541 0.941 . . . . 74.12 113.541 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.555 ' O ' HG22 ' A' ' 91' ' ' VAL . 21.7 mmm180 -70.52 -29.3 65.77 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.248 -0.887 . . . . 73.31 108.986 173.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.95 -35.38 73.04 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.03 -0.532 . . . . 71.51 110.188 176.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.8 m -64.64 -36.91 85.8 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 116.745 -0.207 . . . . 73.21 111.077 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 88' ' ' ARG . 3.7 m -64.79 -39.26 85.05 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.885 0 C-N-CA 119.509 -0.876 . . . . 74.3 109.001 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.437 ' HA ' HG22 ' A' ' 95' ' ' VAL . 38.5 m-20 -60.07 -34.96 74.16 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.069 0.461 . . . . 74.3 111.783 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.74 -37.54 65.05 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.905 -0.589 . . . . 73.53 110.351 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.14 -44.76 59.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.138 -0.483 . . . . 65.15 110.741 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 91' ' ' VAL . 14.8 m -61.09 -23.33 29.6 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.019 0 CA-C-N 116.456 -0.338 . . . . 75.11 111.8 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.01 -16.0 63.11 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.664 0.745 . . . . 75.43 110.431 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 25.2 ttp -104.89 9.22 34.78 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.835 -1.075 . . . . 72.02 109.134 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 4.5 p-10 -37.4 -49.52 1.01 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 113.812 1.041 . . . . 73.23 113.812 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -115.44 104.17 11.5 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-O 121.744 0.783 . . . . 70.24 110.268 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 106' ' ' THR . 14.5 t -145.15 173.62 11.77 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 114.712 -1.131 . . . . 70.32 108.644 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.14 115.76 48.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.827 0.822 . . . . 71.15 110.301 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -122.58 117.71 26.48 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.034 -1.099 . . . . 75.41 108.034 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.454 ' CZ ' ' HA ' ' A' ' 48' ' ' SER . 54.3 mtt180 62.26 33.6 16.52 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.79 0.836 . . . . 74.01 112.841 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.37 -2.64 81.19 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 114.7 -1.136 . . . . 72.42 114.137 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.687 ' HG3' ' OD1' ' A' ' 43' ' ' ASN . 18.0 ptp180 -130.21 154.84 47.15 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 117.479 0.64 . . . . 74.1 111.293 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 100' ' ' THR . 88.6 m -83.65 120.96 26.63 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 116.063 -0.517 . . . . 71.44 111.277 -174.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.656 ' HA ' ' HB3' ' A' ' 43' ' ' ASN . 40.3 pt -99.83 172.13 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 C-N-CA 120.595 -0.442 . . . . 62.31 111.968 -174.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 54.1 tptt -131.4 126.65 35.7 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.094 -0.957 . . . . 72.42 109.572 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 35.9 t -127.93 128.69 69.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.368 -0.605 . . . . 74.31 109.368 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.542 ' HB2' ' HD2' ' A' ' 111' ' ' PRO 0.295 0.0 OUTLIER -148.45 161.94 31.91 Favored Pre-proline 0 C--N 1.303 -1.433 0 CA-C-O 117.604 -1.189 . . . . 75.04 108.301 174.15 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.542 ' HD2' ' HB2' ' A' ' 110' ' ' LEU . 50.4 Cg_endo -67.73 149.47 78.76 Favored 'Trans proline' 0 C--N 1.357 1.02 0 CA-C-N 121.833 1.69 . . . . 54.22 109.122 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.473 ' HE2' ' HB2' ' A' ' 38' ' ' SER . 35.8 ttpt -70.04 93.19 0.78 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.332 -1.359 . . . . 71.45 107.332 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.492 ' HD3' ' OD1' ' A' ' 115' ' ' ASN 0.262 0.9 OUTLIER -75.26 137.92 41.53 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 118.581 2.808 . . . . 64.13 118.581 -163.813 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 32.5 p -103.0 -11.92 17.82 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 113.373 -1.739 . . . . 54.13 107.991 172.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.492 ' OD1' ' HD3' ' A' ' 113' ' ' ARG . 19.3 m120 70.74 -68.21 0.22 Allowed 'General case' 0 C--N 1.351 0.666 0 C-N-CA 125.936 1.695 . . . . 72.01 113.513 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 25.2 mmt -109.38 107.81 59.74 Favored Pre-proline 0 C--N 1.308 -1.204 0 CA-C-N 116.218 -0.446 . . . . 65.55 111.501 -176.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -88.08 -1.72 7.09 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.565 2.176 . . . . 72.42 111.194 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -108.03 -54.48 0.63 Allowed Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 110.86 -0.896 . . . . 64.34 110.86 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.9 mm -72.42 97.42 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.022 0.439 . . . . 72.43 110.879 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.9 t -177.19 155.65 1.17 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.143 -1.799 . . . . 64.23 106.143 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 49.4 m -130.38 98.13 4.61 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.295 0.569 . . . . 73.11 110.738 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.4 m -77.17 85.05 3.64 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 121.71 0.767 . . . . 74.21 110.399 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 170.72 -25.95 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 125.722 1.609 . . . . 73.45 107.028 -177.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 . . . . . 0 C--O 1.248 1.005 0 CA-C-N 114.912 -1.04 . . . . 74.13 109.739 -178.59 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.381 0 CA-C-O 121.375 0.607 . . . . 45.52 109.886 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.405 HD12 ' N ' ' B' ' 2' ' ' ILE . 2.5 mp -91.04 133.31 33.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 107.858 -1.164 . . . . 71.14 107.858 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -130.77 125.2 21.27 Favored Pre-proline 0 C--N 1.303 -1.451 0 CA-C-N 116.775 -0.193 . . . . 74.12 110.938 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -61.3 -51.01 4.84 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.387 2.058 . . . . 65.52 109.354 175.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' B' ' 118' ' ' GLY . 76.9 m -161.33 123.07 2.93 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 105.01 -2.219 . . . . 45.25 105.01 175.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.26 97.79 6.87 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 119.407 -0.917 . . . . 74.55 113.26 -178.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 56.53 -86.81 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.924 1.69 . . . . 62.12 113.658 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 41.6 p -94.79 97.12 9.82 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 120.895 0.379 . . . . 64.11 110.807 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 98.4 m -78.44 96.93 5.5 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.179 0.514 . . . . 75.52 109.907 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -85.76 83.27 7.9 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 108.415 -0.957 . . . . 73.31 108.415 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 41.6 m -151.41 157.53 42.52 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.827 -1.175 . . . . 75.32 107.827 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -89.2 -17.69 28.59 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.446 -0.576 . . . . 64.21 109.446 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 64.9 mtt 70.54 -59.27 0.53 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.862 1.265 . . . . 65.53 112.315 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 39.1 m -68.45 -40.6 81.05 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 108.874 -0.787 . . . . 63.5 108.874 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.85 94.21 4.95 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 109.195 -0.668 . . . . 72.32 109.195 174.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.7 -60.12 0.29 Allowed Glycine 0 CA--C 1.484 -1.867 0 N-CA-C 109.429 -1.468 . . . . 74.51 109.429 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 88.24 4.56 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 106.997 -1.483 . . . . 74.11 106.997 172.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -64.16 128.23 34.88 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.4 -0.818 . . . . 74.43 111.482 -175.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 40.8 m -89.0 112.21 23.09 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 109.073 -0.714 . . . . 75.35 109.073 177.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . 0.403 ' HB2' ' HG2' ' B' ' 23' ' ' PRO . 36.8 mt-10 -84.3 1.86 42.93 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 122.099 0.952 . . . . 71.43 110.396 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.65 -100.98 2.31 Favored Glycine 0 C--N 1.3 -1.419 0 CA-C-N 114.015 -1.448 . . . . 71.02 110.325 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.534 ' HG2' ' HD3' ' B' ' 23' ' ' PRO . 2.2 Cg_endo -40.84 -51.21 3.76 Favored 'Trans proline' 0 CA--C 1.561 1.87 0 C-N-CA 124.158 3.239 . . . . 71.23 113.791 172.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.534 ' HD3' ' HG2' ' B' ' 22' ' ' PRO . 1.5 Cg_endo -82.96 123.59 3.64 Favored 'Trans proline' 0 C--N 1.375 1.97 0 CA-C-N 120.825 1.33 . . . . 34.32 109.763 173.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -62.29 150.39 84.85 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 115.613 -0.721 . . . . 61.14 111.447 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.38 109.86 0.44 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.476 2.784 . . . . 73.24 112.914 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.557 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -107.67 148.63 29.13 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.986 -1.116 . . . . 65.14 107.986 175.421 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.477 ' HB3' ' OE2' ' B' ' 30' ' ' GLU . 40.1 t -61.04 145.86 49.26 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.206 0.817 . . . . 75.34 113.206 -170.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.653 ' O ' ' HG2' ' B' ' 32' ' ' LYS . . . -49.5 -35.25 19.31 Favored 'General case' 0 C--O 1.196 -1.732 0 CA-C-N 114.638 -1.165 . . . . 74.32 110.95 172.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.401 ' HA ' ' HG2' ' B' ' 32' ' ' LYS . 45.8 mt-10 -66.26 -34.95 79.17 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.104 0.409 . . . . 75.54 112.104 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.477 ' OE2' ' HB3' ' B' ' 27' ' ' SER . 0.7 OUTLIER -66.76 -35.23 79.61 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 109.096 -0.705 . . . . 60.43 109.096 172.409 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -69.82 -37.23 76.15 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.512 -0.767 . . . . 62.41 110.947 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.68 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 30.6 mmmt -57.63 -46.87 83.59 Favored 'General case' 0 C--O 1.204 -1.333 0 N-CA-C 109.85 -0.426 . . . . 74.32 109.85 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -66.23 -47.94 72.16 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.102 -0.499 . . . . 64.02 111.516 -175.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.473 HG12 ' O ' ' B' ' 30' ' ' GLU . 16.1 pt -70.97 -36.11 62.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.766 -0.652 . . . . 71.24 112.143 -178.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.434 ' HB3' ' HD2' ' B' ' 112' ' ' LYS . 29.0 m-20 -76.48 -20.14 57.29 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.093 0.775 . . . . 75.52 113.093 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.68 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 95.9 mttt -67.09 -25.04 66.03 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.783 0.802 . . . . 73.43 109.64 174.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.629 ' HD3' ' O ' ' B' ' 86' ' ' ALA . 97.3 mtt180 -97.93 13.9 29.11 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.59 -1.186 . . . . 64.03 109.284 -174.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.515 ' OG ' ' HE3' ' B' ' 112' ' ' LYS . 43.6 t -107.15 169.41 8.58 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 115.029 -0.987 . . . . 65.43 110.533 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.49 164.25 33.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 123.651 0.781 . . . . 65.23 110.244 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . 0.572 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 18.6 t80 -110.17 125.83 53.45 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 107.741 -1.207 . . . . 75.14 107.741 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.07 112.42 39.51 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 N-CA-C 107.636 -1.246 . . . . 75.25 107.636 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.29 163.2 13.68 Favored Glycine 0 N--CA 1.421 -2.305 0 C-N-CA 120.041 -1.076 . . . . 74.21 113.46 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 7.9 t30 56.56 22.79 6.97 Favored 'General case' 0 CA--C 1.564 1.507 0 C-N-CA 125.983 1.713 . . . . 52.53 112.802 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 10.6 p -57.5 134.67 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 109.116 -0.698 . . . . 73.21 109.116 174.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -66.25 141.5 58.01 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.061 -0.718 . . . . 64.14 109.061 -177.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -64.51 -10.77 27.98 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-O 121.558 0.694 . . . . 70.32 109.892 -176.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.47 -10.09 58.4 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-N 115.677 -0.692 . . . . 54.12 113.026 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.5 m -98.21 79.7 2.59 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-N 118.685 1.242 . . . . 53.23 110.994 176.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . 0.443 ' OG1' HG22 ' A' ' 49' ' ' THR . 22.6 p -71.06 -177.48 1.68 Allowed 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 113.632 0.975 . . . . 75.11 113.632 175.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.581 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -51.13 -51.5 52.93 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 115.01 1.485 . . . . 65.11 115.01 -164.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -58.21 -53.52 57.29 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 112.825 0.676 . . . . 64.33 112.825 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -63.5 -40.59 97.48 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-O 121.568 0.699 . . . . 54.32 111.02 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 2.7 tt -67.73 -46.76 71.24 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.901 -1.045 . . . . 74.13 109.298 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.411 ' OE1' ' HE3' ' A' ' 72' ' ' LYS . 29.5 tt0 -58.84 -48.28 81.9 Favored 'General case' 0 C--O 1.206 -1.206 0 C-N-CA 122.474 0.31 . . . . 62.21 111.422 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.64 -37.63 68.48 Favored 'General case' 0 C--O 1.262 1.726 0 CA-C-O 121.389 0.614 . . . . 74.42 110.757 -178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -64.92 -40.73 95.51 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.133 -0.94 . . . . 74.43 110.23 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -83.33 -21.94 33.03 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.715 1.006 . . . . 75.41 113.715 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 40.5 t -62.93 -32.66 74.01 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 123.812 0.845 . . . . 73.12 110.06 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 18.2 m -62.42 -24.88 67.65 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-N 116.15 -0.477 . . . . 54.34 111.197 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 58.8 m -96.04 5.93 50.01 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 112.903 0.705 . . . . 62.24 112.903 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.24 -177.29 30.12 Favored Glycine 0 C--N 1.32 -0.345 0 C-N-CA 118.823 -1.656 . . . . 62.34 114.433 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 20.1 m -96.0 114.95 26.71 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.384 0.611 . . . . 71.21 110.287 -177.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 62.4 mt -85.55 131.44 34.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.789 -0.641 . . . . 53.32 111.866 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . 0.434 HD21 ' HB2' ' B' ' 86' ' ' ALA . 1.0 OUTLIER -99.04 -41.65 7.46 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.406 -0.816 . . . . 62.04 111.514 177.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -151.32 160.9 43.55 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 107.886 -1.153 . . . . 63.01 107.886 -177.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.581 HD11 ' HB1' ' B' ' 50' ' ' ALA . 23.6 pt -145.32 138.23 21.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.379 -1.341 . . . . 64.24 107.379 172.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 54.0 m -125.64 120.77 31.64 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 107.577 -1.268 . . . . 71.45 107.577 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 68' ' ' ILE . 3.2 mp -117.83 116.82 52.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 106.612 -1.625 . . . . 62.21 106.612 -177.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.275 1.1 pt? -120.9 124.5 45.11 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 120.211 -0.595 . . . . 73.33 112.33 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 66.4 m -117.51 134.56 54.72 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 108.859 -0.793 . . . . 73.41 108.859 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 2.8 p30 -125.54 143.2 51.12 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.575 -0.85 . . . . 61.41 108.822 177.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -118.72 15.53 13.57 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.124 -0.695 . . . . 64.54 109.124 -177.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -70.4 -11.28 60.81 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.317 0.579 . . . . 75.14 111.954 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 50.5 m -89.87 3.48 52.85 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.63 -0.713 . . . . 72.31 110.135 174.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.76 -47.89 2.05 Favored Glycine 0 CA--C 1.498 -1.018 0 N-CA-C 110.28 -1.128 . . . . 74.32 110.28 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -96.09 135.09 22.92 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 106.648 -1.612 . . . . 72.24 106.648 175.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.62 118.36 5.29 Favored 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 120.716 0.944 . . . . 62.32 110.609 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 32.9 mtmm -96.76 144.12 27.04 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 109.287 -0.635 . . . . 63.23 109.287 -178.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -119.42 132.01 9.31 Favored Glycine 0 N--CA 1.415 -2.728 0 C-N-CA 120.123 -1.037 . . . . 65.45 112.063 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -150.79 143.91 24.76 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 123.959 0.904 . . . . 72.53 109.641 175.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.36 156.48 45.82 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.078 0.466 . . . . 75.02 111.613 -173.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' TYR . . . . . 0.444 ' CG ' ' HE2' ' B' ' 112' ' ' LYS . 27.2 m-85 -115.99 130.83 56.99 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.526 -1.287 . . . . 73.3 107.526 174.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.483 HG23 HG22 ' B' ' 66' ' ' ILE . 35.8 mm -114.51 110.74 33.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.621 -0.881 . . . . 74.35 108.621 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -86.24 119.34 26.41 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.48 -0.327 . . . . 75.45 110.988 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.25 165.21 11.2 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.909 0.385 . . . . 73.33 109.997 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.629 ' O ' ' HD3' ' B' ' 37' ' ' ARG . . . -79.46 -34.56 41.39 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.34 -0.391 . . . . 55.44 112.018 176.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -111.18 150.46 29.47 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.137 0.494 . . . . 73.41 112.282 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.597 ' O ' HG22 ' B' ' 91' ' ' VAL . 21.2 mmm180 -68.95 -28.8 66.97 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.411 -0.813 . . . . 74.54 109.533 172.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -63.7 -29.33 70.57 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.633 -0.712 . . . . 73.05 111.143 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 19.5 m -67.74 -36.36 80.42 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 116.664 -0.244 . . . . 71.13 110.491 177.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.597 HG22 ' O ' ' B' ' 88' ' ' ARG . 3.6 m -64.24 -39.53 85.84 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.775 0 N-CA-C 108.802 -0.814 . . . . 75.11 108.802 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.402 ' HA ' HG22 ' B' ' 95' ' ' VAL . 6.0 m-20 -57.08 -37.22 71.57 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.513 0.561 . . . . 65.31 112.513 175.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.55 -35.93 65.57 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.947 -0.569 . . . . 70.42 110.526 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.46 -42.72 52.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.869 -0.605 . . . . 64.44 110.942 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . 0.505 HG13 ' O ' ' B' ' 91' ' ' VAL . 19.2 m -62.11 -23.36 31.5 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.962 0 N-CA-C 111.896 0.332 . . . . 73.42 111.896 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.7 -16.19 63.3 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.28 0.562 . . . . 44.02 110.442 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 16.5 ttm -101.3 3.03 40.35 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 123.994 0.918 . . . . 73.24 109.013 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . 0.586 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 4.2 p-10 -35.85 -50.36 0.65 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 116.291 1.96 . . . . 71.5 116.291 -172.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -115.77 93.49 4.29 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 118.204 -1.398 . . . . 75.03 110.945 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 13.1 t -135.2 172.8 12.49 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.145 -1.389 . . . . 62.14 109.925 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.0 p -101.58 128.63 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 108.876 -0.787 . . . . 74.21 108.876 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -130.51 119.63 22.88 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.941 -0.763 . . . . 73.12 108.941 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 31.0 ttm-85 50.71 33.42 8.29 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.612 1.565 . . . . 73.45 112.151 -175.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 99.57 -2.93 57.51 Favored Glycine 0 C--N 1.296 -1.64 0 CA-C-N 114.439 -1.255 . . . . 63.12 114.345 172.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -131.77 149.18 52.55 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 118.171 0.986 . . . . 75.32 112.162 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 25.7 m -75.5 124.86 27.91 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.994 -0.548 . . . . 62.04 110.929 -174.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 43.1 pt -102.83 171.56 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.016 0.436 . . . . 73.31 110.832 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . 0.586 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 55.0 tptt -135.41 131.93 36.87 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.0 -1.111 . . . . 71.54 108.0 178.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 28.0 t -127.28 134.35 66.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.608 -0.515 . . . . 75.42 109.608 -177.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.686 ' HB3' ' HD2' ' B' ' 111' ' ' PRO 0.262 0.1 OUTLIER -144.13 170.0 9.2 Favored Pre-proline 0 C--O 1.215 -0.76 0 N-CA-C 105.292 -2.114 . . . . 75.4 105.292 174.167 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.686 ' HD2' ' HB3' ' B' ' 110' ' ' LEU . 73.6 Cg_endo -73.53 151.51 47.44 Favored 'Trans proline' 0 CA--C 1.552 1.422 0 C-N-CA 122.015 1.81 . . . . 65.51 110.114 171.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.515 ' HE3' ' OG ' ' B' ' 38' ' ' SER . 35.1 ttmt -86.77 140.77 29.4 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.007 0.432 . . . . 63.51 110.742 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -143.88 125.34 14.82 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.337 -1.357 . . . . 74.31 107.337 172.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.563 ' HA ' ' OH ' ' A' ' 18' ' ' TYR . 85.5 m -146.85 115.25 6.69 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 112.795 0.665 . . . . 43.33 112.795 -175.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 11.9 m120 45.42 106.94 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 117.064 2.246 . . . . 72.41 117.064 169.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.65 117.75 68.65 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 106.75 -1.574 . . . . 73.22 106.75 175.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -79.65 102.92 1.53 Allowed 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.038 1.825 . . . . 64.34 111.167 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' B' ' 5' ' ' CYS . . . -80.8 57.72 4.78 Favored Glycine 0 N--CA 1.439 -1.122 0 CA-C-N 115.797 -0.638 . . . . 34.01 112.217 -177.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 10.2 tt -152.26 130.78 2.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.773 -0.825 . . . . 73.5 108.773 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 56.3 m -152.54 158.52 42.65 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.425 -0.954 . . . . 61.51 108.425 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 35.1 m -79.81 103.98 10.09 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.97 -0.752 . . . . 60.43 108.97 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 62.3 m -105.49 119.04 38.11 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 116.274 -0.421 . . . . 70.4 110.169 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -150.73 -56.0 0.16 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.185 -0.672 . . . . 74.04 109.185 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 . . . . . 0 N--CA 1.43 -1.441 0 CA-C-N 115.644 -0.707 . . . . 74.2 111.667 -176.348 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.56 0 N-CA-C 109.387 -0.597 . . . . 71.51 109.387 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 66.7 mt -81.51 112.86 20.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 121.167 0.508 . . . . 65.44 110.516 -177.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.07 117.0 15.77 Favored Pre-proline 0 C--N 1.298 -1.641 0 N-CA-C 107.932 -1.136 . . . . 72.42 107.932 177.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -65.82 99.53 0.39 Allowed 'Trans proline' 0 C--O 1.241 0.646 0 C-N-CA 122.286 1.991 . . . . 70.03 112.637 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 66.9 m -116.79 94.63 4.68 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 108.782 -0.822 . . . . 61.45 108.782 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.419 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 81.8 mtp -127.83 131.38 49.53 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.699 -0.852 . . . . 74.12 108.699 -177.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -122.52 119.57 31.29 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.019 0.438 . . . . 61.24 110.849 -177.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 59.7 m -152.86 150.14 29.01 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.215 -0.448 . . . . 54.24 109.869 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.0 m 74.91 -73.03 0.1 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.586 1.154 . . . . 50.02 112.658 175.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.589 ' HA ' ' HD3' ' A' ' 108' ' ' LYS 0.342 16.3 p80 44.81 81.04 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.244 1.572 . . . . 75.03 115.244 -176.131 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.4 m -82.58 161.42 22.27 Favored 'General case' 0 C--O 1.247 0.954 0 CA-C-N 115.462 -0.79 . . . . 65.04 109.799 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.433 ' HB2' ' SD ' ' A' ' 13' ' ' MET . 63.6 pttt -168.59 157.58 8.77 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 111.748 0.277 . . . . 74.44 111.748 -176.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.433 ' SD ' ' HB2' ' A' ' 12' ' ' LYS . 1.5 mpt? 54.01 113.77 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.703 1.742 . . . . 73.13 115.703 173.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 t -163.32 162.73 25.25 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-N 116.39 -0.368 . . . . 75.14 111.42 178.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.61 ' HA ' ' HB ' ' A' ' 114' ' ' THR . . . -150.37 128.66 12.05 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.262 0.625 . . . . 53.1 110.798 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 158.27 129.0 1.05 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 121.02 -0.61 . . . . 73.14 112.967 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' B' ' 19' ' ' THR . . . -170.49 103.82 0.27 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.908 0.883 . . . . 74.14 109.735 177.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -146.2 -26.88 0.43 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 117.341 2.349 . . . . 73.31 117.341 -174.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.522 ' HB ' ' O ' ' B' ' 17' ' ' ALA . 24.9 m -133.48 138.0 45.94 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 120.822 1.646 . . . . 72.21 112.556 -169.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -126.07 -78.43 0.59 Allowed 'General case' 0 CA--C 1.557 1.244 0 N-CA-C 110.313 -0.254 . . . . 74.23 110.313 174.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.74 -139.73 3.48 Favored Glycine 0 N--CA 1.473 1.162 0 N-CA-C 111.275 -0.73 . . . . 54.52 111.275 176.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -51.0 -49.93 15.49 Favored 'Trans proline' 0 CA--C 1.556 1.612 0 C-N-CA 122.672 2.248 . . . . 52.32 112.212 174.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.11 135.86 65.2 Favored 'Trans proline' 0 C--N 1.388 2.609 0 N-CA-C 108.584 -1.352 . . . . 74.31 108.584 170.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.42 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 29.4 mm-40 -78.88 159.06 74.43 Favored Pre-proline 0 C--N 1.296 -1.726 0 C-N-CA 120.78 -0.368 . . . . 71.21 111.744 -173.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 24' ' ' GLN . 27.3 Cg_endo -70.23 58.13 1.75 Allowed 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 123.217 2.611 . . . . 64.11 113.463 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.405 ' HB3' ' H ' ' A' ' 27' ' ' SER . 5.5 mp 36.3 -166.04 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 117.068 2.247 . . . . 73.11 117.068 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.405 ' H ' ' HB3' ' A' ' 26' ' ' LEU . 10.9 m -90.44 150.76 21.69 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 114.191 -1.368 . . . . 61.14 107.484 174.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.507 ' HA ' ' HE3' ' A' ' 31' ' ' LYS . . . -51.92 -47.0 64.87 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.663 0.616 . . . . 73.41 112.663 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -76.26 -30.37 57.83 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 113.941 1.089 . . . . 71.31 113.941 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.33 -35.22 73.44 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 120.381 -0.528 . . . . 74.42 110.04 172.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.507 ' HE3' ' HA ' ' A' ' 28' ' ' ALA . 48.5 mtmt -66.22 -45.83 79.34 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 115.187 -0.915 . . . . 73.42 111.841 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.719 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -64.94 -30.99 72.02 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 119.644 -0.822 . . . . 63.23 112.576 177.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -64.4 -47.05 80.65 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.2 0.524 . . . . 61.03 110.971 174.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . 0.26 15.5 pt -70.94 -35.65 60.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 113.204 0.816 . . . . 74.33 113.204 -178.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -61.43 -41.4 97.12 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.207 1.003 . . . . 73.03 109.416 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.497 ' HG2' ' HG2' ' A' ' 88' ' ' ARG . 28.3 ttmt -58.51 -25.51 62.47 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 125.18 1.392 . . . . 73.42 112.767 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.437 ' HA ' HG11 ' A' ' 91' ' ' VAL . 88.5 mtm180 -119.52 10.38 11.8 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 112.389 0.514 . . . . 64.51 112.389 -175.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.0 t -98.32 154.7 17.63 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.253 0.549 . . . . 52.35 111.778 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.604 HG13 ' CG2' ' A' ' 91' ' ' VAL . 0.2 OUTLIER -140.64 161.9 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 C-N-CA 124.062 0.945 . . . . 31.31 111.719 176.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 25.7 t80 -112.49 126.5 55.38 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 107.642 -1.244 . . . . 72.44 107.642 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 59.7 t -113.32 110.35 31.87 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 N-CA-C 107.082 -1.451 . . . . 65.13 107.082 176.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.36 165.92 12.84 Favored Glycine 0 C--N 1.291 -1.958 0 C-N-CA 119.512 -1.328 . . . . 52.04 114.272 -175.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.464 ' O ' ' HD3' ' A' ' 105' ' ' ARG . 9.8 t30 64.58 24.72 13.08 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.121 1.368 . . . . 72.14 112.193 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.431 HG21 HD21 ' A' ' 53' ' ' LEU . 8.0 p -106.07 95.38 3.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-O 122.058 0.932 . . . . 71.41 110.451 176.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.526 ' HA ' ' HA3' ' A' ' 79' ' ' GLY . 4.9 m-20 -106.3 137.9 43.43 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 118.563 -0.732 . . . . 73.11 109.903 -169.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.566 ' CE1' ' HB2' ' A' ' 77' ' ' PRO 0.394 50.2 m-85 42.02 -60.52 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 121.247 3.795 . . . . 74.53 121.247 169.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.8 -20.46 62.03 Favored Glycine 0 N--CA 1.466 0.635 0 N-CA-C 115.073 0.789 . . . . 62.31 115.073 -173.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.9 m -95.69 134.7 38.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 117.477 0.638 . . . . 63.23 109.893 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 47.9 p -98.85 176.34 5.64 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 109.173 -0.677 . . . . 74.01 109.173 -177.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.484 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -60.2 -44.35 95.2 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 110.061 -0.348 . . . . 65.41 110.061 176.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -57.18 -46.29 82.95 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 116.547 -0.297 . . . . 75.53 110.621 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -56.44 -42.72 78.57 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.239 0.542 . . . . 62.12 111.446 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.431 HD21 HG21 ' A' ' 44' ' ' VAL . 62.4 mt -73.38 -49.3 27.93 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.267 -0.879 . . . . 64.52 111.696 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.18 -49.47 71.91 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.953 -0.567 . . . . 62.44 110.965 -176.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.31 -42.35 91.17 Favored 'General case' 0 C--O 1.267 2.001 0 CA-C-O 121.442 0.639 . . . . 44.31 111.752 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -66.42 -34.75 78.66 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.877 -0.602 . . . . 73.23 109.61 -176.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . 0.25 49.3 m-85 -82.31 -20.95 36.39 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 113.499 0.926 . . . . 70.12 113.499 175.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.0 m -61.05 -32.62 72.25 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.257 -0.646 . . . . 73.45 109.257 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 m -58.65 -30.74 67.56 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.945 -0.57 . . . . 52.52 110.618 174.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 61.0 m -97.71 -1.27 43.86 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 112.536 0.569 . . . . 73.43 112.536 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' A' ' 90' ' ' SER . . . 168.16 -174.18 43.01 Favored Glycine 0 C--O 1.223 -0.546 0 C-N-CA 118.379 -1.867 . . . . 74.05 116.0 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.4 p -70.55 -71.7 0.24 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.938 0.895 . . . . 62.2 112.428 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.3 73.7 mt 99.77 113.12 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 C-N-CA 126.71 2.004 . . . . 54.53 112.669 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.516 ' OD1' ' HB2' ' A' ' 86' ' ' ALA . 3.7 m-20 -106.81 -28.24 10.25 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-N 114.354 -1.293 . . . . 74.45 112.57 -177.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.478 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 75.3 mtt180 -151.61 155.45 38.44 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.788 -0.819 . . . . 61.54 108.788 174.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.498 HG22 HG23 ' A' ' 83' ' ' ILE . 20.5 pt -144.02 137.25 23.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 105.428 -2.064 . . . . 72.53 105.428 169.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 58.5 m -125.09 125.21 43.41 Favored 'General case' 0 C--N 1.262 -3.224 0 N-CA-C 107.708 -1.219 . . . . 73.4 107.708 -177.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mp -122.0 118.32 55.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 106.188 -1.782 . . . . 72.33 106.188 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.41 HD23 ' N ' ' A' ' 69' ' ' LEU 0.298 0.9 OUTLIER -121.53 133.19 55.02 Favored 'General case' 0 C--N 1.278 -2.525 0 C-N-CA 120.047 -0.661 . . . . 74.2 111.942 177.058 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 79.3 m -116.67 124.99 51.08 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.211 -1.033 . . . . 74.42 108.211 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.517 ' HB2' ' CD2' ' A' ' 73' ' ' PHE . 2.9 p-10 -112.12 138.43 48.8 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 119.047 -1.061 . . . . 64.2 112.131 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -117.13 7.48 13.04 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 114.763 -1.108 . . . . 72.32 110.239 173.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.517 ' CD2' ' HB2' ' A' ' 71' ' ' ASP . 37.3 p90 -69.58 -15.93 63.31 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.93 0.871 . . . . 75.05 109.637 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.2 m -86.92 6.98 29.31 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 114.727 -1.124 . . . . 73.34 109.515 175.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.34 -53.99 4.44 Favored Glycine 0 CA--C 1.503 -0.661 0 N-CA-C 110.596 -1.001 . . . . 64.23 110.596 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -96.24 138.15 21.59 Favored Pre-proline 0 C--N 1.298 -1.646 0 CA-C-N 114.27 -0.965 . . . . 71.13 108.774 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.566 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 46.9 Cg_endo -71.62 118.43 5.65 Favored 'Trans proline' 0 C--O 1.247 0.951 0 C-N-CA 122.203 1.936 . . . . 73.23 112.719 -177.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 29.1 mtmm -113.21 165.54 12.31 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 109.07 -0.715 . . . . 72.21 109.07 175.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 45' ' ' ASP . . . -138.2 146.0 17.66 Favored Glycine 0 N--CA 1.42 -2.403 0 C-N-CA 120.235 -0.983 . . . . 63.41 113.405 175.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -154.08 145.22 22.83 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.569 -0.816 . . . . 71.04 109.674 175.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 67' ' ' THR . . . -132.74 152.72 51.68 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.482 -0.326 . . . . 74.52 110.882 -172.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.408 ' CZ ' ' HD1' ' A' ' 40' ' ' TYR . 77.3 m-85 -123.9 131.56 53.6 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.556 -0.905 . . . . 75.43 108.556 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.498 HG23 HG22 ' A' ' 66' ' ' ILE . 23.4 mm -115.38 120.6 65.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 109.227 -0.657 . . . . 61.3 109.227 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 65' ' ' ARG . 1.9 mp0 -100.14 121.59 41.67 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.882 -0.414 . . . . 74.51 109.882 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -98.81 161.83 13.43 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.699 -0.228 . . . . 73.0 110.796 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.516 ' HB2' ' OD1' ' A' ' 64' ' ' ASN . . . -85.16 -29.89 24.4 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.802 -0.359 . . . . 70.44 111.231 175.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.467 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 5.6 mp0 -97.81 142.94 28.96 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.639 -0.504 . . . . 73.21 109.639 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.497 ' HG2' ' HG2' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -71.17 -30.79 66.88 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 105.882 -1.896 . . . . 61.21 105.882 176.08 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -67.57 -35.55 79.22 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.583 -1.189 . . . . 74.25 110.605 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.467 ' OG ' ' HB2' ' A' ' 87' ' ' GLU . 50.1 m -70.93 -36.81 72.79 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 120.696 0.284 . . . . 72.01 111.742 -177.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.604 ' CG2' HG13 ' A' ' 39' ' ' VAL . 14.5 p -65.99 -37.22 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 109.257 -0.645 . . . . 60.43 109.257 177.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -65.29 -31.58 72.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.518 -0.764 . . . . 63.1 110.035 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.5 -31.57 63.8 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.854 -0.612 . . . . 75.23 110.845 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.61 -43.94 53.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.039 -0.528 . . . . 65.52 110.451 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 20.5 m -58.25 -22.41 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 112.942 0.719 . . . . 54.33 112.942 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.46 -13.15 61.73 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.372 0.606 . . . . 71.0 110.415 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 47.7 ttp -103.4 9.46 37.8 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.007 -0.738 . . . . 73.21 109.007 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.592 ' HA ' ' HB ' ' A' ' 109' ' ' VAL . 5.5 p-10 -37.37 -57.09 0.93 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 115.016 1.487 . . . . 62.44 115.016 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 6' ' ' MET . 35.8 tt0 -110.09 85.12 2.05 Favored 'General case' 0 N--CA 1.397 -3.117 0 CA-C-O 122.167 0.984 . . . . 74.41 109.419 -174.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.2 p -129.6 167.47 17.9 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 113.849 -1.523 . . . . 70.04 111.904 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.2 p -110.73 106.18 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.163 0 CA-C-O 121.855 0.836 . . . . 74.21 109.017 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -105.69 126.23 51.91 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.115 -0.948 . . . . 73.44 108.543 -176.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 41.4 ttt-85 52.29 32.91 11.68 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 124.731 1.212 . . . . 72.14 111.348 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.72 -4.88 76.34 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 115.107 -0.951 . . . . 60.4 114.288 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.464 ' HD3' ' O ' ' A' ' 43' ' ' ASN . 4.6 ptp180 -121.88 138.41 54.41 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 117.593 0.696 . . . . 64.43 111.218 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 45.6 m -76.12 122.13 23.84 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-O 120.803 0.335 . . . . 53.44 110.761 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 44.6 pt -101.78 171.87 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.909 -0.587 . . . . 73.52 111.119 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.589 ' HD3' ' HA ' ' A' ' 10' ' ' HIS . 15.0 mmmt -125.1 131.13 53.35 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-N 114.952 -1.022 . . . . 72.51 109.245 176.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.609 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 24.7 t -127.47 116.19 42.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 108.361 -0.978 . . . . 70.02 108.361 174.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.426 ' CD1' ' HD2' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -146.99 156.4 47.29 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 106.912 -1.514 . . . . 60.24 106.912 177.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -62.61 129.3 25.97 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 121.841 1.694 . . . . 63.1 113.373 -175.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.03 100.48 13.29 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 103.155 -2.905 . . . . 72.12 103.155 173.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.432 ' HE ' ' HB2' ' A' ' 116' ' ' MET . 2.7 tmt_? -160.73 93.91 1.02 Allowed 'General case' 0 C--N 1.272 -2.787 0 N-CA-C 106.638 -1.615 . . . . 75.12 106.638 -164.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.61 ' HB ' ' HA ' ' A' ' 15' ' ' ALA . 40.6 p -106.27 -76.7 0.6 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.528 -1.669 . . . . 64.53 111.42 -170.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -79.71 110.9 15.49 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 102.842 -3.022 . . . . 73.34 102.842 170.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.432 ' HB2' ' HE ' ' A' ' 113' ' ' ARG . 24.7 ptt? -137.72 162.3 55.33 Favored Pre-proline 0 C--N 1.272 -2.776 0 N-CA-C 114.812 1.412 . . . . 73.14 114.812 -159.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -61.18 137.29 70.19 Favored 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 122.83 2.353 . . . . 54.41 109.386 169.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 108.47 35.47 2.45 Favored Glycine 0 C--N 1.299 -1.517 0 N-CA-C 110.298 -1.121 . . . . 53.02 110.298 -175.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . 0.29 9.7 tt 42.06 79.49 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 125.953 1.701 . . . . 75.13 115.118 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 55.6 p -95.24 -22.35 17.86 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.77 -0.65 . . . . 73.01 109.343 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.1 m 63.72 -163.36 0.27 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.331 -0.849 . . . . 75.55 110.742 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.2 m 75.23 88.53 0.09 Allowed 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.097 0.959 . . . . 73.34 112.452 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -161.41 -46.23 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 114.142 -1.39 . . . . 64.24 108.472 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 . . . . . 0 C--N 1.313 -1.01 0 CA-C-N 115.169 -0.923 . . . . 73.03 110.212 176.788 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 110.469 -0.197 . . . . 74.14 110.469 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 2.3 mp -97.71 134.61 35.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.918 -0.771 . . . . 65.43 108.918 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.99 101.4 9.43 Favored Pre-proline 0 C--N 1.312 -1.03 0 N-CA-C 110.276 -0.268 . . . . 73.23 110.276 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -75.94 121.46 6.23 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 122.327 2.018 . . . . 72.13 111.491 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 54.1 t -146.15 103.38 3.72 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.849 -0.614 . . . . 72.43 109.784 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 22.5 ptp -146.77 144.12 29.15 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.788 0.328 . . . . 74.01 110.887 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . 0.435 ' HB2' ' NH1' ' B' ' 113' ' ' ARG . 27.1 mt-30 -118.58 116.18 26.09 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.974 -1.491 . . . . 70.41 106.974 174.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 8.8 t -79.82 144.94 33.07 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.356 0.598 . . . . 75.4 110.855 -174.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 11.4 t -168.82 173.55 7.06 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 107.019 -1.475 . . . . 75.04 107.019 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -128.21 100.41 5.83 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.945 -0.391 . . . . 62.51 109.945 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t -143.67 -167.59 2.62 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.906 -1.146 . . . . 62.12 107.906 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -84.98 164.63 18.18 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.626 -0.509 . . . . 72.33 109.626 -177.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 25.8 ptm -95.01 3.31 55.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.131 0.491 . . . . 73.13 110.023 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 29.6 p -74.77 84.61 2.15 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 121.611 0.719 . . . . 73.12 110.757 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.446 ' HA ' ' OG1' ' A' ' 19' ' ' THR . . . -113.51 117.71 32.42 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.257 -0.883 . . . . 63.41 109.87 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.64 34.92 0.75 Allowed Glycine 0 C--N 1.294 -1.757 0 N-CA-C 110.944 -0.863 . . . . 40.4 110.944 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.522 ' O ' ' HB ' ' A' ' 19' ' ' THR . . . 67.11 -83.71 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 124.401 1.08 . . . . 63.34 109.783 -175.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 19' ' ' THR . 96.8 m-85 -139.64 -75.56 0.35 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.511 0.196 . . . . 73.34 111.244 175.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 10.2 t 166.85 30.45 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.775 -1.194 . . . . 73.23 107.775 -171.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -59.95 -82.97 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 114.704 1.372 . . . . 73.24 114.704 -166.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.09 -91.25 0.23 Allowed Glycine 0 C--N 1.28 -2.575 0 C-N-CA 119.016 -1.564 . . . . 55.32 110.828 -171.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.584 ' HG3' ' CZ ' ' A' ' 40' ' ' TYR . 2.3 Cg_endo -43.64 -51.82 5.82 Favored 'Trans proline' 0 CA--C 1.556 1.588 0 C-N-CA 123.418 2.745 . . . . 75.54 113.268 176.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.432 ' HD3' ' HG2' ' B' ' 22' ' ' PRO . 11.2 Cg_exo -71.92 123.62 9.47 Favored 'Trans proline' 0 C--N 1.38 2.196 0 N-CA-C 108.132 -1.526 . . . . 75.44 108.132 171.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.422 ' CD ' ' H ' ' B' ' 24' ' ' GLN . 0.5 OUTLIER -73.5 160.12 83.08 Favored Pre-proline 0 C--N 1.288 -2.093 0 CA-C-N 115.287 -0.87 . . . . 73.12 109.784 -177.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.94 101.27 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 122.381 2.054 . . . . 75.01 111.457 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.747 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -72.49 171.98 11.35 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 114.21 -1.359 . . . . 75.13 111.42 178.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.522 ' HB3' ' OE1' ' B' ' 30' ' ' GLU . 34.3 t -65.08 145.99 55.59 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.704 0.764 . . . . 60.23 112.276 -173.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.23 -40.87 25.89 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.85 -1.523 . . . . 53.03 111.673 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -75.93 -30.25 58.64 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 113.746 1.017 . . . . 73.4 113.746 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.522 ' OE1' ' HB3' ' B' ' 27' ' ' SER . 1.1 mp0 -60.73 -34.61 74.67 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 120.32 -0.552 . . . . 74.33 109.814 171.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -66.18 -50.71 62.95 Favored 'General case' 0 C--O 1.199 -1.553 0 CA-C-N 115.81 -0.632 . . . . 65.44 109.756 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.687 ' N ' ' HE2' ' B' ' 32' ' ' LYS . 0.4 OUTLIER -61.43 -29.71 70.11 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 119.839 -0.744 . . . . 75.35 112.123 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' B' ' 36' ' ' LYS . 9.4 tp10 -69.23 -44.72 71.43 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 108.558 -0.905 . . . . 71.33 108.558 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . 0.25 11.8 pt -71.95 -35.21 53.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 112.608 0.596 . . . . 71.52 112.608 177.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' B' ' 113' ' ' ARG . 9.6 m-20 -58.41 -43.63 88.73 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.323 0.582 . . . . 73.15 110.616 177.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' B' ' 33' ' ' GLU . 15.0 ptpt -68.88 -18.34 64.12 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.457 0.54 . . . . 73.3 112.457 -173.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.63 ' HD2' ' O ' ' B' ' 85' ' ' PHE . 21.7 ptt180 -118.83 15.91 13.48 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.596 0.591 . . . . 71.02 112.596 -178.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 47.3 t -102.35 154.87 18.65 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.274 0.559 . . . . 44.3 111.738 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.618 HG13 ' CG2' ' B' ' 91' ' ' VAL . 0.3 OUTLIER -140.31 164.01 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 C-N-CA 124.287 1.035 . . . . 75.2 112.072 178.554 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . 0.619 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 30.7 t80 -115.71 127.39 55.1 Favored 'General case' 0 CA--C 1.48 -1.726 0 CA-C-N 114.557 -1.201 . . . . 74.4 107.76 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.36 109.65 29.31 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 N-CA-C 107.256 -1.387 . . . . 43.12 107.256 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -109.41 170.13 14.23 Favored Glycine 0 N--CA 1.435 -1.415 0 C-N-CA 120.257 -0.973 . . . . 51.55 112.602 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.2 t30 63.96 -0.66 0.77 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 126.213 1.805 . . . . 73.32 112.54 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.548 HG21 HD21 ' B' ' 53' ' ' LEU . 3.6 p -58.39 130.89 22.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 108.913 -0.773 . . . . 74.44 108.913 175.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -76.09 153.26 36.46 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 115.694 -0.685 . . . . 75.52 111.624 -173.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -50.55 -34.1 24.26 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 126.172 1.789 . . . . 75.44 111.214 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.7 3.99 78.73 Favored Glycine 0 CA--C 1.501 -0.842 0 C-N-CA 119.897 -1.144 . . . . 72.02 113.72 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 36.8 t -73.06 118.84 16.5 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 105.137 -2.172 . . . . 63.01 105.137 172.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.49 166.92 12.29 Favored 'General case' 0 N--CA 1.405 -2.701 0 N-CA-C 109.201 -0.666 . . . . 61.53 109.201 -169.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.448 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -56.08 -45.5 79.35 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 117.911 0.323 . . . . 72.3 111.439 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . 0.4 ' H ' ' CD ' ' B' ' 51' ' ' GLN . 22.1 mp0 -57.18 -44.84 83.94 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.525 0.516 . . . . 53.42 111.042 178.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -57.17 -45.1 83.95 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 121.167 0.508 . . . . 71.24 111.348 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.548 HD21 HG21 ' B' ' 44' ' ' VAL . 80.5 mt -72.2 -49.2 37.32 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.399 -0.818 . . . . 70.03 111.585 -177.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -63.2 -49.4 74.39 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 116.105 -0.498 . . . . 63.33 111.151 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.46 97.77 Favored 'General case' 0 C--O 1.267 2.014 0 CA-C-O 121.522 0.677 . . . . 70.54 111.812 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -66.39 -34.43 77.95 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.821 -0.627 . . . . 75.42 109.697 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -82.48 -21.36 35.59 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 113.678 0.992 . . . . 71.12 113.678 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 71.8 m -61.88 -30.69 71.04 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 116.379 -0.373 . . . . 62.44 110.295 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 17.4 m -58.69 -31.14 67.94 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 115.895 -0.593 . . . . 74.43 110.265 175.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 63.0 m -91.44 6.47 45.35 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 113.474 0.916 . . . . 35.45 113.474 -177.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.23 -159.93 26.25 Favored Glycine 0 N--CA 1.469 0.856 0 C-N-CA 118.914 -1.613 . . . . 70.32 115.108 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 12.9 m -101.48 123.26 45.24 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.021 0.439 . . . . 75.5 110.406 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 57.6 mt -92.04 134.91 28.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 123.583 0.753 . . . . 53.51 112.073 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . 0.525 ' ND2' ' HB2' ' B' ' 86' ' ' ALA . 0.8 OUTLIER -103.98 -33.15 8.92 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.711 0.805 . . . . 64.24 112.021 176.462 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.452 ' HB2' ' HB2' ' B' ' 84' ' ' GLU . 82.8 mtt180 -151.86 156.87 41.02 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.218 -0.66 . . . . 64.24 109.218 178.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.514 HG22 HG23 ' B' ' 83' ' ' ILE . 17.7 pt -143.61 138.15 25.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 105.824 -1.917 . . . . 64.41 105.824 168.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 53.8 m -125.29 125.73 44.0 Favored 'General case' 0 C--N 1.269 -2.926 0 N-CA-C 107.668 -1.234 . . . . 70.22 107.668 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.8 mp -122.78 117.54 52.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 106.337 -1.727 . . . . 73.31 106.337 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.402 HD23 ' N ' ' B' ' 69' ' ' LEU 0.288 0.9 OUTLIER -121.03 132.52 54.95 Favored 'General case' 0 C--N 1.283 -2.288 0 C-N-CA 120.028 -0.669 . . . . 62.14 111.8 177.774 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' CYS . . . . . 0.493 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 70.6 m -116.98 123.01 45.88 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 108.73 -0.841 . . . . 72.14 108.73 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.606 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 2.8 p30 -110.2 132.09 54.48 Favored 'General case' 0 C--O 1.208 -1.11 0 C-N-CA 119.913 -0.715 . . . . 73.24 110.115 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -118.9 10.8 12.38 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.937 -1.134 . . . . 72.0 107.937 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.494 ' CD2' ' HB2' ' B' ' 71' ' ' ASP . 4.1 p90 -56.86 -17.41 9.3 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 115.902 1.816 . . . . 64.12 115.902 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 30.6 m -110.32 9.73 23.58 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 118.242 0.473 . . . . 72.21 111.61 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.39 -55.63 0.52 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.257 -0.973 . . . . 75.32 112.368 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -96.16 129.72 33.03 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 109.956 -0.387 . . . . 72.44 109.956 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.606 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 92.0 Cg_endo -77.04 119.61 5.12 Favored 'Trans proline' 0 N--CA 1.441 -1.617 0 C-N-CA 121.8 1.667 . . . . 74.33 111.932 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 30.1 mtmm -102.32 164.45 11.67 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 108.199 -1.037 . . . . 65.42 108.199 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -134.28 141.16 12.43 Favored Glycine 0 N--CA 1.423 -2.226 0 C-N-CA 119.658 -1.258 . . . . 73.44 113.027 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . 0.452 ' HA ' ' CG1' ' B' ' 44' ' ' VAL . 19.5 p90 -150.71 143.34 24.47 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.183 -0.509 . . . . 75.03 110.117 173.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.45 152.33 51.55 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.419 -0.355 . . . . 74.3 110.872 -172.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' TYR . . . . . 0.574 ' CD2' ' HG3' ' B' ' 112' ' ' LYS . 88.1 m-85 -124.15 130.05 51.88 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 108.944 -0.762 . . . . 71.11 108.944 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.514 HG23 HG22 ' B' ' 66' ' ' ILE . 23.5 mm -113.27 121.6 65.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 109.004 -0.739 . . . . 73.2 109.004 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' B' ' 65' ' ' ARG . 1.2 mp0 -100.14 119.68 38.71 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.463 -0.569 . . . . 44.35 109.463 176.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.63 ' O ' ' HD2' ' B' ' 37' ' ' ARG . 96.5 m-85 -94.48 162.32 13.86 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 110.274 -0.269 . . . . 73.31 110.274 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.525 ' HB2' ' ND2' ' B' ' 64' ' ' ASN . . . -81.41 -34.58 31.5 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.305 -0.407 . . . . 42.23 110.608 174.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . 0.409 ' HB2' ' OG ' ' B' ' 90' ' ' SER . 9.7 mp0 -99.96 147.95 25.02 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.199 -0.6 . . . . 73.12 111.472 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.522 ' O ' HG12 ' B' ' 91' ' ' VAL . 0.0 OUTLIER -74.16 -31.64 62.79 Favored 'General case' 0 C--O 1.212 -0.891 0 N-CA-C 106.215 -1.772 . . . . 73.52 106.215 177.438 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -71.69 -29.18 64.3 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 120.479 -0.488 . . . . 74.35 111.885 177.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' SER . . . . . 0.409 ' OG ' ' HB2' ' B' ' 87' ' ' GLU . 49.4 m -71.49 -36.98 71.31 Favored 'General case' 0 N--CA 1.439 -0.99 0 O-C-N 122.224 -0.297 . . . . 73.53 111.349 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.618 ' CG2' HG13 ' B' ' 39' ' ' VAL . 14.5 p -65.87 -37.69 80.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 108.64 -0.874 . . . . 73.34 108.64 177.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -63.77 -33.56 75.94 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.394 -0.821 . . . . 60.34 109.816 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.12 -31.3 64.21 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.829 -0.623 . . . . 75.14 110.539 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.67 -44.71 48.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.979 -0.555 . . . . 74.54 110.396 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 21.1 m -58.61 -22.46 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 112.41 0.522 . . . . 74.04 112.41 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.76 -18.49 63.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.897 0.855 . . . . 64.13 111.034 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 43.8 ttp -98.87 11.94 37.26 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 114.34 -1.3 . . . . 73.35 109.213 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . 0.56 ' HA ' ' HB ' ' B' ' 109' ' ' VAL . 9.8 t70 -35.11 -61.23 0.44 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 117.037 2.236 . . . . 63.12 117.037 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' B' ' 107' ' ' ILE . 35.7 tt0 -115.74 34.98 4.65 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 119.542 1.065 . . . . 73.11 110.631 -174.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 76.4 p -77.72 -175.22 3.8 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.735 -0.666 . . . . 74.13 111.106 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -103.0 135.42 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 N-CA-C 109.334 -0.617 . . . . 71.23 109.334 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -142.23 128.19 19.53 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.596 -0.89 . . . . 74.45 108.596 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 57.2 ttt-85 56.3 32.99 21.46 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.277 1.031 . . . . 72.31 110.377 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.57 5.5 89.87 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.127 -0.942 . . . . 74.25 114.462 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -129.27 166.11 20.07 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 117.867 0.834 . . . . 61.42 109.976 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 32.4 m -90.99 122.74 33.91 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.785 -0.45 . . . . 63.32 109.785 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' B' ' 99' ' ' GLU . 39.7 pt -101.21 173.38 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 120.739 0.304 . . . . 74.03 111.763 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -130.86 120.76 24.14 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.241 -1.022 . . . . 70.33 108.241 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.619 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 42.3 t -127.0 116.04 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 123.361 0.413 . . . . 73.42 109.922 -177.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.472 HD13 ' HB3' ' B' ' 40' ' ' TYR . 0.0 OUTLIER -146.45 155.88 49.48 Favored Pre-proline 0 C--N 1.314 -0.963 0 N-CA-C 107.263 -1.384 . . . . 72.12 107.263 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.73 134.38 46.85 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.67 2.247 . . . . 72.35 113.151 -175.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.574 ' HG3' ' CD2' ' B' ' 82' ' ' TYR . 3.2 tmmm? -105.54 123.73 48.38 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 106.831 -1.544 . . . . 74.14 106.831 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.519 ' HB2' ' HB3' ' B' ' 35' ' ' ASP . 13.7 ptm180 -166.55 162.2 16.53 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-O 121.331 0.586 . . . . 64.35 112.149 -177.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 30.8 p -104.81 -172.53 2.12 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 114.09 -1.414 . . . . 61.34 108.508 173.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' ASN . . . . . 0.489 ' O ' ' HD3' ' B' ' 117' ' ' PRO . 27.8 t-20 -150.56 150.89 31.8 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.778 -0.453 . . . . 71.4 109.778 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 26.7 ttt -107.48 93.24 9.59 Favored Pre-proline 0 C--N 1.314 -0.959 0 N-CA-C 109.396 -0.594 . . . . 74.42 109.396 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' B' ' 115' ' ' ASN . 51.6 Cg_endo -94.7 15.61 1.14 Allowed 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.798 2.332 . . . . 55.25 111.85 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.16 66.84 3.55 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.936 -0.575 . . . . 65.34 112.021 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 23.1 pt -131.53 128.29 60.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 109.298 -0.631 . . . . 64.12 109.298 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 25.0 t -117.55 88.67 2.96 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 120.399 -0.52 . . . . 74.04 110.363 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 39.2 m 52.26 25.25 3.26 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.355 1.062 . . . . 54.35 112.947 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 22.4 m -89.1 84.41 6.56 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 120.996 0.426 . . . . 52.35 110.501 -175.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -168.36 142.14 3.21 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.624 -0.716 . . . . 74.43 109.455 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 . . . . . 0 C--N 1.311 -1.089 0 O-C-N 123.246 0.341 . . . . 75.12 110.67 178.853 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.556 0 N-CA-C 109.578 -0.527 . . . . 73.33 109.578 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 mp -83.97 110.19 18.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 109.3 -0.63 . . . . 71.21 109.3 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -117.34 98.95 52.43 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 108.942 -0.762 . . . . 52.43 108.942 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -88.12 96.62 0.4 Allowed 'Trans proline' 0 N--CA 1.427 -2.434 0 C-N-CA 122.308 2.005 . . . . 73.05 111.312 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 58.8 m -95.37 102.81 14.64 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.04 -0.726 . . . . 72.32 109.04 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.554 ' HG3' ' O ' ' B' ' 74' ' ' SER . 26.8 ttt -121.39 93.33 3.98 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.893 -0.78 . . . . 41.41 108.893 -177.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -128.83 116.09 18.92 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.691 -0.686 . . . . 64.41 111.785 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 t -90.46 -7.71 52.36 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.933 -0.766 . . . . 75.21 108.933 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.467 HG21 ' HA ' ' A' ' 23' ' ' PRO . 88.6 m 70.96 89.06 0.1 Allowed 'General case' 0 C--O 1.244 0.794 0 CA-C-N 114.626 -1.17 . . . . 75.2 111.458 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -100.71 77.3 1.87 Allowed 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.969 0.89 . . . . 73.33 110.395 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.8 p -177.29 -177.45 0.71 Allowed 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 113.686 -1.597 . . . . 73.21 107.066 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -159.79 138.44 10.61 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.701 -0.481 . . . . 63.52 109.701 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -128.92 -67.9 0.77 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.651 -1.611 . . . . 64.04 106.651 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.3 m 50.9 30.91 5.59 Favored 'General case' 0 CA--C 1.583 2.221 0 C-N-CA 124.407 1.083 . . . . 74.52 113.749 168.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.48 -25.41 57.34 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.374 -0.829 . . . . 53.44 110.731 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.75 50.08 0.98 Allowed Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.276 -0.964 . . . . 72.23 113.385 176.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.0 86.47 2.28 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 109.699 -0.482 . . . . 61.1 109.699 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.511 ' H ' HG23 ' B' ' 14' ' ' THR . 96.0 m-85 62.39 25.08 14.96 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.96 0.904 . . . . 72.54 109.388 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.9 m -91.26 149.27 21.83 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 114.138 -1.392 . . . . 74.0 110.122 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.478 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 4.5 mm-40 -94.26 27.48 2.88 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 107.032 -1.47 . . . . 71.41 107.032 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.88 -109.5 2.86 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 109.718 -1.353 . . . . 42.21 109.718 -170.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.611 ' HG3' ' CZ ' ' B' ' 40' ' ' TYR . 2.1 Cg_endo -51.67 -53.54 6.86 Favored 'Trans proline' 0 CA--C 1.574 2.513 0 C-N-CA 123.418 2.746 . . . . 60.41 114.387 174.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.517 ' HD3' ' HG2' ' A' ' 22' ' ' PRO . 11.7 Cg_exo -70.36 133.83 25.34 Favored 'Trans proline' 0 C--N 1.386 2.526 0 CA-C-N 120.96 1.379 . . . . 62.54 110.753 173.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.8 pm0 -73.04 161.76 77.82 Favored Pre-proline 0 C--N 1.297 -1.688 0 CA-C-N 115.023 -0.989 . . . . 75.02 109.107 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.79 100.26 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.537 1.491 . . . . 53.04 109.236 173.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.548 ' HG ' ' H ' ' A' ' 27' ' ' SER . 0.5 OUTLIER -65.52 -84.83 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.457 -0.792 . . . . 61.44 111.999 -176.419 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.548 ' H ' ' HG ' ' A' ' 26' ' ' LEU . 29.3 t -140.43 143.71 35.75 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 120.409 -0.516 . . . . 72.0 110.381 172.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.81 -40.37 75.85 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 124.006 0.816 . . . . 72.42 109.51 171.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.28 39.7 mt-10 -76.65 -29.24 56.33 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 113.992 1.108 . . . . 73.01 113.992 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.511 ' HB2' ' HB3' ' A' ' 27' ' ' SER . 14.7 tp10 -64.12 -38.91 92.77 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 106.385 -1.709 . . . . 70.4 106.385 175.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -64.82 -45.16 87.36 Favored 'General case' 0 C--O 1.199 -1.591 0 CA-C-N 114.713 -1.131 . . . . 75.23 108.813 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.558 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -56.79 -46.99 81.18 Favored 'General case' 0 N--CA 1.42 -1.936 0 C-N-CA 123.514 0.726 . . . . 74.1 111.686 178.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -68.41 -44.45 75.0 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 121.028 -0.269 . . . . 75.33 111.389 -177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 30' ' ' GLU . 12.9 pt -66.64 -34.22 68.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.08 0.467 . . . . 75.04 110.742 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.24 -40.01 89.91 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.65 1.18 . . . . 55.51 110.985 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.558 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 98.6 mttt -64.2 -21.0 66.41 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.596 0.712 . . . . 73.44 110.492 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.522 ' HD3' ' O ' ' A' ' 86' ' ' ALA . 90.9 mtt180 -109.64 16.48 22.12 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.35 -0.841 . . . . 71.41 109.657 -174.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 46.9 m -101.05 158.4 16.04 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 121.471 0.653 . . . . 40.12 111.762 178.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.5 m -134.58 163.56 36.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.583 -0.735 . . . . 73.2 109.684 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.691 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 23.3 t80 -109.49 128.13 54.94 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.545 -1.28 . . . . 73.32 107.545 174.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.9 t -120.94 109.28 24.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 107.843 -1.169 . . . . 72.24 107.843 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.65 170.99 15.87 Favored Glycine 0 C--N 1.293 -1.842 0 C-N-CA 119.785 -1.198 . . . . 40.35 113.783 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t30 67.55 17.31 9.98 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 125.297 1.439 . . . . 63.24 112.163 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.439 ' O ' ' HA3' ' A' ' 79' ' ' GLY . 14.5 p -72.16 141.58 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 109.257 -0.646 . . . . 71.12 109.257 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -107.24 165.27 11.5 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 112.077 0.399 . . . . 53.34 112.077 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.408 ' CE1' ' HB3' ' A' ' 70' ' ' CYS . 21.7 m-85 -59.31 -26.51 65.06 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.316 0.646 . . . . 74.51 111.948 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.94 -16.57 80.58 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.36 -0.696 . . . . 53.45 111.36 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 24.7 m -95.8 125.96 40.73 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 107.342 -1.355 . . . . 72.34 107.342 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.48 HG21 ' HB ' ' B' ' 49' ' ' THR 0.253 3.6 p -126.31 179.31 5.34 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 114.527 1.306 . . . . 75.35 114.527 -172.023 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.463 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -56.86 -52.65 64.28 Favored 'General case' 0 C--O 1.213 -0.818 0 N-CA-C 114.459 1.281 . . . . 54.34 114.459 -168.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.25 28.1 pt20 -64.37 -32.14 73.63 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 119.103 -1.039 . . . . 72.12 112.941 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -59.9 -44.93 93.97 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.101 -0.703 . . . . 51.14 109.101 176.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 69.8 mt -73.04 -48.54 35.17 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.562 -1.199 . . . . 71.5 111.214 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.34 -49.62 74.86 Favored 'General case' 0 C--O 1.198 -1.625 0 CA-C-N 116.197 -0.456 . . . . 73.11 111.429 -177.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.6 -41.73 86.48 Favored 'General case' 0 C--O 1.257 1.482 0 CA-C-O 121.434 0.635 . . . . 64.13 111.98 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -68.02 -39.2 83.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.995 -1.002 . . . . 73.14 110.023 -176.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -82.23 -21.52 36.29 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.213 0.82 . . . . 65.15 113.213 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.3 t -68.83 -24.29 64.36 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.988 -0.745 . . . . 72.43 108.988 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.2 m -60.28 -33.92 73.02 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.521 0.677 . . . . 71.44 109.526 172.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 63.4 m -90.33 5.05 48.91 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.515 -0.766 . . . . 73.33 112.373 -177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.83 -168.62 29.96 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 118.688 -1.72 . . . . 73.34 115.08 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.436 ' HB2' ' HB3' ' A' ' 86' ' ' ALA . 9.9 m -97.96 122.73 41.43 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.315 -0.624 . . . . 74.01 109.315 -176.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.5 mt -91.46 131.23 39.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 113.018 0.747 . . . . 74.31 113.018 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -100.05 -40.95 7.37 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.162 -0.926 . . . . 71.12 110.905 176.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.431 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 88.6 mtt180 -149.91 158.91 44.64 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 108.837 -0.801 . . . . 75.12 108.837 -177.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.463 HD11 ' HB1' ' A' ' 50' ' ' ALA . 27.3 pt -144.95 140.82 23.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 106.941 -1.503 . . . . 61.33 106.941 169.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.0 m -125.25 125.35 43.44 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 106.498 -1.667 . . . . 74.33 106.498 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.458 HD12 ' O ' ' B' ' 68' ' ' ILE . 3.4 mp -122.12 118.57 55.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.812 -1.551 . . . . 72.32 106.812 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.263 1.2 pt? -120.09 122.81 41.9 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 120.206 -0.597 . . . . 63.35 111.111 178.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.445 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 64.2 m -116.85 132.63 56.65 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.271 -1.011 . . . . 74.14 108.271 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 3.6 p-10 -118.74 138.18 52.84 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 119.559 -0.856 . . . . 62.04 112.005 -176.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -117.59 13.25 14.28 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.297 -0.865 . . . . 63.1 109.631 173.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.46 ' CD2' ' HB2' ' A' ' 71' ' ' ASP . 13.9 p90 -65.8 -23.53 66.72 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.428 0.632 . . . . 64.13 110.395 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.1 t -83.49 0.55 45.91 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.781 -0.645 . . . . 65.4 110.151 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.92 -58.72 1.05 Allowed Glycine 0 N--CA 1.438 -1.213 0 N-CA-C 110.533 -1.027 . . . . 44.32 110.533 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -95.13 130.35 32.81 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 108.703 -0.851 . . . . 71.04 108.703 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 24.3 Cg_endo -62.32 119.28 6.31 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 123.028 2.486 . . . . 72.13 114.183 -175.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -104.43 -168.92 1.55 Allowed 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.582 -1.266 . . . . 75.35 107.582 171.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 70' ' ' CYS . . . -172.33 141.79 6.47 Favored Glycine 0 N--CA 1.407 -3.299 0 C-N-CA 119.792 -1.194 . . . . 71.23 112.726 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -151.57 145.47 25.15 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 123.813 0.845 . . . . 63.14 109.033 175.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.91 159.46 42.14 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-O 120.925 0.393 . . . . 50.1 111.178 -172.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -123.06 123.34 40.62 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.988 -0.745 . . . . 61.33 108.988 175.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.431 HG23 HG22 ' A' ' 66' ' ' ILE . 33.4 mm -103.06 119.93 52.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 106.624 -1.621 . . . . 73.03 106.624 177.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 38' ' ' SER . 35.0 mt-10 -107.12 119.31 39.03 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.068 0.461 . . . . 53.11 110.049 -176.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -100.58 167.48 10.33 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.389 0.614 . . . . 72.04 112.468 -174.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.522 ' O ' ' HD3' ' A' ' 37' ' ' ARG . . . -83.85 -33.26 24.89 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.184 -0.916 . . . . 72.4 111.665 174.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.421 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 4.5 mp0 -104.55 143.66 32.74 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 110.119 -0.326 . . . . 62.32 110.119 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.479 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -73.04 -29.66 63.15 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 106.005 -1.85 . . . . 75.42 106.005 177.174 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' A' ' 92' ' ' ASP . 13.9 m120 -60.48 -28.07 68.06 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.989 -1.459 . . . . 71.15 110.425 177.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 87' ' ' GLU . 26.8 m -67.35 -36.38 81.28 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 116.553 -0.294 . . . . 62.03 110.922 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 88' ' ' ARG . 3.2 m -64.06 -39.05 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 N-CA-C 108.429 -0.952 . . . . 74.14 108.429 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 89' ' ' ASN . 21.2 t70 -55.89 -39.6 71.8 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.929 0.768 . . . . 75.34 110.585 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.23 -37.43 63.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.891 -0.595 . . . . 62.33 111.452 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.56 -45.24 62.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.945 0.402 . . . . 54.24 111.357 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.485 HG11 ' HD3' ' A' ' 111' ' ' PRO . 28.6 m -56.97 -22.15 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 113.16 0.8 . . . . 73.4 113.16 178.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.69 -17.73 64.81 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.277 0.561 . . . . 72.43 110.806 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.51 ' O ' HG22 ' A' ' 100' ' ' THR . 66.2 mtm -99.58 8.11 44.71 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.754 -0.657 . . . . 73.03 110.676 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -41.75 -42.33 2.57 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 115.476 1.658 . . . . 61.31 115.476 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 41.9 tt0 -107.36 16.33 24.05 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 118.737 0.699 . . . . 64.34 112.439 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 97' ' ' MET . 7.3 t -81.79 175.38 10.49 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 118.809 -1.156 . . . . 73.44 109.865 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.3 m -108.8 118.91 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 CA-C-O 121.652 0.739 . . . . 64.34 110.884 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.479 ' HB2' HD13 ' A' ' 107' ' ' ILE . 61.0 t80 -92.06 117.79 30.18 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 107.494 -1.298 . . . . 74.34 107.494 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 50.03 32.85 6.12 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.801 1.241 . . . . 73.21 112.135 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 99.5 -4.97 58.45 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 114.855 0.702 . . . . 61.23 114.855 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -118.67 137.02 53.6 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 118.209 1.004 . . . . 72.51 110.68 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.6 m -70.26 119.09 13.93 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.131 0.491 . . . . 64.22 110.38 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 102' ' ' PHE . 45.7 pt -103.51 172.65 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 CA-C-N 116.054 -0.521 . . . . 70.43 110.223 177.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.427 ' HD2' ' HA ' ' A' ' 108' ' ' LYS . 19.8 mmmt -123.94 129.41 50.91 Favored 'General case' 0 CA--C 1.472 -2.03 0 CA-C-N 115.739 -0.664 . . . . 75.42 109.621 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.691 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 22.7 t -127.77 122.81 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 108.651 -0.87 . . . . 75.1 108.651 176.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.52 HD13 ' HB3' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -146.73 155.35 48.48 Favored Pre-proline 0 C--N 1.292 -1.913 0 N-CA-C 107.464 -1.31 . . . . 74.12 107.464 175.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.485 ' HD3' HG11 ' A' ' 95' ' ' VAL . 49.7 Cg_endo -66.29 140.92 60.42 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.134 1.223 . . . . 62.13 110.061 -175.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -61.06 106.33 0.58 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.249 0.547 . . . . 75.01 111.038 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -123.15 -171.16 2.24 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.345 -0.843 . . . . 74.4 109.797 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.0 m 78.76 69.68 0.04 OUTLIER 'General case' 0 C--O 1.246 0.901 0 CA-C-O 122.911 1.339 . . . . 63.3 109.99 -176.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -168.6 103.6 0.42 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 112.714 -2.039 . . . . 75.52 106.979 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 27.4 ttt -102.46 119.19 56.91 Favored Pre-proline 0 C--N 1.3 -1.547 0 CA-C-N 116.205 -0.452 . . . . 73.43 111.498 -176.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -71.94 100.12 1.05 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.001 1.801 . . . . 63.25 109.599 174.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.56 87.71 1.55 Allowed Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 115.745 -0.661 . . . . 61.15 113.311 -175.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 21.6 pt -128.22 87.58 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-O 121.962 0.887 . . . . 63.42 109.484 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.1 m -84.26 144.82 28.65 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.344 -0.844 . . . . 70.44 112.571 -172.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 50.5 m -148.33 103.08 3.4 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.604 -0.726 . . . . 71.32 109.356 175.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 43.0 m -107.48 -30.9 8.38 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.979 -0.555 . . . . 65.14 110.584 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.3 t70 73.21 -47.31 0.66 Allowed 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 124.141 0.976 . . . . 72.4 113.469 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 . . . . . 0 C--N 1.308 -1.223 0 N-CA-C 110.006 -0.368 . . . . 74.52 110.006 -179.432 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.496 0 N-CA-C 110.007 -0.368 . . . . 55.2 110.007 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 47.1 mm -123.14 110.19 25.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 108.978 -0.749 . . . . 71.24 108.978 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -144.82 85.4 8.37 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 109.867 -0.419 . . . . 71.43 109.867 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -80.63 -10.28 13.19 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 122.945 2.43 . . . . 61.01 112.092 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 70.9 m 59.47 90.18 0.06 Allowed 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.973 0.909 . . . . 64.34 111.674 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 24.1 mmt -82.32 101.13 10.36 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.023 -0.732 . . . . 74.15 109.023 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -125.9 100.28 6.31 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.502 -0.555 . . . . 53.23 109.502 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 50.2 m -73.45 97.27 2.52 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 115.764 -0.653 . . . . 75.15 110.693 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 23.5 p -137.18 -67.91 0.49 Allowed 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.045 -0.724 . . . . 70.32 109.045 175.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 62.75 19.73 11.63 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 121.879 0.847 . . . . 74.42 110.369 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 32.4 t -172.89 174.62 3.51 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.198 -1.408 . . . . 54.44 107.198 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -108.13 98.5 8.05 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.67 -1.233 . . . . 73.3 107.67 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 64.1 mtt -106.85 110.76 23.0 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.317 -0.401 . . . . 65.45 110.243 -175.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.511 HG23 ' H ' ' A' ' 18' ' ' TYR . 8.9 t -133.26 136.19 45.38 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.388 0.613 . . . . 74.22 111.706 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.69 178.33 8.25 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.538 -0.755 . . . . 63.42 109.966 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.06 -75.11 0.79 Allowed Glycine 0 N--CA 1.443 -0.842 0 O-C-N 123.596 0.56 . . . . 64.3 113.298 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.41 104.73 4.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.061 0.457 . . . . 71.32 111.344 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -150.74 91.71 1.76 Allowed 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.104 -0.702 . . . . 74.12 109.104 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 48.9 m -135.59 139.77 44.11 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.211 -0.663 . . . . 75.41 109.211 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . 0.46 ' O ' ' HD2' ' B' ' 23' ' ' PRO . 2.4 mp0 -51.89 -28.35 15.9 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 114.201 1.186 . . . . 74.53 114.201 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.11 -130.72 10.08 Favored Glycine 0 CA--C 1.502 -0.762 0 N-CA-C 111.045 -0.822 . . . . 73.44 111.045 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -51.13 -45.04 39.09 Favored 'Trans proline' 0 CA--C 1.566 2.105 0 C-N-CA 123.542 2.828 . . . . 74.55 114.884 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.46 ' HD2' ' O ' ' B' ' 20' ' ' GLU . 62.1 Cg_exo -54.51 150.53 34.29 Favored 'Trans proline' 0 C--N 1.394 2.952 0 C-N-CA 121.839 1.692 . . . . 73.41 111.937 176.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -73.16 139.25 79.06 Favored Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 116.368 -0.378 . . . . 70.24 110.806 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -69.79 140.95 43.81 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.744 2.296 . . . . 74.2 113.517 -176.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.585 HD23 ' HB3' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -90.13 177.86 6.33 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.911 -1.041 . . . . 71.32 111.033 173.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 46.2 t -59.7 144.67 47.42 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 112.712 0.634 . . . . 51.34 112.712 -175.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.03 -37.74 54.56 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.994 -1.003 . . . . 64.23 111.024 171.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -76.43 -28.49 56.63 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 113.116 0.784 . . . . 70.14 113.116 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.585 ' HB3' HD23 ' B' ' 26' ' ' LEU . 3.7 tp10 -64.5 -39.3 93.53 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 106.276 -1.75 . . . . 73.51 106.276 175.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -64.87 -44.32 90.08 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 114.424 -1.262 . . . . 73.44 108.697 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.61 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 0.1 OUTLIER -57.2 -47.57 80.95 Favored 'General case' 0 N--CA 1.413 -2.309 0 C-N-CA 123.597 0.759 . . . . 71.33 111.745 179.095 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.409 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 80.4 mm-40 -68.42 -44.57 74.7 Favored 'General case' 0 CA--C 1.505 -0.751 0 O-C-N 123.068 0.23 . . . . 72.12 111.363 -177.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.502 HG12 ' O ' ' B' ' 30' ' ' GLU . 11.3 pt -66.35 -34.93 73.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 O-C-N 123.376 0.422 . . . . 72.12 110.428 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -65.6 -42.07 92.04 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.49 0.716 . . . . 75.4 109.91 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.61 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 99.1 mttt -61.07 -24.19 66.03 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.613 -0.721 . . . . 70.51 110.777 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.55 ' HD3' ' O ' ' B' ' 86' ' ' ALA . 67.6 mtt180 -106.89 17.05 23.62 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.561 -0.745 . . . . 71.33 110.12 -174.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.433 ' HB2' ' HB3' ' B' ' 112' ' ' LYS . 26.2 m -106.43 169.08 8.73 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.176 0.512 . . . . 55.13 111.976 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 28.1 m -139.91 164.74 22.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 124.129 0.972 . . . . 74.23 110.211 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . 0.69 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 28.6 t80 -109.73 129.03 55.65 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.669 -1.234 . . . . 75.04 107.669 174.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 97.5 t -122.18 111.93 32.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 108.451 -0.944 . . . . 73.11 108.451 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.93 171.22 16.66 Favored Glycine 0 C--N 1.289 -2.044 0 C-N-CA 120.022 -1.085 . . . . 64.12 113.558 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 61.4 t30 65.95 23.67 11.22 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.144 1.778 . . . . 73.25 112.754 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 14.1 p -65.83 130.95 31.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.838 -0.801 . . . . 72.43 108.838 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -99.95 161.37 13.65 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.39 -0.823 . . . . 63.35 111.393 -175.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' TYR . . . . . 0.764 ' CE1' ' HB2' ' B' ' 77' ' ' PRO . 17.7 m-85 -71.47 92.06 1.08 Allowed 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.489 -0.778 . . . . 71.01 109.793 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 164.75 -23.2 0.16 Allowed Glycine 0 N--CA 1.419 -2.446 0 CA-C-N 114.353 -1.294 . . . . 60.04 110.03 -177.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 40.3 m -79.47 128.54 33.48 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 109.097 -0.705 . . . . 70.12 109.097 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . 0.48 ' HB ' HG21 ' A' ' 49' ' ' THR . 82.7 p -92.45 170.2 9.95 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 108.575 -0.898 . . . . 71.41 108.575 177.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.59 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -61.27 -44.07 97.83 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 110.274 -0.269 . . . . 74.21 110.274 175.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -62.36 -36.35 81.97 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.444 0.535 . . . . 65.23 112.444 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -56.64 -45.72 81.43 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.622 0.725 . . . . 71.04 109.727 176.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 57.0 mt -69.97 -48.24 59.05 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.664 -1.153 . . . . 54.54 111.642 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -62.1 -49.41 76.03 Favored 'General case' 0 C--O 1.199 -1.603 0 C-N-CA 122.831 0.452 . . . . 61.13 111.503 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.43 96.34 Favored 'General case' 0 C--O 1.252 1.23 0 CA-C-O 120.936 0.398 . . . . 43.54 110.651 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -66.37 -39.59 89.21 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.145 -0.48 . . . . 62.3 110.172 -176.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -82.18 -21.6 36.43 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 113.556 0.947 . . . . 71.32 113.556 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 23.2 t -70.09 -23.56 63.08 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.452 -0.944 . . . . 74.0 108.452 -178.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.3 m -58.66 -31.18 67.93 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-O 121.234 0.54 . . . . 54.53 109.773 172.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 69.5 m -95.3 10.72 35.15 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.809 -0.632 . . . . 73.34 112.567 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 143.42 -172.4 24.81 Favored Glycine 0 N--CA 1.462 0.388 0 C-N-CA 119.67 -1.252 . . . . 12.15 113.992 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 36.0 t -97.03 127.26 42.83 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 109.787 -0.449 . . . . 71.24 109.787 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 71.1 mt -90.62 133.62 31.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 115.789 -0.642 . . . . 73.24 112.661 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . 0.487 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 95.8 m-20 -101.39 -35.46 9.2 Favored 'General case' 0 C--O 1.206 -1.203 0 CA-C-N 115.488 -0.778 . . . . 71.23 111.68 176.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.437 ' HB2' ' HB2' ' B' ' 84' ' ' GLU . 94.0 mtt180 -153.19 159.72 42.72 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.885 -0.783 . . . . 75.23 108.885 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.59 HD11 ' HB1' ' B' ' 50' ' ' ALA . 24.6 pt -145.37 139.39 21.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.112 -1.44 . . . . 72.31 107.112 170.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 90.7 m -125.43 123.71 39.87 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 107.638 -1.245 . . . . 74.24 107.638 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.458 ' O ' HD12 ' A' ' 68' ' ' ILE . 2.3 mp -119.63 121.23 65.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 106.078 -1.823 . . . . 73.32 106.078 -177.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 66' ' ' ILE 0.298 1.2 pt? -121.06 122.85 40.97 Favored 'General case' 0 C--N 1.28 -2.434 0 C-N-CA 120.21 -0.596 . . . . 70.44 111.881 176.508 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' CYS . . . . . 0.437 ' HA ' ' HA2' ' B' ' 79' ' ' GLY . 64.6 m -116.74 130.99 57.06 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.939 -1.134 . . . . 73.11 107.939 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.537 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 3.5 p-10 -121.15 144.16 48.72 Favored 'General case' 0 C--O 1.201 -1.475 0 C-N-CA 119.756 -0.778 . . . . 61.31 110.627 -176.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -121.69 5.16 10.03 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.199 -0.667 . . . . 64.02 109.199 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.441 ' CD2' ' HB2' ' B' ' 71' ' ' ASP . 34.5 p90 -67.31 -26.52 66.56 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-O 121.132 0.492 . . . . 63.33 109.836 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.554 ' O ' ' HG3' ' A' ' 6' ' ' MET . 41.0 m -66.15 -18.8 65.58 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.555 -0.748 . . . . 75.24 111.758 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.34 -51.76 0.76 Allowed Glycine 0 CA--C 1.482 -2.028 0 N-CA-C 108.308 -1.917 . . . . 74.14 108.308 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 53.9 m170 -97.14 148.92 35.11 Favored Pre-proline 0 CA--C 1.479 -1.77 0 N-CA-C 105.851 -1.907 . . . . 73.35 105.851 173.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.764 ' HB2' ' CE1' ' B' ' 46' ' ' TYR . 74.5 Cg_endo -80.49 116.51 3.27 Favored 'Trans proline' 0 N--CA 1.417 -3.016 0 N-CA-C 108.955 -1.209 . . . . 75.43 108.955 173.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' LYS . . . . . 0.44 ' HZ3' ' CG ' ' B' ' 71' ' ' ASP . 23.9 mtmm -104.83 -168.52 1.49 Allowed 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 108.643 -0.873 . . . . 62.14 108.643 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' B' ' 70' ' ' CYS . . . -168.38 139.77 5.85 Favored Glycine 0 N--CA 1.403 -3.559 0 C-N-CA 119.7 -1.238 . . . . 54.12 113.17 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -150.12 144.67 25.86 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 114.662 -0.769 . . . . 61.13 109.344 174.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.44 159.91 41.07 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-O 120.716 0.293 . . . . 64.25 110.763 -172.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -123.0 125.55 45.45 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.427 -0.953 . . . . 74.15 108.427 174.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.433 HG23 HG22 ' B' ' 66' ' ' ILE . 44.6 mm -103.87 120.46 54.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 106.752 -1.573 . . . . 72.5 106.752 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' B' ' 65' ' ' ARG . 34.3 mt-10 -107.4 118.73 37.5 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.079 0.466 . . . . 73.54 110.025 -175.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -99.93 166.73 10.92 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.998 0.74 . . . . 63.32 112.998 -173.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.55 ' O ' ' HD3' ' B' ' 37' ' ' ARG . . . -77.57 -36.84 51.64 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.641 -1.163 . . . . 52.33 111.378 174.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -109.08 146.82 33.37 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.15 0.5 . . . . 61.14 112.029 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.486 ' O ' HG22 ' B' ' 91' ' ' VAL . 0.6 OUTLIER -73.93 -29.77 62.21 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 106.407 -1.701 . . . . 72.53 106.407 178.759 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -64.15 -24.08 67.55 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 114.773 -1.103 . . . . 71.14 110.667 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 19.8 m -68.33 -36.28 79.04 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 116.394 -0.366 . . . . 62.34 110.314 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.486 HG22 ' O ' ' B' ' 88' ' ' ARG . 3.1 m -64.49 -38.99 84.03 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.071 0 N-CA-C 108.373 -0.973 . . . . 74.35 108.373 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.3 -38.56 74.19 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 123.769 0.668 . . . . 33.34 110.601 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.27 -35.4 63.76 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.054 -0.521 . . . . 74.33 111.3 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.77 -45.24 59.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.911 0.386 . . . . 54.15 111.056 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . 0.43 HG13 ' O ' ' B' ' 91' ' ' VAL . 26.0 m -57.79 -21.58 16.74 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 N-CA-C 112.935 0.717 . . . . 70.33 112.935 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.25 -15.4 63.16 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 121.581 0.705 . . . . 71.11 110.62 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 67.3 mtm -103.35 12.27 35.61 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.536 -0.756 . . . . 74.24 109.662 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . 0.614 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 2.1 p-10 -36.21 -43.45 0.35 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.249 1.574 . . . . 65.04 115.249 -176.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -130.09 61.76 1.58 Allowed 'General case' 0 N--CA 1.421 -1.918 0 C-N-CA 118.665 -1.214 . . . . 73.43 111.129 174.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 15.0 t -89.84 173.84 8.03 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 113.914 -1.493 . . . . 74.4 109.995 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.35 128.77 63.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.261 0.553 . . . . 45.42 109.841 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -140.68 126.11 18.84 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.647 -1.242 . . . . 74.52 107.647 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . 0.366 12.6 ptm85 50.37 55.03 10.11 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.114 1.524 . . . . 73.34 115.114 -176.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.72 -4.4 9.73 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 114.616 -1.175 . . . . 74.43 115.484 177.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -127.76 161.89 27.91 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 117.897 0.849 . . . . 72.55 110.666 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 37.1 m -95.64 128.37 42.45 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 109.53 -0.544 . . . . 62.12 109.53 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 35.8 pt -102.49 171.69 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 120.922 -0.311 . . . . 54.12 111.075 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . 0.614 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 41.7 tptt -131.04 126.8 36.83 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 109.394 -0.595 . . . . 73.33 109.394 -176.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.69 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 18.1 t -126.88 131.58 70.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.112 -0.699 . . . . 72.14 109.112 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.659 ' HB3' ' HD2' ' B' ' 111' ' ' PRO 0.266 0.2 OUTLIER -136.26 168.42 17.26 Favored Pre-proline 0 CA--C 1.502 -0.894 0 N-CA-C 105.493 -2.04 . . . . 71.13 105.493 172.387 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.659 ' HD2' ' HB3' ' B' ' 110' ' ' LEU . 95.3 Cg_endo -76.55 148.75 29.82 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.363 1.375 . . . . 62.31 109.887 171.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' B' ' 38' ' ' SER . 72.3 tttt -89.72 124.25 34.45 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.217 -1.771 . . . . 63.53 106.217 178.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.7 78.09 1.78 Allowed 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.958 -1.497 . . . . 53.24 106.958 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.587 HG22 ' H ' ' B' ' 115' ' ' ASN . 4.4 m -154.08 -142.24 0.11 Allowed 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 107.428 -1.323 . . . . 70.15 107.428 -175.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' ASN . . . . . 0.587 ' H ' HG22 ' B' ' 114' ' ' THR . 7.4 t30 165.31 179.13 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 103.873 -2.639 . . . . 64.03 103.873 174.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 28.0 ttt -126.85 71.22 74.41 Favored Pre-proline 0 C--N 1.297 -1.706 0 C-N-CA 118.995 -1.082 . . . . 71.54 110.713 172.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' B' ' 14' ' ' THR . 74.0 Cg_endo -107.65 24.56 0.07 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.837 0 C-N-CA 123.644 2.896 . . . . 75.23 109.566 175.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.04 -9.38 63.22 Favored Glycine 0 CA--C 1.493 -1.308 0 CA-C-N 115.501 -0.772 . . . . 53.11 112.02 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 60.4 mt -79.2 86.87 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.017 0 N-CA-C 107.289 -1.375 . . . . 64.04 107.289 175.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 42.6 m -148.06 111.97 5.12 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.735 -0.839 . . . . 75.44 108.735 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 53.4 m -152.38 127.15 9.54 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.721 -0.474 . . . . 72.03 109.721 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 38.7 m -85.78 93.24 8.83 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-O 121.554 0.692 . . . . 73.11 109.546 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -87.54 78.1 8.64 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.938 0.875 . . . . 74.32 109.404 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.456 ' C ' ' HE ' ' B' ' 124' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.494 -1.195 0 N-CA-C 106.883 -1.525 . . . . 74.35 106.883 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.572 0 N-CA-C 110.025 -0.361 . . . . 72.45 110.025 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.3 pt -80.96 135.56 24.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 120.857 0.361 . . . . 74.41 110.051 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.83 112.11 9.65 Favored Pre-proline 0 C--N 1.305 -1.354 0 CA-C-N 116.477 -0.329 . . . . 43.21 110.857 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.82 104.05 1.84 Allowed 'Trans proline' 0 N--CA 1.44 -1.658 0 C-N-CA 121.81 1.673 . . . . 62.35 110.173 176.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 58.0 m -106.76 115.72 30.69 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.481 -0.781 . . . . 62.14 109.198 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.541 ' HG2' ' OE1' ' A' ' 99' ' ' GLU . 1.6 mpt? -84.69 88.05 7.33 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.181 0.515 . . . . 61.42 111.927 -176.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -97.35 102.79 14.63 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.703 -1.592 . . . . 75.52 106.703 177.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.3 t -163.49 172.21 14.78 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.341 -0.985 . . . . 63.54 108.341 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -168.49 -178.82 3.65 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 107.923 -1.14 . . . . 75.42 107.923 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.425 ' CB ' ' HG ' ' A' ' 110' ' ' LEU . 8.2 p80 -124.66 153.33 42.44 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.045 -0.724 . . . . 65.15 109.045 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.7 m -76.26 94.61 3.58 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 109.877 -0.416 . . . . 73.24 109.877 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -75.03 91.27 2.52 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 122.242 1.02 . . . . 72.12 111.871 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.6 ttp -165.66 151.44 9.27 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.739 -1.573 . . . . 64.2 106.944 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.8 m -57.53 116.9 3.65 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.559 -0.534 . . . . 72.24 109.559 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.79 -33.64 76.07 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 115.99 -0.55 . . . . 53.12 112.143 -176.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.7 -179.47 16.24 Favored Glycine 0 N--CA 1.429 -1.802 0 C-N-CA 120.407 -0.901 . . . . 74.14 111.721 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -108.64 158.67 17.38 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 109.977 -0.379 . . . . 74.35 109.977 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -108.21 136.32 48.06 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.092 -0.706 . . . . 75.35 109.092 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.0 m -74.84 97.17 3.24 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.943 -0.571 . . . . 64.32 109.861 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -70.83 159.1 35.2 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.536 -0.913 . . . . 71.3 108.536 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.429 ' HA3' ' HD3' ' A' ' 22' ' ' PRO . . . -87.91 -108.06 0.97 Allowed Glycine 0 C--N 1.306 -1.101 0 C-N-CA 120.491 -0.862 . . . . 61.42 113.861 -174.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.476 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 8.6 Cg_endo -75.82 -20.78 14.97 Favored 'Trans proline' 0 CA--C 1.589 3.26 0 N-CA-C 119.179 2.723 . . . . 70.22 119.179 -177.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 22' ' ' PRO . 11.7 Cg_endo -52.74 124.48 15.45 Favored 'Trans proline' 0 C--N 1.403 3.429 0 CA-C-N 122.85 2.053 . . . . 71.41 113.575 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -59.71 150.55 66.82 Favored Pre-proline 0 C--O 1.245 0.849 0 CA-C-N 115.256 -0.884 . . . . 63.23 112.591 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -55.37 121.62 10.25 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.675 2.917 . . . . 62.41 116.097 -176.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.641 HD13 ' H ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -102.93 164.1 11.82 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.272 -1.751 . . . . 71.51 106.272 165.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.469 ' HB3' ' OE2' ' A' ' 30' ' ' GLU . 46.1 t -59.99 143.79 50.87 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 113.234 0.827 . . . . 73.21 113.234 -172.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.401 ' O ' ' HE2' ' A' ' 32' ' ' LYS . . . -53.39 -33.18 52.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.1 -1.409 . . . . 71.12 110.801 174.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -66.75 -38.58 86.91 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 116.672 -0.24 . . . . 73.52 111.253 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.469 ' OE2' ' HB3' ' A' ' 27' ' ' SER . 0.6 OUTLIER -65.08 -34.82 79.33 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 116.449 -0.341 . . . . 73.02 110.909 174.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -67.13 -45.47 77.04 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.022 0.439 . . . . 53.3 110.36 -176.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.401 ' HE2' ' O ' ' A' ' 28' ' ' ALA . 46.6 mtmt -61.2 -42.64 98.94 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.936 -0.575 . . . . 70.43 112.07 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.48 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 11.3 mm-40 -71.27 -40.66 70.8 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-N 116.045 -0.525 . . . . 72.35 112.3 -176.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.9 pt -65.37 -35.59 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 112.934 0.716 . . . . 72.2 112.934 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -71.15 -29.5 65.29 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 119.878 -0.729 . . . . 71.1 110.778 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -73.69 -15.91 61.21 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.525 0.73 . . . . 74.54 110.067 176.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 98.3 mtt180 -104.9 12.02 32.95 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.303 -0.862 . . . . 71.23 109.019 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.453 ' HB3' ' HE2' ' A' ' 112' ' ' LYS . 33.0 t -107.21 156.65 18.61 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 121.58 0.705 . . . . 74.05 110.853 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.514 ' CG1' ' HB ' ' A' ' 91' ' ' VAL . 34.3 m -136.23 164.58 31.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.359 -0.837 . . . . 70.53 109.66 -177.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.585 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 22.4 t80 -110.18 127.0 54.69 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 107.847 -1.168 . . . . 72.54 107.847 176.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 58.0 t -121.31 112.73 36.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 107.518 -1.29 . . . . 75.42 107.518 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -117.81 172.71 14.48 Favored Glycine 0 C--N 1.294 -1.789 0 C-N-CA 118.978 -1.582 . . . . 73.4 114.036 -176.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.7 t30 60.41 20.86 10.49 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 125.749 1.62 . . . . 71.55 112.198 -176.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.87 139.92 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 121.093 0.473 . . . . 62.53 110.039 176.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -82.83 156.03 23.85 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.672 -0.862 . . . . 74.11 108.672 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -68.63 -18.62 64.33 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.741 0.781 . . . . 72.14 109.235 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.4 -15.7 81.18 Favored Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 115.055 -0.975 . . . . 74.1 112.296 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.4 m -87.1 127.34 35.13 Favored 'General case' 0 N--CA 1.411 -2.388 0 N-CA-C 108.011 -1.107 . . . . 34.14 108.011 176.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.3 p -105.49 178.67 4.49 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.613 -0.514 . . . . 74.15 109.613 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.585 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -60.7 -46.07 91.79 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.753 -0.462 . . . . 45.23 109.753 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -58.41 -36.25 73.29 Favored 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 115.596 -0.729 . . . . 73.14 111.305 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -67.45 -40.61 85.43 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.206 0.526 . . . . 62.14 110.463 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.6 mt -66.49 -47.94 71.43 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 115.165 -0.925 . . . . 60.24 111.744 -177.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -60.62 -46.39 90.46 Favored 'General case' 0 C--O 1.181 -2.528 0 N-CA-C 113.645 0.98 . . . . 55.31 113.645 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.38 -47.83 75.23 Favored 'General case' 0 C--O 1.271 2.189 0 CA-C-O 121.662 0.744 . . . . 52.25 111.455 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -63.86 -43.01 97.38 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.851 -1.068 . . . . 74.01 110.568 -178.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -82.13 -22.21 36.27 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 114.843 1.423 . . . . 63.01 114.843 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.4 t -67.07 -26.97 67.0 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.284 -0.636 . . . . 53.42 109.284 -177.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.2 m -59.1 -24.94 63.38 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 120.534 -0.466 . . . . 71.4 111.004 173.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 76.7 m -95.72 7.2 46.96 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.876 1.065 . . . . 63.44 113.876 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.38 -147.25 18.4 Favored Glycine 0 C--O 1.238 0.35 0 C-N-CA 118.51 -1.805 . . . . 60.0 115.067 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 52.8 p -112.95 122.97 49.23 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.021 0.438 . . . . 62.5 111.541 -175.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.3 mt -89.39 130.52 38.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-O 121.21 0.528 . . . . 71.34 112.03 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -92.68 -48.95 6.33 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.043 -0.981 . . . . 70.53 109.055 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.42 ' HG2' ' HB2' ' B' ' 71' ' ' ASP . 79.2 mtm180 -155.83 163.78 39.37 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.613 -0.884 . . . . 74.41 108.613 -176.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.585 HD11 ' HB1' ' A' ' 50' ' ' ALA . 31.3 pt -145.87 144.51 20.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 109.185 -0.672 . . . . 64.11 109.185 176.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.4 m -125.71 126.03 43.96 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 107.334 -1.358 . . . . 75.12 107.334 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.8 mp -122.48 122.89 67.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.113 -1.44 . . . . 71.32 107.113 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.286 1.0 OUTLIER -121.0 128.37 52.64 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 120.207 -0.597 . . . . 71.03 111.918 176.143 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 62.6 m -114.36 125.38 53.8 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.543 -1.28 . . . . 72.45 107.543 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' A' ' 78' ' ' LYS . 2.2 p-10 -110.64 130.43 55.57 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 118.462 -1.295 . . . . 55.24 112.013 -177.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -107.49 13.03 27.26 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.368 -1.345 . . . . 72.41 107.368 170.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -61.47 -36.63 80.98 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 113.921 -1.491 . . . . 75.34 108.508 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.5 t -81.68 7.78 11.57 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-N 115.495 -0.775 . . . . 55.53 111.154 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.74 -47.95 3.25 Favored Glycine 0 N--CA 1.462 0.418 0 O-C-N 121.615 -0.678 . . . . 74.14 111.429 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -95.77 137.28 21.89 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 106.737 -1.579 . . . . 74.44 106.737 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.34 117.01 4.66 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 CA-C-N 119.313 0.79 . . . . 72.41 110.706 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.447 ' HB2' ' OD1' ' A' ' 71' ' ' ASP . 13.0 mmmm -104.96 -176.47 3.09 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 115.0 -1.0 . . . . 75.22 108.663 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.54 137.59 4.91 Favored Glycine 0 N--CA 1.41 -3.061 0 C-N-CA 119.596 -1.288 . . . . 52.33 112.785 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -154.43 143.29 20.96 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 123.931 0.892 . . . . 71.33 109.27 173.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.26 151.8 50.04 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-O 120.9 0.381 . . . . 62.22 110.574 -172.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 28.1 m-85 -118.82 115.68 24.93 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 108.386 -0.968 . . . . 72.1 108.386 176.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.479 HG23 HG22 ' A' ' 66' ' ' ILE . 40.0 mm -97.57 122.03 48.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.223 -1.029 . . . . 74.53 108.223 -176.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -102.38 119.79 39.41 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.195 -0.669 . . . . 55.42 109.195 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.26 156.47 16.41 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-O 121.062 0.458 . . . . 73.34 110.533 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.22 -27.84 56.95 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.156 -0.475 . . . . 51.54 110.051 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -112.48 136.86 51.49 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.826 -0.625 . . . . 54.02 110.848 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.464 ' O ' HG22 ' A' ' 91' ' ' VAL . 1.4 tmm_? -69.72 -32.12 70.51 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.815 -1.18 . . . . 70.31 107.815 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -67.68 -21.67 65.33 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 115.807 -0.633 . . . . 71.32 111.498 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.3 m -67.85 -36.04 79.61 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.739 -0.467 . . . . 62.53 109.739 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.514 ' HB ' ' CG1' ' A' ' 39' ' ' VAL . 2.2 m -67.15 -38.57 81.37 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 N-CA-C 108.354 -0.98 . . . . 73.21 108.354 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -61.36 -35.55 77.76 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.439 -0.801 . . . . 70.23 110.735 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.31 -31.65 62.56 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.079 -0.509 . . . . 64.12 110.826 175.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 97' ' ' MET . . . -76.46 -42.93 42.08 Favored 'General case' 0 C--O 1.205 -1.269 0 CA-C-N 115.999 -0.546 . . . . 75.44 111.094 -177.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 91' ' ' VAL . 19.9 m -56.09 -21.37 11.37 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.957 0 N-CA-C 113.458 0.91 . . . . 75.02 113.458 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.07 -10.54 58.12 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-O 121.933 0.873 . . . . 65.35 110.235 176.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.515 ' HA ' ' OG1' ' A' ' 100' ' ' THR . 18.7 mtp -101.62 9.65 40.93 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 125.111 1.364 . . . . 71.2 109.866 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 12.4 t70 -35.73 -57.95 0.63 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 115.703 1.742 . . . . 74.24 115.703 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.541 ' OE1' ' HG2' ' A' ' 6' ' ' MET . 42.0 tt0 -116.99 30.39 7.36 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 122.327 1.06 . . . . 64.51 109.329 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.515 ' OG1' ' HA ' ' A' ' 97' ' ' MET . 89.8 m -74.71 167.39 21.89 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.915 -1.039 . . . . 74.22 110.195 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.25 133.12 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 CA-C-O 121.356 0.598 . . . . 50.31 110.143 -173.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -133.23 127.79 34.49 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.476 -0.784 . . . . 70.42 109.059 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 103' ' ' ARG . 21.0 ttt180 57.05 32.64 22.02 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 122.303 1.049 . . . . 73.21 110.484 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.19 5.85 87.45 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.012 -0.995 . . . . 75.55 113.444 177.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -124.88 145.75 49.66 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 117.086 0.443 . . . . 71.43 110.137 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.5 m -79.31 119.74 22.79 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 110.018 -0.364 . . . . 61.25 110.018 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 45.9 pt -102.72 171.11 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 109.758 -0.46 . . . . 62.03 109.758 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 22.5 mmmt -118.02 130.15 56.0 Favored 'General case' 0 CA--C 1.472 -2.05 0 N-CA-C 108.883 -0.784 . . . . 75.4 108.883 176.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 41.1 t -125.59 111.79 28.53 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 107.304 -1.369 . . . . 70.33 107.304 172.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.43 HD13 ' CD2' ' A' ' 40' ' ' TYR 0.266 0.0 OUTLIER -138.9 146.75 51.27 Favored Pre-proline 0 N--CA 1.432 -1.345 0 C-N-CA 119.215 -0.994 . . . . 73.23 108.363 178.103 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.411 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 62.0 Cg_endo -76.53 137.29 18.29 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.614 1.543 . . . . 63.01 112.217 -173.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.453 ' HE2' ' HB3' ' A' ' 38' ' ' SER . 37.6 ttpt -83.39 86.56 7.05 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 108.498 -0.927 . . . . 71.21 108.498 -177.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.411 ' HG2' ' HB2' ' A' ' 111' ' ' PRO . 6.6 ptm180 -178.74 179.89 0.68 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.158 -0.928 . . . . 75.04 111.831 -172.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.5 t -100.89 157.26 16.86 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 115.405 -0.816 . . . . 64.53 109.118 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -139.9 156.42 46.7 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.628 -1.249 . . . . 71.1 107.628 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 27.3 ttt -57.01 112.41 4.56 Favored Pre-proline 0 CA--C 1.536 0.408 0 O-C-N 123.616 0.572 . . . . 63.53 111.36 -177.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.89 -29.9 14.68 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.52 2.147 . . . . 61.21 112.241 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.38 -64.44 3.23 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.742 -0.742 . . . . 42.31 111.707 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.5 pt -86.15 7.0 2.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.35 0.595 . . . . 71.51 111.068 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.1 t -149.39 162.69 39.59 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 107.264 -1.384 . . . . 75.15 107.264 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 62.4 p -148.24 -161.18 1.28 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.87 -0.789 . . . . 74.04 108.87 -176.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.6 p -74.71 0.26 15.8 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 112.447 0.536 . . . . 54.51 112.447 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -78.56 104.32 9.08 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 109.15 -0.685 . . . . 64.51 109.15 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.489 0 CA-C-N 115.927 -0.579 . . . . 73.22 112.294 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.558 0 CA-C-O 120.621 0.248 . . . . 55.13 110.522 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 51.0 mm -97.94 129.39 48.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.42 -0.955 . . . . 73.24 108.42 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.78 91.8 32.39 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 111.967 0.358 . . . . 42.31 111.967 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -98.62 178.73 0.35 Allowed 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 123.058 2.505 . . . . 71.43 110.857 176.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 21.8 p -101.61 -2.96 29.22 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.178 0.514 . . . . 54.34 110.718 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 20.9 ptp -90.28 107.5 19.18 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.424 0.63 . . . . 61.43 111.545 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -138.02 97.4 3.4 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.511 -0.768 . . . . 63.14 110.758 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 42.5 m -72.68 -28.82 62.93 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.113 -0.494 . . . . 75.32 111.058 -178.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 19.6 m -73.98 81.0 1.69 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 116.493 -0.321 . . . . 64.01 111.491 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 13.5 m170 176.38 -32.7 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 127.8 2.44 . . . . 74.21 110.192 177.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 54.1 p -64.68 134.7 54.78 Favored 'General case' 0 C--O 1.244 0.779 0 O-C-N 123.283 0.364 . . . . 74.35 111.185 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -72.36 95.64 1.77 Allowed 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.122 -0.695 . . . . 74.22 109.122 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -48.12 -44.49 32.0 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.798 1.036 . . . . 55.12 113.798 -174.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 70.1 m 68.76 95.34 0.07 Allowed 'General case' 0 CA--C 1.55 0.973 0 CA-C-O 122.286 1.041 . . . . 54.22 113.342 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.4 -159.44 0.99 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 105.394 -2.076 . . . . 75.12 105.394 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.6 -38.18 70.47 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 109.951 -1.26 . . . . 74.14 109.951 174.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.59 94.41 8.07 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 107.042 -1.466 . . . . 72.54 107.042 171.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.461 ' CE2' ' HB3' ' B' ' 20' ' ' GLU . 66.1 t80 -101.0 -19.58 15.77 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.54 -0.755 . . . . 72.13 111.555 -174.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 30.7 m 57.92 -59.6 0.03 OUTLIER 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 114.451 1.278 . . . . 62.43 114.451 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . 0.461 ' HB3' ' CE2' ' B' ' 18' ' ' TYR . 41.6 tt0 -54.9 -26.96 39.34 Favored 'General case' 0 CA--C 1.572 1.815 0 C-N-CA 126.168 1.787 . . . . 55.32 111.869 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.412 ' HA3' ' HD2' ' B' ' 22' ' ' PRO . . . 79.33 -120.86 5.37 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 116.021 1.168 . . . . 73.41 116.021 171.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.577 ' HG3' ' CE1' ' A' ' 40' ' ' TYR . 2.8 Cg_endo -41.69 -52.91 3.59 Favored 'Trans proline' 0 C--N 1.366 1.451 1 C-N-CA 125.475 4.117 . . . . 64.21 118.287 -173.658 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -58.63 123.7 14.16 Favored 'Trans proline' 0 C--N 1.379 2.179 0 CA-C-N 120.802 1.322 . . . . 73.32 111.557 -174.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -59.79 136.47 90.07 Favored Pre-proline 0 N--CA 1.435 -1.216 0 CA-C-N 115.573 -0.74 . . . . 75.32 110.356 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.52 103.08 0.09 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 123.237 2.625 . . . . 75.32 114.149 -172.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.69 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -70.56 170.84 11.32 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 114.973 -1.012 . . . . 74.2 109.876 174.376 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 47.6 t -59.42 143.47 49.7 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.53 0.681 . . . . 71.24 112.707 -173.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.5 ' O ' ' HE2' ' B' ' 32' ' ' LYS . . . -52.73 -36.25 57.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.328 -1.306 . . . . 74.41 111.703 176.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -60.98 -49.2 78.42 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.555 -0.535 . . . . 63.32 109.555 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.457 ' HB2' HD23 ' B' ' 26' ' ' LEU . 0.8 OUTLIER -61.52 -36.51 80.75 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-N 115.997 -0.547 . . . . 72.41 112.09 178.595 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.533 ' HA ' HG12 ' B' ' 34' ' ' ILE 0.516 5.3 ptpt -71.48 -35.43 70.82 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 115.049 1.5 . . . . 73.43 115.049 -179.146 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.5 ' HE2' ' O ' ' B' ' 28' ' ' ALA . 45.6 mtmt -64.41 -40.94 96.74 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.04 0.447 . . . . 54.01 111.066 174.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.548 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 38.6 mm-40 -71.07 -42.98 68.68 Favored 'General case' 0 C--O 1.211 -0.929 0 CA-C-N 115.622 -0.717 . . . . 73.41 112.768 -177.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.533 HG12 ' HA ' ' B' ' 31' ' ' LYS . 13.6 pt -64.79 -35.53 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 112.843 0.682 . . . . 73.54 112.843 -176.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -72.91 -23.69 60.73 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 119.994 -0.682 . . . . 70.01 111.329 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.446 ' HG3' ' HB ' ' B' ' 114' ' ' THR . 55.5 mtpt -77.1 -14.99 59.72 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.709 0.804 . . . . 74.44 109.741 174.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' B' ' 33' ' ' GLU . 89.7 mtt180 -109.22 14.1 24.01 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 115.218 -0.901 . . . . 74.52 108.883 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 49.6 m -101.31 153.71 19.41 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.191 -0.913 . . . . 71.21 110.937 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.495 ' CG1' ' HB ' ' B' ' 91' ' ' VAL . 35.7 m -133.3 163.85 36.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.321 -0.854 . . . . 61.24 109.273 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 35.0 t80 -110.9 124.47 52.16 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 107.623 -1.251 . . . . 73.42 107.623 177.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 59.1 t -122.91 110.1 25.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 107.923 -1.14 . . . . 73.31 107.923 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' B' ' 43' ' ' ASN . . . -133.88 109.02 0.77 Allowed Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 115.547 -3.216 . . . . 63.44 116.42 -177.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' B' ' 42' ' ' GLY . 62.0 t30 166.41 26.35 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 125.868 1.667 . . . . 75.21 108.011 157.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 12.0 p -69.67 136.22 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 115.208 -0.905 . . . . 75.03 109.921 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -111.9 167.09 10.65 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.666 -0.697 . . . . 63.52 110.788 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' TYR . . . . . 0.537 ' CE1' ' HB2' ' B' ' 77' ' ' PRO . 5.5 m-85 -69.25 101.55 1.52 Allowed 'General case' 0 CA--C 1.496 -1.13 0 CA-C-O 121.629 0.728 . . . . 73.4 109.796 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . 0.467 ' HA3' ' NH1' ' B' ' 103' ' ' ARG . . . 159.7 -33.58 0.45 Allowed Glycine 0 N--CA 1.413 -2.879 0 N-CA-C 109.218 -1.553 . . . . 43.34 109.218 -175.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.46 ' OG ' ' HE2' ' B' ' 102' ' ' PHE . 18.3 m -90.78 135.14 33.92 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 108.361 -0.977 . . . . 73.04 108.361 176.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 82.0 p -105.45 178.83 4.45 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 116.219 -0.446 . . . . 52.35 109.972 -177.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.623 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -61.98 -41.98 98.63 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.265 -1.013 . . . . 61.02 108.265 175.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -58.29 -35.41 71.77 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 114.949 -1.023 . . . . 74.32 111.392 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -69.55 -41.3 76.1 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 121.087 0.47 . . . . 75.4 110.472 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 61.2 mt -63.94 -47.82 78.98 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.348 -0.842 . . . . 73.22 112.244 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -60.14 -47.31 86.43 Favored 'General case' 0 C--O 1.182 -2.467 0 N-CA-C 113.796 1.036 . . . . 43.42 113.796 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.54 -48.02 75.38 Favored 'General case' 0 C--O 1.266 1.952 0 CA-C-N 118.413 0.551 . . . . 71.23 110.408 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -64.08 -41.57 97.27 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.549 -0.751 . . . . 74.13 110.719 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -82.51 -21.78 35.33 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 114.95 1.463 . . . . 71.3 114.95 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 48.5 t -66.89 -27.96 67.93 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.6 -0.518 . . . . 71.03 109.6 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.8 m -58.61 -31.55 68.17 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-O 121.003 0.43 . . . . 73.13 110.19 173.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 85.9 m -91.79 1.76 56.95 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.32 0.859 . . . . 64.24 113.32 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.65 -159.11 28.11 Favored Glycine 0 C--O 1.243 0.663 0 C-N-CA 118.033 -2.032 . . . . 35.35 116.383 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 17.5 m -106.05 116.21 31.54 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.053 -0.574 . . . . 75.51 110.592 -175.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 77.4 mt -84.18 132.16 32.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 121.594 0.712 . . . . 73.04 112.617 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -94.82 -49.07 5.75 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.635 -1.166 . . . . 65.22 109.281 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -155.93 164.32 38.64 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.659 -0.867 . . . . 74.4 108.659 -176.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.623 HD11 ' HB1' ' B' ' 50' ' ' ALA . 31.3 pt -145.98 144.59 20.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 109.002 -0.74 . . . . 71.11 109.002 176.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 58.5 m -125.47 125.71 43.74 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.263 -1.384 . . . . 74.33 107.263 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.7 mp -122.43 122.63 66.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 106.881 -1.526 . . . . 74.21 106.881 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.262 1.4 pt? -121.09 128.32 52.47 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.98 -0.688 . . . . 65.31 111.611 176.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 64.3 m -113.92 125.62 54.25 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.734 -1.21 . . . . 74.2 107.734 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.42 ' HB2' ' HG2' ' A' ' 65' ' ' ARG . 3.3 p-10 -112.01 130.04 56.0 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 118.895 -1.122 . . . . 71.24 112.284 -177.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.413 ' HE3' ' OH ' ' B' ' 46' ' ' TYR . 97.9 mttt -106.85 10.98 30.52 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.086 -1.079 . . . . 71.34 108.086 172.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -59.82 -33.69 72.09 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 113.733 -1.576 . . . . 73.24 107.892 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 24.8 m -82.35 8.31 11.68 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 115.087 -0.961 . . . . 53.2 111.799 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.2 -49.1 3.93 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-O 121.872 0.706 . . . . 72.21 111.388 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -95.01 131.63 29.81 Favored Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 105.37 -2.085 . . . . 53.25 105.37 176.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.537 ' HB2' ' CE1' ' B' ' 46' ' ' TYR . 19.7 Cg_endo -63.42 116.67 3.77 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.212 1.275 . . . . 63.35 111.691 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' LYS . . . . . 0.408 ' HB2' ' OD1' ' B' ' 71' ' ' ASP . 13.4 mmmm -103.8 -178.61 3.71 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.239 -0.891 . . . . 64.23 109.303 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.55 136.44 4.22 Favored Glycine 0 N--CA 1.412 -2.945 0 C-N-CA 119.66 -1.257 . . . . 75.42 113.1 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -152.24 144.8 24.17 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 123.976 0.91 . . . . 75.13 109.756 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.98 151.48 49.05 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-O 121.001 0.429 . . . . 73.24 110.41 -172.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' B' ' 39' ' ' VAL . 28.1 m-85 -118.83 115.93 25.46 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 108.129 -1.063 . . . . 74.25 108.129 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.497 HG23 HG22 ' B' ' 66' ' ' ILE . 40.7 mm -97.2 122.18 48.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 108.151 -1.055 . . . . 73.01 108.151 -177.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -101.97 119.46 38.83 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.067 -0.716 . . . . 71.31 109.067 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -98.02 155.66 17.0 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 116.279 -0.419 . . . . 64.32 109.972 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.97 -30.28 55.92 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.277 0.56 . . . . 74.24 109.644 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . 0.513 ' HB2' ' OG ' ' B' ' 90' ' ' SER . 35.6 mt-10 -105.14 136.71 44.14 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.862 -0.608 . . . . 74.1 109.627 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.403 ' O ' HG22 ' B' ' 91' ' ' VAL . 1.5 tmm_? -72.52 -32.32 66.05 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.349 -1.352 . . . . 70.2 107.349 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -66.54 -22.42 66.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.429 -0.805 . . . . 72.34 111.357 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' SER . . . . . 0.513 ' OG ' ' HB2' ' B' ' 87' ' ' GLU . 49.6 m -67.48 -36.01 80.29 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.976 -0.379 . . . . 75.55 109.976 176.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.498 ' O ' HG13 ' B' ' 95' ' ' VAL . 2.0 m -67.01 -38.4 81.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 N-CA-C 108.121 -1.066 . . . . 73.32 108.121 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.34 -37.48 83.46 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.405 -0.816 . . . . 55.44 110.219 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.34 -30.92 63.66 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.195 0.521 . . . . 73.15 110.835 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.13 -44.79 36.75 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-N 116.086 -0.506 . . . . 73.51 111.352 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . 0.498 HG13 ' O ' ' B' ' 91' ' ' VAL . 25.7 m -55.46 -21.63 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.924 0.89 . . . . 74.24 112.819 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.62 -8.96 52.04 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.306 0.574 . . . . 62.25 110.481 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 32.9 mtm -105.02 12.97 31.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.495 -0.775 . . . . 75.34 110.583 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . 0.42 ' HA ' ' H ' ' B' ' 109' ' ' VAL . 3.7 p30 -39.55 -44.32 1.42 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.195 1.183 . . . . 74.4 114.195 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -110.05 95.14 5.4 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 121.545 0.688 . . . . 72.12 110.274 172.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' B' ' 106' ' ' THR . 6.7 p -132.11 156.08 46.99 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.119 -0.946 . . . . 64.34 111.934 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.68 127.14 65.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 121.095 0.474 . . . . 71.23 109.904 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' PHE . . . . . 0.46 ' HE2' ' OG ' ' B' ' 48' ' ' SER . 43.1 t80 -143.18 126.22 16.35 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.708 -1.59 . . . . 71.54 106.708 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . 0.467 ' NH1' ' HA3' ' B' ' 47' ' ' GLY . 72.9 mtp85 62.59 33.36 15.88 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.208 0.603 . . . . 72.21 111.101 -175.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.08 14.56 66.17 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 115.524 -0.762 . . . . 73.24 113.141 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -130.81 143.93 51.09 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 122.404 -0.468 . . . . 70.13 110.126 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' B' ' 100' ' ' THR . 53.5 m -83.0 126.68 32.8 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 120.777 0.322 . . . . 75.42 110.356 -177.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . 0.429 HG22 ' HB3' ' B' ' 43' ' ' ASN . 38.7 pt -100.87 167.26 2.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 109.227 -0.657 . . . . 60.24 109.227 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 44.9 tptt -121.26 124.99 45.98 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.577 -0.898 . . . . 73.0 108.577 -175.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 35.6 t -122.01 119.19 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 108.413 -0.958 . . . . 75.15 108.413 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.327 0.3 OUTLIER -143.53 137.37 14.45 Favored Pre-proline 0 C--N 1.285 -2.197 0 N-CA-C 106.454 -1.684 . . . . 72.01 106.454 -169.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -77.18 130.11 10.9 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 120.771 1.311 . . . . 71.3 110.446 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -69.4 -42.06 75.61 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.08 -0.648 . . . . 74.14 110.597 -174.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.482 ' HG2' ' H ' ' B' ' 114' ' ' THR . 30.0 ttm-85 68.6 171.33 0.29 Allowed 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.044 0.938 . . . . 71.3 111.765 174.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.482 ' H ' ' HG2' ' B' ' 113' ' ' ARG . 28.8 m -160.75 169.68 22.28 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 104.326 -2.472 . . . . 74.02 104.326 -177.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -72.56 141.12 48.43 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-O 121.015 0.436 . . . . 63.35 111.122 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 94.7 mmm -77.38 116.3 56.62 Favored Pre-proline 0 C--N 1.31 -1.124 0 CA-C-N 115.272 -0.876 . . . . 70.14 109.219 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.35 14.9 0.86 Allowed 'Trans proline' 0 N--CA 1.478 0.581 0 C-N-CA 123.165 2.576 . . . . 35.23 113.584 -177.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.04 -135.32 32.09 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 121.311 -0.471 . . . . 61.14 112.2 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 34.9 pt -130.72 -175.51 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 109.678 -0.49 . . . . 72.24 109.678 -178.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 33.8 m 69.14 79.87 0.2 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 114.209 1.189 . . . . 61.41 114.209 175.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 18.9 p -92.31 -69.14 0.76 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.663 -1.236 . . . . 64.11 107.663 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 24.1 p -144.01 -52.39 0.33 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.765 -1.198 . . . . 70.45 107.765 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 33.4 t70 64.3 107.78 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.861 1.264 . . . . 62.54 111.664 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 . . . . . 0 C--N 1.301 -1.533 0 CA-C-O 118.636 -0.697 . . . . 55.32 110.106 -176.954 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.299 0 CA-C-O 121.099 0.476 . . . . 71.12 110.204 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.9 mm -106.95 135.85 44.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 109.042 -0.725 . . . . 73.31 109.042 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.85 99.74 49.04 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 110.172 -0.307 . . . . 72.02 110.172 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.99 101.8 1.55 Allowed 'Trans proline' 0 N--CA 1.442 -1.508 0 C-N-CA 122.103 1.868 . . . . 62.34 110.54 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 23.8 p -91.33 -42.37 10.4 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.536 -0.756 . . . . 55.54 109.667 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 63.0 mtm 61.05 22.62 12.87 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.047 0.939 . . . . 55.0 111.051 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -90.5 94.61 9.79 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.252 0.549 . . . . 73.52 109.772 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 99.0 m -145.87 132.19 19.56 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.77 -0.65 . . . . 40.1 110.951 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.2 p -106.56 153.51 22.23 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.227 -1.027 . . . . 73.43 108.227 175.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 -137.14 137.28 39.05 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.846 -0.742 . . . . 74.3 112.677 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' A' ' 12' ' ' LYS . 28.9 t 59.5 91.08 0.05 OUTLIER 'General case' 0 C--O 1.246 0.912 0 C-N-CA 125.306 1.442 . . . . 74.12 113.524 175.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 11' ' ' SER . 20.3 mtmm 171.59 126.2 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.092 0 C-N-CA 126.953 2.101 . . . . 65.2 110.305 175.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -120.4 23.43 10.88 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.926 -1.139 . . . . 72.13 107.926 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.3 p -68.79 97.71 0.85 Allowed 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 114.991 -1.004 . . . . 55.44 113.366 -176.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.413 ' HB2' ' HB ' ' A' ' 114' ' ' THR . . . -146.38 127.81 14.98 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.1 -0.955 . . . . 72.41 109.151 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.93 86.16 0.08 OUTLIER Glycine 0 C--N 1.3 -1.47 0 C-N-CA 120.486 -0.864 . . . . 54.13 111.4 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -119.42 27.45 8.78 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 120.695 0.283 . . . . 62.03 110.902 -177.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.585 ' CE1' ' HA ' ' B' ' 15' ' ' ALA . 47.1 t80 -106.5 115.22 29.84 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.499 0.666 . . . . 65.44 111.162 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.4 m -148.38 -84.84 0.1 Allowed 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 106.721 -1.585 . . . . 61.4 106.721 170.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 60.75 -77.88 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 125.0 1.32 . . . . 74.24 114.125 173.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.28 -124.65 7.68 Favored Glycine 0 N--CA 1.429 -1.826 0 N-CA-C 109.449 -1.46 . . . . 70.1 109.449 -175.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.58 ' HG2' ' CE2' ' B' ' 40' ' ' TYR . 52.1 Cg_exo -56.88 -41.66 72.94 Favored 'Trans proline' 0 CA--C 1.576 2.625 0 C-N-CA 123.407 2.738 . . . . 73.23 114.963 176.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 22' ' ' PRO . 7.4 Cg_endo -56.49 144.92 82.51 Favored 'Trans proline' 0 C--N 1.395 2.979 0 C-N-CA 121.473 1.449 . . . . 51.52 110.569 171.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -70.05 124.34 90.52 Favored Pre-proline 0 C--N 1.316 -0.887 0 C-N-CA 120.327 -0.549 . . . . 61.04 111.458 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -68.59 121.97 8.92 Favored 'Trans proline' 0 N--CA 1.435 -1.927 0 C-N-CA 122.243 1.962 . . . . 64.13 110.343 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.735 HD13 ' H ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -73.94 169.94 16.42 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.601 -0.727 . . . . 72.0 110.876 -179.482 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.7 t -63.27 143.84 57.46 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.462 0.648 . . . . 72.14 112.412 -170.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.17 -41.05 64.81 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 114.686 -1.143 . . . . 70.21 113.157 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.265 27.3 mt-10 -66.25 -37.79 86.35 Favored 'General case' 0 CA--C 1.494 -1.188 0 C-N-CA 118.683 -1.207 . . . . 75.25 112.52 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.48 ' O ' HG12 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -58.07 -37.78 75.12 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 123.597 0.561 . . . . 74.03 109.532 172.102 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -67.65 -42.46 82.2 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.487 -0.779 . . . . 64.23 111.76 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.73 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -71.21 -36.06 71.75 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 118.772 -1.171 . . . . 73.14 111.412 177.26 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -63.6 -40.8 97.85 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.728 0.299 . . . . 75.43 110.431 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 30' ' ' GLU . 13.2 pt -71.63 -35.97 57.88 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 CA-C-N 115.578 -0.737 . . . . 71.13 110.747 176.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -58.98 -42.61 90.38 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 120.831 0.348 . . . . 74.34 110.169 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.73 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 88.9 mttt -60.26 -26.8 66.73 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.889 0.876 . . . . 71.5 111.804 -176.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.459 ' HD3' ' O ' ' A' ' 86' ' ' ALA . 15.8 ptp180 -112.55 21.91 15.15 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.672 0.748 . . . . 74.3 109.93 -176.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 56.9 m -113.83 170.83 7.97 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.372 -0.831 . . . . 62.21 110.78 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.88 162.14 31.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.421 0.629 . . . . 74.11 111.567 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.557 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -96.33 125.58 40.93 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 105.996 -1.853 . . . . 44.13 105.996 169.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.44 ' N ' ' HD1' ' A' ' 40' ' ' TYR . 94.4 t -128.37 106.54 14.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 107.247 -1.39 . . . . 72.4 107.247 173.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -151.89 113.06 0.56 Allowed Glycine 0 N--CA 1.423 -2.216 0 C-N-CA 116.174 -2.917 . . . . 74.45 117.783 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.579 ' HB3' ' HA ' ' A' ' 107' ' ' ILE . 9.3 t30 176.18 23.85 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 103.346 -2.835 . . . . 73.43 103.346 161.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.435 ' CG2' ' HB2' ' A' ' 48' ' ' SER . 7.1 p -107.76 100.82 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-N 113.03 -1.895 . . . . 72.54 110.816 -173.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.408 ' HA ' ' HA3' ' A' ' 79' ' ' GLY . 7.9 m-20 -92.16 170.44 9.82 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.861 -1.063 . . . . 71.14 108.165 -175.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -28.08 -32.97 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 117.465 2.395 . . . . 52.14 117.465 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.94 -32.7 42.24 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.743 -0.265 . . . . 61.14 113.152 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.435 ' HB2' ' CG2' ' A' ' 44' ' ' VAL . 41.4 m -109.93 154.08 23.61 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 109.641 -0.503 . . . . 61.2 109.641 176.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 63.7 p -121.83 178.6 4.8 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 112.046 0.387 . . . . 64.12 112.046 -171.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.497 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -63.15 -44.27 95.97 Favored 'General case' 0 C--O 1.215 -0.76 0 C-N-CA 123.636 0.775 . . . . 71.53 111.636 -177.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -58.13 -38.36 76.38 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.871 0.367 . . . . 72.33 111.517 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -64.17 -32.69 74.35 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.525 0.678 . . . . 64.22 109.608 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 62.8 mt -69.87 -46.08 66.3 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 114.185 -1.37 . . . . 72.41 110.595 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -57.89 -50.12 74.4 Favored 'General case' 0 C--O 1.191 -1.988 0 C-N-CA 120.944 -0.302 . . . . 75.52 111.211 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.33 -48.3 79.33 Favored 'General case' 0 C--O 1.263 1.809 0 CA-C-O 121.653 0.74 . . . . 63.53 112.458 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -69.56 -40.78 76.59 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.775 -1.102 . . . . 73.23 111.119 -175.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -82.63 -22.66 34.62 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 114.592 1.33 . . . . 74.13 114.592 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.5 t -71.26 -23.53 62.0 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.655 -0.498 . . . . 74.44 109.655 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.0 t -57.98 -31.63 67.1 Favored 'General case' 0 CA--C 1.558 1.255 0 N-CA-C 108.944 -0.762 . . . . 64.32 108.944 172.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 60.7 m -90.51 -0.35 57.63 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 112.751 0.649 . . . . 70.3 112.751 -177.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.64 -169.86 29.15 Favored Glycine 0 C--O 1.229 -0.18 0 C-N-CA 119.505 -1.331 . . . . 53.12 114.436 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.0 m -95.68 123.21 39.14 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 121.15 0.5 . . . . 55.51 110.453 -177.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 72.7 mt -91.56 124.84 44.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.777 -0.647 . . . . 61.34 110.875 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.488 ' ND2' ' HA ' ' A' ' 86' ' ' ALA . 65.8 m-80 -91.47 -35.54 14.28 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-O 121.077 0.465 . . . . 74.33 111.835 177.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.481 ' HD2' ' OE2' ' A' ' 84' ' ' GLU 0.266 0.0 OUTLIER -157.21 152.97 26.86 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.708 -1.219 . . . . 73.2 107.708 -167.489 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.527 HG22 ' HA ' ' A' ' 83' ' ' ILE . 34.5 pt -148.21 143.86 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 CA-C-N 118.451 0.569 . . . . 73.22 109.908 174.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.3 m -126.26 123.87 39.08 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.747 -1.205 . . . . 72.44 107.747 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.598 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.2 mp -120.95 121.26 64.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 106.041 -1.837 . . . . 71.21 106.041 -176.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.41 ' N ' HD23 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -120.55 130.15 54.1 Favored 'General case' 0 C--N 1.275 -2.642 0 C-N-CA 120.199 -0.6 . . . . 75.43 112.032 179.067 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 69.1 m -112.07 111.79 22.96 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.998 -1.112 . . . . 63.12 107.998 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -102.16 120.22 40.09 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 108.408 -0.96 . . . . 65.33 108.408 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.545 ' HE2' ' HB3' ' A' ' 77' ' ' PRO . 38.9 ttmt -111.0 15.65 21.6 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.059 -0.719 . . . . 74.42 109.059 -178.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -67.75 -18.0 64.74 Favored 'General case' 0 C--N 1.35 0.607 0 CA-C-O 121.341 0.591 . . . . 70.54 111.187 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.8 m -78.29 -7.28 57.02 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.913 -0.585 . . . . 63.21 110.654 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.26 -51.05 1.28 Allowed Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 109.308 -1.517 . . . . 70.54 109.308 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -96.38 134.42 23.51 Favored Pre-proline 0 C--N 1.287 -2.111 0 N-CA-C 105.677 -1.972 . . . . 74.13 105.677 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.545 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 41.5 Cg_endo -66.3 118.05 5.2 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.274 1.316 . . . . 73.35 112.232 -175.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -100.66 141.53 33.4 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.368 -0.833 . . . . 74.42 108.865 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 44' ' ' VAL . . . -127.76 140.51 11.88 Favored Glycine 0 N--CA 1.41 -3.045 0 C-N-CA 119.738 -1.22 . . . . 51.12 112.73 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . 0.25 3.1 p90 -156.65 146.92 21.29 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 123.745 0.818 . . . . 74.03 110.07 175.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.598 ' HB2' HG23 ' A' ' 68' ' ' ILE . . . -139.48 155.06 47.8 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-O 121.489 0.661 . . . . 74.44 109.233 -172.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.603 ' CD2' ' HD3' ' A' ' 112' ' ' LYS . 84.8 m-85 -121.27 115.89 23.84 Favored 'General case' 0 C--N 1.263 -3.172 0 N-CA-C 108.231 -1.026 . . . . 63.13 108.231 175.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.527 ' HA ' HG22 ' A' ' 66' ' ' ILE . 35.9 mm -95.9 119.04 43.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.318 -1.364 . . . . 64.41 107.318 -176.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.481 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 31.7 mt-10 -101.95 117.94 35.87 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.527 -0.546 . . . . 64.3 109.527 -174.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -102.23 169.56 8.64 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 121.986 0.898 . . . . 75.5 113.326 -173.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.488 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . . . -74.41 -38.82 62.97 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.36 -1.291 . . . . 62.1 112.45 174.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -126.03 159.07 33.71 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.552 -0.859 . . . . 62.11 113.145 -175.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.453 ' O ' HG22 ' A' ' 91' ' ' VAL . 11.4 mmm180 -66.44 -31.32 72.0 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 114.487 -1.233 . . . . 75.12 108.687 173.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -57.66 -39.35 76.85 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 114.133 -1.394 . . . . 71.13 109.951 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.0 m -67.71 -38.38 83.54 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.978 -0.555 . . . . 73.54 111.148 -177.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 88' ' ' ARG . 3.2 m -68.22 -39.15 80.7 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.224 0 C-N-CA 119.733 -0.787 . . . . 75.21 108.978 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -58.43 -38.62 77.84 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.614 0.766 . . . . 73.13 110.202 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.47 -38.07 63.02 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.667 -0.697 . . . . 71.43 111.187 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.17 -45.24 57.64 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 116.243 -0.435 . . . . 60.25 111.706 -176.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 91' ' ' VAL . 25.8 m -57.32 -22.16 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.286 0.634 . . . . 74.1 112.669 177.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.41 -14.03 62.68 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.444 0.64 . . . . 72.24 110.256 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 60.1 mtm -100.38 11.49 39.3 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.718 -0.673 . . . . 53.24 110.231 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.452 ' HA ' ' HB ' ' A' ' 109' ' ' VAL . 6.4 p-10 -36.71 -49.54 0.78 Allowed 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 115.356 1.613 . . . . 62.21 115.356 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -107.25 25.5 11.33 Favored 'General case' 0 CA--C 1.556 1.186 0 CA-C-O 120.908 0.385 . . . . 74.11 111.627 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 67.7 p -84.0 172.41 12.06 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 119.417 -0.913 . . . . 71.11 111.571 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 106' ' ' THR . 8.3 p -102.95 135.91 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.912 0 N-CA-C 109.019 -0.734 . . . . 54.54 109.019 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -123.78 118.18 26.58 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.626 -0.509 . . . . 73.53 109.626 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 103' ' ' ARG . 43.4 mtp180 45.3 32.34 0.98 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.834 1.653 . . . . 64.54 113.568 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.27 -10.55 33.59 Favored Glycine 0 CA--C 1.522 0.49 0 CA-C-N 115.264 -0.88 . . . . 72.41 113.896 174.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.434 ' HD3' ' O ' ' A' ' 43' ' ' ASN . 3.8 ptp180 -124.25 132.53 53.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 117.059 0.429 . . . . 54.04 111.779 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 101' ' ' VAL . 87.6 m -71.35 121.56 18.75 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.101 -0.499 . . . . 75.33 110.478 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.579 ' HA ' ' HB3' ' A' ' 43' ' ' ASN . 33.2 pt -103.02 172.13 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 115.787 -0.642 . . . . 73.11 111.593 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.506 ' HE2' HD12 ' A' ' 110' ' ' LEU . 19.0 tptm -118.71 126.67 52.42 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.582 -0.896 . . . . 60.54 108.582 177.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 23.4 t -125.62 121.52 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 108.045 -1.095 . . . . 73.13 108.045 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.506 HD12 ' HE2' ' A' ' 108' ' ' LYS 0.253 0.0 OUTLIER -142.59 153.47 61.93 Favored Pre-proline 0 C--O 1.208 -1.125 0 N-CA-C 107.693 -1.225 . . . . 65.31 107.693 174.627 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.33 149.67 28.01 Favored 'Trans proline' 0 CA--C 1.507 -0.861 0 CA-C-N 120.721 1.293 . . . . 61.4 112.634 -175.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.603 ' HD3' ' CD2' ' A' ' 82' ' ' TYR . 47.3 mtmt -84.07 125.57 32.24 Favored 'General case' 0 N--CA 1.409 -2.519 0 N-CA-C 105.765 -1.939 . . . . 62.41 105.765 172.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -130.06 131.15 45.68 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 120.217 -0.593 . . . . 71.54 111.131 -170.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' A' ' 15' ' ' ALA . 9.9 t -141.32 -156.09 0.65 Allowed 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 107.279 -1.378 . . . . 71.41 107.279 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.618 ' O ' ' HE2' ' A' ' 36' ' ' LYS . 39.2 m-80 -43.37 156.26 0.05 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 126.224 1.81 . . . . 62.51 113.684 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.05 164.52 58.48 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.829 -0.623 . . . . 71.4 111.086 -177.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -66.79 123.72 11.39 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.866 1.711 . . . . 54.41 107.936 169.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 101.3 93.22 2.17 Favored Glycine 0 C--N 1.298 -1.547 0 N-CA-C 107.974 -2.05 . . . . 71.43 107.974 -171.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 66.2 mt 74.7 86.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 124.479 1.112 . . . . 75.3 108.142 -171.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 11.5 t -100.8 53.5 0.86 Allowed 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 114.85 -1.068 . . . . 72.12 108.374 -173.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.6 t 78.81 178.88 0.12 Allowed 'General case' 0 C--N 1.35 0.629 0 C-N-CA 125.219 1.407 . . . . 73.32 109.01 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.1 p -82.14 -65.98 0.95 Allowed 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.159 0.504 . . . . 60.14 109.761 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.0 t70 169.36 -60.13 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 126.664 1.986 . . . . 72.44 105.829 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.2 ptt85 . . . . . 0 C--N 1.297 -1.717 0 CA-C-N 113.837 -1.529 . . . . 72.01 110.148 177.758 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 109.651 -0.5 . . . . 73.14 109.651 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 51.1 mm -93.89 110.72 23.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 109.296 -0.631 . . . . 62.5 109.296 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.06 107.11 59.05 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 116.056 -0.52 . . . . 35.21 110.066 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.29 130.32 13.94 Favored 'Trans proline' 0 C--O 1.247 0.967 0 C-N-CA 122.399 2.066 . . . . 62.01 111.551 178.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 28.1 p -133.19 141.2 47.97 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.265 -0.643 . . . . 62.55 109.265 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 25.2 ptm -99.0 106.56 18.83 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.734 0.778 . . . . 42.31 110.489 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -91.28 111.34 22.78 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 115.681 -0.69 . . . . 74.33 110.685 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 35.4 p -104.33 -178.13 3.57 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 107.772 -1.196 . . . . 73.0 107.772 175.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 40.7 p -77.36 98.73 5.32 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 119.732 -0.787 . . . . 43.53 109.579 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -126.6 97.23 4.94 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-O 122.098 0.951 . . . . 73.31 110.875 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 40.5 t -157.49 110.59 2.49 Favored 'General case' 0 C--N 1.278 -2.5 0 N-CA-C 105.711 -1.959 . . . . 70.53 105.711 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -168.0 175.19 6.85 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.454 -0.339 . . . . 74.41 110.245 -172.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 86.5 mtp 66.99 102.45 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.651 1.181 . . . . 73.53 113.654 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 25.3 m -116.44 34.84 4.82 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 106.41 -1.7 . . . . 72.33 106.41 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.585 ' HA ' ' CE1' ' A' ' 18' ' ' TYR . . . -76.51 127.82 33.58 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.124 -1.398 . . . . 75.13 111.291 -176.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.63 11.71 30.16 Favored Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 120.555 -0.831 . . . . 41.34 111.754 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.96 83.64 5.22 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.409 0.623 . . . . 64.34 110.472 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -118.82 171.25 8.35 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.253 -0.885 . . . . 74.41 109.205 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 19.6 m -87.34 136.11 33.06 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 120.225 -0.59 . . . . 65.25 110.954 -176.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -131.28 -48.09 0.99 Allowed 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 104.671 -2.344 . . . . 63.52 104.671 173.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.461 ' HA3' ' HD3' ' B' ' 22' ' ' PRO . . . 72.4 -124.36 9.77 Favored Glycine 0 N--CA 1.422 -2.29 0 CA-C-N 114.63 -1.168 . . . . 42.54 114.329 172.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.53 ' HG2' ' CE2' ' A' ' 40' ' ' TYR . 43.4 Cg_exo -55.04 -49.6 16.01 Favored 'Trans proline' 0 CA--C 1.578 2.702 0 C-N-CA 123.896 3.064 . . . . 75.24 115.564 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -54.29 138.25 72.32 Favored 'Trans proline' 0 C--N 1.398 3.144 0 CA-C-N 121.302 1.501 . . . . 63.13 109.635 173.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -64.08 122.23 76.27 Favored Pre-proline 0 N--CA 1.434 -1.249 0 C-N-CA 120.572 -0.451 . . . . 72.32 111.589 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -67.89 125.9 13.81 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.938 2.425 . . . . 70.51 110.664 -175.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.71 HD13 ' H ' ' B' ' 26' ' ' LEU 0.348 0.0 OUTLIER -77.73 171.43 14.97 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.812 -0.755 . . . . 71.12 112.014 -179.66 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.587 ' HB2' ' OE1' ' B' ' 30' ' ' GLU . 68.4 m -70.23 145.5 51.34 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 115.033 1.494 . . . . 70.52 115.033 -171.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.71 -45.7 70.52 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 114.864 -1.062 . . . . 71.33 113.428 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' B' ' 33' ' ' GLU . 8.6 mm-40 -63.15 -41.96 99.36 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 122.078 -0.389 . . . . 61.4 110.635 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.587 ' OE1' ' HB2' ' B' ' 27' ' ' SER . 3.6 mp0 -56.26 -39.21 72.25 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 109.86 -0.422 . . . . 73.4 109.86 172.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.539 ' HE3' ' O ' ' B' ' 26' ' ' LEU . 98.7 mttt -69.39 -41.7 76.11 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.616 -0.72 . . . . 70.22 111.776 -177.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.687 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 0.4 OUTLIER -70.42 -35.61 73.51 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 118.977 -1.089 . . . . 72.14 111.349 176.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' B' ' 29' ' ' GLU . 17.6 mt-10 -68.31 -37.7 80.87 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 120.126 -0.63 . . . . 55.52 111.569 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 15.4 pt -70.78 -34.63 57.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 C-N-CA 120.545 -0.462 . . . . 63.43 110.368 176.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' B' ' 31' ' ' LYS . 0.9 OUTLIER -64.82 -37.09 86.44 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.732 -0.84 . . . . 70.23 108.732 -177.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.687 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 95.8 mttt -62.02 -28.82 69.85 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.932 -1.031 . . . . 74.4 110.679 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.504 ' HD2' ' O ' ' B' ' 86' ' ' ALA . 71.7 mtm180 -106.29 18.13 22.44 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.601 -0.727 . . . . 64.33 111.221 -176.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 44.3 m -110.23 170.56 8.0 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 116.237 -0.438 . . . . 71.12 110.544 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.442 ' HA ' ' H ' ' B' ' 112' ' ' LYS . 30.5 m -137.41 164.66 28.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.171 0.51 . . . . 72.34 111.47 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . 0.58 ' CE2' ' HG2' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -106.46 120.78 42.81 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 126.41 1.884 . . . . 72.41 106.273 175.608 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 100.0 t -124.79 106.68 16.95 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 N-CA-C 107.742 -1.207 . . . . 64.14 107.742 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.66 113.2 0.58 Allowed Glycine 0 N--CA 1.423 -2.228 0 C-N-CA 116.318 -2.849 . . . . 64.11 117.724 -175.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.635 ' HB3' ' HA ' ' B' ' 107' ' ' ILE . 9.2 t30 176.22 23.76 0.0 OUTLIER 'General case' 0 C--O 1.209 -1.042 0 N-CA-C 105.41 -2.07 . . . . 73.22 105.41 160.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.473 ' O ' ' HA3' ' B' ' 79' ' ' GLY . 5.7 p -103.53 96.18 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-N 113.746 -1.57 . . . . 64.14 108.903 -178.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' B' ' 77' ' ' PRO . 6.0 m-20 -106.98 102.67 12.01 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.558 -1.645 . . . . 70.52 106.558 -170.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 51.21 -177.96 0.02 OUTLIER 'General case' 0 C--O 1.248 1.018 0 N-CA-C 114.935 1.457 . . . . 55.53 114.935 -173.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.22 -59.55 4.97 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 111.176 -0.77 . . . . 62.44 111.176 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.2 m -88.83 155.28 19.64 Favored 'General case' 0 N--CA 1.421 -1.875 0 N-CA-C 109.358 -0.608 . . . . 73.04 109.358 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 44.6 p -119.64 178.91 4.39 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 120.713 -0.395 . . . . 75.11 111.391 -174.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.548 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -64.53 -40.68 96.05 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 123.21 0.604 . . . . 74.32 109.904 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -58.39 -41.21 84.38 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 116.167 -0.47 . . . . 63.25 111.989 174.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -59.9 -35.88 75.8 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.637 0.732 . . . . 72.35 109.656 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' B' ' 50' ' ' ALA . 86.6 mt -67.65 -45.68 74.62 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.838 -1.074 . . . . 74.32 111.354 178.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -58.17 -50.82 72.19 Favored 'General case' 0 C--O 1.189 -2.13 0 C-N-CA 120.751 -0.38 . . . . 72.42 111.856 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.8 -48.25 80.25 Favored 'General case' 0 C--O 1.257 1.463 0 CA-C-O 120.937 0.398 . . . . 71.33 111.537 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -68.82 -40.22 79.6 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.675 -0.693 . . . . 74.25 111.192 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -83.36 -22.68 32.75 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 114.976 1.472 . . . . 73.33 114.976 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 35.7 t -72.24 -26.63 62.09 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 110.06 -0.348 . . . . 53.25 110.06 -177.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 20.4 m -64.49 -27.18 68.8 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 119.498 -0.881 . . . . 34.32 109.428 174.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 57.3 m -95.58 9.21 40.99 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.681 -0.69 . . . . 64.24 112.04 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.92 -167.37 32.71 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 118.619 -1.753 . . . . 74.33 115.815 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 20.4 m -108.17 116.29 31.69 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.302 -0.629 . . . . 51.44 109.302 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 64.9 mt -91.11 123.4 43.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.063 0.458 . . . . 73.42 111.579 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -95.79 -34.43 11.89 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.596 -0.729 . . . . 71.02 111.944 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.526 ' HD2' ' OE1' ' B' ' 84' ' ' GLU 0.253 0.0 OUTLIER -157.87 153.41 26.29 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.593 -1.262 . . . . 70.22 107.593 -169.922 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.548 HD11 ' HB1' ' B' ' 50' ' ' ALA . 35.0 pt -148.33 144.0 18.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 109.115 -0.698 . . . . 70.13 109.115 174.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 36.3 m -125.45 124.41 41.35 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.58 -1.637 . . . . 72.24 106.58 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.617 HG23 ' HB2' ' B' ' 81' ' ' ALA . 1.1 mp -121.85 121.55 64.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 106.11 -1.811 . . . . 61.22 106.11 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.71 130.59 54.13 Favored 'General case' 0 C--N 1.277 -2.566 0 C-N-CA 120.337 -0.545 . . . . 72.12 112.27 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 85.5 m -112.52 111.86 23.0 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.243 -1.021 . . . . 50.4 108.243 178.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -101.18 116.39 32.72 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.211 -1.033 . . . . 51.01 108.211 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.422 ' HE3' ' HB3' ' B' ' 77' ' ' PRO . 46.7 mtpt -112.37 4.77 17.81 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.324 -0.551 . . . . 42.43 110.6 -177.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -80.49 -6.64 58.47 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 119.308 -0.957 . . . . 74.34 110.727 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 33.7 t -80.93 7.82 9.76 Favored 'General case' 0 CA--C 1.557 1.249 0 CA-C-N 114.89 -1.05 . . . . 70.04 108.716 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.57 -58.87 2.59 Favored Glycine 0 CA--C 1.492 -1.392 0 N-CA-C 110.371 -1.092 . . . . 72.23 110.371 178.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -97.11 137.38 21.24 Favored Pre-proline 0 C--N 1.284 -2.253 0 N-CA-C 108.687 -0.857 . . . . 74.24 108.687 175.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.422 ' HB3' ' HE3' ' B' ' 72' ' ' LYS . 15.7 Cg_endo -61.21 117.89 4.72 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.662 1.575 . . . . 63.51 111.54 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -108.7 140.66 41.78 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 108.67 -0.863 . . . . 64.32 108.67 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' B' ' 44' ' ' VAL . . . -128.37 138.16 10.18 Favored Glycine 0 N--CA 1.411 -3.025 0 C-N-CA 120.495 -0.86 . . . . 55.31 112.469 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -154.51 147.01 24.05 Favored 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 123.695 0.798 . . . . 73.35 109.74 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.617 ' HB2' HG23 ' B' ' 68' ' ' ILE . . . -138.57 152.83 48.51 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-N 115.969 -0.559 . . . . 64.41 110.78 -172.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' TYR . . . . . 0.462 ' CE2' ' HB2' ' B' ' 40' ' ' TYR . 59.8 m-85 -118.47 115.3 24.34 Favored 'General case' 0 C--N 1.266 -3.062 0 N-CA-C 108.515 -0.92 . . . . 74.44 108.515 175.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.535 ' HA ' HG22 ' B' ' 66' ' ' ILE . 37.7 mm -95.3 118.72 42.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.668 -1.604 . . . . 74.2 106.668 -176.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' GLU . . . . . 0.526 ' OE1' ' HD2' ' B' ' 65' ' ' ARG . 32.3 mt-10 -102.78 117.79 35.42 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.308 -0.627 . . . . 63.43 109.308 -174.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -103.88 168.62 9.01 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.738 0.78 . . . . 73.51 112.261 -174.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.504 ' O ' ' HD2' ' B' ' 37' ' ' ARG . . . -81.01 -34.56 32.83 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.635 -1.166 . . . . 70.44 111.793 174.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -112.75 149.94 32.27 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 113.186 0.81 . . . . 74.42 113.186 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.426 ' O ' HG22 ' B' ' 91' ' ' VAL . 10.5 mmm180 -67.71 -31.16 70.91 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 107.542 -1.281 . . . . 64.54 107.542 168.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -56.79 -41.45 77.74 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 113.838 -1.528 . . . . 75.03 109.713 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 18.2 m -65.69 -39.5 91.35 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 116.06 -0.518 . . . . 72.15 111.356 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.446 ' O ' HG13 ' B' ' 95' ' ' VAL . 3.1 m -67.91 -38.73 80.53 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.354 0 C-N-CA 119.493 -0.883 . . . . 71.42 108.803 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.71 -38.76 79.01 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.678 0.791 . . . . 71.2 110.296 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.37 -36.96 63.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.624 -0.716 . . . . 63.24 111.223 177.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.4 -45.1 48.92 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 116.285 -0.416 . . . . 63.31 111.447 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . 0.446 HG13 ' O ' ' B' ' 91' ' ' VAL . 25.6 m -58.56 -21.98 19.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 C-N-CA 123.778 0.831 . . . . 52.11 112.358 177.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.31 -14.49 62.96 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.106 0.479 . . . . 73.44 110.229 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 72.0 mtm -99.26 13.65 32.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.542 -0.754 . . . . 72.31 110.152 178.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -36.27 -56.28 0.77 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 114.294 1.22 . . . . 74.41 114.294 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -107.1 91.6 3.73 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.541 0.686 . . . . 74.23 110.224 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 33.4 p -135.13 169.19 17.82 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.959 -1.019 . . . . 74.53 111.64 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 11.7 p -102.58 138.76 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 N-CA-C 108.866 -0.79 . . . . 74.41 108.866 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' PHE . . . . . 0.483 ' O ' ' HG2' ' B' ' 105' ' ' ARG . 57.3 t80 -141.15 116.44 10.03 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 107.632 -1.248 . . . . 75.34 107.632 177.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' B' ' 103' ' ' ARG . 20.4 ttt180 56.31 33.62 22.6 Favored 'General case' 0 CA--C 1.559 1.324 0 CA-C-O 122.684 1.231 . . . . 71.41 111.039 -176.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.18 2.54 87.9 Favored Glycine 0 C--N 1.314 -0.666 0 CA-C-N 114.754 -1.112 . . . . 75.13 114.259 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' B' ' 102' ' ' PHE . 4.1 ptp180 -120.02 137.28 54.19 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.419 -0.586 . . . . 53.52 109.419 177.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 28.0 m -78.39 120.92 23.82 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.529 -0.545 . . . . 74.45 109.529 -176.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . 0.635 ' HA ' ' HB3' ' B' ' 43' ' ' ASN . 41.2 pt -102.3 167.22 2.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 120.403 -0.519 . . . . 74.33 111.618 -177.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -118.76 126.13 51.18 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.014 -0.994 . . . . 71.43 109.185 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 21.5 t -124.17 122.37 64.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 N-CA-C 107.969 -1.123 . . . . 73.0 107.969 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.553 HD13 ' HD2' ' B' ' 40' ' ' TYR 0.306 0.1 OUTLIER -146.76 144.03 19.63 Favored Pre-proline 0 C--N 1.284 -2.251 0 N-CA-C 105.729 -1.952 . . . . 75.21 105.729 -172.38 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.465 ' O ' HG23 ' B' ' 114' ' ' THR . 17.4 Cg_endo -66.0 136.19 43.75 Favored 'Trans proline' 0 C--N 1.357 1.019 0 CA-C-N 121.657 1.627 . . . . 71.41 111.832 -177.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.442 ' H ' ' HA ' ' B' ' 39' ' ' VAL . 86.3 tttt -55.67 -50.65 69.68 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.244 0.617 . . . . 62.55 111.21 -171.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -83.81 75.63 10.07 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.827 -0.624 . . . . 71.43 110.141 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.465 HG23 ' O ' ' B' ' 111' ' ' PRO . 1.1 p -95.98 90.0 5.41 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.891 0.853 . . . . 61.14 112.109 176.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -164.42 140.76 6.2 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.739 -1.578 . . . . 65.25 106.739 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 26.7 ttt -64.16 109.46 2.75 Favored Pre-proline 0 C--N 1.321 -0.643 0 O-C-N 123.935 0.772 . . . . 73.41 110.425 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -88.25 -175.14 1.27 Allowed 'Trans proline' 0 N--CA 1.442 -1.501 0 C-N-CA 122.275 1.983 . . . . 73.33 112.441 -177.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -98.43 91.58 1.14 Allowed Glycine 0 N--CA 1.429 -1.8 0 N-CA-C 110.067 -1.213 . . . . 64.24 110.067 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 13.1 tt -150.81 150.05 13.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.573 -0.899 . . . . 54.53 108.573 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 31.6 t -77.72 -54.87 5.85 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.812 -1.181 . . . . 72.12 107.812 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 31.5 t 66.8 166.46 0.22 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.308 1.043 . . . . 70.01 112.173 176.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 9.4 t -171.05 155.22 4.36 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.287 -1.005 . . . . 73.23 108.287 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -156.11 148.65 23.76 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 109.353 -0.61 . . . . 54.22 109.353 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? . . . . . 0 C--N 1.287 -2.117 0 N-CA-C 107.272 -1.381 . . . . 73.21 107.272 177.684 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.585 0 N-CA-C 109.643 -0.502 . . . . 43.03 109.643 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.3 mp -85.11 110.64 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 107.497 -1.297 . . . . 71.21 107.497 177.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . . . -115.0 123.25 32.14 Favored Pre-proline 0 N--CA 1.426 -1.652 0 CA-C-N 116.442 -0.344 . . . . 74.13 111.389 -176.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 3' ' ' ALA . 7.4 Cg_exo -75.03 141.41 26.52 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.476 2.117 . . . . 61.01 110.147 174.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 45.9 t -84.4 93.51 8.29 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.602 -0.888 . . . . 70.33 108.602 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 84.8 mtp -82.59 107.87 15.56 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.677 -0.692 . . . . 72.43 109.716 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -138.52 117.35 12.35 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.66 0.743 . . . . 72.33 111.359 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.9 t -163.1 144.81 9.91 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 106.197 -1.779 . . . . 75.2 106.197 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.418 ' HA ' ' OD2' ' B' ' 92' ' ' ASP . 57.5 m -68.8 91.62 0.46 Allowed 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 121.584 0.706 . . . . 61.14 111.238 -177.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -104.42 -5.32 21.78 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.599 0.714 . . . . 72.31 109.305 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.2 t -85.52 96.22 9.55 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 107.632 -1.247 . . . . 70.44 107.632 176.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -78.79 -75.26 0.24 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.728 -0.669 . . . . 72.33 111.001 -176.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 16.2 tpt -174.92 131.69 0.32 Allowed 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 106.646 -1.613 . . . . 63.34 106.646 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -161.92 175.23 12.08 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.029 0.442 . . . . 74.12 110.135 -177.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.07 -18.35 21.08 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.948 -1.13 . . . . 51.24 107.948 175.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.84 156.31 28.29 Favored Glycine 0 N--CA 1.42 -2.368 0 CA-C-N 114.627 -1.169 . . . . 52.43 111.401 -178.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.12 99.86 12.07 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.521 -0.918 . . . . 61.23 108.521 176.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -134.49 169.9 16.58 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 112.884 0.698 . . . . 74.52 112.884 -176.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 31.1 m 70.17 70.05 0.22 Allowed 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.445 -1.252 . . . . 53.11 109.96 -177.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.502 ' HB3' ' HG2' ' A' ' 23' ' ' PRO . 1.0 OUTLIER 72.98 -39.15 0.44 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 113.971 -1.468 . . . . 73.14 112.654 179.49 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.431 ' HA3' ' HD2' ' A' ' 22' ' ' PRO . . . 76.74 -109.95 2.91 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 119.275 -0.736 . . . . 63.42 113.039 177.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.431 ' HD2' ' HA3' ' A' ' 21' ' ' GLY . 1.7 Cg_endo -37.6 -53.78 1.36 Allowed 'Trans proline' 0 CA--C 1.561 1.846 1 C-N-CA 125.52 4.147 . . . . 43.02 117.11 179.404 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.502 ' HG2' ' HB3' ' A' ' 20' ' ' GLU . 37.7 Cg_endo -61.67 147.26 95.74 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 121.475 1.45 . . . . 72.32 111.281 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -68.35 142.17 94.31 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 109.24 -0.652 . . . . 62.45 109.24 -175.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.56 102.83 0.1 OUTLIER 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.913 2.408 . . . . 51.12 112.374 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.709 HD13 ' H ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -82.17 168.53 17.6 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 114.997 -1.001 . . . . 72.55 112.026 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.1 t -79.22 153.59 29.86 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-O 121.211 0.529 . . . . 71.35 110.839 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.89 -33.99 8.3 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.66 -1.154 . . . . 75.12 111.609 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -70.71 -36.29 73.17 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 113.078 0.77 . . . . 73.55 113.078 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.541 ' O ' HG12 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -59.5 -36.37 75.95 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 109.023 -0.732 . . . . 65.24 109.023 173.109 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.585 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 66.1 mttm -63.32 -42.63 99.0 Favored 'General case' 0 C--O 1.196 -1.721 0 O-C-N 123.823 0.702 . . . . 74.54 111.08 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.717 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -64.44 -44.62 90.59 Favored 'General case' 0 C--O 1.202 -1.403 0 C-N-CA 119.677 -0.809 . . . . 63.04 111.679 177.254 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.406 ' HA ' ' OE1' ' A' ' 33' ' ' GLU . 5.3 mm-40 -65.81 -42.83 90.17 Favored 'General case' 0 C--O 1.211 -0.934 0 C-N-CA 120.645 -0.422 . . . . 65.24 111.652 -174.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 30' ' ' GLU . 12.8 pt -70.33 -35.32 62.09 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.182 0 C-N-CA 120.981 -0.288 . . . . 65.33 110.945 178.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.585 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 7.0 t70 -73.06 -32.02 64.76 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.731 0.777 . . . . 73.25 109.717 -176.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.565 ' HA ' ' HG2' ' A' ' 113' ' ' ARG . 52.9 mtpt -71.51 -19.17 62.22 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 115.042 -0.981 . . . . 72.21 110.298 176.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -107.56 9.2 29.51 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.784 -0.644 . . . . 74.2 110.4 -177.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 69.2 m -95.36 149.81 20.95 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.587 0.708 . . . . 75.45 109.96 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 32.4 m -128.33 160.93 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 CA-C-N 115.028 -0.987 . . . . 75.43 109.779 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.605 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 18.5 t80 -105.63 121.07 43.23 Favored 'General case' 0 C--N 1.269 -2.898 0 C-N-CA 124.896 1.278 . . . . 74.51 108.072 176.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.6 t -113.9 108.92 26.73 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 107.809 -1.182 . . . . 61.15 107.809 176.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.31 165.36 12.76 Favored Glycine 0 C--N 1.296 -1.67 0 C-N-CA 119.596 -1.288 . . . . 63.14 113.711 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.6 t30 57.75 20.57 6.57 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.976 1.711 . . . . 61.12 113.374 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.3 p -62.41 133.26 28.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 CA-C-O 121.497 0.665 . . . . 61.33 109.301 174.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.448 ' HB3' ' HD2' ' A' ' 103' ' ' ARG . 15.0 t70 -80.73 153.93 27.56 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.235 -1.024 . . . . 75.52 108.235 -177.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -65.55 -17.08 64.3 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.386 0.612 . . . . 75.32 109.523 -174.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.54 -22.17 71.27 Favored Glycine 0 N--CA 1.439 -1.117 0 CA-C-N 115.905 -0.589 . . . . 64.43 112.944 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.5 m -92.29 145.0 24.83 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 119.296 -0.962 . . . . 72.31 111.483 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.2 p -124.28 179.83 4.74 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.831 -1.077 . . . . 72.54 109.197 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.88 -50.28 72.98 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 112.634 0.605 . . . . 73.42 112.634 -174.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -58.55 -43.03 89.18 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.452 0.538 . . . . 72.53 112.452 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.49 -44.36 97.22 Favored 'General case' 0 C--O 1.254 1.328 0 CA-C-O 121.762 0.791 . . . . 73.22 109.414 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 76.2 mt -68.31 -46.06 71.32 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-N 114.733 -1.121 . . . . 75.44 112.037 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -58.6 -47.89 82.81 Favored 'General case' 0 C--O 1.203 -1.366 0 N-CA-C 113.09 0.774 . . . . 61.13 113.09 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.7 -47.66 76.44 Favored 'General case' 0 C--O 1.276 2.496 0 CA-C-O 120.89 0.376 . . . . 43.33 110.779 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -64.29 -34.89 79.16 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 120.103 -0.639 . . . . 73.14 110.928 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -81.45 -21.63 38.67 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.812 1.042 . . . . 75.23 113.812 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.2 m -64.55 -26.62 68.5 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 121.067 0.46 . . . . 42.01 110.006 -178.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.0 m -57.7 -32.58 67.52 Favored 'General case' 0 CA--C 1.567 1.62 0 CA-C-N 116.065 -0.516 . . . . 61.03 110.455 172.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.1 m -91.21 4.5 52.12 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 113.599 0.963 . . . . 62.11 113.599 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.21 -164.97 27.52 Favored Glycine 0 CA--C 1.511 -0.191 0 C-N-CA 118.944 -1.598 . . . . 74.33 113.978 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.7 m -101.72 121.94 42.98 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.228 -0.286 . . . . 73.2 110.228 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.5 mt -78.97 127.98 38.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 121.715 0.769 . . . . 62.23 112.262 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -87.03 -47.12 9.19 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.371 -1.286 . . . . 51.11 108.766 177.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.536 ' HB2' ' OE1' ' A' ' 84' ' ' GLU . 50.1 mtm180 -155.39 165.02 37.91 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.168 -0.679 . . . . 74.04 109.168 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.423 HG13 HG12 ' A' ' 83' ' ' ILE . 1.1 tt -149.18 133.35 8.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 122.966 0.506 . . . . 75.22 111.557 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.0 m -125.65 131.77 52.57 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.674 -1.232 . . . . 71.31 107.674 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mp -128.66 124.16 60.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 107.335 -1.357 . . . . 75.4 107.335 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.437 ' HB3' HG23 ' B' ' 67' ' ' THR . 1.6 pt? -120.67 131.95 54.85 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.959 -0.696 . . . . 75.52 111.643 176.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 66.7 m -117.36 127.43 54.04 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 108.867 -0.79 . . . . 64.35 108.867 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.535 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 3.1 p30 -104.73 119.31 38.69 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 119.298 -0.961 . . . . 71.55 109.09 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -110.06 -4.11 16.04 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 120.072 -0.651 . . . . 71.15 112.084 -175.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.585 ' HB3' ' OD1' ' B' ' 64' ' ' ASN . 50.7 p90 -58.1 -20.29 38.86 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 119.447 -0.901 . . . . 54.43 111.188 176.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 28.5 t -79.22 -3.66 46.86 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.165 0.586 . . . . 61.45 111.42 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.0 -61.16 0.8 Allowed Glycine 0 CA--C 1.496 -1.126 0 N-CA-C 109.748 -1.341 . . . . 64.33 109.748 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -95.23 120.49 63.96 Favored Pre-proline 0 CA--C 1.484 -1.575 0 N-CA-C 106.689 -1.597 . . . . 70.53 106.689 173.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 65.6 Cg_endo -68.9 119.34 6.34 Favored 'Trans proline' 0 N--CA 1.442 -1.553 0 C-N-CA 121.841 1.694 . . . . 74.21 111.5 -176.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 32.6 mtmm -95.9 151.92 18.98 Favored 'General case' 0 CA--C 1.472 -2.021 0 N-CA-C 107.619 -1.252 . . . . 75.24 107.619 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.05 144.24 15.47 Favored Glycine 0 N--CA 1.405 -3.432 0 C-N-CA 118.743 -1.694 . . . . 12.12 113.492 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -152.14 146.32 25.4 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.479 -0.86 . . . . 60.35 109.018 172.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.11 154.08 50.91 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 120.691 0.282 . . . . 71.2 111.416 -171.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.45 ' OH ' ' HA3' ' B' ' 21' ' ' GLY . 92.6 m-85 -126.74 122.67 35.51 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.613 -0.884 . . . . 64.14 108.613 175.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.423 HG12 HG13 ' A' ' 66' ' ' ILE . 76.1 mt -122.71 134.17 66.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 116.139 -0.482 . . . . 70.12 110.886 -174.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.536 ' OE1' ' HB2' ' A' ' 65' ' ' ARG . 2.9 mp0 -102.02 134.48 45.18 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.921 -0.77 . . . . 63.14 108.921 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -102.44 160.26 14.71 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.841 -0.429 . . . . 71.2 109.841 173.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.87 -37.69 87.88 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.944 0.402 . . . . 73.2 111.395 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -110.58 149.77 29.91 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.144 -0.48 . . . . 70.23 111.403 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.42 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.9 OUTLIER -74.77 -30.02 61.32 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.242 -1.392 . . . . 70.34 107.242 178.716 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -67.46 -21.18 65.55 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.395 -0.82 . . . . 73.24 111.28 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.7 m -70.49 -35.22 73.12 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 109.451 -0.574 . . . . 72.54 109.451 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 88' ' ' ARG . 2.2 m -65.63 -37.99 81.28 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 N-CA-C 108.209 -1.034 . . . . 65.12 108.209 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -56.49 -38.58 71.94 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.923 -0.58 . . . . 73.41 110.435 177.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.85 -31.49 63.2 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.598 0.713 . . . . 62.1 111.347 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.39 -44.88 34.2 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.715 -0.675 . . . . 71.12 110.795 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.7 m -62.36 -21.65 27.47 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.772 0 C-N-CA 122.656 0.383 . . . . 72.33 111.991 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.91 -10.33 52.31 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.639 0.733 . . . . 44.34 110.047 174.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 35.4 mtm -102.73 11.23 37.92 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.586 -0.734 . . . . 73.55 110.302 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -46.52 -46.85 19.46 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.525 0.565 . . . . 63.11 112.525 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -95.44 93.28 7.12 Favored 'General case' 0 N--CA 1.437 -1.1 0 O-C-N 121.708 -0.62 . . . . 74.55 109.496 174.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 21.9 p -148.88 160.01 43.65 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 122.594 0.357 . . . . 72.15 110.817 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.2 p -107.78 126.01 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 109.03 -0.73 . . . . 75.03 109.03 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -133.49 119.58 19.74 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 108.441 -0.948 . . . . 75.11 108.441 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.448 ' HD2' ' HB3' ' A' ' 45' ' ' ASP . 48.6 ttm-85 55.26 54.27 8.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.957 0.884 . . . . 75.43 112.411 -177.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.24 -8.44 17.64 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 114.54 -1.209 . . . . 65.53 115.888 176.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -130.88 156.58 44.8 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 118.044 0.922 . . . . 72.15 110.997 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.4 m -84.3 125.25 32.09 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 120.985 0.421 . . . . 64.54 110.483 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 47.6 pt -101.76 172.07 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 116.079 -0.509 . . . . 70.12 110.011 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.42 134.43 47.11 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.191 -0.913 . . . . 74.54 109.874 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 28.0 t -124.74 126.0 70.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.992 -1.114 . . . . 53.21 107.992 177.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.487 ' HB2' ' HB3' ' A' ' 40' ' ' TYR . 97.0 mt -134.89 161.63 62.51 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 108.616 -0.883 . . . . 64.44 108.616 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.53 140.5 24.11 Favored 'Trans proline' 0 N--CA 1.44 -1.658 0 N-CA-C 107.977 -1.586 . . . . 60.05 107.977 171.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 64.7 tttm -69.02 -29.65 67.87 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 119.891 -0.723 . . . . 72.23 110.835 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.565 ' HG2' ' HA ' ' A' ' 36' ' ' LYS 0.32 0.0 OUTLIER -87.92 112.78 22.91 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 119.408 -0.917 . . . . 71.14 111.504 171.58 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.6 p -145.45 164.46 31.51 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.41 -0.814 . . . . 70.02 109.21 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -156.78 99.06 1.83 Allowed 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.741 -0.466 . . . . 71.52 109.741 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 28.1 ttt -114.73 103.46 54.82 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 109.428 -0.582 . . . . 64.41 109.428 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.83 124.34 10.56 Favored 'Trans proline' 0 C--O 1.242 0.712 0 C-N-CA 122.538 2.159 . . . . 63.52 111.562 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -92.05 -120.81 2.69 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.866 -0.894 . . . . 64.53 110.866 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.9 tt -154.3 103.97 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 121.588 0.709 . . . . 74.54 111.611 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.8 m -144.08 106.3 4.37 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.02 -0.733 . . . . 73.1 109.02 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 50.6 m -85.8 106.84 17.33 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 121.321 0.582 . . . . 74.31 110.45 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 57.7 m -151.3 94.77 2.07 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.555 -0.906 . . . . 70.23 108.555 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -149.45 153.18 36.89 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.941 -0.572 . . . . 71.02 109.743 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 . . . . . 0 C--N 1.296 -1.734 0 CA-C-N 115.437 -0.801 . . . . 75.43 110.162 -177.817 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.505 0 CA-C-O 121.539 0.685 . . . . 50.14 109.906 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 48.0 mm -96.22 136.47 26.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 115.226 -0.897 . . . . 74.32 109.291 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.61 129.24 24.6 Favored Pre-proline 0 C--N 1.308 -1.198 0 N-CA-C 109.547 -0.538 . . . . 62.31 109.547 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -74.64 96.18 0.98 Allowed 'Trans proline' 0 C--O 1.249 1.037 0 C-N-CA 122.105 1.87 . . . . 75.23 110.973 177.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 62.7 m -148.41 95.55 2.47 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.298 -1.001 . . . . 65.34 108.298 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.68 113.66 21.45 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.933 -0.576 . . . . 63.15 111.038 -176.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -136.61 78.28 1.69 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.385 1.088 . . . . 62.03 111.872 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 3.5 p -139.22 112.22 7.97 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 113.886 -1.507 . . . . 54.31 108.731 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 71.9 p 65.67 107.0 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.042 1.737 . . . . 70.1 110.987 -173.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -67.79 154.55 41.29 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 116.112 -0.494 . . . . 75.41 111.343 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 13.4 p -68.76 -43.43 75.83 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 116.166 -0.47 . . . . 34.14 110.571 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -89.3 132.22 35.02 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 107.885 -1.154 . . . . 75.24 107.885 175.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 18.0 ptm -159.55 139.74 11.92 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.57 -0.452 . . . . 63.4 111.903 -174.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 54.9 p -88.37 30.98 0.84 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.871 0.868 . . . . 73.44 110.749 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.34 147.3 21.6 Favored 'General case' 0 CA--C 1.504 -0.819 0 C-N-CA 124.592 1.157 . . . . 53.42 113.544 -176.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.406 ' O ' ' HG ' ' B' ' 26' ' ' LEU . . . 148.25 -169.16 28.94 Favored Glycine 0 N--CA 1.412 -2.959 0 CA-C-N 115.322 -0.853 . . . . 64.53 111.995 175.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.97 92.24 8.27 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.667 -0.864 . . . . 54.52 108.667 177.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.472 ' C ' ' H ' ' B' ' 20' ' ' GLU . 92.7 m-85 -134.97 -162.77 1.29 Allowed 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 115.062 -0.972 . . . . 75.33 109.615 -178.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.443 HG23 ' HA ' ' B' ' 25' ' ' PRO . 42.4 p 50.94 -23.19 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.701 0 N-CA-C 116.712 2.115 . . . . 72.53 116.712 -170.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . 0.472 ' H ' ' C ' ' B' ' 18' ' ' TYR . 39.5 mt-10 -74.45 82.63 1.96 Allowed 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 108.179 -1.045 . . . . 71.43 108.179 178.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.45 ' HA3' ' OH ' ' A' ' 82' ' ' TYR . . . 99.81 -150.6 19.08 Favored Glycine 0 C--N 1.33 0.237 0 CA-C-N 114.176 -1.375 . . . . 41.33 110.002 -175.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.569 ' N ' ' HD2' ' B' ' 23' ' ' PRO . 52.7 Cg_exo -54.36 -40.24 83.75 Favored 'Trans proline' 0 CA--C 1.586 3.092 0 C-N-CA 123.409 2.739 . . . . 73.23 115.855 177.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' B' ' 22' ' ' PRO . 16.8 Cg_exo -30.21 126.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.411 3.866 0 C-N-CA 124.822 3.681 . . . . 74.05 115.85 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' B' ' 18' ' ' TYR . 15.2 mm100 -61.3 140.84 94.48 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 124.157 0.983 . . . . 74.05 112.888 -177.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.443 ' HA ' HG23 ' B' ' 19' ' ' THR . 41.8 Cg_exo -40.94 149.54 0.17 Allowed 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 125.039 3.826 . . . . 62.22 117.595 -177.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.61 HD23 ' HB2' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -134.39 164.64 26.98 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 105.542 -2.022 . . . . 73.44 105.542 177.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.45 ' HB3' ' OE1' ' B' ' 30' ' ' GLU . 45.8 t -76.01 144.79 40.69 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 118.264 -1.375 . . . . 53.04 112.576 -172.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.43 -32.9 8.38 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.034 -1.439 . . . . 53.52 111.62 173.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -71.45 -35.04 70.77 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 112.982 0.734 . . . . 64.52 112.982 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.61 ' HB2' HD23 ' B' ' 26' ' ' LEU . 0.9 OUTLIER -59.17 -37.85 78.36 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 109.03 -0.73 . . . . 71.12 109.03 172.6 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' B' ' 35' ' ' ASP . 65.1 mttm -63.29 -42.22 99.06 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 115.403 -0.817 . . . . 74.43 111.232 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.647 ' N ' ' HE2' ' B' ' 32' ' ' LYS . 0.5 OUTLIER -64.54 -44.47 90.71 Favored 'General case' 0 C--O 1.204 -1.3 0 C-N-CA 119.817 -0.753 . . . . 72.32 111.553 176.228 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -65.07 -42.27 94.33 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.782 -0.367 . . . . 52.11 111.346 -175.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.503 HG12 ' O ' ' B' ' 30' ' ' GLU . 11.7 pt -70.96 -34.68 56.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 116.254 -0.43 . . . . 75.43 111.482 178.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.48 ' HB3' ' HB2' ' B' ' 113' ' ' ARG . 3.8 m-20 -68.03 -41.32 82.29 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.971 0.509 . . . . 74.31 111.786 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -68.44 -23.53 64.62 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.14 -0.936 . . . . 74.12 110.519 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -101.89 10.54 39.7 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.641 -0.708 . . . . 64.55 110.947 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' B' ' 84' ' ' GLU . 16.3 t -105.24 155.1 19.38 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-O 121.317 0.58 . . . . 74.23 110.622 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.458 HG22 ' O ' ' B' ' 83' ' ' ILE . 32.5 m -131.05 164.13 35.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.423 -0.808 . . . . 74.24 110.777 -176.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . 0.615 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 22.5 t80 -109.54 122.81 48.25 Favored 'General case' 0 C--N 1.281 -2.394 0 C-N-CA 125.712 1.605 . . . . 73.35 108.031 176.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 46.6 t -115.95 112.92 41.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 107.759 -1.2 . . . . 73.13 107.759 176.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.3 175.81 16.51 Favored Glycine 0 C--N 1.306 -1.102 0 C-N-CA 119.806 -1.188 . . . . 53.32 113.732 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 10.7 t30 62.68 1.75 0.84 Allowed 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 126.462 1.905 . . . . 64.21 115.001 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.01 105.64 16.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.042 -1.036 . . . . 72.54 110.561 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -114.92 130.67 56.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 118.694 -0.669 . . . . 73.41 109.526 -171.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' TYR . . . . . 0.74 ' CE1' ' HB2' ' B' ' 77' ' ' PRO 0.344 13.6 m-85 52.11 -52.76 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 121.213 3.783 . . . . 72.12 121.213 170.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.74 -36.32 89.37 Favored Glycine 0 C--N 1.312 -0.777 0 N-CA-C 114.25 0.46 . . . . 72.14 114.25 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -91.44 147.84 22.74 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.095 0.474 . . . . 71.23 109.977 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 66.6 p -119.31 178.56 4.49 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.703 -0.68 . . . . 73.01 109.518 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.32 -50.29 74.22 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.021 0.378 . . . . 51.44 112.021 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -58.53 -40.81 83.97 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 120.972 0.415 . . . . 71.11 111.122 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -63.06 -47.74 81.64 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-N 115.665 -0.698 . . . . 74.33 109.766 -178.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 81.3 mt -62.36 -46.21 89.7 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-N 115.384 -0.826 . . . . 75.43 112.248 177.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -58.38 -47.69 83.03 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 112.636 0.606 . . . . 74.54 112.636 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.74 -45.44 78.01 Favored 'General case' 0 C--O 1.264 1.818 0 CA-C-O 121.463 0.649 . . . . 73.12 112.595 -176.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -67.35 -35.7 79.9 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.499 -0.773 . . . . 73.21 110.455 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -81.11 -22.94 38.74 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.052 0.76 . . . . 74.03 113.052 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . 0.61 ' HA ' ' O ' ' B' ' 61' ' ' GLY . 68.6 m -67.09 -28.73 68.42 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 116.428 -0.351 . . . . 62.01 110.829 -177.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 16.0 m -59.33 -30.56 68.46 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.059 0.457 . . . . 72.12 110.845 175.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 71.4 m -106.73 -0.16 23.75 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 113.449 0.907 . . . . 74.32 113.449 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' B' ' 58' ' ' SER . . . 178.07 164.83 31.93 Favored Glycine 0 C--O 1.215 -1.075 0 C-N-CA 118.844 -1.646 . . . . 60.15 114.144 -177.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 40.1 m -98.92 120.92 40.17 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.829 -0.804 . . . . 34.45 108.829 177.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 84.7 mt -82.16 129.44 37.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 114.717 1.377 . . . . 52.43 114.717 -173.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . 0.585 ' OD1' ' HB3' ' A' ' 73' ' ' PHE . 31.1 t-20 -88.22 -46.21 9.43 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.598 1.559 . . . . 72.4 109.265 177.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.485 ' HG2' ' HA ' ' A' ' 71' ' ' ASP . 52.5 mtm180 -156.05 166.04 34.65 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.556 -0.535 . . . . 71.35 109.556 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.402 HG13 HG12 ' B' ' 83' ' ' ILE . 1.3 tt -149.76 134.51 9.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 115.869 -0.605 . . . . 74.31 111.478 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . 0.437 HG23 ' HB3' ' A' ' 69' ' ' LEU . 28.2 m -125.76 133.16 52.15 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.527 -1.286 . . . . 71.3 107.527 -178.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.426 HD12 ' N ' ' B' ' 68' ' ' ILE . 1.5 mp -130.25 125.04 59.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 107.052 -1.462 . . . . 71.13 107.052 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.255 1.3 pt? -121.11 132.21 54.73 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.169 -0.612 . . . . 75.45 111.657 175.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 86.1 m -117.3 126.71 53.17 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.326 -0.99 . . . . 51.1 108.326 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.611 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 3.1 p-10 -113.13 134.46 54.54 Favored 'General case' 0 CA--C 1.489 -1.394 0 C-N-CA 119.328 -0.949 . . . . 61.41 110.759 -177.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.499 ' HE2' ' HB3' ' B' ' 77' ' ' PRO . 35.8 ttmt -119.49 14.26 12.75 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 105.698 -1.964 . . . . 61.1 105.698 176.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -43.75 -37.93 2.95 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 127.418 2.287 . . . . 73.5 113.27 177.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 49.8 m -110.37 22.24 15.73 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 120.891 0.377 . . . . 75.12 111.865 -177.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.83 -51.96 1.31 Allowed Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.366 -0.921 . . . . 74.35 112.857 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -95.4 119.16 65.84 Favored Pre-proline 0 C--N 1.311 -1.083 0 C-N-CA 120.586 -0.446 . . . . 72.43 110.385 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.74 ' HB2' ' CE1' ' B' ' 46' ' ' TYR . 57.3 Cg_endo -70.18 118.64 5.8 Favored 'Trans proline' 0 C--N 1.32 -0.97 0 C-N-CA 122.727 2.285 . . . . 53.32 113.335 -175.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 32.4 mtmm -113.83 166.25 11.75 Favored 'General case' 0 C--O 1.211 -0.963 0 CA-C-N 115.616 -0.72 . . . . 70.14 109.426 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -138.89 146.98 18.87 Favored Glycine 0 N--CA 1.421 -2.319 0 C-N-CA 120.042 -1.075 . . . . 45.43 114.177 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -153.16 146.3 24.66 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.467 -0.867 . . . . 74.14 108.891 172.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.38 154.12 48.95 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 120.946 0.403 . . . . 55.55 111.46 -172.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -127.64 121.07 29.5 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.863 -0.792 . . . . 74.03 108.863 175.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.458 ' O ' HG22 ' B' ' 39' ' ' VAL . 71.2 mt -121.2 136.02 59.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 116.344 -0.389 . . . . 53.4 110.101 -174.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' B' ' 38' ' ' SER 0.387 1.3 pm0 -110.82 132.63 54.03 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.81 1.041 . . . . 65.21 113.81 174.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -97.99 162.02 13.44 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.473 -0.785 . . . . 73.14 111.755 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.69 -38.26 81.08 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.24 -0.891 . . . . 74.11 112.119 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . 0.493 ' CD ' ' H ' ' B' ' 88' ' ' ARG . 0.3 OUTLIER -120.67 156.42 31.77 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 120.045 -0.662 . . . . 73.23 111.122 178.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.493 ' H ' ' CD ' ' B' ' 87' ' ' GLU . 0.8 OUTLIER -75.22 -32.32 61.11 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 107.157 -1.423 . . . . 74.3 107.157 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -63.82 -22.77 67.07 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.527 -0.76 . . . . 61.02 110.857 176.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 16.0 m -71.07 -35.66 71.96 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 109.315 -0.624 . . . . 72.4 109.315 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.417 HG22 ' O ' ' B' ' 88' ' ' ARG . 2.1 m -66.53 -37.12 78.92 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.157 0 N-CA-C 108.601 -0.888 . . . . 65.23 108.601 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.418 ' OD2' ' HA ' ' A' ' 9' ' ' THR . 23.1 t70 -57.38 -38.46 74.27 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.353 0.597 . . . . 74.23 110.367 177.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.73 -33.0 64.15 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.458 -0.792 . . . . 73.42 110.043 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' B' ' 97' ' ' MET . . . -75.45 -43.67 48.31 Favored 'General case' 0 C--O 1.209 -1.049 0 CA-C-O 121.082 0.468 . . . . 63.42 110.562 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 24.7 m -63.24 -20.61 26.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 112.325 0.491 . . . . 74.14 112.325 176.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.95 -12.17 61.42 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 121.873 0.844 . . . . 53.13 109.882 174.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' MET . . . . . 0.494 ' HB2' ' O ' ' B' ' 94' ' ' ALA . 40.0 mtp -99.66 10.18 41.8 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.583 -1.19 . . . . 62.41 109.51 178.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . 0.684 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 6.9 p-10 -36.57 -45.41 0.51 Allowed 'General case' 0 C--O 1.206 -1.218 0 N-CA-C 115.564 1.691 . . . . 74.14 115.564 -176.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -124.52 49.41 1.82 Allowed 'General case' 0 C--O 1.241 0.614 0 CA-C-N 119.98 1.264 . . . . 75.35 112.258 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 31.7 p -81.54 177.26 9.04 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.761 -0.654 . . . . 72.14 112.363 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 8.7 p -108.06 136.37 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-O 121.156 0.503 . . . . 63.21 110.174 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -139.17 120.92 15.35 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.77 -1.567 . . . . 73.24 106.77 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 53.71 33.27 16.35 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.315 0.857 . . . . 61.22 113.315 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.59 1.49 87.57 Favored Glycine 0 C--N 1.314 -0.647 0 CA-C-N 115.828 -0.624 . . . . 62.44 113.7 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -120.81 157.19 30.29 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.073 -0.714 . . . . 71.44 109.073 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 52.1 m -91.61 120.3 32.27 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 109.166 -0.679 . . . . 72.4 109.166 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 pp -102.14 164.67 3.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 119.668 -0.813 . . . . 74.42 111.089 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . 0.684 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 16.4 tptm -125.69 125.13 42.55 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.985 -0.746 . . . . 63.44 108.985 -169.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.615 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 22.9 t -121.16 131.37 73.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 110.046 -0.353 . . . . 74.04 110.046 -175.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.44 ' HB2' ' HB3' ' B' ' 40' ' ' TYR . 96.9 mt -138.77 163.71 44.72 Favored Pre-proline 0 C--O 1.211 -0.924 0 C-N-CA 123.533 0.733 . . . . 65.04 109.34 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.31 142.38 26.87 Favored 'Trans proline' 0 CA--C 1.554 1.513 0 C-N-CA 122.506 2.137 . . . . 52.12 108.924 171.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.615 ' HG2' ' HD2' ' B' ' 113' ' ' ARG . 35.6 ttpt -85.27 -57.57 3.02 Favored 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 114.04 1.126 . . . . 74.15 114.04 -171.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.615 ' HD2' ' HG2' ' B' ' 112' ' ' LYS . 4.2 mpt_? -133.52 148.86 51.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.743 -1.223 . . . . 74.41 112.235 175.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 20.9 m -151.72 26.75 0.65 Allowed 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 107.212 -1.403 . . . . 71.32 107.212 174.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -149.99 173.76 13.47 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 107.172 -1.418 . . . . 54.12 107.172 -178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 65.1 mtt 74.02 103.64 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 125.397 1.479 . . . . 72.55 113.588 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' PRO . . . . . 0.471 ' HA ' ' HD3' ' B' ' 32' ' ' LYS . 63.7 Cg_endo -94.26 -172.29 0.28 Allowed 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 123.213 2.609 . . . . 73.54 112.234 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -153.04 167.53 31.74 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.883 -0.887 . . . . 62.24 110.883 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 12.8 tt -156.13 128.72 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.394 0.616 . . . . 65.0 112.046 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 35.7 t -136.25 94.35 3.02 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.304 -1.739 . . . . 52.54 106.304 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 23.2 t -94.43 -55.82 3.03 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.021 -0.536 . . . . 61.41 110.867 -174.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 48.8 m 64.29 95.35 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.621 0.769 . . . . 73.31 111.709 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -135.94 140.97 44.42 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 115.829 -0.623 . . . . 64.22 110.117 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 . . . . . 0 C--N 1.304 -1.391 0 N-CA-C 108.907 -0.775 . . . . 74.43 108.907 179.182 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.53 0 N-CA-C 109.659 -0.497 . . . . 54.3 109.659 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 27.9 pt -120.72 128.03 76.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.118 0.485 . . . . 74.42 110.366 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -102.27 121.44 50.21 Favored Pre-proline 0 C--N 1.286 -2.168 0 N-CA-C 108.053 -1.091 . . . . 73.53 108.053 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.02 120.24 7.94 Favored 'Trans proline' 0 C--O 1.245 0.846 0 C-N-CA 122.349 2.032 . . . . 60.25 110.767 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 63.3 m -101.96 116.8 33.47 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.742 -0.663 . . . . 61.43 110.362 -177.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -96.97 122.34 39.85 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.415 -0.587 . . . . 72.34 109.415 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -82.91 101.71 11.2 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.917 -0.713 . . . . 74.45 109.78 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.6 p -59.23 124.47 20.1 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.85 -1.068 . . . . 54.44 112.081 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -88.27 130.41 35.11 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-O 121.496 0.665 . . . . 71.21 109.602 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -131.65 92.64 3.19 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.461 -0.79 . . . . 63.22 110.719 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.1 t -78.57 146.83 34.0 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.606 -1.179 . . . . 60.24 110.323 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -85.8 97.36 10.13 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 109.177 -0.675 . . . . 72.11 109.177 177.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.4 ptm -72.46 109.22 6.0 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.615 -1.254 . . . . 72.3 107.615 174.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -81.51 137.6 35.57 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.838 -1.074 . . . . 73.2 113.43 -168.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.424 ' H ' ' HG3' ' B' ' 78' ' ' LYS . . . -85.65 91.63 8.34 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 114.863 -1.062 . . . . 55.1 108.198 171.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.46 75.44 2.0 Favored Glycine 0 CA--C 1.495 -1.194 0 N-CA-C 110.035 -1.226 . . . . 65.12 110.035 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -100.89 133.55 45.21 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 122.699 0.4 . . . . 73.34 111.235 -176.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.583 ' HB3' ' O ' ' A' ' 24' ' ' GLN . 90.7 m-85 -79.62 77.63 6.21 Favored 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 108.213 -1.032 . . . . 74.32 108.213 175.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.493 HG21 ' NH2' ' A' ' 65' ' ' ARG . 26.5 m -105.35 -71.89 0.73 Allowed 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 115.664 1.727 . . . . 52.14 115.664 -177.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -149.99 149.38 30.28 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.982 -1.118 . . . . 62.2 107.982 -167.351 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.63 -133.01 11.49 Favored Glycine 0 C--N 1.317 -0.523 0 N-CA-C 110.527 -1.029 . . . . 73.13 110.527 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -51.18 -50.37 14.12 Favored 'Trans proline' 0 CA--C 1.566 2.123 0 C-N-CA 122.465 2.11 . . . . 62.15 113.116 174.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.521 ' HG2' ' O ' ' A' ' 20' ' ' GLU . 3.9 Cg_endo -54.58 134.97 64.78 Favored 'Trans proline' 0 C--N 1.397 3.121 0 C-N-CA 121.697 1.598 . . . . 71.03 110.913 171.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.583 ' O ' ' HB3' ' A' ' 18' ' ' TYR . 16.2 mm100 -84.37 163.01 49.35 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-N 116.19 -0.459 . . . . 72.41 110.571 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.87 125.16 18.2 Favored 'Trans proline' 0 C--O 1.247 0.968 0 C-N-CA 122.681 2.254 . . . . 74.33 113.816 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.708 HD13 ' H ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.24 166.14 16.99 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.607 -1.178 . . . . 75.24 112.498 177.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.4 t -73.48 157.37 36.93 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 113.624 0.972 . . . . 74.55 113.624 -172.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.71 -45.7 74.07 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.338 -1.301 . . . . 74.22 112.39 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -58.67 -44.08 90.08 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.175 0.19 . . . . 72.43 110.686 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.467 ' O ' HG12 ' A' ' 34' ' ' ILE . 0.5 OUTLIER -59.33 -36.24 75.31 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 116.401 -0.363 . . . . 75.33 111.905 177.713 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -65.62 -51.79 56.93 Favored 'General case' 0 CA--C 1.5 -0.966 0 O-C-N 123.324 0.39 . . . . 63.55 110.056 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.557 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 47.7 mtmt -53.6 -34.87 59.94 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 113.925 1.083 . . . . 75.34 113.925 177.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -70.96 -49.18 48.28 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.262 0.468 . . . . 72.43 112.262 174.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 30' ' ' GLU . 16.0 pt -70.37 -36.1 65.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 112.926 0.714 . . . . 55.01 112.926 -175.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.95 -39.16 74.03 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-O 120.985 0.422 . . . . 73.01 111.422 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.557 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 99.0 mttt -57.35 -37.27 72.33 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 112.711 0.634 . . . . 73.23 112.711 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.566 ' HA ' HG11 ' A' ' 91' ' ' VAL . 4.9 ptp180 -114.44 14.74 17.91 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 114.492 1.293 . . . . 64.25 114.492 -165.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 62.7 p -104.21 158.19 16.61 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.219 1.192 . . . . 54.44 114.219 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.5 ' CG1' HG23 ' A' ' 91' ' ' VAL . 16.2 m -140.36 164.92 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 113.118 0.785 . . . . 64.55 113.118 -177.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.606 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 16.0 t80 -113.04 127.84 56.33 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 126.576 1.951 . . . . 75.23 108.448 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.28 114.41 43.8 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 N-CA-C 107.591 -1.263 . . . . 71.12 107.591 176.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.26 168.0 12.89 Favored Glycine 0 N--CA 1.425 -2.075 0 C-N-CA 119.729 -1.224 . . . . 72.41 113.909 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . 0.255 10.0 t30 60.63 67.07 0.86 Allowed 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 126.025 1.73 . . . . 72.35 114.988 -178.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 p -120.65 135.21 61.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 114.597 -1.183 . . . . 55.4 109.743 171.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -112.81 167.02 10.83 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.902 -1.518 . . . . 74.24 106.902 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -59.93 103.65 0.23 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 122.083 0.944 . . . . 75.14 113.029 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -179.51 -44.32 0.08 OUTLIER Glycine 0 N--CA 1.42 -2.428 0 N-CA-C 107.163 -2.375 . . . . 75.25 107.163 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 73.3 m -94.16 150.44 20.32 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.06 -0.57 . . . . 55.33 109.609 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.9 p -124.67 179.18 5.08 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.497 -0.774 . . . . 50.15 109.027 -178.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.669 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -61.25 -45.38 94.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.072 0.463 . . . . 61.24 109.837 -178.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -58.66 -39.18 79.89 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.61 -0.723 . . . . 72.03 111.431 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -67.48 -37.95 83.66 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-O 121.692 0.758 . . . . 64.11 109.09 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.4 mt -66.33 -46.22 77.6 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 114.569 -1.196 . . . . 63.52 111.454 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.426 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 35.3 mt-10 -58.38 -47.32 84.23 Favored 'General case' 0 C--O 1.187 -2.185 0 N-CA-C 113.002 0.741 . . . . 73.14 113.002 178.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.03 -47.42 74.77 Favored 'General case' 0 C--O 1.267 2.016 0 CA-C-O 121.006 0.431 . . . . 75.2 111.857 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -66.2 -39.17 89.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.987 -0.552 . . . . 65.41 110.666 -176.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -82.28 -22.63 35.64 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.883 1.068 . . . . 74.52 113.883 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.7 t -67.38 -30.89 70.79 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 123.377 0.671 . . . . 74.14 109.692 -176.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.0 m -62.06 -21.07 64.64 Favored 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 120.332 -0.547 . . . . 73.21 111.035 175.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 90' ' ' SER . 77.3 m -96.59 4.89 51.7 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 112.687 0.625 . . . . 71.34 112.687 178.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.28 -172.02 26.19 Favored Glycine 0 CA--C 1.503 -0.676 0 C-N-CA 119.215 -1.469 . . . . 53.23 114.325 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.2 m -94.67 118.54 31.87 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.273 0.559 . . . . 65.51 110.618 -177.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.426 ' CD1' ' HA ' ' A' ' 54' ' ' GLU . 51.2 mt -76.34 132.67 32.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.313 -0.858 . . . . 71.03 111.314 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -97.33 -46.47 6.08 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.948 -1.023 . . . . 73.42 110.172 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.493 ' NH2' HG21 ' A' ' 19' ' ' THR . 38.8 mtp180 -155.85 162.62 40.42 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.191 -1.411 . . . . 61.04 107.191 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.669 HD11 ' HB1' ' A' ' 50' ' ' ALA . 29.0 pt -147.93 144.24 19.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 108.775 -0.824 . . . . 74.33 108.775 173.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.4 m -125.44 130.24 51.44 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.426 -1.324 . . . . 72.35 107.426 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.441 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.8 mp -129.32 120.43 51.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 106.527 -1.657 . . . . 65.21 106.527 -178.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.286 1.3 pt? -122.09 134.24 54.77 Favored 'General case' 0 C--N 1.283 -2.324 0 C-N-CA 119.635 -0.826 . . . . 61.43 112.629 177.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 60.9 m -117.03 126.84 53.48 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.777 -0.823 . . . . 74.11 108.777 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -112.44 130.07 56.11 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 107.404 -1.332 . . . . 65.21 107.404 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -128.94 13.38 6.28 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 120.111 -0.636 . . . . 73.12 110.294 -176.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -63.08 -20.51 65.42 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.22 1.192 . . . . 64.52 114.22 -171.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 52.1 m -96.16 9.62 40.35 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.211 0.449 . . . . 74.42 112.211 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.42 -56.08 0.48 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.012 -1.089 . . . . 42.12 113.09 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 42.2 m-70 -95.11 133.35 26.34 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 108.834 -0.802 . . . . 61.31 108.834 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 76' ' ' HIS . 2.0 Cg_endo -76.82 117.57 4.54 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 C-N-CA 121.302 1.335 . . . . 51.02 110.503 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -100.28 140.51 34.43 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 108.253 -1.017 . . . . 52.05 108.253 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -129.63 147.85 18.1 Favored Glycine 0 N--CA 1.397 -3.904 0 C-N-CA 119.313 -1.423 . . . . 64.35 112.417 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -149.8 143.47 25.39 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 114.109 -1.046 . . . . 74.33 109.087 174.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.81 150.19 52.19 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 116.255 -0.43 . . . . 72.33 110.611 -171.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -120.87 117.53 27.6 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 109.141 -0.688 . . . . 72.24 109.141 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.454 HG23 HG22 ' A' ' 66' ' ' ILE . 34.3 mm -99.72 127.49 52.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.281 -1.377 . . . . 65.23 107.281 -178.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -113.15 124.25 52.12 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.762 -0.829 . . . . 72.34 108.762 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -98.24 165.67 11.76 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 111.602 0.223 . . . . 74.0 111.602 -177.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.05 -33.47 57.25 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.265 -0.425 . . . . 74.52 111.99 176.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -121.05 162.11 20.54 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 113.393 0.886 . . . . 54.43 113.393 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.408 ' HD3' ' HB3' ' A' ' 36' ' ' LYS . 16.5 mmm180 -66.39 -33.71 76.32 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 114.45 -1.25 . . . . 74.05 111.692 174.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -66.91 -29.28 69.11 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.61 -0.436 . . . . 71.12 111.47 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 60' ' ' CYS . 9.6 m -71.01 -42.08 70.04 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-O 120.723 0.296 . . . . 32.34 110.533 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.566 HG11 ' HA ' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -67.64 -39.49 82.31 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 N-CA-C 110.313 -0.254 . . . . 73.44 110.313 176.649 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -61.69 -37.21 83.27 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.354 0.597 . . . . 65.02 110.267 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.37 -31.29 62.33 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.804 -0.635 . . . . 73.34 110.829 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.88 -44.77 38.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.652 0.263 . . . . 54.05 111.161 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.404 HG11 ' HG3' ' A' ' 111' ' ' PRO . 32.5 m -57.74 -22.48 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 112.508 0.558 . . . . 73.52 112.508 177.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.2 -11.59 61.01 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 120.988 0.423 . . . . 75.43 110.05 176.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 64.9 mtm -102.75 10.78 38.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.224 -0.444 . . . . 75.41 110.293 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.619 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 4.7 p-10 -37.71 -48.71 1.09 Allowed 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.848 1.055 . . . . 73.45 113.848 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -114.72 99.92 7.87 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-O 121.975 0.893 . . . . 73.2 109.803 175.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 106' ' ' THR . 17.5 p -138.91 167.02 22.94 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.146 -1.388 . . . . 73.55 110.829 -178.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.0 p -113.85 105.55 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 CA-C-O 122.191 0.996 . . . . 62.0 109.494 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.568 ' O ' ' HG2' ' A' ' 105' ' ' ARG . 89.9 t80 -113.95 124.9 53.3 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.822 -1.081 . . . . 74.42 108.396 -176.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 20.6 ttt85 54.41 47.89 21.86 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 122.255 1.026 . . . . 73.55 110.131 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.57 8.0 55.14 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 113.769 -1.56 . . . . 73.1 115.146 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 102' ' ' PHE . 15.1 ptp180 -131.92 145.88 51.77 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 118.101 0.951 . . . . 55.11 111.135 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 100' ' ' THR . 27.8 m -77.76 120.18 22.31 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 120.903 0.382 . . . . 72.14 110.049 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 39.7 pt -102.55 171.25 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 109.596 -0.52 . . . . 73.35 109.596 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.619 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 42.0 tptt -134.73 130.8 36.8 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.894 -0.78 . . . . 71.14 108.894 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 17.7 t -121.13 127.81 75.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.043 -0.725 . . . . 73.3 109.043 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 89.7 mt -132.08 160.94 65.71 Favored Pre-proline 0 C--O 1.199 -1.605 0 N-CA-C 108.749 -0.834 . . . . 63.13 108.749 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.404 ' HG3' HG11 ' A' ' 95' ' ' VAL . 8.1 Cg_exo -77.65 140.74 19.03 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.031 1.821 . . . . 75.41 110.869 173.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -107.02 109.22 21.05 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 104.928 -2.249 . . . . 51.23 104.928 173.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.577 ' HD2' ' O ' ' A' ' 113' ' ' ARG . 5.7 ppt_? -161.87 137.45 7.55 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 113.946 1.091 . . . . 74.35 113.946 -170.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 39.1 m -91.79 84.17 5.37 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 122.249 1.023 . . . . 74.11 108.82 171.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.46 ' HB3' ' HD3' ' A' ' 113' ' ' ARG . 26.8 t-20 -125.58 142.96 51.23 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.16 -1.793 . . . . 71.42 106.16 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 47.3 ttm 71.06 135.82 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.809 0 O-C-N 124.544 1.153 . . . . 73.24 110.095 -176.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -58.41 106.4 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.001 1.801 . . . . 74.15 111.12 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.36 17.93 0.3 Allowed Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.872 -0.68 . . . . 71.5 112.311 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.407 HG13 ' HA ' ' B' ' 17' ' ' ALA . 12.3 tt -91.72 134.19 30.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 108.103 -1.073 . . . . 52.32 108.103 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.7 t -94.05 90.08 6.28 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.643 -0.823 . . . . 54.24 110.995 -177.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.2 m -160.91 -84.29 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.725 -0.67 . . . . 73.31 109.852 177.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.1 t 174.35 32.31 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 106.871 -1.529 . . . . 73.44 106.871 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.9 t70 75.07 142.64 0.07 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 114.489 -1.232 . . . . 64.14 111.816 -174.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 . . . . . 0 C--O 1.25 1.114 0 CA-C-O 121.977 0.894 . . . . 64.42 110.211 -177.428 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.585 0 N-CA-C 110.041 -0.355 . . . . 74.41 110.041 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 49.5 mm -85.49 119.32 33.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 109.115 -0.698 . . . . 72.34 109.115 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -117.19 94.63 45.47 Favored Pre-proline 0 C--N 1.309 -1.195 0 CA-C-N 116.621 -0.263 . . . . 52.44 110.56 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -85.65 142.49 8.07 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 122.192 1.928 . . . . 61.15 112.415 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 10.1 p -75.53 106.78 7.26 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.881 -0.6 . . . . 63.24 110.307 177.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 85.1 mtp -122.82 103.1 8.42 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.547 -0.752 . . . . 64.23 109.204 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 62.52 34.58 15.17 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.598 0.759 . . . . 63.31 110.574 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 61.6 m -69.84 102.71 2.01 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.305 -0.862 . . . . 64.04 110.473 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -95.64 147.94 23.06 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 115.711 -0.677 . . . . 63.21 109.186 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 65.2 t-80 -113.61 -29.34 7.18 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.516 -0.473 . . . . 55.04 110.384 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 31.5 t -97.57 144.09 27.61 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.215 -0.661 . . . . 73.13 109.215 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 65.51 78.47 0.27 Allowed 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.975 0.91 . . . . 74.34 111.766 -178.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 63.9 mtt -111.04 -159.68 0.69 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.444 -1.253 . . . . 75.13 107.968 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 24.8 p -57.29 -34.63 68.89 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 120.996 0.427 . . . . 73.02 110.253 175.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.45 102.38 6.84 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.697 -0.853 . . . . 54.21 108.697 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.9 -33.39 2.73 Favored Glycine 0 C--N 1.299 -1.497 0 N-CA-C 108.979 -1.648 . . . . 60.41 108.979 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.407 ' HA ' HG13 ' A' ' 119' ' ' ILE . . . -85.23 -47.31 10.21 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.874 -1.158 . . . . 74.34 107.874 173.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -132.18 151.61 51.71 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.792 -1.095 . . . . 75.11 110.695 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 9.8 t -152.27 -168.83 3.18 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 105.839 -1.912 . . . . 71.32 105.839 176.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -74.64 -49.86 19.87 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.029 -1.1 . . . . 72.11 108.029 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 160.0 -113.01 0.55 Allowed Glycine 0 CA--C 1.495 -1.159 0 N-CA-C 107.872 -2.091 . . . . 71.24 107.872 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -53.95 -40.29 81.49 Favored 'Trans proline' 0 CA--C 1.574 2.501 0 C-N-CA 122.744 2.296 . . . . 72.35 113.887 172.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.69 136.12 60.55 Favored 'Trans proline' 0 C--N 1.394 2.964 0 C-N-CA 121.301 1.334 . . . . 72.11 111.379 173.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -66.54 141.11 96.86 Favored Pre-proline 0 C--N 1.31 -1.14 0 CA-C-N 115.289 -0.868 . . . . 74.24 110.892 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -59.06 116.45 3.27 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 122.7 2.267 . . . . 63.3 111.112 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.661 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -67.14 160.75 26.15 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.751 -1.113 . . . . 51.21 112.068 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.524 ' HB3' ' OE1' ' B' ' 30' ' ' GLU . 29.6 t -82.04 164.68 21.25 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.507 0.67 . . . . 74.1 112.332 -173.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.4 -38.68 63.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.5 -1.227 . . . . 52.53 112.617 -178.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -69.47 -36.38 76.51 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 120.706 -0.398 . . . . 72.24 111.551 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.524 ' OE1' ' HB3' ' B' ' 27' ' ' SER . 3.6 mp0 -62.37 -35.23 78.51 Favored 'General case' 0 CA--C 1.503 -0.832 0 O-C-N 123.481 0.488 . . . . 73.34 110.645 175.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -66.03 -51.35 59.04 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 123.302 0.377 . . . . 75.24 110.466 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.485 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 47.9 mtmt -53.93 -35.52 61.78 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 114.141 1.163 . . . . 53.44 114.141 176.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.538 ' O ' ' HD3' ' B' ' 37' ' ' ARG . 24.5 mm-40 -70.25 -47.55 60.84 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.198 0.444 . . . . 74.34 112.198 174.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.53 HD12 ' HA ' ' B' ' 115' ' ' ASN . 10.3 pt -70.92 -35.7 60.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 112.934 0.716 . . . . 71.42 112.934 -176.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.32 -35.49 65.2 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.229 0.537 . . . . 72.4 111.21 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 97.9 mttt -63.3 -35.07 79.14 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.126 -0.943 . . . . 74.01 112.685 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.538 ' HD3' ' O ' ' B' ' 33' ' ' GLU . 11.3 mtp180 -111.3 5.41 19.81 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 114.727 1.38 . . . . 73.14 114.727 -164.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.583 ' HB2' ' O ' ' B' ' 112' ' ' LYS . 15.5 m -96.97 154.98 16.98 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 112.906 0.706 . . . . 75.1 112.906 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.5 ' CG1' HG23 ' B' ' 91' ' ' VAL . 11.4 m -139.54 164.99 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.609 1.163 . . . . 41.43 112.522 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . 0.65 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 18.4 t80 -113.51 126.88 55.8 Favored 'General case' 0 CA--C 1.489 -1.372 0 C-N-CA 126.624 1.97 . . . . 73.42 108.592 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 66.2 t -121.03 114.25 42.72 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 N-CA-C 108.303 -0.999 . . . . 62.23 108.303 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.27 174.05 15.28 Favored Glycine 0 N--CA 1.421 -2.311 0 C-N-CA 119.514 -1.327 . . . . 54.33 113.176 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.5 t30 64.65 21.28 12.38 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.95 1.7 . . . . 63.54 112.877 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 8.7 p -69.81 123.68 24.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.092 -0.707 . . . . 74.32 109.092 173.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -82.39 159.71 22.95 Favored 'General case' 0 C--O 1.253 1.281 0 CA-C-N 115.48 -0.782 . . . . 75.0 109.675 -174.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -76.24 91.07 3.17 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-O 121.743 0.782 . . . . 74.03 108.945 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 168.2 -18.92 0.08 OUTLIER Glycine 0 N--CA 1.41 -3.048 0 CA-C-N 114.694 -1.139 . . . . 53.31 110.543 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -84.19 143.3 29.71 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 107.799 -1.185 . . . . 74.3 107.799 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 77.8 p -99.89 170.19 8.7 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 110.296 -0.261 . . . . 72.24 110.296 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.677 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -67.05 -39.85 87.01 Favored 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 108.87 -0.789 . . . . 73.04 108.87 175.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -57.43 -44.55 84.75 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.553 -1.203 . . . . 72.12 110.961 174.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.05 -47.89 77.05 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.384 0.611 . . . . 64.44 110.86 174.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 41.2 mt -58.76 -47.04 86.05 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 114.493 -1.23 . . . . 63.42 112.52 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.45 ' HA ' ' CD1' ' B' ' 63' ' ' ILE . 93.9 mt-10 -58.85 -47.87 83.37 Favored 'General case' 0 C--O 1.183 -2.431 0 N-CA-C 112.57 0.582 . . . . 72.11 112.57 177.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.13 -47.73 74.63 Favored 'General case' 0 C--O 1.27 2.142 0 N-CA-C 112.334 0.494 . . . . 60.4 112.334 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -67.16 -38.39 85.4 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.02 -0.536 . . . . 61.32 110.598 -176.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -82.61 -22.0 34.93 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.686 0.995 . . . . 71.33 113.686 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 37.8 t -64.55 -32.22 73.78 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 123.693 0.797 . . . . 75.2 109.454 -178.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.8 m -59.6 -24.34 63.71 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-N 116.271 -0.422 . . . . 71.15 110.978 174.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' B' ' 90' ' ' SER . 68.8 m -88.1 -4.0 58.82 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.435 0.531 . . . . 74.33 112.435 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.94 -159.67 26.57 Favored Glycine 0 C--N 1.318 -0.425 0 C-N-CA 119.394 -1.384 . . . . 61.52 114.08 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 50.7 m -94.6 119.09 32.71 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 121.091 0.472 . . . . 73.12 112.102 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.45 ' CD1' ' HA ' ' B' ' 54' ' ' GLU . 68.0 mt -78.67 128.24 38.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.692 -0.686 . . . . 70.15 111.625 177.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . 0.489 ' OD1' ' HG3' ' B' ' 65' ' ' ARG . 19.0 t-20 -90.66 -50.23 6.03 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.797 -1.092 . . . . 71.23 108.529 -177.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.489 ' HG3' ' OD1' ' B' ' 64' ' ' ASN . 41.2 mtp180 -155.31 164.79 38.28 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 107.41 -1.33 . . . . 75.02 107.41 -177.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.677 HD11 ' HB1' ' B' ' 50' ' ' ALA . 28.9 pt -148.34 144.29 18.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.407 -0.96 . . . . 74.15 108.407 173.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 61.5 m -125.65 130.58 51.9 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 107.055 -1.461 . . . . 73.04 107.055 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.415 HD12 ' N ' ' B' ' 68' ' ' ILE . 1.9 mp -129.32 119.9 49.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 106.657 -1.609 . . . . 70.33 106.657 -178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.479 HD12 HH22 ' A' ' 65' ' ' ARG 0.264 1.5 pt? -121.77 134.14 54.92 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 119.701 -0.799 . . . . 74.01 112.272 177.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 61.9 m -117.11 125.72 51.7 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.52 -0.918 . . . . 63.15 108.52 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.532 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 10.3 t70 -105.74 127.18 52.93 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.624 -1.25 . . . . 72.23 107.624 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' B' ' 77' ' ' PRO . 40.2 ttmt -127.01 17.56 7.24 Favored 'General case' 0 N--CA 1.423 -1.799 0 C-N-CA 120.719 -0.393 . . . . 73.13 110.138 -177.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . 0.255 1.4 p90 -70.25 -16.25 63.01 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 118.367 -1.333 . . . . 65.12 112.672 -177.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 46.0 m -94.42 17.89 12.21 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.203 -0.453 . . . . 71.32 110.393 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.42 -63.76 1.95 Allowed Glycine 0 CA--C 1.492 -1.354 0 C-N-CA 120.75 -0.738 . . . . 51.51 111.569 176.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . 0.255 89.6 m-70 -96.4 125.07 48.91 Favored Pre-proline 0 C--N 1.291 -1.975 0 C-N-CA 120.414 -0.514 . . . . 63.35 110.852 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 98.6 Cg_endo -73.6 135.72 22.39 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.944 2.429 . . . . 54.35 115.051 -171.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' LYS . . . . . 0.424 ' HG3' ' H ' ' A' ' 15' ' ' ALA . 12.8 mmmm -112.12 146.13 38.56 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 124.883 1.273 . . . . 73.34 107.842 176.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.8 148.03 17.86 Favored Glycine 0 N--CA 1.412 -2.961 0 C-N-CA 119.142 -1.504 . . . . 73.32 112.968 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . 0.437 ' OH ' ' HB ' ' A' ' 19' ' ' THR . 31.0 p90 -151.48 143.37 23.82 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 114.362 -0.919 . . . . 74.5 109.736 172.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.13 151.61 51.69 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 116.169 -0.468 . . . . 61.5 110.657 -172.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' TYR . . . . . 0.735 ' CD1' ' HE2' ' B' ' 112' ' ' LYS . 89.9 m-85 -122.32 116.52 24.21 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 109.253 -0.647 . . . . 63.25 109.253 177.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.491 HG23 HG22 ' B' ' 66' ' ' ILE . 34.3 mm -98.86 127.21 51.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 107.31 -1.367 . . . . 63.3 107.31 -178.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' B' ' 38' ' ' SER . 29.3 mt-10 -112.36 125.62 54.4 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 108.836 -0.801 . . . . 72.53 108.836 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -100.07 162.38 13.01 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.432 0.634 . . . . 64.1 112.245 -177.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.45 -29.77 53.0 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.328 -0.851 . . . . 71.32 111.387 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -122.67 150.0 43.28 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 112.9 0.704 . . . . 54.15 112.9 -175.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.469 ' HD3' ' HB3' ' B' ' 36' ' ' LYS . 14.4 mmm180 -63.08 -34.89 78.56 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.116 0.566 . . . . 75.54 110.676 175.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -62.73 -32.15 73.22 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.577 -0.738 . . . . 71.35 110.913 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' B' ' 60' ' ' CYS . 15.1 m -71.15 -41.4 70.47 Favored 'General case' 0 N--CA 1.433 -1.313 0 O-C-N 122.335 -0.228 . . . . 75.55 110.949 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.5 HG23 ' CG1' ' B' ' 39' ' ' VAL . 0.2 OUTLIER -68.05 -38.98 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 C-N-CA 120.727 -0.389 . . . . 74.02 111.016 176.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -63.01 -36.68 84.36 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.476 0.655 . . . . 72.11 109.579 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.49 -31.03 63.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.797 -0.638 . . . . 71.24 111.789 178.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.05 -44.95 36.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.584 -0.734 . . . . 73.33 110.763 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 33.1 m -58.75 -22.29 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 112.334 0.494 . . . . 75.4 112.334 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.91 -14.91 63.28 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 121.51 0.671 . . . . 53.31 111.331 176.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 65.6 mtm -100.54 12.74 36.66 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.334 -0.848 . . . . 73.23 109.951 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . 0.694 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 3.0 p-10 -35.6 -51.98 0.66 Allowed 'General case' 0 C--O 1.178 -2.659 0 N-CA-C 115.51 1.67 . . . . 61.43 115.51 -174.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' B' ' 107' ' ' ILE . 19.0 tt0 -129.36 40.52 3.59 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 117.794 -1.562 . . . . 55.1 110.323 -178.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 47.6 p -75.63 -173.54 2.21 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.573 -1.194 . . . . 63.44 111.445 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.58 136.14 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 O-C-N 122.098 -0.376 . . . . 73.5 110.4 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -138.23 128.5 25.99 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 122.992 0.517 . . . . 64.44 109.924 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 50.17 32.45 6.02 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 124.998 1.319 . . . . 64.23 112.689 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.11 2.74 60.65 Favored Glycine 0 C--N 1.315 -0.617 0 CA-C-N 114.771 -1.104 . . . . 60.22 114.756 173.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -134.16 158.64 43.14 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 118.002 0.901 . . . . 72.34 111.169 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 68.4 m -85.47 119.85 26.27 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.338 -0.616 . . . . 54.34 109.338 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' B' ' 99' ' ' GLU . 42.1 pt -102.86 172.2 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 109.648 -0.501 . . . . 73.1 109.648 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . 0.694 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 0.1 OUTLIER -131.18 132.06 44.46 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.618 -1.253 . . . . 65.11 107.618 -179.654 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 21.2 t -121.67 130.82 74.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 108.099 -1.074 . . . . 74.14 108.099 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 90.1 mt -136.49 162.68 54.82 Favored Pre-proline 0 C--O 1.19 -2.046 0 N-CA-C 108.871 -0.789 . . . . 70.22 108.871 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -73.77 147.53 39.86 Favored 'Trans proline' 0 CA--C 1.564 1.98 0 C-N-CA 122.733 2.289 . . . . 70.32 110.564 173.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.735 ' HE2' ' CD1' ' B' ' 82' ' ' TYR . 0.0 OUTLIER -157.61 -173.21 4.28 Favored 'General case' 0 CA--C 1.56 1.331 0 N-CA-C 109.633 -0.506 . . . . 70.31 109.633 -172.372 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.574 ' H ' ' HD2' ' B' ' 112' ' ' LYS . 0.3 OUTLIER -153.24 127.96 9.46 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.541 0.736 . . . . 64.0 110.653 175.575 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 47.8 m -111.04 -83.28 0.57 Allowed 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 118.532 -1.267 . . . . 73.12 111.361 176.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' ASN . . . . . 0.53 ' HA ' HD12 ' B' ' 34' ' ' ILE . 34.0 m-20 179.68 -164.84 0.06 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.704 1.202 . . . . 71.43 110.456 -176.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' MET . . . . . 0.495 ' HG2' ' HG ' ' B' ' 26' ' ' LEU . 23.1 ptm -153.44 157.26 32.81 Favored Pre-proline 0 N--CA 1.441 -0.891 0 N-CA-C 106.099 -1.815 . . . . 71.22 106.099 174.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -92.77 -162.62 0.1 Allowed 'Trans proline' 0 N--CA 1.439 -1.689 0 C-N-CA 122.178 1.919 . . . . 54.12 114.099 -173.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -162.4 -164.87 18.35 Favored Glycine 0 N--CA 1.423 -2.227 0 N-CA-C 107.515 -2.234 . . . . 74.31 107.515 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 11.1 tt -64.1 107.56 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.87 0 CA-C-O 122.168 0.985 . . . . 60.51 112.363 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 36.1 p -93.27 118.53 31.38 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.694 -1.139 . . . . 63.33 108.493 176.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 5.4 p -69.76 106.44 3.11 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 113.231 0.826 . . . . 74.1 113.231 -177.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 9.7 t -142.46 28.14 1.67 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 106.276 -1.75 . . . . 53.22 106.276 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -69.45 156.36 38.98 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 113.647 -1.615 . . . . 74.11 111.531 -176.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 . . . . . 0 C--N 1.304 -1.371 0 N-CA-C 108.268 -1.012 . . . . 73.33 108.268 179.409 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.835 0 N-CA-C 109.286 -0.635 . . . . 65.42 109.286 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.465 ' O ' HD12 ' A' ' 2' ' ' ILE . 2.3 pp -120.05 129.33 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 112.919 0.711 . . . . 64.13 112.919 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.71 92.23 31.4 Favored Pre-proline 0 C--N 1.302 -1.478 0 CA-C-N 115.476 -0.784 . . . . 53.42 109.64 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.85 113.82 3.51 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.671 2.247 . . . . 62.53 110.953 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.6 p -90.72 103.09 15.83 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 110.275 -0.269 . . . . 54.23 110.275 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.2 ttt -168.79 144.64 3.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.001 0.429 . . . . 72.35 110.779 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -144.9 152.31 40.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.754 -1.572 . . . . 70.31 106.754 176.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.491 ' HA ' ' OE1' ' A' ' 99' ' ' GLU . 15.1 t -146.71 142.85 28.26 Favored 'General case' 0 N--CA 1.422 -1.841 0 C-N-CA 118.399 -1.321 . . . . 70.22 113.858 -177.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.1 p -140.49 -176.62 4.7 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 126.799 2.04 . . . . 62.2 106.642 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -149.26 112.64 4.98 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 118.479 0.581 . . . . 74.12 110.875 175.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.6 p -89.57 -89.93 0.15 Allowed 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 116.0 -0.545 . . . . 71.45 112.201 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -164.16 155.14 15.57 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.771 -0.455 . . . . 70.4 109.771 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -132.8 95.14 3.52 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.956 -0.757 . . . . 60.12 108.956 177.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.2 m -154.38 140.43 18.36 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.327 -0.397 . . . . 73.23 112.053 -173.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 72.4 -175.57 0.17 Allowed 'General case' 0 C--O 1.262 1.736 0 N-CA-C 115.798 1.777 . . . . 34.32 115.798 167.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.62 115.62 3.11 Favored Glycine 0 N--CA 1.422 -2.252 0 CA-C-N 113.883 -1.508 . . . . 62.12 111.753 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' B' ' 19' ' ' THR . . . -87.81 -174.71 4.86 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.013 -0.736 . . . . 73.4 109.013 175.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.445 ' HE2' ' NH1' ' A' ' 65' ' ' ARG . 69.7 t80 -148.89 126.69 11.82 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 120.643 -0.423 . . . . 74.33 110.74 -175.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.6 m -102.82 154.42 19.21 Favored 'General case' 0 CA--C 1.56 1.356 0 CA-C-N 115.99 -0.55 . . . . 70.11 110.087 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -130.69 -72.27 0.57 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 120.85 0.357 . . . . 74.41 110.041 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.514 ' HA3' ' OH ' ' B' ' 82' ' ' TYR . . . 118.62 -141.69 16.27 Favored Glycine 0 N--CA 1.469 0.891 0 CA-C-N 116.379 -0.373 . . . . 54.24 112.528 177.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.524 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 62.3 Cg_exo -51.9 -43.08 54.36 Favored 'Trans proline' 0 CA--C 1.567 2.149 0 C-N-CA 124.306 3.337 . . . . 51.55 116.579 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 22' ' ' PRO . 2.4 Cg_endo -43.13 142.36 2.49 Favored 'Trans proline' 0 C--N 1.404 3.458 0 C-N-CA 123.689 2.926 . . . . 73.41 113.607 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -53.77 134.52 56.07 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 115.831 -0.622 . . . . 74.24 111.107 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.87 -176.04 2.8 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 122.722 2.281 . . . . 75.15 113.322 -175.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.03 166.12 26.25 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 114.568 -1.196 . . . . 71.02 109.732 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.446 ' HB3' ' OE1' ' A' ' 30' ' ' GLU . 23.3 t -82.56 164.22 20.99 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 120.681 0.277 . . . . 73.5 111.584 -172.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.711 ' O ' ' HG2' ' A' ' 32' ' ' LYS . . . -48.75 -46.71 41.57 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 115.56 -0.745 . . . . 73.33 112.226 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.434 ' HA ' ' HG2' ' A' ' 32' ' ' LYS . 17.0 mm-40 -63.62 -32.88 74.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.793 0.664 . . . . 72.34 112.793 -178.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.535 ' O ' HG12 ' A' ' 34' ' ' ILE . 1.9 mp0 -63.88 -37.74 88.5 Favored 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 120.683 -0.407 . . . . 53.22 110.202 173.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -68.12 -44.76 75.41 Favored 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 124.003 0.814 . . . . 74.21 109.403 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.711 ' HG2' ' O ' ' A' ' 28' ' ' ALA . 29.3 mmmt -53.69 -48.27 69.68 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 123.197 0.599 . . . . 63.32 109.97 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -72.29 -42.1 65.89 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 113.786 1.032 . . . . 74.23 113.786 -175.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 30' ' ' GLU . 23.1 pt -69.33 -33.99 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.771 0.319 . . . . 75.34 111.457 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -62.32 -38.54 89.85 Favored 'General case' 0 C--O 1.203 -1.387 0 CA-C-N 115.611 -0.722 . . . . 72.22 111.521 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 62.8 mttt -70.35 -16.1 62.94 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 120.521 0.201 . . . . 63.33 111.17 -175.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.483 ' HA ' ' CG1' ' A' ' 91' ' ' VAL . 3.9 ptp180 -113.39 16.65 18.87 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 112.384 0.513 . . . . 74.03 112.384 -173.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.547 ' HB2' ' HG3' ' A' ' 84' ' ' GLU . 43.9 t -99.9 159.67 14.9 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-O 121.535 0.683 . . . . 65.3 111.607 177.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.484 ' CG1' HG23 ' A' ' 91' ' ' VAL . 5.5 m -139.7 164.12 24.16 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.942 0 C-N-CA 124.492 1.117 . . . . 73.34 110.686 176.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.644 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 16.4 t80 -118.9 128.39 54.38 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 125.236 1.415 . . . . 74.41 108.009 178.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 60.8 t -116.58 116.7 53.06 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 107.929 -1.137 . . . . 71.21 107.929 178.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.08 176.47 17.09 Favored Glycine 0 C--N 1.294 -1.771 0 C-N-CA 119.831 -1.176 . . . . 72.33 113.567 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.433 ' ND2' ' HD3' ' A' ' 105' ' ' ARG . 7.1 t30 68.51 8.52 6.73 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.759 1.624 . . . . 72.02 113.405 177.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.4 p -91.15 104.45 15.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.634 0.731 . . . . 73.33 109.766 176.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.407 ' CG ' ' HA ' ' A' ' 78' ' ' LYS . 28.6 m-20 -116.79 102.98 9.87 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 106.985 -1.487 . . . . 75.12 106.985 -172.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 49.26 -175.78 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.594 1.331 . . . . 54.03 114.594 -172.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.69 -56.78 5.04 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.868 -0.682 . . . . 45.52 111.96 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.6 m -86.14 143.56 27.96 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 121.107 0.479 . . . . 61.1 110.071 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 61.7 p -114.79 178.82 4.14 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.199 -0.667 . . . . 73.55 109.199 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.52 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -58.91 -43.24 91.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.163 0.506 . . . . 64.23 109.777 178.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -56.96 -44.93 83.09 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 115.304 -0.862 . . . . 65.3 111.814 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -61.12 -42.49 98.64 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.513 0.673 . . . . 72.11 110.57 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.4 mt -69.89 -47.36 62.83 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 114.755 -1.111 . . . . 74.5 111.623 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.501 ' HB2' ' OH ' ' B' ' 46' ' ' TYR . 21.5 tt0 -59.15 -50.6 73.42 Favored 'General case' 0 C--O 1.194 -1.836 0 C-N-CA 121.108 -0.237 . . . . 72.24 111.486 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.32 79.67 Favored 'General case' 0 C--O 1.265 1.878 0 CA-C-O 121.763 0.792 . . . . 74.3 110.999 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -67.31 -38.45 84.99 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.209 -1.36 . . . . 71.13 110.107 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . 0.278 46.5 m-85 -82.48 -21.14 35.67 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 114.516 1.302 . . . . 64.24 114.516 177.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 71.4 m -64.81 -28.81 69.82 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 109.523 -0.547 . . . . 62.41 109.523 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.8 m -58.48 -25.23 62.09 Favored 'General case' 0 CA--C 1.56 1.351 0 CA-C-N 115.815 -0.63 . . . . 74.24 110.09 173.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 61.1 m -107.63 3.24 24.58 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 112.859 0.689 . . . . 71.33 112.859 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 58' ' ' SER . . . 173.51 177.54 42.81 Favored Glycine 0 N--CA 1.466 0.683 0 C-N-CA 118.551 -1.785 . . . . 31.44 115.159 -177.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.8 m -78.25 -61.09 2.11 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 122.389 0.276 . . . . 74.0 111.159 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 85' ' ' PHE 0.264 56.2 mt 99.85 117.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 126.11 1.764 . . . . 61.32 113.261 175.729 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.46 ' ND2' ' HA ' ' A' ' 86' ' ' ALA . 80.2 m-20 -98.59 -39.18 8.83 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 115.275 -0.875 . . . . 73.12 111.692 177.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.445 ' NH1' ' HE2' ' A' ' 18' ' ' TYR . 96.6 mtt180 -151.45 159.52 44.16 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.816 -0.809 . . . . 75.53 108.816 -177.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.52 HD11 ' HB1' ' A' ' 50' ' ' ALA . 17.1 pt -148.32 144.48 18.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.073 -1.455 . . . . 75.54 107.073 171.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.534 ' OG1' ' HB2' ' A' ' 82' ' ' TYR . 43.0 p -123.49 138.74 54.51 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 106.018 -1.845 . . . . 63.43 106.018 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.465 HD12 ' O ' ' B' ' 68' ' ' ILE . 2.9 mp -129.89 116.4 37.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 106.371 -1.714 . . . . 74.31 106.371 175.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -120.55 125.66 48.38 Favored 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 120.078 -0.649 . . . . 53.44 111.037 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.435 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 82.9 m -115.61 133.55 55.93 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.19 -0.67 . . . . 75.4 109.19 -177.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -119.07 127.97 53.89 Favored 'General case' 0 CA--C 1.509 -0.629 0 C-N-CA 118.63 -1.228 . . . . 74.11 110.513 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 77' ' ' PRO . 36.7 ttmt -121.32 12.14 10.88 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.549 -0.908 . . . . 75.44 108.549 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -62.64 -22.04 66.13 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.273 0.471 . . . . 71.44 112.273 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.5 t -90.72 5.11 49.51 Favored 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 115.98 -0.554 . . . . 73.43 110.668 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.48 -56.25 0.48 Allowed Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.702 -0.761 . . . . 54.42 111.977 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -96.26 136.48 21.98 Favored Pre-proline 0 C--N 1.304 -1.394 0 N-CA-C 110.149 -0.315 . . . . 74.4 110.149 176.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.433 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 80.3 Cg_endo -79.54 119.0 3.98 Favored 'Trans proline' 0 N--CA 1.441 -1.593 0 C-N-CA 121.774 1.649 . . . . 71.21 113.051 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.407 ' HA ' ' CG ' ' A' ' 45' ' ' ASP . 37.1 mtmm -105.34 -163.82 0.98 Allowed 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.785 -1.098 . . . . 64.35 108.742 175.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 70' ' ' CYS . . . 173.64 162.56 25.72 Favored Glycine 0 N--CA 1.412 -2.936 0 C-N-CA 119.591 -1.29 . . . . 73.24 114.453 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -158.53 153.91 25.84 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 113.641 -1.279 . . . . 75.05 108.988 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.92 152.95 50.79 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 120.386 0.136 . . . . 41.11 111.106 -173.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.534 ' HB2' ' OG1' ' A' ' 67' ' ' THR . 27.0 m-85 -118.22 130.05 55.85 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.572 -0.529 . . . . 74.45 109.572 174.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.449 HG23 HG22 ' A' ' 66' ' ' ILE . 32.8 mm -111.4 112.49 40.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 109.086 -0.709 . . . . 75.24 109.086 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.547 ' HG3' ' HB2' ' A' ' 38' ' ' SER . 4.1 mp0 -94.84 120.24 34.74 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.147 0.499 . . . . 65.23 110.943 176.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 99.1 m-85 -92.78 164.12 13.47 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.791 -0.448 . . . . 74.24 109.791 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.46 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . . . -85.02 -17.97 35.86 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.111 0.482 . . . . 63.1 109.969 174.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.426 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 0.7 OUTLIER -117.24 141.85 47.78 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 115.407 -0.815 . . . . 72.0 111.171 -178.313 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -75.57 -29.39 59.33 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 108.362 -0.977 . . . . 71.11 108.362 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -67.71 -24.79 65.43 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.76 -0.587 . . . . 74.32 110.713 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.426 ' OG ' ' HB2' ' A' ' 87' ' ' GLU . 20.1 m -71.69 -37.1 70.74 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 112.092 0.404 . . . . 74.14 112.092 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.484 HG23 ' CG1' ' A' ' 39' ' ' VAL . 0.2 OUTLIER -65.87 -38.46 82.21 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 C-N-CA 120.095 -0.642 . . . . 64.55 109.507 173.871 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.08 -37.59 77.46 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.291 0.567 . . . . 65.1 110.239 175.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.52 -31.76 63.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.101 -0.499 . . . . 72.52 111.429 177.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.34 -41.17 49.22 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.117 -0.492 . . . . 71.11 111.161 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.409 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 30.9 m -60.95 -21.99 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 112.716 0.636 . . . . 64.15 112.716 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.13 -10.92 60.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.525 0.678 . . . . 40.33 110.455 176.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 8.8 ttp -111.37 8.2 21.22 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.978 -1.119 . . . . 75.51 107.978 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.698 ' HA ' ' HB ' ' A' ' 109' ' ' VAL . 0.5 OUTLIER -44.31 -44.15 7.91 Favored 'General case' 0 CA--C 1.473 -1.982 0 N-CA-C 114.431 1.271 . . . . 60.41 114.431 -176.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.491 ' OE1' ' HA ' ' A' ' 8' ' ' THR . 34.6 tt0 -122.89 98.66 6.01 Favored 'General case' 0 N--CA 1.389 -3.481 0 CA-C-O 122.511 1.148 . . . . 70.22 110.061 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 106' ' ' THR . 19.7 p -140.02 173.25 11.71 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 113.187 -1.824 . . . . 73.4 111.122 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.0 p -111.51 112.58 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.804 0 CA-C-O 122.316 1.055 . . . . 73.15 110.036 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -121.48 126.55 49.52 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.355 -1.293 . . . . 73.42 107.643 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.7 ttt-85 58.81 33.15 22.87 Favored 'General case' 0 CA--C 1.558 1.259 0 CA-C-O 122.054 0.93 . . . . 75.23 109.759 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.47 1.56 86.5 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.3 -0.864 . . . . 72.44 113.898 178.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.433 ' HD3' ' ND2' ' A' ' 43' ' ' ASN . 13.1 ptp180 -126.13 153.7 44.19 Favored 'General case' 0 C--N 1.314 -0.974 0 O-C-N 122.25 -0.559 . . . . 74.32 110.289 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 100' ' ' THR . 27.2 m -79.75 119.74 23.07 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.447 -0.575 . . . . 62.24 109.447 -178.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 pp -102.82 159.0 4.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 C-N-CA 119.601 -0.839 . . . . 64.42 109.815 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 57.7 tptt -123.56 129.89 51.86 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.321 -0.622 . . . . 65.24 109.321 -170.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.698 ' HB ' ' HA ' ' A' ' 98' ' ' ASP . 21.7 t -118.53 128.13 75.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 108.728 -0.842 . . . . 62.13 108.728 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 40' ' ' TYR . 93.5 mt -125.51 141.36 38.77 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 108.999 -0.741 . . . . 74.32 108.999 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.07 136.96 18.88 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.546 1.497 . . . . 72.34 111.811 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 38' ' ' SER . 0.3 OUTLIER -97.72 120.19 37.66 Favored 'General case' 0 C--N 1.276 -2.59 0 N-CA-C 104.075 -2.565 . . . . 73.34 104.075 170.564 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 76.4 ttt180 166.69 -37.86 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.279 -1.748 . . . . 73.21 106.279 -174.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 23.3 p -91.54 99.79 12.66 Favored 'General case' 0 N--CA 1.405 -2.677 0 CA-C-N 114.225 -1.352 . . . . 63.22 110.567 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -81.52 -24.42 36.66 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.18 -1.415 . . . . 65.24 107.18 176.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 66.6 mtt -142.01 147.15 43.35 Favored Pre-proline 0 N--CA 1.441 -0.886 0 N-CA-C 106.114 -1.81 . . . . 62.33 106.114 174.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.52 139.17 52.64 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 122.154 1.903 . . . . 74.42 112.418 -177.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 85.57 -68.74 3.37 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.042 -0.599 . . . . 42.25 111.932 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 11.2 tt -137.91 143.32 33.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.361 -0.977 . . . . 63.54 108.361 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 54.0 m -120.07 103.02 8.94 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 121.272 0.558 . . . . 73.25 111.864 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.9 m -107.2 108.52 19.99 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 106.761 -1.57 . . . . 72.31 106.761 173.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 44.9 m -64.19 143.8 57.61 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 123.243 0.617 . . . . 73.52 111.28 -175.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -62.82 129.15 39.2 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.79 0.805 . . . . 74.52 112.58 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 . . . . . 0 C--N 1.298 -1.653 0 CA-C-N 114.27 -1.332 . . . . 74.33 110.854 -178.833 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.801 0 CA-C-O 121.35 0.595 . . . . 61.01 110.272 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 49.0 mm -107.5 121.95 61.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 115.599 -0.728 . . . . 73.51 109.484 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.88 114.7 55.73 Favored Pre-proline 0 C--N 1.31 -1.145 0 N-CA-C 109.295 -0.631 . . . . 63.5 109.295 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.19 109.42 1.54 Allowed 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.804 2.336 . . . . 72.34 112.593 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 26.3 p -154.13 134.9 13.68 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.347 -0.983 . . . . 54.1 108.347 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -95.68 96.19 8.84 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.873 -0.331 . . . . 71.02 110.287 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -81.3 76.09 8.24 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 122.136 0.969 . . . . 74.54 110.238 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 6.9 t -168.7 83.74 0.16 Allowed 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 113.579 -1.646 . . . . 61.11 107.388 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 24.0 p -100.51 169.03 9.35 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.81 -1.086 . . . . 75.42 111.263 -176.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 175.93 -176.6 0.12 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 105.606 -1.998 . . . . 72.55 105.606 -177.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 32.8 m -61.23 160.48 10.39 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 108.949 -0.76 . . . . 63.44 108.949 172.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -60.23 104.13 0.29 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 113.745 1.017 . . . . 74.22 113.745 -176.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -110.33 75.84 0.95 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.812 0.815 . . . . 64.14 109.939 169.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 91.5 m -107.1 112.21 25.01 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.82 -1.082 . . . . 61.55 109.667 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.79 159.74 33.03 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.294 -1.002 . . . . 50.31 108.294 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.15 -44.95 6.43 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 110.851 -0.9 . . . . 34.14 110.851 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.85 97.96 7.72 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.693 -0.854 . . . . 73.12 108.693 177.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -52.51 -24.67 8.51 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 115.267 1.58 . . . . 74.41 115.267 -177.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 12.3 t -172.83 -13.29 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.067 0.46 . . . . 64.23 110.243 178.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . 0.433 ' HB3' ' HG2' ' B' ' 23' ' ' PRO . 39.3 mt-10 -56.67 -52.54 64.51 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.06 0.944 . . . . 73.32 112.098 -178.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.473 ' HA3' ' OH ' ' A' ' 82' ' ' TYR . . . 104.29 -119.8 6.41 Favored Glycine 0 CA--C 1.504 -0.628 0 C-N-CA 120.214 -0.993 . . . . 63.2 113.291 175.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.439 ' N ' ' HD2' ' B' ' 23' ' ' PRO . 54.1 Cg_exo -52.35 -44.44 46.65 Favored 'Trans proline' 0 CA--C 1.565 2.027 0 C-N-CA 123.792 2.995 . . . . 50.32 115.508 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' B' ' 22' ' ' PRO . 11.3 Cg_endo -53.78 146.72 44.01 Favored 'Trans proline' 0 C--N 1.389 2.696 0 C-N-CA 121.757 1.638 . . . . 70.03 112.349 177.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 15.3 pm0 -70.37 150.36 95.79 Favored Pre-proline 0 C--N 1.303 -1.436 0 CA-C-N 115.172 -0.922 . . . . 75.02 111.012 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.23 119.31 6.31 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.569 2.179 . . . . 71.03 112.144 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.625 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -77.03 168.5 19.98 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.168 -0.924 . . . . 64.4 110.69 176.271 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.62 ' HB3' ' OE1' ' B' ' 30' ' ' GLU . 47.4 t -68.12 147.06 52.84 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.612 0.967 . . . . 63.23 113.612 -173.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.718 ' O ' ' HG2' ' B' ' 32' ' ' LYS . . . -48.22 -46.22 35.01 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-N 114.001 -1.454 . . . . 64.14 111.949 177.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.403 ' HA ' ' CG ' ' B' ' 32' ' ' LYS . 69.9 mm-40 -63.65 -36.2 83.05 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.996 0.739 . . . . 74.22 112.996 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.62 ' OE1' ' HB3' ' B' ' 27' ' ' SER . 2.0 mp0 -63.12 -35.84 81.62 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.467 -0.493 . . . . 72.33 110.127 173.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' B' ' 26' ' ' LEU . 97.5 mttt -68.03 -43.59 78.39 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.032 -0.531 . . . . 75.15 109.581 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.718 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 28.9 mmmt -55.03 -47.36 74.84 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.628 0.771 . . . . 64.44 110.329 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -70.33 -46.28 64.49 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.341 -0.845 . . . . 54.22 111.745 -175.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 17.1 pt -69.72 -35.02 63.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.927 0.394 . . . . 74.42 111.569 -175.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.87 -44.36 96.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.768 -0.651 . . . . 74.54 111.825 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.586 ' HG2' ' O ' ' B' ' 32' ' ' LYS . 12.3 ptpt -68.47 -10.64 56.78 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 112.48 0.548 . . . . 62.2 112.48 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.432 ' HD3' ' O ' ' B' ' 86' ' ' ALA . 92.3 mtt180 -107.3 9.51 29.97 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.966 0.412 . . . . 73.2 110.871 -176.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.514 ' HB2' ' HB3' ' B' ' 112' ' ' LYS . 24.3 m -103.01 162.39 12.97 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 114.226 1.195 . . . . 74.43 114.226 -175.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.462 ' CG1' HG23 ' B' ' 91' ' ' VAL . 12.1 m -141.22 164.45 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.551 1.14 . . . . 75.24 111.907 176.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . 0.562 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 17.6 t80 -119.11 130.96 55.85 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 126.109 1.764 . . . . 71.34 107.999 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 58.1 t -119.42 117.58 54.48 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 C-N-CA 123.945 0.898 . . . . 64.43 108.81 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.77 166.13 14.78 Favored Glycine 0 C--N 1.293 -1.806 0 C-N-CA 120.205 -0.998 . . . . 63.54 111.961 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 60.3 t30 66.29 20.36 11.03 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.738 1.615 . . . . 73.24 113.152 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 11.3 p -64.32 133.33 29.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 O-C-N 121.544 -0.723 . . . . 75.0 109.651 177.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.483 ' HB2' ' HD3' ' B' ' 105' ' ' ARG . 21.7 t70 -72.43 141.34 48.65 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 108.294 -1.002 . . . . 74.52 108.294 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' TYR . . . . . 0.501 ' OH ' ' HB2' ' A' ' 54' ' ' GLU . 4.6 t80 -56.92 -28.15 61.73 Favored 'General case' 0 CA--C 1.551 0.996 0 O-C-N 124.187 0.929 . . . . 71.4 109.754 -178.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.33 0.77 81.51 Favored Glycine 0 N--CA 1.427 -1.924 0 CA-C-N 115.787 -0.642 . . . . 65.11 113.366 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 18.6 m -78.99 135.33 36.88 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 107.781 -1.192 . . . . 71.55 107.781 176.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 63.6 p -94.38 169.97 9.83 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 119.115 -1.034 . . . . 71.54 110.457 -176.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.628 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -60.47 -38.61 84.79 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.506 -0.924 . . . . 44.31 108.506 174.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -57.26 -46.68 82.82 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.191 -0.913 . . . . 51.53 111.242 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -58.55 -47.49 84.06 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.669 0.747 . . . . 43.4 110.183 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 66.2 mt -64.88 -48.03 75.69 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.645 -1.162 . . . . 71.33 112.344 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -59.7 -50.71 72.79 Favored 'General case' 0 C--O 1.206 -1.231 0 N-CA-C 111.656 0.243 . . . . 73.22 111.656 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.53 -45.42 81.15 Favored 'General case' 0 C--O 1.269 2.106 0 CA-C-O 121.631 0.729 . . . . 70.24 111.127 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -66.78 -39.21 87.73 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.457 -1.247 . . . . 62.31 109.942 -174.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . 0.259 46.4 m-85 -82.09 -21.47 36.77 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 114.617 1.339 . . . . 70.51 114.617 177.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 68.2 m -64.57 -28.03 69.36 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.166 0.508 . . . . 72.33 109.784 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 18.8 m -58.42 -28.94 65.7 Favored 'General case' 0 CA--C 1.557 1.248 0 CA-C-N 115.892 -0.595 . . . . 74.24 110.837 173.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 82.2 m -95.89 3.17 53.83 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 113.616 0.969 . . . . 61.33 113.616 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.9 -169.67 27.27 Favored Glycine 0 N--CA 1.464 0.515 0 C-N-CA 118.662 -1.733 . . . . 52.15 115.244 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 27.1 m -93.73 127.88 39.67 Favored 'General case' 0 C--O 1.216 -0.68 0 C-N-CA 123.391 0.677 . . . . 71.32 110.372 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 85.5 mt -97.88 132.04 43.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 124.023 0.929 . . . . 72.04 113.284 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . 0.468 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 75.5 m-20 -100.03 -38.69 8.47 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.84 0.856 . . . . 72.24 112.304 176.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.433 ' HB2' ' HB2' ' B' ' 84' ' ' GLU . 95.3 mtt180 -151.76 160.36 43.61 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.096 -0.705 . . . . 71.31 109.096 -177.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.628 HD11 ' HB1' ' B' ' 50' ' ' ALA . 20.1 pt -148.52 144.52 18.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.094 -1.447 . . . . 75.0 107.094 172.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . 0.546 ' OG1' ' HB2' ' B' ' 82' ' ' TYR . 43.4 p -123.98 139.7 53.7 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 105.936 -1.876 . . . . 63.01 105.936 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.465 ' O ' HD12 ' A' ' 68' ' ' ILE . 2.4 mp -130.61 118.41 42.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 106.009 -1.848 . . . . 64.02 106.009 175.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.293 1.0 OUTLIER -121.39 125.56 47.24 Favored 'General case' 0 C--N 1.28 -2.44 0 C-N-CA 120.348 -0.541 . . . . 74.13 111.977 177.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' CYS . . . . . 0.467 ' HA ' ' HA2' ' B' ' 79' ' ' GLY . 68.7 m -116.53 133.5 55.94 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.198 -0.667 . . . . 63.22 109.198 -176.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 5.4 p-10 -122.52 133.82 54.57 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 118.701 -1.2 . . . . 74.04 111.426 -179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.4 ' HE3' ' HG3' ' B' ' 77' ' ' PRO . 39.9 mtpt -116.74 17.36 15.2 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.551 -1.648 . . . . 75.2 106.551 178.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -44.64 -35.03 2.41 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.811 2.044 . . . . 74.32 112.847 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 39.9 m -115.24 26.29 10.21 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 111.773 0.286 . . . . 74.41 111.773 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.27 -60.22 0.49 Allowed Glycine 0 C--O 1.236 0.276 0 C-N-CA 120.617 -0.802 . . . . 64.21 114.054 175.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . 0.408 ' HA ' ' HD3' ' B' ' 77' ' ' PRO . 12.0 m170 -84.78 141.91 38.81 Favored Pre-proline 0 C--N 1.31 -1.147 0 N-CA-C 110.176 -0.305 . . . . 73.04 110.176 -177.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' B' ' 76' ' ' HIS . 3.0 Cg_exo -78.88 118.04 4.03 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 121.177 1.251 . . . . 74.04 111.854 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -112.43 -166.47 1.08 Allowed 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 109.207 -0.664 . . . . 75.44 109.207 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' B' ' 70' ' ' CYS . . . 171.58 159.41 17.74 Favored Glycine 0 N--CA 1.414 -2.768 0 C-N-CA 119.652 -1.261 . . . . 63.25 114.16 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -154.64 152.14 29.62 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 125.06 1.344 . . . . 70.53 109.091 176.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.08 153.93 51.17 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 122.001 0.121 . . . . 65.22 110.982 -173.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' TYR . . . . . 0.546 ' HB2' ' OG1' ' B' ' 67' ' ' THR . 30.8 m-85 -119.95 127.0 52.26 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 110.047 -0.353 . . . . 75.45 110.047 174.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.484 HG23 HG22 ' B' ' 66' ' ' ILE . 23.8 mm -107.97 118.74 56.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 107.497 -1.297 . . . . 64.11 107.497 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' GLU . . . . . 0.433 ' HB2' ' HB2' ' B' ' 65' ' ' ARG . 61.6 mt-10 -105.73 119.63 39.64 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.249 0.547 . . . . 71.15 110.235 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -95.81 162.0 13.78 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.671 -0.695 . . . . 71.5 112.285 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.468 ' HA ' ' ND2' ' B' ' 64' ' ' ASN . . . -79.03 -32.04 44.86 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.771 -1.104 . . . . 64.24 111.168 175.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.39 146.4 34.5 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 120.06 -0.656 . . . . 65.55 110.26 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -74.69 -26.67 59.99 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 108.015 -1.105 . . . . 73.43 108.015 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -72.51 -20.28 61.39 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 119.723 -0.791 . . . . 71.2 111.625 177.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 21.9 m -69.46 -37.35 77.28 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 110.505 -0.183 . . . . 62.4 110.505 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.462 HG23 ' CG1' ' B' ' 39' ' ' VAL . 0.2 OUTLIER -67.08 -39.05 82.43 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 C-N-CA 120.427 -0.509 . . . . 61.2 109.905 175.173 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.93 -37.08 75.88 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.213 0.53 . . . . 74.14 110.716 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.42 -31.41 62.3 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.033 -0.53 . . . . 62.15 111.173 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.73 -43.02 48.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.197 -0.456 . . . . 63.54 111.167 -178.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 33.6 m -57.11 -22.24 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 112.724 0.638 . . . . 73.34 112.724 177.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.4 -15.74 63.85 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.219 0.533 . . . . 71.2 110.515 176.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 11.2 mtm -98.71 15.64 24.63 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.654 0.782 . . . . 75.21 111.436 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 6.0 t70 -33.85 -52.25 0.42 Allowed 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 114.807 1.41 . . . . 75.55 114.807 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -123.91 64.42 1.05 Allowed 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 118.778 -1.169 . . . . 71.43 111.182 174.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 10.8 t -97.72 -177.63 3.85 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.772 -1.104 . . . . 65.43 110.087 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 9.7 p -108.6 134.5 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 CA-C-O 121.254 0.55 . . . . 51.03 109.652 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -130.31 115.83 17.48 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.073 -0.714 . . . . 61.43 109.073 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 40.0 mtp-105 49.98 32.24 5.49 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.471 1.508 . . . . 75.23 112.23 -178.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.66 -6.32 62.7 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.502 -0.772 . . . . 73.31 112.879 175.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.483 ' HD3' ' HB2' ' B' ' 45' ' ' ASP . 30.2 mtp180 -110.14 133.56 53.09 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.808 -0.442 . . . . 71.3 109.808 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 14.4 m -75.57 120.51 21.08 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.044 -1.095 . . . . 72.24 108.044 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 41.6 pt -103.13 172.08 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-O 121.475 0.655 . . . . 74.22 112.262 -178.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 57.6 tptt -125.93 126.44 44.37 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.667 -1.151 . . . . 74.43 107.97 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 48.5 t -117.71 122.06 68.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.904 -0.776 . . . . 74.03 108.904 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.46 ' HB2' ' HB3' ' B' ' 40' ' ' TYR . 95.8 mt -121.53 145.19 42.12 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 108.918 -0.771 . . . . 70.12 108.918 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.55 130.84 13.07 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.857 1.705 . . . . 75.22 109.66 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.514 ' HB3' ' HB2' ' B' ' 38' ' ' SER . 25.7 ttpp -86.11 135.93 33.42 Favored 'General case' 0 CA--C 1.5 -0.981 0 C-N-CA 119.981 -0.688 . . . . 64.12 112.368 -178.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -139.18 136.28 34.89 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 106.635 -1.617 . . . . 73.34 106.635 171.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 14.9 t -73.95 -175.66 2.23 Favored 'General case' 0 N--CA 1.413 -2.299 0 CA-C-O 122.192 0.996 . . . . 74.21 110.607 -176.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -143.28 135.63 27.2 Favored 'General case' 0 N--CA 1.394 -3.275 0 N-CA-C 108.132 -1.062 . . . . 62.22 108.132 -174.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 46.3 ttm -156.17 105.12 2.06 Favored Pre-proline 0 N--CA 1.428 -1.548 0 N-CA-C 109.318 -0.623 . . . . 75.3 109.318 -176.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.7 164.21 16.61 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.434 2.089 . . . . 61.32 110.46 175.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.14 57.03 4.63 Favored Glycine 0 C--N 1.313 -0.742 0 C-N-CA 120.777 -0.725 . . . . 61.3 113.01 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . 0.301 2.0 pp 49.39 178.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 126.876 2.071 . . . . 75.12 115.839 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 49.4 m -134.22 119.84 19.28 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.186 -1.042 . . . . 71.22 108.186 175.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 36.5 t -163.45 128.92 3.08 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 108.713 -0.847 . . . . 74.5 108.713 -177.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 86.7 m -143.3 101.02 3.73 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.622 -0.881 . . . . 53.3 108.622 175.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -81.39 144.46 31.42 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.927 -1.138 . . . . 52.14 107.927 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.545 ' C ' ' HE ' ' B' ' 124' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.374 0 N-CA-C 107.66 -1.237 . . . . 73.02 107.66 -174.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.497 0 CA-C-O 121.131 0.491 . . . . 71.35 110.838 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.7 mm -83.26 112.69 21.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 115.852 -0.613 . . . . 44.13 109.738 178.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.87 125.82 6.39 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 108.365 -0.976 . . . . 72.32 108.365 178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -66.95 103.96 0.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 121.828 1.685 . . . . 51.21 111.236 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 46.0 t -90.97 105.99 18.21 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.469 -0.567 . . . . 73.54 109.469 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 65.2 mtt -136.13 146.45 46.95 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.94 -0.573 . . . . 72.12 109.61 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -77.45 101.18 6.29 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.47 -0.567 . . . . 75.13 109.47 176.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.9 p -78.83 98.27 6.26 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 115.315 -0.857 . . . . 62.34 111.265 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -164.15 94.85 0.75 Allowed 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 115.195 -0.911 . . . . 62.44 109.191 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -93.23 131.84 37.96 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.94 -0.573 . . . . 73.41 110.137 -177.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.0 t -60.97 109.03 0.96 Allowed 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 108.497 -0.927 . . . . 71.32 108.497 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -127.18 112.72 15.46 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.472 -1.307 . . . . 63.34 107.472 -177.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.8 ptp -126.71 142.43 51.54 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.782 -0.644 . . . . 73.43 111.558 -175.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.2 m -148.0 151.62 36.07 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.003 -1.48 . . . . 73.2 107.003 -178.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.21 86.76 6.16 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 119.991 -0.683 . . . . 63.31 109.566 175.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.43 68.89 3.38 Favored Glycine 0 CA--C 1.497 -1.038 0 N-CA-C 111.039 -0.825 . . . . 63.32 111.039 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.74 -162.73 1.33 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.913 -0.773 . . . . 60.34 108.913 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 65.39 84.81 0.15 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.946 0.899 . . . . 71.15 111.7 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.0 m 149.22 -72.82 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 129.851 3.26 . . . . 64.13 105.464 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 44.4 -175.66 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.699 1.6 . . . . 75.4 114.469 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.571 ' HA2' ' CE1' ' B' ' 40' ' ' TYR . . . 116.49 -149.91 18.68 Favored Glycine 0 N--CA 1.402 -3.577 0 N-CA-C 106.846 -2.502 . . . . 61.42 106.846 177.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.719 ' HA ' ' OH ' ' B' ' 82' ' ' TYR . 56.7 Cg_exo -50.26 -34.36 39.86 Favored 'Trans proline' 0 CA--C 1.601 3.849 0 C-N-CA 122.479 2.119 . . . . 71.41 115.264 171.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -106.8 170.01 0.12 Allowed 'Trans proline' 0 C--N 1.375 1.93 0 N-CA-C 117.35 2.019 . . . . 71.45 117.35 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.517 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 21.8 mm-40 -109.44 120.78 44.37 Favored Pre-proline 0 N--CA 1.418 -2.028 0 CA-C-N 112.26 -2.245 . . . . 74.24 106.781 177.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.14 123.07 8.55 Favored 'Trans proline' 0 C--O 1.244 0.821 0 C-N-CA 122.622 2.215 . . . . 73.24 112.229 -177.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 24' ' ' GLN . 0.4 OUTLIER -160.5 175.31 12.88 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 114.515 -1.22 . . . . 72.41 112.708 -174.361 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.3 t -89.73 156.35 18.59 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.36 -0.836 . . . . 65.35 110.167 178.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.76 -44.32 63.29 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 112.609 0.596 . . . . 74.32 112.609 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -64.65 -30.19 71.21 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 112.104 0.409 . . . . 74.21 112.104 178.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -64.81 -34.22 77.85 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.498 -1.297 . . . . 73.5 107.498 176.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.481 ' HA ' HG12 ' A' ' 34' ' ' ILE . 95.7 mttt -69.83 -50.55 41.7 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.05 -0.977 . . . . 62.32 110.766 -174.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.564 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -57.2 -39.5 75.54 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 119.889 -0.725 . . . . 73.22 111.75 -178.49 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -72.58 -40.42 66.61 Favored 'General case' 0 N--CA 1.415 -2.196 0 C-N-CA 119.203 -0.999 . . . . 72.14 112.74 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.481 HG12 ' HA ' ' A' ' 31' ' ' LYS . 15.8 pt -65.94 -34.33 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 120.46 -0.496 . . . . 71.32 110.827 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -61.16 -42.6 98.85 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.779 -0.823 . . . . 72.13 108.779 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -78.64 -26.79 45.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.363 -0.835 . . . . 72.25 112.386 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.438 HH21 HG23 ' A' ' 34' ' ' ILE . 89.3 mtm180 -89.71 12.96 15.46 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 123.068 0.547 . . . . 64.35 111.943 -177.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.3 t -96.64 145.21 25.96 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.277 0.561 . . . . 75.14 111.403 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.48 ' CG1' ' HB ' ' A' ' 91' ' ' VAL . 28.3 m -128.17 160.02 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.764 0 CA-C-N 115.839 -0.619 . . . . 72.21 110.487 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.572 ' CZ ' ' HG3' ' B' ' 22' ' ' PRO . 15.1 t80 -110.4 121.21 44.75 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 107.692 -1.225 . . . . 72.41 107.692 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.716 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 66.6 t -121.55 108.8 23.1 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 N-CA-C 107.404 -1.332 . . . . 70.5 107.404 173.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.18 172.03 17.42 Favored Glycine 0 C--N 1.284 -2.359 0 C-N-CA 118.813 -1.661 . . . . 64.44 112.825 -176.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.3 t30 61.64 34.1 17.79 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 124.269 1.028 . . . . 71.45 110.421 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.499 ' HA ' ' NH1' ' A' ' 105' ' ' ARG . 7.4 p -90.89 14.11 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.706 0 CA-C-N 115.03 -0.986 . . . . 64.42 111.231 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -36.62 112.27 0.18 Allowed 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 127.929 2.492 . . . . 64.45 114.69 -177.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . 0.524 32.1 m-85 50.11 -43.91 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.846 1 N-CA-C 122.467 4.247 . . . . 74.33 122.467 173.418 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.84 0.18 46.49 Favored Glycine 0 C--N 1.306 -1.108 0 CA-C-N 119.145 0.884 . . . . 30.0 113.32 -175.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.489 ' HB2' HG22 ' A' ' 44' ' ' VAL . 49.6 m -129.48 137.31 50.76 Favored 'General case' 0 N--CA 1.409 -2.497 0 O-C-N 122.45 -0.441 . . . . 64.14 110.046 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 47.1 p -125.25 179.34 5.12 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.238 -1.023 . . . . 64.31 108.238 -176.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.96 -49.77 76.38 Favored 'General case' 0 C--O 1.207 -1.159 0 CA-C-N 118.349 0.522 . . . . 63.2 111.134 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -58.26 -41.12 83.54 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.888 0.699 . . . . 63.3 112.888 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -62.93 -44.64 95.52 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.941 0.877 . . . . 63.31 110.1 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.45 ' HB3' ' HE2' ' A' ' 57' ' ' PHE . 63.4 mt -73.0 -46.72 50.59 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.497 -1.229 . . . . 73.24 112.482 -175.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.5 ' HG3' ' OH ' ' B' ' 46' ' ' TYR . 6.1 tm-20 -57.48 -48.68 78.57 Favored 'General case' 0 C--O 1.196 -1.711 0 C-N-CA 122.804 0.442 . . . . 74.35 110.441 -176.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.22 -42.73 77.74 Favored 'General case' 0 C--O 1.267 2.008 0 CA-C-O 121.724 0.773 . . . . 43.02 110.747 176.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -68.08 -43.59 78.22 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.248 -0.887 . . . . 71.2 111.335 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.609 ' CD2' HG12 ' A' ' 83' ' ' ILE . 65.9 m-85 -80.15 -22.98 41.44 Favored 'General case' 0 C--O 1.225 -0.218 0 O-C-N 121.91 -0.494 . . . . 71.25 111.435 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.9 t -69.46 -24.14 63.76 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.9 -0.778 . . . . 41.23 108.9 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.8 m -63.27 -22.57 66.96 Favored 'General case' 0 CA--C 1.568 1.641 0 CA-C-N 116.121 -0.49 . . . . 55.11 110.78 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 78.7 m -97.03 7.43 46.67 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.821 0.674 . . . . 74.25 112.821 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 142.97 -161.79 27.52 Favored Glycine 0 C--O 1.221 -0.682 0 C-N-CA 119.45 -1.357 . . . . 65.24 113.838 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.3 m -99.26 129.81 45.51 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.404 -0.591 . . . . 63.54 109.404 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.44 HD11 ' HB2' ' A' ' 57' ' ' PHE . 72.0 mt -85.23 133.3 29.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 113.084 0.772 . . . . 65.24 113.084 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.496 ' OD1' ' HG3' ' A' ' 65' ' ' ARG . 24.1 t-20 -94.7 -48.19 6.17 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.865 1.266 . . . . 64.44 108.234 178.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.496 ' HG3' ' OD1' ' A' ' 64' ' ' ASN . 98.9 mtt180 -148.57 158.84 44.4 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.506 -0.77 . . . . 72.21 109.003 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.417 ' HB ' HG13 ' A' ' 83' ' ' ILE . 1.5 tt -149.31 127.6 2.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 C-N-CA 123.198 0.599 . . . . 54.15 110.138 173.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 30.2 m -125.08 133.65 52.81 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.627 -1.249 . . . . 62.53 107.627 -173.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.0 mp -131.03 120.6 47.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 106.646 -1.613 . . . . 63.44 106.646 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.469 ' H ' HD23 ' A' ' 69' ' ' LEU . 1.6 pt? -120.63 134.33 55.29 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.871 -0.332 . . . . 72.01 110.14 178.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 80.8 m -116.58 126.51 53.38 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.642 -0.873 . . . . 73.24 108.642 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.603 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 4.3 p30 -105.29 126.6 52.29 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.403 -0.519 . . . . 73.54 111.108 -177.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.451 ' HG2' ' HB3' ' A' ' 77' ' ' PRO . 96.3 mttt -119.47 2.53 11.25 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 112.62 0.6 . . . . 61.23 112.62 177.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.664 ' HB3' ' OD1' ' B' ' 64' ' ' ASN . 41.8 p90 -56.96 -27.67 61.49 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 113.924 1.083 . . . . 74.14 113.924 -176.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.0 t -97.24 10.87 38.31 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.259 0.552 . . . . 64.4 110.191 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.35 -55.78 0.55 Allowed Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 121.072 -0.585 . . . . 42.41 112.677 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.3 m80 -95.5 125.56 49.12 Favored Pre-proline 0 C--N 1.308 -1.237 0 C-N-CA 120.964 -0.294 . . . . 75.22 110.946 -177.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.603 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 26.5 Cg_endo -67.88 119.59 6.59 Favored 'Trans proline' 0 C--O 1.247 0.94 0 C-N-CA 122.829 2.353 . . . . 63.4 112.744 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.453 ' HB2' ' OD2' ' A' ' 71' ' ' ASP . 28.1 mtmm -113.21 -160.37 0.72 Allowed 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.796 -1.187 . . . . 72.14 107.796 172.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 69' ' ' LEU . . . 179.04 153.15 11.23 Favored Glycine 0 N--CA 1.423 -2.225 0 C-N-CA 119.145 -1.502 . . . . 63.22 114.786 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.414 ' O ' HD23 ' A' ' 69' ' ' LEU . 24.9 m-85 -136.22 153.31 51.26 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.628 -1.99 . . . . 71.51 105.628 174.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.486 ' HB2' HG11 ' A' ' 44' ' ' VAL . . . -131.64 131.19 42.99 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.588 -0.893 . . . . 72.15 108.588 176.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -115.39 120.45 39.63 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.594 -1.261 . . . . 71.41 107.594 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.609 HG12 ' CD2' ' A' ' 57' ' ' PHE . 1.1 mp -113.76 129.05 70.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 108.894 -0.78 . . . . 71.33 108.894 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 65' ' ' ARG . 2.1 mp0 -99.6 124.43 44.79 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.2 -1.408 . . . . 74.24 107.2 174.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -94.03 155.93 16.86 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 121.248 -0.181 . . . . 74.23 110.628 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.29 -32.05 72.78 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.427 -0.352 . . . . 14.31 111.427 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.86 148.34 44.17 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.777 -0.769 . . . . 74.11 110.163 175.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -70.76 -27.09 63.67 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.319 -0.855 . . . . 75.24 109.608 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -62.49 -33.91 75.81 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.921 -0.582 . . . . 71.23 110.521 174.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.5 m -66.75 -35.94 81.28 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 116.048 -0.524 . . . . 53.5 110.902 -177.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.504 ' O ' HG13 ' A' ' 95' ' ' VAL . 1.5 m -68.95 -37.69 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 108.435 -0.95 . . . . 72.34 108.435 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.639 ' O ' HG22 ' A' ' 95' ' ' VAL . 9.9 t70 -68.02 -30.52 69.77 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.722 0.772 . . . . 64.33 109.499 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.01 -31.24 64.36 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.667 -0.697 . . . . 73.11 110.088 175.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.85 -36.17 59.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.889 -0.596 . . . . 53.21 111.453 -177.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 92' ' ' ASP . 11.2 m -53.86 -21.63 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 112.597 0.592 . . . . 74.14 112.597 178.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.75 -12.2 44.6 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.304 0.573 . . . . 54.23 110.991 177.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.565 ' HA ' ' OG1' ' A' ' 100' ' ' THR . 68.0 mtm -100.43 5.43 44.25 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 116.1 -0.5 . . . . 64.32 111.092 178.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.541 ' HA ' ' H ' ' A' ' 109' ' ' VAL . 0.4 OUTLIER -48.4 -49.02 36.53 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.569 1.322 . . . . 74.35 114.569 -177.171 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -101.97 12.82 36.29 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-O 121.887 0.851 . . . . 72.23 110.539 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.565 ' OG1' ' HA ' ' A' ' 97' ' ' MET . 62.9 m -72.24 151.93 42.53 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.917 -0.583 . . . . 73.14 109.984 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -101.56 134.34 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 N-CA-C 108.559 -0.904 . . . . 73.52 108.559 -177.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.48 ' HE2' ' OG ' ' A' ' 48' ' ' SER . 82.6 t80 -130.12 118.81 22.05 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 115.654 -0.703 . . . . 74.35 109.17 -173.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 54.55 32.06 16.18 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.717 1.006 . . . . 64.02 113.717 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.71 -5.47 73.33 Favored Glycine 0 N--CA 1.461 0.352 0 CA-C-N 115.227 -0.897 . . . . 64.15 113.406 174.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.499 ' NH1' ' HA ' ' A' ' 44' ' ' VAL . 21.9 ptt85 -121.52 145.49 47.9 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 122.846 0.458 . . . . 74.43 110.301 178.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.2 m -82.61 122.24 27.86 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.545 -0.909 . . . . 64.44 108.545 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 41.3 pt -101.44 171.52 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 N-CA-C 108.44 -0.948 . . . . 63.13 108.44 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.716 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 22.9 mmmt -121.91 128.23 51.32 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 109.685 -0.487 . . . . 71.15 109.685 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.541 ' H ' ' HA ' ' A' ' 98' ' ' ASP . 60.5 t -117.48 112.16 37.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 105.127 -2.175 . . . . 62.52 105.127 173.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 tt -140.41 129.97 13.38 Favored Pre-proline 0 C--N 1.274 -2.681 0 N-CA-C 105.146 -2.168 . . . . 75.31 105.146 -172.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -55.12 136.81 74.81 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 121.584 1.523 . . . . 72.41 109.736 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.25 24.2 ttpp -79.33 65.68 4.57 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 122.615 1.197 . . . . 71.43 112.204 -178.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 35.51 -99.31 0.02 OUTLIER 'General case' 0 C--O 1.246 0.887 0 CA-C-N 111.543 -2.571 . . . . 62.13 115.512 -178.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 62.2 m 71.01 -47.4 0.66 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.943 1.697 . . . . 73.02 109.272 -175.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -75.72 104.4 6.26 Favored 'General case' 0 N--CA 1.418 -2.03 0 C-N-CA 125.651 1.58 . . . . 61.05 109.299 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 1.5 mmt -115.65 161.38 30.63 Favored Pre-proline 0 C--N 1.291 -1.968 0 N-CA-C 108.629 -0.878 . . . . 62.52 108.629 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.18 -15.85 46.92 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.755 2.303 . . . . 71.53 111.88 177.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -133.32 177.77 18.72 Favored Glycine 0 N--CA 1.437 -1.25 0 N-CA-C 109.442 -1.463 . . . . 62.23 109.442 176.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 27.3 pt -91.99 106.78 18.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 117.646 0.723 . . . . 74.21 110.533 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.2 t -89.76 127.2 35.92 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.6 -0.727 . . . . 63.55 109.681 -177.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.401 ' OG ' ' HD3' ' A' ' 124' ' ' ARG . 39.6 p -101.11 98.16 8.62 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.496 -0.32 . . . . 73.12 110.222 178.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.6 m -81.76 120.71 25.49 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.536 -0.542 . . . . 71.41 109.536 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.4 t70 64.57 92.7 0.07 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.851 0.861 . . . . 73.41 112.345 -178.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.401 ' HD3' ' OG ' ' A' ' 121' ' ' SER . 32.6 ptt180 . . . . . 0 C--N 1.306 -1.29 0 CA-C-N 115.262 -0.881 . . . . 62.34 109.659 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.726 0 CA-C-O 120.618 0.247 . . . . 75.52 110.342 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 64.3 mt -92.97 110.74 23.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 107.895 -1.15 . . . . 72.21 107.895 177.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.37 134.9 33.54 Favored Pre-proline 0 C--N 1.298 -1.662 0 CA-C-N 115.88 -0.6 . . . . 60.14 110.515 -176.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.37 101.68 0.44 Allowed 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 122.156 1.904 . . . . 74.14 110.419 176.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 61.0 m -85.01 172.89 10.95 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.447 -0.797 . . . . 75.41 109.606 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -76.36 -178.24 4.49 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.719 -0.474 . . . . 71.41 109.719 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -80.09 85.76 5.62 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 119.883 -0.727 . . . . 73.21 111.927 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 95.4 m -97.54 102.06 13.74 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 107.503 -1.295 . . . . 73.1 107.503 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.537 ' HA ' ' NH2' ' B' ' 113' ' ' ARG . 12.6 t -143.04 164.77 29.2 Favored 'General case' 0 N--CA 1.407 -2.594 0 C-N-CA 119.946 -0.702 . . . . 63.32 111.312 -176.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -136.2 22.09 3.23 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.978 -1.49 . . . . 71.5 106.978 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 79.1 p -80.2 171.59 14.88 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.317 -0.856 . . . . 74.34 112.723 -176.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 58.5 tttm 175.38 168.83 0.33 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 102.648 -3.093 . . . . 73.41 102.648 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 64.3 mtt -67.97 93.04 0.4 Allowed 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 120.029 1.286 . . . . 64.31 108.484 172.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 14.5 p -112.15 171.5 7.47 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 114.492 -1.231 . . . . 60.13 109.425 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.436 ' HB1' ' HA ' ' B' ' 18' ' ' TYR . . . -126.91 100.38 6.13 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 113.449 0.907 . . . . 65.05 113.449 -175.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.465 ' HA3' ' OD1' ' B' ' 35' ' ' ASP . . . -76.42 -42.23 23.25 Favored Glycine 0 CA--C 1.491 -1.431 0 N-CA-C 106.53 -2.628 . . . . 61.31 106.53 169.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.6 85.28 5.65 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 106.749 -1.574 . . . . 65.13 106.749 169.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.436 ' HA ' ' HB1' ' B' ' 15' ' ' ALA . 56.1 t80 -69.58 170.18 11.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.827 -1.079 . . . . 72.31 108.975 -175.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 49.2 p -68.73 81.83 0.28 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.589 0.709 . . . . 75.13 109.439 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . 0.539 ' O ' ' HD2' ' B' ' 22' ' ' PRO . 27.7 tt0 -70.29 -24.87 63.11 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 113.925 -1.489 . . . . 72.31 110.782 -177.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.52 -106.03 2.98 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.768 -0.651 . . . . 71.2 113.417 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.572 ' HG3' ' CZ ' ' A' ' 40' ' ' TYR . 0.9 OUTLIER -40.54 -57.27 1.3 Allowed 'Trans proline' 0 CA--C 1.573 2.47 0 C-N-CA 124.797 3.665 . . . . 54.15 116.192 -178.794 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.525 ' HG2' ' OE2' ' B' ' 20' ' ' GLU . 4.8 Cg_exo -83.95 165.61 13.31 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 121.95 1.767 . . . . 64.4 110.734 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -103.91 145.38 30.53 Favored Pre-proline 0 C--N 1.283 -2.31 0 N-CA-C 109.382 -0.599 . . . . 65.01 109.382 176.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -46.78 127.6 12.23 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.266 2.644 . . . . 43.54 113.841 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.802 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -61.61 -167.97 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 114.47 -1.241 . . . . 65.54 113.837 178.754 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.572 ' O ' ' HG3' ' B' ' 31' ' ' LYS . 47.0 t -54.19 143.51 22.56 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.765 0.793 . . . . 52.44 112.583 -176.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.423 ' O ' ' HE2' ' B' ' 32' ' ' LYS . . . -60.89 -43.74 98.06 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.16 -1.382 . . . . 72.43 111.709 178.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -66.92 -33.02 74.68 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 111.715 0.265 . . . . 52.33 111.715 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.64 ' HB3' HD23 ' B' ' 26' ' ' LEU . 10.8 tp10 -62.64 -34.89 77.97 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 107.631 -1.248 . . . . 52.04 107.631 177.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.572 ' HG3' ' O ' ' B' ' 27' ' ' SER . 92.6 mttt -70.07 -50.43 41.11 Favored 'General case' 0 C--O 1.203 -1.359 0 CA-C-N 115.341 -0.845 . . . . 72.32 111.101 -174.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.532 ' N ' ' HE2' ' B' ' 32' ' ' LYS . 0.2 OUTLIER -57.66 -37.42 73.36 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 120.106 -0.637 . . . . 72.15 112.062 -177.455 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.659 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 7.1 mm-40 -71.14 -47.41 58.04 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.074 -0.512 . . . . 72.03 110.635 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.509 HG12 ' HA ' ' B' ' 31' ' ' LYS . 21.4 pt -64.83 -34.65 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 122.975 0.172 . . . . 63.15 111.211 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.588 ' HB3' ' O ' ' B' ' 114' ' ' THR . 67.8 m-20 -60.63 -42.66 97.33 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-O 121.183 0.516 . . . . 74.35 109.807 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.436 ' O ' ' HD3' ' B' ' 88' ' ' ARG . 98.4 mttt -78.38 -25.87 46.38 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.153 0.798 . . . . 75.31 113.153 -176.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.659 ' HG2' ' O ' ' B' ' 33' ' ' GLU . 14.7 ptp180 -108.29 31.96 5.17 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.704 0.764 . . . . 74.54 112.2 -174.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' B' ' 84' ' ' GLU . 35.2 t -95.55 155.78 16.6 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.092 -1.447 . . . . 63.21 107.092 172.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.495 ' CG1' ' HB ' ' B' ' 91' ' ' VAL . 26.8 m -135.49 158.39 40.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.931 -0.48 . . . . 75.32 110.11 176.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . 0.571 ' CE1' ' HA2' ' A' ' 21' ' ' GLY . 22.1 t80 -107.73 119.82 40.51 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 107.354 -1.35 . . . . 63.41 107.354 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 67.3 t -122.0 107.57 20.14 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 N-CA-C 106.806 -1.553 . . . . 51.05 106.806 173.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.86 171.49 19.99 Favored Glycine 0 C--N 1.276 -2.802 0 C-N-CA 118.29 -1.909 . . . . 75.42 112.712 -176.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 66.6 t30 66.57 28.66 9.26 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.289 1.436 . . . . 72.33 112.208 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 14.7 p -58.49 134.5 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-O 121.412 0.625 . . . . 71.25 109.862 175.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -73.69 146.32 44.57 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.479 -0.782 . . . . 73.22 109.547 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' TYR . . . . . 0.5 ' OH ' ' HG3' ' A' ' 54' ' ' GLU . 45.8 t80 -61.71 -19.24 62.17 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.794 0.838 . . . . 72.42 110.93 -176.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.32 -0.53 55.75 Favored Glycine 0 N--CA 1.427 -1.924 0 CA-C-N 116.01 -0.541 . . . . 73.01 112.551 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 34.0 m -84.64 133.36 34.41 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.895 -0.78 . . . . 74.42 108.895 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 62.0 p -113.02 178.73 4.18 Favored 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 119.74 -0.784 . . . . 64.22 111.132 -177.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.8 -43.36 99.01 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.741 -0.663 . . . . 53.41 110.984 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -58.62 -43.13 89.58 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 111.724 0.268 . . . . 74.35 111.724 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -60.34 -47.93 83.93 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.912 0.863 . . . . 71.32 109.614 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.462 ' HB3' ' HE2' ' B' ' 57' ' ' PHE . 69.4 mt -68.73 -47.32 66.61 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-N 114.271 -1.331 . . . . 74.44 112.816 -177.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -57.34 -48.85 77.92 Favored 'General case' 0 C--O 1.205 -1.284 0 C-N-CA 122.872 0.469 . . . . 64.2 110.569 -176.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.34 -42.72 78.2 Favored 'General case' 0 C--O 1.258 1.522 0 CA-C-O 121.286 0.565 . . . . 70.24 110.631 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -69.1 -42.03 76.67 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.363 -0.835 . . . . 72.14 111.201 -176.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.572 ' CD2' HG13 ' B' ' 83' ' ' ILE . 66.2 m-85 -80.52 -23.17 40.23 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.454 -0.499 . . . . 70.24 111.114 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 32.9 t -71.37 -24.54 62.1 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.435 -0.58 . . . . 75.45 109.435 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 23.8 m -63.95 -27.01 68.85 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.1 0.476 . . . . 71.1 110.005 176.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 63.5 m -97.43 7.51 46.38 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.574 0.583 . . . . 74.33 112.574 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.09 -165.18 29.78 Favored Glycine 0 CA--C 1.507 -0.461 0 C-N-CA 118.169 -1.967 . . . . 74.32 115.783 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 14.7 m -98.18 123.99 42.53 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.862 -0.669 . . . . 72.31 109.442 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.45 HD11 ' HB2' ' B' ' 57' ' ' PHE . 61.9 mt -88.72 131.83 35.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 113.223 0.823 . . . . 73.54 113.223 -178.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . 0.664 ' OD1' ' HB3' ' A' ' 73' ' ' PHE . 18.8 t-20 -99.73 -45.25 5.82 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 124.5 1.12 . . . . 54.52 109.955 177.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.483 ' HB2' ' HB2' ' B' ' 84' ' ' GLU . 98.3 mtt180 -147.46 158.47 43.99 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.181 -0.674 . . . . 70.22 109.181 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -148.93 127.49 3.19 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 C-N-CA 123.658 0.783 . . . . 65.22 109.972 174.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 38.6 m -125.93 133.21 51.92 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.065 -0.971 . . . . 72.52 108.61 -175.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.418 HD12 ' N ' ' B' ' 68' ' ' ILE . 1.2 mp -129.9 122.34 54.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 106.353 -1.721 . . . . 75.33 106.353 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.479 HD23 ' H ' ' B' ' 69' ' ' LEU . 1.7 pt? -121.71 135.25 54.95 Favored 'General case' 0 C--N 1.287 -2.151 0 C-N-CA 120.6 -0.44 . . . . 62.3 110.468 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 64.5 m -115.87 127.08 54.74 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.03 -1.1 . . . . 72.14 108.03 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.484 ' HB3' ' NE2' ' A' ' 24' ' ' GLN . 3.7 p30 -107.8 127.52 53.78 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.258 -0.645 . . . . 72.45 109.258 -177.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.487 ' HE3' ' HB3' ' B' ' 77' ' ' PRO . 44.9 mtpt -124.1 10.88 8.81 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 120.732 -0.387 . . . . 63.21 110.015 -178.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -61.51 -22.7 65.34 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 113.893 1.072 . . . . 74.41 113.893 -177.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 19.8 m -97.81 14.08 28.25 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.025 0.44 . . . . 62.22 109.99 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.22 -44.37 3.09 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 111.275 -0.73 . . . . 75.3 111.275 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -91.37 125.62 57.44 Favored Pre-proline 0 CA--C 1.505 -0.762 0 N-CA-C 110.011 -0.366 . . . . 70.11 110.011 178.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.487 ' HB3' ' HE3' ' B' ' 72' ' ' LYS . 69.3 Cg_endo -76.57 119.55 5.24 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.905 2.404 . . . . 70.44 112.843 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' LYS . . . . . 0.43 ' HB2' ' OD2' ' B' ' 71' ' ' ASP . 24.6 mtmm -118.77 -160.82 0.81 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.094 -1.076 . . . . 70.33 108.094 175.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 178.79 158.26 20.95 Favored Glycine 0 N--CA 1.416 -2.698 0 C-N-CA 119.193 -1.48 . . . . 62.31 114.226 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . 0.405 ' O ' HD23 ' B' ' 69' ' ' LEU . 30.2 m-85 -136.17 153.95 51.1 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 105.784 -1.932 . . . . 73.01 105.784 173.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.37 130.33 40.57 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 109.935 -0.394 . . . . 73.01 109.935 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' TYR . . . . . 0.719 ' OH ' ' HA ' ' A' ' 22' ' ' PRO . 64.0 m-85 -114.03 122.39 46.77 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.912 -1.144 . . . . 54.33 107.912 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.572 HG13 ' CD2' ' B' ' 57' ' ' PHE . 4.6 mm -114.03 129.38 70.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.106 -1.072 . . . . 74.02 108.106 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' B' ' 65' ' ' ARG . 1.3 mp0 -99.48 120.74 40.11 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.54 -1.281 . . . . 74.32 107.54 173.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -88.9 152.8 21.52 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 108.515 -0.92 . . . . 71.34 108.515 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.63 -24.23 64.53 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 110.239 -0.282 . . . . 71.43 110.239 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -120.91 147.09 45.9 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.924 -0.58 . . . . 73.11 110.675 -178.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.436 ' HD3' ' O ' ' B' ' 36' ' ' LYS . 0.0 OUTLIER -72.59 -34.14 67.21 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.0 -0.741 . . . . 73.43 109.0 177.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -59.46 -35.26 73.71 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.204 -0.907 . . . . 74.43 110.465 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 30.8 m -65.78 -36.26 83.02 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.931 -0.577 . . . . 71.54 110.555 -178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.517 ' O ' HG13 ' B' ' 95' ' ' VAL . 1.4 m -69.12 -37.46 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 108.906 -0.775 . . . . 73.52 108.906 -178.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.662 ' O ' HG22 ' B' ' 95' ' ' VAL . 7.2 t70 -68.49 -31.05 70.04 Favored 'General case' 0 C--O 1.215 -0.763 0 CA-C-O 121.67 0.748 . . . . 65.33 109.066 -178.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.99 -31.15 64.32 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.842 -0.617 . . . . 73.21 109.868 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.32 -35.55 61.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.796 -0.638 . . . . 73.51 111.481 -178.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . 0.662 HG22 ' O ' ' B' ' 92' ' ' ASP . 10.4 m -54.31 -21.18 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 112.582 0.586 . . . . 70.31 112.582 178.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.57 -13.97 61.73 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.213 0.53 . . . . 43.41 110.835 177.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 67.1 mtm -96.9 12.98 30.37 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 116.263 -0.426 . . . . 44.03 110.627 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -35.41 -58.36 0.58 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.283 1.033 . . . . 63.41 113.082 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -112.02 98.95 7.7 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 118.553 -1.259 . . . . 63.04 109.14 170.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 75.4 m -139.44 150.85 45.71 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.526 -1.215 . . . . 74.44 109.941 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.05 122.59 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-O 121.481 0.657 . . . . 74.32 110.302 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -120.36 124.89 46.64 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.736 -0.839 . . . . 74.22 108.736 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 61.0 ttt-85 47.9 31.5 2.36 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 125.566 1.546 . . . . 71.03 112.044 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 100.4 -6.36 57.67 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 115.666 -0.697 . . . . 32.42 114.35 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -121.91 150.97 41.23 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 117.838 0.819 . . . . 73.1 111.304 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 30.0 m -82.07 121.58 26.74 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 116.431 -0.35 . . . . 74.33 110.232 -176.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 45.8 pt -101.2 170.66 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 120.577 -0.449 . . . . 60.25 110.151 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 46.7 tptt -128.81 121.61 28.69 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.955 -1.128 . . . . 72.11 107.955 -176.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 95.6 t -115.19 114.42 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 N-CA-C 107.374 -1.343 . . . . 72.31 107.374 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.411 HD23 ' HD2' ' B' ' 111' ' ' PRO . 3.6 tt -138.83 131.12 15.67 Favored Pre-proline 0 C--N 1.292 -1.925 0 N-CA-C 105.938 -1.875 . . . . 71.04 105.938 -173.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.411 ' HD2' HD23 ' B' ' 110' ' ' LEU . 73.6 Cg_exo -53.57 133.51 53.95 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.871 1.714 . . . . 74.03 112.888 178.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' B' ' 38' ' ' SER . 45.1 tttm -109.94 103.6 12.39 Favored 'General case' 0 N--CA 1.389 -3.485 0 N-CA-C 106.495 -1.668 . . . . 65.33 106.495 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.537 ' NH2' ' HA ' ' B' ' 9' ' ' THR 0.358 3.4 ppt_? -115.57 98.68 6.85 Favored 'General case' 0 N--CA 1.409 -2.498 0 C-N-CA 117.57 -1.652 . . . . 72.42 108.825 -177.223 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.588 ' O ' ' HB3' ' B' ' 35' ' ' ASP . 23.4 m -80.29 161.72 24.95 Favored 'General case' 0 C--N 1.27 -2.853 0 CA-C-N 112.275 -2.238 . . . . 74.13 108.378 -173.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -161.11 107.67 1.43 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.63 -0.428 . . . . 72.11 109.95 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 47.4 ttm -104.11 104.21 42.46 Favored Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 109.214 -0.662 . . . . 53.12 109.214 176.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -81.63 103.71 1.4 Allowed 'Trans proline' 0 N--CA 1.442 -1.556 0 C-N-CA 121.792 1.661 . . . . 70.41 109.556 175.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -151.32 60.62 0.41 Allowed Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 119.768 -1.205 . . . . 63.34 113.24 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 32.8 pt -88.6 150.26 3.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 109.12 -0.696 . . . . 71.24 109.12 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 47.7 m -76.63 107.41 8.91 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.195 0.521 . . . . 73.42 109.878 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 23.7 p -106.09 150.82 25.42 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 108.603 -0.888 . . . . 74.21 108.603 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 9.0 t -66.15 140.24 58.19 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.11 0.481 . . . . 63.25 109.888 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -85.38 116.86 23.95 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.215 -0.661 . . . . 54.31 109.215 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 . . . . . 0 C--N 1.301 -1.508 0 N-CA-C 108.484 -0.932 . . . . 75.33 108.484 -179.59 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.104 0 CA-C-O 120.65 0.262 . . . . 70.33 110.949 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.9 pt -94.58 110.75 24.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.589 0.709 . . . . 75.44 111.27 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.81 136.18 15.1 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 108.395 -0.965 . . . . 75.42 108.395 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -61.98 109.21 0.76 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.359 2.039 . . . . 70.4 111.126 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.2 p -119.3 10.59 12.01 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.637 0.732 . . . . 73.53 109.737 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.14 153.74 18.24 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 115.374 -0.83 . . . . 72.01 110.396 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -133.47 106.29 7.38 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 105.058 -2.201 . . . . 65.33 105.058 174.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 79.9 p 71.53 111.95 0.06 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.155 1.782 . . . . 63.41 110.796 -171.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.4 m -58.89 133.5 56.09 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.055 -0.521 . . . . 70.1 111.299 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -80.58 128.44 33.61 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.618 -0.882 . . . . 74.42 108.618 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.4 t -74.3 166.85 22.76 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-O 120.877 0.37 . . . . 73.54 111.7 -176.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp 67.74 -70.97 0.11 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.499 1.52 . . . . 74.14 111.238 -175.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 27.4 ttt -125.44 120.75 31.88 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.43 -1.322 . . . . 74.15 107.43 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.0 p -78.93 -29.36 44.1 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 112.772 0.656 . . . . 62.44 112.772 -173.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -126.94 -167.24 1.7 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.204 0.526 . . . . 52.44 111.166 -176.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 165.37 -143.65 8.63 Favored Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 107.546 -2.222 . . . . 74.42 107.546 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.488 ' HA ' ' CZ ' ' A' ' 65' ' ' ARG . . . 72.88 151.36 0.11 Allowed 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.528 0.936 . . . . 33.31 113.528 174.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.647 ' CD1' ' HG2' ' A' ' 117' ' ' PRO . 55.7 m-85 -94.27 -163.85 1.1 Allowed 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 105.878 -1.897 . . . . 74.3 105.878 175.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.621 ' OG1' ' HA ' ' A' ' 25' ' ' PRO . 34.6 m -111.15 75.3 0.91 Allowed 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 107.717 -1.216 . . . . 71.52 107.717 171.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.51 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -100.64 102.27 13.36 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 115.357 -0.838 . . . . 71.53 111.603 178.28 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.45 -132.6 14.75 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 115.526 -0.761 . . . . 63.31 113.37 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.34 -41.83 69.87 Favored 'Trans proline' 0 CA--C 1.572 2.376 0 C-N-CA 124.267 3.311 . . . . 64.4 117.36 -178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.51 ' HD2' ' O ' ' A' ' 20' ' ' GLU . 43.2 Cg_exo -43.06 151.06 0.29 Allowed 'Trans proline' 0 C--N 1.403 3.421 0 C-N-CA 123.204 2.603 . . . . 75.11 113.819 177.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -76.88 136.77 66.41 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 116.182 -0.463 . . . . 74.14 112.077 -174.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.621 ' HA ' ' OG1' ' A' ' 19' ' ' THR . 27.8 Cg_endo -63.04 132.18 35.67 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.121 2.547 . . . . 61.25 113.605 -177.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.401 ' H ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -116.4 172.26 7.31 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.18 -0.918 . . . . 54.31 111.602 177.139 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.1 t -73.34 146.78 44.99 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.845 -0.616 . . . . 73.53 112.412 -176.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.97 -34.08 8.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.638 -1.164 . . . . 61.43 111.2 172.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -59.87 -47.1 87.13 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.394 0.678 . . . . 52.1 109.201 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.559 ' O ' HG12 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -64.05 -41.75 97.27 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 116.673 -0.24 . . . . 75.41 111.179 177.287 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.18 -42.24 98.23 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.699 0.761 . . . . 75.31 109.356 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.518 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -70.97 -37.68 72.77 Favored 'General case' 0 N--CA 1.379 -3.98 0 CA-C-N 114.771 -1.104 . . . . 74.12 112.589 -178.54 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 41.3 mm-40 -71.17 -44.13 66.11 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.236 0.458 . . . . 74.34 112.236 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.559 HG12 ' O ' ' A' ' 30' ' ' GLU . 21.2 pt -67.42 -35.17 72.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.177 0.513 . . . . 63.0 111.541 -177.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.411 ' OD1' ' HB3' ' A' ' 115' ' ' ASN . 34.7 t70 -68.9 -24.02 64.26 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.881 -0.6 . . . . 74.03 110.471 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 99.7 mttt -77.92 -32.03 51.42 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.2 0.524 . . . . 75.31 110.746 176.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 96.5 mtt180 -94.49 10.8 33.14 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.605 0.717 . . . . 71.35 110.56 -171.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.574 ' HB3' ' HG2' ' A' ' 84' ' ' GLU . 13.6 p -112.16 169.4 8.89 Favored 'General case' 0 N--CA 1.401 -2.887 0 CA-C-N 115.424 -0.807 . . . . 61.01 111.771 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 27.3 m -135.32 158.62 40.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 116.155 -0.475 . . . . 75.55 110.912 -175.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.673 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 46.7 t80 -99.0 121.78 41.4 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 124.572 1.149 . . . . 74.5 108.665 175.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 58.2 t -115.07 113.53 43.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 107.639 -1.245 . . . . 71.35 107.639 174.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.23 170.23 14.0 Favored Glycine 0 C--N 1.305 -1.182 0 C-N-CA 120.052 -1.07 . . . . 41.53 113.769 -177.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.471 ' O ' ' HD3' ' A' ' 105' ' ' ARG . 65.4 t30 68.71 21.49 7.81 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 126.425 1.89 . . . . 61.54 112.505 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.496 ' O ' ' HA3' ' A' ' 79' ' ' GLY . 7.4 p -91.63 103.65 14.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 O-C-N 121.203 -0.936 . . . . 71.11 110.99 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.404 ' HB2' ' NH2' ' A' ' 105' ' ' ARG . 2.3 m-20 -86.71 166.74 15.06 Favored 'General case' 0 C--O 1.261 1.686 0 N-CA-C 108.391 -0.966 . . . . 63.44 108.391 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -50.81 131.77 26.28 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 123.41 0.444 . . . . 73.13 109.825 174.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 137.89 -38.49 1.7 Allowed Glycine 0 N--CA 1.427 -1.945 0 N-CA-C 110.1 -1.2 . . . . 75.32 110.1 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.4 m -84.08 131.97 34.75 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 108.131 -1.063 . . . . 74.33 108.131 176.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.0 p -94.1 162.86 13.7 Favored 'General case' 0 N--CA 1.418 -2.066 0 N-CA-C 109.678 -0.49 . . . . 72.25 109.678 -179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.666 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -65.9 -41.64 91.2 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 109.902 -0.407 . . . . 71.33 109.902 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.535 HE21 ' N ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -61.06 -37.31 82.22 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 120.21 -0.596 . . . . 63.11 112.254 178.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.535 ' N ' HE21 ' A' ' 51' ' ' GLN 0.279 1.9 p30 -73.57 -28.21 61.73 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 119.368 -0.933 . . . . 63.43 110.87 178.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.3 mt -62.61 -46.37 88.59 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 115.431 -0.804 . . . . 71.13 110.076 172.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -58.45 -47.43 84.03 Favored 'General case' 0 C--O 1.189 -2.124 0 N-CA-C 112.957 0.725 . . . . 72.44 112.957 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.59 -47.37 73.43 Favored 'General case' 0 C--O 1.27 2.136 0 CA-C-O 120.957 0.408 . . . . 75.41 111.054 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -64.04 -43.04 96.77 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.147 -0.933 . . . . 74.53 110.825 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -82.65 -25.6 32.94 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 116.081 1.882 . . . . 71.33 116.081 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.5 m -69.89 -28.07 65.32 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-O 120.761 0.315 . . . . 61.4 110.932 -176.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.1 m -59.34 -26.53 65.11 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 120.412 -0.515 . . . . 75.41 110.886 173.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 79.0 m -105.99 9.24 32.63 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.013 0.746 . . . . 71.5 113.013 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' A' ' 90' ' ' SER . . . 163.46 176.5 35.49 Favored Glycine 0 CA--C 1.502 -0.74 0 C-N-CA 118.176 -1.964 . . . . 71.35 115.484 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.5 m -100.66 116.47 32.64 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.107 -0.546 . . . . 75.21 110.109 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.4 mt -83.78 128.29 38.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 115.352 -0.84 . . . . 24.25 112.862 -176.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.536 HD21 ' HA ' ' A' ' 86' ' ' ALA . 89.2 m-20 -87.25 -45.55 10.52 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 115.424 -0.807 . . . . 74.03 109.621 175.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.519 ' HD3' ' OE1' ' A' ' 84' ' ' GLU . 53.8 mtp180 -159.27 165.96 32.35 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.242 -1.392 . . . . 75.15 107.242 -173.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.666 HD11 ' HB1' ' A' ' 50' ' ' ALA . 22.4 pt -146.19 141.94 21.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.193 -1.04 . . . . 75.03 108.193 174.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.6 m -125.32 125.41 43.45 Favored 'General case' 0 C--N 1.269 -2.933 0 N-CA-C 107.217 -1.401 . . . . 62.15 107.217 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.9 mp -120.46 115.88 48.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 105.541 -2.022 . . . . 74.24 105.541 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.574 HD12 ' NH2' ' B' ' 65' ' ' ARG . 1.0 OUTLIER -121.09 128.87 53.0 Favored 'General case' 0 C--N 1.283 -2.292 0 C-N-CA 120.348 -0.541 . . . . 53.32 112.096 -178.477 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 66.1 m -117.37 133.6 55.79 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.805 -0.634 . . . . 64.43 109.795 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -118.41 144.48 45.9 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 120.343 -0.543 . . . . 64.51 110.743 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -111.64 12.04 21.17 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.25 0.548 . . . . 64.32 111.208 174.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.614 ' CE2' ' HB3' ' B' ' 64' ' ' ASN . 30.5 m-85 -66.75 -20.73 66.02 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.633 -0.712 . . . . 75.31 111.275 175.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.6 t -86.13 3.87 40.84 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.71 -0.677 . . . . 65.13 109.658 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.1 -44.26 3.29 Favored Glycine 0 CA--C 1.502 -0.776 0 N-CA-C 110.149 -1.181 . . . . 63.35 110.149 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -96.81 147.16 32.51 Favored Pre-proline 0 C--N 1.292 -1.909 0 N-CA-C 105.915 -1.883 . . . . 73.44 105.915 177.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -75.44 116.57 4.54 Favored 'Trans proline' 0 N--CA 1.432 -2.125 0 N-CA-C 108.792 -1.272 . . . . 64.4 108.792 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 24.7 mtmm -108.05 156.93 18.71 Favored 'General case' 0 CA--C 1.461 -2.449 0 N-CA-C 107.73 -1.211 . . . . 73.33 107.73 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 44' ' ' VAL . . . -136.34 145.25 17.16 Favored Glycine 1 N--CA 1.395 -4.035 0 C-N-CA 119.167 -1.492 . . . . 61.21 112.226 176.724 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -146.2 143.55 29.32 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 108.31 -0.996 . . . . 74.31 108.31 174.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.09 144.37 51.31 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-O 120.777 0.322 . . . . 63.44 110.577 -173.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.741 ' CD1' ' HD2' ' A' ' 112' ' ' LYS . 68.7 m-85 -115.83 115.54 26.43 Favored 'General case' 0 N--CA 1.409 -2.482 0 CA-C-N 115.908 -0.587 . . . . 74.41 109.599 177.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.448 HG23 HG22 ' A' ' 66' ' ' ILE . 33.0 mm -99.85 119.51 48.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 107.632 -1.248 . . . . 73.14 107.632 -177.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.574 ' HG2' ' HB3' ' A' ' 38' ' ' SER . 43.5 mt-10 -96.18 119.96 35.61 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.793 -0.363 . . . . 75.03 110.583 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -99.66 153.14 19.32 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.09 0.472 . . . . 53.44 110.136 177.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.536 ' HA ' HD21 ' A' ' 64' ' ' ASN . . . -64.13 -37.18 86.53 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.667 -0.697 . . . . 70.11 111.515 177.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -116.94 145.38 43.65 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.502 -0.772 . . . . 63.14 112.905 -176.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.544 ' O ' HG22 ' A' ' 91' ' ' VAL . 17.5 mmm180 -62.34 -33.16 74.18 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.381 -0.827 . . . . 75.44 109.549 171.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -62.81 -32.41 73.6 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.217 -0.901 . . . . 72.41 110.449 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.467 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . 47.3 m -67.75 -36.86 81.31 Favored 'General case' 0 N--CA 1.426 -1.67 0 O-C-N 122.383 -0.198 . . . . 61.33 110.546 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 88' ' ' ARG . 2.9 m -64.92 -39.18 84.81 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.886 0 C-N-CA 119.656 -0.818 . . . . 73.23 109.877 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -60.22 -36.3 77.4 Favored 'General case' 0 CA--C 1.502 -0.902 0 O-C-N 123.361 0.413 . . . . 75.51 111.935 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.73 -36.67 65.21 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.055 0.455 . . . . 54.23 110.298 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.07 -45.32 57.95 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.887 -0.597 . . . . 52.34 111.574 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 91' ' ' VAL . 22.1 m -55.39 -21.58 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 113.101 0.778 . . . . 74.52 113.101 177.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.97 -19.04 65.73 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.293 0.568 . . . . 75.32 110.461 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 56.9 mtm -96.19 9.43 41.0 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.653 -0.703 . . . . 63.1 110.173 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.597 ' HA ' HG12 ' A' ' 109' ' ' VAL . 2.7 p-10 -41.97 -41.71 2.59 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.825 0.676 . . . . 73.33 112.825 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -102.22 101.49 11.79 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 119.668 -0.813 . . . . 63.55 109.539 170.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.7 p -140.61 148.27 40.65 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.276 -0.874 . . . . 61.34 110.309 174.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.1 p -113.57 93.14 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 CA-C-O 122.764 1.269 . . . . 62.31 108.981 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -112.36 128.81 56.4 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 114.058 -1.428 . . . . 74.42 107.553 -173.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 59.0 ttt-85 61.1 33.18 19.59 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.27 1.028 . . . . 71.53 109.566 -175.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.59 -2.4 63.32 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 114.768 -1.105 . . . . 75.15 114.5 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.471 ' HD3' ' O ' ' A' ' 43' ' ' ASN . 5.5 ptp180 -113.0 141.14 47.18 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 122.058 -0.672 . . . . 73.31 109.523 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.0 m -83.68 119.72 25.12 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 108.322 -0.992 . . . . 74.34 108.322 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 33.3 pt -101.7 172.16 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 109.619 -0.512 . . . . 75.55 109.619 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 55.3 tptt -132.89 132.32 41.93 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.644 -0.873 . . . . 62.22 108.644 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.673 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 5.0 p -128.18 123.17 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 O-C-N 123.355 0.41 . . . . 71.41 110.498 175.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . 0.289 0.0 OUTLIER -141.95 146.79 42.05 Favored Pre-proline 0 N--CA 1.431 -1.383 0 N-CA-C 108.99 -0.744 . . . . 74.3 108.99 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.46 ' HD3' HG11 ' A' ' 95' ' ' VAL . 37.2 Cg_endo -68.95 131.01 21.43 Favored 'Trans proline' 0 C--O 1.244 0.818 0 C-N-CA 122.099 1.866 . . . . 72.24 114.017 -171.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.741 ' HD2' ' CD1' ' A' ' 82' ' ' TYR . 48.3 mtpt -76.15 152.89 36.58 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.484 -1.235 . . . . 75.53 112.735 -177.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -167.96 160.86 12.49 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 115.584 -0.735 . . . . 71.34 112.348 173.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 114' ' ' THR . 25.3 m 68.76 18.48 8.65 Favored 'General case' 0 CA--C 1.568 1.638 0 C-N-CA 125.096 1.358 . . . . 70.14 114.514 169.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.411 ' HB3' ' OD1' ' A' ' 35' ' ' ASP . 48.0 t30 -97.95 122.58 41.24 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.571 -1.331 . . . . 75.43 108.607 173.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 27.1 ttt -122.95 95.37 46.3 Favored Pre-proline 0 C--N 1.29 -1.982 0 N-CA-C 109.027 -0.731 . . . . 75.23 109.027 177.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.647 ' HG2' ' CD1' ' A' ' 18' ' ' TYR . 50.8 Cg_exo -58.79 111.42 0.88 Allowed 'Trans proline' 0 C--O 1.247 0.939 0 C-N-CA 122.722 2.282 . . . . 55.35 111.677 178.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -164.41 -20.52 0.02 OUTLIER Glycine 0 N--CA 1.432 -1.615 0 CA-C-N 114.769 -1.105 . . . . 75.34 110.91 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 mp 74.55 -11.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.385 0 C-N-CA 123.254 0.622 . . . . 74.53 112.311 175.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 47.3 m 57.57 69.25 0.76 Allowed 'General case' 0 C--O 1.245 0.822 0 CA-C-O 122.283 1.04 . . . . 60.22 108.284 -171.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 50.1 m -93.26 103.36 15.62 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 114.668 -1.151 . . . . 74.15 113.503 -171.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.7 m -92.2 -16.72 25.85 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 105.588 -2.004 . . . . 74.45 105.588 169.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -59.67 128.52 37.37 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 112.335 -2.211 . . . . 75.1 112.677 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 . . . . . 0 C--O 1.248 1.019 0 N-CA-C 109.485 -0.561 . . . . 64.13 109.485 175.403 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.698 0 N-CA-C 109.775 -0.454 . . . . 52.13 109.775 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 32.3 pt -94.03 120.55 43.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 121.305 0.574 . . . . 74.22 111.45 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.79 142.45 10.05 Favored Pre-proline 0 C--N 1.308 -1.229 0 N-CA-C 109.068 -0.715 . . . . 73.14 109.068 178.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -82.08 11.56 3.1 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.604 2.203 . . . . 73.25 112.261 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 52.4 t -95.35 100.44 12.22 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.363 0.602 . . . . 74.02 112.28 -177.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -132.43 101.38 5.32 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 105.293 -2.114 . . . . 64.12 105.293 172.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -137.65 100.88 4.32 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.654 -0.418 . . . . 63.34 111.148 -175.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 55.8 m -125.16 81.41 1.96 Allowed 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.966 -1.124 . . . . 64.24 107.966 174.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 12.9 p -87.63 92.1 8.98 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 114.211 1.189 . . . . 71.32 114.211 -173.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 17.8 p80 175.96 151.49 0.14 Allowed 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 125.877 1.671 . . . . 75.4 107.257 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 20.3 p -72.2 148.15 45.84 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.03 0.443 . . . . 65.32 111.287 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -107.5 170.12 8.17 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.952 -0.567 . . . . 72.2 110.177 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -79.15 79.03 5.6 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.616 0.722 . . . . 73.34 112.281 -176.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 86.0 m -157.7 100.86 1.79 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.141 -0.936 . . . . 73.2 108.495 176.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.5 148.08 9.2 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 108.43 -0.952 . . . . 71.03 108.43 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.456 ' HA3' ' HB2' ' B' ' 24' ' ' GLN . . . -143.63 -158.9 7.75 Favored Glycine 0 N--CA 1.415 -2.704 0 N-CA-C 111.058 -0.817 . . . . 74.2 111.058 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.97 68.45 10.02 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 113.035 0.754 . . . . 31.52 113.035 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . 0.251 94.3 m-85 74.19 -161.24 0.08 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 114.442 1.275 . . . . 74.3 114.442 173.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 5.2 t -92.7 170.57 9.61 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 113.803 1.038 . . . . 62.13 113.803 -165.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . 0.293 31.1 tt0 48.03 140.69 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 129.662 3.185 . . . . 74.3 117.96 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.14 -145.96 30.13 Favored Glycine 0 CA--C 1.501 -0.798 0 CA-C-N 113.874 -1.512 . . . . 50.53 114.056 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -50.52 -44.3 40.56 Favored 'Trans proline' 0 CA--C 1.553 1.444 0 C-N-CA 124.326 3.351 . . . . 74.41 115.339 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -46.47 133.03 16.24 Favored 'Trans proline' 0 C--N 1.396 3.029 0 C-N-CA 122.301 2.001 . . . . 72.53 112.94 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.456 ' HB2' ' HA3' ' B' ' 16' ' ' GLY . 16.0 mm100 -65.87 140.4 97.21 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 115.835 -0.62 . . . . 63.3 110.957 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.16 119.46 6.53 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 122.746 2.297 . . . . 74.11 113.283 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.69 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -79.91 176.0 10.12 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.034 -0.985 . . . . 62.11 110.394 177.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.583 ' HB3' ' OE1' ' B' ' 30' ' ' GLU . 41.2 t -67.71 144.54 55.4 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.927 0.714 . . . . 54.35 112.927 -173.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.99 -35.53 34.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.371 -1.286 . . . . 71.14 111.349 173.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -65.43 -45.33 84.28 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 116.392 -0.367 . . . . 60.23 110.923 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.583 ' OE1' ' HB3' ' B' ' 27' ' ' SER . 2.8 mp0 -64.19 -38.68 91.91 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 120.776 -0.37 . . . . 72.43 110.974 176.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.1 -41.95 98.73 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.493 0.663 . . . . 75.14 109.294 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.532 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 0.0 OUTLIER -72.27 -38.0 68.93 Favored 'General case' 0 N--CA 1.384 -3.739 0 CA-C-N 115.225 -0.898 . . . . 72.04 112.59 -178.438 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -71.24 -41.36 70.21 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.311 0.486 . . . . 73.11 112.311 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.432 HG12 ' O ' ' B' ' 30' ' ' GLU . 15.7 pt -70.01 -35.42 64.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.367 -0.379 . . . . 74.42 110.983 -177.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.65 ' OD2' ' HB2' ' B' ' 113' ' ' ARG . 12.5 t70 -69.38 -27.37 65.25 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.686 -0.688 . . . . 75.0 109.378 -177.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 99.3 mttt -71.18 -34.26 70.76 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.631 -0.713 . . . . 51.01 111.133 176.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -99.77 19.65 15.6 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.051 0.929 . . . . 73.23 110.33 -175.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 68.6 m -96.55 158.33 15.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.192 -1.367 . . . . 75.31 108.554 173.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' B' ' 82' ' ' TYR . 28.2 m -131.74 157.64 43.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.458 -0.571 . . . . 74.3 109.458 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . 0.649 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 40.7 t80 -103.93 119.07 38.16 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.041 -1.096 . . . . 71.05 108.041 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 58.5 t -112.02 109.79 29.84 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 107.414 -1.328 . . . . 74.3 107.414 175.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -113.44 173.96 15.42 Favored Glycine 0 N--CA 1.438 -1.197 0 C-N-CA 120.621 -0.799 . . . . 62.24 112.788 -176.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 7.4 t30 61.01 9.01 2.13 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 126.002 1.721 . . . . 45.03 111.542 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 5.6 p -84.33 90.84 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 106.394 -1.706 . . . . 72.45 106.394 173.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -82.14 84.93 6.88 Favored 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 115.474 1.657 . . . . 53.32 115.474 -165.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' TYR . . . . . 0.565 ' HA ' ' SG ' ' B' ' 70' ' ' CYS . 7.6 t80 70.68 -69.54 0.18 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 113.658 -1.61 . . . . 73.34 113.986 163.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.08 -4.53 22.35 Favored Glycine 0 N--CA 1.468 0.786 0 N-CA-C 116.432 1.333 . . . . 75.5 116.432 -170.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 71.2 m -71.22 130.34 41.18 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 117.989 0.894 . . . . 70.42 110.515 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 36.1 p -79.83 151.71 30.11 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.185 -0.462 . . . . 54.4 111.556 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.63 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -69.29 -41.56 76.66 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.437 0.695 . . . . 72.23 111.573 -175.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -41.8 81.7 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.868 -0.605 . . . . 75.43 111.587 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -69.04 -34.64 75.52 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.837 -0.62 . . . . 64.12 110.994 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 21.3 mt -61.51 -46.45 89.93 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-N 115.485 -0.779 . . . . 74.25 111.638 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -58.64 -47.05 85.72 Favored 'General case' 0 C--O 1.194 -1.827 0 N-CA-C 113.501 0.926 . . . . 75.53 113.501 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.64 -47.66 73.22 Favored 'General case' 0 C--O 1.268 2.029 0 CA-C-N 118.041 0.382 . . . . 70.1 111.185 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -64.26 -42.14 96.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.373 -0.831 . . . . 70.41 111.007 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -82.8 -25.63 32.53 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 115.903 1.816 . . . . 53.14 115.903 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 69.5 m -69.78 -25.0 63.59 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 120.651 0.262 . . . . 71.51 110.673 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 21.4 m -58.44 -27.25 64.18 Favored 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 120.432 -0.507 . . . . 72.12 110.764 172.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 68.2 m -99.94 7.36 44.88 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.741 1.015 . . . . 70.42 113.741 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.41 -167.96 32.54 Favored Glycine 0 CA--C 1.5 -0.856 0 C-N-CA 118.24 -1.933 . . . . 71.51 115.242 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 14.6 m -101.54 120.72 40.75 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 123.127 0.571 . . . . 63.0 110.087 -176.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 64.3 mt -87.52 125.82 41.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.07 0.462 . . . . 53.03 112.178 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . 0.614 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 90.5 m-20 -85.65 -46.85 10.37 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.959 0.885 . . . . 75.13 110.084 177.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.574 ' NH2' HD12 ' A' ' 69' ' ' LEU . 49.6 mtp180 -158.7 165.73 33.67 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.613 -1.625 . . . . 65.41 106.613 -172.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.63 HD11 ' HB1' ' B' ' 50' ' ' ALA . 23.2 pt -146.08 142.09 21.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.142 -1.059 . . . . 74.52 108.142 175.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 91.5 m -125.31 125.73 43.96 Favored 'General case' 0 C--N 1.272 -2.784 0 N-CA-C 107.351 -1.351 . . . . 72.11 107.351 -178.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mp -120.4 116.69 50.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 105.162 -2.162 . . . . 74.34 105.162 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.444 HD12 ' NH2' ' A' ' 65' ' ' ARG 0.256 1.0 OUTLIER -121.36 129.86 53.29 Favored 'General case' 0 C--N 1.277 -2.577 0 C-N-CA 120.308 -0.557 . . . . 73.13 112.106 -178.935 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' CYS . . . . . 0.565 ' SG ' ' HA ' ' B' ' 46' ' ' TYR . 63.1 m -118.02 131.7 56.45 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 115.484 -0.78 . . . . 55.42 109.446 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.539 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 4.5 p-10 -113.5 137.83 51.0 Favored 'General case' 0 CA--C 1.492 -1.282 0 C-N-CA 119.681 -0.808 . . . . 72.32 109.696 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -120.16 12.44 11.85 Favored 'General case' 0 N--CA 1.423 -1.81 0 C-N-CA 119.69 -0.804 . . . . 73.52 108.97 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.408 ' CD2' ' HB2' ' B' ' 71' ' ' ASP . 38.3 p90 -69.79 -22.33 63.33 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 108.48 -0.933 . . . . 73.11 108.48 176.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 40.3 m -75.71 4.27 8.15 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 114.809 -1.087 . . . . 55.21 110.367 175.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.12 -52.99 4.8 Favored Glycine 0 CA--C 1.496 -1.116 0 N-CA-C 110.5 -1.04 . . . . 65.34 110.5 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -95.38 122.74 58.71 Favored Pre-proline 0 C--N 1.287 -2.148 0 N-CA-C 106.952 -1.499 . . . . 72.0 106.952 174.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 59.4 Cg_endo -68.37 119.79 6.78 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 122.068 1.846 . . . . 55.31 111.903 -175.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' LYS . . . . . 0.445 ' HZ3' ' CG ' ' B' ' 71' ' ' ASP . 27.7 mtmm -106.22 162.92 13.23 Favored 'General case' 0 CA--C 1.476 -1.888 0 N-CA-C 108.285 -1.006 . . . . 74.31 108.285 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -133.97 144.55 16.53 Favored Glycine 0 N--CA 1.407 -3.257 0 C-N-CA 119.498 -1.334 . . . . 64.31 112.14 175.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -148.68 143.28 26.37 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.622 -0.881 . . . . 75.03 108.622 172.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.79 144.55 51.53 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 120.851 0.358 . . . . 44.13 110.734 -172.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' B' ' 39' ' ' VAL . 72.6 m-85 -115.31 115.65 26.99 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 115.852 -0.613 . . . . 70.5 109.455 176.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.45 HG23 HG22 ' B' ' 66' ' ' ILE . 33.1 mm -100.37 118.52 47.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 107.425 -1.324 . . . . 70.23 107.425 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' GLU . . . . . 0.427 ' OE1' ' HD3' ' B' ' 65' ' ' ARG . 46.5 mt-10 -95.6 119.21 33.7 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.667 -0.413 . . . . 72.35 110.331 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -97.4 153.71 17.93 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.005 0.431 . . . . 65.53 110.855 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.456 ' HA ' HD21 ' B' ' 64' ' ' ASN . . . -61.14 -30.31 70.31 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.492 -0.776 . . . . 73.02 112.046 177.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -131.27 157.82 42.27 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.477 0.656 . . . . 74.21 112.3 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.59 ' O ' HG22 ' B' ' 91' ' ' VAL . 19.8 mmm180 -68.29 -33.36 74.2 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.535 -1.212 . . . . 74.31 109.941 172.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -65.26 -28.6 69.46 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.312 -0.404 . . . . 73.12 111.461 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 39.9 m -68.77 -37.23 79.18 Favored 'General case' 0 N--CA 1.433 -1.298 0 O-C-N 122.273 -0.267 . . . . 45.33 110.36 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.59 HG22 ' O ' ' B' ' 88' ' ' ARG . 3.6 m -65.89 -38.48 82.25 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 N-CA-C 108.894 -0.78 . . . . 72.41 108.894 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -62.76 -35.83 81.1 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.549 0.74 . . . . 73.34 109.424 -177.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.38 -37.8 63.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.762 -0.654 . . . . 65.31 110.858 177.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.0 -45.23 61.72 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.951 -0.568 . . . . 51.32 111.659 -176.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . 0.509 HG13 ' O ' ' B' ' 91' ' ' VAL . 25.5 m -54.53 -21.86 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 113.191 0.812 . . . . 52.01 113.191 178.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.97 -12.42 61.64 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.107 0.48 . . . . 63.13 110.862 177.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 60.6 mtm -100.03 9.72 42.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.171 -0.468 . . . . 54.2 110.707 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . 0.553 ' HA ' HG12 ' B' ' 109' ' ' VAL . 2.5 p-10 -46.91 -34.5 5.52 Favored 'General case' 0 C--O 1.201 -1.483 0 N-CA-C 115.549 1.685 . . . . 70.32 115.549 -177.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -100.52 29.62 4.34 Favored 'General case' 0 CA--C 1.58 2.104 0 CA-C-N 119.81 1.187 . . . . 74.32 111.941 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 43.4 p -88.95 160.17 17.28 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.259 -0.9 . . . . 73.12 111.815 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' B' ' 106' ' ' THR . 14.9 p -97.16 139.61 19.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.465 -0.569 . . . . 74.21 109.465 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -138.92 122.84 17.76 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 109.185 -0.672 . . . . 73.21 109.185 -176.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 62.5 ttp85 54.44 32.51 16.8 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 125.279 1.431 . . . . 74.32 111.292 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.81 -7.6 63.1 Favored Glycine 0 C--N 1.305 -1.166 0 CA-C-N 115.035 -0.984 . . . . 41.21 114.741 175.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -132.8 153.58 51.12 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 117.862 0.831 . . . . 74.23 110.218 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' B' ' 101' ' ' VAL . 56.8 m -77.89 126.46 30.88 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 120.595 0.236 . . . . 52.4 111.015 -174.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 2.4 pp -102.83 172.58 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 120.456 -0.497 . . . . 71.04 111.202 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 56.7 tptt -129.58 132.71 46.86 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.67 -0.863 . . . . 65.14 108.67 -178.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.649 ' HA ' ' O ' ' B' ' 40' ' ' TYR 0.276 6.2 p -127.4 126.94 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-O 121.638 0.732 . . . . 72.44 110.277 175.333 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.321 0.3 OUTLIER -143.1 137.08 14.51 Favored Pre-proline 0 C--N 1.285 -2.202 0 N-CA-C 105.916 -1.883 . . . . 72.45 105.916 -168.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.576 ' HB2' ' OG1' ' B' ' 114' ' ' THR . 58.2 Cg_endo -74.2 136.75 22.65 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 121.775 1.65 . . . . 72.15 112.862 -177.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -92.81 146.45 23.64 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 115.641 -0.709 . . . . 73.43 110.28 -176.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.65 ' HB2' ' OD2' ' B' ' 35' ' ' ASP . 9.2 tpt180 54.82 32.41 17.59 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.371 1.081 . . . . 73.11 110.138 175.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.576 ' OG1' ' HB2' ' B' ' 111' ' ' PRO . 95.5 m -80.08 84.57 5.78 Favored 'General case' 0 N--CA 1.399 -3.0 0 CA-C-O 122.352 1.072 . . . . 71.44 112.9 -175.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -108.47 92.78 4.2 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 103.705 -2.702 . . . . 74.45 103.705 169.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 24.1 ttt -120.28 139.54 28.72 Favored Pre-proline 0 C--N 1.284 -2.279 0 CA-C-N 115.053 -0.976 . . . . 74.31 110.715 -169.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -67.85 99.58 0.56 Allowed 'Trans proline' 0 N--CA 1.445 -1.362 0 N-CA-C 108.117 -1.532 . . . . 72.53 108.117 170.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.65 -176.81 33.9 Favored Glycine 0 N--CA 1.431 -1.68 0 CA-C-N 115.391 -0.822 . . . . 73.34 113.612 -174.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 2.0 mp 70.44 108.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.772 0 C-N-CA 124.174 0.99 . . . . 70.11 110.966 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 39.5 p -62.05 133.99 56.03 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 114.954 -1.021 . . . . 63.42 109.958 178.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 20.3 p -72.05 95.02 1.56 Allowed 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 120.914 0.388 . . . . 71.3 111.159 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 40.8 p -128.82 102.12 6.41 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.315 0.579 . . . . 55.55 110.912 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -111.47 123.82 51.0 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.423 -0.584 . . . . 75.34 109.423 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 . . . . . 0 C--N 1.307 -1.249 0 CA-C-O 118.663 -0.684 . . . . 72.2 110.544 -178.349 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.845 0 N-CA-C 109.67 -0.493 . . . . 75.5 109.67 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.413 ' N ' HD12 ' A' ' 2' ' ' ILE . 2.4 mp -86.05 117.66 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 107.7 -1.222 . . . . 64.14 107.7 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -123.99 135.69 26.62 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 116.21 -0.45 . . . . 70.51 110.128 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.8 103.58 0.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.26 1.974 . . . . 74.25 111.033 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.1 p -155.69 147.42 23.09 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.365 -0.834 . . . . 61.2 109.162 -177.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 27.5 ttt -139.68 104.48 4.92 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.43 -0.582 . . . . 71.22 109.43 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -138.86 101.86 4.41 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.888 0.852 . . . . 74.44 110.485 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.5 m -145.2 83.64 1.68 Allowed 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.785 -0.82 . . . . 70.23 108.785 178.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.6 p -143.43 81.81 1.72 Allowed 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.419 -0.81 . . . . 63.45 112.611 -178.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -138.52 88.03 2.27 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.499 -1.297 . . . . 75.05 107.499 174.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.1 p -139.46 2.62 2.05 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 112.682 0.623 . . . . 60.41 112.682 -176.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.459 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 11.2 mptt -107.13 94.63 5.2 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.37 0.605 . . . . 62.23 109.796 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.486 ' O ' ' HB2' ' B' ' 22' ' ' PRO . 12.2 tpt -126.99 -55.72 1.37 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.161 -1.051 . . . . 61.01 108.161 -177.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.7 m -72.07 131.89 43.47 Favored 'General case' 0 C--O 1.252 1.215 0 N-CA-C 108.803 -0.814 . . . . 72.24 108.803 177.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.585 ' HA ' ' NZ ' ' A' ' 78' ' ' LYS . . . -132.55 -82.97 0.49 Allowed 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 115.601 1.704 . . . . 63.3 115.601 -171.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.89 -155.72 16.08 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.851 -1.166 . . . . 72.41 112.75 -176.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.52 -170.37 1.71 Allowed 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.621 0.724 . . . . 44.51 112.679 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -126.33 122.97 36.95 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 124.28 1.032 . . . . 65.52 108.223 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.8 m -142.55 141.34 32.02 Favored 'General case' 0 CA--C 1.553 1.085 0 O-C-N 123.403 0.439 . . . . 73.43 110.859 -171.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -156.49 -172.25 4.0 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 105.252 -2.129 . . . . 64.42 105.252 175.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.402 ' H ' ' HD2' ' A' ' 23' ' ' PRO . . . -126.65 -99.62 1.11 Allowed Glycine 0 C--N 1.312 -0.771 0 N-CA-C 110.294 -1.123 . . . . 64.03 110.294 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.457 ' HD2' ' OH ' ' B' ' 82' ' ' TYR . 10.3 Cg_endo -53.68 -39.17 84.33 Favored 'Trans proline' 0 CA--C 1.577 2.672 0 C-N-CA 122.793 2.328 . . . . 74.54 116.273 176.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.402 ' HD2' ' H ' ' A' ' 21' ' ' GLY . 84.7 Cg_endo -76.5 138.61 19.72 Favored 'Trans proline' 0 C--N 1.392 2.861 0 CA-C-N 121.64 1.621 . . . . 73.31 113.034 -176.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -135.34 165.69 34.5 Favored Pre-proline 0 C--N 1.297 -1.688 0 N-CA-C 106.816 -1.549 . . . . 72.43 106.816 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -50.26 112.27 0.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.461 2.107 . . . . 73.24 112.373 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.819 HD13 ' H ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -61.72 -160.98 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 126.759 2.023 . . . . 72.31 114.203 178.467 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.533 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 42.7 m -60.5 145.67 47.63 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 121.969 -0.457 . . . . 60.23 111.157 -178.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.722 ' O ' ' HG2' ' A' ' 32' ' ' LYS . . . -54.94 -49.16 72.05 Favored 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 114.688 1.366 . . . . 50.25 114.688 -172.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.531 ' OE2' ' HG3' ' A' ' 32' ' ' LYS . 32.7 mm-40 -73.34 -29.93 63.0 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 113.295 0.85 . . . . 70.52 113.295 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.435 ' CB ' HD23 ' A' ' 26' ' ' LEU . 4.3 mp0 -60.87 -37.63 82.8 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.104 -0.332 . . . . 73.22 110.104 171.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 27' ' ' SER . 94.5 mttt -62.1 -50.86 70.25 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 108.312 -0.995 . . . . 72.31 108.312 179.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.722 ' HG2' ' O ' ' A' ' 28' ' ' ALA . 10.4 mmmm -53.05 -47.04 68.72 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-N 114.677 -1.147 . . . . 72.54 110.114 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -71.09 -45.88 62.89 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.864 -1.062 . . . . 73.45 111.072 -172.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 20.4 pt -71.35 -37.95 67.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 112.386 0.513 . . . . 72.45 112.386 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.506 ' OD2' ' HA ' ' A' ' 114' ' ' THR . 31.8 t70 -65.23 -32.2 73.75 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.931 0.492 . . . . 75.42 111.489 -177.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.691 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 98.2 mttt -56.73 -26.2 56.51 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.461 0.648 . . . . 73.12 111.206 177.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 -115.9 15.79 16.24 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-N 115.871 -0.604 . . . . 73.43 111.258 -172.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.563 ' OG ' ' HE2' ' A' ' 112' ' ' LYS . 10.3 t -95.66 143.95 26.5 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 121.569 0.7 . . . . 74.44 110.168 -177.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.723 HG22 HG23 ' A' ' 91' ' ' VAL . 13.7 t -127.36 148.42 32.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 115.663 -0.698 . . . . 51.52 109.459 -175.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.63 ' CZ ' ' HG3' ' B' ' 22' ' ' PRO . 35.7 t80 -96.32 124.86 40.47 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.907 -1.145 . . . . 62.31 107.907 169.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.1 t -118.51 112.18 37.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.438 -1.319 . . . . 54.54 107.438 174.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.66 164.04 12.65 Favored Glycine 0 C--N 1.289 -2.066 0 C-N-CA 119.637 -1.268 . . . . 75.54 113.836 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.554 HD21 ' HB2' ' A' ' 105' ' ' ARG . 12.3 t30 55.79 32.28 19.22 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.487 1.515 . . . . 71.31 112.905 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.0 p -55.92 132.48 19.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 121.479 0.657 . . . . 64.41 109.564 172.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -69.33 140.96 54.36 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 114.994 -1.003 . . . . 72.32 108.852 -174.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.541 ' CD2' ' HB2' ' A' ' 77' ' ' PRO . 0.7 OUTLIER -74.95 93.82 2.74 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 108.33 -0.989 . . . . 54.33 108.33 -179.52 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.76 -20.73 1.15 Allowed Glycine 0 N--CA 1.414 -2.821 0 N-CA-C 109.037 -1.625 . . . . 74.21 109.037 -174.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.528 ' OG ' ' HD3' ' A' ' 103' ' ' ARG . 73.1 m -91.89 78.52 5.36 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-O 121.951 0.881 . . . . 73.32 109.614 177.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.582 HG21 ' HB ' ' B' ' 49' ' ' THR . 51.5 p -65.39 -178.03 0.47 Allowed 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 114.429 -1.259 . . . . 64.24 113.15 177.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.501 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -51.22 -48.5 62.04 Favored 'General case' 0 C--O 1.202 -1.404 0 CA-C-N 115.12 -0.946 . . . . 61.55 112.152 -173.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -60.45 -38.81 85.36 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.711 0.634 . . . . 75.32 112.711 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -39.89 95.1 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 107.657 -1.238 . . . . 65.42 107.657 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.5 mt -71.97 -43.31 65.35 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 113.934 -1.484 . . . . 74.31 111.43 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 51.0 mt-10 -57.62 -48.93 78.08 Favored 'General case' 0 C--O 1.181 -2.509 0 CA-C-O 119.396 -0.335 . . . . 73.42 110.848 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.93 -48.28 80.37 Favored 'General case' 0 C--O 1.264 1.862 0 CA-C-O 121.341 0.591 . . . . 64.51 111.356 -177.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -66.33 -38.88 88.7 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.324 -0.853 . . . . 74.45 110.95 -176.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -81.37 -22.39 38.4 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 113.793 1.035 . . . . 72.52 113.793 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.8 t -68.74 -25.42 64.73 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.679 -0.86 . . . . 64.34 108.679 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.6 m -62.01 -28.51 69.63 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 116.026 -0.534 . . . . 73.23 110.004 174.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 61.1 m -95.68 0.27 52.43 Favored 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 112.917 0.71 . . . . 54.44 112.917 178.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.37 -159.32 28.07 Favored Glycine 0 C--O 1.22 -0.745 0 C-N-CA 118.865 -1.636 . . . . 62.04 115.424 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.9 m -112.85 127.95 56.32 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 122.523 0.329 . . . . 53.43 110.899 -175.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.466 ' CD1' ' HA ' ' A' ' 54' ' ' GLU . 75.3 mt -89.14 134.15 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 N-CA-C 113.186 0.81 . . . . 74.21 113.186 -177.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -101.54 -44.41 5.6 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.537 1.135 . . . . 54.24 111.869 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.435 ' HD3' ' OE2' ' A' ' 84' ' ' GLU . 26.7 mtp180 -145.15 152.82 40.63 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 108.266 -1.012 . . . . 63.43 108.266 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.1 tt -149.03 132.47 7.64 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-N 115.782 -0.644 . . . . 71.3 109.895 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.3 m -124.73 129.17 49.97 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.136 -1.431 . . . . 53.44 107.136 -176.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 mp -128.18 119.93 52.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 106.384 -1.71 . . . . 73.2 106.384 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.58 ' HG ' ' CE1' ' A' ' 80' ' ' TYR 0.352 1.0 OUTLIER -120.75 130.99 54.26 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 119.672 -0.811 . . . . 74.4 112.13 176.344 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.553 ' HB2' HG23 ' B' ' 66' ' ' ILE . 66.4 m -113.43 118.64 35.09 Favored 'General case' 0 N--CA 1.411 -2.402 0 C-N-CA 124.461 1.105 . . . . 72.43 108.754 -176.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.517 ' HA ' ' HA ' ' B' ' 65' ' ' ARG . 9.5 t0 -116.23 118.23 32.22 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 122.77 0.428 . . . . 73.5 109.968 -176.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 39.0 ttmt -114.65 16.48 17.51 Favored 'General case' 0 C--N 1.274 -2.686 0 C-N-CA 123.646 0.778 . . . . 61.21 110.632 -174.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.4 ' HB3' ' HB3' ' B' ' 64' ' ' ASN . 0.7 OUTLIER -63.07 -23.7 67.57 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 119.481 -0.888 . . . . 73.13 112.773 -176.154 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.0 t -92.39 11.5 25.87 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.396 0.617 . . . . 75.34 110.831 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.18 -52.66 1.62 Allowed Glycine 0 CA--C 1.5 -0.888 0 C-N-CA 120.474 -0.87 . . . . 65.15 111.319 178.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -89.98 126.88 55.84 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 107.748 -1.205 . . . . 61.13 107.748 175.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.541 ' HB2' ' CD2' ' A' ' 46' ' ' TYR . 73.4 Cg_endo -72.58 118.71 5.71 Favored 'Trans proline' 0 N--CA 1.436 -1.878 0 C-N-CA 121.586 1.524 . . . . 72.55 112.225 -176.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.585 ' NZ ' ' HA ' ' A' ' 15' ' ' ALA . 23.7 mtmt -89.78 173.15 8.42 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 114.842 -1.072 . . . . 73.35 109.175 178.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.15 137.52 4.83 Favored Glycine 1 N--CA 1.386 -4.667 0 C-N-CA 120.361 -0.923 . . . . 25.22 111.106 -178.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.58 ' CE1' ' HG ' ' A' ' 69' ' ' LEU 0.263 0.0 OUTLIER -150.49 143.53 24.79 Favored 'General case' 0 C--N 1.273 -2.74 0 CA-C-N 114.906 -0.647 . . . . 74.22 110.032 173.642 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.45 147.56 52.56 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.68 -0.691 . . . . 65.13 109.568 -173.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 80.7 m-85 -122.66 119.15 29.9 Favored 'General case' 0 C--N 1.273 -2.733 0 N-CA-C 108.198 -1.038 . . . . 73.01 108.198 176.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.6 mm -108.93 136.0 46.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 107.775 -1.194 . . . . 70.35 107.775 -175.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.435 ' OE2' ' HD3' ' A' ' 65' ' ' ARG . 41.7 mt-10 -113.82 124.88 53.31 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.098 -0.704 . . . . 74.12 109.098 176.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -97.11 164.25 12.58 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 111.806 0.298 . . . . 74.04 111.806 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.69 -41.98 59.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.234 0.54 . . . . 61.51 110.659 174.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.441 ' HB3' ' ND2' ' A' ' 89' ' ' ASN . 27.9 mm-40 -101.6 144.56 30.19 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.298 0.57 . . . . 54.4 112.134 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.77 -25.4 59.05 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.178 -1.416 . . . . 75.43 107.178 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.441 ' ND2' ' HB3' ' A' ' 87' ' ' GLU . 9.0 p30 -72.43 -20.96 61.32 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.266 -0.574 . . . . 72.43 111.085 178.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 m -71.58 -39.89 70.29 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 122.208 -0.307 . . . . 54.12 110.561 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.723 HG23 HG22 ' A' ' 39' ' ' VAL . 2.8 p -67.52 -39.38 82.32 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 C-N-CA 120.295 -0.562 . . . . 52.42 109.88 178.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -61.84 -32.5 72.83 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.766 -0.652 . . . . 74.43 110.149 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.89 -35.23 64.67 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.209 -0.451 . . . . 60.42 111.255 176.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.29 -38.09 56.62 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 116.216 -0.447 . . . . 73.14 111.239 -175.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 91' ' ' VAL . 14.4 m -56.84 -21.76 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 114.043 1.127 . . . . 73.1 114.043 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.49 -11.57 60.94 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.934 0.873 . . . . 62.13 110.385 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 7.1 ttp -101.25 5.36 42.47 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.855 -1.066 . . . . 70.21 108.546 -176.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 1.3 p-10 -37.7 -42.11 0.54 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.799 1.407 . . . . 72.1 114.799 -177.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -117.42 104.53 11.19 Favored 'General case' 0 N--CA 1.408 -2.539 0 CA-C-O 121.841 0.829 . . . . 72.13 109.777 174.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.5 t -147.49 165.2 31.0 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 114.01 -1.45 . . . . 65.14 108.451 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 106' ' ' THR . 7.1 p -112.7 110.58 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-O 122.244 1.021 . . . . 73.03 109.551 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -107.31 123.58 48.54 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.792 -1.094 . . . . 62.5 109.416 -173.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.528 ' HD3' ' OG ' ' A' ' 48' ' ' SER . 42.8 mtp-105 44.5 31.34 0.59 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.287 1.435 . . . . 75.43 114.632 -176.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 104.23 -4.34 44.5 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 114.984 -1.007 . . . . 74.13 113.342 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.554 ' HB2' HD21 ' A' ' 43' ' ' ASN . 1.3 ptp180 -130.02 139.97 50.94 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 113.182 0.808 . . . . 70.24 113.182 176.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 101' ' ' VAL . 31.9 m -72.05 122.61 21.21 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.439 -0.801 . . . . 60.5 111.088 -177.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 43.6 pt -102.53 170.74 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 120.844 0.354 . . . . 70.01 110.765 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 27.0 mmmt -127.01 122.86 35.67 Favored 'General case' 0 CA--C 1.486 -1.487 0 C-N-CA 124.159 0.984 . . . . 74.53 109.632 176.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 32.9 m -128.31 115.95 40.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-O 121.048 0.451 . . . . 60.43 109.89 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.486 HD23 ' NH1' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -146.15 160.13 43.79 Favored Pre-proline 0 C--N 1.289 -2.064 0 N-CA-C 108.758 -0.83 . . . . 64.02 108.758 -177.186 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.43 139.94 13.23 Favored 'Trans proline' 0 N--CA 1.436 -1.884 0 C-N-CA 121.118 1.212 . . . . 64.21 111.335 -173.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.563 ' HE2' ' OG ' ' A' ' 38' ' ' SER . 33.3 mtmt -77.92 135.91 37.93 Favored 'General case' 0 N--CA 1.406 -2.651 0 N-CA-C 106.533 -1.655 . . . . 65.33 106.533 175.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.486 ' NH1' HD23 ' A' ' 110' ' ' LEU . 10.2 mpt_? -78.45 -64.73 1.1 Allowed 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 113.336 0.865 . . . . 74.13 113.336 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.506 ' HA ' ' OD2' ' A' ' 35' ' ' ASP . 20.4 p -148.85 98.07 2.8 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.863 0.319 . . . . 71.21 111.863 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.597 ' HB2' ' HB ' ' B' ' 19' ' ' THR . 39.1 t30 -157.89 107.3 2.09 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 121.669 0.747 . . . . 73.31 112.418 173.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 23.9 ptp -67.36 125.19 90.75 Favored Pre-proline 0 C--N 1.304 -1.386 0 CA-C-N 114.302 -1.317 . . . . 73.11 111.331 -178.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -94.32 174.95 1.33 Allowed 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.615 2.21 . . . . 70.22 111.942 176.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -102.3 148.2 17.49 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 111.788 -0.525 . . . . 40.15 111.788 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.499 HG22 HD12 ' A' ' 26' ' ' LEU . 10.8 tt -148.71 171.04 2.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 107.844 -1.169 . . . . 75.23 107.844 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.2 m -70.51 99.66 1.66 Allowed 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.573 -0.529 . . . . 64.44 109.573 175.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.5 m -79.52 96.66 6.17 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 115.803 -0.635 . . . . 65.03 110.132 -178.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.7 t -137.97 137.85 38.35 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 109.611 -0.515 . . . . 74.12 109.611 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -172.36 -72.24 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.801 -0.636 . . . . 71.25 109.342 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 . . . . . 0 C--N 1.31 -1.127 0 CA-C-N 115.618 -0.719 . . . . 74.32 109.28 -179.456 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.421 0 CA-C-O 121.563 0.697 . . . . 71.13 109.791 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 22.6 pt -99.73 110.35 26.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 115.115 -0.948 . . . . 55.15 111.41 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . 0.508 ' HB1' ' HD2' ' B' ' 4' ' ' PRO . . . -151.36 173.75 4.14 Favored Pre-proline 0 C--N 1.302 -1.472 0 N-CA-C 107.445 -1.317 . . . . 54.11 107.445 -178.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.508 ' HD2' ' HB1' ' B' ' 3' ' ' ALA . 52.9 Cg_exo -26.58 120.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.393 2.885 0 C-N-CA 124.982 3.788 . . . . 75.15 114.337 175.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 12.2 p -57.02 98.33 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 114.775 1.398 . . . . 70.31 114.775 -175.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -169.44 156.33 6.7 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.488 -1.301 . . . . 52.02 107.488 176.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -91.48 148.8 22.04 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.622 -0.431 . . . . 54.34 109.925 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 28.2 p -75.15 85.48 2.38 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 121.613 0.721 . . . . 72.53 111.364 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 5.2 t -144.16 135.92 26.06 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.095 -1.076 . . . . 54.11 108.095 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -89.43 76.63 7.46 Favored 'General case' 0 CA--C 1.494 -1.211 0 CA-C-O 121.713 0.768 . . . . 70.4 109.846 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 22.0 p -146.44 93.86 2.36 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 114.51 -1.223 . . . . 65.01 109.969 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -108.15 -41.51 4.89 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.203 -0.908 . . . . 74.31 109.256 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 27.9 ttt -143.15 82.22 1.74 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.705 -0.68 . . . . 74.24 109.753 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 5.3 t -158.84 95.92 1.32 Allowed 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 114.869 -1.06 . . . . 71.43 109.425 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.07 134.12 35.54 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.754 -0.657 . . . . 52.31 109.682 -178.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.52 -48.17 4.0 Favored Glycine 0 C--N 1.306 -1.093 0 CA-C-N 116.518 -0.31 . . . . 74.03 112.679 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.02 99.76 7.82 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.101 0.477 . . . . 70.24 111.829 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -135.89 -57.11 0.77 Allowed 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 106.55 -1.648 . . . . 74.43 106.55 176.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.597 ' HB ' ' HB2' ' A' ' 115' ' ' ASN 0.524 49.3 m 88.83 66.44 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 118.521 2.785 . . . . 64.01 118.521 169.548 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . 0.421 ' H ' ' CD ' ' B' ' 20' ' ' GLU . 0.1 OUTLIER -108.13 -30.72 8.25 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 102.445 -3.168 . . . . 75.2 102.445 163.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.417 ' HA3' ' HD2' ' B' ' 22' ' ' PRO . . . 101.16 -100.73 2.14 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 112.483 -2.144 . . . . 35.41 113.162 170.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.63 ' HG3' ' CZ ' ' A' ' 40' ' ' TYR . 6.6 Cg_endo -43.1 -55.55 2.75 Favored 'Trans proline' 0 CA--C 1.6 3.801 0 C-N-CA 124.657 3.571 . . . . 71.32 115.607 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.558 ' HG3' ' HB3' ' A' ' 15' ' ' ALA . 19.8 Cg_endo -91.4 167.5 3.45 Favored 'Trans proline' 0 C--N 1.364 1.358 0 C-N-CA 122.498 2.132 . . . . 72.23 111.729 177.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -124.96 155.52 70.43 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-O 118.991 -0.528 . . . . 74.35 110.372 176.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -27.82 115.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.167 1 C-N-CA 125.967 4.445 . . . . 45.43 116.623 -176.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.692 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -78.12 172.04 14.14 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.302 -1.317 . . . . 63.02 112.174 175.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 19.6 m -69.19 147.81 50.78 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 113.798 1.036 . . . . 73.03 113.798 -175.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.716 ' O ' ' HG2' ' B' ' 32' ' ' LYS . . . -53.74 -46.68 70.93 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 114.992 -1.004 . . . . 72.35 110.458 174.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.542 ' HA ' ' CG ' ' B' ' 32' ' ' LYS . 68.5 mm-40 -68.95 -29.41 67.64 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 112.988 0.736 . . . . 72.11 112.988 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.514 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.4 OUTLIER -61.39 -37.61 84.04 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.502 -0.479 . . . . 64.11 110.608 172.116 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -63.12 -50.26 71.15 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 107.651 -1.241 . . . . 73.42 107.651 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.716 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 10.4 mmmm -52.06 -47.05 65.33 Favored 'General case' 0 C--O 1.214 -0.771 0 C-N-CA 124.459 1.103 . . . . 73.13 110.764 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -66.3 -49.87 65.57 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 114.005 1.113 . . . . 74.4 114.005 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.514 HG12 ' O ' ' B' ' 30' ' ' GLU . 28.6 pt -70.52 -36.17 64.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 111.969 0.359 . . . . 63.34 111.969 -174.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.61 ' OD2' ' HD2' ' B' ' 113' ' ' ARG . 7.6 t70 -63.04 -36.37 83.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.809 -0.632 . . . . 64.01 111.449 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.655 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 98.5 mttt -56.69 -25.26 53.59 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.474 0.654 . . . . 74.13 110.795 177.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.574 ' HD3' ' O ' ' B' ' 85' ' ' PHE . 70.1 mtt85 -112.37 14.11 20.35 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 115.515 -0.766 . . . . 74.12 111.857 -172.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 42.4 m -93.89 143.45 26.33 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.474 0.654 . . . . 71.14 110.946 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.655 HG22 HG23 ' B' ' 91' ' ' VAL . 14.7 t -129.85 152.71 37.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.714 -0.847 . . . . 60.54 108.714 -178.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . 0.612 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 18.9 t80 -105.33 123.42 47.83 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 107.117 -1.438 . . . . 73.23 107.117 173.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 48.9 t -116.76 111.58 35.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 107.364 -1.347 . . . . 71.32 107.364 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . 0.431 ' O ' ' HB ' ' B' ' 107' ' ' ILE . . . -112.9 169.7 13.08 Favored Glycine 0 C--N 1.291 -1.941 0 C-N-CA 119.463 -1.351 . . . . 74.32 114.127 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 64.7 t30 62.98 17.32 9.99 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 126.059 1.743 . . . . 73.23 113.267 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.423 HG22 ' HB2' ' B' ' 48' ' ' SER . 11.9 p -62.08 131.59 27.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.264 0.554 . . . . 71.4 109.943 176.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -75.43 156.72 35.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.52 -0.764 . . . . 70.05 109.067 -176.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -68.92 -18.16 64.07 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-O 121.808 0.813 . . . . 72.13 109.839 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.18 -12.73 80.37 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 115.559 -0.746 . . . . 32.12 111.808 178.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.423 ' HB2' HG22 ' B' ' 44' ' ' VAL . 25.1 m -87.23 133.07 33.71 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 108.45 -0.945 . . . . 71.44 108.45 178.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . 0.582 ' HB ' HG21 ' A' ' 49' ' ' THR . 63.2 p -111.9 178.87 4.18 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 116.178 -0.464 . . . . 74.11 111.565 -172.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.439 ' O ' ' HG3' ' B' ' 54' ' ' GLU . . . -63.11 -48.12 79.9 Favored 'General case' 0 C--O 1.2 -1.549 0 N-CA-C 109.954 -0.387 . . . . 71.03 109.954 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -59.12 -39.59 82.77 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 111.946 0.35 . . . . 75.32 111.946 176.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.526 ' HB2' ' H ' ' B' ' 49' ' ' THR . 0.8 OUTLIER -55.94 -46.28 78.58 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.818 0.818 . . . . 74.04 109.765 173.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 99.2 mt -68.35 -43.88 76.51 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.369 -1.287 . . . . 72.3 112.149 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.46 ' HA ' ' CD1' ' B' ' 63' ' ' ILE . 48.3 mt-10 -57.97 -50.11 74.51 Favored 'General case' 0 C--O 1.183 -2.432 0 C-N-CA 120.645 -0.422 . . . . 75.03 111.061 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.44 -48.1 77.73 Favored 'General case' 0 C--O 1.25 1.081 0 O-C-N 123.554 0.534 . . . . 62.22 111.643 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -67.3 -37.66 83.72 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.486 -0.779 . . . . 72.11 110.868 -175.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -82.58 -22.88 34.68 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.647 0.98 . . . . 75.03 113.647 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 38.9 t -67.78 -27.96 67.19 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.891 -0.781 . . . . 23.53 108.891 -177.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 21.8 m -60.06 -25.4 65.34 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 115.806 -0.633 . . . . 74.02 110.673 174.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 77.1 m -102.1 2.97 38.14 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.092 0.775 . . . . 52.4 113.092 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.66 -167.6 29.82 Favored Glycine 0 N--CA 1.461 0.321 0 C-N-CA 119.058 -1.544 . . . . 72.31 114.977 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 19.4 t -105.86 127.92 53.43 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-O 120.857 0.36 . . . . 40.45 110.548 -176.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.46 ' CD1' ' HA ' ' B' ' 54' ' ' GLU . 74.2 mt -87.04 133.51 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 113.519 0.933 . . . . 74.1 113.519 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . 0.419 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 94.2 m-20 -103.88 -35.94 7.98 Favored 'General case' 0 C--O 1.172 -3.022 0 CA-C-N 115.823 -0.626 . . . . 71.3 111.757 174.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 43.3 mtp180 -149.02 152.29 36.01 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.622 -0.881 . . . . 72.2 108.622 178.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.553 HG23 ' HB2' ' A' ' 70' ' ' CYS . 0.3 OUTLIER -149.51 131.39 5.65 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.698 0 C-N-CA 124.024 0.93 . . . . 72.13 109.886 177.231 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' B' ' 81' ' ' ALA . 74.1 m -124.79 128.68 49.11 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 106.964 -1.495 . . . . 75.21 106.964 -176.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.16 121.76 60.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 106.098 -1.816 . . . . 64.12 106.098 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.389 1.2 pt? -120.7 132.35 55.03 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 119.311 -0.956 . . . . 73.0 112.64 175.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' B' ' 78' ' ' LYS . 63.7 m -114.43 118.19 33.13 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 107.527 -1.286 . . . . 70.12 107.527 -178.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 8.8 t70 -110.75 115.33 29.37 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 118.788 -1.165 . . . . 64.42 109.276 -176.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -112.63 3.74 16.82 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.191 -1.411 . . . . 64.44 107.191 -178.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -56.96 -21.72 32.47 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 126.551 1.94 . . . . 72.24 113.755 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 43.4 m -109.84 13.81 23.42 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.014 0.435 . . . . 74.23 111.005 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.27 -64.85 0.29 Allowed Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.779 -0.724 . . . . 71.3 112.128 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -96.4 129.63 32.89 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 109.83 -0.433 . . . . 70.02 109.83 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 84.1 Cg_endo -75.4 118.58 5.22 Favored 'Trans proline' 0 N--CA 1.435 -1.957 0 C-N-CA 121.39 1.393 . . . . 74.22 112.714 -178.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' B' ' 70' ' ' CYS . 39.6 mtpt -94.16 -179.59 4.99 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 125.278 1.431 . . . . 75.44 109.578 175.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.35 135.58 3.94 Favored Glycine 0 N--CA 1.403 -3.503 0 C-N-CA 119.177 -1.487 . . . . 63.25 113.407 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . 0.266 0.2 OUTLIER -151.23 145.49 25.42 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 114.616 -0.792 . . . . 75.53 109.97 172.307 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' B' ' 67' ' ' THR . . . -130.75 148.2 52.5 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.553 -0.748 . . . . 71.34 110.265 -174.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' TYR . . . . . 0.457 ' OH ' ' HD2' ' A' ' 22' ' ' PRO . 81.6 m-85 -123.16 116.63 23.75 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.816 -0.809 . . . . 63.33 108.816 177.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 11.4 mm -107.47 133.9 50.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 107.791 -1.188 . . . . 73.11 107.791 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' B' ' 37' ' ' ARG . 53.4 mt-10 -112.2 125.31 54.0 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.171 -1.048 . . . . 75.34 108.171 175.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.574 ' O ' ' HD3' ' B' ' 37' ' ' ARG . 89.4 m-85 -96.54 167.23 11.27 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 112.032 0.382 . . . . 64.4 112.032 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.419 ' HA ' ' ND2' ' B' ' 64' ' ' ASN . . . -81.92 -37.17 27.2 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.923 -0.58 . . . . 75.31 110.811 174.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . 0.541 ' HB2' ' OG ' ' B' ' 90' ' ' SER . 6.9 mp0 -98.73 141.84 31.03 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.462 -0.57 . . . . 61.22 109.462 178.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.25 -26.86 59.17 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 106.762 -1.57 . . . . 72.54 106.762 177.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . 0.442 ' ND2' ' HB3' ' B' ' 87' ' ' GLU . 9.1 p30 -70.97 -21.79 62.28 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.641 -0.709 . . . . 63.12 111.278 177.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' SER . . . . . 0.541 ' OG ' ' HB2' ' B' ' 87' ' ' GLU . 51.4 m -71.95 -37.19 70.02 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 111.957 0.354 . . . . 73.42 111.957 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.655 HG23 HG22 ' B' ' 39' ' ' VAL . 2.2 p -67.83 -41.24 84.85 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 C-N-CA 119.407 -0.917 . . . . 61.22 109.489 175.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -59.16 -33.68 71.19 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.994 -0.548 . . . . 72.21 110.502 178.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.53 -34.24 65.12 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.209 -0.45 . . . . 45.13 111.848 176.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.86 -39.55 50.71 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-O 120.701 0.286 . . . . 74.51 111.163 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . 0.527 HG13 ' O ' ' B' ' 91' ' ' VAL . 19.9 m -56.25 -21.81 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 113.1 0.778 . . . . 44.0 113.1 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.99 -11.24 60.73 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.567 0.699 . . . . 73.14 110.819 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 19.9 mtm -93.88 -0.49 55.68 Favored 'General case' 0 C--O 1.175 -2.83 0 CA-C-O 117.872 -1.061 . . . . 75.15 110.994 175.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . 0.575 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 2.2 p-10 -35.82 -46.27 0.44 Allowed 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 115.372 1.619 . . . . 62.33 115.372 -168.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -93.63 85.33 4.84 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.052 -1.462 . . . . 70.24 107.052 169.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . 0.627 ' HB ' HG12 ' B' ' 107' ' ' ILE . 1.3 m -95.7 137.72 34.37 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 119.979 -0.688 . . . . 63.53 109.404 -175.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 3.7 p -99.91 103.81 15.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 107.664 -1.236 . . . . 54.14 107.664 173.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -134.08 123.68 24.89 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.79 -1.095 . . . . 72.25 109.48 -173.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 58.29 33.48 23.18 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 122.405 1.098 . . . . 55.34 111.356 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.54 2.4 84.77 Favored Glycine 0 C--N 1.317 -0.475 0 CA-C-N 114.827 -1.079 . . . . 75.22 112.522 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -109.7 163.57 13.36 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 109.551 -0.537 . . . . 75.33 109.551 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' B' ' 100' ' ' THR . 62.0 m -108.36 118.73 37.54 Favored 'General case' 0 N--CA 1.404 -2.755 0 N-CA-C 106.985 -1.487 . . . . 61.42 106.985 172.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . 0.627 HG12 ' HB ' ' B' ' 100' ' ' THR . 46.3 pt -103.45 171.61 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 C-N-CA 119.792 -0.763 . . . . 74.43 109.293 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 26.7 mmmt -125.2 125.62 43.92 Favored 'General case' 0 CA--C 1.479 -1.782 0 O-C-N 123.652 0.595 . . . . 74.42 110.019 -177.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 33.9 m -128.12 115.78 39.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 123.786 0.679 . . . . 74.22 109.739 176.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.2 158.56 47.74 Favored Pre-proline 0 C--N 1.294 -1.819 0 N-CA-C 108.762 -0.829 . . . . 73.05 108.762 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.23 146.43 25.14 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 121.498 1.465 . . . . 74.15 114.001 -172.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.479 ' NZ ' ' HA ' ' B' ' 112' ' ' LYS . 0.2 OUTLIER -108.15 138.12 44.97 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.19 -1.411 . . . . 55.2 107.19 176.15 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.61 ' HD2' ' OD2' ' B' ' 35' ' ' ASP . 18.7 tpt180 -167.03 133.22 2.24 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.845 -0.342 . . . . 70.22 110.91 -175.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.439 HG23 HD22 ' B' ' 115' ' ' ASN . 10.0 t -156.63 161.52 39.9 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.064 0.946 . . . . 74.14 109.544 175.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' ASN . . . . . 0.439 HD22 HG23 ' B' ' 114' ' ' THR . 43.3 m-80 68.14 111.86 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.424 0 C-N-CA 124.445 1.098 . . . . 74.53 113.406 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 49.4 ttm -152.64 114.37 2.81 Favored Pre-proline 0 N--CA 1.477 0.917 0 O-C-N 121.716 -0.615 . . . . 65.11 111.417 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -91.91 -38.12 0.04 OUTLIER 'Trans proline' 0 CA--C 1.562 1.899 0 C-N-CA 122.405 2.07 . . . . 62.24 113.196 175.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . 94.19 26.06 15.12 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.849 -0.691 . . . . 60.03 112.531 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 2.3 pp -140.64 179.67 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 122.963 0.505 . . . . 75.43 111.059 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 76.0 p 61.06 89.96 0.07 Allowed 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.941 1.296 . . . . 72.32 113.162 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 27.8 p -140.54 155.66 46.54 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.127 -0.942 . . . . 33.13 110.011 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 34.7 p -64.67 117.41 7.4 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 122.52 0.328 . . . . 75.2 110.639 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -66.85 -54.87 18.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.909 0.385 . . . . 75.43 110.319 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 . . . . . 0 C--N 1.307 -1.251 0 N-CA-C 108.838 -0.801 . . . . 52.21 108.838 176.715 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.637 0 N-CA-C 109.757 -0.46 . . . . 64.3 109.757 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.1 pt -110.09 136.26 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 121.605 0.717 . . . . 74.21 112.029 -177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -150.15 153.65 35.53 Favored Pre-proline 0 C--N 1.291 -1.973 0 N-CA-C 106.066 -1.828 . . . . 64.31 106.066 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.472 ' HB2' ' HG2' ' A' ' 7' ' ' GLN . 34.2 Cg_exo -56.55 127.88 27.77 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.61 1.54 . . . . 74.44 109.952 177.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 65.0 m -72.24 116.25 12.45 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.905 -0.589 . . . . 74.5 109.916 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 65.1 mtt 64.58 79.07 0.26 Allowed 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.618 0.767 . . . . 72.01 111.398 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.472 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 49.7 mt-30 -81.43 124.06 29.11 Favored 'General case' 0 CA--C 1.486 -1.514 0 CA-C-N 115.37 -0.832 . . . . 75.13 109.779 178.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.9 p -81.9 95.93 7.5 Favored 'General case' 0 N--CA 1.41 -2.452 0 N-CA-C 108.953 -0.758 . . . . 42.53 108.953 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.444 HG22 ' OD2' ' A' ' 92' ' ' ASP . 40.9 p -105.61 -70.13 0.79 Allowed 'General case' 0 N--CA 1.416 -2.175 0 N-CA-C 108.858 -0.794 . . . . 72.25 108.858 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 57.3 22.83 8.15 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.397 1.079 . . . . 63.43 110.085 177.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.3 t -86.16 79.41 9.12 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-O 121.911 0.862 . . . . 74.44 110.74 -175.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -126.59 83.64 2.19 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.268 -1.382 . . . . 64.33 107.268 174.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 14.9 tpt -159.85 156.69 27.83 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.725 -1.213 . . . . 63.44 107.725 -175.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.0 m -132.97 89.69 2.65 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-O 121.739 0.78 . . . . 72.14 110.14 175.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.54 ' HB3' ' HG2' ' A' ' 112' ' ' LYS . . . -115.03 115.02 26.15 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 115.071 -0.968 . . . . 74.1 108.52 178.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.75 -121.39 0.48 Allowed Glycine 0 N--CA 1.427 -1.937 0 CA-C-N 115.602 -0.726 . . . . 74.33 114.139 -175.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.74 -173.75 3.79 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.321 0.581 . . . . 72.51 112.339 -170.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -133.86 -166.19 1.75 Allowed 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 105.153 -2.166 . . . . 73.42 105.153 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.6 t -137.85 139.05 39.71 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 120.028 1.285 . . . . 62.42 111.026 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.421 ' HG2' ' ND2' ' A' ' 115' ' ' ASN . 17.5 mm-40 -75.4 -177.16 3.44 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 115.028 1.492 . . . . 75.32 115.028 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.0 -113.97 2.9 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 113.587 -1.642 . . . . 65.43 110.85 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.64 -42.84 60.93 Favored 'Trans proline' 0 CA--C 1.575 2.527 0 C-N-CA 123.744 2.963 . . . . 72.21 116.835 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.58 143.39 74.97 Favored 'Trans proline' 0 C--N 1.39 2.715 0 CA-C-N 121.443 1.551 . . . . 42.24 113.594 -178.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -101.42 170.8 6.04 Favored Pre-proline 0 C--N 1.295 -1.77 0 CA-C-N 114.255 -1.339 . . . . 72.22 109.037 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.415 ' C ' HD13 ' A' ' 26' ' ' LEU . 59.5 Cg_exo -57.5 -156.17 0.01 OUTLIER 'Trans proline' 0 CA--C 1.561 1.846 0 C-N-CA 122.577 2.184 . . . . 65.14 113.926 174.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.415 HD13 ' C ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -134.68 -167.53 2.0 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 104.321 -2.474 . . . . 74.43 104.321 -173.338 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.569 ' HB3' ' OE1' ' A' ' 30' ' ' GLU . 20.9 t -73.57 155.12 39.46 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 108.085 -1.08 . . . . 73.42 108.085 173.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.48 -47.55 57.09 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 113.716 1.006 . . . . 74.44 113.716 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -64.86 -39.24 93.24 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.906 0.384 . . . . 63.52 111.472 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.569 ' OE1' ' HB3' ' A' ' 27' ' ' SER . 4.5 mp0 -59.91 -35.27 74.51 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 115.749 -0.66 . . . . 74.31 111.396 177.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -67.6 -50.67 57.09 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.551 0.691 . . . . 74.02 109.367 -178.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 37.0 mtpt -61.48 -38.79 88.56 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 114.687 1.366 . . . . 63.44 114.687 -177.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -69.47 -43.45 73.18 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 111.841 0.312 . . . . 72.42 111.841 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 30' ' ' GLU . 29.4 pt -71.07 -33.91 53.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.01 0.433 . . . . 70.41 111.556 -178.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.85 -34.67 69.97 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.572 1.149 . . . . 73.53 110.372 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 91.6 mttt -77.96 -16.46 58.14 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.591 -1.186 . . . . 71.2 111.035 -177.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.423 ' HG2' ' HA ' ' A' ' 88' ' ' ARG . 89.7 mtt180 -123.89 18.21 9.36 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 114.209 1.189 . . . . 73.01 114.209 -164.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.543 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 33.0 m -96.2 150.72 20.22 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 120.092 -0.643 . . . . 45.2 110.365 176.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 83' ' ' ILE . 33.2 m -140.02 164.11 23.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.125 0.488 . . . . 74.32 110.271 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.72 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 13.3 t80 -110.48 134.86 51.95 Favored 'General case' 0 C--N 1.284 -2.244 0 C-N-CA 124.974 1.31 . . . . 60.21 108.736 177.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.516 HG22 HG12 ' A' ' 109' ' ' VAL . 61.4 t -121.94 118.18 54.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.499 -1.297 . . . . 74.21 107.499 174.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -111.16 166.33 12.26 Favored Glycine 0 C--N 1.286 -2.232 0 C-N-CA 119.276 -1.44 . . . . 73.2 113.688 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.46 ' ND2' ' HB3' ' A' ' 105' ' ' ARG . 66.3 t30 56.3 27.42 11.83 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 126.137 1.775 . . . . 70.14 113.558 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.448 HG22 ' HB2' ' A' ' 48' ' ' SER . 14.6 p -61.55 138.64 21.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 N-CA-C 108.94 -0.763 . . . . 64.2 108.94 173.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.62 150.39 39.65 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.419 -0.586 . . . . 75.5 109.419 -173.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.494 ' CD1' ' HB2' ' A' ' 77' ' ' PRO . 78.3 t80 -65.36 -14.2 60.3 Favored 'General case' 0 CA--C 1.558 1.285 0 CA-C-O 121.586 0.708 . . . . 63.24 110.232 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.53 -7.39 59.15 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 116.003 -0.544 . . . . 73.12 112.921 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.448 ' HB2' HG22 ' A' ' 44' ' ' VAL . 26.4 m -80.03 133.97 36.18 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 117.424 0.612 . . . . 75.44 110.087 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.0 p -97.62 170.71 8.83 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 120.944 -0.303 . . . . 73.23 111.069 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.526 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -62.28 -45.22 94.23 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.594 -0.521 . . . . 75.21 109.594 175.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.82 -44.9 86.72 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.084 0.554 . . . . 41.31 109.885 176.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -55.91 -43.69 77.54 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.119 0.485 . . . . 54.32 111.55 176.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.3 mt -70.86 -47.55 58.71 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.522 -0.763 . . . . 74.11 111.71 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.35 -48.0 83.31 Favored 'General case' 0 C--O 1.204 -1.326 0 C-N-CA 123.424 0.69 . . . . 63.55 110.85 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.35 -42.57 96.01 Favored 'General case' 0 C--O 1.259 1.601 0 CA-C-O 121.523 0.678 . . . . 54.24 111.151 176.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -64.26 -41.89 96.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.41 -0.813 . . . . 61.35 110.428 -175.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -81.21 -20.51 40.95 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 113.289 0.848 . . . . 70.42 113.289 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.0 t -65.85 -26.63 67.74 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.712 -0.676 . . . . 71.34 109.481 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.4 m -60.19 -33.73 72.63 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-O 121.362 0.601 . . . . 75.32 110.023 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.427 ' SG ' ' SD ' ' A' ' 97' ' ' MET . 72.6 m -92.97 4.32 54.19 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 113.699 1.0 . . . . 70.14 113.699 -177.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.44 -169.92 33.39 Favored Glycine 0 CA--C 1.497 -1.053 0 C-N-CA 118.627 -1.749 . . . . 74.1 114.623 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.9 m -102.64 127.63 49.67 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.295 -0.631 . . . . 74.0 109.295 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.6 mt -95.6 130.05 44.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 113.788 1.033 . . . . 74.01 113.788 -175.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -91.53 -44.76 8.89 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-N 115.355 -0.839 . . . . 74.21 110.908 176.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.409 ' HD2' ' OE1' ' A' ' 84' ' ' GLU . 66.2 mtt180 -151.46 159.51 44.16 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 115.324 -0.853 . . . . 74.53 109.669 -173.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.526 HD11 ' HB1' ' A' ' 50' ' ' ALA . 28.2 pt -148.34 143.52 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 107.766 -1.198 . . . . 61.0 107.766 173.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.3 m -126.2 132.21 51.82 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 106.969 -1.493 . . . . 75.22 106.969 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 68' ' ' ILE . 2.4 mp -127.78 123.34 60.84 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 N-CA-C 106.085 -1.82 . . . . 33.15 106.085 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.46 ' HB3' ' HA ' ' B' ' 67' ' ' THR 0.345 1.0 OUTLIER -121.17 125.39 47.06 Favored 'General case' 0 C--N 1.273 -2.76 0 C-N-CA 120.073 -0.651 . . . . 72.45 112.588 175.861 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.406 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 81.8 m -116.73 128.61 55.49 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.784 -0.821 . . . . 71.11 108.784 -177.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.623 ' HA ' ' HA ' ' B' ' 65' ' ' ARG . 2.8 p-10 -121.35 152.14 39.32 Favored 'General case' 0 C--O 1.19 -2.056 0 C-N-CA 119.647 -0.821 . . . . 70.22 110.554 -177.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -127.06 15.81 7.32 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 108.63 -0.878 . . . . 62.31 108.63 175.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.468 ' HB3' ' HB3' ' B' ' 64' ' ' ASN . 37.7 p90 -66.84 -20.57 65.96 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 119.864 -0.734 . . . . 65.22 111.453 -177.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.6 m -86.82 9.16 19.97 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 116.162 -0.472 . . . . 74.55 110.833 176.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.33 -46.15 3.19 Favored Glycine 0 CA--C 1.501 -0.811 0 N-CA-C 111.084 -0.806 . . . . 52.13 111.084 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -95.5 129.2 35.52 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 106.779 -1.563 . . . . 50.14 106.779 176.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 72.2 Cg_endo -72.61 119.27 6.01 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 121.55 1.5 . . . . 61.45 111.404 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -110.71 -165.61 1.01 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.4 -0.818 . . . . 74.01 109.589 -176.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 70' ' ' CYS . . . -171.18 148.58 11.31 Favored Glycine 0 N--CA 1.407 -3.267 0 C-N-CA 120.367 -0.92 . . . . 72.23 113.166 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -149.61 143.53 25.6 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 124.512 1.125 . . . . 75.24 109.236 172.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.37 156.1 47.25 Favored 'General case' 0 C--O 1.192 -1.959 0 CA-C-O 120.664 0.269 . . . . 64.12 110.927 -172.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.467 ' HE2' ' HZ3' ' A' ' 112' ' ' LYS . 44.3 m-85 -124.24 124.63 42.85 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.482 -0.562 . . . . 62.31 109.482 176.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.48 HG23 HG22 ' A' ' 66' ' ' ILE . 29.1 mm -108.94 124.88 65.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 109.224 -0.658 . . . . 74.04 109.224 -177.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.409 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 32.0 tt0 -102.35 119.57 39.03 Favored 'General case' 0 C--O 1.25 1.112 0 N-CA-C 108.605 -0.887 . . . . 72.33 108.605 177.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -98.1 157.29 16.23 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.431 0.634 . . . . 73.21 112.708 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.19 -43.09 83.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.217 -0.902 . . . . 65.25 112.339 176.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -112.89 155.92 23.85 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 121.222 0.534 . . . . 74.21 111.836 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.494 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -69.91 -35.0 74.23 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.271 -1.011 . . . . 72.34 108.271 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -21.42 66.84 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 115.759 -0.655 . . . . 50.24 112.109 -177.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.9 m -68.21 -36.28 79.29 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 109.82 -0.437 . . . . 42.21 109.82 176.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 95' ' ' VAL . 3.1 m -69.31 -40.03 79.68 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.054 0 N-CA-C 108.97 -0.752 . . . . 74.44 108.97 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.444 ' OD2' HG22 ' A' ' 9' ' ' THR . 3.6 m-20 -56.87 -35.95 69.49 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.765 0.793 . . . . 73.12 110.032 176.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.34 -36.2 63.64 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.62 -0.718 . . . . 63.31 111.472 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.45 -42.49 43.71 Favored 'General case' 0 C--O 1.204 -1.309 0 CA-C-N 115.733 -0.667 . . . . 61.55 111.319 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 91' ' ' VAL . 23.8 m -56.69 -22.45 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 112.756 0.65 . . . . 72.02 112.756 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.34 -9.27 52.61 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.523 0.678 . . . . 35.11 110.469 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.427 ' SD ' ' SG ' ' A' ' 60' ' ' CYS . 37.8 mtp -105.67 4.52 30.22 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.176 -0.92 . . . . 73.53 110.405 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.515 ' HA ' HG22 ' A' ' 109' ' ' VAL . 1.6 p-10 -44.54 -36.89 3.21 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 114.884 1.439 . . . . 72.25 114.884 -176.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -115.33 92.29 3.88 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.341 -0.944 . . . . 72.44 109.537 171.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.9 p -138.45 172.31 13.08 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.263 -1.335 . . . . 45.12 110.649 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.4 p -119.75 126.28 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-O 121.412 0.625 . . . . 74.11 110.527 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -128.16 124.03 35.82 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 108.358 -0.978 . . . . 74.21 108.358 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 49.37 33.15 5.1 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.543 1.537 . . . . 73.45 111.204 -174.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.78 0.74 87.56 Favored Glycine 0 C--N 1.308 -1.016 0 CA-C-N 115.153 -0.93 . . . . 62.51 113.39 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.46 ' HB3' ' ND2' ' A' ' 43' ' ' ASN . 58.3 mtt180 -106.6 140.46 39.44 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.395 -0.594 . . . . 71.23 109.395 175.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.1 m -80.5 119.2 22.86 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.705 -1.22 . . . . 64.42 107.705 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 38.3 pt -101.49 169.46 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 C-N-CA 120.451 -0.5 . . . . 64.1 110.527 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 53.9 tptt -134.99 134.2 40.25 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.462 -0.79 . . . . 73.14 109.67 -177.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.72 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 16.0 m -127.17 126.84 68.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 O-C-N 123.044 0.215 . . . . 74.23 111.055 174.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . 0.255 0.0 OUTLIER -145.83 144.61 22.63 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 109.2 -0.667 . . . . 53.35 109.2 176.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -62.82 139.87 76.89 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 123.191 2.594 . . . . 74.24 113.782 -175.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 38' ' ' SER . 39.7 mtpt -145.73 173.96 11.63 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.981 -0.554 . . . . 73.05 111.761 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -99.44 -32.37 11.17 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.783 -1.192 . . . . 65.13 107.783 175.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.1 m 75.41 -69.83 0.16 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.259 -1.337 . . . . 64.55 113.328 171.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.421 ' ND2' ' HG2' ' A' ' 20' ' ' GLU . 7.5 t30 176.49 -30.72 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 112.009 0.374 . . . . 75.34 112.009 -174.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.4 ' HB3' HD21 ' A' ' 26' ' ' LEU . 57.4 mtt 74.13 57.47 0.3 Allowed Pre-proline 0 N--CA 1.484 1.265 0 O-C-N 124.455 1.097 . . . . 73.11 108.26 -172.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.5 ' HB3' HD12 ' B' ' 69' ' ' LEU . 0.2 OUTLIER -19.44 -80.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.384 2.439 1 C-N-CA 126.181 4.587 . . . . 75.33 118.762 -168.519 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 171.3 -177.57 44.12 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 119.042 -1.551 . . . . 74.42 113.052 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.46 HG12 ' N ' ' A' ' 120' ' ' SER . 11.2 tt -173.02 177.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 105.332 -2.099 . . . . 74.31 105.332 -175.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.46 ' N ' HG12 ' A' ' 119' ' ' ILE . 29.5 m -77.13 92.48 3.79 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 105.48 -2.044 . . . . 75.52 105.48 168.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 49.6 m -53.78 130.54 37.21 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 114.314 1.228 . . . . 63.1 114.314 -172.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.7 t -164.3 155.04 15.14 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 105.802 -1.925 . . . . 61.35 105.802 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -148.78 -72.36 0.19 Allowed 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 120.588 -0.445 . . . . 54.34 111.888 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 . . . . . 0 C--N 1.309 -1.19 0 N-CA-C 109.506 -0.553 . . . . 74.02 109.506 -177.709 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.514 0 CA-C-O 121.713 0.768 . . . . 52.13 109.978 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 67.7 mt -83.79 121.39 36.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 115.075 -0.966 . . . . 54.53 109.192 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -161.0 129.09 2.85 Favored Pre-proline 0 C--N 1.316 -0.888 0 N-CA-C 110.158 -0.312 . . . . 62.42 110.158 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.57 104.44 1.81 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.596 2.197 . . . . 71.31 111.592 178.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 50.1 t -80.05 147.46 31.47 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.258 -0.645 . . . . 63.44 109.258 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . 0.629 ' SD ' ' HB ' ' B' ' 9' ' ' THR . 24.7 ptt? -149.7 135.72 18.79 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.145 -0.687 . . . . 65.24 109.145 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -64.57 -60.05 3.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.576 0.703 . . . . 54.02 109.109 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 8.4 t -149.0 122.47 9.09 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 115.36 -0.836 . . . . 73.23 109.405 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.629 ' HB ' ' SD ' ' B' ' 6' ' ' MET . 62.2 m -150.06 87.96 1.5 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.583 0.706 . . . . 73.15 110.711 176.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -150.16 90.52 1.68 Allowed 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.024 -0.989 . . . . 65.23 108.994 174.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 34.2 t -133.76 152.83 51.98 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 108.096 -1.076 . . . . 75.01 108.096 -176.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -71.07 163.93 26.6 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.282 -1.007 . . . . 75.21 108.282 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 27.9 ttt -69.45 86.65 0.44 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.984 0.897 . . . . 62.21 111.878 -174.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 46.2 m -148.4 -75.57 0.17 Allowed 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.894 -1.048 . . . . 74.23 109.023 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . 67.59 -31.05 0.17 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.562 1.319 . . . . 55.14 114.562 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.43 -93.86 0.16 Allowed Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 110.506 -1.038 . . . . 31.14 110.506 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.02 101.79 12.01 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.318 -0.623 . . . . 73.42 109.318 177.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.454 ' O ' ' HG3' ' B' ' 25' ' ' PRO . 25.7 p90 -137.71 -5.2 1.75 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.033 -0.531 . . . . 65.31 110.098 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.436 HG22 ' NZ ' ' A' ' 112' ' ' LYS . 61.4 m -75.63 82.38 2.63 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 114.571 1.323 . . . . 70.42 114.571 -175.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . 0.483 ' OE2' ' HG2' ' B' ' 23' ' ' PRO . 30.8 tt0 -133.85 126.85 31.35 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 102.938 -2.986 . . . . 74.01 102.938 176.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.78 -79.56 1.21 Allowed Glycine 0 CA--C 1.531 1.042 0 N-CA-C 115.695 1.038 . . . . 63.14 115.695 -169.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.576 ' HD3' ' CZ ' ' A' ' 40' ' ' TYR . 1.6 Cg_endo -40.12 -53.79 2.38 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 125.079 3.852 . . . . 74.11 114.505 -177.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.495 ' HD3' ' HG2' ' B' ' 22' ' ' PRO . 22.1 Cg_endo -93.17 122.81 0.48 Allowed 'Trans proline' 0 N--CA 1.416 -3.074 0 N-CA-C 108.442 -1.407 . . . . 64.3 108.442 170.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -69.02 135.8 89.55 Favored Pre-proline 0 C--N 1.313 -1.012 0 C-N-CA 120.145 -0.622 . . . . 72.14 109.884 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.454 ' HG3' ' O ' ' B' ' 18' ' ' TYR . 73.3 Cg_exo -28.73 104.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.385 2.485 1 C-N-CA 125.354 4.036 . . . . 75.13 113.57 -174.587 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.539 HD13 ' H ' ' B' ' 26' ' ' LEU 0.283 0.0 OUTLIER -52.64 153.16 3.28 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 113.333 -1.758 . . . . 64.34 115.079 -176.954 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.513 ' O ' ' HG3' ' B' ' 31' ' ' LYS . 14.8 m -60.46 163.83 4.94 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 125.687 1.595 . . . . 44.34 113.35 -177.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.5 75.74 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.021 -0.536 . . . . 73.44 112.393 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -73.21 -31.07 63.94 Favored 'General case' 0 CA--C 1.49 -1.352 0 CA-C-O 120.974 0.416 . . . . 72.35 111.851 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.405 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.4 OUTLIER -60.4 -33.92 73.18 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.228 -0.896 . . . . 75.43 110.457 173.313 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' B' ' 27' ' ' SER . 95.7 mttt -69.58 -51.56 34.18 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.397 -0.594 . . . . 61.34 109.397 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' B' ' 36' ' ' LYS . 0.7 OUTLIER -53.97 -47.32 71.49 Favored 'General case' 0 C--N 1.359 1.014 0 N-CA-C 113.516 0.932 . . . . 70.34 113.516 179.474 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' B' ' 37' ' ' ARG . 11.2 mm-40 -64.81 -44.39 90.06 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.471 0.545 . . . . 75.33 112.471 -174.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.405 HG12 ' O ' ' B' ' 30' ' ' GLU . 24.3 pt -70.47 -33.33 53.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.196 0.522 . . . . 73.14 110.793 -178.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -56.92 -38.41 72.83 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.182 1.393 . . . . 50.34 111.311 -177.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 90.0 mttt -75.86 -25.26 56.03 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.639 -1.164 . . . . 72.12 112.327 -176.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' B' ' 33' ' ' GLU . 20.5 ptt180 -118.72 25.69 10.07 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 114.047 1.129 . . . . 73.52 114.047 -168.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 37.1 m -96.69 148.44 22.87 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 116.642 -0.254 . . . . 72.24 111.268 175.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.409 HG22 ' O ' ' B' ' 83' ' ' ILE . 29.3 m -139.97 165.29 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-O 121.09 0.471 . . . . 72.01 111.541 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . 0.697 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 9.7 t80 -114.29 132.18 56.26 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 125.68 1.592 . . . . 72.0 108.721 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 59.1 t -119.51 118.4 57.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 124.568 1.147 . . . . 75.11 108.124 174.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.38 172.51 14.33 Favored Glycine 0 C--N 1.293 -1.849 0 C-N-CA 119.339 -1.41 . . . . 72.43 113.387 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 65.7 t30 63.99 8.52 3.99 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 126.211 1.804 . . . . 72.15 114.597 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.64 126.49 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-O 121.577 0.704 . . . . 74.4 109.747 175.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.99 156.72 25.78 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.475 -0.784 . . . . 43.44 111.399 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' TYR . . . . . 0.592 ' CD2' ' HB2' ' B' ' 77' ' ' PRO . 9.4 t80 -75.36 86.3 2.53 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 106.314 -1.735 . . . . 75.05 106.314 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.83 -27.62 0.07 OUTLIER Glycine 0 N--CA 1.419 -2.481 0 N-CA-C 109.728 -1.349 . . . . 65.0 109.728 -174.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 26.6 t -84.44 148.15 26.72 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 106.749 -1.574 . . . . 65.21 106.749 173.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 50.5 p -111.74 178.07 4.44 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 110.242 -0.281 . . . . 71.32 110.242 -177.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.505 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -62.31 -47.74 82.94 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 110.19 -0.3 . . . . 73.33 110.19 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -57.48 -44.02 84.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.208 -0.451 . . . . 72.34 110.534 177.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -60.36 -40.01 89.26 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-O 121.68 0.753 . . . . 63.45 109.789 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 56.0 mt -72.64 -47.31 48.6 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.086 -0.961 . . . . 73.32 112.288 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.54 -48.68 80.7 Favored 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 123.269 0.628 . . . . 72.35 110.727 -178.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.32 -42.77 87.51 Favored 'General case' 0 C--O 1.255 1.347 0 CA-C-O 121.252 0.548 . . . . 62.2 110.925 176.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -64.14 -41.58 97.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.556 -0.747 . . . . 70.12 110.496 -176.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.421 ' CZ ' HG11 ' B' ' 109' ' ' VAL 0.268 51.7 m-85 -81.83 -20.77 38.31 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 113.747 1.017 . . . . 73.21 113.747 178.451 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 33.4 t -66.67 -24.18 66.24 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.537 -0.912 . . . . 72.25 108.537 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 15.6 m -58.94 -31.91 69.12 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 115.934 -0.575 . . . . 61.42 110.155 172.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 74.7 m -93.89 7.33 45.4 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.973 0.731 . . . . 71.4 112.973 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.72 -148.51 20.22 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 118.242 -1.933 . . . . 64.21 115.698 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' B' ' 86' ' ' ALA . 15.6 m -110.94 124.48 52.2 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.73 -0.47 . . . . 70.34 109.73 -176.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 63.8 mt -94.69 130.55 43.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 113.642 0.978 . . . . 65.02 113.642 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . 0.482 ' ND2' ' HA ' ' B' ' 86' ' ' ALA . 93.0 m-20 -94.82 -43.55 8.17 Favored 'General case' 0 C--O 1.197 -1.658 0 CA-C-N 115.208 -0.906 . . . . 73.0 110.827 175.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.623 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 67.4 mtt180 -152.45 157.44 41.19 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 109.399 -0.593 . . . . 71.44 109.399 -175.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.523 HG22 HG23 ' B' ' 83' ' ' ILE . 23.2 pt -147.3 142.87 20.11 Favored 'Isoleucine or valine' 0 C--O 1.191 -2.002 0 N-CA-C 106.77 -1.567 . . . . 73.33 106.77 173.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . 0.46 ' HA ' ' HB3' ' A' ' 69' ' ' LEU . 61.8 m -126.4 131.64 51.69 Favored 'General case' 0 C--N 1.272 -2.769 0 N-CA-C 106.914 -1.513 . . . . 74.02 106.914 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 3.0 mp -127.25 120.54 55.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 106.697 -1.594 . . . . 65.1 106.697 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.5 HD12 ' HB3' ' A' ' 117' ' ' PRO 0.282 1.1 pt? -120.49 127.75 52.5 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 120.065 -0.654 . . . . 50.55 111.62 177.131 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 80.1 m -116.91 130.23 56.57 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.217 -0.902 . . . . 63.21 109.342 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.702 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 4.0 p30 -111.57 127.76 55.83 Favored 'General case' 0 C--O 1.216 -0.682 0 C-N-CA 119.497 -0.881 . . . . 72.35 110.488 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.442 ' O ' ' HG2' ' B' ' 72' ' ' LYS . 33.2 ttmt -123.45 4.4 9.04 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.193 0.52 . . . . 71.23 109.931 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' B' ' 71' ' ' ASP . 53.3 p90 -64.04 -6.97 7.22 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 113.831 1.049 . . . . 70.3 113.831 -174.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 42.8 m -106.56 6.38 29.99 Favored 'General case' 0 C--N 1.313 -1.009 0 O-C-N 121.782 -0.574 . . . . 73.22 111.24 175.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.6 -61.86 0.3 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.835 -0.698 . . . . 70.21 111.745 -178.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -96.26 129.65 33.06 Favored Pre-proline 0 C--N 1.305 -1.337 0 N-CA-C 109.757 -0.46 . . . . 75.13 109.757 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.702 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 96.2 Cg_endo -79.32 126.69 7.03 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.639 2.226 . . . . 63.45 113.561 -177.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -107.35 -167.7 1.3 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.897 -1.149 . . . . 73.03 107.897 176.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.54 147.74 11.7 Favored Glycine 0 N--CA 1.415 -2.758 0 C-N-CA 119.791 -1.195 . . . . 44.25 113.576 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -151.64 144.79 24.62 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 124.502 1.121 . . . . 71.13 108.81 172.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -134.05 155.21 50.42 Favored 'General case' 0 C--O 1.194 -1.863 0 CA-C-O 120.681 0.277 . . . . 63.02 111.199 -172.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' TYR . . . . . 0.425 ' CD2' ' HD3' ' B' ' 112' ' ' LYS . 51.7 m-85 -124.32 124.09 41.63 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.279 -0.637 . . . . 61.34 109.279 176.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.523 HG23 HG22 ' B' ' 66' ' ' ILE . 30.4 mm -107.9 124.79 64.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 109.038 -0.727 . . . . 71.24 109.038 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' GLU . . . . . 0.424 ' HB3' ' HB2' ' B' ' 65' ' ' ARG . 36.6 tt0 -103.57 119.4 38.82 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.739 -1.208 . . . . 72.41 107.739 176.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -94.89 162.73 13.63 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 110.331 -0.248 . . . . 75.31 110.331 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.482 ' HA ' ' ND2' ' B' ' 64' ' ' ASN . . . -83.63 -21.24 32.57 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.101 0.477 . . . . 35.42 111.343 175.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . 0.457 ' HB2' ' OG ' ' B' ' 90' ' ' SER . 27.9 mt-10 -119.39 145.23 46.39 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 116.187 -0.46 . . . . 73.41 109.763 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.463 ' O ' HG22 ' B' ' 91' ' ' VAL . 0.5 OUTLIER -72.03 -34.29 68.68 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 107.203 -1.406 . . . . 71.31 107.203 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -59.31 -32.17 69.82 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.719 -1.128 . . . . 75.52 108.996 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' SER . . . . . 0.457 ' OG ' ' HB2' ' B' ' 87' ' ' GLU . 23.3 m -63.46 -35.94 82.11 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.757 -0.656 . . . . 75.41 110.955 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.534 ' O ' HG13 ' B' ' 95' ' ' VAL . 3.1 m -69.35 -39.41 78.87 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.192 0 C-N-CA 119.302 -0.959 . . . . 73.11 108.678 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -57.72 -37.75 74.07 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.082 0.468 . . . . 73.3 110.811 176.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.46 -34.06 65.18 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.936 -0.575 . . . . 71.43 110.437 178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.6 -44.65 33.48 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 116.785 -0.189 . . . . 60.03 111.154 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . 0.534 HG13 ' O ' ' B' ' 91' ' ' VAL . 22.0 m -56.65 -22.85 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 112.68 0.622 . . . . 73.43 112.68 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.1 -9.33 45.5 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.349 0.595 . . . . 75.24 110.651 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 56.5 mtm -104.69 10.2 34.83 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.757 -0.656 . . . . 74.15 110.984 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . 0.264 4.1 p-10 -44.46 -44.95 8.88 Favored 'General case' 0 C--O 1.204 -1.298 0 N-CA-C 114.91 1.448 . . . . 72.14 114.91 -176.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -110.84 71.38 0.74 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-N 119.822 1.192 . . . . 74.42 112.146 167.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 47.4 p -115.84 168.43 10.06 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.115 -0.493 . . . . 53.23 111.771 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 9.6 p -100.64 136.42 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-O 121.41 0.624 . . . . 74.24 109.52 -177.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -132.39 109.91 10.18 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 107.961 -1.126 . . . . 61.15 107.961 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 49.53 32.21 4.68 Favored 'General case' 0 CA--C 1.563 1.46 0 C-N-CA 125.4 1.48 . . . . 65.22 112.628 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.22 -9.58 39.2 Favored Glycine 0 C--N 1.318 -0.428 0 C-N-CA 120.674 -0.774 . . . . 23.44 113.741 174.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -116.4 151.85 35.14 Favored 'General case' 0 C--O 1.206 -1.215 0 CA-C-N 117.135 0.467 . . . . 53.34 109.883 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 92.9 m -86.87 120.14 27.84 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.835 -1.172 . . . . 75.12 107.835 174.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 2.6 pp -102.13 166.74 2.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 119.691 -0.804 . . . . 62.44 110.267 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 54.3 tptt -125.37 132.99 52.7 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.734 -0.469 . . . . 72.51 109.734 -172.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.697 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 15.7 m -127.0 128.79 70.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.277 0.56 . . . . 65.15 111.301 176.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.333 0.4 OUTLIER -147.01 133.43 9.71 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 106.279 -1.749 . . . . 63.31 106.279 -169.802 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.5 141.78 87.81 Favored 'Trans proline' 0 N--CA 1.486 1.038 0 C-N-CA 122.504 2.136 . . . . 62.44 113.068 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.425 ' HD3' ' CD2' ' B' ' 82' ' ' TYR . 22.6 ttpp -120.42 144.87 47.71 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 109.138 -0.69 . . . . 65.44 109.138 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -106.25 162.68 13.45 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 107.227 -1.398 . . . . 72.21 107.227 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 54.3 m -134.33 -41.85 0.79 Allowed 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 112.49 0.552 . . . . 72.45 112.49 -176.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' ASN . . . . . 0.617 HD22 ' N ' ' B' ' 116' ' ' MET . 0.2 OUTLIER -89.07 134.99 33.8 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 123.592 0.757 . . . . 72.3 110.202 -173.725 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' MET . . . . . 0.617 ' N ' HD22 ' B' ' 115' ' ' ASN . 26.5 ptt? -144.19 167.96 13.8 Favored Pre-proline 0 C--N 1.304 -1.387 0 N-CA-C 105.952 -1.87 . . . . 74.44 105.952 174.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -48.03 -40.74 33.7 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 122.6 2.2 . . . . 73.13 112.361 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.71 -144.49 29.07 Favored Glycine 0 N--CA 1.436 -1.33 0 CA-C-N 115.94 -0.573 . . . . 65.13 112.054 176.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 55.4 mt 69.29 3.9 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 C-N-CA 124.175 0.99 . . . . 75.15 110.205 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 37.8 m 63.67 96.87 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.233 1.013 . . . . 64.32 111.009 -177.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 4.8 p -70.19 85.91 0.56 Allowed 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 113.913 1.079 . . . . 72.34 113.913 -176.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 24.7 m -126.16 16.07 7.84 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.047 -1.464 . . . . 74.4 107.047 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -118.49 127.47 53.67 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 113.824 -1.534 . . . . 71.13 110.132 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? . . . . . 0 C--N 1.305 -1.356 0 N-CA-C 107.243 -1.392 . . . . 64.34 107.243 178.35 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.932 0 N-CA-C 109.05 -0.722 . . . . 73.42 109.05 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.485 ' O ' HD12 ' A' ' 2' ' ' ILE . 2.5 pp -89.2 137.63 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 110.205 -0.294 . . . . 74.54 110.205 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.26 113.51 11.69 Favored Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 108.048 -1.093 . . . . 75.12 108.048 176.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.77 109.9 1.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.806 2.337 . . . . 71.34 113.295 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 63.1 m -80.51 -56.4 4.2 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 106.332 -1.729 . . . . 43.24 106.332 172.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.408 ' HB3' ' H ' ' A' ' 7' ' ' GLN . 64.9 mtt 50.47 -159.22 0.08 Allowed 'General case' 0 C--N 1.353 0.738 0 CA-C-N 115.144 -0.934 . . . . 74.33 112.391 175.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.408 ' H ' ' HB3' ' A' ' 6' ' ' MET . 77.2 mt-30 76.52 -19.44 0.42 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.403 1.081 . . . . 72.42 112.618 176.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.4 p -76.67 90.58 3.39 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 108.806 -0.813 . . . . 74.25 108.806 174.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.404 ' HA ' ' CB ' ' B' ' 24' ' ' GLN . 10.7 t -115.39 3.11 14.08 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 115.815 -0.63 . . . . 71.34 111.482 -174.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.617 ' HB2' ' O ' ' B' ' 25' ' ' PRO . 38.6 m80 65.16 -68.35 0.11 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.052 1.341 . . . . 65.35 112.341 178.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.4 t -166.11 114.95 0.95 Allowed 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 122.792 0.437 . . . . 70.33 110.804 -177.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -151.02 159.12 44.76 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 110.028 -0.36 . . . . 52.1 110.028 173.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.459 ' H ' ' HB2' ' B' ' 17' ' ' ALA . 25.5 ptt? -160.31 94.64 1.09 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.834 -0.802 . . . . 72.44 108.834 177.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.3 m 62.3 87.28 0.1 Allowed 'General case' 0 C--O 1.246 0.881 0 CA-C-O 121.925 0.869 . . . . 64.0 111.053 -175.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.07 153.06 29.01 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.393 -0.821 . . . . 54.32 111.568 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 177.08 -104.38 0.19 Allowed Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 110.337 -1.105 . . . . 64.53 110.337 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -155.98 146.5 21.82 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.685 -0.487 . . . . 65.15 109.685 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -118.08 -159.95 0.77 Allowed 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.84 -0.8 . . . . 74.01 108.84 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.2 t -80.58 152.13 28.73 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 108.973 -0.751 . . . . 62.5 108.973 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.74 -39.95 6.46 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 116.593 -0.276 . . . . 71.42 110.365 177.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 160.83 -129.81 2.22 Favored Glycine 0 N--CA 1.453 -0.223 0 N-CA-C 110.485 -1.046 . . . . 33.22 110.485 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.66 -38.56 55.91 Favored 'Trans proline' 0 CA--C 1.58 2.817 0 C-N-CA 123.938 3.092 . . . . 71.03 116.247 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -49.94 167.66 0.2 Allowed 'Trans proline' 0 C--N 1.395 2.997 0 C-N-CA 123.054 2.502 . . . . 73.42 114.064 175.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -70.8 138.49 85.52 Favored Pre-proline 0 C--N 1.309 -1.154 0 CA-C-N 115.906 -0.588 . . . . 62.05 112.476 -176.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -79.15 106.16 2.02 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 122.645 2.23 . . . . 73.24 110.647 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.665 HD13 ' H ' ' A' ' 26' ' ' LEU 0.304 0.0 OUTLIER -73.07 153.5 40.81 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 112.498 0.555 . . . . 74.42 112.498 -179.953 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -71.97 160.68 32.1 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.56 -0.745 . . . . 44.23 112.155 -173.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.48 -43.74 35.15 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 114.825 -1.08 . . . . 73.1 112.953 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -67.2 -34.19 76.98 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 119.674 -0.81 . . . . 72.12 113.036 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.514 ' O ' HG12 ' A' ' 34' ' ' ILE . 0.5 OUTLIER -60.04 -34.9 74.03 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 109.854 -0.424 . . . . 64.52 109.854 173.337 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -66.1 -40.18 90.57 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 123.639 0.587 . . . . 73.43 109.708 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.625 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -64.92 -45.81 84.3 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 120.799 -0.361 . . . . 74.2 111.01 175.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -71.46 -41.08 69.86 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 113.759 1.022 . . . . 73.21 113.759 -174.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 30' ' ' GLU . 15.4 pt -63.06 -33.69 62.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.641 -0.424 . . . . 74.2 110.511 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.44 -38.45 81.15 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 108.949 -0.76 . . . . 61.22 108.949 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -66.01 -42.0 90.28 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 114.468 1.284 . . . . 55.42 114.468 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.673 ' HG3' ' O ' ' A' ' 85' ' ' PHE . 3.4 ptm180 -102.85 19.18 19.82 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 111.797 0.295 . . . . 75.4 111.797 -169.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.9 p -110.52 167.12 10.45 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.658 0.985 . . . . 34.05 113.658 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.404 ' CG1' HG23 ' A' ' 91' ' ' VAL . 9.7 m -140.3 164.95 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.277 1.031 . . . . 73.44 112.023 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.659 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 27.9 t80 -109.89 127.03 54.47 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 124.882 1.273 . . . . 72.25 108.469 176.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.7 t -115.58 112.01 38.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 107.812 -1.181 . . . . 75.41 107.812 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.427 ' HA3' ' CZ ' ' A' ' 40' ' ' TYR . . . -121.62 -177.34 15.48 Favored Glycine 0 N--CA 1.435 -1.385 0 C-N-CA 119.556 -1.307 . . . . 73.32 114.738 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.3 t30 72.7 -7.35 1.45 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.062 2.145 . . . . 61.33 112.475 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.78 103.55 4.13 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.929 0 CA-C-O 121.488 0.661 . . . . 63.11 109.866 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -81.06 83.57 6.71 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 114.162 1.171 . . . . 72.21 114.162 -168.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.55 ' H ' ' HA3' ' A' ' 79' ' ' GLY . 63.6 t80 68.22 -20.52 0.14 Allowed 'General case' 0 CA--C 1.577 1.989 0 N-CA-C 115.526 1.676 . . . . 73.12 115.526 163.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.27 5.35 45.15 Favored Glycine 0 C--O 1.241 0.577 0 N-CA-C 116.912 1.525 . . . . 51.02 116.912 -169.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.2 t -87.65 147.74 25.12 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 119.318 1.559 . . . . 70.32 109.885 176.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.549 HG22 HG22 ' B' ' 49' ' ' THR . 82.6 p -97.37 158.92 15.22 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.007 -0.542 . . . . 71.33 111.207 -176.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.484 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -65.16 -48.25 74.19 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 122.557 0.343 . . . . 54.31 110.835 -177.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.01 -40.3 80.46 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.333 0.494 . . . . 72.33 112.333 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.9 -38.06 76.18 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.216 0.531 . . . . 72.12 110.515 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.2 mt -68.77 -47.2 66.82 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.381 -0.827 . . . . 64.25 111.209 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -61.92 -48.19 81.54 Favored 'General case' 0 C--O 1.202 -1.433 0 CA-C-N 115.755 -0.657 . . . . 65.14 110.875 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.65 -43.99 80.86 Favored 'General case' 0 C--O 1.26 1.609 0 CA-C-O 121.789 0.804 . . . . 52.44 111.256 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -64.77 -38.51 91.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.667 -1.152 . . . . 74.44 110.355 -176.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -82.33 -21.64 35.94 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.496 0.925 . . . . 64.23 113.496 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.7 t -70.63 -23.88 62.61 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.845 -0.616 . . . . 74.41 109.78 -176.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.8 m -59.97 -27.27 66.69 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-O 121.055 0.455 . . . . 62.55 110.36 173.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 62.7 m -92.66 7.93 41.32 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 112.568 0.581 . . . . 73.02 112.568 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.67 -169.82 25.04 Favored Glycine 0 CA--C 1.505 -0.538 0 C-N-CA 119.559 -1.305 . . . . 74.34 113.28 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.1 m -96.08 126.44 41.32 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 121.614 0.721 . . . . 71.14 110.156 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.5 mt -85.02 134.38 27.16 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.398 0 CA-C-N 114.938 -1.028 . . . . 75.31 112.462 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.462 ' OD1' ' HG3' ' A' ' 65' ' ' ARG . 50.9 t-20 -89.72 -54.24 4.15 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.633 -1.167 . . . . 73.44 108.51 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.462 ' HG3' ' OD1' ' A' ' 64' ' ' ASN . 66.0 mtp180 -154.34 164.17 39.02 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 106.624 -1.621 . . . . 74.24 106.624 -176.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.484 HD11 ' HB1' ' A' ' 50' ' ' ALA . 31.4 pt -143.59 142.59 24.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 107.166 -1.42 . . . . 73.31 107.166 172.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.7 m -124.81 125.14 43.54 Favored 'General case' 0 C--N 1.273 -2.726 0 N-CA-C 107.912 -1.144 . . . . 63.14 107.912 -177.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.0 mp -123.57 116.39 48.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 106.139 -1.8 . . . . 74.22 106.139 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.461 ' HG ' ' CE1' ' A' ' 80' ' ' TYR 0.286 0.8 OUTLIER -121.43 128.79 52.53 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 120.376 -0.53 . . . . 62.44 112.372 179.525 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 74.3 m -117.48 130.61 56.56 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 109.031 -0.729 . . . . 72.45 109.031 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.557 ' HA ' ' HA ' ' B' ' 65' ' ' ARG . 3.1 p30 -118.63 146.49 44.61 Favored 'General case' 0 CA--C 1.484 -1.588 0 C-N-CA 120.024 -0.67 . . . . 73.32 110.691 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -120.1 11.1 11.58 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.681 -0.859 . . . . 74.41 108.681 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.596 ' HB3' ' OD1' ' B' ' 64' ' ' ASN . 10.8 p90 -66.82 -19.95 65.84 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 120.325 -0.55 . . . . 75.44 110.958 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 31.2 t -79.59 -1.21 36.95 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 115.111 -0.95 . . . . 55.01 110.045 178.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.47 -51.39 1.58 Allowed Glycine 0 CA--C 1.491 -1.458 0 N-CA-C 110.093 -1.203 . . . . 73.2 110.093 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -96.08 133.48 25.1 Favored Pre-proline 0 C--N 1.29 -2.004 0 N-CA-C 106.683 -1.599 . . . . 75.52 106.683 175.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.478 ' HB2' ' CD1' ' A' ' 46' ' ' TYR . 63.3 Cg_endo -71.06 118.76 5.86 Favored 'Trans proline' 0 N--CA 1.44 -1.652 0 C-N-CA 121.081 1.188 . . . . 44.42 111.001 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm -101.07 158.35 16.08 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.594 -1.184 . . . . 74.4 109.607 -175.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.55 ' HA3' ' H ' ' A' ' 46' ' ' TYR . . . -136.25 138.69 10.07 Favored Glycine 0 N--CA 1.418 -2.531 0 C-N-CA 120.497 -0.859 . . . . 62.5 112.581 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.461 ' CE1' ' HG ' ' A' ' 69' ' ' LEU . 12.6 p90 -154.79 144.18 21.27 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 123.905 0.882 . . . . 70.35 110.32 174.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.75 150.03 52.21 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 116.026 -0.533 . . . . 74.25 109.658 -172.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.656 ' CD2' ' HD3' ' A' ' 112' ' ' LYS . 90.2 m-85 -126.74 130.85 51.14 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.738 -0.838 . . . . 72.34 108.738 177.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.446 HG23 HG22 ' A' ' 66' ' ' ILE . 34.1 mm -108.78 117.08 53.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 109.301 -0.629 . . . . 63.23 109.301 -177.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -93.17 119.24 32.14 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.716 -0.846 . . . . 65.33 108.716 176.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.673 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 95.6 m-85 -96.02 161.95 13.76 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 112.753 0.649 . . . . 71.21 112.753 -178.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.0 -15.55 60.65 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 115.264 -0.88 . . . . 74.32 111.424 174.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.5 161.33 42.33 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 118.504 -1.279 . . . . 73.14 111.857 177.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -64.21 -34.95 79.27 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 114.338 -1.301 . . . . 74.53 110.843 173.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -61.24 -33.52 73.65 Favored 'General case' 0 CA--C 1.509 -0.61 0 C-N-CA 120.13 -0.628 . . . . 72.11 111.036 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.0 m -69.67 -40.28 76.49 Favored 'General case' 0 N--CA 1.42 -1.952 0 O-C-N 122.299 -0.251 . . . . 73.15 111.213 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.452 HG11 ' HA ' ' A' ' 37' ' ' ARG 0.266 0.2 OUTLIER -65.63 -47.31 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 120.586 -0.446 . . . . 52.11 111.954 176.626 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.13 -32.41 68.12 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.192 0.52 . . . . 63.31 111.727 176.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.08 -36.51 64.29 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.204 0.526 . . . . 52.34 111.884 177.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.68 -43.76 45.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.688 -0.687 . . . . 71.33 111.943 -176.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 91' ' ' VAL . 34.2 m -50.92 -22.42 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 113.025 0.75 . . . . 74.23 113.025 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.24 -11.45 50.18 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.919 0.39 . . . . 63.41 111.438 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 68.5 mtm -99.48 7.41 45.42 Favored 'General case' 0 C--O 1.216 -0.695 0 CA-C-N 116.29 -0.414 . . . . 72.41 110.929 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 3.6 p-10 -42.86 -41.33 3.24 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.707 1.373 . . . . 71.35 114.707 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -111.83 100.34 8.84 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.792 -0.818 . . . . 73.33 108.792 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 106' ' ' THR . 11.2 t -151.08 166.3 31.19 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.899 -0.591 . . . . 74.42 109.451 -177.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.89 118.61 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-O 121.825 0.821 . . . . 61.12 109.647 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -134.28 121.58 21.48 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.002 -0.999 . . . . 74.42 108.762 -177.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 54.0 54.84 9.1 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 114.538 1.31 . . . . 74.32 114.538 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.53 3.16 53.2 Favored Glycine 0 N--CA 1.468 0.829 0 CA-C-N 114.901 -1.045 . . . . 70.54 115.642 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -135.29 157.0 48.01 Favored 'General case' 0 C--N 1.298 -1.63 0 CA-C-N 117.399 0.6 . . . . 75.13 111.349 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 100' ' ' THR . 33.9 m -88.31 120.01 29.27 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.834 -1.543 . . . . 65.44 106.834 175.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 44.8 pt -101.69 171.14 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 119.31 -0.956 . . . . 73.52 110.709 -176.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 55.4 tptt -129.33 125.75 37.4 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.163 -0.68 . . . . 71.01 109.163 -176.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 12.1 p -129.78 121.85 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-O 121.158 0.504 . . . . 62.14 111.61 178.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.89 159.91 42.01 Favored Pre-proline 0 C--N 1.294 -1.827 0 N-CA-C 107.085 -1.45 . . . . 75.22 107.085 -178.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.71 134.12 52.24 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.279 1.986 . . . . 75.42 113.508 -175.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.656 ' HD3' ' CD2' ' A' ' 82' ' ' TYR . 35.5 ttpt -80.94 101.78 9.7 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 105.46 -2.052 . . . . 65.22 105.46 173.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -132.13 123.97 28.2 Favored 'General case' 0 C--N 1.288 -2.076 0 C-N-CA 119.895 -0.722 . . . . 72.5 112.174 -168.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 91.5 m -82.37 106.3 14.14 Favored 'General case' 0 N--CA 1.4 -2.966 0 N-CA-C 105.45 -2.056 . . . . 75.35 105.45 172.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -76.99 104.28 7.4 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.863 0.84 . . . . 71.33 112.063 -172.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 21.2 ptp -140.25 156.01 70.1 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 106.638 -1.615 . . . . 74.15 106.638 177.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -51.16 -46.95 28.17 Favored 'Trans proline' 0 C--O 1.24 0.582 0 C-N-CA 122.869 2.38 . . . . 65.05 112.183 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 169.48 -179.53 41.95 Favored Glycine 0 N--CA 1.425 -2.086 0 N-CA-C 110.106 -1.197 . . . . 62.14 110.106 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.436 HG12 ' HG2' ' A' ' 32' ' ' LYS . 1.9 mp -82.12 82.32 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 108.962 -0.755 . . . . 62.11 108.962 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.8 t -174.47 -36.94 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.095 -1.446 . . . . 73.12 107.095 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 39.4 p -72.92 108.73 6.01 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 106.834 -1.543 . . . . 62.2 106.834 173.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.6 m 67.68 76.31 0.27 Allowed 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.0 -1.481 . . . . 70.41 107.0 -168.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -85.43 107.39 17.38 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-N 115.055 -0.975 . . . . 70.52 110.813 -174.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 . . . . . 0 C--N 1.296 -1.744 0 CA-C-N 115.0 -1.0 . . . . 72.15 108.83 177.191 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.595 0 N-CA-C 109.651 -0.5 . . . . 45.13 109.651 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.464 ' O ' HD12 ' B' ' 2' ' ' ILE . 2.4 pp -123.31 136.8 58.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 112.744 0.646 . . . . 73.44 112.744 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.34 152.09 18.03 Favored Pre-proline 0 C--N 1.293 -1.889 0 N-CA-C 106.28 -1.748 . . . . 31.12 106.28 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -52.56 117.25 3.48 Favored 'Trans proline' 0 C--O 1.246 0.903 0 C-N-CA 122.627 2.218 . . . . 63.01 111.835 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 13.3 p -77.99 -27.03 48.95 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.109 -0.496 . . . . 64.11 110.671 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -81.11 150.16 28.86 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.66 -0.7 . . . . 61.31 110.006 176.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -152.05 134.69 15.43 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 107.644 -1.243 . . . . 74.21 107.644 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 15.0 m -111.4 94.08 4.79 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.267 0.556 . . . . 72.45 110.177 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 23.0 p -137.48 147.64 45.42 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.776 -1.194 . . . . 74.1 107.776 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . 0.262 11.1 p80 -78.04 69.35 4.25 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.582 0.956 . . . . 72.44 113.582 -177.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 71.8 m -178.81 112.22 0.06 Allowed 'General case' 0 C--O 1.24 0.566 0 C-N-CA 128.255 2.622 . . . . 73.14 107.448 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -109.25 16.74 22.21 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.723 -0.843 . . . . 65.33 108.723 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.04 121.71 6.4 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.99 -1.004 . . . . 74.34 110.621 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 29.5 m -82.71 -28.48 30.48 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.874 0.845 . . . . 60.32 108.764 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.46 116.07 7.17 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 114.99 -1.005 . . . . 74.14 108.427 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.425 ' HA2' ' HD3' ' B' ' 31' ' ' LYS . . . -143.96 -80.82 0.05 OUTLIER Glycine 0 N--CA 1.427 -1.926 0 C-N-CA 120.423 -0.894 . . . . 53.32 111.429 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.459 ' HB2' ' H ' ' A' ' 13' ' ' MET . . . -101.61 103.83 14.66 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.257 0.551 . . . . 72.43 110.429 178.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -145.92 127.25 14.89 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.354 -1.35 . . . . 61.14 107.354 177.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 48.5 m -80.58 94.18 6.24 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 120.977 0.418 . . . . 70.04 111.819 -174.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . 0.672 ' HB2' ' O ' ' B' ' 23' ' ' PRO . 33.6 mt-10 -69.46 -33.28 72.69 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.923 -0.769 . . . . 51.13 108.923 175.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.31 -95.19 1.34 Allowed Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.749 -0.659 . . . . 71.53 111.787 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.547 ' HG2' ' HD3' ' B' ' 23' ' ' PRO . 2.0 Cg_endo -47.51 -56.91 2.66 Favored 'Trans proline' 0 CA--C 1.582 2.895 0 C-N-CA 122.478 2.119 . . . . 73.33 111.464 171.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.672 ' O ' ' HB2' ' B' ' 20' ' ' GLU . 11.8 Cg_endo -89.52 136.37 2.72 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 121.406 1.404 . . . . 60.31 109.161 169.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.404 ' CB ' ' HA ' ' A' ' 9' ' ' THR . 15.2 mm100 -100.69 139.2 20.4 Favored Pre-proline 0 C--N 1.288 -2.073 0 C-N-CA 119.403 -0.919 . . . . 73.4 109.93 175.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.617 ' O ' ' HB2' ' A' ' 10' ' ' HIS . 39.1 Cg_exo -29.55 124.07 0.06 OUTLIER 'Trans proline' 0 C--N 1.361 1.216 1 C-N-CA 125.674 4.249 . . . . 52.35 114.069 -175.34 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.775 HD13 ' H ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -56.09 169.34 0.4 Allowed 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.384 -0.826 . . . . 53.22 113.053 178.542 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' B' ' 31' ' ' LYS . 8.4 t -74.57 165.03 25.89 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.38 0.61 . . . . 44.33 111.925 -172.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.401 ' HA ' ' HD2' ' B' ' 31' ' ' LYS . . . -52.15 -46.41 65.43 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 114.685 -1.143 . . . . 62.44 113.873 -175.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -65.02 -39.39 93.31 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 112.001 0.371 . . . . 60.24 112.001 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.482 ' O ' HG12 ' B' ' 34' ' ' ILE . 4.0 mp0 -60.02 -34.82 73.88 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 116.064 -0.516 . . . . 75.11 110.301 174.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' B' ' 27' ' ' SER . 97.5 mttt -65.37 -41.39 93.82 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.521 -0.548 . . . . 75.41 109.521 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.605 ' N ' ' HE2' ' B' ' 32' ' ' LYS . 0.5 OUTLIER -63.46 -46.73 84.89 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 120.796 -0.362 . . . . 62.41 111.138 176.188 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -71.75 -37.86 70.49 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 113.915 1.08 . . . . 74.41 113.915 -174.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.482 HG12 ' O ' ' B' ' 30' ' ' GLU . 17.9 pt -67.3 -34.04 66.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 C-N-CA 120.136 -0.626 . . . . 64.44 110.649 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -68.73 -44.82 73.02 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.892 -1.151 . . . . 62.51 107.892 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.481 ' HG3' ' HB2' ' B' ' 116' ' ' MET . 33.6 ttmt -63.01 -36.16 82.64 Favored 'General case' 0 CA--C 1.558 1.254 0 CA-C-N 114.235 -1.348 . . . . 71.42 111.864 -177.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -102.0 14.05 33.03 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.33 0.863 . . . . 75.43 113.33 -174.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.589 ' OG ' ' HE2' ' B' ' 112' ' ' LYS . 39.1 t -103.03 163.81 11.99 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 113.238 0.829 . . . . 74.22 113.238 -177.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.446 ' CG1' HG23 ' B' ' 91' ' ' VAL . 11.8 m -137.25 163.49 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 124.502 1.121 . . . . 71.4 111.475 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . 0.703 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 29.1 t80 -111.6 125.6 54.11 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 125.248 1.419 . . . . 70.34 108.433 177.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 58.1 t -112.78 110.59 32.77 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 106.953 -1.499 . . . . 73.25 106.953 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.95 171.36 13.86 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 119.551 -1.309 . . . . 73.22 113.61 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 65.4 t30 65.79 9.21 5.84 Favored 'General case' 0 C--O 1.213 -0.852 0 C-N-CA 126.321 1.848 . . . . 75.01 111.459 -177.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.14 118.6 6.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.386 -0.968 . . . . 62.1 108.386 174.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -68.38 145.47 54.11 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.328 -0.851 . . . . 74.14 111.405 -173.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' TYR . . . . . 0.415 ' CD1' ' HB2' ' B' ' 77' ' ' PRO . 72.4 t80 -61.45 90.2 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 114.626 -1.17 . . . . 72.15 108.016 177.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.39 -16.77 0.35 Allowed Glycine 0 N--CA 1.426 -2.005 0 CA-C-N 115.334 -0.848 . . . . 61.32 112.521 -175.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 68.0 m -72.29 148.62 45.25 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 118.026 0.913 . . . . 64.31 109.244 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . 0.549 HG22 HG22 ' A' ' 49' ' ' THR . 59.3 p -99.63 162.5 12.98 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.735 -0.386 . . . . 74.2 111.327 -177.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.485 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -65.1 -45.35 85.53 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 122.712 0.405 . . . . 74.54 109.981 178.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.9 -49.94 74.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.667 -0.697 . . . . 72.4 110.129 178.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -61.31 -40.64 94.93 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 121.038 0.447 . . . . 73.51 110.742 -177.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 45.5 mt -65.44 -47.56 75.75 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.574 -0.739 . . . . 62.12 111.895 177.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.22 -48.6 77.6 Favored 'General case' 0 C--O 1.2 -1.55 0 C-N-CA 122.612 0.365 . . . . 74.03 110.781 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.35 -41.23 75.77 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 120.87 0.367 . . . . 71.3 110.842 178.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -67.96 -37.59 81.75 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.881 -0.6 . . . . 75.43 110.156 -176.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -82.25 -21.97 36.04 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 113.386 0.884 . . . . 63.51 113.386 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 25.7 t -71.92 -24.45 61.64 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.813 -0.63 . . . . 75.44 109.532 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 28.1 m -62.46 -26.29 68.44 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.255 0.55 . . . . 64.21 109.803 172.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 63.5 m -110.08 15.33 22.55 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.242 -0.436 . . . . 72.4 111.383 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . 0.412 ' HA3' ' HB3' ' B' ' 90' ' ' SER . . . 172.98 173.77 39.64 Favored Glycine 0 C--O 1.216 -1.026 0 C-N-CA 118.29 -1.909 . . . . 53.11 115.197 -177.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 10.2 p -73.23 -69.39 0.42 Allowed 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.015 0.436 . . . . 60.03 111.718 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . 0.358 57.5 mt 102.71 112.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 C-N-CA 127.302 2.241 . . . . 64.43 111.839 177.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . 0.596 ' OD1' ' HB3' ' A' ' 73' ' ' PHE . 32.5 t30 -90.66 -49.9 6.22 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 113.604 -1.634 . . . . 72.35 109.548 -177.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.557 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 65.1 mtp180 -154.58 162.88 40.93 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 106.841 -1.541 . . . . 74.23 106.841 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.486 HG22 HG23 ' B' ' 83' ' ' ILE . 24.4 pt -144.0 142.14 24.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 106.676 -1.601 . . . . 74.43 106.676 172.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 34.2 m -125.17 125.01 43.01 Favored 'General case' 0 C--N 1.27 -2.869 0 N-CA-C 107.86 -1.163 . . . . 74.43 107.86 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.4 mp -122.72 116.18 48.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.18 -1.785 . . . . 70.42 106.18 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.515 ' HG ' ' CE1' ' B' ' 80' ' ' TYR 0.272 0.9 OUTLIER -121.19 128.86 52.87 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-O 121.031 0.444 . . . . 64.45 112.006 179.584 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 75.2 m -117.21 133.6 55.8 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.653 -0.869 . . . . 73.22 108.653 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 4.1 p30 -117.58 134.53 54.77 Favored 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 119.281 -0.968 . . . . 71.24 110.433 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' B' ' 77' ' ' PRO . 41.2 ttmt -124.26 5.94 8.45 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.1 0.476 . . . . 64.15 109.95 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.439 ' HB3' ' OD1' ' A' ' 64' ' ' ASN . 53.8 p90 -60.47 -25.96 66.43 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.16 0.8 . . . . 75.31 113.16 -177.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 41.9 m -87.92 6.57 35.06 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 120.865 -0.334 . . . . 63.5 111.095 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.04 -58.17 0.42 Allowed Glycine 0 N--CA 1.437 -1.274 0 N-CA-C 111.445 -0.662 . . . . 52.12 111.445 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -95.41 127.6 41.44 Favored Pre-proline 0 C--N 1.307 -1.257 0 N-CA-C 109.574 -0.528 . . . . 71.21 109.574 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 96.8 Cg_endo -76.56 122.78 6.63 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.759 2.306 . . . . 75.2 112.805 -177.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' B' ' 78' ' ' LYS . 33.9 mtpt -106.15 159.27 16.21 Favored 'General case' 0 CA--C 1.484 -1.579 0 CA-C-N 115.263 -0.881 . . . . 75.44 111.477 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -132.56 136.43 8.73 Favored Glycine 0 N--CA 1.422 -2.266 0 C-N-CA 120.571 -0.823 . . . . 22.32 113.252 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . 0.515 ' CE1' ' HG ' ' B' ' 69' ' ' LEU . 11.7 p90 -152.68 143.55 22.93 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 124.24 1.016 . . . . 63.41 110.198 174.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.49 150.34 52.17 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 116.168 -0.469 . . . . 44.1 109.971 -173.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' TYR . . . . . 0.791 ' CD1' ' HD3' ' B' ' 112' ' ' LYS . 96.1 m-85 -126.53 129.9 49.52 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.995 -0.743 . . . . 65.45 108.995 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.486 HG23 HG22 ' B' ' 66' ' ' ILE . 34.2 mm -108.75 115.47 49.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 109.358 -0.608 . . . . 75.45 109.358 -177.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -91.51 119.19 31.24 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.546 -0.538 . . . . 62.15 109.546 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -98.78 156.67 16.74 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.956 -0.465 . . . . 72.14 109.761 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.35 -17.9 44.02 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.277 0.561 . . . . 65.41 110.379 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . 0.429 ' HB3' ' OD1' ' B' ' 89' ' ' ASN . 28.6 mt-10 -124.47 140.96 52.46 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.579 -0.737 . . . . 75.25 111.111 -177.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -63.71 -33.72 76.27 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.34 0.59 . . . . 75.01 110.454 172.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . 0.429 ' OD1' ' HB3' ' B' ' 87' ' ' GLU . 2.8 p-10 -61.94 -32.22 72.62 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.564 -0.744 . . . . 73.23 112.278 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' SER . . . . . 0.42 ' OG ' ' HB2' ' B' ' 87' ' ' GLU . 15.2 m -67.85 -41.24 83.21 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 120.834 0.35 . . . . 54.41 110.655 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.447 ' O ' HG13 ' B' ' 95' ' ' VAL 0.325 0.4 OUTLIER -65.87 -44.7 92.63 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 112.722 0.638 . . . . 74.43 112.722 178.667 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -59.51 -33.03 70.84 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.942 0.401 . . . . 64.11 112.006 174.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.79 -37.22 65.01 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 120.819 0.343 . . . . 65.23 110.521 177.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.12 -44.38 54.03 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.075 0.398 . . . . 63.3 112.075 -176.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . 0.447 HG13 ' O ' ' B' ' 91' ' ' VAL . 29.7 m -51.65 -22.42 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 113.632 0.975 . . . . 61.0 113.632 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.2 -17.56 63.66 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.988 0.423 . . . . 65.32 111.439 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 60.2 mtm -95.47 6.86 47.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.33 -0.395 . . . . 73.21 110.932 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . 0.599 ' O ' ' HA ' ' B' ' 108' ' ' LYS . 5.2 p-10 -39.27 -47.62 1.71 Allowed 'General case' 0 C--O 1.204 -1.324 0 N-CA-C 114.925 1.454 . . . . 70.42 114.925 -176.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -113.37 92.62 4.06 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 119.267 0.94 . . . . 73.3 109.718 176.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' B' ' 106' ' ' THR . 31.6 p -142.16 173.59 11.38 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.671 -1.15 . . . . 62.24 110.989 -178.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.16 129.33 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.761 0 CA-C-O 121.559 0.695 . . . . 72.15 110.036 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -135.57 121.59 20.02 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.897 -1.149 . . . . 71.13 107.897 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 48.1 ttt-85 60.01 33.42 21.36 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 122.155 0.979 . . . . 70.43 111.23 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.38 -5.23 80.71 Favored Glycine 0 C--N 1.317 -0.491 0 CA-C-N 114.847 -1.069 . . . . 72.13 114.507 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -129.47 156.9 43.37 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 117.827 0.814 . . . . 73.23 111.458 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' B' ' 100' ' ' THR . 62.9 m -80.76 120.49 24.71 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 116.352 -0.385 . . . . 75.14 110.282 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 44.5 pt -102.06 171.99 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.983 -0.377 . . . . 71.51 109.983 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' B' ' 98' ' ' ASP . 55.6 tptt -134.06 127.47 32.27 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.803 -0.814 . . . . 61.23 108.803 -178.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.703 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 8.3 p -129.25 122.66 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-O 121.07 0.462 . . . . 64.32 111.684 177.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.37 159.59 41.52 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 107.026 -1.472 . . . . 74.14 107.026 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.96 131.03 35.1 Favored 'Trans proline' 0 N--CA 1.48 0.719 0 C-N-CA 122.476 2.117 . . . . 71.01 113.039 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.791 ' HD3' ' CD1' ' B' ' 82' ' ' TYR . 37.1 ttpt -78.41 93.24 4.69 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 108.93 -0.767 . . . . 60.23 108.93 178.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 58.63 120.35 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.676 0 O-C-N 125.141 1.526 . . . . 75.23 111.78 -173.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 15.9 m -97.67 82.46 3.06 Favored 'General case' 0 N--CA 1.407 -2.591 0 C-N-CA 118.147 -1.421 . . . . 75.14 110.318 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 115' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -91.93 91.48 7.9 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.02 -1.104 . . . . 72.24 108.02 176.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 116' ' ' MET . . . . . 0.481 ' HB2' ' HG3' ' B' ' 36' ' ' LYS . 26.6 ttt -162.65 137.23 5.04 Favored Pre-proline 0 C--N 1.293 -1.88 0 N-CA-C 107.832 -1.174 . . . . 63.04 107.832 -174.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -65.78 109.61 1.5 Allowed 'Trans proline' 0 N--CA 1.441 -1.58 0 C-N-CA 121.235 1.29 . . . . 61.11 109.947 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.98 -45.55 95.89 Favored Glycine 0 CA--C 1.493 -1.312 0 N-CA-C 110.429 -1.069 . . . . 74.05 110.429 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 10.0 tt -79.25 127.37 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.062 0 N-CA-C 108.347 -0.983 . . . . 64.24 108.347 174.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 38.7 m -69.52 117.0 10.59 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 108.74 -0.837 . . . . 74.13 108.74 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 32.8 m -62.66 98.4 0.12 Allowed 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.838 0.828 . . . . 72.43 111.01 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 25.4 p -138.61 -165.46 1.82 Allowed 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 114.12 -1.4 . . . . 63.01 107.423 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -77.99 -25.77 48.26 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.063 0.459 . . . . 63.55 110.461 177.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? . . . . . 0 C--N 1.308 -1.214 0 N-CA-C 107.653 -1.24 . . . . 64.25 107.653 179.569 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.28 0 CA-C-O 120.744 0.307 . . . . 34.41 110.278 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.2 pt -116.02 137.47 49.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-O 120.931 0.396 . . . . 73.12 110.719 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.19 144.11 62.04 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 108.835 -0.802 . . . . 62.05 108.835 175.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -61.36 144.63 98.51 Favored 'Trans proline' 0 C--O 1.243 0.727 0 C-N-CA 122.537 2.158 . . . . 74.15 111.918 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 68.4 m -73.28 108.68 6.29 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 116.299 -0.409 . . . . 61.33 109.924 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 66.3 mtt -86.09 153.4 22.13 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.894 -0.594 . . . . 74.42 109.445 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -122.27 137.29 54.89 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.002 0.429 . . . . 75.34 111.342 -176.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 t -150.92 102.39 2.97 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.478 -0.934 . . . . 70.04 108.478 176.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p -88.27 132.9 34.21 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 116.017 -0.538 . . . . 74.41 111.67 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -90.73 165.18 13.81 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.003 -1.11 . . . . 63.33 108.003 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.4 t -82.19 152.97 26.2 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.056 -0.72 . . . . 71.24 109.056 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -87.6 168.7 12.8 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.07 -0.715 . . . . 74.3 109.07 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.3 mtt -71.79 94.31 1.39 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.399 0.619 . . . . 75.31 111.384 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.0 p -82.17 134.07 35.29 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.169 -0.923 . . . . 70.44 111.326 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -98.28 170.89 8.56 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.802 -0.636 . . . . 70.24 110.437 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.98 39.38 6.15 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 116.233 -0.439 . . . . 74.32 112.146 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -108.56 105.56 15.24 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 110.028 -0.36 . . . . 72.03 110.028 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -136.37 -53.29 0.73 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.49 -0.323 . . . . 72.34 111.539 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.9 t -134.6 145.73 48.92 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-O 121.277 0.561 . . . . 52.44 112.175 -177.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -137.11 -20.08 1.26 Allowed 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 125.208 1.403 . . . . 74.2 109.232 176.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.43 -167.06 54.79 Favored Glycine 0 N--CA 1.429 -1.77 0 CA-C-N 114.919 -1.037 . . . . 51.34 111.598 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -57.74 -39.86 84.01 Favored 'Trans proline' 0 CA--C 1.564 1.998 0 C-N-CA 122.715 2.277 . . . . 75.23 117.384 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -90.64 167.49 4.03 Favored 'Trans proline' 0 N--CA 1.416 -3.046 0 N-CA-C 115.93 1.473 . . . . 73.25 115.93 -169.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.484 ' HG2' ' NH1' ' A' ' 65' ' ' ARG . 19.3 mt-30 -93.93 117.26 67.18 Favored Pre-proline 0 N--CA 1.379 -3.976 0 N-CA-C 103.912 -2.625 . . . . 71.14 103.912 175.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.538 ' C ' HD12 ' A' ' 26' ' ' LEU . 74.2 Cg_endo -84.95 96.5 0.66 Allowed 'Trans proline' 0 C--O 1.249 1.047 0 C-N-CA 121.941 1.761 . . . . 73.23 112.636 -177.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.538 HD12 ' C ' ' A' ' 25' ' ' PRO . 4.7 mp -142.09 169.54 17.4 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.52 -1.218 . . . . 72.31 109.425 -178.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 68.6 m -74.43 148.79 40.8 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 108.337 -0.986 . . . . 64.43 108.337 170.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.29 -45.53 62.2 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 111.944 0.35 . . . . 61.11 111.944 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -61.47 -37.24 82.87 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.951 0.405 . . . . 75.14 111.449 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.533 ' HB3' HD23 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -61.75 -40.09 93.88 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.749 -0.66 . . . . 71.51 111.222 175.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -73.97 -38.96 64.01 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.723 -0.473 . . . . 72.41 109.723 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 51.6 mtpt -59.2 -41.9 89.64 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.586 0.587 . . . . 71.5 112.586 176.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -67.57 -40.84 84.86 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.416 0.525 . . . . 70.35 112.416 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.461 HG21 ' CZ ' ' B' ' 73' ' ' PHE . 20.2 pt -70.32 -34.36 58.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.425 -0.807 . . . . 63.13 112.697 -174.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -67.5 -31.57 71.78 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.227 0.537 . . . . 75.04 110.689 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 93.5 mttt -70.03 -24.19 63.23 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.688 -0.687 . . . . 74.15 111.072 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -109.3 16.96 22.01 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.598 -0.728 . . . . 74.22 109.806 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.41 ' OG ' ' HG2' ' A' ' 84' ' ' GLU . 36.4 t -107.88 159.72 16.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 121.699 0.761 . . . . 63.12 112.204 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.554 HG13 ' CG2' ' A' ' 91' ' ' VAL . 0.2 OUTLIER -140.42 163.7 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 C-N-CA 124.678 1.191 . . . . 53.52 112.195 -179.445 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.608 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 23.1 t80 -105.75 128.27 53.59 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 126.216 1.806 . . . . 74.31 107.195 176.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 65.5 t -118.87 116.08 50.0 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 107.539 -1.282 . . . . 61.12 107.539 177.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.82 167.46 13.05 Favored Glycine 0 C--N 1.297 -1.626 0 C-N-CA 120.033 -1.08 . . . . 74.11 114.247 -177.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.7 t30 59.87 62.24 1.72 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.431 1.892 . . . . 64.44 114.751 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.4 p -114.44 131.19 67.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.926 -1.034 . . . . 64.32 110.363 173.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.33 163.39 15.36 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.231 -1.396 . . . . 63.24 107.231 178.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -55.84 123.78 15.38 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.871 0.843 . . . . 75.24 112.311 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.12 -42.37 0.73 Allowed Glycine 0 N--CA 1.412 -2.948 0 N-CA-C 107.46 -2.256 . . . . 63.52 107.46 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.3 m -92.64 136.02 33.59 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 108.179 -1.045 . . . . 65.24 108.179 174.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.1 p -112.17 179.04 4.11 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.373 -0.603 . . . . 72.22 109.373 -178.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.556 ' HB1' HD11 ' A' ' 66' ' ' ILE . . . -61.73 -39.25 90.9 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.291 -0.633 . . . . 61.34 109.291 176.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -58.08 -46.5 85.38 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.401 -0.818 . . . . 55.24 111.489 174.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -58.53 -40.35 82.71 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.505 0.669 . . . . 54.51 110.071 178.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.2 mt -69.94 -48.27 59.08 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.704 -1.135 . . . . 72.21 111.265 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.5 -50.26 74.28 Favored 'General case' 0 C--O 1.193 -1.893 0 O-C-N 123.119 0.262 . . . . 61.44 111.704 -178.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.27 -42.57 91.53 Favored 'General case' 0 C--O 1.248 1.025 0 CA-C-O 121.083 0.468 . . . . 74.31 110.78 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -67.22 -39.78 86.29 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.748 -0.66 . . . . 72.2 110.39 -175.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -82.03 -21.44 36.98 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 112.928 0.714 . . . . 73.44 112.928 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.9 t -70.35 -24.37 62.97 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.181 -0.674 . . . . 75.15 109.181 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.7 m -60.15 -30.34 69.24 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-O 120.977 0.418 . . . . 52.25 110.104 173.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 63.8 m -90.65 1.67 56.6 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 112.782 0.66 . . . . 64.23 112.782 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 147.38 -162.48 28.65 Favored Glycine 0 N--CA 1.462 0.427 0 C-N-CA 119.282 -1.437 . . . . 71.42 114.164 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.3 t -104.63 132.41 50.9 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.857 -0.423 . . . . 75.13 109.857 -177.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 72.0 mt -97.84 135.66 31.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.354 0.597 . . . . 52.14 112.581 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.55 ' HB3' ' CE2' ' B' ' 73' ' ' PHE . 79.5 m-20 -96.42 -42.05 8.3 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.236 -0.893 . . . . 73.53 111.909 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.484 ' NH1' ' HG2' ' A' ' 24' ' ' GLN . 43.8 mtt180 -153.57 161.83 41.84 Favored 'General case' 0 CA--C 1.486 -1.494 0 CA-C-N 115.71 -0.677 . . . . 74.22 109.699 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.556 HD11 ' HB1' ' A' ' 50' ' ' ALA . 29.3 pt -148.35 142.73 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 107.665 -1.235 . . . . 62.14 107.665 173.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.3 m -125.15 127.34 46.68 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 106.886 -1.524 . . . . 24.31 106.886 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 68' ' ' ILE . 2.1 mp -125.71 122.7 62.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 106.269 -1.752 . . . . 74.3 106.269 -177.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.433 ' HA ' ' O ' ' B' ' 66' ' ' ILE 0.253 1.3 pt? -121.24 126.36 49.41 Favored 'General case' 0 C--N 1.28 -2.421 0 C-N-CA 120.277 -0.569 . . . . 73.21 111.545 176.299 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 66.2 m -116.44 134.59 54.69 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.124 -0.695 . . . . 73.23 109.124 -177.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' B' ' 65' ' ' ARG . 2.0 p30 -126.65 152.91 46.08 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 119.773 -0.771 . . . . 70.44 113.034 -177.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.563 ' HE2' ' HB3' ' A' ' 77' ' ' PRO . 0.5 OUTLIER -121.93 18.81 10.95 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.817 -0.629 . . . . 70.11 109.722 169.256 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -67.78 -21.89 65.23 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 118.942 -1.103 . . . . 75.11 109.421 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.8 m -84.44 2.26 41.65 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.405 -0.816 . . . . 60.02 110.382 174.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.61 -44.13 2.27 Favored Glycine 0 CA--C 1.507 -0.423 0 N-CA-C 110.997 -0.841 . . . . 33.25 110.997 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -97.18 144.21 27.49 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 108.234 -1.024 . . . . 74.42 108.234 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.563 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 55.8 Cg_endo -65.43 116.85 4.13 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 123.168 2.579 . . . . 72.42 110.464 175.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -122.86 -162.56 1.03 Allowed 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.571 -1.27 . . . . 73.1 107.571 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 172.39 159.16 18.28 Favored Glycine 1 N--CA 1.396 -4.011 0 C-N-CA 119.631 -1.271 . . . . 44.43 113.516 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -151.41 147.78 27.31 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 125.12 1.368 . . . . 73.21 109.319 176.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.12 150.6 49.16 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.046 0.451 . . . . 73.43 110.327 -171.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.42 ' CZ ' ' HD1' ' A' ' 40' ' ' TYR . 39.9 m-85 -118.77 121.81 40.96 Favored 'General case' 0 C--N 1.28 -2.43 0 C-N-CA 123.596 0.758 . . . . 75.23 110.326 176.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.424 ' HA ' HG22 ' A' ' 66' ' ' ILE . 26.4 mm -105.65 127.86 60.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 107.712 -1.218 . . . . 60.2 107.712 -178.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.41 ' HG2' ' OG ' ' A' ' 38' ' ' SER . 32.8 mt-10 -110.39 119.28 38.68 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.544 -0.539 . . . . 64.31 109.544 178.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -95.22 162.67 13.6 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.562 0.696 . . . . 62.35 112.079 -177.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.543 ' HA ' HD21 ' A' ' 64' ' ' ASN . . . -80.22 -28.47 38.57 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.915 -1.038 . . . . 70.21 111.942 176.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.8 150.1 43.28 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.583 -0.847 . . . . 74.24 112.022 -178.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.567 ' O ' HG12 ' A' ' 91' ' ' VAL . 8.9 mmm180 -69.04 -32.71 72.41 Favored 'General case' 0 C--O 1.215 -0.719 0 C-N-CA 123.264 0.626 . . . . 70.44 109.791 177.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -66.9 -28.83 68.63 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.463 -0.895 . . . . 75.11 110.807 177.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.7 m -70.22 -39.41 75.14 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 109.818 -0.438 . . . . 74.23 109.818 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 88' ' ' ARG . 8.3 p -66.19 -38.84 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.652 -0.499 . . . . 71.43 109.652 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -66.98 -30.04 70.05 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-O 120.93 0.395 . . . . 72.45 111.697 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.75 -33.02 64.12 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.541 -0.54 . . . . 64.41 109.541 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.93 -45.07 52.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.735 -0.666 . . . . 73.41 111.089 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 91' ' ' VAL . 19.0 m -57.21 -22.07 16.2 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 N-CA-C 112.762 0.653 . . . . 63.14 112.762 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.04 -20.06 66.05 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.607 0.718 . . . . 73.42 110.887 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 69.0 mtm -94.92 7.91 44.47 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.174 -0.921 . . . . 74.53 110.24 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.662 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 5.1 p-10 -40.23 -45.66 2.11 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 113.814 1.042 . . . . 74.42 113.814 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -118.94 116.6 26.81 Favored 'General case' 0 N--CA 1.405 -2.679 0 N-CA-C 108.158 -1.053 . . . . 70.35 108.158 172.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 106' ' ' THR . 8.2 t -168.9 -179.77 3.82 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.103 -0.953 . . . . 54.45 108.621 -177.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.48 125.73 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-O 121.533 0.683 . . . . 72.25 110.364 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -130.51 128.96 42.24 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.297 -1.001 . . . . 73.44 108.297 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 54.45 33.03 17.85 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.763 1.225 . . . . 73.43 110.487 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.01 -1.81 88.66 Favored Glycine 0 C--N 1.311 -0.831 0 CA-C-N 114.765 -1.107 . . . . 74.53 114.25 177.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -122.31 152.46 40.08 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 117.589 0.694 . . . . 64.22 111.318 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 100' ' ' THR . 30.8 m -81.98 120.72 25.6 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 110.263 -0.273 . . . . 71.03 110.263 -178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 40.0 pt -103.1 172.09 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 116.329 -0.396 . . . . 43.02 110.48 176.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.662 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 57.6 tptt -129.49 133.55 47.34 Favored 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 109.233 -0.655 . . . . 64.42 109.233 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 23.6 t -127.23 114.52 37.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.002 -0.74 . . . . 75.22 109.002 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.424 HD11 ' CG ' ' B' ' 22' ' ' PRO 0.258 0.0 OUTLIER -143.35 146.24 35.32 Favored Pre-proline 0 C--O 1.211 -0.953 0 C-N-CA 119.277 -0.969 . . . . 74.52 109.432 179.168 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -52.08 137.53 53.79 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 123.386 2.724 . . . . 73.52 113.692 -173.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -67.93 97.93 0.71 Allowed 'General case' 0 C--O 1.248 0.981 0 CA-C-O 121.2 0.524 . . . . 74.34 111.886 -176.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.44 ' O ' ' HB ' ' A' ' 114' ' ' THR . 40.2 ptt180 173.81 -164.13 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 126.145 1.778 . . . . 64.32 106.993 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 113' ' ' ARG . 86.3 m 80.53 143.87 0.08 Allowed 'General case' 0 CA--C 1.543 0.69 0 O-C-N 123.865 0.728 . . . . 70.41 110.968 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 78.2 14.61 1.46 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.414 1.086 . . . . 75.32 110.504 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 25.9 ttt -88.13 128.24 54.36 Favored Pre-proline 0 C--N 1.311 -1.092 0 CA-C-N 115.246 -0.888 . . . . 44.24 109.106 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -59.63 150.56 75.69 Favored 'Trans proline' 0 C--O 1.249 1.027 0 C-N-CA 122.415 2.077 . . . . 55.54 111.281 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -156.15 -152.84 6.38 Favored Glycine 0 N--CA 1.427 -1.925 0 C-N-CA 120.584 -0.817 . . . . 72.43 111.791 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.443 ' O ' HD12 ' A' ' 119' ' ' ILE 0.264 2.3 pp -57.77 114.1 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 114.134 1.161 . . . . 65.2 114.134 -178.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.2 t -173.69 122.25 0.34 Allowed 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.216 -1.401 . . . . 73.41 107.216 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.7 p -83.27 84.75 7.38 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 121.683 0.754 . . . . 71.13 111.065 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.1 p -81.68 149.3 28.57 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.274 -0.875 . . . . 52.44 112.247 -177.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -121.12 109.08 14.58 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.394 -0.965 . . . . 74.12 108.394 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? . . . . . 0 C--N 1.305 -1.334 0 N-CA-C 108.742 -0.836 . . . . 72.01 108.742 -177.667 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.651 0 N-CA-C 109.185 -0.672 . . . . 73.32 109.185 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 66.1 mt -123.17 112.52 34.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 109.085 -0.709 . . . . 63.22 109.085 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.91 156.62 54.1 Favored Pre-proline 0 C--N 1.308 -1.216 0 N-CA-C 109.398 -0.593 . . . . 73.43 109.398 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -63.46 118.28 5.21 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.437 2.091 . . . . 62.31 111.198 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 26.2 p 52.79 83.44 0.06 Allowed 'General case' 0 C--O 1.246 0.886 0 C-N-CA 124.749 1.22 . . . . 63.32 112.434 -177.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 65.5 mtm -83.57 82.82 8.13 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.255 -0.884 . . . . 73.32 110.953 -178.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -158.96 -71.09 0.08 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.867 -1.06 . . . . 53.14 109.188 176.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 56.6 m -157.5 151.46 24.41 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.62 -0.511 . . . . 74.11 109.62 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 34.7 m 74.89 108.16 0.07 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.59 1.33 . . . . 65.44 114.59 173.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -129.21 119.72 24.52 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.924 -0.769 . . . . 74.01 108.924 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 49.5 m 53.26 86.74 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.522 1.304 . . . . 64.02 114.522 176.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -178.29 166.16 1.87 Allowed 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 124.514 1.125 . . . . 64.43 109.629 176.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 27.5 ttt -68.5 88.67 0.34 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.707 1.003 . . . . 65.54 113.707 -175.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 16.7 p -162.38 150.96 14.82 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 126.147 1.779 . . . . 74.13 106.685 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.6 95.39 2.33 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 118.045 0.384 . . . . 63.54 110.476 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.95 -117.36 11.13 Favored Glycine 0 C--O 1.245 0.832 0 N-CA-C 110.575 -1.01 . . . . 75.3 110.575 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.63 -0.73 57.6 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.104 0.478 . . . . 71.04 110.746 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -81.31 128.81 34.22 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 121.371 0.605 . . . . 72.23 110.158 177.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 59.6 m -164.31 171.49 14.77 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 103.752 -2.685 . . . . 74.13 103.752 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.89 -46.31 78.36 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 119.493 1.042 . . . . 64.23 109.398 177.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.79 -123.57 6.45 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 115.687 -0.688 . . . . 70.13 113.615 173.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.424 ' CG ' HD11 ' A' ' 110' ' ' LEU . 53.8 Cg_exo -53.17 -40.3 77.61 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 124.568 3.512 . . . . 72.43 116.88 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.8 136.05 74.12 Favored 'Trans proline' 0 C--N 1.391 2.768 0 CA-C-N 121.365 1.523 . . . . 71.35 110.377 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.417 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 83.9 mm-40 -60.47 134.3 91.38 Favored Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 123.56 0.538 . . . . 64.22 111.59 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' B' ' 24' ' ' GLN . 26.8 Cg_exo -57.88 179.6 0.15 Allowed 'Trans proline' 0 C--O 1.244 0.817 0 C-N-CA 123.484 2.789 . . . . 74.51 114.069 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.599 HD23 ' HB2' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -148.8 159.65 43.96 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 113.598 -1.637 . . . . 62.22 107.397 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.459 ' HB3' ' HG2' ' B' ' 30' ' ' GLU . 39.1 t -57.26 145.47 31.74 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 113.768 1.025 . . . . 70.11 113.768 -171.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.78 -38.89 67.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.451 -1.25 . . . . 32.44 111.142 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -64.79 -34.9 79.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.442 -0.345 . . . . 71.1 110.279 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.599 ' HB2' HD23 ' B' ' 26' ' ' LEU . 17.9 mm-40 -65.43 -35.31 80.55 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 116.207 -0.451 . . . . 75.03 110.008 177.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -72.66 -47.02 50.92 Favored 'General case' 0 CA--C 1.483 -1.611 0 CA-C-N 115.427 -0.806 . . . . 73.14 110.862 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.455 ' O ' ' HE3' ' B' ' 36' ' ' LYS . 50.3 mtpt -54.87 -43.06 72.8 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 115.861 -0.609 . . . . 74.41 111.767 176.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.508 ' O ' ' HG3' ' B' ' 37' ' ' ARG . 0.3 OUTLIER -65.89 -41.13 91.93 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.819 0.847 . . . . 71.1 111.439 -178.517 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . 0.277 11.7 pt -71.27 -34.66 54.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 113.131 0.789 . . . . 75.32 113.131 -175.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.555 ' OD1' ' HE2' ' B' ' 112' ' ' LYS . 62.7 m-20 -64.01 -41.62 97.4 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-O 121.312 0.577 . . . . 74.05 109.851 -179.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.608 ' HZ2' ' HA ' ' B' ' 117' ' ' PRO . 84.0 mttt -60.27 -27.28 67.14 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.377 0.671 . . . . 75.3 111.63 -177.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' B' ' 33' ' ' GLU . 20.4 mtm180 -104.46 15.41 28.21 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 115.901 -0.591 . . . . 75.1 110.336 -174.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.717 ' OG ' ' HD3' ' B' ' 112' ' ' LYS . 77.7 p -114.89 169.26 9.22 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 113.915 1.08 . . . . 73.44 113.915 -177.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.592 HG13 ' CG2' ' B' ' 91' ' ' VAL . 0.2 OUTLIER -145.46 164.64 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 124.93 1.292 . . . . 73.13 113.24 -174.717 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . 0.543 ' O ' ' HA ' ' B' ' 109' ' ' VAL . 30.4 t80 -105.59 125.98 51.61 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 127.125 2.17 . . . . 74.34 106.719 178.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 59.9 t -117.12 115.48 48.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 108.184 -1.043 . . . . 63.5 108.184 176.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.25 166.18 13.31 Favored Glycine 0 C--N 1.3 -1.471 0 C-N-CA 120.166 -1.016 . . . . 63.42 113.125 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 56.1 t30 62.6 65.75 0.82 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.4 1.48 . . . . 70.24 113.454 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.2 118.15 7.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.319 -0.855 . . . . 64.3 111.864 175.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -80.8 167.18 20.23 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 106.498 -1.668 . . . . 74.34 106.498 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' TYR . . . . . 0.604 ' HB3' ' SG ' ' B' ' 70' ' ' CYS . 48.3 p90 -75.33 5.24 5.88 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.145 0.498 . . . . 75.24 112.04 -178.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.34 -24.84 74.4 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.417 -1.073 . . . . 75.33 110.417 174.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 28.2 m -91.84 145.75 24.31 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 106.275 -1.75 . . . . 62.43 106.275 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 43.6 p -103.79 174.5 5.84 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 118.988 -1.085 . . . . 73.41 111.665 -173.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.602 ' HB1' HD11 ' B' ' 66' ' ' ILE . . . -64.7 -38.4 90.86 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 108.593 -0.892 . . . . 30.21 108.593 175.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -58.56 -42.46 87.95 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.379 -0.828 . . . . 74.34 111.06 176.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -59.05 -46.38 88.39 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.32 0.581 . . . . 74.4 110.027 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 55.6 mt -65.26 -48.6 72.65 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.898 -1.047 . . . . 73.24 111.969 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.512 ' HG2' HD12 ' B' ' 63' ' ' ILE . 0.8 OUTLIER -62.24 -49.09 77.11 Favored 'General case' 0 C--O 1.195 -1.801 0 N-CA-C 111.983 0.364 . . . . 70.41 111.983 -177.825 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.84 -41.51 87.11 Favored 'General case' 0 C--O 1.26 1.635 0 CA-C-O 121.531 0.681 . . . . 71.3 112.309 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -67.93 -41.22 82.93 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.918 -1.037 . . . . 74.33 109.967 -175.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -82.19 -22.07 36.17 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.395 0.517 . . . . 74.43 112.395 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 29.1 t -71.36 -23.86 61.98 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 109.163 -0.68 . . . . 65.43 109.163 -178.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 38.7 m -64.26 -18.93 65.03 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 115.821 -0.627 . . . . 74.41 109.808 175.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 56.0 m -107.38 10.03 29.69 Favored 'General case' 0 CA--C 1.556 1.211 0 N-CA-C 112.013 0.375 . . . . 74.44 112.013 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 147.89 -168.45 28.76 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 119.577 -1.297 . . . . 72.34 114.511 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 57.6 p -107.19 126.64 52.66 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 121.519 0.676 . . . . 55.31 110.502 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.512 HD12 ' HG2' ' B' ' 54' ' ' GLU . 78.9 mt -90.93 135.27 27.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.305 -0.862 . . . . 72.51 113.112 -175.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -93.03 -40.3 10.61 Favored 'General case' 0 CA--C 1.49 -1.344 0 CA-C-N 116.27 -0.423 . . . . 72.4 110.49 177.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 47.9 mtt180 -154.84 161.0 41.62 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 116.27 -0.423 . . . . 70.31 110.026 -177.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.602 HD11 ' HB1' ' B' ' 50' ' ' ALA . 26.7 pt -147.31 143.2 20.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 107.319 -1.363 . . . . 74.1 107.319 172.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 66.0 m -125.81 124.88 41.94 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 106.76 -1.57 . . . . 65.31 106.76 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.4 mp -124.33 120.2 58.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 106.926 -1.509 . . . . 71.11 106.926 -177.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.251 1.3 pt? -120.74 127.82 52.35 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.999 -0.68 . . . . 54.23 111.426 177.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' B' ' 46' ' ' TYR . 69.3 m -116.59 133.79 55.6 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.081 -0.711 . . . . 73.4 109.081 -177.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.642 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 4.1 p-10 -119.65 137.72 53.71 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 118.704 -1.198 . . . . 71.43 113.519 -176.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -104.81 10.38 34.53 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.78 0.8 . . . . 73.45 109.714 171.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.55 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 19.7 m-85 -73.42 -2.38 22.13 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.263 -0.88 . . . . 73.53 112.221 175.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 25.2 m -110.92 13.06 22.18 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 114.633 -1.167 . . . . 64.13 108.779 176.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.51 -55.76 5.03 Favored Glycine 0 C--N 1.343 0.958 0 N-CA-C 110.735 -0.946 . . . . 73.55 110.735 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -97.22 136.46 21.43 Favored Pre-proline 0 C--N 1.288 -2.09 0 CA-C-N 114.272 -0.964 . . . . 72.3 108.655 175.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 51.5 Cg_endo -69.55 118.31 5.6 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 121.603 1.535 . . . . 61.2 111.752 -178.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm -112.22 -157.56 0.62 Allowed 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 106.998 -1.482 . . . . 72.32 106.998 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 171.59 158.6 15.95 Favored Glycine 0 N--CA 1.409 -3.165 0 C-N-CA 119.071 -1.538 . . . . 62.02 114.232 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -149.5 144.3 26.2 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 125.468 1.507 . . . . 72.22 109.134 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.43 150.17 51.78 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 112.082 0.401 . . . . 64.33 112.082 -172.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' TYR . . . . . 0.51 ' HH ' ' HD1' ' B' ' 40' ' ' TYR . 26.4 m-85 -117.72 120.44 37.97 Favored 'General case' 0 C--N 1.286 -2.164 0 C-N-CA 123.398 0.679 . . . . 64.43 111.092 177.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.433 HG23 HG22 ' B' ' 66' ' ' ILE . 24.9 mm -106.5 124.36 61.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 108.337 -0.986 . . . . 74.33 108.337 -178.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' GLU . . . . . 0.435 ' HG2' ' CB ' ' B' ' 38' ' ' SER . 30.8 mt-10 -109.14 119.29 39.09 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 110.172 -0.307 . . . . 52.33 110.172 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -97.61 166.58 11.43 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.529 0.566 . . . . 74.43 112.529 -176.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.09 -34.39 26.15 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.321 -0.854 . . . . 61.43 112.265 175.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -114.26 149.84 35.27 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 120.95 0.405 . . . . 74.25 111.295 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.558 ' O ' HG12 ' B' ' 91' ' ' VAL . 19.4 mtp180 -74.87 -28.68 60.75 Favored 'General case' 0 CA--C 1.463 -2.372 0 CA-C-O 122.301 1.048 . . . . 72.12 111.796 176.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -61.31 -32.27 72.13 Favored 'General case' 1 C--N 1.234 -4.419 0 CA-C-N 114.178 -1.373 . . . . 71.42 110.503 172.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 16.5 m -71.24 -37.88 71.97 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 110.267 -0.272 . . . . 73.15 110.267 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.592 ' CG2' HG13 ' B' ' 39' ' ' VAL . 7.5 p -66.85 -38.78 82.14 Favored 'Isoleucine or valine' 0 C--N 1.348 0.527 0 C-N-CA 120.313 -0.555 . . . . 60.52 109.505 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -67.35 -30.43 70.23 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-O 121.101 0.477 . . . . 73.31 111.677 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.1 -32.23 64.83 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.185 0.517 . . . . 75.11 109.83 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.9 -44.87 46.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.761 -0.654 . . . . 61.42 111.28 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . 0.494 HG11 ' HG3' ' B' ' 111' ' ' PRO . 30.2 m -57.53 -23.26 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 112.553 0.575 . . . . 55.2 112.553 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.37 -17.28 64.68 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.23 0.538 . . . . 74.53 110.078 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 69.1 mtm -95.46 7.63 45.65 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.122 -0.49 . . . . 72.32 111.719 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . 0.408 ' HA ' ' H ' ' B' ' 109' ' ' VAL . 0.8 OUTLIER -49.1 -36.54 18.98 Favored 'General case' 0 C--O 1.201 -1.449 0 N-CA-C 114.312 1.227 . . . . 75.21 114.312 -177.573 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -105.08 17.83 23.41 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-N 119.349 0.977 . . . . 71.44 112.053 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 76.4 p -81.28 172.11 14.01 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 119.276 -0.97 . . . . 52.32 112.561 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.96 122.88 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 CA-C-O 121.746 0.784 . . . . 64.12 111.248 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -117.77 122.96 44.83 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.317 -0.994 . . . . 70.42 108.317 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 53.32 32.74 14.19 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.033 0.753 . . . . 73.22 113.033 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.22 4.6 83.77 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.93 -0.652 . . . . 63.01 114.115 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -125.86 151.39 46.92 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 117.533 0.666 . . . . 74.53 110.065 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 55.2 m -83.34 121.33 27.0 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 109.672 -0.492 . . . . 73.43 109.672 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 39.6 pt -102.05 172.54 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.175 -0.676 . . . . 71.13 109.175 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 56.3 tptt -128.48 132.59 48.38 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.681 -0.859 . . . . 73.54 108.681 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' B' ' 40' ' ' TYR . 20.9 t -126.5 120.21 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 107.999 -1.111 . . . . 72.03 107.999 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.322 0.3 OUTLIER -145.28 133.28 10.56 Favored Pre-proline 0 C--O 1.192 -1.97 0 N-CA-C 107.841 -1.17 . . . . 72.2 107.841 -167.449 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.494 ' HG3' HG11 ' B' ' 95' ' ' VAL . 51.4 Cg_exo -57.16 151.95 48.02 Favored 'Trans proline' 0 N--CA 1.507 2.299 0 C-N-CA 123.504 2.803 . . . . 75.45 116.303 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.717 ' HD3' ' OG ' ' B' ' 38' ' ' SER . 76.2 tttt -109.69 117.4 33.81 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 125.326 1.45 . . . . 62.43 109.84 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 61.7 168.99 0.11 Allowed 'General case' 0 N--CA 1.51 2.562 0 C-N-CA 124.308 1.043 . . . . 73.23 113.549 175.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 20.6 p -142.01 139.64 32.43 Favored 'General case' 0 CA--C 1.566 1.577 0 C-N-CA 124.117 0.967 . . . . 53.45 111.262 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 115' ' ' ASN . . . . . 0.581 ' HB3' ' HE2' ' B' ' 36' ' ' LYS . 3.7 t-20 177.78 151.52 0.23 Allowed 'General case' 0 N--CA 1.505 2.291 0 C-N-CA 123.656 0.782 . . . . 71.33 110.038 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 116' ' ' MET . . . . . 0.433 ' HA ' ' HD3' ' B' ' 117' ' ' PRO . 0.0 OUTLIER -81.11 144.34 54.39 Favored Pre-proline 0 N--CA 1.481 1.102 0 C-N-CA 122.777 0.431 . . . . 62.44 110.588 179.127 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 117' ' ' PRO . . . . . 0.608 ' HA ' ' HZ2' ' B' ' 36' ' ' LYS . 3.8 Cg_exo -76.27 161.75 34.67 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 123.97 3.113 . . . . 72.23 115.987 -174.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . -145.13 -176.14 18.86 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 115.283 -0.871 . . . . 72.41 110.946 176.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 68.0 mt -137.45 141.93 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 117.654 0.727 . . . . 73.05 110.051 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 67.5 m -156.57 141.39 17.03 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.782 0.433 . . . . 72.54 110.354 178.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 31.7 m -142.79 168.4 19.8 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 110.247 -0.279 . . . . 62.24 110.247 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 78.0 m -144.68 124.34 13.3 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.884 0.373 . . . . 72.24 110.383 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -133.16 -170.18 2.42 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.503 -0.925 . . . . 64.21 108.503 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 . . . . . 0 N--CA 1.433 -1.324 0 N-CA-C 106.723 -1.584 . . . . 74.41 106.723 173.275 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.337 0 N-CA-C 109.126 -0.694 . . . . 52.45 109.126 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.2 mt -106.91 113.38 43.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 108.603 -0.888 . . . . 74.5 108.603 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -150.69 145.58 18.52 Favored Pre-proline 0 C--N 1.305 -1.34 0 N-CA-C 108.92 -0.771 . . . . 70.44 108.92 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.3 162.94 25.0 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 122.356 2.037 . . . . 75.23 111.763 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 72.6 m -77.28 158.05 30.44 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.991 -0.55 . . . . 74.32 109.963 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.4 127.74 32.48 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.904 -0.318 . . . . 75.12 110.467 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -151.74 6.12 0.45 Allowed 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.303 0.573 . . . . 60.33 111.976 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.8 t -117.43 135.42 53.91 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 106.279 -1.748 . . . . 73.25 106.279 174.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.0 p -141.85 172.88 12.08 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 111.897 0.332 . . . . 75.34 111.897 -172.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 76.7 t60 69.36 -55.07 0.58 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.264 1.426 . . . . 63.22 113.285 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.457 ' HB3' ' OG1' ' B' ' 14' ' ' THR . 49.8 m -89.48 138.84 31.11 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 116.24 -0.437 . . . . 71.42 110.289 -177.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.487 ' HD3' ' N ' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -161.52 -2.85 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.839 -0.619 . . . . 74.33 111.875 -173.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.7 mtt -70.99 102.91 2.53 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.659 0.742 . . . . 74.41 112.633 -176.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.8 m -154.45 -55.77 0.1 Allowed 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.526 -1.215 . . . . 54.34 108.629 175.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.522 ' HA ' ' OE2' ' A' ' 20' ' ' GLU . . . -158.83 167.57 29.1 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-N 116.453 -0.34 . . . . 62.11 110.649 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.29 -107.74 0.5 Allowed Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 110.44 -1.064 . . . . 74.41 110.44 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.41 26.95 0.93 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 122.182 0.991 . . . . 64.01 108.505 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -136.23 -15.95 1.67 Allowed 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 114.512 1.301 . . . . 74.11 114.512 -171.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.3 m -126.26 29.51 5.8 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.51 -1.663 . . . . 71.11 106.51 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.522 ' OE2' ' HA ' ' A' ' 15' ' ' ALA . 2.3 mp0 -100.85 97.03 7.68 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 116.396 1.999 . . . . 71.41 116.396 -169.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 50.05 -149.35 5.91 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 119.314 2.485 . . . . 55.45 119.314 167.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.445 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 78.8 Cg_exo -48.11 -45.56 25.14 Favored 'Trans proline' 0 C--N 1.365 1.415 1 C-N-CA 125.925 4.417 . . . . 64.22 118.388 -173.505 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.481 ' HG3' ' CE2' ' B' ' 80' ' ' TYR . 2.6 Cg_endo -42.35 129.49 4.75 Favored 'Trans proline' 0 C--N 1.391 2.781 0 C-N-CA 122.659 2.239 . . . . 64.41 112.388 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -58.79 139.31 86.54 Favored Pre-proline 0 C--O 1.247 0.968 0 CA-C-N 115.316 -0.856 . . . . 73.03 111.991 -177.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -72.1 103.28 1.47 Allowed 'Trans proline' 0 N--CA 1.432 -2.113 0 C-N-CA 122.112 1.874 . . . . 71.12 110.413 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.659 HD13 ' H ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -63.85 175.54 1.14 Allowed 'General case' 0 C--O 1.247 0.929 0 CA-C-N 115.158 -0.928 . . . . 72.32 111.671 177.812 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.9 m -53.35 143.43 18.9 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.879 0.696 . . . . 63.33 112.879 -172.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 31' ' ' LYS . . . -55.7 -46.13 77.72 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.721 -1.127 . . . . 73.4 112.189 -178.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -69.38 -31.76 70.35 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.467 -0.893 . . . . 65.32 112.923 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.416 ' CB ' HD23 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -61.63 -34.1 75.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.485 -0.325 . . . . 55.22 110.256 170.701 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.45 ' HE2' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -65.45 -47.41 76.25 Favored 'General case' 0 C--O 1.211 -0.964 0 N-CA-C 108.334 -0.987 . . . . 43.44 108.334 178.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.549 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -53.4 -47.0 69.92 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-O 120.401 0.143 . . . . 74.3 110.798 177.746 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -70.45 -43.44 69.85 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 113.291 0.848 . . . . 70.23 113.291 -174.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.45 HD11 ' HE2' ' A' ' 31' ' ' LYS . 18.7 pt -70.31 -35.77 64.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 C-N-CA 119.722 -0.791 . . . . 42.14 111.863 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.46 -29.32 69.42 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.232 0.539 . . . . 72.2 111.263 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 54.0 mtmt -77.76 -10.75 59.7 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.895 -0.593 . . . . 73.23 111.649 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -118.09 18.74 13.8 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.163 -0.471 . . . . 74.23 110.711 -174.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -94.83 139.09 31.77 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.928 -0.767 . . . . 72.24 108.928 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 83' ' ' ILE . 32.1 m -126.18 160.76 33.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 109.616 -0.512 . . . . 64.42 109.616 178.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.531 ' CD2' ' HG2' ' B' ' 22' ' ' PRO . 38.4 t80 -114.56 123.08 48.47 Favored 'General case' 0 C--N 1.274 -2.693 0 C-N-CA 125.159 1.384 . . . . 75.23 108.343 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 108' ' ' LYS . 97.1 t -112.45 108.28 25.12 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.877 0 N-CA-C 107.087 -1.449 . . . . 71.21 107.087 177.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.07 163.07 20.15 Favored Glycine 0 C--N 1.284 -2.359 0 C-N-CA 119.62 -1.276 . . . . 72.45 112.231 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.408 ' ND2' ' HB3' ' A' ' 105' ' ' ARG . 66.5 t30 57.7 21.12 7.0 Favored 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 125.779 1.632 . . . . 72.43 113.562 178.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 p -54.39 135.44 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-O 121.38 0.61 . . . . 62.42 109.849 175.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.36 148.92 40.84 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 108.081 -1.081 . . . . 73.51 108.081 -176.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -70.24 -15.88 62.97 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.076 0.941 . . . . 64.0 109.189 -176.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.44 -11.62 83.01 Favored Glycine 0 N--CA 1.427 -1.955 0 CA-C-N 115.383 -0.826 . . . . 34.32 112.323 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.6 m -74.5 122.28 22.81 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-O 121.56 0.695 . . . . 63.43 110.069 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.1 p -100.86 171.73 7.49 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.309 -0.86 . . . . 74.24 108.903 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.02 -50.13 75.27 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 118.142 0.428 . . . . 71.32 111.194 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -57.49 -42.03 81.9 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.725 0.639 . . . . 73.23 112.725 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -67.09 -41.2 86.71 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.227 0.537 . . . . 70.2 110.315 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.2 mt -71.37 -48.37 50.46 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.707 -0.679 . . . . 75.12 111.815 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.453 ' HG3' ' OH ' ' B' ' 46' ' ' TYR . 14.2 tm-20 -59.73 -49.07 79.15 Favored 'General case' 0 C--O 1.208 -1.1 0 C-N-CA 123.547 0.739 . . . . 71.41 111.317 -178.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.35 -42.82 87.72 Favored 'General case' 0 C--O 1.27 2.165 0 CA-C-O 121.51 0.672 . . . . 65.02 111.214 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -63.63 -43.51 96.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.741 -1.118 . . . . 72.03 110.517 -175.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -81.36 -21.4 39.11 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 113.73 1.011 . . . . 74.45 113.73 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 69.4 m -66.59 -24.58 66.36 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 120.969 0.414 . . . . 55.43 110.885 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.1 m -58.62 -26.3 63.56 Favored 'General case' 0 CA--C 1.562 1.413 0 CA-C-O 121.144 0.497 . . . . 72.22 110.562 173.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 59.7 m -91.0 -2.78 57.65 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 112.945 0.72 . . . . 74.0 112.945 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.42 -161.86 27.95 Favored Glycine 0 C--N 1.317 -0.48 0 C-N-CA 119.456 -1.354 . . . . 52.41 113.913 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.1 m -97.26 120.26 37.3 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.562 0.696 . . . . 44.52 111.382 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.2 mt -82.01 129.53 37.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 115.001 -0.999 . . . . 71.52 111.168 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.434 ' OD1' ' HA ' ' B' ' 73' ' ' PHE . 48.4 t30 -93.54 -36.95 12.16 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.029 -0.987 . . . . 72.44 109.777 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.544 ' HD2' ' OE1' ' A' ' 84' ' ' GLU . 99.4 mtt180 -157.34 162.43 39.1 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.391 -0.822 . . . . 72.25 109.51 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.596 HG22 HG23 ' A' ' 83' ' ' ILE . 34.7 pt -142.68 137.81 28.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 107.259 -1.385 . . . . 73.34 107.259 171.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' B' ' 68' ' ' ILE . 49.9 m -126.54 130.96 51.58 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 107.55 -1.278 . . . . 61.55 107.55 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.2 mt -125.87 118.11 50.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.315 -1.365 . . . . 51.35 107.315 -177.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.55 ' HA ' ' O ' ' B' ' 66' ' ' ILE 0.342 0.9 OUTLIER -121.59 125.5 46.89 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 119.944 -0.702 . . . . 44.52 112.795 176.798 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 66.1 m -116.38 130.63 56.87 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.923 -1.14 . . . . 64.03 107.923 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.608 ' O ' ' HA ' ' A' ' 77' ' ' PRO . 3.8 p-10 -115.78 137.14 52.37 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 119.196 -1.002 . . . . 72.45 112.377 -176.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -110.61 12.54 22.7 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.679 -0.691 . . . . 63.54 110.13 173.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.514 ' CD2' ' HB2' ' A' ' 71' ' ' ASP . 13.7 p90 -72.66 -9.97 59.24 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.789 0.804 . . . . 75.32 109.447 176.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.7 m -94.22 8.87 40.17 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 114.357 -1.292 . . . . 63.4 109.47 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.28 -54.42 4.53 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 110.492 -1.043 . . . . 55.13 110.492 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -95.61 131.26 29.81 Favored Pre-proline 0 C--N 1.299 -1.587 0 N-CA-C 106.772 -1.566 . . . . 70.22 106.772 176.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.608 ' HA ' ' O ' ' A' ' 71' ' ' ASP . 33.3 Cg_endo -66.7 118.36 5.48 Favored 'Trans proline' 0 C--O 1.243 0.748 0 C-N-CA 121.536 1.491 . . . . 75.21 112.557 -177.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.407 ' HB2' ' OD1' ' A' ' 71' ' ' ASP . 25.0 mtmm -100.09 -169.39 1.73 Allowed 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.959 -1.126 . . . . 53.41 107.959 174.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.05 139.8 6.11 Favored Glycine 0 N--CA 1.41 -3.1 0 C-N-CA 119.727 -1.225 . . . . 75.22 112.763 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -151.12 143.31 24.07 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.797 -0.816 . . . . 72.23 108.797 172.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.08 152.01 50.0 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 116.747 -0.206 . . . . 71.43 111.23 -173.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 95.6 m-85 -120.4 115.63 23.89 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 109.044 -0.724 . . . . 75.31 109.044 174.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.596 HG23 HG22 ' A' ' 66' ' ' ILE . 38.6 mm -101.65 121.27 52.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.515 -1.291 . . . . 71.11 107.515 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.544 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 33.7 mt-10 -106.07 123.09 47.45 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 120.242 -0.583 . . . . 64.53 109.5 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -94.45 156.64 16.38 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 112.525 0.565 . . . . 74.33 112.525 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.06 -36.32 55.99 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.515 -0.766 . . . . 61.52 110.404 176.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -103.01 146.23 28.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.771 0.319 . . . . 71.43 110.185 175.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.45 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.77 -32.34 62.03 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.103 -1.443 . . . . 74.15 107.103 178.606 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -60.46 -31.48 70.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.283 -1.326 . . . . 75.11 110.338 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 31.5 m -64.41 -36.64 84.83 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 116.235 -0.439 . . . . 64.45 110.503 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 95' ' ' VAL . 2.3 m -67.68 -38.3 80.13 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.533 0 C-N-CA 119.61 -0.836 . . . . 70.42 109.241 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -58.3 -36.1 72.81 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.064 0.459 . . . . 74.21 111.59 176.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.34 -32.8 64.77 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.929 0.395 . . . . 73.1 110.658 177.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.36 -40.63 50.61 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 116.174 -0.466 . . . . 71.41 111.627 -177.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 91' ' ' VAL . 31.7 m -55.76 -21.85 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 113.117 0.784 . . . . 61.43 113.117 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.08 -14.44 61.74 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 121.586 0.708 . . . . 74.53 110.535 176.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 28.3 mtp -98.17 8.1 45.29 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 124.471 1.108 . . . . 62.34 110.771 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 108' ' ' LYS . 4.5 p-10 -36.57 -53.47 0.88 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.904 1.076 . . . . 72.3 113.904 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -118.87 106.14 12.2 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-O 121.704 0.764 . . . . 65.12 109.451 175.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.0 t -150.1 173.02 14.35 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 114.811 -1.086 . . . . 74.02 109.275 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.87 131.99 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.221 0 N-CA-C 108.754 -0.832 . . . . 63.32 108.754 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -138.32 113.64 9.47 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 107.289 -1.374 . . . . 72.15 107.289 -177.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 37.5 mtp85 56.1 33.31 21.72 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.906 0.882 . . . . 74.32 112.127 -175.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.06 -10.18 71.77 Favored Glycine 0 C--N 1.312 -0.795 0 CA-C-N 115.215 -0.902 . . . . 24.01 113.191 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.408 ' HB3' ' ND2' ' A' ' 43' ' ' ASN . 93.7 mtt180 -99.31 143.81 29.15 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.839 -0.801 . . . . 73.5 108.839 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.0 m -86.41 119.72 26.98 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.934 -1.506 . . . . 54.53 106.934 174.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 47.8 pt -102.01 171.35 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 120.15 -0.62 . . . . 70.44 110.976 -177.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 57.6 tptt -127.87 125.98 40.71 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.138 -0.937 . . . . 64.34 108.731 -177.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.9 t -114.32 115.53 49.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 106.275 -1.75 . . . . 75.02 106.275 177.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.637 HD21 ' HB3' ' A' ' 115' ' ' ASN 0.272 2.5 tt -138.87 128.56 14.52 Favored Pre-proline 0 C--O 1.196 -1.72 0 N-CA-C 106.972 -1.492 . . . . 74.24 106.972 -170.511 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.66 127.71 15.07 Favored 'Trans proline' 0 C--N 1.355 0.884 0 CA-C-N 121.485 1.566 . . . . 62.2 109.771 175.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 -7.01 58.24 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.584 0.707 . . . . 75.23 110.744 -170.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.496 ' HD2' ' O ' ' A' ' 113' ' ' ARG . 3.4 tmm_? -90.02 -33.98 16.14 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.861 -0.792 . . . . 74.11 108.861 175.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.7 m -84.24 -47.73 10.5 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.624 -0.716 . . . . 62.02 112.351 -172.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.637 ' HB3' HD21 ' A' ' 110' ' ' LEU . 38.1 t-20 -121.12 110.08 15.78 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.845 0.831 . . . . 55.23 112.236 -174.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 66.9 mtm -127.43 108.92 21.07 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 107.854 -1.165 . . . . 33.4 107.854 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.11 163.88 25.07 Favored 'Trans proline' 0 C--O 1.242 0.704 0 C-N-CA 122.953 2.435 . . . . 54.21 113.539 -176.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 139.27 -141.79 12.16 Favored Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 115.47 -0.786 . . . . 73.12 111.513 177.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.7 mm -107.32 146.87 13.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 106.893 -1.521 . . . . 63.22 106.893 178.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.8 m -65.92 96.9 0.32 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.115 0.483 . . . . 73.43 110.263 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.4 m -121.14 76.78 1.25 Allowed 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 121.966 0.889 . . . . 52.11 108.969 177.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.2 m -150.49 83.32 1.36 Allowed 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 107.169 -1.419 . . . . 73.52 107.169 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -161.13 148.01 14.96 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.895 -0.593 . . . . 71.3 109.627 -178.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 . . . . . 0 C--N 1.295 -1.789 0 CA-C-N 115.658 -0.701 . . . . 73.21 109.642 -178.793 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.271 0 CA-C-O 121.149 0.499 . . . . 62.32 110.213 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.442 ' O ' HD12 ' B' ' 2' ' ' ILE 0.303 2.3 pp -82.06 111.65 18.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 122.255 1.026 . . . . 65.32 113.347 179.736 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.42 165.38 18.31 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 107.928 -1.138 . . . . 54.33 107.928 -177.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -59.73 94.11 0.09 OUTLIER 'Trans proline' 0 C--N 1.364 1.354 0 C-N-CA 122.103 1.869 . . . . 54.15 110.793 175.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' CYS . . . . . . . . . . . . . 45.8 t -162.56 161.68 26.94 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 107.097 -1.446 . . . . 51.02 107.097 -176.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 65.3 mtt 70.37 167.85 0.3 Allowed 'General case' 0 C--O 1.247 0.945 0 C-N-CA 124.301 1.04 . . . . 72.12 111.42 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -112.94 119.62 38.57 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.99 -0.55 . . . . 73.32 109.745 -178.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 34.6 p -81.21 105.79 12.69 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.745 0.783 . . . . 73.02 110.575 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 34.6 p -88.71 131.18 35.13 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 115.881 -0.599 . . . . 75.33 111.663 -177.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -97.51 -11.28 23.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.997 -0.547 . . . . 75.23 110.297 177.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.42 ' CB ' ' HA ' ' B' ' 115' ' ' ASN . 10.2 p -132.8 -176.12 4.0 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.87 -0.605 . . . . 74.12 111.126 -177.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -106.57 104.86 14.65 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.099 -1.074 . . . . 73.32 108.099 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' MET . . . . . . . . . . . . . 24.6 ttt -110.97 140.7 45.27 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.857 -0.61 . . . . 65.33 112.464 -173.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.457 ' OG1' ' HB3' ' A' ' 11' ' ' SER . 5.9 t -89.83 140.91 29.13 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.775 -1.194 . . . . 62.44 107.775 171.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.98 115.25 18.54 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.046 0.45 . . . . 60.3 110.161 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.05 -87.29 0.22 Allowed Glycine 0 N--CA 1.428 -1.891 0 N-CA-C 110.704 -0.959 . . . . 32.01 110.704 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.77 150.23 32.73 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.369 -0.604 . . . . 71.31 109.369 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.432 ' HB3' ' HE2' ' B' ' 31' ' ' LYS . 71.1 m-85 -85.76 124.92 32.81 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.559 -0.904 . . . . 63.32 108.559 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 9.5 t -146.25 142.61 28.53 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.397 0.617 . . . . 61.33 111.295 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . 0.505 ' HG3' ' HB3' ' A' ' 15' ' ' ALA . 1.1 mp0 -80.2 -26.89 38.98 Favored 'General case' 0 CA--C 1.566 1.561 0 CA-C-N 115.117 -0.947 . . . . 70.13 109.897 178.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.69 -125.24 1.45 Allowed Glycine 0 CA--C 1.502 -0.738 0 N-CA-C 109.717 -1.353 . . . . 75.11 109.717 178.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.531 ' HG2' ' CD2' ' A' ' 40' ' ' TYR . 76.3 Cg_exo -52.9 -37.98 78.33 Favored 'Trans proline' 0 CA--C 1.566 2.103 0 C-N-CA 122.742 2.295 . . . . 62.52 114.225 172.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -55.1 129.67 36.57 Favored 'Trans proline' 0 C--N 1.397 3.081 0 C-N-CA 121.499 1.466 . . . . 71.32 110.99 172.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -54.16 141.5 50.51 Favored Pre-proline 0 C--N 1.302 -1.487 0 CA-C-N 114.257 -1.338 . . . . 75.11 111.277 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.86 114.15 2.3 Favored 'Trans proline' 0 N--CA 1.443 -1.467 0 C-N-CA 122.098 1.866 . . . . 72.23 111.045 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 6.1 mp -61.83 165.83 4.97 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.821 -1.081 . . . . 74.54 109.882 176.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.42 ' O ' ' HG2' ' B' ' 31' ' ' LYS . 25.2 m -58.93 144.94 43.2 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.278 -0.638 . . . . 64.1 109.278 176.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' B' ' 31' ' ' LYS . . . -52.49 -44.18 65.48 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 123.569 0.543 . . . . 71.44 111.775 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -71.31 -30.98 66.88 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.828 0.677 . . . . 71.42 112.828 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.529 ' O ' HG12 ' B' ' 34' ' ' ILE . 0.5 OUTLIER -60.57 -34.58 74.4 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 109.653 -0.499 . . . . 74.2 109.653 170.013 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' B' ' 28' ' ' ALA . 25.2 mmmt -65.84 -46.89 76.83 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 115.58 -0.736 . . . . 70.41 109.956 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.518 ' N ' ' HE2' ' B' ' 32' ' ' LYS . 0.5 OUTLIER -53.7 -46.36 70.71 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.8 -0.36 . . . . 72.44 110.734 176.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.77 -45.76 70.54 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.314 0.857 . . . . 63.42 113.314 -174.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.529 HG12 ' O ' ' B' ' 30' ' ' GLU . 26.3 pt -69.58 -35.37 65.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 C-N-CA 120.751 -0.38 . . . . 73.42 111.828 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.9 -35.09 79.23 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.915 0.388 . . . . 75.31 110.781 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' B' ' 32' ' ' LYS . 55.1 mtmt -75.12 -11.08 60.01 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.393 0.516 . . . . 42.33 112.393 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -118.23 18.37 13.76 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.328 0.585 . . . . 71.44 110.918 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' B' ' 84' ' ' GLU . 82.8 p -98.9 156.5 16.86 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 115.897 -0.592 . . . . 53.55 111.444 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.428 HG22 ' O ' ' B' ' 83' ' ' ILE . 31.2 m -137.08 163.89 31.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.931 0.396 . . . . 70.25 110.562 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . 0.503 ' HD1' ' CE1' ' B' ' 82' ' ' TYR . 38.7 t80 -115.57 123.03 47.44 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 126.118 1.767 . . . . 72.41 107.936 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' B' ' 108' ' ' LYS . 85.8 t -112.45 108.02 24.46 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.939 0 N-CA-C 107.461 -1.311 . . . . 72.52 107.461 176.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . 0.467 ' O ' ' HB ' ' B' ' 107' ' ' ILE . . . -98.83 164.97 20.87 Favored Glycine 0 C--N 1.289 -2.037 0 C-N-CA 119.697 -1.24 . . . . 75.54 112.201 -177.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 64.0 t30 60.29 18.45 7.99 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.639 1.176 . . . . 75.4 112.875 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 8.0 p -61.49 132.19 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 109.162 -0.681 . . . . 65.24 109.162 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.38 143.95 56.83 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.61 -0.723 . . . . 41.13 109.879 -176.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' TYR . . . . . 0.481 ' CD1' ' HB2' ' B' ' 77' ' ' PRO . 71.7 t80 -55.07 -21.98 14.51 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 124.878 1.271 . . . . 74.43 111.999 -177.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.26 10.84 54.76 Favored Glycine 0 N--CA 1.422 -2.267 0 C-N-CA 120.562 -0.828 . . . . 54.13 113.761 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 12.8 m -75.0 122.32 23.33 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 118.492 1.146 . . . . 70.0 108.687 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 61.8 p -96.57 167.62 11.03 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 111.663 0.245 . . . . 72.3 111.663 -175.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.96 -51.15 70.92 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 112.853 0.686 . . . . 71.01 112.853 -175.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -57.53 -38.4 74.63 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 112.473 0.545 . . . . 75.4 112.473 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -69.49 -42.21 75.1 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.082 0.468 . . . . 74.35 109.973 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.41 -48.56 55.53 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.646 -0.706 . . . . 70.24 112.036 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 tm-20 -59.91 -49.74 76.51 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.198 0.599 . . . . 72.54 111.289 -177.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.41 -42.07 81.57 Favored 'General case' 0 C--O 1.27 2.154 0 CA-C-O 121.602 0.715 . . . . 70.41 111.355 177.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -64.59 -42.79 95.35 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 114.879 -1.055 . . . . 53.42 110.761 -175.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -81.68 -21.43 38.1 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 113.571 0.952 . . . . 71.5 113.571 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 75.4 m -64.74 -26.09 68.21 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 116.36 -0.382 . . . . 51.0 110.946 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' SER . . . . . . . . . . . . . 19.4 m -58.17 -26.85 63.24 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-O 121.038 0.447 . . . . 61.54 110.524 174.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' B' ' 94' ' ' ALA . 61.7 m -92.05 -0.61 57.46 Favored 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 112.885 0.698 . . . . 55.33 112.885 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.35 -154.83 26.21 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 119.054 -1.546 . . . . 65.31 114.681 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 44.1 m -105.27 117.97 35.37 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.033 0.444 . . . . 74.21 111.229 -176.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 67.3 mt -79.46 130.72 35.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.743 -0.662 . . . . 74.43 112.655 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . 0.556 ' OD1' ' HG3' ' B' ' 65' ' ' ARG . 23.6 t-20 -91.16 -41.91 10.75 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.186 0.995 . . . . 75.24 108.356 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.556 ' HG3' ' OD1' ' B' ' 64' ' ' ASN . 99.2 mtt180 -158.05 163.52 37.62 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.842 0.857 . . . . 64.45 109.125 -177.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.628 HG22 HG23 ' B' ' 83' ' ' ILE . 34.8 pt -142.43 137.67 28.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 107.099 -1.445 . . . . 74.21 107.099 170.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 33.4 m -126.74 131.18 51.4 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 107.069 -1.456 . . . . 73.21 107.069 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 67' ' ' THR . 17.1 mt -125.91 117.47 49.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 107.128 -1.434 . . . . 73.02 107.128 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . 0.308 0.9 OUTLIER -121.49 125.88 47.91 Favored 'General case' 0 C--N 1.283 -2.313 0 C-N-CA 120.21 -0.596 . . . . 70.21 112.241 177.296 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' CYS . . . . . . . . . . . . . 77.1 m -116.27 129.15 56.13 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 108.302 -0.999 . . . . 44.32 108.302 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . 0.715 ' O ' ' HA ' ' B' ' 77' ' ' PRO . 4.8 p-10 -110.63 126.78 54.84 Favored 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 119.48 -0.888 . . . . 60.11 111.021 -177.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -113.49 15.2 19.1 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.039 -1.467 . . . . 74.01 107.039 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.434 ' HA ' ' OD1' ' A' ' 64' ' ' ASN . 30.8 t80 -44.72 -44.3 9.09 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.511 2.324 . . . . 63.14 112.096 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 24.1 m -100.82 18.99 18.04 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 116.208 -0.451 . . . . 71.43 111.558 -175.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.1 -53.17 2.52 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.095 -1.05 . . . . 75.34 111.388 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -91.55 119.89 68.4 Favored Pre-proline 0 CA--C 1.497 -1.085 0 N-CA-C 109.367 -0.605 . . . . 52.42 109.367 177.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' PRO . . . . . 0.715 ' HA ' ' O ' ' B' ' 71' ' ' ASP . 75.3 Cg_endo -77.81 121.1 5.33 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 122.522 2.148 . . . . 64.13 113.682 -174.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' LYS . . . . . . . . . . . . . 25.8 mtmm -99.98 -167.16 1.42 Allowed 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.397 -0.964 . . . . 55.1 108.397 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.93 140.71 6.67 Favored Glycine 0 N--CA 1.408 -3.2 0 C-N-CA 120.252 -0.975 . . . . 73.13 112.663 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' TYR . . . . . 0.481 ' CE2' ' HG3' ' A' ' 23' ' ' PRO . 16.3 p90 -151.73 143.44 23.65 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.509 -0.923 . . . . 75.54 108.509 171.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.33 152.19 50.81 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-O 121.023 0.44 . . . . 75.34 110.022 -173.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' TYR . . . . . 0.653 ' CD1' ' HD3' ' B' ' 112' ' ' LYS . 96.4 m-85 -121.31 115.21 22.54 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.411 -0.588 . . . . 72.55 109.411 175.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.628 HG23 HG22 ' B' ' 66' ' ' ILE . 40.5 mm -100.12 122.8 52.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 106.904 -1.517 . . . . 72.33 106.904 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' GLU . . . . . 0.555 ' OE1' ' HD2' ' B' ' 65' ' ' ARG . 31.1 mt-10 -107.73 124.15 49.59 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.165 -0.68 . . . . 70.41 109.165 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -96.83 154.1 17.49 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 112.893 0.701 . . . . 71.42 112.893 -177.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.69 -40.47 72.89 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.147 -0.933 . . . . 71.42 110.251 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -105.76 147.94 28.04 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 116.005 -0.543 . . . . 74.21 111.471 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.488 ' O ' HG22 ' B' ' 91' ' ' VAL . 0.0 OUTLIER -74.26 -33.56 63.34 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.398 -1.334 . . . . 73.04 107.398 -179.762 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -63.03 -25.42 68.37 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 115.494 -0.775 . . . . 63.03 111.425 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 42.9 m -66.11 -36.89 84.37 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 110.243 -0.28 . . . . 73.02 110.243 177.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.488 HG22 ' O ' ' B' ' 88' ' ' ARG . 3.2 m -67.83 -38.67 80.54 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 N-CA-C 109.003 -0.74 . . . . 61.25 109.003 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -56.87 -38.08 72.25 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.169 0.509 . . . . 73.45 111.576 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.69 -31.58 63.5 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.061 0.457 . . . . 65.43 111.083 177.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . 0.454 ' HA ' ' SG ' ' B' ' 60' ' ' CYS . . . -76.32 -40.8 50.49 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.192 -0.458 . . . . 75.45 111.454 -178.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . 0.439 HG13 ' O ' ' B' ' 91' ' ' VAL . 22.0 m -56.58 -21.77 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 113.0 0.741 . . . . 62.41 113.0 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.75 -18.85 65.42 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.292 0.567 . . . . 63.02 110.189 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 48.1 mtm -95.06 13.54 24.85 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.699 -0.682 . . . . 64.24 110.872 177.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . 0.473 ' HA ' ' HB ' ' B' ' 109' ' ' VAL . 11.1 t70 -33.8 -55.09 0.47 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.471 1.508 . . . . 64.23 113.683 -178.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . 0.419 ' HG3' ' OD1' ' B' ' 98' ' ' ASP . 45.6 mt-10 -124.83 62.33 1.15 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.166 -1.013 . . . . 74.3 112.775 171.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 35.0 p -91.69 174.75 7.19 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.297 -0.865 . . . . 62.54 111.72 174.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.4 p -101.67 137.81 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 109.122 -0.695 . . . . 72.51 109.122 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' PHE . . . . . 0.419 ' HB2' HD12 ' B' ' 107' ' ' ILE . 85.5 t80 -142.72 118.61 10.58 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.532 -0.914 . . . . 75.0 108.532 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 45.3 mtp180 55.68 33.22 20.87 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.509 1.123 . . . . 75.13 113.539 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.53 -0.87 65.88 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.038 -0.983 . . . . 71.31 114.191 174.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -130.81 160.62 33.84 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.176 -0.676 . . . . 72.42 109.176 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 85.7 m -92.52 126.98 37.84 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.188 -0.671 . . . . 63.32 109.188 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' B' ' 42' ' ' GLY . 0.2 OUTLIER -102.8 172.3 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 118.198 -1.401 . . . . 63.2 110.334 177.485 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' B' ' 41' ' ' VAL . 56.8 tptt -119.21 124.72 47.46 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.641 -1.244 . . . . 55.53 107.641 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' B' ' 98' ' ' ASP . 47.1 t -113.91 113.97 45.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 107.065 -1.458 . . . . 62.21 107.065 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . 0.273 3.0 tt -139.66 128.53 13.61 Favored Pre-proline 0 C--O 1.187 -2.195 0 N-CA-C 106.454 -1.684 . . . . 70.2 106.454 -170.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.35 129.54 28.66 Favored 'Trans proline' 0 CA--C 1.551 1.37 0 CA-C-N 121.499 1.571 . . . . 74.02 112.056 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.653 ' HD3' ' CD1' ' B' ' 82' ' ' TYR . 36.0 ttpt -88.29 131.56 34.74 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 116.199 -0.455 . . . . 75.21 111.039 -174.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 45.28 -175.32 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 116.94 2.2 . . . . 74.35 116.94 173.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 88.5 m -162.71 95.07 0.88 Allowed 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 125.824 1.649 . . . . 73.14 106.84 173.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 115' ' ' ASN . . . . . 0.42 ' HA ' ' CB ' ' B' ' 11' ' ' SER . 16.4 t30 -78.19 99.63 6.3 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.776 0.798 . . . . 64.52 111.785 -177.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 116' ' ' MET . . . . . . . . . . . . . 50.1 ttm -156.07 95.22 2.38 Favored Pre-proline 0 C--N 1.312 -1.043 0 CA-C-N 114.723 -1.126 . . . . 51.13 111.034 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 117' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -94.89 -1.34 2.6 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 122.829 2.353 . . . . 55.52 110.712 172.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.34 -72.27 2.78 Favored Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 111.343 -0.703 . . . . 62.21 111.343 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 55.6 mt 59.68 89.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.247 0.929 0 C-N-CA 124.25 1.02 . . . . 71.0 110.444 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 16.4 m -105.23 111.4 24.13 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 115.4 -0.818 . . . . 60.11 109.438 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 25.5 p -132.76 85.09 2.19 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 121.319 0.58 . . . . 70.32 109.893 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 23.7 p -129.51 6.31 5.22 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.217 -0.901 . . . . 74.23 110.52 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 70.39 -47.0 0.63 Allowed 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 125.237 1.415 . . . . 75.25 111.629 -175.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 . . . . . 0 N--CA 1.416 -2.17 0 N-CA-C 106.692 -1.596 . . . . 71.22 106.692 174.294 . . . . . . . . 0 0 . 1 stop_ save_